NAME.FIB	category	SIZE_FIB	NES_FIB	NOM.p.val	FDR.q.val	NAME.ESC	SIZE_ESC	NES_ESC	NOM.p.val.1	FDR.q.val.1	fib_add_esc	fib_minus_esc
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	c2.CGP_ chemical and genetic perturbations	181	2.6708176	0	0	FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	182	1.2585335	0.04969574	0.49856934	3.9293511	1.4122841
GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP	C7_ immunologic signatures	180	2.4632242	0	0	GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP	182	0.87061095	0.80061036	1	3.33383515	1.59261325
GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP	C7_ immunologic signatures	181	2.452133	0	0	GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP	183	0.7284301	0.9595551	1	3.1805631	1.7237029
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	c2.CGP_ chemical and genetic perturbations	115	2.386002	0	0	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	115	0.8095835	0.8335057	1	3.1955855	1.5764185
GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP	C7_ immunologic signatures	173	2.3661048	0	0	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP	172	-1.1617005	0	0.42770147	1.2044043	3.5278053
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	c2.CGP_ chemical and genetic perturbations	50	2.364527	0	0	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	50	1.3563555	0.05986696	0.38075727	3.7208825	1.0081715
KONG_E2F3_TARGETS	c2.CGP_ chemical and genetic perturbations	89	2.3574996	0	0	KONG_E2F3_TARGETS	89	-1.2397095	0.02	0.335616	1.1177901	3.5972091
LEE_EARLY_T_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	86	2.3532774	0	0	LEE_EARLY_T_LYMPHOCYTE_UP	87	1.0422708	0.41473684	0.85481846	3.3955482	1.3110066
GNF2_CENPF	c4.CGN_ cancer gene neighborhoods	59	2.3387566	0	0	GNF2_CENPF	59	1.2059346	0.17971334	0.5820841	3.5446912	1.132822
FISCHER_G2_M_CELL_CYCLE	c2.CGP_ chemical and genetic perturbations	212	2.337517	0	0	FISCHER_G2_M_CELL_CYCLE	212	1.4594053	0	0.28321648	3.7969223	0.8781117
GNF2_CDC20	c4.CGN_ cancer gene neighborhoods	54	2.3323674	0	0	GNF2_CDC20	54	1.3910121	0.032511212	0.34734055	3.7233795	0.9413553
GNF2_CDC2	c4.CGN_ cancer gene neighborhoods	60	2.3159914	0	0	GNF2_CDC2	60	1.1901394	0.20238096	0.6055016	3.5061308	1.125852
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	c2.CGP_ chemical and genetic perturbations	77	2.3154259	0	0	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	77	-1.6588099	0	0.06880856	0.656616	3.9742358
GNF2_CCNA2	c4.CGN_ cancer gene neighborhoods	66	2.3076653	0	0	GNF2_CCNA2	66	1.2380098	0.12459372	0.5287975	3.5456751	1.0696555
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	c2.CGP_ chemical and genetic perturbations	130	2.305436	0	0	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	130	0.83348775	0.8246888	1	3.13892375	1.47194825
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	c2.CGP_ chemical and genetic perturbations	296	2.3050807	0	0	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	300	-1.2107177	0	0.36788628	1.094363	3.5157984
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	c2.CGP_ chemical and genetic perturbations	47	2.3044913	0	0	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	47	0.8556135	0.718294	1	3.1601048	1.4488778
ZHANG_TLX_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	87	2.2975068	0	0	ZHANG_TLX_TARGETS_DN	87	-1.9844267	0	0.009506441	0.3130801	4.2819335
GNF2_CCNB2	c4.CGN_ cancer gene neighborhoods	55	2.2951384	0	0	GNF2_CCNB2	55	1.3273326	0.07236842	0.40464127	3.622471	0.9678058
GNF2_PCNA	c4.CGN_ cancer gene neighborhoods	65	2.2862422	0	0	GNF2_PCNA	65	0.92323625	0.6202805	1	3.20947845	1.36300595
GNF2_HMMR	c4.CGN_ cancer gene neighborhoods	47	2.274189	0	0	GNF2_HMMR	47	1.3347219	0.08022599	0.3979096	3.6089109	0.9394671
GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP	C7_ immunologic signatures	140	2.2690163	0	0	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP	143	1.1291078	0.25643668	0.7076546	3.3981241	1.1399085
ZHAN_MULTIPLE_MYELOMA_PR_UP	c2.CGP_ chemical and genetic perturbations	40	2.2624507	0	0	ZHAN_MULTIPLE_MYELOMA_PR_UP	40	1.3816003	0.044879172	0.35616276	3.644051	0.8808504
ISHIDA_E2F_TARGETS	c2.CGP_ chemical and genetic perturbations	48	2.2614703	0	0	ISHIDA_E2F_TARGETS	48	-1.2524072	0.11	0.32104066	1.0090631	3.5138775
GNF2_CENPE	c4.CGN_ cancer gene neighborhoods	39	2.2435346	0	0	GNF2_CENPE	39	1.5031661	0.012716763	0.2502827	3.7467007	0.7403685
GO_MITOTIC_SISTER_CHROMATID_SEGREGATION	c5.BP_ GO biological process	82	2.237635	0	0	GO_MITOTIC_SISTER_CHROMATID_SEGREGATION	82	1.3537788	0.045310855	0.38241583	3.5914138	0.8838562
GSE14415_NATURAL_TREG_VS_TCONV_DN	C7_ immunologic signatures	164	2.234346	0	0	GSE14415_NATURAL_TREG_VS_TCONV_DN	165	0.8200011	0.8655207	1	3.0543471	1.4143449
REICHERT_MITOSIS_LIN9_TARGETS	c2.CGP_ chemical and genetic perturbations	27	2.2337132	0	0	REICHERT_MITOSIS_LIN9_TARGETS	27	1.621994	0.00124533	0.13936126	3.8557072	0.6117192
GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP	C7_ immunologic signatures	173	2.232174	0	0	GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP	173	0.71347755	0.9646107	1	2.94565155	1.51869645
ODONNELL_TFRC_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	119	2.231764	0	0	ODONNELL_TFRC_TARGETS_DN	120	1.0590056	0.3846154	0.82652175	3.2907696	1.1727584
CHANG_CYCLING_GENES	c2.CGP_ chemical and genetic perturbations	131	2.223086	0	0	CHANG_CYCLING_GENES	131	0.8967387	0.7236025	1	3.1198247	1.3263473
GO_NUCLEAR_CHROMOSOME_SEGREGATION	c5.BP_ GO biological process	194	2.2226744	0	0	GO_NUCLEAR_CHROMOSOME_SEGREGATION	200	1.3234265	0.009063444	0.41042	3.5461009	0.8992479
NABA_ECM_GLYCOPROTEINS	c2.CP_ Canonical pathways	168	2.2185538	0	0	NABA_ECM_GLYCOPROTEINS	179	1.6510966	0	0.11439832	3.8696504	0.5674572
GNF2_ESPL1	c4.CGN_ cancer gene neighborhoods	35	2.2072906	0	0	GNF2_ESPL1	35	0.9170528	0.62893814	1	3.1243434	1.2902378
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	c2.CGP_ chemical and genetic perturbations	135	2.2020206	0	0	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	135	0.8879075	0.73346895	1	3.0899281	1.3141131
KANG_DOXORUBICIN_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	49	2.2011592	0	0	KANG_DOXORUBICIN_RESISTANCE_UP	49	1.0079904	0.47362515	0.91055024	3.2091496	1.1931688
GO_SISTER_CHROMATID_SEGREGATION	c5.BP_ GO biological process	157	2.1963773	0	0	GO_SISTER_CHROMATID_SEGREGATION	158	1.1922013	0.11734694	0.6027096	3.3885786	1.004176
GO_CHROMOSOME_SEGREGATION	c5.BP_ GO biological process	234	2.195088	0	0	GO_CHROMOSOME_SEGREGATION	240	1.2603891	0.02414487	0.49598998	3.4554771	0.9346989
WHITFIELD_CELL_CYCLE_LITERATURE	c2.CGP_ chemical and genetic perturbations	44	2.1936727	0	0	WHITFIELD_CELL_CYCLE_LITERATURE	44	-1.5088285	0.0078125	0.13710012	0.6848442	3.7025012
GNF2_RRM2	c4.CGN_ cancer gene neighborhoods	40	2.1896958	0	0	GNF2_RRM2	40	1.4722608	0.027842227	0.27604064	3.6619566	0.717435
GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP	C7_ immunologic signatures	183	2.1818633	0	2.29E-05	GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP	184	-0.99221575	0.5	0.69853806	1.18964755	3.17407905
GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN	C7_ immunologic signatures	174	2.1766632	0	2.24E-05	GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN	174	0.9236433	0.68421054	1	3.1003065	1.2530199
GNF2_MKI67	c4.CGN_ cancer gene neighborhoods	27	2.1651971	0	2.19E-05	GNF2_MKI67	27	1.5389843	0.015834348	0.21070127	3.7041814	0.6262128
TANG_SENESCENCE_TP53_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	52	2.1646588	0	2.14E-05	TANG_SENESCENCE_TP53_TARGETS_DN	52	1.1705399	0.21331829	0.63740253	3.3351987	0.9941189
GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP	C7_ immunologic signatures	183	2.1589003	0	2.09E-05	GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP	186	0.8449187	0.8363821	1	3.003819	1.3139816
NABA_CORE_MATRISOME	c2.CP_ Canonical pathways	238	2.1487718	0	2.04E-05	NABA_CORE_MATRISOME	249	1.6124402	0	0.14787738	3.761212	0.5363316
GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP	C7_ immunologic signatures	182	2.1351216	0	2.00E-05	GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP	182	0.9537972	0.61538464	0.9777275	3.0889188	1.1813244
GNF2_RRM1	c4.CGN_ cancer gene neighborhoods	83	2.1337764	0	1.96E-05	GNF2_RRM1	83	0.91117615	0.65531915	1	3.04495255	1.22260025
GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP	C7_ immunologic signatures	162	2.1280377	0	1.92E-05	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP	166	1.0430055	0.39473686	0.8534308	3.1710432	1.0850322
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	c2.CGP_ chemical and genetic perturbations	62	2.1275573	0	1.88E-05	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	63	1.9101015	0	0.008701779	4.0376588	0.2174558
BURTON_ADIPOGENESIS_3	c2.CGP_ chemical and genetic perturbations	99	2.12385	0	1.84E-05	BURTON_ADIPOGENESIS_3	99	-1.1822357	0.0882353	0.40256038	0.9416143	3.3060857
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	149	2.1219463	0	1.81E-05	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	152	0.8038569	0.86809814	1	2.9258032	1.3180894
PYEON_HPV_POSITIVE_TUMORS_UP	c2.CGP_ chemical and genetic perturbations	79	2.1211874	0	1.77E-05	PYEON_HPV_POSITIVE_TUMORS_UP	78	-1.3597802	0.015873017	0.23471324	0.7614072	3.4809676
GO_EXTRACELLULAR_MATRIX	c5.CC_ GO cellular component	358	2.1200643	0	1.74E-05	GO_EXTRACELLULAR_MATRIX	384	1.4024907	0	0.3365544	3.522555	0.7175736
GNF2_BUB1	c4.CGN_ cancer gene neighborhoods	26	2.1190999	0	1.71E-05	GNF2_BUB1	26	0.80534756	0.7708082	1	2.92444746	1.31375234
GO_CHROMOSOME_CENTROMERIC_REGION	c5.CC_ GO cellular component	155	2.1185548	0	1.68E-05	GO_CHROMOSOME_CENTROMERIC_REGION	156	0.96469074	0.5875764	0.9653944	3.08324554	1.15386406
GO_CONDENSED_CHROMOSOME_CENTROMERIC_REGION	c5.CC_ GO cellular component	85	2.117521	0	1.65E-05	GO_CONDENSED_CHROMOSOME_CENTROMERIC_REGION	86	1.1326791	0.24546425	0.7018288	3.2502001	0.9848419
AMUNDSON_GAMMA_RADIATION_RESPONSE	c2.CGP_ chemical and genetic perturbations	39	2.1167536	0	1.62E-05	AMUNDSON_GAMMA_RADIATION_RESPONSE	39	1.32544	0.09942196	0.4067504	3.4421936	0.7913136
VERNELL_RETINOBLASTOMA_PATHWAY_UP	c2.CGP_ chemical and genetic perturbations	65	2.1126585	0	1.59E-05	VERNELL_RETINOBLASTOMA_PATHWAY_UP	66	-2.3883898	0	0	-0.2757313	4.5010483
GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	155	2.1073997	0	1.57E-05	GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	159	1.2710881	0.052200615	0.4839425	3.3784878	0.8363116
CROONQUIST_IL6_DEPRIVATION_DN	c2.CGP_ chemical and genetic perturbations	95	2.1065726	0	1.54E-05	CROONQUIST_IL6_DEPRIVATION_DN	95	-1.24986	0.06521739	0.32351708	0.8567126	3.3564326
ZHANG_TLX_TARGETS_36HR_DN	c2.CGP_ chemical and genetic perturbations	178	2.096143	0	3.05E-05	ZHANG_TLX_TARGETS_36HR_DN	178	-1.538509	0	0.12126102	0.557634	3.634652
GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	165	2.0934744	0	3.00E-05	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP	168	0.96032095	0.5914634	0.97129977	3.05379535	1.13315345
GO_EXTRACELLULAR_MATRIX_COMPONENT	c5.CC_ GO cellular component	113	2.0882633	0	2.95E-05	GO_EXTRACELLULAR_MATRIX_COMPONENT	115	1.2716368	0.06741573	0.48349825	3.3599001	0.8166265
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	c2.CGP_ chemical and genetic perturbations	82	2.0841782	0	4.35E-05	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	82	1.1991937	0.16666667	0.5933817	3.2833719	0.8849845
WHITFIELD_CELL_CYCLE_G2	c2.CGP_ chemical and genetic perturbations	160	2.0795038	0	4.29E-05	WHITFIELD_CELL_CYCLE_G2	161	1.4324642	0.00101833	0.3121264	3.511968	0.6470396
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	80	2.0732117	0	7.03E-05	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	81	-1.0919954	0.24	0.5302583	0.9812163	3.1652071
GO_MITOTIC_NUCLEAR_DIVISION	c5.BP_ GO biological process	326	2.070263	0	8.31E-05	GO_MITOTIC_NUCLEAR_DIVISION	329	1.038702	0.369	0.8606342	3.108965	1.031561
GO_CONDENSED_CHROMOSOME	c5.CC_ GO cellular component	166	2.0697007	0	9.56E-05	GO_CONDENSED_CHROMOSOME	171	1.2885662	0.034412954	0.46058774	3.3582669	0.7811345
GNF2_SMC4L1	c4.CGN_ cancer gene neighborhoods	81	2.0669763	0	9.42E-05	GNF2_SMC4L1	81	-1.4073733	0	0.2017133	0.659603	3.4743496
GILDEA_METASTASIS	c2.CGP_ chemical and genetic perturbations	23	2.0659518	0	9.29E-05	GILDEA_METASTASIS	24	-0.92732775	0.5888889	0.7872784	1.13862405	2.99327955
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	c2.CGP_ chemical and genetic perturbations	61	2.0612142	0	0.000104608	ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	61	-1.1809231	0.12345679	0.40314865	0.8802911	3.2421373
GO_PROTEINACEOUS_EXTRACELLULAR_MATRIX	c5.CC_ GO cellular component	296	2.0604706	0	0.000103175	GO_PROTEINACEOUS_EXTRACELLULAR_MATRIX	321	1.3333772	0	0.399881	3.3938478	0.7270934
GO_KINETOCHORE	c5.CC_ GO cellular component	105	2.0579267	0	0.000101781	GO_KINETOCHORE	106	1.0428143	0.4018595	0.8538036	3.100741	1.0151124
RICKMAN_HEAD_AND_NECK_CANCER_F	c2.CGP_ chemical and genetic perturbations	41	2.056415	0	0.000100424	RICKMAN_HEAD_AND_NECK_CANCER_F	49	1.611063	0.002290951	0.1478612	3.667478	0.445352
RB_P107_DN.V1_UP	C6_ oncogenic signatures	129	2.0510054	0	0.000136178	RB_P107_DN.V1_UP	131	-1.590534	0	0.09447536	0.4604714	3.6415394
GNF2_TTK	c4.CGN_ cancer gene neighborhoods	38	2.0496604	0	0.000146575	GNF2_TTK	38	1.297108	0.11280846	0.44712454	3.3467684	0.7525524
MORI_IMMATURE_B_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	85	2.049573	0	0.000144696	MORI_IMMATURE_B_LYMPHOCYTE_DN	86	-1.4850863	0.016949153	0.15162657	0.5644867	3.5346593
GO_SPINDLE_POLE	c5.CC_ GO cellular component	110	2.0464482	0	0.000178538	GO_SPINDLE_POLE	110	1.3081301	0.042094454	0.42848828	3.3545783	0.7383181
GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP	C7_ immunologic signatures	152	2.0448916	0	0.000176306	GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP	153	1.4025315	0.005138746	0.33678415	3.4474231	0.6423601
GNF2_SMC2L1	c4.CGN_ cancer gene neighborhoods	32	2.0448856	0	0.00017413	GNF2_SMC2L1	32	1.1973261	0.19952211	0.5972169	3.2422117	0.8475595
GO_ORGANELLE_FISSION	c5.BP_ GO biological process	430	2.0438328	0	0.000172006	GO_ORGANELLE_FISSION	441	1.2103025	0.022	0.57612526	3.2541353	0.8335303
BURTON_ADIPOGENESIS_PEAK_AT_24HR	c2.CGP_ chemical and genetic perturbations	42	2.0376892	0	0.000215276	BURTON_ADIPOGENESIS_PEAK_AT_24HR	40	1.5978113	0.006944445	0.16138306	3.6355005	0.4398779
GNF2_H2AFX	c4.CGN_ cancer gene neighborhoods	30	2.0375395	0	0.000212713	GNF2_H2AFX	30	1.2824867	0.12860577	0.4689355	3.3200262	0.7550528
GNF2_BUB1B	c4.CGN_ cancer gene neighborhoods	49	2.0338924	0	0.00021021	GNF2_BUB1B	49	0.99781686	0.5050392	0.9259743	3.03170926	1.03607554
GREENBAUM_E2A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	30	2.032213	0	0.000218703	GREENBAUM_E2A_TARGETS_UP	31	1.1655763	0.24792407	0.6460736	3.1977893	0.8666367
GO_CHROMOSOME_CONDENSATION	c5.BP_ GO biological process	24	2.0305884	0	0.000226945	GO_CHROMOSOME_CONDENSATION	25	1.2683764	0.15782984	0.4866515	3.2989648	0.762212
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN	C7_ immunologic signatures	139	2.029737	0	0.000224366	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN	144	1.357391	0.01734694	0.37924546	3.387128	0.672346
GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP	C7_ immunologic signatures	183	2.0257876	0	0.000232406	GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP	187	0.96823394	0.5925177	0.96350753	2.99402154	1.05755366
GO_CENTROSOME_CYCLE	c5.BP_ GO biological process	43	2.0241678	0	0.000240301	GO_CENTROSOME_CYCLE	43	0.92583156	0.5986079	1	2.94999936	1.09833624
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	c2.CGP_ chemical and genetic perturbations	179	2.0232573	0	0.000237661	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	184	1.2882476	0.032128513	0.4611906	3.3115049	0.7350097
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN	C7_ immunologic signatures	157	2.0226738	0	0.000235077	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN	154	1.3944838	0.006116208	0.3454734	3.4171576	0.62819
GO_STRAND_DISPLACEMENT	c5.BP_ GO biological process	24	2.0189805	0	0.000242668	GO_STRAND_DISPLACEMENT	24	-1.5087999	0.02347418	0.13685994	0.5101806	3.5277804
WHITEFORD_PEDIATRIC_CANCER_MARKERS	c2.CGP_ chemical and genetic perturbations	106	2.0188637	0	0.000250159	WHITEFORD_PEDIATRIC_CANCER_MARKERS	107	0.8419065	0.7875	1	2.8607702	1.1769572
GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN	C7_ immunologic signatures	182	2.0175488	0	0.000257382	GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN	186	0.87489474	0.7777778	1	2.89244354	1.14265406
GO_SISTER_CHROMATID_COHESION	c5.BP_ GO biological process	98	2.0157437	0	0.000274251	GO_SISTER_CHROMATID_COHESION	99	0.93747514	0.6165099	0.9933122	2.95321884	1.07826856
KOBAYASHI_EGFR_SIGNALING_24HR_DN	c2.CGP_ chemical and genetic perturbations	236	2.014553	0	0.000281198	KOBAYASHI_EGFR_SIGNALING_24HR_DN	236	-1.5621548	0	0.10832647	0.4523982	3.5767078
CROONQUIST_NRAS_SIGNALING_DN	c2.CGP_ chemical and genetic perturbations	69	2.013082	0	0.000278329	CROONQUIST_NRAS_SIGNALING_DN	69	0.97398645	0.5650273	0.95691764	2.98706845	1.03909555
LINDVALL_IMMORTALIZED_BY_TERT_DN	c2.CGP_ chemical and genetic perturbations	73	2.0117056	0	0.000285001	LINDVALL_IMMORTALIZED_BY_TERT_DN	74	1.1954721	0.18063112	0.59698457	3.2071777	0.8162335
BROWNE_HCMV_INFECTION_2HR_UP	c2.CGP_ chemical and genetic perturbations	33	2.0113184	0	0.000291537	BROWNE_HCMV_INFECTION_2HR_UP	33	1.224083	0.20070012	0.55063695	3.2354014	0.7872354
GNF2_MCM4	c4.CGN_ cancer gene neighborhoods	52	2.009415	0	0.00028865	GNF2_MCM4	52	0.8826515	0.670045	1	2.8920665	1.1267635
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN	C7_ immunologic signatures	156	2.0031621	0	0.000294957	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN	152	1.2178959	0.10390946	0.5600342	3.221058	0.7852662
GO_POSITIVE_REGULATION_OF_CYTOKINESIS	c5.BP_ GO biological process	27	2.002294	0	0.00030126	GO_POSITIVE_REGULATION_OF_CYTOKINESIS	29	1.0204015	0.45768774	0.8914635	3.0226955	0.9818925
GO_CHROMOSOME_LOCALIZATION	c5.BP_ GO biological process	54	2.001214	0	0.0003074	GO_CHROMOSOME_LOCALIZATION	55	1.1632946	0.23898679	0.64795744	3.1645086	0.8379194
GO_REGULATION_OF_MICROTUBULE_BASED_PROCESS	c5.BP_ GO biological process	214	1.998376	0	0.000340323	GO_REGULATION_OF_MICROTUBULE_BASED_PROCESS	217	1.0496813	0.3700708	0.84066105	3.0480573	0.9486947
GSE45365_WT_VS_IFNAR_KO_BCELL_DN	C7_ immunologic signatures	138	1.9921737	0	0.000354851	GSE45365_WT_VS_IFNAR_KO_BCELL_DN	144	1.2678846	0.06026558	0.48690256	3.2600583	0.7242891
MODULE_54	c4.CM_ cancer modules	230	1.9915825	0	0.000351534	MODULE_54	234	0.810484	0.89849246	1	2.8020665	1.1810985
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	c2.CGP_ chemical and genetic perturbations	64	1.9905313	0	0.000357023	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	64	0.78012365	0.8490153	1	2.77065495	1.21040765
GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	173	1.9892881	0	0.000362319	GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	178	-1.0497085	0.2631579	0.60639066	0.9395796	3.0389966
GO_MITOTIC_SPINDLE_ORGANIZATION	c5.BP_ GO biological process	62	1.9854223	0	0.000410455	GO_MITOTIC_SPINDLE_ORGANIZATION	63	1.2558057	0.12087912	0.5016508	3.241228	0.7296166
GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP	C7_ immunologic signatures	179	1.9829623	0	0.00045751	GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP	181	0.94487655	0.6313646	0.9875846	2.92783885	1.03808575
FARMER_BREAST_CANCER_CLUSTER_2	c2.CGP_ chemical and genetic perturbations	30	1.9775095	0.001510574	0.000503774	FARMER_BREAST_CANCER_CLUSTER_2	31	0.8638808	0.68082523	1	2.8413903	1.1136287
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	c2.CGP_ chemical and genetic perturbations	264	1.976974	0	0.000507659	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	261	0.9141367	0.7306533	1	2.8911107	1.0628373
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN	C7_ immunologic signatures	159	1.9769621	0	0.000503206	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN	159	1.3225392	0.017223911	0.41171667	3.2995013	0.6544229
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	c2.CGP_ chemical and genetic perturbations	141	1.9735491	0	0.000515265	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	144	0.79774696	0.89081633	1	2.77129606	1.17580214
RUIZ_TNC_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	133	1.9728254	0	0.000510823	RUIZ_TNC_TARGETS_DN	132	-1.5318935	0	0.12444296	0.4409319	3.5047189
GO_POSITIVE_REGULATION_OF_CELL_DIVISION	c5.BP_ GO biological process	105	1.972191	0	0.000506457	GO_POSITIVE_REGULATION_OF_CELL_DIVISION	113	1.205241	0.14895834	0.58253825	3.177432	0.76695
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	H_ hallmark gene sets	190	1.9685831	0	0.000541943	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	191	0.8067356	0.89658636	1	2.7753187	1.1618475
GO_CENTROMERE_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	31	1.9638509	0	0.000592694	GO_CENTROMERE_COMPLEX_ASSEMBLY	31	0.9949048	0.5041225	0.9301575	2.9587557	0.9689461
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN	C7_ immunologic signatures	165	1.9612005	0	0.000642528	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN	162	1.2363878	0.076767676	0.5310748	3.1975883	0.7248127
GO_REGULATION_OF_CHROMOSOME_SEGREGATION	c5.BP_ GO biological process	75	1.9594907	0	0.000652781	GO_REGULATION_OF_CHROMOSOME_SEGREGATION	76	0.8331871	0.783029	1	2.7926778	1.1263036
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	c2.CGP_ chemical and genetic perturbations	50	1.9572632	0	0.000678113	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	49	1.0339873	0.44243792	0.8696125	2.9912505	0.9232759
GNF2_CKS2	c4.CGN_ cancer gene neighborhoods	49	1.9526311	0	0.000764399	GNF2_CKS2	49	0.80212504	0.8067416	1	2.75475614	1.15050606
GO_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR	c5.BP_ GO biological process	65	1.9520874	0	0.000780933	GO_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR	65	-1.2991799	0.032608695	0.28384268	0.6529075	3.2512673
GO_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY	c5.BP_ GO biological process	41	1.9491392	0	0.000827277	GO_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY	44	1.1173347	0.30011326	0.7281827	3.0664739	0.8318045
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN	C7_ immunologic signatures	169	1.9489311	0	0.000820712	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN	174	1.2087803	0.08713272	0.57948995	3.1577114	0.7401508
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	c2.CGP_ chemical and genetic perturbations	70	1.9486253	0	0.000821709	QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	71	2.0612538	0	0	4.0098791	-0.1126285
KATSANOU_ELAVL1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	149	1.9458311	0	0.00088876	KATSANOU_ELAVL1_TARGETS_UP	152	1.4892919	0.00304878	0.2598611	3.435123	0.4565392
GO_CONDENSED_NUCLEAR_CHROMOSOME	c5.CC_ GO cellular component	70	1.9419551	0	0.000962108	GO_CONDENSED_NUCLEAR_CHROMOSOME	74	1.7701201	0	0.057444964	3.7120752	0.171835
REACTOME_MITOTIC_PROMETAPHASE	c2.CP_REACTOME_ Reactome gene sets	78	1.9416599	0	0.000976349	REACTOME_MITOTIC_PROMETAPHASE	79	0.7392514	0.90677965	1	2.6809113	1.2024085
EGUCHI_CELL_CYCLE_RB1_TARGETS	c2.CGP_ chemical and genetic perturbations	23	1.9411042	0	0.000983271	EGUCHI_CELL_CYCLE_RB1_TARGETS	23	-1.3128934	0.12631579	0.27206177	0.6282108	3.2539976
HALLMARK_G2M_CHECKPOINT	H_ hallmark gene sets	189	1.9404415	0	0.000982929	HALLMARK_G2M_CHECKPOINT	189	-1.4078233	0	0.20174807	0.5326182	3.3482648
GO_REGULATION_OF_CYTOKINESIS	c5.BP_ GO biological process	53	1.9402964	0	0.000975539	GO_REGULATION_OF_CYTOKINESIS	55	0.7357395	0.8998875	1	2.6760359	1.2045569
ZHANG_TLX_TARGETS_60HR_DN	c2.CGP_ chemical and genetic perturbations	255	1.9382843	0	0.001045216	ZHANG_TLX_TARGETS_60HR_DN	256	-2.378975	0	0	-0.4406907	4.3172593
GAVIN_FOXP3_TARGETS_CLUSTER_P6	c2.CGP_ chemical and genetic perturbations	85	1.9382659	0	0.001037474	GAVIN_FOXP3_TARGETS_CLUSTER_P6	84	1.2797058	0.09022556	0.47266454	3.2179717	0.6585601
VANTVEER_BREAST_CANCER_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	103	1.9381685	0	0.001036715	VANTVEER_BREAST_CANCER_METASTASIS_DN	104	-1.0504857	0.27450982	0.6052261	0.8876828	2.9886542
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	c2.CGP_ chemical and genetic perturbations	43	1.9375502	0	0.001042816	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	43	0.99506885	0.47957993	0.9303716	2.93261905	0.94248135
GO_MEIOTIC_CELL_CYCLE_PROCESS	c5.BP_ GO biological process	122	1.9364018	0	0.001069332	GO_MEIOTIC_CELL_CYCLE_PROCESS	131	1.5831655	0	0.17482802	3.5195673	0.3532363
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN	C7_ immunologic signatures	157	1.9363351	0	0.001068412	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN	161	1.108468	0.2622449	0.74068105	3.0448031	0.8278671
REN_BOUND_BY_E2F	c2.CGP_ chemical and genetic perturbations	56	1.9362632	0	0.00106078	REN_BOUND_BY_E2F	56	-1.360294	0.04901961	0.2346043	0.5759692	3.2965572
SCIBETTA_KDM5B_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	72	1.9359735	0	0.001059923	SCIBETTA_KDM5B_TARGETS_DN	71	1.337543	0.046436284	0.39793202	3.2735165	0.5984305
REACTOME_MUSCLE_CONTRACTION	c2.CP_REACTOME_ Reactome gene sets	41	1.9319224	0	0.001178177	REACTOME_MUSCLE_CONTRACTION	45	1.0172038	0.4751445	0.8937496	2.9491262	0.9147186
GO_PROSTATE_GLAND_MORPHOGENESIS	c5.BP_ GO biological process	21	1.9304929	0	0.001235511	GO_PROSTATE_GLAND_MORPHOGENESIS	23	-1.1957268	0.22325581	0.38703233	0.7347661	3.1262197
GO_SPINDLE	c5.CC_ GO cellular component	262	1.9304898	0	0.001226931	GO_SPINDLE	265	1.1371852	0.15631263	0.6949297	3.067675	0.7933046
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION	c2.CGP_ chemical and genetic perturbations	48	1.9301604	0	0.001218469	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION	48	1.1476566	0.27088037	0.67284435	3.077817	0.7825038
HALLMARK_E2F_TARGETS	H_ hallmark gene sets	192	1.9301287	0	0.001210124	HALLMARK_E2F_TARGETS	192	-2.032595	0	0.005966018	-0.1024663	3.9627237
AFFAR_YY1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	182	1.9299412	0	0.001214692	AFFAR_YY1_TARGETS_UP	192	1.57199	0	0.18686509	3.5019312	0.3579512
GO_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	c5.BP_ GO biological process	25	1.929941	0	0.001206485	GO_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	25	-1.7510581	0.014354067	0.043505408	0.1788829	3.6809991
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	c2.CGP_ chemical and genetic perturbations	148	1.9288709	0	0.001217267	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	151	0.87620044	0.75406504	1	2.80507134	1.05267046
GO_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	51	1.9278224	0	0.00122162	GO_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT	54	-1.0071069	0.42857143	0.67525	0.9207155	2.9349293
PID_FANCONI_PATHWAY	c2.CP_ Canonical pathways	43	1.927293	0	0.001232231	PID_FANCONI_PATHWAY	43	-1.0285604	0.3897059	0.6416161	0.8987326	2.9558534
GO_BASEMENT_MEMBRANE	c5.CC_ GO cellular component	82	1.9266859	0	0.001242665	GO_BASEMENT_MEMBRANE	84	1.3334228	0.04038257	0.39999282	3.2601087	0.5932631
KAMMINGA_EZH2_TARGETS	c2.CGP_ chemical and genetic perturbations	40	1.9262297	0	0.001259196	KAMMINGA_EZH2_TARGETS	40	0.9908362	0.49714285	0.9346977	2.9170659	0.9353935
FURUKAWA_DUSP6_TARGETS_PCI35_DN	c2.CGP_ chemical and genetic perturbations	65	1.9258578	0	0.001263219	FURUKAWA_DUSP6_TARGETS_PCI35_DN	67	1.2120532	0.15665236	0.57438725	3.137911	0.7138046
GNF2_FEN1	c4.CGN_ cancer gene neighborhoods	55	1.9244105	0	0.001327862	GNF2_FEN1	55	-1.1631316	0.15625	0.42657286	0.7612789	3.0875421
MODULE_403	c4.CM_ cancer modules	45	1.9244097	0	0.00131935	MODULE_403	45	-0.9810641	0.5090909	0.7136335	0.9433456	2.9054738
GO_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	c5.GO molecular function	62	1.9239339	0	0.001322937	GO_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	69	1.1583776	0.23227917	0.6563333	3.0823115	0.7655563
GO_REGULATION_OF_CELL_DIVISION	c5.BP_ GO biological process	232	1.9236324	0	0.001326449	GO_REGULATION_OF_CELL_DIVISION	244	1.0882468	0.2758275	0.7733879	3.0118792	0.8353856
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	c2.CGP_ chemical and genetic perturbations	80	1.9220173	0	0.001377168	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	79	-1.7253158	0	0.049590148	0.1967015	3.6473331
GO_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION	c5.BP_ GO biological process	156	1.9204987	0	0.001421494	GO_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION	159	1.0854255	0.32451677	0.7771551	3.0059242	0.8350732
GO_METAPHASE_PLATE_CONGRESSION	c5.BP_ GO biological process	39	1.9200858	0	0.001418464	GO_METAPHASE_PLATE_CONGRESSION	39	1.2173585	0.1911935	0.5612757	3.1374443	0.7027273
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN	C7_ immunologic signatures	169	1.917094	0	0.001502522	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN	173	1.2214898	0.08138352	0.55354375	3.1385838	0.6956042
GSE14415_INDUCED_VS_NATURAL_TREG_DN	C7_ immunologic signatures	165	1.9167832	0	0.001499114	GSE14415_INDUCED_VS_NATURAL_TREG_DN	165	-1.0643071	0.36363637	0.5803013	0.8524761	2.9810903
GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN	C7_ immunologic signatures	179	1.9150854	0	0.001507144	GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN	179	0.9339991	0.65989846	0.9957465	2.8490845	0.9810863
TSAI_RESPONSE_TO_RADIATION_THERAPY	c2.CGP_ chemical and genetic perturbations	29	1.9130225	0	0.001577887	TSAI_RESPONSE_TO_RADIATION_THERAPY	30	0.8922789	0.64504284	1	2.8053014	1.0207436
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN	C7_ immunologic signatures	143	1.9118116	0	0.001602426	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN	147	1.315561	0.022564102	0.4172372	3.2273726	0.5962506
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	c2.CGP_ chemical and genetic perturbations	91	1.9102904	0	0.001626513	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	93	0.9586902	0.5812236	0.9719327	2.8689806	0.9516002
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	c2.CP_REACTOME_ Reactome gene sets	32	1.9099655	0	0.00163362	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	32	-1.7217892	0	0.04984065	0.1881763	3.6317547
GO_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION	c5.BP_ GO biological process	19	1.9089282	0	0.001640686	GO_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION	22	1.3021008	0.13275434	0.43822643	3.211029	0.6068274
GO_STRUCTURAL_CONSTITUENT_OF_MUSCLE	c5.GO molecular function	35	1.908307	0	0.001647573	GO_STRUCTURAL_CONSTITUENT_OF_MUSCLE	39	1.534853	0.016222479	0.21596383	3.44316	0.373454
GO_MEIOTIC_CHROMOSOME_SEGREGATION	c5.BP_ GO biological process	46	1.9060205	0	0.001687348	GO_MEIOTIC_CHROMOSOME_SEGREGATION	51	1.7631353	0	0.055060133	3.6691558	0.1428852
GO_MEIOTIC_CELL_CYCLE	c5.BP_ GO biological process	151	1.9059073	0	0.001677537	GO_MEIOTIC_CELL_CYCLE	163	1.5619391	0	0.197541	3.4678464	0.3439682
GO_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY	c5.BP_ GO biological process	185	1.9052508	0	0.001689589	GO_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY	189	1.034538	0.4176707	0.8681616	2.9397888	0.8707128
PUJANA_XPRSS_INT_NETWORK	c2.CGP_ chemical and genetic perturbations	154	1.9033669	0	0.001712271	PUJANA_XPRSS_INT_NETWORK	154	-1.7838806	0	0.036336277	0.1194863	3.6872475
GO_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	45	1.9033313	0	0.001702486	GO_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT	48	1.235893	0.15695067	0.5317904	3.1392243	0.6674383
GO_OOCYTE_MATURATION	c5.BP_ GO biological process	15	1.9024307	0	0.001719444	GO_OOCYTE_MATURATION	16	1.4445105	0.036363635	0.29909274	3.3469412	0.4579202
FISCHER_G1_S_CELL_CYCLE	c2.CGP_ chemical and genetic perturbations	173	1.9010097	0	0.00173632	FISCHER_G1_S_CELL_CYCLE	174	-1.8614101	0	0.02270229	0.0395996	3.7624198
FINETTI_BREAST_CANCER_KINOME_RED	c2.CGP_ chemical and genetic perturbations	16	1.899274	0	0.001768757	FINETTI_BREAST_CANCER_KINOME_RED	16	1.3773501	0.09387223	0.35773152	3.2766241	0.5219239
GO_BASAL_LAMINA	c5.CC_ GO cellular component	20	1.8989486	0	0.001769365	GO_BASAL_LAMINA	20	1.4576346	0.026007803	0.28462404	3.3565832	0.441314
GO_OOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	30	1.8985072	0	0.001785609	GO_OOCYTE_DIFFERENTIATION	34	1.5356857	0.007125891	0.21597262	3.4341929	0.3628215
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	c2.CGP_ chemical and genetic perturbations	223	1.8982852	0	0.001780937	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	230	1.1162634	0.21407035	0.72880584	3.0145486	0.7820218
REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2	c2.CP_REACTOME_ Reactome gene sets	15	1.896361	0	0.001858999	REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2	15	1.1345354	0.30463576	0.6980282	3.0308964	0.7618256
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN	C7_ immunologic signatures	190	1.8958142	0	0.001859083	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN	190	1.0549375	0.37131232	0.8331656	2.9507517	0.8408767
KAUFFMANN_MELANOMA_RELAPSE_UP	c2.CGP_ chemical and genetic perturbations	58	1.8957418	0	0.001848979	KAUFFMANN_MELANOMA_RELAPSE_UP	58	-1.7127248	0	0.052231207	0.183017	3.6084666
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP	c2.CGP_ chemical and genetic perturbations	296	1.8934191	0	0.001910189	FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP	317	1.3646715	0	0.37301275	3.2580906	0.5287476
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN	c2.CGP_ chemical and genetic perturbations	21	1.8929421	0	0.001915061	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN	21	1.3472257	0.08031088	0.38570017	3.2401678	0.5457164
GO_CHROMOSOMAL_REGION	c5.CC_ GO cellular component	276	1.8896024	0	0.002060384	GO_CHROMOSOMAL_REGION	279	0.83672774	0.8766299	1	2.72633014	1.05287466
LIU_PROSTATE_CANCER_DN	c2.CGP_ chemical and genetic perturbations	423	1.8894086	0	0.002054444	LIU_PROSTATE_CANCER_DN	433	1.4506401	0	0.29145002	3.3400487	0.4387685
BASAKI_YBX1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	253	1.888978	0	0.002078362	BASAKI_YBX1_TARGETS_UP	255	0.9088298	0.7492477	1	2.7978078	0.9801482
GO_HEPARIN_BINDING	c5.GO molecular function	127	1.8883456	0	0.002101915	GO_HEPARIN_BINDING	134	1.1612109	0.18988648	0.6511957	3.0495565	0.7271347
GO_CELL_DIVISION	c5.BP_ GO biological process	416	1.8877363	0	0.002130324	GO_CELL_DIVISION	422	0.91813195	0.772	1	2.80586825	0.96960435
REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	21	1.8868979	0	0.00216812	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION	21	-1.1264297	0.2631579	0.477117	0.7604682	3.0133276
GO_AMINOGLYCAN_CATABOLIC_PROCESS	c5.BP_ GO biological process	60	1.886642	0	0.002166634	GO_AMINOGLYCAN_CATABOLIC_PROCESS	60	1.3353076	0.06858407	0.39796582	3.2219496	0.5513344
FARMER_BREAST_CANCER_CLUSTER_4	c2.CGP_ chemical and genetic perturbations	19	1.886588	0	0.002160294	FARMER_BREAST_CANCER_CLUSTER_4	19	-1.2260793	0.16972478	0.34931546	0.6605087	3.1126673
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	c2.CGP_ chemical and genetic perturbations	159	1.885561	0	0.002216614	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	161	0.7931572	0.8907048	1	2.6787182	1.0924038
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	c2.CGP_ chemical and genetic perturbations	53	1.8837845	0	0.002310897	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	53	-1.6184393	0	0.08481243	0.2653452	3.5022238
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	c2.CGP_ chemical and genetic perturbations	160	1.8833874	0	0.002313492	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	160	0.7822634	0.89808273	1	2.6656508	1.101124
CORDENONSI_YAP_CONSERVED_SIGNATURE	C6_ oncogenic signatures	54	1.8815237	0	0.002391839	CORDENONSI_YAP_CONSERVED_SIGNATURE	54	0.7709378	0.8412162	1	2.6524615	1.1105859
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	c2.CGP_ chemical and genetic perturbations	97	1.8809317	0	0.002398795	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	98	1.1793263	0.16929547	0.62389123	3.060258	0.7016054
GO_REGULATION_OF_CENTROSOME_CYCLE	c5.BP_ GO biological process	35	1.8796487	0.001459854	0.002452602	GO_REGULATION_OF_CENTROSOME_CYCLE	35	0.8680298	0.6791315	1	2.7476785	1.0116189
GO_MEIOSIS_I	c5.BP_ GO biological process	66	1.87915	0	0.002505903	GO_MEIOSIS_I	73	1.6420531	0	0.12260657	3.5212031	0.2370969
WANG_SMARCE1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	251	1.8789542	0	0.002502824	WANG_SMARCE1_TARGETS_UP	257	1.3457532	0.004012036	0.3881889	3.2247074	0.533201
LI_WILMS_TUMOR_ANAPLASTIC_UP	c2.CGP_ chemical and genetic perturbations	19	1.8774608	0	0.002546094	LI_WILMS_TUMOR_ANAPLASTIC_UP	19	1.2651242	0.16859716	0.49042657	3.142585	0.6123366
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	c2.CGP_ chemical and genetic perturbations	40	1.8767339	0	0.002588919	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	41	1.3961779	0.044982698	0.34757	3.2729118	0.480556
GO_NEGATIVE_REGULATION_OF_CELL_DIVISION	c5.BP_ GO biological process	54	1.8766321	0	0.00257629	GO_NEGATIVE_REGULATION_OF_CELL_DIVISION	57	0.9181146	0.6422222	1	2.7947467	0.9585175
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	c2.CGP_ chemical and genetic perturbations	117	1.8760124	0	0.002604776	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	119	1.0682167	0.3561786	0.80899245	2.9442291	0.8077957
GO_OOGENESIS	c5.BP_ GO biological process	54	1.8756524	0	0.002610377	GO_OOGENESIS	60	1.7163538	0	0.07349006	3.5920062	0.1592986
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP	C7_ immunologic signatures	137	1.8745154	0	0.00269726	GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP	144	1.4090132	0.010162601	0.3275357	3.2835286	0.4655022
GO_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE	c5.BP_ GO biological process	37	1.8735998	0	0.002747198	GO_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE	41	1.7259711	0	0.07064888	3.5995709	0.1476287
MODULE_47	c4.CM_ cancer modules	209	1.8729476	0	0.002769911	MODULE_47	210	1.1259736	0.20281124	0.7124958	2.9989212	0.746974
PETROVA_PROX1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	27	1.8726078	0	0.002779057	PETROVA_PROX1_TARGETS_UP	27	0.9649003	0.5231707	0.9656248	2.8375081	0.9077075
GO_CELL_CYCLE_PHASE_TRANSITION	c5.BP_ GO biological process	237	1.872122	0	0.002792544	GO_CELL_CYCLE_PHASE_TRANSITION	238	-1.2616972	0	0.3138366	0.6104248	3.1338192
GO_CARDIAC_CELL_DEVELOPMENT	c5.BP_ GO biological process	41	1.8715891	0	0.002805988	GO_CARDIAC_CELL_DEVELOPMENT	44	0.8250491	0.7457045	1	2.6966382	1.04654
GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	C7_ immunologic signatures	172	1.8710955	0	0.002845597	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	170	1.3805399	0.009109312	0.35581806	3.2516354	0.4905556
GO_HOMOLOGOUS_CHROMOSOME_SEGREGATION	c5.BP_ GO biological process	35	1.8707378	0	0.002841143	GO_HOMOLOGOUS_CHROMOSOME_SEGREGATION	39	1.7615023	0	0.05505882	3.6322401	0.1092355
GNF2_RFC3	c4.CGN_ cancer gene neighborhoods	39	1.8697782	0	0.002862814	GNF2_RFC3	39	0.7607958	0.8418014	1	2.630574	1.1089824
PID_PLK1_PATHWAY	c2.CP_ Canonical pathways	41	1.8695006	0	0.002858253	PID_PLK1_PATHWAY	41	1.1993778	0.2144522	0.5935252	3.0688784	0.6701228
GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP	C7_ immunologic signatures	179	1.8674967	0	0.002948602	GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP	180	1.2058771	0.08695652	0.58177626	3.0733738	0.6616196
REACTOME_SMOOTH_MUSCLE_CONTRACTION	c2.CP_REACTOME_ Reactome gene sets	22	1.8670354	0	0.002969358	REACTOME_SMOOTH_MUSCLE_CONTRACTION	22	-0.8603254	0.71428573	0.8600142	1.00671	2.7273608
YANG_BCL3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	331	1.8663814	0	0.002990033	YANG_BCL3_TARGETS_UP	332	1.170114	0.084084086	0.63828814	3.0364954	0.6962674
GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN	C7_ immunologic signatures	141	1.8661708	0	0.002985	GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN	145	0.85124385	0.8124363	1	2.71741465	1.01492695
GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP	C7_ immunologic signatures	176	1.865912	0	0.002992766	GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP	179	0.796122	0.910387	1	2.662034	1.06979
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	c2.CGP_ chemical and genetic perturbations	65	1.863852	0	0.003092939	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	66	1.0371798	0.43722942	0.8640203	2.9010318	0.8266722
GSE14000_UNSTIM_VS_4H_LPS_DC_DN	C7_ immunologic signatures	164	1.862464	0	0.003163038	GSE14000_UNSTIM_VS_4H_LPS_DC_DN	163	1.0082401	0.48167005	0.9112716	2.8707041	0.8542239
GSE14415_INDUCED_TREG_VS_TCONV_UP	C7_ immunologic signatures	157	1.8620936	0	0.00319081	GSE14415_INDUCED_TREG_VS_TCONV_UP	158	0.7735495	0.9156504	1	2.6356431	1.0885441
PID_E2F_PATHWAY	c2.CP_ Canonical pathways	69	1.8613412	0	0.003234824	PID_E2F_PATHWAY	71	-1.7242727	0	0.049514838	0.1370685	3.5856139
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN	C7_ immunologic signatures	150	1.860924	0	0.003245451	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN	151	1.2158214	0.09229209	0.56467885	3.0767454	0.6451026
DELPUECH_FOXO3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	37	1.8608141	0	0.003239468	DELPUECH_FOXO3_TARGETS_DN	36	0.8266927	0.760514	1	2.6875068	1.0341214
SHEPARD_BMYB_TARGETS	c2.CGP_ chemical and genetic perturbations	62	1.8607388	0	0.003229454	SHEPARD_BMYB_TARGETS	66	1.0372882	0.43278688	0.86384857	2.898027	0.8234506
RHODES_UNDIFFERENTIATED_CANCER	c2.CGP_ chemical and genetic perturbations	64	1.859477	0	0.003309411	RHODES_UNDIFFERENTIATED_CANCER	64	0.85682243	0.7236842	1	2.71629943	1.00265457
GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	182	1.8584807	0	0.003356227	GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP	181	0.8279101	0.86018234	1	2.6863908	1.0305706
GSE42021_TREG_VS_TCONV_PLN_UP	C7_ immunologic signatures	166	1.8582574	0	0.003345796	GSE42021_TREG_VS_TCONV_PLN_UP	163	1.4540842	0.003064351	0.28888595	3.3123416	0.4041732
GSE2706_UNSTIM_VS_8H_R848_DC_DN	C7_ immunologic signatures	162	1.8574238	0	0.003379884	GSE2706_UNSTIM_VS_8H_R848_DC_DN	164	1.2987946	0.031729784	0.44421458	3.1562184	0.5586292
GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	C7_ immunologic signatures	157	1.8553835	0	0.003502099	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	162	1.2161305	0.09368636	0.5640771	3.071514	0.639253
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	c2.CGP_ chemical and genetic perturbations	382	1.8552296	0	0.003495161	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	388	1.2877481	0.002004008	0.4612801	3.1429777	0.5674815
GSE2706_R848_VS_LPS_2H_STIM_DC_DN	C7_ immunologic signatures	130	1.8506056	0	0.003846719	GSE2706_R848_VS_LPS_2H_STIM_DC_DN	132	1.250844	0.0764526	0.5089236	3.1014496	0.5997616
GO_SPINDLE_MICROTUBULE	c5.CC_ GO cellular component	55	1.847759	0	0.004088352	GO_SPINDLE_MICROTUBULE	56	1.525294	0.008978676	0.23091632	3.373053	0.322465
KEGG_OTHER_GLYCAN_DEGRADATION	c2.CP_BIOCARTA_ BioCarta gene sets	16	1.8476433	0	0.004075113	KEGG_OTHER_GLYCAN_DEGRADATION	16	1.5652381	0.013297873	0.19426262	3.4128814	0.2824052
HU_GENOTOXIC_DAMAGE_4HR	c2.CGP_ chemical and genetic perturbations	35	1.8474714	0	0.004065968	HU_GENOTOXIC_DAMAGE_4HR	35	0.9900787	0.49822065	0.9353613	2.8375501	0.8573927
REACTOME_G0_AND_EARLY_G1	c2.CP_REACTOME_ Reactome gene sets	23	1.8458337	0	0.004197951	REACTOME_G0_AND_EARLY_G1	23	-1.4873286	0.05882353	0.15018095	0.3585051	3.3331623
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	144	1.8456326	0	0.00418838	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	144	-1.4344534	0	0.18390201	0.4111792	3.280086
THUM_MIR21_TARGETS_HEART_DISEASE_UP	c2.CGP_ chemical and genetic perturbations	16	1.8456062	0	0.004171072	THUM_MIR21_TARGETS_HEART_DISEASE_UP	16	0.6434	0.91099477	1	2.4890062	1.2022062
GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	C7_ immunologic signatures	171	1.8442159	0	0.004246831	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	170	1.0819261	0.3050505	0.7835664	2.926142	0.7622898
GO_GLYCOSAMINOGLYCAN_BINDING	c5.GO molecular function	168	1.8433354	0	0.004310345	GO_GLYCOSAMINOGLYCAN_BINDING	176	1.1579355	0.15672396	0.6575349	3.0012709	0.6853999
GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	169	1.8430288	0	0.004323434	GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	169	-1.0052595	0.52380955	0.6771904	0.8377693	2.8482883
GNF2_CKS1B	c4.CGN_ cancer gene neighborhoods	37	1.8402889	0	0.004569044	GNF2_CKS1B	37	0.63812286	0.95915985	1	2.47841176	1.20216604
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	c2.CGP_ chemical and genetic perturbations	160	1.8388908	0	0.004649516	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	161	0.8842357	0.74949086	1	2.7231265	0.9546551
GO_MALE_MEIOSIS	c5.BP_ GO biological process	31	1.8379759	0	0.00473307	GO_MALE_MEIOSIS	35	1.6481118	0.003605769	0.117718145	3.4860877	0.1898641
MODULE_122	c4.CM_ cancer modules	123	1.837972	0	0.004714061	MODULE_122	127	1.087209	0.30524153	0.77511376	2.925181	0.750763
GO_REGULATION_OF_SISTER_CHROMATID_SEGREGATION	c5.BP_ GO biological process	60	1.8369335	0	0.004781774	GO_REGULATION_OF_SISTER_CHROMATID_SEGREGATION	60	0.6840471	0.92865235	1	2.5209806	1.1528864
MODULE_481	c4.CM_ cancer modules	70	1.8366535	0	0.004785162	MODULE_481	73	0.74647975	0.8826754	1	2.58313325	1.09017375
CHICAS_RB1_TARGETS_GROWING	c2.CGP_ chemical and genetic perturbations	216	1.8364406	0	0.004777352	CHICAS_RB1_TARGETS_GROWING	217	-1.1917263	0	0.39213803	0.6447143	3.0281669
MARKEY_RB1_ACUTE_LOF_UP	c2.CGP_ chemical and genetic perturbations	214	1.8349234	0	0.004866124	MARKEY_RB1_ACUTE_LOF_UP	214	-1.2824326	0	0.29987687	0.5524908	3.117356
GO_DETECTION_OF_MECHANICAL_STIMULUS	c5.BP_ GO biological process	34	1.8340479	0.001428571	0.004932106	GO_DETECTION_OF_MECHANICAL_STIMULUS	39	1.5108427	0.027777778	0.24253044	3.3448906	0.3232052
GO_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE	c5.BP_ GO biological process	176	1.8332887	0	0.004979127	GO_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE	177	0.9727353	0.5791075	0.9581341	2.806024	0.8605534
FUJII_YBX1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	188	1.8329377	0	0.004985414	FUJII_YBX1_TARGETS_DN	188	-1.3974614	0	0.20916523	0.4354763	3.2303991
SHEPARD_CRUSH_AND_BURN_MUTANT_DN	c2.CGP_ chemical and genetic perturbations	155	1.8319916	0	0.005031827	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	163	0.91458386	0.68832487	1	2.74657546	0.91740774
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	c2.CGP_ chemical and genetic perturbations	165	1.8314866	0	0.005070695	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	162	0.8605084	0.789899	1	2.691995	0.9709782
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	c2.CGP_ chemical and genetic perturbations	134	1.8314139	0	0.005065617	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	133	1.2367334	0.09989806	0.5310419	3.0681473	0.5946805
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	c2.CGP_ chemical and genetic perturbations	22	1.8313357	0	0.005056961	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	22	0.9475602	0.5604534	0.9844306	2.7788959	0.8837755
GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	C7_ immunologic signatures	176	1.8311896	0	0.005055624	GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	182	1.2567859	0.04752275	0.50030935	3.0879755	0.5744037
HALLMARK_MITOTIC_SPINDLE	H_ hallmark gene sets	193	1.8301346	0	0.005133201	HALLMARK_MITOTIC_SPINDLE	194	1.121823	0.21941355	0.72246355	2.9519576	0.7083116
HALLMARK_MYOGENESIS	H_ hallmark gene sets	187	1.8280542	0	0.005284905	HALLMARK_MYOGENESIS	192	1.3114884	0.024340771	0.42291737	3.1395426	0.5165658
GSE7852_LN_VS_THYMUS_TCONV_DN	C7_ immunologic signatures	179	1.827372	0	0.005343263	GSE7852_LN_VS_THYMUS_TCONV_DN	179	0.8723992	0.7868687	1	2.6997712	0.9549728
MODULE_320	c4.CM_ cancer modules	19	1.8267132	0.0015625	0.005401024	MODULE_320	19	0.9342091	0.57306224	0.99548995	2.7609223	0.8925041
GO_LYSOSOMAL_LUMEN	c5.CC_ GO cellular component	79	1.8262196	0	0.005423093	GO_LYSOSOMAL_LUMEN	81	1.5494949	0.002143623	0.20632078	3.3757145	0.2767247
PRC2_EZH2_UP.V1_DN	C6_ oncogenic signatures	167	1.8251446	0	0.005536467	PRC2_EZH2_UP.V1_DN	169	0.78840387	0.8919192	1	2.61354847	1.03674073
YU_MYC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	38	1.8249189	0	0.00554736	YU_MYC_TARGETS_UP	38	-1.2357297	0.13157895	0.33967575	0.5891892	3.0606486
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	c2.CGP_ chemical and genetic perturbations	47	1.8248857	0	0.005526738	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	47	-1.269252	0.06923077	0.30948246	0.5556337	3.0941377
WHITFIELD_CELL_CYCLE_S	c2.CGP_ chemical and genetic perturbations	126	1.8227956	0	0.005725622	WHITFIELD_CELL_CYCLE_S	127	0.8219349	0.84275436	1	2.6447305	1.0008607
GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN	C7_ immunologic signatures	177	1.821113	0	0.005881175	GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN	180	0.85740465	0.8248988	1	2.67851765	0.96370835
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	c2.CGP_ chemical and genetic perturbations	30	1.8201476	0	0.005935629	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	30	1.3532313	0.09188544	0.38197622	3.1733789	0.4669163
VILLANUEVA_LIVER_CANCER_KRT19_UP	c2.CGP_ chemical and genetic perturbations	155	1.8188373	0	0.006041416	VILLANUEVA_LIVER_CANCER_KRT19_UP	156	0.6504142	0.9858012	1	2.4692515	1.1684231
BIOCARTA_INTRINSIC_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	20	1.8186548	0.001602564	0.006036469	BIOCARTA_INTRINSIC_PATHWAY	21	1.6864852	0.002496879	0.08656973	3.50514	0.1321696
LE_EGR2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	100	1.8185146	0	0.006052177	LE_EGR2_TARGETS_UP	100	0.8470459	0.77916664	1	2.6655605	0.9714687
REACTOME_SHC_MEDIATED_CASCADE	c2.CP_REACTOME_ Reactome gene sets	27	1.8181634	0	0.006050746	REACTOME_SHC_MEDIATED_CASCADE	27	-1.132779	0.26630434	0.4675191	0.6853844	2.9509424
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	c2.CGP_ chemical and genetic perturbations	18	1.8169072	0	0.006157859	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	19	0.661878	0.88701296	1	2.4787852	1.1550292
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	c2.CGP_ chemical and genetic perturbations	411	1.8156644	0	0.006227035	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	413	-1.3073632	0	0.27651483	0.5083012	3.1230276
GO_CELL_CYCLE_CHECKPOINT	c5.BP_ GO biological process	170	1.8153818	0	0.006238406	GO_CELL_CYCLE_CHECKPOINT	170	0.8636895	0.7925101	1	2.6790713	0.9516923
KEGG_CELL_CYCLE	c2.CP_BIOCARTA_ BioCarta gene sets	118	1.8152177	0	0.006229588	KEGG_CELL_CYCLE	120	-1.1367524	0.18181819	0.4622421	0.6784653	2.9519701
WANG_LSD1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	23	1.8146242	0.004491018	0.006254202	WANG_LSD1_TARGETS_UP	23	1.1267143	0.32456142	0.7114879	2.9413385	0.6879099
GO_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS	c5.BP_ GO biological process	22	1.8126873	0	0.006491954	GO_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS	23	1.158951	0.2689394	0.65469396	2.9716383	0.6537363
MACAEVA_PBMC_RESPONSE_TO_IR	c2.CGP_ chemical and genetic perturbations	78	1.8122796	0	0.006518897	MACAEVA_PBMC_RESPONSE_TO_IR	79	0.5996295	0.98596114	1	2.4119091	1.2126501
GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN	C7_ immunologic signatures	153	1.8113798	0	0.006611622	GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN	155	0.87555486	0.76386034	1	2.68693466	0.93582494
CUI_TCF21_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	35	1.8105505	0.00148368	0.006687393	CUI_TCF21_TARGETS_UP	35	-1.1974586	0.2012987	0.3853767	0.6130919	3.0080091
OLSSON_E2F3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	38	1.8104093	0	0.006687058	OLSSON_E2F3_TARGETS_DN	38	-1.253029	0.13333334	0.32150093	0.5573803	3.0634383
GO_CELLULAR_RESPONSE_TO_VITAMIN	c5.BP_ GO biological process	25	1.808792	0	0.006856874	GO_CELLULAR_RESPONSE_TO_VITAMIN	25	1.247871	0.17052375	0.5146894	3.056663	0.560921
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	c2.CGP_ chemical and genetic perturbations	109	1.8086468	0	0.006846112	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	109	-1.3617538	0	0.23312087	0.446893	3.1704006
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	c2.CP_REACTOME_ Reactome gene sets	17	1.8086069	0	0.006825664	REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	17	-1.668469	0.017391304	0.06567402	0.1401379	3.4770759
GO_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	27	1.8081813	0	0.00682161	GO_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT	29	0.9290824	0.5954382	0.9990835	2.7372637	0.8790989
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	125	1.8080037	0	0.006817544	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN	132	1.1250294	0.2147303	0.71525294	2.9330331	0.6829743
GO_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY	c5.BP_ GO biological process	145	1.8070977	0	0.00692288	GO_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY	149	1.1019133	0.2917093	0.75378793	2.909011	0.7051844
MODULE_125	c4.CM_ cancer modules	43	1.8062991	0	0.006989111	MODULE_125	43	-1.8556737	0	0.023845388	-0.0493746	3.6619728
GO_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS	c5.BP_ GO biological process	211	1.8050671	0	0.007137764	GO_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS	221	1.0327337	0.41490433	0.8722609	2.8378008	0.7723334
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	C7_ immunologic signatures	179	1.8047233	0	0.007161305	GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	181	0.9488799	0.6200608	0.9832616	2.7536032	0.8558434
GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION	c5.BP_ GO biological process	132	1.8041483	0	0.007219682	GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION	132	1.020862	0.45342886	0.8910377	2.8250103	0.7832863
GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	C7_ immunologic signatures	161	1.8029896	0	0.007375692	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	159	1.3221148	0.018348623	0.41122136	3.1251044	0.4808748
ONGUSAHA_TP53_TARGETS	c2.CGP_ chemical and genetic perturbations	33	1.8028264	0	0.007366682	ONGUSAHA_TP53_TARGETS	33	1.7678599	0	0.05379408	3.5706863	0.0349665
GO_CELL_CYCLE_G1_S_PHASE_TRANSITION	c5.BP_ GO biological process	103	1.8010769	0	0.00759949	GO_CELL_CYCLE_G1_S_PHASE_TRANSITION	103	-1.9762896	0	0.010099907	-0.1752127	3.7773665
WHITFIELD_CELL_CYCLE_G2_M	c2.CGP_ chemical and genetic perturbations	191	1.8010571	0	0.007577286	WHITFIELD_CELL_CYCLE_G2_M	192	0.7725869	0.9226857	1	2.573644	1.0284702
GSE13411_NAIVE_VS_MEMORY_BCELL_UP	C7_ immunologic signatures	145	1.8010001	0	0.007555203	GSE13411_NAIVE_VS_MEMORY_BCELL_UP	155	0.9667563	0.5858896	0.96433115	2.7677564	0.8342438
GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	C7_ immunologic signatures	171	1.7999339	0	0.007642209	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	173	0.6781669	0.9858443	1	2.4781008	1.121767
GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN	C7_ immunologic signatures	157	1.7998431	0	0.007635591	GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN	163	0.7438666	0.9296636	1	2.5437097	1.0559765
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	c2.CGP_ chemical and genetic perturbations	21	1.7992853	0.001501502	0.007687605	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	21	0.9218228	0.5849057	1	2.7211081	0.8774625
MODULE_544	c4.CM_ cancer modules	70	1.7983243	0	0.007816507	MODULE_544	73	0.7451396	0.8886486	1	2.5434639	1.0531847
GO_MICROTUBULE_MOTOR_ACTIVITY	c5.GO molecular function	70	1.7966487	0	0.007996595	GO_MICROTUBULE_MOTOR_ACTIVITY	72	1.3434052	0.043991417	0.39085326	3.1400539	0.4532435
GO_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION	c5.BP_ GO biological process	37	1.7957829	0	0.008077679	GO_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION	37	0.99906063	0.4837587	0.9245231	2.79484353	0.79672227
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	c2.CP_REACTOME_ Reactome gene sets	25	1.7957175	0	0.00806669	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	26	1.3949982	0.07281554	0.34599096	3.1907157	0.4007193
GO_MESODERMAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	22	1.7926689	0	0.008505551	GO_MESODERMAL_CELL_DIFFERENTIATION	25	1.051476	0.4127764	0.83688384	2.8441449	0.7411929
GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP	C7_ immunologic signatures	170	1.79197	0	0.00862366	GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP	172	0.99476564	0.51762336	0.9302773	2.78673564	0.79720436
GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION	c5.BP_ GO biological process	28	1.7908436	0	0.00877425	GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION	29	1.3312734	0.094247244	0.40049508	3.122117	0.4595702
INGRAM_SHH_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	112	1.7906718	0	0.008761167	INGRAM_SHH_TARGETS_UP	115	1.0423415	0.4	0.85480994	2.8330133	0.7483303
GO_MITOTIC_CELL_CYCLE_CHECKPOINT	c5.BP_ GO biological process	123	1.7906114	0	0.008748139	GO_MITOTIC_CELL_CYCLE_CHECKPOINT	123	1.0367155	0.41407868	0.86423904	2.8273269	0.7538959
GO_REGULATION_OF_MUSCLE_SYSTEM_PROCESS	c5.BP_ GO biological process	168	1.7897023	0	0.008843003	GO_REGULATION_OF_MUSCLE_SYSTEM_PROCESS	180	1.2986023	0.02123357	0.44399887	3.0883046	0.4911
GO_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION	c5.BP_ GO biological process	77	1.789176	0	0.008913453	GO_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION	77	1.071715	0.35275424	0.80277973	2.860891	0.717461
GO_DEVELOPMENTAL_CELL_GROWTH	c5.BP_ GO biological process	71	1.7888964	0	0.008956538	GO_DEVELOPMENTAL_CELL_GROWTH	73	1.0401555	0.41585234	0.8591737	2.8290519	0.7487409
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	c2.CGP_ chemical and genetic perturbations	121	1.7885588	0	0.008978683	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	122	1.2240597	0.10880829	0.550537	3.0126185	0.5644991
BIOCARTA_G2_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	24	1.7871969	0.001529052	0.009139507	BIOCARTA_G2_PATHWAY	24	0.9704733	0.52853596	0.96112674	2.7576702	0.8167236
GO_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	17	1.7871901	0	0.009110857	GO_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT	18	0.9314365	0.5832241	0.99811	2.7186266	0.8557536
BENPORATH_PROLIFERATION	c2.CGP_ chemical and genetic perturbations	125	1.7865777	0	0.009179308	BENPORATH_PROLIFERATION	125	-1.3180364	0	0.26853544	0.4685413	3.1046141
GO_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY	c5.GO molecular function	28	1.7856725	0.001526718	0.009282482	GO_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY	30	1.3665234	0.071428575	0.37188554	3.1521959	0.4191491
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN	c2.CGP_ chemical and genetic perturbations	266	1.7845813	0	0.009364734	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN	275	1.3764056	0.001002004	0.3580094	3.1609869	0.4081757
REACTOME_HS_GAG_DEGRADATION	c2.CP_REACTOME_ Reactome gene sets	19	1.7840651	0	0.009425934	REACTOME_HS_GAG_DEGRADATION	20	1.5499547	0.019753087	0.2067168	3.3340198	0.2341104
GO_RESPONSE_TO_TYPE_I_INTERFERON	c5.BP_ GO biological process	56	1.7838036	0	0.00943452	GO_RESPONSE_TO_TYPE_I_INTERFERON	55	1.1206987	0.31447965	0.7231211	2.9045023	0.6631049
GNF2_RFC4	c4.CGN_ cancer gene neighborhoods	58	1.7831994	0	0.009547203	GNF2_RFC4	58	-1.4245218	0.010989011	0.19173145	0.3586776	3.2077212
PTEN_DN.V1_UP	C6_ oncogenic signatures	146	1.7826366	0	0.009621703	PTEN_DN.V1_UP	153	1.2108638	0.098277606	0.57580155	2.9935004	0.5717728
KANG_GIST_WITH_PDGFRA_UP	c2.CGP_ chemical and genetic perturbations	46	1.7822006	0	0.009643994	KANG_GIST_WITH_PDGFRA_UP	47	-0.9927012	0.44144145	0.69937205	0.7894994	2.7749018
GO_DOPAMINERGIC_NEURON_DIFFERENTIATION	c5.BP_ GO biological process	25	1.7815803	0.001545595	0.009711956	GO_DOPAMINERGIC_NEURON_DIFFERENTIATION	27	-1.3263354	0.074285716	0.26040348	0.4552449	3.1079157
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	c2.CP_REACTOME_ Reactome gene sets	30	1.779551	0	0.009987895	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	33	0.98631555	0.5011765	0.9402196	2.76586655	0.79323545
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	c2.CGP_ chemical and genetic perturbations	68	1.7786872	0	0.010094222	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	68	0.85520333	0.73695654	1	2.63389053	0.92348387
GO_CENTROSOME_DUPLICATION	c5.BP_ GO biological process	31	1.7783325	0	0.010123283	GO_CENTROSOME_DUPLICATION	31	0.5455087	0.9855769	1	2.3238412	1.2328238
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN	C7_ immunologic signatures	148	1.7780887	0	0.010138108	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN	146	1.392353	0.007186858	0.34792742	3.1704417	0.3857357
GO_PROTEOGLYCAN_BINDING	c5.GO molecular function	22	1.7771152	0.001515152	0.010262772	GO_PROTEOGLYCAN_BINDING	25	-1.2041646	0.17977528	0.3767928	0.5729506	2.9812798
CHR14Q22	C1: positional gene sets	43	1.7768135	0.001404494	0.010291227	CHR14Q22	44	-1.161211	0.144	0.42812195	0.6156025	2.9380245
MODULE_158	c4.CM_ cancer modules	42	1.7766578	0	0.010285804	MODULE_158	42	-1.77606	0	0.037780885	0.0005978	3.5527178
KRASNOSELSKAYA_ILF3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	30	1.776101	0	0.010347447	KRASNOSELSKAYA_ILF3_TARGETS_UP	31	1.3387959	0.08423586	0.39699396	3.1148969	0.4373051
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	c2.CGP_ chemical and genetic perturbations	46	1.7760112	0	0.010330707	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	47	0.9088277	0.631101	1	2.6848389	0.8671835
GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS	c5.BP_ GO biological process	190	1.7757616	0	0.010327905	GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS	194	0.929148	0.6780341	0.9992731	2.7049096	0.8466136
GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	C7_ immunologic signatures	180	1.775506	0	0.010347328	GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	182	0.9942195	0.5137056	0.93111336	2.7697255	0.7812865
ZHANG_TLX_TARGETS_60HR_UP	c2.CGP_ chemical and genetic perturbations	269	1.7752949	0	0.010338947	ZHANG_TLX_TARGETS_60HR_UP	273	1.6677107	0	0.09685223	3.4430056	0.1075842
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	c2.CP_REACTOME_ Reactome gene sets	31	1.7749779	0.001470588	0.010358125	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	32	1.1089369	0.33695653	0.7396459	2.8839148	0.666041
CHANDRAN_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	266	1.7749262	0	0.010338813	CHANDRAN_METASTASIS_DN	273	1.1766561	0.09346734	0.6268505	2.9515823	0.5982701
KEGG_P53_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	58	1.7744784	0	0.010352525	KEGG_P53_SIGNALING_PATHWAY	60	1.16585	0.2246696	0.645881	2.9403284	0.6086284
GO_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION	c5.BP_ GO biological process	49	1.7744101	0	0.010347007	GO_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION	51	1.2565445	0.12067039	0.50048864	3.0309546	0.5178656
GO_CELL_CYCLE_G2_M_PHASE_TRANSITION	c5.BP_ GO biological process	129	1.7738718	0	0.010409569	GO_CELL_CYCLE_G2_M_PHASE_TRANSITION	130	0.86575717	0.74666667	1	2.63962897	0.90811463
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN	C7_ immunologic signatures	182	1.7729297	0	0.010542321	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN	181	0.9342887	0.66700506	0.9955011	2.7072184	0.838641
ZHU_SKIL_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	19	1.7727773	0	0.010525466	ZHU_SKIL_TARGETS_UP	20	0.8436693	0.71318823	1	2.6164466	0.929108
GO_MICROTUBULE	c5.CC_ GO cellular component	360	1.7717351	0	0.01068406	GO_MICROTUBULE	369	1.3489221	0.002	0.3833465	3.1206572	0.422813
BROWNE_INTERFERON_RESPONSIVE_GENES	c2.CGP_ chemical and genetic perturbations	56	1.7716554	0	0.0106696	BROWNE_INTERFERON_RESPONSIVE_GENES	54	1.5779147	0.003311258	0.18128914	3.3495701	0.1937407
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	C7_ immunologic signatures	170	1.7715088	0	0.010668639	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	170	1.025286	0.43743643	0.88353854	2.7967948	0.7462228
GO_VASODILATION	c5.BP_ GO biological process	23	1.7709731	0.003039514	0.010748018	GO_VASODILATION	24	1.4109226	0.05321782	0.3252142	3.1818957	0.3600505
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	25	1.770795	0	0.010741488	REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	25	1.2242397	0.19849247	0.5503486	2.9950347	0.5465553
GO_NEUROMUSCULAR_JUNCTION	c5.CC_ GO cellular component	51	1.7694262	0.002906977	0.01094562	GO_NEUROMUSCULAR_JUNCTION	52	1.463534	0.010044643	0.28136712	3.2329602	0.3058922
GO_ENDOCHONDRAL_BONE_MORPHOGENESIS	c5.BP_ GO biological process	41	1.7689364	0	0.011015504	GO_ENDOCHONDRAL_BONE_MORPHOGENESIS	43	0.90961456	0.6200924	1	2.67855096	0.85932184
GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP	C7_ immunologic signatures	157	1.7685716	0	0.011048045	GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP	156	1.3663753	0.01417004	0.37075052	3.1349469	0.4021963
GO_REGULATION_OF_MUSCLE_HYPERTROPHY	c5.BP_ GO biological process	36	1.7656336	0	0.011494858	GO_REGULATION_OF_MUSCLE_HYPERTROPHY	35	1.186728	0.24158654	0.6121186	2.9523616	0.5789056
MORI_PRE_BI_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	74	1.7652754	0	0.011525948	MORI_PRE_BI_LYMPHOCYTE_UP	73	0.8657338	0.71995705	1	2.6310092	0.8995416
GO_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	94	1.7645972	0	0.011653676	GO_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT	95	1.1656682	0.18238993	0.6459991	2.9302654	0.598929
GO_KINESIN_COMPLEX	c5.CC_ GO cellular component	49	1.764405	0	0.011655306	GO_KINESIN_COMPLEX	50	1.3258075	0.080267556	0.40614703	3.0902125	0.4385975
GO_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE	c5.BP_ GO biological process	25	1.7640607	0.00155521	0.011682962	GO_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE	29	1.36765	0.06738869	0.37049595	3.1317107	0.3964107
GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION	c5.BP_ GO biological process	21	1.7634338	0	0.011733881	GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION	21	1.0995033	0.36283186	0.7578761	2.8629371	0.6639305
GO_MICROTUBULE_CYTOSKELETON_ORGANIZATION	c5.BP_ GO biological process	305	1.7630132	0	0.011794915	GO_MICROTUBULE_CYTOSKELETON_ORGANIZATION	309	1.2223802	0.04004004	0.5527718	2.9853934	0.540633
SCHRAETS_MLL_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	33	1.7628043	0.001481482	0.011819341	SCHRAETS_MLL_TARGETS_UP	33	1.0893339	0.34620023	0.77181786	2.8521382	0.6734704
GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP	C7_ immunologic signatures	178	1.7620368	0	0.011928877	GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP	180	0.8048048	0.89350915	1	2.5668416	0.957232
GO_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION	c5.BP_ GO biological process	33	1.7603818	0.001481482	0.012163954	GO_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION	36	1.2178032	0.19181287	0.5602677	2.978185	0.5425786
GO_G2_DNA_DAMAGE_CHECKPOINT	c5.BP_ GO biological process	28	1.7583609	0	0.012556982	GO_G2_DNA_DAMAGE_CHECKPOINT	28	-1.1727885	0.19148937	0.4141937	0.5855724	2.9311494
GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	C7_ immunologic signatures	152	1.7568965	0	0.01280166	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	151	1.3357306	0.015432099	0.3986455	3.0926271	0.4211659
BRACHAT_RESPONSE_TO_CISPLATIN	c2.CGP_ chemical and genetic perturbations	19	1.7555748	0.006279435	0.013024469	BRACHAT_RESPONSE_TO_CISPLATIN	19	1.2495099	0.2	0.51169556	3.0050847	0.5060649
GO_DOUBLE_STRAND_BREAK_REPAIR	c5.BP_ GO biological process	133	1.7549646	0	0.013090869	GO_DOUBLE_STRAND_BREAK_REPAIR	134	-0.8684107	0.96153843	0.8550832	0.8865539	2.6233753
GO_REGULATION_OF_NUCLEAR_DIVISION	c5.BP_ GO biological process	143	1.7544398	0	0.013162125	GO_REGULATION_OF_NUCLEAR_DIVISION	152	1.1708773	0.15313463	0.6373044	2.9253171	0.5835625
MODULE_315	c4.CM_ cancer modules	16	1.7536845	0.001592357	0.013271	MODULE_315	16	1.4074699	0.0646438	0.32932702	3.1611544	0.3462146
GO_REGULATION_OF_HEART_RATE	c5.BP_ GO biological process	70	1.7535139	0.001344086	0.013288361	GO_REGULATION_OF_HEART_RATE	79	1.5183282	0.005359057	0.23488031	3.2718421	0.2351857
REACTOME_FRS2_MEDIATED_CASCADE	c2.CP_REACTOME_ Reactome gene sets	35	1.753477	0.001453488	0.013257751	REACTOME_FRS2_MEDIATED_CASCADE	35	-1.0410886	0.35507247	0.62014365	0.7123884	2.7945656
BOQUEST_STEM_CELL_UP	c2.CGP_ chemical and genetic perturbations	242	1.7527366	0	0.013410482	BOQUEST_STEM_CELL_UP	246	1.2284414	0.04819277	0.54406583	2.981178	0.5242952
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN	C7_ immunologic signatures	103	1.7516382	0	0.013582671	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN	113	1.2256848	0.11721992	0.5485763	2.977323	0.5259534
GO_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE	c5.BP_ GO biological process	110	1.750903	0	0.013709016	GO_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE	117	1.2049421	0.15329218	0.58255297	2.9558451	0.5459609
GO_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION	c5.BP_ GO biological process	41	1.7502367	0	0.013852096	GO_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION	47	1.1793599	0.24054983	0.6241129	2.9295966	0.5708768
REACTOME_CELL_CYCLE_MITOTIC	c2.CP_REACTOME_ Reactome gene sets	288	1.7489784	0	0.014086414	REACTOME_CELL_CYCLE_MITOTIC	290	-1.213313	0	0.36410698	0.5356654	2.9622914
GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	C7_ immunologic signatures	164	1.7489715	0	0.014049247	GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	159	1.2245228	0.092573754	0.5496806	2.9734943	0.5244487
GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP	C7_ immunologic signatures	146	1.7489254	0	0.014027098	GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP	146	0.81045085	0.85222673	1	2.55937625	0.93847455
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	c2.CGP_ chemical and genetic perturbations	300	1.7485873	0	0.014037116	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	307	1.0912071	0.232	0.7696421	2.8397944	0.6573802
MORF_BUB1	c4.CGN_ cancer gene neighborhoods	48	1.7479699	0.001426534	0.014106187	MORF_BUB1	48	-0.9789463	0.49586776	0.71570915	0.7690236	2.7269162
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	c2.CGP_ chemical and genetic perturbations	20	1.7477418	0	0.0141356	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	20	1.3367168	0.10150376	0.39815718	3.0844586	0.411025
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	c2.CGP_ chemical and genetic perturbations	22	1.7474457	0.0015625	0.01415262	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	23	1.2828007	0.14819588	0.46812138	3.0302464	0.464645
GO_RESPONSE_TO_MUSCLE_STRETCH	c5.BP_ GO biological process	19	1.7457484	0	0.014489152	GO_RESPONSE_TO_MUSCLE_STRETCH	19	1.5164042	0.024421593	0.23485194	3.2621526	0.2293442
GO_SPINDLE_CHECKPOINT	c5.BP_ GO biological process	22	1.7456884	0	0.014473516	GO_SPINDLE_CHECKPOINT	22	1.3030235	0.12763321	0.43663853	3.0487119	0.4426649
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN	C7_ immunologic signatures	145	1.745359	0	0.01453319	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN	150	1.2091564	0.10985626	0.5783888	2.9545154	0.5362026
GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN	C7_ immunologic signatures	150	1.7444808	0	0.014655529	GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN	152	1.1517789	0.19367991	0.66697806	2.8962597	0.5927019
GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP	C7_ immunologic signatures	170	1.7444727	0	0.014617854	GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP	168	0.8525244	0.8046796	1	2.5969971	0.8919483
GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	C7_ immunologic signatures	167	1.7441262	0	0.014669563	GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	166	1.3052717	0.026289182	0.43388936	3.0493979	0.4388545
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	c2.CGP_ chemical and genetic perturbations	32	1.7436194	0	0.014766614	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	33	0.7419351	0.8485207	1	2.4855545	1.0016843
GO_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS	c5.BP_ GO biological process	205	1.7431303	0	0.014808057	GO_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS	214	1.1479446	0.16750251	0.67201203	2.8910749	0.5951857
GO_POSITIVE_REGULATION_OF_CELL_CYCLE	c5.BP_ GO biological process	285	1.7427154	0	0.014861379	GO_POSITIVE_REGULATION_OF_CELL_CYCLE	297	1.0790823	0.25502008	0.7890726	2.8217977	0.6636331
PID_AURORA_B_PATHWAY	c2.CP_ Canonical pathways	37	1.7422588	0.003007519	0.01491197	PID_AURORA_B_PATHWAY	37	0.95216626	0.57621247	0.9793981	2.69442506	0.79009254
GO_DNA_REPLICATION_INDEPENDENT_NUCLEOSOME_ORGANIZATION	c5.BP_ GO biological process	36	1.7419502	0.001424501	0.014943242	GO_DNA_REPLICATION_INDEPENDENT_NUCLEOSOME_ORGANIZATION	36	0.8576462	0.7011628	1	2.5995964	0.884304
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	c2.CGP_ chemical and genetic perturbations	339	1.7418928	0	0.014919701	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	341	1.1371219	0.119	0.6947091	2.8790147	0.6047709
SANA_RESPONSE_TO_IFNG_UP	c2.CGP_ chemical and genetic perturbations	59	1.7415	0.001381216	0.014998007	SANA_RESPONSE_TO_IFNG_UP	58	1.4716015	0.013333334	0.27573052	3.2131015	0.2698985
KEGG_TGF_BETA_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	77	1.7413918	0	0.014988713	KEGG_TGF_BETA_SIGNALING_PATHWAY	78	0.7205309	0.9169329	1	2.4619227	1.0208609
MODULE_234	c4.CM_ cancer modules	46	1.7410362	0.001477105	0.015024213	MODULE_234	50	-1.7021446	0.00952381	0.054633334	0.0388916	3.4431808
MODULE_57	c4.CM_ cancer modules	55	1.7410038	0	0.014988998	MODULE_57	55	-1.3287764	0.05154639	0.257602	0.4122274	3.0697802
GSE22045_TREG_VS_TCONV_UP	C7_ immunologic signatures	136	1.7409011	0	0.014977391	GSE22045_TREG_VS_TCONV_UP	144	0.9334881	0.6447639	0.99653745	2.6743892	0.807413
GO_MICROTUBULE_BINDING	c5.GO molecular function	179	1.739938	0	0.015115391	GO_MICROTUBULE_BINDING	180	1.4212756	0.004036327	0.31975213	3.1612136	0.3186624
MODULE_1	c4.CM_ cancer modules	335	1.7397336	0	0.015131473	MODULE_1	341	1.1334287	0.12612613	0.70053065	2.8731623	0.6063049
SWEET_LUNG_CANCER_KRAS_DN	c2.CGP_ chemical and genetic perturbations	378	1.7395122	0	0.015147459	SWEET_LUNG_CANCER_KRAS_DN	387	1.0181243	0.43943945	0.89258546	2.7576365	0.7213879
CHR11Q23	C1: positional gene sets	96	1.7393899	0	0.015144847	CHR11Q23	102	0.7016496	0.9538784	1	2.4410395	1.0377403
GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP	C7_ immunologic signatures	166	1.7385399	0	0.015325123	GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP	169	1.0261779	0.4361055	0.88242364	2.7647178	0.712362
GO_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION	c5.BP_ GO biological process	40	1.7376821	0.001424501	0.015485873	GO_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION	43	0.88987625	0.66061294	1	2.62755835	0.84780585
MODULE_451	c4.CM_ cancer modules	31	1.7373755	0.002967359	0.015540065	MODULE_451	32	1.01214	0.45707375	0.9037799	2.7495155	0.7252355
GO_RECOMBINATIONAL_REPAIR	c5.BP_ GO biological process	67	1.7371111	0.001345895	0.015591749	GO_RECOMBINATIONAL_REPAIR	68	0.77929795	0.8580786	1	2.51640905	0.95781315
GO_MITOTIC_DNA_INTEGRITY_CHECKPOINT	c5.BP_ GO biological process	88	1.7370104	0	0.015572054	GO_MITOTIC_DNA_INTEGRITY_CHECKPOINT	88	0.95246494	0.59496325	0.9789596	2.68947534	0.78454546
GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN	C7_ immunologic signatures	179	1.73647	0	0.015669195	GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN	180	1.0686889	0.3296146	0.80780345	2.8051589	0.6677811
GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN	C7_ immunologic signatures	138	1.7362195	0	0.015695015	GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN	146	1.3262967	0.024539877	0.40586707	3.0625162	0.4099228
GO_DNA_INTEGRITY_CHECKPOINT	c5.BP_ GO biological process	128	1.7362033	0	0.015661573	GO_DNA_INTEGRITY_CHECKPOINT	128	0.79675037	0.8588957	1	2.53295367	0.93945293
KRASNOSELSKAYA_ILF3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	43	1.7359793	0.002824859	0.015655579	KRASNOSELSKAYA_ILF3_TARGETS_DN	43	-1.0987196	0.2815534	0.52144873	0.6372597	2.8346989
GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN	C7_ immunologic signatures	165	1.7358282	0	0.01566321	GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN	163	1.0866085	0.3027245	0.775378	2.8224367	0.6492197
SNF5_DN.V1_UP	C6_ oncogenic signatures	141	1.7342829	0	0.015980298	SNF5_DN.V1_UP	147	0.61259115	0.99589324	1	2.34687405	1.12169175
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	18	1.734181	0.003246753	0.015980225	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	18	1.4122801	0.07003891	0.32346168	3.1464611	0.3219009
GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN	C7_ immunologic signatures	173	1.734172	0	0.015946517	GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN	179	0.8869497	0.7538149	1	2.6211217	0.8472223
ZHANG_TLX_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	101	1.7334751	0	0.016099185	ZHANG_TLX_TARGETS_UP	100	1.7018249	0	0.083827145	3.4353	0.0316502
GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP	C7_ immunologic signatures	162	1.7310089	0	0.016640356	GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP	162	-1.1477664	0.0625	0.44616506	0.5832425	2.8787753
TACGGGT_MIR99A_MIR100_MIR99B	c3.MIR_ microRNA targets	20	1.7302339	0.003225806	0.016792908	TACGGGT_MIR99A_MIR100_MIR99B	21	-1.4616735	0.050251257	0.16535783	0.2685604	3.1919074
GO_G_PROTEIN_ALPHA_SUBUNIT_BINDING	c5.GO molecular function	22	1.7296131	0	0.016946925	GO_G_PROTEIN_ALPHA_SUBUNIT_BINDING	21	1.3181627	0.117197454	0.4135031	3.0477758	0.4114504
ZWANG_DOWN_BY_2ND_EGF_PULSE	c2.CGP_ chemical and genetic perturbations	167	1.7292411	0	0.01701788	ZWANG_DOWN_BY_2ND_EGF_PULSE	171	1.1964331	0.11818182	0.5963868	2.9256742	0.532808
GO_REGULATION_OF_SENSORY_PERCEPTION	c5.BP_ GO biological process	27	1.7291031	0	0.017026408	GO_REGULATION_OF_SENSORY_PERCEPTION	33	1.5187843	0.015240328	0.23635113	3.2478874	0.2103188
GO_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	20	1.7281764	0.00155521	0.01721189	GO_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	20	-0.6939321	0.8995215	0.96347463	1.0342443	2.4221085
GO_REGULATION_OF_MUSCLE_ADAPTATION	c5.BP_ GO biological process	61	1.727934	0.001373626	0.017219966	GO_REGULATION_OF_MUSCLE_ADAPTATION	61	0.97422326	0.5381215	0.9566336	2.70215726	0.75371074
PID_FOXM1_PATHWAY	c2.CP_ Canonical pathways	38	1.7274052	0.001472754	0.017313838	PID_FOXM1_PATHWAY	39	1.2490151	0.13151659	0.5121121	2.9764203	0.4783901
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN	C7_ immunologic signatures	181	1.7270104	0	0.017372116	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN	185	1.2778614	0.03538928	0.4754021	3.0048718	0.449149
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	C7_ immunologic signatures	178	1.7264109	0	0.017487142	GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	178	1.1727527	0.122469634	0.63285923	2.8991636	0.5536582
WARTERS_IR_RESPONSE_5GY	c2.CGP_ chemical and genetic perturbations	37	1.726168	0.001494768	0.017520828	WARTERS_IR_RESPONSE_5GY	37	1.3096554	0.115340255	0.4260498	3.0358234	0.4165126
YATTNATC_UNKNOWN	c3.TFT_ transcription factor targets	314	1.7246426	0	0.017931262	YATTNATC_UNKNOWN	329	1.0596763	0.33366734	0.82510066	2.7843189	0.6649663
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN	C7_ immunologic signatures	130	1.7245781	0	0.017902818	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN	138	1.2572558	0.07223942	0.49937823	2.9818339	0.4673223
GO_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS	c5.BP_ GO biological process	100	1.7243401	0	0.017917914	GO_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS	102	0.9373692	0.63350785	0.9932492	2.6617093	0.7869709
GO_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION	c5.BP_ GO biological process	192	1.7242101	0	0.017919933	GO_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION	198	1.0191731	0.4451158	0.8919132	2.7433832	0.705037
GO_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION	c5.BP_ GO biological process	32	1.7240373	0.001494768	0.017911179	GO_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION	32	1.3027714	0.10963856	0.4368486	3.0268087	0.4212659
GO_NEGATIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION	c5.BP_ GO biological process	31	1.7239685	0.003058104	0.01788948	GO_NEGATIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION	31	1.0123049	0.46060607	0.90354824	2.7362734	0.7116636
GO_AXIS_ELONGATION	c5.BP_ GO biological process	25	1.7237556	0	0.01790866	GO_AXIS_ELONGATION	26	-1.2650906	0.12435233	0.31119838	0.458665	2.9888462
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	c2.CGP_ chemical and genetic perturbations	43	1.7235464	0.004279601	0.017932033	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	43	0.9349128	0.59885716	0.9951111	2.6584592	0.7886336
GO_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	c5.BP_ GO biological process	34	1.7234086	0.00295858	0.017929658	GO_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	36	1.4131145	0.05011655	0.32395437	3.1365231	0.3102941
LIM_MAMMARY_STEM_CELL_UP	c2.CGP_ chemical and genetic perturbations	437	1.7231266	0	0.017963693	LIM_MAMMARY_STEM_CELL_UP	442	1.2596741	0.005	0.496769	2.9828007	0.4634525
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	C7_ immunologic signatures	154	1.7225686	0	0.018082816	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	153	1.2491148	0.059063137	0.5120759	2.9716834	0.4734538
THILLAINADESAN_ZNF217_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	39	1.7219168	0.005961252	0.018203462	THILLAINADESAN_ZNF217_TARGETS_UP	39	-0.8744456	0.6597222	0.8498668	0.8474712	2.5963624
GO_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS	c5.BP_ GO biological process	15	1.7207507	0.00805153	0.018487008	GO_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS	17	1.1187674	0.3138021	0.72445405	2.8395181	0.6019833
PUJANA_BREAST_CANCER_LIT_INT_NETWORK	c2.CGP_ chemical and genetic perturbations	94	1.7201079	0	0.018646447	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	94	0.6625272	0.9738767	1	2.3826351	1.0575807
CERVERA_SDHB_TARGETS_2	c2.CGP_ chemical and genetic perturbations	87	1.7199887	0	0.018640464	CERVERA_SDHB_TARGETS_2	97	1.3625433	0.020042194	0.37652782	3.082532	0.3574454
HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR	c2.CGP_ chemical and genetic perturbations	17	1.7185361	0.003305785	0.018975642	HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR	17	-0.73358727	0.8220339	0.94507605	0.98494883	2.45212337
GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	173	1.7183785	0	0.018979443	GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN	178	0.78183544	0.9023162	1	2.50021394	0.93654306
GO_MOTOR_ACTIVITY	c5.GO molecular function	116	1.7181859	0	0.018970668	GO_MOTOR_ACTIVITY	123	1.4519645	0.005165289	0.29211542	3.1701504	0.2662214
GO_MITOTIC_SPINDLE	c5.CC_ GO cellular component	50	1.7181648	0.0013947	0.018932624	GO_MITOTIC_SPINDLE	50	1.238172	0.1516165	0.5285146	2.9563368	0.4799928
MOSERLE_IFNA_RESPONSE	c2.CGP_ chemical and genetic perturbations	25	1.7179523	0.001589825	0.01894275	MOSERLE_IFNA_RESPONSE	23	0.96812934	0.5301353	0.963733	2.68608164	0.74982296
GO_PHOSPHOLIPID_TRANSLOCATING_ATPASE_ACTIVITY	c5.GO molecular function	16	1.7175505	0.003225806	0.019025775	GO_PHOSPHOLIPID_TRANSLOCATING_ATPASE_ACTIVITY	16	0.84394723	0.69908017	1	2.56149773	0.87360327
GO_SPINDLE_ASSEMBLY	c5.BP_ GO biological process	63	1.7175332	0	0.018989885	GO_SPINDLE_ASSEMBLY	65	1.0206269	0.45695364	0.89096797	2.7381601	0.6969063
GO_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	92	1.7173036	0	0.019010227	GO_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT	101	1.4905049	0	0.25973785	3.2078085	0.2267987
GO_PROTEIN_LOCALIZATION_TO_CYTOSKELETON	c5.BP_ GO biological process	28	1.7172916	0.004716981	0.018970426	GO_PROTEIN_LOCALIZATION_TO_CYTOSKELETON	27	1.2688718	0.1577061	0.48594353	2.9861634	0.4484198
WARTERS_RESPONSE_TO_IR_SKIN	c2.CGP_ chemical and genetic perturbations	62	1.7160465	0	0.019273773	WARTERS_RESPONSE_TO_IR_SKIN	63	1.2075299	0.18666667	0.58071274	2.9235764	0.5085166
MODULE_397	c4.CM_ cancer modules	108	1.7155362	0	0.019355124	MODULE_397	107	1.2934922	0.057053942	0.45229694	3.0090284	0.422044
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	c2.CGP_ chemical and genetic perturbations	41	1.715397	0.001438849	0.019355955	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	40	1.2315065	0.1552723	0.5371899	2.9469035	0.4838905
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	c2.CGP_ chemical and genetic perturbations	53	1.7153455	0	0.0193301	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	58	1.2232751	0.1611479	0.5515971	2.9386206	0.4920704
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	150	1.7146018	0	0.01950288	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN	155	1.1030221	0.28790984	0.7513706	2.8176239	0.6115797
GSE11386_NAIVE_VS_MEMORY_BCELL_UP	C7_ immunologic signatures	166	1.7143723	0	0.01950333	GSE11386_NAIVE_VS_MEMORY_BCELL_UP	167	0.6395795	0.9857724	1	2.3539518	1.0747928
NEWMAN_ERCC6_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	34	1.7139709	0.004316547	0.019556768	NEWMAN_ERCC6_TARGETS_DN	35	1.532883	0.010452962	0.21903309	3.2468539	0.1810879
FERRANDO_HOX11_NEIGHBORS	c2.CGP_ chemical and genetic perturbations	17	1.7134745	0.001605136	0.01964045	FERRANDO_HOX11_NEIGHBORS	18	-0.9924137	0.43396226	0.6994863	0.7210608	2.7058882
GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN	C7_ immunologic signatures	165	1.7134076	0	0.019610187	GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN	167	1.341752	0.017293997	0.39352718	3.0551596	0.3716556
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE	c2.CP_REACTOME_ Reactome gene sets	48	1.7131438	0.002805049	0.019646881	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE	49	0.9320646	0.6002265	0.9976306	2.6452084	0.7810792
GOLDRATH_ANTIGEN_RESPONSE	c2.CGP_ chemical and genetic perturbations	300	1.7127373	0	0.019725917	GOLDRATH_ANTIGEN_RESPONSE	301	-1.1526097	0	0.4401381	0.5601276	2.865347
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	c2.CGP_ chemical and genetic perturbations	39	1.7124127	0.002928258	0.019788504	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	41	1.3390964	0.083333336	0.3970268	3.0515091	0.3733163
GO_BLOOD_VESSEL_REMODELING	c5.BP_ GO biological process	30	1.7116616	0	0.019925106	GO_BLOOD_VESSEL_REMODELING	31	1.1208146	0.32527205	0.7227438	2.8324762	0.590847
GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN	C7_ immunologic signatures	169	1.7112447	0	0.020001011	GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN	168	1.1596326	0.17209776	0.6536533	2.8708773	0.5516121
PUJANA_BRCA_CENTERED_NETWORK	c2.CGP_ chemical and genetic perturbations	113	1.7108833	0	0.020060446	PUJANA_BRCA_CENTERED_NETWORK	113	-1.7585735	0	0.041792467	-0.0476902	3.4694568
BIOCARTA_ATM_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	1.710679	0.003016591	0.020065796	BIOCARTA_ATM_PATHWAY	18	0.8291498	0.7096774	1	2.5398288	0.8815292
GO_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.BP_ GO biological process	57	1.7099793	0	0.020266702	GO_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	61	1.4231689	0.016611295	0.31769413	3.1331482	0.2868104
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	c2.CGP_ chemical and genetic perturbations	289	1.7098849	0	0.020251626	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	289	-1.3393239	0	0.24926117	0.370561	3.0492088
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	c2.CGP_ chemical and genetic perturbations	66	1.7093998	0	0.020375667	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	66	1.3135288	0.0794702	0.4201751	3.0229286	0.395871
GO_GOLGI_LUMEN	c5.CC_ GO cellular component	71	1.708678	0	0.020572573	GO_GOLGI_LUMEN	80	1.4668931	0.006349206	0.27675003	3.1755711	0.2417849
GO_GROWTH_FACTOR_BINDING	c5.GO molecular function	115	1.7081171	0	0.020679664	GO_GROWTH_FACTOR_BINDING	116	1.2418739	0.09006211	0.52313566	2.949991	0.4662432
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN	C7_ immunologic signatures	167	1.7078977	0	0.02071106	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN	169	0.76005316	0.93346983	1	2.46795086	0.94784454
HALLMARK_INTERFERON_ALPHA_RESPONSE	H_ hallmark gene sets	87	1.7076651	0	0.020730628	HALLMARK_INTERFERON_ALPHA_RESPONSE	84	1.6021152	0.002120891	0.15535963	3.3097803	0.1055499
CHR5Q11	C1: positional gene sets	30	1.7072467	0.001430615	0.020807188	CHR5Q11	29	-0.9896851	0.45212767	0.70271325	0.7175616	2.6969318
LY_AGING_OLD_DN	c2.CGP_ chemical and genetic perturbations	52	1.7070947	0.001369863	0.020799061	LY_AGING_OLD_DN	52	1.1396968	0.27403316	0.6910288	2.8467915	0.5673979
BECKER_TAMOXIFEN_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	40	1.7068068	0.001461988	0.020830093	BECKER_TAMOXIFEN_RESISTANCE_UP	42	1.0498554	0.4216028	0.8403688	2.7566622	0.6569514
GO_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION	c5.BP_ GO biological process	56	1.70676	0	0.020792639	GO_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION	55	0.96897954	0.5294772	0.9623694	2.67573954	0.73778046
GSE2706_R848_VS_LPS_8H_STIM_DC_DN	C7_ immunologic signatures	147	1.7057078	0	0.021028314	GSE2706_R848_VS_LPS_8H_STIM_DC_DN	155	1.1064032	0.27106598	0.7442226	2.812111	0.5993046
GO_MITOTIC_RECOMBINATION	c5.BP_ GO biological process	39	1.7054195	0.001459854	0.021050975	GO_MITOTIC_RECOMBINATION	39	-1.3716223	0.0729927	0.22523853	0.3337972	3.0770418
NABA_BASEMENT_MEMBRANES	c2.CP_ Canonical pathways	39	1.7051991	0	0.021069543	NABA_BASEMENT_MEMBRANES	39	1.645321	0.004739337	0.11829825	3.3505201	0.0598781
GO_MICROTUBULE_ORGANIZING_CENTER_PART	c5.CC_ GO cellular component	131	1.7043214	0	0.021308841	GO_MICROTUBULE_ORGANIZING_CENTER_PART	132	1.0230162	0.46747968	0.8867144	2.7273376	0.6813052
REACTOME_CELL_CYCLE	c2.CP_REACTOME_ Reactome gene sets	348	1.7042139	0	0.021299781	REACTOME_CELL_CYCLE	351	0.79282105	0.9468405	1	2.49703495	0.91139285
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	c2.CGP_ chemical and genetic perturbations	388	1.7038122	0	0.02139685	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	390	0.7082681	0.996	1	2.4120803	0.9955441
GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP	C7_ immunologic signatures	158	1.7029445	0	0.021634193	GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP	164	1.3435473	0.014227643	0.39092714	3.0464918	0.3593972
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	45	1.7028214	0.001349528	0.021661114	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	47	1.496509	0.008055236	0.25541565	3.1993304	0.2063124
GO_T_TUBULE	c5.CC_ GO cellular component	43	1.702646	0.002777778	0.021672511	GO_T_TUBULE	44	1.6325773	0.001150748	0.13267797	3.3352233	0.0700687
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	c2.CGP_ chemical and genetic perturbations	15	1.7014393	0.011666667	0.021991927	BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	15	0.9294191	0.58984375	0.9989679	2.6308584	0.7720202
GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN	C7_ immunologic signatures	169	1.7014009	0	0.0219549	GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN	168	0.99748695	0.5040486	0.9258484	2.69888785	0.70391395
GO_REGULATION_OF_ASTROCYTE_DIFFERENTIATION	c5.BP_ GO biological process	23	1.7008644	0.001531394	0.022079926	GO_REGULATION_OF_ASTROCYTE_DIFFERENTIATION	27	0.9936204	0.4981685	0.9310284	2.6944848	0.707244
GO_MUSCLE_HYPERTROPHY	c5.BP_ GO biological process	25	1.700525	0.004518072	0.022099918	GO_MUSCLE_HYPERTROPHY	26	1.307917	0.11383109	0.42909652	3.008442	0.392608
BOWIE_RESPONSE_TO_TAMOXIFEN	c2.CGP_ chemical and genetic perturbations	15	1.6998854	0.006589786	0.022254497	BOWIE_RESPONSE_TO_TAMOXIFEN	15	0	0	0	1.6998854	1.6998854
GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	180	1.6997137	0	0.022272207	GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	181	-0.98805785	0.6666667	0.70593035	0.71165585	2.68777155
GO_REGULATION_OF_HEART_GROWTH	c5.BP_ GO biological process	39	1.699235	0	0.022376748	GO_REGULATION_OF_HEART_GROWTH	42	1.2850264	0.11503417	0.4634883	2.9842614	0.4142086
GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN	C7_ immunologic signatures	167	1.6990284	0	0.022397846	GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN	177	1.3959386	0.002026343	0.3476293	3.094967	0.3030898
GO_LUNG_ALVEOLUS_DEVELOPMENT	c5.BP_ GO biological process	39	1.6988007	0.002941177	0.02241508	GO_LUNG_ALVEOLUS_DEVELOPMENT	39	0.8865043	0.67444575	1	2.585305	0.8122964
GO_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION	c5.BP_ GO biological process	51	1.6985877	0	0.022415401	GO_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION	57	1.3763814	0.05082873	0.35773626	3.0749691	0.3222063
REACTOME_ION_CHANNEL_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	45	1.6984284	0.00143472	0.022428762	REACTOME_ION_CHANNEL_TRANSPORT	53	0.7947088	0.8017917	1	2.4931372	0.9037196
SONG_TARGETS_OF_IE86_CMV_PROTEIN	c2.CGP_ chemical and genetic perturbations	56	1.6984195	0.002797203	0.022393439	SONG_TARGETS_OF_IE86_CMV_PROTEIN	56	-1.8483939	0	0.024859605	-0.1499744	3.5468134
GO_DNA_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	102	1.6971126	0	0.022782413	GO_DNA_BIOSYNTHETIC_PROCESS	102	-1.1143619	0.20754717	0.49894235	0.5827507	2.8114745
GO_MEMBRANE_DEPOLARIZATION	c5.BP_ GO biological process	53	1.6968948	0.00140647	0.022815553	GO_MEMBRANE_DEPOLARIZATION	55	1.522203	0.005714286	0.23379599	3.2190978	0.1746918
GO_VACUOLAR_LUMEN	c5.CC_ GO cellular component	100	1.6965464	0	0.022883939	GO_VACUOLAR_LUMEN	104	1.4933562	0.002087683	0.25811675	3.1899026	0.2031902
MODULE_330	c4.CM_ cancer modules	26	1.6964072	0.001470588	0.022875775	MODULE_330	26	1.1113335	0.34155363	0.7356204	2.8077407	0.5850737
GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN	C7_ immunologic signatures	171	1.6958315	0	0.023049267	GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN	176	1.3665496	0.010111224	0.3721359	3.0623811	0.3292819
GO_HISTONE_EXCHANGE	c5.BP_ GO biological process	34	1.6956003	0.001508296	0.023088923	GO_HISTONE_EXCHANGE	36	1.0227654	0.45110023	0.88675797	2.7183657	0.6728349
GO_MUSCLE_STRUCTURE_DEVELOPMENT	c5.BP_ GO biological process	383	1.6953754	0	0.023124926	GO_MUSCLE_STRUCTURE_DEVELOPMENT	400	1.0042057	0.504008	0.91656595	2.6995811	0.6911697
GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	C7_ immunologic signatures	177	1.6948538	0	0.02323618	GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	178	0.75832283	0.9251769	1	2.45317663	0.93653097
GO_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION	c5.BP_ GO biological process	37	1.6948465	0.004297994	0.023190709	GO_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION	37	-1.364761	0.07462686	0.23035575	0.3300855	3.0596075
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP	C7_ immunologic signatures	156	1.6946801	0	0.023215167	GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP	160	1.2385106	0.07317073	0.527643	2.9331907	0.4561695
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	c2.CGP_ chemical and genetic perturbations	15	1.6946055	0.0016	0.023186436	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	15	1.6709182	0.002656043	0.09639369	3.3655237	0.0236873
LY_AGING_MIDDLE_DN	c2.CGP_ chemical and genetic perturbations	15	1.6942478	0.0096	0.023249261	LY_AGING_MIDDLE_DN	15	1.6062739	0.008275862	0.14985117	3.3005217	0.0879739
GO_LIPID_TRANSLOCATION	c5.BP_ GO biological process	20	1.6941897	0.003205128	0.02322417	GO_LIPID_TRANSLOCATION	20	0.9394298	0.5808081	0.9904388	2.6336195	0.7547599
SMIRNOV_RESPONSE_TO_IR_2HR_DN	c2.CGP_ chemical and genetic perturbations	51	1.6938612	0	0.02328848	SMIRNOV_RESPONSE_TO_IR_2HR_DN	51	1.039407	0.40924466	0.85910034	2.7332682	0.6544542
GO_SPROUTING_ANGIOGENESIS	c5.BP_ GO biological process	42	1.6937727	0	0.023274278	GO_SPROUTING_ANGIOGENESIS	42	1.066074	0.37793428	0.8121998	2.7598467	0.6276987
GO_SPINDLE_MIDZONE	c5.CC_ GO cellular component	25	1.6936661	0.004636785	0.02326207	GO_SPINDLE_MIDZONE	25	1.3033912	0.12839507	0.43645984	2.9970573	0.3902749
GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN	C7_ immunologic signatures	157	1.69344	0	0.02328066	GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN	157	0.96007794	0.5987842	0.9713479	2.65351794	0.73336206
ZHU_CMV_ALL_DN	c2.CGP_ chemical and genetic perturbations	116	1.6931722	0	0.023308083	ZHU_CMV_ALL_DN	121	-1.2662799	0	0.31047893	0.4268923	2.9594521
GO_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC	c5.BP_ GO biological process	28	1.693	0.010736196	0.023335466	GO_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC	29	-0.9564992	0.53488374	0.74713826	0.7365008	2.6494992
GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP	C7_ immunologic signatures	124	1.6925923	0	0.023429297	GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP	141	1.1955189	0.12037037	0.59715	2.8881112	0.4970734
GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN	C7_ immunologic signatures	143	1.6919162	0	0.023567759	GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN	149	1.082899	0.296334	0.782223	2.7748152	0.6090172
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	c2.CGP_ chemical and genetic perturbations	78	1.691295	0.001264223	0.023703912	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	79	1.6306301	0.001061571	0.13326965	3.3219251	0.0606649
GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION	c5.BP_ GO biological process	89	1.6909394	0	0.023784144	GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION	89	1.027288	0.44712043	0.8803248	2.7182274	0.6636514
GO_CELLULAR_RESPONSE_TO_NUTRIENT	c5.BP_ GO biological process	38	1.6904075	0.001422475	0.023919517	GO_CELLULAR_RESPONSE_TO_NUTRIENT	38	0.9902224	0.5172825	0.9353841	2.6806299	0.7001851
SIMBULAN_PARP1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	31	1.6895483	0.001477105	0.024159314	SIMBULAN_PARP1_TARGETS_UP	31	1.416762	0.05807201	0.3205318	3.1063103	0.2727863
MODULE_112	c4.CM_ cancer modules	206	1.6894227	0	0.024163386	MODULE_112	224	1.3501353	0.004024145	0.38369423	3.039558	0.3392874
GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN	C7_ immunologic signatures	172	1.6883574	0	0.02449955	GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN	175	1.1810695	0.13852376	0.62171656	2.8694269	0.5072879
GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	C7_ immunologic signatures	183	1.687614	0	0.024719208	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	184	-1.6574024	0	0.06902915	0.0302116	3.3450164
REACTOME_MITOTIC_G2_G2_M_PHASES	c2.CP_REACTOME_ Reactome gene sets	75	1.6874695	0	0.02473464	REACTOME_MITOTIC_G2_G2_M_PHASES	75	0.6475977	0.9741379	1	2.3350672	1.0398718
BLUM_RESPONSE_TO_SALIRASIB_DN	c2.CGP_ chemical and genetic perturbations	317	1.6863441	0	0.02506082	BLUM_RESPONSE_TO_SALIRASIB_DN	319	-1.4421501	0	0.17859815	0.244194	3.1284942
WILCOX_RESPONSE_TO_PROGESTERONE_DN	c2.CGP_ chemical and genetic perturbations	60	1.6861385	0	0.025094852	WILCOX_RESPONSE_TO_PROGESTERONE_DN	61	1.1506022	0.23509933	0.6680384	2.8367407	0.5355363
PID_BARD1_PATHWAY	c2.CP_ Canonical pathways	25	1.6858058	0.002928258	0.025142806	PID_BARD1_PATHWAY	25	-1.338618	0.110497236	0.2493808	0.3471878	3.0244238
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	c2.CGP_ chemical and genetic perturbations	98	1.685676	0	0.025157323	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	98	1.1782578	0.18651211	0.6243132	2.8639338	0.5074182
DANG_REGULATED_BY_MYC_DN	c2.CGP_ chemical and genetic perturbations	224	1.6856061	0	0.025141928	DANG_REGULATED_BY_MYC_DN	227	1.0623024	0.34202608	0.8187103	2.7479085	0.6233037
PEART_HDAC_PROLIFERATION_CLUSTER_UP	c2.CGP_ chemical and genetic perturbations	57	1.6853713	0.00137931	0.025180792	PEART_HDAC_PROLIFERATION_CLUSTER_UP	57	0.93200845	0.5871254	0.99754536	2.61737975	0.75336285
GO_NEUROMUSCULAR_JUNCTION_DEVELOPMENT	c5.BP_ GO biological process	35	1.6848521	0	0.025315655	GO_NEUROMUSCULAR_JUNCTION_DEVELOPMENT	35	1.4687603	0.02308627	0.2762005	3.1536124	0.2160918
GO_CENTRIOLE	c5.CC_ GO cellular component	90	1.6846517	0.001321004	0.025350632	GO_CENTRIOLE	90	0.9593634	0.5703781	0.9709905	2.6440151	0.7252883
GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN	C7_ immunologic signatures	152	1.6842968	0	0.025411587	GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN	154	1.0808794	0.32135522	0.78612614	2.7651762	0.6034174
CHR19P12	C1: positional gene sets	15	1.6839759	0.00477707	0.02546362	CHR19P12	16	1.0064294	0.48871183	0.91332346	2.6904053	0.6775465
GO_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY	c5.BP_ GO biological process	19	1.6838201	0.004680187	0.025456525	GO_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY	19	0.92582	0.60051215	1	2.6096401	0.7580001
GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN	C7_ immunologic signatures	167	1.6828945	0	0.025708925	GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN	166	1.1204468	0.2535211	0.7226343	2.8033413	0.5624477
GO_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	47	1.6828644	0.001457726	0.025678953	GO_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY	49	1.071961	0.35634744	0.80272484	2.7548254	0.6109034
GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN	C7_ immunologic signatures	163	1.682634	0	0.025719775	GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN	162	-1.6661441	0	0.06645583	0.0164899	3.3487781
GO_SULFUR_COMPOUND_BINDING	c5.GO molecular function	200	1.6814315	0	0.02612348	GO_SULFUR_COMPOUND_BINDING	210	1.2332435	0.05757576	0.5357717	2.914675	0.448188
GO_COLLAGEN_TRIMER	c5.CC_ GO cellular component	67	1.68106	0	0.026220113	GO_COLLAGEN_TRIMER	72	1.3105285	0.05952381	0.42540422	2.9915885	0.3705315
GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	175	1.6810108	0	0.026191123	GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP	177	0.85686696	0.8069106	1	2.53787776	0.82414384
GO_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	61	1.6805955	0.001404494	0.026295662	GO_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY	68	1.1657367	0.23535791	0.64585936	2.8463322	0.5148588
OUYANG_PROSTATE_CANCER_MARKERS	c2.CGP_ chemical and genetic perturbations	18	1.6804156	0.006289308	0.02631955	OUYANG_PROSTATE_CANCER_MARKERS	18	0.84526503	0.6916996	1	2.52568063	0.83515057
CHR10P11	C1: positional gene sets	20	1.6802149	0.003338898	0.026340013	CHR10P11	20	1.1298572	0.30530402	0.70565826	2.8100721	0.5503577
GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN	C7_ immunologic signatures	164	1.6802047	0	0.026297392	GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN	162	1.2666599	0.039836567	0.4890987	2.9468646	0.4135448
GO_PROTEIN_LOCALIZATION_TO_CHROMOSOME	c5.BP_ GO biological process	37	1.6795646	0.002915452	0.026501354	GO_PROTEIN_LOCALIZATION_TO_CHROMOSOME	37	1.1522071	0.26604435	0.6661827	2.8317717	0.5273575
GO_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	242	1.6788719	0	0.026716432	GO_MUSCLE_TISSUE_DEVELOPMENT	253	0.9149416	0.7492477	1	2.5938135	0.7639303
GO_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	16	1.678539	0.006546645	0.026790146	GO_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY	17	1.6783208	0.003942181	0.0940427	3.3568598	0.0002182
GO_PROTEIN_BINDING_INVOLVED_IN_CELL_ADHESION	c5.GO molecular function	16	1.6784648	0.00955414	0.026772354	GO_PROTEIN_BINDING_INVOLVED_IN_CELL_ADHESION	17	0.6252251	0.9443726	1	2.3036899	1.0532397
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN	C7_ immunologic signatures	189	1.6781697	0	0.026838914	GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN	188	1.2135043	0.0881459	0.5715644	2.891674	0.4646654
RGTTAMWNATT_HNF1_01	c3.TFT_ transcription factor targets	58	1.6780217	0.002713704	0.02685317	RGTTAMWNATT_HNF1_01	62	0.9531339	0.5984513	0.9779544	2.6311556	0.7248878
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	c2.CGP_ chemical and genetic perturbations	38	1.677949	0.00882353	0.02682697	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	40	0.92995894	0.5916955	0.99913186	2.60790794	0.74799006
FARMER_BREAST_CANCER_CLUSTER_1	c2.CGP_ chemical and genetic perturbations	31	1.6777211	0.003012048	0.026839474	FARMER_BREAST_CANCER_CLUSTER_1	35	0.8355861	0.7201405	1	2.5133072	0.842135
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN	C7_ immunologic signatures	179	1.6776953	0	0.026793297	GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN	179	0.6979695	0.96653146	1	2.3756648	0.9797258
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP	C7_ immunologic signatures	161	1.6773537	0	0.026889386	GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP	166	0.7057583	0.9595551	1	2.383112	0.9715954
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN	C7_ immunologic signatures	151	1.6772845	0	0.026868314	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN	154	1.3062358	0.029561672	0.43138772	2.9835203	0.3710487
GO_POSITIVE_REGULATION_OF_HEART_CONTRACTION	c5.BP_ GO biological process	30	1.6764835	0.003169572	0.027082382	GO_POSITIVE_REGULATION_OF_HEART_CONTRACTION	34	1.4938843	0.025974026	0.25780544	3.1703678	0.1825992
GENTILE_UV_LOW_DOSE_UP	c2.CGP_ chemical and genetic perturbations	25	1.6764438	0.007587254	0.027057746	GENTILE_UV_LOW_DOSE_UP	25	1.4218025	0.04872107	0.3188556	3.0982463	0.2546413
BIOCARTA_ALK_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	35	1.675607	0.001510574	0.027355107	BIOCARTA_ALK_PATHWAY	36	0.9398984	0.58323497	0.99012554	2.6155054	0.7357086
GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP	C7_ immunologic signatures	126	1.6751782	0.001254705	0.027459275	GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP	131	1.167064	0.17599186	0.64219445	2.8422422	0.5081142
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	c2.CGP_ chemical and genetic perturbations	88	1.6747974	0	0.027553128	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	87	1.4247024	0.014814815	0.31864634	3.0994998	0.250095
HORIUCHI_WTAP_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	283	1.6742778	0	0.027717628	HORIUCHI_WTAP_TARGETS_DN	285	0.7817416	0.9487437	1	2.4560194	0.8925362
GO_REGULATION_OF_CENTROSOME_DUPLICATION	c5.BP_ GO biological process	28	1.674229	0.010819165	0.027677227	GO_REGULATION_OF_CENTROSOME_DUPLICATION	28	0.7248566	0.86900586	1	2.3990856	0.9493724
PUJANA_BRCA2_PCC_NETWORK	c2.CGP_ chemical and genetic perturbations	382	1.674199	0	0.027637	PUJANA_BRCA2_PCC_NETWORK	384	-1.5021402	0	0.14091168	0.1720588	3.1763392
GO_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION	c5.BP_ GO biological process	18	1.6735018	0.01010101	0.027843202	GO_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION	19	1.3757645	0.078125	0.35722747	3.0492663	0.2977373
LIU_SMARCA4_TARGETS	c2.CGP_ chemical and genetic perturbations	49	1.6732796	0.001402525	0.027863404	LIU_SMARCA4_TARGETS	49	1.3616515	0.061433446	0.37617508	3.0349311	0.3116281
GO_NEURON_PROJECTION_GUIDANCE	c5.BP_ GO biological process	187	1.6723589	0	0.028160224	GO_NEURON_PROJECTION_GUIDANCE	197	1.0307752	0.41750503	0.8740791	2.7031341	0.6415837
GO_SYNAPSE_ASSEMBLY	c5.BP_ GO biological process	62	1.67228	0.002673797	0.028139032	GO_SYNAPSE_ASSEMBLY	65	0.95981807	0.56365615	0.97090304	2.63209807	0.71246193
GO_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	c5.BP_ GO biological process	84	1.6720717	0	0.028175011	GO_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	87	1.0680496	0.37250787	0.808827	2.7401213	0.6040221
MODULE_512	c4.CM_ cancer modules	36	1.6715736	0	0.028298857	MODULE_512	35	1.6304365	0.002358491	0.13260113	3.3020101	0.0411371
GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN	C7_ immunologic signatures	170	1.6709235	0	0.028498681	GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN	175	1.2860938	0.029352227	0.46316722	2.9570173	0.3848297
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	c2.CGP_ chemical and genetic perturbations	20	1.6708368	0.00493421	0.028481932	NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	22	0.7136705	0.8420398	1	2.3845073	0.9571663
GO_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	c5.BP_ GO biological process	192	1.670581	0	0.028521914	GO_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	196	0.9143459	0.72329605	1	2.5849269	0.7562351
MODULE_176	c4.CM_ cancer modules	180	1.6702806	0	0.028615227	MODULE_176	197	1.3602182	0.004012036	0.37715423	3.0304988	0.3100624
WEINMANN_ADAPTATION_TO_HYPOXIA_DN	c2.CGP_ chemical and genetic perturbations	35	1.670197	0.002980626	0.028593503	WEINMANN_ADAPTATION_TO_HYPOXIA_DN	39	1.0269597	0.43829295	0.8812338	2.6971567	0.6432373
GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP	C7_ immunologic signatures	176	1.6701463	0	0.028563786	GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP	182	1.283467	0.029381966	0.46701643	2.9536133	0.3866793
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	c2.CGP_ chemical and genetic perturbations	289	1.6698252	0	0.028653134	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	290	1.2783607	0.013	0.47400746	2.9481859	0.3914645
GO_ATP_DEPENDENT_MICROTUBULE_MOTOR_ACTIVITY	c5.GO molecular function	17	1.6696374	0.006389776	0.028673107	GO_ATP_DEPENDENT_MICROTUBULE_MOTOR_ACTIVITY	17	1.5786091	0.006527415	0.1823847	3.2482465	0.0910283
MTOR_UP.V1_DN	C6_ oncogenic signatures	167	1.6694518	0	0.028697936	MTOR_UP.V1_DN	165	1.0416228	0.39836568	0.85628474	2.7110746	0.627829
GO_POSITIVE_REGULATION_OF_HEART_GROWTH	c5.BP_ GO biological process	25	1.6690106	0.00456621	0.028826743	GO_POSITIVE_REGULATION_OF_HEART_GROWTH	27	1.1171408	0.32009628	0.7282979	2.7861514	0.5518698
GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP	C7_ immunologic signatures	167	1.666855	0	0.029594082	GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP	167	1.0932316	0.27991885	0.768039	2.7600866	0.5736234
GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	171	1.666409	0	0.029724015	GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	169	1.2384847	0.067005076	0.5273339	2.9048937	0.4279243
GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN	C7_ immunologic signatures	153	1.6661327	0	0.02977237	GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN	157	1.1004955	0.25510204	0.75652075	2.7666282	0.5656372
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	c2.CGP_ chemical and genetic perturbations	29	1.6660914	0.001587302	0.029736297	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	29	-0.99059176	0.43274853	0.70181197	0.67549964	2.65668316
REACTOME_G2_M_CHECKPOINTS	c2.CP_REACTOME_ Reactome gene sets	41	1.6659589	0.001492537	0.029749544	REACTOME_G2_M_CHECKPOINTS	41	-1.8786428	0	0.020285154	-0.2126839	3.5446017
GO_TISSUE_REMODELING	c5.BP_ GO biological process	81	1.6659112	0.005340454	0.02971679	GO_TISSUE_REMODELING	83	1.1434957	0.22741765	0.6835101	2.8094069	0.5224155
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP	C7_ immunologic signatures	169	1.6658573	0	0.029695252	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP	176	0.97666824	0.56565654	0.9533176	2.64252554	0.68918906
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	c2.CGP_ chemical and genetic perturbations	17	1.6649463	0.006557377	0.029980194	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	18	1.100225	0.33548388	0.756475	2.7651713	0.5647213
RB_DN.V1_UP	C6_ oncogenic signatures	123	1.6648184	0	0.029988168	RB_DN.V1_UP	125	1.0490278	0.38065845	0.8415775	2.7138462	0.6157906
SHEPARD_BMYB_MORPHOLINO_DN	c2.CGP_ chemical and genetic perturbations	173	1.6645203	0	0.03006853	SHEPARD_BMYB_MORPHOLINO_DN	184	0.9718313	0.5796954	0.9599781	2.6363516	0.692689
GO_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH	c5.BP_ GO biological process	78	1.6638793	0	0.030288521	GO_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH	77	0.9298103	0.6139785	0.99894106	2.5936896	0.734069
BRACHAT_RESPONSE_TO_METHOTREXATE_UP	c2.CGP_ chemical and genetic perturbations	22	1.6634045	0.002976191	0.030421449	BRACHAT_RESPONSE_TO_METHOTREXATE_UP	22	1.5182674	0.02631579	0.23434284	3.1816719	0.1451371
GO_CYCLIC_NUCLEOTIDE_BINDING	c5.GO molecular function	33	1.66331	0.005934718	0.03040367	GO_CYCLIC_NUCLEOTIDE_BINDING	33	1.004019	0.45165095	0.91717076	2.667329	0.659291
GO_CYTOSOLIC_CALCIUM_ION_TRANSPORT	c5.BP_ GO biological process	44	1.6632541	0.002886003	0.030371834	GO_CYTOSOLIC_CALCIUM_ION_TRANSPORT	49	1.2698354	0.11123723	0.48552936	2.9330895	0.3934187
GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP	C7_ immunologic signatures	171	1.6630504	0	0.030410351	GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP	174	1.1764886	0.11895161	0.6272817	2.839539	0.4865618
GO_CARDIOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	83	1.6626074	0	0.030540725	GO_CARDIOCYTE_DIFFERENTIATION	89	0.7395767	0.90246516	1	2.4021841	0.9230307
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	c2.CGP_ chemical and genetic perturbations	31	1.6623354	0.001481482	0.030602174	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	31	1.0711907	0.37985438	0.803148	2.7335261	0.5911447
GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN	C7_ immunologic signatures	176	1.6614943	0	0.030925775	GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN	177	0.69934475	0.9736041	1	2.36083905	0.96214955
GO_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.BP_ GO biological process	16	1.6604867	0.008038585	0.031299457	GO_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	15	0.9383266	0.56613755	0.99247164	2.5988133	0.7221601
GO_ORGAN_FORMATION	c5.BP_ GO biological process	31	1.6591275	0.006051437	0.03186255	GO_ORGAN_FORMATION	33	-1.0069448	0.38926175	0.6753732	0.6521827	2.6660723
GO_REGULATION_OF_MUSCLE_CONTRACTION	c5.BP_ GO biological process	122	1.6578542	0	0.032303154	GO_REGULATION_OF_MUSCLE_CONTRACTION	135	1.3423856	0.019467212	0.39260522	3.0002398	0.3154686
REACTOME_DNA_REPLICATION	c2.CP_REACTOME_ Reactome gene sets	174	1.657466	0	0.032399833	REACTOME_DNA_REPLICATION	176	-1.5156345	0	0.13372612	0.1418315	3.1731005
GO_REGULATION_OF_DNA_REPAIR	c5.BP_ GO biological process	61	1.6573892	0.005464481	0.032369833	GO_REGULATION_OF_DNA_REPAIR	61	0.7016248	0.9301552	1	2.359014	0.9557644
GO_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL	c5.BP_ GO biological process	32	1.6569737	0.010028653	0.032478318	GO_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL	35	1.6082689	0.004756243	0.14919272	3.2652426	0.0487048
GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION	c5.BP_ GO biological process	273	1.656248	0	0.03277381	GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION	280	1.3331592	0.002002002	0.40012836	2.9894072	0.3230888
GO_POSITIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION	c5.BP_ GO biological process	45	1.6559122	0.004279601	0.032861352	GO_POSITIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION	44	1.0316935	0.44925883	0.8738699	2.6876057	0.6242187
GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	151	1.6558061	0	0.032852188	GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	151	1.2230685	0.09081633	0.5513083	2.8788746	0.4327376
GO_MITOTIC_SPINDLE_ASSEMBLY	c5.BP_ GO biological process	37	1.6554036	0.004322767	0.032953084	GO_MITOTIC_SPINDLE_ASSEMBLY	38	1.1143779	0.3125721	0.73128986	2.7697815	0.5410257
LIM_MAMMARY_LUMINAL_MATURE_DN	c2.CGP_ chemical and genetic perturbations	96	1.6553241	0	0.03293164	LIM_MAMMARY_LUMINAL_MATURE_DN	93	0.8396014	0.78548557	1	2.4949255	0.8157227
GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	C7_ immunologic signatures	173	1.6544684	0	0.03327251	GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	169	1.1869273	0.109201215	0.6115452	2.8413957	0.4675411
GO_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION	c5.BP_ GO biological process	48	1.6541933	0.001426534	0.03337982	GO_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION	56	1.4053075	0.04171364	0.33388886	3.0595008	0.2488858
GO_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	34	1.6532384	0.007507508	0.03377079	GO_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT	35	1.375546	0.058894232	0.35661557	3.0287844	0.2776924
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	C7_ immunologic signatures	182	1.6527	0	0.033945255	GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	181	1.1301382	0.21218275	0.705656	2.7828382	0.5225618
GO_AXONAL_FASCICULATION	c5.BP_ GO biological process	18	1.6525961	0.006269592	0.033928372	GO_AXONAL_FASCICULATION	20	-1.2626817	0.16055046	0.31308925	0.3899144	2.9152778
GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP	C7_ immunologic signatures	181	1.6517782	0.001182033	0.034240976	GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP	181	1.1246799	0.21752267	0.71558815	2.7764581	0.5270983
GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN	C7_ immunologic signatures	158	1.6515929	0	0.034249343	GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN	158	1.2659229	0.055555556	0.48970684	2.9175158	0.38567
CHR2Q22	C1: positional gene sets	15	1.6503001	0.005172414	0.034727518	CHR2Q22	15	0.8558766	0.66577893	1	2.5061767	0.7944235
GO_SYNAPSIS	c5.BP_ GO biological process	26	1.6502675	0.00147929	0.034686994	GO_SYNAPSIS	30	1.9064621	0	0.00813899	3.5567296	-0.2561946
GO_SYNAPSE_ORGANIZATION	c5.BP_ GO biological process	134	1.6493099	0.002472188	0.035080597	GO_SYNAPSE_ORGANIZATION	140	1.2693444	0.058581706	0.48553392	2.9186543	0.3799655
GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN	C7_ immunologic signatures	177	1.649278	0	0.035038125	GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN	178	0.9033983	0.7387755	1	2.5526763	0.7458797
GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	165	1.6490427	0	0.035066206	GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	172	1.04491	0.40913707	0.84977645	2.6939527	0.6041327
KEGG_ECM_RECEPTOR_INTERACTION	c2.CP_BIOCARTA_ BioCarta gene sets	80	1.6489325	0	0.035050806	KEGG_ECM_RECEPTOR_INTERACTION	81	1.3003596	0.08012821	0.4416993	2.9492921	0.3485729
GO_BONE_MORPHOGENESIS	c5.BP_ GO biological process	72	1.6489283	0	0.034999635	GO_BONE_MORPHOGENESIS	76	0.7806724	0.85331905	1	2.4296007	0.8682559
GO_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	23	1.6481539	0.006462036	0.035291288	GO_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT	25	-1.1957512	0.18781726	0.38732368	0.4524027	2.8439051
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	c2.CGP_ chemical and genetic perturbations	119	1.6477987	0.001264223	0.035418417	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	130	1.3664408	0.010330578	0.37150207	3.0142395	0.2813579
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	c2.CGP_ chemical and genetic perturbations	16	1.6474931	0.003367003	0.03549608	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	17	0.75557095	0.7961039	1	2.40306405	0.89192215
GO_REGULATION_OF_CARTILAGE_DEVELOPMENT	c5.BP_ GO biological process	55	1.646769	0.005420054	0.035809055	GO_REGULATION_OF_CARTILAGE_DEVELOPMENT	57	1.0667682	0.39029768	0.81166154	2.7135372	0.5800008
HORIUCHI_WTAP_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	256	1.6460199	0	0.036143348	HORIUCHI_WTAP_TARGETS_UP	258	1.3399297	0.004004004	0.3965825	2.9859496	0.3060902
MODULE_474	c4.CM_ cancer modules	16	1.6459856	0.011494253	0.036105663	MODULE_474	17	0.7631086	0.80126584	1	2.4090942	0.882877
TOMLINS_PROSTATE_CANCER_DN	c2.CGP_ chemical and genetic perturbations	35	1.6458154	0.001545595	0.036127187	TOMLINS_PROSTATE_CANCER_DN	36	1.4210778	0.04540163	0.31867018	3.0668932	0.2247376
GO_REGULATION_OF_CYTOSKELETON_ORGANIZATION	c5.BP_ GO biological process	444	1.6455908	0	0.036151554	GO_REGULATION_OF_CYTOSKELETON_ORGANIZATION	453	1.0502368	0.333	0.84001505	2.6958276	0.595354
GO_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS	c5.BP_ GO biological process	71	1.6453304	0.001335114	0.036230236	GO_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS	77	1.077796	0.34623656	0.7916445	2.7231264	0.5675344
GO_SEMAPHORIN_RECEPTOR_BINDING	c5.GO molecular function	22	1.6448684	0.009202454	0.036395278	GO_SEMAPHORIN_RECEPTOR_BINDING	22	-0.9279926	0.5635359	0.7868968	0.7168758	2.572861
GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	175	1.6438073	0	0.036790088	GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	180	0.6720097	0.9787234	1	2.315817	0.9717976
GO_PROTEIN_LOCALIZATION_TO_CENTROSOME	c5.BP_ GO biological process	15	1.6434846	0.009983361	0.0368835	GO_PROTEIN_LOCALIZATION_TO_CENTROSOME	15	1.1634166	0.27662337	0.64809334	2.8069012	0.480068
GO_DNA_PACKAGING_COMPLEX	c5.CC_ GO cellular component	55	1.6434443	0.002853067	0.036845114	GO_DNA_PACKAGING_COMPLEX	55	1.336087	0.08651686	0.39818698	2.9795313	0.3073573
GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN	C7_ immunologic signatures	176	1.6431513	0	0.036917757	GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN	183	1.4082237	0.004028197	0.32792214	3.051375	0.2349276
PID_AURORA_A_PATHWAY	c2.CP_ Canonical pathways	30	1.6431153	0.004444445	0.03688088	PID_AURORA_A_PATHWAY	30	1.2297982	0.18258767	0.5415002	2.8729135	0.4133171
GO_DNA_REPLICATION_INITIATION	c5.BP_ GO biological process	27	1.6428658	0.00877193	0.036931466	GO_DNA_REPLICATION_INITIATION	28	-2.5166306	0	0	-0.8737648	4.1594964
CAIRO_HEPATOBLASTOMA_CLASSES_DN	c2.CGP_ chemical and genetic perturbations	179	1.6428214	0	0.036900524	CAIRO_HEPATOBLASTOMA_CLASSES_DN	188	1.4949417	0	0.2571318	3.1377631	0.1478797
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	c2.CGP_ chemical and genetic perturbations	226	1.6425955	0	0.03694802	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	235	1.0742419	0.30637008	0.7980865	2.7168374	0.5683536
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	53	1.642424	0.002906977	0.036973532	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	52	1.185268	0.2076566	0.61308146	2.827692	0.457156
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN	C7_ immunologic signatures	164	1.6418198	0	0.03721158	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN	169	0.8015525	0.8955375	1	2.4433723	0.8402673
GO_WNT_ACTIVATED_RECEPTOR_ACTIVITY	c5.GO molecular function	22	1.6417478	0.010339734	0.03717752	GO_WNT_ACTIVATED_RECEPTOR_ACTIVITY	22	0.8381246	0.7063291	1	2.4798724	0.8036232
CHR15Q24	C1: positional gene sets	63	1.6413755	0.002820875	0.03730053	CHR15Q24	64	1.5620838	0.002178649	0.1980442	3.2034593	0.0792917
GO_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY	c5.BP_ GO biological process	19	1.6411482	0.004615385	0.037352897	GO_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY	23	1.4148889	0.058080807	0.32243916	3.0560371	0.2262593
CROONQUIST_STROMAL_STIMULATION_UP	c2.CGP_ chemical and genetic perturbations	52	1.6410072	0.002824859	0.037364725	CROONQUIST_STROMAL_STIMULATION_UP	53	0.7994411	0.7957589	1	2.4404483	0.8415661
PID_AVB3_INTEGRIN_PATHWAY	c2.CP_ Canonical pathways	68	1.6404335	0.001342282	0.037580185	PID_AVB3_INTEGRIN_PATHWAY	70	1.0719512	0.37211856	0.80261886	2.7123847	0.5684823
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP	C7_ immunologic signatures	147	1.6396987	0	0.03789818	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP	148	1.216398	0.095918365	0.5634672	2.8560967	0.4233007
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	181	1.6395061	0	0.037910596	GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	182	0.8213955	0.8646999	1	2.4609016	0.8181106
GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN	C7_ immunologic signatures	121	1.6394802	0	0.03787152	GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN	128	1.1122776	0.24590164	0.7340918	2.7517578	0.5272026
GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN	C7_ immunologic signatures	117	1.6388482	0	0.038150553	GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN	122	0.92863035	0.653886	0.99943244	2.56747855	0.71021785
GO_MICROTUBULE_ASSOCIATED_COMPLEX	c5.CC_ GO cellular component	132	1.6387302	0	0.03816253	GO_MICROTUBULE_ASSOCIATED_COMPLEX	135	1.2288266	0.10051282	0.5433311	2.8675568	0.4099036
GO_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR	c5.BP_ GO biological process	28	1.63816	0.003021148	0.038389042	GO_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR	28	0.8383149	0.73341525	1	2.4764749	0.7998451
GO_TISSUE_MIGRATION	c5.BP_ GO biological process	74	1.6380756	0.001328021	0.038369343	GO_TISSUE_MIGRATION	78	1.1708275	0.21520342	0.63716537	2.8089031	0.4672481
GO_SUPRAMOLECULAR_FIBER	c5.CC_ GO cellular component	497	1.6379423	0	0.038356777	GO_SUPRAMOLECULAR_FIBER	497	0	0	0	1.6379423	1.6379423
GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_UP	C7_ immunologic signatures	171	1.6373578	0	0.03858626	GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_UP	172	0.911377	0.72239107	1	2.5487348	0.7259808
GO_MITOTIC_G2_M_TRANSITION_CHECKPOINT	c5.BP_ GO biological process	16	1.6367661	0.0096	0.038805146	GO_MITOTIC_G2_M_TRANSITION_CHECKPOINT	16	0.81594265	0.7208388	1	2.45270875	0.82082345
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	c2.CGP_ chemical and genetic perturbations	28	1.6360086	0.00443787	0.039160248	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	26	1.703004	0.001243781	0.08328656	3.3390126	-0.0669954
GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN	C7_ immunologic signatures	176	1.6352746	0	0.03948469	GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN	180	0.82171017	0.8742393	1	2.45698477	0.81356443
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	C7_ immunologic signatures	129	1.6351793	0	0.039472014	GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	135	1.2054665	0.11031665	0.5824828	2.8406458	0.4297128
KANG_FLUOROURACIL_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	21	1.6349932	0.010606061	0.039490245	KANG_FLUOROURACIL_RESISTANCE_UP	21	1.3017607	0.13299875	0.43884945	2.9367539	0.3332325
GO_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL	c5.BP_ GO biological process	37	1.634847	0.005899705	0.039515454	GO_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL	38	1.5354689	0.013888889	0.21580757	3.1703159	0.0993781
GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN	C7_ immunologic signatures	175	1.6343081	0	0.03972404	GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN	177	-1.1085584	0	0.50492865	0.5257497	2.7428665
MACLACHLAN_BRCA1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	15	1.634076	0.009630819	0.039783727	MACLACHLAN_BRCA1_TARGETS_DN	15	-1.1753155	0.21886793	0.41074643	0.4587605	2.8093915
CHR9P13	C1: positional gene sets	45	1.6340703	0.004201681	0.039726026	CHR9P13	47	0.8066335	0.7743764	1	2.4407038	0.8274368
CACTTTG_MIR520G_MIR520H	c3.MIR_ microRNA targets	208	1.6333534	0	0.04003788	CACTTTG_MIR520G_MIR520H	214	0.9531992	0.6305221	0.9780171	2.5865526	0.6801542
GO_NEGATIVE_REGULATION_OF_CELL_CYCLE	c5.BP_ GO biological process	385	1.632626	0	0.0403754	GO_NEGATIVE_REGULATION_OF_CELL_CYCLE	391	0.97053194	0.6156156	0.961189	2.60315794	0.66209406
GO_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	95	1.6324908	0.00128041	0.040381033	GO_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS	99	0.769214	0.8867925	1	2.4017048	0.8632768
DAUER_STAT3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	42	1.6324092	0.004304161	0.040375523	DAUER_STAT3_TARGETS_DN	42	1.5922126	0.004540295	0.17036608	3.2246218	0.0401966
REACTOME_FANCONI_ANEMIA_PATHWAY	c2.CP_REACTOME_ Reactome gene sets	18	1.6321349	0.012422361	0.040443543	REACTOME_FANCONI_ANEMIA_PATHWAY	18	-0.74228597	0.8730159	0.94055754	0.88984893	2.37442087
PID_INTEGRIN1_PATHWAY	c2.CP_ Canonical pathways	63	1.6320335	0.001340483	0.04042273	PID_INTEGRIN1_PATHWAY	64	0.9910083	0.5136911	0.93448865	2.6230418	0.6410252
GO_CHEMOREPELLENT_ACTIVITY	c5.GO molecular function	27	1.6317967	0.004815409	0.040473685	GO_CHEMOREPELLENT_ACTIVITY	27	0.7189542	0.87682927	1	2.3507509	0.9128425
GO_MICROTUBULE_BASED_PROCESS	c5.BP_ GO biological process	459	1.631502	0	0.040556297	GO_MICROTUBULE_BASED_PROCESS	465	1.2323568	0.012	0.5369646	2.8638588	0.3991452
GO_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER	c5.BP_ GO biological process	24	1.6312587	0.01065449	0.04061539	GO_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER	28	-1.2249286	0.15469614	0.34981138	0.4063301	2.8561873
CHX10_01	c3.TFT_ transcription factor targets	182	1.6309568	0	0.040716745	CHX10_01	201	0.9835715	0.5472837	0.9435133	2.6145283	0.6473853
E2F1_Q4_01	c3.TFT_ transcription factor targets	198	1.6309352	0	0.040666867	E2F1_Q4_01	204	-1.5393258	0	0.121083215	0.0916094	3.170261
GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP	C7_ immunologic signatures	180	1.630896	0	0.0406226	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP	180	-0.9761523	0.53846157	0.7189208	0.6547437	2.6070483
RICKMAN_HEAD_AND_NECK_CANCER_B	c2.CGP_ chemical and genetic perturbations	29	1.6303174	0.01055807	0.040826388	RICKMAN_HEAD_AND_NECK_CANCER_B	34	1.2518495	0.15571776	0.50814134	2.8821669	0.3784679
GO_BRANCH_ELONGATION_OF_AN_EPITHELIUM	c5.BP_ GO biological process	16	1.6302491	0.01141925	0.04079702	GO_BRANCH_ELONGATION_OF_AN_EPITHELIUM	16	-1.4239972	0.08130081	0.19176865	0.2062519	3.0542463
GEORGES_CELL_CYCLE_MIR192_TARGETS	c2.CGP_ chemical and genetic perturbations	58	1.6300341	0.006802721	0.040844202	GEORGES_CELL_CYCLE_MIR192_TARGETS	58	-1.2583914	0.074074075	0.31569552	0.3716427	2.8884255
CORRE_MULTIPLE_MYELOMA_DN	c2.CGP_ chemical and genetic perturbations	55	1.6297952	0.004178273	0.04089268	CORRE_MULTIPLE_MYELOMA_DN	55	0.9177535	0.632107	1	2.5475487	0.7120417
E2F_Q6_01	c3.TFT_ transcription factor targets	207	1.6288345	0	0.041307203	E2F_Q6_01	213	-1.7252215	0	0.049463265	-0.096387	3.354056
SABATES_COLORECTAL_ADENOMA_DN	c2.CGP_ chemical and genetic perturbations	221	1.6287247	0	0.04130725	SABATES_COLORECTAL_ADENOMA_DN	238	1.1783341	0.0950455	0.6243306	2.8070588	0.4503906
GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN	C7_ immunologic signatures	162	1.6283991	0	0.041430894	GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN	176	0.91103554	0.7195122	1	2.53943464	0.71736356
GO_ANKYRIN_BINDING	c5.GO molecular function	19	1.6283629	0.010670732	0.04139007	GO_ANKYRIN_BINDING	20	1.2164606	0.21045752	0.5633564	2.8448235	0.4119023
GO_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION	c5.BP_ GO biological process	25	1.628079	0.009345794	0.04147936	GO_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION	25	1.0739455	0.39526185	0.79881626	2.7020245	0.5541335
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	c2.CGP_ chemical and genetic perturbations	154	1.6280571	0	0.04142641	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	159	1.2395952	0.05900305	0.5260466	2.8676523	0.3884619
GO_GLYCOPROTEIN_COMPLEX	c5.CC_ GO cellular component	19	1.6275744	0.014354067	0.041615307	GO_GLYCOPROTEIN_COMPLEX	21	1.0985932	0.36363637	0.75877744	2.7261676	0.5289812
GSE14415_NATURAL_TREG_VS_TCONV_UP	C7_ immunologic signatures	131	1.6271566	0	0.041733496	GSE14415_NATURAL_TREG_VS_TCONV_UP	139	1.3195555	0.026449643	0.4128674	2.9467121	0.3076011
GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	177	1.6268809	0	0.0418218	GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP	177	0.80828935	0.8794326	1	2.43517025	0.81859155
GO_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	c5.BP_ GO biological process	95	1.6268634	0	0.041770034	GO_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	95	0.8565868	0.7736842	1	2.4834502	0.7702766
E2F_Q3_01	c3.TFT_ transcription factor targets	203	1.6268618	0	0.04171036	E2F_Q3_01	209	-1.5369763	0	0.12209354	0.0898855	3.1638381
BURTON_ADIPOGENESIS_PEAK_AT_0HR	c2.CGP_ chemical and genetic perturbations	59	1.6267844	0.004070556	0.04168703	BURTON_ADIPOGENESIS_PEAK_AT_0HR	59	0.92528033	0.6283186	1	2.55206473	0.70150407
GO_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING	c5.GO molecular function	47	1.6267546	0.008534851	0.041638352	GO_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING	46	1.0853653	0.3511628	0.7771255	2.7121199	0.5413893
GO_CAMP_BINDING	c5.GO molecular function	21	1.6260189	0.006299213	0.04196804	GO_CAMP_BINDING	21	0.9949922	0.49113923	0.9299535	2.6210111	0.6310267
GSE2706_UNSTIM_VS_2H_LPS_DC_DN	C7_ immunologic signatures	159	1.6259537	0	0.041941795	GSE2706_UNSTIM_VS_2H_LPS_DC_DN	158	1.1569341	0.18450561	0.6590525	2.7828878	0.4690196
GO_REGULATION_OF_BMP_SIGNALING_PATHWAY	c5.BP_ GO biological process	69	1.6256367	0.004137931	0.04204096	GO_REGULATION_OF_BMP_SIGNALING_PATHWAY	73	0.8740994	0.7022412	1	2.4997361	0.7515373
GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP	C7_ immunologic signatures	161	1.6255848	0	0.04200667	GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP	159	1.2364829	0.074338086	0.5308624	2.8620677	0.3891019
REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	34	1.6254709	0.004491018	0.042008393	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING	34	-1.1292673	0.24074075	0.47219524	0.4962036	2.7547382
MODULE_382	c4.CM_ cancer modules	18	1.6252166	0.012403101	0.04206586	MODULE_382	23	1.070636	0.38261998	0.8041482	2.6958526	0.5545806
CHR3P21	C1: positional gene sets	192	1.6251388	0	0.042054176	CHR3P21	201	-1.180044	0	0.4039722	0.4450948	2.8051828
GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN	C7_ immunologic signatures	177	1.6250716	0	0.042043924	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN	180	1.3589187	0.008097166	0.37808016	2.9839903	0.2661529
GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	179	1.6248869	0	0.042082515	GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN	181	0.9896206	0.52573156	0.9354122	2.6145075	0.6352663
GSE4142_PLASMA_CELL_VS_GC_BCELL_UP	C7_ immunologic signatures	174	1.6246884	0	0.042122416	GSE4142_PLASMA_CELL_VS_GC_BCELL_UP	180	1.307522	0.023302939	0.42885324	2.9322104	0.3171664
WESTON_VEGFA_TARGETS_6HR	c2.CGP_ chemical and genetic perturbations	53	1.6237528	0.001412429	0.042526193	WESTON_VEGFA_TARGETS_6HR	54	-1.2064664	0.13541667	0.3730362	0.4172864	2.8302192
GO_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION	c5.BP_ GO biological process	29	1.6237298	0.004531722	0.042481113	GO_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION	32	1.4493992	0.033333335	0.29166463	3.073129	0.1743306
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	71	1.6227161	0.001347709	0.042947333	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	74	1.3422314	0.055737704	0.3928718	2.9649475	0.2804847
VALK_AML_CLUSTER_13	c2.CGP_ chemical and genetic perturbations	25	1.6225519	0.00456621	0.04298709	VALK_AML_CLUSTER_13	27	1.3540245	0.08856089	0.38279504	2.9765764	0.2685274
GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	C7_ immunologic signatures	174	1.6221228	0	0.043140728	GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	178	1.0400958	0.4158215	0.8589868	2.6622186	0.582027
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	c2.CGP_ chemical and genetic perturbations	16	1.6216716	0.00610687	0.043305673	JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	17	-0.79057986	0.7767442	0.91379946	0.83109174	2.41225146
GO_CHROMOSOME_SEPARATION	c5.BP_ GO biological process	15	1.6216307	0.00619195	0.043263704	GO_CHROMOSOME_SEPARATION	16	1.3134713	0.12188729	0.41961214	2.935102	0.3081594
REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	c2.CP_REACTOME_ Reactome gene sets	29	1.6215345	0.00729927	0.0432506	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	29	-2.388131	0	0	-0.7665965	4.0096655
HNF3B_01	c3.TFT_ transcription factor targets	178	1.62147	0.001166861	0.043228444	HNF3B_01	188	1.1856321	0.10898083	0.6134271	2.8071021	0.4358379
GO_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION	c5.BP_ GO biological process	22	1.6213899	0.007668712	0.043212768	GO_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION	22	-0.6790785	0.9380952	0.9684039	0.9423114	2.3004684
GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN	C7_ immunologic signatures	153	1.6212177	0	0.043241397	GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN	160	0.973284	0.5768057	0.95808315	2.5945017	0.6479337
GO_FEMALE_MEIOTIC_DIVISION	c5.BP_ GO biological process	21	1.6212083	0.00764526	0.04318686	GO_FEMALE_MEIOTIC_DIVISION	22	1.5239693	0.020884521	0.23238383	3.1451776	0.097239
GO_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE	c5.BP_ GO biological process	122	1.6210318	0	0.043214165	GO_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE	126	1.1235067	0.24871531	0.7187807	2.7445385	0.4975251
GO_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION	c5.BP_ GO biological process	85	1.6209902	0.001312336	0.04317147	GO_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION	93	1.3721322	0.032700423	0.36511704	2.9931224	0.248858
DOANE_RESPONSE_TO_ANDROGEN_DN	c2.CGP_ chemical and genetic perturbations	212	1.619682	0	0.043826915	DOANE_RESPONSE_TO_ANDROGEN_DN	216	1.1302934	0.19095477	0.7059287	2.7499754	0.4893886
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	c2.CGP_ chemical and genetic perturbations	92	1.6194768	0.001305483	0.043871257	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	91	1.0232685	0.4340021	0.8862528	2.6427453	0.5962083
GO_CELLULAR_RESPONSE_TO_CALCIUM_ION	c5.BP_ GO biological process	43	1.6191674	0.008571428	0.043969654	GO_CELLULAR_RESPONSE_TO_CALCIUM_ION	44	1.4717873	0.025114154	0.27631044	3.0909547	0.1473801
GO_POSITIVE_REGULATION_OF_GLUCOSE_TRANSPORT	c5.BP_ GO biological process	36	1.6191397	0.003021148	0.043922268	GO_POSITIVE_REGULATION_OF_GLUCOSE_TRANSPORT	38	-0.8262722	0.79577464	0.88585603	0.7928675	2.4454119
CHR13Q34	C1: positional gene sets	30	1.6189361	0.013554217	0.043957278	CHR13Q34	30	1.1047655	0.346651	0.7474886	2.7237016	0.5141706
E2F_Q3	c3.TFT_ transcription factor targets	192	1.6187797	0	0.043996066	E2F_Q3	200	-1.8571863	0	0.023622876	-0.2384066	3.475966
GO_REGULATION_OF_HEART_CONTRACTION	c5.BP_ GO biological process	188	1.6186166	0	0.044033475	GO_REGULATION_OF_HEART_CONTRACTION	207	1.3856394	0.002018163	0.35067976	3.004256	0.2329772
GO_REGULATION_OF_BLOOD_CIRCULATION	c5.BP_ GO biological process	243	1.6179321	0	0.044313908	GO_REGULATION_OF_BLOOD_CIRCULATION	273	1.4923241	0	0.2573432	3.1102562	0.125608
NAKAMURA_ADIPOGENESIS_EARLY_DN	c2.CGP_ chemical and genetic perturbations	36	1.61744	0.011594203	0.04450677	NAKAMURA_ADIPOGENESIS_EARLY_DN	36	-1.0135069	0.3649635	0.66839004	0.6039331	2.6309469
GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	C7_ immunologic signatures	101	1.6163323	0.001264223	0.045064148	GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	113	1.5365674	0.002053388	0.21514831	3.1528997	0.0797649
GO_RESPONSE_TO_MECHANICAL_STIMULUS	c5.BP_ GO biological process	188	1.6161034	0	0.0451318	GO_RESPONSE_TO_MECHANICAL_STIMULUS	199	1.219191	0.07692308	0.556197	2.8352944	0.3969124
GO_REGULATION_OF_GLUCOSE_IMPORT	c5.BP_ GO biological process	53	1.6157715	0.00284495	0.045271832	GO_REGULATION_OF_GLUCOSE_IMPORT	54	0.769031	0.85123044	1	2.3848025	0.8467405
GO_RESPONSE_TO_UV_B	c5.BP_ GO biological process	15	1.6154048	0.014827018	0.04540762	GO_RESPONSE_TO_UV_B	15	0	0	0	1.6154048	1.6154048
GO_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS	c5.BP_ GO biological process	25	1.6150757	0.009063444	0.04551388	GO_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS	26	0.86308557	0.6781751	1	2.47816127	0.75199013
GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	187	1.6146177	0	0.045684543	GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN	190	1.1128798	0.2512563	0.73308283	2.7274975	0.5017379
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP	C7_ immunologic signatures	169	1.6144578	0	0.04570787	GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP	175	1.2765094	0.038345106	0.47861254	2.8909672	0.3379484
KARAKAS_TGFB1_SIGNALING	c2.CGP_ chemical and genetic perturbations	15	1.6141824	0.008103727	0.045831054	KARAKAS_TGFB1_SIGNALING	15	-1.0267932	0.3707317	0.6456099	0.5873892	2.6409756
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP	C7_ immunologic signatures	171	1.6139827	0	0.045874186	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP	176	0.7827536	0.910101	1	2.3967363	0.8312291
GO_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION	c5.BP_ GO biological process	59	1.6131896	0.00265252	0.046264015	GO_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION	61	1.1650892	0.21945946	0.64623857	2.7782788	0.4481004
GO_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS	c5.BP_ GO biological process	15	1.6131687	0.014802632	0.046207037	GO_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS	16	0.98920697	0.50259066	0.93626523	2.60237567	0.62396173
GO_RESPONSE_TO_ALKALOID	c5.BP_ GO biological process	114	1.6128389	0	0.04632124	GO_RESPONSE_TO_ALKALOID	126	1.2441239	0.08367769	0.5210024	2.8569628	0.368715
GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	C7_ immunologic signatures	183	1.6126266	0	0.046361066	GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	184	1.0137147	0.4651163	0.9000312	2.6263413	0.5989119
GEORGANTAS_HSC_MARKERS	c2.CGP_ chemical and genetic perturbations	49	1.6122417	0.002886003	0.046479765	GEORGANTAS_HSC_MARKERS	54	1.2720146	0.114735655	0.48259205	2.8842563	0.3402271
GO_CELLULAR_RESPONSE_TO_IONIZING_RADIATION	c5.BP_ GO biological process	49	1.6118966	0.005698006	0.046610728	GO_CELLULAR_RESPONSE_TO_IONIZING_RADIATION	49	1.1055934	0.313416	0.7463566	2.71749	0.5063032
GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN	C7_ immunologic signatures	161	1.6115277	0	0.046765115	GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN	164	0.8806972	0.7658487	1	2.4922249	0.7308305
CHR8P12	C1: positional gene sets	28	1.6114081	0.012066365	0.046761695	CHR8P12	27	0.89694536	0.6328502	1	2.50835346	0.71446274
GO_DNA_DEPENDENT_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY	c5.BP_ GO biological process	16	1.6111462	0.004784689	0.04684795	GO_DNA_DEPENDENT_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY	16	-0.87081707	0.6570248	0.85451514	0.74032913	2.48196327
STTTCRNTTT_IRF_Q6	c3.TFT_ transcription factor targets	170	1.6110468	0	0.046843056	STTTCRNTTT_IRF_Q6	173	1.0548474	0.37209302	0.83327657	2.6658942	0.5561994
PID_SYNDECAN_1_PATHWAY	c2.CP_ Canonical pathways	40	1.6109383	0.00723589	0.046833184	PID_SYNDECAN_1_PATHWAY	41	0.84898967	0.7107728	1	2.45992797	0.76194863
GO_MUSCLE_ORGAN_DEVELOPMENT	c5.BP_ GO biological process	239	1.6101596	0	0.047217418	GO_MUSCLE_ORGAN_DEVELOPMENT	253	1.0428091	0.3815261	0.8536787	2.6529687	0.5673505
GO_DNA_SECONDARY_STRUCTURE_BINDING	c5.GO molecular function	20	1.6097473	0.007518797	0.047404643	GO_DNA_SECONDARY_STRUCTURE_BINDING	21	-0.9546004	0.5247525	0.75053656	0.6551469	2.5643477
GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	158	1.6096416	0	0.04740404	GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN	158	0.57987	0.9979613	1	2.1895116	1.0297716
GO_REGULATION_OF_CELL_CYCLE_PROCESS	c5.BP_ GO biological process	491	1.6090744	0	0.04764256	GO_REGULATION_OF_CELL_CYCLE_PROCESS	491	0	0	0	1.6090744	1.6090744
KANG_DOXORUBICIN_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	17	1.6090037	0.015822785	0.047623158	KANG_DOXORUBICIN_RESISTANCE_DN	17	0.5918926	0.9520104	1	2.2008963	1.0171111
GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP	C7_ immunologic signatures	151	1.6087986	0	0.047701407	GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP	154	1.3623571	0.005107252	0.37555397	2.9711557	0.2464415
GO_REGULATION_OF_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS	c5.BP_ GO biological process	15	1.6085473	0.00974026	0.04779787	GO_REGULATION_OF_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS	16	0.95679235	0.5516796	0.9753847	2.56533965	0.65175495
GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	C7_ immunologic signatures	178	1.6079221	0	0.04809741	GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	180	1.0390123	0.407669	0.8598989	2.6469344	0.5689098
GO_MATING	c5.BP_ GO biological process	31	1.6076337	0.010542168	0.04821279	GO_MATING	31	1.258643	0.13793103	0.49830085	2.8662767	0.3489907
PIT1_Q6	c3.TFT_ transcription factor targets	190	1.607227	0	0.04840028	PIT1_Q6	204	0.95878756	0.6028226	0.9719996	2.56601456	0.64843944
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	c2.CP_REACTOME_ Reactome gene sets	60	1.6068212	0.002766252	0.04855307	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	60	0.6965705	0.922049	1	2.3033917	0.9102507
E2F_Q6	c3.TFT_ transcription factor targets	202	1.606513	0	0.048672296	E2F_Q6	207	-1.7957581	0	0.03351138	-0.1892451	3.4022711
GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	C7_ immunologic signatures	183	1.606292	0	0.048744734	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	183	0.86819625	0.7957317	1	2.47448825	0.73809575
KAUFFMANN_DNA_REPAIR_GENES	c2.CGP_ chemical and genetic perturbations	213	1.6062509	0	0.048710715	KAUFFMANN_DNA_REPAIR_GENES	214	-0.8300832	1	0.8824396	0.7761677	2.4363341
EINAV_INTERFERON_SIGNATURE_IN_CANCER	c2.CGP_ chemical and genetic perturbations	21	1.6060514	0.0171875	0.048768334	EINAV_INTERFERON_SIGNATURE_IN_CANCER	20	1.0787331	0.39490446	0.78960043	2.6847845	0.5273183
GO_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY	c5.GO molecular function	25	1.606009	0.009345794	0.048733078	GO_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY	25	-1.3752967	0.06285714	0.22334507	0.2307123	2.9813057
GO_POSITIVE_REGULATION_OF_BLOOD_PRESSURE	c5.BP_ GO biological process	28	1.6058978	0.011887073	0.048735667	GO_POSITIVE_REGULATION_OF_BLOOD_PRESSURE	31	1.2829785	0.1216545	0.467597	2.8888763	0.3229193
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	c2.CGP_ chemical and genetic perturbations	109	1.6054916	0.003831418	0.048884153	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	107	1.1793516	0.15756303	0.62396973	2.7848432	0.42614
GO_SYNAPTONEMAL_COMPLEX_ORGANIZATION	c5.BP_ GO biological process	17	1.6054182	0.007886435	0.04885624	GO_SYNAPTONEMAL_COMPLEX_ORGANIZATION	20	1.7258792	0.001272265	0.06928819	3.3312974	-0.120461
GO_CELL_MORPHOGENESIS_INVOLVED_IN_NEURON_DIFFERENTIATION	c5.BP_ GO biological process	337	1.6053659	0	0.04882353	GO_CELL_MORPHOGENESIS_INVOLVED_IN_NEURON_DIFFERENTIATION	352	0.9291389	0.726	0.99917084	2.5345048	0.676227
GO_TUBULIN_BINDING	c5.GO molecular function	244	1.6048434	0	0.04904999	GO_TUBULIN_BINDING	244	1.2841587	0.015060241	0.4655824	2.8890021	0.3206847
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	c2.CGP_ chemical and genetic perturbations	26	1.6045763	0.010752688	0.049148824	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	26	1.3897272	0.06832298	0.34554952	2.9943035	0.2148491
GSE3982_DC_VS_MAC_DN	C7_ immunologic signatures	163	1.6045383	0	0.049109768	GSE3982_DC_VS_MAC_DN	170	0.9542226	0.6010152	0.9770991	2.5587609	0.6503157
GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	C7_ immunologic signatures	145	1.6045079	0	0.049069636	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	149	1.2800161	0.055837564	0.4720773	2.884524	0.3244918
GO_EPITHELIAL_CELL_PROLIFERATION	c5.BP_ GO biological process	82	1.6037946	0	0.049411338	GO_EPITHELIAL_CELL_PROLIFERATION	84	-1.0486048	0.30612245	0.6081794	0.5551898	2.6523994
GABRIELY_MIR21_TARGETS	c2.CGP_ chemical and genetic perturbations	265	1.6027088	0	0.049980734	GABRIELY_MIR21_TARGETS	266	0.8893309	0.7931727	1	2.4920397	0.7133779
GO_FEMALE_GAMETE_GENERATION	c5.BP_ GO biological process	79	1.6021249	0.002673797	0.05026181	GO_FEMALE_GAMETE_GENERATION	88	1.6982785	0	0.08118156	3.3004034	-0.0961536
E2F1DP1RB_01	c3.TFT_ transcription factor targets	202	1.6017172	0	0.0504496	E2F1DP1RB_01	208	-1.9203188	0	0.015758729	-0.3186016	3.522036
GO_REGULATION_OF_REPRODUCTIVE_PROCESS	c5.BP_ GO biological process	112	1.6014752	0.001272265	0.05054825	GO_REGULATION_OF_REPRODUCTIVE_PROCESS	122	0.8105666	0.84782606	1	2.4120418	0.7909086
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	c2.CGP_ chemical and genetic perturbations	70	1.6011711	0.005540166	0.050666988	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	73	0.9921524	0.49733192	0.9335131	2.5933235	0.6090187
MODULE_259	c4.CM_ cancer modules	44	1.6008421	0.008298756	0.050793804	MODULE_259	44	1.0170556	0.4875	0.89407396	2.6178977	0.5837865
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	c2.CGP_ chemical and genetic perturbations	20	1.60071	0.009677419	0.05080206	WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	19	-1.4789381	0.06481481	0.1558474	0.1217719	3.0796481
GO_REPLACEMENT_OSSIFICATION	c5.BP_ GO biological process	23	1.6003696	0.01863354	0.050936718	GO_REPLACEMENT_OSSIFICATION	24	-1.2114279	0.1790393	0.36679766	0.3889417	2.8117975
HAN_JNK_SINGALING_UP	c2.CGP_ chemical and genetic perturbations	32	1.6003011	0.01174743	0.050911427	HAN_JNK_SINGALING_UP	31	-1.0591959	0.35428572	0.58914155	0.5411052	2.659497
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	c2.CGP_ chemical and genetic perturbations	465	1.6002411	0	0.050879106	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	470	1.3759764	0	0.3574645	2.9762175	0.2242647
E2F_Q4	c3.TFT_ transcription factor targets	204	1.5995339	0.001154734	0.051199596	E2F_Q4	210	-1.8490435	0	0.024938483	-0.2495096	3.4485774
GO_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION	c5.BP_ GO biological process	135	1.5991902	0	0.05133175	GO_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION	136	1.0940018	0.299389	0.7673532	2.693192	0.5051884
HECKER_IFNB1_TARGETS	c2.CGP_ chemical and genetic perturbations	67	1.5989662	0.002677376	0.051408045	HECKER_IFNB1_TARGETS	65	1.670308	0	0.09616382	3.2692742	-0.0713418
E2F1_Q3	c3.TFT_ transcription factor targets	214	1.5988828	0	0.051379934	E2F1_Q3	219	-1.6604184	0	0.068229035	-0.0615356	3.2593012
GO_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY	c5.BP_ GO biological process	17	1.5987878	0.011006289	0.051385023	GO_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY	17	0.6154735	0.93979055	1	2.2142613	0.9833143
GO_SPINDLE_LOCALIZATION	c5.BP_ GO biological process	37	1.598472	0.00739645	0.051521085	GO_SPINDLE_LOCALIZATION	37	0.9640408	0.5219454	0.9667081	2.5625128	0.6344312
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	c2.CGP_ chemical and genetic perturbations	38	1.5984106	0.013615734	0.051492937	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	39	1.05645	0.37955347	0.8305711	2.6548606	0.5419606
IRF7_01	c3.TFT_ transcription factor targets	215	1.5979512	0	0.051692184	IRF7_01	225	1.2079607	0.061491936	0.58049935	2.8059119	0.3899905
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	c2.CGP_ chemical and genetic perturbations	275	1.5978317	0	0.051691007	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	274	0.7074566	0.984985	1	2.3052883	0.8903751
GO_AXON_EXTENSION	c5.BP_ GO biological process	36	1.5973514	0.00466563	0.051895432	GO_AXON_EXTENSION	36	0.80850136	0.778436	1	2.40585276	0.78885004
GO_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS	c5.BP_ GO biological process	22	1.5971786	0.020802377	0.051931493	GO_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS	22	-1.0388298	0.3915344	0.6243415	0.5583488	2.6360084
GO_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION	c5.BP_ GO biological process	34	1.5971754	0.011713031	0.05186674	GO_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION	34	1.2932788	0.13404508	0.45215836	2.8904542	0.3038966
GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP	C7_ immunologic signatures	173	1.5971557	0	0.05181503	GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP	175	0.9573327	0.60507613	0.9747674	2.5544884	0.639823
PODAR_RESPONSE_TO_ADAPHOSTIN_UP	c2.CGP_ chemical and genetic perturbations	127	1.5970513	0	0.051821962	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	128	0.9018937	0.6890496	1	2.498945	0.6951576
KANG_IMMORTALIZED_BY_TERT_UP	c2.CGP_ chemical and genetic perturbations	76	1.5966564	0.002713704	0.051978197	KANG_IMMORTALIZED_BY_TERT_UP	78	1.1216518	0.27331188	0.7222563	2.7183082	0.4750046
VALK_AML_WITH_EVI1	c2.CGP_ chemical and genetic perturbations	19	1.5964842	0.008090615	0.052017476	VALK_AML_WITH_EVI1	21	1.1770375	0.25977302	0.62652826	2.7735217	0.4194467
COWLING_MYCN_TARGETS	c2.CGP_ chemical and genetic perturbations	36	1.5961542	0.005747126	0.05216138	COWLING_MYCN_TARGETS	39	1.2400782	0.15758981	0.5258013	2.8362324	0.356076
GO_CARDIAC_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	65	1.5961297	0.001385042	0.052110776	GO_CARDIAC_MUSCLE_CELL_DIFFERENTIATION	69	0.8145797	0.79332614	1	2.4107094	0.78155
GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP	C7_ immunologic signatures	179	1.5960554	0	0.052095164	GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP	179	-1.0036479	0.42857143	0.6783246	0.5924075	2.5997033
CHR3Q22	C1: positional gene sets	34	1.5956684	0.004424779	0.052282706	CHR3Q22	35	0.90726334	0.61871344	1	2.50293174	0.68840506
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	c2.CGP_ chemical and genetic perturbations	28	1.595479	0.004538578	0.05232257	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	30	0.6218697	0.9390681	1	2.2173487	0.9736093
GO_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	32	1.5954264	0.010463378	0.05229285	GO_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION	33	1.0729967	0.37793428	0.80079216	2.6684231	0.5224297
GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN	C7_ immunologic signatures	180	1.5945551	0	0.052775066	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN	181	1.2830942	0.037373737	0.46735293	2.8776493	0.3114609
E2F1_Q6	c3.TFT_ transcription factor targets	206	1.5943153	0	0.052870702	E2F1_Q6	209	-1.7661216	0	0.040083893	-0.1718063	3.3604369
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	c2.CGP_ chemical and genetic perturbations	32	1.5941421	0.00739645	0.052909557	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	39	1.5601648	0.008215962	0.19774967	3.1543069	0.0339773
PLASARI_TGFB1_TARGETS_10HR_DN	c2.CGP_ chemical and genetic perturbations	227	1.5935011	0	0.05328571	PLASARI_TGFB1_TARGETS_10HR_DN	225	1.1416888	0.18054162	0.6875919	2.7351899	0.4518123
GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN	C7_ immunologic signatures	174	1.5934789	0	0.05323661	GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN	173	-1.669727	0	0.06514815	-0.0762481	3.2632059
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	169	1.5930685	0	0.05342319	GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	175	1.0345896	0.42654508	0.8680908	2.6276581	0.5584789
CHICAS_RB1_TARGETS_CONFLUENT	c2.CGP_ chemical and genetic perturbations	499	1.5929772	0	0.053410728	CHICAS_RB1_TARGETS_CONFLUENT	499	0	0	0	1.5929772	1.5929772
GO_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	23	1.5928503	0.009630819	0.05341668	GO_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	25	1.2001091	0.23197116	0.592092	2.7929594	0.3927412
GO_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY	c5.BP_ GO biological process	36	1.5926231	0.013533834	0.053474072	GO_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY	36	0.842768	0.7115151	1	2.4353911	0.7498551
KRAS.PROSTATE_UP.V1_UP	C6_ oncogenic signatures	107	1.5923511	0.003802281	0.05358375	KRAS.PROSTATE_UP.V1_UP	110	1.4612986	0.004149378	0.2819753	3.0536497	0.1310525
GO_NEURON_PROJECTION_MORPHOGENESIS	c5.BP_ GO biological process	364	1.5920074	0	0.053728662	GO_NEURON_PROJECTION_MORPHOGENESIS	383	0.9950496	0.5365365	0.9303005	2.587057	0.5969578
NIELSEN_LEIOMYOSARCOMA_DN	c2.CGP_ chemical and genetic perturbations	15	1.5918016	0.022375215	0.05378886	NIELSEN_LEIOMYOSARCOMA_DN	15	0.9276157	0.60367453	1	2.5194173	0.6641859
GO_CARBOHYDRATE_DERIVATIVE_CATABOLIC_PROCESS	c5.BP_ GO biological process	155	1.5914927	0	0.05390584	GO_CARBOHYDRATE_DERIVATIVE_CATABOLIC_PROCESS	157	1.1694684	0.15955284	0.6386178	2.7609611	0.4220243
HALMOS_CEBPA_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	43	1.5905809	0.00736377	0.054420784	HALMOS_CEBPA_TARGETS_UP	44	0.9935891	0.4864865	0.9310155	2.58417	0.5969918
GO_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION	c5.BP_ GO biological process	24	1.58984	0.014729951	0.054821916	GO_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION	27	1.6141748	0.00120337	0.14701332	3.2040148	-0.0243348
GO_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	208	1.5897397	0	0.054827232	GO_MUSCLE_CELL_DIFFERENTIATION	217	0.9883503	0.54334676	0.93713766	2.57809	0.6013894
GO_RESPONSE_TO_COCAINE	c5.BP_ GO biological process	38	1.5892491	0.013081395	0.055085305	GO_RESPONSE_TO_COCAINE	42	0.8797958	0.66323024	1	2.4690449	0.7094533
CHR11Q24	C1: positional gene sets	58	1.5888329	0.006821282	0.055305384	CHR11Q24	61	1.361512	0.05698324	0.37600452	2.9503449	0.2273209
GO_REGULATION_OF_CALCIUM_ION_TRANSPORT	c5.BP_ GO biological process	165	1.5881886	0	0.055681027	GO_REGULATION_OF_CALCIUM_ION_TRANSPORT	180	1.4635414	0	0.28186736	3.05173	0.1246472
GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP	C7_ immunologic signatures	176	1.5869716	0	0.056410223	GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP	179	0.82459795	0.8634985	1	2.41156955	0.76237365
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	c2.CGP_ chemical and genetic perturbations	171	1.5868093	0	0.056455437	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	174	0.83635765	0.8331648	1	2.42316695	0.75045165
E2F_Q4_01	c3.TFT_ transcription factor targets	202	1.5864378	0	0.056626607	E2F_Q4_01	208	-1.7456208	0	0.0443294	-0.159183	3.3320586
GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	C7_ immunologic signatures	167	1.5863843	0.001191895	0.056588072	GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	173	1.0047433	0.4811417	0.91585726	2.5911276	0.581641
MODULE_12	c4.CM_ cancer modules	322	1.5863278	0	0.05655525	MODULE_12	327	0.97850126	0.578	0.9512555	2.56482906	0.60782654
GAVIN_FOXP3_TARGETS_CLUSTER_P4	c2.CGP_ chemical and genetic perturbations	91	1.5861624	0	0.056596592	GAVIN_FOXP3_TARGETS_CLUSTER_P4	93	1.5086209	0.002114165	0.24369381	3.0947833	0.0775415
REACTOME_MITOTIC_M_M_G1_PHASES	c2.CP_REACTOME_ Reactome gene sets	155	1.5859348	0.00249066	0.056656998	REACTOME_MITOTIC_M_M_G1_PHASES	157	-1.5431718	0	0.11890275	0.042763	3.1291066
HFH8_01	c3.TFT_ transcription factor targets	173	1.5855033	0	0.05688393	HFH8_01	179	1.0080428	0.485309	0.91090786	2.5935461	0.5774605
GO_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS	c5.BP_ GO biological process	23	1.5853975	0.015313936	0.05687774	GO_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS	24	-1.1261362	0.2752809	0.47755584	0.4592613	2.7115337
REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	c2.CP_REACTOME_ Reactome gene sets	15	1.585146	0.016155088	0.05696981	REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	15	1.1006476	0.35231787	0.7564543	2.6857936	0.4844984
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	c2.CGP_ chemical and genetic perturbations	38	1.5849329	0.011560693	0.05705281	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	39	1.0193715	0.46272188	0.8916705	2.6043044	0.5655614
GO_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	22	1.5848858	0.02764977	0.057016358	GO_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION	26	-0.8284256	0.7970297	0.8838947	0.7564602	2.4133114
GO_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION	c5.BP_ GO biological process	36	1.5848371	0.011976048	0.05697994	GO_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION	42	1.1639191	0.25115207	0.6474911	2.7487562	0.420918
GO_DEVELOPMENTAL_GROWTH	c5.BP_ GO biological process	299	1.5848291	0	0.056916956	GO_DEVELOPMENTAL_GROWTH	309	0.88685846	0.81444335	1	2.47168756	0.69797064
GO_ACTIN_MEDIATED_CELL_CONTRACTION	c5.BP_ GO biological process	62	1.5845634	0.006839945	0.057035178	GO_ACTIN_MEDIATED_CELL_CONTRACTION	69	1.5059329	0.007600434	0.24616066	3.0904963	0.0786305
GO_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION	c5.BP_ GO biological process	24	1.5843552	0.024024025	0.057101976	GO_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION	29	1.0932906	0.33861145	0.76808554	2.6776458	0.4910646
GO_MICROTUBULE_POLYMERIZATION	c5.BP_ GO biological process	25	1.5843166	0.011994003	0.057061203	GO_MICROTUBULE_POLYMERIZATION	25	0.786227	0.8002436	1	2.3705436	0.7980896
GO_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	62	1.5841136	0.009831461	0.057138957	GO_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT	68	1.3624579	0.033659067	0.37616584	2.9465715	0.2216557
ONDER_CDH1_TARGETS_2_UP	c2.CGP_ chemical and genetic perturbations	238	1.5840824	0	0.057089448	ONDER_CDH1_TARGETS_2_UP	241	1.0835705	0.27208835	0.78051996	2.6676529	0.5005119
GO_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION	c5.BP_ GO biological process	15	1.583602	0.021416804	0.05736245	GO_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION	15	0.6902876	0.8831341	1	2.2738896	0.8933144
LINDGREN_BLADDER_CANCER_CLUSTER_2B	c2.CGP_ chemical and genetic perturbations	331	1.5834333	0	0.057385545	LINDGREN_BLADDER_CANCER_CLUSTER_2B	340	1.0991507	0.21943888	0.7582364	2.682584	0.4842826
GO_REGULATION_OF_WOUND_HEALING	c5.BP_ GO biological process	105	1.5831712	0.002570694	0.057494428	GO_REGULATION_OF_WOUND_HEALING	110	1.8730088	0	0.01686056	3.45618	-0.2898376
GO_MUSCLE_SYSTEM_PROCESS	c5.BP_ GO biological process	245	1.5831369	0	0.057452384	GO_MUSCLE_SYSTEM_PROCESS	262	1.354038	0.002006018	0.38306358	2.9371749	0.2290989
GO_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT	c5.BP_ GO biological process	22	1.5830648	0.012403101	0.05742586	GO_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT	23	0.84630084	0.7039801	1	2.42936564	0.73676396
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	c2.CGP_ chemical and genetic perturbations	146	1.582741	0	0.057536636	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	153	1.3017323	0.031536113	0.4384624	2.8844733	0.2810087
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	c2.CGP_ chemical and genetic perturbations	108	1.582468	0.003875969	0.057659123	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	108	1.2681592	0.056818184	0.48666608	2.8506272	0.3143088
GO_CENTROSOME	c5.CC_ GO cellular component	440	1.5821483	0	0.057812992	GO_CENTROSOME	442	0.91466385	0.778	1	2.49681215	0.66748445
GO_SUBSTRATE_DEPENDENT_CELL_MIGRATION	c5.BP_ GO biological process	24	1.5820826	0.012658228	0.057783965	GO_SUBSTRATE_DEPENDENT_CELL_MIGRATION	24	0.7301797	0.84126985	1	2.3122623	0.8519029
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	c2.CGP_ chemical and genetic perturbations	244	1.5814631	0	0.058092464	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	246	0.7231505	0.9739479	1	2.3046136	0.8583126
MODULE_200	c4.CM_ cancer modules	26	1.5807273	0.006153846	0.058496468	MODULE_200	27	1.3131739	0.123581335	0.42025384	2.8939012	0.2675534
MODULE_201	c4.CM_ cancer modules	46	1.5803742	0.005813954	0.05867058	MODULE_201	48	1.5754656	0.004550626	0.18356127	3.1558398	0.0049086
GO_REGULATION_OF_SPINDLE_ORGANIZATION	c5.BP_ GO biological process	18	1.5802557	0.014469453	0.058685303	GO_REGULATION_OF_SPINDLE_ORGANIZATION	18	1.0531793	0.41482446	0.83599997	2.633435	0.5270764
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN	C7_ immunologic signatures	174	1.5797879	0	0.05892291	GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN	172	1.0860363	0.29685917	0.7761168	2.6658242	0.4937516
ZHU_CMV_24_HR_DN	c2.CGP_ chemical and genetic perturbations	81	1.5796446	0.00273224	0.05894702	ZHU_CMV_24_HR_DN	85	-1.3717067	0	0.22544055	0.2079379	2.9513513
GO_DNA_PACKAGING	c5.BP_ GO biological process	131	1.5793513	0	0.059084117	GO_DNA_PACKAGING	133	1.0184685	0.4596527	0.89219606	2.5978198	0.5608828
GO_MICROTUBULE_END	c5.CC_ GO cellular component	20	1.579329	0.012698413	0.059033282	GO_MICROTUBULE_END	20	1.232164	0.19358975	0.5369667	2.811493	0.347165
GO_GERM_CELL_NUCLEUS	c5.CC_ GO cellular component	15	1.5790519	0.024350649	0.059148233	GO_GERM_CELL_NUCLEUS	17	1.3295422	0.11068211	0.40310422	2.9085941	0.2495097
REACTOME_SIGNALING_BY_FGFR_MUTANTS	c2.CP_REACTOME_ Reactome gene sets	42	1.5789022	0.012693935	0.05919372	REACTOME_SIGNALING_BY_FGFR_MUTANTS	42	0.8978661	0.66009283	1	2.4767683	0.6810361
WALLACE_PROSTATE_CANCER_RACE_UP	c2.CGP_ chemical and genetic perturbations	218	1.5786806	0	0.059277937	WALLACE_PROSTATE_CANCER_RACE_UP	233	1.1010606	0.24172518	0.7554986	2.6797412	0.47762
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN	C7_ immunologic signatures	179	1.577796	0	0.059799895	GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN	180	0.6991048	0.97379035	1	2.2769008	0.8786912
GO_REGULATION_OF_MITOTIC_CELL_CYCLE	c5.BP_ GO biological process	418	1.5776962	0	0.059783053	GO_REGULATION_OF_MITOTIC_CELL_CYCLE	430	0.9562058	0.6576577	0.97561175	2.533902	0.6214904
GO_CONTRACTILE_FIBER	c5.CC_ GO cellular component	182	1.577622	0	0.05977152	GO_CONTRACTILE_FIBER	199	1.420493	0.001013171	0.3184796	2.998115	0.157129
GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	C7_ immunologic signatures	167	1.5771885	0	0.05998916	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	163	1.1079098	0.28600407	0.7410435	2.6850983	0.4692787
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	c2.CGP_ chemical and genetic perturbations	54	1.5771501	0.008344923	0.059939954	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	56	1.1192545	0.28139013	0.72382766	2.6964046	0.4578956
GO_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION	c5.BP_ GO biological process	34	1.5771277	0.007451565	0.0598855	GO_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION	33	0.79589427	0.7837209	1	2.37302197	0.78123343
GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	C7_ immunologic signatures	118	1.577105	0.001246883	0.05982792	GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	128	1.2281675	0.098663926	0.54367846	2.8052725	0.3489375
REACTOME_KINESINS	c2.CP_REACTOME_ Reactome gene sets	22	1.5753025	0.015873017	0.06100447	REACTOME_KINESINS	23	1.0109615	0.45566502	0.90594006	2.586264	0.564341
GO_ANGIOGENESIS	c5.BP_ GO biological process	266	1.575178	0	0.061015222	GO_ANGIOGENESIS	272	1.1262586	0.17068273	0.7124632	2.7014366	0.4489194
GO_ACTOMYOSIN_STRUCTURE_ORGANIZATION	c5.BP_ GO biological process	69	1.575039	0.005434783	0.06102811	GO_ACTOMYOSIN_STRUCTURE_ORGANIZATION	74	0.98017406	0.5385439	0.94910324	2.55521306	0.59486494
GO_GROWTH	c5.BP_ GO biological process	367	1.5749539	0	0.0610218	GO_GROWTH	378	0.93188965	0.717	0.99765766	2.50684355	0.64306425
GO_EPIDERMIS_MORPHOGENESIS	c5.BP_ GO biological process	20	1.5748746	0.019607844	0.061019722	GO_EPIDERMIS_MORPHOGENESIS	26	0.7343466	0.86512756	1	2.3092212	0.840528
GO_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	38	1.5748385	0.008583691	0.06096875	GO_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION	40	0.9981302	0.4868421	0.92573935	2.5729687	0.5767083
GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN	C7_ immunologic signatures	131	1.5743104	0	0.06128667	GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN	135	1.3465719	0.020449897	0.38694948	2.9208823	0.2277385
GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN	C7_ immunologic signatures	152	1.5740551	0.002460025	0.061405323	GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN	167	1.1459997	0.18522267	0.6772127	2.7200548	0.4280554
GO_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION	c5.BP_ GO biological process	19	1.5739839	0.015974442	0.061386928	GO_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION	21	1.5478079	0.014906832	0.20674673	3.1217918	0.026176
REACTOME_PI_3K_CASCADE	c2.CP_REACTOME_ Reactome gene sets	53	1.5739148	0.004219409	0.061372805	REACTOME_PI_3K_CASCADE	53	0.8663254	0.7176339	1	2.4402402	0.7075894
GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN	C7_ immunologic signatures	170	1.5737488	0	0.06142746	GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN	175	1.3192602	0.02431611	0.41236287	2.893009	0.2544886
GO_G1_DNA_DAMAGE_CHECKPOINT	c5.BP_ GO biological process	65	1.5736954	0.002766252	0.06139534	GO_G1_DNA_DAMAGE_CHECKPOINT	65	1.0080112	0.4733406	0.91060925	2.5817066	0.5656842
GO_TELOMERE_MAINTENANCE_VIA_RECOMBINATION	c5.BP_ GO biological process	30	1.573204	0.020895522	0.061668415	GO_TELOMERE_MAINTENANCE_VIA_RECOMBINATION	30	-1.6042875	0.021978023	0.08965843	-0.0310835	3.1774915
E2F_03	c3.TFT_ transcription factor targets	218	1.572825	0.001158749	0.06184294	E2F_03	222	-1.8082509	0	0.031599443	-0.2354259	3.3810759
GO_HISTONE_KINASE_ACTIVITY	c5.GO molecular function	17	1.5725596	0.023026315	0.06196428	GO_HISTONE_KINASE_ACTIVITY	17	1.463638	0.04150454	0.2820673	3.0361976	0.1089216
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	176	1.5723885	0	0.062019043	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	179	0.8324006	0.852077	1	2.4047891	0.7399879
GO_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	124	1.5722716	0	0.062032744	GO_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT	131	0.96789247	0.5870237	0.9637594	2.54016407	0.60437913
GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN	C7_ immunologic signatures	128	1.5722432	0	0.0619844	GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN	132	0.99960935	0.49740395	0.9243847	2.57185255	0.57263385
GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP	C7_ immunologic signatures	134	1.5722384	0.00120773	0.061919425	GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP	140	1.0007039	0.48416752	0.9229025	2.5729423	0.5715345
GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP	C7_ immunologic signatures	172	1.5720859	0.002409639	0.061962515	GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP	178	0.9309268	0.6730575	0.9981113	2.5030127	0.6411591
GO_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	34	1.5719383	0.020648967	0.06198986	GO_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT	32	1.3101224	0.1056511	0.42544377	2.8820607	0.2618159
GO_MUSCLE_CELL_DEVELOPMENT	c5.BP_ GO biological process	107	1.5718017	0	0.062028464	GO_MUSCLE_CELL_DEVELOPMENT	115	1.0769156	0.3425358	0.79407585	2.6487173	0.4948861
GO_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX	c5.CC_ GO cellular component	36	1.571196	0.008915304	0.0623887	GO_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX	37	1.3355186	0.09248555	0.39830434	2.9067146	0.2356774
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	c2.CGP_ chemical and genetic perturbations	65	1.5707525	0.005398111	0.06266476	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	67	1.2113364	0.1476293	0.5758242	2.7820889	0.3594161
GU_PDEF_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	68	1.5706297	0.00265252	0.0626755	GU_PDEF_TARGETS_UP	71	0.84336853	0.7626753	1	2.41399823	0.72726117
GO_REGULATION_OF_EPITHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	152	1.5705019	0	0.06270496	GO_REGULATION_OF_EPITHELIAL_CELL_MIGRATION	155	1.2512716	0.06345957	0.5090651	2.8217735	0.3192303
GO_PROSTATE_GLAND_DEVELOPMENT	c5.BP_ GO biological process	38	1.5703852	0.016491754	0.06270314	GO_PROSTATE_GLAND_DEVELOPMENT	40	0.7092729	0.8832952	1	2.2796581	0.8611123
GO_MUSCLE_FIBER_DEVELOPMENT	c5.BP_ GO biological process	35	1.570299	0.008982036	0.06268891	GO_MUSCLE_FIBER_DEVELOPMENT	39	0.99369234	0.51105934	0.9311729	2.56399134	0.57660666
GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP	C7_ immunologic signatures	165	1.5699327	0	0.06288624	GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP	165	1.1569091	0.15789473	0.65899765	2.7268418	0.4130236
TRAYNOR_RETT_SYNDROM_UP	c2.CGP_ chemical and genetic perturbations	36	1.5690747	0.008595988	0.06341278	TRAYNOR_RETT_SYNDROM_UP	38	1.1965618	0.22169249	0.5967422	2.7656365	0.3725129
HASLINGER_B_CLL_WITH_13Q14_DELETION	c2.CGP_ chemical and genetic perturbations	22	1.5690576	0.01875	0.063349165	HASLINGER_B_CLL_WITH_13Q14_DELETION	22	0.9891025	0.49873096	0.9362367	2.5581601	0.5799551
BIOCARTA_PAR1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	36	1.5690283	0.00748503	0.06330428	BIOCARTA_PAR1_PATHWAY	36	1.6203921	0.004716981	0.14079554	3.1894204	-0.0513638
GO_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY	c5.GO molecular function	29	1.5690014	0.018072288	0.06324917	GO_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY	29	-0.90060866	0.6208791	0.8201155	0.66839274	2.46961006
GO_COMPLEX_OF_COLLAGEN_TRIMERS	c5.CC_ GO cellular component	22	1.5688047	0.012618297	0.063310735	GO_COMPLEX_OF_COLLAGEN_TRIMERS	22	0.8646695	0.6799502	1	2.4334742	0.7041352
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	c2.CGP_ chemical and genetic perturbations	16	1.568636	0.022764228	0.06335977	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	16	-0.837656	0.7226891	0.8763666	0.73098	2.406292
GO_CALCIUM_ION_IMPORT	c5.BP_ GO biological process	51	1.5684683	0.006830601	0.0634149	GO_CALCIUM_ION_IMPORT	58	1.3499707	0.06519337	0.38308093	2.918439	0.2184976
GSE30083_SP1_VS_SP2_THYMOCYTE_DN	C7_ immunologic signatures	170	1.5682474	0.001219512	0.063497685	GSE30083_SP1_VS_SP2_THYMOCYTE_DN	183	1.4242795	0.00404449	0.31789738	2.9925269	0.1439679
AAAYWAACM_HFH4_01	c3.TFT_ transcription factor targets	210	1.5680908	0	0.0635413	AAAYWAACM_HFH4_01	225	1.0194253	0.45372233	0.8917271	2.5875161	0.5486655
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	c2.CGP_ chemical and genetic perturbations	124	1.567992	0.006142506	0.06353855	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	133	1.1302812	0.23384616	0.7058178	2.6982732	0.4377108
GO_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY	c5.BP_ GO biological process	18	1.5679828	0.01255887	0.063475415	GO_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY	19	-1.1290001	0.30555555	0.4725211	0.4389827	2.6969829
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	c2.CGP_ chemical and genetic perturbations	70	1.5677286	0.001324503	0.063587435	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	72	1.3355535	0.07042254	0.39845905	2.9032821	0.2321751
GCM_SIRT2	c4.CGN_ cancer gene neighborhoods	36	1.5675476	0.012012012	0.06364302	GCM_SIRT2	36	1.2239136	0.18265896	0.55039227	2.7914612	0.343634
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	179	1.5673311	0.001153403	0.063729174	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	179	0.74090046	0.9533941	1	2.30823156	0.82643064
GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP	C7_ immunologic signatures	171	1.5672177	0	0.06374362	GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP	175	0.7379793	0.94949496	1	2.305197	0.8292384
GSE27786_CD8_TCELL_VS_MONO_MAC_DN	C7_ immunologic signatures	166	1.5671098	0.001187649	0.063759096	GSE27786_CD8_TCELL_VS_MONO_MAC_DN	173	0.657489	0.98880976	1	2.2245988	0.9096208
GO_MYOFILAMENT	c5.CC_ GO cellular component	21	1.5670533	0.024577573	0.063728675	GO_MYOFILAMENT	24	0.73920006	0.8578492	1	2.30625336	0.82785324
GO_VASOCONSTRICTION	c5.BP_ GO biological process	22	1.5666752	0.019386107	0.063918	GO_VASOCONSTRICTION	24	0.8206512	0.7226368	1	2.3873264	0.746024
GO_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS	c5.BP_ GO biological process	17	1.5665503	0.018808777	0.06391588	GO_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS	19	1.6741866	0.002554278	0.09432103	3.2407369	-0.1076363
GSE13306_RA_VS_UNTREATED_TREG_DN	C7_ immunologic signatures	168	1.5665429	0.001194743	0.06385091	GSE13306_RA_VS_UNTREATED_TREG_DN	175	1.151263	0.16445352	0.6676848	2.7178059	0.4152799
GNF2_IGFBP1	c4.CGN_ cancer gene neighborhoods	25	1.5664594	0.012345679	0.06384587	GNF2_IGFBP1	31	1.8130364	0	0.029335113	3.3794958	-0.246577
GO_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	103	1.5663347	0.001277139	0.063870125	GO_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION	105	1.266605	0.05956113	0.48909953	2.8329397	0.2997297
GO_NEURON_PROJECTION_DEVELOPMENT	c5.BP_ GO biological process	490	1.5660884	0	0.06398857	GO_NEURON_PROJECTION_DEVELOPMENT	490	0	0	0	1.5660884	1.5660884
GEISS_RESPONSE_TO_DSRNA_UP	c2.CGP_ chemical and genetic perturbations	32	1.5659615	0.016691957	0.06400664	GEISS_RESPONSE_TO_DSRNA_UP	33	1.2420368	0.17070217	0.5232878	2.8079983	0.3239247
GO_CARDIAC_CHAMBER_DEVELOPMENT	c5.BP_ GO biological process	131	1.5658907	0	0.0639802	GO_CARDIAC_CHAMBER_DEVELOPMENT	139	1.1454663	0.20326865	0.6780165	2.711357	0.4204244
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	c2.CGP_ chemical and genetic perturbations	35	1.565439	0.011869436	0.06421406	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	36	1.2229078	0.17612293	0.5518323	2.7883468	0.3425312
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	c2.CP_REACTOME_ Reactome gene sets	139	1.565352	0.001222494	0.06420261	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	154	1.2646538	0.06938776	0.4903984	2.8300058	0.3006982
GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP	C7_ immunologic signatures	126	1.5650777	0	0.06432908	GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP	130	1.0829114	0.31069958	0.7823163	2.6479891	0.4821663
GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN	C7_ immunologic signatures	122	1.5643958	0.001270648	0.064712524	GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN	132	1.2607565	0.07304527	0.49508923	2.8251523	0.3036393
GO_ACTION_POTENTIAL	c5.BP_ GO biological process	81	1.564203	0.002617801	0.06475991	GO_ACTION_POTENTIAL	89	1.3933865	0.021413276	0.34690046	2.9575895	0.1708165
GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP	C7_ immunologic signatures	126	1.5626868	0.001204819	0.06579888	GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP	134	1.2052087	0.12422998	0.58249205	2.7678955	0.3574781
GO_CELL_GROWTH	c5.BP_ GO biological process	126	1.5626508	0	0.06574977	GO_CELL_GROWTH	128	0.9697279	0.5625	0.96161604	2.5323787	0.5929229
GO_NEGATIVE_REGULATION_OF_CHEMOTAXIS	c5.BP_ GO biological process	45	1.5626408	0.006793478	0.06568674	GO_NEGATIVE_REGULATION_OF_CHEMOTAXIS	47	1.0533879	0.4032258	0.8364209	2.6160287	0.5092529
GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN	C7_ immunologic signatures	163	1.5625814	0	0.06565986	GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN	165	1.632936	0	0.13309577	3.1955174	-0.0703546
ATF2_S_UP.V1_DN	C6_ oncogenic signatures	161	1.5624717	0	0.06567496	ATF2_S_UP.V1_DN	169	1.2401962	0.05606524	0.5261337	2.8026679	0.3222755
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	c2.CGP_ chemical and genetic perturbations	58	1.5624471	0.008595988	0.06562321	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	59	0.89921296	0.6666667	1	2.46166006	0.66323414
NABA_ECM_AFFILIATED	c2.CP_ Canonical pathways	118	1.5623738	0	0.06561241	NABA_ECM_AFFILIATED	129	1.2068443	0.12487206	0.58071715	2.7692181	0.3555295
GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	97	1.5623091	0.002594034	0.06559268	GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION	98	1.2979908	0.06133056	0.44524062	2.8602999	0.2643183
DAZARD_UV_RESPONSE_CLUSTER_G6	c2.CGP_ chemical and genetic perturbations	137	1.5621532	0.00120773	0.06563763	DAZARD_UV_RESPONSE_CLUSTER_G6	137	1.1979332	0.13877551	0.59610885	2.7600864	0.36422
ACAACTT_MIR382	c3.MIR_ microRNA targets	62	1.561822	0.0027894	0.06579674	ACAACTT_MIR382	64	1.2295588	0.1431694	0.5419378	2.7913808	0.3322632
GO_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	47	1.5615137	0.01793722	0.06595747	GO_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS	48	0.80701596	0.7930649	1	2.36852966	0.75449774
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	C7_ immunologic signatures	172	1.5614983	0.001201923	0.065900795	GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	174	1.1150101	0.24365482	0.730763	2.6765084	0.4464882
GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN	C7_ immunologic signatures	163	1.5612329	0.002424242	0.066011526	GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN	161	0.75793	0.9308943	1	2.3191629	0.8033029
GO_NEGATIVE_REGULATION_OF_PROTEOLYSIS	c5.BP_ GO biological process	246	1.5611489	0	0.06600234	GO_NEGATIVE_REGULATION_OF_PROTEOLYSIS	270	1.3298529	0.004008016	0.40303183	2.8910018	0.231296
GO_HISTONE_PHOSPHORYLATION	c5.BP_ GO biological process	22	1.561036	0.009202454	0.066011	GO_HISTONE_PHOSPHORYLATION	22	1.346353	0.09846547	0.38716662	2.907389	0.214683
GO_CARDIAC_CHAMBER_MORPHOGENESIS	c5.BP_ GO biological process	94	1.5609158	0.002614379	0.06603843	GO_CARDIAC_CHAMBER_MORPHOGENESIS	101	0.95982325	0.57009345	0.97102046	2.52073905	0.60109255
GO_STRIATUM_DEVELOPMENT	c5.BP_ GO biological process	15	1.5607787	0.018333333	0.066057906	GO_STRIATUM_DEVELOPMENT	16	-1.5513481	0.030701755	0.11430619	0.0094306	3.1121268
GO_POSITIVE_REGULATION_OF_OSSIFICATION	c5.BP_ GO biological process	79	1.5605807	0.006578947	0.06614232	GO_POSITIVE_REGULATION_OF_OSSIFICATION	80	1.0509876	0.41001064	0.83810914	2.6115683	0.5095931
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	c2.CGP_ chemical and genetic perturbations	231	1.5597789	0	0.06665553	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	235	1.1595315	0.12964824	0.6536175	2.7193104	0.4002474
GO_ACTIN_CYTOSKELETON	c5.CC_ GO cellular component	396	1.5597343	0	0.06662999	GO_ACTIN_CYTOSKELETON	413	1.2228154	0.021042084	0.55201226	2.7825497	0.3369189
FRIDMAN_SENESCENCE_UP	c2.CGP_ chemical and genetic perturbations	72	1.5596368	0.005517242	0.06664681	FRIDMAN_SENESCENCE_UP	74	0.9186444	0.616453	1	2.4782812	0.6409924
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN	C7_ immunologic signatures	181	1.5595701	0	0.06661253	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN	183	0.7171639	0.9727548	1	2.276734	0.8424062
PLASARI_NFIC_TARGETS_BASAL_UP	c2.CGP_ chemical and genetic perturbations	24	1.5594656	0.013740458	0.06662042	PLASARI_NFIC_TARGETS_BASAL_UP	25	1.3424088	0.07835821	0.39281198	2.9018744	0.2170568
GO_REGULATION_OF_LIPID_KINASE_ACTIVITY	c5.BP_ GO biological process	40	1.5593377	0.01459854	0.066637136	GO_REGULATION_OF_LIPID_KINASE_ACTIVITY	46	1.2011893	0.20924856	0.59007376	2.760527	0.3581484
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	c2.CGP_ chemical and genetic perturbations	22	1.5593185	0.02728732	0.06657757	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	25	1.5423946	0.014457831	0.20966516	3.1017131	0.0169239
GO_AXIS_SPECIFICATION	c5.BP_ GO biological process	82	1.5592291	0.006622517	0.066559166	GO_AXIS_SPECIFICATION	87	-1.2102224	0.10526316	0.3678933	0.3490067	2.7694515
CHR4P16	C1: positional gene sets	78	1.559075	0.004076087	0.066616915	CHR4P16	83	0.8667362	0.73673034	1	2.4258112	0.6923388
GO_NEURON_PROJECTION_EXTENSION	c5.BP_ GO biological process	51	1.5590532	0.015320335	0.06656244	GO_NEURON_PROJECTION_EXTENSION	52	0.9705504	0.55444443	0.96125776	2.5296036	0.5885028
HFH3_01	c3.TFT_ transcription factor targets	163	1.5589868	0	0.06654313	HFH3_01	170	1.1870153	0.11740891	0.6113187	2.7460021	0.3719715
GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	C7_ immunologic signatures	168	1.5589188	0	0.066533625	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	173	1.2284404	0.06199187	0.54386437	2.7873592	0.3304784
EN1_01	c3.TFT_ transcription factor targets	99	1.558292	0.004021448	0.066904895	EN1_01	104	1.1391765	0.23375262	0.69157743	2.6974685	0.4191155
GSE27786_NKTCELL_VS_ERYTHROBLAST_DN	C7_ immunologic signatures	174	1.5580968	0	0.066984326	GSE27786_NKTCELL_VS_ERYTHROBLAST_DN	185	1.2348672	0.06962664	0.53334194	2.792964	0.3232296
GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN	C7_ immunologic signatures	189	1.5577266	0	0.067185715	GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN	191	-1.1164002	0	0.4939175	0.4413264	2.6741268
PID_PRL_SIGNALING_EVENTS_PATHWAY	c2.CP_ Canonical pathways	23	1.5576688	0.018808777	0.067153275	PID_PRL_SIGNALING_EVENTS_PATHWAY	23	-0.7485385	0.8448276	0.93936366	0.8091303	2.3062073
GO_REGULATION_OF_JNK_CASCADE	c5.BP_ GO biological process	143	1.55757	0	0.067146026	GO_REGULATION_OF_JNK_CASCADE	149	1.1020268	0.26294416	0.7535743	2.6595968	0.4555432
GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN	C7_ immunologic signatures	148	1.5573975	0.002450981	0.06719006	GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN	156	1.4831828	0.001013171	0.26567793	3.0405803	0.0742147
YU_BAP1_TARGETS	c2.CGP_ chemical and genetic perturbations	28	1.5570533	0.016393442	0.06740487	YU_BAP1_TARGETS	28	-1.5795798	0.012195122	0.100024246	-0.0225265	3.1366331
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	c2.CGP_ chemical and genetic perturbations	20	1.5566758	0.012861736	0.067627035	WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	21	1.0930718	0.33080807	0.76812774	2.6497476	0.463604
BOQUEST_STEM_CELL_DN	c2.CGP_ chemical and genetic perturbations	179	1.5565963	0	0.06762228	BOQUEST_STEM_CELL_DN	189	1.3937922	0.003036437	0.34634253	2.9503885	0.1628041
CHYLA_CBFA2T3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	204	1.5565492	0	0.06758284	CHYLA_CBFA2T3_TARGETS_DN	210	1.1431968	0.17457114	0.6838766	2.699746	0.4133524
MITSIADES_RESPONSE_TO_APLIDIN_DN	c2.CGP_ chemical and genetic perturbations	237	1.5564778	0	0.06756755	MITSIADES_RESPONSE_TO_APLIDIN_DN	237	0.70063114	0.984879	1	2.25710894	0.85584666
MATZUK_MEIOTIC_AND_DNA_REPAIR	c2.CGP_ chemical and genetic perturbations	38	1.5560603	0.008583691	0.06782209	MATZUK_MEIOTIC_AND_DNA_REPAIR	38	1.39017	0.04895105	0.34511662	2.9462303	0.1658903
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP	C7_ immunologic signatures	156	1.5558558	0	0.067922786	GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP	160	1.114607	0.2380468	0.73105603	2.6704628	0.4412488
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	c2.CP_REACTOME_ Reactome gene sets	74	1.5558314	0.005369128	0.06787456	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	76	1.2619313	0.09554832	0.49407053	2.8177627	0.2939001
GO_LYMPH_VESSEL_DEVELOPMENT	c5.BP_ GO biological process	19	1.555311	0.01898734	0.06817791	GO_LYMPH_VESSEL_DEVELOPMENT	20	1.2478093	0.17156863	0.5145267	2.8031203	0.3075017
RIGGI_EWING_SARCOMA_PROGENITOR_UP	c2.CGP_ chemical and genetic perturbations	370	1.5551132	0	0.06827311	RIGGI_EWING_SARCOMA_PROGENITOR_UP	382	1.3103654	0.003003003	0.42550394	2.8654786	0.2447478
LEE_NEURAL_CREST_STEM_CELL_DN	c2.CGP_ chemical and genetic perturbations	100	1.5549642	0.002621232	0.06832693	LEE_NEURAL_CREST_STEM_CELL_DN	104	1.2860098	0.06533193	0.4623042	2.840974	0.2689544
FOX_Q2	c3.TFT_ transcription factor targets	186	1.5548887	0	0.06831579	FOX_Q2	192	1.0316708	0.4137235	0.87367374	2.5865595	0.5232179
DAZARD_RESPONSE_TO_UV_NHEK_DN	c2.CGP_ chemical and genetic perturbations	289	1.5548744	0	0.068254076	DAZARD_RESPONSE_TO_UV_NHEK_DN	288	1.0404447	0.3943944	0.8588071	2.5953191	0.5144297
GO_REGULATION_OF_CALCIUM_ION_IMPORT	c5.BP_ GO biological process	81	1.5544463	0.006756757	0.06850499	GO_REGULATION_OF_CALCIUM_ION_IMPORT	86	1.4330764	0.011615628	0.31287464	2.9875227	0.1213699
GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	C7_ immunologic signatures	130	1.5542817	0.002503129	0.06856883	GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	139	1.3578421	0.01734694	0.37888384	2.9121238	0.1964396
GO_REGULATION_OF_CELL_CYCLE_CHECKPOINT	c5.BP_ GO biological process	25	1.5538151	0.020408163	0.06885218	GO_REGULATION_OF_CELL_CYCLE_CHECKPOINT	26	-0.87798184	0.6713615	0.8464657	0.67583326	2.43179694
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	c2.CGP_ chemical and genetic perturbations	145	1.5538005	0	0.06879395	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	155	1.1917301	0.12704918	0.6037528	2.7455306	0.3620704
LEE_AGING_MUSCLE_UP	c2.CGP_ chemical and genetic perturbations	42	1.5537868	0.014450867	0.068735845	LEE_AGING_MUSCLE_UP	42	0.89393497	0.6357466	1	2.44772177	0.65985183
GNF2_KISS1	c4.CGN_ cancer gene neighborhoods	34	1.5537333	0.010752688	0.06870545	GNF2_KISS1	40	1.7691305	0	0.054110475	3.3228638	-0.2153972
GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN	C7_ immunologic signatures	151	1.5533029	0	0.06895923	GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN	153	1.4007798	0.00712831	0.33858573	2.9540827	0.1525231
GO_CELL_PROLIFERATION_IN_FOREBRAIN	c5.BP_ GO biological process	25	1.5529829	0.017804155	0.06916037	GO_CELL_PROLIFERATION_IN_FOREBRAIN	26	-1.1366607	0.21176471	0.4617669	0.4163222	2.6896436
GO_REGULATION_OF_REGULATED_SECRETORY_PATHWAY	c5.BP_ GO biological process	109	1.5529642	0.001256281	0.06910027	GO_REGULATION_OF_REGULATED_SECRETORY_PATHWAY	117	0.9751411	0.5414079	0.95580435	2.5281053	0.5778231
NIELSEN_LEIOMYOSARCOMA_CNN1_UP	c2.CGP_ chemical and genetic perturbations	17	1.5528141	0.028938906	0.06913941	NIELSEN_LEIOMYOSARCOMA_CNN1_UP	18	0.8564365	0.67312664	1	2.4092506	0.6963776
TAVAZOIE_METASTASIS	c2.CGP_ chemical and genetic perturbations	88	1.5525156	0	0.069285095	TAVAZOIE_METASTASIS	90	1.1967375	0.1601686	0.59687674	2.7492531	0.3557781
GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN	C7_ immunologic signatures	157	1.5517808	0	0.06975371	GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN	157	1.1030638	0.26020408	0.7513431	2.6548446	0.448717
GO_LUNG_MORPHOGENESIS	c5.BP_ GO biological process	42	1.551753	0.016853932	0.06970268	GO_LUNG_MORPHOGENESIS	42	0.7699131	0.83157897	1	2.3216661	0.7818399
NAKAMURA_ADIPOGENESIS_LATE_DN	c2.CGP_ chemical and genetic perturbations	35	1.551683	0.02431611	0.06967621	NAKAMURA_ADIPOGENESIS_LATE_DN	35	-0.8995886	0.67785233	0.8216292	0.6520944	2.4512716
IRF1_01	c3.TFT_ transcription factor targets	209	1.5513425	0	0.06986312	IRF1_01	214	1.2610388	0.028311426	0.49452946	2.8123813	0.2903037
MORF_THRA	c4.CGN_ cancer gene neighborhoods	36	1.5512998	0.018597998	0.069842145	MORF_THRA	44	1.0625169	0.37356323	0.81851006	2.6138167	0.4887829
SRF_C	c3.TFT_ transcription factor targets	192	1.551091	0	0.06994963	SRF_C	197	0.87909013	0.80040324	1	2.43018113	0.67200087
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	c2.CGP_ chemical and genetic perturbations	93	1.5508016	0.007761966	0.07009819	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	93	1.3923773	0.021966526	0.3482242	2.9431789	0.1584243
GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP	C7_ immunologic signatures	88	1.5507351	0.001267427	0.070093915	GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP	92	1.2626683	0.088607594	0.49250096	2.8134034	0.2880668
GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN	C7_ immunologic signatures	169	1.5507119	0.001182033	0.07003537	GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN	177	1.1673818	0.13981763	0.6414287	2.7180937	0.3833301
MODULE_199	c4.CM_ cancer modules	52	1.5505158	0.011204482	0.07011425	MODULE_199	55	1.1700749	0.23814774	0.63810635	2.7205907	0.3804409
GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP	C7_ immunologic signatures	170	1.5502187	0	0.070289046	GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP	174	1.2930709	0.03242148	0.45228407	2.8432896	0.2571478
REACTOME_SIGNALING_BY_FGFR	c2.CP_REACTOME_ Reactome gene sets	102	1.5497782	0.003896104	0.07054359	REACTOME_SIGNALING_BY_FGFR	103	0.95523506	0.59309626	0.97581905	2.50501326	0.59454314
BIOCARTA_MYOSIN_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	29	1.5492972	0.01529052	0.070861965	BIOCARTA_MYOSIN_PATHWAY	30	1.4049708	0.05686032	0.3326793	2.954268	0.1443264
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	c2.CGP_ chemical and genetic perturbations	39	1.5489942	0.014684288	0.07101519	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	39	0.92456573	0.59228975	1	2.47355993	0.62442847
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	c2.CGP_ chemical and genetic perturbations	177	1.5489461	0	0.0709831	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	177	1.2953211	0.027327936	0.44911134	2.8442672	0.253625
TTCCGTT_MIR191	c3.MIR_ microRNA targets	28	1.5488877	0.009259259	0.07094175	TTCCGTT_MIR191	28	-0.95995766	0.54651165	0.74248743	0.58893004	2.50884536
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	c2.CGP_ chemical and genetic perturbations	186	1.5488538	0.001204819	0.0708986	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	189	1.2696422	0.038267877	0.4847471	2.818496	0.2792116
GO_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING	c5.GO molecular function	27	1.5487173	0.02021773	0.070935294	GO_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING	27	0.84372056	0.71	1	2.39243786	0.70499674
GO_DNA_RECOMBINATION	c5.BP_ GO biological process	180	1.5486401	0.002317497	0.070918135	GO_DNA_RECOMBINATION	184	-1.2450963	0	0.329025	0.3035438	2.7937364
CHR11P14	C1: positional gene sets	20	1.5479512	0.014492754	0.07131819	CHR11P14	21	1.0824165	0.38329238	0.78319454	2.6303677	0.4655347
GSE2706_2H_VS_8H_R848_STIM_DC_DN	C7_ immunologic signatures	147	1.5478153	0.001216545	0.071361594	GSE2706_2H_VS_8H_R848_STIM_DC_DN	151	1.2681266	0.056737587	0.48655912	2.8159419	0.2796887
GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP	C7_ immunologic signatures	130	1.5476316	0.001210654	0.07145579	GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP	133	1.1551732	0.20082389	0.66167635	2.7028048	0.3924584
GO_PHOSPHATIDYLINOSITOL_BINDING	c5.GO molecular function	188	1.547509	0	0.071491696	GO_PHOSPHATIDYLINOSITOL_BINDING	189	1.27985	0.03632694	0.47253764	2.827359	0.267659
WGGAATGY_TEF1_Q6	c3.TFT_ transcription factor targets	321	1.5474064	0	0.07151278	WGGAATGY_TEF1_Q6	332	1.0104237	0.4699399	0.9063911	2.5578301	0.5369827
GO_COLLAGEN_FIBRIL_ORGANIZATION	c5.BP_ GO biological process	35	1.5473311	0.018018018	0.07151544	GO_COLLAGEN_FIBRIL_ORGANIZATION	36	1.0950694	0.3400236	0.7646229	2.6424005	0.4522617
DER_IFN_ALPHA_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	64	1.5473168	0.014666666	0.071459286	DER_IFN_ALPHA_RESPONSE_UP	64	1.3142719	0.07027027	0.4193948	2.8615887	0.2330449
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	C7_ immunologic signatures	126	1.5472912	0.003717472	0.07141696	GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	131	1.3173621	0.035714287	0.41524914	2.8646533	0.2299291
GO_NEGATIVE_REGULATION_OF_GROWTH	c5.BP_ GO biological process	202	1.5462105	0	0.07222893	GO_NEGATIVE_REGULATION_OF_GROWTH	207	1.0119886	0.4612286	0.9041078	2.5581991	0.5342219
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	c2.CGP_ chemical and genetic perturbations	18	1.5460601	0.028037382	0.07226938	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	18	0.80503124	0.7444005	1	2.35109134	0.74102886
GO_PROTEIN_DEPOLYMERIZATION	c5.BP_ GO biological process	23	1.5460248	0.01854714	0.07223284	GO_PROTEIN_DEPOLYMERIZATION	23	0.9900343	0.51307595	0.9351127	2.5360591	0.5559905
GO_ESC_E_Z_COMPLEX	c5.CC_ GO cellular component	16	1.5455766	0.024711696	0.07248629	GO_ESC_E_Z_COMPLEX	16	-1.0868201	0.35021096	0.53946126	0.4587565	2.6323967
GO_PLATELET_ALPHA_GRANULE	c5.CC_ GO cellular component	63	1.5455685	0.008426966	0.07241762	GO_PLATELET_ALPHA_GRANULE	64	1.4815667	0.00974026	0.2670792	3.0271352	0.0640018
HOELZEL_NF1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	92	1.5455062	0.002580645	0.072397426	HOELZEL_NF1_TARGETS_DN	95	1.1197306	0.2566278	0.7235555	2.6652368	0.4257756
GO_RECIPROCAL_DNA_RECOMBINATION	c5.BP_ GO biological process	33	1.545337	0.013254787	0.07246222	GO_RECIPROCAL_DNA_RECOMBINATION	35	0.9692467	0.5087925	0.9619722	2.5145837	0.5760903
GO_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	260	1.5452828	0	0.07243663	GO_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION	268	1.6162821	0	0.14554931	3.1615649	-0.0709993
GO_MULTICELLULAR_ORGANISM_AGING	c5.BP_ GO biological process	28	1.5452418	0.013846153	0.07239469	GO_MULTICELLULAR_ORGANISM_AGING	28	0.8077568	0.7574257	1	2.3529986	0.737485
GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN	C7_ immunologic signatures	158	1.5449805	0.001206273	0.07251651	GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN	173	1.3796768	0.004052685	0.35648757	2.9246573	0.1653037
GSE369_IFNG_KO_VS_WT_LIVER_UP	C7_ immunologic signatures	177	1.5447359	0	0.07263548	GSE369_IFNG_KO_VS_WT_LIVER_UP	178	1.1635125	0.16361788	0.64783406	2.7082484	0.3812234
GO_ACTIN_FILAMENT_BASED_MOVEMENT	c5.BP_ GO biological process	81	1.5444998	0.004109589	0.072774984	GO_ACTIN_FILAMENT_BASED_MOVEMENT	88	1.4871557	0.002111933	0.26348475	3.0316555	0.0573441
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	c2.CGP_ chemical and genetic perturbations	174	1.544496	0.00238379	0.07270837	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	172	1.3778683	0.005060729	0.3569308	2.9223643	0.1666277
GO_RESPONSE_TO_MONOAMINE	c5.BP_ GO biological process	33	1.5441508	0.013392857	0.07288748	GO_RESPONSE_TO_MONOAMINE	33	1.3279182	0.1014151	0.40377897	2.872069	0.2162326
ESC_V6.5_UP_EARLY.V1_DN	C6_ oncogenic signatures	157	1.5438014	0.001218027	0.0731042	ESC_V6.5_UP_EARLY.V1_DN	163	1.0736092	0.32489878	0.79927146	2.6174106	0.4701922
GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN	C7_ immunologic signatures	162	1.5433356	0.001196172	0.073432654	GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN	176	0.9263877	0.68154156	1	2.4697233	0.6169479
GO_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION	c5.BP_ GO biological process	41	1.5433	0.017266188	0.0733765	GO_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION	46	-1.3883412	0.026548672	0.21446575	0.1549588	2.9316412
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	175	1.5430181	0	0.07351993	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP	181	1.4554546	0.001012146	0.28647807	2.9984727	0.0875635
GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN	C7_ immunologic signatures	169	1.5430071	0	0.07345567	GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN	177	1.1198075	0.22528033	0.72353786	2.6628146	0.4231996
GO_MYOSIN_FILAMENT	c5.CC_ GO cellular component	15	1.5427411	0.03294893	0.07358536	GO_MYOSIN_FILAMENT	20	1.1662962	0.26732674	0.6446623	2.7090373	0.3764449
SMID_BREAST_CANCER_NORMAL_LIKE_UP	c2.CGP_ chemical and genetic perturbations	381	1.5424529	0	0.07373363	SMID_BREAST_CANCER_NORMAL_LIKE_UP	398	1.2253808	0.025025025	0.5485114	2.7678337	0.3170721
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	c2.CGP_ chemical and genetic perturbations	153	1.5422931	0.001204819	0.073789865	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	158	1.3240703	0.020576132	0.40927503	2.8663634	0.2182228
GO_NEURON_FATE_COMMITMENT	c5.BP_ GO biological process	52	1.5422152	0.014005602	0.07378847	GO_NEURON_FATE_COMMITMENT	64	0.74092203	0.8900979	1	2.28313723	0.80129317
GO_REPLICATION_FORK	c5.CC_ GO cellular component	59	1.5420759	0.012278308	0.07382034	GO_REPLICATION_FORK	59	-1.5947939	0.020618556	0.09333103	-0.052718	3.1368698
GO_NEGATIVE_REGULATION_OF_LOCOMOTION	c5.BP_ GO biological process	228	1.5419325	0.001117318	0.07388079	GO_NEGATIVE_REGULATION_OF_LOCOMOTION	237	0.8854772	0.80220884	1	2.4274097	0.6564553
GO_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	63	1.5418084	0.009628611	0.07392591	GO_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION	64	1.2710745	0.10714286	0.48376402	2.8128829	0.2707339
GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN	C7_ immunologic signatures	158	1.5416542	0.001204819	0.073998734	GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN	163	0.90775055	0.70618033	1	2.44940475	0.63390365
YNGTTNNNATT_UNKNOWN	c3.TFT_ transcription factor targets	329	1.5414327	0	0.07409547	YNGTTNNNATT_UNKNOWN	337	1.062198	0.2975952	0.81886494	2.6036307	0.4792347
BIOCARTA_P53_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	1.5413682	0.02685624	0.07406968	BIOCARTA_P53_PATHWAY	16	-0.9349802	0.5313808	0.7780095	0.606388	2.4763484
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN	C7_ immunologic signatures	160	1.5412748	0	0.074069805	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN	166	0.7611845	0.93237704	1	2.3024593	0.7800903
GO_INTEGRIN_BINDING	c5.GO molecular function	95	1.5411546	0.00397878	0.07409678	GO_INTEGRIN_BINDING	100	1.1124438	0.27684212	0.7341193	2.6535984	0.4287108
CATTTCA_MIR203	c3.MIR_ microRNA targets	265	1.5410203	0	0.074128956	CATTTCA_MIR203	268	-0.9503468	1	0.7546016	0.5906735	2.4913671
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	c2.CGP_ chemical and genetic perturbations	26	1.540994	0.02173913	0.074075654	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	28	0.87297595	0.6755127	1	2.41396995	0.66801805
GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP	C7_ immunologic signatures	155	1.5405996	0.002386635	0.07433365	GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP	160	1.1762915	0.14663951	0.6274725	2.7168911	0.3643081
GO_GLUTAMATE_SECRETION	c5.BP_ GO biological process	27	1.5405533	0.012288787	0.07429624	GO_GLUTAMATE_SECRETION	27	1.0725111	0.38471022	0.8023679	2.6130644	0.4680422
GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP	C7_ immunologic signatures	172	1.5405179	0.001166861	0.07425097	GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP	173	0.8781313	0.76703966	1	2.4186492	0.6623866
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	c2.CGP_ chemical and genetic perturbations	110	1.5400242	0.003787879	0.07459124	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	113	0.991214	0.5113636	0.93427885	2.5312382	0.5488102
GO_BLOOD_VESSEL_MORPHOGENESIS	c5.BP_ GO biological process	333	1.5399339	0	0.074588224	GO_BLOOD_VESSEL_MORPHOGENESIS	341	1.0278299	0.39679357	0.8793672	2.5677638	0.512104
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	c2.CGP_ chemical and genetic perturbations	440	1.5399083	0	0.07454098	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	444	1.2726598	0.005	0.4822142	2.8125681	0.2672485
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	c2.CGP_ chemical and genetic perturbations	194	1.5395354	0	0.07478562	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	200	1.1096641	0.23511605	0.73814356	2.6491995	0.4298713
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP	C7_ immunologic signatures	135	1.5395268	0.001254705	0.07472062	GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP	141	1.4843543	0.004081633	0.2660699	3.0238811	0.0551725
GO_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT	c5.BP_ GO biological process	62	1.5394975	0.005405406	0.07467426	GO_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT	69	1.0738829	0.36373508	0.7989365	2.6133804	0.4656146
FRIDMAN_IMMORTALIZATION_DN	c2.CGP_ chemical and genetic perturbations	32	1.5390204	0.016034985	0.075002685	FRIDMAN_IMMORTALIZATION_DN	32	0.9004512	0.6373494	1	2.4394716	0.6385692
BIOCARTA_CTLA4_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	1.5382111	0.034539472	0.075556636	BIOCARTA_CTLA4_PATHWAY	18	1.0296787	0.43134716	0.8758924	2.5678898	0.5085324
KEGG_OOCYTE_MEIOSIS	c2.CP_BIOCARTA_ BioCarta gene sets	99	1.5381274	0.005095542	0.07554748	KEGG_OOCYTE_MEIOSIS	102	0.8742783	0.7331256	1	2.4124057	0.6638491
GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP	C7_ immunologic signatures	164	1.5372458	0.001197605	0.07615796	GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP	170	1.424303	0	0.31824216	2.9615488	0.1129428
HALLMARK_UV_RESPONSE_DN	H_ hallmark gene sets	138	1.5363388	0.002460025	0.07686205	HALLMARK_UV_RESPONSE_DN	138	1.1488367	0.19857433	0.6699251	2.6851755	0.3875021
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	c2.CP_REACTOME_ Reactome gene sets	21	1.536259	0.021806853	0.07685341	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	23	-1.0619783	0.35	0.58461124	0.4742807	2.5982373
GO_SARCOPLASMIC_RETICULUM_MEMBRANE	c5.CC_ GO cellular component	32	1.5361427	0.025677603	0.07687645	GO_SARCOPLASMIC_RETICULUM_MEMBRANE	32	1.2067436	0.19809069	0.5805859	2.7428863	0.3293991
GO_RESPONSE_TO_NICOTINE	c5.BP_ GO biological process	41	1.5361073	0.016129032	0.0768337	GO_RESPONSE_TO_NICOTINE	49	1.18816	0.2164262	0.6084629	2.7242673	0.3479473
GSE22886_IL2_VS_IL15_STIM_NKCELL_UP	C7_ immunologic signatures	154	1.5358458	0.001206273	0.076984465	GSE22886_IL2_VS_IL15_STIM_NKCELL_UP	171	1.2872189	0.030425964	0.46220535	2.8230647	0.2486269
SWEET_KRAS_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	74	1.5357794	0.005540166	0.0769714	SWEET_KRAS_TARGETS_UP	74	1.4144678	0.021390375	0.32300857	2.9502472	0.1213116
GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN	C7_ immunologic signatures	168	1.5355161	0	0.07710434	GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN	168	1.3501346	0.005060729	0.38339162	2.8856507	0.1853815
STREICHER_LSM1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	16	1.5354285	0.020634921	0.077106066	STREICHER_LSM1_TARGETS_DN	16	-1.5991944	0.029045643	0.091197945	-0.0637659	3.1346229
GSE17186_MEMORY_VS_NAIVE_BCELL_DN	C7_ immunologic signatures	180	1.5352577	0	0.07718707	GSE17186_MEMORY_VS_NAIVE_BCELL_DN	180	1.0520921	0.37931034	0.8370208	2.5873498	0.4831656
HALLMARK_INTERFERON_GAMMA_RESPONSE	H_ hallmark gene sets	179	1.5352317	0.001201923	0.07712945	HALLMARK_INTERFERON_GAMMA_RESPONSE	174	1.2327507	0.0755287	0.53628874	2.7679824	0.302481
WONG_ENDMETRIUM_CANCER_DN	c2.CGP_ chemical and genetic perturbations	72	1.5352205	0.008053691	0.07707195	WONG_ENDMETRIUM_CANCER_DN	74	1.2255346	0.1416122	0.5486408	2.7607551	0.3096859
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN	C7_ immunologic signatures	141	1.5351793	0.001210654	0.07703716	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN	148	1.0137818	0.4568528	0.90004736	2.5489611	0.5213975
CIZ_01	c3.TFT_ transcription factor targets	203	1.5351307	0	0.07700154	CIZ_01	213	1.0962089	0.26283988	0.7626725	2.6313396	0.4389218
REACTOME_SIGNALING_BY_BMP	c2.CP_REACTOME_ Reactome gene sets	20	1.5351136	0.02265861	0.0769426	REACTOME_SIGNALING_BY_BMP	21	0.79653144	0.75757575	1	2.33164504	0.73858216
GO_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION	c5.BP_ GO biological process	33	1.5347875	0.01857585	0.07715153	GO_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION	34	-1.083989	0.30379745	0.54409635	0.4507985	2.6187765
GO_INTERSTRAND_CROSS_LINK_REPAIR	c5.BP_ GO biological process	37	1.5347395	0.033045977	0.07712891	GO_INTERSTRAND_CROSS_LINK_REPAIR	37	0.5227297	0.9918415	1	2.0574692	1.0120098
BILBAN_B_CLL_LPL_DN	c2.CGP_ chemical and genetic perturbations	39	1.5347285	0.01775148	0.077066526	BILBAN_B_CLL_LPL_DN	39	1.1961823	0.2182681	0.5965886	2.7309108	0.3385462
GO_NEUROMUSCULAR_PROCESS	c5.BP_ GO biological process	82	1.5343933	0.007989348	0.0772697	GO_NEUROMUSCULAR_PROCESS	92	0.9245742	0.63018066	1	2.4589675	0.6098191
GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN	C7_ immunologic signatures	168	1.5343896	0	0.077200405	GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN	170	1.0028939	0.4898374	0.9187948	2.5372835	0.5314957
GSE34006_WT_VS_A2AR_KO_TREG_DN	C7_ immunologic signatures	178	1.5340877	0.00239521	0.07738823	GSE34006_WT_VS_A2AR_KO_TREG_DN	179	1.075629	0.31434384	0.7949183	2.6097167	0.4584587
GO_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS	c5.BP_ GO biological process	16	1.5339118	0.020344287	0.077466324	GO_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS	16	0.6805106	0.8702983	1	2.2144224	0.8534012
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	c2.CGP_ chemical and genetic perturbations	36	1.5337733	0.024320457	0.07749529	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	40	1.2022171	0.20319635	0.5887055	2.7359904	0.3315562
GO_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION	c5.BP_ GO biological process	68	1.5332334	0.005434783	0.077887096	GO_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION	72	1.1014919	0.31351352	0.7544682	2.6347253	0.4317415
SANSOM_WNT_PATHWAY_REQUIRE_MYC	c2.CGP_ chemical and genetic perturbations	55	1.5329161	0.008141113	0.07810209	SANSOM_WNT_PATHWAY_REQUIRE_MYC	57	-1.2584811	0.07608695	0.3158498	0.274435	2.7913972
GSE360_DC_VS_MAC_T_GONDII_UP	C7_ immunologic signatures	160	1.5328397	0	0.078095965	GSE360_DC_VS_MAC_T_GONDII_UP	170	1.2920405	0.0254842	0.4539937	2.8248802	0.2407992
GO_STRIATED_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	149	1.5327601	0.004907975	0.0780881	GO_STRIATED_MUSCLE_CELL_DIFFERENTIATION	158	0.91299963	0.70408165	1	2.44575973	0.61976047
GO_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE	c5.BP_ GO biological process	178	1.5326811	0.001189061	0.078074284	GO_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE	184	1.0866429	0.2923387	0.7753806	2.619324	0.4460382
GO_ORGAN_INDUCTION	c5.BP_ GO biological process	16	1.5319413	0.02685624	0.07864808	GO_ORGAN_INDUCTION	16	1.3376644	0.10408432	0.39804152	2.8696057	0.1942769
GO_MUSCLE_CONTRACTION	c5.BP_ GO biological process	201	1.531929	0	0.0785867	GO_MUSCLE_CONTRACTION	217	1.3533871	0.003030303	0.38263535	2.8853161	0.1785419
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	c2.CGP_ chemical and genetic perturbations	71	1.5317099	0.005354752	0.0786819	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	70	1.1495478	0.248104	0.6705604	2.6812577	0.3821621
GO_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	51	1.5316461	0.00862069	0.07866084	GO_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION	58	0.99438083	0.5156951	0.93077886	2.52602693	0.53726527
GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	C7_ immunologic signatures	165	1.5315273	0.001164144	0.07869521	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	162	1.2728742	0.044715445	0.48224747	2.8044015	0.2586531
GAL_LEUKEMIC_STEM_CELL_DN	c2.CGP_ chemical and genetic perturbations	192	1.5313883	0.001140251	0.07873887	GAL_LEUKEMIC_STEM_CELL_DN	195	1.273159	0.035282258	0.48175532	2.8045473	0.2582293
FREAC2_01	c3.TFT_ transcription factor targets	220	1.5309509	0.002267574	0.07900412	FREAC2_01	229	0.90054595	0.7462387	1	2.43149685	0.63040495
GO_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING	c5.BP_ GO biological process	126	1.5305195	0.002534854	0.0792875	GO_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING	133	0.972219	0.5509165	0.9591605	2.5027385	0.5583005
MODULE_109	c4.CM_ cancer modules	32	1.5303961	0.02835821	0.07932283	MODULE_109	31	1.1632787	0.25634825	0.6478516	2.6936748	0.3671174
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	c2.CGP_ chemical and genetic perturbations	91	1.5303843	0.002624672	0.07926552	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	92	0.99914855	0.48674443	0.9245998	2.52953285	0.53123575
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP	C7_ immunologic signatures	176	1.5303074	0	0.07924235	GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP	178	-1.2182921	0	0.35818556	0.3120153	2.7485995
GO_BONE_REMODELING	c5.BP_ GO biological process	33	1.5301648	0.020155039	0.07928613	GO_BONE_REMODELING	33	0.9808841	0.4940048	0.9481563	2.5110489	0.5492807
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	c2.CGP_ chemical and genetic perturbations	42	1.5300181	0.013473053	0.07935274	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	42	1.0444535	0.40112993	0.84996533	2.5744716	0.4855646
GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	C7_ immunologic signatures	166	1.5297348	0.00122549	0.07954042	GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	166	1.1719788	0.13719513	0.63467854	2.7017136	0.357756
MODULE_118	c4.CM_ cancer modules	359	1.5296934	0	0.07950943	MODULE_118	373	0.8993117	0.809	1	2.4290051	0.6303817
GO_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	16	1.529505	0.01842546	0.07961205	GO_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT	17	1.4912004	0.037483267	0.25882524	3.0207054	0.0383046
GO_GLAND_MORPHOGENESIS	c5.BP_ GO biological process	90	1.5294571	0.007894737	0.07958524	GO_GLAND_MORPHOGENESIS	94	1.0947751	0.31452456	0.7653605	2.6242322	0.434682
GSE24210_RESTING_TREG_VS_TCONV_UP	C7_ immunologic signatures	180	1.529415	0.001168224	0.07955184	GSE24210_RESTING_TREG_VS_TCONV_UP	179	1.4089175	0.001025641	0.32708922	2.9383325	0.1204975
GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP	C7_ immunologic signatures	148	1.5293174	0.002398082	0.079562165	GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP	146	0.9376076	0.64154786	0.99329275	2.466925	0.5917098
GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	146	1.5292115	0.004901961	0.07957764	GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	148	0.8587181	0.801636	1	2.3879296	0.6704934
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	c2.CGP_ chemical and genetic perturbations	140	1.5291216	0.001242236	0.079577915	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	140	1.1853558	0.1496945	0.6130525	2.7144774	0.3437658
GO_REGULATION_OF_AXON_GUIDANCE	c5.BP_ GO biological process	36	1.5288073	0.021367522	0.07976982	GO_REGULATION_OF_AXON_GUIDANCE	39	1.0322027	0.43091336	0.8731675	2.56101	0.4966046
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	c2.CGP_ chemical and genetic perturbations	17	1.5287554	0.03164557	0.0797447	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	21	0.8631187	0.6883117	1	2.3918741	0.6656367
GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP	C7_ immunologic signatures	171	1.5281819	0.001196172	0.0801677	GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP	176	1.1213568	0.21248741	0.7218481	2.6495387	0.4068251
GO_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL	c5.BP_ GO biological process	75	1.5279967	0.002739726	0.08025294	GO_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL	81	1.367114	0.03601695	0.370779	2.8951107	0.1608827
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN	c2.CGP_ chemical and genetic perturbations	26	1.5278618	0.019292604	0.08030368	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN	27	1.113163	0.33573142	0.7329013	2.6410248	0.4146988
SEKI_INFLAMMATORY_RESPONSE_LPS_DN	c2.CGP_ chemical and genetic perturbations	21	1.5274551	0.02992126	0.08058287	SEKI_INFLAMMATORY_RESPONSE_LPS_DN	20	0.85538626	0.6874206	1	2.38284136	0.67206884
GSE6259_DEC205_POS_DC_VS_BCELL_UP	C7_ immunologic signatures	120	1.527433	0.001253133	0.0805329	GSE6259_DEC205_POS_DC_VS_BCELL_UP	139	1.1933128	0.12271805	0.60057694	2.7207458	0.3341202
ROZANOV_MMP14_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	27	1.5272037	0.023364486	0.080661625	ROZANOV_MMP14_TARGETS_DN	28	1.602986	0.003676471	0.15453175	3.1301897	-0.0757823
MMEF2_Q6	c3.TFT_ transcription factor targets	229	1.5272006	0.00116144	0.08059249	MMEF2_Q6	244	1.2052703	0.06243706	0.5825955	2.7324709	0.3219303
GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	C7_ immunologic signatures	169	1.5269066	0.002386635	0.08078708	GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	180	1.0279018	0.44659206	0.8795001	2.5548084	0.4990048
GO_ACTIN_MYOSIN_FILAMENT_SLIDING	c5.BP_ GO biological process	31	1.5265155	0.022123894	0.08102784	GO_ACTIN_MYOSIN_FILAMENT_SLIDING	36	1.1436644	0.28235295	0.68358755	2.6701799	0.3828511
GO_MULTI_ORGANISM_BEHAVIOR	c5.BP_ GO biological process	64	1.5263721	0.006906077	0.081075184	GO_MULTI_ORGANISM_BEHAVIOR	69	-1.1824354	0.14772727	0.40243474	0.3439367	2.7088075
YTAATTAA_LHX3_01	c3.TFT_ transcription factor targets	163	1.526119	0.002392344	0.08123795	YTAATTAA_LHX3_01	174	0.9115706	0.6903553	1	2.4376896	0.6145484
GO_POSITIVE_REGULATION_OF_EXOCYTOSIS	c5.BP_ GO biological process	71	1.5257957	0.005326232	0.08142214	GO_POSITIVE_REGULATION_OF_EXOCYTOSIS	75	1.2093585	0.15727949	0.5778795	2.7351542	0.3164372
RIGGI_EWING_SARCOMA_PROGENITOR_DN	c2.CGP_ chemical and genetic perturbations	163	1.5256455	0.00117096	0.08147554	RIGGI_EWING_SARCOMA_PROGENITOR_DN	164	1.2264367	0.07459678	0.5476395	2.7520822	0.2992088
REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	26	1.5256255	0.020376176	0.081419356	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING	26	0.75772667	0.8114144	1	2.28335217	0.76789883
GO_PHAGOCYTOSIS_ENGULFMENT	c5.BP_ GO biological process	19	1.5255842	0.027419355	0.08138653	GO_PHAGOCYTOSIS_ENGULFMENT	25	1.5850219	0.004938272	0.17692925	3.1106061	-0.0594377
GO_CELL_CYCLE_ARREST	c5.BP_ GO biological process	137	1.5253706	0.001242236	0.08148948	GO_CELL_CYCLE_ARREST	136	0.77657723	0.9039256	1	2.30194783	0.74879337
GO_I_BAND	c5.CC_ GO cellular component	109	1.5250827	0.002610966	0.08166091	GO_I_BAND	116	1.6996876	0	0.08164517	3.2247703	-0.1746049
GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	156	1.5250717	0	0.08159733	GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP	166	1.0046674	0.49848023	0.9157351	2.5297391	0.5204043
CHR3P24	C1: positional gene sets	30	1.5248525	0.022123894	0.08170806	CHR3P24	32	0.7950427	0.7690476	1	2.3198952	0.7298098
GO_CELLULAR_RESPONSE_TO_CAMP	c5.BP_ GO biological process	46	1.5246205	0.01780822	0.081835136	GO_CELLULAR_RESPONSE_TO_CAMP	49	1.2192898	0.17171717	0.5559465	2.7439103	0.3053307
PEREZ_TP53_AND_TP63_TARGETS	c2.CGP_ chemical and genetic perturbations	168	1.5243852	0	0.08195301	PEREZ_TP53_AND_TP63_TARGETS	172	1.5386192	0	0.21109276	3.0630044	-0.014234
MODULE_127	c4.CM_ cancer modules	21	1.5241536	0.023183925	0.082074665	MODULE_127	21	-1.5095681	0.03301887	0.13687861	0.0145855	3.0337217
GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP	C7_ immunologic signatures	180	1.5240043	0	0.082145944	GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP	183	0.95359147	0.6024218	0.97776717	2.47759577	0.57041283
GSE3982_BCELL_VS_NKCELL_DN	C7_ immunologic signatures	157	1.5238811	0	0.082174316	GSE3982_BCELL_VS_NKCELL_DN	161	1.2855908	0.040609136	0.4630451	2.8094719	0.2382903
GO_POSITIVE_REGULATION_OF_COAGULATION	c5.BP_ GO biological process	20	1.5238734	0.022727273	0.08210825	GO_POSITIVE_REGULATION_OF_COAGULATION	20	1.5224826	0.024265645	0.2345114	3.046356	0.0013908
KEGG_HOMOLOGOUS_RECOMBINATION	c2.CP_BIOCARTA_ BioCarta gene sets	23	1.5238063	0.025757575	0.08210627	KEGG_HOMOLOGOUS_RECOMBINATION	23	-0.6813674	0.94736844	0.9681817	0.8424389	2.2051737
MODULE_387	c4.CM_ cancer modules	46	1.5237228	0.014224751	0.08210508	MODULE_387	47	1.4655739	0.01920904	0.2792179	2.9892967	0.0581489
GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN	C7_ immunologic signatures	187	1.5234334	0	0.08226461	GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN	190	1.1859962	0.11561866	0.6128799	2.7094296	0.3374372
GO_DNA_REPLICATION	c5.BP_ GO biological process	186	1.5232531	0	0.082324736	GO_DNA_REPLICATION	187	-2.0042114	0	0.007868676	-0.4809583	3.5274645
GSE6259_BCELL_VS_CD8_TCELL_DN	C7_ immunologic signatures	161	1.5229894	0	0.08246658	GSE6259_BCELL_VS_CD8_TCELL_DN	166	0.7885663	0.9016227	1	2.3115557	0.7344231
GO_FORMATION_OF_PRIMARY_GERM_LAYER	c5.BP_ GO biological process	98	1.5229318	0.009043927	0.0824521	GO_FORMATION_OF_PRIMARY_GERM_LAYER	106	0.7958632	0.8590957	1	2.318795	0.7270686
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	c2.CGP_ chemical and genetic perturbations	29	1.522888	0.019817073	0.08241556	IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	29	-1.6223531	0.00591716	0.08343054	-0.0994651	3.1452411
NADERI_BREAST_CANCER_PROGNOSIS_UP	c2.CGP_ chemical and genetic perturbations	42	1.522792	0.018624641	0.082420774	NADERI_BREAST_CANCER_PROGNOSIS_UP	44	-1.1819897	0.18320611	0.402782	0.3408023	2.7047817
GO_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	78	1.5227342	0.008010681	0.08241038	GO_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION	81	0.71515286	0.91014796	1	2.23788706	0.80758134
GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN	C7_ immunologic signatures	141	1.522465	0	0.08256372	GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN	146	0.84243697	0.8228106	1	2.36490197	0.68002803
GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP	C7_ immunologic signatures	167	1.5223937	0.002339181	0.08254351	GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP	177	0.9153245	0.6892713	1	2.4377182	0.6070692
GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP	C7_ immunologic signatures	175	1.5222827	0	0.08256383	GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP	177	1.4486369	0.002038736	0.29220158	2.9709196	0.0736458
GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	185	1.522053	0	0.08267192	GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN	187	1.133119	0.2006079	0.70078045	2.655172	0.388934
SMID_BREAST_CANCER_LUMINAL_A_UP	c2.CGP_ chemical and genetic perturbations	72	1.5219159	0.013793103	0.08271161	SMID_BREAST_CANCER_LUMINAL_A_UP	77	0.99414766	0.5021231	0.93110687	2.51606356	0.52776824
REACTOME_MEIOTIC_RECOMBINATION	c2.CP_REACTOME_ Reactome gene sets	43	1.5217687	0.017910447	0.082764305	REACTOME_MEIOTIC_RECOMBINATION	44	1.0319471	0.43913537	0.8733523	2.5537158	0.4898216
REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES	c2.CP_REACTOME_ Reactome gene sets	53	1.5217453	0.008141113	0.08271806	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES	53	0.6195342	0.9740991	1	2.1412795	0.9022111
CHIBA_RESPONSE_TO_TSA	c2.CGP_ chemical and genetic perturbations	44	1.5217096	0.01971831	0.08267266	CHIBA_RESPONSE_TO_TSA	44	0.99964905	0.48156682	0.9245063	2.52135865	0.52206055
GO_POSITIVE_REGULATION_OF_CELL_CYCLE_ARREST	c5.BP_ GO biological process	74	1.5215846	0.005494506	0.08270422	GO_POSITIVE_REGULATION_OF_CELL_CYCLE_ARREST	75	-1.1091307	0.21428572	0.5048613	0.4124539	2.6307153
GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	C7_ immunologic signatures	182	1.5213653	0.001193318	0.08283834	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	188	0.7809247	0.9143145	1	2.30229	0.7404406
GO_BONE_DEVELOPMENT	c5.BP_ GO biological process	139	1.5212262	0.003778338	0.08288581	GO_BONE_DEVELOPMENT	145	0.86280215	0.78128177	1	2.38402835	0.65842405
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN	C7_ immunologic signatures	163	1.5212058	0.002424242	0.082832426	GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN	165	1.2216263	0.0951417	0.553939	2.7428321	0.2995795
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	c2.CGP_ chemical and genetic perturbations	85	1.5210085	0.006570302	0.08294919	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	89	1.1731827	0.20042194	0.63375974	2.6941912	0.3478258
REACTOME_COLLAGEN_FORMATION	c2.CP_REACTOME_ Reactome gene sets	46	1.5207436	0.01980198	0.08311478	REACTOME_COLLAGEN_FORMATION	47	1.0741787	0.39184597	0.79821616	2.5949223	0.4465649
CHR5Q35	C1: positional gene sets	82	1.5207005	0.003963012	0.08307502	CHR5Q35	86	0.9634443	0.5738758	0.96732724	2.4841448	0.5572562
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP	C7_ immunologic signatures	180	1.5203215	0	0.08334063	GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP	182	1.3952744	0.008080808	0.34616852	2.9155959	0.1250471
CHR1Q32	C1: positional gene sets	116	1.520317	0.005	0.0832734	CHR1Q32	117	1.3690865	0.02079002	0.36900356	2.8894035	0.1512305
E2F1_Q4	c3.TFT_ transcription factor targets	217	1.5203024	0	0.08321193	E2F1_Q4	220	-1.5626787	0	0.10814617	-0.0423763	3.0829811
GO_REGULATION_OF_SYSTEM_PROCESS	c5.BP_ GO biological process	419	1.5202113	0	0.08323222	GO_REGULATION_OF_SYSTEM_PROCESS	467	1.3640609	0	0.37321553	2.8842722	0.1561504
CHIBA_RESPONSE_TO_TSA_UP	c2.CGP_ chemical and genetic perturbations	49	1.5200772	0.018335683	0.08327981	CHIBA_RESPONSE_TO_TSA_UP	49	0.80320394	0.7938144	1	2.32328114	0.71687326
ATM_DN.V1_UP	C6_ oncogenic signatures	117	1.5198864	0.002531646	0.083364084	ATM_DN.V1_UP	122	1.178285	0.15201655	0.6243684	2.6981714	0.3416014
AACATTC_MIR4093P	c3.MIR_ microRNA targets	130	1.5198616	0.002472188	0.08331715	AACATTC_MIR4093P	130	-0.8931254	0.7826087	0.8291887	0.6267362	2.412987
GO_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION	c5.BP_ GO biological process	26	1.5197809	0.025	0.08331096	GO_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION	27	-1.1045026	0.259887	0.51010567	0.4152783	2.6242835
GO_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY	c5.BP_ GO biological process	17	1.519408	0.022116903	0.08353319	GO_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY	19	-1.639813	0.00877193	0.0763952	-0.120405	3.159221
MODULE_2	c4.CM_ cancer modules	346	1.5193137	0	0.0835492	MODULE_2	352	1.2572261	0.012024048	0.49928513	2.7765398	0.2620876
LAU_APOPTOSIS_CDKN2A_UP	c2.CGP_ chemical and genetic perturbations	51	1.5192988	0.014025246	0.08349111	LAU_APOPTOSIS_CDKN2A_UP	50	-1.0440164	0.3490566	0.61649203	0.4752824	2.5633152
REACTOME_STRIATED_MUSCLE_CONTRACTION	c2.CP_REACTOME_ Reactome gene sets	23	1.5192622	0.022970904	0.08345939	REACTOME_STRIATED_MUSCLE_CONTRACTION	27	1.1536274	0.26658475	0.6626506	2.6728896	0.3656348
VANASSE_BCL2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	63	1.5192113	0.009283819	0.083428495	VANASSE_BCL2_TARGETS_DN	65	1.0766838	0.3478735	0.7945114	2.5958951	0.4425275
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	c2.CGP_ chemical and genetic perturbations	82	1.5190644	0.004016064	0.083469965	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	84	1.2438412	0.1154661	0.5216075	2.7629056	0.2752232
GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN	C7_ immunologic signatures	172	1.5190507	0.001191895	0.08341133	GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN	172	1.0606282	0.36437246	0.8225145	2.5796789	0.4584225
GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN	C7_ immunologic signatures	178	1.5189611	0	0.08341469	GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN	180	0.93734735	0.641129	0.993052	2.45630845	0.58161375
GO_SMOOTH_MUSCLE_CONTRACTION	c5.BP_ GO biological process	38	1.518736	0.02529762	0.083520435	GO_SMOOTH_MUSCLE_CONTRACTION	43	0.93290657	0.5966102	0.9974105	2.45164257	0.58582943
GO_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR	c5.BP_ GO biological process	113	1.5185354	0.002583979	0.0836291	GO_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR	114	1.1889093	0.15800416	0.6070259	2.7074447	0.3296261
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS	c5.BP_ GO biological process	40	1.5180916	0.015736766	0.083944164	GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS	38	1.1269397	0.30715936	0.711748	2.6450313	0.3911519
GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN	C7_ immunologic signatures	184	1.5176725	0	0.0842492	GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN	188	-1.2597632	0	0.31543988	0.2579093	2.7774357
GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	C7_ immunologic signatures	163	1.5175318	0	0.08431032	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	166	1.203005	0.10408163	0.58665216	2.7205368	0.3145268
E2F4DP1_01	c3.TFT_ transcription factor targets	211	1.5173112	0	0.08444007	E2F4DP1_01	214	-1.7974216	0	0.033262033	-0.2801104	3.3147328
PEDRIOLI_MIR31_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	321	1.5172309	0	0.08442287	PEDRIOLI_MIR31_TARGETS_DN	341	1.3455632	0	0.38795817	2.8627941	0.1716677
CCAWWNAAGG_SRF_Q4	c3.TFT_ transcription factor targets	81	1.5171798	0.001351351	0.08439228	CCAWWNAAGG_SRF_Q4	81	-1.0246423	0.33333334	0.65083253	0.4925375	2.5418221
FOXD3_01	c3.TFT_ transcription factor targets	166	1.5170741	0.004739337	0.084403425	FOXD3_01	179	1.024019	0.44612285	0.88504237	2.5410931	0.4930551
HNF1_Q6	c3.TFT_ transcription factor targets	208	1.5170717	0.001153403	0.08433587	HNF1_Q6	217	1.2109064	0.065590315	0.57600045	2.7279781	0.3061653
GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	C7_ immunologic signatures	179	1.5170686	0.00238379	0.08426766	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	180	1.4052396	0.002014099	0.33371416	2.9223082	0.111829
GO_CARDIAC_CONDUCTION	c5.BP_ GO biological process	70	1.5170274	0.009575923	0.0842325	GO_CARDIAC_CONDUCTION	77	1.3157324	0.065005414	0.41684368	2.8327598	0.201295
GO_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY	c5.GO molecular function	15	1.5167986	0.03902439	0.084349714	GO_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY	15	0.96792424	0.5282523	0.96392244	2.48472284	0.54887436
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	c2.CGP_ chemical and genetic perturbations	19	1.5167117	0.021212121	0.084354624	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	19	-1.0262167	0.39823008	0.64705163	0.490495	2.5429284
GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP	C7_ immunologic signatures	190	1.5166104	0.001173709	0.08437989	GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP	189	1.2546136	0.044265594	0.5026044	2.771224	0.2619968
GNF2_TIMP2	c4.CGN_ cancer gene neighborhoods	34	1.5164275	0.023880597	0.084466934	GNF2_TIMP2	39	1.7473915	0	0.065993525	3.263819	-0.230964
GO_WALKING_BEHAVIOR	c5.BP_ GO biological process	29	1.5162953	0.032163743	0.08451553	GO_WALKING_BEHAVIOR	31	-0.8162424	0.8023256	0.89206195	0.7000529	2.3325377
KEGG_REGULATION_OF_AUTOPHAGY	c2.CP_BIOCARTA_ BioCarta gene sets	32	1.5155464	0.030746706	0.085080646	KEGG_REGULATION_OF_AUTOPHAGY	33	0.5300741	0.9892857	1	2.0456205	0.9854723
GO_CYTOSKELETON_DEPENDENT_CYTOKINESIS	c5.BP_ GO biological process	36	1.5153228	0.019817073	0.08521611	GO_CYTOSKELETON_DEPENDENT_CYTOKINESIS	36	1.0639875	0.39336494	0.8158961	2.5793103	0.4513353
REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	c2.CP_REACTOME_ Reactome gene sets	18	1.5153079	0.021705426	0.08515549	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	19	0.5899877	0.9460154	1	2.1052956	0.9253202
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN	C7_ immunologic signatures	184	1.5152923	0	0.08509652	GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN	185	1.2755367	0.03959391	0.47940928	2.790829	0.2397556
GO_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	c5.BP_ GO biological process	28	1.5152329	0.017405063	0.08507503	GO_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	29	1.0361625	0.43855423	0.8656819	2.5513954	0.4790704
GSE22886_CTRL_VS_LPS_24H_DC_DN	C7_ immunologic signatures	162	1.5150797	0	0.08514235	GSE22886_CTRL_VS_LPS_24H_DC_DN	163	1.1932589	0.11349693	0.6000716	2.7083386	0.3218208
GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	C7_ immunologic signatures	142	1.5150707	0.001233046	0.085081965	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	145	1.2027572	0.101434425	0.5874041	2.7178279	0.3123135
GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN	C7_ immunologic signatures	174	1.5150328	0	0.08504188	GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN	174	1.3585362	0.009109312	0.3782373	2.873569	0.1564966
GO_MATING_BEHAVIOR	c5.BP_ GO biological process	20	1.514939	0.024038462	0.08505467	GO_MATING_BEHAVIOR	20	1.2043307	0.24191462	0.58343303	2.7192697	0.3106083
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP	C7_ immunologic signatures	168	1.514913	0	0.085008495	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP	170	0.77362907	0.9079879	1	2.28854207	0.74128393
SASAKI_ADULT_T_CELL_LEUKEMIA	c2.CGP_ chemical and genetic perturbations	160	1.5147978	0	0.08503368	SASAKI_ADULT_T_CELL_LEUKEMIA	160	0.9189106	0.68686867	1	2.4337084	0.5958872
GO_AGING	c5.BP_ GO biological process	233	1.514719	0	0.08502937	GO_AGING	242	1.0985377	0.25175527	0.75824004	2.6132567	0.4161813
REACTOME_CGMP_EFFECTS	c2.CP_REACTOME_ Reactome gene sets	18	1.5147069	0.042056076	0.084964745	REACTOME_CGMP_EFFECTS	19	-1.3493605	0.11004785	0.24263628	0.1653464	2.8640674
MODULE_329	c4.CM_ cancer modules	47	1.5144694	0.018156424	0.085104324	MODULE_329	49	1.4505607	0.018599562	0.2912189	2.9650301	0.0639087
P53_DN.V1_DN	C6_ oncogenic signatures	167	1.5142154	0.001190476	0.08522673	P53_DN.V1_DN	171	1.3222473	0.01622718	0.41125262	2.8364627	0.1919681
YAATNANRNNNCAG_UNKNOWN	c3.TFT_ transcription factor targets	53	1.5137786	0.014144272	0.08551717	YAATNANRNNNCAG_UNKNOWN	55	1.1826544	0.21524663	0.61856264	2.696433	0.3311242
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR	c2.CP_REACTOME_ Reactome gene sets	92	1.5137218	0.006468305	0.08550175	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR	93	1.0212353	0.46413502	0.89065176	2.5349571	0.4924865
RRAGTTGT_UNKNOWN	c3.TFT_ transcription factor targets	213	1.5136908	0.002347418	0.085460864	RRAGTTGT_UNKNOWN	226	0.837157	0.86606246	1	2.3508478	0.6765338
HFH1_01	c3.TFT_ transcription factor targets	197	1.5136788	0	0.08540236	HFH1_01	211	0.8473785	0.8443775	1	2.3610573	0.6663003
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	c2.CGP_ chemical and genetic perturbations	463	1.5131305	0	0.08584642	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	463	0.8341562	0.952953	1	2.3472867	0.6789743
GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	C7_ immunologic signatures	180	1.512879	0	0.08601917	GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	181	0.7438446	0.9443883	1	2.2567236	0.7690344
TAGCTTT_MIR9	c3.MIR_ microRNA targets	222	1.5126767	0	0.08612628	TAGCTTT_MIR9	225	0.86388993	0.83131313	1	2.37656663	0.64878677
COLINA_TARGETS_OF_4EBP1_AND_4EBP2	c2.CGP_ chemical and genetic perturbations	330	1.5126191	0	0.08610578	COLINA_TARGETS_OF_4EBP1_AND_4EBP2	330	1.0983922	0.2	0.75875163	2.6110113	0.4142269
GO_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS	c5.BP_ GO biological process	16	1.5124243	0.028708134	0.08620807	GO_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS	16	-0.98003113	0.46846846	0.7138467	0.53239317	2.49245543
WHITFIELD_CELL_CYCLE_G1_S	c2.CGP_ chemical and genetic perturbations	120	1.5122329	0.00498132	0.08630794	WHITFIELD_CELL_CYCLE_G1_S	122	-2.2448118	0	0.000537199	-0.7325789	3.7570447
WEINMANN_ADAPTATION_TO_HYPOXIA_UP	c2.CGP_ chemical and genetic perturbations	24	1.5118178	0.02681388	0.0866413	WEINMANN_ADAPTATION_TO_HYPOXIA_UP	26	0.8165624	0.74759614	1	2.3283802	0.6952554
GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN	C7_ immunologic signatures	170	1.5117769	0.001189061	0.08659519	GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN	169	1.1475493	0.1783894	0.6728274	2.6593262	0.3642276
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	c2.CGP_ chemical and genetic perturbations	25	1.5116781	0.035928145	0.08660652	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	25	0.8242193	0.7394015	1	2.3358974	0.6874588
ZHANG_TLX_TARGETS_36HR_UP	c2.CGP_ chemical and genetic perturbations	208	1.5115924	0	0.086606346	ZHANG_TLX_TARGETS_36HR_UP	209	1.5079951	0	0.24417403	3.0195875	0.0035973
GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	C7_ immunologic signatures	173	1.5115342	0	0.08658789	GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	173	0.827227	0.8606061	1	2.3387612	0.6843072
GO_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY	c5.BP_ GO biological process	47	1.5111405	0.018181818	0.08687287	GO_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY	50	0.887724	0.6640361	1	2.3988645	0.6234165
GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN	C7_ immunologic signatures	123	1.5109512	0.004926108	0.08697539	GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN	128	1.0812999	0.3299389	0.7857584	2.5922511	0.4296513
GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	C7_ immunologic signatures	184	1.5108004	0.004672897	0.08704432	GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	184	-1.2180343	0	0.35834005	0.2927661	2.7288347
GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP	C7_ immunologic signatures	160	1.510646	0.002403846	0.08711686	GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP	172	1.075236	0.3306288	0.79637456	2.585882	0.43541
GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP	C7_ immunologic signatures	174	1.5105354	0.001213592	0.087149814	GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP	176	-1.5363723	0	0.122099176	-0.0258369	3.0469077
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	c2.CGP_ chemical and genetic perturbations	17	1.5101616	0.051359516	0.08740981	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	16	0.93638134	0.56413615	0.9938329	2.44654294	0.57378026
GO_NEGATIVE_REGULATION_OF_AXON_GUIDANCE	c5.BP_ GO biological process	25	1.5101146	0.02887538	0.08738251	GO_NEGATIVE_REGULATION_OF_AXON_GUIDANCE	27	0.8636884	0.6629766	1	2.373803	0.6464262
GO_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION	c5.BP_ GO biological process	25	1.5100744	0.021875	0.087352894	GO_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION	27	-1.056888	0.33519554	0.594369	0.4531864	2.5669624
GSE2706_UNSTIM_VS_2H_R848_DC_DN	C7_ immunologic signatures	160	1.5099051	0.001240695	0.087420374	GSE2706_UNSTIM_VS_2H_R848_DC_DN	163	1.155454	0.16463415	0.6616053	2.6653591	0.3544511
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	17	1.5098825	0.036124796	0.087371886	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	17	1.4928312	0.037086092	0.2577723	3.0027137	0.0170513
GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP	C7_ immunologic signatures	171	1.5097771	0	0.0873939	GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP	170	1.4392354	0.002026343	0.30464986	2.9490125	0.0705417
GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN	C7_ immunologic signatures	180	1.5095752	0	0.08747628	GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN	180	-1.1569499	0.09090909	0.43452653	0.3526253	2.6665251
GO_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS	c5.BP_ GO biological process	130	1.5094525	0	0.08751244	GO_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS	138	1.0681803	0.35589743	0.8088522	2.5776328	0.4412722
GO_CELL_JUNCTION_ORGANIZATION	c5.BP_ GO biological process	167	1.5093956	0.002364066	0.0875033	GO_CELL_JUNCTION_ORGANIZATION	173	1.16383	0.1502538	0.64737874	2.6732256	0.3455656
ZHU_CMV_8_HR_UP	c2.CGP_ chemical and genetic perturbations	41	1.5093918	0.015558699	0.08743456	ZHU_CMV_8_HR_UP	39	1.6639543	0.001140251	0.09962118	3.1733461	-0.1545625
CHR9P22	C1: positional gene sets	30	1.509177	0.023148147	0.08754966	CHR9P22	30	1.0964781	0.35315102	0.7617674	2.6056551	0.4126989
CARD_MIR302A_TARGETS	c2.CGP_ chemical and genetic perturbations	76	1.5084542	0.005369128	0.08816609	CARD_MIR302A_TARGETS	76	0.84578454	0.7583244	1	2.35423874	0.66266966
GO_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	18	1.508447	0.045088567	0.088099994	GO_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	20	1.2614706	0.14810127	0.49423146	2.7699176	0.2469764
THEODOROU_MAMMARY_TUMORIGENESIS	c2.CGP_ chemical and genetic perturbations	26	1.5084394	0.023988007	0.08803703	THEODOROU_MAMMARY_TUMORIGENESIS	27	0.97443753	0.5345455	0.9561489	2.48287693	0.53400187
GO_ODONTOGENESIS	c5.BP_ GO biological process	87	1.5083377	0.002538071	0.08803949	GO_ODONTOGENESIS	98	1.0084836	0.4846885	0.91129375	2.5168213	0.4998541
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	c2.CGP_ chemical and genetic perturbations	48	1.5083188	0.02097902	0.08798569	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	49	0.86467665	0.71571904	1	2.37299545	0.64364215
ZHU_CMV_8_HR_DN	c2.CGP_ chemical and genetic perturbations	49	1.5079366	0.021398002	0.088249825	ZHU_CMV_8_HR_DN	50	0.79592526	0.7972973	1	2.30386186	0.71201134
GO_NEUROPILIN_BINDING	c5.GO molecular function	15	1.5077184	0.028764805	0.08838555	GO_NEUROPILIN_BINDING	15	0.79550123	0.7535854	1	2.30321963	0.71221717
GO_RESPIRATORY_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	185	1.5075216	0.001175088	0.08850454	GO_RESPIRATORY_SYSTEM_DEVELOPMENT	189	1.0013992	0.4893401	0.9214381	2.5089208	0.5061224
GO_ALPHA_ACTININ_BINDING	c5.GO molecular function	19	1.5073045	0.030063292	0.08862855	GO_ALPHA_ACTININ_BINDING	21	1.0359995	0.45268542	0.8657901	2.543304	0.471305
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	c2.CGP_ chemical and genetic perturbations	119	1.5072333	0.002512563	0.08862233	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	120	1.1858327	0.1594203	0.6130575	2.693066	0.3214006
GO_ADULT_BEHAVIOR	c5.BP_ GO biological process	116	1.5066892	0.006297229	0.08901559	GO_ADULT_BEHAVIOR	127	1.0082818	0.47736627	0.91167647	2.514971	0.4984074
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	c2.CGP_ chemical and genetic perturbations	70	1.5066346	0.010914052	0.08899789	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	68	0.8609577	0.74372953	1	2.3675923	0.6456769
GO_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL	c5.BP_ GO biological process	61	1.5063839	0.013908206	0.08914424	GO_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL	64	1.372609	0.04278075	0.36410317	2.8789929	0.1337749
GSE17721_LPS_VS_POLYIC_16H_BMDC_DN	C7_ immunologic signatures	181	1.5063311	0	0.08911748	GSE17721_LPS_VS_POLYIC_16H_BMDC_DN	182	1.0152429	0.4587996	0.8966035	2.521574	0.4910882
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	c2.CGP_ chemical and genetic perturbations	76	1.5063269	0.009271523	0.089049086	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	83	1.1891724	0.17382199	0.60617423	2.6954993	0.3171545
HOWLIN_CITED1_TARGETS_1_UP	c2.CGP_ chemical and genetic perturbations	29	1.5061848	0.020864382	0.08912214	HOWLIN_CITED1_TARGETS_1_UP	30	1.0820799	0.37801933	0.78346443	2.5882647	0.4241049
GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP	C7_ immunologic signatures	129	1.5058771	0	0.08934756	GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP	136	1.1834235	0.14649034	0.6174236	2.6893006	0.3224536
GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	177	1.505552	0.002350176	0.08957993	GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP	178	0.79724896	0.8989899	1	2.30280096	0.70830304
CHR9Q31	C1: positional gene sets	40	1.5055462	0.015873017	0.089513615	CHR9Q31	40	0.7705267	0.8380282	1	2.2760729	0.7350195
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	c2.CGP_ chemical and genetic perturbations	91	1.5053651	0.011392405	0.08960015	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	94	1.1859711	0.16153029	0.6128022	2.6913362	0.319394
GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_CONTRACTION	c5.BP_ GO biological process	25	1.5051868	0.03805175	0.08970741	GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_CONTRACTION	25	1.4113148	0.04213135	0.32473198	2.9165016	0.093872
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS	c2.CP_REACTOME_ Reactome gene sets	25	1.5050287	0.022255193	0.0897737	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS	25	0.79824686	0.7776413	1	2.30327556	0.70678184
GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP	C7_ immunologic signatures	175	1.5050117	0.001194743	0.08971854	GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP	180	0.95984197	0.6134283	0.971095	2.46485367	0.54516973
GO_SMOOTH_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	27	1.5047436	0.04023845	0.08988223	GO_SMOOTH_MUSCLE_CELL_DIFFERENTIATION	27	0.7065989	0.8730351	1	2.2113425	0.7981447
CHR6P22	C1: positional gene sets	54	1.5046352	0.01977401	0.08991055	CHR6P22	55	1.0678688	0.37222221	0.8094797	2.572504	0.4367664
GO_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION	c5.BP_ GO biological process	292	1.5045491	0.001104972	0.08991521	GO_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION	297	0.9437381	0.6753769	0.9887527	2.4482872	0.560811
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP	C7_ immunologic signatures	156	1.5044675	0.004801921	0.08992721	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP	154	1.0758525	0.32277834	0.7950034	2.58032	0.428615
PRC2_SUZ12_UP.V1_DN	C6_ oncogenic signatures	138	1.5043151	0.00617284	0.0899997	PRC2_SUZ12_UP.V1_DN	149	1.2877446	0.042857144	0.46104884	2.7920597	0.2165705
GO_CELL_CORTEX	c5.CC_ GO cellular component	215	1.5038848	0	0.090313576	GO_CELL_CORTEX	220	1.2431822	0.032128513	0.522998	2.747067	0.2607026
GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN	C7_ immunologic signatures	168	1.5038767	0.00243309	0.09024727	GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN	170	1.292339	0.028484233	0.4533043	2.7962157	0.2115377
CORRE_MULTIPLE_MYELOMA_UP	c2.CGP_ chemical and genetic perturbations	56	1.5035273	0.01396648	0.09050027	CORRE_MULTIPLE_MYELOMA_UP	59	1.2305763	0.16061606	0.5392836	2.7341036	0.272951
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	c2.CGP_ chemical and genetic perturbations	15	1.5032924	0.037441496	0.09065357	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	18	-1.142052	0.25221238	0.45393804	0.3612404	2.6453444
GSE18893_TCONV_VS_TREG_24H_CULTURE_DN	C7_ immunologic signatures	182	1.5032293	0	0.09065466	GSE18893_TCONV_VS_TREG_24H_CULTURE_DN	184	1.2619226	0.042296074	0.49387836	2.7651519	0.2413067
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	c2.CGP_ chemical and genetic perturbations	126	1.5029444	0.001231527	0.090838395	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	135	1.2489043	0.07881269	0.5123785	2.7518487	0.2540401
GO_MESODERM_MORPHOGENESIS	c5.BP_ GO biological process	58	1.5028591	0.013755159	0.09085334	GO_MESODERM_MORPHOGENESIS	63	1.0246537	0.4454054	0.884131	2.5275128	0.4782054
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	139	1.5027736	0.003690037	0.09085654	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP	145	1.269523	0.055384614	0.4850216	2.7722966	0.2332506
GO_REGULATION_OF_CELL_SUBSTRATE_ADHESION	c5.BP_ GO biological process	151	1.5026911	0.004807693	0.09086987	GO_REGULATION_OF_CELL_SUBSTRATE_ADHESION	157	1.1745383	0.14387755	0.63055235	2.6772294	0.3281528
GO_POSITIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	77	1.502663	0.013717421	0.090820365	GO_POSITIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT	85	1.5609924	0	0.19749191	3.0636554	-0.0583294
CTGRYYYNATT_UNKNOWN	c3.TFT_ transcription factor targets	59	1.5020945	0.016304348	0.091265626	CTGRYYYNATT_UNKNOWN	61	1.0794923	0.35072142	0.78813285	2.5815868	0.4226022
TGCACTT_MIR519C_MIR519B_MIR519A	c3.MIR_ microRNA targets	407	1.5020688	0.001068376	0.09122172	TGCACTT_MIR519C_MIR519B_MIR519A	413	0.9770973	0.614	0.9528402	2.4791661	0.5249715
CHR5P15	C1: positional gene sets	48	1.5020382	0.022630835	0.091186665	CHR5P15	52	0.65027976	0.94570136	1	2.15231796	0.85175844
P53_DN.V1_UP	C6_ oncogenic signatures	161	1.5011914	0.003550296	0.091867335	P53_DN.V1_UP	168	1.1730028	0.137577	0.63332605	2.6741942	0.3281886
GO_CARDIAC_ATRIUM_DEVELOPMENT	c5.BP_ GO biological process	26	1.5006545	0.025157232	0.092297934	GO_CARDIAC_ATRIUM_DEVELOPMENT	28	1.1793022	0.25731707	0.6236288	2.6799567	0.3213523
GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP	C7_ immunologic signatures	102	1.5004826	0.008739077	0.09237426	GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP	106	1.1793966	0.17512953	0.6241312	2.6798792	0.321086
SMID_BREAST_CANCER_LUMINAL_A_DN	c2.CGP_ chemical and genetic perturbations	16	1.4999692	0.031347964	0.09281094	SMID_BREAST_CANCER_LUMINAL_A_DN	18	0.7486902	0.80078125	1	2.2486594	0.751279
GNF2_MMP11	c4.CGN_ cancer gene neighborhoods	30	1.4997499	0.011940299	0.09294622	GNF2_MMP11	35	1.8112866	0	0.029065957	3.3110365	-0.3115367
GNF2_CDKN1C	c4.CGN_ cancer gene neighborhoods	22	1.4997071	0.022900764	0.09291725	GNF2_CDKN1C	25	1.569531	0.007528231	0.19071206	3.0692381	-0.0698239
HNF3ALPHA_Q6	c3.TFT_ transcription factor targets	172	1.499647	0	0.092899196	HNF3ALPHA_Q6	185	1.1702058	0.13983904	0.6382239	2.6698528	0.3294412
GO_SCHWANN_CELL_DEVELOPMENT	c5.BP_ GO biological process	25	1.4996203	0.02366864	0.09284999	GO_SCHWANN_CELL_DEVELOPMENT	25	0.82708067	0.7256098	1	2.32670097	0.67253963
GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP	C7_ immunologic signatures	169	1.4996026	0.004756243	0.09278853	GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP	174	1.1647433	0.15571284	0.64646024	2.6643459	0.3348593
GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN	C7_ immunologic signatures	152	1.4995342	0.003699137	0.09278512	GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN	163	1.4185202	0.004040404	0.31959182	2.9180544	0.081014
REACTOME_CHROMOSOME_MAINTENANCE	c2.CP_REACTOME_ Reactome gene sets	85	1.4989969	0.007863696	0.09321779	REACTOME_CHROMOSOME_MAINTENANCE	86	1.4129323	0.01923077	0.32418603	2.9119292	0.0860646
CHR15Q22	C1: positional gene sets	70	1.4989519	0.014945652	0.09319381	CHR15Q22	72	1.234433	0.13606912	0.5342354	2.7333849	0.2645189
GO_CELL_SUBSTRATE_ADHESION	c5.BP_ GO biological process	152	1.498599	0.003610108	0.093463816	GO_CELL_SUBSTRATE_ADHESION	157	1.2130629	0.10418795	0.5719853	2.7116619	0.2855361
GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN	C7_ immunologic signatures	102	1.4984397	0.002538071	0.09355365	GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN	110	1.484555	0.005202914	0.26594386	2.9829947	0.0138847
GO_GLYCOLIPID_BINDING	c5.GO molecular function	16	1.4982289	0.03322785	0.09368166	GO_GLYCOLIPID_BINDING	17	0.64542353	0.9081365	1	2.14365243	0.85280537
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	c2.CGP_ chemical and genetic perturbations	417	1.4981242	0	0.09369701	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	419	1.1372279	0.09	0.6949059	2.6353521	0.3608963
GO_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	18	1.4981108	0.040650405	0.093644656	GO_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION	19	-1.514978	0.047413792	0.13377425	-0.0168672	3.0130888
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN	C7_ immunologic signatures	71	1.4977707	0.004048583	0.09392629	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN	83	1.5393434	0.001040583	0.21120669	3.0371141	-0.0415727
KANNAN_TP53_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	52	1.4976244	0.016877636	0.09399532	KANNAN_TP53_TARGETS_UP	52	1.1002637	0.3176734	0.7566204	2.5978881	0.3973607
GNF2_EGFR	c4.CGN_ cancer gene neighborhoods	25	1.4976238	0.026865672	0.09392417	GNF2_EGFR	27	1.8027128	0	0.03351561	3.3003366	-0.305089
SMAD3_Q6	c3.TFT_ transcription factor targets	199	1.497554	0.002309469	0.09392279	SMAD3_Q6	215	1.157257	0.14112903	0.65805894	2.654811	0.340297
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	c2.CGP_ chemical and genetic perturbations	32	1.497473	0.033033032	0.09393793	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	33	-1.1513284	0.25531915	0.4405921	0.3461446	2.6488014
GO_INTERCALATED_DISC	c5.CC_ GO cellular component	45	1.4969647	0.025280898	0.09438305	GO_INTERCALATED_DISC	49	0.9572346	0.54295534	0.9746921	2.4541993	0.5397301
CTIP_DN.V1_UP	C6_ oncogenic signatures	99	1.4968532	0.007915568	0.09442146	CTIP_DN.V1_UP	107	1.4124042	0.008438818	0.32385433	2.9092574	0.084449
GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN	C7_ immunologic signatures	127	1.4962	0.004842615	0.09495351	GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN	130	1.6751673	0	0.095988296	3.1713673	-0.1789673
GO_REGULATION_OF_OSSIFICATION	c5.BP_ GO biological process	160	1.4960103	0.002358491	0.0950477	GO_REGULATION_OF_OSSIFICATION	166	0.92700434	0.6595311	1	2.42301464	0.56900596
VECCHI_GASTRIC_CANCER_EARLY_UP	c2.CGP_ chemical and genetic perturbations	354	1.4959052	0	0.0950662	VECCHI_GASTRIC_CANCER_EARLY_UP	366	0.8298324	0.9199199	1	2.3257376	0.6660728
BENPORATH_PRC2_TARGETS	c2.CGP_ chemical and genetic perturbations	491	1.4959022	0	0.09499753	BENPORATH_PRC2_TARGETS	491	0	0	0	1.4959022	1.4959022
VECCHI_GASTRIC_CANCER_EARLY_DN	c2.CGP_ chemical and genetic perturbations	271	1.4958795	0	0.0949411	VECCHI_GASTRIC_CANCER_EARLY_DN	288	1.1786975	0.09218437	0.6237177	2.674577	0.317182
BROWNE_HCMV_INFECTION_8HR_UP	c2.CGP_ chemical and genetic perturbations	90	1.4955391	0.005228758	0.095219135	BROWNE_HCMV_INFECTION_8HR_UP	89	0.9780295	0.54258674	0.9517538	2.4735686	0.5175096
GO_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION	c5.BP_ GO biological process	339	1.4953059	0	0.09537776	GO_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION	350	1.0200542	0.438	0.8914601	2.5153601	0.4752517
GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP	C7_ immunologic signatures	136	1.4951468	0.003680982	0.0954692	GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP	141	1.3620263	0.01017294	0.37574923	2.8571731	0.1331205
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	c2.CGP_ chemical and genetic perturbations	44	1.4951332	0.028443113	0.09541259	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	47	1.1591327	0.2591362	0.65421736	2.6542659	0.3360005
HUANG_DASATINIB_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	63	1.4948989	0.012482663	0.09557646	HUANG_DASATINIB_RESISTANCE_DN	64	1.1068994	0.32683983	0.7426812	2.6017983	0.3879995
GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	169	1.4947743	0.001191895	0.09563771	GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN	170	1.0650554	0.3414387	0.81402665	2.5598297	0.4297189
WINTER_HYPOXIA_DN	c2.CGP_ chemical and genetic perturbations	40	1.4937515	0.021645023	0.09651866	WINTER_HYPOXIA_DN	42	1.6270928	0.003444317	0.13449267	3.1208443	-0.1333413
GO_DNA_REPAIR	c5.BP_ GO biological process	406	1.4937204	0	0.096470565	GO_DNA_REPAIR	406	0	0	0	1.4937204	1.4937204
CHR3P14	C1: positional gene sets	30	1.4936954	0.035426732	0.09642333	CHR3P14	33	0.8472193	0.7117225	1	2.3409147	0.6464761
GO_MESONEPHROS_DEVELOPMENT	c5.BP_ GO biological process	85	1.4935502	0.009345794	0.09646899	GO_MESONEPHROS_DEVELOPMENT	88	1.1374215	0.24200426	0.69485265	2.6309717	0.3561287
BIOCARTA_CELLCYCLE_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	1.4935411	0.036090225	0.09640627	BIOCARTA_CELLCYCLE_PATHWAY	22	1.0165246	0.47571605	0.89508677	2.5100657	0.4770165
GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	173	1.4934614	0.004739337	0.09639949	GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	173	0.880461	0.77619535	1	2.3739224	0.6130004
RNCTGNYNRNCTGNY_UNKNOWN	c3.TFT_ transcription factor targets	69	1.4933391	0.006896552	0.09645556	RNCTGNYNRNCTGNY_UNKNOWN	73	1.5650057	0.001072961	0.19401413	3.0583448	-0.0716666
E2F1_UP.V1_UP	C6_ oncogenic signatures	167	1.493064	0.004744959	0.096642025	E2F1_UP.V1_UP	168	-1.2224354	0	0.35287738	0.2706286	2.7154994
GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	C7_ immunologic signatures	117	1.492973	0.00498132	0.09666543	GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	123	0.6807706	0.96784234	1	2.1737436	0.8122024
GO_ARTERY_DEVELOPMENT	c5.BP_ GO biological process	73	1.4929172	0.009695291	0.0966556	GO_ARTERY_DEVELOPMENT	75	0.89786196	0.6869565	1	2.39077916	0.59505524
GO_POSITIVE_REGULATION_OF_WOUND_HEALING	c5.BP_ GO biological process	37	1.4929023	0.034379672	0.09659655	GO_POSITIVE_REGULATION_OF_WOUND_HEALING	39	1.7773961	0	0.05217417	3.2702984	-0.2844938
NABA_COLLAGENS	c2.CP_ Canonical pathways	37	1.4926128	0.023426061	0.09680648	NABA_COLLAGENS	38	1.432902	0.037558686	0.31299424	2.9255148	0.0597108
GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	18	1.4925945	0.035426732	0.09675582	GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION	19	-0.8912039	0.6378378	0.8316646	0.6013906	2.3837984
GCNP_SHH_UP_LATE.V1_UP	C6_ oncogenic signatures	164	1.4925774	0	0.09669965	GCNP_SHH_UP_LATE.V1_UP	164	0.8032518	0.87449396	1	2.2958292	0.6893256
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN	c2.CGP_ chemical and genetic perturbations	15	1.4925433	0.038785834	0.096655436	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN	17	1.0986406	0.36228287	0.7588777	2.5911839	0.3939027
LIANG_SILENCED_BY_METHYLATION_2	c2.CGP_ chemical and genetic perturbations	37	1.4922885	0.022354694	0.09683518	LIANG_SILENCED_BY_METHYLATION_2	35	1.4464405	0.039759036	0.29523993	2.938729	0.045848
GO_AXO_DENDRITIC_TRANSPORT	c5.BP_ GO biological process	32	1.4917641	0.03291536	0.0972819	GO_AXO_DENDRITIC_TRANSPORT	32	0.92308205	0.60697114	1	2.41484615	0.56868205
GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP	C7_ immunologic signatures	181	1.4917272	0	0.097245134	GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP	183	1.1412683	0.18245968	0.6880059	2.6329955	0.3504589
IGLESIAS_E2F_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	136	1.4914738	0.003699137	0.09743028	IGLESIAS_E2F_TARGETS_UP	142	-1.2359295	0	0.33958393	0.2555443	2.7274033
MODULE_60	c4.CM_ cancer modules	369	1.4913161	0	0.09750734	MODULE_60	387	1.1884103	0.039078157	0.608231	2.6797264	0.3029058
GO_DEFENSE_RESPONSE_TO_VIRUS	c5.BP_ GO biological process	135	1.4911903	0.005006258	0.09757736	GO_DEFENSE_RESPONSE_TO_VIRUS	134	0.9588311	0.5886598	0.9721201	2.4500214	0.5323592
GO_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS	c5.BP_ GO biological process	48	1.4911513	0.02112676	0.09754395	GO_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS	50	0.9065927	0.63820225	1	2.397744	0.5845586
GO_LYSOPHOSPHOLIPASE_ACTIVITY	c5.GO molecular function	18	1.4910045	0.035656404	0.09760003	GO_LYSOPHOSPHOLIPASE_ACTIVITY	18	1.1871663	0.25378788	0.6109929	2.6781708	0.3038382
MODULE_99	c4.CM_ cancer modules	285	1.4909579	0	0.09757635	MODULE_99	310	1.1853706	0.04804805	0.6133486	2.6763285	0.3055873
GO_CELL_MATRIX_ADHESION	c5.BP_ GO biological process	107	1.4908407	0.003836317	0.097614095	GO_CELL_MATRIX_ADHESION	112	1.157328	0.19537815	0.6582562	2.6481687	0.3335127
GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP	C7_ immunologic signatures	146	1.490523	0.002496879	0.09785517	GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP	146	0.8953944	0.73367345	1	2.3859174	0.5951286
ZHAN_MULTIPLE_MYELOMA_MS_UP	c2.CGP_ chemical and genetic perturbations	40	1.490497	0.019662922	0.09780983	ZHAN_MULTIPLE_MYELOMA_MS_UP	42	0.9985716	0.48979592	0.92513114	2.4890686	0.4919254
LHX3_01	c3.TFT_ transcription factor targets	189	1.4904841	0.001183432	0.09775621	LHX3_01	205	1.0682095	0.32698095	0.8088724	2.5586936	0.4222746
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	c2.CGP_ chemical and genetic perturbations	65	1.4904449	0.010914052	0.09772074	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	68	1.2418271	0.1343785	0.52291334	2.732272	0.2486178
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	168	1.4902457	0.00120337	0.09784855	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN	176	0.806475	0.8718209	1	2.2967207	0.6837707
GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION	c5.BP_ GO biological process	18	1.4900028	0.03846154	0.09801221	GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION	20	1.4583656	0.04481434	0.28340092	2.9483684	0.0316372
ESC_J1_UP_LATE.V1_UP	C6_ oncogenic signatures	165	1.4899235	0.00365408	0.098023795	ESC_J1_UP_LATE.V1_UP	173	1.3734089	0.004048583	0.36257145	2.8633324	0.1165146
GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	155	1.4898758	0.002372479	0.09800071	GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	162	0.77576405	0.90640897	1	2.26563985	0.71411175
GO_AXONAL_GROWTH_CONE	c5.CC_ GO cellular component	17	1.4897009	0.033816423	0.09809952	GO_AXONAL_GROWTH_CONE	18	0.87896436	0.6368222	1	2.36866526	0.61073654
GO_SECRETORY_GRANULE_LUMEN	c5.CC_ GO cellular component	70	1.489678	0.01212938	0.09805285	GO_SECRETORY_GRANULE_LUMEN	75	1.2923967	0.082706764	0.45356065	2.7820747	0.1972813
GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP	C7_ immunologic signatures	171	1.4890223	0.003579952	0.09865262	GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP	172	-1.0864398	0.071428575	0.5397922	0.4025825	2.5754621
KIM_GERMINAL_CENTER_T_HELPER_DN	c2.CGP_ chemical and genetic perturbations	19	1.4889435	0.045454547	0.098651215	KIM_GERMINAL_CENTER_T_HELPER_DN	19	1.0573305	0.4035309	0.8286543	2.546274	0.431613
MACLACHLAN_BRCA1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	20	1.4888449	0.0352	0.09867615	MACLACHLAN_BRCA1_TARGETS_UP	21	-0.81639457	0.74761903	0.89215136	0.67245033	2.30523947
GO_AUTOPHAGOSOME_ORGANIZATION	c5.BP_ GO biological process	38	1.4887002	0.023909986	0.09874994	GO_AUTOPHAGOSOME_ORGANIZATION	38	1.0144073	0.4611872	0.8991012	2.5031075	0.4742929
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN	C7_ immunologic signatures	168	1.4884888	0.001184834	0.09886778	GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN	178	1.1177614	0.23910841	0.72732645	2.6062502	0.3707274
GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP	C7_ immunologic signatures	173	1.4879333	0	0.09937314	GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP	172	0.84572905	0.8246687	1	2.33366235	0.64220425
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN	C7_ immunologic signatures	175	1.4878645	0.003525264	0.0993623	GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN	176	1.1215816	0.22256097	0.7224368	2.6094461	0.3662829
GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP	C7_ immunologic signatures	166	1.4874771	0.002369668	0.09966235	GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP	169	1.1702871	0.12701613	0.6382187	2.6577642	0.31719
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	c2.CGP_ chemical and genetic perturbations	91	1.4873562	0.008053691	0.09973025	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	96	0.9685377	0.56038135	0.9629995	2.4558939	0.5188185
GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	140	1.4870518	0.003726708	0.0999328	GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	145	1.3907343	0.009249743	0.3464988	2.8777861	0.0963175
RODWELL_AGING_KIDNEY_NO_BLOOD_UP	c2.CGP_ chemical and genetic perturbations	181	1.4870125	0.004640371	0.09989968	RODWELL_AGING_KIDNEY_NO_BLOOD_UP	186	1.1605997	0.15640767	0.65196776	2.6476122	0.3264128
GO_FOREBRAIN_REGIONALIZATION	c5.BP_ GO biological process	21	1.4868848	0.04601227	0.09996466	GO_FOREBRAIN_REGIONALIZATION	24	-0.9727798	0.49162012	0.7248179	0.514105	2.4596646
GO_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	171	1.4867631	0.003508772	0.10000895	GO_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION	176	1.610022	0	0.14801086	3.0967851	-0.1232589
GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP	C7_ immunologic signatures	175	1.4867324	0.001187649	0.09997232	GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP	178	-0.9423331	0.6363636	0.7667226	0.5443993	2.4290655
CAR_IGFBP1	c4.CGN_ cancer gene neighborhoods	38	1.4865922	0.030612245	0.10002886	CAR_IGFBP1	43	1.6658138	0	0.09853249	3.152406	-0.1792216
WOO_LIVER_CANCER_RECURRENCE_UP	c2.CGP_ chemical and genetic perturbations	98	1.4865696	0.014084507	0.09997861	WOO_LIVER_CANCER_RECURRENCE_UP	98	0.7942003	0.837037	1	2.2807699	0.6923693
GO_VASCULATURE_DEVELOPMENT	c5.BP_ GO biological process	430	1.4862713	0	0.10018531	GO_VASCULATURE_DEVELOPMENT	443	1.0088638	0.46246246	0.91020477	2.4951351	0.4774075
DOUGLAS_BMI1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	276	1.4862344	0.002265006	0.10014735	DOUGLAS_BMI1_TARGETS_DN	284	1.0357348	0.405	0.8661695	2.5219692	0.4504996
RIZ_ERYTHROID_DIFFERENTIATION_12HR	c2.CGP_ chemical and genetic perturbations	40	1.486106	0.023054754	0.10020283	RIZ_ERYTHROID_DIFFERENTIATION_12HR	42	1.1766009	0.2175926	0.6269347	2.6627069	0.3095051
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	c2.CGP_ chemical and genetic perturbations	233	1.486034	0.002283105	0.10020784	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	240	1.5091997	0	0.24395163	2.9952337	-0.0231657
GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP	C7_ immunologic signatures	143	1.4858354	0.003631961	0.10035391	GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP	146	1.4994377	0	0.25503105	2.9852731	-0.0136023
GO_REGULATION_OF_CELL_GROWTH	c5.BP_ GO biological process	350	1.485781	0	0.10033361	GO_REGULATION_OF_CELL_GROWTH	363	1.1062303	0.17034069	0.7445388	2.5920113	0.3795507
GO_PEPTIDE_HORMONE_BINDING	c5.GO molecular function	31	1.4854357	0.026865672	0.10062976	GO_PEPTIDE_HORMONE_BINDING	34	0.8925622	0.6349584	1	2.3779979	0.5928735
BCAT.100_UP.V1_DN	C6_ oncogenic signatures	22	1.4854088	0.036484245	0.100583464	BCAT.100_UP.V1_DN	27	1.1228483	0.32709113	0.72041553	2.6082571	0.3625605
GO_REPRODUCTIVE_BEHAVIOR	c5.BP_ GO biological process	24	1.4853727	0.02130898	0.100553505	GO_REPRODUCTIVE_BEHAVIOR	25	1.1391878	0.30456227	0.6916885	2.6245605	0.3461849
GO_CELL_CELL_CONTACT_ZONE	c5.CC_ GO cellular component	56	1.4853325	0.019886363	0.100533165	GO_CELL_CELL_CONTACT_ZONE	62	0.9235296	0.6161396	1	2.4088621	0.5618029
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	c2.CP_REACTOME_ Reactome gene sets	35	1.485142	0.022865854	0.100658745	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	35	-2.345899	0	0.000107551	-0.860757	3.831041
GO_MULTICELLULAR_ORGANISM_METABOLIC_PROCESS	c5.BP_ GO biological process	71	1.4851226	0.014844804	0.10060441	GO_MULTICELLULAR_ORGANISM_METABOLIC_PROCESS	78	1.3519778	0.055201698	0.38253394	2.8371004	0.1331448
GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP	C7_ immunologic signatures	180	1.485023	0.001176471	0.100624	GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP	180	1.0235804	0.45959595	0.88584423	2.5086034	0.4614426
GSE369_SOCS3_KO_VS_WT_LIVER_DN	C7_ immunologic signatures	179	1.4848361	0.003512881	0.100718066	GSE369_SOCS3_KO_VS_WT_LIVER_DN	181	1.0579187	0.35252526	0.82756317	2.5427548	0.4269174
GO_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY	c5.BP_ GO biological process	37	1.4843805	0.030215828	0.10111496	GO_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY	40	0.7942276	0.7988304	1	2.2786081	0.6901529
GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN	C7_ immunologic signatures	173	1.4843651	0.001157407	0.10105643	GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN	177	1.1321876	0.20121334	0.7024364	2.6165527	0.3521775
GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN	C7_ immunologic signatures	176	1.4842511	0.001175088	0.101104684	GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN	177	0.78647524	0.8986829	1	2.27072634	0.69777586
GO_ACTIN_BINDING	c5.GO molecular function	348	1.4842192	0.00110742	0.10105975	GO_ACTIN_BINDING	363	1.3449302	0.003	0.3894051	2.8291494	0.139289
GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN	C7_ immunologic signatures	182	1.4841852	0	0.10102764	GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN	183	-1.1550788	0	0.4371278	0.3291064	2.639264
MORF_BUB1B	c4.CGN_ cancer gene neighborhoods	62	1.484155	0.004178273	0.10099226	MORF_BUB1B	63	-1.0978061	0.26373628	0.5228022	0.3863489	2.5819611
GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP	C7_ immunologic signatures	170	1.4839785	0.001184834	0.10111317	GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP	175	1.0855613	0.30111903	0.77670413	2.5695398	0.3984172
GO_DNA_DEPENDENT_DNA_REPLICATION	c5.BP_ GO biological process	84	1.4839654	0.00811908	0.10105152	GO_DNA_DEPENDENT_DNA_REPLICATION	85	-2.4617872	0	0	-0.9778218	3.9457526
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	c2.CGP_ chemical and genetic perturbations	93	1.4839587	0.007623888	0.1009859	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	99	1.0115795	0.46465698	0.9041762	2.4955382	0.4723792
GO_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY	c5.BP_ GO biological process	42	1.4837801	0.015736766	0.10109719	GO_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY	45	0.8519872	0.7089888	1	2.3357673	0.6317929
GO_RESPONSE_TO_IONIZING_RADIATION	c5.BP_ GO biological process	132	1.4834627	0.003754693	0.101324454	GO_RESPONSE_TO_IONIZING_RADIATION	132	0.7208437	0.94877046	1	2.2043064	0.762619
GO_NEURON_RECOGNITION	c5.BP_ GO biological process	31	1.483034	0.027734976	0.101684295	GO_NEURON_RECOGNITION	33	0.7963262	0.804401	1	2.2793602	0.6867078
GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	C7_ immunologic signatures	157	1.4829566	0.001199041	0.10169953	GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	158	0.97095	0.5709939	0.96025056	2.4539066	0.5120066
GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN	C7_ immunologic signatures	170	1.4826542	0.002409639	0.101949446	GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN	176	1.0347112	0.43015075	0.86785746	2.5173654	0.447943
GSE3982_DC_VS_TH2_DN	C7_ immunologic signatures	174	1.4825115	0.002375297	0.102028795	GSE3982_DC_VS_TH2_DN	180	0.94228506	0.64984864	0.9892011	2.42479656	0.54022644
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP	C7_ immunologic signatures	132	1.4824133	0.007352941	0.1020599	GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP	132	1.4209116	0.004069176	0.31833398	2.9033249	0.0615017
GO_PERICENTRIOLAR_MATERIAL	c5.CC_ GO cellular component	18	1.4823965	0.032258064	0.1020053	GO_PERICENTRIOLAR_MATERIAL	18	-1.0967938	0.28688523	0.5230903	0.3856027	2.5791903
GSE2706_2H_VS_8H_LPS_STIM_DC_DN	C7_ immunologic signatures	147	1.4820852	0.002447981	0.10224158	GSE2706_2H_VS_8H_LPS_STIM_DC_DN	150	1.2122868	0.093237706	0.574118	2.694372	0.2697984
GO_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS	c5.BP_ GO biological process	17	1.481669	0.050955415	0.10259831	GO_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS	17	0.911282	0.6150845	1	2.392951	0.570387
GO_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION	c5.BP_ GO biological process	147	1.4815792	0.003627569	0.10263086	GO_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION	164	0.9793418	0.5581633	0.9502305	2.460921	0.5022374
GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN	C7_ immunologic signatures	176	1.480938	0.001184834	0.10320359	GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN	175	1.1289128	0.2024415	0.7067113	2.6098508	0.3520252
GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	C7_ immunologic signatures	181	1.480523	0.001190476	0.1035442	GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	181	0.68497527	0.9848178	1	2.16549827	0.79554773
GO_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY	c5.BP_ GO biological process	23	1.480508	0.03115727	0.10348148	GO_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY	24	0.8343689	0.7114673	1	2.3148769	0.6461391
GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	175	1.4805003	0.009433962	0.10341351	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	173	1.0344917	0.41742656	0.86820567	2.514992	0.4460086
SENESE_HDAC2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	107	1.4804837	0.006281407	0.103360295	SENESE_HDAC2_TARGETS_DN	112	1.2299937	0.11375388	0.54104054	2.7104774	0.25049
GO_CYTOKINESIS	c5.BP_ GO biological process	79	1.4803792	0.005420054	0.10338687	GO_CYTOKINESIS	80	1.177145	0.20106952	0.62619036	2.6575242	0.3032342
WINZEN_DEGRADED_VIA_KHSRP	c2.CGP_ chemical and genetic perturbations	89	1.4803674	0.006544503	0.10332513	WINZEN_DEGRADED_VIA_KHSRP	90	1.3952951	0.023255814	0.34648946	2.8756625	0.0850723
GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN	C7_ immunologic signatures	174	1.4800653	0.00476758	0.1035608	GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN	175	-0.9698355	0.5833333	0.7293656	0.5102298	2.4499008
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	c2.CGP_ chemical and genetic perturbations	50	1.4798801	0.021770682	0.1036886	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	51	0.89105	0.65685165	1	2.3709301	0.5888301
GSE30083_SP2_VS_SP3_THYMOCYTE_UP	C7_ immunologic signatures	170	1.4796296	0.003432494	0.10386797	GSE30083_SP2_VS_SP3_THYMOCYTE_UP	183	1.3492606	0.008088979	0.3829803	2.8288902	0.130369
GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	C7_ immunologic signatures	142	1.4794289	0.00240096	0.103970826	GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	150	1.0523325	0.37626776	0.8368632	2.5317614	0.4270964
AFFAR_YY1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	211	1.4787854	0	0.104554854	AFFAR_YY1_TARGETS_DN	214	0.7734666	0.9256281	1	2.252252	0.7053188
GO_ACTOMYOSIN	c5.CC_ GO cellular component	59	1.4782598	0.016597511	0.105055846	GO_ACTOMYOSIN	60	-0.9732404	0.5673077	0.72413504	0.5050194	2.4515002
PID_ATF2_PATHWAY	c2.CP_ Canonical pathways	52	1.4780252	0.019525802	0.105227195	PID_ATF2_PATHWAY	55	0.83517605	0.7519466	1	2.31320125	0.64284915
GO_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE	c5.BP_ GO biological process	52	1.4779891	0.018651363	0.105190225	GO_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE	55	0.845897	0.7373168	1	2.3238861	0.6320921
NOJIMA_SFRP2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	25	1.4779477	0.043818466	0.10515067	NOJIMA_SFRP2_TARGETS_UP	26	1.507355	0.027811367	0.24338992	2.9853027	-0.0294073
LU_EZH2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	330	1.4777886	0	0.105246335	LU_EZH2_TARGETS_DN	332	0.88766634	0.81863725	1	2.36545494	0.59012226
CHR14Q11	C1: positional gene sets	102	1.4775732	0.007672634	0.10537802	CHR14Q11	123	0.7254761	0.9337411	1	2.2030493	0.7520971
TATTATA_MIR374	c3.MIR_ microRNA targets	263	1.4774204	0.001133787	0.10547808	TATTATA_MIR374	271	0.8282647	0.9007021	1	2.3056851	0.6491557
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	48	1.4773611	0.011347517	0.105460145	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	51	1.2280765	0.14074914	0.54390913	2.7054376	0.2492846
BIOCARTA_ECM_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	23	1.4772904	0.048742138	0.10546065	BIOCARTA_ECM_PATHWAY	24	-0.73481643	0.89893615	0.9446528	0.74247397	2.21210683
GO_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	c5.BP_ GO biological process	110	1.4770975	0.002557545	0.105601124	GO_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	115	1.3951397	0.014447885	0.34625307	2.8722372	0.0819578
GO_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION	c5.BP_ GO biological process	23	1.477072	0.04447853	0.10555426	GO_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION	23	0.88867074	0.6503667	1	2.36574274	0.58840126
GO_SYNAPTONEMAL_COMPLEX	c5.CC_ GO cellular component	28	1.4769073	0.028064992	0.10564389	GO_SYNAPTONEMAL_COMPLEX	31	1.918492	0	0.008435532	3.3953993	-0.4415847
FREAC4_01	c3.TFT_ transcription factor targets	127	1.4768478	0.007537689	0.105628476	FREAC4_01	130	1.241687	0.090441935	0.5231066	2.7185348	0.2351608
GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	118	1.4768268	0.008782936	0.10557449	GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	128	0.9299255	0.6396304	0.9991059	2.4067523	0.5469013
GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_UP	C7_ immunologic signatures	169	1.4766357	0.001193318	0.10569672	GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_UP	177	1.00567	0.4959514	0.9137781	2.4823057	0.4709657
KORKOLA_YOLK_SAC_TUMOR	c2.CGP_ chemical and genetic perturbations	45	1.4765797	0.014450867	0.10568003	KORKOLA_YOLK_SAC_TUMOR	52	1.3435465	0.06437292	0.39063483	2.8201262	0.1330332
SENESE_HDAC1_AND_HDAC2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	193	1.4765651	0.00232288	0.10561239	SENESE_HDAC1_AND_HDAC2_TARGETS_DN	197	1.128167	0.1949495	0.7085588	2.6047321	0.3483981
FURUKAWA_DUSP6_TARGETS_PCI35_UP	c2.CGP_ chemical and genetic perturbations	55	1.476494	0.024691358	0.10560879	FURUKAWA_DUSP6_TARGETS_PCI35_UP	58	1.0990002	0.33856502	0.758302	2.5754942	0.3774938
GO_RESPONSE_TO_CALCIUM_ION	c5.BP_ GO biological process	105	1.4762858	0.005148005	0.105759345	GO_RESPONSE_TO_CALCIUM_ION	108	1.500848	0.002076843	0.2525549	2.9771338	-0.0245622
ONDER_CDH1_TARGETS_1_UP	c2.CGP_ chemical and genetic perturbations	121	1.4760231	0.004914005	0.1059358	ONDER_CDH1_TARGETS_1_UP	122	1.2718121	0.06993737	0.48321477	2.7478352	0.204211
GO_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	56	1.4760214	0.014164306	0.10586294	GO_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS	57	0.73725986	0.88618785	1	2.21328126	0.73876154
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	c2.CGP_ chemical and genetic perturbations	56	1.4760207	0.020718232	0.10579017	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	56	0.97677433	0.54813135	0.95360494	2.45279503	0.49924637
RASHI_RESPONSE_TO_IONIZING_RADIATION_2	c2.CGP_ chemical and genetic perturbations	115	1.4753307	0.01509434	0.106431626	RASHI_RESPONSE_TO_IONIZING_RADIATION_2	119	1.2975953	0.05388601	0.44609648	2.772926	0.1777354
E2F1DP2_01	c3.TFT_ transcription factor targets	207	1.4752178	0	0.10648545	E2F1DP2_01	211	-1.9647586	0	0.010817216	-0.4895408	3.4399764
BROWNE_HCMV_INFECTION_24HR_DN	c2.CGP_ chemical and genetic perturbations	131	1.4751896	0.003712871	0.106437124	BROWNE_HCMV_INFECTION_24HR_DN	135	1.3883187	0.012332991	0.3484203	2.8635083	0.0868709
GO_RESPONSE_TO_PROSTAGLANDIN	c5.BP_ GO biological process	26	1.4751688	0.033898305	0.106388874	GO_RESPONSE_TO_PROSTAGLANDIN	31	1.04294	0.4261501	0.853564	2.5181088	0.4322288
GO_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	114	1.475129	0.003722085	0.106351085	GO_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS	130	1.4232006	0.004102564	0.31803316	2.8983296	0.0519284
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	c2.CGP_ chemical and genetic perturbations	42	1.4748678	0.02186589	0.10657288	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	44	-1.6317012	0	0.07912618	-0.1568334	3.106569
GO_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY	c5.BP_ GO biological process	58	1.4746042	0.02086231	0.106781535	GO_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY	60	0.88725656	0.66888887	1	2.36186076	0.58734764
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	c2.CGP_ chemical and genetic perturbations	17	1.4745263	0.04731861	0.10678494	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	18	0.7869524	0.77324843	1	2.2614787	0.6875739
EVI1_05	c3.TFT_ transcription factor targets	150	1.4744354	0.005006258	0.10681231	EVI1_05	158	1.1879739	0.124117054	0.60876566	2.6624093	0.2864615
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	c2.CGP_ chemical and genetic perturbations	17	1.4741303	0.038523275	0.10707275	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	18	0.7271698	0.8245161	1	2.2013001	0.7469605
GO_REGULATION_OF_MAST_CELL_ACTIVATION	c5.BP_ GO biological process	31	1.4740968	0.029542098	0.10703723	GO_REGULATION_OF_MAST_CELL_ACTIVATION	33	1.3627006	0.065804936	0.37625924	2.8367974	0.1113962
GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP	C7_ immunologic signatures	158	1.4740553	0.002403846	0.10700879	GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP	162	0.87889814	0.7602459	1	2.35295344	0.59515716
E2F1DP1_01	c3.TFT_ transcription factor targets	207	1.4739236	0.002317497	0.107068256	E2F1DP1_01	211	-1.815129	0	0.030608114	-0.3412054	3.2890526
GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	154	1.4739096	0.004778972	0.1070102	GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP	162	1.1620198	0.1573604	0.6503896	2.6359294	0.3118898
GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	45	1.4737818	0.023154847	0.10706839	GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION	47	0.924884	0.6125	1	2.3986658	0.5488978
GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP	C7_ immunologic signatures	177	1.4737514	0	0.107017495	GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP	184	1.3360893	0.017137097	0.39846423	2.8098407	0.1376621
GO_CELL_FATE_COMMITMENT	c5.BP_ GO biological process	189	1.4735302	0.001179245	0.10715476	GO_CELL_FATE_COMMITMENT	217	0.8760594	0.79275656	1	2.3495896	0.5974708
GO_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS	c5.GO molecular function	77	1.4735034	0.013531799	0.10710903	GO_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS	78	1.1612049	0.22611465	0.6510505	2.6347083	0.3122985
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	c2.CGP_ chemical and genetic perturbations	124	1.4732748	0.00879397	0.10726278	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	133	1.0876749	0.31460676	0.7741004	2.5609497	0.3855999
GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	C7_ immunologic signatures	175	1.4731632	0	0.10731152	GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	177	1.2357619	0.07489879	0.5319563	2.7089251	0.2374013
GO_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION	c5.BP_ GO biological process	38	1.472954	0.032951288	0.10745274	GO_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION	36	1.0825788	0.36785713	0.78322244	2.5555328	0.3903752
GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP	C7_ immunologic signatures	159	1.4729483	0.002398082	0.107385084	GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP	165	1.2057416	0.104568526	0.581807	2.6786899	0.2672067
E2F_02	c3.TFT_ transcription factor targets	207	1.4728508	0.003508772	0.1074176	E2F_02	211	-1.9271108	0	0.014839527	-0.45426	3.3999616
GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	C7_ immunologic signatures	177	1.4727536	0.004750594	0.10744109	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	174	1.1549561	0.15587045	0.66199243	2.6277097	0.3177975
MODULE_24	c4.CM_ cancer modules	374	1.4727467	0	0.107374884	MODULE_24	398	1.0644628	0.285	0.81530434	2.5372095	0.4082839
GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP	C7_ immunologic signatures	182	1.4726461	0.007042253	0.10742471	GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP	186	1.3437974	0.011178861	0.39150298	2.8164435	0.1288487
GO_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY	c5.BP_ GO biological process	21	1.4726212	0.043818466	0.10737846	GO_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY	21	0.8775833	0.65311307	1	2.3502045	0.5950379
GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN	C7_ immunologic signatures	151	1.4725509	0.002466091	0.10739427	GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN	151	-1.358618	0	0.23567095	0.1139329	2.8311689
GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	C7_ immunologic signatures	125	1.4725032	0.007481297	0.107374266	GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	133	1.4106644	0.014256619	0.32492453	2.8831676	0.0618388
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	c2.CGP_ chemical and genetic perturbations	120	1.4724385	0.008739077	0.10736261	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	122	0.8341803	0.8108673	1	2.3066188	0.6382582
GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN	C7_ immunologic signatures	167	1.4720169	0.004667445	0.107726045	GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN	174	1.35827	0.006079027	0.37791193	2.8302869	0.1137469
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	c2.CGP_ chemical and genetic perturbations	144	1.4717655	0.003694581	0.10791361	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	145	0.92818505	0.6646279	0.9993676	2.39995055	0.54358045
GO_GASTRULATION	c5.BP_ GO biological process	131	1.4715648	0.005012531	0.10806597	GO_GASTRULATION	144	0.84863526	0.80898875	1	2.32020006	0.62292954
GO_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT	c5.BP_ GO biological process	23	1.4713148	0.03949447	0.10824992	GO_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT	24	0.8659417	0.66129035	1	2.3372565	0.6053731
GO_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION	c5.BP_ GO biological process	94	1.4711899	0.014884979	0.108298145	GO_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION	92	0.9828567	0.52587116	0.9444728	2.4540466	0.4883332
GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL	c5.BP_ GO biological process	35	1.4710609	0.024926687	0.10836789	GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL	41	1.2964172	0.12529002	0.44740292	2.7674781	0.1746437
GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN	C7_ immunologic signatures	174	1.4709116	0.002358491	0.108438835	GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN	174	0.92005193	0.68415743	1	2.39096353	0.55085967
GO_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE	c5.BP_ GO biological process	16	1.4705662	0.03966942	0.108728155	GO_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE	19	0.6972163	0.8754864	1	2.1677825	0.7733499
GTGCCAA_MIR96	c3.MIR_ microRNA targets	276	1.4704508	0	0.10880387	GTGCCAA_MIR96	283	1.0538629	0.34538153	0.83583415	2.5243137	0.4165879
GO_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS	c5.BP_ GO biological process	48	1.4704238	0.032394364	0.108755834	GO_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS	50	0.9511235	0.56738394	0.98085576	2.4215473	0.5193003
GSE17721_0.5H_VS_12H_CPG_BMDC_DN	C7_ immunologic signatures	179	1.4704181	0.002369668	0.10868819	GSE17721_0.5H_VS_12H_CPG_BMDC_DN	177	1.1055093	0.27087575	0.7464168	2.5759274	0.3649088
GO_GLYCEROLIPID_CATABOLIC_PROCESS	c5.BP_ GO biological process	32	1.4703209	0.03671072	0.10872453	GO_GLYCEROLIPID_CATABOLIC_PROCESS	35	-0.7151058	0.9548387	0.9524998	0.7552151	2.1854267
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	c2.CGP_ chemical and genetic perturbations	53	1.4700029	0.024556616	0.10898402	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	53	1.0219109	0.45594713	0.8890029	2.4919138	0.448092
KRAS.DF.V1_DN	C6_ oncogenic signatures	162	1.4699872	0	0.108926505	KRAS.DF.V1_DN	168	1.3208201	0.01621074	0.4111262	2.7908073	0.1491671
GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	177	1.4698547	0.004801921	0.10898978	GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP	180	1.1070478	0.23678862	0.74248385	2.5769025	0.3628069
GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN	C7_ immunologic signatures	174	1.4692768	0.002389486	0.10952957	GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN	179	1.1040325	0.25937185	0.74943703	2.5733093	0.3652443
GO_OLFACTORY_LOBE_DEVELOPMENT	c5.BP_ GO biological process	33	1.46926	0.02586207	0.10946989	GO_OLFACTORY_LOBE_DEVELOPMENT	36	1.190944	0.23241955	0.60440177	2.660204	0.278316
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B	c2.CGP_ chemical and genetic perturbations	466	1.4691149	0	0.1095579	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B	480	1.4133127	0	0.32410964	2.8824276	0.0558022
HADDAD_B_LYMPHOCYTE_PROGENITOR	c2.CGP_ chemical and genetic perturbations	227	1.4691133	0.001132503	0.10948631	HADDAD_B_LYMPHOCYTE_PROGENITOR	236	1.1138722	0.20703517	0.73185736	2.5829855	0.3552411
PID_BMP_PATHWAY	c2.CP_ Canonical pathways	36	1.4690719	0.030523255	0.10945635	PID_BMP_PATHWAY	39	0.7682802	0.82790697	1	2.2373521	0.7007917
GO_CELLULAR_RESPONSE_TO_RADIATION	c5.BP_ GO biological process	133	1.4688225	0.002427185	0.109653	GO_CELLULAR_RESPONSE_TO_RADIATION	129	0.96116114	0.5742268	0.9699198	2.42998364	0.50766136
MODULE_493	c4.CM_ cancer modules	58	1.4686975	0.013679891	0.109704815	MODULE_493	57	0.7325427	0.8816504	1	2.2012402	0.7361548
MORF_STK17A	c4.CGN_ cancer gene neighborhoods	133	1.4686785	0.004872107	0.10964966	MORF_STK17A	149	1.3103397	0.025303643	0.42534724	2.7790182	0.1583388
GO_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION	c5.BP_ GO biological process	15	1.4686779	0.04893964	0.109576985	GO_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION	15	1.0301659	0.4392157	0.875162	2.4988438	0.438512
VANHARANTA_UTERINE_FIBROID_DN	c2.CGP_ chemical and genetic perturbations	56	1.4683661	0.02585034	0.10984644	VANHARANTA_UTERINE_FIBROID_DN	59	0.88124555	0.69187987	1	2.34961165	0.58712055
GO_POSITIVE_REGULATION_OF_MAPK_CASCADE	c5.BP_ GO biological process	395	1.4681678	0.001062699	0.109977014	GO_POSITIVE_REGULATION_OF_MAPK_CASCADE	414	1.2334342	0.009	0.5359661	2.701602	0.2347336
GSE34515_CD16_POS_MONOCYTE_VS_DC_DN	C7_ immunologic signatures	177	1.4680655	0.002447981	0.11002394	GSE34515_CD16_POS_MONOCYTE_VS_DC_DN	179	1.2148314	0.08888889	0.56738514	2.6828969	0.2532341
GO_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION	c5.BP_ GO biological process	72	1.4680419	0.01986755	0.10997439	GO_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION	85	1.5880209	0	0.17646544	3.0560628	-0.119979
REACTOME_INTERFERON_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	129	1.4677697	0.006053269	0.11021475	REACTOME_INTERFERON_SIGNALING	128	-0.842857	0.85714287	0.8734363	0.6249127	2.3106267
GSE557_CIITA_KO_VS_I_AB_KO_DC_UP	C7_ immunologic signatures	175	1.4677272	0.007109005	0.110187024	GSE557_CIITA_KO_VS_I_AB_KO_DC_UP	177	1.1743101	0.14328961	0.6306822	2.6420373	0.2934171
GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	C7_ immunologic signatures	139	1.4671309	0.00483676	0.11077274	GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	145	1.1649008	0.17325228	0.64623666	2.6320317	0.3022301
GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP	C7_ immunologic signatures	183	1.4671046	0.001194743	0.110729724	GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP	184	0.816125	0.8728557	1	2.2832296	0.6509796
CATTGTYY_SOX9_B1	c3.TFT_ transcription factor targets	323	1.4668114	0	0.110962756	CATTGTYY_SOX9_B1	329	0.7114445	0.98998	1	2.1782559	0.7553669
GO_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS	c5.BP_ GO biological process	29	1.4666064	0.042772863	0.11111426	GO_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS	30	0.9421598	0.5707434	0.98868847	2.4087662	0.5244466
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	27	1.4665961	0.035439137	0.11105051	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	27	0.7287499	0.8538647	1	2.195346	0.7378462
GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP	C7_ immunologic signatures	172	1.4664167	0.002339181	0.11116946	GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP	172	1.4923879	0	0.25779217	2.9588046	-0.0259712
ZHANG_INTERFERON_RESPONSE	c2.CGP_ chemical and genetic perturbations	20	1.4664137	0.0570523	0.11110077	ZHANG_INTERFERON_RESPONSE	18	0.89204526	0.64458597	1	2.35845896	0.57436844
GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP	C7_ immunologic signatures	180	1.4663666	0.002424242	0.11109003	GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP	180	0.95157266	0.61967546	0.98043567	2.41793926	0.51479394
GO_MIDBODY	c5.CC_ GO cellular component	121	1.4661955	0.007490637	0.11119432	GO_MIDBODY	122	1.2322838	0.10164271	0.5370667	2.6984793	0.2339117
GO_OSSIFICATION	c5.BP_ GO biological process	226	1.4661058	0.002290951	0.11119973	GO_OSSIFICATION	238	0.7499992	0.9628141	1	2.216105	0.7161066
LI_CISPLATIN_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	27	1.4659563	0.02529762	0.1112803	LI_CISPLATIN_RESISTANCE_DN	28	1.1534374	0.2977191	0.6628515	2.6193937	0.3125189
GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN	C7_ immunologic signatures	150	1.4658676	0.003690037	0.111302994	GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN	157	-1.0736322	0.0952381	0.5635221	0.3922354	2.5394998
GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP	C7_ immunologic signatures	169	1.4657509	0.003722085	0.11135049	GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP	168	1.0572712	0.36474165	0.8286157	2.5230221	0.4084797
GO_NOTOCHORD_DEVELOPMENT	c5.BP_ GO biological process	16	1.465715	0.0448505	0.111313604	GO_NOTOCHORD_DEVELOPMENT	17	0.9824473	0.51125	0.9453064	2.4481623	0.4832677
SANA_TNF_SIGNALING_DN	c2.CGP_ chemical and genetic perturbations	81	1.4656539	0.022457067	0.11130707	SANA_TNF_SIGNALING_DN	81	1.2365391	0.12325831	0.5312633	2.702193	0.2291148
GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	C7_ immunologic signatures	175	1.4654986	0.002317497	0.11140151	GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	176	1.33664	0.012232416	0.39785942	2.8021386	0.1288586
GO_DNA_DOUBLE_STRAND_BREAK_PROCESSING	c5.BP_ GO biological process	18	1.4654206	0.04225352	0.111423485	GO_DNA_DOUBLE_STRAND_BREAK_PROCESSING	18	-1.2635264	0.16143498	0.31294763	0.2018942	2.728947
GSE30083_SP1_VS_SP3_THYMOCYTE_DN	C7_ immunologic signatures	164	1.4653637	0.003525264	0.111414455	GSE30083_SP1_VS_SP3_THYMOCYTE_DN	173	1.0943333	0.28194726	0.7666283	2.559697	0.3710304
GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	176	1.4651322	0.002347418	0.11160455	GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP	176	1.191909	0.11480363	0.6034984	2.6570412	0.2732232
GSE36009_WT_VS_NLRP10_KO_DC_UP	C7_ immunologic signatures	181	1.4651157	0.004672897	0.1115534	GSE36009_WT_VS_NLRP10_KO_DC_UP	180	1.2987128	0.02431611	0.44379333	2.7638285	0.1664029
WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	c2.CGP_ chemical and genetic perturbations	59	1.4648348	0.018232819	0.111811504	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	62	0.9648016	0.55	0.9652849	2.4296364	0.5000332
GO_ESTABLISHMENT_OF_CELL_POLARITY	c5.BP_ GO biological process	79	1.4647489	0.018396847	0.111823834	GO_ESTABLISHMENT_OF_CELL_POLARITY	85	0.9306062	0.6259378	0.9984457	2.3953551	0.5341427
E2F4DP2_01	c3.TFT_ transcription factor targets	207	1.4646273	0.003488372	0.11189658	E2F4DP2_01	211	-1.8904417	0	0.018718276	-0.4258144	3.355069
GO_REGULATION_OF_METAL_ION_TRANSPORT	c5.BP_ GO biological process	265	1.4642433	0.001127396	0.11225072	GO_REGULATION_OF_METAL_ION_TRANSPORT	286	1.3805473	0.001001001	0.35613468	2.8447906	0.083696
REACTOME_PHOSPHORYLATION_OF_THE_APC_C	c2.CP_REACTOME_ Reactome gene sets	16	1.4642402	0.043844856	0.11217906	REACTOME_PHOSPHORYLATION_OF_THE_APC_C	16	1.2214484	0.21066667	0.55331546	2.6856886	0.2427918
GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP	C7_ immunologic signatures	184	1.4642276	0.002352941	0.11212224	GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP	184	0.8138136	0.8704454	1	2.2780412	0.650414
MEL18_DN.V1_DN	C6_ oncogenic signatures	124	1.4642123	0.003726708	0.112061836	MEL18_DN.V1_DN	127	1.0634091	0.36717948	0.8166578	2.5276214	0.4008032
GO_RESPONSE_TO_CAMP	c5.BP_ GO biological process	94	1.4641111	0.006369427	0.11209359	GO_RESPONSE_TO_CAMP	102	1.3381239	0.037190083	0.39776984	2.802235	0.1259872
GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	C7_ immunologic signatures	177	1.4640429	0.002427185	0.11208112	GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	176	1.3606522	0.006066734	0.37717968	2.8246951	0.1033907
GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_DN	C7_ immunologic signatures	174	1.4636554	0.005988024	0.112442836	GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_DN	178	-1.5533442	0	0.113474056	-0.0896888	3.0169996
TRAYNOR_RETT_SYNDROM_DN	c2.CGP_ chemical and genetic perturbations	17	1.4633441	0.042139385	0.1127207	TRAYNOR_RETT_SYNDROM_DN	17	-1.1024321	0.2850679	0.5138434	0.360912	2.5657762
GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN	C7_ immunologic signatures	99	1.4633226	0.014048532	0.112669274	GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN	120	1.3699087	0.018927446	0.36904663	2.8332313	0.0934139
CHR14Q24	C1: positional gene sets	80	1.4632604	0.019337017	0.11266144	CHR14Q24	82	1.2653219	0.080168776	0.49027827	2.7285823	0.1979385
GO_CALCIUM_ION_IMPORT_INTO_CYTOSOL	c5.BP_ GO biological process	33	1.4629849	0.03686636	0.1129007	GO_CALCIUM_ION_IMPORT_INTO_CYTOSOL	38	1.2720859	0.14551805	0.48301473	2.7350708	0.190899
GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN	C7_ immunologic signatures	175	1.4628603	0.004667445	0.11296901	GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN	180	0.9306834	0.65925175	0.99847245	2.3935437	0.5321769
GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	174	1.4625823	0.00365408	0.113209516	GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN	176	0.96362346	0.59453994	0.96697813	2.42620576	0.49895884
MODULE_202	c4.CM_ cancer modules	25	1.4623501	0.043010753	0.11337404	MODULE_202	27	1.2587279	0.16849817	0.49838305	2.721078	0.2036222
GO_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS	c5.BP_ GO biological process	124	1.4623461	0.006257822	0.11330407	GO_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS	124	0.67322683	0.98136646	1	2.13557293	0.78911927
GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN	C7_ immunologic signatures	172	1.462139	0.003640777	0.11344634	GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN	174	0.8955844	0.7423935	1	2.3577234	0.5665546
GSE37532_WT_VS_PPARG_KO_LN_TREG_DN	C7_ immunologic signatures	94	1.462061	0.017015707	0.11346246	GSE37532_WT_VS_PPARG_KO_LN_TREG_DN	104	1.4231611	0.011591149	0.31728277	2.8852221	0.0388999
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	c2.CGP_ chemical and genetic perturbations	45	1.4619372	0.017167382	0.11353202	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	46	0.72674406	0.8847032	1	2.18868126	0.73519314
GO_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS	c5.GO molecular function	15	1.4619313	0.050080776	0.11346824	GO_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS	17	-0.5252669	0.9954128	0.9910853	0.9366644	1.9871982
KRAS.LUNG.BREAST_UP.V1_DN	C6_ oncogenic signatures	105	1.46176	0.012562814	0.113587014	KRAS.LUNG.BREAST_UP.V1_DN	107	0.9513932	0.5927835	0.9807547	2.4131532	0.5103668
GO_ENDODERMAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	35	1.4614009	0.030837005	0.113931835	GO_ENDODERMAL_CELL_DIFFERENTIATION	38	0.71397895	0.8960739	1	2.17537985	0.74742195
XU_GH1_EXOGENOUS_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	95	1.4612818	0.002554278	0.11399542	XU_GH1_EXOGENOUS_TARGETS_DN	98	1.1428066	0.22210637	0.6846972	2.6040884	0.3184752
GO_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS	c5.BP_ GO biological process	27	1.4611036	0.033794165	0.114108816	GO_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS	27	-0.9255958	0.60465115	0.7883478	0.5355078	2.3866994
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	c2.CGP_ chemical and genetic perturbations	176	1.4607822	0.003627569	0.11439311	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	177	1.0531718	0.35323888	0.8358824	2.513954	0.4076104
KEGG_CALCIUM_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	155	1.4607812	0.003745318	0.11431992	KEGG_CALCIUM_SIGNALING_PATHWAY	163	1.6296759	0	0.13222522	3.0904571	-0.1688947
GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	177	1.4607017	0.007142857	0.114333436	GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	178	1.1335276	0.21010101	0.7005699	2.5942293	0.3271741
GO_CELLULAR_RESPONSE_TO_ALCOHOL	c5.BP_ GO biological process	104	1.4602439	0.003841229	0.11477738	GO_CELLULAR_RESPONSE_TO_ALCOHOL	102	0.80152476	0.83315957	1	2.26176866	0.65871914
GO_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION	c5.BP_ GO biological process	39	1.4601083	0.043541364	0.11486439	GO_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION	40	-1.2650672	0.0942029	0.31092635	0.1950411	2.7251755
GO_MITOTIC_CYTOKINESIS	c5.BP_ GO biological process	29	1.4600735	0.044444446	0.114829786	GO_MITOTIC_CYTOKINESIS	29	0.8964564	0.6554217	1	2.3565299	0.5636171
CHR8P21	C1: positional gene sets	67	1.4600679	0.01864181	0.11476139	CHR8P21	67	1.2332942	0.1431718	0.5359718	2.6933621	0.2267737
GO_EAR_DEVELOPMENT	c5.BP_ GO biological process	172	1.4598792	0.002339181	0.11489244	GO_EAR_DEVELOPMENT	189	0.8792005	0.7891019	1	2.3390797	0.5806787
TAVOR_CEBPA_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	44	1.4598578	0.02020202	0.114847586	TAVOR_CEBPA_TARGETS_UP	44	0.82900155	0.7517241	1	2.28885935	0.63085625
BIDUS_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	194	1.4597293	0.001153403	0.11490834	BIDUS_METASTASIS_UP	194	-1.5564637	0	0.111627854	-0.0967344	3.016193
GO_KIDNEY_EPITHELIUM_DEVELOPMENT	c5.BP_ GO biological process	118	1.4596074	0.006297229	0.11497318	GO_KIDNEY_EPITHELIUM_DEVELOPMENT	121	1.0185208	0.4409938	0.89227295	2.4781282	0.4410866
REACTOME_NCAM1_INTERACTIONS	c2.CP_REACTOME_ Reactome gene sets	38	1.4595948	0.03976436	0.11491879	REACTOME_NCAM1_INTERACTIONS	38	1.1045614	0.33333334	0.7479487	2.5641562	0.3550334
GO_MICROTUBULE_PLUS_END	c5.CC_ GO cellular component	16	1.459485	0.044303797	0.11497811	GO_MICROTUBULE_PLUS_END	16	1.2656052	0.15546772	0.4897419	2.7250902	0.1938798
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	c2.CGP_ chemical and genetic perturbations	334	1.4593527	0	0.115053624	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	346	0.77010274	0.9709419	1	2.22945544	0.68924996
GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	175	1.4593363	0.005889282	0.11499446	GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP	176	1.0532584	0.3629929	0.83609104	2.5125947	0.4060779
GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP	C7_ immunologic signatures	178	1.4592953	0.005773672	0.11496059	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP	180	0.9854353	0.548583	0.941295	2.4447306	0.47386
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP	C7_ immunologic signatures	168	1.4592831	0.004728132	0.11489674	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP	174	1.0146072	0.46309403	0.8988535	2.4738903	0.4446759
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	29	1.4592534	0.041411042	0.114852175	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	28	0.8335506	0.7287933	1	2.292804	0.6257028
GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN	C7_ immunologic signatures	159	1.4590268	0.003680982	0.11503855	GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN	163	1.1913866	0.12032356	0.60404134	2.6504134	0.2676402
GO_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION	c5.BP_ GO biological process	472	1.4589081	0.002118644	0.1151025	GO_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION	491	0.9653915	0.63	0.9648902	2.4242996	0.4935166
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	c2.CGP_ chemical and genetic perturbations	67	1.4588279	0.01519337	0.11510637	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	65	0.8250545	0.7770492	1	2.2838824	0.6337734
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	c2.CGP_ chemical and genetic perturbations	25	1.4588087	0.041731067	0.11505524	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	28	0.963888	0.52933985	0.96684974	2.4226967	0.4949207
GO_REGULATION_OF_MEMBRANE_REPOLARIZATION	c5.BP_ GO biological process	25	1.4587305	0.039694656	0.11506097	GO_REGULATION_OF_MEMBRANE_REPOLARIZATION	28	1.4339954	0.052058112	0.31264096	2.8927259	0.0247351
GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP	C7_ immunologic signatures	133	1.4584433	0.001267427	0.11531714	GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP	138	1.3320551	0.029896908	0.40008426	2.7904984	0.1263882
ZHAN_LATE_DIFFERENTIATION_GENES_DN	c2.CGP_ chemical and genetic perturbations	15	1.4583536	0.047393367	0.115334615	ZHAN_LATE_DIFFERENTIATION_GENES_DN	15	1.4524429	0.04597701	0.29164106	2.9107965	0.0059107
CHR7Q36	C1: positional gene sets	50	1.4583008	0.03380282	0.115327	CHR7Q36	53	-1.1177201	0.19607843	0.4926721	0.3405807	2.5760209
GO_SARCOLEMMA	c5.CC_ GO cellular component	118	1.45818	0.007453416	0.115380846	GO_SARCOLEMMA	121	1.5233505	0	0.23347528	2.9815305	-0.0651705
GO_PERICARDIUM_DEVELOPMENT	c5.BP_ GO biological process	16	1.4580387	0.046925567	0.11547944	GO_PERICARDIUM_DEVELOPMENT	17	0.8151177	0.71832883	1	2.2731564	0.642921
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN	C7_ immunologic signatures	144	1.4579914	0.004914005	0.11545455	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN	146	1.1102273	0.2607362	0.7374437	2.5682187	0.3477641
GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN	C7_ immunologic signatures	179	1.4578552	0.004860268	0.11552904	GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN	182	1.2097303	0.10070494	0.57757443	2.6675855	0.2481249
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	c2.CGP_ chemical and genetic perturbations	229	1.45772	0.003452244	0.11560228	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	232	1.1958123	0.09072581	0.5969707	2.6535323	0.2619077
VALK_AML_CLUSTER_10	c2.CGP_ chemical and genetic perturbations	28	1.4576576	0.03709199	0.11559272	VALK_AML_CLUSTER_10	30	1.3784815	0.064629845	0.35579628	2.8361391	0.0791761
GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN	C7_ immunologic signatures	164	1.4576472	0.00238379	0.115531504	GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN	170	1.245895	0.06896552	0.517443	2.7035422	0.2117522
GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	C7_ immunologic signatures	182	1.4576274	0.003614458	0.115479216	GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	186	0.8256797	0.87322515	1	2.2833071	0.6319477
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	c2.CGP_ chemical and genetic perturbations	66	1.4570612	0.019283747	0.11603667	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	65	1.507761	0.008762322	0.24420321	2.9648222	-0.0506998
GO_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION	c5.BP_ GO biological process	61	1.457005	0.032697547	0.1160245	GO_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION	63	1.1633711	0.2204126	0.6479572	2.6203761	0.2936339
MODULE_419	c4.CM_ cancer modules	33	1.4567398	0.03652968	0.1162311	MODULE_419	34	-0.9186123	0.624	0.7975118	0.5381275	2.3753521
CERVERA_SDHB_TARGETS_1_UP	c2.CGP_ chemical and genetic perturbations	95	1.456355	0.014066496	0.11656175	CERVERA_SDHB_TARGETS_1_UP	101	1.612404	0	0.14695045	3.068759	-0.156049
GO_SEGMENTATION	c5.BP_ GO biological process	82	1.4561125	0.022606382	0.116754785	GO_SEGMENTATION	87	-1.2335818	0.08510638	0.34159282	0.2225307	2.6896943
GO_REGULATION_OF_MEIOTIC_CELL_CYCLE	c5.BP_ GO biological process	35	1.4560859	0.031746034	0.11671086	GO_REGULATION_OF_MEIOTIC_CELL_CYCLE	39	1.3633559	0.07159353	0.37484226	2.8194418	0.09273
GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	C7_ immunologic signatures	151	1.4556025	0.004872107	0.11717941	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	152	1.6335479	0	0.13298373	3.0891504	-0.1779454
MODULE_129	c4.CM_ cancer modules	187	1.4553766	0.002421308	0.117358655	MODULE_129	197	1.1435509	0.17724068	0.6837759	2.5989275	0.3118257
JAEGER_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	38	1.4553692	0.03660322	0.11729083	JAEGER_METASTASIS_UP	40	-0.9470817	0.57246375	0.7603959	0.5082875	2.4024509
GSE360_CTRL_VS_T_GONDII_DC_DN	C7_ immunologic signatures	167	1.4551139	0.004733728	0.11753807	GSE360_CTRL_VS_T_GONDII_DC_DN	172	1.0744016	0.32692307	0.79782593	2.5295155	0.3807123
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	c2.CGP_ chemical and genetic perturbations	22	1.455047	0.040650405	0.11753739	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	22	0.9388332	0.5647349	0.9915372	2.3938802	0.5162138
GO_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING	c5.BP_ GO biological process	63	1.4549428	0.025815217	0.11758629	GO_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING	67	1.4167758	0.027144408	0.320906	2.8717186	0.038167
GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP	C7_ immunologic signatures	113	1.4549242	0.011494253	0.11753438	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP	124	1.468764	0.004127967	0.2767376	2.9236882	-0.0138398
KONDO_EZH2_TARGETS	c2.CGP_ chemical and genetic perturbations	192	1.4546412	0.002366864	0.117769845	KONDO_EZH2_TARGETS	202	1.0127637	0.47325933	0.90226966	2.4674049	0.4418775
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	c2.CGP_ chemical and genetic perturbations	38	1.4546226	0.028653296	0.11771965	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	40	0.73702025	0.875576	1	2.19164285	0.71760235
GO_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS	c5.BP_ GO biological process	149	1.4544438	0.004651163	0.117843546	GO_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS	158	1.0650294	0.3478261	0.81400216	2.5194732	0.3894144
GO_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS	c5.BP_ GO biological process	49	1.454414	0.03064067	0.11780917	GO_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS	58	1.4280995	0.024309393	0.31763893	2.8825135	0.0263145
GO_CELL_MATURATION	c5.BP_ GO biological process	113	1.4541703	0.006337136	0.118019104	GO_CELL_MATURATION	121	0.9920742	0.517418	0.9335272	2.4462445	0.4620961
HMEF2_Q6	c3.TFT_ transcription factor targets	118	1.4541185	0.008894537	0.11801353	HMEF2_Q6	124	1.2197078	0.11053719	0.5558558	2.6738263	0.2344107
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	c2.CGP_ chemical and genetic perturbations	94	1.4541044	0.012658228	0.117961004	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	97	0.8696916	0.74497354	1	2.323796	0.5844128
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	c2.CGP_ chemical and genetic perturbations	59	1.4539667	0.02739726	0.1180444	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	62	1.2865367	0.0824295	0.4623406	2.7405034	0.16743
REACTOME_MEIOSIS	c2.CP_REACTOME_ Reactome gene sets	71	1.4538023	0.02108037	0.11815348	REACTOME_MEIOSIS	72	1.5246465	0.003222342	0.23128536	2.9784488	-0.0708442
MODULE_573	c4.CM_ cancer modules	20	1.453712	0.050769232	0.11819526	MODULE_573	21	-1.3948449	0.07692308	0.21056171	0.0588671	2.8485569
BROWNE_HCMV_INFECTION_4HR_UP	c2.CGP_ chemical and genetic perturbations	49	1.45351	0.022922637	0.1183568	BROWNE_HCMV_INFECTION_4HR_UP	49	1.0446724	0.39756367	0.8503567	2.4981824	0.4088376
RICKMAN_HEAD_AND_NECK_CANCER_A	c2.CGP_ chemical and genetic perturbations	79	1.4534504	0.013333334	0.11833752	RICKMAN_HEAD_AND_NECK_CANCER_A	83	1.0820774	0.3340494	0.7833225	2.5355278	0.371373
RASHI_RESPONSE_TO_IONIZING_RADIATION_4	c2.CGP_ chemical and genetic perturbations	51	1.453271	0.027662518	0.11847304	RASHI_RESPONSE_TO_IONIZING_RADIATION_4	53	-1.047204	0.3478261	0.6114009	0.406067	2.500475
GO_ACTIN_FILAMENT_BUNDLE	c5.CC_ GO cellular component	52	1.4531916	0.028409092	0.118494585	GO_ACTIN_FILAMENT_BUNDLE	53	0.862506	0.6970721	1	2.3156976	0.5906856
GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	149	1.4531764	0.008599509	0.11843324	GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN	152	1.2235616	0.090263695	0.55092096	2.676738	0.2296148
GO_ARTERY_MORPHOGENESIS	c5.BP_ GO biological process	49	1.4531221	0.024113474	0.11842746	GO_ARTERY_MORPHOGENESIS	51	0.9114014	0.6556656	1	2.3645235	0.5417207
GO_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION	c5.BP_ GO biological process	48	1.4531013	0.025280898	0.11837731	GO_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION	49	1.271593	0.12458287	0.4834597	2.7246943	0.1815083
GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	148	1.4529389	0.006082725	0.11849976	GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	152	1.3460968	0.01122449	0.38780576	2.7990357	0.1068421
GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN	C7_ immunologic signatures	183	1.4528245	0.002369668	0.11854449	GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN	183	0.7567888	0.9369278	1	2.2096133	0.6960357
KENNY_CTNNB1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	46	1.4522543	0.028409092	0.119119704	KENNY_CTNNB1_TARGETS_UP	45	-1.055423	0.35114503	0.59457815	0.3968313	2.5076773
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	c2.CGP_ chemical and genetic perturbations	17	1.4517069	0.057877813	0.11966697	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	17	-0.51425767	0.99557525	0.9916046	0.93744923	1.96596457
GO_REGULATION_OF_INTERLEUKIN_2_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	1.4512937	0.07472178	0.120070495	GO_REGULATION_OF_INTERLEUKIN_2_BIOSYNTHETIC_PROCESS	18	1.3894988	0.08646616	0.34564018	2.8407925	0.0617949
GO_REGULATION_OF_MACROPHAGE_ACTIVATION	c5.BP_ GO biological process	22	1.4511957	0.049919486	0.120108366	GO_REGULATION_OF_MACROPHAGE_ACTIVATION	24	1.3117955	0.12393682	0.42274246	2.7629912	0.1394002
GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN	C7_ immunologic signatures	146	1.4510852	0.006203474	0.12014911	GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN	157	1.2408367	0.07324517	0.5245104	2.6919219	0.2102485
GO_MUSCLE_ADAPTATION	c5.BP_ GO biological process	27	1.4510562	0.045592707	0.12011554	GO_MUSCLE_ADAPTATION	28	1.1645983	0.26508877	0.64607155	2.6156545	0.2864579
GO_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS	c5.BP_ GO biological process	15	1.4510016	0.0528	0.12009943	GO_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS	15	0	0	0	1.4510016	1.4510016
AFP1_Q6	c3.TFT_ transcription factor targets	224	1.4508764	0.001144165	0.120166205	AFP1_Q6	237	0.9336421	0.6773547	0.9964608	2.3845185	0.5172343
GGCCAGT_MIR193A_MIR193B	c3.MIR_ microRNA targets	81	1.4507215	0.016393442	0.120265834	GGCCAGT_MIR193A_MIR193B	84	0.60806596	0.99244875	1	2.05878746	0.84265554
NAKAMURA_CANCER_MICROENVIRONMENT_DN	c2.CGP_ chemical and genetic perturbations	43	1.4506546	0.036986303	0.12026465	NAKAMURA_CANCER_MICROENVIRONMENT_DN	43	0.7346924	0.86052006	1	2.185347	0.7159622
EVI1_04	c3.TFT_ transcription factor targets	199	1.4506023	0.003567182	0.12024609	EVI1_04	209	1.1137916	0.22713567	0.73191136	2.5643939	0.3368107
BENPORATH_NOS_TARGETS	c2.CGP_ chemical and genetic perturbations	158	1.4505259	0.008333334	0.12027042	BENPORATH_NOS_TARGETS	160	0.85807794	0.794898	1	2.30860384	0.59244796
GO_LUNG_EPITHELIUM_DEVELOPMENT	c5.BP_ GO biological process	32	1.4504467	0.036809817	0.120284274	GO_LUNG_EPITHELIUM_DEVELOPMENT	34	0.8803842	0.67103696	1	2.3308309	0.5700625
GO_LEUKOCYTE_MEDIATED_CYTOTOXICITY	c5.BP_ GO biological process	25	1.4503702	0.04731861	0.12028772	GO_LEUKOCYTE_MEDIATED_CYTOTOXICITY	28	-1.3465924	0.08092485	0.24398501	0.1037778	2.7969626
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE	c2.CP_REACTOME_ Reactome gene sets	116	1.4500185	0.01142132	0.12062232	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE	117	0.9573055	0.5729059	0.9745952	2.407324	0.492713
GSE3982_BASOPHIL_VS_TH1_UP	C7_ immunologic signatures	170	1.4499353	0.005889282	0.12064865	GSE3982_BASOPHIL_VS_TH1_UP	173	0.9284772	0.6659878	0.99938536	2.3784125	0.5214581
GO_ADAPTATION_OF_SIGNALING_PATHWAY	c5.BP_ GO biological process	16	1.4498662	0.066086955	0.12065423	GO_ADAPTATION_OF_SIGNALING_PATHWAY	20	0.9665475	0.54394907	0.96437377	2.4164137	0.4833187
RODRIGUES_DCC_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	111	1.4497131	0.010139417	0.120770164	RODRIGUES_DCC_TARGETS_DN	112	1.3954746	0.013499481	0.3462426	2.8451877	0.0542385
MODULE_252	c4.CM_ cancer modules	219	1.449527	0.003351955	0.12092692	MODULE_252	221	-1.9047554	0	0.017407054	-0.4552284	3.3542824
MORF_FLT1	c4.CGN_ cancer gene neighborhoods	92	1.4493977	0.010512483	0.12101856	MORF_FLT1	107	1.288915	0.059498955	0.4596477	2.7383127	0.1604827
GO_CELL_DIVISION_SITE	c5.CC_ GO cellular component	52	1.4492159	0.023357663	0.12114747	GO_CELL_DIVISION_SITE	52	0.72374415	0.8836689	1	2.17296005	0.72547175
GO_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION	c5.BP_ GO biological process	104	1.4487541	0.011658032	0.12161114	GO_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION	105	0.7108705	0.9405631	1	2.1596246	0.7378836
ROY_WOUND_BLOOD_VESSEL_UP	c2.CGP_ chemical and genetic perturbations	46	1.4487197	0.032033425	0.121579304	ROY_WOUND_BLOOD_VESSEL_UP	48	0.6637664	0.9310345	1	2.1124861	0.7849533
PITX2_Q2	c3.TFT_ transcription factor targets	215	1.4481943	0.001158749	0.122102864	PITX2_Q2	222	0.9131389	0.7124117	1	2.3613332	0.5350554
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	c2.CP_BIOCARTA_ BioCarta gene sets	101	1.4481744	0.009079118	0.12204841	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	107	1.2158432	0.11887383	0.56478226	2.6640176	0.2323312
GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN	C7_ immunologic signatures	158	1.4480215	0.005931198	0.12215218	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN	161	0.9900593	0.51269037	0.9352972	2.4380808	0.4579622
GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	C7_ immunologic signatures	181	1.4479535	0.002364066	0.1221602	GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	174	1.1689744	0.12436805	0.6392901	2.6169279	0.2789791
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN	C7_ immunologic signatures	150	1.4479069	0.00968523	0.1221459	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN	152	1.264191	0.05691057	0.4909894	2.7120979	0.1837159
MODULE_100	c4.CM_ cancer modules	473	1.4475687	0	0.122471906	MODULE_100	491	1.2284812	0.001	0.5440887	2.6760499	0.2190875
SENESE_HDAC1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	209	1.4475677	0.001158749	0.122397974	SENESE_HDAC1_TARGETS_DN	216	0.9627815	0.60542166	0.9681333	2.4103492	0.4847862
BAELDE_DIABETIC_NEPHROPATHY_DN	c2.CGP_ chemical and genetic perturbations	407	1.4475518	0	0.12234241	BAELDE_DIABETIC_NEPHROPATHY_DN	407	1.0291036	0.409	0.8771257	2.4766554	0.4184482
MODULE_342	c4.CM_ cancer modules	182	1.4475062	0.005896227	0.122330345	MODULE_342	185	1.572437	0	0.18660146	3.0199432	-0.1249308
GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	157	1.4470128	0.003627569	0.122829944	GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN	167	1.2697723	0.036548223	0.484879	2.7167851	0.1772405
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP	C7_ immunologic signatures	168	1.4467613	0.002375297	0.12303942	GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP	167	-0.93082654	0.68421054	0.7824353	0.51593476	2.37758784
PEREZ_TP63_TARGETS	c2.CGP_ chemical and genetic perturbations	288	1.446487	0.001094092	0.12327194	PEREZ_TP63_TARGETS	294	1.392116	0	0.3471821	2.838603	0.054371
BENPORATH_ES_CORE_NINE_CORRELATED	c2.CGP_ chemical and genetic perturbations	93	1.4463669	0.008997429	0.12334068	BENPORATH_ES_CORE_NINE_CORRELATED	95	-1.7922137	0	0.03449857	-0.3458468	3.2385806
PID_WNT_SIGNALING_PATHWAY	c2.CP_ Canonical pathways	26	1.446296	0.04379562	0.12335022	PID_WNT_SIGNALING_PATHWAY	28	-1.0858635	0.24096386	0.5411019	0.3604325	2.5321595
GO_LUNG_CELL_DIFFERENTIATION	c5.BP_ GO biological process	23	1.4460945	0.049079753	0.1235202	GO_LUNG_CELL_DIFFERENTIATION	25	0.8921864	0.6634027	1	2.3382809	0.5539081
BROWNE_HCMV_INFECTION_12HR_DN	c2.CGP_ chemical and genetic perturbations	91	1.4459711	0.011952192	0.123578966	BROWNE_HCMV_INFECTION_12HR_DN	91	1.1771697	0.19978859	0.6264314	2.6231408	0.2688014
GO_PLATELET_ALPHA_GRANULE_LUMEN	c5.CC_ GO cellular component	46	1.4457737	0.037921347	0.12373665	GO_PLATELET_ALPHA_GRANULE_LUMEN	48	1.5046753	0.011481056	0.24778982	2.950449	-0.0589016
CHR4Q35	C1: positional gene sets	24	1.4456867	0.05457464	0.12377829	CHR4Q35	26	1.469558	0.030674847	0.2760267	2.9152447	-0.0238713
GO_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	c5.BP_ GO biological process	80	1.4455875	0.015727391	0.12382333	GO_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	83	0.9213931	0.63703704	1	2.3669806	0.5241944
AREB6_04	c3.TFT_ transcription factor targets	221	1.4452728	0	0.12412743	AREB6_04	231	-1.2958981	0	0.28801128	0.1493747	2.7411709
GO_DEVELOPMENTAL_MATURATION	c5.BP_ GO biological process	166	1.4451256	0.004830918	0.12422768	GO_DEVELOPMENTAL_MATURATION	180	0.9601138	0.61561865	0.9713548	2.4052394	0.4850118
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	c2.CGP_ chemical and genetic perturbations	154	1.4448409	0.006009616	0.12449882	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	155	0.7837532	0.8993902	1	2.2285941	0.6610877
GO_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING	c5.BP_ GO biological process	32	1.4445862	0.041853514	0.12471926	GO_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING	35	1.470366	0.029308323	0.27622277	2.9149522	-0.0257798
LABBE_WNT3A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	99	1.4443638	0.019354839	0.12489526	LABBE_WNT3A_TARGETS_UP	102	0.870447	0.7507788	1	2.3148108	0.5739168
GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP	C7_ immunologic signatures	145	1.4443302	0.008484849	0.124858566	GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP	147	1.0582837	0.35758197	0.82746035	2.5026139	0.3860465
GO_REGULATION_OF_ERBB_SIGNALING_PATHWAY	c5.BP_ GO biological process	74	1.4442402	0.012211669	0.12488804	GO_REGULATION_OF_ERBB_SIGNALING_PATHWAY	77	1.3512592	0.04767064	0.3838844	2.7954994	0.092981
GO_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM	c5.BP_ GO biological process	48	1.4441823	0.04532578	0.12488469	GO_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM	52	0.9505778	0.59910417	0.9813679	2.3947601	0.4936045
LUI_THYROID_CANCER_CLUSTER_1	c2.CGP_ chemical and genetic perturbations	48	1.4440503	0.027181689	0.12494739	LUI_THYROID_CANCER_CLUSTER_1	48	0.8766068	0.69028574	1	2.3206571	0.5674435
GO_RESPONSE_TO_RADIATION	c5.BP_ GO biological process	375	1.4437975	0.002181025	0.12517245	GO_RESPONSE_TO_RADIATION	376	0.8459658	0.9198397	1	2.2897633	0.5978317
GO_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY	c5.BP_ GO biological process	30	1.4436789	0.039940827	0.12523483	GO_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY	33	1.3947246	0.06729634	0.34577966	2.8384035	0.0489543
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	C7_ immunologic signatures	171	1.4435177	0.008264462	0.12534517	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	174	1.1956927	0.1106599	0.5967593	2.6392104	0.247825
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN	C7_ immunologic signatures	176	1.4433215	0.002283105	0.12550825	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN	176	0.7908229	0.90316004	1	2.2341444	0.6524986
MODULE_137	c4.CM_ cancer modules	471	1.4432925	0	0.12546177	MODULE_137	492	1.2232565	0.011	0.5514795	2.666549	0.220036
GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	C7_ immunologic signatures	161	1.4431998	0.007100592	0.12551373	GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	173	1.2860547	0.032686416	0.46284226	2.7292545	0.1571451
CHR2P24	C1: positional gene sets	44	1.443173	0.03142857	0.125469	CHR2P24	44	-0.9266412	0.5839416	0.78806335	0.5165318	2.3698142
CHR15Q21	C1: positional gene sets	76	1.4428941	0.016348774	0.12574956	CHR15Q21	78	1.1283015	0.2750533	0.70859474	2.5711956	0.3145926
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	121	1.4428473	0.00887199	0.1257267	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN	132	1.4593573	0.006134969	0.2828613	2.9022046	-0.01651
GO_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	23	1.4427714	0.057453416	0.12574975	GO_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	24	1.4586556	0.03375	0.28360406	2.901427	-0.0158842
GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	176	1.4425063	0.004790419	0.12599789	GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	179	0.7840636	0.9207317	1	2.2265699	0.6584427
GO_REGULATION_OF_PROTEIN_MATURATION	c5.BP_ GO biological process	68	1.4423782	0.024096385	0.12605773	GO_REGULATION_OF_PROTEIN_MATURATION	73	1.6324617	0.001077586	0.13172863	3.0748399	-0.1900835
ONDER_CDH1_SIGNALING_VIA_CTNNB1	c2.CGP_ chemical and genetic perturbations	77	1.4423482	0.015873017	0.1260129	ONDER_CDH1_SIGNALING_VIA_CTNNB1	77	1.4745324	0.013978494	0.2749351	2.9168806	-0.0321842
GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP	C7_ immunologic signatures	165	1.442296	0.006857143	0.12600337	GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP	164	1.2649472	0.052093975	0.49074122	2.7072432	0.1773488
GO_LOCOMOTORY_BEHAVIOR	c5.BP_ GO biological process	160	1.4422182	0.008353222	0.12603351	GO_LOCOMOTORY_BEHAVIOR	172	1.1225184	0.21681865	0.7211489	2.5647366	0.3196998
MODULE_52	c4.CM_ cancer modules	387	1.4421811	0	0.12600213	MODULE_52	391	0.7337082	0.995	1	2.1758893	0.7084729
MODULE_524	c4.CM_ cancer modules	29	1.4421133	0.03851852	0.12600765	MODULE_524	30	-1.0823469	0.30285713	0.54727954	0.3597664	2.5244602
HNF3_Q6	c3.TFT_ transcription factor targets	152	1.4419185	0.009791922	0.12614603	HNF3_Q6	168	0.9102132	0.7030303	1	2.3521317	0.5317053
GSE7460_CD8_TCELL_VS_TREG_ACT_DN	C7_ immunologic signatures	182	1.4418873	0.005868545	0.12610687	GSE7460_CD8_TCELL_VS_TREG_ACT_DN	182	0.8166765	0.88698286	1	2.2585638	0.6252108
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	c2.CGP_ chemical and genetic perturbations	20	1.4417624	0.05263158	0.12618758	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	22	1.4318393	0.05388471	0.31279254	2.8736017	0.0099231
TTTGCAC_MIR19A_MIR19B	c3.MIR_ microRNA targets	470	1.4415312	0	0.12639357	TTTGCAC_MIR19A_MIR19B	479	1.0414858	0.344	0.85657007	2.483017	0.4000454
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	c2.CGP_ chemical and genetic perturbations	193	1.4415306	0.001160093	0.12631865	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	191	1.0468838	0.38945234	0.8447907	2.4884144	0.3946468
CHR9Q22	C1: positional gene sets	61	1.4409771	0.025920874	0.12687491	CHR9Q22	64	1.150951	0.2516129	0.6681163	2.5919281	0.2900261
GO_PHOSPHOLIPID_BINDING	c5.GO molecular function	317	1.4409376	0.001101322	0.1268471	GO_PHOSPHOLIPID_BINDING	329	1.424762	0	0.31933144	2.8656996	0.0161756
GO_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	101	1.4409256	0.015364917	0.12678763	GO_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION	103	1.5565926	0	0.20216681	2.9975182	-0.115667
TTANWNANTGGM_UNKNOWN	c3.TFT_ transcription factor targets	47	1.4408408	0.037089873	0.12682432	TTANWNANTGGM_UNKNOWN	53	1.035716	0.41978022	0.8661037	2.4765568	0.4051248
GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP	C7_ immunologic signatures	165	1.4404973	0.004761905	0.12713914	GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP	182	1.2060055	0.0995935	0.58235884	2.6465028	0.2344918
GO_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY	c5.BP_ GO biological process	21	1.4404241	0.051004637	0.12714791	GO_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY	23	1.061165	0.3768116	0.821669	2.5015891	0.3792591
GO_RESPONSE_TO_DIETARY_EXCESS	c5.BP_ GO biological process	15	1.4402311	0.06677525	0.12733191	GO_RESPONSE_TO_DIETARY_EXCESS	19	1.4165224	0.063802086	0.32049245	2.8567535	0.0237087
GO_NEURON_MATURATION	c5.BP_ GO biological process	28	1.439967	0.045385778	0.12758838	GO_NEURON_MATURATION	29	1.0187534	0.4530864	0.8921867	2.4587204	0.4212136
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	c2.CGP_ chemical and genetic perturbations	35	1.4398452	0.025525525	0.12766439	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	35	1.2492592	0.1672556	0.51191163	2.6891044	0.190586
GO_HEAD_MORPHOGENESIS	c5.BP_ GO biological process	33	1.4396647	0.05052006	0.12780844	GO_HEAD_MORPHOGENESIS	35	0.979571	0.52588236	0.9502132	2.4192357	0.4600937
GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP	C7_ immunologic signatures	185	1.4395226	0.003550296	0.1278986	GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP	186	0.8294708	0.8557013	1	2.2689934	0.6100518
GO_RESPONSE_TO_EPINEPHRINE	c5.BP_ GO biological process	16	1.4394422	0.051321927	0.12791783	GO_RESPONSE_TO_EPINEPHRINE	16	1.4437996	0.05019305	0.29849967	2.8832418	-0.0043574
GO_NEGATIVE_REGULATION_OF_AXON_EXTENSION	c5.BP_ GO biological process	35	1.4394147	0.044615384	0.12787187	GO_NEGATIVE_REGULATION_OF_AXON_EXTENSION	37	-1.1206758	0.2746479	0.4884064	0.3187389	2.5600905
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	c2.CGP_ chemical and genetic perturbations	43	1.4390237	0.031791907	0.12823741	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	44	1.1861073	0.20911215	0.6133112	2.625131	0.2529164
MODULE_85	c4.CM_ cancer modules	46	1.4389222	0.02853067	0.12828739	MODULE_85	50	0.98813087	0.49227372	0.93769157	2.42705307	0.45079133
GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN	C7_ immunologic signatures	159	1.4388608	0.010962241	0.12828873	GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN	164	1.236113	0.06938776	0.5314488	2.6749738	0.2027478
GO_ENDOTHELIAL_CELL_PROLIFERATION	c5.BP_ GO biological process	22	1.4388351	0.051908396	0.12824209	GO_ENDOTHELIAL_CELL_PROLIFERATION	23	-0.859298	0.76555026	0.8611133	0.5795371	2.2981331
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	c2.CGP_ chemical and genetic perturbations	25	1.4387945	0.044444446	0.1282137	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	25	1.1240342	0.31365314	0.71731657	2.5628287	0.3147603
GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN	C7_ immunologic signatures	164	1.4385513	0.008313539	0.12842008	GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN	164	0.89269984	0.7308869	1	2.33125114	0.54585146
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	c2.CGP_ chemical and genetic perturbations	21	1.4384909	0.04375	0.12841913	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	21	1.4726585	0.029374203	0.27529338	2.9111494	-0.0341676
GO_MONOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	15	1.43826	0.058631923	0.12861241	GO_MONOCYTE_DIFFERENTIATION	15	0.7958846	0.7316422	1	2.2341446	0.6423754
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	125	1.43819	0.00875	0.12861966	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP	134	1.3230503	0.02755102	0.41106743	2.7612403	0.1151397
BIOCARTA_NO1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	27	1.4381033	0.058641974	0.12866147	BIOCARTA_NO1_PATHWAY	27	1.367874	0.07038835	0.37101185	2.8059773	0.0702293
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	c2.CGP_ chemical and genetic perturbations	23	1.4380602	0.05925926	0.12864663	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	24	1.5509329	0.020531401	0.20816417	2.9889931	-0.1128727
REACTOME_DOUBLE_STRAND_BREAK_REPAIR	c2.CP_REACTOME_ Reactome gene sets	20	1.4379079	0.05320814	0.1287669	REACTOME_DOUBLE_STRAND_BREAK_REPAIR	20	-0.9952107	0.44978166	0.6938635	0.4426972	2.4331186
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	c2.CGP_ chemical and genetic perturbations	98	1.4376265	0.006544503	0.12906148	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	98	1.1227448	0.26890758	0.72073317	2.5603713	0.3148817
GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN	C7_ immunologic signatures	162	1.437508	0.009815951	0.12911235	GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN	171	1.0309778	0.42213115	0.8741041	2.4684858	0.4065302
GO_PROTEIN_POLYMERIZATION	c5.BP_ GO biological process	60	1.4374834	0.024725275	0.12907097	GO_PROTEIN_POLYMERIZATION	60	0.66235685	0.94795126	1	2.09984025	0.77512655
GSE3039_B2_VS_B1_BCELL_UP	C7_ immunologic signatures	175	1.4373282	0.003571429	0.12918079	GSE3039_B2_VS_B1_BCELL_UP	177	0.9874239	0.5187058	0.9386974	2.4247521	0.4499043
GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN	C7_ immunologic signatures	183	1.4367476	0.002372479	0.12981741	GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN	184	1.3186836	0.01621074	0.4129991	2.7554312	0.118064
GO_KERATINOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	64	1.4360515	0.03809524	0.13059363	GO_KERATINOCYTE_DIFFERENTIATION	63	1.1625215	0.24751382	0.64947164	2.598573	0.27353
TTAYRTAA_E4BP4_01	c3.TFT_ transcription factor targets	224	1.4360051	0.001145475	0.13058	TTAYRTAA_E4BP4_01	233	1.1556355	0.13796575	0.66093886	2.5916406	0.2803696
CHR13Q13	C1: positional gene sets	20	1.4357617	0.06987578	0.1307834	CHR13Q13	23	0.8473522	0.72503084	1	2.2831139	0.5884095
JAK2_DN.V1_UP	C6_ oncogenic signatures	126	1.4356167	0.013681592	0.1308898	JAK2_DN.V1_UP	146	1.0522013	0.38945234	0.83698744	2.487818	0.3834154
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	c2.CP_REACTOME_ Reactome gene sets	62	1.4349442	0.029372497	0.13166317	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	62	0.98658895	0.50328225	0.94014597	2.42153315	0.44835525
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	c2.CGP_ chemical and genetic perturbations	77	1.4348888	0.019255456	0.13166419	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	83	1.1365856	0.25159237	0.6950516	2.5714744	0.2983032
GO_NEGATIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	31	1.4344393	0.04881657	0.1321454	GO_NEGATIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS	38	1.0439701	0.41426927	0.8508919	2.4784094	0.3904692
GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP	C7_ immunologic signatures	172	1.4343706	0.003550296	0.13215318	GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP	176	0.92149687	0.68324876	1	2.35586747	0.51287373
GO_NEGATIVE_REGULATION_OF_CELL_GROWTH	c5.BP_ GO biological process	151	1.4341782	0.00483676	0.13231614	GO_NEGATIVE_REGULATION_OF_CELL_GROWTH	158	0.9797284	0.56836736	0.9501984	2.4139066	0.4544498
MODULE_66	c4.CM_ cancer modules	480	1.433944	0	0.13253386	MODULE_66	498	1.2310829	0.012	0.5380434	2.6650269	0.2028611
GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP	C7_ immunologic signatures	127	1.4338223	0.009852217	0.13262734	GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP	133	1.2263775	0.09528688	0.54769796	2.6601998	0.2074448
GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	C7_ immunologic signatures	153	1.4336721	0.0157767	0.13273975	GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	154	-1.1873016	0.05882353	0.39691308	0.2463705	2.6209737
GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN	C7_ immunologic signatures	159	1.4334761	0.004801921	0.13291346	GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN	180	1.2217104	0.06788247	0.5537445	2.6551865	0.2117657
GO_POSITIVE_REGULATION_OF_HEART_RATE	c5.BP_ GO biological process	19	1.4333218	0.07465008	0.1330283	GO_POSITIVE_REGULATION_OF_HEART_RATE	22	1.5761575	0.011335013	0.18279204	3.0094793	-0.1428357
GO_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION	c5.BP_ GO biological process	87	1.4332585	0.01724138	0.1330307	GO_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION	86	1.2777582	0.07290533	0.47535563	2.7110167	0.1555003
GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	C7_ immunologic signatures	167	1.4331269	0.00973236	0.13311818	GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	168	0.84980065	0.831643	1	2.28292755	0.58332625
FOXO1_01	c3.TFT_ transcription factor targets	214	1.4327824	0.005727377	0.1334934	FOXO1_01	214	0.81950223	0.8841893	1	2.25228463	0.61328017
GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN	C7_ immunologic signatures	189	1.4325277	0.004778972	0.13375217	GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN	190	-1.347557	0	0.2435965	0.0849707	2.7800847
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN	C7_ immunologic signatures	173	1.4321324	0.007075472	0.13416809	GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN	178	0.7587678	0.93636364	1	2.1909002	0.6733646
PID_LYMPH_ANGIOGENESIS_PATHWAY	c2.CP_ Canonical pathways	24	1.432111	0.057098765	0.13411358	PID_LYMPH_ANGIOGENESIS_PATHWAY	24	-0.88598543	0.6633166	0.8380582	0.54612557	2.31809643
KEGG_DILATED_CARDIOMYOPATHY	c2.CP_BIOCARTA_ BioCarta gene sets	82	1.4320041	0.012064343	0.13416612	KEGG_DILATED_CARDIOMYOPATHY	87	1.0995413	0.30076003	0.7578588	2.5315454	0.3324628
GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP	C7_ immunologic signatures	115	1.4317518	0.011349306	0.13443416	GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP	127	1.0435437	0.3946557	0.8522739	2.4752955	0.3882081
GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN	C7_ immunologic signatures	168	1.4315728	0.004744959	0.13458648	GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN	174	1.2220217	0.07497467	0.55337703	2.6535945	0.2095511
GO_CIRCULATORY_SYSTEM_PROCESS	c5.BP_ GO biological process	298	1.4314711	0.003351955	0.13463171	GO_CIRCULATORY_SYSTEM_PROCESS	330	1.4678032	0	0.2770608	2.8992743	-0.0363321
GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	45	1.4314022	0.03281027	0.13463478	GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT	50	1.7242414	0.001136364	0.068470135	3.1556436	-0.2928392
POOLA_INVASIVE_BREAST_CANCER_DN	c2.CGP_ chemical and genetic perturbations	118	1.4313428	0.015643803	0.13463078	POOLA_INVASIVE_BREAST_CANCER_DN	121	1.414014	0.011316872	0.3237787	2.8453568	0.0173288
GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN	C7_ immunologic signatures	175	1.4311712	0.004744959	0.13477294	GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN	177	1.0690219	0.3268839	0.8072561	2.5001931	0.3621493
CASTELLANO_NRAS_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	57	1.4310539	0.02892562	0.13484553	CASTELLANO_NRAS_TARGETS_UP	58	1.4954225	0.01230425	0.2569265	2.9264764	-0.0643686
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	18	1.4304247	0.066246055	0.1355643	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN	18	0.7744906	0.767927	1	2.2049153	0.6559341
GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	C7_ immunologic signatures	178	1.4301834	0.008092485	0.13582604	GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	178	1.1080666	0.24444444	0.7414151	2.53825	0.3221168
MODULE_198	c4.CM_ cancer modules	284	1.4298285	0.001118568	0.13619177	MODULE_198	286	-1.8888506	0	0.018890247	-0.4590221	3.3186791
GO_NEGATIVE_REGULATION_OF_ANION_TRANSPORT	c5.BP_ GO biological process	27	1.4297372	0.05981595	0.13621755	GO_NEGATIVE_REGULATION_OF_ANION_TRANSPORT	29	1.4841539	0.032490976	0.26498556	2.9138911	-0.0544167
GO_ESTABLISHMENT_OF_SPINDLE_ORIENTATION	c5.BP_ GO biological process	25	1.4297161	0.0578125	0.13616924	GO_ESTABLISHMENT_OF_SPINDLE_ORIENTATION	25	0.9231241	0.6034063	1	2.3528402	0.506592
GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	C7_ immunologic signatures	180	1.4295723	0.007100592	0.1362804	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	185	1.0051188	0.4858871	0.9146704	2.4346911	0.4244535
CHR7P14	C1: positional gene sets	32	1.4295706	0.056402437	0.13620368	CHR7P14	33	1.236898	0.18019094	0.5307433	2.6664686	0.1926726
GO_SULFUR_COMPOUND_CATABOLIC_PROCESS	c5.BP_ GO biological process	37	1.4295486	0.052478135	0.13615708	GO_SULFUR_COMPOUND_CATABOLIC_PROCESS	37	1.2194276	0.18566392	0.55591923	2.6489762	0.210121
GO_STRIATED_MUSCLE_ADAPTATION	c5.BP_ GO biological process	22	1.4294907	0.05345912	0.1361496	GO_STRIATED_MUSCLE_ADAPTATION	22	1.0851349	0.36087486	0.7769497	2.5146256	0.3443558
GO_RESPONSE_TO_ALCOHOL	c5.BP_ GO biological process	324	1.4294072	0.001097695	0.13618018	GO_RESPONSE_TO_ALCOHOL	339	0.9832193	0.5641283	0.9441205	2.4126265	0.4461879
GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	115	1.4293548	0.008883249	0.13617912	GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	124	0.9056549	0.67622954	1	2.3350097	0.5236999
GO_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY	c5.BP_ GO biological process	21	1.4292781	0.06750392	0.13620308	GO_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY	22	1.3283329	0.10780669	0.40353572	2.757611	0.1009452
GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	172	1.4292263	0.003601441	0.13619293	GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	178	0.78106964	0.90020365	1	2.21029594	0.64815666
GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN	C7_ immunologic signatures	154	1.4291197	0.009876544	0.13625395	GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN	153	0.83654314	0.8203046	1	2.26566284	0.59257656
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP	C7_ immunologic signatures	114	1.4287889	0.011138614	0.13660993	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP	124	1.1376911	0.21878225	0.69441223	2.56648	0.2910978
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	c2.CP_REACTOME_ Reactome gene sets	160	1.4286641	0.008187135	0.1366855	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	175	1.2434806	0.04853387	0.5225327	2.6721447	0.1851835
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	c2.CGP_ chemical and genetic perturbations	433	1.4286349	0	0.13665009	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	440	1.0777577	0.232	0.7915115	2.5063926	0.3508772
GO_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES	c5.BP_ GO biological process	26	1.4285603	0.04754358	0.13667971	GO_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES	26	-1.2558423	0.15300547	0.31883675	0.172718	2.6844026
GSE2706_UNSTIM_VS_8H_LPS_DC_DN	C7_ immunologic signatures	164	1.4285128	0.004878049	0.1366614	GSE2706_UNSTIM_VS_8H_LPS_DC_DN	164	1.0380046	0.3985729	0.86198527	2.4665174	0.3905082
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	c2.CP_ Canonical pathways	50	1.4284635	0.03281027	0.13665001	PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	48	0.7194533	0.89666665	1	2.1479168	0.7090102
KAMIKUBO_MYELOID_MN1_NETWORK	c2.CGP_ chemical and genetic perturbations	18	1.4284335	0.0671875	0.13660717	KAMIKUBO_MYELOID_MN1_NETWORK	18	0.84521544	0.69849247	1	2.27364894	0.58321806
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	c2.CGP_ chemical and genetic perturbations	44	1.4283593	0.032167833	0.13661024	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	44	0.54986805	0.99422634	1	1.97822735	0.87849125
GO_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	138	1.4282705	0.011124846	0.136644	GO_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS	139	0.778621	0.9074074	1	2.2068915	0.6496495
REACTOME_RAP1_SIGNALLING	c2.CP_REACTOME_ Reactome gene sets	15	1.4282393	0.06472492	0.13660982	REACTOME_RAP1_SIGNALLING	15	-1.105775	0.31496063	0.50858945	0.3224643	2.5340143
UROSEVIC_RESPONSE_TO_IMIQUIMOD	c2.CGP_ chemical and genetic perturbations	17	1.4280844	0.047169812	0.13673756	UROSEVIC_RESPONSE_TO_IMIQUIMOD	17	1.0358962	0.45641026	0.8659334	2.4639806	0.3921882
GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN	C7_ immunologic signatures	151	1.4278498	0.007220217	0.13695735	GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN	166	0.8352144	0.8422131	1	2.2630642	0.5926354
GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	C7_ immunologic signatures	136	1.4275441	0.006157635	0.13727196	GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	136	1.1474855	0.19734152	0.6726044	2.5750296	0.2800586
GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN	C7_ immunologic signatures	164	1.427384	0.004694836	0.13739164	GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN	162	1.1096685	0.24392712	0.7382824	2.5370525	0.3177155
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	c2.CGP_ chemical and genetic perturbations	65	1.4273465	0.026536312	0.13736868	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	68	1.0874103	0.3401728	0.77469146	2.5147568	0.3399362
GO_REGULATION_OF_COAGULATION	c5.BP_ GO biological process	73	1.4273459	0.016194332	0.13729182	GO_REGULATION_OF_COAGULATION	77	1.841512	0	0.025737606	3.2688579	-0.4141661
POU1F1_Q6	c3.TFT_ transcription factor targets	200	1.4271071	0.002309469	0.1375278	POU1F1_Q6	219	0.87286	0.8010101	1	2.2999671	0.5542471
GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	C7_ immunologic signatures	159	1.427029	0.004825091	0.13756192	GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	163	0.89705676	0.73373985	1	2.32408576	0.52997224
GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	119	1.4268692	0.013580247	0.13768794	GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP	125	1.0464886	0.40695298	0.8457665	2.4733578	0.3803806
BURTON_ADIPOGENESIS_PEAK_AT_2HR	c2.CGP_ chemical and genetic perturbations	49	1.4268482	0.037037037	0.13763694	BURTON_ADIPOGENESIS_PEAK_AT_2HR	49	1.0908673	0.3400901	0.7697687	2.5177155	0.3359809
GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP	C7_ immunologic signatures	158	1.4267647	0.007067138	0.13768414	GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP	172	1.2084572	0.10243408	0.5801847	2.6352219	0.2183075
OCT1_07	c3.TFT_ transcription factor targets	136	1.4267528	0.013647643	0.13761953	OCT1_07	141	0.9613632	0.5797546	0.96963036	2.388116	0.4653896
GO_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY	c5.BP_ GO biological process	27	1.4262947	0.06431853	0.1381444	GO_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY	34	1.5424699	0.011792453	0.21099633	2.9687646	-0.1161752
IL21_UP.V1_DN	C6_ oncogenic signatures	131	1.4262383	0.007407407	0.1381444	IL21_UP.V1_DN	142	1.1948577	0.12257405	0.5971192	2.621096	0.2313806
GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY	c5.GO molecular function	17	1.4262369	0.07822086	0.13806802	GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY	17	1.2054014	0.22280473	0.58259934	2.6316383	0.2208355
GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	C7_ immunologic signatures	131	1.4261354	0.01	0.13811605	GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	131	1.2600765	0.06422018	0.4959413	2.6862119	0.1660589
GO_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION	c5.BP_ GO biological process	110	1.4260043	0.016581632	0.13820332	GO_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION	114	0.96322316	0.5723205	0.9674025	2.38922746	0.46278114
GO_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS	c5.BP_ GO biological process	35	1.4256148	0.048529413	0.1386259	GO_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS	38	1.193265	0.22209436	0.6002265	2.6188798	0.2323498
GO_DESMOSOME	c5.CC_ GO cellular component	22	1.4255853	0.067073174	0.13858886	GO_DESMOSOME	23	1.3348471	0.08219178	0.3979859	2.7604324	0.0907382
E2F3_UP.V1_UP	C6_ oncogenic signatures	160	1.4253267	0.005903188	0.13884433	E2F3_UP.V1_UP	165	-1.4451963	0	0.17709823	-0.0198696	2.870523
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	c2.CGP_ chemical and genetic perturbations	16	1.4253055	0.06185567	0.13879196	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	16	1.6059371	0.005134788	0.14971969	3.0312426	-0.1806316
GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP	C7_ immunologic signatures	166	1.4250884	0.009615385	0.13899933	GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP	174	0.8975293	0.72194135	1	2.3226177	0.5275591
KIM_MYC_AMPLIFICATION_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	78	1.4250774	0.01591512	0.13893172	KIM_MYC_AMPLIFICATION_TARGETS_DN	79	1.2253215	0.13205537	0.548573	2.6503989	0.1997559
GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	118	1.4249473	0.013994911	0.13902035	GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	130	1.1197064	0.24948454	0.72317666	2.5446537	0.3052409
GO_CYTOPLASMIC_REGION	c5.CC_ GO cellular component	259	1.424671	0.004479284	0.13929749	GO_CYTOPLASMIC_REGION	264	1.2261295	0.04709419	0.5473705	2.6508005	0.1985415
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	c2.CGP_ chemical and genetic perturbations	108	1.4246209	0.010322581	0.1392937	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	108	1.3286556	0.039378237	0.40424395	2.7532765	0.0959653
KEEN_RESPONSE_TO_ROSIGLITAZONE_DN	c2.CGP_ chemical and genetic perturbations	91	1.4245279	0.02077922	0.1393376	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN	95	1.2168517	0.1282586	0.5625704	2.6413796	0.2076762
GO_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT	c5.BP_ GO biological process	34	1.4243958	0.047040973	0.13943738	GO_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT	36	1.3329004	0.077726215	0.3994066	2.7572962	0.0914954
GAL_LEUKEMIC_STEM_CELL_UP	c2.CGP_ chemical and genetic perturbations	111	1.4243494	0.024111675	0.13942203	GAL_LEUKEMIC_STEM_CELL_UP	114	1.2867554	0.05427975	0.46242765	2.7111048	0.137594
GO_CELLULAR_RESPONSE_TO_ALKALOID	c5.BP_ GO biological process	28	1.4242219	0.05882353	0.13950852	GO_CELLULAR_RESPONSE_TO_ALKALOID	27	1.2863123	0.12285012	0.46278152	2.7105342	0.1379096
AP2REP_01	c3.TFT_ transcription factor targets	156	1.4242117	0.007202881	0.13944253	AP2REP_01	164	0.8883285	0.7487335	1	2.3125402	0.5358832
GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN	C7_ immunologic signatures	165	1.4239757	0.003541913	0.13966386	GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN	170	1.2433009	0.053807106	0.5231151	2.6672766	0.1806748
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	c2.CP_BIOCARTA_ BioCarta gene sets	78	1.4239092	0.026560426	0.13967341	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	81	1.0394042	0.4106952	0.85896826	2.4633134	0.384505
WANG_RESPONSE_TO_BEXAROTENE_DN	c2.CGP_ chemical and genetic perturbations	25	1.4236094	0.04416404	0.13998014	WANG_RESPONSE_TO_BEXAROTENE_DN	26	0.82210755	0.7396088	1	2.24571695	0.60150185
CROMER_TUMORIGENESIS_UP	c2.CGP_ chemical and genetic perturbations	47	1.4235837	0.026279392	0.13993953	CROMER_TUMORIGENESIS_UP	54	1.1602765	0.25617978	0.6518994	2.5838602	0.2633072
GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP	C7_ immunologic signatures	180	1.4235574	0.012775842	0.13990313	GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP	180	1.0822035	0.3108652	0.7835227	2.5057609	0.3413539
BMI1_DN_MEL18_DN.V1_DN	C6_ oncogenic signatures	119	1.4234142	0.012970169	0.14000633	BMI1_DN_MEL18_DN.V1_DN	126	1.1845342	0.1556701	0.6139254	2.6079484	0.23888
JI_METASTASIS_REPRESSED_BY_STK11	c2.CGP_ chemical and genetic perturbations	24	1.4231707	0.054095827	0.14024071	JI_METASTASIS_REPRESSED_BY_STK11	23	1.0917875	0.354798	0.7696235	2.5149582	0.3313832
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	c2.CGP_ chemical and genetic perturbations	62	1.4229134	0.035961274	0.14048493	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	64	0.9761032	0.51564187	0.9541118	2.3990166	0.4468102
FINAK_BREAST_CANCER_SDPP_SIGNATURE	c2.CGP_ chemical and genetic perturbations	16	1.4228507	0.06711409	0.14049138	FINAK_BREAST_CANCER_SDPP_SIGNATURE	20	1.1104921	0.34324658	0.7366682	2.5333428	0.3123586
NABA_ECM_REGULATORS	c2.CP_ Canonical pathways	182	1.4227624	0.008264462	0.1405171	NABA_ECM_REGULATORS	198	1.4084343	0.005040322	0.32756948	2.8311967	0.0143281
GO_CYTOPLASMIC_MICROTUBULE	c5.CC_ GO cellular component	47	1.42275	0.047486033	0.14045201	GO_CYTOPLASMIC_MICROTUBULE	49	1.2915784	0.094076656	0.4556674	2.7143284	0.1311716
GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP	C7_ immunologic signatures	112	1.4225755	0.016581632	0.14058971	GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP	120	1.0900279	0.3140496	0.7712655	2.5126034	0.3325476
CAHOY_ASTROGLIAL	C6_ oncogenic signatures	91	1.4225216	0.015978696	0.14057489	CAHOY_ASTROGLIAL	89	1.1497595	0.23485653	0.670067	2.5722811	0.2727621
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	c2.CGP_ chemical and genetic perturbations	33	1.4223987	0.04066265	0.14066364	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	33	1.2814103	0.13012049	0.47073624	2.703809	0.1409884
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	149	1.4223918	0.006031363	0.1405939	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN	162	1.2851098	0.034623217	0.4633949	2.7075016	0.137282
MODULE_58	c4.CM_ cancer modules	18	1.4222223	0.06750392	0.14075398	MODULE_58	17	1.4740691	0.034120735	0.2752864	2.8962914	-0.0518468
GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	132	1.422143	0.011464968	0.14076912	GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	139	1.1192732	0.2520576	0.723903	2.5414162	0.3028698
MEF2_02	c3.TFT_ transcription factor targets	190	1.4219904	0.01056338	0.1408846	MEF2_02	199	1.0115056	0.5020161	0.90433127	2.433496	0.4104848
BROWNE_HCMV_INFECTION_30MIN_UP	c2.CGP_ chemical and genetic perturbations	43	1.4219166	0.039647575	0.14090745	BROWNE_HCMV_INFECTION_30MIN_UP	45	1.4858752	0.022170361	0.26439244	2.9077918	-0.0639586
GO_SKELETAL_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	399	1.4215457	0.002139038	0.1413219	GO_SKELETAL_SYSTEM_DEVELOPMENT	426	0.8747902	0.872	1	2.2963359	0.5467555
GSE17721_0.5H_VS_8H_CPG_BMDC_DN	C7_ immunologic signatures	178	1.4214685	0.008464329	0.14134227	GSE17721_0.5H_VS_8H_CPG_BMDC_DN	176	0.89572495	0.739615	1	2.31719345	0.52574355
GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY	c5.GO molecular function	77	1.4211797	0.027667984	0.14163843	GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY	80	1.187307	0.18336888	0.61074626	2.6084867	0.2338727
GO_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	123	1.4211622	0.01972873	0.14158237	GO_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS	123	1.1965508	0.123700626	0.59660226	2.617713	0.2246114
GSE7460_TREG_VS_TCONV_ACT_UP	C7_ immunologic signatures	168	1.4210937	0.006038647	0.141598	GSE7460_TREG_VS_TCONV_ACT_UP	173	1.1094456	0.24214792	0.7380511	2.5305393	0.3116481
GO_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	133	1.4206659	0.010217113	0.14206009	GO_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT	146	1.4324893	0.005081301	0.31252453	2.8531552	-0.0118234
CAGTATT_MIR200B_MIR200C_MIR429	c3.MIR_ microRNA targets	429	1.420607	0	0.14206041	CAGTATT_MIR200B_MIR200C_MIR429	440	0.69307834	0.997	1	2.11368534	0.72752866
CHUNG_BLISTER_CYTOTOXICITY_DN	c2.CGP_ chemical and genetic perturbations	35	1.4205885	0.049418606	0.14200324	CHUNG_BLISTER_CYTOTOXICITY_DN	35	0.9367992	0.5806832	0.99319035	2.3573877	0.4837893
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	c2.CGP_ chemical and genetic perturbations	50	1.4205353	0.047552448	0.14198922	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	50	1.2819893	0.09497207	0.46952173	2.7025246	0.138546
KIM_WT1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	410	1.4205135	0	0.14194448	KIM_WT1_TARGETS_DN	410	0.71801025	0.993	1	2.13852375	0.70250325
GO_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES	c5.BP_ GO biological process	123	1.4204919	0.012820513	0.1418905	GO_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES	139	1.2952749	0.044989776	0.449044	2.7157668	0.125217
GO_APICAL_JUNCTION_COMPLEX	c5.CC_ GO cellular component	109	1.420287	0.016372796	0.14207722	GO_APICAL_JUNCTION_COMPLEX	113	0.89576083	0.70442843	1	2.31604783	0.52452617
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	c2.CGP_ chemical and genetic perturbations	48	1.4199264	0.035868004	0.14247294	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	48	-1.3915632	0.033613447	0.21394616	0.0283632	2.8114896
GO_NEGATIVE_REGULATION_OF_CELL_ACTIVATION	c5.BP_ GO biological process	130	1.41988	0.009925558	0.14245678	GO_NEGATIVE_REGULATION_OF_CELL_ACTIVATION	135	0.99540657	0.5153689	0.93034226	2.41528657	0.42447343
FRASOR_RESPONSE_TO_ESTRADIOL_DN	c2.CGP_ chemical and genetic perturbations	70	1.4197482	0.02312925	0.14254098	FRASOR_RESPONSE_TO_ESTRADIOL_DN	73	1.355902	0.04442037	0.38054964	2.7756502	0.0638462
MODULE_222	c4.CM_ cancer modules	16	1.4196712	0.06763285	0.14256874	MODULE_222	16	0.78794014	0.7592105	1	2.20761134	0.63173106
GO_ADRENERGIC_RECEPTOR_BINDING	c5.GO molecular function	17	1.4195722	0.06774194	0.14262003	GO_ADRENERGIC_RECEPTOR_BINDING	18	1.1649852	0.2767624	0.6462137	2.5845574	0.254587
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP	c2.CGP_ chemical and genetic perturbations	17	1.4194496	0.06065574	0.14270198	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP	18	-0.98104846	0.45089287	0.71291363	0.43840114	2.40049806
GO_NEURAL_PRECURSOR_CELL_PROLIFERATION	c5.BP_ GO biological process	62	1.4193157	0.02688172	0.1428114	GO_NEURAL_PRECURSOR_CELL_PROLIFERATION	67	-1.2280768	0.11494253	0.34752172	0.1912389	2.6473925
MAHADEVAN_RESPONSE_TO_MP470_DN	c2.CGP_ chemical and genetic perturbations	18	1.4193075	0.076033056	0.14274806	MAHADEVAN_RESPONSE_TO_MP470_DN	18	0.9175666	0.60157275	1	2.3368741	0.5017409
BIOCARTA_SPPA_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	1.4192269	0.05967742	0.14277977	BIOCARTA_SPPA_PATHWAY	22	1.4303077	0.045566503	0.3143326	2.8495346	-0.0110808
PID_P73PATHWAY	c2.CP_ Canonical pathways	72	1.4191983	0.01884253	0.1427451	PID_P73PATHWAY	72	1.0867468	0.33297643	0.77538073	2.5059451	0.3324515
GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN	C7_ immunologic signatures	172	1.4190602	0.010452962	0.14285383	GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN	174	1.4961709	0	0.2558665	2.9152311	-0.0771107
GO_SENSORY_ORGAN_MORPHOGENESIS	c5.BP_ GO biological process	214	1.4186956	0.001142857	0.14323665	GO_SENSORY_ORGAN_MORPHOGENESIS	230	0.91326994	0.73493975	1	2.33196554	0.50542566
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	c2.CGP_ chemical and genetic perturbations	17	1.4186736	0.055384614	0.143187	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17	1.2272083	0.21319798	0.5461812	2.6458819	0.1914653
CCCAGAG_MIR326	c3.MIR_ microRNA targets	135	1.4186132	0.012254902	0.14319043	CCCAGAG_MIR326	142	0.9610928	0.59589744	0.9697562	2.379706	0.4575204
GSE7460_TCONV_VS_TREG_LN_DN	C7_ immunologic signatures	181	1.4185361	0.008303678	0.14321873	GSE7460_TCONV_VS_TREG_LN_DN	185	1.1020428	0.2626775	0.7536566	2.5205789	0.3164933
GO_DEVELOPMENTAL_INDUCTION	c5.BP_ GO biological process	26	1.4179755	0.068217054	0.1438794	GO_DEVELOPMENTAL_INDUCTION	27	1.2656138	0.12931034	0.48992923	2.6835893	0.1523617
GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN	C7_ immunologic signatures	177	1.4175664	0.004711425	0.1443348	GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN	181	0.80813843	0.88956434	1	2.22570483	0.60942797
MODULE_213	c4.CM_ cancer modules	61	1.417498	0.03230148	0.14434299	MODULE_213	69	1.3521545	0.039087947	0.38312495	2.7696525	0.0653435
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP	C7_ immunologic signatures	161	1.4171058	0.004907975	0.1447942	GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP	164	1.0476727	0.38235295	0.8437158	2.4647785	0.3694331
GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	175	1.4171003	0.003472222	0.14472358	GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	180	0.92449033	0.7025381	1	2.34159063	0.49260997
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	c2.CGP_ chemical and genetic perturbations	119	1.4169248	0.025423728	0.14487284	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	120	1.1215175	0.24561404	0.7223999	2.5384423	0.2954073
PILON_KLF1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	440	1.416801	0.001053741	0.1449563	PILON_KLF1_TARGETS_UP	451	0.9902619	0.543	0.93537194	2.4070629	0.4265391
GO_NEURON_PROJECTION_REGENERATION	c5.BP_ GO biological process	29	1.4165708	0.04858934	0.14517266	GO_NEURON_PROJECTION_REGENERATION	30	0.5926889	0.96926713	1	2.0092597	0.8238819
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	c2.CGP_ chemical and genetic perturbations	44	1.4164927	0.044755246	0.14519726	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	45	1.6516632	0.001133787	0.11450862	3.0681559	-0.2351705
PRC2_EZH2_UP.V1_UP	C6_ oncogenic signatures	157	1.4164758	0.009744215	0.14514133	PRC2_EZH2_UP.V1_UP	165	1.25921	0.045546558	0.49742126	2.6756858	0.1572658
GO_PRIMARY_LYSOSOME	c5.CC_ GO cellular component	15	1.4164654	0.07755776	0.14507733	GO_PRIMARY_LYSOSOME	16	1.1397048	0.3022339	0.6913306	2.5561702	0.2767606
GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	153	1.4160677	0.007281554	0.14554296	GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP	154	1.1833125	0.14242116	0.6173751	2.5993802	0.2327552
GO_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY	c5.BP_ GO biological process	124	1.4160185	0.018404908	0.14552735	GO_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY	131	0.8674887	0.7735656	1	2.2835072	0.5485298
GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	C7_ immunologic signatures	184	1.4159274	0.004645761	0.1455613	GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	184	-1.2271179	0	0.3483197	0.1888095	2.6430453
CSR_EARLY_UP.V1_DN	C6_ oncogenic signatures	121	1.4156153	0.017010937	0.14588799	CSR_EARLY_UP.V1_DN	123	0.97948587	0.53814435	0.950257	2.39510117	0.43612943
GO_REGULATION_OF_DNA_METABOLIC_PROCESS	c5.BP_ GO biological process	291	1.4155569	0.002219756	0.14590208	GO_REGULATION_OF_DNA_METABOLIC_PROCESS	299	0.8730572	0.8326653	1	2.2886141	0.5424997
POOLA_INVASIVE_BREAST_CANCER_UP	c2.CGP_ chemical and genetic perturbations	232	1.4154713	0	0.14592806	POOLA_INVASIVE_BREAST_CANCER_UP	241	1.1910288	0.093655586	0.60438097	2.6065001	0.2244425
GO_CELL_AGGREGATION	c5.BP_ GO biological process	18	1.4153347	0.06612903	0.14604227	GO_CELL_AGGREGATION	18	0.8810842	0.65414506	1	2.2964189	0.5342505
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	c2.CGP_ chemical and genetic perturbations	73	1.4152652	0.022941971	0.14605613	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	75	1.1780276	0.19829424	0.62502456	2.5932928	0.2372376
GO_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS	c5.BP_ GO biological process	42	1.4152033	0.039589442	0.14606246	GO_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS	43	1.1415476	0.28669724	0.68755615	2.5567509	0.2736557
GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP	C7_ immunologic signatures	170	1.4151438	0.00968523	0.14606023	GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP	171	1.1368067	0.19455644	0.6946833	2.5519505	0.2783371
GO_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY	c5.BP_ GO biological process	173	1.4151344	0.008363202	0.14599259	GO_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY	194	1.3277742	0.018237082	0.4040431	2.7429086	0.0873602
GO_NEGATIVE_REGULATION_OF_CELL_ADHESION	c5.BP_ GO biological process	187	1.4151112	0.005854801	0.14594916	GO_NEGATIVE_REGULATION_OF_CELL_ADHESION	192	0.99364346	0.52323234	0.93121654	2.40875466	0.42146774
SAGIV_CD24_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	42	1.4149753	0.04384724	0.14605299	SAGIV_CD24_TARGETS_DN	43	1.3306584	0.07736721	0.40111792	2.7456337	0.0843169
GO_GLUTAMATE_RECEPTOR_ACTIVITY	c5.GO molecular function	25	1.4149543	0.06521739	0.14600506	GO_GLUTAMATE_RECEPTOR_ACTIVITY	26	1.700071	0.001231527	0.082449496	3.1150253	-0.2851167
GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN	C7_ immunologic signatures	183	1.4149234	0.004683841	0.14596665	GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN	181	0.8650015	0.8089431	1	2.2799249	0.5499219
GO_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY	c5.BP_ GO biological process	22	1.4148474	0.062305298	0.14599158	GO_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY	25	1.1756163	0.24691358	0.6284305	2.5904637	0.2392311
MIZUSHIMA_AUTOPHAGOSOME_FORMATION	c2.CGP_ chemical and genetic perturbations	18	1.4146609	0.062903225	0.14616553	MIZUSHIMA_AUTOPHAGOSOME_FORMATION	18	1.0747347	0.3963494	0.7975592	2.4893956	0.3399262
GO_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	24	1.4146049	0.061417323	0.1461613	GO_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT	25	0.9989112	0.4804878	0.92481816	2.4135161	0.4156937
GO_EMBRYONIC_PATTERN_SPECIFICATION	c5.BP_ GO biological process	53	1.4143741	0.042699724	0.14638545	GO_EMBRYONIC_PATTERN_SPECIFICATION	56	-1.119273	0.21	0.49008983	0.2951011	2.5336471
KRIGE_AMINO_ACID_DEPRIVATION	c2.CGP_ chemical and genetic perturbations	28	1.4143709	0.0608828	0.14631143	KRIGE_AMINO_ACID_DEPRIVATION	28	1.064917	0.399754	0.8143516	2.4792879	0.3494539
GO_ADHERENS_JUNCTION_ORGANIZATION	c5.BP_ GO biological process	61	1.4142537	0.033707865	0.14640272	GO_ADHERENS_JUNCTION_ORGANIZATION	64	0.8843735	0.68546635	1	2.2986272	0.5298802
GO_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY	c5.GO molecular function	82	1.4140854	0.027638191	0.14654273	GO_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY	88	1.4437728	0.013669821	0.29810837	2.8578582	-0.0296874
GO_RESPONSE_TO_ISOQUINOLINE_ALKALOID	c5.BP_ GO biological process	25	1.4140638	0.07788162	0.14649726	GO_RESPONSE_TO_ISOQUINOLINE_ALKALOID	29	1.3028353	0.12095808	0.43710348	2.7168991	0.1112285
MODULE_11	c4.CM_ cancer modules	472	1.4139869	0	0.14652473	MODULE_11	487	1.2437818	0.004	0.52164555	2.6577687	0.1702051
TGFB_UP.V1_DN	C6_ oncogenic signatures	162	1.4136674	0.008599509	0.14687686	TGFB_UP.V1_DN	168	1.2419035	0.075987846	0.5232225	2.6555709	0.1717639
RIGGINS_TAMOXIFEN_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	195	1.4134643	0.004624277	0.14704928	RIGGINS_TAMOXIFEN_RESISTANCE_DN	196	1.2741978	0.027272727	0.48146588	2.6876621	0.1392665
GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP	C7_ immunologic signatures	173	1.4133861	0.009378663	0.14708139	GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP	179	1.0882486	0.28426397	0.7735325	2.5016347	0.3251375
GO_ATP_DEPENDENT_CHROMATIN_REMODELING	c5.BP_ GO biological process	55	1.4133067	0.047748975	0.14711113	GO_ATP_DEPENDENT_CHROMATIN_REMODELING	57	0.7146366	0.8937853	1	2.1279433	0.6986701
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	c2.CGP_ chemical and genetic perturbations	404	1.4132059	0.001072961	0.14717217	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	412	1.2587947	0.011022044	0.49831444	2.6720006	0.1544112
GROSS_HYPOXIA_VIA_ELK3_UP	c2.CGP_ chemical and genetic perturbations	194	1.4131312	0.007050529	0.14719082	GROSS_HYPOXIA_VIA_ELK3_UP	196	1.128831	0.1993927	0.70693415	2.5419622	0.2843002
GO_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE	c5.BP_ GO biological process	17	1.4129931	0.067434214	0.14730157	GO_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE	19	-1.0270914	0.38990825	0.6450924	0.3859017	2.4400845
HOXA4_Q2	c3.TFT_ transcription factor targets	215	1.4129156	0.005767013	0.14732699	HOXA4_Q2	232	1.1603066	0.11859296	0.652115	2.5732222	0.252609
GO_REGULATION_OF_ERK1_AND_ERK2_CASCADE	c5.BP_ GO biological process	191	1.4128066	0.003500583	0.14741701	GO_REGULATION_OF_ERK1_AND_ERK2_CASCADE	201	1.2696425	0.036144577	0.4849781	2.6824491	0.1431641
THUM_SYSTOLIC_HEART_FAILURE_UP	c2.CGP_ chemical and genetic perturbations	349	1.4126923	0.002185792	0.14749019	THUM_SYSTOLIC_HEART_FAILURE_UP	357	1.0306547	0.4104104	0.87444043	2.443347	0.3820376
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	c2.CGP_ chemical and genetic perturbations	105	1.4126145	0.016905071	0.14752097	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	106	1.1689408	0.18568465	0.6390884	2.5815553	0.2436737
GO_FOREBRAIN_NEURON_DEVELOPMENT	c5.BP_ GO biological process	29	1.4125601	0.042521995	0.14751504	GO_FOREBRAIN_NEURON_DEVELOPMENT	33	1.3721002	0.06504065	0.3648882	2.7846603	0.0404599
GO_ENDODERM_FORMATION	c5.BP_ GO biological process	45	1.4125423	0.045845274	0.14746144	GO_ENDODERM_FORMATION	48	-0.94669145	0.54867256	0.76044315	0.46585085	2.35923375
GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP	C7_ immunologic signatures	163	1.4124974	0.010856453	0.1474446	GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP	173	0.81246936	0.87550604	1	2.22496676	0.60002804
GO_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	c5.BP_ GO biological process	116	1.4122802	0.015384615	0.14764893	GO_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	119	0.9407987	0.6291322	0.9897586	2.3530789	0.4714815
GO_SUBPALLIUM_DEVELOPMENT	c5.BP_ GO biological process	20	1.4120667	0.08082409	0.14785388	GO_SUBPALLIUM_DEVELOPMENT	22	-0.9667486	0.5163044	0.73386073	0.4453181	2.3788153
GO_DIENCEPHALON_DEVELOPMENT	c5.BP_ GO biological process	66	1.411928	0.04155496	0.14795408	GO_DIENCEPHALON_DEVELOPMENT	73	-1.407128	0.025316456	0.2017254	0.0048	2.819056
GO_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY	c5.BP_ GO biological process	55	1.411886	0.046176046	0.14793204	GO_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY	57	1.2058927	0.18161435	0.58188987	2.6177787	0.2059933
GSE40273_EOS_KO_VS_WT_TREG_DN	C7_ immunologic signatures	174	1.4118683	0.005868545	0.14787647	GSE40273_EOS_KO_VS_WT_TREG_DN	178	1.0665643	0.34282807	0.8116765	2.4784326	0.345304
GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	152	1.4118676	0.011792453	0.14779967	GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	153	1.3496757	0.015384615	0.38268378	2.7615433	0.0621919
CHR17Q22	C1: positional gene sets	20	1.4116257	0.06803797	0.14807019	CHR17Q22	27	-0.6251629	0.97159094	0.9805767	0.7864628	2.0367886
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP	C7_ immunologic signatures	155	1.4114987	0.006097561	0.14817254	GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP	158	1.5037174	0	0.24933556	2.9152161	-0.0922187
GO_ADULT_LOCOMOTORY_BEHAVIOR	c5.BP_ GO biological process	73	1.4114794	0.025032938	0.14812924	GO_ADULT_LOCOMOTORY_BEHAVIOR	78	1.0880835	0.35070574	0.77380526	2.4995629	0.3233959
XU_AKT1_TARGETS_6HR	c2.CGP_ chemical and genetic perturbations	20	1.4113197	0.058359623	0.14827143	XU_AKT1_TARGETS_6HR	21	1.1658562	0.26199263	0.64603335	2.5771759	0.2454635
VANHARANTA_UTERINE_FIBROID_UP	c2.CGP_ chemical and genetic perturbations	40	1.4112765	0.045911048	0.14825971	VANHARANTA_UTERINE_FIBROID_UP	41	1.2122815	0.18591224	0.5739386	2.623558	0.198995
HELLER_HDAC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	261	1.4112746	0	0.14818542	HELLER_HDAC_TARGETS_UP	264	1.2112755	0.05115346	0.57590026	2.6225501	0.1999991
GO_REGULATION_OF_ACTION_POTENTIAL	c5.BP_ GO biological process	33	1.4112442	0.05882353	0.14815454	GO_REGULATION_OF_ACTION_POTENTIAL	35	1.426282	0.039488968	0.31823632	2.8375262	-0.0150378
GO_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	31	1.4112023	0.055954088	0.14813992	GO_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT	31	-0.9066599	0.65363127	0.8138067	0.5045424	2.3178622
GCAAGAC_MIR431	c3.MIR_ microRNA targets	39	1.4111656	0.039881833	0.14810957	GCAAGAC_MIR431	41	1.0916032	0.35894495	0.76998556	2.5027688	0.3195624
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN	C7_ immunologic signatures	178	1.4111223	0.010714286	0.14809453	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN	179	1.2059137	0.10212336	0.58198005	2.617036	0.2052086
GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP	C7_ immunologic signatures	168	1.4108166	0.012135922	0.14844564	GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP	172	1.1854376	0.114519425	0.613965	2.5962542	0.225379
FREAC7_01	c3.TFT_ transcription factor targets	155	1.410759	0.009456265	0.1484378	FREAC7_01	162	1.1847901	0.12854251	0.61441207	2.5955491	0.2259689
GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN	C7_ immunologic signatures	166	1.4106958	0.008343265	0.14845107	GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN	166	1.0707257	0.3438134	0.80404466	2.4814215	0.3399701
GO_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	c5.BP_ GO biological process	62	1.4106102	0.029972753	0.14850073	GO_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	64	0.68046284	0.94279426	1	2.09107304	0.73014736
SERVITJA_LIVER_HNF1A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	124	1.4105984	0.020050125	0.14843892	SERVITJA_LIVER_HNF1A_TARGETS_UP	123	1.275425	0.06867846	0.4793946	2.6860234	0.1351734
GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	C7_ immunologic signatures	179	1.4105014	0.012033694	0.14848192	GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	179	1.2150973	0.08510638	0.5665634	2.6255987	0.1954041
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN	C7_ immunologic signatures	128	1.410439	0.013732834	0.14848919	GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN	138	1.0898533	0.30337077	0.771291	2.5002923	0.3205857
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN	C7_ immunologic signatures	131	1.4101895	0.012547052	0.14875442	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN	133	0.9488951	0.59856266	0.98334265	2.3590846	0.4612944
GO_KINASE_INHIBITOR_ACTIVITY	c5.GO molecular function	82	1.4101387	0.027777778	0.14873902	GO_KINASE_INHIBITOR_ACTIVITY	84	0.76954204	0.86595744	1	2.17968074	0.64059666
GO_NEGATIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS	c5.BP_ GO biological process	477	1.4098496	0	0.14905737	GO_NEGATIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS	495	1.003749	0.475	0.91738313	2.4135986	0.4061006
GSE27786_LSK_VS_ERYTHROBLAST_DN	C7_ immunologic signatures	156	1.4098265	0.011904762	0.14900813	GSE27786_LSK_VS_ERYTHROBLAST_DN	168	1.2515393	0.060728744	0.5090182	2.6613658	0.1582872
GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN	C7_ immunologic signatures	181	1.409698	0.011947432	0.14912653	GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN	179	0.8879331	0.76185673	1	2.2976311	0.5217649
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN	C7_ immunologic signatures	181	1.40955	0.003516999	0.14925209	GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN	182	1.2671503	0.046700507	0.4881964	2.6767003	0.1423997
GO_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY	c5.BP_ GO biological process	58	1.4095432	0.047106326	0.14918528	GO_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY	61	1.0617316	0.39845476	0.8202045	2.4712748	0.3478116
GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP	C7_ immunologic signatures	150	1.4094094	0.012531328	0.14928104	GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP	150	1.3538895	0.013278856	0.38261744	2.7632989	0.0555199
GO_REGULATION_OF_AMINE_TRANSPORT	c5.BP_ GO biological process	52	1.4093475	0.043356642	0.14929341	GO_REGULATION_OF_AMINE_TRANSPORT	62	1.4984764	0.004329004	0.2540091	2.9078239	-0.0891289
GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN	C7_ immunologic signatures	165	1.4093251	0.011042945	0.1492525	GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN	165	0.96790797	0.5661538	0.96384114	2.37723307	0.44141713
GO_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS	c5.BP_ GO biological process	108	1.4091926	0.014981274	0.14934906	GO_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS	112	1.1047943	0.280829	0.7475153	2.5139869	0.3043983
GO_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION	c5.BP_ GO biological process	24	1.4089682	0.06800618	0.1495964	GO_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION	26	1.01633	0.47400242	0.8950216	2.4252982	0.3926382
GO_RESPONSE_TO_PROSTAGLANDIN_E	c5.BP_ GO biological process	20	1.4089061	0.07073955	0.14959338	GO_RESPONSE_TO_PROSTAGLANDIN_E	25	0.9660517	0.55583125	0.9650123	2.3749578	0.4428544
GO_RESPONSE_TO_LEPTIN	c5.BP_ GO biological process	18	1.4088585	0.07255521	0.14957723	GO_RESPONSE_TO_LEPTIN	19	0.9148925	0.6007557	1	2.323751	0.493966
GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN	C7_ immunologic signatures	185	1.4088278	0.005793743	0.14954706	GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN	185	1.0230944	0.44838056	0.8868196	2.4319222	0.3857334
GO_FEEDING_BEHAVIOR	c5.BP_ GO biological process	65	1.4083952	0.030585106	0.15007707	GO_FEEDING_BEHAVIOR	80	-1.1048746	0.27941176	0.5098416	0.3035206	2.5132698
GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP	C7_ immunologic signatures	111	1.4080403	0.020910209	0.15051076	GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP	124	-1.2692704	0	0.3097833	0.1387699	2.6773107
GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE	c5.BP_ GO biological process	68	1.4079729	0.044715445	0.15052032	GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE	68	0.8501804	0.74702704	1	2.2581533	0.5577925
ST_WNT_BETA_CATENIN_PATHWAY	c2.CP_ Canonical pathways	33	1.4079429	0.045925926	0.15048239	ST_WNT_BETA_CATENIN_PATHWAY	33	-0.66247225	0.97619045	0.9735485	0.74547065	2.07041515
GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	C7_ immunologic signatures	179	1.4077115	0.007168459	0.15074137	GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	178	0.77531946	0.9173387	1	2.18303096	0.63239204
GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_UP	C7_ immunologic signatures	172	1.4075087	0.010514019	0.15094802	GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_UP	172	0.77979106	0.90909094	1	2.18729976	0.62771764
GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP	C7_ immunologic signatures	107	1.407277	0.029908972	0.15117423	GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP	112	1.3654	0.028008299	0.37198585	2.772677	0.041877
SUBTIL_PROGESTIN_TARGETS	c2.CGP_ chemical and genetic perturbations	35	1.4072766	0.058479533	0.15109876	SUBTIL_PROGESTIN_TARGETS	35	0.8791133	0.66976744	1	2.2863899	0.5281633
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	c2.CGP_ chemical and genetic perturbations	148	1.406935	0.013365735	0.15147726	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	153	0.7784821	0.90091	1	2.1854171	0.6284529
GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN	C7_ immunologic signatures	181	1.4068304	0.003409091	0.1515328	GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN	180	0.97798896	0.5592705	0.9516239	2.38481936	0.42884144
VALK_AML_WITH_FLT3_ITD	c2.CGP_ chemical and genetic perturbations	34	1.4068129	0.046224963	0.15148386	VALK_AML_WITH_FLT3_ITD	35	1.1908337	0.22716628	0.6041657	2.5976466	0.2159792
GO_DNA_CONFORMATION_CHANGE	c5.BP_ GO biological process	201	1.4066081	0.006960557	0.15169093	GO_DNA_CONFORMATION_CHANGE	203	0.7750874	0.9283552	1	2.1816955	0.6315207
VALK_AML_CLUSTER_9	c2.CGP_ chemical and genetic perturbations	32	1.4065056	0.05882353	0.15175976	VALK_AML_CLUSTER_9	33	-0.9925174	0.4551282	0.69953877	0.4139882	2.399023
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	c2.CP_REACTOME_ Reactome gene sets	17	1.4064238	0.09134615	0.15178852	REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	17	0.80918884	0.72955143	1	2.21561264	0.59723496
TGGNNNNNNKCCAR_UNKNOWN	c3.TFT_ transcription factor targets	360	1.4062035	0.004329004	0.15199085	TGGNNNNNNKCCAR_UNKNOWN	374	1.0999995	0.19	0.75703096	2.506203	0.306204
AP4_Q5	c3.TFT_ transcription factor targets	231	1.4061536	0.002239642	0.15197656	AP4_Q5	234	1.1862416	0.09327984	0.61305356	2.5923952	0.219912
CACCAGC_MIR138	c3.MIR_ microRNA targets	202	1.406117	0.007125891	0.15194052	CACCAGC_MIR138	204	0.8274056	0.8718466	1	2.2335226	0.5787114
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	C7_ immunologic signatures	181	1.4060781	0.004807693	0.1519127	GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	183	0.91384494	0.71428573	1	2.31992304	0.49223316
GO_NEGATIVE_CHEMOTAXIS	c5.BP_ GO biological process	39	1.406076	0.04906205	0.15183826	GO_NEGATIVE_CHEMOTAXIS	39	0.8986141	0.63340807	1	2.3046901	0.5074619
MASSARWEH_TAMOXIFEN_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	488	1.4059855	0.001042753	0.15187067	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	495	1.2565995	0.003	0.50090015	2.662585	0.149386
GO_RESPONSE_TO_KETONE	c5.BP_ GO biological process	162	1.405967	0.004914005	0.15181655	GO_RESPONSE_TO_KETONE	168	0.98442453	0.5289929	0.9420259	2.39039153	0.42154247
CHR11Q21	C1: positional gene sets	26	1.4058999	0.05808477	0.1518447	CHR11Q21	30	0.8274883	0.72727275	1	2.2333882	0.5784116
PID_INTEGRIN3_PATHWAY	c2.CP_ Canonical pathways	41	1.40574	0.04657933	0.15199377	PID_INTEGRIN3_PATHWAY	42	1.4987174	0.012775842	0.25393885	2.9044574	-0.0929774
GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP	C7_ immunologic signatures	174	1.4057235	0.01048951	0.1519382	GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP	175	0.8443961	0.8262195	1	2.2501196	0.5613274
GO_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	c5.BP_ GO biological process	380	1.4056902	0.002157497	0.1519115	GO_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	390	0.95306534	0.657	0.9780496	2.35875554	0.45262486
GO_SCAVENGER_RECEPTOR_ACTIVITY	c5.GO molecular function	32	1.4055449	0.045454547	0.1520542	GO_SCAVENGER_RECEPTOR_ACTIVITY	33	1.5433657	0.013033175	0.21005791	2.9489106	-0.1378208
REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA	c2.CP_REACTOME_ Reactome gene sets	22	1.4054579	0.06069803	0.15209076	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA	22	1.1305923	0.32627645	0.70604086	2.5360502	0.2748656
GO_HEART_DEVELOPMENT	c5.BP_ GO biological process	424	1.4052495	0.001070664	0.15228583	GO_HEART_DEVELOPMENT	440	1.0310372	0.4044044	0.87443274	2.4362867	0.3742123
REACTOME_DNA_STRAND_ELONGATION	c2.CP_REACTOME_ Reactome gene sets	29	1.4049863	0.040723983	0.152565	REACTOME_DNA_STRAND_ELONGATION	29	-2.1556597	0	0.001426018	-0.7506734	3.560646
GO_AMEBOIDAL_TYPE_CELL_MIGRATION	c5.BP_ GO biological process	136	1.4048163	0.014723927	0.15272647	GO_AMEBOIDAL_TYPE_CELL_MIGRATION	147	0.9053723	0.7030612	1	2.3101886	0.499444
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	c2.CGP_ chemical and genetic perturbations	69	1.4047508	0.032388665	0.15272722	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	71	0.9977282	0.4950495	0.9258938	2.402479	0.4070226
GO_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS	c5.BP_ GO biological process	62	1.4045945	0.04689655	0.15287715	GO_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS	67	1.2216021	0.16286644	0.55384475	2.6261966	0.1829924
GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP	C7_ immunologic signatures	178	1.4044935	0.006045949	0.15292974	GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP	183	0.97940654	0.5475708	0.95041263	2.38390004	0.42508696
GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN	C7_ immunologic signatures	173	1.404218	0.004778972	0.1532514	GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN	178	0.6878646	0.9807497	1	2.0920826	0.7163534
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN	C7_ immunologic signatures	151	1.4041402	0.010935602	0.15327379	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN	164	1.4785011	0.001014199	0.26960883	2.8826413	-0.0743609
MIKKELSEN_ES_HCP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	32	1.404135	0.04447853	0.15320261	MIKKELSEN_ES_HCP_WITH_H3K27ME3	35	1.4346639	0.044970416	0.31134632	2.8387989	-0.0305289
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP	C7_ immunologic signatures	184	1.4040883	0.007185629	0.15319304	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP	189	0.67227536	0.9818182	1	2.07636366	0.73181294
YRCCAKNNGNCGC_UNKNOWN	c3.TFT_ transcription factor targets	56	1.4038951	0.047945205	0.15339561	YRCCAKNNGNCGC_UNKNOWN	57	0.99885803	0.49385476	0.92474306	2.40275313	0.40503707
GSE39556_CD8A_DC_VS_NK_CELL_UP	C7_ immunologic signatures	181	1.4037949	0.004744959	0.15346128	GSE39556_CD8A_DC_VS_NK_CELL_UP	185	1.2049114	0.08888889	0.58248913	2.6087063	0.1988835
MODULE_196	c4.CM_ cancer modules	23	1.4037747	0.063467495	0.15341587	MODULE_196	23	1.5486901	0.023255814	0.20684272	2.9524648	-0.1449154
GO_PROTEIN_K11_LINKED_UBIQUITINATION	c5.BP_ GO biological process	23	1.4037648	0.075968996	0.15335576	GO_PROTEIN_K11_LINKED_UBIQUITINATION	23	0.9227296	0.59222084	1	2.3264944	0.4810352
GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN	C7_ immunologic signatures	180	1.4037058	0.007017544	0.15335712	GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN	181	1.0200946	0.4479272	0.89143384	2.4238004	0.3836112
GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP	C7_ immunologic signatures	108	1.4035726	0.023316063	0.15346535	GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP	115	0.8440307	0.79710144	1	2.2476033	0.5595419
GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	168	1.4034278	0.009478673	0.15358302	GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN	174	1.2835145	0.03340081	0.4670636	2.6869423	0.1199133
TACAATC_MIR508	c3.MIR_ microRNA targets	57	1.4033569	0.033850495	0.1536042	TACAATC_MIR508	57	-1.1265875	0.20731707	0.47704908	0.2767694	2.5299444
MANALO_HYPOXIA_UP	c2.CGP_ chemical and genetic perturbations	192	1.403251	0.011778563	0.15367128	MANALO_HYPOXIA_UP	192	1.4179341	0	0.32030755	2.8211851	-0.0146831
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN	C7_ immunologic signatures	165	1.4031025	0.008343265	0.15381004	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN	167	1.1686226	0.15314402	0.63913757	2.5717251	0.2344799
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	c2.CP_REACTOME_ Reactome gene sets	69	1.4029765	0.033195022	0.15390788	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	69	1.1149863	0.30387932	0.73054874	2.5179628	0.2879902
GSE45365_NK_CELL_VS_CD8_TCELL_UP	C7_ immunologic signatures	137	1.402834	0.009708738	0.15404029	GSE45365_NK_CELL_VS_CD8_TCELL_UP	141	1.2220901	0.10429448	0.55326307	2.6249241	0.1807439
HUANG_DASATINIB_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	71	1.4028212	0.04353562	0.15399012	HUANG_DASATINIB_RESISTANCE_UP	72	1.4199245	0.019396551	0.31912136	2.8227457	-0.0171033
GO_EPIDERMAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	99	1.4028211	0.023690773	0.1539125	GO_EPIDERMAL_CELL_DIFFERENTIATION	101	0.9599996	0.57591623	0.97121847	2.3628207	0.4428215
GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN	C7_ immunologic signatures	137	1.402801	0.018072288	0.15386528	GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN	143	1.011461	0.47433266	0.9043666	2.414262	0.39134
GO_SOMITOGENESIS	c5.BP_ GO biological process	56	1.4022782	0.031855956	0.15449545	GO_SOMITOGENESIS	60	-0.94206095	0.5	0.76600283	0.46021725	2.34433915
GSE12366_GC_VS_MEMORY_BCELL_DN	C7_ immunologic signatures	165	1.4022181	0.014251782	0.15450431	GSE12366_GC_VS_MEMORY_BCELL_DN	171	1.1451776	0.2034588	0.67868865	2.5473957	0.2570405
GO_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION	c5.BP_ GO biological process	37	1.4021403	0.061516453	0.15453056	GO_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION	39	1.0773633	0.3722026	0.79266495	2.4795036	0.324777
GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN	C7_ immunologic signatures	177	1.4019204	0.010550996	0.15474351	GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN	180	1.224947	0.06955645	0.54920787	2.6268674	0.1769734
GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN	C7_ immunologic signatures	163	1.4018495	0.013095238	0.1547606	GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN	164	-1.1689053	0	0.41831368	0.2329442	2.5707548
NIELSEN_SYNOVIAL_SARCOMA_UP	c2.CGP_ chemical and genetic perturbations	16	1.4016871	0.07949126	0.15492165	NIELSEN_SYNOVIAL_SARCOMA_UP	17	1.411805	0.060927153	0.32344234	2.8134921	-0.0101179
GO_REGULATION_OF_MEMBRANE_POTENTIAL	c5.BP_ GO biological process	290	1.4016709	0.00443459	0.15486602	GO_REGULATION_OF_MEMBRANE_POTENTIAL	313	1.3163385	0.002002002	0.4160857	2.7180094	0.0853324
ATAAGCT_MIR21	c3.MIR_ microRNA targets	104	1.4015636	0.024265645	0.15494154	ATAAGCT_MIR21	104	0.7213583	0.9192872	1	2.1229219	0.6802053
GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP	C7_ immunologic signatures	187	1.4015435	0.008235294	0.1548921	GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP	186	0.8381308	0.8429003	1	2.2396743	0.5634127
GO_SEGMENT_SPECIFICATION	c5.BP_ GO biological process	15	1.4012369	0.083333336	0.15526703	GO_SEGMENT_SPECIFICATION	17	-1.3571641	0.11814346	0.23614089	0.0440728	2.758401
DCA_UP.V1_UP	C6_ oncogenic signatures	143	1.4008833	0.016666668	0.15567927	DCA_UP.V1_UP	151	1.3052887	0.025458248	0.43407413	2.706172	0.0955946
BIOCARTA_ACH_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	1.400828	0.090614885	0.1556822	BIOCARTA_ACH_PATHWAY	16	1.231185	0.20546164	0.5382041	2.632013	0.169643
WILCOX_RESPONSE_TO_PROGESTERONE_UP	c2.CGP_ chemical and genetic perturbations	130	1.4007065	0.0125	0.15576878	WILCOX_RESPONSE_TO_PROGESTERONE_UP	129	1.0848914	0.3190184	0.777427	2.4855979	0.3158151
BILD_E2F3_ONCOGENIC_SIGNATURE	c2.CGP_ chemical and genetic perturbations	211	1.4007012	0.003468208	0.15569699	BILD_E2F3_ONCOGENIC_SIGNATURE	214	-1.387211	0	0.21521412	0.0134902	2.7879122
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN	C7_ immunologic signatures	182	1.4005823	0.005868545	0.15578821	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN	181	0.95656866	0.6048632	0.9750664	2.35715096	0.44401364
GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP	C7_ immunologic signatures	156	1.4005325	0.00969697	0.15577282	GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP	160	1.2409487	0.06376518	0.5242307	2.6414812	0.1595838
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	c2.CP_REACTOME_ Reactome gene sets	23	1.4002624	0.06163328	0.15607804	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	23	0.72308743	0.8483354	1	2.12334983	0.67717497
GO_SKELETAL_SYSTEM_MORPHOGENESIS	c5.BP_ GO biological process	182	1.400189	0.00117096	0.15609765	GO_SKELETAL_SYSTEM_MORPHOGENESIS	192	0.99843997	0.51004016	0.9253657	2.39862897	0.40174903
GO_MESENCHYME_DEVELOPMENT	c5.BP_ GO biological process	167	1.3997263	0.013189448	0.1566593	GO_MESENCHYME_DEVELOPMENT	178	-1.316166	0	0.26992205	0.0835603	2.7158923
GO_FIBRIL_ORGANIZATION	c5.BP_ GO biological process	18	1.3996419	0.086124405	0.15669647	GO_FIBRIL_ORGANIZATION	18	1.2663456	0.17529881	0.48906234	2.6659875	0.1332963
MODULE_19	c4.CM_ cancer modules	278	1.3996247	0.002232143	0.1566446	MODULE_19	289	1.0040007	0.5	0.917102	2.4036254	0.395624
GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN	C7_ immunologic signatures	158	1.3995119	0.016990291	0.15671268	GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN	166	1.1116599	0.24847251	0.7350516	2.5111718	0.287852
GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	C7_ immunologic signatures	171	1.3994759	0.007067138	0.1566903	GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	181	0.7710756	0.925813	1	2.1705515	0.6284003
CHR5Q12	C1: positional gene sets	31	1.3994391	0.075	0.15666792	CHR5Q12	32	0.9782536	0.5085784	0.9518965	2.3776927	0.4211855
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	c2.CGP_ chemical and genetic perturbations	35	1.3993834	0.06746627	0.15667418	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	37	-1.9863812	0	0.009291896	-0.5869978	3.3857646
PID_ENDOTHELIN_PATHWAY	c2.CP_ Canonical pathways	56	1.3993227	0.051282052	0.15668175	PID_ENDOTHELIN_PATHWAY	60	1.4641699	0.015538291	0.28255546	2.8634926	-0.0648472
CAATGCA_MIR33	c3.MIR_ microRNA targets	86	1.3991954	0.03267974	0.15678416	CAATGCA_MIR33	86	0.97985137	0.5395299	0.9500163	2.37904677	0.41934403
SRF_Q4	c3.TFT_ transcription factor targets	201	1.3990393	0.012542759	0.15693592	SRF_Q4	206	0.87105334	0.80404043	1	2.27009264	0.52798596
GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP	C7_ immunologic signatures	108	1.3988314	0.022164276	0.15714175	GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP	123	1.3902962	0.019730011	0.3454424	2.7891276	0.0085352
CHR3P25	C1: positional gene sets	59	1.3987006	0.03971631	0.15724277	CHR3P25	61	0.6941856	0.9350935	1	2.0928862	0.704515
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	c2.CGP_ chemical and genetic perturbations	41	1.3985772	0.047965117	0.15734236	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	45	1.1105535	0.3118527	0.7366952	2.5091307	0.2880237
GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	393	1.3982695	0.001070664	0.15769343	GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION	405	1.0153737	0.444	0.8963524	2.4136432	0.3828958
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP	C7_ immunologic signatures	158	1.3981955	0.013253012	0.15771721	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP	161	1.3398359	0.012170386	0.3966289	2.7380314	0.0583596
GO_EPITHELIAL_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	25	1.3980061	0.071539655	0.15790765	GO_EPITHELIAL_CELL_APOPTOTIC_PROCESS	25	1.2474546	0.16645807	0.515244	2.6454607	0.1505515
SRF_Q5_01	c3.TFT_ transcription factor targets	195	1.3979919	0.011682243	0.15785366	SRF_Q5_01	198	0.77445394	0.9262626	1	2.17244584	0.62353796
GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE	c5.BP_ GO biological process	65	1.3979753	0.03133515	0.15780155	GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE	74	1.3977463	0.03655914	0.34512663	2.7957216	0.000229
GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	C7_ immunologic signatures	177	1.3978842	0.013349514	0.15783545	GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	181	0.62188685	0.99697274	1	2.01977105	0.77599735
CHR2Q36	C1: positional gene sets	33	1.397848	0.052388288	0.15780579	CHR2Q36	34	-1.0055772	0.43209878	0.6765948	0.3922708	2.4034252
AGGAAGC_MIR5163P	c3.MIR_ microRNA targets	103	1.3978251	0.023809524	0.15775518	AGGAAGC_MIR5163P	106	0.94910514	0.6213389	0.98319334	2.34693024	0.44871996
GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	182	1.3978173	0.005882353	0.1576898	GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	185	1.2498014	0.05177665	0.51150227	2.6476187	0.1480159
WANG_LSD1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	33	1.3977902	0.06306306	0.15765837	WANG_LSD1_TARGETS_DN	37	1.3708289	0.06674473	0.36700633	2.7686191	0.0269613
GO_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	c5.BP_ GO biological process	424	1.3976535	0.001072961	0.15776928	GO_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	434	1.1166517	0.136	0.72846526	2.5143052	0.2810018
MEIS1BHOXA9_01	c3.TFT_ transcription factor targets	119	1.3976419	0.022222223	0.15770495	MEIS1BHOXA9_01	128	1.0554559	0.3831102	0.8322286	2.4530978	0.342186
SASSON_RESPONSE_TO_FORSKOLIN_DN	c2.CGP_ chemical and genetic perturbations	83	1.3976208	0.027559055	0.1576545	SASSON_RESPONSE_TO_FORSKOLIN_DN	83	1.049465	0.40405118	0.8412993	2.4470858	0.3481558
GSE3982_BCELL_VS_TH1_DN	C7_ immunologic signatures	174	1.3976159	0.013253012	0.15758608	GSE3982_BCELL_VS_TH1_DN	175	1.0723068	0.33502537	0.80224186	2.4699227	0.3253091
GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP	C7_ immunologic signatures	177	1.3975357	0.009512485	0.15761627	GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP	180	0.8770797	0.78083587	1	2.2746154	0.520456
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	c2.CGP_ chemical and genetic perturbations	383	1.3974549	0.001067236	0.1576588	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	387	1.2659976	0.009	0.49007747	2.6634525	0.1314573
REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE	c2.CP_REACTOME_ Reactome gene sets	24	1.39728	0.072072074	0.15780865	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE	24	1.1799463	0.2503098	0.62361467	2.5772263	0.2173337
PETRETTO_CARDIAC_HYPERTROPHY	c2.CGP_ chemical and genetic perturbations	33	1.3970466	0.05029586	0.15805814	PETRETTO_CARDIAC_HYPERTROPHY	33	0.78845435	0.7911165	1	2.18550095	0.60859225
ELVIDGE_HYPOXIA_UP	c2.CGP_ chemical and genetic perturbations	162	1.3970344	0.013268999	0.1580003	ELVIDGE_HYPOXIA_UP	163	1.3049307	0.022132797	0.43370834	2.7019651	0.0921037
HUTTMANN_B_CLL_POOR_SURVIVAL_UP	c2.CGP_ chemical and genetic perturbations	236	1.3969076	0.007990868	0.15811235	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	240	1.1717836	0.11511511	0.6348739	2.5686912	0.225124
MORF_TNFRSF25	c4.CGN_ cancer gene neighborhoods	211	1.396779	0.002339181	0.1582123	MORF_TNFRSF25	231	1.1577734	0.15245737	0.6577704	2.5545524	0.2390056
GO_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	38	1.3967416	0.057636887	0.15819333	GO_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY	39	1.4911062	0.011918951	0.2584991	2.8878478	-0.0943646
GO_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS	c5.BP_ GO biological process	18	1.3967079	0.08794788	0.15817112	GO_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS	19	0.76692396	0.78293604	1	2.16363186	0.62978394
GSE12366_GC_VS_NAIVE_BCELL_UP	C7_ immunologic signatures	166	1.3966659	0.016568048	0.15816171	GSE12366_GC_VS_NAIVE_BCELL_UP	169	-1.3256047	0	0.26078027	0.0710612	2.7222706
RORA2_01	c3.TFT_ transcription factor targets	128	1.3965805	0.017654477	0.15820202	RORA2_01	131	0.6539047	0.9814815	1	2.0504852	0.7426758
HALLMARK_SPERMATOGENESIS	H_ hallmark gene sets	119	1.3964255	0.016331658	0.1583344	HALLMARK_SPERMATOGENESIS	124	1.1079689	0.27450982	0.74125195	2.5043944	0.2884566
ROZANOV_MMP14_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	228	1.3961288	0.004581902	0.15866351	ROZANOV_MMP14_TARGETS_UP	238	1.2539427	0.03517588	0.5030797	2.6500715	0.1421861
GO_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE	c5.BP_ GO biological process	91	1.3960508	0.02457956	0.15869845	GO_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE	98	1.068979	0.34823284	0.8072937	2.4650298	0.3270718
GO_POSITIVE_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	21	1.3960462	0.0796875	0.15863003	GO_POSITIVE_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS	22	1.3284307	0.10920245	0.40398479	2.7244769	0.0676155
GSE7831_1H_VS_4H_CPG_STIM_PDC_DN	C7_ immunologic signatures	170	1.395934	0.011709602	0.15872516	GSE7831_1H_VS_4H_CPG_STIM_PDC_DN	180	1.1707927	0.13272543	0.637145	2.5667267	0.2251413
GO_REGULATION_OF_DEVELOPMENTAL_GROWTH	c5.BP_ GO biological process	262	1.3958695	0.007909604	0.15873845	GO_REGULATION_OF_DEVELOPMENTAL_GROWTH	275	1.1061534	0.21042085	0.7447349	2.5020229	0.2897161
GO_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS	c5.BP_ GO biological process	17	1.3958513	0.07903226	0.15868667	GO_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS	21	-0.9345779	0.5753425	0.7788279	0.4612734	2.3304292
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	c2.CGP_ chemical and genetic perturbations	148	1.3954699	0.017094018	0.1591705	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	150	1.2060297	0.10851927	0.58244807	2.6014996	0.1894402
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	c2.CGP_ chemical and genetic perturbations	122	1.3953948	0.02252816	0.15920432	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	122	0.6306061	0.99590164	1	2.0260009	0.7647887
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	C7_ immunologic signatures	146	1.3952283	0.011806375	0.15936084	GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	148	1.2866585	0.040123455	0.46209064	2.6818868	0.1085698
GO_MICROTUBULE_NUCLEATION	c5.BP_ GO biological process	18	1.395078	0.087692305	0.15950115	GO_MICROTUBULE_NUCLEATION	18	0.77501667	0.7872611	1	2.17009467	0.62006133
GO_CALCIUM_CHANNEL_COMPLEX	c5.CC_ GO cellular component	52	1.3950449	0.049723756	0.15946278	GO_CALCIUM_CHANNEL_COMPLEX	53	1.4236367	0.025641026	0.31784356	2.8186816	-0.0285918
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	c2.CGP_ chemical and genetic perturbations	22	1.3948964	0.07028754	0.15961207	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	22	1.2860847	0.14727722	0.4629621	2.6809811	0.1088117
KEGG_GAP_JUNCTION	c2.CP_BIOCARTA_ BioCarta gene sets	79	1.394866	0.035567716	0.15957783	KEGG_GAP_JUNCTION	82	1.3755891	0.029787235	0.35714155	2.7704551	0.0192769
GO_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT	c5.BP_ GO biological process	380	1.394815	0.001083424	0.15957466	GO_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT	391	1.0595586	0.312	0.82546717	2.4543736	0.3352564
REACTOME_MITOTIC_G1_G1_S_PHASES	c2.CP_REACTOME_ Reactome gene sets	124	1.3947045	0.016229713	0.15964745	REACTOME_MITOTIC_G1_G1_S_PHASES	124	-1.8522576	0	0.024469648	-0.4575531	3.2469621
GO_CAMP_MEDIATED_SIGNALING	c5.BP_ GO biological process	33	1.3942538	0.061443932	0.16022398	GO_CAMP_MEDIATED_SIGNALING	34	1.1139519	0.31272295	0.7319745	2.5082057	0.2803019
LANDIS_ERBB2_BREAST_TUMORS_65_DN	c2.CGP_ chemical and genetic perturbations	35	1.3942066	0.045454547	0.1602132	LANDIS_ERBB2_BREAST_TUMORS_65_DN	35	1.0675962	0.37367803	0.8097796	2.4618028	0.3266104
SU_TESTIS	c2.CGP_ chemical and genetic perturbations	62	1.3941724	0.031811897	0.16018058	SU_TESTIS	65	1.1380031	0.25350595	0.6937893	2.5321755	0.2561693
GO_PML_BODY	c5.CC_ GO cellular component	90	1.394081	0.031168832	0.16024244	GO_PML_BODY	90	-1.0188445	0.3220339	0.6615172	0.3752365	2.4129255
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	c2.CGP_ chemical and genetic perturbations	24	1.393918	0.06864274	0.16040596	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	27	1.2359152	0.19782871	0.5319094	2.6298332	0.1580028
GO_SYNAPTIC_SIGNALING	c5.BP_ GO biological process	356	1.3938733	0.002150538	0.16040426	GO_SYNAPTIC_SIGNALING	388	1.2217542	0.022022022	0.55374694	2.6156275	0.1721191
GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	181	1.3938676	0.007025761	0.16033748	GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	181	-0.87077487	0.8888889	0.8542251	0.52309273	2.26464247
GO_NEGATIVE_REGULATION_OF_ION_TRANSPORT	c5.BP_ GO biological process	95	1.393746	0.018543046	0.1604456	GO_NEGATIVE_REGULATION_OF_ION_TRANSPORT	110	1.3547943	0.024793388	0.38245392	2.7485403	0.0389517
GO_PDZ_DOMAIN_BINDING	c5.GO molecular function	82	1.393736	0.03629032	0.16038154	GO_PDZ_DOMAIN_BINDING	84	1.0861634	0.31517094	0.77569824	2.4798994	0.3075726
GSE37301_PRO_BCELL_VS_CD4_TCELL_DN	C7_ immunologic signatures	135	1.3936809	0.02238806	0.16038123	GSE37301_PRO_BCELL_VS_CD4_TCELL_DN	141	1.1165795	0.2545639	0.7286297	2.5102604	0.2771014
GSE4142_NAIVE_VS_MEMORY_BCELL_UP	C7_ immunologic signatures	168	1.3936704	0.014354067	0.1603173	GSE4142_NAIVE_VS_MEMORY_BCELL_UP	179	1.203822	0.10681587	0.5848153	2.5974924	0.1898484
GSE13547_WT_VS_ZFX_KO_BCELL_DN	C7_ immunologic signatures	152	1.3934844	0.013431014	0.16052483	GSE13547_WT_VS_ZFX_KO_BCELL_DN	153	-0.9786251	0.41666666	0.7155707	0.4148593	2.3721095
LTE2_UP.V1_DN	C6_ oncogenic signatures	162	1.3933684	0.008403362	0.16061747	LTE2_UP.V1_DN	164	1.1455033	0.18604651	0.6781878	2.5388717	0.2478651
GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN	C7_ immunologic signatures	177	1.3932568	0.011029412	0.16070001	GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN	177	1.1630788	0.16396761	0.6480868	2.5563356	0.230178
SASSON_RESPONSE_TO_GONADOTROPHINS_DN	c2.CGP_ chemical and genetic perturbations	82	1.3931158	0.03328895	0.16081938	SASSON_RESPONSE_TO_GONADOTROPHINS_DN	82	1.0851836	0.35325506	0.7770365	2.4782994	0.3079322
LE_NEURONAL_DIFFERENTIATION_UP	c2.CGP_ chemical and genetic perturbations	17	1.393112	0.08617886	0.16074589	LE_NEURONAL_DIFFERENTIATION_UP	17	1.318823	0.10857909	0.41273126	2.711935	0.074289
MAHADEVAN_IMATINIB_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	15	1.3927108	0.091362126	0.16127804	MAHADEVAN_IMATINIB_RESISTANCE_UP	17	1.6899072	0.00260078	0.08487349	3.082618	-0.2971964
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN	C7_ immunologic signatures	180	1.392634	0.005875441	0.16132127	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN	182	1.3254066	0.01510574	0.40662056	2.7180406	0.0672274
NKX25_02	c3.TFT_ transcription factor targets	209	1.3924912	0.006960557	0.16146779	NKX25_02	235	1.1691717	0.10721443	0.63929474	2.5616629	0.2233195
REACTOME_LAGGING_STRAND_SYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	18	1.3922299	0.09667195	0.16176097	REACTOME_LAGGING_STRAND_SYNTHESIS	18	-1.6922206	0.009009009	0.05814334	-0.2999907	3.0844505
SOX9_B1	c3.TFT_ transcription factor targets	215	1.392047	0.007990868	0.16195391	SOX9_B1	217	0.86299336	0.827447	1	2.25504036	0.52905364
ATGCAGT_MIR217	c3.MIR_ microRNA targets	103	1.3919847	0.030978935	0.1619669	ATGCAGT_MIR217	106	1.0469124	0.4010471	0.8449594	2.4388971	0.3450723
GO_REGULATION_OF_EXTENT_OF_CELL_GROWTH	c5.BP_ GO biological process	95	1.3918059	0.026560426	0.16215648	GO_REGULATION_OF_EXTENT_OF_CELL_GROWTH	97	0.8824379	0.7088204	1	2.2742438	0.509368
GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN	C7_ immunologic signatures	111	1.3915415	0.026992287	0.1624692	GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN	115	1.4225484	0.007284079	0.3176347	2.8140899	-0.0310069
KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	171	1.3913382	0.012672811	0.16268998	KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP	172	0.80141985	0.8975659	1	2.19275805	0.58991835
GO_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY	c5.GO molecular function	47	1.3913034	0.05050505	0.16266099	GO_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY	48	0.78435385	0.8133484	1	2.17565725	0.60694955
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	169	1.391181	0.012019231	0.16275197	GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	173	0.8638608	0.80928355	1	2.2550418	0.5273202
GO_REGULATION_OF_CALCINEURIN_NFAT_SIGNALING_CASCADE	c5.BP_ GO biological process	15	1.3910486	0.08866995	0.16286084	GO_REGULATION_OF_CALCINEURIN_NFAT_SIGNALING_CASCADE	16	1.300358	0.12231183	0.44145143	2.6914066	0.0906906
LEE_LIVER_CANCER_CIPROFIBRATE_UP	c2.CGP_ chemical and genetic perturbations	51	1.3910196	0.05203938	0.16282916	LEE_LIVER_CANCER_CIPROFIBRATE_UP	50	1.2673315	0.121145375	0.48812512	2.6583511	0.1236881
GSE28408_LY6G_POS_VS_NEG_DC_DN	C7_ immunologic signatures	171	1.3909289	0.013002364	0.16288127	GSE28408_LY6G_POS_VS_NEG_DC_DN	175	0.6447756	0.9898888	1	2.0357045	0.7461533
GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN	C7_ immunologic signatures	154	1.3907821	0.014475271	0.16300526	GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN	156	-1.0232441	0.3888889	0.6544386	0.367538	2.4140262
GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	171	1.3905914	0.014976959	0.16320117	GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	168	1.0279752	0.42857143	0.87963337	2.4185666	0.3626162
GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN	C7_ immunologic signatures	173	1.3904644	0.011848342	0.16329534	GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN	175	1.2510921	0.060790274	0.5089602	2.6415565	0.1393723
GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT	c5.BP_ GO biological process	34	1.3903149	0.055397727	0.16343556	GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT	41	1.2881199	0.12714776	0.46121415	2.6784348	0.102195
GO_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	171	1.3899409	0.012880562	0.16391344	GO_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT	186	1.3999038	0.006072875	0.34003076	2.7898447	-0.0099629
GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN	C7_ immunologic signatures	170	1.389932	0.009512485	0.16384995	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN	173	1.1535505	0.18375635	0.66249466	2.5434825	0.2363815
CHR4Q26	C1: positional gene sets	15	1.3898734	0.08934169	0.16384706	CHR4Q26	15	0.8451894	0.6989664	1	2.2350628	0.544684
MASSARWEH_RESPONSE_TO_ESTRADIOL	c2.CGP_ chemical and genetic perturbations	57	1.3897672	0.04539007	0.1639263	MASSARWEH_RESPONSE_TO_ESTRADIOL	56	1.0302107	0.43370786	0.87512314	2.4199779	0.3595565
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	177	1.3897123	0.010613208	0.16393365	GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	179	-1.3320439	0	0.25438058	0.0576684	2.7217562
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	c2.CGP_ chemical and genetic perturbations	182	1.3896611	0.009302326	0.16393343	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	197	1.1975116	0.086519115	0.59711266	2.5871727	0.1921495
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP	C7_ immunologic signatures	173	1.3895638	0.014084507	0.16398776	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP	182	0.96689504	0.5939086	0.9643772	2.35645884	0.42266876
GO_FOREBRAIN_DEVELOPMENT	c5.BP_ GO biological process	320	1.389259	0.002159827	0.16436845	GO_FOREBRAIN_DEVELOPMENT	345	0.88435817	0.837	1	2.27361717	0.50490083
GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP	C7_ immunologic signatures	139	1.3892565	0.013349514	0.1642924	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP	144	1.5892233	0	0.17440653	2.9784798	-0.1999668
GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP	C7_ immunologic signatures	168	1.3891517	0.016509434	0.16436675	GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP	172	1.0516669	0.38046795	0.83693886	2.4408186	0.3374848
GO_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS	c5.BP_ GO biological process	90	1.3889195	0.02464332	0.16462286	GO_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS	97	0.8403407	0.78229165	1	2.2292602	0.5485788
GO_CARTILAGE_DEVELOPMENT	c5.BP_ GO biological process	128	1.3888153	0.018564356	0.16469163	GO_CARTILAGE_DEVELOPMENT	136	-1.3472526	0	0.2436797	0.0415627	2.7360679
GO_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY	c5.BP_ GO biological process	37	1.388784	0.06110283	0.16466111	GO_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY	37	1.4154437	0.042431194	0.32213575	2.8042277	-0.0266597
PKCA_DN.V1_UP	C6_ oncogenic signatures	140	1.3885758	0.018382354	0.16488428	PKCA_DN.V1_UP	145	1.379745	0.013238289	0.3573136	2.7683208	0.0088308
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	174	1.3885045	0.014851485	0.1649002	GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN	182	1.0370986	0.41775984	0.86393005	2.4256031	0.3514059
GO_REGULATION_OF_AXONOGENESIS	c5.BP_ GO biological process	159	1.3884641	0.01641266	0.16488874	GO_REGULATION_OF_AXONOGENESIS	163	0.8836978	0.7568389	1	2.2721619	0.5047663
IVANOVSKA_MIR106B_TARGETS	c2.CGP_ chemical and genetic perturbations	82	1.3884455	0.03626943	0.16483818	IVANOVSKA_MIR106B_TARGETS	82	-1.0066513	0.44230768	0.67507666	0.3817942	2.3950968
GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR	c5.BP_ GO biological process	50	1.3883306	0.052478135	0.16493192	GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR	51	1.2297161	0.14350797	0.5414616	2.6180467	0.1586145
GO_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION	c5.BP_ GO biological process	62	1.3882861	0.04971591	0.16492821	GO_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION	63	1.2867988	0.10879121	0.46248662	2.6750849	0.1014873
GO_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT	c5.BP_ GO biological process	26	1.3882645	0.0761035	0.1648875	GO_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT	27	1.4252009	0.05548854	0.31826958	2.8134654	-0.0369364
GO_PLATELET_DEGRANULATION	c5.BP_ GO biological process	91	1.3882221	0.024390243	0.16487034	GO_PLATELET_DEGRANULATION	93	1.3858807	0.015822785	0.35048643	2.7741028	0.0023414
REACTOME_REGULATION_OF_INSULIN_SECRETION	c2.CP_REACTOME_ Reactome gene sets	76	1.3881376	0.03125	0.1649243	REACTOME_REGULATION_OF_INSULIN_SECRETION	85	1.0980853	0.31769723	0.7593979	2.4862229	0.2900523
GO_HEART_GROWTH	c5.BP_ GO biological process	22	1.3881058	0.06534954	0.16488889	GO_HEART_GROWTH	22	0.80909735	0.75252527	1	2.19720315	0.57900845
GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN	C7_ immunologic signatures	178	1.3880476	0.014268728	0.16489662	GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN	184	1.0381587	0.39430895	0.86162156	2.4262063	0.3498889
GO_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM	c5.BP_ GO biological process	132	1.387993	0.018518519	0.16490176	GO_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM	149	1.350841	0.00408998	0.3842263	2.738834	0.037152
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	c2.CP_BIOCARTA_ BioCarta gene sets	77	1.3879796	0.037711315	0.1648456	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	82	1.0859702	0.32302773	0.7762529	2.4739498	0.3020094
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	C7_ immunologic signatures	162	1.3879794	0.008383233	0.16476777	GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	164	-0.87491864	0.9285714	0.8491683	0.51306076	2.26289804
MODULE_130	c4.CM_ cancer modules	19	1.3879435	0.070336394	0.164741	MODULE_130	19	1.5599906	0.010638298	0.19736801	2.9479341	-0.1720471
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	166	1.3875408	0.012269938	0.1652771	GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN	166	1.1615747	0.17276423	0.65089405	2.5491155	0.2259661
BROWNE_HCMV_INFECTION_8HR_DN	c2.CGP_ chemical and genetic perturbations	43	1.3875192	0.057720058	0.16523682	BROWNE_HCMV_INFECTION_8HR_DN	43	1.1508272	0.2759009	0.6676705	2.5383464	0.236692
GO_SOMITE_DEVELOPMENT	c5.BP_ GO biological process	71	1.3874062	0.04138852	0.16532408	GO_SOMITE_DEVELOPMENT	75	-1.2709594	0.046153847	0.30880412	0.1164468	2.6583656
GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.BP_ GO biological process	26	1.3871619	0.07001522	0.16562769	GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	28	1.513157	0.018359853	0.23793365	2.9003189	-0.1259951
GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP	C7_ immunologic signatures	160	1.3871561	0.012315271	0.16556029	GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP	173	1.3042264	0.030456852	0.4346589	2.6913825	0.0829297
GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN	C7_ immunologic signatures	167	1.3870039	0.019790454	0.16569553	GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN	171	1.1553524	0.17568947	0.6615541	2.5423563	0.2316515
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	75	1.3869648	0.044270832	0.16568474	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	77	0.8881042	0.6880435	1	2.275069	0.4988606
IRF2_01	c3.TFT_ transcription factor targets	110	1.3869301	0.02661597	0.1656554	IRF2_01	111	1.1528078	0.20790021	0.66444194	2.5397379	0.2341223
GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN	C7_ immunologic signatures	157	1.3868818	0.010882708	0.1656495	GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN	163	1.0552777	0.37892604	0.8328566	2.4421595	0.3316041
GSE40273_XBP1_KO_VS_WT_TREG_DN	C7_ immunologic signatures	177	1.3866882	0.014117647	0.16584933	GSE40273_XBP1_KO_VS_WT_TREG_DN	183	1.1219615	0.21681865	0.7222809	2.5086497	0.2647267
GO_REGULATION_OF_CHEMOTAXIS	c5.BP_ GO biological process	146	1.386058	0.01668653	0.16675405	GO_REGULATION_OF_CHEMOTAXIS	155	1.3655573	0.011178861	0.37239495	2.7516153	0.0205007
GO_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA	c5.BP_ GO biological process	136	1.3859259	0.020961776	0.16686979	GO_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA	137	1.0515845	0.3944387	0.8368502	2.4375104	0.3343414
FOXO4_01	c3.TFT_ transcription factor targets	209	1.385788	0.005767013	0.16700089	FOXO4_01	213	0.95928264	0.5947581	0.97099537	2.34507064	0.42650536
GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	163	1.3856674	0.01754386	0.16710484	GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	170	1.3524977	0.013278856	0.383112	2.7381651	0.0331697
KRAS.600.LUNG.BREAST_UP.V1_DN	C6_ oncogenic signatures	212	1.3853443	0.008009153	0.1675034	KRAS.600.LUNG.BREAST_UP.V1_DN	220	1.2002194	0.08072654	0.5919695	2.5855637	0.1851249
GO_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION	c5.BP_ GO biological process	58	1.3851304	0.049723756	0.16772375	GO_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION	60	-1.1836874	0.125	0.40044522	0.201443	2.5688178
GO_SENSORY_ORGAN_DEVELOPMENT	c5.BP_ GO biological process	437	1.3851007	0.005257624	0.16769187	GO_SENSORY_ORGAN_DEVELOPMENT	471	0.9374793	0.7387387	0.9934269	2.32258	0.4476214
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	c2.CGP_ chemical and genetic perturbations	146	1.3850149	0.015738498	0.16773649	ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	158	1.7216077	0	0.06791015	3.1066226	-0.3365928
GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	C7_ immunologic signatures	175	1.3849024	0.016470589	0.16782457	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	176	1.0897582	0.29806715	0.7715727	2.4746606	0.2951442
GO_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	49	1.3847121	0.057522126	0.16802764	GO_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY	58	1.1769221	0.21854305	0.6267068	2.5616342	0.20779
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP	C7_ immunologic signatures	171	1.3846214	0.010638298	0.16809563	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP	177	1.0042868	0.49137056	0.9168198	2.3889082	0.3803346
MODULE_38	c4.CM_ cancer modules	410	1.3845106	0.001064963	0.16819534	MODULE_38	425	1.1298603	0.11	0.70581025	2.5143709	0.2546503
GO_CARDIAC_SEPTUM_DEVELOPMENT	c5.BP_ GO biological process	78	1.3843715	0.03529412	0.16832839	GO_CARDIAC_SEPTUM_DEVELOPMENT	81	1.0968469	0.30662394	0.7611841	2.4812184	0.2875246
GO_REGULATION_OF_CATECHOLAMINE_SECRETION	c5.BP_ GO biological process	28	1.3840408	0.069321536	0.16877508	GO_REGULATION_OF_CATECHOLAMINE_SECRETION	36	1.6239345	0.007017544	0.13811296	3.0079753	-0.2398937
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	c2.CGP_ chemical and genetic perturbations	68	1.3837744	0.045833334	0.16908737	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	68	1.4072542	0.015184382	0.32970697	2.7910286	-0.0234798
GSE14350_IL2RB_KO_VS_WT_TEFF_UP	C7_ immunologic signatures	172	1.3837727	0.009512485	0.16901073	GSE14350_IL2RB_KO_VS_WT_TEFF_UP	179	1.4428655	0.003058104	0.2995122	2.8266382	-0.0590928
GSE30083_SP1_VS_SP4_THYMOCYTE_DN	C7_ immunologic signatures	172	1.3836331	0.011961723	0.16914815	GSE30083_SP1_VS_SP4_THYMOCYTE_DN	176	1.4662454	0.002030457	0.2781898	2.8498785	-0.0826123
GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP	C7_ immunologic signatures	161	1.3836137	0.014545455	0.16909736	GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP	175	1.2968378	0.021319797	0.44668743	2.6804515	0.0867759
GSE3982_CTRL_VS_LPS_4H_MAC_DN	C7_ immunologic signatures	176	1.3836095	0.015204678	0.16902657	GSE3982_CTRL_VS_LPS_4H_MAC_DN	177	0.9601806	0.5939394	0.9713913	2.3437901	0.4234289
GO_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	33	1.3832692	0.05652174	0.16948262	GO_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION	35	-0.952316	0.53741497	0.75395167	0.4309532	2.3355852
GO_PEPTIDASE_INHIBITOR_ACTIVITY	c5.GO molecular function	115	1.3827068	0.026184538	0.17024247	GO_PEPTIDASE_INHIBITOR_ACTIVITY	133	1.3101828	0.033776868	0.4254554	2.6928896	0.072524
GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	99	1.382601	0.02631579	0.17032096	GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	106	1.3324031	0.042487048	0.39959848	2.7150041	0.0501979
GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN	C7_ immunologic signatures	160	1.3824669	0.019002376	0.17044957	GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN	163	0.75777256	0.93686354	1	2.14023946	0.62469434
MIKKELSEN_MEF_LCP_WITH_H3K4ME3	c2.CGP_ chemical and genetic perturbations	112	1.3823807	0.024173029	0.17050137	MIKKELSEN_MEF_LCP_WITH_H3K4ME3	107	1.0070428	0.47623968	0.91229904	2.3894235	0.3753379
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	c2.CGP_ chemical and genetic perturbations	45	1.3820955	0.051319648	0.17088202	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	47	1.091234	0.34162897	0.7696759	2.4733295	0.2908615
GO_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH	c5.BP_ GO biological process	59	1.3820686	0.030812325	0.1708511	GO_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH	69	0.943372	0.5925134	0.9887516	2.3254406	0.4386966
GO_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY	c5.BP_ GO biological process	32	1.3819922	0.058912385	0.17088684	GO_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY	38	1.1060013	0.31738624	0.744953	2.4879935	0.2759909
MODULE_84	c4.CM_ cancer modules	435	1.3819605	0.002136752	0.17085949	MODULE_84	458	1.2409967	0.011	0.52420884	2.6229572	0.1409638
GO_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE	c5.BP_ GO biological process	404	1.3816283	0.001070664	0.17131183	GO_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE	433	1.0976335	0.17517518	0.7594493	2.4792618	0.2839948
GO_CELLULAR_RESPONSE_TO_FATTY_ACID	c5.BP_ GO biological process	44	1.3813472	0.06376812	0.17168069	GO_CELLULAR_RESPONSE_TO_FATTY_ACID	49	1.1980275	0.19574945	0.5960783	2.5793747	0.1833197
GO_REGULATION_OF_MAP_KINASE_ACTIVITY	c5.BP_ GO biological process	291	1.3812727	0.007709251	0.17171475	GO_REGULATION_OF_MAP_KINASE_ACTIVITY	298	1.2555403	0.017034069	0.50210786	2.636813	0.1257324
PID_ATR_PATHWAY	c2.CP_ Canonical pathways	38	1.3811239	0.04908836	0.17185792	PID_ATR_PATHWAY	38	-1.5992596	0	0.091368735	-0.2181357	2.9803835
MODULE_80	c4.CM_ cancer modules	31	1.3811092	0.06422018	0.17180622	MODULE_80	32	1.1758207	0.23536439	0.6280073	2.5569299	0.2052885
GO_NEGATIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION	c5.BP_ GO biological process	15	1.381092	0.0752	0.17174761	GO_NEGATIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION	15	0.90998274	0.62207794	1	2.29107474	0.47110926
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP	C7_ immunologic signatures	176	1.3809884	0.012941176	0.17183629	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP	186	0.91387576	0.6998993	1	2.29486416	0.46711264
GO_BONE_RESORPTION	c5.BP_ GO biological process	20	1.3808959	0.07587253	0.17189847	GO_BONE_RESORPTION	19	1.2191455	0.21419518	0.55620503	2.6000414	0.1617504
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	c2.CGP_ chemical and genetic perturbations	30	1.3808688	0.07526882	0.17187122	FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	31	1.0140187	0.44970414	0.8997975	2.3948875	0.3668501
GO_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT	c5.BP_ GO biological process	16	1.3807963	0.08934169	0.17189553	GO_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT	21	1.6717297	0.001272265	0.096090384	3.052526	-0.2909334
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	181	1.3806891	0.017523365	0.17197528	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	184	1.057938	0.37638748	0.8276283	2.4386271	0.3227511
GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP	C7_ immunologic signatures	178	1.3804927	0.014184397	0.17220262	GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP	175	1.238997	0.054325957	0.52674437	2.6194897	0.1414957
TGFB_UP.V1_UP	C6_ oncogenic signatures	170	1.3804817	0.018007202	0.17214018	TGFB_UP.V1_UP	168	1.352153	0.015166835	0.3828217	2.7326347	0.0283287
GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP	C7_ immunologic signatures	176	1.3801262	0.011723329	0.17261319	GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP	177	0.91174436	0.72239107	1	2.29187056	0.46838184
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	c2.CP_BIOCARTA_ BioCarta gene sets	18	1.3800427	0.08056872	0.17266087	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	19	1.4812586	0.026683608	0.26687077	2.8613013	-0.1012159
GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP	C7_ immunologic signatures	177	1.3793844	0.018248174	0.1735678	GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP	180	1.1290239	0.18218623	0.7077005	2.5084083	0.2503605
GO_SECRETION_BY_CELL	c5.BP_ GO biological process	416	1.3791955	0	0.17376325	GO_SECRETION_BY_CELL	437	1.1852847	0.041041043	0.6131853	2.5644802	0.1939108
GO_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION	c5.BP_ GO biological process	41	1.3789041	0.060921248	0.17412671	GO_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION	42	0.95584416	0.5616279	0.97590107	2.33474826	0.42305994
GO_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	17	1.378873	0.07882535	0.17410527	GO_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS	17	0.8510169	0.68906456	1	2.2298899	0.5278561
CTCTATG_MIR368	c3.MIR_ microRNA targets	37	1.3788184	0.08055556	0.17410906	CTCTATG_MIR368	38	0.65479326	0.92741936	1	2.03361166	0.72402514
BIOCARTA_ATRBRCA_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	19	1.3787768	0.0942813	0.17409258	BIOCARTA_ATRBRCA_PATHWAY	19	-0.8426995	0.6712329	0.87335855	0.5360773	2.2214763
GSE21063_WT_VS_NFATC1_KO_BCELL_DN	C7_ immunologic signatures	183	1.3787222	0.014268728	0.174086	GSE21063_WT_VS_NFATC1_KO_BCELL_DN	185	-0.8485683	0.90909094	0.8698232	0.5301539	2.2272905
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	c2.CGP_ chemical and genetic perturbations	63	1.3785776	0.038303692	0.17423591	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	63	1.0713449	0.36700338	0.8027836	2.4499225	0.3072327
GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	174	1.3785657	0.0094451	0.17417412	GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN	177	1.1826594	0.13549039	0.6187268	2.5612251	0.1959063
GO_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION	c5.BP_ GO biological process	46	1.3785226	0.04526167	0.17415586	GO_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION	47	1.1936214	0.20257612	0.59990555	2.572144	0.1849012
GO_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	20	1.378474	0.079934746	0.17414698	GO_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION	21	1.0108504	0.46878982	0.90594935	2.3893244	0.3676236
PTF1BETA_Q6	c3.TFT_ transcription factor targets	201	1.3783729	0.012542759	0.17422645	PTF1BETA_Q6	211	0.8003056	0.90936553	1	2.1786785	0.5780673
BROWNE_HCMV_INFECTION_18HR_UP	c2.CGP_ chemical and genetic perturbations	165	1.3783442	0.00976801	0.17418587	BROWNE_HCMV_INFECTION_18HR_UP	165	-0.98531896	0.46153846	0.7066348	0.39302524	2.36366316
LEF1_UP.V1_DN	C6_ oncogenic signatures	158	1.3783388	0.018159807	0.17411304	LEF1_UP.V1_DN	168	1.4867232	0	0.26306528	2.865062	-0.1083844
GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	160	1.3783332	0.021712907	0.17404245	GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	166	1.0409099	0.39473686	0.85786474	2.4192431	0.3374233
GO_BONE_MINERALIZATION	c5.BP_ GO biological process	37	1.3782835	0.068350665	0.17403558	GO_BONE_MINERALIZATION	38	1.0246594	0.44883722	0.88425153	2.4029429	0.3536241
GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	C7_ immunologic signatures	172	1.3781329	0.00820633	0.17418535	GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	173	1.1504279	0.18661258	0.6684954	2.5285608	0.227705
GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN	C7_ immunologic signatures	175	1.3781075	0.014184397	0.1741457	GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN	182	1.031017	0.43145162	0.8743737	2.4091245	0.3470905
PID_ALPHA_SYNUCLEIN_PATHWAY	c2.CP_ Canonical pathways	27	1.3780737	0.07656968	0.17412357	PID_ALPHA_SYNUCLEIN_PATHWAY	29	0.82370204	0.74271846	1	2.20177574	0.55437166
ONO_FOXP3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	37	1.3780711	0.062038403	0.17404757	ONO_FOXP3_TARGETS_DN	35	-0.98762447	0.54375	0.70539165	0.39044663	2.36569557
GHANDHI_DIRECT_IRRADIATION_UP	c2.CGP_ chemical and genetic perturbations	77	1.377983	0.03937008	0.17409156	GHANDHI_DIRECT_IRRADIATION_UP	78	1.5855832	0.001079914	0.17659636	2.9635662	-0.2076002
GO_DENDRITIC_CELL_DIFFERENTIATION	c5.BP_ GO biological process	28	1.3778119	0.08623298	0.17427386	GO_DENDRITIC_CELL_DIFFERENTIATION	28	1.0494434	0.41502464	0.8409469	2.4272553	0.3283685
ALK_DN.V1_DN	C6_ oncogenic signatures	107	1.3776057	0.029374203	0.17451735	ALK_DN.V1_DN	115	1.2076026	0.13725491	0.5807823	2.5852083	0.1700031
ZHAN_MULTIPLE_MYELOMA_CD1_UP	c2.CGP_ chemical and genetic perturbations	41	1.3775069	0.06676558	0.17457575	ZHAN_MULTIPLE_MYELOMA_CD1_UP	42	1.0019565	0.4827586	0.9202491	2.3794634	0.3755504
GO_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE	c5.BP_ GO biological process	87	1.3774523	0.03398693	0.17457458	GO_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE	87	0.96624744	0.5469905	0.96460843	2.34369974	0.41120486
GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP	C7_ immunologic signatures	160	1.3772863	0.01783591	0.17475624	GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP	167	0.7570103	0.9473151	1	2.1342966	0.620276
GO_CELL_JUNCTION_ASSEMBLY	c5.BP_ GO biological process	123	1.3772004	0.028325124	0.17481576	GO_CELL_JUNCTION_ASSEMBLY	125	1.1456714	0.22095436	0.67774564	2.5228718	0.231529
MARCHINI_TRABECTEDIN_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	46	1.3771807	0.07173601	0.17476916	MARCHINI_TRABECTEDIN_RESISTANCE_DN	46	-1.0122247	0.39784947	0.6700644	0.364956	2.3894054
GSE14000_UNSTIM_VS_16H_LPS_DC_DN	C7_ immunologic signatures	174	1.3769677	0.015133876	0.17501101	GSE14000_UNSTIM_VS_16H_LPS_DC_DN	175	0.9295094	0.6629667	0.9990843	2.3064771	0.4474583
GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN	C7_ immunologic signatures	165	1.3769523	0.012062727	0.17495364	GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN	168	0.9495269	0.622335	0.98273486	2.3264792	0.4274254
MATZUK_SPERMATOCYTE	c2.CGP_ chemical and genetic perturbations	67	1.3769517	0.052069426	0.17487507	MATZUK_SPERMATOCYTE	69	1.4089601	0.028138528	0.32732633	2.7859118	-0.0320084
CHR10P12	C1: positional gene sets	28	1.3768271	0.08435583	0.17499696	CHR10P12	31	0.8891603	0.6345238	1	2.2659874	0.4876668
MODULE_135	c4.CM_ cancer modules	17	1.3766888	0.08647799	0.17512989	MODULE_135	18	1.7251782	0.001262626	0.06874401	3.101867	-0.3484894
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	c2.CGP_ chemical and genetic perturbations	335	1.376681	0.003296703	0.17506239	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	349	1.1017492	0.195	0.7539198	2.4784302	0.2749318
GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	165	1.3766613	0.020556228	0.17501198	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	172	0.76755005	0.9200405	1	2.14421135	0.60911125
GO_MESODERM_DEVELOPMENT	c5.BP_ GO biological process	100	1.3765433	0.03612903	0.17511034	GO_MESODERM_DEVELOPMENT	106	0.7276699	0.93473685	1	2.1042132	0.6488734
GSE7852_TREG_VS_TCONV_THYMUS_UP	C7_ immunologic signatures	174	1.376291	0.013079667	0.17542669	GSE7852_TREG_VS_TCONV_THYMUS_UP	178	1.2047588	0.09035533	0.58280206	2.5810498	0.1715322
MCCLUNG_COCAINE_REWARD_5D	c2.CGP_ chemical and genetic perturbations	75	1.3760769	0.034059945	0.17566109	MCCLUNG_COCAINE_REWARD_5D	76	0.72772425	0.90618336	1	2.10380115	0.64835265
HELLER_SILENCED_BY_METHYLATION_UP	c2.CGP_ chemical and genetic perturbations	226	1.3760554	0.011148272	0.17561561	HELLER_SILENCED_BY_METHYLATION_UP	229	1.408883	0.003027245	0.3268234	2.7849384	-0.0328276
GO_REGULATION_OF_GLUCOSE_TRANSPORT	c5.BP_ GO biological process	87	1.3759646	0.03963012	0.17568277	GO_REGULATION_OF_GLUCOSE_TRANSPORT	91	0.61769193	0.9915612	1	1.99365653	0.75827267
GO_EYE_MORPHOGENESIS	c5.BP_ GO biological process	123	1.3758947	0.027954256	0.17570485	GO_EYE_MORPHOGENESIS	129	0.860065	0.7750258	1	2.2359597	0.5158297
GSE14415_INDUCED_VS_NATURAL_TREG_UP	C7_ immunologic signatures	133	1.375871	0.0124533	0.17566921	GSE14415_INDUCED_VS_NATURAL_TREG_UP	134	1.1187744	0.25720164	0.7245813	2.4946454	0.2570966
GO_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS	c5.BP_ GO biological process	177	1.3756748	0.010625738	0.17590292	GO_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS	184	0.91584355	0.7217742	1	2.29151835	0.45983125
GO_UBIQUITIN_LIKE_PROTEIN_TRANSFERASE_ACTIVITY	c5.GO molecular function	383	1.3755643	0.002132196	0.17599604	GO_UBIQUITIN_LIKE_PROTEIN_TRANSFERASE_ACTIVITY	389	0.79023135	0.972973	1	2.16579565	0.58533295
GO_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION	c5.BP_ GO biological process	159	1.3755548	0.020556228	0.17592894	GO_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION	186	1.2096856	0.096251264	0.5775869	2.5852404	0.1658692
GSE17721_0.5H_VS_24H_CPG_BMDC_DN	C7_ immunologic signatures	179	1.3754818	0.010575793	0.17597209	GSE17721_0.5H_VS_24H_CPG_BMDC_DN	178	1.3077052	0.023397762	0.42940924	2.683187	0.0677766
GO_NEURAL_CREST_CELL_DIFFERENTIATION	c5.BP_ GO biological process	67	1.3754505	0.037138928	0.17594099	GO_NEURAL_CREST_CELL_DIFFERENTIATION	74	-1.5755198	0	0.10194302	-0.2000693	2.9509703
GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	174	1.3754152	0.015276146	0.17591895	GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP	172	0.868902	0.7792472	1	2.2443172	0.5065132
GO_POSITIVE_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS	c5.BP_ GO biological process	16	1.3754085	0.101472996	0.17584652	GO_POSITIVE_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS	18	0.97935283	0.5247148	0.9503332	2.35476133	0.39605567
GOUYER_TATI_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	16	1.3751992	0.09286899	0.17610052	GOUYER_TATI_TARGETS_DN	16	1.2880197	0.13906448	0.4608927	2.6632189	0.0871795
GO_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	25	1.3751576	0.08042488	0.17608513	GO_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	27	1.1695182	0.25061125	0.6385642	2.5446758	0.2056394
SPIRA_SMOKERS_LUNG_CANCER_DN	c2.CGP_ chemical and genetic perturbations	16	1.375006	0.095846646	0.17625497	SPIRA_SMOKERS_LUNG_CANCER_DN	16	0.6891843	0.86605984	1	2.0641903	0.6858217
GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN	C7_ immunologic signatures	170	1.3749944	0.02117647	0.17619221	GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN	174	1.4172907	0.00508647	0.3199592	2.7922851	-0.0422963
MULLIGHAN_NPM1_SIGNATURE_3_UP	c2.CGP_ chemical and genetic perturbations	294	1.3748577	0.005476452	0.17630933	MULLIGHAN_NPM1_SIGNATURE_3_UP	298	0.8518857	0.8766299	1	2.2267434	0.522972
TEF1_Q6	c3.TFT_ transcription factor targets	190	1.3745228	0.012987013	0.17676581	TEF1_Q6	197	1.1822001	0.11382114	0.61957514	2.5567229	0.1923227
GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP	C7_ immunologic signatures	152	1.3744813	0.018007202	0.1767493	GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP	154	0.93150073	0.65056527	0.99818164	2.30598203	0.44298057
GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	178	1.3743197	0.017857144	0.17691156	GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	175	0.6475711	0.98876405	1	2.0218908	0.7267486
AGCATTA_MIR155	c3.MIR_ microRNA targets	123	1.3743101	0.027227722	0.17684741	AGCATTA_MIR155	126	-1.1643106	0.057142857	0.42504534	0.2099995	2.5386207
GO_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	17	1.3742758	0.10223642	0.17682715	GO_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE	17	1.083935	0.3629139	0.7794886	2.4582108	0.2903408
GO_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY	c5.GO molecular function	24	1.3742133	0.082840234	0.17685525	GO_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY	24	0.91064364	0.6233454	1	2.28485694	0.46356966
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN	C7_ immunologic signatures	160	1.3742012	0.017772513	0.17679372	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN	167	1.1410186	0.18998979	0.6888199	2.5152198	0.2331826
WANG_MLL_TARGETS	c2.CGP_ chemical and genetic perturbations	266	1.3741938	0.005574136	0.17672512	WANG_MLL_TARGETS	266	1.5526409	0	0.2059092	2.9268347	-0.1784471
GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP	C7_ immunologic signatures	162	1.3739802	0.018159807	0.17697644	GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP	169	1.2352765	0.06795132	0.5330291	2.6092567	0.1387037
GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	C7_ immunologic signatures	190	1.3739712	0.015815085	0.17691158	GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	189	0.63629293	0.9959718	1	2.01026413	0.73767827
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	c2.CGP_ chemical and genetic perturbations	298	1.3738837	0.008898776	0.17697734	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	306	1.0993788	0.22367102	0.75782245	2.4732625	0.2745049
GO_DOPAMINE_METABOLIC_PROCESS	c5.BP_ GO biological process	18	1.3738594	0.097288676	0.1769368	GO_DOPAMINE_METABOLIC_PROCESS	23	0.8241712	0.73464376	1	2.1980306	0.5496882
GO_CYCLIC_NUCLEOTIDE_MEDIATED_SIGNALING	c5.BP_ GO biological process	41	1.3736917	0.05029586	0.17710409	GO_CYCLIC_NUCLEOTIDE_MEDIATED_SIGNALING	41	1.0979221	0.34140715	0.7593672	2.4716138	0.2757696
RAO_BOUND_BY_SALL4_ISOFORM_A	c2.CGP_ chemical and genetic perturbations	135	1.3735471	0.02375	0.17726526	RAO_BOUND_BY_SALL4_ISOFORM_A	152	1.160217	0.15762538	0.65200764	2.5337641	0.2133301
GO_SITE_OF_DOUBLE_STRAND_BREAK	c5.CC_ GO cellular component	25	1.3735356	0.06787331	0.17720506	GO_SITE_OF_DOUBLE_STRAND_BREAK	25	0.8113001	0.7623153	1	2.1848357	0.5622355
GO_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	104	1.3733935	0.025839793	0.17735188	GO_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT	114	1.520055	0	0.23636548	2.8934485	-0.1466615
GO_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION	c5.BP_ GO biological process	160	1.3732835	0.013301089	0.17745805	GO_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION	163	1.1036797	0.27005076	0.74994737	2.4769632	0.2696038
GO_REGULATION_OF_VASCULATURE_DEVELOPMENT	c5.BP_ GO biological process	204	1.3732249	0.010575793	0.1774736	GO_REGULATION_OF_VASCULATURE_DEVELOPMENT	207	1.3237501	0.013144591	0.40967184	2.696975	0.0494748
GO_RESPONSE_TO_RETINOIC_ACID	c5.BP_ GO biological process	91	1.3731084	0.029224904	0.17757532	GO_RESPONSE_TO_RETINOIC_ACID	98	0.8914274	0.6845426	1	2.2645358	0.481681
MODULE_197	c4.CM_ cancer modules	156	1.3730992	0.019559903	0.17751259	MODULE_197	158	-1.3093996	0	0.27531788	0.0636996	2.6824988
GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN	C7_ immunologic signatures	166	1.3724852	0.012165451	0.17839283	GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN	176	1.1543771	0.1691996	0.6627593	2.5268623	0.2181081
GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP	C7_ immunologic signatures	146	1.372427	0.01728395	0.17840081	GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP	140	1.1958004	0.11495422	0.5968268	2.5682274	0.1766266
GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP	C7_ immunologic signatures	172	1.3720312	0.004790419	0.17895454	GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP	177	0.8719229	0.7767677	1	2.2439541	0.5001083
GO_REGULATION_OF_CAMP_METABOLIC_PROCESS	c5.BP_ GO biological process	93	1.3720031	0.034255598	0.17892388	GO_REGULATION_OF_CAMP_METABOLIC_PROCESS	109	1.3295391	0.04054054	0.40283605	2.7015422	0.042464
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP	C7_ immunologic signatures	175	1.3718781	0.017709563	0.17903842	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP	182	1.0109988	0.4888889	0.90592915	2.3828769	0.3608793
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	c2.CGP_ chemical and genetic perturbations	378	1.3718091	0.001082251	0.17907405	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	384	1.0917345	0.229	0.7695442	2.4635436	0.2800746
GO_SEX_CHROMOSOME	c5.CC_ GO cellular component	25	1.3716584	0.08259587	0.17923559	GO_SEX_CHROMOSOME	27	1.2575461	0.16199756	0.4994585	2.6292045	0.1141123
MODULE_421	c4.CM_ cancer modules	22	1.3715072	0.07535322	0.17939483	MODULE_421	22	0.8558879	0.68041235	1	2.2273951	0.5156193
ZHANG_RESPONSE_TO_CANTHARIDIN_UP	c2.CGP_ chemical and genetic perturbations	19	1.3713317	0.088785045	0.17959496	ZHANG_RESPONSE_TO_CANTHARIDIN_UP	17	1.0062656	0.47843137	0.9136805	2.3775973	0.3650661
GO_REGULATION_OF_EXOCYTOSIS	c5.BP_ GO biological process	159	1.3712585	0.018691588	0.17963743	GO_REGULATION_OF_EXOCYTOSIS	169	1.0966092	0.28484848	0.76164186	2.4678677	0.2746493
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	145	1.371207	0.03194103	0.17964396	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN	154	0.8784254	0.76151484	1	2.2496324	0.4927816
OLSSON_E2F3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	17	1.3712003	0.100323625	0.1795715	OLSSON_E2F3_TARGETS_UP	19	1.4400249	0.0464191	0.30459103	2.8112252	-0.0688246
GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN	C7_ immunologic signatures	183	1.3710179	0.016806724	0.1797835	GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN	181	1.2170188	0.08248472	0.56222963	2.5880367	0.1539991
GO_COLLAGEN_BINDING	c5.GO molecular function	57	1.3708919	0.064425774	0.1798951	GO_COLLAGEN_BINDING	60	1.3076788	0.082969435	0.42873815	2.6785707	0.0632131
GO_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION	c5.BP_ GO biological process	122	1.3708043	0.020961776	0.17995267	GO_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION	126	0.854756	0.7933884	1	2.2255603	0.5160483
GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN	C7_ immunologic signatures	153	1.3707961	0.018495684	0.17988478	GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN	167	0.93627805	0.65883553	0.9938954	2.30707415	0.43451805
GO_REGULATION_OF_CELL_MATRIX_ADHESION	c5.BP_ GO biological process	83	1.3707526	0.038821954	0.17986628	GO_REGULATION_OF_CELL_MATRIX_ADHESION	84	1.3808292	0.033970278	0.35616153	2.7515818	-0.0100766
GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP	C7_ immunologic signatures	177	1.3707148	0.017462166	0.17985405	GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP	179	0.9531378	0.61538464	0.97807366	2.3238526	0.417577
GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP	C7_ immunologic signatures	171	1.3706971	0.012004802	0.17979705	GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP	172	1.1573465	0.15858586	0.65851694	2.5280436	0.2133506
GSE42724_MEMORY_VS_B1_BCELL_DN	C7_ immunologic signatures	165	1.3705822	0.019305019	0.17989816	GSE42724_MEMORY_VS_B1_BCELL_DN	165	1.1289169	0.21421319	0.70702785	2.4994991	0.2416653
CHR8P22	C1: positional gene sets	29	1.3703367	0.06508876	0.18020862	CHR8P22	30	0.8305143	0.73365617	1	2.200851	0.5398224
CDX2_Q5	c3.TFT_ transcription factor targets	214	1.3702171	0.009080591	0.18031892	CDX2_Q5	223	1.0857836	0.2868687	0.7764586	2.4560007	0.2844335
BAKKER_FOXO3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	57	1.370124	0.061026353	0.18038271	BAKKER_FOXO3_TARGETS_UP	57	1.1453078	0.25476992	0.6782403	2.5154318	0.2248162
REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS	c2.CP_REACTOME_ Reactome gene sets	35	1.3699096	0.0761194	0.1806398	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS	35	0.94924664	0.57738096	0.98298496	2.31915624	0.42066296
GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	C7_ immunologic signatures	175	1.3697294	0.017921148	0.18084651	GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	174	1.0795747	0.30131447	0.78820896	2.4493041	0.2901547
GSE3982_MAC_VS_TH2_UP	C7_ immunologic signatures	176	1.3696954	0.010663508	0.18082358	GSE3982_MAC_VS_TH2_UP	180	1.2287084	0.06477733	0.5434543	2.5984038	0.140987
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN	C7_ immunologic signatures	164	1.3696822	0.02045728	0.18077049	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN	170	1.186012	0.10909091	0.61318	2.5556942	0.1836702
HAND1E47_01	c3.TFT_ transcription factor targets	225	1.3695351	0.010465116	0.18091711	HAND1E47_01	237	0.81824553	0.9024145	1	2.18778063	0.55128957
GO_RESPONSE_TO_GONADOTROPIN	c5.BP_ GO biological process	25	1.369333	0.077044025	0.18115672	GO_RESPONSE_TO_GONADOTROPIN	26	-1.041471	0.37853107	0.62012404	0.327862	2.410804
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP	C7_ immunologic signatures	179	1.3692493	0.016528925	0.18120766	GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP	184	1.1303488	0.19837233	0.70600563	2.4995981	0.2389005
AMIT_EGF_RESPONSE_480_MCF10A	c2.CGP_ chemical and genetic perturbations	39	1.369191	0.0706922	0.18122171	AMIT_EGF_RESPONSE_480_MCF10A	40	0.7573753	0.84	1	2.1265663	0.6118157
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN	c2.CGP_ chemical and genetic perturbations	48	1.3691365	0.054093566	0.18123329	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN	52	0.8771722	0.67963386	1	2.2463087	0.4919643
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	131	1.3690655	0.01726264	0.18126556	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	134	1.3533579	0.023541454	0.382425	2.7224234	0.0157076
NKX22_01	c3.TFT_ transcription factor targets	152	1.3690569	0.017220173	0.18119846	NKX22_01	165	0.9736285	0.559633	0.95737964	2.3426854	0.3954284
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	c2.CP_REACTOME_ Reactome gene sets	16	1.3689679	0.110749185	0.18125373	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	16	1.2373748	0.2	0.53009564	2.6063427	0.1315931
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	c2.CGP_ chemical and genetic perturbations	78	1.3687074	0.044757035	0.18159297	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	81	1.2551482	0.11075269	0.50250655	2.6238556	0.1135592
GO_REGULATION_OF_CELL_SIZE	c5.BP_ GO biological process	156	1.3686107	0.017114915	0.18167682	GO_REGULATION_OF_CELL_SIZE	163	0.9007755	0.7245935	1	2.2693862	0.4678352
MODULE_241	c4.CM_ cancer modules	64	1.3685073	0.052702703	0.18176548	MODULE_241	67	1.1564372	0.23387977	0.65928465	2.5249445	0.2120701
GO_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY	c5.BP_ GO biological process	226	1.3684304	0.012457531	0.18180801	GO_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY	231	0.8736489	0.81124496	1	2.2420793	0.4947815
GO_OUTFLOW_TRACT_MORPHOGENESIS	c5.BP_ GO biological process	52	1.3683631	0.047091413	0.18184067	GO_OUTFLOW_TRACT_MORPHOGENESIS	55	-1.006723	0.43434343	0.6756631	0.3616401	2.3750861
CHR5Q13	C1: positional gene sets	51	1.3681839	0.05742297	0.18204223	CHR5Q13	51	0.8148854	0.7688787	1	2.1830693	0.5532985
HOWLIN_CITED1_TARGETS_1_DN	c2.CGP_ chemical and genetic perturbations	35	1.3681737	0.08308605	0.1819795	HOWLIN_CITED1_TARGETS_1_DN	35	1.1238648	0.29859486	0.7177672	2.4920385	0.2443089
ZHENG_BOUND_BY_FOXP3	c2.CGP_ chemical and genetic perturbations	433	1.3681203	0.004219409	0.18199073	ZHENG_BOUND_BY_FOXP3	442	1.1171765	0.119	0.7282793	2.4852968	0.2509438
MODULE_291	c4.CM_ cancer modules	58	1.368115	0.05196629	0.18192357	MODULE_291	59	1.0848806	0.3409836	0.7773276	2.4529956	0.2832344
YKACATTT_UNKNOWN	c3.TFT_ transcription factor targets	234	1.367657	0.01146789	0.18258347	YKACATTT_UNKNOWN	243	1.0198299	0.4458918	0.89150417	2.3874869	0.3478271
CHR1P36	C1: positional gene sets	254	1.3676116	0.00678733	0.18257928	CHR1P36	274	1.3245424	0.005005005	0.4091246	2.692154	0.0430692
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN	C7_ immunologic signatures	154	1.3676064	0.02877698	0.18250825	GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN	163	1.1747669	0.1461929	0.6300523	2.5423733	0.1928395
GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	180	1.367588	0.008284024	0.18245943	GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN	180	1.3501079	0.009118541	0.38318747	2.7176959	0.0174801
GO_HORMONE_BINDING	c5.GO molecular function	56	1.3675601	0.060648803	0.18242368	GO_HORMONE_BINDING	60	0.9552247	0.5644105	0.9755888	2.3227848	0.4123354
GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP	C7_ immunologic signatures	158	1.36756	0.013253012	0.18234423	GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP	169	1.2519706	0.057692308	0.508055	2.6195306	0.1155894
GO_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE	c5.BP_ GO biological process	47	1.3675444	0.0705036	0.18228452	GO_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE	50	-0.98599684	0.42553192	0.7064813	0.38154756	2.35354124
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP	C7_ immunologic signatures	179	1.3672781	0.021327015	0.18264265	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP	183	1.0174943	0.4576613	0.893726	2.3847724	0.3497838
MODULE_174	c4.CM_ cancer modules	83	1.3671067	0.046875	0.18283786	MODULE_174	88	1.1256968	0.27889714	0.71329427	2.4928035	0.2414099
GO_NOTCH_RECEPTOR_PROCESSING	c5.BP_ GO biological process	15	1.3670949	0.084375	0.18277961	GO_NOTCH_RECEPTOR_PROCESSING	15	0.8806151	0.6611342	1	2.24771	0.4864798
MAHAJAN_RESPONSE_TO_IL1A_UP	c2.CGP_ chemical and genetic perturbations	64	1.367087	0.043417368	0.18271363	MAHAJAN_RESPONSE_TO_IL1A_UP	67	0.7695878	0.8508108	1	2.1366748	0.5974992
GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP	C7_ immunologic signatures	176	1.3670487	0.013017751	0.18269557	GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP	181	1.4319569	0	0.31336182	2.7990056	-0.0649082
CHR15Q23	C1: positional gene sets	25	1.3670168	0.07906977	0.18266149	CHR15Q23	25	0.5784119	0.97416973	1	1.9454287	0.7886049
GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	157	1.3669927	0.016949153	0.18262415	GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP	168	1.3271503	0.015212982	0.4047895	2.694143	0.0398424
REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS	c2.CP_REACTOME_ Reactome gene sets	69	1.3669496	0.044354837	0.18262038	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS	78	0.80751073	0.82769555	1	2.17446033	0.55943887
GO_POSITIVE_REGULATION_OF_LOCOMOTION	c5.BP_ GO biological process	352	1.3669381	0.001076426	0.18255953	GO_POSITIVE_REGULATION_OF_LOCOMOTION	368	1.239275	0.019	0.5268277	2.6062131	0.1276631
CHR17P12	C1: positional gene sets	21	1.3667996	0.09500805	0.18270849	CHR17P12	21	1.2781701	0.1433869	0.47433984	2.6449697	0.0886295
REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION	c2.CP_REACTOME_ Reactome gene sets	23	1.3665689	0.085443035	0.18298475	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION	23	1.1788766	0.26270136	0.6237817	2.5454455	0.1876923
PASINI_SUZ12_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	298	1.3665038	0.004424779	0.18301053	PASINI_SUZ12_TARGETS_DN	298	0.82298857	0.913	1	2.18949237	0.54351523
ATF2_UP.V1_DN	C6_ oncogenic signatures	160	1.3664281	0.012925969	0.1830569	ATF2_UP.V1_DN	164	1.290367	0.036734693	0.45742667	2.6567951	0.0760611
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN	C7_ immunologic signatures	145	1.366206	0.021479713	0.18333113	GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN	152	0.92664385	0.66228515	1	2.29284985	0.43956215
GO_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION	c5.BP_ GO biological process	56	1.3661186	0.06346968	0.18340233	GO_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION	57	1.0211222	0.47071823	0.890967	2.3872408	0.3449964
GO_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	52	1.3658208	0.050632913	0.18378153	GO_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS	51	1.149367	0.25345623	0.67071784	2.5151878	0.2164538
GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP	C7_ immunologic signatures	181	1.3657596	0.017772513	0.18380205	GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP	183	1.3805138	0.003021148	0.3555681	2.7462734	-0.0147542
GO_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY	c5.BP_ GO biological process	19	1.3656836	0.103559874	0.18383312	GO_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY	18	1.3350152	0.108005084	0.39763048	2.7006988	0.0306684
GO_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	c5.GO molecular function	84	1.3656205	0.04605263	0.18384537	GO_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	90	1.2268502	0.12992546	0.54678816	2.5924707	0.1387703
GO_REGULATION_OF_DNA_RECOMBINATION	c5.BP_ GO biological process	45	1.365574	0.072463766	0.18384348	GO_REGULATION_OF_DNA_RECOMBINATION	47	-0.8952144	0.67241377	0.8272819	0.4703596	2.2607884
GO_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE	c5.CC_ GO cellular component	172	1.3655145	0.021556886	0.183857	GO_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE	195	1.3480045	0.01718908	0.38403198	2.713519	0.01751
MODULE_51	c4.CM_ cancer modules	34	1.3654344	0.07647059	0.18389113	MODULE_51	36	1.3051611	0.101992965	0.43357465	2.6705955	0.0602733
GO_HEART_MORPHOGENESIS	c5.BP_ GO biological process	195	1.3654293	0.011682243	0.18381755	GO_HEART_MORPHOGENESIS	208	0.8860193	0.76969695	1	2.2514486	0.47941
GO_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	48	1.3653612	0.0670554	0.18384288	GO_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION	51	-1.0754355	0.29411766	0.5605663	0.2899257	2.4407967
PAX5_02	c3.TFT_ transcription factor targets	15	1.3652076	0.10183639	0.18401577	PAX5_02	15	-1.3345138	0.12062257	0.25201166	0.0306938	2.6997214
GO_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING	c5.GO molecular function	109	1.3651954	0.03661616	0.18396157	GO_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING	109	1.2056642	0.13236815	0.5819543	2.5708596	0.1595312
GO_MULTICELLULAR_ORGANISMAL_MACROMOLECULE_METABOLIC_PROCESS	c5.BP_ GO biological process	61	1.3651061	0.053206004	0.18403998	GO_MULTICELLULAR_ORGANISMAL_MACROMOLECULE_METABOLIC_PROCESS	66	1.2122215	0.1715847	0.57401425	2.5773276	0.1528846
GO_MYOBLAST_DIFFERENTIATION	c5.BP_ GO biological process	35	1.3649722	0.060150377	0.18416809	GO_MYOBLAST_DIFFERENTIATION	35	0.7480393	0.8502857	1	2.1130115	0.6169329
GO_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	c5.BP_ GO biological process	94	1.3646777	0.047865458	0.1845568	GO_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	97	0.9724164	0.55626327	0.9587458	2.3370941	0.3922613
GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN	C7_ immunologic signatures	99	1.364527	0.03566879	0.1847174	GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN	105	1.1366422	0.24016564	0.6949512	2.5011692	0.2278848
GO_GLYCOPROTEIN_BINDING	c5.GO molecular function	85	1.3644547	0.04095112	0.1847522	GO_GLYCOPROTEIN_BINDING	92	-1.1853939	0.17391305	0.39849094	0.1790608	2.5498486
DURAND_STROMA_S_UP	c2.CGP_ chemical and genetic perturbations	273	1.3640394	0.006857143	0.18532974	DURAND_STROMA_S_UP	270	1.3190222	0.009027082	0.41246212	2.6830616	0.0450172
GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN	C7_ immunologic signatures	165	1.3639867	0.02345679	0.18533322	GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN	164	1.1203125	0.23123732	0.72310853	2.4842992	0.2436742
GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	C7_ immunologic signatures	152	1.3639631	0.022194821	0.18529414	GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	153	1.2551142	0.06428572	0.50222033	2.6190773	0.1088489
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	c2.CP_REACTOME_ Reactome gene sets	72	1.3638095	0.045081966	0.18545994	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	76	1.0523994	0.39828694	0.8368741	2.4162089	0.3114101
GO_REGULATION_OF_STEM_CELL_PROLIFERATION	c5.BP_ GO biological process	80	1.3637064	0.038809832	0.18554763	GO_REGULATION_OF_STEM_CELL_PROLIFERATION	85	-1.1028326	0.20689656	0.51308113	0.2608738	2.466539
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	c2.CGP_ chemical and genetic perturbations	142	1.3637015	0.02021403	0.18547338	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	149	1.3640149	0.016359918	0.37303934	2.7277164	-0.0003134
OUYANG_PROSTATE_CANCER_PROGRESSION_UP	c2.CGP_ chemical and genetic perturbations	16	1.3635646	0.09313726	0.18559271	OUYANG_PROSTATE_CANCER_PROGRESSION_UP	18	1.6292162	0.005108557	0.13214208	2.9927808	-0.2656516
ALX4_01	c3.TFT_ transcription factor targets	15	1.3634673	0.11714771	0.18567306	ALX4_01	15	0	0	0	1.3634673	1.3634673
GO_RESPONSE_TO_TESTOSTERONE	c5.BP_ GO biological process	34	1.3634195	0.0653789	0.18566705	GO_RESPONSE_TO_TESTOSTERONE	34	1.2151976	0.19019139	0.56650347	2.5786171	0.1482219
GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN	C7_ immunologic signatures	158	1.3633089	0.022836538	0.18577567	GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN	163	1.1328799	0.2147923	0.7015615	2.4961888	0.230429
GO_POSITIVE_REGULATION_OF_DNA_REPAIR	c5.BP_ GO biological process	31	1.3630515	0.083076924	0.18610556	GO_POSITIVE_REGULATION_OF_DNA_REPAIR	31	0.8026201	0.7592372	1	2.1656716	0.5604314
RIZ_ERYTHROID_DIFFERENTIATION_HBZ	c2.CGP_ chemical and genetic perturbations	37	1.3630278	0.061933536	0.18606864	RIZ_ERYTHROID_DIFFERENTIATION_HBZ	39	-1.5247805	0.024793388	0.12768747	-0.1617527	2.8878083
GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP	C7_ immunologic signatures	167	1.3630189	0.020023556	0.18600601	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP	168	1.3180012	0.020304568	0.41310534	2.6810201	0.0450177
GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN	C7_ immunologic signatures	170	1.3628404	0.018337408	0.18623042	GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN	171	1.1997144	0.10212336	0.59292936	2.5625548	0.163126
GO_TISSUE_MORPHOGENESIS	c5.BP_ GO biological process	476	1.362656	0.003154574	0.18646248	GO_TISSUE_MORPHOGENESIS	476	0	0	0	1.362656	1.362656
GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	C7_ immunologic signatures	156	1.3625699	0.019277109	0.18653321	GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	158	1.2196445	0.08638211	0.5555262	2.5822144	0.1429254
TCTCTCC_MIR185	c3.MIR_ microRNA targets	102	1.3624214	0.034255598	0.18669127	TCTCTCC_MIR185	109	1.2008228	0.13527575	0.59095114	2.5632442	0.1615986
GO_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM	c5.BP_ GO biological process	21	1.362347	0.0910518	0.18674065	GO_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM	21	1.3205239	0.12105927	0.4117596	2.6828709	0.0418231
CART1_01	c3.TFT_ transcription factor targets	177	1.3623188	0.018115941	0.18670313	CART1_01	192	1.0918292	0.27373737	0.7695836	2.454148	0.2704896
GO_REGULATION_OF_ORGAN_GROWTH	c5.BP_ GO biological process	66	1.3622996	0.051841747	0.18666045	GO_REGULATION_OF_ORGAN_GROWTH	71	1.2443966	0.12717392	0.5200495	2.6066962	0.117903
GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN	C7_ immunologic signatures	164	1.3622688	0.015550239	0.1866314	GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN	176	0.7773218	0.9108409	1	2.1395906	0.584947
BIOCARTA_G1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	27	1.3622677	0.083333336	0.18655398	BIOCARTA_G1_PATHWAY	27	-1.055884	0.30588236	0.59511614	0.3063837	2.4181517
GO_POSITIVE_REGULATION_OF_AXON_EXTENSION	c5.BP_ GO biological process	35	1.3619705	0.08494784	0.18693851	GO_POSITIVE_REGULATION_OF_AXON_EXTENSION	35	0.87213707	0.6705608	1	2.23410757	0.48983343
WEST_ADRENOCORTICAL_TUMOR_UP	c2.CGP_ chemical and genetic perturbations	273	1.3619035	0.01230425	0.18695702	WEST_ADRENOCORTICAL_TUMOR_UP	273	-0.970464	0.5	0.72852856	0.3914395	2.3323675
GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN	C7_ immunologic signatures	174	1.3618932	0.025641026	0.18689667	GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN	172	0.85720456	0.8262195	1	2.21909776	0.50468864
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	c2.CP_REACTOME_ Reactome gene sets	33	1.3616124	0.06636501	0.18727152	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	34	1.4501814	0.039906103	0.2914497	2.8117938	-0.088569
GO_DAMAGED_DNA_BINDING	c5.GO molecular function	62	1.3615469	0.041835357	0.18729894	GO_DAMAGED_DNA_BINDING	62	0.80384034	0.80368763	1	2.16538724	0.55770656
GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN	C7_ immunologic signatures	182	1.3615083	0.014976959	0.1872829	GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN	182	1.1732625	0.14415322	0.63356906	2.5347708	0.1882458
GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP	C7_ immunologic signatures	155	1.3615015	0.016746411	0.18721777	GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP	156	0.9977254	0.5020325	0.9257658	2.3592269	0.3637761
GSE27786_BCELL_VS_ERYTHROBLAST_DN	C7_ immunologic signatures	155	1.3614358	0.020286396	0.18724844	GSE27786_BCELL_VS_ERYTHROBLAST_DN	173	1.2398818	0.0597166	0.5260359	2.6013176	0.121554
CTTGTAT_MIR381	c3.MIR_ microRNA targets	184	1.3613572	0.018648019	0.18729217	CTTGTAT_MIR381	185	0.7635847	0.93218625	1	2.1249419	0.5977725
GO_SYNAPTIC_TRANSMISSION_CHOLINERGIC	c5.BP_ GO biological process	25	1.361186	0.09745128	0.18749823	GO_SYNAPTIC_TRANSMISSION_CHOLINERGIC	30	1.1951036	0.2173913	0.59713787	2.5562896	0.1660824
AMIT_SERUM_RESPONSE_120_MCF10A	c2.CGP_ chemical and genetic perturbations	61	1.3610988	0.04931507	0.18756531	AMIT_SERUM_RESPONSE_120_MCF10A	61	0.9796966	0.5355932	0.950036	2.3407954	0.3814022
GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	C7_ immunologic signatures	174	1.3610303	0.021791767	0.18759325	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	177	1.1293483	0.19695431	0.70703477	2.4903786	0.231682
GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	176	1.361009	0.021403091	0.18754728	GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	178	1.1563865	0.173428	0.65934896	2.5173955	0.2046225
GO_ACTIN_FILAMENT	c5.CC_ GO cellular component	66	1.3609966	0.04172099	0.18748745	GO_ACTIN_FILAMENT	67	1.1205152	0.29053319	0.72297865	2.4815118	0.2404814
GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN	C7_ immunologic signatures	159	1.3607042	0.02291918	0.18786868	GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN	163	1.1053457	0.26144457	0.7460674	2.4660499	0.2553585
VERHAAK_AML_WITH_NPM1_MUTATED_DN	c2.CGP_ chemical and genetic perturbations	213	1.3606076	0.006944445	0.18795407	VERHAAK_AML_WITH_NPM1_MUTATED_DN	219	1.0880079	0.286002	0.7736813	2.4486155	0.2725997
GO_RESPONSE_TO_IMMOBILIZATION_STRESS	c5.BP_ GO biological process	18	1.360542	0.1105919	0.1879842	GO_RESPONSE_TO_IMMOBILIZATION_STRESS	20	1.5401987	0.022049287	0.21127567	2.9007407	-0.1796567
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	c2.CGP_ chemical and genetic perturbations	25	1.360443	0.0813253	0.18808228	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	25	-1.0468875	0.37198067	0.61123204	0.3135555	2.4073305
GO_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY	c5.GO molecular function	297	1.3604003	0.006674083	0.1880711	GO_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY	303	1.4868187	0	0.26336393	2.847219	-0.1264184
GO_ACTIN_NUCLEATION	c5.BP_ GO biological process	20	1.3601665	0.08988764	0.18836834	GO_ACTIN_NUCLEATION	20	0.7603116	0.81210595	1	2.1204781	0.5998549
GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN	C7_ immunologic signatures	173	1.3599414	0.020094562	0.18868244	GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN	178	-1.2597411	0	0.3151791	0.1002003	2.6196825
GO_POSITIVE_REGULATION_OF_ORGAN_GROWTH	c5.BP_ GO biological process	34	1.3599207	0.06942393	0.18863615	GO_POSITIVE_REGULATION_OF_ORGAN_GROWTH	37	1.1380792	0.2878966	0.6939313	2.4979999	0.2218415
GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP	C7_ immunologic signatures	182	1.3597598	0.014251782	0.18880461	GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP	185	1.4928757	0	0.2582516	2.8526355	-0.1331159
GO_TELENCEPHALON_DEVELOPMENT	c5.BP_ GO biological process	209	1.3597356	0.008168028	0.18876232	GO_TELENCEPHALON_DEVELOPMENT	224	0.95710695	0.62739176	0.9747196	2.31684255	0.40262865
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN	C7_ immunologic signatures	123	1.3597032	0.018939395	0.18873422	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN	125	1.0226659	0.4382139	0.8868774	2.3823691	0.3370373
GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN	C7_ immunologic signatures	159	1.3596506	0.02877698	0.18873733	GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN	171	1.11073	0.24821973	0.7363612	2.4703806	0.2489206
KEGG_BLADDER_CANCER	c2.CP_BIOCARTA_ BioCarta gene sets	38	1.3593918	0.0706922	0.18909629	KEGG_BLADDER_CANCER	39	0.9975016	0.48173517	0.925929	2.3568934	0.3618902
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP	c2.CGP_ chemical and genetic perturbations	18	1.3593322	0.10551948	0.18911272	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP	18	0.90531427	0.62151897	1	2.26464647	0.45401793
GO_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION	c5.BP_ GO biological process	24	1.3592098	0.10031348	0.18923046	GO_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION	29	1.2697947	0.15073529	0.4854806	2.6290045	0.0894151
GO_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY	c5.BP_ GO biological process	24	1.3590604	0.10757576	0.18940283	GO_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY	24	-0.8801026	0.6770833	0.84480804	0.4789578	2.239163
HOQUE_METHYLATED_IN_CANCER	c2.CGP_ chemical and genetic perturbations	49	1.358921	0.06647807	0.18955895	HOQUE_METHYLATED_IN_CANCER	53	1.1508383	0.2379349	0.667787	2.5097593	0.2080827
GO_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT	c5.BP_ GO biological process	266	1.3588253	0.012318029	0.18963434	GO_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT	285	0.79408413	0.9296482	1	2.15290943	0.56474117
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	c2.CGP_ chemical and genetic perturbations	326	1.3587484	0.006644518	0.18968004	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	328	1.0738177	0.278	0.7989293	2.4325661	0.2849307
FOXJ2_01	c3.TFT_ transcription factor targets	153	1.3587037	0.020581113	0.1896666	FOXJ2_01	158	1.0883499	0.31344792	0.773373	2.4470536	0.2703538
GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	177	1.3585641	0.021226415	0.1898172	GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	180	1.135685	0.19878297	0.69574237	2.4942491	0.2228791
CHR1P31	C1: positional gene sets	64	1.3585232	0.04138852	0.18981364	CHR1P31	66	0.7828448	0.8369565	1	2.141368	0.5756784
CHR5Q23	C1: positional gene sets	45	1.3585145	0.07194245	0.18974552	CHR5Q23	48	0.6739863	0.9431438	1	2.0325008	0.6845282
GSE3039_CD4_TCELL_VS_B2_BCELL_UP	C7_ immunologic signatures	177	1.3585131	0.023752969	0.1896692	GSE3039_CD4_TCELL_VS_B2_BCELL_UP	181	1.1371424	0.2048436	0.6947968	2.4956555	0.2213707
GO_SECRETORY_GRANULE	c5.CC_ GO cellular component	282	1.3582582	0.008879024	0.19000706	GO_SECRETORY_GRANULE	312	1.2154392	0.04509018	0.56559163	2.5736974	0.142819
GO_BODY_MORPHOGENESIS	c5.BP_ GO biological process	41	1.3581772	0.06241135	0.19006705	GO_BODY_MORPHOGENESIS	43	0.90766907	0.6602492	1	2.26584627	0.45050813
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	c2.CGP_ chemical and genetic perturbations	24	1.3578529	0.079877116	0.19051598	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	24	1.3957163	0.061480552	0.34769744	2.7535692	-0.0378634
GO_CELLULAR_RESPONSE_TO_VIRUS	c5.BP_ GO biological process	20	1.3578017	0.08846761	0.19052674	GO_CELLULAR_RESPONSE_TO_VIRUS	19	-0.6628207	0.9466019	0.97408235	0.694981	2.0206224
ZHANG_BREAST_CANCER_PROGENITORS_UP	c2.CGP_ chemical and genetic perturbations	384	1.3576324	0.003191489	0.19074188	ZHANG_BREAST_CANCER_PROGENITORS_UP	384	0	0	0	1.3576324	1.3576324
GO_PRONUCLEUS	c5.CC_ GO cellular component	15	1.3576014	0.105960265	0.190709	GO_PRONUCLEUS	15	0.7191936	0.848	1	2.076795	0.6384078
GO_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY	c5.BP_ GO biological process	20	1.3575706	0.09463722	0.19067696	GO_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY	20	1.1810409	0.26092544	0.6216769	2.5386115	0.1765297
GO_REGULATION_OF_SODIUM_ION_TRANSPORT	c5.BP_ GO biological process	69	1.3573368	0.040166207	0.19099331	GO_REGULATION_OF_SODIUM_ION_TRANSPORT	71	1.2397573	0.12513484	0.5259552	2.5970941	0.1175795
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP	C7_ immunologic signatures	173	1.3573064	0.013033175	0.19097441	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP	174	1.2611291	0.038617887	0.49504206	2.6184355	0.0961773
GO_DETECTION_OF_ABIOTIC_STIMULUS	c5.BP_ GO biological process	100	1.3572401	0.04859335	0.19100177	GO_DETECTION_OF_ABIOTIC_STIMULUS	103	1.1981823	0.15141957	0.5961245	2.5554224	0.1590578
GO_REGULATION_OF_ENERGY_HOMEOSTASIS	c5.BP_ GO biological process	16	1.3570337	0.116883114	0.19126333	GO_REGULATION_OF_ENERGY_HOMEOSTASIS	15	0.92904586	0.5839895	0.99893796	2.28607956	0.42798784
REACTOME_BASIGIN_INTERACTIONS	c2.CP_REACTOME_ Reactome gene sets	22	1.3569186	0.09379968	0.19136608	REACTOME_BASIGIN_INTERACTIONS	24	-0.93940324	0.5388889	0.7709117	0.41751536	2.29632184
PID_GLYPICAN_1PATHWAY	c2.CP_ Canonical pathways	24	1.3568714	0.082822084	0.19136621	PID_GLYPICAN_1PATHWAY	26	0.9213704	0.5990099	1	2.2782418	0.435501
SABATES_COLORECTAL_ADENOMA_UP	c2.CGP_ chemical and genetic perturbations	94	1.3567833	0.037958115	0.19143426	SABATES_COLORECTAL_ADENOMA_UP	108	1.0683419	0.36185566	0.8087338	2.4251252	0.2884414
GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN	C7_ immunologic signatures	180	1.3567547	0.011614402	0.19140826	GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN	184	1.1239678	0.22469635	0.7174599	2.4807225	0.2327869
GO_REGULATION_OF_ION_HOMEOSTASIS	c5.BP_ GO biological process	166	1.3563895	0.015457789	0.19192514	GO_REGULATION_OF_ION_HOMEOSTASIS	180	1.3795277	0.011088709	0.35596576	2.7359172	-0.0231382
GO_REGULATION_OF_MONOOXYGENASE_ACTIVITY	c5.BP_ GO biological process	52	1.3562704	0.062240664	0.1920597	GO_REGULATION_OF_MONOOXYGENASE_ACTIVITY	54	1.1930575	0.20633188	0.60025626	2.5493279	0.1632129
GO_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	39	1.3561355	0.07883818	0.19220126	GO_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT	44	0.7064395	0.89702517	1	2.062575	0.649696
GO_REGULATION_OF_KERATINOCYTE_PROLIFERATION	c5.BP_ GO biological process	23	1.3559206	0.096062995	0.19249393	GO_REGULATION_OF_KERATINOCYTE_PROLIFERATION	24	1.3474098	0.10493827	0.3853046	2.7033304	0.0085108
MODULE_214	c4.CM_ cancer modules	21	1.3558034	0.0984375	0.19260533	MODULE_214	26	1.4773353	0.03375	0.2714009	2.8331387	-0.1215319
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	35	1.3555535	0.074235804	0.19293486	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	35	0.90663105	0.6332547	1	2.26218455	0.44892245
PID_ATM_PATHWAY	c2.CP_ Canonical pathways	31	1.3554379	0.082840234	0.19303791	PID_ATM_PATHWAY	31	0.5665887	0.97466826	1	1.9220266	0.7888492
PHONG_TNF_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	56	1.3554264	0.064136125	0.19297576	PHONG_TNF_TARGETS_UP	56	1.2565131	0.12541993	0.5003889	2.6119395	0.0989133
GSE39022_LN_VS_SPLEEN_DC_UP	C7_ immunologic signatures	177	1.3554034	0.016746411	0.19293551	GSE39022_LN_VS_SPLEEN_DC_UP	176	0.7966154	0.8926039	1	2.1520188	0.558788
BERENJENO_TRANSFORMED_BY_RHOA_UP	c2.CGP_ chemical and genetic perturbations	498	1.3552154	0.001039501	0.19317016	BERENJENO_TRANSFORMED_BY_RHOA_UP	498	0	0	0	1.3552154	1.3552154
GO_DEFENSE_RESPONSE_TO_OTHER_ORGANISM	c5.BP_ GO biological process	347	1.3550439	0.003289474	0.19339043	GO_DEFENSE_RESPONSE_TO_OTHER_ORGANISM	368	0.8581313	0.882	1	2.2131752	0.4969126
GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL	c5.BP_ GO biological process	41	1.3549073	0.08869814	0.19352761	GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL	45	1.5019575	0.012208657	0.252037	2.8568648	-0.1470502
GO_ANATOMICAL_STRUCTURE_HOMEOSTASIS	c5.BP_ GO biological process	232	1.3549018	0.019252548	0.19345525	GO_ANATOMICAL_STRUCTURE_HOMEOSTASIS	237	0.956616	0.637827	0.9753045	2.3115178	0.3982858
JAK2_DN.V1_DN	C6_ oncogenic signatures	99	1.3545996	0.033505153	0.19389156	JAK2_DN.V1_DN	105	0.7821238	0.8660999	1	2.1367234	0.5724758
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	133	1.3545914	0.030339805	0.19382611	GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	136	1.260163	0.0625	0.49580866	2.6147544	0.0944284
STK33_UP	C6_ oncogenic signatures	239	1.3544441	0.014789534	0.19398052	STK33_UP	241	0.99350256	0.53722334	0.9312009	2.34794666	0.36094154
KERLEY_RESPONSE_TO_CISPLATIN_UP	c2.CGP_ chemical and genetic perturbations	38	1.3544363	0.087278105	0.1939101	KERLEY_RESPONSE_TO_CISPLATIN_UP	38	1.3922421	0.05807201	0.3471677	2.7466784	-0.0378058
GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP	C7_ immunologic signatures	120	1.3543401	0.03612903	0.19399531	GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP	129	1.2709309	0.05803109	0.4834472	2.625271	0.0834092
GO_MULTICELLULAR_ORGANISM_GROWTH	c5.BP_ GO biological process	69	1.3542463	0.05758427	0.1940789	GO_MULTICELLULAR_ORGANISM_GROWTH	71	0.8690351	0.71899015	1	2.2232814	0.4852112
GO_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS	c5.BP_ GO biological process	30	1.3540828	0.08501441	0.19426988	GO_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS	33	0.59436005	0.98045975	1	1.94844285	0.75972275
GSE14000_4H_VS_16H_LPS_DC_DN	C7_ immunologic signatures	164	1.3540648	0.017793594	0.19421846	GSE14000_4H_VS_16H_LPS_DC_DN	164	0.6672713	0.98587286	1	2.0213361	0.6867935
SRF_Q6	c3.TFT_ transcription factor targets	215	1.3540112	0.011428571	0.19423747	SRF_Q6	222	0.8113811	0.89748746	1	2.1653923	0.5426301
LINDSTEDT_DENDRITIC_CELL_MATURATION_B	c2.CGP_ chemical and genetic perturbations	51	1.353945	0.069503546	0.19426246	LINDSTEDT_DENDRITIC_CELL_MATURATION_B	51	1.1359735	0.27221596	0.69589347	2.4899185	0.2179715
BROWNE_HCMV_INFECTION_48HR_UP	c2.CGP_ chemical and genetic perturbations	160	1.3539394	0.025703795	0.1941925	BROWNE_HCMV_INFECTION_48HR_UP	164	0.8567242	0.827551	1	2.2106636	0.4972152
MZF1_01	c3.TFT_ transcription factor targets	210	1.3539305	0.015151516	0.19412796	MZF1_01	212	0.8522882	0.83704454	1	2.2062187	0.5016423
GO_REGULATION_OF_CELL_CYCLE_ARREST	c5.BP_ GO biological process	92	1.353916	0.042690814	0.19406936	GO_REGULATION_OF_CELL_CYCLE_ARREST	94	0.81131774	0.833682	1	2.16523374	0.54259826
GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP	C7_ immunologic signatures	147	1.353874	0.025578562	0.1940641	GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP	148	0.89711535	0.7170385	1	2.25098935	0.45675865
GACAATC_MIR219	c3.MIR_ microRNA targets	131	1.3538219	0.025445292	0.19406961	GACAATC_MIR219	134	1.133575	0.22620267	0.70101595	2.4873969	0.2202469
GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	C7_ immunologic signatures	174	1.353771	0.019953052	0.19406171	GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	172	1.1738805	0.14562118	0.63158965	2.5276515	0.1798905
GO_ORGANELLE_LOCALIZATION	c5.BP_ GO biological process	377	1.3536413	0.004319654	0.19420007	GO_ORGANELLE_LOCALIZATION	381	1.2075737	0.028	0.5807185	2.561215	0.1460676
GO_MORPHOGENESIS_OF_AN_EPITHELIUM	c5.BP_ GO biological process	356	1.3535942	0.003250271	0.19420014	GO_MORPHOGENESIS_OF_AN_EPITHELIUM	383	0.90489936	0.794	1	2.25849356	0.44869484
GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP	C7_ immunologic signatures	107	1.3534278	0.027415143	0.19440094	GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP	123	1.1255822	0.2517839	0.71350336	2.47901	0.2278456
GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP	C7_ immunologic signatures	158	1.353337	0.012091898	0.19447918	GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP	167	1.0481466	0.37804878	0.84299433	2.4014836	0.3051904
GO_RESPONSE_TO_LITHIUM_ION	c5.BP_ GO biological process	26	1.3533202	0.10413476	0.19443297	GO_RESPONSE_TO_LITHIUM_ION	27	1.3622483	0.083028086	0.37559813	2.7155685	-0.0089281
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	c2.CGP_ chemical and genetic perturbations	21	1.3532774	0.09967846	0.19442843	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	21	1.0518109	0.4094388	0.8372107	2.4050883	0.3014665
CEBP_01	c3.TFT_ transcription factor targets	222	1.3531436	0.012443439	0.194559	CEBP_01	236	0.9251912	0.6974874	1	2.2783348	0.4279524
MODULE_53	c4.CM_ cancer modules	348	1.3530552	0.001082251	0.19463453	MODULE_53	363	0.8122006	0.95	1	2.1652558	0.5408546
MORF_CCNF	c4.CGN_ cancer gene neighborhoods	72	1.3530272	0.054242004	0.19460213	MORF_CCNF	72	-1.0547057	0.28395063	0.5960116	0.2983215	2.4077329
GO_ADHERENS_JUNCTION_ASSEMBLY	c5.BP_ GO biological process	33	1.3529966	0.06853147	0.19457595	GO_ADHERENS_JUNCTION_ASSEMBLY	33	0.790856	0.78494626	1	2.1438526	0.5621406
GO_CEREBELLAR_CORTEX_DEVELOPMENT	c5.BP_ GO biological process	43	1.3527638	0.05874126	0.1948721	GO_CEREBELLAR_CORTEX_DEVELOPMENT	45	1.0479174	0.39747995	0.84383315	2.4006812	0.3048464
GSE7852_TREG_VS_TCONV_LN_UP	C7_ immunologic signatures	181	1.3524559	0.01880141	0.19530857	GSE7852_TREG_VS_TCONV_LN_UP	181	1.0469106	0.3838384	0.84481966	2.3993665	0.3055453
WIERENGA_STAT5A_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	177	1.3522556	0.012672811	0.1955724	WIERENGA_STAT5A_TARGETS_DN	182	1.326884	0.014127145	0.40497562	2.6791396	0.0253716
REACTOME_HEMOSTASIS	c2.CP_REACTOME_ Reactome gene sets	398	1.3520195	0	0.19590257	REACTOME_HEMOSTASIS	412	1.1226075	0.14714715	0.72105294	2.474627	0.229412
MODULE_256	c4.CM_ cancer modules	50	1.3520035	0.05839416	0.19585364	MODULE_256	50	1.0061226	0.45870537	0.91352606	2.3581261	0.3458809
GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_UP	C7_ immunologic signatures	136	1.3519623	0.033939395	0.19585195	GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_UP	139	1.3224453	0.028600613	0.41154936	2.6744076	0.029517
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	c2.CGP_ chemical and genetic perturbations	16	1.3519617	0.09904154	0.19577274	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	16	-0.935378	0.51376146	0.77800184	0.4165837	2.2873397
GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN	C7_ immunologic signatures	187	1.3515717	0.012761021	0.1963361	GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN	192	1.3296598	0.010090818	0.40322387	2.6812315	0.0219119
GO_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION	c5.BP_ GO biological process	64	1.3514463	0.07417583	0.19647667	GO_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION	66	1.0788604	0.36612022	0.7896204	2.4303067	0.2725859
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP	C7_ immunologic signatures	170	1.3512464	0.032979976	0.19673385	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP	176	1.2263032	0.060790274	0.54761934	2.5775496	0.1249432
GSE21063_WT_VS_NFATC1_KO_BCELL_UP	C7_ immunologic signatures	173	1.3512365	0.016528925	0.19667278	GSE21063_WT_VS_NFATC1_KO_BCELL_UP	180	0.96326023	0.6028369	0.96741027	2.31449673	0.38797627
TGATTTRY_GFI1_01	c3.TFT_ transcription factor targets	231	1.3510659	0.012571429	0.19686136	TGATTTRY_GFI1_01	248	1.28717	0.016048145	0.46215004	2.6382359	0.0638959
GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP	C7_ immunologic signatures	182	1.3508774	0.021101993	0.19709645	GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP	185	1.1978337	0.0951417	0.59636444	2.5487111	0.1530437
REACTOME_SIGNALING_BY_RHO_GTPASES	c2.CP_REACTOME_ Reactome gene sets	105	1.3507882	0.03354037	0.19716842	REACTOME_SIGNALING_BY_RHO_GTPASES	110	1.7157667	0	0.07299257	3.0665549	-0.3649785
GO_CARDIAC_VENTRICLE_DEVELOPMENT	c5.BP_ GO biological process	95	1.3507835	0.043941412	0.19709818	GO_CARDIAC_VENTRICLE_DEVELOPMENT	102	1.0884129	0.32746115	0.7732343	2.4391964	0.2623706
RYTAAWNNNTGAY_UNKNOWN	c3.TFT_ transcription factor targets	53	1.3503414	0.059766766	0.19775194	RYTAAWNNNTGAY_UNKNOWN	58	0.7907425	0.8024417	1	2.1410839	0.5595989
ERB2_UP.V1_DN	C6_ oncogenic signatures	164	1.3503379	0.033694346	0.19767646	ERB2_UP.V1_DN	166	0.7243463	0.96555215	1	2.0746842	0.6259916
GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP	C7_ immunologic signatures	164	1.3502985	0.022619048	0.1976652	GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP	168	1.1943548	0.11975435	0.59806526	2.5446533	0.1559437
GO_REGENERATION	c5.BP_ GO biological process	142	1.3500606	0.021924483	0.19798765	GO_REGENERATION	148	0.9346468	0.6390593	0.9954166	2.2847074	0.4154138
SIMBULAN_PARP1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	17	1.3500297	0.11631664	0.19795024	SIMBULAN_PARP1_TARGETS_DN	17	-1.3082058	0.13145539	0.27610624	0.0418239	2.6582355
BASSO_HAIRY_CELL_LEUKEMIA_UP	c2.CGP_ chemical and genetic perturbations	75	1.3499851	0.04509284	0.1979392	BASSO_HAIRY_CELL_LEUKEMIA_UP	77	1.2050889	0.15961945	0.58247834	2.555074	0.1448962
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	c2.CGP_ chemical and genetic perturbations	27	1.3498609	0.08610272	0.19806811	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	28	0.7691291	0.8123515	1	2.11899	0.5807318
OCT_C	c3.TFT_ transcription factor targets	215	1.3497752	0.011587486	0.1981438	OCT_C	222	1.1075834	0.21897073	0.7416038	2.4573586	0.2421918
GO_POSTREPLICATION_REPAIR	c5.BP_ GO biological process	45	1.3487948	0.087267525	0.19975796	GO_POSTREPLICATION_REPAIR	45	-1.2273899	0.11290322	0.3481343	0.1214049	2.5761847
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	c2.CGP_ chemical and genetic perturbations	35	1.3487779	0.08748115	0.19970627	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	34	-1.2253065	0.13690476	0.350066	0.1234714	2.5740844
GO_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE	c5.BP_ GO biological process	111	1.3487712	0.03409091	0.19963682	GO_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE	119	1.026413	0.44731405	0.88216704	2.3751842	0.3223582
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN	c2.CGP_ chemical and genetic perturbations	35	1.3487425	0.092920355	0.19960546	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN	37	1.1211457	0.31947744	0.72203517	2.4698882	0.2275968
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	c2.CGP_ chemical and genetic perturbations	72	1.3485495	0.061141305	0.19984756	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	74	-1.322694	0.045454547	0.26251522	0.0258555	2.6712435
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	c2.CGP_ chemical and genetic perturbations	282	1.3485384	0.008879024	0.19978887	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	298	1.1896238	0.064257026	0.60596305	2.5381622	0.1589146
GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN	C7_ immunologic signatures	178	1.3484075	0.022352941	0.19995162	GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN	180	0.7982277	0.9219858	1	2.1466352	0.5501798
ELVIDGE_HYPOXIA_BY_DMOG_UP	c2.CGP_ chemical and genetic perturbations	125	1.348348	0.029040404	0.19997753	ELVIDGE_HYPOXIA_BY_DMOG_UP	127	1.3325424	0.03398558	0.39992428	2.6808904	0.0158056
GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP	C7_ immunologic signatures	180	1.3483163	0.016746411	0.19994836	GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP	181	0.92954016	0.6835187	0.9991236	2.27785646	0.41877614
GO_EPHRIN_RECEPTOR_BINDING	c5.GO molecular function	24	1.348154	0.09351433	0.20012924	GO_EPHRIN_RECEPTOR_BINDING	24	-0.78587013	0.80088496	0.91733253	0.56228387	2.13402413
GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN	C7_ immunologic signatures	171	1.348096	0.022326674	0.20015967	GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN	178	1.019986	0.4529828	0.8911642	2.368082	0.32811
MODULE_438	c4.CM_ cancer modules	62	1.3479823	0.051034484	0.20026392	MODULE_438	64	1.2581602	0.1222467	0.49862966	2.6061425	0.0898221
PID_CIRCADIAN_PATHWAY	c2.CP_ Canonical pathways	15	1.3477814	0.10393701	0.20053278	PID_CIRCADIAN_PATHWAY	15	-0.62749815	0.95057034	0.9808856	0.72028325	1.97527955
GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	C7_ immunologic signatures	165	1.3477565	0.02754491	0.20049578	GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	166	1.0334483	0.42915392	0.8713092	2.3812048	0.3143082
WAKASUGI_HAVE_ZNF143_BINDING_SITES	c2.CGP_ chemical and genetic perturbations	55	1.347691	0.05942029	0.20052113	WAKASUGI_HAVE_ZNF143_BINDING_SITES	55	-0.9869714	0.5	0.70578086	0.3607196	2.3346624
GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	C7_ immunologic signatures	135	1.3476567	0.021978023	0.20050506	GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	141	0.9887875	0.525355	0.93658596	2.3364442	0.3588692
PID_TAP63_PATHWAY	c2.CP_ Canonical pathways	48	1.3476224	0.08011445	0.20049164	PID_TAP63_PATHWAY	50	1.4285976	0.032992035	0.31732792	2.77622	-0.0809752
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN	C7_ immunologic signatures	149	1.347584	0.025059666	0.2004685	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN	171	1.2540889	0.04949495	0.50288767	2.6016729	0.0934951
GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	176	1.3475205	0.017052375	0.20048957	GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	178	0.9009582	0.7252525	1	2.2484787	0.4465623
GO_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION	c5.BP_ GO biological process	49	1.3473965	0.056277055	0.20062171	GO_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION	51	0.9429542	0.5888158	0.9885256	2.2903507	0.4044423
GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN	C7_ immunologic signatures	98	1.347331	0.028387098	0.2006604	GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN	115	1.2994696	0.043165468	0.44355696	2.6468006	0.0478614
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	179	1.3472649	0.02270012	0.20069154	GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	183	0.9228733	0.6882591	1	2.2701382	0.4243916
GO_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	162	1.3472556	0.020833334	0.20062786	GO_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS	181	1.4027725	0.004040404	0.3371565	2.7500281	-0.0555169
AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D	c3.MIR_ microRNA targets	310	1.3470976	0.008820287	0.2008299	AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D	316	1.1146861	0.17234468	0.73101234	2.4617837	0.2324115
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	155	1.3470529	0.018094089	0.20083225	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN	160	1.0257994	0.44297352	0.8831377	2.3728523	0.3212535
GO_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY	c5.BP_ GO biological process	19	1.34692	0.09538461	0.20098281	GO_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY	21	1.4942911	0.026888605	0.25784472	2.8412111	-0.1473711
LU_AGING_BRAIN_UP	c2.CGP_ chemical and genetic perturbations	236	1.346904	0.01146789	0.20092887	LU_AGING_BRAIN_UP	242	1.1454679	0.14457831	0.67817944	2.4923719	0.2014361
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	175	1.346775	0.017814728	0.20106985	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP	169	1.3797183	0.006072875	0.35704473	2.7264933	-0.0329433
GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP	C7_ immunologic signatures	136	1.3467236	0.025149701	0.20108004	GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP	136	1.2266257	0.10235415	0.5473745	2.5733493	0.1200979
GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP	C7_ immunologic signatures	174	1.3466537	0.028708134	0.20112714	GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP	177	1.3332729	0.015274949	0.39997172	2.6799266	0.0133808
MODULE_303	c4.CM_ cancer modules	28	1.3466529	0.101208456	0.20104732	MODULE_303	28	0.9349885	0.5631068	0.99501425	2.2816414	0.4116644
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS	c5.BP_ GO biological process	227	1.3465892	0.003436426	0.20107973	GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS	242	1.1821558	0.10251256	0.619601	2.528745	0.1644334
GO_ACTIN_FILAMENT_BASED_PROCESS	c5.BP_ GO biological process	406	1.3461491	0.002134472	0.20177932	GO_ACTIN_FILAMENT_BASED_PROCESS	419	1.236501	0.01001001	0.5312126	2.5826501	0.1096481
CHR14Q32	C1: positional gene sets	98	1.3461467	0.044678055	0.20170121	CHR14Q32	114	1.3089561	0.036382537	0.42747226	2.6551028	0.0371906
GO_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY	c5.BP_ GO biological process	306	1.346088	0.003303965	0.20171781	GO_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY	329	1.1355103	0.122122124	0.6963897	2.4815983	0.2105777
MODULE_189	c4.CM_ cancer modules	18	1.3460149	0.1095008	0.20175727	MODULE_189	18	-1.4502543	0.04845815	0.17322323	-0.1042394	2.7962692
GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY	c5.GO molecular function	62	1.3460052	0.058423914	0.20169237	GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY	64	1.0644077	0.38653636	0.8154019	2.4104129	0.2815975
GO_REGULATION_OF_FIBROBLAST_PROLIFERATION	c5.BP_ GO biological process	74	1.3457814	0.06081081	0.20200154	GO_REGULATION_OF_FIBROBLAST_PROLIFERATION	76	1.0766679	0.35275424	0.7942764	2.4224493	0.2691135
CHR17Q23	C1: positional gene sets	58	1.3457581	0.055020634	0.20196211	CHR17Q23	62	1.3031005	0.07776561	0.43659505	2.6488586	0.0426576
GO_REFLEX	c5.BP_ GO biological process	16	1.3456541	0.10894309	0.20207202	GO_REFLEX	19	1.0731622	0.40101522	0.8005043	2.4188163	0.2724919
GO_REGULATION_OF_PHOSPHATASE_ACTIVITY	c5.BP_ GO biological process	106	1.345557	0.048933502	0.20214586	GO_REGULATION_OF_PHOSPHATASE_ACTIVITY	110	1.0073681	0.4906639	0.9117284	2.3529251	0.3381889
MODULE_205	c4.CM_ cancer modules	253	1.3455315	0.015801355	0.20210645	MODULE_205	262	1.0764552	0.2994975	0.7943005	2.4219867	0.2690763
GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN	C7_ immunologic signatures	137	1.3452594	0.04117647	0.2024947	GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN	141	-1.0662566	0.2962963	0.5764681	0.2790028	2.411516
GO_AORTA_MORPHOGENESIS	c5.BP_ GO biological process	21	1.3451855	0.10350318	0.20253155	GO_AORTA_MORPHOGENESIS	22	-1.0921305	0.30481285	0.5302422	0.253055	2.437316
BILD_CTNNB1_ONCOGENIC_SIGNATURE	c2.CGP_ chemical and genetic perturbations	69	1.3450596	0.062334217	0.20267668	BILD_CTNNB1_ONCOGENIC_SIGNATURE	70	0.70580167	0.92290986	1	2.05086127	0.63925793
GO_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT	c5.BP_ GO biological process	117	1.3450007	0.02685422	0.20271188	GO_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT	122	0.87204516	0.7528205	1	2.21704586	0.47295554
GO_TISSUE_REGENERATION	c5.BP_ GO biological process	41	1.3448182	0.078461535	0.20294727	GO_TISSUE_REGENERATION	44	-1.2714921	0.06451613	0.30895975	0.0733261	2.6163103
GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN	C7_ immunologic signatures	160	1.3448113	0.019583844	0.20287926	GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN	165	1.0971332	0.27878788	0.76048714	2.4419445	0.2476781
JEON_SMAD6_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	21	1.344634	0.10801964	0.20312408	JEON_SMAD6_TARGETS_UP	20	1.5515518	0.016709512	0.20723552	2.8961858	-0.2069178
GO_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS	c5.BP_ GO biological process	32	1.3445916	0.086181276	0.2031195	GO_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS	34	0.8126498	0.7699531	1	2.1572414	0.5319418
MEF2_Q6_01	c3.TFT_ transcription factor targets	206	1.3444924	0.017084282	0.20320909	MEF2_Q6_01	216	1.0175693	0.45216516	0.89369684	2.3620617	0.3269231
GO_PROTEOGLYCAN_METABOLIC_PROCESS	c5.BP_ GO biological process	76	1.3444188	0.05170068	0.20325468	GO_PROTEOGLYCAN_METABOLIC_PROCESS	80	1.2463638	0.10430107	0.51713413	2.5907826	0.098055
GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP	C7_ immunologic signatures	132	1.3443878	0.03101737	0.20322618	GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP	135	0.7919584	0.8886619	1	2.1363462	0.5524294
GO_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION	c5.BP_ GO biological process	27	1.3443189	0.09633028	0.20326452	GO_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION	27	1.1787152	0.2309613	0.6240008	2.5230341	0.1656037
GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP	C7_ immunologic signatures	173	1.3442553	0.02021403	0.20328675	GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP	177	1.2385054	0.06504065	0.5274531	2.5827607	0.1057499
GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION	c5.BP_ GO biological process	137	1.344148	0.028151775	0.20339662	GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION	140	0.94390094	0.62538385	0.9887621	2.28804894	0.40024706
REACTOME_HS_GAG_BIOSYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	28	1.3441168	0.09561128	0.20336483	REACTOME_HS_GAG_BIOSYNTHESIS	30	1.2941985	0.13438256	0.4509509	2.6383153	0.0499183
GO_CELL_FATE_DETERMINATION	c5.BP_ GO biological process	31	1.3440764	0.07573416	0.20335534	GO_CELL_FATE_DETERMINATION	41	0.83975214	0.74625146	1	2.18382854	0.50432426
GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	C7_ immunologic signatures	172	1.344075	0.02	0.2032763	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	176	1.1103283	0.24365482	0.73713523	2.4544033	0.2337467
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	c2.CGP_ chemical and genetic perturbations	313	1.3440261	0.004376368	0.203274	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	325	1.2352746	0.035105314	0.5328281	2.5793007	0.1087515
GO_VACUOLE_ORGANIZATION	c5.BP_ GO biological process	148	1.3438978	0.02997602	0.20343049	GO_VACUOLE_ORGANIZATION	149	1.1891541	0.13061224	0.60606545	2.5330519	0.1547437
GSE17721_POLYIC_VS_CPG_16H_BMDC_UP	C7_ immunologic signatures	174	1.343754	0.018359853	0.20359579	GSE17721_POLYIC_VS_CPG_16H_BMDC_UP	182	0.91287404	0.7128413	1	2.25662804	0.43087996
GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN	C7_ immunologic signatures	169	1.3436849	0.025029797	0.20362967	GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN	169	0.888991	0.75458246	1	2.2326759	0.4546939
GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN	C7_ immunologic signatures	172	1.3436487	0.031400967	0.20362115	GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN	181	1.2425511	0.057401814	0.5219062	2.5861998	0.1010976
GO_STEROID_HYDROXYLASE_ACTIVITY	c5.GO molecular function	23	1.3435396	0.10664606	0.20371626	GO_STEROID_HYDROXYLASE_ACTIVITY	24	1.6874712	0.006060606	0.086155005	3.0310108	-0.3439316
GO_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS	c5.GO molecular function	101	1.3433927	0.048780486	0.20389315	GO_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS	102	0.9489394	0.6151452	0.98346704	2.2923321	0.3944533
GO_ANTIPORTER_ACTIVITY	c5.GO molecular function	60	1.3433855	0.045779686	0.20382783	GO_ANTIPORTER_ACTIVITY	66	1.0340114	0.44444445	0.8696595	2.3773969	0.3093741
GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN	C7_ immunologic signatures	176	1.3432682	0.014475271	0.20395243	GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN	181	1.1004877	0.25075835	0.756397	2.4437559	0.2427805
GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN	C7_ immunologic signatures	172	1.3432424	0.024881518	0.2039105	GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN	181	0.7159648	0.9606855	1	2.0592072	0.6272776
JEON_SMAD6_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	18	1.3429289	0.10191083	0.20437145	JEON_SMAD6_TARGETS_DN	19	1.2748084	0.15057915	0.4808055	2.6177373	0.0681205
GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS	c5.BP_ GO biological process	27	1.3428077	0.103235744	0.2045094	GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS	26	0.8909389	0.6506765	1	2.2337466	0.4518688
GAJATE_RESPONSE_TO_TRABECTEDIN_UP	c2.CGP_ chemical and genetic perturbations	60	1.3427352	0.069986545	0.20454955	GAJATE_RESPONSE_TO_TRABECTEDIN_UP	61	0.9957041	0.4989035	0.9297499	2.3384393	0.3470311
ESC_J1_UP_EARLY.V1_DN	C6_ oncogenic signatures	162	1.3426471	0.029515939	0.20462038	ESC_J1_UP_EARLY.V1_DN	166	0.9860532	0.5283401	0.9407893	2.3287003	0.3565939
GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN	C7_ immunologic signatures	168	1.3426163	0.02286402	0.2045905	GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN	170	1.1120858	0.25714287	0.7343412	2.4547021	0.2305305
GO_HORMONE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	34	1.342541	0.09763314	0.2046368	GO_HORMONE_BIOSYNTHETIC_PROCESS	37	1.1268048	0.28950405	0.7115452	2.4693458	0.2157362
GO_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT	c5.BP_ GO biological process	67	1.3424144	0.061728396	0.20477	GO_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT	66	1.1279863	0.28910464	0.7089256	2.4704007	0.2144281
GSE3982_MAC_VS_BCELL_UP	C7_ immunologic signatures	181	1.3423771	0.021052632	0.20475015	GSE3982_MAC_VS_BCELL_UP	184	1.520414	0	0.23674046	2.8627911	-0.1780369
GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN	C7_ immunologic signatures	184	1.3423765	0.026284348	0.20467037	GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN	186	-0.91386086	0.85714287	0.8020281	0.42851564	2.25623736
HALLMARK_P53_PATHWAY	H_ hallmark gene sets	186	1.342211	0.01635514	0.20488939	HALLMARK_P53_PATHWAY	188	1.6177615	0	0.1443071	2.9599725	-0.2755505
TAAYNRNNTCC_UNKNOWN	c3.TFT_ transcription factor targets	147	1.3421819	0.030012004	0.20485866	TAAYNRNNTCC_UNKNOWN	152	0.90823525	0.6963563	1	2.25041715	0.43394665
LINDSTEDT_DENDRITIC_CELL_MATURATION_C	c2.CGP_ chemical and genetic perturbations	59	1.342142	0.06433567	0.20485197	LINDSTEDT_DENDRITIC_CELL_MATURATION_C	62	0.99134964	0.518559	0.93418497	2.33349164	0.35079236
CHR8P23	C1: positional gene sets	38	1.3421038	0.10058309	0.20482837	CHR8P23	43	1.2836546	0.11149425	0.46671107	2.6257584	0.0584492
GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP	C7_ immunologic signatures	135	1.3420986	0.048250906	0.20475866	GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP	139	1.0395598	0.43002027	0.8590285	2.3816584	0.3025388
LANDIS_BREAST_CANCER_PROGRESSION_DN	c2.CGP_ chemical and genetic perturbations	65	1.3420857	0.059863947	0.20470189	LANDIS_BREAST_CANCER_PROGRESSION_DN	67	1.0309196	0.43311402	0.87390476	2.3730053	0.3111661
GO_TRANSLESION_SYNTHESIS	c5.BP_ GO biological process	34	1.3418796	0.07324365	0.20498738	GO_TRANSLESION_SYNTHESIS	34	-1.0618707	0.33734939	0.5841634	0.2800089	2.4037503
KIM_GLIS2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	73	1.3418244	0.055405404	0.20501268	KIM_GLIS2_TARGETS_UP	74	1.1714195	0.20927724	0.6356785	2.5132439	0.1704049
GO_EPIDERMIS_DEVELOPMENT	c5.BP_ GO biological process	189	1.3417963	0.017605634	0.20497546	GO_EPIDERMIS_DEVELOPMENT	200	1.1733005	0.12323232	0.63356274	2.5150968	0.1684958
SENESE_HDAC3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	456	1.3417331	0.002096436	0.2050066	SENESE_HDAC3_TARGETS_DN	465	1.055075	0.296	0.8330025	2.3968081	0.2866581
PEDRIOLI_MIR31_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	159	1.3416529	0.04186603	0.20506865	PEDRIOLI_MIR31_TARGETS_UP	170	1.0314286	0.4326241	0.87438995	2.3730815	0.3102243
GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP	C7_ immunologic signatures	171	1.3414764	0.017401392	0.20530033	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP	174	1.1804485	0.12462006	0.6233289	2.5219249	0.1610279
GO_AMMONIUM_ION_BINDING	c5.GO molecular function	42	1.3414403	0.07647908	0.20528142	GO_AMMONIUM_ION_BINDING	58	1.2811322	0.109877914	0.4706808	2.6225725	0.0603081
GO_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS	c5.BP_ GO biological process	17	1.3413721	0.11433172	0.20531833	GO_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS	18	1.2738147	0.15223098	0.48164204	2.6151868	0.0675574
CEBP_C	c3.TFT_ transcription factor targets	175	1.3411866	0.033613447	0.2055829	CEBP_C	177	0.9872483	0.5479314	0.9390854	2.3284349	0.3539383
GO_MYOSIN_COMPLEX	c5.CC_ GO cellular component	53	1.3411124	0.07042254	0.20562592	GO_MYOSIN_COMPLEX	62	1.3397934	0.047566373	0.3964897	2.6809058	0.001319
GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP	C7_ immunologic signatures	178	1.341026	0.022300469	0.2056944	GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP	179	1.0154579	0.46686748	0.896577	2.3564839	0.3255681
MODULE_6	c4.CM_ cancer modules	352	1.340986	0.007526882	0.20567803	MODULE_6	365	1.2697749	0.01001001	0.48510277	2.6107609	0.0712111
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	c2.CGP_ chemical and genetic perturbations	53	1.3408172	0.072524406	0.2058742	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	54	1.1199745	0.2916201	0.7230675	2.4607917	0.2208427
GO_REGULATION_OF_TELOMERASE_ACTIVITY	c5.BP_ GO biological process	41	1.3407947	0.089855075	0.20582946	GO_REGULATION_OF_TELOMERASE_ACTIVITY	41	1.1633526	0.24393064	0.64786035	2.5041473	0.1774421
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	c2.CGP_ chemical and genetic perturbations	142	1.3406621	0.027127003	0.20598498	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	143	1.5133951	0.001026694	0.2379311	2.8540572	-0.172733
GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	C7_ immunologic signatures	175	1.3406287	0.023170732	0.20595989	GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	181	1.220575	0.076845296	0.5546086	2.5612037	0.1200537
GO_RESPONSE_TO_ACETYLCHOLINE	c5.BP_ GO biological process	15	1.3405662	0.1267388	0.20599441	GO_RESPONSE_TO_ACETYLCHOLINE	15	0	0	0	1.3405662	1.3405662
GO_NOTCH_BINDING	c5.GO molecular function	17	1.3404456	0.12539186	0.20611475	GO_NOTCH_BINDING	16	-0.9257073	0.5767635	0.78843325	0.4147383	2.2661529
GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	179	1.3402593	0.024852071	0.2063437	GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP	182	0.9319149	0.6787879	0.9977107	2.2721742	0.4083444
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP	C7_ immunologic signatures	145	1.3400117	0.030864198	0.20669867	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP	148	1.1654959	0.16276704	0.6459085	2.5055076	0.1745158
GO_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION	c5.BP_ GO biological process	174	1.3398725	0.025943397	0.2068591	GO_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION	190	0.78455806	0.9103726	1	2.12443056	0.55531444
NELSON_RESPONSE_TO_ANDROGEN_DN	c2.CGP_ chemical and genetic perturbations	17	1.3398595	0.11447811	0.20680346	NELSON_RESPONSE_TO_ANDROGEN_DN	18	0.98752964	0.5070243	0.93899095	2.32738914	0.35232986
GO_TAXIS	c5.BP_ GO biological process	381	1.339757	0.007462686	0.20691347	GO_TAXIS	407	1.0830216	0.257	0.78209627	2.4227786	0.2567354
GO_MECHANORECEPTOR_DIFFERENTIATION	c5.BP_ GO biological process	45	1.3397163	0.067746684	0.20690207	GO_MECHANORECEPTOR_DIFFERENTIATION	47	0.87068087	0.69515014	1	2.21039717	0.46903543
GO_NEGATIVE_REGULATION_OF_TOR_SIGNALING	c5.BP_ GO biological process	30	1.3395272	0.09009009	0.20714393	GO_NEGATIVE_REGULATION_OF_TOR_SIGNALING	30	0.7098425	0.880579	1	2.0493697	0.6296847
GO_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION	c5.BP_ GO biological process	84	1.3395241	0.05628272	0.20707113	GO_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION	90	1.0127882	0.47775424	0.9023135	2.3523123	0.3267359
GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP	C7_ immunologic signatures	160	1.3394144	0.02286402	0.20718707	GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP	162	0.9483879	0.60510206	0.98383766	2.2878023	0.3910265
P53_02	c3.TFT_ transcription factor targets	222	1.3392109	0.016055046	0.20743796	P53_02	227	1.3239979	0.01004016	0.40901235	2.6632088	0.015213
GO_CEREBRAL_CORTEX_DEVELOPMENT	c5.BP_ GO biological process	97	1.3389972	0.042384107	0.20773554	GO_CEREBRAL_CORTEX_DEVELOPMENT	101	0.9782219	0.5240586	0.95187557	2.3172191	0.3607753
HALLMARK_TGF_BETA_SIGNALING	H_ hallmark gene sets	53	1.3388212	0.08146068	0.20796764	HALLMARK_TGF_BETA_SIGNALING	53	0.7689821	0.8442714	1	2.1078033	0.5698391
GO_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION	c5.BP_ GO biological process	88	1.3387747	0.054474708	0.20797469	GO_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION	91	-1.1785561	0.15789473	0.40615374	0.1602186	2.5173308
GO_METALLOENDOPEPTIDASE_ACTIVITY	c5.GO molecular function	92	1.3385773	0.053040102	0.20824727	GO_METALLOENDOPEPTIDASE_ACTIVITY	98	1.2665745	0.099894844	0.4890161	2.6051518	0.0720028
GO_ORGAN_GROWTH	c5.BP_ GO biological process	61	1.338398	0.06397775	0.20846567	GO_ORGAN_GROWTH	62	-1.001064	0.45555556	0.68421316	0.337334	2.339462
CHR4Q32	C1: positional gene sets	27	1.3381482	0.09911243	0.20883714	CHR4Q32	31	1.0686704	0.39479905	0.8077372	2.4068186	0.2694778
GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP	C7_ immunologic signatures	151	1.3381279	0.03071253	0.2087883	GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP	155	1.0096563	0.4903357	0.9083287	2.3477842	0.3284716
BEIER_GLIOMA_STEM_CELL_UP	c2.CGP_ chemical and genetic perturbations	31	1.3380817	0.095826894	0.20879082	BEIER_GLIOMA_STEM_CELL_UP	32	1.002624	0.4799514	0.9188779	2.3407057	0.3354577
GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	172	1.3379472	0.021582734	0.20896949	GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	178	1.1376927	0.1951466	0.6945749	2.4756399	0.2002545
GO_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR	c5.BP_ GO biological process	153	1.3378611	0.03229665	0.2090289	GO_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR	153	-0.99850124	0.4375	0.68802017	0.33935986	2.33636234
WESTON_VEGFA_TARGETS	c2.CGP_ chemical and genetic perturbations	93	1.337792	0.04712042	0.20907503	WESTON_VEGFA_TARGETS	95	0.9479079	0.58606124	0.98407775	2.2856999	0.3898841
GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP	C7_ immunologic signatures	179	1.3376851	0.021818181	0.20917824	GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP	176	0.8621288	0.7912867	1	2.1998139	0.4755563
CDPCR3HD_01	c3.TFT_ transcription factor targets	208	1.3375806	0.01033295	0.2092893	CDPCR3HD_01	211	0.95027524	0.64040405	0.9818379	2.28785584	0.38730536
MORF_PAX7	c4.CGN_ cancer gene neighborhoods	200	1.3374388	0.025345622	0.20946375	MORF_PAX7	222	1.0675848	0.3279678	0.8096817	2.4050236	0.269854
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN	C7_ immunologic signatures	183	1.3371358	0.028402368	0.20992059	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN	181	0.7966422	0.8978766	1	2.133778	0.5404936
HALLMARK_KRAS_SIGNALING_DN	H_ hallmark gene sets	153	1.3369876	0.029940119	0.21009947	HALLMARK_KRAS_SIGNALING_DN	170	1.1928356	0.11405295	0.60030764	2.5298232	0.144152
GO_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS	c5.BP_ GO biological process	95	1.3369853	0.041775458	0.21002351	GO_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS	95	1.0946926	0.3080125	0.7654393	2.4316779	0.2422927
GO_EPHRIN_RECEPTOR_ACTIVITY	c5.GO molecular function	18	1.3368516	0.10064935	0.21016419	GO_EPHRIN_RECEPTOR_ACTIVITY	19	0.9390285	0.55266577	0.99118847	2.2758801	0.3978231
GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	89	1.3367373	0.04576043	0.21027862	GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	98	0.9210114	0.66560847	1	2.2577487	0.4157259
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN	C7_ immunologic signatures	169	1.3367232	0.020334927	0.21022195	GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN	170	0.68222505	0.974645	1	2.01894825	0.65449815
GO_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT	c5.BP_ GO biological process	28	1.3366847	0.084226646	0.21021016	GO_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT	30	1.3284265	0.08225617	0.40372482	2.6651112	0.0082582
GO_DNA_DEPENDENT_ATPASE_ACTIVITY	c5.GO molecular function	75	1.33657	0.045393858	0.21033356	GO_DNA_DEPENDENT_ATPASE_ACTIVITY	75	-1.3701118	0	0.22667451	-0.0335418	2.7066818
GAGACTG_MIR452	c3.MIR_ microRNA targets	91	1.336425	0.05511811	0.21050751	GAGACTG_MIR452	92	-1.0736897	0.29508197	0.56375974	0.2627353	2.4101147
GO_REGULATION_OF_LIPASE_ACTIVITY	c5.BP_ GO biological process	74	1.3363836	0.07198953	0.2105032	GO_REGULATION_OF_LIPASE_ACTIVITY	77	0.9945884	0.5059331	0.93039477	2.330972	0.3417952
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	c2.CGP_ chemical and genetic perturbations	192	1.3362598	0.030373832	0.21064857	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	211	1.295678	0.022088353	0.44916376	2.6319378	0.0405818
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	C7_ immunologic signatures	183	1.3362586	0.022093024	0.2105698	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	184	-1.3643348	0	0.230603	-0.0280762	2.7005934
CUI_TCF21_TARGETS_2_UP	c2.CGP_ chemical and genetic perturbations	383	1.3357784	0.005411256	0.21131888	CUI_TCF21_TARGETS_2_UP	393	0.7140834	0.993994	1	2.0498618	0.621695
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	c2.CGP_ chemical and genetic perturbations	35	1.3356131	0.08656716	0.21151839	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	35	1.0068611	0.48541424	0.9124626	2.3424742	0.328752
GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP	C7_ immunologic signatures	171	1.3355297	0.026097272	0.2115819	GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP	172	-1.0746582	0.26666668	0.5620305	0.2608715	2.4101879
GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	152	1.3354731	0.032412965	0.21159984	GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	151	0.807212	0.87742597	1	2.1426851	0.5282611
GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN	C7_ immunologic signatures	153	1.335465	0.035194173	0.21153429	GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN	160	1.0361798	0.41860464	0.8657577	2.3716448	0.2992852
GO_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY	c5.BP_ GO biological process	31	1.335312	0.075235106	0.21172027	GO_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY	33	1.0405613	0.4247246	0.8586131	2.3758733	0.2947507
GSE22886_TH1_VS_TH2_48H_ACT_UP	C7_ immunologic signatures	160	1.3352168	0.015240328	0.2118017	GSE22886_TH1_VS_TH2_48H_ACT_UP	170	1.1768949	0.14022517	0.62664497	2.5121117	0.1583219
GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP	C7_ immunologic signatures	146	1.3349817	0.033088237	0.21214062	GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP	153	0.8719967	0.7783452	1	2.2069784	0.462985
HOOI_ST7_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	97	1.3342239	0.053915277	0.21342641	HOOI_ST7_TARGETS_DN	101	1.3532884	0.028451001	0.38207772	2.6875123	-0.0190645
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	c2.CGP_ chemical and genetic perturbations	54	1.3341464	0.072524406	0.21348028	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	54	1.1939276	0.1768018	0.5992467	2.528074	0.1402188
GO_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY	c5.BP_ GO biological process	29	1.3341238	0.109445274	0.21343851	GO_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY	30	-0.89590216	0.6136364	0.8270559	0.43822164	2.23002596
GO_SODIUM_CHANNEL_REGULATOR_ACTIVITY	c5.GO molecular function	28	1.3341238	0.11566618	0.21335688	GO_SODIUM_CHANNEL_REGULATOR_ACTIVITY	28	1.0885825	0.3595238	0.77307975	2.4227063	0.2455413
GO_MYELOID_DENDRITIC_CELL_DIFFERENTIATION	c5.BP_ GO biological process	19	1.3339723	0.09595203	0.21354909	GO_MYELOID_DENDRITIC_CELL_DIFFERENTIATION	17	0.92717695	0.58877283	1	2.26114925	0.40679535
GO_SALIVARY_GLAND_DEVELOPMENT	c5.BP_ GO biological process	31	1.3338277	0.10892587	0.21370885	GO_SALIVARY_GLAND_DEVELOPMENT	30	0.9246276	0.6041924	1	2.2584553	0.4092001
GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN	C7_ immunologic signatures	157	1.3337684	0.035409037	0.2137378	GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN	167	0.79319495	0.88426393	1	2.12696335	0.54057345
GGGCATT_MIR365	c3.MIR_ microRNA targets	100	1.3336786	0.045572918	0.21382003	GGGCATT_MIR365	102	1.0868441	0.32423925	0.7755639	2.4205227	0.2468345
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	347	1.333646	0.005324814	0.21379684	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3	393	1.3038194	0.001	0.43576798	2.6374654	0.0298266
XU_GH1_AUTOCRINE_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	125	1.3335972	0.03762136	0.21380621	XU_GH1_AUTOCRINE_TARGETS_DN	125	0.91434866	0.68237704	1	2.24794586	0.41924854
WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	c2.CGP_ chemical and genetic perturbations	45	1.3334595	0.088405795	0.21395949	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	48	1.4717982	0.012443439	0.27685547	2.8052577	-0.1383387
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	c2.CGP_ chemical and genetic perturbations	18	1.3334582	0.10869565	0.2138797	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	18	1.0557839	0.3953186	0.83168584	2.3892421	0.2776743
GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN	C7_ immunologic signatures	164	1.3333691	0.026252983	0.21394873	GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN	166	1.2155925	0.0938446	0.5653085	2.5489616	0.1177766
AAANWWTGC_UNKNOWN	c3.TFT_ transcription factor targets	171	1.3333173	0.03229665	0.21394998	AAANWWTGC_UNKNOWN	178	0.9342776	0.64271253	0.99540806	2.2675949	0.3990397
MIKKELSEN_IPS_WITH_HCP_H3K27ME3	c2.CGP_ chemical and genetic perturbations	84	1.3331605	0.047872342	0.21417865	MIKKELSEN_IPS_WITH_HCP_H3K27ME3	96	1.5840797	0.001041667	0.17455961	2.9172402	-0.2509192
BMI1_DN.V1_UP	C6_ oncogenic signatures	130	1.3331184	0.04331683	0.21417111	BMI1_DN.V1_UP	131	1.5611058	0.001039501	0.19803497	2.8942242	-0.2279874
GRANDVAUX_IRF3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	16	1.332898	0.1184	0.21449634	GRANDVAUX_IRF3_TARGETS_DN	17	1.0597985	0.40985733	0.82486063	2.3926965	0.2730995
GO_REGULATION_OF_P38MAPK_CASCADE	c5.BP_ GO biological process	24	1.3328289	0.102009274	0.214533	GO_REGULATION_OF_P38MAPK_CASCADE	24	1.053427	0.4160494	0.83639956	2.3862559	0.2794019
GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP	C7_ immunologic signatures	179	1.332807	0.02173913	0.21449076	GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP	183	1.0071285	0.48882115	0.9121008	2.3399355	0.3256785
GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP	C7_ immunologic signatures	177	1.332794	0.028368793	0.21443203	GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP	178	1.2146046	0.09173387	0.5680325	2.5473986	0.1181894
GO_EXOCYTOSIS	c5.BP_ GO biological process	271	1.3327733	0.01230425	0.21437736	GO_EXOCYTOSIS	280	1.3343084	0.002004008	0.39869073	2.6670817	-0.0015351
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	c2.CGP_ chemical and genetic perturbations	215	1.332601	0.01836969	0.21461134	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	220	1.0989287	0.25401607	0.7583226	2.4315297	0.2336723
GO_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY	c5.BP_ GO biological process	38	1.332572	0.085074626	0.21457973	GO_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY	41	1.0398132	0.43422586	0.8592805	2.3723852	0.2927588
GO_REGULATION_OF_INTERFERON_BETA_PRODUCTION	c5.BP_ GO biological process	40	1.3324546	0.08689459	0.21470502	GO_REGULATION_OF_INTERFERON_BETA_PRODUCTION	40	0.76505184	0.83314544	1	2.09750644	0.56740276
GO_CARDIAC_SEPTUM_MORPHOGENESIS	c5.BP_ GO biological process	45	1.3324279	0.09343065	0.21467564	GO_CARDIAC_SEPTUM_MORPHOGENESIS	47	-0.9661458	0.5068493	0.7345306	0.3662821	2.2985737
GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN	C7_ immunologic signatures	174	1.3323575	0.021924483	0.21470927	GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN	182	1.0347186	0.41229838	0.8679723	2.3670761	0.2976389
GO_COCHLEA_MORPHOGENESIS	c5.BP_ GO biological process	20	1.3323169	0.119195044	0.21471414	GO_COCHLEA_MORPHOGENESIS	21	0.82189894	0.74654955	1	2.15421584	0.51041796
MODULE_92	c4.CM_ cancer modules	106	1.3323008	0.04725415	0.21466132	MODULE_92	124	1.1974678	0.13729508	0.5971101	2.5297686	0.134833
ALPHACP1_01	c3.TFT_ transcription factor targets	226	1.3322921	0.008101852	0.21459429	ALPHACP1_01	239	1.0349132	0.4264113	0.86802864	2.3672053	0.2973789
CTGAGCC_MIR24	c3.MIR_ microRNA targets	209	1.3322389	0.026436782	0.21460333	CTGAGCC_MIR24	212	0.9221162	0.694332	1	2.2543551	0.4101227
GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN	C7_ immunologic signatures	169	1.3321536	0.02606635	0.2146676	GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN	173	0.9901595	0.53509665	0.9352043	2.3223131	0.3419941
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	178	1.3320804	0.022274327	0.21472014	GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	178	1.1157522	0.2413442	0.73003435	2.4478326	0.2163282
GO_NEGATIVE_REGULATION_OF_MAPK_CASCADE	c5.BP_ GO biological process	135	1.3319407	0.038509317	0.21490158	GO_NEGATIVE_REGULATION_OF_MAPK_CASCADE	138	0.879034	0.7417355	1	2.2109747	0.4529067
GO_PROTEIN_HETERODIMERIZATION_ACTIVITY	c5.GO molecular function	374	1.3318503	0.005364807	0.21498549	GO_PROTEIN_HETERODIMERIZATION_ACTIVITY	392	1.0576818	0.309	0.8280099	2.3895321	0.2741685
GSE7852_LN_VS_THYMUS_TREG_DN	C7_ immunologic signatures	183	1.3317412	0.026837807	0.21509318	GSE7852_LN_VS_THYMUS_TREG_DN	181	0.6920216	0.9696663	1	2.0237628	0.6397196
MORF_MYC	c4.CGN_ cancer gene neighborhoods	61	1.3317122	0.06320225	0.21507187	MORF_MYC	69	0.9373923	0.6186349	0.9933073	2.2691045	0.3943199
GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	117	1.3315557	0.03379224	0.21527694	GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	119	0.9263139	0.6642562	1	2.2578696	0.4052418
GO_CELLULAR_RESPONSE_TO_KETONE	c5.BP_ GO biological process	65	1.3315226	0.06639566	0.21525528	GO_CELLULAR_RESPONSE_TO_KETONE	65	0.5910861	0.9846491	1	1.9226087	0.7404365
WEBER_METHYLATED_IN_COLON_CANCER	c2.CGP_ chemical and genetic perturbations	15	1.3314024	0.13311689	0.21539858	WEBER_METHYLATED_IN_COLON_CANCER	17	-1.1107895	0.28514057	0.50489885	0.2206129	2.4421919
GSE3982_NKCELL_VS_TH2_UP	C7_ immunologic signatures	165	1.3311983	0.03221957	0.21567585	GSE3982_NKCELL_VS_TH2_UP	166	1.0013714	0.5147808	0.9214079	2.3325697	0.3298269
GO_CATECHOLAMINE_METABOLIC_PROCESS	c5.BP_ GO biological process	28	1.3309798	0.10194903	0.21598251	GO_CATECHOLAMINE_METABOLIC_PROCESS	36	0.7121052	0.88644266	1	2.043085	0.6188746
GO_LYMPHOCYTE_MEDIATED_IMMUNITY	c5.BP_ GO biological process	95	1.3308117	0.052287582	0.21620247	GO_LYMPHOCYTE_MEDIATED_IMMUNITY	110	1.0723184	0.36666667	0.8023391	2.4031301	0.2584933
GO_NEGATIVE_REGULATION_OF_VIRAL_PROCESS	c5.BP_ GO biological process	69	1.3307685	0.062334217	0.2161961	GO_NEGATIVE_REGULATION_OF_VIRAL_PROCESS	71	0.94472766	0.5771739	0.98767334	2.27549616	0.38604084
GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP	C7_ immunologic signatures	133	1.3307475	0.03663004	0.21615079	GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP	134	1.2575824	0.06714876	0.49954003	2.5883299	0.0731651
GO_RIBONUCLEOTIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	27	1.3307236	0.10438729	0.21611188	GO_RIBONUCLEOTIDE_CATABOLIC_PROCESS	27	1.0027881	0.475	0.91864747	2.3335117	0.3279355
KEGG_AXON_GUIDANCE	c2.CP_BIOCARTA_ BioCarta gene sets	124	1.3306379	0.0373599	0.21618761	KEGG_AXON_GUIDANCE	125	1.1179705	0.25746652	0.7271519	2.4486084	0.2126674
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	C7_ immunologic signatures	179	1.3305312	0.0315534	0.21631128	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	182	1.204233	0.096056625	0.58367425	2.5347642	0.1262982
GO_REGULATION_OF_URINE_VOLUME	c5.BP_ GO biological process	16	1.3305117	0.12857144	0.21626812	GO_REGULATION_OF_URINE_VOLUME	19	1.3324382	0.10161091	0.39974216	2.6629499	-0.0019265
GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN	C7_ immunologic signatures	181	1.3303318	0.02366864	0.21652158	GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN	181	0.99364054	0.5365112	0.9310907	2.32397234	0.33669126
SESTO_RESPONSE_TO_UV_C2	c2.CGP_ chemical and genetic perturbations	52	1.3302817	0.07647908	0.21653141	SESTO_RESPONSE_TO_UV_C2	52	-1.0421461	0.3898305	0.6183778	0.2881356	2.3724278
GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN	C7_ immunologic signatures	123	1.3302357	0.04477612	0.21654685	GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN	126	1.2131582	0.10564102	0.57235736	2.5433939	0.1170775
GO_ENDOCRINE_PROCESS	c5.BP_ GO biological process	33	1.3300666	0.092953525	0.21677846	GO_ENDOCRINE_PROCESS	40	0.62445855	0.96342856	1	1.95452515	0.70560805
GATA1_04	c3.TFT_ transcription factor targets	214	1.3300353	0.021965317	0.21675694	GATA1_04	220	1.1121942	0.21586345	0.7341529	2.4422295	0.2178411
GO_EXTRACELLULAR_MATRIX_DISASSEMBLY	c5.BP_ GO biological process	64	1.3300314	0.06957708	0.21668054	GO_EXTRACELLULAR_MATRIX_DISASSEMBLY	65	1.3572654	0.04189636	0.37906078	2.6872968	-0.027234
ACATTCC_MIR1_MIR206	c3.MIR_ microRNA targets	271	1.3300037	0.013498313	0.21664053	ACATTCC_MIR1_MIR206	273	-0.9787698	0.6666667	0.71587163	0.3512339	2.3087735
GSE27786_CD4_VS_CD8_TCELL_UP	C7_ immunologic signatures	178	1.3297795	0.031212484	0.21698213	GSE27786_CD4_VS_CD8_TCELL_UP	181	1.1954256	0.10942249	0.59700876	2.5252051	0.1343539
OHM_METHYLATED_IN_ADULT_CANCERS	c2.CGP_ chemical and genetic perturbations	25	1.3297758	0.114779875	0.21691237	OHM_METHYLATED_IN_ADULT_CANCERS	26	1.3584615	0.079746835	0.3778757	2.6882373	-0.0286857
GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP	C7_ immunologic signatures	177	1.3296032	0.026378896	0.2171473	GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP	175	1.0926012	0.29137057	0.768421	2.4222044	0.237002
GO_PHOSPHOLIPASE_C_ACTIVITY	c5.GO molecular function	26	1.3295815	0.11377245	0.21710181	GO_PHOSPHOLIPASE_C_ACTIVITY	30	1.3537894	0.07526882	0.38268393	2.6833709	-0.0242079
CTAWWWATA_RSRFC4_Q2	c3.TFT_ transcription factor targets	311	1.3295184	0.013422819	0.21713975	CTAWWWATA_RSRFC4_Q2	325	1.029096	0.4034034	0.87701696	2.3586144	0.3004224
GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP	C7_ immunologic signatures	134	1.3293827	0.04477612	0.21730174	GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP	144	0.9694758	0.5574771	0.96184504	2.2988585	0.3599069
GO_WNT_PROTEIN_BINDING	c5.GO molecular function	29	1.3292881	0.09212481	0.21739714	GO_WNT_PROTEIN_BINDING	29	1.216939	0.19193155	0.5623859	2.5462271	0.1123491
GO_PROTEIN_KINASE_C_ACTIVITY	c5.GO molecular function	15	1.3291698	0.12643678	0.21752581	GO_PROTEIN_KINASE_C_ACTIVITY	16	1.502055	0.020887729	0.25240278	2.8312248	-0.1728852
GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	183	1.3290197	0.02275449	0.21771365	GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	183	1.0589142	0.36455187	0.8264733	2.3879339	0.2701055
GO_HORMONE_ACTIVITY	c5.GO molecular function	67	1.3287861	0.06821282	0.21807463	GO_HORMONE_ACTIVITY	86	1.00335	0.50537634	0.917394	2.3321361	0.3254361
GO_ACTIVATION_OF_JUN_KINASE_ACTIVITY	c5.BP_ GO biological process	28	1.3287015	0.108024694	0.2181491	GO_ACTIVATION_OF_JUN_KINASE_ACTIVITY	30	1.2654511	0.13431014	0.48995113	2.5941526	0.0632504
GO_MUSCLE_ORGAN_MORPHOGENESIS	c5.BP_ GO biological process	59	1.3286533	0.07978723	0.2181641	GO_MUSCLE_ORGAN_MORPHOGENESIS	67	0.9279121	0.610687	0.9998003	2.2565654	0.4007412
GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	141	1.3285185	0.037304454	0.21833749	GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	141	0.8938821	0.72131145	1	2.2224006	0.4346364
GO_RESPONSE_TO_OXYGEN_LEVELS	c5.BP_ GO biological process	286	1.3285103	0.01655629	0.21827152	GO_RESPONSE_TO_OXYGEN_LEVELS	293	1.1981151	0.052261308	0.5958624	2.5266254	0.1303952
CHR6P12	C1: positional gene sets	35	1.3284574	0.0890511	0.21829623	CHR6P12	36	1.1434246	0.27920562	0.6836717	2.471882	0.1850328
GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP	C7_ immunologic signatures	166	1.3284289	0.027710844	0.21826215	GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP	177	1.0471306	0.37793666	0.8447553	2.3755595	0.2812983
LIEN_BREAST_CARCINOMA_METAPLASTIC	c2.CGP_ chemical and genetic perturbations	34	1.3280833	0.0960961	0.21881905	LIEN_BREAST_CARCINOMA_METAPLASTIC	35	1.0210379	0.4499411	0.8908878	2.3491212	0.3070454
GSE45365_BCELL_VS_CD8_TCELL_UP	C7_ immunologic signatures	125	1.3280514	0.039653037	0.2187932	GSE45365_BCELL_VS_CD8_TCELL_UP	137	1.351559	0.016309887	0.38341123	2.6796104	-0.0235076
GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN	C7_ immunologic signatures	182	1.327969	0.030480657	0.2188541	GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN	183	0.80968016	0.88531184	1	2.13764916	0.51828884
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	C7_ immunologic signatures	167	1.3278697	0.036275696	0.21895875	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	166	1.2440869	0.057985757	0.5207302	2.5719566	0.0837828
GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT	c5.BP_ GO biological process	84	1.3278575	0.057951484	0.2188986	GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT	93	1.592273	0.001058201	0.17120183	2.9201305	-0.2644155
LEIN_CEREBELLUM_MARKERS	c2.CGP_ chemical and genetic perturbations	73	1.3276163	0.05104712	0.21927494	LEIN_CEREBELLUM_MARKERS	78	0.97877246	0.5229456	0.95081425	2.30638876	0.34884384
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP	C7_ immunologic signatures	118	1.3275837	0.034883723	0.21925549	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP	129	1.3818042	0.01039501	0.3560926	2.7093879	-0.0542205
GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN	C7_ immunologic signatures	146	1.3275454	0.04779412	0.21924387	GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN	150	0.7754593	0.89837396	1	2.1030047	0.5520861
GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	C7_ immunologic signatures	135	1.3273797	0.053682897	0.21945846	GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	138	-0.9153871	0.84	0.8013579	0.4119926	2.2427668
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN	C7_ immunologic signatures	177	1.327135	0.021201413	0.219825	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN	179	1.2014613	0.09543147	0.589426	2.5285963	0.1256737
SRF_01	c3.TFT_ transcription factor targets	46	1.3269383	0.07768361	0.22008896	SRF_01	46	0.9461553	0.578354	0.98608506	2.2730936	0.380783
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	c2.CGP_ chemical and genetic perturbations	167	1.3267816	0.023337223	0.22029486	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	169	1.2587279	0.05775076	0.49815997	2.5855095	0.0680537
MODULE_5	c4.CM_ cancer modules	373	1.3265661	0.00750268	0.2206166	MODULE_5	388	1.3107008	0.002	0.42529982	2.6372669	0.0158653
GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN	C7_ immunologic signatures	168	1.3263913	0.033653848	0.22084486	GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN	168	-1.2957424	0	0.28793582	0.0306489	2.6221337
NIELSEN_LIPOSARCOMA_DN	c2.CGP_ chemical and genetic perturbations	19	1.3263826	0.11821086	0.22077902	NIELSEN_LIPOSARCOMA_DN	19	0.7176998	0.8657289	1	2.0440824	0.6086828
GO_MULTICELLULAR_ORGANISMAL_SIGNALING	c5.BP_ GO biological process	106	1.3262877	0.053315993	0.22086412	GO_MULTICELLULAR_ORGANISMAL_SIGNALING	115	1.1285985	0.24453694	0.707717	2.4548862	0.1976892
MCCLUNG_COCAIN_REWARD_4WK	c2.CGP_ chemical and genetic perturbations	63	1.326164	0.08219178	0.22099997	MCCLUNG_COCAIN_REWARD_4WK	66	1.1214725	0.29053319	0.7219556	2.4476365	0.2046915
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN	C7_ immunologic signatures	169	1.3261521	0.020310633	0.22094205	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN	180	1.5187272	0	0.23580268	2.8448793	-0.1925751
GO_MESONEPHRIC_TUBULE_MORPHOGENESIS	c5.BP_ GO biological process	50	1.325941	0.09192201	0.22124635	GO_MESONEPHRIC_TUBULE_MORPHOGENESIS	52	1.2508601	0.13213886	0.50907147	2.5768011	0.0750809
GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN	C7_ immunologic signatures	149	1.3259287	0.034355827	0.22119305	GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN	160	1.2395195	0.067540325	0.52618176	2.5654482	0.0864092
MODULE_253	c4.CM_ cancer modules	21	1.3258302	0.11145038	0.22129281	MODULE_253	21	1.4211906	0.043708608	0.31961197	2.7470208	-0.0953604
GSE3982_MAST_CELL_VS_TH1_DN	C7_ immunologic signatures	176	1.3257577	0.020286396	0.2213414	GSE3982_MAST_CELL_VS_TH1_DN	179	0.6977369	0.97469634	1	2.0234946	0.6280208
GO_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION	c5.BP_ GO biological process	26	1.325693	0.08688784	0.22137997	GO_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION	23	1.2509035	0.19001219	0.50908816	2.5765965	0.0747895
GSE3982_BCELL_VS_TH2_DN	C7_ immunologic signatures	169	1.3256904	0.028950542	0.22130266	GSE3982_BCELL_VS_TH2_DN	173	0.8492227	0.827447	1	2.1749131	0.4764677
GO_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING	c5.GO molecular function	47	1.3255577	0.09050445	0.22147317	GO_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING	47	1.4896599	0.01368301	0.25933105	2.8152176	-0.1641022
GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP	C7_ immunologic signatures	176	1.325492	0.027027028	0.22151417	GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP	178	1.1729707	0.14097363	0.6329209	2.4984627	0.1525213
GO_CELL_FATE_SPECIFICATION	c5.BP_ GO biological process	57	1.325385	0.078296706	0.22162664	GO_CELL_FATE_SPECIFICATION	68	-1.1091253	0.225	0.50453025	0.2162597	2.4345103
GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP	C7_ immunologic signatures	173	1.3253181	0.036427733	0.22165653	GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP	173	-0.87022233	0.84615386	0.8532528	0.45509577	2.19554043
GSE14350_IL2RB_KO_VS_WT_TREG_DN	C7_ immunologic signatures	183	1.3252933	0.025761124	0.2216226	GSE14350_IL2RB_KO_VS_WT_TREG_DN	187	1.4508741	0.001004016	0.29263607	2.7761674	-0.1255808
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	c2.CGP_ chemical and genetic perturbations	407	1.3252685	0.008547009	0.2215897	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	426	1.32259	0.003	0.41178185	2.6478585	0.0026785
DER_IFN_GAMMA_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	63	1.3251402	0.083102494	0.22173664	DER_IFN_GAMMA_RESPONSE_UP	63	1.2565938	0.11310191	0.5007045	2.581734	0.0685464
SMIRNOV_RESPONSE_TO_IR_6HR_DN	c2.CGP_ chemical and genetic perturbations	101	1.32513	0.05269923	0.22167572	SMIRNOV_RESPONSE_TO_IR_6HR_DN	102	1.1023712	0.30389065	0.7532479	2.4275012	0.2227588
MODULE_458	c4.CM_ cancer modules	27	1.3251026	0.10906298	0.22164907	MODULE_458	28	0.97204506	0.53163016	0.95936054	2.29714766	0.35305754
GO_DIGESTIVE_TRACT_MORPHOGENESIS	c5.BP_ GO biological process	42	1.3250471	0.068571426	0.22167158	GO_DIGESTIVE_TRACT_MORPHOGENESIS	46	-1.2413329	0.07258064	0.3336598	0.0837142	2.56638
GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN	C7_ immunologic signatures	147	1.3250418	0.037214886	0.22159621	GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN	163	1.1870826	0.115384616	0.6111951	2.5121244	0.1379592
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	c2.CGP_ chemical and genetic perturbations	36	1.324725	0.10559006	0.2221057	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	39	1.4021708	0.044032443	0.3368704	2.7268958	-0.0774458
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	c2.CGP_ chemical and genetic perturbations	150	1.3246925	0.042787287	0.22207622	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	151	0.8449788	0.8149284	1	2.1696713	0.4797137
REACTOME_PLATELET_HOMEOSTASIS	c2.CP_REACTOME_ Reactome gene sets	70	1.3246799	0.06892068	0.22201604	REACTOME_PLATELET_HOMEOSTASIS	73	0.7104259	0.91603875	1	2.0351058	0.614254
POU6F1_01	c3.TFT_ transcription factor targets	197	1.3245739	0.028070176	0.22210993	POU6F1_01	204	1.1248255	0.19677094	0.7157341	2.4493994	0.1997484
GO_TRIGLYCERIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	16	1.3245667	0.1322314	0.2220421	GO_TRIGLYCERIDE_CATABOLIC_PROCESS	19	-0.94597864	0.5633803	0.76070815	0.37858806	2.27054534
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	c2.CGP_ chemical and genetic perturbations	50	1.3245432	0.091836736	0.2220057	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	50	1.1614999	0.24772727	0.6508858	2.4860431	0.1630433
STEGER_ADIPOGENESIS_DN	c2.CGP_ chemical and genetic perturbations	25	1.3245202	0.113354035	0.22197036	STEGER_ADIPOGENESIS_DN	25	-1.2352568	0.15270936	0.34003288	0.0892634	2.559777
GO_RESPONSE_TO_UV	c5.BP_ GO biological process	118	1.3243821	0.027777778	0.22214483	GO_RESPONSE_TO_UV	116	0.9133706	0.6840459	1	2.2377527	0.4110115
GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN	C7_ immunologic signatures	162	1.3243698	0.036363635	0.22208613	GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN	170	1.0320348	0.43438452	0.87328297	2.3564046	0.292335
GO_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT	c5.BP_ GO biological process	32	1.3241807	0.088141024	0.2223595	GO_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT	32	1.2999423	0.11604938	0.4426512	2.624123	0.0242384
GO_PROTEIN_KINASE_C_BINDING	c5.GO molecular function	47	1.3240143	0.08882522	0.22259223	GO_PROTEIN_KINASE_C_BINDING	47	1.2494173	0.1369863	0.5118761	2.5734316	0.074597
GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP	C7_ immunologic signatures	170	1.3239356	0.036172695	0.22266214	GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP	173	1.1269051	0.21963562	0.711744	2.4508407	0.1970305
CACCCBINDINGFACTOR_Q6	c3.TFT_ transcription factor targets	238	1.3239124	0.015981736	0.22262736	CACCCBINDINGFACTOR_Q6	245	0.76058096	0.9488978	1	2.08449336	0.56333144
AMIT_EGF_RESPONSE_240_MCF10A	c2.CGP_ chemical and genetic perturbations	19	1.3238689	0.12836768	0.2226319	AMIT_EGF_RESPONSE_240_MCF10A	19	0.71520174	0.8754967	1	2.03907064	0.60866716
GO_POSITIVE_REGULATION_OF_HISTONE_METHYLATION	c5.BP_ GO biological process	27	1.3237892	0.121987954	0.22269036	GO_POSITIVE_REGULATION_OF_HISTONE_METHYLATION	29	-1.3108841	0.09195402	0.27350876	0.0129051	2.6346733
GO_ARACHIDONIC_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	40	1.3237774	0.09051724	0.22263363	GO_ARACHIDONIC_ACID_METABOLIC_PROCESS	39	1.6531937	0.00116144	0.11385633	2.9769711	-0.3294163
GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	C7_ immunologic signatures	183	1.3236784	0.026097272	0.22272511	GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	183	-1.0133747	0.44444445	0.66799265	0.3103037	2.3370531
CTATGCA_MIR153	c3.MIR_ microRNA targets	193	1.3236338	0.016548464	0.22272784	CTATGCA_MIR153	197	0.9088511	0.71471775	1	2.2324849	0.4147827
GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	158	1.323589	0.035714287	0.2227284	GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN	158	1.2976658	0.028629856	0.44609788	2.6212548	0.0259232
GO_RESPONSE_TO_VITAMIN_D	c5.BP_ GO biological process	32	1.3235757	0.1	0.22267447	GO_RESPONSE_TO_VITAMIN_D	32	1.2949411	0.11990408	0.44937992	2.6185168	0.0286346
GO_TRANSMITTER_GATED_CHANNEL_ACTIVITY	c5.GO molecular function	23	1.323523	0.114832535	0.22270055	GO_TRANSMITTER_GATED_CHANNEL_ACTIVITY	26	1.6161116	0.003717472	0.14487916	2.9396346	-0.2925886
LIU_VMYB_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	112	1.3234435	0.056441717	0.22275788	LIU_VMYB_TARGETS_UP	113	1.1767098	0.18467996	0.62677383	2.5001533	0.1467337
GO_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	105	1.3232809	0.046272494	0.22300614	GO_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS	117	1.2225692	0.10309278	0.55232877	2.5458501	0.1007117
GO_AXON_REGENERATION	c5.BP_ GO biological process	22	1.3232733	0.11278196	0.22293709	GO_AXON_REGENERATION	22	0.5579998	0.96441716	1	1.8812731	0.7652735
DORSEY_GAB2_TARGETS	c2.CGP_ chemical and genetic perturbations	28	1.3231941	0.100903615	0.2230172	DORSEY_GAB2_TARGETS	31	1.3024215	0.10714286	0.43746346	2.6256156	0.0207726
GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP	C7_ immunologic signatures	143	1.323087	0.035279807	0.2231373	GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP	145	1.3488138	0.024539877	0.3834265	2.6719008	-0.0257268
NABA_PROTEOGLYCANS	c2.CP_ Canonical pathways	33	1.3229806	0.10309278	0.2232571	NABA_PROTEOGLYCANS	32	0.99018955	0.5077289	0.93522984	2.31317015	0.33279105
GO_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	103	1.3229599	0.0625	0.22321273	GO_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY	119	1.092886	0.32065776	0.7682089	2.4158459	0.2300739
GO_CALCIUM_ION_TRANSPORT	c5.BP_ GO biological process	177	1.3229296	0.036231883	0.22319062	GO_CALCIUM_ION_TRANSPORT	197	1.3708735	0.006036217	0.36718205	2.6938031	-0.0479439
GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP	C7_ immunologic signatures	178	1.3229102	0.022592152	0.2231398	GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP	180	1.0844115	0.3097166	0.7785348	2.4073217	0.2384987
STK33_NOMO_UP	C6_ oncogenic signatures	244	1.3228796	0.014908257	0.2231212	STK33_NOMO_UP	247	1.2116183	0.051102206	0.5747586	2.5344979	0.1112613
GO_ENZYME_ACTIVATOR_ACTIVITY	c5.GO molecular function	411	1.3228157	0.004241782	0.22315529	GO_ENZYME_ACTIVATOR_ACTIVITY	420	1.2747052	0.005005005	0.4810137	2.5975209	0.0481105
MARKEY_RB1_ACUTE_LOF_DN	c2.CGP_ chemical and genetic perturbations	186	1.3227317	0.02476415	0.22323515	MARKEY_RB1_ACUTE_LOF_DN	191	1.1643081	0.14386319	0.6463931	2.4870398	0.1584236
GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP	C7_ immunologic signatures	191	1.3226773	0.02886836	0.22325572	GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP	193	1.3310461	0.013171226	0.4002103	2.6537234	-0.0083688
GSE27786_NKCELL_VS_ERYTHROBLAST_DN	C7_ immunologic signatures	162	1.3223499	0.028811524	0.22377603	GSE27786_NKCELL_VS_ERYTHROBLAST_DN	173	1.3011737	0.017171716	0.43944868	2.6235236	0.0211762
GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP	C7_ immunologic signatures	171	1.3223386	0.033939395	0.22371623	GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP	179	0.6644599	0.9828109	1	1.9867985	0.6578787
GSE11924_TH2_VS_TH17_CD4_TCELL_UP	C7_ immunologic signatures	167	1.3222613	0.03274854	0.22378589	GSE11924_TH2_VS_TH17_CD4_TCELL_UP	176	0.9952489	0.52138495	0.9302347	2.3175102	0.3270124
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN	C7_ immunologic signatures	164	1.3219949	0.037214886	0.22421345	GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN	172	0.8254724	0.8395939	1	2.1474673	0.4965225
GSE12366_GC_VS_MEMORY_BCELL_UP	C7_ immunologic signatures	164	1.3219402	0.046838406	0.22423749	GSE12366_GC_VS_MEMORY_BCELL_UP	168	-1.0012989	0.47058824	0.683837	0.3206413	2.3232391
GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	184	1.3216838	0.032886725	0.22463521	GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP	187	1.2601877	0.041330647	0.49614623	2.5818715	0.0614961
GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP	C7_ immunologic signatures	130	1.3215648	0.033962265	0.22477295	GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP	131	1.3183336	0.025693731	0.41334954	2.6398984	0.0032312
GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	178	1.3215007	0.029550828	0.2248121	GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	180	-0.9236123	0.8095238	0.79094833	0.3978884	2.245113
GO_POSTSYNAPTIC_MEMBRANE_ORGANIZATION	c5.BP_ GO biological process	25	1.3214449	0.12998523	0.2248379	GO_POSTSYNAPTIC_MEMBRANE_ORGANIZATION	25	-1.4415965	0.04347826	0.17805958	-0.1201516	2.7630414
WEST_ADRENOCORTICAL_TUMOR_DN	c2.CGP_ chemical and genetic perturbations	488	1.3212775	0.006269592	0.22506903	WEST_ADRENOCORTICAL_TUMOR_DN	497	1.2325946	0.012	0.53675467	2.5538721	0.0886829
GO_MESENCHYMAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	121	1.321262	0.048843186	0.22501817	GO_MESENCHYMAL_CELL_DIFFERENTIATION	129	-1.3964146	0	0.2101236	-0.0751526	2.7176766
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	174	1.3211063	0.024154589	0.22523603	GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	174	0.67268944	0.98582995	1	1.99379574	0.64841686
YNTTTNNNANGCARM_UNKNOWN	c3.TFT_ transcription factor targets	57	1.321031	0.06733524	0.2252977	YNTTTNNNANGCARM_UNKNOWN	62	1.3122795	0.08240534	0.42216834	2.6333105	0.0087515
GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP	C7_ immunologic signatures	139	1.3209084	0.032258064	0.22544277	GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP	140	0.72706735	0.9375	1	2.04797575	0.59384105
GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	111	1.3209074	0.05707196	0.22536261	GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP	116	1.0882616	0.31127197	0.7736266	2.409169	0.2326458
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN	C7_ immunologic signatures	173	1.3208596	0.03301887	0.22536404	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN	178	1.0807648	0.3047427	0.78602743	2.4016244	0.2400948
GO_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY	c5.BP_ GO biological process	75	1.3208392	0.06721536	0.22531866	GO_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY	79	1.0466777	0.39679146	0.84538543	2.3675169	0.2741615
KRCTCNNNNMANAGC_UNKNOWN	c3.TFT_ transcription factor targets	30	1.3208371	0.120178044	0.22524135	KRCTCNNNNMANAGC_UNKNOWN	30	-1.1887865	0.16393442	0.39518604	0.1320506	2.5096236
GO_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY	c5.BP_ GO biological process	74	1.3208009	0.06284153	0.225236	GO_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY	78	1.0573878	0.39828694	0.8286984	2.3781887	0.2634131
GO_ATRIAL_SEPTUM_DEVELOPMENT	c5.BP_ GO biological process	17	1.3206769	0.12164297	0.22535725	GO_ATRIAL_SEPTUM_DEVELOPMENT	17	0.9390292	0.57506704	0.99131584	2.2597061	0.3816477
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN	C7_ immunologic signatures	168	1.3206165	0.040718563	0.22538745	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN	175	1.5261446	0	0.22930251	2.8467611	-0.2055281
GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN	C7_ immunologic signatures	173	1.3202991	0.031578947	0.22589378	GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN	174	1.268942	0.050556116	0.4863374	2.5892411	0.0513571
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	c2.CGP_ chemical and genetic perturbations	155	1.3200281	0.041262135	0.22632731	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	158	1.3827283	0.00716479	0.35494053	2.7027564	-0.0627002
GO_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION	c5.BP_ GO biological process	307	1.3200184	0.010857764	0.22626437	GO_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION	318	0.83508927	0.907	1	2.15510767	0.48492913
GR_Q6	c3.TFT_ transcription factor targets	217	1.3199577	0.024054984	0.22628869	GR_Q6	227	0.9533923	0.62940586	0.9779129	2.27335	0.3665654
GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN	C7_ immunologic signatures	74	1.3199458	0.058583107	0.22622749	GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN	80	1.462851	0.004219409	0.28187186	2.7827968	-0.1429052
NFY_01	c3.TFT_ transcription factor targets	217	1.3199412	0.025316456	0.22615619	NFY_01	225	0.9310523	0.68373495	0.99850154	2.2509935	0.3888889
GO_REGULATION_OF_GENE_EXPRESSION_BY_GENETIC_IMPRINTING	c5.BP_ GO biological process	15	1.3198701	0.1292407	0.22621118	GO_REGULATION_OF_GENE_EXPRESSION_BY_GENETIC_IMPRINTING	15	-1.424562	0.08130081	0.19196992	-0.1046919	2.7444321
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	c2.CGP_ chemical and genetic perturbations	27	1.319844	0.10159652	0.22617887	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	27	-1.3239754	0.08695652	0.261239	-0.0041314	2.6438194
BRN2_01	c3.TFT_ transcription factor targets	208	1.3198233	0.019813519	0.22613265	BRN2_01	218	1.1193421	0.19798996	0.72391367	2.4391654	0.2004812
GO_EATING_BEHAVIOR	c5.BP_ GO biological process	20	1.3197367	0.13376835	0.22623304	GO_EATING_BEHAVIOR	28	1.1551058	0.26658624	0.66181296	2.4748425	0.1646309
GO_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY	c5.GO molecular function	92	1.3196187	0.055771723	0.22637857	GO_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY	93	1.3826271	0.01985371	0.35496783	2.7022458	-0.0630084
GO_AORTA_DEVELOPMENT	c5.BP_ GO biological process	40	1.3195177	0.10410557	0.22648223	GO_AORTA_DEVELOPMENT	41	-1.0698315	0.34848484	0.57046163	0.2496862	2.3893492
GCM_Q2	c3.TFT_ transcription factor targets	210	1.3193566	0.027154664	0.22669928	GCM_Q2	220	1.0058938	0.4914228	0.9140211	2.3252504	0.3134628
AR_Q6	c3.TFT_ transcription factor targets	214	1.3193451	0.016317016	0.22664057	AR_Q6	224	0.88606673	0.77665997	1	2.20541183	0.43327837
GO_REGULATION_OF_NEURON_PROJECTION_REGENERATION	c5.BP_ GO biological process	20	1.3191547	0.14238952	0.22693047	GO_REGULATION_OF_NEURON_PROJECTION_REGENERATION	20	1.0089602	0.47826087	0.9099585	2.3281149	0.3101945
GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP	C7_ immunologic signatures	155	1.3191369	0.04161712	0.22688511	GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP	155	0.8914229	0.7263479	1	2.2105598	0.427714
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	c2.CGP_ chemical and genetic perturbations	61	1.3191108	0.07198953	0.22685261	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	61	1.4136802	0.02320442	0.3236907	2.732791	-0.0945694
KIM_MYCN_AMPLIFICATION_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	75	1.3190868	0.076524	0.22681318	KIM_MYCN_AMPLIFICATION_TARGETS_UP	80	0.98649544	0.53104925	0.94022346	2.30558224	0.33259136
BIOCARTA_AGR_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	34	1.3190838	0.10237389	0.22673632	BIOCARTA_AGR_PATHWAY	34	1.1218475	0.31897557	0.72251	2.4409313	0.1972363
HUANG_FOXA2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	37	1.318692	0.10279001	0.22738864	HUANG_FOXA2_TARGETS_UP	41	0.759243	0.82511735	1	2.077935	0.559449
GO_DNA_STRAND_ELONGATION	c5.BP_ GO biological process	28	1.3185054	0.106983654	0.22767228	GO_DNA_STRAND_ELONGATION	28	-1.6067911	0.016949153	0.08880837	-0.2882857	2.9252965
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	186	1.3182206	0.02476415	0.22813308	GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	187	0.6718264	0.98375636	1	1.990047	0.6463942
ACCAAAG_MIR9	c3.MIR_ microRNA targets	453	1.3181585	0.008342023	0.22817399	ACCAAAG_MIR9	458	0.81547624	0.96	1	2.13363474	0.50268226
GO_NEGATIVE_REGULATION_OF_WOUND_HEALING	c5.BP_ GO biological process	48	1.3180287	0.10215827	0.2283463	GO_NEGATIVE_REGULATION_OF_WOUND_HEALING	52	1.7267667	0	0.07106502	3.0447954	-0.408738
HAN_SATB1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	342	1.3178288	0.008714597	0.22863355	HAN_SATB1_TARGETS_UP	348	1.1728617	0.089	0.6332565	2.4906905	0.1449671
GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN	C7_ immunologic signatures	175	1.3176483	0.033653848	0.22887532	GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN	179	1.2594149	0.037755102	0.49767542	2.5770632	0.0582334
GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	C7_ immunologic signatures	163	1.3174738	0.039426524	0.22913004	GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	163	0.795381	0.8876518	1	2.1128548	0.5220928
RB_P130_DN.V1_UP	C6_ oncogenic signatures	113	1.3173338	0.04822335	0.22931354	RB_P130_DN.V1_UP	118	1.0209988	0.4556701	0.89076215	2.3383326	0.296335
GO_CARDIAC_MUSCLE_CELL_CONTRACTION	c5.BP_ GO biological process	25	1.3171139	0.121684864	0.22964983	GO_CARDIAC_MUSCLE_CELL_CONTRACTION	27	1.7339061	0.001179245	0.06840885	3.05102	-0.4167922
REACTOME_INTERFERON_GAMMA_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	43	1.3169786	0.081491716	0.2298101	REACTOME_INTERFERON_GAMMA_SIGNALING	43	-0.9580237	0.53846157	0.7448287	0.3589549	2.2750023
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	c2.CGP_ chemical and genetic perturbations	43	1.3169773	0.0919708	0.22973183	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	45	0.8461134	0.7321226	1	2.1630907	0.4708639
ONDER_CDH1_TARGETS_2_DN	c2.CGP_ chemical and genetic perturbations	389	1.3169004	0.002159827	0.22979774	ONDER_CDH1_TARGETS_2_DN	409	1.7233404	0	0.06692875	3.0402408	-0.40644
GSE3982_MAST_CELL_VS_BASOPHIL_DN	C7_ immunologic signatures	163	1.316876	0.039379474	0.2297567	GSE3982_MAST_CELL_VS_BASOPHIL_DN	161	0.73392016	0.93711966	1	2.05079616	0.58295584
GO_NEGATIVE_REGULATION_OF_OSSIFICATION	c5.BP_ GO biological process	55	1.3167565	0.086419754	0.22991619	GO_NEGATIVE_REGULATION_OF_OSSIFICATION	61	0.85790646	0.71192056	1	2.17466296	0.45885004
GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	C7_ immunologic signatures	180	1.3167553	0.032902468	0.22983629	GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	186	1.1913334	0.10707071	0.6040936	2.5080887	0.1254219
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	c2.CGP_ chemical and genetic perturbations	32	1.3167434	0.11678832	0.22977486	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	31	0.54844785	0.9878788	1	1.86519125	0.76829555
GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN	C7_ immunologic signatures	163	1.3167008	0.029797377	0.22977005	GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN	169	1.1846397	0.13880445	0.61398965	2.5013405	0.1320611
GSE17721_12H_VS_24H_CPG_BMDC_UP	C7_ immunologic signatures	177	1.3166851	0.03169014	0.22971636	GSE17721_12H_VS_24H_CPG_BMDC_UP	179	0.9282836	0.6828283	0.9993283	2.2449687	0.3884015
GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN	C7_ immunologic signatures	172	1.3166621	0.036643025	0.22967404	GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN	179	0.9696998	0.5712841	0.9615808	2.2863619	0.3469623
RAO_BOUND_BY_SALL4_ISOFORM_B	c2.CGP_ chemical and genetic perturbations	451	1.3165979	0.002139038	0.22971606	RAO_BOUND_BY_SALL4_ISOFORM_B	463	0.8410361	0.932	1	2.157634	0.4755618
REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS	c2.CP_REACTOME_ Reactome gene sets	31	1.3165355	0.10207101	0.2297571	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS	31	0.7250878	0.866426	1	2.0416233	0.5914477
GSE30083_SP3_VS_SP4_THYMOCYTE_UP	C7_ immunologic signatures	163	1.3164222	0.037484884	0.22988278	GSE30083_SP3_VS_SP4_THYMOCYTE_UP	176	1.3024608	0.023445465	0.4375481	2.618883	0.0139614
GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP	C7_ immunologic signatures	108	1.3163846	0.060991105	0.22986954	GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP	118	0.8997371	0.7157676	1	2.2161217	0.4166475
GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN	C7_ immunologic signatures	118	1.3159038	0.057934508	0.23070234	GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN	128	0.9535506	0.6094553	0.9776439	2.2694544	0.3623532
GO_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN	c5.BP_ GO biological process	31	1.315901	0.112443775	0.23062444	GO_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN	35	-1.5713338	0.013513514	0.10442884	-0.2554328	2.8872348
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	118	1.3157802	0.05519897	0.23075931	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN	126	1.4357042	0.009240246	0.3096926	2.7514844	-0.119924
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP	C7_ immunologic signatures	170	1.315774	0.049878344	0.23068812	GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP	173	1.0700899	0.33973712	0.80476755	2.3858639	0.2456841
GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS	c5.BP_ GO biological process	184	1.3157687	0.030516433	0.23061399	GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS	197	1.4828162	0	0.2662302	2.7985849	-0.1670475
GO_BETA_AMYLOID_BINDING	c5.GO molecular function	31	1.315655	0.09242424	0.23075303	GO_BETA_AMYLOID_BINDING	33	1.2425568	0.16728167	0.52209777	2.5582118	0.0730982
GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	C7_ immunologic signatures	147	1.3156345	0.04042806	0.23071161	GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	148	0.88628036	0.75255626	1	2.20191486	0.42935414
GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	C7_ immunologic signatures	179	1.3154559	0.037259616	0.23097534	GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	180	1.2082778	0.09908999	0.5806159	2.5237337	0.1071781
GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP	C7_ immunologic signatures	160	1.3154026	0.03760282	0.23100173	GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP	161	0.8699335	0.7648262	1	2.1853361	0.4454691
WANG_CISPLATIN_RESPONSE_AND_XPC_UP	c2.CGP_ chemical and genetic perturbations	166	1.3153983	0.029126214	0.2309266	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	174	1.0159513	0.47870183	0.8957211	2.3313496	0.299447
GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP	C7_ immunologic signatures	185	1.3153198	0.026190476	0.23100363	GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP	186	1.1210432	0.22672065	0.72217035	2.436363	0.1942766
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	102	1.3152686	0.063719116	0.2310207	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	112	1.1214842	0.27159208	0.72205824	2.4367528	0.1937844
GO_INSULIN_LIKE_GROWTH_FACTOR_BINDING	c5.GO molecular function	24	1.3152353	0.11831442	0.23100609	GO_INSULIN_LIKE_GROWTH_FACTOR_BINDING	25	1.1975763	0.22620519	0.59721047	2.5128116	0.117659
GO_CELL_KILLING	c5.BP_ GO biological process	38	1.3152056	0.093659945	0.23097886	GO_CELL_KILLING	42	-1.6336478	0	0.078888305	-0.3184422	2.9488534
GTGACTT_MIR224	c3.MIR_ microRNA targets	144	1.315183	0.037453182	0.23093444	GTGACTT_MIR224	147	1.1076311	0.27530363	0.7417065	2.4228141	0.2075519
GO_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	140	1.3151609	0.04944376	0.2308944	GO_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION	142	0.8833269	0.7396569	1	2.1984878	0.431834
GO_ENZYME_INHIBITOR_ACTIVITY	c5.GO molecular function	294	1.3151336	0.015819209	0.23087163	GO_ENZYME_INHIBITOR_ACTIVITY	316	1.0242318	0.4332999	0.8850278	2.3393654	0.2909018
GO_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT	c5.BP_ GO biological process	120	1.3149004	0.046035804	0.2312473	GO_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT	121	1.3575207	0.022540983	0.37909752	2.6724211	-0.0426203
GO_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS	c5.BP_ GO biological process	51	1.3144356	0.08831522	0.2320973	GO_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS	56	1.2306501	0.14606741	0.539151	2.5450857	0.0837855
GO_CHONDROCYTE_DIFFERENTIATION	c5.BP_ GO biological process	54	1.3144221	0.09470752	0.23204228	GO_CHONDROCYTE_DIFFERENTIATION	58	-1.5353097	0	0.12244027	-0.2208876	2.8497318
GO_CENTRIOLAR_SATELLITE	c5.CC_ GO cellular component	23	1.3142959	0.11464968	0.23220462	GO_CENTRIOLAR_SATELLITE	24	1.1969063	0.21924482	0.5964923	2.5112022	0.1173896
GSE27786_BCELL_VS_NKTCELL_UP	C7_ immunologic signatures	185	1.3141953	0.027251184	0.23232605	GSE27786_BCELL_VS_NKTCELL_UP	186	0.97569543	0.5569106	0.955431	2.28989073	0.33849987
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	c2.CGP_ chemical and genetic perturbations	178	1.3141905	0.029274005	0.23225476	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	182	1.2354761	0.06802031	0.5327732	2.5496666	0.0787144
ZIRN_TRETINOIN_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	19	1.3140491	0.12598425	0.23244208	ZIRN_TRETINOIN_RESPONSE_UP	17	1.3501674	0.1125158	0.38388366	2.6642165	-0.0361183
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	c2.CGP_ chemical and genetic perturbations	335	1.3140072	0.015486726	0.23243593	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	341	1.2735679	0.008	0.48175523	2.5875751	0.0404393
GO_BLOOD_COAGULATION_INTRINSIC_PATHWAY	c5.BP_ GO biological process	15	1.3137057	0.12286159	0.23288216	GO_BLOOD_COAGULATION_INTRINSIC_PATHWAY	16	1.2747049	0.17218544	0.48077622	2.5884106	0.0390008
GSE25677_MPL_VS_R848_STIM_BCELL_DN	C7_ immunologic signatures	167	1.3136138	0.034802783	0.2329778	GSE25677_MPL_VS_R848_STIM_BCELL_DN	168	0.9980604	0.5136502	0.9258685	2.3116742	0.3155534
GO_STARTLE_RESPONSE	c5.BP_ GO biological process	17	1.3135118	0.124615386	0.23310898	GO_STARTLE_RESPONSE	23	1.1795866	0.2535211	0.624	2.4930984	0.1339252
GO_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	112	1.3134695	0.045918368	0.23310833	GO_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT	119	1.1391755	0.23608248	0.69141257	2.452645	0.174294
WGTTNNNNNAAA_UNKNOWN	c3.TFT_ transcription factor targets	455	1.3134379	0.006322445	0.2330865	WGTTNNNNNAAA_UNKNOWN	475	1.0190862	0.431	0.89197433	2.3325241	0.2943517
GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	C7_ immunologic signatures	133	1.313398	0.042606518	0.23308419	GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	138	1.3909103	0.008230452	0.3465894	2.7043083	-0.0775123
STAT3_01	c3.TFT_ transcription factor targets	19	1.3130766	0.14241001	0.23363277	STAT3_01	19	0.92910534	0.5786083	0.9991443	2.24218194	0.38397126
GO_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY	c5.BP_ GO biological process	20	1.3130621	0.12658228	0.23357847	GO_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY	22	0.9667492	0.5351418	0.9642199	2.2798113	0.3463129
GO_INNER_EAR_MORPHOGENESIS	c5.BP_ GO biological process	81	1.3129498	0.06869221	0.23371892	GO_INNER_EAR_MORPHOGENESIS	91	1.040739	0.43828452	0.8583002	2.3536888	0.2722108
CHEN_HOXA5_TARGETS_9HR_UP	c2.CGP_ chemical and genetic perturbations	184	1.3129079	0.028202115	0.23372786	CHEN_HOXA5_TARGETS_9HR_UP	184	0.7455667	0.93957704	1	2.0584746	0.5673412
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN	C7_ immunologic signatures	183	1.312735	0.025851939	0.23397546	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN	184	-1.036418	0.21428572	0.62778056	0.276317	2.349153
GO_ASYMMETRIC_PROTEIN_LOCALIZATION	c5.BP_ GO biological process	18	1.3126332	0.13210702	0.23410937	GO_ASYMMETRIC_PROTEIN_LOCALIZATION	18	-1.0299743	0.3966942	0.6400773	0.2826589	2.3426075
GO_GROWTH_FACTOR_ACTIVITY	c5.GO molecular function	139	1.3125364	0.05049261	0.23421337	GO_GROWTH_FACTOR_ACTIVITY	141	0.90654874	0.702454	1	2.21908514	0.40598766
GSE27786_BCELL_VS_CD4_TCELL_UP	C7_ immunologic signatures	175	1.3123072	0.03052503	0.2345612	GSE27786_BCELL_VS_CD4_TCELL_UP	173	0.57383025	1	1	1.88613745	0.73847695
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	21	1.3121871	0.14263566	0.234719	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	21	1.2641758	0.16771753	0.49083322	2.5763629	0.0480113
GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP	C7_ immunologic signatures	166	1.312137	0.037712894	0.23474343	GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP	171	1.1675417	0.15142277	0.64119786	2.4796787	0.1445953
GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP	C7_ immunologic signatures	162	1.3120211	0.03337306	0.23489363	GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP	168	1.2602401	0.05065856	0.49616206	2.5722612	0.051781
GO_COCHLEA_DEVELOPMENT	c5.BP_ GO biological process	36	1.3119202	0.1071953	0.23499964	GO_COCHLEA_DEVELOPMENT	38	1.0863328	0.36208853	0.77585995	2.398253	0.2255874
OCT1_03	c3.TFT_ transcription factor targets	188	1.311883	0.0295858	0.23498811	OCT1_03	200	0.9010515	0.73917425	1	2.2129345	0.4108315
TAATAAT_MIR126	c3.MIR_ microRNA targets	197	1.3117287	0.034400947	0.23520845	TAATAAT_MIR126	205	0.62535685	0.99394554	1	1.93708555	0.68637185
GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN	C7_ immunologic signatures	183	1.3115233	0.021377672	0.23554061	GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN	185	1.053508	0.38250256	0.83650076	2.3650313	0.2580153
DURAND_STROMA_NS_UP	c2.CGP_ chemical and genetic perturbations	145	1.3113804	0.04767726	0.23573224	DURAND_STROMA_NS_UP	149	1.427015	0.00304878	0.31810063	2.7383954	-0.1156346
GSE22886_NEUTROPHIL_VS_MONOCYTE_UP	C7_ immunologic signatures	136	1.3113354	0.05256571	0.23575062	GSE22886_NEUTROPHIL_VS_MONOCYTE_UP	148	1.3541781	0.016309887	0.38380313	2.6655135	-0.0428427
GO_REGULATION_OF_CELL_ACTIVATION	c5.BP_ GO biological process	376	1.3108786	0.00972973	0.23654076	GO_REGULATION_OF_CELL_ACTIVATION	412	1.1079419	0.177	0.74121755	2.4188205	0.2029367
GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	C7_ immunologic signatures	123	1.3106754	0.05315204	0.2368654	GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	129	1.2197642	0.11076923	0.55600107	2.5304396	0.0909112
GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP	C7_ immunologic signatures	175	1.3106196	0.03276699	0.23688711	GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP	176	0.9565307	0.6038697	0.9750619	2.2671503	0.3540889
GO_LIPOPROTEIN_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	81	1.3104991	0.07764391	0.23703715	GO_LIPOPROTEIN_BIOSYNTHETIC_PROCESS	82	0.5631843	0.99040514	1	1.8736834	0.7473148
MODULE_64	c4.CM_ cancer modules	418	1.3104417	0.005336179	0.23707058	MODULE_64	459	1.242113	0.005	0.52336717	2.5525547	0.0683287
GO_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT	c5.BP_ GO biological process	21	1.3104213	0.1232	0.23702787	GO_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT	21	0.8860841	0.63557214	1	2.1965054	0.4243372
GO_ANCHORED_COMPONENT_OF_MEMBRANE	c5.CC_ GO cellular component	118	1.3103817	0.05412054	0.2370284	GO_ANCHORED_COMPONENT_OF_MEMBRANE	130	1.5177457	0	0.23439606	2.8281274	-0.207364
GO_REGULATED_EXOCYTOSIS	c5.BP_ GO biological process	193	1.3101774	0.031137725	0.237351	GO_REGULATED_EXOCYTOSIS	198	1.4512975	0	0.29177094	2.7614749	-0.1411201
GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN	C7_ immunologic signatures	171	1.3101603	0.033816423	0.23730725	GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN	172	0.8108059	0.88169867	1	2.1209662	0.4993544
GO_MICROFILAMENT_MOTOR_ACTIVITY	c5.GO molecular function	18	1.3100345	0.15325077	0.2374675	GO_MICROFILAMENT_MOTOR_ACTIVITY	19	1.386997	0.070063695	0.34875312	2.6970315	-0.0769625
TFIIA_Q6	c3.TFT_ transcription factor targets	223	1.3098704	0.021965317	0.23770608	TFIIA_Q6	233	0.7263812	0.972973	1	2.0362516	0.5834892
GO_IONOTROPIC_GLUTAMATE_RECEPTOR_COMPLEX	c5.CC_ GO cellular component	44	1.309865	0.08211144	0.23763458	GO_IONOTROPIC_GLUTAMATE_RECEPTOR_COMPLEX	46	1.1857405	0.22747748	0.6133102	2.4956055	0.1241245
GO_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS	c5.BP_ GO biological process	32	1.3098592	0.103186645	0.2375621	GO_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS	33	-1.178425	0.17948718	0.40576094	0.1314342	2.4882842
GCM_IL6ST	c4.CGN_ cancer gene neighborhoods	49	1.3097304	0.08321378	0.23772672	GCM_IL6ST	49	-0.9679965	0.46601942	0.73277557	0.3417339	2.2777269
GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	C7_ immunologic signatures	164	1.3095452	0.039906103	0.23802283	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	165	1.47167	0.003058104	0.27609134	2.7812152	-0.1621248
GO_NEURAL_CREST_CELL_MIGRATION	c5.BP_ GO biological process	45	1.3094604	0.10982659	0.23809123	GO_NEURAL_CREST_CELL_MIGRATION	50	-1.7320346	0	0.04794248	-0.4225742	3.041495
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	c2.CGP_ chemical and genetic perturbations	373	1.3094115	0.006382979	0.23810288	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	390	1.1727545	0.061061062	0.6330291	2.482166	0.136657
GSE14026_TH1_VS_TH17_DN	C7_ immunologic signatures	167	1.309358	0.03473054	0.2381243	GSE14026_TH1_VS_TH17_DN	177	0.97485226	0.55420464	0.95602185	2.28421026	0.33450574
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	c2.CGP_ chemical and genetic perturbations	20	1.3091501	0.12715855	0.23845889	NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	20	1.3357261	0.09706258	0.39837918	2.6448762	-0.026576
GO_NEGATIVE_REGULATION_OF_AXONOGENESIS	c5.BP_ GO biological process	60	1.3088645	0.07660167	0.23892818	GO_NEGATIVE_REGULATION_OF_AXONOGENESIS	62	0.73173887	0.8855886	1	2.04060337	0.57712563
GO_POLYSACCHARIDE_BINDING	c5.GO molecular function	17	1.3086957	0.11960133	0.23918773	GO_POLYSACCHARIDE_BINDING	18	1.4555563	0.039540816	0.2871182	2.764252	-0.1468606
GO_MICROTUBULE_ANCHORING	c5.BP_ GO biological process	17	1.3086756	0.1263823	0.23914409	GO_MICROTUBULE_ANCHORING	17	0.8474623	0.69922876	1	2.1561379	0.4612133
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	c2.CGP_ chemical and genetic perturbations	308	1.3086417	0.014130435	0.23912609	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	328	1.3000427	0.00501002	0.44248572	2.6086844	0.008599
STK33_SKM_UP	C6_ oncogenic signatures	222	1.3086344	0.023255814	0.23905914	STK33_SKM_UP	226	0.9934555	0.53266335	0.93082404	2.3020899	0.3151789
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	c2.CGP_ chemical and genetic perturbations	86	1.3085456	0.061923582	0.2391501	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	87	1.3446469	0.044303797	0.38953224	2.6531925	-0.0361013
GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN	C7_ immunologic signatures	175	1.3085328	0.03533569	0.23909263	GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN	177	0.8603605	0.8228745	1	2.1688933	0.4481723
VANTVEER_BREAST_CANCER_BRCA1_DN	c2.CGP_ chemical and genetic perturbations	41	1.308504	0.091292135	0.23907168	VANTVEER_BREAST_CANCER_BRCA1_DN	41	-0.6706037	0.94736844	0.9717811	0.6379003	1.9791077
RP58_01	c3.TFT_ transcription factor targets	184	1.3084568	0.030023094	0.23908104	RP58_01	186	0.9542805	0.61421317	0.9770349	2.2627373	0.3541763
RAAGNYNNCTTY_UNKNOWN	c3.TFT_ transcription factor targets	130	1.3083652	0.05392157	0.23918526	RAAGNYNNCTTY_UNKNOWN	136	1.0395443	0.4148073	0.85894954	2.3479095	0.2688209
DAZARD_UV_RESPONSE_CLUSTER_G2	c2.CGP_ chemical and genetic perturbations	20	1.3083618	0.13292117	0.23910943	DAZARD_UV_RESPONSE_CLUSTER_G2	22	0.684747	0.89179105	1	1.9931088	0.6236148
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP	C7_ immunologic signatures	148	1.3083528	0.050970875	0.23904501	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP	161	1.2908915	0.034517765	0.45676	2.5992443	0.0174613
GO_VESICLE_LUMEN	c5.CC_ GO cellular component	86	1.3083252	0.061923582	0.23901767	GO_VESICLE_LUMEN	93	1.2573808	0.0893796	0.4994966	2.565706	0.0509444
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	c2.CP_BIOCARTA_ BioCarta gene sets	24	1.3081852	0.13198757	0.23921432	KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	24	-0.64126325	0.974359	0.9775604	0.66692195	1.94944845
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	c2.CGP_ chemical and genetic perturbations	98	1.3081111	0.064968154	0.23926966	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	101	1.4188936	0.013457557	0.3200254	2.7270047	-0.1107825
ACCTGTTG_UNKNOWN	c3.TFT_ transcription factor targets	136	1.3079507	0.036809817	0.23952028	ACCTGTTG_UNKNOWN	140	1.1175919	0.26153848	0.72763133	2.4255426	0.1903588
AAGCACA_MIR218	c3.MIR_ microRNA targets	359	1.3078426	0.012847966	0.23963961	AAGCACA_MIR218	371	0.75128555	0.981982	1	2.05912815	0.55655705
GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP	C7_ immunologic signatures	179	1.3077998	0.024532711	0.23963669	GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP	178	-1.1559352	0	0.43653542	0.1518646	2.463735
MODULE_436	c4.CM_ cancer modules	99	1.3076826	0.062901154	0.23977777	MODULE_436	105	1.4352808	0.009307136	0.31020907	2.7429634	-0.1275982
YAMAZAKI_TCEB3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	158	1.307644	0.040718563	0.23977509	YAMAZAKI_TCEB3_TARGETS_UP	163	1.2318734	0.07995951	0.5367779	2.5395174	0.0757706
GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP	C7_ immunologic signatures	110	1.3073976	0.05242967	0.2401763	GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP	120	1.1484812	0.21289662	0.67071956	2.4558788	0.1589164
GO_RESPONSE_TO_DRUG	c5.BP_ GO biological process	384	1.3073757	0.008510638	0.24013178	GO_RESPONSE_TO_DRUG	403	1.2320356	0.02002002	0.5369013	2.5394113	0.0753401
GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP	C7_ immunologic signatures	172	1.3072187	0.033136096	0.24034804	GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP	179	0.77917117	0.9175992	1	2.08638987	0.52804753
GO_REGULATION_OF_POTASSIUM_ION_TRANSPORT	c5.BP_ GO biological process	69	1.3072169	0.072289154	0.24026982	GO_REGULATION_OF_POTASSIUM_ION_TRANSPORT	78	1.3269259	0.059322033	0.4050738	2.6341428	-0.019709
CHANG_CORE_SERUM_RESPONSE_DN	c2.CGP_ chemical and genetic perturbations	187	1.3071954	0.027874565	0.24023113	CHANG_CORE_SERUM_RESPONSE_DN	185	1.2684076	0.037601627	0.48675174	2.575603	0.0387878
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP	C7_ immunologic signatures	172	1.3070412	0.036904763	0.2404587	GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP	179	0.8954031	0.7505071	1	2.2024443	0.4116381
GO_NEUROTROPHIN_SIGNALING_PATHWAY	c5.BP_ GO biological process	23	1.3070214	0.13731825	0.24040924	GO_NEUROTROPHIN_SIGNALING_PATHWAY	23	1.0460955	0.40125787	0.8470196	2.3531169	0.2609259
GO_REGULATION_OF_TRANSPORTER_ACTIVITY	c5.BP_ GO biological process	165	1.306913	0.037125748	0.24054891	GO_REGULATION_OF_TRANSPORTER_ACTIVITY	177	1.2170573	0.08113591	0.5622526	2.5239703	0.0898557
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN	C7_ immunologic signatures	182	1.306843	0.034564957	0.240613	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN	186	1.0977149	0.28008088	0.75952786	2.4045579	0.2091281
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	c2.CGP_ chemical and genetic perturbations	43	1.3066839	0.09801137	0.24085836	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	43	1.4015679	0.042725172	0.33812726	2.7082518	-0.094884
GO_CAMP_METABOLIC_PROCESS	c5.BP_ GO biological process	32	1.3066357	0.11463047	0.24087207	GO_CAMP_METABOLIC_PROCESS	32	1.142164	0.2857143	0.68673384	2.4487997	0.1644717
GO_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION	c5.BP_ GO biological process	250	1.3066332	0.011494253	0.24079268	GO_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION	257	0.969099	0.6032064	0.96235704	2.2757322	0.3375342
GO_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION	c5.BP_ GO biological process	21	1.3066263	0.12908243	0.24072334	GO_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION	23	1.2660036	0.17375	0.49027783	2.5726299	0.0406227
JNK_DN.V1_UP	C6_ oncogenic signatures	148	1.3066062	0.050868485	0.24068037	JNK_DN.V1_UP	162	0.9866413	0.53292805	0.94022846	2.2932475	0.3199649
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	100	1.3065668	0.06080207	0.24067739	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	103	1.264661	0.07621009	0.49081826	2.5712278	0.0419058
GO_EAR_MORPHOGENESIS	c5.BP_ GO biological process	99	1.3065073	0.071339175	0.24072172	GO_EAR_MORPHOGENESIS	111	0.87340784	0.7541841	1	2.17991514	0.43309946
SGCGSSAAA_E2F1DP2_01	c3.TFT_ transcription factor targets	148	1.3063565	0.032967035	0.24093659	SGCGSSAAA_E2F1DP2_01	151	-2.091264	0	0.003072516	-0.7849075	3.3976205
PID_RB_1PATHWAY	c2.CP_ Canonical pathways	60	1.3061621	0.07489598	0.2412514	PID_RB_1PATHWAY	62	0.7447172	0.8730853	1	2.0508793	0.5614449
CADWELL_ATG16L1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	54	1.3061401	0.09410112	0.2412097	CADWELL_ATG16L1_TARGETS_DN	56	0.90234286	0.6511628	1	2.20848296	0.40379724
GO_REGULATION_OF_JUN_KINASE_ACTIVITY	c5.BP_ GO biological process	71	1.3061116	0.07891332	0.2411821	GO_REGULATION_OF_JUN_KINASE_ACTIVITY	74	1.1551032	0.23060344	0.6616509	2.4612148	0.1510084
REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS	c2.CP_REACTOME_ Reactome gene sets	64	1.306101	0.09224599	0.24112174	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS	63	0.92449135	0.6280353	1	2.23059235	0.38160965
GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN	C7_ immunologic signatures	176	1.3059626	0.047785547	0.24131818	GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN	180	0.67057645	0.9868154	1	1.97653905	0.63538615
GO_DIVALENT_INORGANIC_CATION_TRANSPORT	c5.BP_ GO biological process	220	1.3059448	0.036046512	0.24127202	GO_DIVALENT_INORGANIC_CATION_TRANSPORT	241	1.3201506	0.009045227	0.41184363	2.6260954	-0.0142058
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	c2.CGP_ chemical and genetic perturbations	31	1.3059276	0.09895053	0.24122262	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	31	-0.97357	0.4409938	0.7238534	0.3323576	2.2794976
GO_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS	c5.BP_ GO biological process	15	1.3058618	0.13722397	0.24127087	GO_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS	16	-0.8768488	0.6204082	0.84729797	0.429013	2.1827106
GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	C7_ immunologic signatures	182	1.3058562	0.029274005	0.24120066	GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	180	1.1675304	0.13807106	0.6410718	2.4733866	0.1383258
MARZEC_IL2_SIGNALING_DN	c2.CGP_ chemical and genetic perturbations	35	1.3058144	0.11208151	0.24119623	MARZEC_IL2_SIGNALING_DN	34	1.1652496	0.2563805	0.6460227	2.471064	0.1405648
GO_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE	c5.BP_ GO biological process	49	1.3057666	0.09090909	0.24120589	GO_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE	49	-0.9120553	0.63793105	0.8049671	0.3937113	2.2178219
GO_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY	c5.GO molecular function	54	1.3057392	0.08794326	0.2411839	GO_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY	70	1.339497	0.053551912	0.39644045	2.6452362	-0.0337578
GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	C7_ immunologic signatures	179	1.3057191	0.03207331	0.2411375	GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	188	0.965495	0.58912385	0.96519786	2.2712141	0.3402241
GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP	C7_ immunologic signatures	166	1.3056775	0.04417178	0.241129	GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP	169	1.169419	0.13434343	0.63849294	2.4750965	0.1362585
GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP	C7_ immunologic signatures	167	1.305595	0.043956045	0.24122916	GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP	168	0.7009247	0.9693251	1	2.0065197	0.6046703
GO_OSTEOBLAST_DEVELOPMENT	c5.BP_ GO biological process	17	1.3054788	0.1437309	0.24138404	GO_OSTEOBLAST_DEVELOPMENT	17	-1.382141	0.10377359	0.21833695	-0.0766622	2.6876198
GAZIN_EPIGENETIC_SILENCING_BY_KRAS	c2.CGP_ chemical and genetic perturbations	24	1.3054761	0.12364761	0.24130693	GAZIN_EPIGENETIC_SILENCING_BY_KRAS	24	1.244822	0.17848411	0.5189684	2.5502981	0.0606541
GO_REGULATION_OF_ORGAN_FORMATION	c5.BP_ GO biological process	29	1.3054756	0.12238806	0.24122573	GO_REGULATION_OF_ORGAN_FORMATION	31	0.7428077	0.8412888	1	2.0482833	0.5626679
GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP	C7_ immunologic signatures	151	1.3053983	0.035024155	0.24128789	GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP	151	1.006545	0.4939148	0.91314465	2.3119433	0.2988533
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP	C7_ immunologic signatures	175	1.3053968	0.048809525	0.24120928	GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP	178	1.1470389	0.18429004	0.67369795	2.4524357	0.1583579
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	144	1.3053849	0.048628427	0.24115214	GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN	145	0.7558906	0.92433536	1	2.0612755	0.5494943
MODULE_79	c4.CM_ cancer modules	82	1.3053803	0.07619048	0.24107777	MODULE_79	86	0.96120757	0.5685654	0.96989226	2.26658787	0.34417273
GO_REGULATION_OF_PLATELET_AGGREGATION	c5.BP_ GO biological process	15	1.3053757	0.14117648	0.24100351	GO_REGULATION_OF_PLATELET_AGGREGATION	16	1.8267577	0	0.026803112	3.1321334	-0.521382
STAT5A_01	c3.TFT_ transcription factor targets	217	1.3053731	0.032332562	0.24092671	STAT5A_01	223	0.9876496	0.54116464	0.9386746	2.2930227	0.3177235
GO_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION	c5.BP_ GO biological process	18	1.3053702	0.13492064	0.2408487	GO_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION	22	1.0930457	0.33617538	0.76793855	2.3984159	0.2123245
GO_ERK1_AND_ERK2_CASCADE	c5.BP_ GO biological process	20	1.3053341	0.1296875	0.2408472	GO_ERK1_AND_ERK2_CASCADE	20	0.78731674	0.7803618	1	2.09265084	0.51801736
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	138	1.3052717	0.03685504	0.24088177	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN	143	1.2616367	0.05948718	0.4939753	2.5669084	0.043635
MORF_LTK	c4.CGN_ cancer gene neighborhoods	122	1.3052315	0.05667506	0.24087274	MORF_LTK	130	1.2821586	0.055271238	0.46906143	2.5873901	0.0230729
GO_CONNECTIVE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	172	1.3051622	0.032687653	0.24092713	GO_CONNECTIVE_TISSUE_DEVELOPMENT	180	-1.1720583	0.07692308	0.41411844	0.1331039	2.4772205
GGCACTT_MIR519E	c3.MIR_ microRNA targets	114	1.3051012	0.06185567	0.24098332	GGCACTT_MIR519E	115	1.0903069	0.30416667	0.7709316	2.3954081	0.2147943
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	c2.CGP_ chemical and genetic perturbations	17	1.3049583	0.13578275	0.24118541	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	17	0.92748153	0.59612906	1	2.23243983	0.37747677
GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN	C7_ immunologic signatures	179	1.3049504	0.03301887	0.24111831	GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN	182	1.2685325	0.03959391	0.48669833	2.5734829	0.0364179
TGGTGCT_MIR29A_MIR29B_MIR29C	c3.MIR_ microRNA targets	463	1.3049355	0.009584664	0.24106751	TGGTGCT_MIR29A_MIR29B_MIR29C	474	0.8686287	0.9	1	2.1735642	0.4363068
GO_REGULATION_OF_DEPHOSPHORYLATION	c5.BP_ GO biological process	132	1.3047155	0.045673076	0.24142492	GO_REGULATION_OF_DEPHOSPHORYLATION	136	1.1179436	0.2545825	0.72711444	2.4226591	0.1867719
CAGTGTT_MIR141_MIR200A	c3.MIR_ microRNA targets	285	1.3047042	0.015712682	0.24136421	CAGTGTT_MIR141_MIR200A	293	0.8000378	0.9429429	1	2.104742	0.5046664
GO_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY	c5.BP_ GO biological process	20	1.3045003	0.14751554	0.24168368	GO_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY	19	0.9218536	0.5981912	1	2.2263539	0.3826467
GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP	C7_ immunologic signatures	172	1.3044697	0.042402826	0.24166256	GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP	177	-0.9268523	0.8125	0.78788996	0.3776174	2.231322
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	c2.CGP_ chemical and genetic perturbations	21	1.3042752	0.1328	0.24198388	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	22	0.85121244	0.6978508	1	2.15548764	0.45306276
GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN	C7_ immunologic signatures	184	1.3042287	0.033816423	0.24199419	GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN	188	0.7793379	0.9299492	1	2.0835666	0.5248908
GO_ACTIVATION_OF_MAPKK_ACTIVITY	c5.BP_ GO biological process	48	1.304175	0.0997151	0.24201371	GO_ACTIVATION_OF_MAPKK_ACTIVITY	48	1.3844849	0.031638417	0.3518539	2.6886599	-0.0803099
MODULE_33	c4.CM_ cancer modules	315	1.3040731	0.01210121	0.24212733	MODULE_33	332	1.1303984	0.13413413	0.7059468	2.4344715	0.1736747
GO_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT	c5.BP_ GO biological process	217	1.30363	0.03274854	0.24294603	GO_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT	224	1.1485358	0.14673367	0.6706379	2.4521658	0.1550942
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP	C7_ immunologic signatures	165	1.3035972	0.03914591	0.24294098	GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP	167	1.0744277	0.32179227	0.79816055	2.3780249	0.2291695
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	c2.CGP_ chemical and genetic perturbations	235	1.3035214	0.023595506	0.243017	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	238	0.9285166	0.7005025	0.9993939	2.232038	0.3750048
GO_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	29	1.3033739	0.12480974	0.24322204	GO_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY	30	1.1157051	0.32419547	0.7300931	2.419079	0.1876688
GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP	C7_ immunologic signatures	163	1.3033322	0.03649635	0.24322541	GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP	169	1.0593019	0.37183383	0.8258254	2.3626341	0.2440303
GSE3982_DC_VS_NKCELL_DN	C7_ immunologic signatures	152	1.3032817	0.044957474	0.24323261	GSE3982_DC_VS_NKCELL_DN	156	1.2561643	0.05775076	0.5012256	2.559446	0.0471174
GSE3982_MAC_VS_TH1_UP	C7_ immunologic signatures	169	1.3032786	0.028235294	0.24315669	GSE3982_MAC_VS_TH1_UP	170	1.3164653	0.01718908	0.41636723	2.6197439	-0.0131867
HALLMARK_TNFA_SIGNALING_VIA_NFKB	H_ hallmark gene sets	190	1.303239	0.03760282	0.24314915	HALLMARK_TNFA_SIGNALING_VIA_NFKB	187	1.1146557	0.24266936	0.7309934	2.4178947	0.1885833
PLASARI_TGFB1_TARGETS_10HR_UP	c2.CGP_ chemical and genetic perturbations	188	1.303206	0.03625731	0.24313213	PLASARI_TGFB1_TARGETS_10HR_UP	191	1.2736098	0.028311426	0.48181695	2.5768158	0.0295962
GO_SODIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	69	1.3031994	0.06929348	0.24306446	GO_SODIUM_ION_TRANSMEMBRANE_TRANSPORT	80	1.2451167	0.13277134	0.51893735	2.5483161	0.0580827
PATTERSON_DOCETAXEL_RESISTANCE	c2.CGP_ chemical and genetic perturbations	28	1.3031462	0.1266187	0.24308397	PATTERSON_DOCETAXEL_RESISTANCE	28	1.4187392	0.045191195	0.3196744	2.7218854	-0.115593
GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN	C7_ immunologic signatures	163	1.3031108	0.033939395	0.2430723	GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN	165	0.8755062	0.7803882	1	2.178617	0.4276046
KEGG_GNRH_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	86	1.303009	0.08278581	0.24319556	KEGG_GNRH_SIGNALING_PATHWAY	93	1.2881147	0.072708115	0.46098688	2.5911237	0.0148943
MODULE_124	c4.CM_ cancer modules	95	1.3029363	0.067371204	0.24326484	MODULE_124	95	-0.9838411	0.4920635	0.7093913	0.3190952	2.2867774
FOXO4_02	c3.TFT_ transcription factor targets	222	1.3027877	0.029646521	0.24347436	FOXO4_02	228	0.9072861	0.7492477	1	2.2100738	0.3955016
GO_SITE_OF_POLARIZED_GROWTH	c5.CC_ GO cellular component	132	1.3026159	0.044957474	0.24372698	GO_SITE_OF_POLARIZED_GROWTH	137	1.0994331	0.28586066	0.757879	2.402049	0.2031828
GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	C7_ immunologic signatures	175	1.3026125	0.037914693	0.24365148	GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	181	1.1912566	0.1132457	0.60389817	2.4938691	0.1113559
GO_CELLULAR_RESPONSE_TO_ACID_CHEMICAL	c5.BP_ GO biological process	148	1.3025048	0.04653938	0.24379694	GO_CELLULAR_RESPONSE_TO_ACID_CHEMICAL	158	0.9567569	0.61133605	0.9752375	2.2592617	0.3457479
GO_POSITIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS	c5.BP_ GO biological process	53	1.3024435	0.08869814	0.24383323	GO_POSITIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS	53	0.6807441	0.94273126	1	1.9831876	0.6216994
GO_REGULATION_OF_VIRAL_GENOME_REPLICATION	c5.BP_ GO biological process	62	1.3023772	0.0877193	0.24388973	GO_REGULATION_OF_VIRAL_GENOME_REPLICATION	60	1.007745	0.48131868	0.9109486	2.3101222	0.2946322
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	c2.CGP_ chemical and genetic perturbations	16	1.3023138	0.136876	0.24393176	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	16	0.99543285	0.48280424	0.9303855	2.29774665	0.30688095
NFAT_Q6	c3.TFT_ transcription factor targets	214	1.3022065	0.03815029	0.24405912	NFAT_Q6	219	1.0197415	0.44578314	0.8915777	2.321948	0.282465
ICSBP_Q6	c3.TFT_ transcription factor targets	224	1.3021439	0.031746034	0.24409707	ICSBP_Q6	226	1.0557615	0.36052367	0.8314911	2.3579054	0.2463824
REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	c2.CP_REACTOME_ Reactome gene sets	15	1.3020833	0.15730338	0.24413976	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	15	1.272365	0.16846362	0.48228905	2.5744483	0.0297183
GO_CELL_AGING	c5.BP_ GO biological process	62	1.3020723	0.08645533	0.24407746	GO_CELL_AGING	62	0.8846346	0.71571904	1	2.1867069	0.4174377
GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP	C7_ immunologic signatures	175	1.3018817	0.029726516	0.24438338	GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP	176	0.5611936	1	1	1.8630753	0.7406881
GO_DEATH_RECEPTOR_BINDING	c5.GO molecular function	15	1.3017163	0.12752722	0.24463177	GO_DEATH_RECEPTOR_BINDING	16	-0.8939138	0.6448598	0.82797664	0.4078025	2.1956301
ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN	c2.CGP_ chemical and genetic perturbations	15	1.301636	0.13821138	0.2447112	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN	15	1.0590643	0.42933333	0.8264107	2.3607003	0.2425717
GO_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS	c5.BP_ GO biological process	45	1.3014483	0.09078404	0.24500911	GO_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS	52	0.8942937	0.67346936	1	2.195742	0.4071546
GO_RESPONSE_TO_AXON_INJURY	c5.BP_ GO biological process	42	1.3013515	0.10285714	0.24511938	GO_RESPONSE_TO_AXON_INJURY	45	1.1521243	0.24942529	0.66587704	2.4534758	0.1492272
GO_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS	c5.BP_ GO biological process	30	1.3012059	0.105417274	0.24534115	GO_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS	31	0.7165354	0.8720096	1	2.0177413	0.5846705
GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	166	1.3011858	0.049043063	0.24529748	GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN	178	0.99307173	0.53137654	0.93184566	2.29425753	0.30811407
RIZ_ERYTHROID_DIFFERENTIATION	c2.CGP_ chemical and genetic perturbations	72	1.3011173	0.07208388	0.24535042	RIZ_ERYTHROID_DIFFERENTIATION	73	-1.3352522	0.04225352	0.25251117	-0.0341349	2.6363695
CHR6Q14	C1: positional gene sets	25	1.3010691	0.120743036	0.24535896	CHR6Q14	28	0.90730745	0.6333333	1	2.20837655	0.39376165
GO_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION	c5.BP_ GO biological process	20	1.300962	0.11022364	0.24547951	GO_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION	21	1.0121254	0.46528623	0.9036952	2.3130874	0.2888366
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	c2.CP_REACTOME_ Reactome gene sets	91	1.300884	0.06878981	0.24555917	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	102	1.2181151	0.11857293	0.5596395	2.5189991	0.0827689
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	c2.CGP_ chemical and genetic perturbations	99	1.300882	0.057285182	0.24548163	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	109	0.84934247	0.7835588	1	2.15022447	0.45153953
RGAANNTTC_HSF1_01	c3.TFT_ transcription factor targets	390	1.3007816	0.007534984	0.24559847	RGAANNTTC_HSF1_01	402	1.0431345	0.34134135	0.8531678	2.3439161	0.2576471
GO_ESTABLISHMENT_OF_MITOTIC_SPINDLE_ORIENTATION	c5.BP_ GO biological process	19	1.300555	0.14104596	0.24597794	GO_ESTABLISHMENT_OF_MITOTIC_SPINDLE_ORIENTATION	19	0.7783785	0.7868217	1	2.0789335	0.5221765
GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP	C7_ immunologic signatures	176	1.3005226	0.035005834	0.24595417	GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP	175	1.2924035	0.023469388	0.4537774	2.5929261	0.0081191
GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	C7_ immunologic signatures	152	1.3004909	0.047445256	0.24593231	GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	152	1.2680981	0.048057258	0.48645794	2.568589	0.0323928
LIANG_SILENCED_BY_METHYLATION_UP	c2.CGP_ chemical and genetic perturbations	22	1.3003993	0.14483821	0.24603866	LIANG_SILENCED_BY_METHYLATION_UP	24	1.4132763	0.06583851	0.32383	2.7136756	-0.112877
CHICAS_RB1_TARGETS_SENESCENT	c2.CGP_ chemical and genetic perturbations	478	1.3003007	0.003144654	0.24615808	CHICAS_RB1_TARGETS_SENESCENT	478	0	0	0	1.3003007	1.3003007
GO_DEFENSE_RESPONSE_TO_BACTERIUM	c5.BP_ GO biological process	127	1.3002908	0.044499382	0.24609649	GO_DEFENSE_RESPONSE_TO_BACTERIUM	145	0.8827013	0.7427983	1	2.1829921	0.4175895
GO_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS	c5.BP_ GO biological process	135	1.3001764	0.0502451	0.24623623	GO_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS	141	0.8654626	0.7678208	1	2.165639	0.4347138
GSE15767_MED_VS_SCS_MAC_LN_UP	C7_ immunologic signatures	173	1.3001311	0.043217286	0.24624619	GSE15767_MED_VS_SCS_MAC_LN_UP	178	1.2584457	0.045454547	0.49872345	2.5585768	0.0416854
GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_UP	C7_ immunologic signatures	171	1.3001235	0.05155875	0.24618188	GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_UP	176	1.1652955	0.14646465	0.64633846	2.465419	0.134828
MEF2_03	c3.TFT_ transcription factor targets	205	1.2999618	0.03699422	0.2464058	MEF2_03	212	1.0066664	0.48689517	0.9128113	2.3066282	0.2932954
MATZUK_EMBRYONIC_GERM_CELL	c2.CGP_ chemical and genetic perturbations	18	1.2999296	0.16561514	0.24637741	MATZUK_EMBRYONIC_GERM_CELL	17	-1.1333187	0.26639345	0.46723038	0.1666109	2.4332483
GO_HINDBRAIN_MORPHOGENESIS	c5.BP_ GO biological process	39	1.299926	0.106414	0.2463015	GO_HINDBRAIN_MORPHOGENESIS	40	1.0805795	0.35450345	0.7862715	2.3805055	0.2193465
VANTVEER_BREAST_CANCER_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	49	1.2998912	0.10081744	0.24628836	VANTVEER_BREAST_CANCER_METASTASIS_UP	52	1.3116581	0.08552632	0.42251128	2.6115493	-0.0117669
CRX_DN.V1_DN	C6_ oncogenic signatures	120	1.299877	0.0608365	0.24623276	CRX_DN.V1_DN	128	1.0960566	0.29098362	0.7628984	2.3959336	0.2038204
GO_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC	c5.BP_ GO biological process	45	1.2998413	0.10304789	0.24621929	GO_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC	48	1.231638	0.15120275	0.5372138	2.5314793	0.0682033
TCTAGAG_MIR517	c3.MIR_ microRNA targets	45	1.299733	0.12280702	0.24635331	TCTAGAG_MIR517	44	-0.99567	0.44262296	0.6935694	0.304063	2.295403
GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN	C7_ immunologic signatures	170	1.2997296	0.045990568	0.24627846	GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN	173	0.9064537	0.7184959	1	2.2061833	0.3932759
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP	C7_ immunologic signatures	169	1.2997127	0.040380046	0.24622859	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP	170	1.3214453	0.016243655	0.41113797	2.621158	-0.0217326
GO_POSITIVE_REGULATION_OF_LIPID_KINASE_ACTIVITY	c5.BP_ GO biological process	26	1.2997005	0.12616822	0.24617241	GO_POSITIVE_REGULATION_OF_LIPID_KINASE_ACTIVITY	31	0.9928942	0.49698433	0.9319726	2.2925947	0.3068063
GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN	C7_ immunologic signatures	150	1.2996756	0.048387095	0.24613748	GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN	165	1.0397424	0.4040404	0.8589952	2.339418	0.2599332
KEGG_MAPK_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	249	1.2995856	0.019362187	0.24623187	KEGG_MAPK_SIGNALING_PATHWAY	257	1.1029948	0.22613065	0.75133127	2.4025804	0.1965908
BENPORATH_OCT4_TARGETS	c2.CGP_ chemical and genetic perturbations	259	1.2994342	0.032474805	0.24645688	BENPORATH_OCT4_TARGETS	263	0.70903563	0.97795594	1	2.00846983	0.59039857
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	c2.CGP_ chemical and genetic perturbations	75	1.2994032	0.078353256	0.24644187	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	78	1.3224769	0.06874329	0.4116959	2.6218801	-0.0230737
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	c2.CGP_ chemical and genetic perturbations	369	1.2993238	0.010799136	0.24651314	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	381	1.2070929	0.031031031	0.5807679	2.5064167	0.0922309
GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN	C7_ immunologic signatures	185	1.2993116	0.03345281	0.24645558	GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN	188	0.63927305	0.99492383	1	1.93858465	0.66003855
GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP	C7_ immunologic signatures	178	1.2991617	0.034077555	0.24667032	GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP	180	0.97408974	0.57403654	0.9566929	2.27325144	0.32507196
GSE7460_TCONV_VS_TREG_THYMUS_DN	C7_ immunologic signatures	171	1.2990987	0.042755343	0.24671686	GSE7460_TCONV_VS_TREG_THYMUS_DN	178	1.3180047	0.016177958	0.41335618	2.6171034	-0.018906
GO_CELL_ADHESION_MOLECULE_BINDING	c5.GO molecular function	161	1.2989696	0.056338027	0.24690327	GO_CELL_ADHESION_MOLECULE_BINDING	167	1.1521531	0.18661258	0.66591024	2.4511227	0.1468165
REACTOME_PI3K_CASCADE	c2.CP_REACTOME_ Reactome gene sets	66	1.2989438	0.083333336	0.24687225	REACTOME_PI3K_CASCADE	67	0.66267973	0.9515608	1	1.96162353	0.63626407
YATGNWAAT_OCT_C	c3.TFT_ transcription factor targets	306	1.2988417	0.012114538	0.24699396	YATGNWAAT_OCT_C	319	0.9005772	0.7797798	1	2.1994189	0.3982645
GO_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT	c5.BP_ GO biological process	29	1.2987853	0.13481481	0.24702667	GO_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT	29	-1.4081509	0.040697675	0.20162337	-0.1093656	2.7069362
GO_REGULATION_OF_OSTEOBLAST_PROLIFERATION	c5.BP_ GO biological process	22	1.2987233	0.1399689	0.24706726	GO_REGULATION_OF_OSTEOBLAST_PROLIFERATION	22	1.1150054	0.33459595	0.7306228	2.4137287	0.1837179
KEGG_FOCAL_ADHESION	c2.CP_BIOCARTA_ BioCarta gene sets	188	1.2987062	0.03985932	0.24702011	KEGG_FOCAL_ADHESION	192	1.226201	0.06464647	0.54746175	2.5249072	0.0725052
GO_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM	c5.BP_ GO biological process	199	1.298699	0.030989273	0.24695536	GO_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM	219	1.3370011	0.004012036	0.39847946	2.6357001	-0.0383021
BMI1_DN_MEL18_DN.V1_UP	C6_ oncogenic signatures	127	1.2986253	0.055282556	0.24702153	BMI1_DN_MEL18_DN.V1_UP	127	1.5179558	0	0.23448917	2.8165811	-0.2193305
CTIP_DN.V1_DN	C6_ oncogenic signatures	101	1.2985553	0.07116105	0.24708545	CTIP_DN.V1_DN	107	-1.350181	0	0.2427503	-0.0516257	2.6487363
MCLACHLAN_DENTAL_CARIES_DN	c2.CGP_ chemical and genetic perturbations	70	1.2985504	0.08548168	0.2470155	MCLACHLAN_DENTAL_CARIES_DN	74	1.0970024	0.325054	0.76093423	2.3955528	0.201548
GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP	C7_ immunologic signatures	185	1.2985318	0.03587963	0.24696942	GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP	186	-1.1232228	0.14285715	0.483743	0.175309	2.4217546
BRUINS_UVC_RESPONSE_EARLY_LATE	c2.CGP_ chemical and genetic perturbations	277	1.2983795	0.016519824	0.24718742	BRUINS_UVC_RESPONSE_EARLY_LATE	281	0.8245252	0.9028056	1	2.1229047	0.4738543
GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	153	1.2982047	0.05035971	0.24744691	GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN	160	1.2171924	0.07857143	0.5618247	2.5153971	0.0810123
GSE17721_12H_VS_24H_LPS_BMDC_UP	C7_ immunologic signatures	185	1.298187	0.039952997	0.24740565	GSE17721_12H_VS_24H_LPS_BMDC_UP	187	0.8613425	0.80827445	1	2.1595295	0.4368445
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	c2.CGP_ chemical and genetic perturbations	50	1.2978928	0.09383754	0.24791731	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	52	1.1937	0.19864559	0.59973264	2.4915928	0.1041928
GO_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS	c5.BP_ GO biological process	19	1.2977935	0.13030303	0.24803993	GO_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS	19	1.1993036	0.24588086	0.5934663	2.4970971	0.0984899
GO_NEGATIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION	c5.BP_ GO biological process	106	1.2977798	0.05761844	0.24798833	GO_NEGATIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION	110	0.7518057	0.9157246	1	2.0495855	0.5459741
GO_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS	c5.BP_ GO biological process	24	1.2975967	0.13608563	0.24827032	GO_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS	24	-1.4001758	0.07329843	0.2061044	-0.1025791	2.6977725
GO_RENAL_TUBULE_DEVELOPMENT	c5.BP_ GO biological process	73	1.2974057	0.076416336	0.24856895	GO_RENAL_TUBULE_DEVELOPMENT	76	1.0976838	0.31624863	0.75936776	2.3950895	0.1997219
GO_FIBROBLAST_GROWTH_FACTOR_BINDING	c5.GO molecular function	20	1.297399	0.11867089	0.248504	GO_FIBROBLAST_GROWTH_FACTOR_BINDING	21	-1.1698612	0.20673077	0.41724354	0.1275378	2.4672602
GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN	C7_ immunologic signatures	150	1.2970325	0.045184303	0.24915038	GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN	151	1.0427203	0.41020408	0.8539096	2.3397528	0.2543122
GO_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS	c5.BP_ GO biological process	15	1.2969882	0.14883721	0.24916418	GO_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS	15	1.1205598	0.342246	0.722933	2.417548	0.1764284
KEGG_NOTCH_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	45	1.2968642	0.09745128	0.24931994	KEGG_NOTCH_SIGNALING_PATHWAY	46	0.6792802	0.9234339	1	1.9761444	0.617584
CTTTGCA_MIR527	c3.MIR_ microRNA targets	223	1.2966712	0.023121387	0.24962705	CTTTGCA_MIR527	227	0.9302469	0.6713427	0.99877894	2.2269181	0.3664243
GO_RESPONSE_TO_WOUNDING	c5.BP_ GO biological process	485	1.2966561	0.00529661	0.24957271	GO_RESPONSE_TO_WOUNDING	485	0	0	0	1.2966561	1.2966561
GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	166	1.2966206	0.037214886	0.24955893	GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	176	1.3300271	0.01816347	0.40266913	2.6266477	-0.0334065
ODONNELL_TFRC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	320	1.2963637	0.015250545	0.2500332	ODONNELL_TFRC_TARGETS_UP	335	1.3552622	0.001	0.3816182	2.6516259	-0.0588985
GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP	C7_ immunologic signatures	178	1.296193	0.03301887	0.2503017	GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP	179	1.202855	0.10851927	0.58714116	2.499048	0.093338
KEGG_LONG_TERM_DEPRESSION	c2.CP_BIOCARTA_ BioCarta gene sets	61	1.296144	0.07377049	0.25032488	KEGG_LONG_TERM_DEPRESSION	66	1.3348049	0.05257393	0.39785978	2.6309489	-0.0386609
GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN	C7_ immunologic signatures	171	1.296097	0.040767387	0.25033492	GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN	175	1.1103764	0.25075835	0.73707056	2.4064734	0.1857206
ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE	c2.CGP_ chemical and genetic perturbations	15	1.2960787	0.15299684	0.2502935	ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE	16	-0.992407	0.42975205	0.69911724	0.3036717	2.2884857
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	c2.CGP_ chemical and genetic perturbations	203	1.2960504	0.036088474	0.2502639	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	209	1.0850129	0.28008088	0.77718997	2.3810633	0.2110375
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	c2.CGP_ chemical and genetic perturbations	485	1.2957662	0.006282723	0.25075668	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	489	1.0372849	0.376	0.8637165	2.3330511	0.2584813
MODULE_168	c4.CM_ cancer modules	16	1.2956334	0.13709678	0.25095305	MODULE_168	16	0.79133177	0.76811594	1	2.08696517	0.50430163
GO_CELL_SEPARATION_AFTER_CYTOKINESIS	c5.BP_ GO biological process	15	1.2956258	0.13562092	0.25088912	GO_CELL_SEPARATION_AFTER_CYTOKINESIS	15	0.64337564	0.9153226	1	1.93900144	0.65225016
GO_CORE_PROMOTER_BINDING	c5.GO molecular function	138	1.2955214	0.045905706	0.25102216	GO_CORE_PROMOTER_BINDING	146	-1.1039011	0.20689656	0.5110556	0.1916203	2.3994225
GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	188	1.2954937	0.047169812	0.2509941	GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP	191	1.3949381	0.005045409	0.34543175	2.6904318	-0.0994444
GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP	C7_ immunologic signatures	155	1.2954558	0.05066345	0.25099468	GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP	155	1.3234485	0.0254842	0.41059655	2.6189043	-0.0279927
GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP	C7_ immunologic signatures	179	1.295379	0.041763343	0.25107154	GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP	180	0.87559927	0.79352224	1	2.17097827	0.41977973
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	169	1.295321	0.04436451	0.251098	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN	175	0.9039014	0.7344064	1	2.1992224	0.3914196
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	c2.CGP_ chemical and genetic perturbations	117	1.2952094	0.06491885	0.25125995	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	120	1.3208225	0.0373444	0.41138527	2.6160319	-0.0256131
GSE12366_GC_VS_NAIVE_BCELL_DN	C7_ immunologic signatures	163	1.2951231	0.042682927	0.25134614	GSE12366_GC_VS_NAIVE_BCELL_DN	164	1.1062742	0.27106598	0.7446578	2.4013973	0.1888489
GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN	C7_ immunologic signatures	131	1.2950374	0.052434456	0.25145158	GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN	141	1.003354	0.48712668	0.9175222	2.2983914	0.2916834
GO_ACTININ_BINDING	c5.GO molecular function	27	1.2947459	0.1183432	0.2519678	GO_ACTININ_BINDING	29	1.0913898	0.35344827	0.76988536	2.3861357	0.2033561
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	c2.CGP_ chemical and genetic perturbations	68	1.2947246	0.092541434	0.2519283	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	68	0.9126847	0.6349892	1	2.2074093	0.3820399
REACTOME_SIGNALING_BY_PDGF	c2.CP_REACTOME_ Reactome gene sets	112	1.2946708	0.054616384	0.25194728	REACTOME_SIGNALING_BY_PDGF	113	1.0763648	0.34397528	0.79440546	2.3710356	0.218306
PAX4_04	c3.TFT_ transcription factor targets	181	1.2946557	0.03337169	0.25189713	PAX4_04	191	1.0922738	0.273374	0.76898295	2.3869295	0.2023819
GO_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	113	1.294646	0.05490196	0.2518351	GO_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	122	1.5098003	0	0.24356613	2.8044463	-0.2151543
PID_FGF_PATHWAY	c2.CP_ Canonical pathways	55	1.2942885	0.09917355	0.2524634	PID_FGF_PATHWAY	54	0.9294364	0.6062992	0.99904805	2.2237249	0.3648521
GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	c5.GO molecular function	15	1.2942674	0.17077176	0.2524228	GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	16	1.3064991	0.14285715	0.4308691	2.6007665	-0.0122317
RPS14_DN.V1_DN	C6_ oncogenic signatures	167	1.2942283	0.04653938	0.2524171	RPS14_DN.V1_DN	167	0.57934517	0.99898684	1	1.87357347	0.71488313
DELYS_THYROID_CANCER_DN	c2.CGP_ chemical and genetic perturbations	198	1.294161	0.037209302	0.25246572	DELYS_THYROID_CANCER_DN	202	1.4159275	0.001013171	0.3216538	2.7100885	-0.1217665
GSE3982_DC_VS_MAC_LPS_STIM_DN	C7_ immunologic signatures	170	1.2939535	0.05399061	0.25281104	GSE3982_DC_VS_MAC_LPS_STIM_DN	176	1.2197276	0.084349595	0.5559704	2.5136811	0.0742259
PID_RAS_PATHWAY	c2.CP_ Canonical pathways	29	1.2939225	0.13097073	0.25279644	PID_RAS_PATHWAY	30	1.3269902	0.110846244	0.40510803	2.6209127	-0.0330677
GO_SECOND_MESSENGER_MEDIATED_SIGNALING	c5.BP_ GO biological process	129	1.2937676	0.05131414	0.25301436	GO_SECOND_MESSENGER_MEDIATED_SIGNALING	136	1.355142	0.022610484	0.381751	2.6489096	-0.0613744
GO_RELAXATION_OF_MUSCLE	c5.BP_ GO biological process	18	1.2937305	0.12379421	0.2530035	GO_RELAXATION_OF_MUSCLE	17	0.5451495	0.9725131	1	1.83888	0.748581
KORKOLA_CORRELATED_WITH_POU5F1	c2.CGP_ chemical and genetic perturbations	28	1.2937045	0.11278196	0.2529708	KORKOLA_CORRELATED_WITH_POU5F1	29	0.8231234	0.7211202	1	2.1168279	0.4705811
GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP	C7_ immunologic signatures	172	1.2935302	0.041062802	0.2532298	GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP	175	1.1383653	0.18839104	0.6933946	2.4318955	0.1551649
GO_BLASTOCYST_GROWTH	c5.BP_ GO biological process	16	1.2932113	0.13870968	0.25379905	GO_BLASTOCYST_GROWTH	16	-0.8150035	0.74891776	0.89263475	0.4782078	2.1082148
REACTOME_G1_S_TRANSITION	c2.CP_REACTOME_ Reactome gene sets	101	1.2931689	0.07721519	0.25379422	REACTOME_G1_S_TRANSITION	101	-2.2486908	0	0.000543672	-0.9555219	3.5418597
GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP	C7_ immunologic signatures	172	1.293119	0.041909195	0.25381553	GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP	179	1.0584555	0.36501518	0.8271608	2.3515745	0.2346635
GO_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT	c5.BP_ GO biological process	67	1.2929064	0.09065934	0.25417352	GO_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT	67	0.82271063	0.79741377	1	2.11561703	0.47019577
GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN	C7_ immunologic signatures	174	1.2928897	0.036188178	0.2541189	GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN	178	1.3922884	0.004040404	0.34739092	2.6851781	-0.0993987
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN	C7_ immunologic signatures	173	1.2928166	0.04866744	0.25419375	GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN	174	1.1492095	0.1841302	0.67041254	2.4420261	0.1436071
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN	C7_ immunologic signatures	150	1.2928096	0.05528846	0.25412494	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN	150	0.7565513	0.90602654	1	2.0493609	0.5362583
GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN	C7_ immunologic signatures	174	1.2925838	0.044496488	0.2545136	GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN	179	1.3623576	0.007070707	0.37588158	2.6549414	-0.0697738
GO_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	16	1.2925135	0.15841584	0.25459093	GO_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT	16	0.9676029	0.5327979	0.96396255	2.2601164	0.3249106
GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP	C7_ immunologic signatures	179	1.2924665	0.04311377	0.25460476	GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP	179	1.0404354	0.41532257	0.85870546	2.3329019	0.2520311
GAVIN_FOXP3_TARGETS_CLUSTER_P7	c2.CGP_ chemical and genetic perturbations	77	1.2922312	0.08481532	0.25500733	GAVIN_FOXP3_TARGETS_CLUSTER_P7	81	1.3621132	0.046709128	0.37574157	2.6543444	-0.069882
GSE12366_NAIVE_VS_MEMORY_BCELL_DN	C7_ immunologic signatures	163	1.2920427	0.047281325	0.2552963	GSE12366_NAIVE_VS_MEMORY_BCELL_DN	168	1.2157744	0.09422492	0.5646919	2.5078171	0.0762683
GO_SMAD_BINDING	c5.GO molecular function	67	1.2919817	0.102564104	0.25534183	GO_SMAD_BINDING	68	0.8441611	0.7462039	1	2.1361428	0.4478206
SMIRNOV_RESPONSE_TO_IR_6HR_UP	c2.CGP_ chemical and genetic perturbations	137	1.2917901	0.0609319	0.25563934	SMIRNOV_RESPONSE_TO_IR_6HR_UP	138	1.1684601	0.17580144	0.6397186	2.4602502	0.12333
GO_REGULATION_OF_CELLULAR_COMPONENT_SIZE	c5.BP_ GO biological process	299	1.2917758	0.031354982	0.25558653	GO_REGULATION_OF_CELLULAR_COMPONENT_SIZE	311	0.9326129	0.7085427	0.99726784	2.2243887	0.3591629
GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	C7_ immunologic signatures	178	1.2917756	0.043274853	0.25550467	GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	180	0.7164533	0.9654471	1	2.0082289	0.5753223
GO_CELL_CELL_JUNCTION	c5.CC_ GO cellular component	326	1.2916723	0.018438177	0.25563553	GO_CELL_CELL_JUNCTION	345	1.1892257	0.044176705	0.60630494	2.480898	0.1024466
GO_REGULATION_OF_MYOBLAST_DIFFERENTIATION	c5.BP_ GO biological process	43	1.291338	0.109281436	0.25625628	GO_REGULATION_OF_MYOBLAST_DIFFERENTIATION	42	1.1933556	0.21688159	0.6005516	2.4846936	0.0979824
GO_ENDOSOME_ORGANIZATION	c5.BP_ GO biological process	54	1.291232	0.10354223	0.256394	GO_ENDOSOME_ORGANIZATION	55	1.0838447	0.36883408	0.77958554	2.3750767	0.2073873
GO_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	34	1.2911899	0.11958147	0.2563937	GO_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS	39	0.9062431	0.6505882	1	2.197433	0.3849468
GSE18893_TCONV_VS_TREG_2H_CULTURE_DN	C7_ immunologic signatures	183	1.2911309	0.040865384	0.2564193	GSE18893_TCONV_VS_TREG_2H_CULTURE_DN	184	0.79412055	0.8888889	1	2.08525145	0.49701035
MASSARWEH_TAMOXIFEN_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	210	1.29096	0.032	0.2567107	MASSARWEH_TAMOXIFEN_RESISTANCE_DN	214	1.2583402	0.03109328	0.49894753	2.5493002	0.0326198
KRAS.KIDNEY_UP.V1_UP	C6_ oncogenic signatures	125	1.2909595	0.04936709	0.256629	KRAS.KIDNEY_UP.V1_UP	131	1.3560642	0.020898642	0.38057998	2.6470237	-0.0651047
GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	C7_ immunologic signatures	170	1.2908325	0.049457178	0.25681466	GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	174	0.79805	0.8853955	1	2.0888825	0.4927825
GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	166	1.2906718	0.05017503	0.25705206	GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	165	1.211265	0.0951417	0.57574	2.5019368	0.0794068
GO_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	169	1.2905037	0.047732696	0.25732613	GO_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS	170	0.7438093	0.9453994	1	2.034313	0.5466944
GO_EXCITATORY_SYNAPSE	c5.CC_ GO cellular component	184	1.2904537	0.038869258	0.25733894	GO_EXCITATORY_SYNAPSE	189	1.1686915	0.14530776	0.6391713	2.4591452	0.1217622
GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP	C7_ immunologic signatures	171	1.2904323	0.044032443	0.25730217	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP	179	1.2377276	0.063572146	0.52935886	2.5281599	0.0527047
DASU_IL6_SIGNALING_SCAR_UP	c2.CGP_ chemical and genetic perturbations	30	1.2902942	0.12443778	0.2574876	DASU_IL6_SIGNALING_SCAR_UP	30	0.9460531	0.5625745	0.9861544	2.2363473	0.3442411
GSE24210_IL35_TREATED_VS_RESTING_TREG_DN	C7_ immunologic signatures	165	1.2902734	0.04800937	0.25744683	GSE24210_IL35_TREATED_VS_RESTING_TREG_DN	171	1.4344289	0.003030303	0.31164122	2.7247023	-0.1441555
GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS	c5.BP_ GO biological process	169	1.2902611	0.04379562	0.25739613	GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS	174	1.1312789	0.19328585	0.7046877	2.42154	0.1589822
GSE17721_CTRL_VS_LPS_1H_BMDC_DN	C7_ immunologic signatures	172	1.2900618	0.037125748	0.25772703	GSE17721_CTRL_VS_LPS_1H_BMDC_DN	177	0.9111404	0.7070707	1	2.2012022	0.3789214
GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN	C7_ immunologic signatures	109	1.2899932	0.067010306	0.2577889	GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN	110	1.3096867	0.050367262	0.42619595	2.5996799	-0.0196935
GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP	C7_ immunologic signatures	174	1.2899233	0.039099526	0.2578487	GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP	180	0.90299106	0.73049647	1	2.19291436	0.38693224
GO_CALMODULIN_BINDING	c5.GO molecular function	164	1.2899021	0.036817104	0.25781804	GO_CALMODULIN_BINDING	173	1.4426568	0.001017294	0.29877013	2.7325589	-0.1527547
GO_PEPTIDYL_SERINE_MODIFICATION	c5.BP_ GO biological process	138	1.2898854	0.06771463	0.2577673	GO_PEPTIDYL_SERINE_MODIFICATION	139	1.197449	0.12994924	0.59700674	2.4873344	0.0924364
GO_RESPONSE_TO_X_RAY	c5.BP_ GO biological process	29	1.2898513	0.13313162	0.2577501	GO_RESPONSE_TO_X_RAY	29	0.9516139	0.5588235	0.98042715	2.2414652	0.3382374
BAELDE_DIABETIC_NEPHROPATHY_UP	c2.CGP_ chemical and genetic perturbations	66	1.2897313	0.08798882	0.2579059	BAELDE_DIABETIC_NEPHROPATHY_UP	69	1.7037182	0.001068376	0.08516399	2.9934495	-0.4139869
GO_EMBRYONIC_MORPHOGENESIS	c5.BP_ GO biological process	481	1.2895398	0.012765957	0.25822276	GO_EMBRYONIC_MORPHOGENESIS	481	0	0	0	1.2895398	1.2895398
RADMACHER_AML_PROGNOSIS	c2.CGP_ chemical and genetic perturbations	70	1.2895187	0.098013245	0.25818306	RADMACHER_AML_PROGNOSIS	70	0.8482612	0.7435345	1	2.1377799	0.4412575
MCCABE_HOXC6_TARGETS_CANCER_UP	c2.CGP_ chemical and genetic perturbations	28	1.289488	0.12538226	0.2581704	MCCABE_HOXC6_TARGETS_CANCER_UP	29	1.1664	0.2542373	0.6443633	2.455888	0.123088
GRADE_COLON_VS_RECTAL_CANCER_UP	c2.CGP_ chemical and genetic perturbations	28	1.2894439	0.1235119	0.25818023	GRADE_COLON_VS_RECTAL_CANCER_UP	27	0.7783325	0.78960097	1	2.0677764	0.5111114
GO_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION	c5.BP_ GO biological process	173	1.2890124	0.047675803	0.25901935	GO_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION	183	0.7482078	0.94495416	1	2.0372202	0.5408046
GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	C7_ immunologic signatures	156	1.2889899	0.05386417	0.25898275	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	155	1.0634526	0.34489796	0.81661135	2.3524425	0.2255373
GSE36009_UNSTIM_VS_LPS_STIM_DC_UP	C7_ immunologic signatures	169	1.2887386	0.051869724	0.25942823	GSE36009_UNSTIM_VS_LPS_STIM_DC_UP	173	0.9780712	0.5673759	0.9517459	2.2668098	0.3106674
GO_COMPLEMENT_ACTIVATION	c5.BP_ GO biological process	33	1.288711	0.122727275	0.25940272	GO_COMPLEMENT_ACTIVATION	47	1.6298697	0	0.13283795	2.9185807	-0.3411587
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	c2.CGP_ chemical and genetic perturbations	413	1.2886511	0.006437768	0.25943533	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	424	1.2057928	0.025	0.58177173	2.4944439	0.0828583
KIM_PTEN_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	16	1.2884922	0.17283951	0.25968298	KIM_PTEN_TARGETS_UP	17	1.2668906	0.16927083	0.48883665	2.5553828	0.0216016
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	c2.CGP_ chemical and genetic perturbations	45	1.2882998	0.11499272	0.2600105	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	45	1.3522619	0.06836616	0.38304612	2.6405617	-0.0639621
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	c2.CGP_ chemical and genetic perturbations	87	1.2882487	0.09436435	0.2600274	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	91	0.96237224	0.55816436	0.96873206	2.25062094	0.32587646
GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP	C7_ immunologic signatures	98	1.2880721	0.07402597	0.2603173	GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP	115	1.1689755	0.189441	0.6394645	2.4570476	0.1190966
GO_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY	c5.GO molecular function	39	1.2880225	0.11874106	0.26033515	GO_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY	40	1.1759315	0.22502871	0.62804496	2.463954	0.112091
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP	C7_ immunologic signatures	155	1.2879727	0.052757792	0.2603571	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP	156	1.4200164	0.00509165	0.3192288	2.7079891	-0.1320437
GO_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION	c5.BP_ GO biological process	276	1.2878834	0.020879121	0.26044714	GO_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION	293	1.057862	0.35771543	0.827651	2.3457454	0.2300214
GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN	C7_ immunologic signatures	175	1.2878602	0.049411766	0.26041085	GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN	178	1.1854124	0.12028542	0.6135261	2.4732726	0.1024478
MODULE_27	c4.CM_ cancer modules	293	1.2872643	0.03258427	0.26154482	MODULE_27	318	1.2361665	0.018018018	0.5316331	2.5234308	0.0510978
GSE17721_LPS_VS_CPG_12H_BMDC_UP	C7_ immunologic signatures	175	1.2872537	0.040983606	0.2614864	GSE17721_LPS_VS_CPG_12H_BMDC_UP	176	1.1680633	0.16158536	0.64052105	2.455317	0.1191904
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	C7_ immunologic signatures	180	1.2871237	0.03882353	0.26168188	GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	184	1.22575	0.07762097	0.54848427	2.5128737	0.0613737
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN	C7_ immunologic signatures	177	1.2870667	0.050480768	0.26172292	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN	179	0.98548144	0.53279513	0.9413957	2.27254814	0.30158526
MODULE_128	c4.CM_ cancer modules	80	1.286731	0.08421053	0.26232946	MODULE_128	84	0.8642422	0.7569002	1	2.1509732	0.4224888
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	c2.CGP_ chemical and genetic perturbations	21	1.2867293	0.15085536	0.26225024	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	22	-0.9185125	0.58522725	0.7973963	0.3682168	2.2052418
GO_FAT_CELL_DIFFERENTIATION	c5.BP_ GO biological process	96	1.2865188	0.08582575	0.26258823	GO_FAT_CELL_DIFFERENTIATION	99	0.9552446	0.5901981	0.97591853	2.2417634	0.3312742
GO_CALCIUM_ION_REGULATED_EXOCYTOSIS	c5.BP_ GO biological process	69	1.2864953	0.08783784	0.26255044	GO_CALCIUM_ION_REGULATED_EXOCYTOSIS	70	1.4374301	0.01194354	0.30729434	2.7239254	-0.1509348
GATA3_01	c3.TFT_ transcription factor targets	213	1.2864317	0.03976608	0.26260138	GATA3_01	219	0.93819964	0.6616466	0.99274015	2.22463134	0.34823206
GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP	C7_ immunologic signatures	153	1.2864118	0.045012165	0.26257014	GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP	156	1.1582872	0.17784552	0.6564303	2.444699	0.1281246
GSE3982_BASOPHIL_VS_TH2_UP	C7_ immunologic signatures	161	1.2864105	0.04704463	0.26248914	GSE3982_BASOPHIL_VS_TH2_UP	163	1.0906322	0.28803244	0.7705288	2.3770427	0.1957783
GENTILE_UV_RESPONSE_CLUSTER_D4	c2.CGP_ chemical and genetic perturbations	53	1.2863832	0.103151865	0.262466	GENTILE_UV_RESPONSE_CLUSTER_D4	53	-0.9174483	0.7128713	0.79836625	0.3689349	2.2038315
GO_NEGATIVE_REGULATION_OF_DNA_REPLICATION	c5.BP_ GO biological process	48	1.286348	0.111428574	0.26245436	GO_NEGATIVE_REGULATION_OF_DNA_REPLICATION	50	-0.8555302	0.80851066	0.8614235	0.4308178	2.1418782
GO_SIGNAL_RELEASE	c5.BP_ GO biological process	151	1.2863394	0.049576785	0.26238868	GO_SIGNAL_RELEASE	160	1.2045618	0.09785933	0.5831585	2.4909012	0.0817776
MARKEY_RB1_CHRONIC_LOF_UP	c2.CGP_ chemical and genetic perturbations	108	1.2863263	0.074742265	0.262335	MARKEY_RB1_CHRONIC_LOF_UP	107	-1.0585763	0.31578946	0.5906438	0.22775	2.3449026
GO_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY	c5.BP_ GO biological process	62	1.2862915	0.101198405	0.26232398	GO_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY	67	1.3052315	0.067961164	0.43379417	2.591523	-0.01894
GSE17721_0.5H_VS_4H_CPG_BMDC_DN	C7_ immunologic signatures	172	1.2862822	0.05755396	0.26226047	GSE17721_0.5H_VS_4H_CPG_BMDC_DN	171	0.89346576	0.7537994	1	2.17974796	0.39281644
REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR	c2.CP_REACTOME_ Reactome gene sets	15	1.2861651	0.15231788	0.26242855	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR	15	1.1914114	0.24435592	0.6041172	2.4775765	0.0947537
GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP	C7_ immunologic signatures	164	1.2861392	0.05344418	0.26239207	GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP	166	0.9183576	0.6921509	1	2.2044968	0.3677816
REACTOME_G1_PHASE	c2.CP_REACTOME_ Reactome gene sets	32	1.2861199	0.13762811	0.26234895	REACTOME_G1_PHASE	32	0.7076791	0.88834953	1	1.993799	0.5784408
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	C7_ immunologic signatures	173	1.2860924	0.04971098	0.26232922	GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	174	-1.0372176	0.2	0.6276735	0.2488748	2.32331
GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN	C7_ immunologic signatures	103	1.2858417	0.08219178	0.26275852	GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN	112	1.1190065	0.2663892	0.72415906	2.4048482	0.1668352
BALDWIN_PRKCI_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	33	1.2858018	0.12669684	0.2627626	BALDWIN_PRKCI_TARGETS_UP	33	-0.9597572	0.5248227	0.7419973	0.3260446	2.245559
MATZUK_SPERMATID_DIFFERENTIATION	c2.CGP_ chemical and genetic perturbations	33	1.2856997	0.14774494	0.26288292	MATZUK_SPERMATID_DIFFERENTIATION	35	0.9896244	0.50904703	0.93553805	2.2753241	0.2960753
OKAWA_NEUROBLASTOMA_1P36_31_DELETION	c2.CGP_ chemical and genetic perturbations	21	1.2856722	0.13650307	0.26285747	OKAWA_NEUROBLASTOMA_1P36_31_DELETION	21	1.0172378	0.46666667	0.8938959	2.30291	0.2684344
AZARE_STAT3_TARGETS	c2.CGP_ chemical and genetic perturbations	22	1.2856606	0.16203703	0.26279718	AZARE_STAT3_TARGETS	22	0.8904799	0.63459194	1	2.1761405	0.3951807
CHUNG_BLISTER_CYTOTOXICITY_UP	c2.CGP_ chemical and genetic perturbations	112	1.285638	0.07160804	0.26275998	CHUNG_BLISTER_CYTOTOXICITY_UP	114	0.7336855	0.9314642	1	2.0193235	0.5519525
SERVITJA_ISLET_HNF1A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	144	1.2855331	0.06909091	0.2629071	SERVITJA_ISLET_HNF1A_TARGETS_UP	151	-1.201914	0	0.3793426	0.0836191	2.4874471
REACTOME_PACKAGING_OF_TELOMERE_ENDS	c2.CP_REACTOME_ Reactome gene sets	19	1.2855314	0.14194578	0.26282698	REACTOME_PACKAGING_OF_TELOMERE_ENDS	20	1.111561	0.34517765	0.7353464	2.3970924	0.1739704
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	c2.CP_REACTOME_ Reactome gene sets	42	1.2855022	0.11929308	0.26280576	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	43	1.4742315	0.0194508	0.27537954	2.7597337	-0.1887293
LIAO_METASTASIS	c2.CGP_ chemical and genetic perturbations	474	1.2851481	0.009414226	0.26348835	LIAO_METASTASIS	478	1.1777223	0.046	0.6257083	2.4628704	0.1074258
KEGG_MELANOGENESIS	c2.CP_BIOCARTA_ BioCarta gene sets	90	1.2850411	0.07874016	0.26363075	KEGG_MELANOGENESIS	96	0.82014996	0.8195173	1	2.10519106	0.46489114
GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP	C7_ immunologic signatures	174	1.2848122	0.05408654	0.26404417	GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP	186	1.2470044	0.053589486	0.5156604	2.5318166	0.0378078
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	149	1.284755	0.057761732	0.26408023	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP	155	1.1233798	0.2320162	0.7192278	2.4081348	0.1613752
GO_RESPONSE_TO_CORTICOSTEROID	c5.BP_ GO biological process	154	1.2847058	0.052884616	0.26409858	GO_RESPONSE_TO_CORTICOSTEROID	156	1.0159755	0.46707192	0.89590156	2.3006813	0.2687303
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	c2.CGP_ chemical and genetic perturbations	155	1.2846228	0.056234717	0.26418945	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	159	0.9363563	0.66700613	0.99378204	2.2209791	0.3482665
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP	C7_ immunologic signatures	178	1.2845755	0.047449585	0.26421288	GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP	178	-1.3885378	0	0.21451695	-0.1039623	2.6731133
TSUNODA_CISPLATIN_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	40	1.2845681	0.12663755	0.2641478	TSUNODA_CISPLATIN_RESISTANCE_DN	42	1.1146886	0.30804598	0.7311631	2.3992567	0.1698795
GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP	C7_ immunologic signatures	149	1.2845658	0.059850372	0.26407057	GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP	162	1.1615865	0.16378434	0.6510226	2.4461523	0.1229793
GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP	C7_ immunologic signatures	162	1.2845007	0.053003535	0.26411486	GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP	170	0.87571645	0.7782258	1	2.16021715	0.40878425
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	c2.CGP_ chemical and genetic perturbations	33	1.2844878	0.12960236	0.264063	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	33	0.86124927	0.7056075	1	2.14573707	0.42323853
SREBP_Q3	c3.TFT_ transcription factor targets	227	1.2843863	0.030439684	0.26419148	SREBP_Q3	232	0.8222117	0.8977956	1	2.106598	0.4621746
LOPES_METHYLATED_IN_COLON_CANCER_UP	c2.CGP_ chemical and genetic perturbations	21	1.2843746	0.1283255	0.26413321	LOPES_METHYLATED_IN_COLON_CANCER_UP	22	1.4164306	0.0563204	0.3203832	2.7008052	-0.132056
NFY_Q6	c3.TFT_ transcription factor targets	223	1.2842494	0.034722224	0.26431718	NFY_Q6	233	1.021349	0.4553661	0.89046705	2.3055984	0.2629004
MODULE_173	c4.CM_ cancer modules	16	1.2840055	0.14533965	0.26474416	MODULE_173	15	1.4135088	0.0655308	0.32387218	2.6975143	-0.1295033
GO_PITUITARY_GLAND_DEVELOPMENT	c5.BP_ GO biological process	35	1.283698	0.14749263	0.26531562	GO_PITUITARY_GLAND_DEVELOPMENT	40	-1.0111064	0.4413793	0.67085665	0.2725916	2.2948044
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP	C7_ immunologic signatures	156	1.283599	0.05854241	0.26544285	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP	164	0.9017642	0.75714284	1	2.1853632	0.3818348
GO_CELL_SUBSTRATE_ADHERENS_JUNCTION_ASSEMBLY	c5.BP_ GO biological process	23	1.2835876	0.13694267	0.26538783	GO_CELL_SUBSTRATE_ADHERENS_JUNCTION_ASSEMBLY	23	1.0915891	0.3603936	0.76989496	2.3751767	0.1919985
RODWELL_AGING_KIDNEY_UP	c2.CGP_ chemical and genetic perturbations	389	1.2833432	0.013043478	0.26582038	RODWELL_AGING_KIDNEY_UP	397	1.1677594	0.068068065	0.6408601	2.4511026	0.1155838
ROVERSI_GLIOMA_LOH_REGIONS	c2.CGP_ chemical and genetic perturbations	38	1.2830989	0.116564415	0.2662293	ROVERSI_GLIOMA_LOH_REGIONS	41	0.9875149	0.5052265	0.93890935	2.2706138	0.295584
GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN	C7_ immunologic signatures	174	1.2830933	0.046373364	0.2661591	GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN	177	1.2682964	0.0354251	0.4865279	2.5513897	0.0147969
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP	C7_ immunologic signatures	171	1.2828965	0.04951691	0.26649544	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP	172	1.2547826	0.05685279	0.5029864	2.5376791	0.0281139
MODULE_389	c4.CM_ cancer modules	181	1.2828892	0.036904763	0.2664251	MODULE_389	186	1.1210811	0.22064777	0.72216433	2.4039703	0.1618081
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	c2.CGP_ chemical and genetic perturbations	30	1.2828776	0.13656388	0.26636872	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	32	1.498978	0.017605634	0.25437495	2.7818556	-0.2161004
GO_MYELOID_DENDRITIC_CELL_ACTIVATION	c5.BP_ GO biological process	22	1.2828523	0.13249211	0.26633936	GO_MYELOID_DENDRITIC_CELL_ACTIVATION	22	0.9842844	0.5131086	0.94226354	2.2671367	0.2985679
GO_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY	c5.BP_ GO biological process	246	1.2828187	0.03153153	0.2663258	GO_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY	259	1.350694	0.004004004	0.38382345	2.6335127	-0.0678753
GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP	C7_ immunologic signatures	177	1.2827847	0.04609929	0.26630992	GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP	178	1.4857116	0.002042901	0.26432347	2.7684963	-0.2029269
HOEBEKE_LYMPHOID_STEM_CELL_DN	c2.CGP_ chemical and genetic perturbations	77	1.2827563	0.085434176	0.26628962	HOEBEKE_LYMPHOID_STEM_CELL_DN	80	0.9004826	0.66200215	1	2.1832389	0.3822737
GO_RESPONSE_TO_ORGANOPHOSPHORUS	c5.BP_ GO biological process	124	1.2826191	0.07605985	0.26650387	GO_RESPONSE_TO_ORGANOPHOSPHORUS	132	1.4124047	0.00610998	0.32425958	2.6950238	-0.1297856
GO_MAMMARY_GLAND_MORPHOGENESIS	c5.BP_ GO biological process	38	1.2825941	0.12247839	0.26647297	GO_MAMMARY_GLAND_MORPHOGENESIS	39	1.3211821	0.09730364	0.41130242	2.6037762	-0.038588
MODULE_244	c4.CM_ cancer modules	181	1.2825042	0.039215688	0.26658478	MODULE_244	183	-0.9324478	0.6666667	0.78118116	0.3500564	2.214952
MEF2_01	c3.TFT_ transcription factor targets	117	1.2824323	0.062271062	0.26665977	MEF2_01	124	1.3668385	0.026831785	0.3714316	2.6492708	-0.0844062
GO_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	c5.GO molecular function	34	1.2824072	0.12682216	0.26663673	GO_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	34	0.9996465	0.4818402	0.9243758	2.2820537	0.2827607
GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP	C7_ immunologic signatures	161	1.2824019	0.039855074	0.26656437	GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP	167	1.3242098	0.023397762	0.40957066	2.6066117	-0.0418079
GO_CELLULAR_RESPONSE_TO_RETINOIC_ACID	c5.BP_ GO biological process	53	1.2823942	0.10437235	0.26649877	GO_CELLULAR_RESPONSE_TO_RETINOIC_ACID	58	0.8749786	0.68357223	1	2.1573728	0.4074156
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	186	1.28239	0.037339557	0.26642403	GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	188	1.2837932	0.028282829	0.46638453	2.5661832	-0.0014032
GSE20715_WT_VS_TLR4_KO_LUNG_UP	C7_ immunologic signatures	181	1.2823628	0.046263345	0.2664071	GSE20715_WT_VS_TLR4_KO_LUNG_UP	179	0.7590123	0.9340771	1	2.0413751	0.5233505
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP	C7_ immunologic signatures	176	1.2822504	0.04084014	0.26654682	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP	178	0.89949167	0.7393075	1	2.18174207	0.38275873
MODULE_44	c4.CM_ cancer modules	276	1.2821668	0.031868134	0.26663586	MODULE_44	286	1.2316163	0.035035037	0.53710896	2.5137831	0.0505505
GO_NEURON_NEURON_SYNAPTIC_TRANSMISSION	c5.BP_ GO biological process	46	1.2821594	0.115277775	0.26656774	GO_NEURON_NEURON_SYNAPTIC_TRANSMISSION	51	1.5441289	0.003428571	0.20876493	2.8262883	-0.2619695
MCDOWELL_ACUTE_LUNG_INJURY_UP	c2.CGP_ chemical and genetic perturbations	43	1.2820443	0.11713031	0.2667272	MCDOWELL_ACUTE_LUNG_INJURY_UP	43	0.91975	0.6047836	1	2.2017943	0.3622943
GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	162	1.2818279	0.038366336	0.2671134	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	162	0.97369975	0.56969696	0.9572622	2.25552765	0.30812815
GO_POSITIVE_REGULATION_OF_KINASE_ACTIVITY	c5.BP_ GO biological process	422	1.2818149	0.012552301	0.26705426	GO_POSITIVE_REGULATION_OF_KINASE_ACTIVITY	441	1.2079922	0.014	0.5805413	2.4898071	0.0738227
GSE16266_CTRL_VS_LPS_STIM_MEF_DN	C7_ immunologic signatures	167	1.2816784	0.043274853	0.26726216	GSE16266_CTRL_VS_LPS_STIM_MEF_DN	178	1.2203357	0.09182644	0.5548724	2.5020141	0.0613427
GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN	C7_ immunologic signatures	178	1.2816437	0.04101327	0.26724714	GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN	177	1.071202	0.31979695	0.8032511	2.3528457	0.2104417
RAF_UP.V1_DN	C6_ oncogenic signatures	171	1.2815379	0.061831154	0.26739717	RAF_UP.V1_DN	177	1.200801	0.1010101	0.59085524	2.4823389	0.0807369
GSE17721_LPS_VS_CPG_0.5H_BMDC_DN	C7_ immunologic signatures	173	1.2815241	0.06338028	0.26734182	GSE17721_LPS_VS_CPG_0.5H_BMDC_DN	182	0.84393954	0.8382204	1	2.12546364	0.43758456
WTTGKCTG_UNKNOWN	c3.TFT_ transcription factor targets	443	1.2815136	0.009594883	0.26728034	WTTGKCTG_UNKNOWN	465	1.0234632	0.399	0.88560414	2.3049768	0.2580504
GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN	C7_ immunologic signatures	181	1.2814147	0.03985932	0.26740822	GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN	182	1.1971517	0.0950455	0.5966794	2.4785664	0.084263
GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN	C7_ immunologic signatures	173	1.2814053	0.043890867	0.26734465	GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN	176	1.0165968	0.45105955	0.895077	2.2980021	0.2648085
AKT_UP.V1_DN	C6_ oncogenic signatures	172	1.2813973	0.04819277	0.2672778	AKT_UP.V1_DN	171	1.1753564	0.12968592	0.6283835	2.4567537	0.1060409
CHR17P11	C1: positional gene sets	55	1.2813807	0.1086351	0.26722753	CHR17P11	57	1.4748334	0.01748634	0.2745561	2.7562141	-0.1934527
GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	C7_ immunologic signatures	165	1.2813803	0.04161712	0.26714545	GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	172	1.2038577	0.09889001	0.58503723	2.485238	0.0775226
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	c2.CGP_ chemical and genetic perturbations	29	1.2811835	0.1324201	0.26746848	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	30	1.2981251	0.10948905	0.44517854	2.5793086	-0.0169416
KRAS.BREAST_UP.V1_DN	C6_ oncogenic signatures	110	1.2809111	0.06982543	0.26795605	KRAS.BREAST_UP.V1_DN	117	1.0852197	0.31908238	0.7771814	2.3661308	0.1956914
GO_EYE_DEVELOPMENT	c5.BP_ GO biological process	295	1.2808692	0.02937976	0.26795766	GO_EYE_DEVELOPMENT	311	0.91537017	0.7487487	1	2.19623937	0.36549903
ESC_J1_UP_EARLY.V1_UP	C6_ oncogenic signatures	150	1.2808477	0.060493827	0.2679198	ESC_J1_UP_EARLY.V1_UP	152	1.3999504	0.005060729	0.34025395	2.6807981	-0.1191027
GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	C7_ immunologic signatures	179	1.2808207	0.043632075	0.26789555	GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	181	0.7305997	0.970618	1	2.0114204	0.550221
BERNARD_PPAPDC1B_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	50	1.2807734	0.117052026	0.26791644	BERNARD_PPAPDC1B_TARGETS_DN	50	1.3904833	0.04	0.3458981	2.6712567	-0.1097099
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN	C7_ immunologic signatures	180	1.2807	0.05923345	0.26799327	GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN	184	1.3230599	0.01629328	0.41130152	2.6037599	-0.0423599
GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP	C7_ immunologic signatures	168	1.28053	0.04394299	0.2682552	GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP	180	0.9961988	0.5091278	0.92939925	2.2767288	0.2843312
GO_NITRIC_OXIDE_SYNTHASE_BINDING	c5.GO molecular function	17	1.2803357	0.15548281	0.268599	GO_NITRIC_OXIDE_SYNTHASE_BINDING	17	1.1145629	0.34251967	0.7309367	2.3948986	0.1657728
GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP	C7_ immunologic signatures	175	1.2802727	0.046511628	0.26865104	GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP	175	0.99639356	0.5080808	0.9289286	2.27666626	0.28387914
GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP	C7_ immunologic signatures	168	1.2802492	0.040621266	0.26861972	GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP	173	1.184333	0.12182741	0.61468554	2.4645822	0.0959162
GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	185	1.2802367	0.044970416	0.26856285	GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP	188	1.4121706	0.004040404	0.32303703	2.6924073	-0.1319339
GO_MYOFIBRIL_ASSEMBLY	c5.BP_ GO biological process	41	1.2801857	0.111428574	0.26859665	GO_MYOFIBRIL_ASSEMBLY	46	1.1245883	0.29617116	0.7158516	2.404774	0.1555974
GO_ORGANIC_CATION_TRANSPORT	c5.BP_ GO biological process	17	1.2801471	0.17607974	0.26860005	GO_ORGANIC_CATION_TRANSPORT	19	1.2773845	0.16838047	0.4761482	2.5575316	0.0027626
WILLIAMS_ESR1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	23	1.2800997	0.16113745	0.26862186	WILLIAMS_ESR1_TARGETS_UP	24	1.0633311	0.3861145	0.8166947	2.3434308	0.2167686
GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	C7_ immunologic signatures	177	1.2799915	0.051068883	0.26878732	GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	181	-1.4058084	0	0.20264813	-0.1258169	2.6857999
GO_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES	c5.BP_ GO biological process	160	1.279821	0.0647482	0.2690659	GO_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES	180	1.1900154	0.10775428	0.6049389	2.4698364	0.0898056
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	c2.CGP_ chemical and genetic perturbations	156	1.279775	0.05642257	0.26907834	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	156	1.2609673	0.05786802	0.49461254	2.5407423	0.0188077
GO_RESPONSE_TO_VITAMIN	c5.BP_ GO biological process	89	1.2797117	0.06949807	0.26913163	GO_RESPONSE_TO_VITAMIN	93	1.4307619	0.008492569	0.31368583	2.7104736	-0.1510502
GO_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION	c5.BP_ GO biological process	39	1.2796923	0.14225352	0.26908946	GO_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION	41	0.7597636	0.84385765	1	2.0394559	0.5199287
BILBAN_B_CLL_LPL_UP	c2.CGP_ chemical and genetic perturbations	57	1.2796922	0.0988858	0.26900646	BILBAN_B_CLL_LPL_UP	58	0.7548692	0.8565121	1	2.0345614	0.524823
GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	177	1.279686	0.051190477	0.26893416	GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	178	0.86037153	0.78781724	1	2.14005753	0.41931447
GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN	C7_ immunologic signatures	107	1.2796606	0.087173104	0.26889881	GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN	113	1.15069	0.21495327	0.66779965	2.4303506	0.1289706
GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	C7_ immunologic signatures	181	1.2795658	0.042056076	0.26901582	GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	182	0.926344	0.67947423	1	2.2059098	0.3532218
PID_BETA_CATENIN_DEG_PATHWAY	c2.CP_ Canonical pathways	16	1.2794392	0.15294118	0.2691963	PID_BETA_CATENIN_DEG_PATHWAY	17	-1.0427836	0.37272727	0.6175414	0.2366556	2.3222228
GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP	C7_ immunologic signatures	121	1.2794096	0.06419753	0.26917765	GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP	130	0.7420712	0.9266529	1	2.0214808	0.5373384
GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP	C7_ immunologic signatures	167	1.2793796	0.062945366	0.26915964	GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP	169	0.8558565	0.81983805	1	2.1352361	0.4235231
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	179	1.2793294	0.045936394	0.26918125	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	183	1.425792	0.002014099	0.31809267	2.7051214	-0.1464626
PID_A6B1_A6B4_INTEGRIN_PATHWAY	c2.CP_ Canonical pathways	45	1.2791804	0.111918606	0.2694094	PID_A6B1_A6B4_INTEGRIN_PATHWAY	45	1.7518559	0	0.06462631	3.0310363	-0.4726755
KIM_LIVER_CANCER_POOR_SURVIVAL_DN	c2.CGP_ chemical and genetic perturbations	35	1.2791097	0.12116788	0.26947978	KIM_LIVER_CANCER_POOR_SURVIVAL_DN	39	1.6072814	0.00456621	0.14954603	2.8863911	-0.3281717
GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP	C7_ immunologic signatures	176	1.2790072	0.06769596	0.2696044	GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP	181	1.0721159	0.33299595	0.8024836	2.3511231	0.2068913
MODULE_70	c4.CM_ cancer modules	35	1.2786028	0.13030303	0.27038097	MODULE_70	38	1.3493705	0.08962264	0.38289055	2.6279733	-0.0707677
GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN	C7_ immunologic signatures	182	1.2785518	0.05172414	0.2703963	GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN	183	1.2569929	0.040774718	0.49963257	2.5355447	0.0215589
GO_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX	c5.CC_ GO cellular component	133	1.2785034	0.07037037	0.27041447	GO_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX	136	0.7729111	0.9128205	1	2.0514145	0.5055923
GO_RESPONSE_TO_METAL_ION	c5.BP_ GO biological process	288	1.2784188	0.02669633	0.2705083	GO_RESPONSE_TO_METAL_ION	303	1.257971	0.01503006	0.49875844	2.5363898	0.0204478
GO_METHYLATED_HISTONE_BINDING	c5.GO molecular function	47	1.2783556	0.109195404	0.27055737	GO_METHYLATED_HISTONE_BINDING	47	-1.0428766	0.39449543	0.61763024	0.235479	2.3212322
GO_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY	c5.BP_ GO biological process	58	1.2781316	0.0979021	0.27095222	GO_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY	62	0.9407121	0.5868853	0.98963284	2.2188437	0.3374195
GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP	C7_ immunologic signatures	177	1.2780746	0.039627038	0.2709931	GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP	179	-1.0941306	0.22222222	0.5270284	0.183944	2.3722052
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	c2.CGP_ chemical and genetic perturbations	163	1.2780626	0.045673076	0.27093223	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	163	1.0509793	0.3865717	0.8379984	2.3290419	0.2270833
GSE7460_TCONV_VS_TREG_LN_UP	C7_ immunologic signatures	171	1.2777938	0.06115108	0.2714064	GSE7460_TCONV_VS_TREG_LN_UP	177	1.3961759	0.006066734	0.3471851	2.6739697	-0.1183821
GSE360_DC_VS_MAC_L_MAJOR_UP	C7_ immunologic signatures	172	1.2777367	0.050059594	0.27144465	GSE360_DC_VS_MAC_L_MAJOR_UP	175	0.8916258	0.7568389	1	2.1693625	0.3861109
CHR1P22	C1: positional gene sets	60	1.2777228	0.10393258	0.27139035	CHR1P22	61	-0.9154573	0.6451613	0.8015361	0.3622655	2.1931801
GO_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT	c5.BP_ GO biological process	422	1.2775817	0.01577287	0.27161714	GO_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT	447	0.9434971	0.703	0.98860925	2.2210788	0.3340846
GO_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING	c5.BP_ GO biological process	52	1.2775333	0.09663866	0.2716297	GO_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING	58	0.9493003	0.5810364	0.9832015	2.2268336	0.328233
GSE12366_GC_BCELL_VS_PLASMA_CELL_UP	C7_ immunologic signatures	169	1.2774831	0.05418139	0.27165654	GSE12366_GC_BCELL_VS_PLASMA_CELL_UP	171	-1.0112834	0.5	0.6710289	0.2661997	2.2887665
GO_REGULATION_OF_RUFFLE_ASSEMBLY	c5.BP_ GO biological process	18	1.2773654	0.15756631	0.2718341	GO_REGULATION_OF_RUFFLE_ASSEMBLY	19	-0.7664034	0.85253453	0.92996967	0.510962	2.0437688
GO_POSITIVE_REGULATION_OF_ION_TRANSPORT	c5.BP_ GO biological process	193	1.2773361	0.041518386	0.27181315	GO_POSITIVE_REGULATION_OF_ION_TRANSPORT	211	1.5818145	0	0.17689437	2.8591506	-0.3044784
HLF_01	c3.TFT_ transcription factor targets	220	1.2773104	0.048109967	0.27177635	HLF_01	228	1.1044147	0.221665	0.74831355	2.3817251	0.1728957
GO_NEGATIVE_REGULATION_OF_EXOCYTOSIS	c5.BP_ GO biological process	23	1.2773087	0.17174959	0.27169928	GO_NEGATIVE_REGULATION_OF_EXOCYTOSIS	24	1.0931344	0.3660606	0.7681634	2.3704431	0.1841743
CSR_LATE_UP.V1_UP	C6_ oncogenic signatures	145	1.2772655	0.063855425	0.2717072	CSR_LATE_UP.V1_UP	149	0.7422571	0.9321175	1	2.0195226	0.5350084
HNF1_01	c3.TFT_ transcription factor targets	201	1.2772472	0.036823936	0.2716638	HNF1_01	208	1.3795978	0.003015075	0.3564215	2.656845	-0.1023506
GSE3982_MAC_VS_TH1_DN	C7_ immunologic signatures	176	1.2772108	0.056603774	0.27165836	GSE3982_MAC_VS_TH1_DN	179	-1.0223441	0.4	0.6560989	0.2548667	2.2995549
GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	155	1.2771876	0.065476194	0.27163082	GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN	166	1.3354638	0.019250253	0.3979477	2.6126514	-0.0582762
GO_REGULATION_OF_BLOOD_PRESSURE	c5.BP_ GO biological process	132	1.2771115	0.063197024	0.27170986	GO_REGULATION_OF_BLOOD_PRESSURE	149	1.3863059	0.007121058	0.34935635	2.6634174	-0.1091944
E4BP4_01	c3.TFT_ transcription factor targets	194	1.2770832	0.050984938	0.27168575	E4BP4_01	202	1.2750621	0.044399597	0.48070487	2.5521453	0.0020211
GO_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY	c5.BP_ GO biological process	27	1.2770815	0.13145539	0.27160683	GO_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY	27	1.1777797	0.2536232	0.6256172	2.4548612	0.0993018
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	c2.CGP_ chemical and genetic perturbations	96	1.2769332	0.08236808	0.27185124	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	97	0.71202874	0.93459916	1	1.98896194	0.56490446
GSE7852_THYMUS_VS_FAT_TREG_DN	C7_ immunologic signatures	171	1.2768686	0.05125149	0.27191156	GSE7852_THYMUS_VS_FAT_TREG_DN	174	1.1245837	0.23761375	0.71571	2.4014523	0.1522849
PAX2_02	c3.TFT_ transcription factor targets	225	1.2768523	0.03374578	0.27185938	PAX2_02	231	0.9953248	0.52620965	0.93050915	2.2721771	0.2815275
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	c2.CGP_ chemical and genetic perturbations	35	1.2768508	0.13929619	0.27178192	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	36	1.0189595	0.4729412	0.8919303	2.2958103	0.2578913
MOHANKUMAR_HOXA1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	146	1.2767961	0.06925881	0.27181125	MOHANKUMAR_HOXA1_TARGETS_DN	154	1.559723	0	0.19722572	2.8365191	-0.2829269
GO_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION	c5.BP_ GO biological process	274	1.2766908	0.038588755	0.27194282	GO_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION	286	1.11321	0.19739479	0.73300207	2.3899008	0.1634808
DCA_UP.V1_DN	C6_ oncogenic signatures	145	1.2766188	0.05140759	0.27202198	DCA_UP.V1_DN	155	1.4328369	0.006122449	0.31273714	2.7094557	-0.1562181
GNF2_CDH11	c4.CGN_ cancer gene neighborhoods	25	1.276571	0.15128593	0.2720466	GNF2_CDH11	25	-1.3464516	0.11764706	0.24389379	-0.0698806	2.6230226
GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	146	1.276376	0.052380953	0.2723723	GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	146	1.4842716	0.003067485	0.26513913	2.7606476	-0.2078956
GO_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY	c5.BP_ GO biological process	25	1.2762938	0.1424	0.272456	GO_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY	26	1.16038	0.2841191	0.65212315	2.4366738	0.1159138
BURTON_ADIPOGENESIS_7	c2.CGP_ chemical and genetic perturbations	48	1.2762696	0.10984308	0.27242798	BURTON_ADIPOGENESIS_7	48	1.0398877	0.41657335	0.8591157	2.3161573	0.2363819
CHR4Q28	C1: positional gene sets	25	1.2761999	0.13859911	0.27249378	CHR4Q28	28	-0.8483799	0.6928105	0.86983764	0.42782	2.1245798
NFAT_Q4_01	c3.TFT_ transcription factor targets	230	1.2761837	0.032657657	0.27244097	NFAT_Q4_01	237	1.1928446	0.08173562	0.6004547	2.4690283	0.0833391
GO_RESPONSE_TO_GROWTH_FACTOR	c5.BP_ GO biological process	435	1.2761731	0.01590668	0.27237913	GO_RESPONSE_TO_GROWTH_FACTOR	446	0.9687588	0.637	0.96275777	2.2449319	0.3074143
GO_APICAL_JUNCTION_ASSEMBLY	c5.BP_ GO biological process	37	1.2761129	0.14592934	0.2724278	GO_APICAL_JUNCTION_ASSEMBLY	37	0.84804773	0.71770334	1	2.12416063	0.42806517
RASHI_RESPONSE_TO_IONIZING_RADIATION_5	c2.CGP_ chemical and genetic perturbations	135	1.2758925	0.07125	0.27282223	RASHI_RESPONSE_TO_IONIZING_RADIATION_5	137	0.93714786	0.6384929	0.9930238	2.21304036	0.33874464
GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	C7_ immunologic signatures	159	1.2758704	0.061668683	0.27278975	GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	163	1.3662138	0.004085802	0.37065297	2.6420842	-0.0903434
GO_CEREBELLAR_CORTEX_MORPHOGENESIS	c5.BP_ GO biological process	29	1.2757373	0.13734567	0.272991	GO_CEREBELLAR_CORTEX_MORPHOGENESIS	30	1.1160403	0.32223544	0.72919893	2.3917776	0.159697
GO_RESPONSE_TO_BMP	c5.BP_ GO biological process	80	1.2757363	0.0810093	0.27290908	GO_RESPONSE_TO_BMP	83	1.0592945	0.37852496	0.8257127	2.3350308	0.2164418
GO_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY	c5.BP_ GO biological process	38	1.2757086	0.124814264	0.2728864	GO_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY	40	0.8047394	0.77726215	1	2.080448	0.4709692
KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN	C7_ immunologic signatures	178	1.2755618	0.045454547	0.2731232	KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN	177	0.69991654	0.9705584	1	1.97547834	0.57564526
GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN	C7_ immunologic signatures	175	1.2754602	0.052948255	0.27324802	GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN	181	0.86474055	0.7979798	1	2.14020075	0.41071965
GO_SECRETORY_VESICLE	c5.CC_ GO cellular component	386	1.2753838	0.019292604	0.2733288	GO_SECRETORY_VESICLE	418	1.2426323	0.009	0.52241045	2.5180161	0.0327515
GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN	C7_ immunologic signatures	161	1.2753179	0.055757575	0.27337733	GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN	181	1.144228	0.17831814	0.68181103	2.4195459	0.1310899
GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN	C7_ immunologic signatures	170	1.2751704	0.06257521	0.273606	GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN	174	0.68479097	0.9827411	1	1.95996137	0.59037943
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	c2.CGP_ chemical and genetic perturbations	49	1.2750638	0.12133891	0.27375	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	50	1.4639614	0.01918736	0.28214422	2.7390252	-0.1888976
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN	C7_ immunologic signatures	172	1.2750511	0.064177364	0.27369362	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN	172	0.837041	0.85973763	1	2.1120921	0.4380101
GO_BHLH_TRANSCRIPTION_FACTOR_BINDING	c5.GO molecular function	25	1.2748463	0.13323124	0.27404192	GO_BHLH_TRANSCRIPTION_FACTOR_BINDING	26	0.72189486	0.865598	1	1.99674116	0.55295144
AAACCAC_MIR140	c3.MIR_ microRNA targets	101	1.2747314	0.070063695	0.27418908	AAACCAC_MIR140	101	0.80932146	0.83716077	1	2.08405286	0.46540994
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	c2.CGP_ chemical and genetic perturbations	22	1.2744312	0.14772727	0.2747673	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	22	1.1213962	0.3137755	0.72199035	2.3958274	0.153035
GSE16385_MONOCYTE_VS_MACROPHAGE_DN	C7_ immunologic signatures	159	1.2744044	0.054021608	0.2747462	GSE16385_MONOCYTE_VS_MACROPHAGE_DN	165	1.1730009	0.15470172	0.6331547	2.4474053	0.1014035
GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP	C7_ immunologic signatures	157	1.2742242	0.06577345	0.27504644	GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP	159	0.8404922	0.84771574	1	2.1147164	0.433732
GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP	C7_ immunologic signatures	174	1.2741286	0.040048543	0.2751661	GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP	175	0.9102969	0.70385396	1	2.1844255	0.3638317
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN	C7_ immunologic signatures	166	1.2741017	0.0488677	0.27514055	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN	171	1.2127664	0.0881459	0.5727428	2.4868681	0.0613353
KRAS.KIDNEY_UP.V1_DN	C6_ oncogenic signatures	104	1.274089	0.085051544	0.27508837	KRAS.KIDNEY_UP.V1_DN	112	1.2461846	0.092611864	0.51704293	2.5202736	0.0279044
WENG_POR_TARGETS_GLOBAL_DN	c2.CGP_ chemical and genetic perturbations	20	1.2739431	0.15625	0.27532712	WENG_POR_TARGETS_GLOBAL_DN	19	1.0701838	0.38113695	0.8046535	2.3441269	0.2037593
SENESE_HDAC3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	434	1.2737216	0.010660981	0.2757322	SENESE_HDAC3_TARGETS_UP	441	0.8651045	0.886	1	2.1388261	0.4086171
GO_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	82	1.2737192	0.08921438	0.2756547	GO_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS	85	1.1450752	0.23340471	0.6789951	2.4187944	0.128644
GO_STEM_CELL_DIFFERENTIATION	c5.BP_ GO biological process	166	1.2736453	0.046783626	0.27573878	GO_STEM_CELL_DIFFERENTIATION	182	-1.2654793	0	0.310848	0.008166	2.5391246
GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	C7_ immunologic signatures	115	1.2736145	0.074165635	0.27571568	GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	128	1.0396439	0.398773	0.8591097	2.3132584	0.2339706
BAE_BRCA1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	29	1.2734646	0.14219475	0.2759471	BAE_BRCA1_TARGETS_DN	29	1.0926818	0.3490338	0.76851517	2.3661464	0.1807828
HOLLERN_EMT_BREAST_TUMOR_DN	c2.CGP_ chemical and genetic perturbations	85	1.2734059	0.09293193	0.27599132	HOLLERN_EMT_BREAST_TUMOR_DN	86	1.3681446	0.02742616	0.37141383	2.6415505	-0.0947387
GO_REGULATION_OF_NEURON_MIGRATION	c5.BP_ GO biological process	23	1.2732948	0.14630468	0.27614847	GO_REGULATION_OF_NEURON_MIGRATION	25	0.7836611	0.7775	1	2.0569559	0.4896337
GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	C7_ immunologic signatures	149	1.2731979	0.05159705	0.27628204	GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	150	0.8912023	0.7198364	1	2.1644002	0.3819956
GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	172	1.2730912	0.05421687	0.2764171	GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	180	0.99799085	0.4908722	0.9258566	2.27108205	0.27510035
MOREIRA_RESPONSE_TO_TSA_DN	c2.CGP_ chemical and genetic perturbations	17	1.2730457	0.18151815	0.27643606	MOREIRA_RESPONSE_TO_TSA_DN	18	0.7036427	0.8695652	1	1.9766884	0.569403
GO_GENETIC_IMPRINTING	c5.BP_ GO biological process	19	1.272974	0.1724138	0.27651286	GO_GENETIC_IMPRINTING	19	-1.6755342	0.018779343	0.06336366	-0.4025602	2.9485082
GO_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	25	1.2729535	0.16618498	0.27647322	GO_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION	25	0.79391587	0.7836478	1	2.06686937	0.47903763
GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN	C7_ immunologic signatures	173	1.2729149	0.052948255	0.2764715	GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN	181	1.3210336	0.018181818	0.4113468	2.5939485	-0.0481187
GO_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY	c5.BP_ GO biological process	34	1.2728751	0.15007657	0.27647755	GO_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY	41	1.5837706	0.003428571	0.17436066	2.8566457	-0.3108955
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	c2.CP_BIOCARTA_ BioCarta gene sets	70	1.2726872	0.083769634	0.27679563	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	74	1.0533664	0.41967213	0.83621895	2.3260536	0.2193208
GO_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY	c5.BP_ GO biological process	49	1.2726747	0.11570248	0.27673474	GO_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY	61	1.3771276	0.03155604	0.35747528	2.6498023	-0.1044529
AMIT_EGF_RESPONSE_60_MCF10A	c2.CGP_ chemical and genetic perturbations	36	1.2726176	0.15	0.27677917	AMIT_EGF_RESPONSE_60_MCF10A	36	1.5193235	0.011806375	0.23687229	2.7919411	-0.2467059
GSE27786_CD4_TCELL_VS_MONO_MAC_DN	C7_ immunologic signatures	176	1.2724855	0.059453033	0.27698147	GSE27786_CD4_TCELL_VS_MONO_MAC_DN	186	0.9180385	0.6936299	1	2.190524	0.354447
GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP	C7_ immunologic signatures	175	1.272457	0.055819478	0.27696463	GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP	177	-1.426863	0	0.19028893	-0.154406	2.69932
GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN	C7_ immunologic signatures	180	1.272307	0.0472255	0.27721512	GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN	181	0.96866626	0.56969696	0.9628181	2.24097326	0.30364074
MODULE_345	c4.CM_ cancer modules	91	1.272035	0.08678757	0.27769005	MODULE_345	95	1.4059944	0.018065887	0.3323384	2.6780294	-0.1339594
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS	c2.CGP_ chemical and genetic perturbations	266	1.2720042	0.022753129	0.277685	FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS	269	1.0640256	0.3282981	0.81588197	2.3360298	0.2079786
KEGG_PATHWAYS_IN_CANCER	c2.CP_BIOCARTA_ BioCarta gene sets	302	1.2719344	0.030939227	0.27774552	KEGG_PATHWAYS_IN_CANCER	311	0.9958186	0.5255767	0.9295983	2.267753	0.2761158
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	c2.CGP_ chemical and genetic perturbations	379	1.2718706	0.016146393	0.277806	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	398	1.2521946	0.011	0.5079897	2.5240652	0.019676
GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN	C7_ immunologic signatures	176	1.2718579	0.044471152	0.2777512	GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN	180	1.154705	0.17408907	0.6619344	2.4265629	0.1171529
CHEBOTAEV_GR_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	112	1.2713715	0.06931964	0.2787257	CHEBOTAEV_GR_TARGETS_DN	113	1.2709999	0.064718165	0.48362207	2.5423714	0.0003716
MARKEY_RB1_CHRONIC_LOF_DN	c2.CGP_ chemical and genetic perturbations	97	1.2713563	0.07029178	0.2786752	MARKEY_RB1_CHRONIC_LOF_DN	100	1.127908	0.26403326	0.7089557	2.3992643	0.1434483
GO_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	15	1.2713207	0.18833333	0.27866185	GO_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION	16	-0.7164683	0.9188034	0.95243686	0.5548524	1.987789
GO_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE	c5.BP_ GO biological process	48	1.2713121	0.13220815	0.27859867	GO_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE	51	-1.2427868	0.09090909	0.3316901	0.0285253	2.5140989
GO_CARDIAC_VENTRICLE_MORPHOGENESIS	c5.BP_ GO biological process	55	1.271299	0.10828877	0.2785476	GO_CARDIAC_VENTRICLE_MORPHOGENESIS	61	0.8069811	0.79847497	1	2.0782801	0.4643179
GO_ATPASE_ACTIVITY	c5.GO molecular function	378	1.2712461	0.020148462	0.2785836	GO_ATPASE_ACTIVITY	388	0.9953112	0.524	0.93041974	2.2665573	0.2759349
GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP	C7_ immunologic signatures	174	1.2711201	0.050984938	0.27877814	GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP	174	1.021044	0.45408678	0.89100575	2.2921641	0.2500761
ZHAN_MULTIPLE_MYELOMA_LB_DN	c2.CGP_ chemical and genetic perturbations	31	1.2710949	0.12759644	0.27874494	ZHAN_MULTIPLE_MYELOMA_LB_DN	31	-0.9598647	0.5590062	0.7423857	0.3112302	2.2309596
GO_STRUCTURE_SPECIFIC_DNA_BINDING	c5.GO molecular function	103	1.2709996	0.09195402	0.27886218	GO_STRUCTURE_SPECIFIC_DNA_BINDING	109	0.63682157	0.9876161	1	1.90782117	0.63417803
GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP	C7_ immunologic signatures	159	1.2709991	0.056804735	0.2787803	GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP	164	0.9598991	0.6046748	0.97116023	2.2308982	0.3111
GO_RESPONSE_TO_ACID_CHEMICAL	c5.BP_ GO biological process	273	1.2708312	0.030612245	0.27906162	GO_RESPONSE_TO_ACID_CHEMICAL	292	0.94389814	0.66633266	0.98850745	2.21472934	0.32693306
HFH4_01	c3.TFT_ transcription factor targets	162	1.2708063	0.062730625	0.27902886	HFH4_01	172	1.1368202	0.17922607	0.6947833	2.4076265	0.1339861
GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN	C7_ immunologic signatures	182	1.270799	0.050887574	0.27896217	GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN	189	1.0915383	0.277666	0.76981527	2.3623373	0.1792607
GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP	C7_ immunologic signatures	174	1.2707882	0.06634499	0.27890608	GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP	179	0.7498491	0.94219065	1	2.0206373	0.5209391
GO_REGULATION_OF_GASTRULATION	c5.BP_ GO biological process	27	1.2706244	0.12519084	0.27917507	GO_REGULATION_OF_GASTRULATION	31	-0.8698061	0.7289157	0.85381687	0.4008183	2.1404305
GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	C7_ immunologic signatures	172	1.2706242	0.052505966	0.2790921	GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	178	0.9191707	0.69617707	1	2.1897949	0.3514535
NCX_01	c3.TFT_ transcription factor targets	143	1.2703283	0.06618532	0.27965415	NCX_01	150	1.0702693	0.33028457	0.80471593	2.3405976	0.200059
GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP	C7_ immunologic signatures	172	1.2702932	0.06362545	0.27964756	GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP	178	1.0998781	0.26794744	0.7574389	2.3701713	0.1704151
GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP	C7_ immunologic signatures	177	1.2702504	0.047732696	0.27965274	GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP	181	1.1147869	0.23654823	0.73100734	2.3850373	0.1554635
GO_CELLULAR_RESPONSE_TO_UV	c5.BP_ GO biological process	65	1.2700708	0.11668928	0.27997577	GO_CELLULAR_RESPONSE_TO_UV	65	1.0901954	0.32372504	0.77111673	2.3602662	0.1798754
JNK_DN.V1_DN	C6_ oncogenic signatures	156	1.269921	0.067836255	0.2802216	JNK_DN.V1_DN	167	1.1204484	0.22551021	0.72295696	2.3903694	0.1494726
GSE17721_4_VS_24H_CPG_BMDC_UP	C7_ immunologic signatures	177	1.2698905	0.04656863	0.28019634	GSE17721_4_VS_24H_CPG_BMDC_UP	181	0.9264164	0.68920285	1	2.1963069	0.3434741
GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN	C7_ immunologic signatures	162	1.2698276	0.06419753	0.28025287	GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN	177	1.4225863	0.002024292	0.31794095	2.6924139	-0.1527587
GO_RESPONSE_TO_MINERALOCORTICOID	c5.BP_ GO biological process	32	1.2697362	0.1396731	0.28036696	GO_RESPONSE_TO_MINERALOCORTICOID	32	-0.858082	0.67901236	0.86186725	0.4116542	2.1278182
GO_CELL_CELL_JUNCTION_ASSEMBLY	c5.BP_ GO biological process	69	1.2696422	0.09630607	0.2804943	GO_CELL_CELL_JUNCTION_ASSEMBLY	71	1.0756372	0.35886213	0.79503673	2.3452794	0.194005
GO_APICAL_PART_OF_CELL	c5.CC_ GO cellular component	304	1.2696422	0.024471635	0.28041092	GO_APICAL_PART_OF_CELL	331	1.4014951	0	0.3372066	2.6711373	-0.1318529
GO_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE	c5.BP_ GO biological process	26	1.2695655	0.14418605	0.28050306	GO_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE	26	0.8530103	0.704797	1	2.1225758	0.4165552
GO_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	15	1.269466	0.15588723	0.28063226	GO_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY	15	0.87154627	0.65257597	1	2.14101227	0.39791973
URS_ADIPOCYTE_DIFFERENTIATION_UP	c2.CGP_ chemical and genetic perturbations	67	1.2694308	0.1061008	0.28062597	URS_ADIPOCYTE_DIFFERENTIATION_UP	70	1.0842056	0.34557235	0.7788715	2.3536364	0.1852252
HALLMARK_COAGULATION	H_ hallmark gene sets	112	1.2693453	0.08510638	0.2807266	HALLMARK_COAGULATION	125	1.4728675	0.002072539	0.27577186	2.7422128	-0.2035222
GNF2_INPP5D	c4.CGN_ cancer gene neighborhoods	33	1.2693324	0.14078374	0.28067732	GNF2_INPP5D	35	1.0134112	0.45307067	0.9009643	2.2827436	0.2559212
GO_SMAD_PROTEIN_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	50	1.2692851	0.11789773	0.28069884	GO_SMAD_PROTEIN_SIGNAL_TRANSDUCTION	50	1.0900118	0.3577053	0.771178	2.3592969	0.1792733
ATGTACA_MIR493	c3.MIR_ microRNA targets	297	1.2691995	0.033076074	0.28080675	ATGTACA_MIR493	299	1.0244699	0.41583166	0.88431835	2.2936694	0.2447296
HUPER_BREAST_BASAL_VS_LUMINAL_UP	c2.CGP_ chemical and genetic perturbations	37	1.269184	0.11914894	0.28076094	HUPER_BREAST_BASAL_VS_LUMINAL_UP	40	1.4347873	0.039170507	0.3113898	2.7039713	-0.1656033
GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN	C7_ immunologic signatures	166	1.269021	0.0692951	0.2810414	GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN	174	1.0005143	0.49643946	0.9235063	2.2695353	0.2685067
CEBPGAMMA_Q6	c3.TFT_ transcription factor targets	208	1.268929	0.04027618	0.28115374	CEBPGAMMA_Q6	218	0.81746066	0.89257026	1	2.08638966	0.45146834
CCAWYNNGAAR_UNKNOWN	c3.TFT_ transcription factor targets	122	1.2687787	0.079404466	0.28139824	CCAWYNNGAAR_UNKNOWN	124	1.0610904	0.3723077	0.8215543	2.3298691	0.2076883
GO_SECRETION	c5.BP_ GO biological process	494	1.2687694	0.010570824	0.28133622	GO_SECRETION	494	0	0	0	1.2687694	1.2687694
GSE13306_RA_VS_UNTREATED_TCONV_DN	C7_ immunologic signatures	164	1.2687262	0.056354918	0.28134462	GSE13306_RA_VS_UNTREATED_TCONV_DN	176	0.991171	0.5351682	0.9341554	2.2598972	0.2775552
GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	180	1.26861	0.050887574	0.2815346	GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN	182	0.99981433	0.5	0.92471904	2.26842433	0.26879567
CHR13Q14	C1: positional gene sets	57	1.268575	0.12059621	0.28152794	CHR13Q14	60	0.89860183	0.6594124	1	2.16717683	0.36997317
AREB6_03	c3.TFT_ transcription factor targets	227	1.2683347	0.042431194	0.28197017	AREB6_03	234	1.1627271	0.125502	0.64885676	2.4310618	0.1056076
GO_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT	c5.BP_ GO biological process	19	1.2681453	0.15224358	0.2823073	GO_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT	20	0.8021331	0.74646074	1	2.0702784	0.4660122
CAMPS_COLON_CANCER_COPY_NUMBER_DN	c2.CGP_ chemical and genetic perturbations	40	1.2680832	0.13629842	0.2823649	CAMPS_COLON_CANCER_COPY_NUMBER_DN	40	0.9260703	0.59505063	1	2.1941535	0.3420129
HOOI_ST7_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	73	1.2680744	0.10761155	0.28230196	HOOI_ST7_TARGETS_UP	76	1.0486526	0.40173724	0.8424526	2.316727	0.2194218
GO_LIPOPROTEIN_METABOLIC_PROCESS	c5.BP_ GO biological process	112	1.2678839	0.07551766	0.28263277	GO_LIPOPROTEIN_METABOLIC_PROCESS	116	0.7381468	0.92657703	1	2.0060307	0.5297371
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	c2.CP_BIOCARTA_ BioCarta gene sets	21	1.2678212	0.1540832	0.2826876	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	22	-1.612267	0.020100502	0.08735744	-0.3444458	2.8800882
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN	C7_ immunologic signatures	165	1.267688	0.06264501	0.28290248	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN	167	1.1773026	0.1402439	0.62690395	2.4449906	0.0903854
GO_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE	c5.BP_ GO biological process	127	1.2676859	0.07098381	0.2828242	GO_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE	137	1.3456585	0.021384928	0.38794377	2.6133444	-0.0779726
GO_VESICLE_DOCKING	c5.BP_ GO biological process	51	1.2675197	0.11764706	0.28311634	GO_VESICLE_DOCKING	52	1.1984684	0.20114286	0.59536135	2.4659881	0.0690513
BAUS_TFF2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	25	1.2675012	0.14710484	0.28307477	BAUS_TFF2_TARGETS_UP	27	1.1069962	0.335	0.7425551	2.3744974	0.160505
GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN	C7_ immunologic signatures	145	1.2674352	0.06715507	0.2831506	GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN	154	1.3570518	0.013319672	0.3794875	2.624487	-0.0896166
GO_NEURAL_TUBE_FORMATION	c5.BP_ GO biological process	91	1.2673329	0.086229086	0.2833012	GO_NEURAL_TUBE_FORMATION	93	0.68479866	0.9550321	1	1.95213156	0.58253424
GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN	C7_ immunologic signatures	132	1.2669947	0.08837772	0.2839738	GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN	141	1.3121972	0.029804727	0.42223567	2.5791919	-0.0452025
GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN	C7_ immunologic signatures	173	1.2669934	0.039285716	0.28389263	GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN	176	0.6919181	0.98486376	1	1.9589115	0.5750753
GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN	C7_ immunologic signatures	150	1.2666507	0.06408706	0.2845686	GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN	151	1.0839931	0.32753327	0.7795391	2.3506438	0.1826576
BERENJENO_TRANSFORMED_BY_RHOA_DN	c2.CGP_ chemical and genetic perturbations	360	1.2665125	0.021436227	0.28481126	BERENJENO_TRANSFORMED_BY_RHOA_DN	359	1.1223102	0.152	0.7212996	2.3888227	0.1442023
GSE7852_LN_VS_FAT_TREG_DN	C7_ immunologic signatures	177	1.2663777	0.0625	0.28502402	GSE7852_LN_VS_FAT_TREG_DN	181	1.0994471	0.27721775	0.7579686	2.3658248	0.1669306
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	177	1.2663034	0.055099647	0.2850967	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN	177	0.70372283	0.9778226	1	1.97002623	0.56258057
MODULE_220	c4.CM_ cancer modules	286	1.2662318	0.03402854	0.2851709	MODULE_220	306	1.2541639	0.023023022	0.50301844	2.5203957	0.0120679
GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	144	1.2662194	0.066747576	0.28511462	GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN	147	1.3946683	0.009183673	0.34558636	2.6608877	-0.1284489
GO_GAMMA_TUBULIN_COMPLEX	c5.CC_ GO cellular component	19	1.2661386	0.16772152	0.28520614	GO_GAMMA_TUBULIN_COMPLEX	19	-0.5651132	0.9770642	0.98888814	0.7010254	1.8312518
GSE40443_INDUCED_VS_TOTAL_TREG_DN	C7_ immunologic signatures	167	1.2659683	0.06115108	0.2855205	GSE40443_INDUCED_VS_TOTAL_TREG_DN	172	0.809	0.8813387	1	2.0749683	0.4569683
BCAT.100_UP.V1_UP	C6_ oncogenic signatures	44	1.2659158	0.11739746	0.28555483	BCAT.100_UP.V1_UP	46	-1.0422498	0.38582677	0.61843866	0.223666	2.3081656
GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	176	1.265789	0.052143686	0.28576583	GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	178	-0.98097175	0.5294118	0.712793	0.28481725	2.24676075
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	c2.CGP_ chemical and genetic perturbations	19	1.2657611	0.14308943	0.28574306	WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	19	0.9240102	0.58919597	1	2.1897713	0.3417509
GSE17721_0.5H_VS_12H_LPS_BMDC_DN	C7_ immunologic signatures	182	1.265693	0.058472555	0.28580907	GSE17721_0.5H_VS_12H_LPS_BMDC_DN	184	0.764251	0.9432624	1	2.029944	0.501442
GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP	C7_ immunologic signatures	167	1.2656348	0.05282113	0.28586364	GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP	175	0.90739334	0.71195096	1	2.17302814	0.35824146
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	c2.CGP_ chemical and genetic perturbations	45	1.2655847	0.1308017	0.2858929	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	44	1.3330852	0.073085845	0.3995727	2.5986699	-0.0675005
PID_INTEGRIN_A4B1_PATHWAY	c2.CP_ Canonical pathways	31	1.2655433	0.15542522	0.28590417	PID_INTEGRIN_A4B1_PATHWAY	31	-0.88249224	0.6824324	0.84147865	0.38305106	2.14803554
TGTGTGA_MIR377	c3.MIR_ microRNA targets	182	1.2654004	0.058252428	0.28613952	TGTGTGA_MIR377	183	0.8664612	0.80445796	1	2.1318616	0.3989392
GO_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC	c5.BP_ GO biological process	21	1.2653763	0.15467075	0.2861136	GO_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC	21	1.6094205	0.007566204	0.14845644	2.8747968	-0.3440442
GO_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY	c5.GO molecular function	317	1.2653244	0.032432433	0.28614694	GO_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY	328	1.1660879	0.08917835	0.6454762	2.4314123	0.0992365
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	c2.CGP_ chemical and genetic perturbations	34	1.265272	0.12857144	0.28617445	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	34	1.058781	0.40621266	0.826471	2.324053	0.206491
CHR1Q31	C1: positional gene sets	36	1.2651415	0.13768116	0.28638604	CHR1Q31	37	1.1960568	0.20681551	0.5965723	2.4611983	0.0690847
AMIT_EGF_RESPONSE_60_HELA	c2.CGP_ chemical and genetic perturbations	43	1.2649767	0.14925373	0.28665513	AMIT_EGF_RESPONSE_60_HELA	43	0.8306064	0.7418631	1	2.0955831	0.4343703
CHR5Q34	C1: positional gene sets	21	1.2648848	0.18831168	0.28678164	CHR5Q34	24	-1.0631297	0.33854166	0.5823612	0.2017551	2.3280145
REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	c2.CP_REACTOME_ Reactome gene sets	38	1.2648215	0.14347826	0.286835	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	38	1.6634842	0.002306805	0.098424695	2.9283057	-0.3986627
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	c2.CGP_ chemical and genetic perturbations	46	1.2646905	0.12518409	0.28704664	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	46	0.75924426	0.84302324	1	2.02393476	0.50544624
GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	164	1.2645259	0.059859157	0.2873223	GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	171	1.3707293	0.009127789	0.36669657	2.6352552	-0.1062034
GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	C7_ immunologic signatures	161	1.2645065	0.05946602	0.28727633	GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	166	1.1002854	0.27935222	0.7568363	2.3647919	0.1642211
GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN	C7_ immunologic signatures	159	1.2644132	0.06	0.28740332	GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN	165	0.8085581	0.87436676	1	2.0729713	0.4558551
GSE24726_WT_VS_E2_2_KO_PDC_UP	C7_ immunologic signatures	179	1.2643921	0.056647398	0.28736767	GSE24726_WT_VS_E2_2_KO_PDC_UP	179	0.71819663	0.9563894	1	1.98258873	0.54619547
ESC_V6.5_UP_LATE.V1_UP	C6_ oncogenic signatures	170	1.2643541	0.0591716	0.287367	ESC_V6.5_UP_LATE.V1_UP	175	1.3073915	0.027522936	0.42909786	2.5717456	-0.0430374
BROWNE_HCMV_INFECTION_16HR_DN	c2.CGP_ chemical and genetic perturbations	79	1.2641679	0.10171731	0.28769976	BROWNE_HCMV_INFECTION_16HR_DN	80	1.1660836	0.2057264	0.6453126	2.4302515	0.0980843
GO_ACID_SECRETION	c5.BP_ GO biological process	53	1.2636085	0.1398892	0.288879	GO_ACID_SECRETION	64	1.2535455	0.11292074	0.5038654	2.517154	0.010063
GO_CAMERA_TYPE_EYE_MORPHOGENESIS	c5.BP_ GO biological process	90	1.2634974	0.09350649	0.2890413	GO_CAMERA_TYPE_EYE_MORPHOGENESIS	95	0.82005644	0.8065539	1	2.08355384	0.44344096
GO_MESENCHYME_MORPHOGENESIS	c5.BP_ GO biological process	37	1.2634687	0.14156626	0.28901973	GO_MESENCHYME_MORPHOGENESIS	38	1.1108918	0.31458095	0.73623496	2.3743605	0.1525769
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	C7_ immunologic signatures	182	1.2631732	0.056074765	0.28957528	GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	182	1.1923666	0.10435664	0.602106	2.4555398	0.0708066
GATA4_Q3	c3.TFT_ transcription factor targets	211	1.2631465	0.053899083	0.28955725	GATA4_Q3	217	1.041971	0.38810483	0.8555161	2.3051175	0.2211755
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	178	1.2631325	0.06398104	0.2895011	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	180	0.871466	0.80384225	1	2.1345985	0.3916665
GO_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	34	1.2631111	0.15606937	0.28946579	GO_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	34	1.139668	0.2737819	0.69082505	2.4027791	0.1234431
GSE14350_TREG_VS_TEFF_UP	C7_ immunologic signatures	180	1.2629914	0.070489846	0.28964025	GSE14350_TREG_VS_TEFF_UP	181	1.1261812	0.2030303	0.71233577	2.3891726	0.1368102
TEF_Q6	c3.TFT_ transcription factor targets	220	1.2629005	0.046029918	0.28977805	TEF_Q6	225	1.2575288	0.03121853	0.49931845	2.5204293	0.0053717
AMIT_SERUM_RESPONSE_40_MCF10A	c2.CGP_ chemical and genetic perturbations	28	1.262782	0.1437309	0.28994736	AMIT_SERUM_RESPONSE_40_MCF10A	27	0.88549376	0.6713948	1	2.14827576	0.37728824
TCF1P_Q6	c3.TFT_ transcription factor targets	231	1.262765	0.038106237	0.2899041	TCF1P_Q6	240	1.1729752	0.112676054	0.6330808	2.4357402	0.0897898
GO_DNA_HELICASE_ACTIVITY	c5.GO molecular function	49	1.2627406	0.14527504	0.28987518	GO_DNA_HELICASE_ACTIVITY	49	-1.6530765	0	0.0705267	-0.3903359	2.9158171
OUILLETTE_CLL_13Q14_DELETION_DN	c2.CGP_ chemical and genetic perturbations	52	1.2626057	0.1270073	0.29009393	OUILLETTE_CLL_13Q14_DELETION_DN	51	1.054378	0.41051453	0.8344656	2.3169837	0.2082277
GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	172	1.2625892	0.05854801	0.29004368	GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN	179	1.0903687	0.27805865	0.77096707	2.3529579	0.1722205
GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN	C7_ immunologic signatures	176	1.2624872	0.05269608	0.29020104	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN	176	1.2081639	0.09939148	0.5803494	2.4706511	0.0543233
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN	C7_ immunologic signatures	178	1.2623771	0.061445784	0.29036215	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN	182	0.84507644	0.82370824	1	2.10745354	0.41730066
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN	C7_ immunologic signatures	183	1.2622612	0.047453705	0.29054442	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN	183	0.70213515	0.97469634	1	1.96439635	0.56012605
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP	C7_ immunologic signatures	186	1.2622117	0.06544202	0.2905726	GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP	188	-1.1774726	0	0.40749705	0.0847391	2.4396843
GO_PROTEIN_TYROSINE_KINASE_ACTIVITY	c5.GO molecular function	164	1.262031	0.06487148	0.29090273	GO_PROTEIN_TYROSINE_KINASE_ACTIVITY	170	1.1059576	0.26985744	0.74498963	2.3679886	0.1560734
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN	C7_ immunologic signatures	171	1.2618204	0.058753	0.29130536	GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN	173	-0.9377424	0.7368421	0.7738896	0.324078	2.1995628
GO_POST_EMBRYONIC_DEVELOPMENT	c5.BP_ GO biological process	81	1.261738	0.11395647	0.29140565	GO_POST_EMBRYONIC_DEVELOPMENT	85	0.6426425	0.9637527	1	1.9043805	0.6190955
GO_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	94	1.2617266	0.09838107	0.29134297	GO_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION	105	0.6753422	0.9585492	1	1.9370688	0.5863844
MODULE_456	c4.CM_ cancer modules	96	1.2616855	0.099616855	0.291351	MODULE_456	98	0.8800722	0.70842105	1	2.1417577	0.3816133
SHIPP_DLBCL_CURED_VS_FATAL_UP	c2.CGP_ chemical and genetic perturbations	32	1.2615774	0.15686275	0.29150647	SHIPP_DLBCL_CURED_VS_FATAL_UP	35	0.76156884	0.8136201	1	2.02314624	0.50000856
GO_SECRETORY_GRANULE_ORGANIZATION	c5.BP_ GO biological process	22	1.2615418	0.16129032	0.29149994	GO_SECRETORY_GRANULE_ORGANIZATION	23	1.0208374	0.43599492	0.8908468	2.2823792	0.2407044
GO_PHOSPHOLIPID_TRANSPORTER_ACTIVITY	c5.GO molecular function	41	1.2614377	0.13671274	0.29165974	GO_PHOSPHOLIPID_TRANSPORTER_ACTIVITY	41	1.3088086	0.10788863	0.42757097	2.5702463	-0.0473709
BIOCARTA_SPRY_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	1.261394	0.15396826	0.29166824	BIOCARTA_SPRY_PATHWAY	17	1.0186749	0.46692607	0.8923572	2.2800689	0.2427191
GO_WOUND_HEALING	c5.BP_ GO biological process	400	1.2613105	0.010845987	0.2917717	GO_WOUND_HEALING	414	1.2239442	0.02	0.55045784	2.4852547	0.0373663
GO_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION	c5.BP_ GO biological process	24	1.2611009	0.1559633	0.2921564	GO_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION	24	-1.6787179	0.00952381	0.062177513	-0.417617	2.9398188
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP	C7_ immunologic signatures	168	1.2609719	0.061576355	0.29236472	GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP	176	1.3614904	0.008032128	0.37575954	2.6224623	-0.1005185
GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	110	1.2609186	0.090314135	0.29240254	GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN	117	0.72757876	0.94043887	1	1.98849736	0.53333984
OHGUCHI_LIVER_HNF4A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	37	1.2608982	0.12625538	0.29236335	OHGUCHI_LIVER_HNF4A_TARGETS_UP	38	1.1453171	0.2822014	0.67837346	2.4062153	0.1155811
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	c2.CGP_ chemical and genetic perturbations	27	1.2608683	0.15454546	0.29234543	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	30	0.90781534	0.6287787	1	2.16868364	0.35305296
ACTTTAT_MIR1425P	c3.MIR_ microRNA targets	261	1.2606406	0.044345897	0.292767	ACTTTAT_MIR1425P	263	0.8743511	0.835	1	2.1349917	0.3862895
GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP	C7_ immunologic signatures	124	1.2605898	0.07524272	0.29278874	GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP	129	1.0914677	0.3023736	0.76998967	2.3520575	0.1691221
GCACCTT_MIR18A_MIR18B	c3.MIR_ microRNA targets	112	1.2605778	0.056818184	0.29273027	GCACCTT_MIR18A_MIR18B	113	0.7688093	0.9019608	1	2.0293871	0.4917685
GO_URONIC_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	17	1.2605182	0.16174184	0.29277244	GO_URONIC_ACID_METABOLIC_PROCESS	18	1.3807436	0.091755316	0.35577148	2.6412618	-0.1202254
GO_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION	c5.BP_ GO biological process	36	1.2604985	0.13657056	0.29272965	GO_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION	36	-0.86106116	0.77372265	0.8595514	0.39943734	2.12155966
MODULE_146	c4.CM_ cancer modules	80	1.2604737	0.10691004	0.29269564	MODULE_146	88	1.0569315	0.36864406	0.8290583	2.3174052	0.2035422
VARELA_ZMPSTE24_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	37	1.260358	0.14202899	0.292873	VARELA_ZMPSTE24_TARGETS_UP	37	-0.8276431	0.8174603	0.88415974	0.4327149	2.0880011
GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	C7_ immunologic signatures	159	1.2602804	0.054761905	0.29296583	GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	160	1.0695806	0.33739838	0.80626893	2.329861	0.1906998
GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN	C7_ immunologic signatures	183	1.2602215	0.074679114	0.2930171	GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN	184	1.368136	0.011156186	0.37111264	2.6283575	-0.1079145
SHIN_B_CELL_LYMPHOMA_CLUSTER_8	c2.CGP_ chemical and genetic perturbations	33	1.2601285	0.13023952	0.29314747	SHIN_B_CELL_LYMPHOMA_CLUSTER_8	35	1.187176	0.23195267	0.61113447	2.4473045	0.0729525
GO_MAINTENANCE_OF_CELL_NUMBER	c5.BP_ GO biological process	125	1.2600433	0.075187966	0.29325455	GO_MAINTENANCE_OF_CELL_NUMBER	131	-1.105839	0.23809524	0.50877565	0.1542043	2.3658823
GO_REGULATION_OF_POSITIVE_CHEMOTAXIS	c5.BP_ GO biological process	20	1.260027	0.18040435	0.29320607	GO_REGULATION_OF_POSITIVE_CHEMOTAXIS	20	1.0626132	0.3939009	0.81824726	2.3226402	0.1974138
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	c2.CGP_ chemical and genetic perturbations	50	1.2599893	0.11927878	0.2932078	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	55	-0.8670528	0.7586207	0.8551103	0.3929365	2.1270421
GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP	C7_ immunologic signatures	137	1.2599373	0.07530864	0.29323968	GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP	143	1.1385943	0.20183486	0.69284487	2.3985316	0.121343
MODULE_23	c4.CM_ cancer modules	457	1.2599244	0.018887723	0.29318228	MODULE_23	495	1.1116633	0.129	0.73519635	2.3715877	0.1482611
GO_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	355	1.2598541	0.024757804	0.29326347	GO_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS	363	0.7708377	0.968969	1	2.0306918	0.4890164
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP	C7_ immunologic signatures	180	1.2598387	0.057109557	0.29321396	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP	179	1.0912951	0.2931727	0.76969945	2.3511338	0.1685436
GO_ASSOCIATIVE_LEARNING	c5.BP_ GO biological process	63	1.2597703	0.12517007	0.29327407	GO_ASSOCIATIVE_LEARNING	68	1.1443679	0.24945055	0.6813295	2.4041382	0.1154024
GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN	C7_ immunologic signatures	187	1.2596803	0.056354918	0.29338557	GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN	187	0.96102065	0.5981873	0.9698644	2.22070095	0.29865965
GENTILE_UV_LOW_DOSE_DN	c2.CGP_ chemical and genetic perturbations	63	1.2596128	0.114709854	0.29345107	GENTILE_UV_LOW_DOSE_DN	63	0.99404246	0.5163044	0.9310904	2.25365526	0.26557034
GO_TERPENOID_METABOLIC_PROCESS	c5.BP_ GO biological process	89	1.2595665	0.093628086	0.29346865	GO_TERPENOID_METABOLIC_PROCESS	90	1.3042618	0.06236559	0.4347731	2.5638283	-0.0446953
KEGG_MELANOMA	c2.CP_BIOCARTA_ BioCarta gene sets	68	1.259341	0.11686587	0.29390034	KEGG_MELANOMA	68	1.1975634	0.17926566	0.5970743	2.4569044	0.0617776
GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP	C7_ immunologic signatures	176	1.2592634	0.06658878	0.29399934	GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP	175	1.1349247	0.19269776	0.69742185	2.3941881	0.1243387
ISRE_01	c3.TFT_ transcription factor targets	221	1.259167	0.046349943	0.29412505	ISRE_01	227	0.90639883	0.7434608	1	2.16556583	0.35276817
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	c2.CGP_ chemical and genetic perturbations	36	1.2591602	0.14692654	0.2940552	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	36	0.7634965	0.828199	1	2.0226567	0.4956637
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	c2.CP_REACTOME_ Reactome gene sets	19	1.2591058	0.16805324	0.2940916	REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	19	0.7542002	0.802356	1	2.013306	0.5049056
GO_BEHAVIOR	c5.BP_ GO biological process	435	1.2590619	0.016251354	0.294106	GO_BEHAVIOR	474	1.0155622	0.45545545	0.89658284	2.2746241	0.2434997
GAGCCTG_MIR484	c3.MIR_ microRNA targets	97	1.2589623	0.09627728	0.2942501	GAGCCTG_MIR484	97	0.99888927	0.48421052	0.92476475	2.25785157	0.26007303
GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP	C7_ immunologic signatures	154	1.2589501	0.06934307	0.29419127	GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP	161	1.3592288	0.009090909	0.3778992	2.6181789	-0.1002787
MODULE_316	c4.CM_ cancer modules	51	1.2584606	0.12137931	0.29522267	MODULE_316	66	1.6349223	0.001089325	0.13229081	2.8933829	-0.3764617
GO_RESPONSE_TO_STEROID_HORMONE	c5.BP_ GO biological process	441	1.2584261	0.01391863	0.2952227	GO_RESPONSE_TO_STEROID_HORMONE	458	1.0660967	0.255	0.81240165	2.3245228	0.1923294
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP	C7_ immunologic signatures	148	1.2582737	0.06947891	0.29549316	GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP	153	1.0163487	0.4805328	0.895086	2.2746224	0.241925
GO_DEFINITIVE_HEMOPOIESIS	c5.BP_ GO biological process	16	1.2582201	0.17275748	0.29553446	GO_DEFINITIVE_HEMOPOIESIS	16	-1.1482885	0.26540285	0.44534966	0.1099316	2.4065086
GO_ACTIN_FILAMENT_ORGANIZATION	c5.BP_ GO biological process	152	1.2581706	0.06583851	0.29555413	GO_ACTIN_FILAMENT_ORGANIZATION	157	0.9717357	0.5656155	0.96005684	2.2299063	0.2864349
YRTCANNRCGC_UNKNOWN	c3.TFT_ transcription factor targets	62	1.258161	0.11416781	0.29549104	YRTCANNRCGC_UNKNOWN	62	0.7752128	0.8338762	1	2.0333738	0.4829482
GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN	C7_ immunologic signatures	179	1.2581521	0.059453033	0.2954226	GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN	181	1.3692449	0.005045409	0.3690988	2.627397	-0.1110928
GO_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM	c5.BP_ GO biological process	124	1.2579004	0.07769424	0.29589188	GO_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM	131	0.7642538	0.8958763	1	2.0221542	0.4936466
GO_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS	c5.BP_ GO biological process	17	1.2578995	0.1703125	0.29580882	GO_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS	19	0.95752335	0.54499364	0.9746663	2.21542285	0.30037615
MORF_BCL2	c4.CGN_ cancer gene neighborhoods	179	1.2577952	0.055555556	0.29596648	MORF_BCL2	198	1.1983666	0.09274194	0.59565115	2.4561618	0.0594286
CHR6P23	C1: positional gene sets	16	1.2577782	0.18668832	0.2959209	CHR6P23	16	1.3397709	0.110126585	0.39628327	2.5975491	-0.0819927
GSE10325_BCELL_VS_LUPUS_BCELL_DN	C7_ immunologic signatures	173	1.2577302	0.06402794	0.29594675	GSE10325_BCELL_VS_LUPUS_BCELL_DN	172	0.90395904	0.7093496	1	2.16168924	0.35377116
GO_REGULATION_OF_ODONTOGENESIS	c5.BP_ GO biological process	20	1.2577078	0.18093699	0.29591194	GO_REGULATION_OF_ODONTOGENESIS	23	0.95981556	0.53836316	0.9707806	2.21752336	0.29789224
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	c2.CGP_ chemical and genetic perturbations	309	1.2575841	0.047200877	0.29609594	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	318	1.1883913	0.06626506	0.60814035	2.4459754	0.0691928
GO_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION	c5.BP_ GO biological process	17	1.2575595	0.16297469	0.2960688	GO_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION	17	0.74719983	0.8047182	1	2.00475933	0.51035967
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION	c2.CP_REACTOME_ Reactome gene sets	33	1.2575526	0.1436865	0.295998	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION	33	1.136413	0.28640193	0.6955444	2.3939656	0.1211396
GO_NEUTRAL_LIPID_CATABOLIC_PROCESS	c5.BP_ GO biological process	21	1.2575086	0.17258064	0.2960155	GO_NEUTRAL_LIPID_CATABOLIC_PROCESS	24	-0.8349434	0.7318436	0.87818944	0.4225652	2.092452
GO_THYROID_GLAND_DEVELOPMENT	c5.BP_ GO biological process	22	1.25749	0.16481775	0.29597	GO_THYROID_GLAND_DEVELOPMENT	24	-1.3380637	0.10152284	0.24979997	-0.0805737	2.5955537
GO_POSITIVE_REGULATION_OF_CYTOKINE_SECRETION	c5.BP_ GO biological process	68	1.2572825	0.115079366	0.29635882	GO_POSITIVE_REGULATION_OF_CYTOKINE_SECRETION	79	1.1200771	0.29773462	0.7232357	2.3773596	0.1372054
GO_REGULATION_OF_ORGAN_MORPHOGENESIS	c5.BP_ GO biological process	222	1.2572727	0.058754407	0.29629597	GO_REGULATION_OF_ORGAN_MORPHOGENESIS	233	0.79564035	0.91758794	1	2.05291305	0.46163235
GO_MISMATCH_REPAIR	c5.BP_ GO biological process	26	1.2571962	0.15301391	0.29639548	GO_MISMATCH_REPAIR	26	-1.0823965	0.32258064	0.54750776	0.1747997	2.3395927
GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP	C7_ immunologic signatures	174	1.2570554	0.069905214	0.29662982	GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP	178	1.230311	0.07497467	0.5400516	2.4873664	0.0267444
GO_REGULATION_OF_T_CELL_PROLIFERATION	c5.BP_ GO biological process	110	1.2570437	0.08405439	0.29657105	GO_REGULATION_OF_T_CELL_PROLIFERATION	118	0.97300625	0.5485537	0.9578437	2.23004995	0.28403745
AAAYRNCTG_UNKNOWN	c3.TFT_ transcription factor targets	316	1.2569855	0.031042129	0.29662707	AAAYRNCTG_UNKNOWN	331	0.88474435	0.8278278	1	2.14172985	0.37224115
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP	C7_ immunologic signatures	175	1.256948	0.067307696	0.2966175	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP	180	1.1081282	0.23481782	0.74128455	2.3650762	0.1488198
GO_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS	c5.BP_ GO biological process	279	1.2567878	0.027964206	0.2969002	GO_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS	287	1.0862298	0.26026025	0.7758598	2.3430176	0.170558
CREBP1_01	c3.TFT_ transcription factor targets	155	1.2567451	0.06996381	0.29692656	CREBP1_01	159	0.9815606	0.54776424	0.9469028	2.2383057	0.2751845
KARLSSON_TGFB1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	189	1.2564495	0.05158265	0.29752204	KARLSSON_TGFB1_TARGETS_DN	191	0.9420088	0.65858585	0.9888983	2.1984583	0.3144407
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	c2.CGP_ chemical and genetic perturbations	43	1.256428	0.15542522	0.29749346	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	48	0.59715456	0.9805269	1	1.85358256	0.65927344
MODULE_170	c4.CM_ cancer modules	82	1.2563964	0.12466488	0.29748166	MODULE_170	86	0.9130193	0.6355841	1	2.1694157	0.3433771
GSE17721_LPS_VS_CPG_4H_BMDC_UP	C7_ immunologic signatures	181	1.2563791	0.06308411	0.2974304	GSE17721_LPS_VS_CPG_4H_BMDC_UP	185	1.0607569	0.3414387	0.8224049	2.317136	0.1956222
MORF_ATRX	c4.CGN_ cancer gene neighborhoods	190	1.2563221	0.06264775	0.2974722	MORF_ATRX	195	0.9163481	0.6963563	1	2.1726702	0.339974
DUAN_PRDM5_TARGETS	c2.CGP_ chemical and genetic perturbations	69	1.2561625	0.1232166	0.2977627	DUAN_PRDM5_TARGETS	73	0.67757607	0.9457701	1	1.93373857	0.57858643
GO_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING	c5.GO molecular function	68	1.2561526	0.12417437	0.2977013	GO_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING	68	1.4311099	0.014069264	0.31300488	2.6872625	-0.1749573
BIOCARTA_PGC1A_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	20	1.2561476	0.15865384	0.29762664	BIOCARTA_PGC1A_PATHWAY	20	0.70613337	0.8794416	1	1.96228097	0.55001423
LE_NEURONAL_DIFFERENTIATION_DN	c2.CGP_ chemical and genetic perturbations	19	1.2559539	0.17252396	0.29799077	LE_NEURONAL_DIFFERENTIATION_DN	19	-0.9242109	0.58411217	0.79034	0.331743	2.1801648
GO_DRUG_METABOLIC_PROCESS	c5.BP_ GO biological process	29	1.2558964	0.14678898	0.29803917	GO_DRUG_METABOLIC_PROCESS	32	1.3541694	0.08062575	0.38352725	2.6100658	-0.098273
GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN	C7_ immunologic signatures	176	1.2558565	0.07491082	0.2980489	GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN	181	1.2561433	0.047667343	0.50110096	2.5119998	-0.0002868
GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	171	1.2558374	0.077380955	0.2980026	GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN	173	0.75529456	0.9203629	1	2.01113196	0.50054284
HOFMANN_CELL_LYMPHOMA_DN	c2.CGP_ chemical and genetic perturbations	35	1.255751	0.15373352	0.2981086	HOFMANN_CELL_LYMPHOMA_DN	36	0.64307123	0.9522673	1	1.89882223	0.61267977
GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	183	1.2556143	0.05357143	0.29833898	GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP	186	0.85024434	0.83095723	1	2.10585864	0.40536996
ACTGAAA_MIR30A3P_MIR30E3P	c3.MIR_ microRNA targets	179	1.2555021	0.07007126	0.29851258	ACTGAAA_MIR30A3P_MIR30E3P	184	0.61260134	0.99387753	1	1.86810344	0.64290076
GSE20715_0H_VS_48H_OZONE_LUNG_DN	C7_ immunologic signatures	182	1.2554855	0.05854801	0.29846618	GSE20715_0H_VS_48H_OZONE_LUNG_DN	186	0.80398685	0.8994975	1	2.05947235	0.45149865
GO_AMINOGLYCAN_METABOLIC_PROCESS	c5.BP_ GO biological process	147	1.2554243	0.06658446	0.2985301	GO_AMINOGLYCAN_METABOLIC_PROCESS	153	1.2646679	0.06026558	0.49102142	2.5200922	-0.0092436
GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	183	1.2553926	0.06761566	0.2985113	GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN	183	-1.0681436	0.3	0.5731602	0.187249	2.3235362
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	C7_ immunologic signatures	184	1.2552488	0.06360424	0.29876173	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	188	1.2517236	0.046558704	0.5084498	2.5069724	0.0035252
GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	179	1.2550344	0.06002401	0.2991474	GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	181	1.2365581	0.06802031	0.53137934	2.4915925	0.0184763
GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_UP	C7_ immunologic signatures	166	1.2549834	0.07829182	0.29917613	GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_UP	174	1.0290531	0.4344758	0.8769109	2.2840365	0.2259303
MORF_ETV3	c4.CGN_ cancer gene neighborhoods	50	1.2549229	0.12044818	0.2992285	MORF_ETV3	57	1.2050056	0.16923077	0.5824623	2.4599285	0.0499173
GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN	C7_ immunologic signatures	174	1.2547691	0.07451923	0.29950672	GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN	174	1.2352661	0.06504065	0.5326529	2.4900352	0.019503
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP	C7_ immunologic signatures	143	1.2547146	0.08588957	0.29955804	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP	145	1.1048133	0.2829418	0.7475899	2.3595279	0.1499013
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP	C7_ immunologic signatures	166	1.2546244	0.0631068	0.299694	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP	173	1.0979207	0.27235773	0.7592163	2.3525451	0.1567037
MODULE_98	c4.CM_ cancer modules	363	1.2545623	0.021482278	0.2997448	MODULE_98	366	-2.0072603	0	0.007712073	-0.752698	3.2618226
GO_ATPASE_ACTIVITY_COUPLED_TO_MOVEMENT_OF_SUBSTANCES	c5.GO molecular function	103	1.2545553	0.0921895	0.29967153	GO_ATPASE_ACTIVITY_COUPLED_TO_MOVEMENT_OF_SUBSTANCES	110	1.3037976	0.042797495	0.43560526	2.5583529	-0.0492423
SANA_TNF_SIGNALING_UP	c2.CGP_ chemical and genetic perturbations	67	1.2545195	0.12584573	0.299666	SANA_TNF_SIGNALING_UP	63	1.1323457	0.27461708	0.7025392	2.3868652	0.1221738
GSE2826_XID_VS_BTK_KO_BCELL_DN	C7_ immunologic signatures	173	1.2544789	0.06892523	0.29967982	GSE2826_XID_VS_BTK_KO_BCELL_DN	177	1.0842142	0.29483283	0.7789879	2.3386931	0.1702647
PIGF_UP.V1_DN	C6_ oncogenic signatures	168	1.2543397	0.06996381	0.29992136	PIGF_UP.V1_DN	173	1.0993112	0.26390293	0.7578091	2.3536509	0.1550285
GO_SCHWANN_CELL_DIFFERENTIATION	c5.BP_ GO biological process	30	1.2543255	0.1751497	0.29987168	GO_SCHWANN_CELL_DIFFERENTIATION	30	0.71891946	0.87560385	1	1.97324496	0.53540604
GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN	C7_ immunologic signatures	103	1.2542833	0.09293193	0.2998731	GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN	117	1.2255118	0.10384216	0.54833806	2.4797951	0.0287715
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	C7_ immunologic signatures	176	1.2539674	0.06014151	0.3005124	GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	177	0.6237492	0.9908999	1	1.8777166	0.6302182
BCAT_BILD_ET_AL_UP	C6_ oncogenic signatures	37	1.2539322	0.14852941	0.3005149	BCAT_BILD_ET_AL_UP	38	-0.8837626	0.6643836	0.84002674	0.3701696	2.1376948
GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	185	1.2538298	0.06946108	0.30066064	GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	186	0.9450663	0.63434345	0.98749495	2.1988961	0.3087635
GO_RESPONSE_TO_LIGHT_STIMULUS	c5.BP_ GO biological process	257	1.2537769	0.03901895	0.3006995	GO_RESPONSE_TO_LIGHT_STIMULUS	258	0.89734703	0.7620482	1	2.15112393	0.35642987
REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	c2.CP_REACTOME_ Reactome gene sets	189	1.2537305	0.06968641	0.30072254	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	193	0.9648718	0.57947683	0.96545076	2.2186023	0.2888587
GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP	C7_ immunologic signatures	154	1.2533835	0.0747198	0.3014277	GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP	166	1.3508699	0.005076142	0.38443688	2.6042534	-0.0974864
GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION	c5.BP_ GO biological process	101	1.2533273	0.10206718	0.30146825	GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION	100	1.0672566	0.3760504	0.8105404	2.3205839	0.1860707
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP	C7_ immunologic signatures	166	1.2533059	0.06609547	0.30142942	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP	167	0.9674876	0.5825735	0.96395236	2.2207935	0.2858183
GO_POSITIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	101	1.2532357	0.080050826	0.30150717	GO_POSITIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS	112	1.576631	0.001029866	0.18251671	2.8298667	-0.3233953
GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN	C7_ immunologic signatures	177	1.253138	0.06602641	0.3016739	GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN	182	1.2456429	0.0583501	0.5179082	2.4987809	0.0074951
E2F1_Q6_01	c3.TFT_ transcription factor targets	211	1.2531296	0.05645161	0.3016096	E2F1_Q6_01	211	-1.6830634	0	0.0603022	-0.4299338	2.936193
GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	170	1.2530624	0.056603774	0.30168915	GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP	177	0.80467397	0.88597375	1	2.05773637	0.44838843
GO_PROTEIN_TRIMERIZATION	c5.BP_ GO biological process	37	1.2529404	0.1567489	0.30187038	GO_PROTEIN_TRIMERIZATION	37	0.98881215	0.51571596	0.9366338	2.24175255	0.26412825
GSE22886_NAIVE_TCELL_VS_NKCELL_DN	C7_ immunologic signatures	168	1.2528435	0.06443914	0.3020038	GSE22886_NAIVE_TCELL_VS_NKCELL_DN	172	1.0974113	0.27522936	0.7598388	2.3502548	0.1554322
ZHAN_MULTIPLE_MYELOMA_SPIKED	c2.CGP_ chemical and genetic perturbations	18	1.252821	0.16256158	0.301969	ZHAN_MULTIPLE_MYELOMA_SPIKED	17	-1.1391479	0.28451884	0.4587499	0.1136731	2.3919689
GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	144	1.2528008	0.06016847	0.30192834	GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP	146	0.6480912	0.98367345	1	1.900892	0.6047096
CHR20P12	C1: positional gene sets	27	1.2527968	0.14396285	0.30185333	CHR20P12	25	0.94333714	0.57557434	0.98873585	2.19613394	0.30945966
KEGG_ONE_CARBON_POOL_BY_FOLATE	c2.CP_BIOCARTA_ BioCarta gene sets	17	1.2526742	0.19110379	0.30206624	KEGG_ONE_CARBON_POOL_BY_FOLATE	17	-1.7383031	0.008032128	0.046442118	-0.4856289	2.9909773
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN	C7_ immunologic signatures	155	1.2526095	0.06755127	0.30212978	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN	164	1.1966312	0.11042945	0.5968028	2.4492407	0.0559783
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP	C7_ immunologic signatures	171	1.2526058	0.068100356	0.30205473	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP	176	1.2287796	0.07244898	0.5433439	2.4813854	0.0238262
GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP	C7_ immunologic signatures	176	1.2526009	0.05155875	0.30198133	GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP	176	0.9448914	0.6356275	0.9876641	2.1974923	0.3077095
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES	c2.CP_REACTOME_ Reactome gene sets	83	1.2525386	0.10040161	0.30204046	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES	88	0.9960518	0.5080214	0.92940354	2.2485904	0.2564868
GSE3982_MAST_CELL_VS_NKCELL_DN	C7_ immunologic signatures	166	1.2524786	0.068801895	0.30209816	GSE3982_MAST_CELL_VS_NKCELL_DN	172	0.95173293	0.6180344	0.98028815	2.20421153	0.30074567
LENAOUR_DENDRITIC_CELL_MATURATION_UP	c2.CGP_ chemical and genetic perturbations	101	1.2524363	0.10169491	0.30211258	LENAOUR_DENDRITIC_CELL_MATURATION_UP	106	1.320557	0.06327801	0.41190147	2.5729933	-0.0681207
GO_SKIN_EPIDERMIS_DEVELOPMENT	c5.BP_ GO biological process	59	1.2524028	0.13527851	0.30211368	GO_SKIN_EPIDERMIS_DEVELOPMENT	66	0.991746	0.50548244	0.9339479	2.2441488	0.2606568
GO_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	19	1.2523909	0.176	0.3020548	GO_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY	20	1.1245271	0.31800765	0.7158164	2.376918	0.1278638
REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	18	1.2521453	0.16612904	0.3025545	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION	18	0.9032785	0.6070496	1	2.1554238	0.3488668
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN	C7_ immunologic signatures	145	1.2520125	0.089696966	0.3027775	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN	145	-1.2841047	0.05	0.29883105	-0.0320922	2.5361172
RPS14_DN.V1_UP	C6_ oncogenic signatures	157	1.2518544	0.07738815	0.30306837	RPS14_DN.V1_UP	162	1.5767168	0	0.18320636	2.8285712	-0.3248624
OCT1_04	c3.TFT_ transcription factor targets	198	1.2517588	0.070847854	0.3031968	OCT1_04	208	1.1878068	0.10728745	0.60916114	2.4395656	0.063952
MEIS1AHOXA9_01	c3.TFT_ transcription factor targets	97	1.2517262	0.107279696	0.30319136	MEIS1AHOXA9_01	105	1.1772211	0.17702845	0.62673676	2.4289473	0.0745051
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP	C7_ immunologic signatures	167	1.2516445	0.07185629	0.30330878	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP	176	1.2631558	0.05279188	0.4917879	2.5148003	-0.0115113
GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN	C7_ immunologic signatures	163	1.251614	0.07451923	0.30329138	GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN	169	1.4015086	0.00712831	0.33756074	2.6531226	-0.1498946
WIERENGA_STAT5A_TARGETS_GROUP2	c2.CGP_ chemical and genetic perturbations	47	1.2516108	0.13323782	0.3032139	WIERENGA_STAT5A_TARGETS_GROUP2	46	1.0909463	0.35254237	0.7697442	2.3425571	0.1606645
CHR3Q13	C1: positional gene sets	57	1.2514262	0.13098592	0.3035599	CHR3Q13	63	0.7547153	0.86876357	1	2.0061415	0.4967109
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP	C7_ immunologic signatures	163	1.2511891	0.07296651	0.30404046	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP	163	0.90499353	0.7209776	1	2.15618263	0.34619557
GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN	C7_ immunologic signatures	182	1.251114	0.05609756	0.30413657	GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN	183	-1.0463806	0.33333334	0.6115986	0.2047334	2.2974946
GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	C7_ immunologic signatures	176	1.2510959	0.06360424	0.30408722	GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	176	0.7988201	0.88473207	1	2.049916	0.4522758
GO_AXON_PART	c5.CC_ GO cellular component	190	1.2510173	0.047897197	0.30420592	GO_AXON_PART	205	1.2486032	0.036363635	0.51282126	2.4996205	0.0024141
GO_NEGATIVE_REGULATION_OF_GLIOGENESIS	c5.BP_ GO biological process	32	1.2509607	0.15588236	0.3042641	GO_NEGATIVE_REGULATION_OF_GLIOGENESIS	37	-0.9701247	0.51111114	0.7291829	0.280836	2.2210854
GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS	c5.BP_ GO biological process	131	1.250948	0.08038977	0.30421436	GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS	133	1.1328101	0.2368692	0.7017179	2.3837581	0.1181379
GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	177	1.250755	0.06498195	0.30457085	GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	180	1.2436849	0.061866127	0.5218498	2.4944399	0.0070701
GO_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION	c5.BP_ GO biological process	24	1.2507368	0.17310664	0.3045336	GO_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION	28	1.4711735	0.028822055	0.27483276	2.7219103	-0.2204367
GSE6259_33D1_POS_DC_VS_BCELL_DN	C7_ immunologic signatures	131	1.250601	0.08262455	0.30476594	GSE6259_33D1_POS_DC_VS_BCELL_DN	135	1.0384488	0.41230768	0.861124	2.2890498	0.2121522
GO_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY	c5.BP_ GO biological process	320	1.2505417	0.028477546	0.30482408	GO_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY	325	0.82557386	0.9099099	1	2.07611556	0.42496784
GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN	C7_ immunologic signatures	105	1.250508	0.09266409	0.30481857	GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN	110	1.1537832	0.18724279	0.66330403	2.4042912	0.0967248
GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN	C7_ immunologic signatures	176	1.2502872	0.06872038	0.30524004	GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN	176	0.607164	0.9959555	1	1.8574512	0.6431232
RAPA_EARLY_UP.V1_UP	C6_ oncogenic signatures	150	1.2501425	0.0713422	0.30550328	RAPA_EARLY_UP.V1_UP	161	1.2445686	0.068297654	0.5197011	2.4947111	0.0055739
GO_NEGATIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	25	1.25008	0.15165165	0.30555445	GO_NEGATIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS	25	1.0279567	0.44014964	0.87942094	2.2780367	0.2221233
GSE3982_DC_VS_NEUTROPHIL_DN	C7_ immunologic signatures	159	1.2500231	0.068509616	0.3055994	GSE3982_DC_VS_NEUTROPHIL_DN	163	1.2331648	0.08163265	0.53549916	2.4831879	0.0168583
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN	C7_ immunologic signatures	163	1.2498739	0.08052885	0.3058578	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN	167	1.1332035	0.22413793	0.7005533	2.3830774	0.1166704
GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_DN	C7_ immunologic signatures	177	1.2498192	0.06007067	0.30590335	GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_DN	181	1.0687081	0.34040403	0.8078716	2.3185273	0.1811111
HNF1_C	c3.TFT_ transcription factor targets	193	1.2497772	0.06352941	0.30591106	HNF1_C	210	1.1616958	0.13955823	0.6510238	2.411473	0.0880814
ZHU_CMV_ALL_UP	c2.CGP_ chemical and genetic perturbations	110	1.2497133	0.10381077	0.305983	ZHU_CMV_ALL_UP	108	1.0476851	0.41554403	0.84380966	2.2973984	0.2020282
STAT5B_01	c3.TFT_ transcription factor targets	211	1.2495098	0.057988167	0.30638373	STAT5B_01	217	0.9364037	0.67738694	0.99389094	2.1859135	0.3131061
AP3_Q6	c3.TFT_ transcription factor targets	197	1.2494692	0.05793743	0.3063946	AP3_Q6	211	1.1339012	0.19635628	0.6999987	2.3833704	0.115568
AGCTCCT_MIR28	c3.MIR_ microRNA targets	82	1.2494236	0.11503268	0.30642325	AGCTCCT_MIR28	84	0.88198435	0.72287863	1	2.13140795	0.36743925
GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN	C7_ immunologic signatures	161	1.2492946	0.07904191	0.30663973	GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN	171	1.0246996	0.45056066	0.88436574	2.2739942	0.224595
GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP	C7_ immunologic signatures	172	1.2492945	0.07590362	0.3065554	GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP	176	1.0393828	0.38967612	0.85891795	2.2886773	0.2099117
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	c2.CGP_ chemical and genetic perturbations	86	1.2490486	0.10280374	0.30702725	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	98	1.4897358	0.003147954	0.25967565	2.7387844	-0.2406872
GO_GLOMERULAR_EPITHELIUM_DEVELOPMENT	c5.BP_ GO biological process	18	1.2489663	0.20094192	0.30713412	GO_GLOMERULAR_EPITHELIUM_DEVELOPMENT	18	1.2103413	0.22363405	0.5761631	2.4593076	0.038625
GTACAGG_MIR486	c3.MIR_ microRNA targets	53	1.2488915	0.14122681	0.30722585	GTACAGG_MIR486	54	0.91226983	0.6409396	1	2.16116133	0.33662167
GO_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION	c5.BP_ GO biological process	60	1.2487581	0.13765182	0.30746526	GO_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION	69	-1.4403114	0	0.17918445	-0.1915533	2.6890695
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	c2.CGP_ chemical and genetic perturbations	314	1.2487535	0.031182796	0.30739304	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	314	0	0	0	1.2487535	1.2487535
S8_01	c3.TFT_ transcription factor targets	210	1.2486289	0.06395349	0.30759612	S8_01	220	1.1575551	0.1470292	0.6577173	2.406184	0.0910738
FERRARI_RESPONSE_TO_FENRETINIDE_UP	c2.CGP_ chemical and genetic perturbations	17	1.2484754	0.18022329	0.3078856	FERRARI_RESPONSE_TO_FENRETINIDE_UP	18	1.3628587	0.09548387	0.37602553	2.6113341	-0.1143833
GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP	C7_ immunologic signatures	152	1.2484424	0.07416268	0.3078833	GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP	155	1.0506992	0.3946557	0.8387529	2.2991416	0.1977432
KEGG_LONG_TERM_POTENTIATION	c2.CP_BIOCARTA_ BioCarta gene sets	63	1.2484362	0.10526316	0.30781174	KEGG_LONG_TERM_POTENTIATION	63	0.77943826	0.8389554	1	2.02787446	0.46899794
DAIRKEE_TERT_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	105	1.2483225	0.08926261	0.30799103	DAIRKEE_TERT_TARGETS_DN	105	1.4109778	0.008359456	0.32543164	2.6593003	-0.1626553
RSRFC4_01	c3.TFT_ transcription factor targets	205	1.2480642	0.055427253	0.30851644	RSRFC4_01	216	1.1177832	0.20362903	0.7273951	2.3658474	0.130281
LEE_LIVER_CANCER_MYC_E2F1_UP	c2.CGP_ chemical and genetic perturbations	49	1.2477841	0.13314448	0.30907312	LEE_LIVER_CANCER_MYC_E2F1_UP	53	1.079507	0.35851184	0.788215	2.3272911	0.1682771
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	c2.CGP_ chemical and genetic perturbations	101	1.2477415	0.10051546	0.30908382	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	110	1.3136556	0.05532787	0.42018595	2.5613971	-0.0659141
MODULE_95	c4.CM_ cancer modules	448	1.2474794	0.026399156	0.3096005	MODULE_95	476	1.4427681	0	0.29886752	2.6902475	-0.1952887
KEGG_CELL_ADHESION_MOLECULES_CAMS	c2.CP_BIOCARTA_ BioCarta gene sets	94	1.2474426	0.12287582	0.30960026	KEGG_CELL_ADHESION_MOLECULES_CAMS	105	1.0510722	0.38935283	0.8380416	2.2985148	0.1963704
GO_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE	c5.BP_ GO biological process	127	1.2474098	0.07814408	0.30959073	GO_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE	134	1.3520093	0.022564102	0.38272956	2.5994191	-0.1045995
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP	C7_ immunologic signatures	162	1.2474071	0.07134364	0.30951175	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP	168	0.76593584	0.92182744	1	2.01334294	0.48147126
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	c2.CGP_ chemical and genetic perturbations	152	1.24733	0.08455882	0.3096073	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	155	1.6418486	0	0.12083719	2.8891786	-0.3945186
AREB6_02	c3.TFT_ transcription factor targets	218	1.2473015	0.059293043	0.30958912	AREB6_02	233	1.0769277	0.2898696	0.79417396	2.3242292	0.1703738
GO_DIGESTIVE_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	126	1.2471536	0.078282826	0.3098404	GO_DIGESTIVE_SYSTEM_DEVELOPMENT	140	0.98486	0.54703474	0.94165236	2.2320136	0.2622936
STAT4_01	c3.TFT_ transcription factor targets	225	1.2470113	0.049086757	0.31010038	STAT4_01	235	1.2658694	0.030241935	0.48971894	2.5128807	-0.0188581
GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP	C7_ immunologic signatures	165	1.2466282	0.068639055	0.31089884	GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP	167	0.87598556	0.76374745	1	2.12261376	0.37064264
FUJII_YBX1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	32	1.2465914	0.16384181	0.3109005	FUJII_YBX1_TARGETS_UP	33	1.5946993	0.007058824	0.16698748	2.8412907	-0.3481079
GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN	C7_ immunologic signatures	167	1.2465171	0.07160194	0.3109964	GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN	167	0.74157214	0.9469929	1	1.98808924	0.50494496
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	c2.CGP_ chemical and genetic perturbations	191	1.2465115	0.0628638	0.31092182	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	193	1.2808204	0.029322548	0.47121948	2.5273319	-0.0343089
GO_POSITIVE_REGULATION_OF_CAMP_METABOLIC_PROCESS	c5.BP_ GO biological process	64	1.2465092	0.11977716	0.3108413	GO_POSITIVE_REGULATION_OF_CAMP_METABOLIC_PROCESS	74	1.5499357	0.004305705	0.20594838	2.7964449	-0.3034265
EGFR_UP.V1_UP	C6_ oncogenic signatures	171	1.2464879	0.06035503	0.31080633	EGFR_UP.V1_UP	170	1.2081934	0.092479676	0.58041	2.4546813	0.0382945
CTCCAAG_MIR432	c3.MIR_ microRNA targets	71	1.2464008	0.12059621	0.31093627	CTCCAAG_MIR432	72	0.70542204	0.92756754	1	1.95182284	0.54097876
GO_PEPTIDE_CROSS_LINKING	c5.BP_ GO biological process	28	1.2463671	0.15535446	0.31093305	GO_PEPTIDE_CROSS_LINKING	23	-0.9653503	0.52606636	0.73538107	0.2810168	2.2117174
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP	C7_ immunologic signatures	162	1.2463597	0.07446808	0.31086203	GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP	177	1.1993868	0.106014274	0.59367603	2.4457465	0.0469729
SOX5_01	c3.TFT_ transcription factor targets	235	1.246252	0.06029579	0.31102747	SOX5_01	238	1.0714693	0.31626505	0.80296457	2.3177213	0.1747827
RADAEVA_RESPONSE_TO_IFNA1_UP	c2.CGP_ chemical and genetic perturbations	45	1.2461946	0.121985815	0.31108326	RADAEVA_RESPONSE_TO_IFNA1_UP	44	1.1892444	0.20571429	0.6065967	2.435439	0.0569502
SMID_BREAST_CANCER_LUMINAL_B_DN	c2.CGP_ chemical and genetic perturbations	436	1.246097	0.028421052	0.31121778	SMID_BREAST_CANCER_LUMINAL_B_DN	465	1.2859232	0.003	0.46241194	2.5320202	-0.0398262
GO_MICROTUBULE_BASED_MOVEMENT	c5.BP_ GO biological process	183	1.2459576	0.067677945	0.3114598	GO_MICROTUBULE_BASED_MOVEMENT	186	1.3221315	0.01622718	0.4114274	2.5680891	-0.0761739
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	c2.CGP_ chemical and genetic perturbations	96	1.2457396	0.10678392	0.31187347	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	96	0.78386134	0.8695198	1	2.02960094	0.46187826
CHR11Q22	C1: positional gene sets	37	1.245696	0.15133531	0.31188765	CHR11Q22	38	1.1966287	0.2078978	0.59662235	2.4423247	0.0490673
GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT	c5.BP_ GO biological process	87	1.2456545	0.094805196	0.31188992	GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT	88	0.83987856	0.7930306	1	2.08553306	0.40577594
GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP	C7_ immunologic signatures	172	1.2456309	0.07482185	0.31186557	GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP	174	1.1687697	0.12841254	0.6389842	2.4144006	0.0768612
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	c2.CP_REACTOME_ Reactome gene sets	180	1.2454096	0.08085612	0.31229654	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	184	1.3534483	0.010152284	0.38305128	2.5988579	-0.1080387
E2A_Q2	c3.TFT_ transcription factor targets	212	1.2450649	0.047398843	0.31299657	E2A_Q2	217	1.0828128	0.3028169	0.7823093	2.3278777	0.1622521
GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	171	1.2450528	0.066985644	0.3129362	GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	181	1.0667541	0.35270134	0.8115762	2.3118069	0.1782987
GO_ENDODERM_DEVELOPMENT	c5.BP_ GO biological process	64	1.2449194	0.12416556	0.31316352	GO_ENDODERM_DEVELOPMENT	67	0.63778156	0.968444	1	1.88270096	0.60713784
GO_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	384	1.2446933	0.03655914	0.31360394	GO_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT	410	0.95049495	0.688	0.98151046	2.19518825	0.29419835
GO_AMPA_GLUTAMATE_RECEPTOR_COMPLEX	c5.CC_ GO cellular component	25	1.244526	0.17834395	0.31389648	GO_AMPA_GLUTAMATE_RECEPTOR_COMPLEX	26	-1.0074546	0.42682928	0.67457277	0.2370714	2.2519806
GO_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	33	1.2444577	0.16251831	0.31397817	GO_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS	35	0.96996915	0.5231707	0.9615705	2.21442685	0.27448855
GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	167	1.2443491	0.077294685	0.314152	GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP	182	1.3147424	0.024217961	0.4180781	2.5590915	-0.0703933
LEE_LIVER_CANCER_E2F1_UP	c2.CGP_ chemical and genetic perturbations	53	1.2441093	0.13110182	0.31464344	LEE_LIVER_CANCER_E2F1_UP	55	1.0766095	0.3585746	0.79407394	2.3207188	0.1674998
MORF_LMO1	c4.CGN_ cancer gene neighborhoods	40	1.2439705	0.14545454	0.3148841	MORF_LMO1	41	1.0718855	0.3643868	0.8026098	2.315856	0.172085
GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP	C7_ immunologic signatures	172	1.2439657	0.077014215	0.31480995	GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP	171	0.82660383	0.85800606	1	2.07056953	0.41736187
YOSHIMURA_MAPK8_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	329	1.2437973	0.036464088	0.31513122	YOSHIMURA_MAPK8_TARGETS_DN	333	0.7007744	0.98998	1	1.9445717	0.5430229
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	c2.CGP_ chemical and genetic perturbations	20	1.2436335	0.19492869	0.3154245	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	20	1.5686193	0.013941699	0.19039415	2.8122528	-0.3249858
BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	c2.CGP_ chemical and genetic perturbations	452	1.2435355	0.026483051	0.31556317	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	461	1.0397849	0.341	0.8591085	2.2833204	0.2037506
VALK_AML_CLUSTER_6	c2.CGP_ chemical and genetic perturbations	29	1.2434466	0.15014577	0.3156932	VALK_AML_CLUSTER_6	31	1.3828326	0.05630355	0.35529524	2.6262792	-0.139386
KRAS.600_UP.V1_DN	C6_ oncogenic signatures	203	1.2433857	0.058553386	0.3157609	KRAS.600_UP.V1_DN	219	1.1542544	0.14271356	0.66229814	2.3976401	0.0891313
GNF2_MLF1	c4.CGN_ cancer gene neighborhoods	63	1.2433125	0.1414966	0.31584108	GNF2_MLF1	69	1.2991952	0.06889128	0.44391683	2.5425077	-0.0558827
GO_TRANSCRIPTION_COFACTOR_BINDING	c5.GO molecular function	23	1.2433122	0.16899225	0.31575605	GO_TRANSCRIPTION_COFACTOR_BINDING	23	0.699486	0.8892944	1	1.9427982	0.5438262
GO_ENDODEOXYRIBONUCLEASE_ACTIVITY	c5.GO molecular function	43	1.2433044	0.1434659	0.31568694	GO_ENDODEOXYRIBONUCLEASE_ACTIVITY	44	0.5308612	0.9907407	1	1.7741656	0.7124432
GSE36095_WT_VS_HDAC9_KO_TREG_UP	C7_ immunologic signatures	167	1.2431871	0.076009504	0.31588075	GSE36095_WT_VS_HDAC9_KO_TREG_UP	169	1.2642343	0.050813008	0.49126643	2.5074214	-0.0210472
VALK_AML_CLUSTER_3	c2.CGP_ chemical and genetic perturbations	26	1.243067	0.16716868	0.31609213	VALK_AML_CLUSTER_3	27	1.4023833	0.0567201	0.3365532	2.6454503	-0.1593163
TTGCACT_MIR130A_MIR301_MIR130B	c3.MIR_ microRNA targets	364	1.2427282	0.034632035	0.316815	TTGCACT_MIR130A_MIR301_MIR130B	369	1.0851977	0.224	0.77712536	2.3279259	0.1575305
GSE7764_NKCELL_VS_SPLENOCYTE_UP	C7_ immunologic signatures	178	1.2425909	0.06042654	0.3170561	GSE7764_NKCELL_VS_SPLENOCYTE_UP	183	1.0080711	0.49846783	0.9109382	2.250662	0.2345198
GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP	C7_ immunologic signatures	161	1.242571	0.08130081	0.31702045	GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP	165	1.0205674	0.45667687	0.8910686	2.2631384	0.2220036
GO_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS	c5.BP_ GO biological process	38	1.2425407	0.16063675	0.3170069	GO_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS	41	1.2404939	0.17281106	0.52521586	2.4830346	0.0020468
LXR_DR4_Q3	c3.TFT_ transcription factor targets	81	1.242486	0.12027027	0.31705564	LXR_DR4_Q3	83	0.7974641	0.8383298	1	2.0399501	0.4450219
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP	C7_ immunologic signatures	186	1.2424781	0.061627906	0.31698537	GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP	187	0.6597544	0.9939577	1	1.9022325	0.5827237
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN	C7_ immunologic signatures	174	1.2424701	0.072705604	0.31691676	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN	182	1.1435924	0.19207317	0.6837515	2.3860625	0.0988777
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	c2.CP_REACTOME_ Reactome gene sets	109	1.2424395	0.115830116	0.31690434	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	111	1.0095686	0.47004133	0.90840226	2.2520081	0.2328709
GO_REGULATION_OF_SPROUTING_ANGIOGENESIS	c5.BP_ GO biological process	28	1.2423661	0.16268657	0.31700134	GO_REGULATION_OF_SPROUTING_ANGIOGENESIS	28	1.0863231	0.3734793	0.7757486	2.3286892	0.156043
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	c2.CGP_ chemical and genetic perturbations	105	1.242167	0.11764706	0.31740168	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	108	0.9703549	0.56062174	0.96114075	2.2125219	0.2718121
MEK_UP.V1_UP	C6_ oncogenic signatures	175	1.2420837	0.0724299	0.31751022	MEK_UP.V1_UP	177	1.1265112	0.21681865	0.71176255	2.3685949	0.1155725
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP	C7_ immunologic signatures	114	1.2420698	0.106821105	0.31746197	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP	124	1.4299688	0.007201646	0.31454965	2.6720386	-0.187899
GO_REGULATION_OF_GLIOGENESIS	c5.BP_ GO biological process	79	1.2420522	0.10960758	0.31741428	GO_REGULATION_OF_GLIOGENESIS	88	0.91619027	0.6552828	1	2.15824247	0.32586193
HALLMARK_APOPTOSIS	H_ hallmark gene sets	152	1.2420517	0.07850242	0.31732976	HALLMARK_APOPTOSIS	153	1.1772262	0.13849287	0.6268925	2.4192779	0.0648255
GO_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	237	1.2420514	0.06313416	0.3172442	GO_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT	252	0.74349666	0.96184736	1	1.98554806	0.49855474
GO_REGULATION_OF_HISTONE_H3_K9_METHYLATION	c5.BP_ GO biological process	15	1.2419964	0.18789808	0.31728974	GO_REGULATION_OF_HISTONE_H3_K9_METHYLATION	16	-1.2286253	0.18884121	0.34716296	0.0133711	2.4706217
GO_CENTRIOLE_ASSEMBLY	c5.BP_ GO biological process	18	1.241753	0.19846153	0.31777886	GO_CENTRIOLE_ASSEMBLY	18	-0.57492363	0.977169	0.9878945	0.66682937	1.81667663
PID_CD8_TCR_PATHWAY	c2.CP_ Canonical pathways	49	1.2417412	0.14245014	0.31772283	PID_CD8_TCR_PATHWAY	52	1.4124509	0.036789298	0.32450312	2.6541921	-0.1707097
NAKAMURA_ADIPOGENESIS_EARLY_UP	c2.CGP_ chemical and genetic perturbations	51	1.2416601	0.12660028	0.31783104	NAKAMURA_ADIPOGENESIS_EARLY_UP	52	1.0560151	0.40432802	0.8311108	2.2976752	0.185645
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN	C7_ immunologic signatures	186	1.2416575	0.06370192	0.3177506	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN	185	1.2425903	0.05065856	0.5221575	2.4842478	-0.0009328
GO_SYNAPTIC_VESICLE_RECYCLING	c5.BP_ GO biological process	22	1.2414745	0.18338558	0.3180976	GO_SYNAPTIC_VESICLE_RECYCLING	23	1.0260509	0.44585988	0.88253	2.2675254	0.2154236
GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	161	1.2414742	0.07673569	0.31801203	GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN	162	0.88778615	0.7461929	1	2.12926035	0.35368805
GSE3982_NKCELL_VS_TH2_DN	C7_ immunologic signatures	172	1.2413486	0.070913464	0.31822306	GSE3982_NKCELL_VS_TH2_DN	176	0.70060736	0.96875	1	1.94195596	0.54074124
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	C7_ immunologic signatures	183	1.2413282	0.055555556	0.3181858	GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	183	-0.9463438	0.78571427	0.76072574	0.2949844	2.187672
GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN	C7_ immunologic signatures	128	1.2412139	0.1002445	0.31837207	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN	139	1.1783417	0.14765784	0.6244794	2.4195556	0.0628722
GO_RESPONSE_TO_DSRNA	c5.BP_ GO biological process	62	1.2411642	0.122733615	0.31840214	GO_RESPONSE_TO_DSRNA	61	0.62414056	0.9679912	1	1.86530476	0.61702364
GO_ACTIN_BASED_CELL_PROJECTION	c5.CC_ GO cellular component	159	1.2411073	0.08372641	0.3184471	GO_ACTIN_BASED_CELL_PROJECTION	166	1.2901891	0.03258656	0.45741653	2.5312964	-0.0490818
GO_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR	c5.BP_ GO biological process	108	1.2410042	0.10604192	0.3186049	GO_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR	108	-0.9638041	0.5135135	0.7370675	0.2772001	2.2048083
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	c2.CGP_ chemical and genetic perturbations	208	1.2409992	0.08132875	0.3185308	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	210	0.83051145	0.87903225	1	2.07151065	0.41048775
GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN	C7_ immunologic signatures	179	1.2409531	0.066985644	0.31855336	GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN	182	1.1665549	0.14889336	0.64382267	2.407508	0.0743982
CHR17Q25	C1: positional gene sets	140	1.2408103	0.07493857	0.31881982	CHR17Q25	146	1.2822187	0.057318322	0.46905652	2.523029	-0.0414084
GO_REGIONALIZATION	c5.BP_ GO biological process	274	1.2407569	0.0472973	0.3188725	GO_REGIONALIZATION	304	0.87331223	0.85470945	1	2.11406913	0.36744467
OCT1_05	c3.TFT_ transcription factor targets	203	1.2405987	0.06557377	0.31916544	OCT1_05	217	1.2553831	0.03507014	0.50237703	2.4959818	-0.0147844
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	c2.CGP_ chemical and genetic perturbations	17	1.2405702	0.20472442	0.31914604	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	17	-1.608122	0.051181104	0.08869374	-0.3675518	2.8486922
CDP_02	c3.TFT_ transcription factor targets	87	1.2404712	0.12176166	0.31929553	CDP_02	93	1.1301973	0.26349208	0.7060391	2.3706685	0.1102739
GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP	C7_ immunologic signatures	170	1.2404459	0.07227488	0.31926733	GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP	172	0.8785174	0.7731434	1	2.1189633	0.3619285
DER_IFN_BETA_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	92	1.2404292	0.105401844	0.31921962	DER_IFN_BETA_RESPONSE_UP	92	1.1882052	0.18114407	0.60861844	2.4286344	0.052224
GO_REGULATION_OF_DNA_REPLICATION	c5.BP_ GO biological process	143	1.2403613	0.076154806	0.31928888	GO_REGULATION_OF_DNA_REPLICATION	148	0.8290415	0.8470948	1	2.0694028	0.4113198
GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN	C7_ immunologic signatures	142	1.2402908	0.07955936	0.31937447	GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN	156	1.1764606	0.13455658	0.6272302	2.4167514	0.0638302
CHR8P11	C1: positional gene sets	33	1.2402643	0.1867647	0.31934816	CHR8P11	34	1.0190384	0.4551887	0.89188987	2.2593027	0.2212259
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP	C7_ immunologic signatures	174	1.2402264	0.08450704	0.31936055	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP	177	-0.9862375	0.4	0.70651186	0.2539889	2.2264639
GSE10325_BCELL_VS_LUPUS_BCELL_UP	C7_ immunologic signatures	148	1.2402213	0.07891492	0.31928828	GSE10325_BCELL_VS_LUPUS_BCELL_UP	157	1.2390349	0.06910569	0.5270054	2.4792562	0.0011864
GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP	C7_ immunologic signatures	158	1.2401137	0.075178996	0.31944612	GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP	169	1.24261	0.07817259	0.5222906	2.4827237	-0.0024963
OCT1_06	c3.TFT_ transcription factor targets	221	1.2400788	0.060919542	0.31944326	OCT1_06	225	0.84702957	0.86807656	1	2.08710837	0.39304923
MODULE_163	c4.CM_ cancer modules	451	1.240029	0.026232949	0.31947538	MODULE_163	479	1.4233674	0	0.31833598	2.6633964	-0.1833384
JI_RESPONSE_TO_FSH_DN	c2.CGP_ chemical and genetic perturbations	56	1.2398823	0.12382234	0.31973585	JI_RESPONSE_TO_FSH_DN	56	-1.1165891	0.2	0.49412233	0.1232932	2.3564714
GO_SODIUM_ION_HOMEOSTASIS	c5.BP_ GO biological process	21	1.239878	0.18325435	0.31966153	GO_SODIUM_ION_HOMEOSTASIS	25	0.96583253	0.5463535	0.96470475	2.20571053	0.27404547
GO_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	71	1.2398143	0.13168724	0.31972465	GO_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS	79	1.1343536	0.2513312	0.6987262	2.3741679	0.1054607
GACAGGG_MIR339	c3.MIR_ microRNA targets	60	1.2397977	0.15948276	0.31967342	GACAGGG_MIR339	62	0.6724401	0.95364237	1	1.9122378	0.5673576
SCHOEN_NFKB_SIGNALING	c2.CGP_ chemical and genetic perturbations	29	1.2397829	0.1710731	0.31962523	SCHOEN_NFKB_SIGNALING	29	1.6147212	0.001212121	0.14691246	2.8545041	-0.3749383
GSE12505_WT_VS_E2_2_HET_PDC_UP	C7_ immunologic signatures	104	1.2397575	0.11010363	0.31960016	GSE12505_WT_VS_E2_2_HET_PDC_UP	110	1.1177603	0.27970558	0.7271694	2.3575178	0.1219972
GO_NUCLEAR_CHROMOSOME	c5.CC_ GO cellular component	429	1.2397354	0.032943677	0.31956956	GO_NUCLEAR_CHROMOSOME	440	0.80112636	0.969	1	2.04086176	0.43860904
OUILLETTE_CLL_13Q14_DELETION_UP	c2.CGP_ chemical and genetic perturbations	60	1.239648	0.14444445	0.31969598	OUILLETTE_CLL_13Q14_DELETION_UP	59	0.85990584	0.71	1	2.09955384	0.37974216
GO_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS	c5.BP_ GO biological process	74	1.239567	0.14049587	0.31979743	GO_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS	74	1.6419098	0	0.12180375	2.8814768	-0.4023428
GO_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS	c5.BP_ GO biological process	244	1.2394081	0.060115606	0.32008794	GO_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS	245	1.0210241	0.45135406	0.89080423	2.2604322	0.218384
CHR1Q23	C1: positional gene sets	61	1.2394046	0.13846155	0.3200064	CHR1Q23	66	0.8086296	0.78571427	1	2.0480342	0.430775
GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN	C7_ immunologic signatures	156	1.2393658	0.09252669	0.32001528	GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN	158	0.9961421	0.5065856	0.9293369	2.2355079	0.2432237
GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN	C7_ immunologic signatures	169	1.2393377	0.077380955	0.31998488	GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN	182	0.8918843	0.75481254	1	2.131222	0.3474534
GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP	C7_ immunologic signatures	140	1.2392836	0.092796095	0.32002002	GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP	145	1.2633239	0.048403706	0.49173278	2.5026075	-0.0240403
MODULE_63	c4.CM_ cancer modules	177	1.2392429	0.07756563	0.32003677	MODULE_63	195	1.2795156	0.030303031	0.4727456	2.5187585	-0.0402727
GO_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY	c5.BP_ GO biological process	143	1.2390516	0.09729064	0.3203981	GO_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY	146	0.77135664	0.9021191	1	2.01040824	0.46769496
GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP	C7_ immunologic signatures	171	1.2389711	0.08275058	0.32051697	GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP	176	1.1931008	0.11526795	0.6002442	2.4320719	0.0458703
WESTON_VEGFA_TARGETS_12HR	c2.CGP_ chemical and genetic perturbations	32	1.2388177	0.18486172	0.32078195	WESTON_VEGFA_TARGETS_12HR	31	0.7631406	0.79804164	1	2.0019583	0.4756771
PAX3_B	c3.TFT_ transcription factor targets	78	1.2385348	0.13351499	0.32140002	PAX3_B	82	0.85228205	0.76824033	1	2.09081685	0.38625275
WNT_UP.V1_UP	C6_ oncogenic signatures	140	1.2385231	0.10913706	0.32134324	WNT_UP.V1_UP	150	1.2946899	0.035641547	0.44946823	2.533213	-0.0561668
GO_NON_RECOMBINATIONAL_REPAIR	c5.BP_ GO biological process	51	1.2384396	0.14782609	0.32145235	GO_NON_RECOMBINATIONAL_REPAIR	51	0.71401775	0.90056497	1	1.95245735	0.52442185
GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP	C7_ immunologic signatures	175	1.2384199	0.08588957	0.3214116	GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP	178	1.26782	0.03939394	0.48673236	2.5062399	-0.0294001
GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN	C7_ immunologic signatures	143	1.2383531	0.100362755	0.3214968	GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN	149	1.2906786	0.048681542	0.45686424	2.5290317	-0.0523255
GO_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.BP_ GO biological process	34	1.2383091	0.1920821	0.32151467	GO_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	35	1.1652668	0.24238876	0.6461121	2.4035759	0.0730423
GSE17721_0.5H_VS_24H_LPS_BMDC_DN	C7_ immunologic signatures	178	1.2380236	0.0776583	0.32212585	GSE17721_0.5H_VS_24H_LPS_BMDC_DN	180	1.0328255	0.41928935	0.87260205	2.2708491	0.2051981
CHR9P21	C1: positional gene sets	23	1.2380031	0.16692668	0.32209253	CHR9P21	24	0.8631018	0.676259	1	2.1011049	0.3749013
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP	C7_ immunologic signatures	183	1.2378654	0.07728894	0.32234544	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP	185	-0.8391698	1	0.87722087	0.3986956	2.0770352
HUMMERICH_SKIN_CANCER_PROGRESSION_DN	c2.CGP_ chemical and genetic perturbations	92	1.2378242	0.11294416	0.32236293	HUMMERICH_SKIN_CANCER_PROGRESSION_DN	94	1.0993241	0.31144068	0.75790805	2.3371483	0.1385001
E2F1_Q3_01	c3.TFT_ transcription factor targets	216	1.2378095	0.07368421	0.32230875	E2F1_Q3_01	221	-1.3701856	0	0.22688472	-0.1323761	2.6079951
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	c2.CGP_ chemical and genetic perturbations	180	1.2377588	0.06508876	0.32233465	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	179	0.8379341	0.83214647	1	2.0756929	0.3998247
DELASERNA_MYOD_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	80	1.2377067	0.12661499	0.32235757	DELASERNA_MYOD_TARGETS_UP	82	1.0643673	0.36769393	0.8152765	2.302074	0.1733394
GCM_ERBB2IP	c4.CGN_ cancer gene neighborhoods	57	1.2374921	0.14206897	0.3227727	GCM_ERBB2IP	57	0.51927626	0.99559957	1	1.75676836	0.71821584
BIOCARTA_TGFB_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	1.2374766	0.2015748	0.3227331	BIOCARTA_TGFB_PATHWAY	18	0.70678014	0.8728477	1	1.94425674	0.53069646
GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP	C7_ immunologic signatures	168	1.2374632	0.08554217	0.32268012	GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP	174	0.95545113	0.6048632	0.97588694	2.19291433	0.28201207
GO_NEGATIVE_REGULATION_OF_ORGAN_GROWTH	c5.BP_ GO biological process	20	1.2373856	0.18070444	0.3227719	GO_NEGATIVE_REGULATION_OF_ORGAN_GROWTH	20	1.4067085	0.058524173	0.33116055	2.6440941	-0.1693229
GO_PROTEIN_AUTOPHOSPHORYLATION	c5.BP_ GO biological process	184	1.2371658	0.07957245	0.32321072	GO_PROTEIN_AUTOPHOSPHORYLATION	187	1.157333	0.13636364	0.6584105	2.3944988	0.0798328
GO_NAD_ADP_RIBOSYLTRANSFERASE_ACTIVITY	c5.GO molecular function	25	1.2371631	0.16485226	0.32312915	GO_NAD_ADP_RIBOSYLTRANSFERASE_ACTIVITY	25	1.1361493	0.31203008	0.6962602	2.3733124	0.1010138
GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR	c5.BP_ GO biological process	29	1.2371372	0.17744361	0.32309985	GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR	29	1.1474261	0.27161998	0.6727171	2.3845633	0.0897111
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN	c2.CGP_ chemical and genetic perturbations	28	1.2368883	0.15648286	0.32359475	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN	29	1.0537797	0.39423078	0.83604735	2.290668	0.1831086
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING	c5.BP_ GO biological process	130	1.236811	0.10075567	0.32369483	GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING	138	1.2290835	0.1017294	0.54259294	2.4658945	0.0077275
AMEF2_Q6	c3.TFT_ transcription factor targets	217	1.236632	0.060158912	0.32404104	AMEF2_Q6	228	1.221291	0.071644805	0.5534342	2.457923	0.015341
WIELAND_UP_BY_HBV_INFECTION	c2.CGP_ chemical and genetic perturbations	76	1.2366246	0.12653062	0.32397336	WIELAND_UP_BY_HBV_INFECTION	80	1.3086473	0.06451613	0.42796347	2.5452719	-0.0720227
GO_APICAL_PLASMA_MEMBRANE	c5.CC_ GO cellular component	247	1.2366234	0.048423424	0.32388952	GO_APICAL_PLASMA_MEMBRANE	271	1.4622158	0	0.28070894	2.6988392	-0.2255924
GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP	C7_ immunologic signatures	177	1.2364197	0.0755608	0.32430896	GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP	178	0.87832224	0.7616162	1	2.11474194	0.35809746
GSE15659_TREG_VS_TCONV_UP	C7_ immunologic signatures	132	1.2361751	0.09974747	0.32481474	GSE15659_TREG_VS_TCONV_UP	133	0.8617918	0.7717503	1	2.0979669	0.3743833
AP4_Q6	c3.TFT_ transcription factor targets	190	1.2361116	0.08104887	0.3248829	AP4_Q6	196	0.8894881	0.768453	1	2.1255997	0.3466235
GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	C7_ immunologic signatures	172	1.236059	0.07636364	0.32494056	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	173	-1.2101583	0.09090909	0.367675	0.0259007	2.4462173
YANG_BREAST_CANCER_ESR1_BULK_DN	c2.CGP_ chemical and genetic perturbations	19	1.2359912	0.19175911	0.32501483	YANG_BREAST_CANCER_ESR1_BULK_DN	20	1.2186123	0.21428572	0.5579864	2.4546035	0.0173789
CHR14Q13	C1: positional gene sets	27	1.2359828	0.19486405	0.32495448	CHR14Q13	27	0.62447363	0.94383395	1	1.86045643	0.61150917
CAIRO_HEPATOBLASTOMA_DN	c2.CGP_ chemical and genetic perturbations	224	1.2358364	0.061573546	0.32521695	CAIRO_HEPATOBLASTOMA_DN	233	1.2322515	0.044354837	0.5370034	2.4680879	0.0035849
GFI1_01	c3.TFT_ transcription factor targets	233	1.2358131	0.06950673	0.3251886	GFI1_01	239	0.9215553	0.71586347	1	2.1573684	0.3142578
GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN	C7_ immunologic signatures	138	1.2356489	0.07257073	0.3254968	GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN	139	1.0715092	0.34329897	0.80308557	2.3071581	0.1641397
SMIRNOV_RESPONSE_TO_IR_2HR_UP	c2.CGP_ chemical and genetic perturbations	45	1.2356485	0.14387465	0.3254107	SMIRNOV_RESPONSE_TO_IR_2HR_UP	44	1.2807063	0.10820045	0.47145545	2.5163548	-0.0450578
GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP	C7_ immunologic signatures	163	1.235647	0.08622754	0.3253292	GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP	165	-1.0701717	0.2	0.5701189	0.1654753	2.3058187
GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN	C7_ immunologic signatures	156	1.235626	0.09472422	0.3253004	GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN	178	1.7016342	0	0.08276124	2.9372602	-0.4660082
ATM_DN.V1_DN	C6_ oncogenic signatures	113	1.2354175	0.09202454	0.32570308	ATM_DN.V1_DN	123	1.097537	0.30331263	0.759726	2.3329545	0.1378805
OCT1_02	c3.TFT_ transcription factor targets	186	1.2350173	0.084014006	0.3265763	OCT1_02	190	1.0037872	0.50506073	0.9173736	2.2388045	0.2312301
GSE2585_CTEC_VS_THYMIC_DC_DN	C7_ immunologic signatures	168	1.2349894	0.07957245	0.32656094	GSE2585_CTEC_VS_THYMIC_DC_DN	180	0.89831454	0.7373737	1	2.13330394	0.33667486
GO_IMMUNOGLOBULIN_PRODUCTION	c5.BP_ GO biological process	36	1.2348979	0.14053254	0.32669318	GO_IMMUNOGLOBULIN_PRODUCTION	39	-0.88816136	0.67114097	0.8373357	0.34673654	2.12305926
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	39	1.2348359	0.17613636	0.32675847	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	39	1.1087835	0.32555425	0.73970616	2.3436194	0.1260524
GO_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	43	1.2347634	0.1626506	0.32684505	GO_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT	44	1.1537166	0.24652778	0.6629318	2.38848	0.0810468
GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP	C7_ immunologic signatures	171	1.2347546	0.091541134	0.32677615	GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP	178	0.64458805	0.9908999	1	1.87934265	0.59016655
PRC2_EED_UP.V1_DN	C6_ oncogenic signatures	178	1.2347331	0.09015421	0.32673457	PRC2_EED_UP.V1_DN	179	0.8031552	0.9047619	1	2.0378883	0.4315779
MENSE_HYPOXIA_UP	c2.CGP_ chemical and genetic perturbations	91	1.2345649	0.13602015	0.327043	MENSE_HYPOXIA_UP	91	0.79014534	0.84326017	1	2.02471024	0.44441956
BORCZUK_MALIGNANT_MESOTHELIOMA_DN	c2.CGP_ chemical and genetic perturbations	83	1.2345248	0.12350598	0.32705545	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	86	1.1709725	0.19488817	0.63705206	2.4054973	0.0635523
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN	C7_ immunologic signatures	171	1.2343796	0.08410138	0.32732695	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN	174	0.6718822	0.97854954	1	1.9062618	0.5624974
CDPCR1_01	c3.TFT_ transcription factor targets	117	1.2342793	0.098522164	0.32747883	CDPCR1_01	119	1.0407248	0.41440502	0.8582121	2.2750041	0.1935545
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	158	1.2339176	0.097005986	0.3282861	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP	168	1.4414583	0.003067485	0.30181584	2.6753759	-0.2075407
GO_REGULATION_OF_CGMP_METABOLIC_PROCESS	c5.BP_ GO biological process	24	1.2338719	0.1899696	0.3283082	GO_REGULATION_OF_CGMP_METABOLIC_PROCESS	24	1.5981004	0.006165228	0.16166915	2.8319723	-0.3642285
MODULE_292	c4.CM_ cancer modules	98	1.2338487	0.11308768	0.32828054	MODULE_292	103	1.37386	0.025	0.36119246	2.6077087	-0.1400113
GCNP_SHH_UP_LATE.V1_DN	C6_ oncogenic signatures	163	1.2335392	0.08023256	0.32895026	GCNP_SHH_UP_LATE.V1_DN	168	1.1052314	0.23630832	0.7461208	2.3387706	0.1283078
GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN	C7_ immunologic signatures	176	1.2331605	0.0783848	0.32979992	GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN	181	1.422171	0.001012146	0.31805784	2.6553315	-0.1890105
GO_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION	c5.BP_ GO biological process	18	1.2327615	0.19055374	0.330671	GO_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION	20	1.5478911	0.01511335	0.20735294	2.7806526	-0.3151296
GO_RESPONSE_TO_PURINE_CONTAINING_COMPOUND	c5.BP_ GO biological process	143	1.2327416	0.08108108	0.33063003	GO_RESPONSE_TO_PURINE_CONTAINING_COMPOUND	151	1.387579	0.008179959	0.34817368	2.6203206	-0.1548374
GO_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	53	1.2326596	0.14710042	0.33074158	GO_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS	57	1.0368884	0.42325056	0.86424017	2.269548	0.1957712
GO_BIOMINERAL_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	60	1.2325557	0.15143247	0.33090657	GO_BIOMINERAL_TISSUE_DEVELOPMENT	66	1.0256826	0.45053762	0.8830409	2.2582383	0.2068731
CHENG_IMPRINTED_BY_ESTRADIOL	c2.CGP_ chemical and genetic perturbations	93	1.2323841	0.11210191	0.33125094	CHENG_IMPRINTED_BY_ESTRADIOL	96	1.092031	0.3131524	0.7694499	2.3244151	0.1403531
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	c2.CGP_ chemical and genetic perturbations	41	1.2323731	0.17261904	0.33119032	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	41	1.0561101	0.38876146	0.83114874	2.2884832	0.176263
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP	C7_ immunologic signatures	178	1.2322438	0.07854631	0.33140215	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP	181	0.99411684	0.51221997	0.9310799	2.22636064	0.23812696
GO_NEURON_DEATH	c5.BP_ GO biological process	43	1.2322388	0.15249267	0.33132786	GO_NEURON_DEATH	44	1.1062636	0.31314287	0.7445441	2.3385024	0.1259752
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	168	1.2322268	0.103942655	0.3312669	GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN	172	0.83363146	0.8380282	1	2.06585826	0.39859534
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN	C7_ immunologic signatures	177	1.2321188	0.08510638	0.3314562	GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN	179	0.77367795	0.92799187	1	2.00579675	0.45844085
GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN	C7_ immunologic signatures	182	1.2319993	0.07701711	0.3316711	GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN	184	0.7077746	0.97979796	1	1.9397739	0.5242247
GO_NUCLEAR_HETEROCHROMATIN	c5.CC_ GO cellular component	30	1.2318559	0.18674698	0.33193672	GO_NUCLEAR_HETEROCHROMATIN	30	-1.541993	0.012903226	0.11919279	-0.3101371	2.7738489
GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP	C7_ immunologic signatures	180	1.2317762	0.07656612	0.33204606	GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP	190	1.0285262	0.42052314	0.8780875	2.2603024	0.20325
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	c2.CGP_ chemical and genetic perturbations	391	1.231733	0.0386681	0.33207074	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	392	0.960243	0.646	0.97130406	2.191976	0.27149
GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY	c5.BP_ GO biological process	66	1.2315078	0.15479451	0.3325502	GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY	66	1.332184	0.07290533	0.39987513	2.5636918	-0.1006762
GSE7852_LN_VS_THYMUS_TREG_UP	C7_ immunologic signatures	169	1.2314337	0.08323564	0.33264115	GSE7852_LN_VS_THYMUS_TREG_UP	169	1.3837544	0.004052685	0.35233966	2.6151881	-0.1523207
CHR9Q32	C1: positional gene sets	23	1.231408	0.18096724	0.3326214	CHR9Q32	25	1.3062907	0.11369193	0.4314158	2.5376987	-0.0748827
GO_HAIR_CELL_DIFFERENTIATION	c5.BP_ GO biological process	30	1.2313812	0.17378917	0.332593	GO_HAIR_CELL_DIFFERENTIATION	32	-1.0889295	0.29333332	0.53588486	0.1424517	2.3203107
PR_Q2	c3.TFT_ transcription factor targets	221	1.2313223	0.07995495	0.33264682	PR_Q2	234	1.1168042	0.21313131	0.7284099	2.3481265	0.1145181
GSE17721_CTRL_VS_CPG_4H_BMDC_DN	C7_ immunologic signatures	172	1.2309778	0.08153477	0.3334181	GSE17721_CTRL_VS_CPG_4H_BMDC_DN	177	0.9994006	0.4969574	0.9246264	2.2303784	0.2315772
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	c2.CGP_ chemical and genetic perturbations	62	1.2309674	0.13812155	0.33336037	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	62	1.101803	0.31064764	0.75382876	2.3327704	0.1291644
GO_CELLULAR_RESPONSE_TO_GAMMA_RADIATION	c5.BP_ GO biological process	18	1.2309153	0.22632423	0.33339185	GO_CELLULAR_RESPONSE_TO_GAMMA_RADIATION	18	1.2994446	0.15225807	0.44340646	2.5303599	-0.0685293
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP	C7_ immunologic signatures	169	1.2308313	0.088505745	0.3335115	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP	176	1.2102807	0.08028455	0.5758212	2.441112	0.0205506
BHAT_ESR1_TARGETS_VIA_AKT1_DN	c2.CGP_ chemical and genetic perturbations	77	1.2308044	0.1328859	0.3334913	BHAT_ESR1_TARGETS_VIA_AKT1_DN	78	1.3939049	0.028481012	0.34632975	2.6247093	-0.1631005
CHR8Q23	C1: positional gene sets	21	1.2307351	0.18348624	0.33359817	CHR8Q23	20	0.7799763	0.7766749	1	2.0107114	0.4507588
GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP	C7_ immunologic signatures	177	1.230687	0.085480094	0.3336286	GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP	182	1.0278897	0.4311741	0.8794073	2.2585767	0.2027973
GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	C7_ immunologic signatures	175	1.2306038	0.07565012	0.3337459	GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	179	1.3533372	0.008130081	0.3821976	2.583941	-0.1227334
GO_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION	c5.BP_ GO biological process	16	1.2306025	0.20097245	0.33366188	GO_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION	20	1.4368095	0.051702395	0.30840003	2.667412	-0.206207
GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	C7_ immunologic signatures	167	1.230542	0.086904764	0.333731	GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	169	1.0352712	0.4142132	0.8670866	2.2658132	0.1952708
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP	C7_ immunologic signatures	143	1.2304826	0.09625	0.3337928	GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP	148	1.1047106	0.2676923	0.7475851	2.3351932	0.125772
GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP	C7_ immunologic signatures	182	1.2304138	0.0775463	0.33386874	GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP	185	0.82652813	0.86192894	1	2.05694193	0.40388567
AATGGAG_MIR136	c3.MIR_ microRNA targets	77	1.2301971	0.123834886	0.3343164	AATGGAG_MIR136	77	0.84240377	0.76375407	1	2.07260087	0.38779333
GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN	C7_ immunologic signatures	150	1.2301898	0.10963856	0.33424774	GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN	154	0.8116198	0.8505155	1	2.0418096	0.41857
PENG_GLUTAMINE_DEPRIVATION_UP	c2.CGP_ chemical and genetic perturbations	36	1.2300146	0.15384616	0.33459914	PENG_GLUTAMINE_DEPRIVATION_UP	36	0.899105	0.6254296	1	2.1291196	0.3309096
GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP	C7_ immunologic signatures	116	1.230002	0.12639405	0.33454347	GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP	128	1.34718	0.02543235	0.38556537	2.577182	-0.117178
GO_OSTEOBLAST_DIFFERENTIATION	c5.BP_ GO biological process	116	1.2299552	0.11837238	0.33457854	GO_OSTEOBLAST_DIFFERENTIATION	121	-1.1853739	0.06382979	0.3981846	0.0445813	2.4153291
GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP	C7_ immunologic signatures	174	1.2299477	0.09219858	0.33450618	GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP	179	0.7391352	0.96236014	1	1.9690829	0.4908125
ARP1_01	c3.TFT_ transcription factor targets	133	1.2294234	0.08531995	0.3357244	ARP1_01	143	0.7958543	0.8857143	1	2.0252777	0.4335691
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	C7_ immunologic signatures	161	1.2294233	0.098574825	0.33563647	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	166	1.264584	0.05070994	0.4902369	2.4940073	-0.0351607
HUANG_FOXA2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	32	1.2293279	0.18074074	0.33578163	HUANG_FOXA2_TARGETS_DN	33	1.5316116	0.015606242	0.22043215	2.7609395	-0.3022837
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	c2.CGP_ chemical and genetic perturbations	55	1.2292464	0.15546219	0.33589754	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	57	1.2709389	0.1118421	0.4836491	2.5001853	-0.0416925
YEGNASUBRAMANIAN_PROSTATE_CANCER	c2.CGP_ chemical and genetic perturbations	90	1.2291725	0.12353706	0.33599693	YEGNASUBRAMANIAN_PROSTATE_CANCER	99	1.044342	0.41293013	0.8498673	2.2735145	0.1848305
MODULE_537	c4.CM_ cancer modules	15	1.2290276	0.18500797	0.33625564	MODULE_537	16	1.0723779	0.37971392	0.80237335	2.3014055	0.1566497
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN	c5.GO molecular function	21	1.2288218	0.18027735	0.336683	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN	20	1.3390754	0.11278196	0.3968001	2.5678972	-0.1102536
GO_SCF_UBIQUITIN_LIGASE_COMPLEX	c5.CC_ GO cellular component	29	1.2287837	0.17298938	0.33668497	GO_SCF_UBIQUITIN_LIGASE_COMPLEX	30	0.73123056	0.8477218	1	1.96001426	0.49755314
GO_GERM_CELL_DEVELOPMENT	c5.BP_ GO biological process	170	1.2287554	0.089097306	0.33667186	GO_GERM_CELL_DEVELOPMENT	186	1.3812046	0.005050505	0.35655057	2.60996	-0.1524492
DIRMEIER_LMP1_RESPONSE_LATE_UP	c2.CGP_ chemical and genetic perturbations	53	1.2287304	0.16086957	0.33664647	DIRMEIER_LMP1_RESPONSE_LATE_UP	53	-1.311241	0.06382979	0.27326384	-0.0825106	2.5399714
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	c2.CGP_ chemical and genetic perturbations	77	1.2286379	0.13324538	0.33679017	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	82	1.715766	0	0.07168913	2.9444039	-0.4871281
GO_RESPONSE_TO_ESTROGEN	c5.BP_ GO biological process	194	1.2285151	0.0820633	0.33699363	GO_RESPONSE_TO_ESTROGEN	203	1.1163511	0.21586345	0.72888654	2.3448662	0.112164
GSE3982_DC_VS_BCELL_UP	C7_ immunologic signatures	173	1.2284049	0.075669385	0.33718395	GSE3982_DC_VS_BCELL_UP	179	1.2490896	0.05983773	0.51197416	2.4774945	-0.0206847
PID_LYSOPHOSPHOLIPID_PATHWAY	c2.CP_ Canonical pathways	63	1.2280865	0.13691275	0.33789435	PID_LYSOPHOSPHOLIPID_PATHWAY	64	1.1561623	0.21978022	0.6602204	2.3842488	0.0719242
GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP	C7_ immunologic signatures	187	1.228035	0.07913669	0.33794144	GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP	188	-1.0672548	0.4	0.57423	0.1607802	2.2952898
GO_INTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY	c5.GO molecular function	24	1.2279441	0.1854714	0.3380783	GO_INTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY	26	1.3082833	0.12742719	0.42840356	2.5362274	-0.0803392
GO_FACE_DEVELOPMENT	c5.BP_ GO biological process	47	1.2278534	0.16690442	0.33822846	GO_FACE_DEVELOPMENT	49	0.9541593	0.5709382	0.977051	2.1820127	0.2736941
GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION	c5.BP_ GO biological process	52	1.2278512	0.14814815	0.33814538	GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION	54	-1.0385605	0.36263737	0.6247647	0.1892907	2.2664117
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	c2.CGP_ chemical and genetic perturbations	58	1.2278143	0.16234653	0.3381508	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	59	0.78450686	0.83058304	1	2.01232116	0.44330744
REACTOME_SPHINGOLIPID_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	57	1.2277311	0.16619319	0.33827952	REACTOME_SPHINGOLIPID_METABOLISM	58	1.2503798	0.12084257	0.5094003	2.4781109	-0.0226487
GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	184	1.227716	0.07938389	0.33822963	GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	186	1.0819616	0.31048387	0.7837106	2.3096776	0.1457544
GO_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX	c5.CC_ GO cellular component	58	1.2276002	0.14850137	0.33843645	GO_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX	59	0.7192734	0.8920705	1	1.9468736	0.5083268
GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	170	1.2275839	0.08033573	0.33838826	GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	173	1.1577659	0.1691996	0.657633	2.3853498	0.069818
GO_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT	c5.BP_ GO biological process	196	1.2275655	0.08092485	0.3383477	GO_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT	202	0.7900155	0.91935486	1	2.017581	0.43755
GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	175	1.2275597	0.08614668	0.3382746	GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN	175	1.0550119	0.36206895	0.83297545	2.2825716	0.1725478
GO_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE	c5.BP_ GO biological process	153	1.2275469	0.1127451	0.33821887	GO_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE	160	1.1681738	0.16020408	0.6407009	2.3957207	0.0593731
PAX8_B	c3.TFT_ transcription factor targets	89	1.2274551	0.12260536	0.33835834	PAX8_B	89	1.2934735	0.0602537	0.4521084	2.5209286	-0.0660184
GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	170	1.2274181	0.08669834	0.3383716	GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN	173	1.196931	0.11573604	0.59676385	2.4243491	0.0304871
GO_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS	c5.BP_ GO biological process	16	1.2273841	0.19706841	0.3383678	GO_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS	18	0.9380463	0.57992077	0.99271566	2.1654304	0.2893378
GSE27786_LIN_NEG_VS_BCELL_DN	C7_ immunologic signatures	169	1.2273083	0.10600707	0.33848205	GSE27786_LIN_NEG_VS_BCELL_DN	172	1.0539747	0.3674089	0.83547753	2.281283	0.1733336
GO_RESPONSE_TO_INTERFERON_GAMMA	c5.BP_ GO biological process	98	1.227249	0.112676054	0.3385454	GO_RESPONSE_TO_INTERFERON_GAMMA	104	1.098192	0.30331263	0.7590578	2.325441	0.129057
GO_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	62	1.227132	0.1603261	0.33874863	GO_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS	72	0.88846457	0.6768559	1	2.11559657	0.33866743
GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	C7_ immunologic signatures	185	1.2270415	0.0860849	0.33887908	GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	186	0.61818224	0.994929	1	1.84522374	0.60885926
GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN	C7_ immunologic signatures	180	1.2270387	0.09375	0.3387982	GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN	181	1.2270622	0.07358871	0.54642874	2.4541009	-2.35E-05
GO_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY	c5.BP_ GO biological process	17	1.2270341	0.2031746	0.33871996	GO_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY	18	0.6926634	0.86459625	1	1.9196975	0.5343707
KAMMINGA_SENESCENCE	c2.CGP_ chemical and genetic perturbations	36	1.2269572	0.16815476	0.33882007	KAMMINGA_SENESCENCE	38	1.098958	0.34817353	0.7583432	2.3259152	0.1279992
GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP	C7_ immunologic signatures	180	1.2268693	0.09601874	0.33895424	GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP	185	0.79179555	0.9048583	1	2.01866485	0.43507375
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	c2.CGP_ chemical and genetic perturbations	80	1.2268609	0.13648649	0.33888403	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	80	0.9508981	0.5974304	0.9812072	2.177759	0.2759628
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP	C7_ immunologic signatures	156	1.2267425	0.09518072	0.3391046	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP	163	1.2231303	0.08805668	0.5518129	2.4498728	0.0036122
GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN	C7_ immunologic signatures	171	1.2265598	0.085409254	0.3394838	GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN	175	1.1743327	0.14939025	0.63076395	2.4008925	0.0522271
GSE11924_TFH_VS_TH1_CD4_TCELL_UP	C7_ immunologic signatures	182	1.226461	0.08192771	0.33963487	GSE11924_TFH_VS_TH1_CD4_TCELL_UP	185	1.3367814	0.009081735	0.3984823	2.5632424	-0.1103204
GO_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	51	1.2263595	0.15299027	0.3398068	GO_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS	57	0.9921924	0.49833888	0.9335012	2.2185519	0.2341671
GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP	C7_ immunologic signatures	177	1.2262374	0.07608695	0.3400199	GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP	177	0.81391054	0.89616936	1	2.04014794	0.41232686
TAL1BETAE47_01	c3.TFT_ transcription factor targets	212	1.226157	0.07217695	0.34012848	TAL1BETAE47_01	220	1.0400982	0.41323972	0.85912275	2.2662552	0.1860588
ROSS_AML_WITH_AML1_ETO_FUSION	c2.CGP_ chemical and genetic perturbations	64	1.2261338	0.14382632	0.3400964	ROSS_AML_WITH_AML1_ETO_FUSION	66	1.3677396	0.03880266	0.37116256	2.5938734	-0.1416058
KUMAR_TARGETS_OF_MLL_AF9_FUSION	c2.CGP_ chemical and genetic perturbations	348	1.2259613	0.041484717	0.3404354	KUMAR_TARGETS_OF_MLL_AF9_FUSION	357	1.1305825	0.12812813	0.70575297	2.3565438	0.0953788
GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP	C7_ immunologic signatures	122	1.2259129	0.122347064	0.3404651	GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP	132	1.1608468	0.17364658	0.65112126	2.3867597	0.0650661
BORLAK_LIVER_CANCER_EGF_UP	c2.CGP_ chemical and genetic perturbations	51	1.2255703	0.1640058	0.34121194	BORLAK_LIVER_CANCER_EGF_UP	52	0.91217095	0.62486005	1	2.13774125	0.31339935
GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP	C7_ immunologic signatures	154	1.2255694	0.10990338	0.3411256	GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP	157	0.855065	0.78812695	1	2.0806344	0.3705044
GSE360_L_MAJOR_VS_T_GONDII_DC_DN	C7_ immunologic signatures	170	1.2255121	0.100728154	0.34117758	GSE360_L_MAJOR_VS_T_GONDII_DC_DN	176	1.0446959	0.38119313	0.85039794	2.270208	0.1808162
GCTCTTG_MIR335	c3.MIR_ microRNA targets	76	1.2255012	0.13396482	0.34111497	GCTCTTG_MIR335	77	-0.74177754	0.97333336	0.9407288	0.48372366	1.96727874
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN	C7_ immunologic signatures	179	1.2254739	0.07827103	0.3410969	GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN	181	-1.0766082	0	0.55833125	0.1488657	2.3020821
GO_REGULATION_OF_LIPID_CATABOLIC_PROCESS	c5.BP_ GO biological process	43	1.2254455	0.18055555	0.34107977	GO_REGULATION_OF_LIPID_CATABOLIC_PROCESS	47	1.1900704	0.20752566	0.6052492	2.4155159	0.0353751
GO_KIDNEY_MESENCHYME_DEVELOPMENT	c5.BP_ GO biological process	16	1.2253089	0.22468354	0.34134227	GO_KIDNEY_MESENCHYME_DEVELOPMENT	16	-1.6146924	0.016064256	0.086268835	-0.3893835	2.8400013
IVANOVA_HEMATOPOIESIS_MATURE_CELL	c2.CGP_ chemical and genetic perturbations	249	1.2252444	0.06712173	0.34141627	IVANOVA_HEMATOPOIESIS_MATURE_CELL	255	0.8554038	0.8455366	1	2.0806482	0.3698406
GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN	C7_ immunologic signatures	173	1.2252108	0.100354195	0.3414023	GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN	177	1.5167999	0	0.23510174	2.7420107	-0.2915891
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	c2.CGP_ chemical and genetic perturbations	63	1.2251791	0.15966387	0.34139153	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	77	1.179736	0.1874311	0.624401	2.4049151	0.0454431
CHOP_01	c3.TFT_ transcription factor targets	211	1.2251049	0.067857146	0.34148422	CHOP_01	214	0.8638895	0.8106747	1	2.0889944	0.3612154
YAGI_AML_WITH_T_8_21_TRANSLOCATION	c2.CGP_ chemical and genetic perturbations	317	1.2250923	0.07087486	0.3414241	YAGI_AML_WITH_T_8_21_TRANSLOCATION	329	1.0931355	0.21242484	0.7683161	2.3182278	0.1319568
GSE22886_DC_VS_MONOCYTE_DN	C7_ immunologic signatures	159	1.2250885	0.094247244	0.34134626	GSE22886_DC_VS_MONOCYTE_DN	163	1.3928179	0.007106599	0.34857807	2.6179064	-0.1677294
BIOCARTA_TOB1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	1.2250277	0.19462025	0.3414055	BIOCARTA_TOB1_PATHWAY	18	0.86164457	0.66580975	1	2.08667227	0.36338313
GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN	C7_ immunologic signatures	171	1.2249849	0.083737865	0.3414228	GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN	179	1.462466	0	0.28151163	2.6874509	-0.2374811
CHR11Q25	C1: positional gene sets	16	1.224896	0.20385233	0.34157512	CHR11Q25	17	1.0524528	0.41025642	0.8369276	2.2773488	0.1724432
GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	173	1.2248579	0.08928572	0.34157923	GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP	178	1.2173737	0.07971746	0.56139755	2.4422316	0.0074842
GO_REGULATION_OF_EMBRYONIC_DEVELOPMENT	c5.BP_ GO biological process	103	1.2248328	0.12207152	0.3415558	GO_REGULATION_OF_EMBRYONIC_DEVELOPMENT	108	0.95741177	0.5835073	0.97464013	2.18224457	0.26742103
GO_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION	c5.BP_ GO biological process	33	1.2248243	0.18247126	0.3414898	GO_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION	38	-1.3874155	0.033333335	0.21524863	-0.1625912	2.6122398
GO_REGULATION_OF_CATION_CHANNEL_ACTIVITY	c5.BP_ GO biological process	70	1.2247729	0.14789689	0.34153244	GO_REGULATION_OF_CATION_CHANNEL_ACTIVITY	77	1.3171154	0.061555076	0.41511092	2.5418883	-0.0923425
GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	162	1.2247298	0.09673519	0.34155604	GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN	163	1.0845689	0.29208925	0.7782628	2.3092987	0.1401609
RODRIGUES_THYROID_CARCINOMA_DN	c2.CGP_ chemical and genetic perturbations	68	1.2247071	0.15384616	0.34152424	RODRIGUES_THYROID_CARCINOMA_DN	67	1.4508307	0.019758508	0.29179633	2.6755378	-0.2261236
GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN	C7_ immunologic signatures	162	1.2245146	0.083932854	0.341905	GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN	164	1.0212845	0.45731708	0.8905956	2.2457991	0.2032301
GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_DN	C7_ immunologic signatures	160	1.2243279	0.10869565	0.34228948	GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_DN	172	1.0967246	0.2786221	0.76127	2.3210525	0.1276033
GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN	C7_ immunologic signatures	160	1.2241223	0.09404762	0.3427194	GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN	163	1.2732164	0.05386179	0.48200652	2.4973387	-0.0490941
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	c2.CP_REACTOME_ Reactome gene sets	232	1.2241219	0.06422018	0.34263203	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	235	0.6729502	0.989899	1	1.8970721	0.5511717
MILI_PSEUDOPODIA	c2.CGP_ chemical and genetic perturbations	40	1.2241125	0.15879828	0.34256724	MILI_PSEUDOPODIA	40	0.696734	0.91843975	1	1.9208465	0.5273785
CHR16Q24	C1: positional gene sets	65	1.2240554	0.13513513	0.34263116	CHR16Q24	67	1.4435284	0.018438177	0.2984085	2.6675838	-0.219473
BIOCARTA_CXCR4_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	1.2240157	0.19598766	0.34264258	BIOCARTA_CXCR4_PATHWAY	23	1.1576029	0.2797546	0.6580259	2.3816186	0.0664128
GO_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	c5.BP_ GO biological process	31	1.2239136	0.18701701	0.34281245	GO_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	32	1.2405027	0.17804877	0.52538264	2.4644163	-0.0165891
HP1SITEFACTOR_Q6	c3.TFT_ transcription factor targets	197	1.2238665	0.09389672	0.34284374	HP1SITEFACTOR_Q6	205	0.9167022	0.7075377	1	2.1405687	0.3071643
GO_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY	c5.BP_ GO biological process	67	1.2237952	0.164	0.34293634	GO_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY	69	0.99064976	0.51122993	0.9351335	2.21444496	0.23314544
GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP	C7_ immunologic signatures	169	1.2237923	0.086269744	0.34285626	GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP	176	1.0033075	0.49340102	0.9174302	2.2270998	0.2204848
GSE27786_LSK_VS_CD8_TCELL_UP	C7_ immunologic signatures	176	1.2236841	0.096584216	0.34304285	GSE27786_LSK_VS_CD8_TCELL_UP	177	1.0639735	0.337386	0.81581247	2.2876576	0.1597106
AAAGACA_MIR511	c3.MIR_ microRNA targets	176	1.22348	0.08263473	0.3434796	AAAGACA_MIR511	179	0.99164057	0.53333336	0.9339378	2.21512057	0.23183943
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN	C7_ immunologic signatures	180	1.2233665	0.087677725	0.34368587	GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN	182	1.423839	0.001015229	0.31848982	2.6472055	-0.2004725
GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN	C7_ immunologic signatures	162	1.2233562	0.08101572	0.34362173	GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN	164	1.2860352	0.037411526	0.46267477	2.5093914	-0.062679
ACCATTT_MIR522	c3.MIR_ microRNA targets	146	1.2232077	0.12575574	0.34390366	ACCATTT_MIR522	147	0.88046116	0.7612245	1	2.10366886	0.34274654
GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN	C7_ immunologic signatures	149	1.2231839	0.10965435	0.3438727	GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN	150	-1.4033302	0	0.20398958	-0.1801463	2.6265141
GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN	C7_ immunologic signatures	152	1.223174	0.09068924	0.34380984	GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN	155	0.93707025	0.64089525	0.9930034	2.16024425	0.28610375
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	c2.CGP_ chemical and genetic perturbations	140	1.2231612	0.09842041	0.34375444	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	141	1.2311707	0.095580675	0.5380661	2.4543319	-0.0080095
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	C7_ immunologic signatures	183	1.2230918	0.09490741	0.34383932	GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	182	0.9919767	0.546371	0.9334922	2.2150685	0.2311151
VDR_Q3	c3.TFT_ transcription factor targets	196	1.2229817	0.083526686	0.34404323	VDR_Q3	203	0.95137817	0.6185671	0.98054314	2.17435987	0.27160353
GO_TUBE_MORPHOGENESIS	c5.BP_ GO biological process	300	1.2229248	0.047830924	0.34409356	GO_TUBE_MORPHOGENESIS	316	0.9622546	0.62625253	0.9687252	2.1851794	0.2606702
GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	168	1.2229016	0.09375	0.34405577	GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN	171	1.0877632	0.29453442	0.7741783	2.3106648	0.1351384
GNF2_IGF1	c4.CGN_ cancer gene neighborhoods	20	1.2228342	0.18971062	0.34413904	GNF2_IGF1	22	1.5730536	0.010856453	0.18780527	2.7958878	-0.3502194
GSE11818_WT_VS_DICER_KO_TREG_UP	C7_ immunologic signatures	120	1.2227982	0.12062257	0.34414673	GSE11818_WT_VS_DICER_KO_TREG_UP	126	1.3413385	0.021694215	0.39482883	2.5641367	-0.1185403
TAL1BETAITF2_01	c3.TFT_ transcription factor targets	219	1.2227165	0.076744184	0.34425154	TAL1BETAITF2_01	225	1.1474942	0.15338042	0.6727392	2.3702107	0.0752223
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	c2.CGP_ chemical and genetic perturbations	22	1.222543	0.18636364	0.3446224	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	24	1.2855482	0.14875	0.46298525	2.5080912	-0.0630052
GO_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS	c5.BP_ GO biological process	20	1.2222571	0.21493903	0.3452465	GO_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS	22	0.9275847	0.5701754	1	2.1498418	0.2946724
GO_PEPTIDE_HORMONE_PROCESSING	c5.BP_ GO biological process	23	1.222151	0.18309858	0.34541753	GO_PEPTIDE_HORMONE_PROCESSING	28	1.0536594	0.41767555	0.83614725	2.2758104	0.1684916
REACTOME_CTLA4_INHIBITORY_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	20	1.2221452	0.20294599	0.3453456	REACTOME_CTLA4_INHIBITORY_SIGNALING	21	0.59748805	0.9498164	1	1.81963325	0.62465715
GO_UBIQUITIN_LIGASE_COMPLEX	c5.CC_ GO cellular component	239	1.2219675	0.06989853	0.34569317	GO_UBIQUITIN_LIGASE_COMPLEX	243	0.6814856	0.9859155	1	1.9034531	0.5404819
GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN	C7_ immunologic signatures	155	1.2219409	0.09951457	0.3456704	GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN	154	1.2427614	0.07309645	0.5228983	2.4647023	-0.0208205
GO_AXON_CYTOPLASM	c5.CC_ GO cellular component	28	1.2219108	0.18625954	0.3456686	GO_AXON_CYTOPLASM	28	0.81356907	0.7545345	1	2.03547987	0.40834173
GO_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING	c5.GO molecular function	19	1.2219008	0.20379147	0.34560567	GO_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING	19	1.1818309	0.23859191	0.62037116	2.4037317	0.0400699
GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN	C7_ immunologic signatures	171	1.2218891	0.09744214	0.34555018	GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN	174	1.0237945	0.45667687	0.88568205	2.2456836	0.1980946
GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP	C7_ immunologic signatures	179	1.2217644	0.08037825	0.34578067	GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP	182	1.1604066	0.16464646	0.6521774	2.382171	0.0613578
SESTO_RESPONSE_TO_UV_C5	c2.CGP_ chemical and genetic perturbations	45	1.2216159	0.16402878	0.3460669	SESTO_RESPONSE_TO_UV_C5	45	1.1188786	0.3089245	0.7245909	2.3404945	0.1027373
KAYO_CALORIE_RESTRICTION_MUSCLE_UP	c2.CGP_ chemical and genetic perturbations	85	1.2216083	0.14896373	0.34599665	KAYO_CALORIE_RESTRICTION_MUSCLE_UP	88	0.9226695	0.6292017	1	2.1442778	0.2989388
GO_PATTERN_SPECIFICATION_PROCESS	c5.BP_ GO biological process	367	1.2215283	0.04077253	0.34609553	GO_PATTERN_SPECIFICATION_PROCESS	404	1.0258734	0.4194194	0.8831098	2.2474017	0.1956549
GO_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT	c5.BP_ GO biological process	24	1.2215066	0.20579268	0.34606597	GO_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT	25	1.1144141	0.32014832	0.73145485	2.3359207	0.1070925
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	171	1.2214504	0.09927361	0.346113	GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP	174	1.1217978	0.20525783	0.72240925	2.3432482	0.0996526
SIRNA_EIF4GI_DN	C6_ oncogenic signatures	80	1.2214373	0.13688213	0.34605742	SIRNA_EIF4GI_DN	81	-1.3902124	0.016393442	0.2141839	-0.1687751	2.6116497
GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	C7_ immunologic signatures	182	1.2212683	0.07593458	0.3463829	GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	183	1.2773248	0.037260827	0.47615656	2.4985931	-0.0560565
GO_RESPONSE_TO_HYDROGEN_PEROXIDE	c5.BP_ GO biological process	101	1.2211715	0.11942257	0.34653857	GO_RESPONSE_TO_HYDROGEN_PEROXIDE	104	0.9294766	0.63097715	0.99905723	2.1506481	0.2916949
GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP	C7_ immunologic signatures	172	1.2211583	0.09367397	0.34648338	GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP	175	1.1362392	0.2165992	0.69600654	2.3573975	0.0849191
GSE6269_FLU_VS_E_COLI_INF_PBMC_UP	C7_ immunologic signatures	139	1.2211312	0.09873418	0.34646583	GSE6269_FLU_VS_E_COLI_INF_PBMC_UP	138	0.96851075	0.5740741	0.9628208	2.18964195	0.25262045
GO_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS	c5.BP_ GO biological process	160	1.2210411	0.10501193	0.3466157	GO_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS	165	0.8623517	0.78622085	1	2.0833928	0.3586894
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP	C7_ immunologic signatures	159	1.220977	0.09179927	0.34669748	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP	165	1.0118178	0.48426396	0.90421456	2.2327948	0.2091592
GO_RESPONSE_TO_FATTY_ACID	c5.BP_ GO biological process	69	1.220952	0.1438172	0.34666088	GO_RESPONSE_TO_FATTY_ACID	78	1.1791526	0.18565401	0.62360775	2.4001046	0.0417994
GO_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL	c5.BP_ GO biological process	29	1.2209502	0.20543806	0.34657854	GO_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL	32	1.5166922	0.013142174	0.23469877	2.7376424	-0.295742
GO_RESPONSE_TO_IRON_ION	c5.BP_ GO biological process	30	1.2209401	0.18960245	0.34651387	GO_RESPONSE_TO_IRON_ION	34	1.3799758	0.0661157	0.3568095	2.6009159	-0.1590357
GO_CELL_CELL_ADHERENS_JUNCTION	c5.CC_ GO cellular component	45	1.2208931	0.18103448	0.34654972	GO_CELL_CELL_ADHERENS_JUNCTION	47	1.2406176	0.15263748	0.5250597	2.4615107	-0.0197245
GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP	C7_ immunologic signatures	158	1.2207597	0.10948905	0.3467981	GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP	177	1.3878576	0.004052685	0.34792146	2.6086173	-0.1670979
GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP	C7_ immunologic signatures	177	1.2207009	0.095794395	0.3468572	GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP	178	1.0465982	0.3846154	0.8455796	2.2672991	0.1741027
GO_NEGATIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS	c5.BP_ GO biological process	114	1.2206285	0.11360799	0.3469497	GO_NEGATIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS	120	0.9113624	0.6824255	1	2.1319909	0.3092661
KAUFFMANN_DNA_REPLICATION_GENES	c2.CGP_ chemical and genetic perturbations	133	1.220541	0.116770186	0.34708744	KAUFFMANN_DNA_REPLICATION_GENES	133	-1.6763153	0	0.06328809	-0.4557743	2.8968563
GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	C7_ immunologic signatures	165	1.2204487	0.10604192	0.34723327	GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	170	1.3483688	0.010080645	0.38333926	2.5688175	-0.1279201
GSE14308_TH17_VS_INDUCED_TREG_UP	C7_ immunologic signatures	180	1.2203898	0.08502994	0.34730187	GSE14308_TH17_VS_INDUCED_TREG_UP	182	0.70916104	0.96044624	1	1.92955084	0.51122876
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP	C7_ immunologic signatures	171	1.2203065	0.099765256	0.34743494	GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP	176	1.0545268	0.36150712	0.8339443	2.2748333	0.1657797
EVI1_06	c3.TFT_ transcription factor targets	17	1.2203003	0.19417475	0.34736088	EVI1_06	19	0.64484495	0.9119898	1	1.86514525	0.57545535
MODULE_207	c4.CM_ cancer modules	190	1.2202895	0.08092485	0.3472976	MODULE_207	198	1.1274935	0.19475277	0.7103403	2.347783	0.092796
NKX3A_01	c3.TFT_ transcription factor targets	183	1.2201117	0.10161663	0.34766823	NKX3A_01	197	-0.95231324	0.7	0.75358087	0.26779846	2.17242494
AP2_Q6	c3.TFT_ transcription factor targets	237	1.2199061	0.09090909	0.34809655	AP2_Q6	241	0.6904609	0.98493975	1	1.910367	0.5294452
GO_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	79	1.2198498	0.14535666	0.3481472	GO_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	80	-0.91562843	0.66101694	0.80148673	0.30422137	2.13547823
GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN	C7_ immunologic signatures	163	1.2195947	0.09375	0.3486949	GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN	164	1.0986146	0.27466938	0.7588343	2.3182093	0.1209801
GSE13229_IMM_VS_MATURE_NKCELL_DN	C7_ immunologic signatures	173	1.2194265	0.108043216	0.34903905	GSE13229_IMM_VS_MATURE_NKCELL_DN	176	1.0371693	0.41354904	0.8639169	2.2565958	0.1822572
REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS	c2.CP_REACTOME_ Reactome gene sets	44	1.219415	0.171875	0.34898648	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS	47	-1.2472185	0.094339624	0.3261315	-0.0278035	2.4666335
COLDREN_GEFITINIB_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	188	1.2192886	0.088474974	0.34921357	COLDREN_GEFITINIB_RESISTANCE_DN	197	1.6454974	0	0.12012673	2.864786	-0.4262088
GATA1_02	c3.TFT_ transcription factor targets	207	1.2190495	0.073903	0.3497353	GATA1_02	217	1.1623746	0.13393757	0.64944863	2.3814241	0.0566749
GO_PRESYNAPTIC_PROCESS_INVOLVED_IN_SYNAPTIC_TRANSMISSION	c5.BP_ GO biological process	103	1.219006	0.14321607	0.34976357	GO_PRESYNAPTIC_PROCESS_INVOLVED_IN_SYNAPTIC_TRANSMISSION	107	1.219992	0.1138976	0.5553758	2.438998	-0.000986
NKX62_Q2	c3.TFT_ transcription factor targets	207	1.2189996	0.088992976	0.34969074	NKX62_Q2	217	1.1681173	0.11334002	0.6406238	2.3871169	0.0508823
GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN	C7_ immunologic signatures	171	1.2189931	0.10735123	0.34961903	GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN	172	0.8511962	0.82626265	1	2.0701893	0.3677969
GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS	c5.BP_ GO biological process	237	1.2188914	0.08108108	0.3497891	GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS	244	1.0714524	0.31658292	0.8027405	2.2903438	0.147439
BIOCARTA_INTEGRIN_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	38	1.2188816	0.1923077	0.34972546	BIOCARTA_INTEGRIN_PATHWAY	38	0.7194723	0.88783944	1	1.9383539	0.4994093
GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN	C7_ immunologic signatures	170	1.2186675	0.09047619	0.35016778	GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN	179	1.1380345	0.19817998	0.69382143	2.356702	0.080633
RNTCANNRNNYNATTW_UNKNOWN	c3.TFT_ transcription factor targets	53	1.2186223	0.15895954	0.35019085	RNTCANNRNNYNATTW_UNKNOWN	59	0.93212134	0.62222224	0.9977119	2.15074364	0.28650096
GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	C7_ immunologic signatures	172	1.2185881	0.10232558	0.35018712	GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	179	1.0777181	0.32897383	0.7915319	2.2963062	0.14087
GO_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY	c5.BP_ GO biological process	30	1.2184861	0.17522658	0.3503613	GO_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY	33	1.4057184	0.051682692	0.33291823	2.6242045	-0.1872323
GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	159	1.2184845	0.0942029	0.35027713	GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN	170	0.97145337	0.57594293	0.96011245	2.18993787	0.24703113
GO_CELL_BODY	c5.CC_ GO cellular component	440	1.2184613	0.04144527	0.35024518	GO_CELL_BODY	464	1.132642	0.091	0.70182896	2.3511033	0.0858193
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	c2.CGP_ chemical and genetic perturbations	198	1.2184442	0.07602339	0.350203	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	204	1.6227745	0	0.13876969	2.8412187	-0.4043303
GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP	C7_ immunologic signatures	168	1.218343	0.105450235	0.35036984	GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP	175	0.90737134	0.72239107	1	2.12571434	0.31097166
GO_ENDOCARDIAL_CUSHION_DEVELOPMENT	c5.BP_ GO biological process	32	1.2183137	0.1908397	0.3503511	GO_ENDOCARDIAL_CUSHION_DEVELOPMENT	32	1.0766562	0.35689047	0.7941774	2.2949699	0.1416575
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	c2.CGP_ chemical and genetic perturbations	57	1.2183061	0.15767635	0.35028267	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	57	0.67968976	0.93281937	1	1.89799586	0.53861634
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP	C7_ immunologic signatures	176	1.2181908	0.09976247	0.3504967	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP	179	1.3923872	0.005035247	0.34856844	2.610578	-0.1741964
GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN	C7_ immunologic signatures	162	1.2181395	0.11070111	0.3505476	GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN	170	1.1191674	0.23154701	0.72375053	2.3373069	0.0989721
GO_INTEGRIN_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	75	1.2180376	0.17222963	0.35072675	GO_INTEGRIN_MEDIATED_SIGNALING_PATHWAY	78	1.1671594	0.22470714	0.6419329	2.385197	0.0508782
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	c2.CP_REACTOME_ Reactome gene sets	41	1.2179542	0.17231223	0.35085368	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	47	0.84894323	0.729638	1	2.06689743	0.36901097
GO_UROGENITAL_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	277	1.217934	0.06881243	0.35082152	GO_UROGENITAL_SYSTEM_DEVELOPMENT	287	0.9761933	0.55611223	0.95407003	2.1941273	0.2417407
ISSAEVA_MLL2_TARGETS	c2.CGP_ chemical and genetic perturbations	49	1.2179288	0.1594203	0.3507481	ISSAEVA_MLL2_TARGETS	53	1.0821877	0.33668903	0.7834391	2.3001165	0.1357411
GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	C7_ immunologic signatures	154	1.2179235	0.09963548	0.3506698	GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	157	1.2903521	0.031664964	0.4572411	2.5082756	-0.0724286
GO_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING	c5.GO molecular function	28	1.2178347	0.20642202	0.35081515	GO_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING	28	1.263638	0.15821256	0.49132216	2.4814727	-0.0458033
GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN	C7_ immunologic signatures	156	1.217779	0.099759616	0.35086656	GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN	164	1.4363062	0.002024292	0.30959025	2.6540852	-0.2185272
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	115	1.2177702	0.12612613	0.35079822	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN	138	1.2006376	0.11225541	0.59141016	2.4184078	0.0171326
GO_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT	c5.BP_ GO biological process	107	1.2175984	0.13770914	0.3511363	GO_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT	113	0.81955415	0.8199792	1	2.03715255	0.39804425
GO_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY	c5.GO molecular function	66	1.2175791	0.14722222	0.3510974	GO_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY	69	1.0648865	0.38841203	0.814335	2.2824656	0.1526926
GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN	C7_ immunologic signatures	183	1.2175541	0.094497606	0.3510676	GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN	185	1.058791	0.3619818	0.82657903	2.2763451	0.1587631
GSE7852_LN_VS_FAT_TCONV_DN	C7_ immunologic signatures	180	1.2174342	0.08994083	0.35126677	GSE7852_LN_VS_FAT_TCONV_DN	183	0.7230234	0.9605662	1	1.9404576	0.4944108
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN	C7_ immunologic signatures	172	1.2171934	0.09879518	0.35177064	GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN	176	0.99906754	0.5076142	0.92463404	2.21626094	0.21812586
KRAS.AMP.LUNG_UP.V1_DN	C6_ oncogenic signatures	104	1.217152	0.13468869	0.35178044	KRAS.AMP.LUNG_UP.V1_DN	115	1.3507036	0.023662552	0.38409293	2.5678556	-0.1335516
GCNP_SHH_UP_EARLY.V1_UP	C6_ oncogenic signatures	151	1.2171407	0.100728154	0.35172227	GCNP_SHH_UP_EARLY.V1_UP	155	0.85288066	0.805726	1	2.07002136	0.36426004
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	c2.CGP_ chemical and genetic perturbations	41	1.2171133	0.18678162	0.35170424	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	45	0.6940464	0.89988357	1	1.9111597	0.5230669
GO_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS	c5.BP_ GO biological process	170	1.2170855	0.11666667	0.351691	GO_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS	171	0.8928509	0.7553084	1	2.1099364	0.3242346
GSE13229_MATURE_VS_INTMATURE_NKCELL_UP	C7_ immunologic signatures	153	1.2170836	0.099520385	0.3516062	GSE13229_MATURE_VS_INTMATURE_NKCELL_UP	169	1.1624767	0.15885948	0.6495102	2.3795603	0.0546069
CHR12P13	C1: positional gene sets	120	1.2170831	0.12625	0.35152084	CHR12P13	127	1.2715042	0.0731205	0.48313195	2.4885873	-0.0544211
ST_GA12_PATHWAY	c2.CP_ Canonical pathways	21	1.2170296	0.20980091	0.35157245	ST_GA12_PATHWAY	23	0.9134804	0.6132191	1	2.13051	0.3035492
GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	C7_ immunologic signatures	175	1.2169226	0.1043578	0.35175815	GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	180	1.2215377	0.077935226	0.55353725	2.4384603	-0.0046151
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE	c2.CP_REACTOME_ Reactome gene sets	81	1.2168103	0.15265201	0.35195285	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE	82	0.69399816	0.95614976	1	1.91080846	0.52281214
ZHAN_MULTIPLE_MYELOMA_LB_UP	c2.CGP_ chemical and genetic perturbations	37	1.2164152	0.18405797	0.3528954	ZHAN_MULTIPLE_MYELOMA_LB_UP	38	1.1801175	0.21271676	0.62353617	2.3965327	0.0362977
GO_REGULATION_OF_RENAL_SYSTEM_PROCESS	c5.BP_ GO biological process	30	1.2163817	0.17878787	0.3528909	GO_REGULATION_OF_RENAL_SYSTEM_PROCESS	34	1.2597373	0.14051522	0.4967329	2.476119	-0.0433556
GSE14308_TH1_VS_INDUCED_TREG_UP	C7_ immunologic signatures	182	1.2163414	0.10431655	0.3528965	GSE14308_TH1_VS_INDUCED_TREG_UP	179	0.99110603	0.5096447	0.9342562	2.20744743	0.22523537
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	c2.CGP_ chemical and genetic perturbations	40	1.2162831	0.17559524	0.35295177	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	42	1.0985465	0.32466063	0.7583558	2.3148296	0.1177366
GO_PROTEIN_DNA_COMPLEX	c5.CC_ GO cellular component	114	1.216185	0.12117347	0.3531189	GO_PROTEIN_DNA_COMPLEX	115	1.0182984	0.45171338	0.8924587	2.2344834	0.1978866
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	141	1.2161685	0.10676157	0.3530734	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP	147	1.3366848	0.023445465	0.39797866	2.5528533	-0.1205163
GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN	C7_ immunologic signatures	175	1.2159524	0.11298077	0.35351908	GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN	182	1.0671707	0.3481332	0.81078506	2.2831231	0.1487817
GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP	C7_ immunologic signatures	172	1.2158169	0.090368606	0.3537729	GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP	174	1.0347563	0.42366025	0.8681004	2.2505732	0.1810606
GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN	C7_ immunologic signatures	175	1.2156651	0.10232558	0.35408443	GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN	176	1.0779915	0.32218844	0.79153484	2.2936566	0.1376736
GO_METANEPHRIC_NEPHRON_DEVELOPMENT	c5.BP_ GO biological process	30	1.2156556	0.18345864	0.35401905	GO_METANEPHRIC_NEPHRON_DEVELOPMENT	31	0.78364426	0.7822014	1	1.99929986	0.43201134
GO_ENDONUCLEASE_ACTIVITY	c5.GO molecular function	104	1.2156193	0.13366961	0.35402998	GO_ENDONUCLEASE_ACTIVITY	108	0.6316772	0.98219895	1	1.8472965	0.5839421
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	c2.CGP_ chemical and genetic perturbations	22	1.2155491	0.18018018	0.35412085	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	27	1.2764626	0.1419598	0.4785798	2.4920117	-0.0609135
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	c2.CGP_ chemical and genetic perturbations	76	1.215541	0.14972527	0.35405383	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	76	1.339944	0.038751345	0.3968273	2.555485	-0.124403
GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP	C7_ immunologic signatures	150	1.2155331	0.09587379	0.353983	GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP	156	0.8785678	0.7743902	1	2.0941009	0.3369653
GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP	C7_ immunologic signatures	185	1.2154688	0.0971564	0.35405546	GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP	186	0.75077957	0.9354839	1	1.96624837	0.46468923
GO_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS	c5.BP_ GO biological process	33	1.2154152	0.18731989	0.35409537	GO_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS	34	1.0657873	0.39691943	0.81272763	2.2812025	0.1496279
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP	C7_ immunologic signatures	178	1.2154125	0.099520385	0.3540138	GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP	181	1.2121118	0.08997955	0.5743135	2.4275243	0.0033007
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	c2.CGP_ chemical and genetic perturbations	144	1.2153394	0.11771844	0.35410666	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	151	1.13122	0.23751274	0.704626	2.3465594	0.0841194
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	c2.CGP_ chemical and genetic perturbations	120	1.2153169	0.13065326	0.35408103	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	122	0.7570262	0.91041666	1	1.9723431	0.4582907
GSE27786_NKTCELL_VS_MONO_MAC_DN	C7_ immunologic signatures	180	1.2150486	0.08948005	0.35468847	GSE27786_NKTCELL_VS_MONO_MAC_DN	188	0.7247227	0.95647776	1	1.9397713	0.4903259
ATATGCA_MIR448	c3.MIR_ microRNA targets	194	1.2148523	0.09237875	0.355101	ATATGCA_MIR448	201	0.9979838	0.4974722	0.92574567	2.2128361	0.2168685
HOXA9_DN.V1_UP	C6_ oncogenic signatures	158	1.2147474	0.10974106	0.35527468	HOXA9_DN.V1_UP	160	1.3311794	0.015182186	0.40029687	2.5459268	-0.116432
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP	C7_ immunologic signatures	172	1.2147053	0.098914355	0.35529214	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP	171	1.3051747	0.027355623	0.43377084	2.51988	-0.0904694
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	c2.CP_REACTOME_ Reactome gene sets	23	1.2145768	0.19019316	0.35554093	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	23	1.2633613	0.14593908	0.49203762	2.4779381	-0.0487845
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP	C7_ immunologic signatures	163	1.2145467	0.11401425	0.3555265	GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP	164	1.2840806	0.035460994	0.46566543	2.4986273	-0.0695339
GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	139	1.2145448	0.11083744	0.35544226	GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP	143	1.4281149	0.001019368	0.31804895	2.6426597	-0.2135701
GO_MYELOID_CELL_DIFFERENTIATION	c5.BP_ GO biological process	168	1.2144578	0.10726643	0.3555784	GO_MYELOID_CELL_DIFFERENTIATION	170	0.9664067	0.5884732	0.9645996	2.1808645	0.2480511
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	c2.CGP_ chemical and genetic perturbations	72	1.2143291	0.13528591	0.35582033	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	72	1.010933	0.48449197	0.90590996	2.2252621	0.2033961
GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP	C7_ immunologic signatures	181	1.2142192	0.11002445	0.35601386	GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP	181	0.81113064	0.8794326	1	2.02534984	0.40308856
GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP	C7_ immunologic signatures	152	1.214093	0.108076006	0.35625672	GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP	155	1.4794873	0	0.26998684	2.6935803	-0.2653943
GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP	C7_ immunologic signatures	178	1.214066	0.10874704	0.3562353	GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP	180	1.209308	0.10623085	0.5779149	2.423374	0.004758
GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN	C7_ immunologic signatures	160	1.2139326	0.11311673	0.35648704	GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN	161	0.8705919	0.76821864	1	2.0845245	0.3433407
LIAO_HAVE_SOX4_BINDING_SITES	c2.CGP_ chemical and genetic perturbations	39	1.2139231	0.1744186	0.3564249	LIAO_HAVE_SOX4_BINDING_SITES	40	1.1215141	0.2990762	0.7220856	2.3354372	0.092409
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	c2.CGP_ chemical and genetic perturbations	80	1.2138911	0.15039578	0.35643065	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	82	0.96600074	0.55	0.9647837	2.17989184	0.24789036
BIOCARTA_CDMAC_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	1.213715	0.20645161	0.35680923	BIOCARTA_CDMAC_PATHWAY	15	0.9395363	0.561039	0.9902365	2.1532513	0.2741787
ODONNELL_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	64	1.2136939	0.15353805	0.3567748	ODONNELL_METASTASIS_UP	68	1.4267254	0.018338727	0.318143	2.6404193	-0.2130315
GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN	C7_ immunologic signatures	177	1.2136829	0.10798122	0.35671487	GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN	176	1.0641354	0.34444445	0.8155459	2.2778183	0.1495475
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	c2.CGP_ chemical and genetic perturbations	139	1.2136713	0.1202454	0.356655	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	151	1.3264047	0.022564102	0.40570414	2.540076	-0.1127334
GO_MALE_SEX_DIFFERENTIATION	c5.BP_ GO biological process	126	1.2135386	0.12484237	0.35690087	GO_MALE_SEX_DIFFERENTIATION	135	0.83395797	0.8300313	1	2.04749657	0.37958063
GO_REGULATION_OF_VASOCONSTRICTION	c5.BP_ GO biological process	51	1.2135092	0.15826331	0.35688823	GO_REGULATION_OF_VASOCONSTRICTION	61	1.3954902	0.02967033	0.3465765	2.6089994	-0.181981
GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN	C7_ immunologic signatures	178	1.2134842	0.10059172	0.3568617	GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN	179	0.65871346	0.9827935	1	1.87219766	0.55477074
GSE13306_TREG_VS_TCONV_UP	C7_ immunologic signatures	170	1.2134675	0.098341234	0.35681257	GSE13306_TREG_VS_TCONV_UP	175	1.3120236	0.02929293	0.42235985	2.5254911	-0.0985561
GTGGGTGK_UNKNOWN	c3.TFT_ transcription factor targets	245	1.2134143	0.084937714	0.3568614	GTGGGTGK_UNKNOWN	258	0.94065154	0.67168677	0.98969483	2.15406584	0.27276276
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	c2.CGP_ chemical and genetic perturbations	142	1.2132735	0.10844893	0.35712865	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	146	1.2725472	0.056237217	0.48220977	2.4858207	-0.0592737
LEE_RECENT_THYMIC_EMIGRANT	c2.CGP_ chemical and genetic perturbations	187	1.2131574	0.1024735	0.35734475	LEE_RECENT_THYMIC_EMIGRANT	191	0.9500407	0.6292929	0.9819602	2.1631981	0.2631167
MYC_UP.V1_DN	C6_ oncogenic signatures	129	1.213103	0.11380145	0.35739034	MYC_UP.V1_DN	133	1.3913686	0.012383901	0.34680277	2.6044716	-0.1782656
GO_FIBRONECTIN_BINDING	c5.GO molecular function	23	1.2128965	0.190625	0.357848	GO_FIBRONECTIN_BINDING	25	1.4729185	0.029655991	0.27619672	2.685815	-0.260022
GO_DNA_REPAIR_COMPLEX	c5.CC_ GO cellular component	36	1.2127264	0.18705036	0.35820633	GO_DNA_REPAIR_COMPLEX	36	0.63428885	0.9357477	1	1.84701525	0.57843755
GTGCAAA_MIR507	c3.MIR_ microRNA targets	115	1.2126946	0.13409962	0.35819188	GTGCAAA_MIR507	119	0.79748535	0.89375	1	2.01017995	0.41520925
GO_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	24	1.2126878	0.19319938	0.35812378	GO_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY	24	1.6652101	0.007326007	0.09860622	2.8778979	-0.4525223
GO_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	51	1.212508	0.1649783	0.358489	GO_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	54	0.9259751	0.62863535	1	2.1384831	0.2865329
GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN	C7_ immunologic signatures	154	1.2124565	0.11311673	0.35853764	GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN	153	1.2477827	0.053752534	0.5144356	2.4602392	-0.0353262
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP	C7_ immunologic signatures	179	1.2123965	0.0936019	0.35860673	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP	183	1.0042535	0.4914401	0.91680837	2.21665	0.208143
GO_TISSUE_HOMEOSTASIS	c5.BP_ GO biological process	141	1.2123718	0.11178615	0.3585847	GO_TISSUE_HOMEOSTASIS	146	1.1072737	0.2532928	0.7425527	2.3196455	0.1050981
NAKAYAMA_FGF2_TARGETS	c2.CGP_ chemical and genetic perturbations	27	1.2122986	0.19604863	0.35866836	NAKAYAMA_FGF2_TARGETS	28	-0.9043476	0.61202186	0.81530315	0.307951	2.1166462
GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN	C7_ immunologic signatures	160	1.2122978	0.109987356	0.3585826	GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN	165	1.414047	0.00203252	0.32405362	2.6263448	-0.2017492
KEGG_TYPE_II_DIABETES_MELLITUS	c2.CP_BIOCARTA_ BioCarta gene sets	41	1.212263	0.18803419	0.3585862	KEGG_TYPE_II_DIABETES_MELLITUS	45	0.96806586	0.5508083	0.9638284	2.18032886	0.24419714
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	C7_ immunologic signatures	155	1.2121934	0.102657005	0.35867667	GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	165	1.0473901	0.37931034	0.8445099	2.2595835	0.1648033
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN	C7_ immunologic signatures	127	1.2121211	0.1358173	0.35877636	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN	136	0.9982497	0.49948928	0.9258407	2.2103708	0.2138714
GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN	C7_ immunologic signatures	180	1.212029	0.09638554	0.35892335	GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN	187	0.9532119	0.5989899	0.97810966	2.1652409	0.2588171
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	c2.CP_REACTOME_ Reactome gene sets	168	1.2119457	0.11111111	0.359036	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	181	1.207278	0.10050762	0.5806883	2.4192237	0.0046677
GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN	C7_ immunologic signatures	181	1.2119187	0.09569378	0.35901606	GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN	181	0.92392164	0.6720648	1	2.13584034	0.28799706
RAMASWAMY_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	55	1.2119159	0.16643742	0.35893452	RAMASWAMY_METASTASIS_DN	58	1.1419412	0.26086956	0.6869305	2.3538571	0.0699747
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	c2.CGP_ chemical and genetic perturbations	51	1.2118095	0.17027417	0.35912955	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	51	1.6231055	0.003393665	0.1390829	2.834915	-0.411296
GGATTA_PITX2_Q2	c3.TFT_ transcription factor targets	490	1.2117559	0.045833334	0.35918587	GGATTA_PITX2_Q2	490	0	0	0	1.2117559	1.2117559
MODULE_358	c4.CM_ cancer modules	71	1.2117333	0.12516823	0.35914952	MODULE_358	72	-0.94883263	0.71666664	0.7579493	0.26290067	2.16056593
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN	C7_ immunologic signatures	108	1.2117211	0.14686248	0.35909572	GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN	117	1.1772544	0.16718267	0.6269413	2.3889755	0.0344667
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP	c2.CGP_ chemical and genetic perturbations	40	1.2116601	0.18168604	0.3591627	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP	45	0.7960182	0.7918552	1	2.0076783	0.4156419
GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN	C7_ immunologic signatures	162	1.2116244	0.11933174	0.3591571	GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN	165	1.1721344	0.16106014	0.6343074	2.3837588	0.03949
PBX1_02	c3.TFT_ transcription factor targets	106	1.2116203	0.13021491	0.359078	PBX1_02	110	1.0955101	0.32817337	0.7641544	2.3071304	0.1161102
GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	C7_ immunologic signatures	109	1.2115966	0.13274336	0.35905117	GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	122	0.98597896	0.52680415	0.9407827	2.19757556	0.22561764
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN	C7_ immunologic signatures	77	1.211477	0.14071038	0.3592692	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN	82	1.5390695	0.003198294	0.21119459	2.7505465	-0.3275925
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP	C7_ immunologic signatures	160	1.2114111	0.10059172	0.3593467	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP	175	1.2165525	0.07467205	0.56332445	2.4279636	-0.0051414
GO_CHONDROCYTE_DEVELOPMENT	c5.BP_ GO biological process	20	1.2113783	0.21774194	0.35933867	GO_CHONDROCYTE_DEVELOPMENT	21	1.3757799	0.07954545	0.35751915	2.5871582	-0.1644016
GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN	C7_ immunologic signatures	155	1.2113655	0.1094711	0.35928804	GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN	160	1.4262835	0.002034588	0.31868458	2.637649	-0.214918
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	c2.CGP_ chemical and genetic perturbations	82	1.2113307	0.16010499	0.3592885	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	84	0.77837706	0.85959274	1	1.98970776	0.43295364
BIOCARTA_UCALPAIN_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	1.2112427	0.2016	0.35943875	BIOCARTA_UCALPAIN_PATHWAY	18	0.90811867	0.6070496	1	2.11936137	0.30312403
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	c2.CP_BIOCARTA_ BioCarta gene sets	199	1.211206	0.0952381	0.35943782	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	202	1.0139736	0.46875	0.89983946	2.2251796	0.1972324
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	c2.CGP_ chemical and genetic perturbations	78	1.21115	0.15290934	0.3594895	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	86	1.4192923	0.014023732	0.31995955	2.6304423	-0.2081423
GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	140	1.2109774	0.11421628	0.35983834	GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP	143	1.1261322	0.22233607	0.7120759	2.3371096	0.0848452
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN	C7_ immunologic signatures	123	1.2109538	0.13440198	0.3598093	GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN	129	1.3742353	0.022610484	0.36021337	2.5851891	-0.1632815
PBX1_01	c3.TFT_ transcription factor targets	204	1.2107669	0.079768784	0.36018714	PBX1_01	213	1.0778048	0.27081245	0.7917583	2.2885717	0.1329621
WILLIAMS_ESR2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	25	1.2106872	0.17874396	0.3603143	WILLIAMS_ESR2_TARGETS_UP	25	1.3324934	0.08957055	0.39982808	2.5431806	-0.1218062
MCGOWAN_RSP6_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	17	1.2106813	0.22943038	0.36023903	MCGOWAN_RSP6_TARGETS_UP	18	1.8300859	0	0.026498932	3.0407672	-0.6194046
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN	C7_ immunologic signatures	161	1.210627	0.09879518	0.36029056	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN	167	1.2411257	0.06484296	0.5240715	2.4517527	-0.0304987
GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN	C7_ immunologic signatures	174	1.2106019	0.105076745	0.36026475	GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN	177	0.76359886	0.94822335	1	1.97420076	0.44700304
NKX61_01	c3.TFT_ transcription factor targets	199	1.2105709	0.08705882	0.3602594	NKX61_01	212	0.93002915	0.6878147	0.9991833	2.14060005	0.28054175
GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN	C7_ immunologic signatures	175	1.2105069	0.07757576	0.3603374	GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN	180	1.1083663	0.24239351	0.7409827	2.3188732	0.1021406
GO_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY	c5.BP_ GO biological process	186	1.2105019	0.09440559	0.3602642	GO_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY	192	1.3172228	0.017206477	0.41522428	2.5277247	-0.1067209
JISON_SICKLE_CELL_DISEASE_UP	c2.CGP_ chemical and genetic perturbations	155	1.2104983	0.1202454	0.3601851	JISON_SICKLE_CELL_DISEASE_UP	159	0.98321605	0.5460993	0.94399583	2.19371435	0.22728225
GO_POTASSIUM_ION_IMPORT	c5.BP_ GO biological process	25	1.2104945	0.20430107	0.36010614	GO_POTASSIUM_ION_IMPORT	29	0.8308866	0.69489413	1	2.0413811	0.3796079
GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	168	1.2101897	0.11084906	0.36080587	GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	167	1.0294925	0.44467005	0.87594163	2.2396822	0.1806972
GO_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS	c5.BP_ GO biological process	90	1.2101458	0.13659793	0.36083397	GO_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS	86	0.8872846	0.6973262	1	2.0974304	0.3228612
GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN	C7_ immunologic signatures	132	1.2101337	0.11318408	0.3607837	GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN	145	0.8494388	0.8118006	1	2.0595725	0.3606949
GSE10325_CD4_TCELL_VS_BCELL_UP	C7_ immunologic signatures	174	1.2101303	0.09472422	0.3607044	GSE10325_CD4_TCELL_VS_BCELL_UP	179	1.2342353	0.06281661	0.53468794	2.4443656	-0.024105
GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP	C7_ immunologic signatures	155	1.2097754	0.10840438	0.36153668	GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP	172	1.1902581	0.11812627	0.60590434	2.4000335	0.0195173
GO_PALATE_DEVELOPMENT	c5.BP_ GO biological process	78	1.2097173	0.1378866	0.36159575	GO_PALATE_DEVELOPMENT	83	-1.1658964	0.1632653	0.42269975	0.0438209	2.3756137
GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP	C7_ immunologic signatures	135	1.2097093	0.12125	0.36152506	GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP	136	1.1130704	0.2631038	0.7330119	2.3227797	0.0966389
GO_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	16	1.2096565	0.22442244	0.3615794	GO_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION	17	-0.9602199	0.52093023	0.74242854	0.2494366	2.1698764
GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN	C7_ immunologic signatures	168	1.2096139	0.10235294	0.36159983	GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN	174	1.3902408	0.004048583	0.34526008	2.5998547	-0.1806269
GO_PALLIUM_DEVELOPMENT	c5.BP_ GO biological process	140	1.209552	0.10771114	0.36166567	GO_PALLIUM_DEVELOPMENT	149	0.9697939	0.58290946	0.9615209	2.1793459	0.2397581
GSE25087_FETAL_VS_ADULT_TCONV_DN	C7_ immunologic signatures	142	1.2095435	0.12177122	0.36159655	GSE25087_FETAL_VS_ADULT_TCONV_DN	143	1.0470802	0.38900203	0.844817	2.2566237	0.1624633
GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN	C7_ immunologic signatures	108	1.2094567	0.124528304	0.36173725	GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN	119	1.3296471	0.032955717	0.40298703	2.5391038	-0.1201904
GSE27786_NKTCELL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	179	1.2093621	0.12412178	0.3619039	GSE27786_NKTCELL_VS_NEUTROPHIL_DN	187	1.0888205	0.29334676	0.77308863	2.2981826	0.1205416
GO_POSITIVE_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION	c5.BP_ GO biological process	16	1.2093405	0.22169812	0.3618654	GO_POSITIVE_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION	16	1.3433127	0.10092962	0.3909163	2.5526532	-0.1339722
KATSANOU_ELAVL1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	139	1.2092568	0.11700844	0.36200234	KATSANOU_ELAVL1_TARGETS_DN	139	0.8182992	0.8479835	1	2.027556	0.3909576
GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN	C7_ immunologic signatures	163	1.2091968	0.11497006	0.36206043	GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN	164	1.5316802	0	0.22098245	2.740877	-0.3224834
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN	C7_ immunologic signatures	185	1.2091514	0.1031653	0.36209607	GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN	186	1.1740012	0.14097363	0.6313964	2.3831526	0.0351502
GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_UP	C7_ immunologic signatures	103	1.2091346	0.1296061	0.362053	GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_UP	106	1.1678764	0.17750257	0.64104545	2.377011	0.0412582
GO_CELLULAR_RESPONSE_TO_LITHIUM_ION	c5.BP_ GO biological process	17	1.2091184	0.25201938	0.36199826	GO_CELLULAR_RESPONSE_TO_LITHIUM_ION	17	1.0056757	0.49674055	0.91389513	2.2147941	0.2034427
GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP	C7_ immunologic signatures	185	1.2089217	0.10477299	0.36240682	GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP	185	-1.5128542	0	0.1350384	-0.3039325	2.7217759
GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP	C7_ immunologic signatures	153	1.2088414	0.10920245	0.36252016	GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP	157	1.0347443	0.41051567	0.86800814	2.2435857	0.1740971
GO_NEUROEPITHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	54	1.2087442	0.17073171	0.3626897	GO_NEUROEPITHELIAL_CELL_DIFFERENTIATION	59	-1.2562463	0.06185567	0.31848046	-0.0475021	2.4649905
MORF_ERCC4	c4.CGN_ cancer gene neighborhoods	244	1.2084724	0.10526316	0.36330253	MORF_ERCC4	265	1.2896055	0.014028057	0.45806783	2.4980779	-0.0811331
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	134	1.2084297	0.13118812	0.36332273	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN	143	1.4158634	0.006160164	0.32147133	2.6242931	-0.2074337
YIH_RESPONSE_TO_ARSENITE_C2	c2.CGP_ chemical and genetic perturbations	18	1.2084252	0.20813772	0.3632485	YIH_RESPONSE_TO_ARSENITE_C2	18	-0.81341195	0.74786323	0.8945686	0.39501325	2.02183715
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	C7_ immunologic signatures	172	1.2083671	0.09367397	0.36332032	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	174	0.822869	0.8680203	1	2.0312361	0.3854981
GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP	C7_ immunologic signatures	152	1.208304	0.1004902	0.3633931	GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP	155	1.0876615	0.30564103	0.7740004	2.2959655	0.1206425
GO_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION	c5.BP_ GO biological process	18	1.2082931	0.20489296	0.3633337	GO_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION	18	0.97258365	0.5296392	0.95854145	2.18087675	0.23570945
GSE40273_XBP1_KO_VS_WT_TREG_UP	C7_ immunologic signatures	176	1.2082819	0.10231425	0.3632771	GSE40273_XBP1_KO_VS_WT_TREG_UP	175	0.81356895	0.8815789	1	2.02185085	0.39471295
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN	C7_ immunologic signatures	125	1.2080716	0.120347396	0.3637422	GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN	138	0.94051653	0.6371134	0.9898619	2.14858813	0.26755507
GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN	C7_ immunologic signatures	168	1.2080568	0.092364535	0.36369926	GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN	175	1.1145996	0.23037717	0.7309309	2.3226564	0.0934572
FIRESTEIN_PROLIFERATION	c2.CGP_ chemical and genetic perturbations	158	1.2079135	0.10701546	0.3639885	FIRESTEIN_PROLIFERATION	164	0.9599226	0.5953109	0.97134537	2.1678361	0.2479909
WANG_METHYLATED_IN_BREAST_CANCER	c2.CGP_ chemical and genetic perturbations	30	1.2079035	0.20653789	0.36392936	WANG_METHYLATED_IN_BREAST_CANCER	31	1.0431577	0.42061612	0.85321414	2.2510612	0.1647458
EVI1_02	c3.TFT_ transcription factor targets	110	1.2078434	0.1281407	0.36399782	EVI1_02	119	0.8747918	0.74665296	1	2.0826352	0.3330516
GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	C7_ immunologic signatures	100	1.2078358	0.15476191	0.36392906	GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	109	1.0444702	0.39581153	0.8500445	2.252306	0.1633656
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP	C7_ immunologic signatures	183	1.2077849	0.10069445	0.36397767	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP	189	1.2210815	0.07638191	0.55418175	2.4288664	-0.0132966
GSE13229_IMM_VS_INTMATURE_NKCELL_UP	C7_ immunologic signatures	150	1.2077067	0.125	0.36408874	GSE13229_IMM_VS_INTMATURE_NKCELL_UP	167	1.1080124	0.24541752	0.74120146	2.3157191	0.0996943
GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN	C7_ immunologic signatures	182	1.2076732	0.0952381	0.36409083	GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN	190	1.1318448	0.18984772	0.7032231	2.339518	0.0758284
GO_LYMPHOCYTE_COSTIMULATION	c5.BP_ GO biological process	50	1.2076297	0.16246499	0.3641192	GO_LYMPHOCYTE_COSTIMULATION	61	0.9348016	0.6013289	0.99506754	2.1424313	0.2728281
ENGELMANN_CANCER_PROGENITORS_DN	c2.CGP_ chemical and genetic perturbations	56	1.2075592	0.16576819	0.3642096	ENGELMANN_CANCER_PROGENITORS_DN	59	1.1984938	0.17627494	0.595443	2.406053	0.0090654
GO_PLATELET_AGGREGATION	c5.BP_ GO biological process	33	1.2074217	0.20451128	0.36448613	GO_PLATELET_AGGREGATION	34	0.9255494	0.6099291	1	2.1329711	0.2818723
GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_DN	C7_ immunologic signatures	124	1.2071316	0.12817259	0.3651539	GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_DN	125	0.8379652	0.7935685	1	2.0450968	0.3691664
RYAAAKNNNNNNTTGW_UNKNOWN	c3.TFT_ transcription factor targets	72	1.2070647	0.14285715	0.365239	RYAAAKNNNNNNTTGW_UNKNOWN	77	0.9900383	0.5148936	0.9352358	2.197103	0.2170264
LA_MEN1_TARGETS	c2.CGP_ chemical and genetic perturbations	21	1.2070419	0.24180967	0.3652125	LA_MEN1_TARGETS	21	-0.7961224	0.7745665	0.90932673	0.4109195	2.0031643
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES	c2.CP_ Canonical pathways	46	1.2070261	0.1691678	0.36516023	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES	47	0.700167	0.9125432	1	1.9071931	0.5068591
LI_CISPLATIN_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	20	1.2069466	0.22734255	0.36526784	LI_CISPLATIN_RESISTANCE_UP	21	0.9622808	0.531477	0.96877015	2.1692274	0.2446658
GO_HISTONE_ACETYLTRANSFERASE_BINDING	c5.GO molecular function	28	1.2068262	0.20977917	0.36549357	GO_HISTONE_ACETYLTRANSFERASE_BINDING	28	1.0185506	0.4530864	0.8924328	2.2253768	0.1882756
ST_G_ALPHA_I_PATHWAY	c2.CP_ Canonical pathways	32	1.2066844	0.20937042	0.36578035	ST_G_ALPHA_I_PATHWAY	33	1.1695838	0.23809524	0.6386227	2.3762682	0.0371006
GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	C7_ immunologic signatures	185	1.2065505	0.108618654	0.36603954	GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	190	0.8661994	0.8121827	1	2.0727499	0.3403511
GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN	C7_ immunologic signatures	169	1.2064097	0.12091898	0.36631966	GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN	171	0.57182074	0.9979798	1	1.77823044	0.63458896
MORF_ITGA2	c4.CGN_ cancer gene neighborhoods	45	1.206393	0.17460318	0.36627504	MORF_ITGA2	46	1.6751357	0.001145475	0.09491121	2.8815287	-0.4687427
CDPCR3_01	c3.TFT_ transcription factor targets	47	1.2063433	0.1713881	0.36631867	CDPCR3_01	48	1.008026	0.4760274	0.9108367	2.2143693	0.1983173
GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY	c5.BP_ GO biological process	35	1.2063376	0.18195051	0.3662476	GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY	36	0.91776705	0.59836066	1	2.12410465	0.28857055
GO_SKIN_DEVELOPMENT	c5.BP_ GO biological process	161	1.2061857	0.113663845	0.3665466	GO_SKIN_DEVELOPMENT	170	1.250803	0.049445003	0.5088655	2.4569887	-0.0446173
CHR4Q25	C1: positional gene sets	26	1.2061262	0.211226	0.36661676	CHR4Q25	26	0.94532746	0.5582822	0.9869088	2.15145366	0.26079874
GO_HINDBRAIN_DEVELOPMENT	c5.BP_ GO biological process	127	1.2060411	0.124223605	0.36675984	GO_HINDBRAIN_DEVELOPMENT	132	0.9633049	0.58488613	0.96752906	2.169346	0.2427362
GO_REGULATION_OF_PLATELET_ACTIVATION	c5.BP_ GO biological process	27	1.2059666	0.22692889	0.3668598	GO_REGULATION_OF_PLATELET_ACTIVATION	30	1.9012759	0	0.007989378	3.1072425	-0.6953093
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	c2.CP_REACTOME_ Reactome gene sets	17	1.2059242	0.21955128	0.36687893	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	17	1.0402492	0.4280303	0.8592101	2.2461734	0.165675
GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP	C7_ immunologic signatures	180	1.2058827	0.10520095	0.36689785	GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP	181	0.8684761	0.7925101	1	2.0743588	0.3374066
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	c2.CP_REACTOME_ Reactome gene sets	50	1.2058663	0.19158201	0.36685026	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	55	0.88312006	0.6708286	1	2.08898636	0.32274624
LEIN_CHOROID_PLEXUS_MARKERS	c2.CGP_ chemical and genetic perturbations	88	1.2058637	0.16846362	0.36676833	LEIN_CHOROID_PLEXUS_MARKERS	95	1.5183544	0.002116402	0.23621504	2.7242181	-0.3124907
GO_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS	c5.BP_ GO biological process	291	1.2058227	0.057331864	0.3667856	GO_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS	308	0.8347354	0.903	1	2.0405581	0.3710873
GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP	C7_ immunologic signatures	159	1.2057668	0.11664642	0.3668503	GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP	163	0.8156662	0.8645096	1	2.021433	0.3901006
GO_CYTOKINE_BINDING	c5.GO molecular function	78	1.2056898	0.14834437	0.36696303	GO_CYTOKINE_BINDING	80	0.9938839	0.5122732	0.9309975	2.1995737	0.2118059
GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN	C7_ immunologic signatures	177	1.2056065	0.11570248	0.36710328	GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN	181	0.80905116	0.88461536	1	2.01465766	0.39655534
GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP	C7_ immunologic signatures	102	1.2055124	0.1389253	0.36726275	GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP	109	1.5855892	0	0.17753737	2.7911016	-0.3800768
GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	171	1.2054629	0.102232665	0.36730376	GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN	176	0.96208143	0.59979635	0.96865356	2.16754433	0.24338147
SRC_UP.V1_UP	C6_ oncogenic signatures	121	1.2052115	0.13357843	0.3678728	SRC_UP.V1_UP	135	1.1914332	0.15148413	0.60420716	2.3966447	0.0137783
GO_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY	c5.BP_ GO biological process	57	1.2051611	0.16620499	0.36791548	GO_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY	58	1.2742164	0.0976431	0.48187014	2.4793775	-0.0690553
STK33_SKM_DN	C6_ oncogenic signatures	223	1.2051088	0.1039261	0.36796418	STK33_SKM_DN	233	1.1647254	0.13782696	0.64618987	2.3698342	0.0403834
PID_FOXO_PATHWAY	c2.CP_ Canonical pathways	46	1.2051026	0.17739628	0.36789143	PID_FOXO_PATHWAY	47	1.0332905	0.44382024	0.8718284	2.2383931	0.1718121
GO_EXTRACELLULAR_GLUTAMATE_GATED_ION_CHANNEL_ACTIVITY	c5.GO molecular function	20	1.2047766	0.22875817	0.36865845	GO_EXTRACELLULAR_GLUTAMATE_GATED_ION_CHANNEL_ACTIVITY	20	1.5912554	0.001264223	0.17147335	2.796032	-0.3864788
GO_RESPONSE_TO_TEMPERATURE_STIMULUS	c5.BP_ GO biological process	126	1.2047708	0.12765957	0.36858615	GO_RESPONSE_TO_TEMPERATURE_STIMULUS	131	1.4671183	0.002068252	0.2770595	2.6718891	-0.2623475
GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	172	1.2047532	0.10213777	0.36854875	GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN	172	1.1144117	0.24141414	0.7313018	2.3191649	0.0903415
PID_P53_DOWNSTREAM_PATHWAY	c2.CP_ Canonical pathways	122	1.2047062	0.12659846	0.36858472	PID_P53_DOWNSTREAM_PATHWAY	123	1.2332615	0.09979424	0.5358937	2.4379677	-0.0285553
IRF_Q6	c3.TFT_ transcription factor targets	215	1.2045522	0.08997722	0.3689025	IRF_Q6	218	1.0661609	0.33737373	0.81241196	2.2707131	0.1383913
GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN	C7_ immunologic signatures	150	1.2045516	0.1257485	0.3688157	GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN	156	1.1335518	0.20756646	0.7007854	2.3381034	0.0709998
PID_SMAD2_3NUCLEAR_PATHWAY	c2.CP_ Canonical pathways	78	1.2044804	0.17051283	0.36892554	PID_SMAD2_3NUCLEAR_PATHWAY	79	-0.9395515	0.5797101	0.77125674	0.2649289	2.1440319
WANG_CLIM2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	198	1.2044401	0.094847776	0.36894366	WANG_CLIM2_TARGETS_UP	202	0.8907925	0.7562941	1	2.0952326	0.3136476
SMITH_LIVER_CANCER	c2.CGP_ chemical and genetic perturbations	42	1.2043645	0.16834532	0.36904928	SMITH_LIVER_CANCER	42	1.0336822	0.43742824	0.87076604	2.2380467	0.1706823
GO_SENSORY_PERCEPTION_OF_PAIN	c5.BP_ GO biological process	59	1.2043054	0.17891817	0.36910042	GO_SENSORY_PERCEPTION_OF_PAIN	70	1.4287946	0.019629225	0.31709418	2.6331	-0.2244892
GSE25087_TREG_VS_TCONV_ADULT_UP	C7_ immunologic signatures	171	1.2043016	0.12066906	0.36902207	GSE25087_TREG_VS_TCONV_ADULT_UP	170	0.9225781	0.6875	1	2.1268797	0.2817235
GO_DNA_LIGATION	c5.BP_ GO biological process	15	1.204266	0.24386252	0.3690275	GO_DNA_LIGATION	15	0.698642	0.84864163	1	1.902908	0.505624
GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	179	1.2042419	0.10034602	0.369001	GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP	179	0.89656943	0.7522659	1	2.10081133	0.30767247
GO_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE	c5.BP_ GO biological process	23	1.2042322	0.22136223	0.36893937	GO_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE	24	1.652988	0.002450981	0.113173164	2.8572202	-0.4487558
CHR1P32	C1: positional gene sets	58	1.2041887	0.1618497	0.36896554	CHR1P32	65	0.9245064	0.63366336	1	2.1286951	0.2796823
GO_HEART_PROCESS	c5.BP_ GO biological process	74	1.2041621	0.1657754	0.3689477	GO_HEART_PROCESS	80	1.412323	0.021253984	0.3237254	2.6164851	-0.2081609
GO_MEMBRANE_INVAGINATION	c5.BP_ GO biological process	28	1.204092	0.2128637	0.36905122	GO_MEMBRANE_INVAGINATION	34	1.4011673	0.04491726	0.33795717	2.6052593	-0.1970753
GSE3982_EOSINOPHIL_VS_MAST_CELL_UP	C7_ immunologic signatures	160	1.2039902	0.112426035	0.369233	GSE3982_EOSINOPHIL_VS_MAST_CELL_UP	167	0.76530874	0.93292683	1	1.96929894	0.43868146
LIU_CDX2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	27	1.2039449	0.21316615	0.3692593	LIU_CDX2_TARGETS_UP	33	1.0076087	0.47523585	0.9110707	2.2115536	0.1963362
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP	C7_ immunologic signatures	162	1.2039144	0.115384616	0.36924648	GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP	166	1.3013444	0.03051882	0.4392782	2.5052588	-0.09743
GO_HYPEROSMOTIC_RESPONSE	c5.BP_ GO biological process	15	1.2039143	0.23183925	0.3691585	GO_HYPEROSMOTIC_RESPONSE	17	1.2106385	0.2396373	0.5760289	2.4145528	-0.0067242
PRC1_BMI_UP.V1_UP	C6_ oncogenic signatures	143	1.2037562	0.10974106	0.36948538	PRC1_BMI_UP.V1_UP	150	0.85073286	0.7897436	1	2.05448906	0.35302334
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	c2.CGP_ chemical and genetic perturbations	307	1.2036606	0.07751938	0.36965948	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	313	1.038099	0.4002006	0.86172116	2.2417596	0.1655616
ALK_DN.V1_UP	C6_ oncogenic signatures	108	1.2036532	0.14100906	0.36959258	ALK_DN.V1_UP	118	0.9456169	0.60307693	0.9866301	2.1492701	0.2580363
GO_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY	c5.BP_ GO biological process	143	1.2035706	0.11721612	0.369716	GO_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY	142	1.084466	0.31525075	0.7784291	2.2880366	0.1191046
GO_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	23	1.2035401	0.22870663	0.36970758	GO_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	25	1.4760786	0.028083028	0.27235267	2.6796187	-0.2725385
FOXJ2_02	c3.TFT_ transcription factor targets	197	1.2035292	0.10105758	0.36965266	FOXJ2_02	202	1.0580046	0.36262625	0.82763475	2.2615338	0.1455246
GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP	C7_ immunologic signatures	161	1.2035239	0.11341464	0.36957762	GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP	176	1.2961166	0.028282829	0.44811934	2.4996405	-0.0925927
GO_NEURAL_TUBE_DEVELOPMENT	c5.BP_ GO biological process	137	1.2035227	0.14357054	0.36949256	GO_NEURAL_TUBE_DEVELOPMENT	145	-1.158976	0.11764706	0.43177637	0.0445467	2.3624987
AGCYRWTTC_UNKNOWN	c3.TFT_ transcription factor targets	99	1.2035023	0.14394905	0.36945862	AGCYRWTTC_UNKNOWN	104	0.8863578	0.6986444	1	2.0898601	0.3171445
VALK_AML_CLUSTER_4	c2.CGP_ chemical and genetic perturbations	23	1.2034545	0.21580547	0.36948505	VALK_AML_CLUSTER_4	25	1.0283604	0.44289342	0.87835103	2.2318149	0.1750941
MORF_NF1	c4.CGN_ cancer gene neighborhoods	135	1.2033517	0.12010114	0.3696618	MORF_NF1	152	1.3499719	0.012257406	0.38338053	2.5533236	-0.1466202
CAGTCAC_MIR134	c3.MIR_ microRNA targets	45	1.203343	0.19914651	0.36959934	CAGTCAC_MIR134	48	0.78700876	0.8261851	1	1.99035176	0.41633424
GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN	C7_ immunologic signatures	169	1.2032837	0.110843375	0.36966422	GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN	176	1.2689477	0.03346856	0.48654678	2.4722314	-0.065664
GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	146	1.2032648	0.11893204	0.36962426	GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	144	1.2095095	0.11156602	0.577799	2.4127743	-0.0062447
CCATCCA_MIR432	c3.MIR_ microRNA targets	53	1.2032357	0.19252874	0.36961496	CCATCCA_MIR432	56	1.0991231	0.32	0.75820976	2.3023588	0.1041126
GO_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION	c5.BP_ GO biological process	16	1.2031324	0.23676012	0.36977604	GO_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION	15	1.3584601	0.078404404	0.37756222	2.5615925	-0.1553277
GSE14308_TH1_VS_TH17_UP	C7_ immunologic signatures	173	1.2031244	0.11647059	0.36971223	GSE14308_TH1_VS_TH17_UP	177	1.0145135	0.48423195	0.89909583	2.2176379	0.1886109
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	c2.CGP_ chemical and genetic perturbations	18	1.2030277	0.2193646	0.36986652	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	18	1.6509382	0.007751938	0.11364564	2.8539659	-0.4479105
TCCAGAT_MIR5165P	c3.MIR_ microRNA targets	100	1.2029061	0.12437186	0.37008947	TCCAGAT_MIR5165P	101	0.98149884	0.55474454	0.9468539	2.18440494	0.22140726
GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	C7_ immunologic signatures	179	1.2028093	0.116197184	0.3702478	GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	185	1.2038212	0.0989899	0.58462447	2.4066305	-0.0010119
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	c2.CP_REACTOME_ Reactome gene sets	23	1.2027875	0.22152886	0.37021264	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	23	-1.0293778	0.41304347	0.6403155	0.1734097	2.2321653
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	c2.CGP_ chemical and genetic perturbations	182	1.2027844	0.105568446	0.3701323	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	187	1.3326057	0.013171226	0.3999545	2.5353901	-0.1298213
LIU_TARGETS_OF_VMYB_VS_CMYB_DN	c2.CGP_ chemical and genetic perturbations	37	1.2027668	0.18853696	0.37008876	LIU_TARGETS_OF_VMYB_VS_CMYB_DN	38	1.1620007	0.26589596	0.6502954	2.3647675	0.0407661
GSE3982_NKCELL_VS_TH1_UP	C7_ immunologic signatures	149	1.2027633	0.110436894	0.37001273	GSE3982_NKCELL_VS_TH1_UP	154	1.4715914	0.00101833	0.27463934	2.6743547	-0.2688281
GO_CGMP_METABOLIC_PROCESS	c5.BP_ GO biological process	21	1.2027103	0.21266969	0.37005544	GO_CGMP_METABOLIC_PROCESS	20	1.0604302	0.4028314	0.8229546	2.2631405	0.1422801
PID_EPHB_FWD_PATHWAY	c2.CP_ Canonical pathways	39	1.202671	0.21313868	0.37007383	PID_EPHB_FWD_PATHWAY	39	-0.88712287	0.6944444	0.8379809	0.31554813	2.08979387
GSE17721_POLYIC_VS_CPG_2H_BMDC_DN	C7_ immunologic signatures	173	1.2026622	0.11497006	0.3700107	GSE17721_POLYIC_VS_CPG_2H_BMDC_DN	171	0.7986144	0.8924949	1	2.0012766	0.4040478
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	c2.CGP_ chemical and genetic perturbations	28	1.2026335	0.20597015	0.36999545	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	28	1.0482811	0.43634117	0.8431411	2.2509146	0.1543524
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP	C7_ immunologic signatures	149	1.2026052	0.12922706	0.36997905	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP	147	0.91788834	0.67987806	1	2.12049354	0.28471686
GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN	C7_ immunologic signatures	170	1.2025231	0.11004785	0.37010953	GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN	177	1.2112311	0.07575758	0.5754922	2.4137542	-0.008708
GO_EMBRYONIC_HEART_TUBE_MORPHOGENESIS	c5.BP_ GO biological process	55	1.202517	0.18443803	0.37003663	GO_EMBRYONIC_HEART_TUBE_MORPHOGENESIS	62	0.83985853	0.76148796	1	2.04237553	0.36265847
GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	180	1.2024201	0.11896349	0.3702012	GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP	184	0.84365916	0.84295845	1	2.04607926	0.35876094
GO_EMBRYONIC_ORGAN_MORPHOGENESIS	c5.BP_ GO biological process	251	1.2023968	0.08671171	0.3701764	GO_EMBRYONIC_ORGAN_MORPHOGENESIS	274	1.0589062	0.3323293	0.8263616	2.261303	0.1434906
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP	C7_ immunologic signatures	150	1.2020268	0.11851852	0.37106708	GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP	162	0.95529866	0.6130346	0.97613734	2.15732546	0.24672814
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN	C7_ immunologic signatures	166	1.2019869	0.11547619	0.37107828	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN	170	1.1359168	0.2090909	0.69598985	2.3379037	0.0660701
GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN	C7_ immunologic signatures	167	1.2017194	0.106024094	0.37170357	GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN	170	1.2253201	0.07077856	0.5483733	2.4270395	-0.0236007
GO_TELOMERE_ORGANIZATION	c5.BP_ GO biological process	78	1.2016594	0.1716129	0.37177172	GO_TELOMERE_ORGANIZATION	78	0.7639178	0.86767894	1	1.9655772	0.4377416
GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	104	1.2015637	0.15701416	0.3719327	GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN	109	-1.2375588	0.025641026	0.3375641	-0.0359951	2.4391225
GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING	c5.GO molecular function	299	1.20133	0.0754717	0.37248746	GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING	318	0.89642316	0.7807808	1	2.09775316	0.30490684
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP	C7_ immunologic signatures	157	1.2013234	0.11876485	0.37241495	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP	156	1.2048714	0.10714286	0.5824733	2.4061948	-0.003548
GO_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY	c5.GO molecular function	16	1.2013117	0.23817292	0.37235868	GO_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY	18	1.4515678	0.05121639	0.29136935	2.6528795	-0.2502561
GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	138	1.201144	0.1107056	0.3727109	GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN	141	1.0400038	0.40755874	0.8590793	2.2411478	0.1611402
GSE12366_GC_BCELL_VS_PLASMA_CELL_DN	C7_ immunologic signatures	158	1.2011216	0.1300716	0.37268355	GSE12366_GC_BCELL_VS_PLASMA_CELL_DN	160	1.16787	0.1395112	0.6408932	2.3689916	0.0332516
GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP	C7_ immunologic signatures	154	1.2010164	0.12028302	0.3728632	GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP	164	0.9447082	0.62398374	0.98760766	2.1457246	0.2563082
GO_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	49	1.2007953	0.19327731	0.37335715	GO_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	50	0.96362996	0.55875576	0.96722466	2.16442526	0.23716534
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN	C7_ immunologic signatures	160	1.200715	0.104116224	0.37347218	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN	168	1.3134965	0.015353122	0.41977862	2.5142115	-0.1127815
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	c2.CGP_ chemical and genetic perturbations	162	1.2007128	0.111644655	0.373388	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	163	1.1123097	0.2535497	0.73426086	2.3130225	0.0884031
GO_INOSITOL_LIPID_MEDIATED_SIGNALING	c5.BP_ GO biological process	111	1.2005998	0.15063292	0.37359458	GO_INOSITOL_LIPID_MEDIATED_SIGNALING	114	1.2364985	0.08472803	0.5310103	2.4370983	-0.0358987
GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	178	1.2005668	0.09468822	0.3735921	GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	180	0.8758897	0.7915408	1	2.0764565	0.3246771
GO_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS	c5.BP_ GO biological process	129	1.2005657	0.12435233	0.37350756	GO_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS	132	1.4675894	0.00716479	0.27611545	2.6681551	-0.2670237
GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP	C7_ immunologic signatures	71	1.2003354	0.16734143	0.37403664	GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP	86	0.94492394	0.5882353	0.9876887	2.14525934	0.25541146
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	c2.CGP_ chemical and genetic perturbations	48	1.2000753	0.1977716	0.3746176	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	51	0.7134999	0.89766407	1	1.9135752	0.4865754
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	c2.CGP_ chemical and genetic perturbations	137	1.1998036	0.13423645	0.375268	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	138	1.5564771	0.001035197	0.20157471	2.7562807	-0.3566735
GO_RENAL_SYSTEM_PROCESS	c5.BP_ GO biological process	84	1.1996291	0.15404041	0.37565205	GO_RENAL_SYSTEM_PROCESS	89	1.3757399	0.033934254	0.35697842	2.575369	-0.1761108
GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP	C7_ immunologic signatures	182	1.1995969	0.11435239	0.3756472	GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP	185	1.1345952	0.19172554	0.6979141	2.3341921	0.0650017
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	c2.CGP_ chemical and genetic perturbations	340	1.1994328	0.058949623	0.37597647	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	338	0.9613956	0.63126254	0.96978724	2.1608284	0.2380372
GO_APPENDAGE_DEVELOPMENT	c5.BP_ GO biological process	153	1.1992832	0.104808874	0.3762729	GO_APPENDAGE_DEVELOPMENT	161	0.99923944	0.51329243	0.92495525	2.19852264	0.20004376
GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP	C7_ immunologic signatures	178	1.1991961	0.12272175	0.37642205	GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP	179	1.3653902	0.011167512	0.37168774	2.5645863	-0.1661941
GO_REGULATION_OF_HEART_MORPHOGENESIS	c5.BP_ GO biological process	26	1.1991701	0.20243531	0.37640068	GO_REGULATION_OF_HEART_MORPHOGENESIS	28	0.8224579	0.7276029	1	2.021628	0.3767122
GO_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	50	1.1991556	0.1804949	0.37634736	GO_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY	59	1.165583	0.22812846	0.6462181	2.3647386	0.0335726
GO_PROTEIN_AUTOUBIQUITINATION	c5.BP_ GO biological process	46	1.1989133	0.194051	0.37690115	GO_PROTEIN_AUTOUBIQUITINATION	47	0.727402	0.86966294	1	1.9263153	0.4715113
GSE45837_WT_VS_GFI1_KO_PDC_UP	C7_ immunologic signatures	147	1.1988032	0.123188406	0.37709644	GSE45837_WT_VS_GFI1_KO_PDC_UP	153	0.8696021	0.7758444	1	2.0684053	0.3292011
GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP	C7_ immunologic signatures	159	1.1987902	0.10963856	0.3770422	GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP	160	0.8068311	0.87678206	1	2.0056213	0.3919591
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN	C7_ immunologic signatures	177	1.1987323	0.11124122	0.37710094	GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN	180	-1.0142229	0.3846154	0.66806334	0.1845094	2.2129552
ZF5_B	c3.TFT_ transcription factor targets	215	1.1987244	0.10669693	0.3770302	ZF5_B	219	-1.2015262	0.1	0.3798105	-0.0028018	2.4002506
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP	C7_ immunologic signatures	170	1.1986942	0.110843375	0.37702242	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP	175	1.3598188	0.014155713	0.37734583	2.558513	-0.1611246
GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	163	1.1985613	0.111638956	0.3772842	GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP	165	1.0655352	0.3510204	0.8134041	2.2640965	0.1330261
GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN	C7_ immunologic signatures	150	1.1985068	0.13277511	0.37735283	GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN	152	1.1813079	0.14663951	0.6207861	2.3798147	0.0171989
GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN	C7_ immunologic signatures	168	1.1982756	0.11826698	0.3779061	GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN	172	0.8615896	0.79432625	1	2.0598652	0.336686
SEMENZA_HIF1_TARGETS	c2.CGP_ chemical and genetic perturbations	30	1.1982254	0.20361991	0.37795407	SEMENZA_HIF1_TARGETS	33	0.5578802	0.9809524	1	1.7561056	0.6403452
BILANGES_SERUM_SENSITIVE_VIA_TSC2	c2.CGP_ chemical and genetic perturbations	36	1.1982058	0.18922853	0.3779177	BILANGES_SERUM_SENSITIVE_VIA_TSC2	36	0.7385503	0.86150235	1	1.9367561	0.4596555
GO_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY	c5.BP_ GO biological process	19	1.1981889	0.23040752	0.37787396	GO_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY	20	1.256395	0.18135376	0.5006865	2.4545839	-0.0582061
GO_SKELETAL_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	46	1.1981816	0.19665273	0.3778061	GO_SKELETAL_MUSCLE_CELL_DIFFERENTIATION	49	0.93881625	0.5940707	0.9914577	2.13699785	0.25936535
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	C7_ immunologic signatures	163	1.1981019	0.11044418	0.3779143	GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	160	1.0890372	0.28278688	0.7725657	2.2871391	0.1090647
GSE13522_WT_VS_IFNG_KO_SKIN_DN	C7_ immunologic signatures	95	1.1978523	0.14416777	0.37849486	GSE13522_WT_VS_IFNG_KO_SKIN_DN	106	1.3453668	0.021852238	0.38840356	2.5432191	-0.1475145
GSE13306_TREG_RA_VS_TCONV_RA_UP	C7_ immunologic signatures	173	1.1976825	0.11995249	0.37887034	GSE13306_TREG_RA_VS_TCONV_RA_UP	177	0.6837098	0.9838384	1	1.8813923	0.5139727
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	179	1.1976248	0.113425925	0.3789313	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP	180	0.97743434	0.56693715	0.95203066	2.17505914	0.22019046
LEE_LIVER_CANCER_MYC_UP	c2.CGP_ chemical and genetic perturbations	47	1.1975884	0.19067797	0.37894288	LEE_LIVER_CANCER_MYC_UP	47	0.7326436	0.86734694	1	1.930232	0.4649448
GRE_C	c3.TFT_ transcription factor targets	108	1.1975731	0.13913043	0.37889338	GRE_C	111	1.1740813	0.17277487	0.6315691	2.3716544	0.0234918
GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN	C7_ immunologic signatures	182	1.1975404	0.10788863	0.37888974	GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN	184	1.203042	0.08989899	0.5868611	2.4005824	-0.0055016
GO_REGULATION_OF_BEHAVIOR	c5.BP_ GO biological process	50	1.1973966	0.20056102	0.3791783	GO_REGULATION_OF_BEHAVIOR	56	-1.1253766	0.23762377	0.47907522	0.07202	2.3227732
AAAGGAT_MIR501	c3.MIR_ microRNA targets	113	1.1973143	0.14054726	0.3792941	AAAGGAT_MIR501	115	-1.0210693	0.46153846	0.6577653	0.176245	2.2183836
GSE45365_WT_VS_IFNAR_KO_BCELL_UP	C7_ immunologic signatures	149	1.1971241	0.12423124	0.37970886	GSE45365_WT_VS_IFNAR_KO_BCELL_UP	150	0.9712605	0.56836736	0.95984405	2.1683846	0.2258636
GO_PEPTIDASE_REGULATOR_ACTIVITY	c5.GO molecular function	148	1.1970398	0.12801932	0.3798341	GO_PEPTIDASE_REGULATOR_ACTIVITY	166	1.1817378	0.11213048	0.6200449	2.3787776	0.015302
BURTON_ADIPOGENESIS_9	c2.CGP_ chemical and genetic perturbations	83	1.1969614	0.15612903	0.3799565	BURTON_ADIPOGENESIS_9	81	1.2333825	0.12955032	0.5359964	2.4303439	-0.0364211
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP	C7_ immunologic signatures	182	1.1969274	0.10243902	0.379961	GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP	183	1.1247556	0.20222446	0.7157339	2.321683	0.0721718
GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	C7_ immunologic signatures	170	1.1968989	0.11384977	0.379959	GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	172	0.7823424	0.9005076	1	1.9792413	0.4145565
GO_POSITIVE_REGULATION_OF_ATPASE_ACTIVITY	c5.BP_ GO biological process	37	1.1968883	0.2	0.3798959	GO_POSITIVE_REGULATION_OF_ATPASE_ACTIVITY	39	1.1038373	0.3431604	0.7500098	2.3007256	0.093051
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN	C7_ immunologic signatures	174	1.1967663	0.11737089	0.38013354	GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN	175	0.94029254	0.64285713	0.98979837	2.13705884	0.25647376
BOSCO_TH1_CYTOTOXIC_MODULE	c2.CGP_ chemical and genetic perturbations	87	1.1967642	0.16384916	0.38005042	BOSCO_TH1_CYTOTOXIC_MODULE	92	0.9103963	0.66560847	1	2.1071605	0.2863679
GO_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING	c5.GO molecular function	32	1.1966922	0.20605187	0.3801499	GO_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING	32	1.3185098	0.09927361	0.4131614	2.515202	-0.1218176
GO_POSITIVE_REGULATION_OF_PROTEIN_MATURATION	c5.BP_ GO biological process	15	1.1966515	0.23675497	0.38017175	GO_POSITIVE_REGULATION_OF_PROTEIN_MATURATION	16	1.3497617	0.10796221	0.38329026	2.5464132	-0.1531102
GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	C7_ immunologic signatures	172	1.1963742	0.12171838	0.3808116	GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	173	1.0305086	0.43191057	0.87476623	2.2268828	0.1658656
GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP	C7_ immunologic signatures	160	1.1963483	0.12879708	0.38078916	GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP	163	1.2831748	0.03767821	0.46749207	2.4795231	-0.0868265
GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP	C7_ immunologic signatures	171	1.196305	0.112941176	0.3808194	GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP	177	1.4290488	0.002028398	0.31664777	2.6253538	-0.2327438
GSE3982_CTRL_VS_LPS_48H_DC_DN	C7_ immunologic signatures	170	1.1962112	0.10308057	0.3809865	GSE3982_CTRL_VS_LPS_48H_DC_DN	173	1.1358844	0.21414141	0.6958133	2.3320956	0.0603268
CHR2Q33	C1: positional gene sets	77	1.1962036	0.16867469	0.38092098	CHR2Q33	83	0.87120754	0.71383315	1	2.06741114	0.32499606
PLASARI_TGFB1_TARGETS_1HR_UP	c2.CGP_ chemical and genetic perturbations	34	1.1960627	0.2217514	0.38119495	PLASARI_TGFB1_TARGETS_1HR_UP	34	1.303721	0.104705885	0.43564308	2.4997837	-0.1076583
MODULE_530	c4.CM_ cancer modules	15	1.1960143	0.23259762	0.38123503	MODULE_530	15	0.9940142	0.50462353	0.9309205	2.1900285	0.2020001
GSE17721_LPS_VS_CPG_2H_BMDC_DN	C7_ immunologic signatures	168	1.1959531	0.10693302	0.38130888	GSE17721_LPS_VS_CPG_2H_BMDC_DN	179	1.017297	0.46975806	0.8938041	2.2132501	0.1786561
KIM_MYCN_AMPLIFICATION_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	84	1.1958615	0.16623376	0.3814656	KIM_MYCN_AMPLIFICATION_TARGETS_DN	87	0.9737934	0.5424974	0.957062	2.1696549	0.2220681
CHO_NR4A1_TARGETS	c2.CGP_ chemical and genetic perturbations	27	1.1958418	0.2238806	0.38143024	CHO_NR4A1_TARGETS	28	0.93384033	0.5588235	0.99598086	2.12968213	0.26200147
GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN	C7_ immunologic signatures	166	1.1957594	0.11358025	0.38155594	GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN	172	1.0527962	0.3846154	0.8361633	2.2485556	0.1429632
MORF_RFC5	c4.CGN_ cancer gene neighborhoods	67	1.1956584	0.17297298	0.38174024	MORF_RFC5	70	0.69800776	0.9211663	1	1.89366616	0.49765064
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP	C7_ immunologic signatures	181	1.1955618	0.11647059	0.3818994	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP	188	1.3137822	0.01718908	0.4199524	2.509344	-0.1182204
ARGGGTTAA_UNKNOWN	c3.TFT_ transcription factor targets	107	1.1954658	0.14451613	0.38206577	ARGGGTTAA_UNKNOWN	108	0.9499744	0.59462255	0.9820432	2.1454402	0.2454914
MODULE_171	c4.CM_ cancer modules	101	1.1954219	0.16145182	0.3820948	MODULE_171	104	1.2630037	0.069864444	0.4917486	2.4584256	-0.0675818
GSE27786_CD8_TCELL_VS_NKCELL_DN	C7_ immunologic signatures	178	1.1953747	0.12305854	0.38212603	GSE27786_CD8_TCELL_VS_NKCELL_DN	179	0.99295396	0.51664984	0.93202466	2.18832866	0.20242074
GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN	C7_ immunologic signatures	132	1.1953509	0.14231738	0.38209823	GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN	136	1.0463606	0.40062112	0.8461718	2.2417115	0.1489903
VANTVEER_BREAST_CANCER_ESR1_UP	c2.CGP_ chemical and genetic perturbations	151	1.1953349	0.14923619	0.38204938	VANTVEER_BREAST_CANCER_ESR1_UP	156	1.4508637	0	0.29216167	2.6461986	-0.2555288
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN	C7_ immunologic signatures	178	1.1953317	0.11435239	0.38196927	GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN	186	1.3276902	0.013184584	0.40408915	2.5230219	-0.1323585
GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN	C7_ immunologic signatures	182	1.1950263	0.10489511	0.38269928	GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN	184	0.6619269	0.98887765	1	1.8569532	0.5330994
GO_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS	c5.BP_ GO biological process	95	1.1949642	0.16791044	0.38277978	GO_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS	97	0.7493004	0.91728526	1	1.9442646	0.4456638
GCAAAAA_MIR129	c3.MIR_ microRNA targets	169	1.1948235	0.12676056	0.38305756	GCAAAAA_MIR129	170	0.9424591	0.648073	0.9891785	2.1372826	0.2523644
GO_OVARIAN_FOLLICLE_DEVELOPMENT	c5.BP_ GO biological process	55	1.1947799	0.20027816	0.38308072	GO_OVARIAN_FOLLICLE_DEVELOPMENT	59	-0.7909816	0.875	0.9139723	0.4037983	1.9857615
GO_NEGATIVE_REGULATION_OF_STAT_CASCADE	c5.BP_ GO biological process	42	1.194749	0.17596567	0.3830728	GO_NEGATIVE_REGULATION_OF_STAT_CASCADE	44	0.94082606	0.58027524	0.9897998	2.13557506	0.25392294
GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP	C7_ immunologic signatures	175	1.1946558	0.10952381	0.38324544	GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP	176	1.2583003	0.04255319	0.49890873	2.4529561	-0.0636445
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP	C7_ immunologic signatures	141	1.194497	0.14041515	0.38357407	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP	146	0.9377823	0.62880325	0.9931458	2.1322793	0.2567147
SHIN_B_CELL_LYMPHOMA_CLUSTER_7	c2.CGP_ chemical and genetic perturbations	25	1.1944267	0.21319018	0.38366616	SHIN_B_CELL_LYMPHOMA_CLUSTER_7	25	0.97038585	0.53136533	0.96116924	2.16481255	0.22404085
ATACCTC_MIR202	c3.MIR_ microRNA targets	167	1.1943932	0.14319248	0.38366362	ATACCTC_MIR202	169	1.054624	0.37804878	0.83381766	2.2490172	0.1397692
GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP	C7_ immunologic signatures	147	1.1943339	0.12590799	0.38373727	GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP	148	0.7100456	0.95501024	1	1.9043795	0.4842883
GO_FOREBRAIN_GENERATION_OF_NEURONS	c5.BP_ GO biological process	57	1.1943214	0.18481375	0.38367826	GO_FOREBRAIN_GENERATION_OF_NEURONS	65	1.062309	0.36882547	0.81882834	2.2566304	0.1320124
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP	C7_ immunologic signatures	168	1.1942521	0.12811388	0.38377938	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP	173	0.99069595	0.5364373	0.9350954	2.18494805	0.20355615
GO_ACTIN_MONOMER_BINDING	c5.GO molecular function	20	1.1942306	0.23414634	0.38374636	GO_ACTIN_MONOMER_BINDING	22	0.8324568	0.7169576	1	2.0266874	0.3617738
GATAAGR_GATA_C	c3.TFT_ transcription factor targets	250	1.1941905	0.09988649	0.3837567	GATAAGR_GATA_C	265	1.1191386	0.17907445	0.7237263	2.3133291	0.0750519
GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	148	1.194151	0.13663845	0.383776	GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP	152	0.84823895	0.7991845	1	2.04238995	0.34591205
GO_PHOSPHATASE_BINDING	c5.GO molecular function	153	1.1941234	0.13598074	0.38376343	GO_PHOSPHATASE_BINDING	156	-0.7470361	1	0.94020766	0.4470873	1.9411595
RTTTNNNYTGGM_UNKNOWN	c3.TFT_ transcription factor targets	138	1.1940113	0.15489466	0.3839813	RTTTNNNYTGGM_UNKNOWN	140	1.051857	0.39506173	0.8373046	2.2458683	0.1421543
POU3F2_02	c3.TFT_ transcription factor targets	220	1.1939822	0.098305084	0.3839751	POU3F2_02	230	0.9804286	0.5532129	0.9489813	2.1744108	0.2135536
GO_REGULATION_OF_STEM_CELL_DIFFERENTIATION	c5.BP_ GO biological process	101	1.1939614	0.13965087	0.383946	GO_REGULATION_OF_STEM_CELL_DIFFERENTIATION	107	-1.0371567	0.3448276	0.62746215	0.1568047	2.2311181
GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	187	1.1939155	0.10581395	0.38398623	GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP	186	0.7153898	0.9606458	1	1.9093053	0.4785257
GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN	C7_ immunologic signatures	132	1.1939127	0.14180024	0.38390568	GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN	140	1.1819962	0.14891417	0.61978954	2.3759089	0.0119165
GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN	C7_ immunologic signatures	178	1.1938674	0.109283194	0.38394728	GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN	176	-1.3438015	0	0.24581309	-0.1499341	2.5376689
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	c2.CGP_ chemical and genetic perturbations	30	1.1937659	0.22590362	0.3841263	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	35	0.99820215	0.47579694	0.92574614	2.19196805	0.19556375
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	c2.CGP_ chemical and genetic perturbations	32	1.1937052	0.22390318	0.38420418	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	33	1.3795604	0.071849234	0.35619125	2.5732656	-0.1858552
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	c2.CGP_ chemical and genetic perturbations	138	1.1936939	0.111793615	0.38414434	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	139	1.1315708	0.23006135	0.7039663	2.3252647	0.0621231
MODULE_97	c4.CM_ cancer modules	86	1.1936815	0.1701847	0.38408604	MODULE_97	88	-1.0138247	0.47727272	0.66854763	0.1798568	2.2075062
GSE7852_THYMUS_VS_FAT_TCONV_UP	C7_ immunologic signatures	173	1.1935908	0.09952607	0.3842357	GSE7852_THYMUS_VS_FAT_TCONV_UP	176	0.8767376	0.7548519	1	2.0703284	0.3168532
HALMOS_CEBPA_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	40	1.1935394	0.19941776	0.38428205	HALMOS_CEBPA_TARGETS_DN	41	0.895312	0.6381733	1	2.0888514	0.2982274
GSE17721_LPS_VS_CPG_16H_BMDC_DN	C7_ immunologic signatures	176	1.1935084	0.13142174	0.38427842	GSE17721_LPS_VS_CPG_16H_BMDC_DN	180	0.88036853	0.7765306	1	2.07387693	0.31313987
GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN	C7_ immunologic signatures	177	1.1934482	0.12880562	0.3843433	GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN	183	0.95745015	0.5997984	0.97477734	2.15089835	0.23599805
GO_K63_LINKED_POLYUBIQUITIN_BINDING	c5.GO molecular function	17	1.1933966	0.25	0.38439184	GO_K63_LINKED_POLYUBIQUITIN_BINDING	17	1.1209536	0.3290653	0.7222668	2.3143502	0.072443
MEISSNER_NPC_HCP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	55	1.193393	0.19602273	0.38431165	MEISSNER_NPC_HCP_WITH_H3K27ME3	74	1.2506857	0.1108719	0.508703	2.4440787	-0.0572927
MYB_Q6	c3.TFT_ transcription factor targets	210	1.1933637	0.10892236	0.38430285	MYB_Q6	219	0.9248764	0.6937751	1	2.1182401	0.2684873
GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN	C7_ immunologic signatures	162	1.1933442	0.12313433	0.38426733	GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN	174	0.9039942	0.7106855	1	2.0973384	0.28935
GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	186	1.1932535	0.119906865	0.38443118	GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP	187	0.78917533	0.89361703	1	1.98242883	0.40407817
GSE36826_WT_VS_IL1R_KO_SKIN_UP	C7_ immunologic signatures	162	1.1931765	0.123636365	0.3845363	GSE36826_WT_VS_IL1R_KO_SKIN_UP	172	1.364591	0.009155646	0.37297416	2.5577675	-0.1714145
MORF_MDM2	c4.CGN_ cancer gene neighborhoods	209	1.1931324	0.114754096	0.38456988	MORF_MDM2	226	1.2670071	0.03021148	0.48858702	2.4601395	-0.0738747
GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	C7_ immunologic signatures	168	1.1931045	0.12103408	0.38455072	GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	168	0.8520252	0.8142857	1	2.0451297	0.3410793
GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	30	1.1931008	0.20933735	0.3844722	GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS	32	1.1595594	0.27283654	0.6536573	2.3526602	0.0335414
GO_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE	c5.CC_ GO cellular component	15	1.1930401	0.24061434	0.38455155	GO_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE	17	-1.0972224	0.2825112	0.52298856	0.0958177	2.2902625
GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP	C7_ immunologic signatures	159	1.1928442	0.1350365	0.38498348	GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP	159	1.083856	0.30566803	0.7796872	2.2767002	0.1089882
AKT_UP.V1_UP	C6_ oncogenic signatures	145	1.1926681	0.13922518	0.38535663	AKT_UP.V1_UP	151	1.5468078	0	0.20620626	2.7394759	-0.3541397
NF1_Q6_01	c3.TFT_ transcription factor targets	233	1.1925507	0.10161663	0.3855768	NF1_Q6_01	235	0.7452202	0.96378267	1	1.9377709	0.4473305
NAGASHIMA_NRG1_SIGNALING_UP	c2.CGP_ chemical and genetic perturbations	164	1.1923351	0.13856813	0.38605824	NAGASHIMA_NRG1_SIGNALING_UP	165	0.9222788	0.67241377	1	2.1146139	0.2700563
GO_CELLULAR_RESPONSE_TO_ANTIBIOTIC	c5.BP_ GO biological process	15	1.1922287	0.24252492	0.38624817	GO_CELLULAR_RESPONSE_TO_ANTIBIOTIC	16	1.3367321	0.11764706	0.39838374	2.5289608	-0.1445034
GO_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY	c5.GO molecular function	44	1.1921014	0.20434782	0.3864941	GO_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY	51	1.4805888	0.019955654	0.26778102	2.6726902	-0.2884874
GO_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION	c5.BP_ GO biological process	33	1.1920614	0.20321637	0.38650686	GO_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION	33	1.1702573	0.27164888	0.6381648	2.3623187	0.0218041
MORF_IL13	c4.CGN_ cancer gene neighborhoods	188	1.1919903	0.11635945	0.38659838	MORF_IL13	206	1.0850819	0.29767913	0.77703637	2.2770722	0.1069084
GTATTAT_MIR3693P	c3.MIR_ microRNA targets	184	1.191919	0.12914692	0.3867061	GTATTAT_MIR3693P	192	0.85677755	0.8231156	1	2.04869655	0.33514145
MODULE_67	c4.CM_ cancer modules	168	1.1919115	0.13285024	0.38663548	MODULE_67	181	1.1850476	0.123732254	0.61338603	2.3769591	0.0068639
GO_HOMOTYPIC_CELL_CELL_ADHESION	c5.BP_ GO biological process	43	1.1918194	0.19530103	0.38679156	GO_HOMOTYPIC_CELL_CELL_ADHESION	45	1.0516396	0.40389016	0.8369047	2.243459	0.1401798
GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN	C7_ immunologic signatures	168	1.1918045	0.119351104	0.38674402	GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN	173	1.1281123	0.21849594	0.7084851	2.3199168	0.0636922
GO_PROTEIN_ACTIVATION_CASCADE	c5.BP_ GO biological process	52	1.1917464	0.18922853	0.38681394	GO_PROTEIN_ACTIVATION_CASCADE	67	1.6277326	0.001083424	0.13419333	2.819479	-0.4359862
GO_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH	c5.BP_ GO biological process	138	1.1916862	0.14075887	0.38688433	GO_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH	151	1.2610623	0.05532787	0.49487457	2.4527485	-0.0693761
GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN	C7_ immunologic signatures	171	1.1916368	0.13641755	0.38691893	GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN	179	1.4443316	0.00304878	0.29921287	2.6359684	-0.2526948
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	c2.CP_REACTOME_ Reactome gene sets	20	1.1912584	0.23510972	0.3878452	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	20	1.37678	0.08582575	0.35769358	2.5680384	-0.1855216
NADERI_BREAST_CANCER_PROGNOSIS_DN	c2.CGP_ chemical and genetic perturbations	18	1.191176	0.22683705	0.38797674	NADERI_BREAST_CANCER_PROGNOSIS_DN	18	0.92380476	0.59699625	1	2.11498076	0.26737124
GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN	C7_ immunologic signatures	166	1.191171	0.1182266	0.3879013	GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN	172	1.023673	0.44387755	0.8858871	2.214844	0.167498
BOYLAN_MULTIPLE_MYELOMA_C_D_DN	c2.CGP_ chemical and genetic perturbations	214	1.1908286	0.112138726	0.38873506	BOYLAN_MULTIPLE_MYELOMA_C_D_DN	214	1.2968941	0.019133938	0.4467235	2.4877227	-0.1060655
GSE1460_DP_VS_CD4_THYMOCYTE_UP	C7_ immunologic signatures	170	1.1905797	0.13365155	0.38930902	GSE1460_DP_VS_CD4_THYMOCYTE_UP	172	0.80598366	0.877551	1	1.99656336	0.38459604
GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN	C7_ immunologic signatures	172	1.190539	0.13276492	0.38932216	GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN	182	0.67099905	0.98790324	1	1.86153805	0.51953995
GO_TRABECULA_MORPHOGENESIS	c5.BP_ GO biological process	37	1.190484	0.19571428	0.38938832	GO_TRABECULA_MORPHOGENESIS	38	-0.9545101	0.59836066	0.7503904	0.2359739	2.1449941
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	151	1.1904632	0.14234875	0.38935393	GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	150	0.7897262	0.8956612	1	1.9801894	0.400737
GO_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	24	1.1903789	0.22541603	0.3894862	GO_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION	24	1.1489438	0.2850062	0.66959465	2.3393227	0.0414351
PID_P38_MKK3_6PATHWAY	c2.CP_ Canonical pathways	26	1.1902015	0.22664624	0.38987204	PID_P38_MKK3_6PATHWAY	26	0.84989256	0.7013142	1	2.04009406	0.34030894
GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP	C7_ immunologic signatures	160	1.1901605	0.13277511	0.38988256	GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP	162	1.1014414	0.27152988	0.754531	2.2916019	0.0887191
GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN	C7_ immunologic signatures	181	1.1900254	0.10672854	0.39014813	GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN	183	0.92896485	0.64903355	0.99892604	2.11899025	0.26106055
GO_MYOSIN_BINDING	c5.GO molecular function	53	1.1897656	0.18057455	0.39074478	GO_MYOSIN_BINDING	56	0.99897844	0.49773756	0.9247036	2.18874404	0.19078716
GO_IMMUNE_EFFECTOR_PROCESS	c5.BP_ GO biological process	373	1.1897343	0.071274295	0.39073724	GO_IMMUNE_EFFECTOR_PROCESS	398	1.0201886	0.43443444	0.891348	2.2099229	0.1695457
GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	152	1.1896654	0.1252955	0.39082372	GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN	152	1.3744491	0.008154944	0.3598065	2.5641145	-0.1847837
GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN	C7_ immunologic signatures	181	1.1896303	0.12150668	0.39082822	GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN	187	1.4599577	0	0.2829893	2.649588	-0.2703274
HSF1_01	c3.TFT_ transcription factor targets	233	1.1895748	0.102477476	0.390886	HSF1_01	240	0.99052525	0.54709417	0.9351917	2.18010005	0.19904955
CHR14Q21	C1: positional gene sets	36	1.1895041	0.2012012	0.39099708	CHR14Q21	37	0.95041925	0.54272515	0.98162353	2.13992335	0.23908485
MORF_RUNX1	c4.CGN_ cancer gene neighborhoods	118	1.1893283	0.16133004	0.3913682	MORF_RUNX1	133	1.029329	0.4573484	0.87647694	2.2186573	0.1599993
GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP	C7_ immunologic signatures	174	1.1892583	0.13620071	0.39145318	GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP	177	1.1133957	0.24647887	0.7324649	2.302654	0.0758626
GO_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	49	1.1889784	0.20113315	0.39214474	GO_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS	52	1.1875328	0.20731707	0.6100856	2.3765112	0.0014456
GO_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS	c5.BP_ GO biological process	41	1.188977	0.1904762	0.3920579	GO_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS	44	0.7125715	0.90289015	1	1.9015485	0.4764055
RREB1_01	c3.TFT_ transcription factor targets	187	1.1888171	0.11820331	0.3924012	RREB1_01	192	0.6916522	0.9827411	1	1.8804693	0.4971649
GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP	C7_ immunologic signatures	141	1.1887167	0.11829268	0.39257267	GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP	148	0.9619563	0.5802469	0.9686839	2.150673	0.2267604
GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN	C7_ immunologic signatures	181	1.1886419	0.105450235	0.39268437	GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN	184	0.8812933	0.77268094	1	2.0699352	0.3073486
GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN	C7_ immunologic signatures	177	1.1884993	0.14130434	0.39297077	GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN	178	0.7872751	0.9049545	1	1.9757744	0.4012242
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN	C7_ immunologic signatures	144	1.1882639	0.1369697	0.3935353	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN	168	1.249746	0.07063572	0.5115185	2.4380099	-0.0614821
GO_CYCLASE_ACTIVITY	c5.GO molecular function	17	1.1881636	0.23089431	0.39371046	GO_CYCLASE_ACTIVITY	18	1.3407577	0.07782101	0.39614037	2.5289213	-0.1525941
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN	C7_ immunologic signatures	157	1.187985	0.13739546	0.39409485	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN	166	1.2641228	0.050813008	0.49084085	2.4521078	-0.0761378
GO_ENDOTHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	51	1.1876507	0.1934605	0.39491728	GO_ENDOTHELIAL_CELL_MIGRATION	53	0.97318524	0.543722	0.9578814	2.16083594	0.21446546
GSE3982_DC_VS_MAC_UP	C7_ immunologic signatures	160	1.1876107	0.13772455	0.39493597	GSE3982_DC_VS_MAC_UP	163	1.2861491	0.03245436	0.46319145	2.4737598	-0.0985384
GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	177	1.1875894	0.110458285	0.3949044	GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN	182	0.9849517	0.53690594	0.9418679	2.1725411	0.2026377
GO_MULTICELLULAR_ORGANISMAL_HOMEOSTASIS	c5.BP_ GO biological process	223	1.1875077	0.11303345	0.39504167	GO_MULTICELLULAR_ORGANISMAL_HOMEOSTASIS	237	1.2715518	0.026078235	0.48339874	2.4590595	-0.0840441
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN	C7_ immunologic signatures	184	1.1873385	0.12872468	0.39541566	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN	186	0.8917304	0.75504035	1	2.0790689	0.2956081
GO_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND	c5.BP_ GO biological process	441	1.1872271	0.06680806	0.39563453	GO_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND	457	0.9461442	0.6963928	0.98598886	2.1333713	0.2410829
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	C7_ immunologic signatures	177	1.1870152	0.1379717	0.39611748	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	178	0.7563286	0.9251769	1	1.9433438	0.4306866
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	c2.CGP_ chemical and genetic perturbations	15	1.1869401	0.23954985	0.39622888	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	16	1.1539538	0.29045093	0.66336155	2.3408939	0.0329863
GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN	C7_ immunologic signatures	178	1.1869069	0.13388626	0.39621955	GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN	178	1.1396704	0.1850354	0.6909839	2.3265773	0.0472365
GO_SINGLE_ORGANISM_BEHAVIOR	c5.BP_ GO biological process	331	1.1868914	0.09880564	0.39617276	GO_SINGLE_ORGANISM_BEHAVIOR	357	1.0637732	0.29246232	0.81610423	2.2506646	0.1231182
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	c2.CGP_ chemical and genetic perturbations	20	1.1868912	0.2487725	0.39608365	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	21	0.97932667	0.5226438	0.9501505	2.16621787	0.20756453
GSE2706_UNSTIM_VS_2H_R848_DC_UP	C7_ immunologic signatures	152	1.186658	0.14631197	0.39660162	GSE2706_UNSTIM_VS_2H_R848_DC_UP	154	0.86358404	0.7744898	1	2.05024204	0.32307396
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	c2.CGP_ chemical and genetic perturbations	23	1.1866283	0.21800947	0.39658645	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	25	0.83556455	0.7170496	1	2.02219285	0.35106375
TGCAAAC_MIR452	c3.MIR_ microRNA targets	98	1.1866139	0.16709845	0.39653012	TGCAAAC_MIR452	101	-1.127325	0.1590909	0.4759661	0.0592889	2.3139389
GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN	C7_ immunologic signatures	164	1.1865997	0.14337349	0.3964819	GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN	172	1.3218119	0.018274112	0.41104153	2.5084116	-0.1352122
HNF4ALPHA_Q6	c3.TFT_ transcription factor targets	227	1.1865617	0.1021814	0.39648768	HNF4ALPHA_Q6	236	0.7253866	0.9808853	1	1.9119483	0.4611751
GRUETZMANN_PANCREATIC_CANCER_UP	c2.CGP_ chemical and genetic perturbations	325	1.1864816	0.07920792	0.3966059	GRUETZMANN_PANCREATIC_CANCER_UP	323	1.0193918	0.4509018	0.8917283	2.2058734	0.1670898
GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	C7_ immunologic signatures	130	1.186411	0.16169155	0.39671057	GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	131	1.3364464	0.029591836	0.3979965	2.5228574	-0.1500354
ATGCTGG_MIR338	c3.MIR_ microRNA targets	100	1.186284	0.1495564	0.396953	ATGCTGG_MIR338	106	1.0566407	0.37945494	0.83018535	2.2429247	0.1296433
GO_CELL_CORTEX_PART	c5.CC_ GO cellular component	104	1.186257	0.17209908	0.3969428	GO_CELL_CORTEX_PART	110	1.1242019	0.25964546	0.7170064	2.3104589	0.0620551
GO_POSITIVE_REGULATION_OF_AXONOGENESIS	c5.BP_ GO biological process	66	1.1861708	0.18046133	0.39708725	GO_POSITIVE_REGULATION_OF_AXONOGENESIS	68	0.9048416	0.6595289	1	2.0910124	0.2813292
GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP	C7_ immunologic signatures	163	1.1860955	0.14508393	0.3971984	GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP	166	0.88418174	0.7617108	1	2.07027724	0.30191376
AAGCCAT_MIR135A_MIR135B	c3.MIR_ microRNA targets	303	1.1859535	0.10033445	0.39749268	AAGCCAT_MIR135A_MIR135B	306	1.0389802	0.3881645	0.85988635	2.2249337	0.1469733
GO_OVULATION_CYCLE	c5.BP_ GO biological process	102	1.1859267	0.14869888	0.39747828	GO_OVULATION_CYCLE	109	0.87097853	0.76086956	1	2.05690523	0.31494817
GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_DN	C7_ immunologic signatures	163	1.1858547	0.12801932	0.39758387	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_DN	166	1.0298575	0.43641913	0.87602365	2.2157122	0.1559972
REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS	c2.CP_REACTOME_ Reactome gene sets	27	1.1858228	0.22488755	0.39757997	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS	31	0.86381286	0.6833741	1	2.04963566	0.32200994
COMP1_01	c3.TFT_ transcription factor targets	103	1.185788	0.17285532	0.3975924	COMP1_01	106	0.9409559	0.6157895	0.9896516	2.1267439	0.2448321
GO_REGULATION_OF_INTERLEUKIN_1_SECRETION	c5.BP_ GO biological process	21	1.1857816	0.24094488	0.39751676	GO_REGULATION_OF_INTERLEUKIN_1_SECRETION	25	1.2507193	0.1725	0.5090029	2.4365009	-0.0649377
YAP1_DN	C6_ oncogenic signatures	34	1.1857425	0.21428572	0.39753184	YAP1_DN	36	1.0057757	0.4716763	0.91405755	2.1915182	0.1799668
GSE6259_CD4_TCELL_VS_CD8_TCELL_DN	C7_ immunologic signatures	152	1.1854916	0.13669065	0.39811355	GSE6259_CD4_TCELL_VS_CD8_TCELL_DN	154	1.1697598	0.16547498	0.6385213	2.3552514	0.0157318
GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN	C7_ immunologic signatures	169	1.1853737	0.13053893	0.39834228	GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN	174	1.0783262	0.30575177	0.79079366	2.2636999	0.1070475
NOTCH_DN.V1_UP	C6_ oncogenic signatures	139	1.1853406	0.14545454	0.3983424	NOTCH_DN.V1_UP	148	1.4152889	0.005117707	0.32226357	2.6006295	-0.2299483
GO_HISTONE_BINDING	c5.GO molecular function	146	1.1851065	0.13027744	0.39889425	GO_HISTONE_BINDING	146	-0.98681945	0.625	0.70588624	0.19828705	2.17192595
GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_UP	C7_ immunologic signatures	162	1.1850805	0.14045618	0.39887843	GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_UP	171	1.1863123	0.1277666	0.61329746	2.3713928	-0.0012318
GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	136	1.1850656	0.13754646	0.39883015	GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP	141	1.0714676	0.34114054	0.80282056	2.2565332	0.113598
GSE17721_LPS_VS_CPG_2H_BMDC_UP	C7_ immunologic signatures	183	1.1850013	0.14067996	0.39891267	GSE17721_LPS_VS_CPG_2H_BMDC_UP	184	0.8672763	0.8213198	1	2.0522776	0.317725
GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP	C7_ immunologic signatures	185	1.184941	0.12573443	0.398988	GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP	187	0.866653	0.80203044	1	2.051594	0.318288
GO_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR	c5.BP_ GO biological process	16	1.184722	0.24754098	0.39949098	GO_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR	16	0.8664618	0.6581306	1	2.0511838	0.3182602
GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP	C7_ immunologic signatures	178	1.184673	0.12926829	0.3995356	GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP	181	0.7523171	0.9398573	1	1.9369901	0.4323559
GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP	C7_ immunologic signatures	170	1.1845449	0.1263036	0.39980274	GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP	177	1.036811	0.41170534	0.8641347	2.2213559	0.1477339
GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_UP	C7_ immunologic signatures	128	1.184537	0.1375	0.39973566	GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_UP	143	0.9693662	0.55129534	0.9620968	2.1539032	0.2151708
GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN	C7_ immunologic signatures	171	1.1844139	0.14404762	0.39997134	GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN	176	0.8912229	0.7550813	1	2.0756368	0.293191
GO_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION	c5.BP_ GO biological process	16	1.1841757	0.23778501	0.4005132	GO_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION	16	-0.8478634	0.6863469	0.8705653	0.3363123	2.0320391
GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	C7_ immunologic signatures	175	1.1840771	0.1404762	0.4006925	GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	181	1.3123436	0.02123357	0.42216372	2.4964207	-0.1282665
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP	C7_ immunologic signatures	159	1.1838895	0.13059251	0.40114	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP	160	0.6221407	0.99390244	1	1.8060302	0.5617488
GO_MEMBRANE_MICRODOMAIN	c5.CC_ GO cellular component	258	1.1838101	0.1048478	0.40126315	GO_MEMBRANE_MICRODOMAIN	268	1.2534527	0.025100403	0.5040578	2.4372628	-0.0696426
GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_DN	C7_ immunologic signatures	162	1.183796	0.13116726	0.40121046	GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_DN	175	1.3224115	0.02034588	0.4114169	2.5062075	-0.1386155
GO_DENDRITIC_SHAFT	c5.CC_ GO cellular component	34	1.1837014	0.21613394	0.4013812	GO_DENDRITIC_SHAFT	33	1.2677292	0.14437869	0.4866733	2.4514306	-0.0840278
GO_DEOXYRIBONUCLEASE_ACTIVITY	c5.GO molecular function	58	1.1836045	0.20708446	0.40154317	GO_DEOXYRIBONUCLEASE_ACTIVITY	60	0.5382867	0.9944629	1	1.7218912	0.6453178
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP	C7_ immunologic signatures	162	1.1835335	0.12632822	0.40164042	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP	163	1.4258547	0.00203252	0.31833005	2.6093882	-0.2423212
KOBAYASHI_EGFR_SIGNALING_24HR_UP	c2.CGP_ chemical and genetic perturbations	88	1.1834828	0.16973685	0.4016952	KOBAYASHI_EGFR_SIGNALING_24HR_UP	89	1.6826336	0	0.08997448	2.8661164	-0.4991508
HOEGERKORP_CD44_TARGETS_DIRECT_UP	c2.CGP_ chemical and genetic perturbations	24	1.1831908	0.23333333	0.40240777	HOEGERKORP_CD44_TARGETS_DIRECT_UP	23	1.3692213	0.07643312	0.3688442	2.5524121	-0.1860305
GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN	C7_ immunologic signatures	158	1.1831646	0.1385902	0.40238577	GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN	160	1.1108613	0.25304878	0.73621553	2.2940259	0.0723033
GO_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	23	1.1831635	0.22706065	0.40229625	GO_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS	24	0.941017	0.5686275	0.9895812	2.1241805	0.2421465
GO_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION	c5.BP_ GO biological process	20	1.1831363	0.24555735	0.402277	GO_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION	21	-1.385659	0.08743169	0.21565042	-0.2025227	2.5687953
GSE17721_CTRL_VS_CPG_8H_BMDC_DN	C7_ immunologic signatures	187	1.1830335	0.12716763	0.40246668	GSE17721_CTRL_VS_CPG_8H_BMDC_DN	186	0.8848376	0.78071064	1	2.0678711	0.2981959
GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP	C7_ immunologic signatures	169	1.1830184	0.13615024	0.40241367	GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP	171	0.7175301	0.970618	1	1.9005485	0.4654883
TGAGATT_MIR216	c3.MIR_ microRNA targets	94	1.1829877	0.16710526	0.40240538	TGAGATT_MIR216	97	0.9202598	0.6540484	1	2.1032475	0.2627279
IKEDA_MIR1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	53	1.182972	0.19971672	0.40235564	IKEDA_MIR1_TARGETS_UP	53	-1.1288362	0.2090909	0.47256783	0.0541358	2.3118082
MODULE_26	c4.CM_ cancer modules	169	1.1829247	0.12974297	0.40239742	MODULE_26	181	1.2667718	0.03632694	0.4888464	2.4496965	-0.0838471
GSE7852_TREG_VS_TCONV_FAT_DN	C7_ immunologic signatures	180	1.1829191	0.13436386	0.402322	GSE7852_TREG_VS_TCONV_FAT_DN	183	0.97297305	0.57735085	0.9578236	2.15589215	0.20994605
GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP	C7_ immunologic signatures	180	1.1828668	0.11915888	0.40237755	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP	181	-1.4132868	0	0.1972948	-0.23042	2.5961536
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP	C7_ immunologic signatures	176	1.1827509	0.113879	0.40260807	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP	178	1.1902113	0.09615385	0.6057308	2.3729622	-0.0074604
GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	116	1.1827444	0.16124837	0.40253815	GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP	122	0.825614	0.83609957	1	2.0083584	0.3571304
GO_RECYCLING_ENDOSOME	c5.CC_ GO cellular component	106	1.1827164	0.16731517	0.40251848	GO_RECYCLING_ENDOSOME	109	0.9613728	0.569055	0.96973336	2.1440892	0.2213436
MORF_IL4	c4.CGN_ cancer gene neighborhoods	143	1.1827015	0.14601228	0.4024693	MORF_IL4	158	1.2474726	0.08085977	0.5153734	2.4301741	-0.0647711
GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP	C7_ immunologic signatures	182	1.182691	0.114219114	0.4024095	GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP	183	1.2207803	0.07092199	0.5541024	2.4034713	-0.0380893
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	c2.CGP_ chemical and genetic perturbations	86	1.1826794	0.17282322	0.40235236	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	88	1.4701694	0.009433962	0.2757908	2.6528488	-0.28749
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN	c2.CGP_ chemical and genetic perturbations	284	1.1826369	0.1027088	0.40238366	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN	287	0.96596384	0.61885655	0.96477985	2.14860074	0.21667306
GSE339_CD8POS_VS_CD4CD8DN_DC_DN	C7_ immunologic signatures	181	1.1825751	0.13200934	0.40246	GSE339_CD8POS_VS_CD4CD8DN_DC_DN	189	1.0983421	0.26390293	0.75883406	2.2809172	0.084233
GO_POSITIVE_REGULATION_OF_SECRETION	c5.BP_ GO biological process	295	1.1825725	0.09371555	0.40237683	GO_POSITIVE_REGULATION_OF_SECRETION	327	1.1088384	0.1891892	0.7396035	2.2914109	0.0737341
GO_RAS_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	c5.GO molecular function	208	1.1824846	0.126021	0.40253377	GO_RAS_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	212	1.4848683	0	0.26566145	2.6673529	-0.3023837
GO_NUCLEAR_REPLICATION_FORK	c5.CC_ GO cellular component	36	1.1823635	0.23121387	0.40279153	GO_NUCLEAR_REPLICATION_FORK	36	-1.8009621	0	0.03276623	-0.6185986	2.9833256
GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN	C7_ immunologic signatures	174	1.1823025	0.13207547	0.40287274	GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN	177	0.72227657	0.9626263	1	1.90457907	0.46002593
GO_REGULATION_OF_PROTEIN_IMPORT	c5.BP_ GO biological process	163	1.1821543	0.13882352	0.40319765	GO_REGULATION_OF_PROTEIN_IMPORT	169	0.8401152	0.83434343	1	2.0222695	0.3420391
BURTON_ADIPOGENESIS_8	c2.CGP_ chemical and genetic perturbations	81	1.1820958	0.16037735	0.403257	BURTON_ADIPOGENESIS_8	81	-0.9776975	0.5070422	0.71684235	0.2043983	2.1597933
GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN	C7_ immunologic signatures	164	1.1820025	0.14387634	0.40342885	GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN	170	1.3279501	0.013104838	0.40392447	2.5099526	-0.1459476
GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP	C7_ immunologic signatures	158	1.1819692	0.14637147	0.40342444	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP	164	1.278689	0.036548223	0.47310352	2.4606582	-0.0967198
GO_LRR_DOMAIN_BINDING	c5.GO molecular function	16	1.1819439	0.23717949	0.40340033	GO_LRR_DOMAIN_BINDING	16	0.8252282	0.6943346	1	2.0071721	0.3567157
GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	177	1.1819074	0.123809524	0.40341058	GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	184	1.058002	0.34274194	0.82749707	2.2399094	0.1239054
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_	c2.CP_REACTOME_ Reactome gene sets	70	1.1816603	0.1920981	0.40400276	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_	72	1.3675389	0.044823907	0.3705947	2.5491992	-0.1858786
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	c2.CGP_ chemical and genetic perturbations	179	1.1814395	0.14779499	0.40449885	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	181	0.640089	0.98991936	1	1.8215285	0.5413505
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP	C7_ immunologic signatures	169	1.1814151	0.14441748	0.40447325	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP	176	1.2610558	0.043610547	0.49467432	2.4424709	-0.0796407
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN	C7_ immunologic signatures	168	1.1813248	0.1358885	0.4046332	GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN	175	0.9716182	0.5698267	0.9600725	2.152943	0.2097066
GO_REGULATION_OF_ION_TRANSPORT	c5.BP_ GO biological process	487	1.1812874	0.05186722	0.4046472	GO_REGULATION_OF_ION_TRANSPORT	487	0	0	0	1.1812874	1.1812874
GO_SYNAPTIC_VESICLE_LOCALIZATION	c5.BP_ GO biological process	94	1.1812826	0.18278146	0.40456656	GO_SYNAPTIC_VESICLE_LOCALIZATION	96	1.3273431	0.04697286	0.4048739	2.5086257	-0.1460605
GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP	C7_ immunologic signatures	149	1.1812427	0.13978495	0.40457729	GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP	150	1.1943768	0.13874614	0.5981588	2.3756195	-0.0131341
GO_METENCEPHALON_DEVELOPMENT	c5.BP_ GO biological process	92	1.1811284	0.16248348	0.4047966	GO_METENCEPHALON_DEVELOPMENT	96	0.99381644	0.5088819	0.93110824	2.17494484	0.18731196
STAT5A_02	c3.TFT_ transcription factor targets	119	1.1810558	0.14321607	0.40490013	STAT5A_02	126	0.97510624	0.5530381	0.9557926	2.15616204	0.20594956
GO_TRABECULA_FORMATION	c5.BP_ GO biological process	22	1.1810094	0.23041475	0.4049455	GO_TRABECULA_FORMATION	23	-0.93854994	0.5761905	0.77260256	0.24245946	2.11955934
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN	C7_ immunologic signatures	176	1.1809565	0.13969733	0.40499666	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN	179	0.8197088	0.8833671	1	2.0006653	0.3612477
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	100	1.1808985	0.17007673	0.40507072	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN	100	1.2106787	0.1328452	0.57625365	2.3915772	-0.0297802
GO_REGULATION_OF_AMINO_ACID_TRANSPORT	c5.BP_ GO biological process	21	1.1808693	0.25722983	0.40505704	GO_REGULATION_OF_AMINO_ACID_TRANSPORT	23	1.4442054	0.038318913	0.29818234	2.6250747	-0.2633361
GO_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION	c5.BP_ GO biological process	32	1.1807846	0.23065694	0.4051988	GO_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION	33	0.9462213	0.5585168	0.98600644	2.1270059	0.2345633
GO_QUATERNARY_AMMONIUM_GROUP_BINDING	c5.GO molecular function	30	1.1807687	0.23313783	0.4051515	GO_QUATERNARY_AMMONIUM_GROUP_BINDING	42	1.452069	0.03837472	0.29230776	2.6328377	-0.2713003
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP	C7_ immunologic signatures	166	1.1807297	0.1359338	0.4051724	GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP	169	1.1948656	0.09674134	0.5972758	2.3755953	-0.0141359
AKT_UP_MTOR_DN.V1_UP	C6_ oncogenic signatures	153	1.1806757	0.14993954	0.40522498	AKT_UP_MTOR_DN.V1_UP	160	1.3330957	0.018237082	0.399806	2.5137714	-0.15242
REACTOME_TIE2_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	17	1.1806133	0.25955415	0.4053087	REACTOME_TIE2_SIGNALING	17	0.562957	0.9559194	1	1.7435703	0.6176563
GO_NUCLEASE_ACTIVITY	c5.GO molecular function	172	1.1803807	0.1508772	0.40585622	GO_NUCLEASE_ACTIVITY	177	0.52085125	1	1	1.70123195	0.65952945
ATGTTTC_MIR494	c3.MIR_ microRNA targets	144	1.1803523	0.14181818	0.40584233	ATGTTTC_MIR494	145	0.92288655	0.67142856	1	2.10323885	0.25746575
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP	C7_ immunologic signatures	163	1.1803316	0.14285715	0.405806	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP	169	0.892006	0.7434077	1	2.0723376	0.2883256
CHR7Q31	C1: positional gene sets	61	1.180305	0.19833565	0.40578693	CHR7Q31	67	1.1262386	0.27891892	0.71239096	2.3065436	0.0540664
GO_RESPONSE_TO_AMMONIUM_ION	c5.BP_ GO biological process	43	1.1802981	0.21479374	0.40571544	GO_RESPONSE_TO_AMMONIUM_ION	42	0.88057786	0.67423385	1	2.06087596	0.29972024
MODULE_433	c4.CM_ cancer modules	53	1.1801286	0.2027972	0.4060929	MODULE_433	53	1.2720598	0.12485812	0.48288402	2.4521884	-0.0919312
GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP	C7_ immunologic signatures	181	1.1800457	0.13571429	0.40622622	GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP	184	1.0486547	0.3753815	0.84258986	2.2287004	0.131391
GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP	C7_ immunologic signatures	178	1.1800354	0.13895486	0.40616533	GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP	182	0.6972482	0.9768379	1	1.8772836	0.4827872
GO_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	79	1.180012	0.18145695	0.40613776	GO_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION	82	0.7922742	0.86417115	1	1.9722862	0.3877378
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	c2.CGP_ chemical and genetic perturbations	290	1.1799724	0.099228226	0.4061585	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	296	0.94213194	0.6883767	0.9886448	2.12210434	0.23784046
GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP	C7_ immunologic signatures	113	1.1798372	0.18625	0.40644857	GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP	120	1.2179978	0.11372951	0.5599758	2.397835	-0.0381606
GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP	C7_ immunologic signatures	133	1.1797768	0.15031056	0.40652013	GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP	138	1.1259062	0.24053223	0.7124892	2.305683	0.0538706
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	c2.CGP_ chemical and genetic perturbations	20	1.1797202	0.21512605	0.4065925	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	20	-1.109146	0.31111112	0.5051735	0.0705742	2.2888662
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP	C7_ immunologic signatures	164	1.1796956	0.140625	0.40657187	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP	167	1.0105679	0.47464502	0.9063727	2.1902635	0.1691277
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP	C7_ immunologic signatures	134	1.1796019	0.13851762	0.40674832	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP	139	1.2337898	0.07392197	0.53563124	2.4133917	-0.0541879
GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	C7_ immunologic signatures	150	1.1793981	0.13975903	0.40721032	GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	150	0.7255964	0.9456967	1	1.9049945	0.4538017
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	c2.CGP_ chemical and genetic perturbations	75	1.1793624	0.18484043	0.4072273	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	80	1.3163701	0.05079365	0.41621625	2.4957325	-0.1370077
GSE6259_CD4_TCELL_VS_CD8_TCELL_UP	C7_ immunologic signatures	162	1.1792613	0.1332533	0.40740934	GSE6259_CD4_TCELL_VS_CD8_TCELL_UP	164	1.2955937	0.037449393	0.44873816	2.474855	-0.1163324
GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP	C7_ immunologic signatures	145	1.1792548	0.1498173	0.40733632	GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP	149	0.8203529	0.86203426	1	1.9996077	0.3589019
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	c2.CGP_ chemical and genetic perturbations	43	1.1792327	0.20869565	0.4073115	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	48	1.160208	0.24211712	0.65187526	2.3394407	0.0190247
GO_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY	c5.BP_ GO biological process	25	1.1792277	0.22981367	0.40723407	GO_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY	25	1.3372818	0.121026896	0.39830905	2.5165095	-0.1580541
GO_VISUAL_BEHAVIOR	c5.BP_ GO biological process	44	1.1791693	0.22174536	0.4073005	GO_VISUAL_BEHAVIOR	49	0.89283586	0.6566667	1	2.07200516	0.28633344
CP2_02	c3.TFT_ transcription factor targets	221	1.1790223	0.12612613	0.40760192	CP2_02	230	1.0198342	0.4562814	0.89163166	2.1988565	0.1591881
GO_CELL_SUBSTRATE_JUNCTION_ASSEMBLY	c5.BP_ GO biological process	40	1.1789331	0.20694645	0.40775678	GO_CELL_SUBSTRATE_JUNCTION_ASSEMBLY	40	1.5281632	0.01173709	0.22430333	2.7070963	-0.3492301
GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN	C7_ immunologic signatures	183	1.1788863	0.13371429	0.40779182	GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN	182	0.8670101	0.81973815	1	2.0458964	0.3118762
GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	160	1.1788387	0.15137067	0.407836	GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP	180	1.4788336	0	0.26969025	2.6576723	-0.2999949
GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	C7_ immunologic signatures	169	1.1788243	0.14133017	0.40778133	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	170	0.75750625	0.92615384	1	1.93633055	0.42131805
GO_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS	c5.BP_ GO biological process	15	1.1787571	0.2507837	0.40787885	GO_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS	16	-1.2545187	0.17826086	0.31954858	-0.0757616	2.4332758
GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE	c5.BP_ GO biological process	25	1.1785578	0.24657534	0.40834364	GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE	31	0.87957495	0.6566265	1	2.05813275	0.29898285
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN	C7_ immunologic signatures	176	1.1784993	0.14149822	0.40841568	GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN	178	0.92828447	0.68149644	0.9994524	2.10678377	0.25021483
HATADA_METHYLATED_IN_LUNG_CANCER_UP	c2.CGP_ chemical and genetic perturbations	315	1.1784837	0.09945946	0.4083707	HATADA_METHYLATED_IN_LUNG_CANCER_UP	335	1.2652946	0.012012012	0.49015632	2.4437783	-0.0868109
GO_KINASE_REGULATOR_ACTIVITY	c5.GO molecular function	167	1.1783504	0.14823815	0.40864035	GO_KINASE_REGULATOR_ACTIVITY	170	0.805616	0.8946302	1	1.9839664	0.3727344
GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN	C7_ immunologic signatures	164	1.1783471	0.13928571	0.4085605	GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN	165	1.410545	0.005050505	0.3245189	2.5888921	-0.2321979
GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP	C7_ immunologic signatures	183	1.1783288	0.14251782	0.40852624	GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP	184	1.0728542	0.3131313	0.8011269	2.251183	0.1054746
GO_LATERAL_PLASMA_MEMBRANE	c5.CC_ GO cellular component	44	1.1782812	0.21388102	0.40856612	GO_LATERAL_PLASMA_MEMBRANE	47	1.177486	0.22757848	0.6265985	2.3557672	0.0007952
GO_SYNAPTIC_VESICLE_CYCLE	c5.BP_ GO biological process	81	1.1782382	0.19148937	0.40859276	GO_SYNAPTIC_VESICLE_CYCLE	83	1.3588088	0.04255319	0.37818617	2.537047	-0.1805706
GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP	C7_ immunologic signatures	174	1.1782223	0.13309777	0.40854415	GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP	178	1.4244499	0.001012146	0.31861034	2.6026722	-0.2462276
NF1_Q6	c3.TFT_ transcription factor targets	228	1.1781766	0.100811124	0.40857324	NF1_Q6	231	0.9196261	0.7152989	1	2.0978027	0.2585505
GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP	C7_ immunologic signatures	180	1.1781044	0.16187051	0.40867797	GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP	183	1.3568791	0.007077857	0.37979499	2.5349835	-0.1787747
GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	179	1.1779675	0.13846155	0.40895507	GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	181	0.91651785	0.7145749	1	2.09448535	0.26144965
GO_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING	c5.BP_ GO biological process	38	1.1778046	0.23546511	0.40930888	GO_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING	38	1.3770134	0.061104584	0.35721862	2.554818	-0.1992088
GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP	C7_ immunologic signatures	128	1.1777116	0.17121588	0.40948948	GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP	135	1.193913	0.13251784	0.5991266	2.3716246	-0.0162014
NFE2L2.V2	C6_ oncogenic signatures	338	1.1776658	0.09659714	0.40952376	NFE2L2.V2	362	1.0804882	0.24324325	0.7862216	2.258154	0.0971776
CHR4P15	C1: positional gene sets	34	1.1776525	0.20028819	0.40947178	CHR4P15	35	0.6713004	0.9193357	1	1.8489529	0.5063521
CHR6Q25	C1: positional gene sets	45	1.1775801	0.22060958	0.40957627	CHR6Q25	45	1.2082691	0.19662921	0.5804538	2.3858492	-0.030689
GO_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER	c5.BP_ GO biological process	125	1.1774985	0.15536375	0.40972024	GO_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER	140	1.2060994	0.11416922	0.58233994	2.3835979	-0.0286009
NABA_SECRETED_FACTORS	c2.CP_ Canonical pathways	253	1.1774913	0.11161218	0.4096496	NABA_SECRETED_FACTORS	276	1.0853401	0.24899599	0.7770903	2.2628314	0.0921512
GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP	C7_ immunologic signatures	166	1.1774311	0.1438849	0.40973142	GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP	171	0.9467619	0.64408493	0.9855705	2.124193	0.2306692
CHR14Q31	C1: positional gene sets	20	1.1774043	0.2488189	0.4097115	CHR14Q31	19	0.8917952	0.62705433	1	2.0691995	0.2856091
GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_UP	C7_ immunologic signatures	164	1.1773763	0.13413173	0.40970472	GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_UP	170	0.955367	0.6102041	0.97603047	2.1327433	0.2220093
TGTATGA_MIR4853P	c3.MIR_ microRNA targets	137	1.1773456	0.14215687	0.40969864	TGTATGA_MIR4853P	140	0.67947716	0.9661191	1	1.85682276	0.49786844
GO_EMBRYONIC_EYE_MORPHOGENESIS	c5.BP_ GO biological process	30	1.1771848	0.23592085	0.41003975	GO_EMBRYONIC_EYE_MORPHOGENESIS	33	1.0049585	0.47948417	0.91516477	2.1821433	0.1722263
GO_RESPONSE_TO_ESTRADIOL	c5.BP_ GO biological process	131	1.177107	0.16728625	0.41015857	GO_RESPONSE_TO_ESTRADIOL	142	-1.0877329	0.16666667	0.538793	0.0893741	2.2648399
WANG_LMO4_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	310	1.1770622	0.10654828	0.4101928	WANG_LMO4_TARGETS_DN	312	0.6597688	0.995992	1	1.836831	0.5172934
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	c2.CGP_ chemical and genetic perturbations	15	1.1770471	0.23968254	0.410141	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	15	0.8506654	0.70595855	1	2.0277125	0.3263817
GO_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	49	1.1770436	0.2079772	0.41005927	GO_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS	58	1.2507068	0.12527473	0.50883263	2.4277504	-0.0736632
GO_NOTCH_SIGNALING_PATHWAY	c5.BP_ GO biological process	97	1.1769662	0.18111254	0.41019833	GO_NOTCH_SIGNALING_PATHWAY	104	1.3260567	0.036194414	0.4057108	2.5030229	-0.1490905
GO_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY	c5.BP_ GO biological process	104	1.1769363	0.17974684	0.41018987	GO_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY	106	0.6918856	0.9595855	1	1.8688219	0.4850507
GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN	C7_ immunologic signatures	182	1.1768382	0.15348288	0.41036516	GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN	186	0.9221958	0.6880081	1	2.099034	0.2546424
GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	C7_ immunologic signatures	96	1.1767342	0.17774937	0.41055375	GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	102	0.8291424	0.7898023	1	2.0058766	0.3475918
CHR9Q33	C1: positional gene sets	48	1.1766137	0.23044693	0.41080707	CHR9Q33	48	1.0956011	0.33863637	0.76389074	2.2722148	0.0810126
GNF2_CASP8	c4.CGN_ cancer gene neighborhoods	21	1.1765429	0.23088685	0.41091275	GNF2_CASP8	22	0.98838705	0.5037594	0.93727505	2.16492995	0.18815585
AIGNER_ZEB1_TARGETS	c2.CGP_ chemical and genetic perturbations	29	1.1765242	0.22018349	0.4108724	AIGNER_ZEB1_TARGETS	31	1.3809558	0.064476885	0.35605982	2.55748	-0.2044316
GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP	C7_ immunologic signatures	173	1.1765189	0.15219976	0.41079512	GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP	176	1.2480191	0.0682281	0.5147174	2.424538	-0.0715002
CAGGGTC_MIR504	c3.MIR_ microRNA targets	78	1.1763453	0.17173052	0.4111795	CAGGGTC_MIR504	79	0.7489162	0.8802589	1	1.9252615	0.4274291
NFY_C	c3.TFT_ transcription factor targets	206	1.1762424	0.12988506	0.4113725	NFY_C	215	0.7475593	0.94789577	1	1.9238017	0.4286831
GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	C7_ immunologic signatures	180	1.1761585	0.13084112	0.4115189	GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	182	0.7017816	0.9777328	1	1.8779401	0.4743769
HOLLERN_MICROACINAR_BREAST_TUMOR_UP	c2.CGP_ chemical and genetic perturbations	29	1.1760961	0.2548435	0.41159594	HOLLERN_MICROACINAR_BREAST_TUMOR_UP	30	1.3379741	0.07904191	0.39775592	2.5140702	-0.161878
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	c2.CGP_ chemical and genetic perturbations	69	1.1759788	0.21360545	0.4118208	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	74	1.0530543	0.3972311	0.83594555	2.2290331	0.1229245
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	c2.CGP_ chemical and genetic perturbations	74	1.175956	0.18691589	0.41178596	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	78	0.898425	0.6864865	1	2.074381	0.277531
GESERICK_TERT_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	21	1.1758645	0.2447665	0.4119504	GESERICK_TERT_TARGETS_DN	21	0.65495414	0.9173127	1	1.83081864	0.52091036
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	c2.CGP_ chemical and genetic perturbations	27	1.1758476	0.23474178	0.41190067	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	26	0.9626778	0.539801	0.96821725	2.1385254	0.2131698
GO_DIVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	150	1.1756829	0.14145142	0.4122673	GO_DIVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	161	1.4178294	0.001009082	0.32022038	2.5935123	-0.2421465
WANG_SMARCE1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	313	1.1756382	0.08508287	0.41229907	WANG_SMARCE1_TARGETS_DN	315	-1.0984858	0	0.52172893	0.0771524	2.274124
GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN	C7_ immunologic signatures	114	1.1756097	0.17232704	0.4122862	GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN	120	1.4224758	0.018867925	0.3174457	2.5980855	-0.2468661
GO_ACTIN_FILAMENT_BINDING	c5.GO molecular function	110	1.1755695	0.16917293	0.4123106	GO_ACTIN_FILAMENT_BINDING	111	1.5064619	0.001038422	0.24529767	2.6820314	-0.3308924
GO_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN	c5.BP_ GO biological process	37	1.1752894	0.22036473	0.413006	GO_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN	42	-1.5460417	0.006849315	0.11723799	-0.3707523	2.7213311
HAHTOLA_SEZARY_SYNDROM_DN	c2.CGP_ chemical and genetic perturbations	31	1.1752733	0.22346368	0.4129619	HAHTOLA_SEZARY_SYNDROM_DN	32	0.97471935	0.53504676	0.9556861	2.14999265	0.20055395
CHR7P15	C1: positional gene sets	53	1.1751335	0.2005457	0.4132673	CHR7P15	56	1.4244434	0.02759382	0.3181895	2.5995769	-0.2493099
E12_Q6	c3.TFT_ transcription factor targets	230	1.1751038	0.12958716	0.41326076	E12_Q6	238	1.0018052	0.5030181	0.92068917	2.176909	0.1732986
MODULE_138	c4.CM_ cancer modules	77	1.1749972	0.19104084	0.4134649	MODULE_138	83	1.0677958	0.35356763	0.80950195	2.242793	0.1072014
GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	C7_ immunologic signatures	168	1.1749581	0.1430333	0.41348282	GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	170	0.9636987	0.58028454	0.96711934	2.1386568	0.2112594
MODULE_72	c4.CM_ cancer modules	290	1.174917	0.1036036	0.41350034	MODULE_72	293	-1.0378811	0.5	0.6260878	0.1370359	2.2127981
REACTOME_GPCR_LIGAND_BINDING	c2.CP_REACTOME_ Reactome gene sets	270	1.1748457	0.12596685	0.41361725	REACTOME_GPCR_LIGAND_BINDING	306	1.0808828	0.25977933	0.78626305	2.2557285	0.0939629
GSE2706_UNSTIM_VS_2H_LPS_DC_UP	C7_ immunologic signatures	123	1.1748354	0.18284994	0.41355482	GSE2706_UNSTIM_VS_2H_LPS_DC_UP	127	0.82708204	0.8290686	1	2.00191744	0.34775336
GO_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION	c5.BP_ GO biological process	30	1.1747762	0.24279211	0.41363207	GO_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION	30	0.9345413	0.56986636	0.995486	2.1093175	0.2402349
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP	C7_ immunologic signatures	182	1.174715	0.14234875	0.41371092	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP	188	1.3098246	0.022155086	0.4261598	2.4845396	-0.1351096
KRAS.300_UP.V1_DN	C6_ oncogenic signatures	98	1.1746843	0.1716515	0.41369793	KRAS.300_UP.V1_DN	107	0.92001337	0.6617801	1	2.09469767	0.25467093
GO_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION	c5.BP_ GO biological process	48	1.1746368	0.2197183	0.41373417	GO_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION	50	1.1739002	0.22690992	0.63168	2.348537	0.0007366
GO_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS	c5.BP_ GO biological process	38	1.1746241	0.22091311	0.41367874	GO_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS	40	1.0288655	0.44379392	0.8775598	2.2034896	0.1457586
GO_MONOSACCHARIDE_TRANSPORT	c5.BP_ GO biological process	44	1.174595	0.21613833	0.4136714	GO_MONOSACCHARIDE_TRANSPORT	48	0.72303075	0.88377446	1	1.89762575	0.45156425
GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP	C7_ immunologic signatures	173	1.1745138	0.14797136	0.4138215	GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP	181	1.0600059	0.3570702	0.8243959	2.2345197	0.1145079
GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP	C7_ immunologic signatures	164	1.1745082	0.15563299	0.41374582	GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP	173	0.9845754	0.54665315	0.9422834	2.1590836	0.1899328
GOLDRATH_IMMUNE_MEMORY	c2.CGP_ chemical and genetic perturbations	60	1.1743915	0.20435968	0.41398358	GOLDRATH_IMMUNE_MEMORY	62	1.4977939	0.004366812	0.25355706	2.6721854	-0.3234024
GUILLAUMOND_KLF10_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	41	1.1743453	0.21637426	0.4140229	GUILLAUMOND_KLF10_TARGETS_UP	45	0.97901505	0.5174353	0.95033586	2.15336035	0.19533025
GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	C7_ immunologic signatures	184	1.1741179	0.13679245	0.41457108	GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	186	0.8024517	0.8909091	1	1.9765696	0.3716662
GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	C7_ immunologic signatures	167	1.1741134	0.13967136	0.41449457	GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	169	1.350452	0.013144591	0.3840843	2.5245654	-0.1763386
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN	C7_ immunologic signatures	137	1.1740503	0.17079207	0.41458166	GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN	135	1.1478064	0.20163767	0.67232555	2.3218567	0.0262439
GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	172	1.1740445	0.15065244	0.4145053	GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	176	1.1961769	0.10040568	0.59641886	2.3702214	-0.0221324
GO_CELL_ACTIVATION	c5.BP_ GO biological process	477	1.1739613	0.06400839	0.41463658	GO_CELL_ACTIVATION	477	0	0	0	1.1739613	1.1739613
GO_TUBE_FORMATION	c5.BP_ GO biological process	123	1.1738719	0.15560916	0.41480073	GO_TUBE_FORMATION	128	-1.0755216	0.18518518	0.5606996	0.0983503	2.2493935
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	c2.CGP_ chemical and genetic perturbations	106	1.1737641	0.1587708	0.41500154	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	108	1.1315515	0.23937824	0.7038875	2.3053156	0.0422126
PAX2_01	c3.TFT_ transcription factor targets	48	1.1737584	0.21783626	0.4149259	PAX2_01	50	1.1718419	0.23076923	0.63496435	2.3456003	0.0019165
MORF_NOS2A	c4.CGN_ cancer gene neighborhoods	216	1.1736604	0.13977273	0.4151125	MORF_NOS2A	237	1.1704065	0.11233701	0.637863	2.3440669	0.0032539
GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	172	1.1736228	0.13120568	0.41512764	GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	174	1.0072677	0.5045593	0.91184086	2.1808905	0.1663551
GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP	C7_ immunologic signatures	158	1.1734221	0.14250913	0.4156152	GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP	166	1.0564957	0.35300103	0.8306621	2.2299178	0.1169264
GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	159	1.173406	0.15776397	0.4155714	GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN	170	1.2965037	0.027383367	0.4475759	2.4699097	-0.1230977
HSF2_01	c3.TFT_ transcription factor targets	216	1.1732831	0.12313003	0.41582036	HSF2_01	224	1.110132	0.22690763	0.737732	2.2834151	0.0631511
CHR14Q23	C1: positional gene sets	38	1.1732458	0.20821114	0.41582972	CHR14Q23	38	1.2972673	0.10377359	0.4469542	2.4705131	-0.1240215
GO_REGULATION_OF_NEUROTRANSMITTER_LEVELS	c5.BP_ GO biological process	167	1.1730496	0.16113745	0.4162767	GO_REGULATION_OF_NEUROTRANSMITTER_LEVELS	177	1.1509935	0.1627907	0.6684208	2.3240431	0.0220561
GO_CELLULAR_RESPONSE_TO_DRUG	c5.BP_ GO biological process	61	1.1730399	0.20357634	0.41621506	GO_CELLULAR_RESPONSE_TO_DRUG	64	0.8578956	0.7236842	1	2.0309355	0.3151443
GO_REGULATION_OF_LIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	243	1.1730381	0.11569301	0.41612962	GO_REGULATION_OF_LIPID_METABOLIC_PROCESS	259	1.1402223	0.15963855	0.69030726	2.3132604	0.0328158
GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	170	1.1730118	0.14752117	0.41611513	GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP	176	1.1568681	0.17492417	0.65901655	2.3298799	0.0161437
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN	C7_ immunologic signatures	176	1.1729836	0.15558195	0.41610003	GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN	177	1.0174416	0.4593496	0.89379734	2.1904252	0.155542
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	c2.CGP_ chemical and genetic perturbations	73	1.1728302	0.19815059	0.41644654	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	75	0.7965702	0.8317359	1	1.9694004	0.37626
GO_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	15	1.1728194	0.27272728	0.4163839	GO_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY	15	0.67016083	0.8955026	1	1.84298023	0.50265857
GO_PROTEIN_PHOSPHATASE_2A_BINDING	c5.GO molecular function	26	1.1725776	0.25454545	0.4169623	GO_PROTEIN_PHOSPHATASE_2A_BINDING	27	-0.70276266	0.9101796	0.95944804	0.46981494	1.87534026
GGARNTKYCCA_UNKNOWN	c3.TFT_ transcription factor targets	64	1.172475	0.20445062	0.41714978	GGARNTKYCCA_UNKNOWN	65	1.1246992	0.28618065	0.71566	2.2971742	0.0477758
HENDRICKS_SMARCA4_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	49	1.1724141	0.21075581	0.41723877	HENDRICKS_SMARCA4_TARGETS_UP	48	1.1715984	0.21906924	0.63502955	2.3440125	0.0008157
ZHENG_GLIOBLASTOMA_PLASTICITY_DN	c2.CGP_ chemical and genetic perturbations	50	1.172329	0.20781033	0.41738063	ZHENG_GLIOBLASTOMA_PLASTICITY_DN	53	1.3557856	0.06354515	0.38034487	2.5281146	-0.1834566
KANG_IMMORTALIZED_BY_TERT_DN	c2.CGP_ chemical and genetic perturbations	78	1.1722828	0.20754717	0.41742173	KANG_IMMORTALIZED_BY_TERT_DN	89	1.14873	0.23529412	0.67007184	2.3210128	0.0235528
GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP	C7_ immunologic signatures	177	1.1719118	0.16190477	0.41835058	GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP	177	0.7604583	0.9364919	1	1.9323701	0.4114535
LTE2_UP.V1_UP	C6_ oncogenic signatures	172	1.1718086	0.14081146	0.41855007	LTE2_UP.V1_UP	176	1.2200972	0.07653061	0.55532575	2.3919058	-0.0482886
MODULE_486	c4.CM_ cancer modules	90	1.1717911	0.16821192	0.41850454	MODULE_486	91	1.2900641	0.060638297	0.45764655	2.4618552	-0.118273
SREBP1_Q6	c3.TFT_ transcription factor targets	219	1.1717228	0.1255814	0.4186041	SREBP1_Q6	224	0.8161249	0.88956434	1	1.9878477	0.3555979
GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP	C7_ immunologic signatures	176	1.1717215	0.14456391	0.4185157	GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP	175	1.0700737	0.3137056	0.80468714	2.2417952	0.1016478
GO_GLAND_DEVELOPMENT	c5.BP_ GO biological process	353	1.1716892	0.111964874	0.41851422	GO_GLAND_DEVELOPMENT	377	0.85234785	0.91	1	2.02403705	0.31934135
SCHURINGA_STAT5A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	19	1.1716748	0.2605178	0.41846034	SCHURINGA_STAT5A_TARGETS_UP	19	0.8182185	0.7351421	1	1.9898933	0.3534563
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN	C7_ immunologic signatures	170	1.1715947	0.13565426	0.4185916	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN	176	0.7703464	0.91658187	1	1.9419411	0.4012483
TAAWWATAG_RSRFC4_Q2	c3.TFT_ transcription factor targets	142	1.1715883	0.16870415	0.41851673	TAAWWATAG_RSRFC4_Q2	147	1.1963648	0.13687436	0.59632605	2.3679531	-0.0247765
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN	C7_ immunologic signatures	157	1.1715639	0.15301205	0.41849095	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN	161	0.8701573	0.7576375	1	2.0417212	0.3014066
GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	160	1.1714913	0.14814815	0.4185801	GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP	160	1.0757706	0.3174442	0.7947579	2.2472619	0.0957207
ZHAN_MULTIPLE_MYELOMA_MS_DN	c2.CGP_ chemical and genetic perturbations	34	1.1712292	0.23423423	0.4192319	ZHAN_MULTIPLE_MYELOMA_MS_DN	34	0.84617174	0.7222884	1	2.01740094	0.32505746
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	c2.CGP_ chemical and genetic perturbations	56	1.1711113	0.20699708	0.4194723	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	55	0.965544	0.5376227	0.9653032	2.1366553	0.2055673
GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN	C7_ immunologic signatures	170	1.1710712	0.15820543	0.41949004	GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN	167	0.9678861	0.58502024	0.96364605	2.1389573	0.2031851
GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN	C7_ immunologic signatures	134	1.171012	0.16981132	0.41956007	GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN	138	1.0889916	0.29724208	0.772466	2.2600036	0.0820204
MODULE_426	c4.CM_ cancer modules	72	1.1709827	0.20372836	0.41954994	MODULE_426	75	1.4982864	0.010660981	0.25334245	2.6692691	-0.3273037
GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN	C7_ immunologic signatures	171	1.1709777	0.14405762	0.41947347	GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN	173	0.84343666	0.840081	1	2.01441436	0.32754104
GO_POSTSYNAPSE	c5.CC_ GO cellular component	341	1.1707531	0.1039823	0.42000914	GO_POSTSYNAPSE	363	1.3150945	0.005005005	0.41825294	2.4858476	-0.1443414
GSE3982_EOSINOPHIL_VS_TH2_UP	C7_ immunologic signatures	165	1.1707435	0.16304348	0.41994262	GSE3982_EOSINOPHIL_VS_TH2_UP	166	1.0320759	0.4182004	0.87326044	2.2028194	0.1386676
MODULE_500	c4.CM_ cancer modules	22	1.1706958	0.23172629	0.41998115	MODULE_500	25	1.3062227	0.11375	0.43118417	2.4769185	-0.1355269
GSE17721_CTRL_VS_CPG_1H_BMDC_DN	C7_ immunologic signatures	167	1.1706214	0.16199756	0.42008626	GSE17721_CTRL_VS_CPG_1H_BMDC_DN	179	0.99509907	0.5226586	0.93053675	2.16572047	0.17552233
GO_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY	c5.BP_ GO biological process	219	1.1705189	0.118857145	0.42027876	GO_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY	225	0.65308	0.9949799	1	1.8235989	0.5174389
GSE3982_DC_VS_BCELL_DN	C7_ immunologic signatures	158	1.1704603	0.1572629	0.4203493	GSE3982_DC_VS_BCELL_DN	161	1.14667	0.19959474	0.67472726	2.3171303	0.0237903
CHR2P11	C1: positional gene sets	40	1.1704185	0.2195122	0.42036533	CHR2P11	43	0.8601528	0.7180068	1	2.0305713	0.3102657
GO_EMBRYONIC_ORGAN_DEVELOPMENT	c5.BP_ GO biological process	367	1.1703668	0.096320346	0.42042592	GO_EMBRYONIC_ORGAN_DEVELOPMENT	394	1.024106	0.431	0.8852596	2.1944728	0.1462608
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	c2.CGP_ chemical and genetic perturbations	223	1.1703014	0.12371134	0.4205164	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	229	1.2467357	0.034102306	0.5166061	2.4170371	-0.0764343
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	c2.CGP_ chemical and genetic perturbations	37	1.170274	0.2189781	0.42049637	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	39	0.924176	0.6098131	1	2.09445	0.246098
CAR_HPX	c4.CGN_ cancer gene neighborhoods	46	1.1701592	0.2294854	0.4207274	CAR_HPX	57	1.556401	0.005537099	0.20092078	2.7265602	-0.3862418
GSE7852_THYMUS_VS_FAT_TCONV_DN	C7_ immunologic signatures	176	1.170019	0.15511164	0.42103493	GSE7852_THYMUS_VS_FAT_TCONV_DN	178	1.005623	0.47052845	0.91367555	2.175642	0.164396
GO_REGULATION_OF_B_CELL_DIFFERENTIATION	c5.BP_ GO biological process	20	1.1698774	0.25188538	0.42134678	GO_REGULATION_OF_B_CELL_DIFFERENTIATION	22	1.3292786	0.10532837	0.40273976	2.499156	-0.1594012
GO_MEMBRANE_DOCKING	c5.BP_ GO biological process	62	1.1698343	0.2038835	0.42137972	GO_MEMBRANE_DOCKING	63	1.0056765	0.48540542	0.9140328	2.1755108	0.1641578
GO_SINGLE_ORGANISM_CELL_ADHESION	c5.BP_ GO biological process	388	1.1698341	0.09903122	0.42128876	GO_SINGLE_ORGANISM_CELL_ADHESION	411	1.0785149	0.236	0.79025507	2.248349	0.0913192
GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN	C7_ immunologic signatures	141	1.1697918	0.17835179	0.42131078	GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN	145	1.2545501	0.06415479	0.50244385	2.4243419	-0.0847583
GO_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION	c5.BP_ GO biological process	77	1.1697814	0.19667944	0.4212468	GO_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION	79	0.99474293	0.49201277	0.9302273	2.16452433	0.17503847
CHR16Q21	C1: positional gene sets	16	1.1695774	0.2891374	0.42173	CHR16Q21	16	0.5201134	0.9843137	1	1.6896908	0.649464
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	173	1.1694506	0.14765906	0.4219958	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	177	0.9350447	0.6596173	0.99497294	2.1044953	0.2344059
MODULE_75	c4.CM_ cancer modules	298	1.169404	0.12777779	0.4220311	MODULE_75	327	1.1404214	0.12324649	0.68989944	2.3098254	0.0289826
DITTMER_PTHLH_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	103	1.1692601	0.1806109	0.42236197	DITTMER_PTHLH_TARGETS_UP	102	0.813009	0.829653	1	1.9822691	0.3562511
GO_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	80	1.1692002	0.20211361	0.42243344	GO_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS	90	1.5665916	0.001061571	0.19146174	2.7357918	-0.3973914
GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN	C7_ immunologic signatures	181	1.1691355	0.147929	0.4225314	GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN	183	-0.97646266	0.5555556	0.7194855	0.19267284	2.14559816
GSE7852_TREG_VS_TCONV_UP	C7_ immunologic signatures	182	1.1690363	0.14733179	0.42271286	GSE7852_TREG_VS_TCONV_UP	185	1.2344409	0.049544994	0.5344044	2.4034772	-0.0654046
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN	C7_ immunologic signatures	161	1.169023	0.16440049	0.42266035	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN	167	1.3962338	0.004081633	0.3477647	2.5652568	-0.2272108
GO_RAS_PROTEIN_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	136	1.1689564	0.1641266	0.42276293	GO_RAS_PROTEIN_SIGNAL_TRANSDUCTION	136	1.0169322	0.47004133	0.8942988	2.1858886	0.1520242
GO_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND	c5.BP_ GO biological process	409	1.1689547	0.09100529	0.42267528	GO_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND	423	0.9891089	0.5335335	0.93634653	2.1580636	0.1798458
KOYAMA_SEMA3B_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	239	1.1689359	0.13926941	0.42263535	KOYAMA_SEMA3B_TARGETS_UP	243	1.4336306	0	0.31293806	2.6025665	-0.2646947
GO_DENDRITE_MORPHOGENESIS	c5.BP_ GO biological process	42	1.1689157	0.22734027	0.42260042	GO_DENDRITE_MORPHOGENESIS	42	0.82749957	0.75230414	1	1.99641527	0.34141613
GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP	C7_ immunologic signatures	133	1.1687007	0.17813268	0.42309576	GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP	136	1.2529911	0.08085977	0.5051731	2.4216918	-0.0842904
GO_MODULATION_OF_SYNAPTIC_TRANSMISSION	c5.BP_ GO biological process	271	1.168689	0.12026726	0.42303547	GO_MODULATION_OF_SYNAPTIC_TRANSMISSION	283	1.0979574	0.22868606	0.75937086	2.2666464	0.0707316
MULLIGHAN_MLL_SIGNATURE_2_DN	c2.CGP_ chemical and genetic perturbations	244	1.1686451	0.12739572	0.42306012	MULLIGHAN_MLL_SIGNATURE_2_DN	252	1.1095431	0.22222222	0.73821855	2.2781882	0.059102
P53_DN.V2_DN	C6_ oncogenic signatures	123	1.1685914	0.17766498	0.42313024	P53_DN.V2_DN	131	1.1205803	0.2525773	0.72316676	2.2891717	0.0480111
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	c2.CGP_ chemical and genetic perturbations	26	1.1684562	0.24404761	0.42341515	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	26	-0.6735011	0.9351351	0.9708968	0.4949551	1.8419573
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	C7_ immunologic signatures	174	1.1683966	0.15011548	0.42348772	GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	176	0.8997465	0.73084676	1	2.0681431	0.2686501
REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	c2.CP_REACTOME_ Reactome gene sets	17	1.1682669	0.25250837	0.42377394	REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	18	1.5170835	0.025873221	0.23565324	2.6853504	-0.3488166
GSE3982_DC_VS_TH2_UP	C7_ immunologic signatures	171	1.1682585	0.15707435	0.4237057	GSE3982_DC_VS_TH2_UP	172	1.41943	0.00304878	0.3199092	2.5876885	-0.2511715
GO_POSITIVE_REGULATION_OF_AMINE_TRANSPORT	c5.BP_ GO biological process	25	1.1682364	0.2413793	0.42367426	GO_POSITIVE_REGULATION_OF_AMINE_TRANSPORT	28	1.639174	0.009720535	0.12491471	2.8074104	-0.4709376
FOSTER_KDM1A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	212	1.1682014	0.15285881	0.42368257	FOSTER_KDM1A_TARGETS_UP	230	1.7467479	0	0.06314048	2.9149493	-0.5785465
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	c2.CGP_ chemical and genetic perturbations	47	1.1681043	0.22401172	0.4238674	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	48	0.8795026	0.698324	1	2.0476069	0.2886017
PID_TCR_PATHWAY	c2.CP_ Canonical pathways	60	1.1680831	0.20897616	0.4238331	PID_TCR_PATHWAY	63	1.3676808	0.030139936	0.37071127	2.5357639	-0.1995977
CHEN_ETV5_TARGETS_TESTIS	c2.CGP_ chemical and genetic perturbations	19	1.168083	0.26751593	0.42374316	CHEN_ETV5_TARGETS_TESTIS	20	-1.590493	0.029850746	0.09428683	-0.42241	2.758576
GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	89	1.168011	0.19028871	0.4238627	GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	100	0.970049	0.56402117	0.96169215	2.13806	0.197962
GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN	C7_ immunologic signatures	176	1.1679925	0.16844602	0.4238245	GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN	184	1.1419505	0.19653767	0.68706053	2.309943	0.026042
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	123	1.1678511	0.184178	0.4241241	GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN	130	1.1301969	0.22176592	0.70587367	2.298048	0.0376542
GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN	C7_ immunologic signatures	179	1.1676828	0.13701923	0.42452556	GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN	186	1.1588182	0.1496461	0.65513295	2.326501	0.0088646
GO_RESPONSE_TO_BACTERIUM	c5.BP_ GO biological process	376	1.1675969	0.097297296	0.424689	GO_RESPONSE_TO_BACTERIUM	404	0.9903243	0.521	0.93554956	2.1579212	0.1772726
GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP	C7_ immunologic signatures	162	1.1675617	0.17512077	0.42470115	GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP	172	1.1497623	0.18686868	0.6702266	2.317324	0.0177994
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN	c2.CGP_ chemical and genetic perturbations	19	1.1675233	0.25077882	0.42472595	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN	19	0.59783804	0.9511568	1	1.76536134	0.56968526
RATTENBACHER_BOUND_BY_CELF1	c2.CGP_ chemical and genetic perturbations	345	1.167509	0.11559433	0.4246692	RATTENBACHER_BOUND_BY_CELF1	355	1.2788066	0.013065327	0.4728448	2.4463156	-0.1112976
GO_DENDRITE_MEMBRANE	c5.CC_ GO cellular component	17	1.1674974	0.26391098	0.42461547	GO_DENDRITE_MEMBRANE	18	0.5431964	0.9739244	1	1.7106938	0.624301
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	129	1.1674731	0.17177914	0.42459282	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP	141	1.5415745	0	0.20975596	2.7090476	-0.3741014
GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP	C7_ immunologic signatures	162	1.1674258	0.15852205	0.42463455	GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP	167	1.0657452	0.33164302	0.8127661	2.233171	0.1016806
YAATNRNNNYNATT_UNKNOWN	c3.TFT_ transcription factor targets	90	1.1674218	0.20948617	0.42455462	YAATNRNNNYNATT_UNKNOWN	93	0.9537768	0.6023085	0.97753185	2.1211986	0.213645
GO_REGULATION_OF_RECEPTOR_ACTIVITY	c5.BP_ GO biological process	107	1.1673945	0.1944793	0.4245412	GO_REGULATION_OF_RECEPTOR_ACTIVITY	109	0.9638914	0.56301653	0.96697253	2.1312859	0.2035031
GO_CELLULAR_RESPONSE_TO_INTERFERON_GAMMA	c5.BP_ GO biological process	78	1.167341	0.19277108	0.4245959	GO_CELLULAR_RESPONSE_TO_INTERFERON_GAMMA	84	1.0267733	0.44823906	0.8815651	2.1941143	0.1405677
GO_RHO_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	c5.GO molecular function	70	1.1672144	0.21186441	0.42486152	GO_RHO_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	72	1.7319413	0	0.06925314	2.8991557	-0.5647269
REACTOME_DNA_REPAIR	c2.CP_REACTOME_ Reactome gene sets	97	1.167104	0.20477387	0.42507645	REACTOME_DNA_REPAIR	97	-0.93499446	0.61764705	0.7787392	0.23210954	2.10209846
REACTOME_OPIOID_SIGNALLING	c2.CP_REACTOME_ Reactome gene sets	71	1.167017	0.2085048	0.4252377	REACTOME_OPIOID_SIGNALLING	73	1.0108545	0.48442534	0.906077	2.1778715	0.1561625
GO_REGULATION_OF_ORGANELLE_ASSEMBLY	c5.BP_ GO biological process	135	1.167003	0.17668712	0.42518964	GO_REGULATION_OF_ORGANELLE_ASSEMBLY	135	0.9433068	0.6057495	0.98857665	2.1103098	0.2236962
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	c2.CGP_ chemical and genetic perturbations	60	1.1669921	0.19547872	0.42513	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	63	0.6978607	0.9346622	1	1.8648528	0.4691314
IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	c2.CGP_ chemical and genetic perturbations	26	1.1669475	0.23709677	0.42516276	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	28	0.8466052	0.7185554	1	2.0135527	0.3203423
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN	C7_ immunologic signatures	167	1.1669416	0.15523465	0.42508885	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN	175	1.1635854	0.13880445	0.64802504	2.330527	0.0033562
FXR_Q3	c3.TFT_ transcription factor targets	95	1.1668913	0.20472442	0.42514157	FXR_Q3	102	1.2932817	0.06434599	0.45239976	2.460173	-0.1263904
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN	C7_ immunologic signatures	172	1.1668775	0.14099526	0.42509228	GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN	172	1.2582529	0.05498982	0.4986793	2.4251304	-0.0913754
GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN	C7_ immunologic signatures	180	1.1668247	0.17142858	0.42514282	GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN	180	0.8311027	0.84771574	1	1.9979274	0.335722
PRC2_SUZ12_UP.V1_UP	C6_ oncogenic signatures	144	1.166807	0.16281895	0.4251047	PRC2_SUZ12_UP.V1_UP	148	1.1416088	0.20366599	0.6876142	2.3084158	0.0251982
BROWNE_HCMV_INFECTION_6HR_UP	c2.CGP_ chemical and genetic perturbations	59	1.166742	0.21220528	0.42519453	BROWNE_HCMV_INFECTION_6HR_UP	65	0.85956216	0.7285559	1	2.02630416	0.30717984
GO_RHYTHMIC_PROCESS	c5.BP_ GO biological process	267	1.1666527	0.13483146	0.42535555	GO_RHYTHMIC_PROCESS	280	0.8819907	0.8258258	1	2.0486434	0.284662
ST_JNK_MAPK_PATHWAY	c2.CP_ Canonical pathways	37	1.1664736	0.23432836	0.42578617	ST_JNK_MAPK_PATHWAY	38	0.8968406	0.64595544	1	2.0633142	0.269633
GO_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY	c5.GO molecular function	74	1.1664698	0.1967655	0.42570582	GO_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY	73	1.1251905	0.2702407	0.7148348	2.2916603	0.0412793
MODULE_182	c4.CM_ cancer modules	88	1.1663202	0.1773142	0.4260319	MODULE_182	90	-0.9047217	0.8	0.8147081	0.2615985	2.0710419
GO_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	c5.BP_ GO biological process	259	1.1663063	0.120089784	0.42598203	GO_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	266	1.2251465	0.046231154	0.5489417	2.3914528	-0.0588402
GO_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	63	1.1662649	0.21270718	0.42601317	GO_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY	63	1.2084862	0.16884531	0.58025193	2.3747511	-0.0422213
KEGG_LYSOSOME	c2.CP_BIOCARTA_ BioCarta gene sets	110	1.1661276	0.17424242	0.42631575	KEGG_LYSOSOME	113	1.3265125	0.03611971	0.406128	2.4926401	-0.1603849
GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	C7_ immunologic signatures	174	1.1661217	0.1544029	0.426241	GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	181	0.9963996	0.5156724	0.92904437	2.1625213	0.1697221
GO_REGULATION_OF_CHROMOSOME_ORGANIZATION	c5.BP_ GO biological process	252	1.1659948	0.124300115	0.4265092	GO_REGULATION_OF_CHROMOSOME_ORGANIZATION	257	0.564744	1	1	1.7307388	0.6012508
GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP	C7_ immunologic signatures	175	1.165913	0.14788732	0.4266515	GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP	180	1.135467	0.18825911	0.6964059	2.30138	0.030446
MARTINEZ_RB1_AND_TP53_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	489	1.1658942	0.09292503	0.42661384	MARTINEZ_RB1_AND_TP53_TARGETS_DN	489	0	0	0	1.1658942	1.1658942
GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	C7_ immunologic signatures	178	1.1658752	0.16009557	0.42657846	GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	178	0.74921733	0.9239351	1	1.91509253	0.41665787
GO_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION	c5.BP_ GO biological process	22	1.1656382	0.26194146	0.42716116	GO_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION	22	-0.86337024	0.6306818	0.8567668	0.30226796	2.02900844
KRAS.PROSTATE_UP.V1_DN	C6_ oncogenic signatures	107	1.1656156	0.18018018	0.427133	KRAS.PROSTATE_UP.V1_DN	113	1.276323	0.073727936	0.47869542	2.4419386	-0.1107074
GO_PROTEIN_SUMOYLATION	c5.BP_ GO biological process	108	1.1655477	0.18481013	0.42722806	GO_PROTEIN_SUMOYLATION	108	-1.1196575	0.16666667	0.4898036	0.0458902	2.2852052
GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	C7_ immunologic signatures	116	1.1653754	0.17617866	0.42762384	GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	124	0.9310884	0.64917696	0.9987731	2.0964638	0.234287
GSE360_L_MAJOR_VS_T_GONDII_DC_UP	C7_ immunologic signatures	154	1.1651484	0.15681544	0.42817354	GSE360_L_MAJOR_VS_T_GONDII_DC_UP	162	0.8899317	0.7403651	1	2.0550801	0.2752167
MODULE_385	c4.CM_ cancer modules	23	1.1649251	0.23919754	0.42871663	MODULE_385	23	-1.2199	0.15873016	0.35559058	-0.0549749	2.3848251
GO_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS	c5.BP_ GO biological process	24	1.164848	0.27357033	0.42884067	GO_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS	24	0.9496964	0.55377007	0.98256856	2.1145444	0.2151516
VEGF_A_UP.V1_UP	C6_ oncogenic signatures	166	1.1647019	0.15029585	0.42915508	VEGF_A_UP.V1_UP	174	1.0647708	0.3427992	0.814686	2.2294727	0.0999311
BROWNE_HCMV_INFECTION_20HR_DN	c2.CGP_ chemical and genetic perturbations	90	1.1646777	0.19286658	0.42912677	BROWNE_HCMV_INFECTION_20HR_DN	90	1.437284	0.011554622	0.30732846	2.6019617	-0.2726063
GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN	C7_ immunologic signatures	172	1.164345	0.16383494	0.42998087	GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN	169	0.9869529	0.52298266	0.93948525	2.1512979	0.1773921
WONG_IFNA2_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	30	1.1642122	0.24464832	0.43026355	WONG_IFNA2_RESISTANCE_DN	30	0.85903925	0.67757577	1	2.02325145	0.30517295
GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP	C7_ immunologic signatures	182	1.1641858	0.14681107	0.43025	GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP	186	1.1166933	0.22548029	0.72843325	2.2808791	0.0474925
BIOCARTA_MPR_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	32	1.1641148	0.24311927	0.43035135	BIOCARTA_MPR_PATHWAY	32	0.5306707	0.99030304	1	1.6947855	0.6334441
IL21_UP.V1_UP	C6_ oncogenic signatures	153	1.1641017	0.16483517	0.43029597	IL21_UP.V1_UP	162	1.2823025	0.039836567	0.4691905	2.4464042	-0.1182008
KORKOLA_TERATOMA	c2.CGP_ chemical and genetic perturbations	36	1.1640922	0.23502994	0.43023276	KORKOLA_TERATOMA	39	1.0309021	0.43246445	0.87383944	2.1949943	0.1331901
CEBP_Q3	c3.TFT_ transcription factor targets	211	1.1640834	0.14853801	0.4301638	CEBP_Q3	222	1.3654943	0.004020101	0.37197337	2.5295777	-0.2014109
GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	C7_ immunologic signatures	176	1.1638937	0.15402843	0.43062818	GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	184	1.3820025	0.005045409	0.35646	2.5458962	-0.2181088
SMID_BREAST_CANCER_LUMINAL_B_UP	c2.CGP_ chemical and genetic perturbations	140	1.1638744	0.16746987	0.43058953	SMID_BREAST_CANCER_LUMINAL_B_UP	150	1.3878242	0.010152284	0.34768227	2.5516986	-0.2239498
GO_L_AMINO_ACID_TRANSPORT	c5.BP_ GO biological process	54	1.1638587	0.22531293	0.43054244	GO_L_AMINO_ACID_TRANSPORT	58	0.8274995	0.7549889	1	1.9913582	0.3363592
GSE17721_CTRL_VS_CPG_12H_BMDC_DN	C7_ immunologic signatures	171	1.1637691	0.16666667	0.4306996	GSE17721_CTRL_VS_CPG_12H_BMDC_DN	176	-1.011097	0.41666666	0.6705047	0.1526721	2.1748661
REACTOME_TIGHT_JUNCTION_INTERACTIONS	c2.CP_REACTOME_ Reactome gene sets	21	1.163766	0.2682927	0.430618	REACTOME_TIGHT_JUNCTION_INTERACTIONS	24	0.57161695	0.97212124	1	1.73538295	0.59214905
GO_REGULATION_OF_TELOMERE_CAPPING	c5.BP_ GO biological process	21	1.163763	0.2608	0.4305367	GO_REGULATION_OF_TELOMERE_CAPPING	21	0.8769821	0.6654275	1	2.0407451	0.2867809
ATF2_UP.V1_UP	C6_ oncogenic signatures	148	1.1637063	0.1680774	0.43061253	ATF2_UP.V1_UP	163	0.9666992	0.55915064	0.9642549	2.1304055	0.1970071
GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	C7_ immunologic signatures	177	1.1636772	0.16346154	0.43060234	GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	179	1.0116739	0.47672066	0.9042252	2.1753511	0.1520033
AACWWCAANK_UNKNOWN	c3.TFT_ transcription factor targets	127	1.1634842	0.17357513	0.43105206	AACWWCAANK_UNKNOWN	127	0.6355184	0.9876543	1	1.7990026	0.5279658
GO_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS	c5.BP_ GO biological process	15	1.1634171	0.26272577	0.43115488	GO_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS	15	-1.7995223	0.003745318	0.032904506	-0.6361052	2.9629394
GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	171	1.1634073	0.16324063	0.4310925	GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN	177	1.251911	0.04757085	0.5081088	2.4153183	-0.0885037
GO_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE	c5.CC_ GO cellular component	18	1.1633972	0.27182865	0.4310264	GO_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE	19	0.7442672	0.81112546	1	1.9076644	0.41913
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	183	1.1633682	0.13500598	0.43102303	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP	184	1.0925459	0.2808081	0.76835704	2.2559141	0.0708223
GO_T_CELL_SELECTION	c5.BP_ GO biological process	31	1.1633478	0.2522936	0.43098584	GO_T_CELL_SELECTION	36	1.3338894	0.07701284	0.3994206	2.4972372	-0.1705416
ATGTTAA_MIR302C	c3.MIR_ microRNA targets	219	1.1632965	0.1372093	0.43104887	ATGTTAA_MIR302C	225	0.7206086	0.9718875	1	1.8839051	0.4426879
GO_MYOBLAST_FUSION	c5.BP_ GO biological process	16	1.163246	0.27450982	0.43109202	GO_MYOBLAST_FUSION	17	0.9515243	0.5246753	0.9804616	2.1147703	0.2117217
GO_SYNAPTIC_VESICLE_ENDOCYTOSIS	c5.BP_ GO biological process	17	1.1631957	0.27559054	0.43113938	GO_SYNAPTIC_VESICLE_ENDOCYTOSIS	17	1.3710077	0.10090556	0.36741573	2.5342034	-0.207812
GO_AUTOPHAGY	c5.BP_ GO biological process	336	1.1631384	0.10405257	0.43120527	GO_AUTOPHAGY	340	0.94103986	0.6966967	0.9896396	2.10417826	0.22209854
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	167	1.1631035	0.17105263	0.43121192	GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	176	1.0190531	0.45020324	0.8919707	2.1821566	0.1440504
GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN	C7_ immunologic signatures	129	1.1630812	0.15906289	0.43118933	GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN	128	1.1176422	0.25793245	0.7275661	2.2807234	0.045439
GO_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION	c5.BP_ GO biological process	16	1.1630713	0.27850163	0.43112892	GO_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION	17	1.8159983	0	0.028795982	2.9790696	-0.652927
OSADA_ASCL1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	40	1.1630268	0.21947674	0.4311616	OSADA_ASCL1_TARGETS_UP	42	1.4711977	0.026166098	0.2753145	2.6342245	-0.3081709
GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP	C7_ immunologic signatures	180	1.1630169	0.16129032	0.43109858	GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP	181	0.8729518	0.79373103	1	2.0359687	0.2900651
YANAGIHARA_ESX1_TARGETS	c2.CGP_ chemical and genetic perturbations	29	1.1629788	0.24851191	0.4311174	YANAGIHARA_ESX1_TARGETS	29	-0.74990433	0.875	0.9393262	0.41307447	1.91288313
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN	C7_ immunologic signatures	130	1.1629518	0.17747858	0.43110025	GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN	136	1.3223712	0.030549899	0.41130325	2.485323	-0.1594194
GO_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY	c5.BP_ GO biological process	50	1.1629193	0.2315341	0.43109968	GO_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY	51	-0.9647402	0.5882353	0.7357027	0.1981791	2.1276595
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	c2.CGP_ chemical and genetic perturbations	73	1.1629173	0.20793433	0.43101376	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	78	1.4885813	0.008412197	0.260914	2.6514986	-0.325664
KYNG_WERNER_SYNDROM_UP	c2.CGP_ chemical and genetic perturbations	17	1.1628466	0.2808642	0.43111938	KYNG_WERNER_SYNDROM_UP	17	0.7425651	0.826972	1	1.9054117	0.4202815
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN	C7_ immunologic signatures	165	1.162756	0.16248506	0.43127456	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN	177	0.8541558	0.8083164	1	2.0169118	0.3086002
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	c2.CGP_ chemical and genetic perturbations	67	1.1626534	0.2123656	0.43147075	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	67	-1.2520384	0.072916664	0.32140017	-0.089385	2.4146918
GO_ANION_ANION_ANTIPORTER_ACTIVITY	c5.GO molecular function	18	1.1624976	0.25791138	0.43181288	GO_ANION_ANION_ANTIPORTER_ACTIVITY	20	1.0938147	0.36340854	0.76774716	2.2563123	0.0686829
NGUYEN_NOTCH1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	80	1.162474	0.21875	0.43178734	NGUYEN_NOTCH1_TARGETS_DN	81	0.832913	0.7925134	1	1.995387	0.329561
GSE13547_WT_VS_ZFX_KO_BCELL_UP	C7_ immunologic signatures	142	1.1624062	0.15107913	0.43187517	GSE13547_WT_VS_ZFX_KO_BCELL_UP	146	1.3184735	0.027635619	0.41304678	2.4808797	-0.1560673
GO_EXTRACELLULAR_MATRIX_ASSEMBLY	c5.BP_ GO biological process	15	1.1623163	0.26130652	0.43204457	GO_EXTRACELLULAR_MATRIX_ASSEMBLY	16	-0.8360404	0.70612246	0.87715095	0.3262759	1.9983567
GO_AUTOPHAGOSOME_MEMBRANE	c5.CC_ GO cellular component	26	1.1623048	0.2942097	0.4319891	GO_AUTOPHAGOSOME_MEMBRANE	26	1.1383964	0.30552146	0.6934207	2.3007012	0.0239084
GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN	C7_ immunologic signatures	176	1.1623017	0.15429917	0.43190587	GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN	176	1.2379994	0.06477733	0.52862936	2.4003011	-0.0756977
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	c2.CGP_ chemical and genetic perturbations	32	1.16223	0.24655436	0.4320239	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	32	1.0856277	0.3702381	0.77671754	2.2478577	0.0766023
GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP	C7_ immunologic signatures	179	1.1622013	0.16705337	0.4320145	GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP	191	1.0523691	0.3830645	0.8368569	2.2145704	0.1098322
BIOCARTA_INSULIN_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	21	1.1621467	0.23882897	0.4320867	BIOCARTA_INSULIN_PATHWAY	22	-1.0545526	0.35321102	0.59607685	0.1075941	2.2166993
GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	160	1.1621253	0.1643026	0.4320607	GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP	165	1.1701895	0.15212981	0.63811266	2.3323148	-0.0080642
GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	C7_ immunologic signatures	178	1.1620996	0.15602838	0.43204182	GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	182	0.89667386	0.74974775	1	2.05877346	0.26542574
GO_AUDITORY_RECEPTOR_CELL_DEVELOPMENT	c5.BP_ GO biological process	17	1.1619335	0.27669904	0.43241623	GO_AUDITORY_RECEPTOR_CELL_DEVELOPMENT	17	-1.0297972	0.40789473	0.63944376	0.1321363	2.1917307
MORF_MAGEA9	c4.CGN_ cancer gene neighborhoods	325	1.1616577	0.123608015	0.4331173	MORF_MAGEA9	352	1.1946282	0.045045044	0.5977908	2.3562859	-0.0329705
GO_POSITIVE_REGULATION_OF_GROWTH	c5.BP_ GO biological process	207	1.161656	0.14454976	0.43303114	GO_POSITIVE_REGULATION_OF_GROWTH	224	1.1553262	0.14056225	0.6614957	2.3169822	0.0063298
GO_SIDE_OF_MEMBRANE	c5.CC_ GO cellular component	336	1.161556	0.10086768	0.43323496	GO_SIDE_OF_MEMBRANE	364	1.2144245	0.027	0.56864864	2.3759805	-0.0528685
GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN	C7_ immunologic signatures	155	1.1615207	0.16747573	0.43324107	GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN	155	-0.8077891	0.93333334	0.8981096	0.3537316	1.9693098
BURTON_ADIPOGENESIS_11	c2.CGP_ chemical and genetic perturbations	52	1.1614563	0.22955523	0.43332905	BURTON_ADIPOGENESIS_11	52	-1.1347001	0.23076923	0.46528873	0.0267562	2.2961564
GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN	C7_ immunologic signatures	180	1.1614262	0.1826809	0.4333221	GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN	185	1.1595137	0.1611279	0.65317607	2.3209399	0.0019125
GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN	C7_ immunologic signatures	168	1.1614121	0.1501182	0.43327418	GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN	171	0.9934736	0.5156724	0.9308941	2.1548857	0.1679385
GO_CATION_TRANSPORTING_ATPASE_ACTIVITY	c5.GO molecular function	46	1.1613778	0.22720897	0.43327993	GO_CATION_TRANSPORTING_ATPASE_ACTIVITY	51	1.0033569	0.47469068	0.9176522	2.1647347	0.1580209
GO_MACROPHAGE_DIFFERENTIATION	c5.BP_ GO biological process	16	1.1612097	0.2931596	0.43366694	GO_MACROPHAGE_DIFFERENTIATION	17	1.0779461	0.3838384	0.79158926	2.2391558	0.0832636
GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	C7_ immunologic signatures	177	1.1611608	0.1514423	0.4337156	GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	181	0.88884676	0.77281946	1	2.05000756	0.27231404
GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	94	1.1611341	0.19633508	0.43370083	GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	100	0.97409445	0.53382665	0.9568128	2.13522855	0.18703965
APPEL_IMATINIB_RESPONSE	c2.CGP_ chemical and genetic perturbations	29	1.1611149	0.23909774	0.43365845	APPEL_IMATINIB_RESPONSE	28	1.4680934	0.026927784	0.27728802	2.6292083	-0.3069785
KEGG_BASAL_CELL_CARCINOMA	c2.CP_BIOCARTA_ BioCarta gene sets	48	1.1610787	0.2296719	0.4336697	KEGG_BASAL_CELL_CARCINOMA	54	-0.9560597	0.5232558	0.74770343	0.205019	2.1171384
GO_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE	c5.BP_ GO biological process	63	1.1609927	0.21807748	0.43382943	GO_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE	66	-1.3410618	0.04819277	0.24805938	-0.1800691	2.5020545
REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING	c2.CP_REACTOME_ Reactome gene sets	29	1.1609416	0.25584796	0.43387952	REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING	29	0.6445157	0.93436754	1	1.8054573	0.5164259
LANDIS_ERBB2_BREAST_TUMORS_324_DN	c2.CGP_ chemical and genetic perturbations	137	1.1609116	0.16383494	0.43386978	LANDIS_ERBB2_BREAST_TUMORS_324_DN	137	0.82693726	0.83811474	1	1.98784886	0.33397434
GO_HYALURONAN_METABOLIC_PROCESS	c5.BP_ GO biological process	27	1.1607734	0.2631579	0.43417624	GO_HYALURONAN_METABOLIC_PROCESS	27	0.83140486	0.72493887	1	1.99217826	0.32936854
GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP	C7_ immunologic signatures	164	1.1607577	0.16428572	0.43412924	GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP	169	0.8135554	0.88617885	1	1.9743131	0.3472023
NUMATA_CSF3_SIGNALING_VIA_STAT3	c2.CGP_ chemical and genetic perturbations	20	1.1607511	0.26969698	0.43405625	NUMATA_CSF3_SIGNALING_VIA_STAT3	22	-1.4523423	0.07462686	0.1718276	-0.2915912	2.6130934
GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP	C7_ immunologic signatures	135	1.160743	0.17967781	0.433985	GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP	137	1.1814693	0.1680162	0.620589	2.3422123	-0.0207263
GCM_MAP4K4	c4.CGN_ cancer gene neighborhoods	155	1.1605924	0.16545893	0.4343145	GCM_MAP4K4	155	0.9654447	0.5891947	0.9649756	2.1260371	0.1951477
GO_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	c5.GO molecular function	413	1.1604723	0.103521876	0.43456727	GO_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	419	1.2872881	0.005005005	0.46219113	2.4477604	-0.1268158
MORF_RAGE	c4.CGN_ cancer gene neighborhoods	124	1.1604578	0.17713568	0.43451732	MORF_RAGE	132	1.07651	0.3135246	0.79435724	2.2369678	0.0839478
MYAATNNNNNNNGGC_UNKNOWN	c3.TFT_ transcription factor targets	97	1.1604272	0.2	0.43451574	MYAATNNNNNNNGGC_UNKNOWN	103	0.789547	0.8557994	1	1.9499742	0.3708802
CHR1Q42	C1: positional gene sets	72	1.1603446	0.21495327	0.43465868	CHR1Q42	74	1.4206933	0.024891775	0.31824782	2.5810379	-0.2603487
GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	C7_ immunologic signatures	143	1.1601131	0.18411553	0.4352313	GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	143	1.161288	0.16207951	0.6511864	2.3214011	-0.0011749
FOSTER_TOLERANT_MACROPHAGE_UP	c2.CGP_ chemical and genetic perturbations	137	1.1600572	0.17676143	0.43531084	FOSTER_TOLERANT_MACROPHAGE_UP	136	1.0183866	0.45667687	0.8923889	2.1784438	0.1416706
PAX8_01	c3.TFT_ transcription factor targets	32	1.1599231	0.23432836	0.43560484	PAX8_01	34	0.634081	0.9481928	1	1.7940041	0.5258421
GO_CHEMOATTRACTANT_ACTIVITY	c5.GO molecular function	21	1.1599076	0.24646781	0.43555817	GO_CHEMOATTRACTANT_ACTIVITY	23	0.7664859	0.80323786	1	1.9263935	0.3934217
FOXM1_01	c3.TFT_ transcription factor targets	209	1.1598475	0.14400922	0.4356426	FOXM1_01	220	1.0496299	0.35850957	0.8407268	2.2094774	0.1102176
NFY_Q6_01	c3.TFT_ transcription factor targets	230	1.1598195	0.13295455	0.43562895	NFY_Q6_01	240	0.90511876	0.76690215	1	2.06493826	0.25470074
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP	C7_ immunologic signatures	186	1.1597744	0.14765906	0.435665	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP	188	1.3254954	0.012170386	0.40679234	2.4852698	-0.165721
YAMAZAKI_TCEB3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	190	1.1596284	0.16295429	0.43598992	YAMAZAKI_TCEB3_TARGETS_DN	191	1.1537292	0.15593562	0.66304934	2.3133576	0.0058992
GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN	C7_ immunologic signatures	131	1.159627	0.17958179	0.43590218	GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN	140	1.0053128	0.49544072	0.9142022	2.1649398	0.1543142
FALVELLA_SMOKERS_WITH_LUNG_CANCER	c2.CGP_ chemical and genetic perturbations	69	1.1596085	0.21045576	0.43586424	FALVELLA_SMOKERS_WITH_LUNG_CANCER	72	0.9389268	0.60714287	0.99138194	2.0985353	0.2206817
GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP	C7_ immunologic signatures	167	1.1595985	0.17411764	0.43579832	GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP	178	1.0312823	0.44252288	0.8742725	2.1908808	0.1283162
GO_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY	c5.BP_ GO biological process	71	1.1592695	0.21512386	0.43665946	GO_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY	72	0.8333817	0.7897545	1	1.9926512	0.3258878
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	c2.CGP_ chemical and genetic perturbations	20	1.159188	0.25974026	0.43680075	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	20	1.0327601	0.4351145	0.87244654	2.1919481	0.1264279
NEWMAN_ERCC6_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	20	1.1590554	0.28363046	0.437087	NEWMAN_ERCC6_TARGETS_UP	20	1.2932531	0.1432258	0.45201167	2.4523085	-0.1341977
GSE3982_DC_VS_TH1_DN	C7_ immunologic signatures	168	1.1590468	0.1688466	0.43701914	GSE3982_DC_VS_TH1_DN	172	0.94577014	0.6203046	0.9862798	2.10481694	0.21327666
GO_NEGATIVE_REGULATION_OF_PROTEIN_BINDING	c5.BP_ GO biological process	75	1.1589762	0.21921515	0.4371281	GO_NEGATIVE_REGULATION_OF_PROTEIN_BINDING	75	1.0132778	0.4814815	0.90106887	2.172254	0.1456984
GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP	C7_ immunologic signatures	151	1.1589297	0.1773399	0.4371639	GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP	154	-1.107922	0.25	0.5061633	0.0510077	2.2668517
GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN	C7_ immunologic signatures	180	1.1589053	0.16488731	0.43714136	GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN	181	1.161116	0.16125761	0.65111613	2.3200213	-0.0022107
REACTOME_G_ALPHA1213_SIGNALLING_EVENTS	c2.CP_REACTOME_ Reactome gene sets	70	1.1586628	0.22913907	0.43772566	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS	71	1.368114	0.043243244	0.3708511	2.5267768	-0.2094512
LEE_LIVER_CANCER_DENA_UP	c2.CGP_ chemical and genetic perturbations	51	1.158604	0.22141823	0.43780002	LEE_LIVER_CANCER_DENA_UP	51	1.207668	0.17425968	0.5806704	2.366272	-0.049064
KEGG_NITROGEN_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	20	1.1585747	0.251497	0.4377878	KEGG_NITROGEN_METABOLISM	22	1.0443407	0.43929914	0.8497267	2.2029154	0.114234
GO_PROTEIN_DEPHOSPHORYLATION	c5.BP_ GO biological process	172	1.1585351	0.16965352	0.43781427	GO_PROTEIN_DEPHOSPHORYLATION	175	1.0534418	0.37588653	0.83663195	2.2119769	0.1050933
GO_CENTROSOME_LOCALIZATION	c5.BP_ GO biological process	17	1.158224	0.27302632	0.43860644	GO_CENTROSOME_LOCALIZATION	17	1.2519946	0.17487046	0.50839484	2.4102186	-0.0937706
KEGG_DORSO_VENTRAL_AXIS_FORMATION	c2.CP_BIOCARTA_ BioCarta gene sets	21	1.1582137	0.26677066	0.4385426	KEGG_DORSO_VENTRAL_AXIS_FORMATION	21	1.1113306	0.3359375	0.7354721	2.2695443	0.0468831
GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	171	1.1581515	0.15632458	0.43861067	GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	184	1.5010828	0	0.25258875	2.6592343	-0.3429313
PDGF_ERK_DN.V1_DN	C6_ oncogenic signatures	129	1.1580547	0.1923077	0.43879515	PDGF_ERK_DN.V1_DN	134	0.632747	0.99185336	1	1.7908017	0.5253077
GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP	C7_ immunologic signatures	165	1.1579919	0.1692491	0.43888652	GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP	180	1.0451405	0.389899	0.8490744	2.2031324	0.1128514
ZHENG_FOXP3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	22	1.1579869	0.25076452	0.43881077	ZHENG_FOXP3_TARGETS_UP	24	0.783108	0.80147964	1	1.9410949	0.3748789
GO_REGULATION_OF_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	349	1.1579592	0.11542611	0.43879923	GO_REGULATION_OF_TRANSMEMBRANE_TRANSPORT	386	1.2740401	0.009009009	0.48164052	2.4319993	-0.1160809
GO_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS	c5.BP_ GO biological process	19	1.1577628	0.26655897	0.43926734	GO_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS	23	1.0444292	0.42458808	0.8497749	2.202192	0.1133336
GO_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	17	1.1576731	0.27316293	0.43943158	GO_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	16	-0.8604234	0.66523606	0.86014867	0.2972497	2.0180965
ELVIDGE_HIF1A_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	87	1.1576568	0.20502645	0.439387	ELVIDGE_HIF1A_TARGETS_DN	87	1.1804188	0.19083156	0.62328595	2.3380756	-0.022762
MORF_CAMK4	c4.CGN_ cancer gene neighborhoods	221	1.1576501	0.15679443	0.43931293	MORF_CAMK4	236	1.3010327	0.014070352	0.43951812	2.4586828	-0.1433826
BIOCARTA_BCELLSURVIVAL_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	1.1575617	0.2752443	0.4394673	BIOCARTA_BCELLSURVIVAL_PATHWAY	16	0.86949474	0.67112297	1	2.02705644	0.28806696
REACTOME_PLC_BETA_MEDIATED_EVENTS	c2.CP_REACTOME_ Reactome gene sets	38	1.157469	0.24671532	0.43964487	REACTOME_PLC_BETA_MEDIATED_EVENTS	39	0.8894521	0.6589057	1	2.0469211	0.2680169
GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP	C7_ immunologic signatures	167	1.1573664	0.1718377	0.43984228	GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP	177	1.1082835	0.27208123	0.74089897	2.2656499	0.0490829
GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP	C7_ immunologic signatures	162	1.1573532	0.17081851	0.43978822	GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP	170	1.0508655	0.39776194	0.83832884	2.2082187	0.1064877
GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN	C7_ immunologic signatures	149	1.1571307	0.17191283	0.4403385	GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN	158	1.0972725	0.27670395	0.7599996	2.2544032	0.0598582
GSE45365_NK_CELL_VS_CD11B_DC_UP	C7_ immunologic signatures	155	1.1569755	0.1626506	0.4406859	GSE45365_NK_CELL_VS_CD11B_DC_UP	176	1.1908845	0.11054767	0.6043001	2.34786	-0.033909
GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN	C7_ immunologic signatures	177	1.1567678	0.15005861	0.44119114	GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN	180	0.8068559	0.8968335	1	1.9636237	0.3499119
REACTOME_NEPHRIN_INTERACTIONS	c2.CP_REACTOME_ Reactome gene sets	19	1.1567076	0.26973686	0.441267	REACTOME_NEPHRIN_INTERACTIONS	19	1.3107591	0.1321474	0.42529878	2.4674667	-0.1540515
GSE14415_INDUCED_TREG_VS_TCONV_DN	C7_ immunologic signatures	136	1.156649	0.18271606	0.44134915	GSE14415_INDUCED_TREG_VS_TCONV_DN	140	1.5473065	0	0.20645916	2.7039555	-0.3906575
GO_SYNAPTIC_MEMBRANE	c5.CC_ GO cellular component	227	1.1565734	0.14053427	0.4414671	GO_SYNAPTIC_MEMBRANE	247	1.3688984	0.004020101	0.36901692	2.5254718	-0.212325
MODULE_166	c4.CM_ cancer modules	45	1.156567	0.22081575	0.44139448	MODULE_166	46	0.98091584	0.52783966	0.9481789	2.13748284	0.17565116
BROWNE_HCMV_INFECTION_12HR_UP	c2.CGP_ chemical and genetic perturbations	90	1.1565198	0.2058433	0.44144246	BROWNE_HCMV_INFECTION_12HR_UP	93	0.87455386	0.71666664	1	2.03107366	0.28196594
GO_LEUKOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	261	1.1564993	0.14333707	0.44140515	GO_LEUKOCYTE_DIFFERENTIATION	267	1.0631263	0.33066133	0.8167167	2.2196256	0.093373
GO_NEPHRON_EPITHELIUM_DEVELOPMENT	c5.BP_ GO biological process	87	1.1564769	0.20560747	0.4413717	GO_NEPHRON_EPITHELIUM_DEVELOPMENT	90	1.0575804	0.38941798	0.8283142	2.2140573	0.0988965
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP	C7_ immunologic signatures	164	1.1564051	0.17064439	0.44148803	GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP	167	0.87220913	0.76993865	1	2.02861423	0.28419597
GO_ACTIVE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	140	1.1563236	0.17490953	0.4416339	GO_ACTIVE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	156	1.2062913	0.100712106	0.58202875	2.3626149	-0.0499677
DING_LUNG_CANCER_BY_MUTATION_RATE	c2.CGP_ chemical and genetic perturbations	18	1.1562955	0.2703125	0.4416183	DING_LUNG_CANCER_BY_MUTATION_RATE	20	1.3353275	0.10459184	0.39817473	2.491623	-0.179032
GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	166	1.1562536	0.16053921	0.4416442	GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	174	1.0611559	0.36317396	0.8215601	2.2174095	0.0950977
GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN	C7_ immunologic signatures	172	1.1562045	0.15933412	0.4416877	GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN	178	1.3816004	0.008130081	0.35652018	2.5378049	-0.2253959
GO_REGULATION_OF_STAT_CASCADE	c5.BP_ GO biological process	122	1.1561918	0.19600499	0.44163096	GO_REGULATION_OF_STAT_CASCADE	129	0.71072894	0.9628483	1	1.86692074	0.44546286
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	c2.CGP_ chemical and genetic perturbations	218	1.1561753	0.14568764	0.4415889	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	227	1.2038274	0.07329317	0.5849824	2.3600027	-0.0476521
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP	C7_ immunologic signatures	178	1.1560943	0.17061612	0.44172832	GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP	181	1.1957252	0.09706774	0.59699565	2.3518195	-0.0396309
GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	188	1.1559831	0.16238318	0.44196025	GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	187	1.108065	0.2347561	0.7412609	2.2640481	0.0479181
LEIN_OLIGODENDROCYTE_MARKERS	c2.CGP_ chemical and genetic perturbations	69	1.1559765	0.22099447	0.44188926	LEIN_OLIGODENDROCYTE_MARKERS	72	1.0352131	0.41847825	0.86719215	2.1911896	0.1207634
GO_RESPONSE_TO_VIRUS	c5.BP_ GO biological process	202	1.1558354	0.1704142	0.44219303	GO_RESPONSE_TO_VIRUS	202	0.90214807	0.7301906	1	2.05798347	0.25368733
GO_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING	c5.GO molecular function	15	1.155711	0.2672956	0.44246545	GO_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING	15	0	0	0	1.155711	1.155711
GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	C7_ immunologic signatures	182	1.1556376	0.17323776	0.44259238	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	182	1.1691283	0.13908629	0.6393144	2.3247659	-0.0134907
HUI_MAPK14_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	20	1.1556348	0.26190478	0.44250956	HUI_MAPK14_TARGETS_UP	20	1.0940871	0.37003842	0.7671104	2.2497219	0.0615477
RGAGGAARY_PU1_Q6	c3.TFT_ transcription factor targets	440	1.1554315	0.11456103	0.44301164	RGAGGAARY_PU1_Q6	456	1.1401296	0.093	0.6903917	2.2955611	0.0153019
GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	C7_ immunologic signatures	176	1.1552957	0.15357143	0.443304	GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	182	1.1942822	0.10909091	0.5982052	2.3495779	-0.0389865
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	c2.CGP_ chemical and genetic perturbations	69	1.1551067	0.21161826	0.44375813	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	71	1.2537858	0.10869565	0.5033149	2.4088925	-0.0986791
GSE6875_TCONV_VS_FOXP3_KO_TREG_UP	C7_ immunologic signatures	166	1.1548569	0.17282479	0.44439968	GSE6875_TCONV_VS_FOXP3_KO_TREG_UP	173	0.8988442	0.7231237	1	2.0537011	0.2560127
GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	C7_ immunologic signatures	174	1.1548088	0.18213867	0.44444692	GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	176	1.3365576	0.010131712	0.39787728	2.4913664	-0.1817488
MODULE_324	c4.CM_ cancer modules	107	1.154622	0.19974227	0.44490868	MODULE_324	116	1.4736503	0.00625	0.27556258	2.6282723	-0.3190283
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN	C7_ immunologic signatures	179	1.1545985	0.16705883	0.44488302	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN	181	1.0252199	0.45171025	0.8835298	2.1798184	0.1293786
RAF_UP.V1_UP	C6_ oncogenic signatures	166	1.1545949	0.17626321	0.4448019	RAF_UP.V1_UP	173	1.2897688	0.034623217	0.4581262	2.4443637	-0.1351739
P53_DECAMER_Q2	c3.TFT_ transcription factor targets	217	1.1545805	0.15525115	0.44475436	P53_DECAMER_Q2	221	1.2196714	0.06653226	0.55561364	2.3742519	-0.0650909
GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	139	1.1545581	0.17813268	0.44472954	GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	144	1.070006	0.36270493	0.8046758	2.2245641	0.0845521
GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	154	1.1544933	0.17028986	0.44482565	GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP	154	-1.6907539	0	0.058635898	-0.5362606	2.8452472
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	C7_ immunologic signatures	172	1.1544591	0.17724551	0.44482225	GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	178	1.1677583	0.1627907	0.6406851	2.3222174	-0.0132992
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	17	1.1543859	0.284127	0.44495824	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	19	1.3297945	0.11734029	0.40298107	2.4841804	-0.1754086
TCF11_01	c3.TFT_ transcription factor targets	224	1.1543856	0.16225547	0.44486696	TCF11_01	232	0.8570491	0.8288288	1	2.0114347	0.2973365
GO_GLIOGENESIS	c5.BP_ GO biological process	157	1.1541885	0.1576414	0.44534543	GO_GLIOGENESIS	161	-1.262473	0.05	0.3131583	-0.1082845	2.4166615
GO_PEPTIDE_TRANSPORT	c5.BP_ GO biological process	62	1.1541749	0.2293956	0.4452943	GO_PEPTIDE_TRANSPORT	68	1.0604463	0.388584	0.82303005	2.2146212	0.0937286
GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN	C7_ immunologic signatures	177	1.1540369	0.17591499	0.44558942	GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN	177	0.85085297	0.8331627	1	2.00488987	0.30318393
GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN	C7_ immunologic signatures	163	1.1539544	0.17261904	0.44572628	GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN	175	0.9675091	0.5779352	0.96400875	2.1214635	0.1864453
GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP	C7_ immunologic signatures	175	1.1538041	0.17570755	0.44606182	GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP	178	1.1305865	0.2218845	0.7059	2.2843906	0.0232176
GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	170	1.1537625	0.18313253	0.44608885	GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	173	1.0022715	0.4863222	0.9196903	2.156034	0.151491
GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	C7_ immunologic signatures	169	1.153733	0.17598097	0.44608325	GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	176	1.1342429	0.19653767	0.6989169	2.2879759	0.0194901
GO_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL	c5.BP_ GO biological process	29	1.1536055	0.24411765	0.44635764	GO_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL	30	0.91551787	0.6041413	1	2.06912337	0.23808763
HALLMARK_WNT_BETA_CATENIN_SIGNALING	H_ hallmark gene sets	41	1.1535842	0.25178826	0.44632584	HALLMARK_WNT_BETA_CATENIN_SIGNALING	41	-0.96048725	0.5	0.7420139	0.19309695	2.11407145
PID_ARF6_TRAFFICKING_PATHWAY	c2.CP_ Canonical pathways	47	1.1535498	0.23382352	0.44633788	PID_ARF6_TRAFFICKING_PATHWAY	49	0.9034675	0.640625	1	2.0570173	0.2500823
RAPA_EARLY_UP.V1_DN	C6_ oncogenic signatures	158	1.1532377	0.18389423	0.44716534	RAPA_EARLY_UP.V1_DN	164	0.7178281	0.96153843	1	1.8710658	0.4354096
GO_ACIDIC_AMINO_ACID_TRANSPORT	c5.BP_ GO biological process	20	1.153189	0.26934984	0.4472127	GO_ACIDIC_AMINO_ACID_TRANSPORT	21	0.85722023	0.68106735	1	2.01040923	0.29596877
HOLLERN_SQUAMOUS_BREAST_TUMOR	c2.CGP_ chemical and genetic perturbations	84	1.153165	0.21813403	0.447184	HOLLERN_SQUAMOUS_BREAST_TUMOR	93	1.2951106	0.063424945	0.4492082	2.4482756	-0.1419456
MORF_FOSL1	c4.CGN_ cancer gene neighborhoods	316	1.1530724	0.121412806	0.44734615	MORF_FOSL1	341	1.2240295	0.02002002	0.55027187	2.3771019	-0.0709571
GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	C7_ immunologic signatures	171	1.153061	0.16666667	0.44728428	GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	174	1.0261985	0.4473684	0.88248277	2.1792595	0.1268625
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN	C7_ immunologic signatures	130	1.1530557	0.18414322	0.44720805	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN	139	1.1199961	0.258956	0.7232957	2.2730518	0.0330596
GO_EXOCRINE_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	41	1.1530281	0.23873875	0.44719842	GO_EXOCRINE_SYSTEM_DEVELOPMENT	41	1.0979	0.33449477	0.7591483	2.2509281	0.0551281
MODULE_521	c4.CM_ cancer modules	31	1.1529169	0.23929098	0.44742146	MODULE_521	34	1.3033597	0.12232779	0.4363317	2.4562766	-0.1504428
GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	C7_ immunologic signatures	124	1.1525416	0.19386503	0.44840118	GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	132	1.2981069	0.033570703	0.4450102	2.4506485	-0.1455653
GO_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	48	1.1522807	0.22521247	0.44907448	GO_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE	48	1.1138476	0.3114383	0.7318122	2.2661283	0.0384331
GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN	C7_ immunologic signatures	122	1.1522369	0.18796068	0.44910198	GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN	132	1.2923565	0.053169735	0.45347834	2.4445934	-0.1401196
GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP	C7_ immunologic signatures	178	1.1522206	0.16113745	0.4490582	GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP	181	1.2390084	0.05691057	0.5269044	2.391229	-0.0867878
GSE2585_THYMIC_DC_VS_MTEC_DN	C7_ immunologic signatures	164	1.1519758	0.18159807	0.44966444	GSE2585_THYMIC_DC_VS_MTEC_DN	169	1.1651967	0.17977528	0.6460859	2.3171725	-0.0132209
GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	157	1.1517849	0.20479041	0.45013493	GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN	160	1.0502146	0.39041793	0.839818	2.2019995	0.1015703
GSE2585_CTEC_VS_THYMIC_DC_UP	C7_ immunologic signatures	161	1.1517762	0.18040621	0.45006388	GSE2585_CTEC_VS_THYMIC_DC_UP	168	1.083189	0.29399797	0.7816552	2.2349652	0.0685872
XU_RESPONSE_TO_TRETINOIN_UP	c2.CGP_ chemical and genetic perturbations	15	1.1517527	0.2983871	0.45003965	XU_RESPONSE_TO_TRETINOIN_UP	15	1.0106314	0.4813864	0.9064123	2.1623841	0.1411213
GSE15330_WT_VS_IKAROS_KO_HSC_UP	C7_ immunologic signatures	180	1.1516804	0.1692491	0.4501437	GSE15330_WT_VS_IKAROS_KO_HSC_UP	185	1.2304081	0.06572295	0.539853	2.3820885	-0.0787277
GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN	C7_ immunologic signatures	120	1.1516541	0.20451693	0.4501258	GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN	128	0.884929	0.7311272	1	2.0365831	0.2667251
GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN	C7_ immunologic signatures	173	1.1516325	0.17827627	0.45009583	GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN	178	1.0828586	0.31350806	0.782253	2.2344911	0.0687739
TAATGTG_MIR323	c3.MIR_ microRNA targets	150	1.151433	0.18973747	0.45057094	TAATGTG_MIR323	152	-0.98504055	0.55	0.70713335	0.16639245	2.13647355
GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	C7_ immunologic signatures	178	1.1514308	0.17556347	0.45048535	GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	181	1.1147925	0.22076613	0.7311419	2.2662233	0.0366383
REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	37	1.1514126	0.24324325	0.4504439	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	40	-1.4390585	0.0390625	0.18033625	-0.2876459	2.5904711
GO_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS	c5.BP_ GO biological process	80	1.1513014	0.20181112	0.45067596	GO_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS	85	1.3375142	0.05010661	0.39776003	2.4888156	-0.1862128
GO_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN	c5.BP_ GO biological process	15	1.1512094	0.28688523	0.45083046	GO_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN	19	0.8393474	0.6848958	1	1.9905568	0.311862
GSE2585_CD80_HIGH_VS_LOW_MTEC_UP	C7_ immunologic signatures	154	1.1511801	0.17338218	0.45082828	GSE2585_CD80_HIGH_VS_LOW_MTEC_UP	170	1.2866707	0.039513677	0.46228737	2.4378508	-0.1354906
GSE2585_CTEC_VS_MTEC_THYMUS_DN	C7_ immunologic signatures	168	1.1511426	0.18083832	0.450851	GSE2585_CTEC_VS_MTEC_THYMUS_DN	174	1.2841789	0.033536587	0.4657347	2.4353215	-0.1330363
GSE23568_ID3_KO_VS_WT_CD8_TCELL_UP	C7_ immunologic signatures	176	1.1511177	0.18612717	0.45083302	GSE23568_ID3_KO_VS_WT_CD8_TCELL_UP	177	0.64494103	0.9938838	1	1.79605873	0.50617667
GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	C7_ immunologic signatures	168	1.1510943	0.16845877	0.45081273	GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	171	1.150922	0.16361788	0.66807544	2.3020163	0.0001723
GO_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM	c5.BP_ GO biological process	30	1.1510161	0.259542	0.4509498	GO_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM	38	1.2513475	0.14350797	0.5093903	2.4023636	-0.1003314
SESTO_RESPONSE_TO_UV_C8	c2.CGP_ chemical and genetic perturbations	68	1.1510075	0.22468793	0.45087484	SESTO_RESPONSE_TO_UV_C8	67	0.7713892	0.8542337	1	1.9223967	0.3796183
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	c2.CGP_ chemical and genetic perturbations	408	1.1509945	0.12025317	0.45081756	GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	411	0.95328295	0.6706707	0.9780107	2.10427745	0.19771155
GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE	c5.BP_ GO biological process	86	1.150974	0.2128778	0.45078272	GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE	85	1.1973001	0.1661409	0.5971449	2.3482741	-0.0463261
GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP	C7_ immunologic signatures	182	1.1509248	0.16548464	0.45083743	GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP	183	0.85183865	0.8248988	1	2.00276345	0.29908615
GO_NEGATIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY	c5.BP_ GO biological process	114	1.1508274	0.22109276	0.4510219	GO_NEGATIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY	122	0.94075483	0.61116856	0.98976284	2.09158223	0.21007257
GO_REGULATION_OF_PEPTIDASE_ACTIVITY	c5.BP_ GO biological process	297	1.1506782	0.123333335	0.45135942	GO_REGULATION_OF_PEPTIDASE_ACTIVITY	318	1.1403829	0.12812813	0.6899019	2.2910611	0.0102953
GO_PROTEIN_PALMITOYLATION	c5.BP_ GO biological process	23	1.1505752	0.2736	0.45157063	GO_PROTEIN_PALMITOYLATION	23	0.71117747	0.8627451	1	1.86175267	0.43939773
GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	178	1.1505597	0.16805722	0.45152208	GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN	179	1.0583193	0.36666667	0.8274535	2.208879	0.0922404
CHR11P11	C1: positional gene sets	50	1.1505593	0.24856322	0.45143035	CHR11P11	53	1.138632	0.26512653	0.6928353	2.2891913	0.0119273
GSE40655_FOXO1_KO_VS_WT_NTREG_DN	C7_ immunologic signatures	166	1.1504163	0.18248175	0.45174673	GSE40655_FOXO1_KO_VS_WT_NTREG_DN	171	0.9211373	0.6774848	1	2.0715536	0.229279
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	164	1.150243	0.19951633	0.45217645	GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN	165	1.2617726	0.057142857	0.4936414	2.4120156	-0.1115296
HARRIS_HYPOXIA	c2.CGP_ chemical and genetic perturbations	71	1.1501806	0.21212122	0.45226693	HARRIS_HYPOXIA	74	1.1490577	0.24538545	0.6702584	2.2992383	0.0011229
GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN	C7_ immunologic signatures	175	1.1501389	0.1872749	0.45229292	GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN	176	1.0044483	0.5005066	0.9164607	2.1545872	0.1456906
REACTOME_MEIOTIC_SYNAPSIS	c2.CP_REACTOME_ Reactome gene sets	42	1.1501198	0.24819624	0.45224965	REACTOME_MEIOTIC_SYNAPSIS	43	1.6907169	0.001166861	0.08494185	2.8408367	-0.5405971
GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	C7_ immunologic signatures	165	1.1500047	0.18170732	0.45249557	GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	165	-0.8585479	1	0.8616356	0.2914568	2.0085526
GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	151	1.1499871	0.1830635	0.45245108	GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	150	1.2893336	0.045918368	0.4589239	2.4393207	-0.1393465
GSE13306_TREG_VS_TCONV_SPLEEN_UP	C7_ immunologic signatures	167	1.1499839	0.1594203	0.45236793	GSE13306_TREG_VS_TCONV_SPLEEN_UP	179	1.1740776	0.14560162	0.6314061	2.3240615	-0.0240937
GO_PLATELET_ACTIVATION	c5.BP_ GO biological process	125	1.1499472	0.19154228	0.452388	GO_PLATELET_ACTIVATION	130	1.3562098	0.032989692	0.3809962	2.506157	-0.2062626
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP	C7_ immunologic signatures	169	1.1499151	0.18224852	0.45239368	GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP	175	1.0952928	0.2887538	0.7642134	2.2452079	0.0546223
PID_NOTCH_PATHWAY	c2.CP_ Canonical pathways	57	1.1498681	0.23170732	0.45244157	PID_NOTCH_PATHWAY	56	0.78147197	0.8101545	1	1.93134007	0.36839613
GO_SOMATIC_RECOMBINATION_OF_IMMUNOGLOBULIN_GENE_SEGMENTS	c5.BP_ GO biological process	19	1.149699	0.2718601	0.4528336	GO_SOMATIC_RECOMBINATION_OF_IMMUNOGLOBULIN_GENE_SEGMENTS	19	-1.5906862	0.03181818	0.094584145	-0.4409872	2.7403852
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	172	1.1495796	0.18323353	0.453094	GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN	176	1.1956978	0.10851927	0.59692764	2.3452774	-0.0461182
BROWNE_HCMV_INFECTION_6HR_DN	c2.CGP_ chemical and genetic perturbations	147	1.1495347	0.17712177	0.4531305	BROWNE_HCMV_INFECTION_6HR_DN	147	1.2686995	0.04883011	0.486195	2.4182342	-0.1191648
ROY_WOUND_BLOOD_VESSEL_DN	c2.CGP_ chemical and genetic perturbations	19	1.1494197	0.2807808	0.45337772	ROY_WOUND_BLOOD_VESSEL_DN	18	1.3523722	0.110539846	0.38327676	2.5017919	-0.2029525
GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN	C7_ immunologic signatures	178	1.1493759	0.16666667	0.45341128	GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN	179	0.80641276	0.8877654	1	1.95578866	0.34296314
GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP	C7_ immunologic signatures	170	1.1492449	0.16566627	0.4537053	GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP	175	1.4261775	0.004032258	0.31770337	2.5754224	-0.2769326
GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN	C7_ immunologic signatures	173	1.1489785	0.16921268	0.45437333	GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN	173	0.9854992	0.55158323	0.94146967	2.1344777	0.1634793
GO_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	41	1.1489592	0.24855492	0.4543412	GO_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS	41	1.5375574	0.011614402	0.21320483	2.6865166	-0.3885982
GO_INOSITOL_PHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	52	1.1489496	0.25176802	0.45427263	GO_INOSITOL_PHOSPHATE_METABOLIC_PROCESS	54	1.081181	0.36271188	0.7858422	2.2301306	0.0677686
GATA_C	c3.TFT_ transcription factor targets	218	1.1488649	0.16930023	0.45442876	GATA_C	234	1.0154096	0.4742684	0.89649045	2.1642745	0.1334553
GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	C7_ immunologic signatures	174	1.148795	0.17577197	0.4545485	GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	179	0.9790419	0.5489405	0.9503716	2.1278369	0.1697531
REACTOME_DAG_AND_IP3_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	27	1.1487494	0.2626728	0.45458913	REACTOME_DAG_AND_IP3_SIGNALING	28	1.0364084	0.42362767	0.8652461	2.1851578	0.112341
BIOCARTA_NFAT_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	47	1.1486964	0.2503597	0.45465446	BIOCARTA_NFAT_PATHWAY	49	1.0887313	0.3495475	0.77317363	2.2374277	0.0599651
PID_INTEGRIN_A9B1_PATHWAY	c2.CP_ Canonical pathways	22	1.1486126	0.2791411	0.4547985	PID_INTEGRIN_A9B1_PATHWAY	23	0.8370184	0.7240099	1	1.985631	0.3115942
NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	c2.CGP_ chemical and genetic perturbations	20	1.1486002	0.28526148	0.4547452	NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	20	0.88578194	0.6348387	1	2.03438214	0.26281826
PRC2_EED_UP.V1_UP	C6_ oncogenic signatures	148	1.1485939	0.19491525	0.45467153	PRC2_EED_UP.V1_UP	157	1.2373354	0.07817259	0.529849	2.3859293	-0.0887415
GO_METALLOPEPTIDASE_ACTIVITY	c5.GO molecular function	155	1.14856	0.18765134	0.45467812	GO_METALLOPEPTIDASE_ACTIVITY	165	1.3807849	0.012158055	0.35599232	2.5293449	-0.2322249
MSX1_01	c3.TFT_ transcription factor targets	150	1.1484256	0.18367347	0.454972	MSX1_01	158	1.0990987	0.28309572	0.7581647	2.2475243	0.0493269
HENDRICKS_SMARCA4_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	38	1.1483818	0.24087591	0.45501167	HENDRICKS_SMARCA4_TARGETS_DN	46	1.1448581	0.26567844	0.67935807	2.2932399	0.0035237
GO_ANCHORING_JUNCTION	c5.CC_ GO cellular component	443	1.1483171	0.105374075	0.45511097	GO_ANCHORING_JUNCTION	446	0.9523839	0.7	0.978953	2.100701	0.1959332
MIKKELSEN_ES_LCP_WITH_H3K4ME3	c2.CGP_ chemical and genetic perturbations	114	1.1482593	0.19017632	0.45518792	MIKKELSEN_ES_LCP_WITH_H3K4ME3	123	1.6177299	0	0.14338444	2.7659892	-0.4694706
GSE22886_TH1_VS_TH2_48H_ACT_DN	C7_ immunologic signatures	175	1.1482346	0.18601896	0.45516255	GSE22886_TH1_VS_TH2_48H_ACT_DN	178	1.0683793	0.34549138	0.8087242	2.2166139	0.0798553
TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D	c3.MIR_ microRNA targets	433	1.1482062	0.117709436	0.45515338	TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D	444	0.6436073	1	1	1.7918135	0.5045989
GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	C7_ immunologic signatures	157	1.1481972	0.17567568	0.45508632	GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	161	1.1282406	0.22020201	0.7085489	2.2764378	0.0199566
GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN	C7_ immunologic signatures	152	1.1481876	0.19268292	0.4550217	GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN	156	0.907296	0.7100712	1	2.0554836	0.2408916
GO_ACTIVATION_OF_GTPASE_ACTIVITY	c5.BP_ GO biological process	67	1.1481606	0.22751322	0.45500553	GO_ACTIVATION_OF_GTPASE_ACTIVITY	70	1.4727769	0.007608695	0.2754673	2.6209375	-0.3246163
GO_CORTICAL_ACTIN_CYTOSKELETON	c5.CC_ GO cellular component	52	1.1481405	0.2397163	0.4549699	GO_CORTICAL_ACTIN_CYTOSKELETON	55	1.2741902	0.11612176	0.4812558	2.4223307	-0.1260497
GO_PROTEIN_LOCALIZATION_TO_CELL_SURFACE	c5.BP_ GO biological process	20	1.1480913	0.28389156	0.45502648	GO_PROTEIN_LOCALIZATION_TO_CELL_SURFACE	21	0.89769095	0.6305733	1	2.04578225	0.25040035
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	170	1.1480752	0.19267139	0.45497787	GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	179	-1.3121836	0	0.2721455	-0.1641084	2.4602588
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	c2.CGP_ chemical and genetic perturbations	59	1.1480278	0.23616734	0.45501837	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	59	1.3904014	0.029768467	0.345814	2.5384292	-0.2423736
MODULE_254	c4.CM_ cancer modules	52	1.1479907	0.24397163	0.45503628	MODULE_254	57	0.9793598	0.54241073	0.95044506	2.1273505	0.1686309
GO_REGULATION_OF_CARDIAC_CONDUCTION	c5.BP_ GO biological process	60	1.1479598	0.24	0.45503047	GO_REGULATION_OF_CARDIAC_CONDUCTION	62	1.0962162	0.3253012	0.76279837	2.244176	0.0517436
GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN	C7_ immunologic signatures	173	1.1479474	0.17598097	0.45497674	GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN	176	0.91265386	0.70724344	1	2.06060126	0.23529354
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	c2.CGP_ chemical and genetic perturbations	145	1.1478742	0.17639752	0.4550948	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	148	1.1784122	0.13920164	0.62434506	2.3262864	-0.030538
GSE27786_BCELL_VS_CD8_TCELL_UP	C7_ immunologic signatures	184	1.1477457	0.17721519	0.45536292	GSE27786_BCELL_VS_CD8_TCELL_UP	186	0.89477557	0.74495965	1	2.04252127	0.25297013
GSE6259_BCELL_VS_CD8_TCELL_UP	C7_ immunologic signatures	164	1.1476257	0.20332937	0.45559853	GSE6259_BCELL_VS_CD8_TCELL_UP	164	1.3967974	0.010152284	0.34652695	2.5444231	-0.2491717
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN	C7_ immunologic signatures	165	1.1475309	0.18886198	0.45579565	GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN	171	0.9954474	0.5101833	0.93046546	2.1429783	0.1520835
ZHAN_EARLY_DIFFERENTIATION_GENES_DN	c2.CGP_ chemical and genetic perturbations	39	1.1474911	0.25269645	0.4558224	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	38	-1.6894628	0.006944445	0.05866295	-0.5419717	2.8369539
GO_REGULATION_OF_INTERLEUKIN_12_PRODUCTION	c5.BP_ GO biological process	39	1.1474843	0.2556391	0.45574832	GO_REGULATION_OF_INTERLEUKIN_12_PRODUCTION	41	0.930529	0.6027554	0.9982931	2.0780133	0.2169553
NUTT_GBM_VS_AO_GLIOMA_UP	c2.CGP_ chemical and genetic perturbations	43	1.1474742	0.23156342	0.45568877	NUTT_GBM_VS_AO_GLIOMA_UP	43	0.7452485	0.84960717	1	1.8927227	0.4022257
GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	181	1.1474092	0.18461539	0.45578673	GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP	183	0.91722286	0.71601206	1	2.06463206	0.23018634
NAKAMURA_ADIPOGENESIS_LATE_UP	c2.CGP_ chemical and genetic perturbations	94	1.1473777	0.21456437	0.45578274	NAKAMURA_ADIPOGENESIS_LATE_UP	94	-0.83942413	0.86153847	0.8771133	0.30795357	1.98680183
GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN	C7_ immunologic signatures	177	1.1472274	0.1789976	0.45610797	GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN	179	1.0612427	0.35995954	0.82148	2.2084701	0.0859847
CHR12Q15	C1: positional gene sets	21	1.1470988	0.2749616	0.45638952	CHR12Q15	22	-1.2720312	0.13461539	0.30864397	-0.1249324	2.41913
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	c2.CGP_ chemical and genetic perturbations	27	1.1470821	0.2957958	0.45634732	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	28	0.6394624	0.9396552	1	1.7865445	0.5076197
GO_STEM_CELL_PROLIFERATION	c5.BP_ GO biological process	53	1.1470612	0.23628692	0.45631832	GO_STEM_CELL_PROLIFERATION	58	0.8456699	0.7535912	1	1.9927311	0.3013913
GO_REGULATION_OF_INTERLEUKIN_6_PRODUCTION	c5.BP_ GO biological process	85	1.147061	0.22709164	0.4562267	GO_REGULATION_OF_INTERLEUKIN_6_PRODUCTION	89	1.1324193	0.27070063	0.7025359	2.2794803	0.0146417
GSE27786_LIN_NEG_VS_CD8_TCELL_DN	C7_ immunologic signatures	186	1.1470035	0.17599067	0.45629248	GSE27786_LIN_NEG_VS_CD8_TCELL_DN	187	1.0316763	0.43434343	0.8737963	2.1786798	0.1153272
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP	C7_ immunologic signatures	155	1.146876	0.21251476	0.4565595	GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP	165	1.1315112	0.2082912	0.7039164	2.2783872	0.0153648
GO_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS	c5.BP_ GO biological process	184	1.1468525	0.17633411	0.45653352	GO_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS	196	0.86254	0.831992	1	2.0093925	0.2843125
HU_ANGIOGENESIS_UP	c2.CGP_ chemical and genetic perturbations	17	1.1468116	0.2963526	0.45655715	HU_ANGIOGENESIS_UP	17	0.92125434	0.5963061	1	2.06806594	0.22555726
GSE3982_MAC_VS_NEUTROPHIL_DN	C7_ immunologic signatures	166	1.1467494	0.18214285	0.45664206	GSE3982_MAC_VS_NEUTROPHIL_DN	174	0.99979836	0.51915324	0.92463905	2.14654776	0.14695104
ZHAN_MULTIPLE_MYELOMA_CD1_DN	c2.CGP_ chemical and genetic perturbations	37	1.1465087	0.24300441	0.4572694	ZHAN_MULTIPLE_MYELOMA_CD1_DN	37	1.0899307	0.36773428	0.7712436	2.2364394	0.056578
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	109	1.146479	0.21492921	0.45726806	GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	111	1.2228053	0.13702929	0.5518511	2.3692843	-0.0763263
GO_LAMELLAR_BODY	c5.CC_ GO cellular component	15	1.1464773	0.29193547	0.45718035	GO_LAMELLAR_BODY	16	1.043121	0.4331126	0.8530774	2.1895983	0.1033563
GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	124	1.1464568	0.22084367	0.45714507	GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN	130	1.0078251	0.476828	0.9107691	2.1542819	0.1386317
GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP	C7_ immunologic signatures	134	1.1463736	0.1830635	0.45729482	GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP	138	-1.2547108	0.035714287	0.31954646	-0.1083372	2.4010844
GO_CORONARY_VASCULATURE_DEVELOPMENT	c5.BP_ GO biological process	34	1.1462895	0.27672035	0.4574486	GO_CORONARY_VASCULATURE_DEVELOPMENT	35	0.75611913	0.8495788	1	1.90240863	0.39017037
GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP	C7_ immunologic signatures	175	1.1461694	0.199284	0.45769918	GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP	179	0.8717641	0.7817259	1	2.0179335	0.2744053
DAZARD_UV_RESPONSE_CLUSTER_G4	c2.CGP_ chemical and genetic perturbations	19	1.1460785	0.28184712	0.45786974	DAZARD_UV_RESPONSE_CLUSTER_G4	19	1.0852447	0.3763021	0.777217	2.2313232	0.0608338
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	160	1.1460775	0.17904994	0.45777926	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP	163	1.0533218	0.37040818	0.835967	2.1993993	0.0927557
GO_HYPOTHALAMUS_DEVELOPMENT	c5.BP_ GO biological process	18	1.1460547	0.28833333	0.45775583	GO_HYPOTHALAMUS_DEVELOPMENT	21	-1.4589651	0.047872342	0.16705397	-0.3129104	2.6050198
GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP	C7_ immunologic signatures	161	1.1460532	0.17840375	0.45766798	GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP	165	1.0839573	0.3092574	0.7795414	2.2300105	0.0620959
GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP	C7_ immunologic signatures	169	1.1460388	0.19497608	0.457621	GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP	175	1.4190047	0.002024292	0.32008132	2.5650435	-0.2729659
GO_REGULATION_OF_CHEMOKINE_PRODUCTION	c5.BP_ GO biological process	52	1.1459619	0.23816356	0.45775163	GO_REGULATION_OF_CHEMOKINE_PRODUCTION	54	1.2877768	0.108843535	0.46140945	2.4337387	-0.1418149
KOYAMA_SEMA3B_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	347	1.1458412	0.14583333	0.45800474	KOYAMA_SEMA3B_TARGETS_DN	355	0.9713563	0.611	0.96004933	2.1171975	0.1744849
GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP	C7_ immunologic signatures	173	1.1458257	0.16627358	0.457963	GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP	183	1.4386115	0.002020202	0.30618826	2.5844372	-0.2927858
RUAN_RESPONSE_TO_TROGLITAZONE_UP	c2.CGP_ chemical and genetic perturbations	23	1.1457704	0.25727412	0.4580249	RUAN_RESPONSE_TO_TROGLITAZONE_UP	24	1.0373441	0.44607842	0.86376244	2.1831145	0.1084263
GO_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	28	1.1457584	0.2734255	0.45796654	GO_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION	31	1.1615615	0.2635379	0.6507937	2.3073199	-0.0158031
GSE15659_TREG_VS_TCONV_DN	C7_ immunologic signatures	139	1.1457008	0.19756098	0.458035	GSE15659_TREG_VS_TCONV_DN	140	1.0811981	0.3099897	0.7859139	2.2268989	0.0645027
GO_OVULATION_CYCLE_PROCESS	c5.BP_ GO biological process	79	1.145695	0.23005319	0.45796204	GO_OVULATION_CYCLE_PROCESS	85	0.8295126	0.7968085	1	1.9752076	0.3161824
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	c2.CGP_ chemical and genetic perturbations	217	1.1455157	0.17139614	0.4583924	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	217	1.1282178	0.2082495	0.7084821	2.2737335	0.0172979
GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	C7_ immunologic signatures	166	1.1454786	0.19760479	0.45840558	GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	168	-1.1812565	0	0.40305087	-0.0357779	2.3267351
GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN	C7_ immunologic signatures	171	1.1454711	0.1767497	0.45833623	GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN	185	1.1175244	0.22345804	0.7277857	2.2629955	0.0279467
GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN	C7_ immunologic signatures	166	1.1454048	0.19141531	0.45844513	GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN	176	1.2270402	0.085192695	0.5463247	2.372445	-0.0816354
GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN	C7_ immunologic signatures	178	1.1453081	0.170441	0.45864072	GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN	180	1.0481746	0.38601825	0.84302604	2.1934827	0.0971335
GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP	C7_ immunologic signatures	149	1.1452976	0.18527316	0.45858192	GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP	153	0.98041147	0.52845526	0.9489094	2.12570907	0.16488613
PID_RHOA_PATHWAY	c2.CP_ Canonical pathways	42	1.1452215	0.2738764	0.45872205	PID_RHOA_PATHWAY	43	0.80858946	0.7852194	1	1.95381096	0.33663204
MTF1_Q4	c3.TFT_ transcription factor targets	222	1.1451259	0.16511628	0.4589054	MTF1_Q4	225	0.98745304	0.53420526	0.9388548	2.13257894	0.15767286
GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	183	1.1451213	0.18661971	0.45882767	GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN	182	0.9886454	0.5237614	0.9368396	2.1337667	0.1564759
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	c2.CGP_ chemical and genetic perturbations	454	1.1450871	0.1106383	0.45883703	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	462	0.9404647	0.717	0.98963666	2.0855518	0.2046224
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	c2.CGP_ chemical and genetic perturbations	98	1.1449897	0.22987013	0.45903775	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	99	1.0056226	0.46881497	0.91353595	2.1506123	0.1393671
GO_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS	c5.BP_ GO biological process	78	1.1448982	0.22758621	0.45922068	GO_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS	82	0.98167825	0.5417559	0.94673544	2.12657645	0.16321995
CEBPB_02	c3.TFT_ transcription factor targets	225	1.1447272	0.17045455	0.45962518	CEBPB_02	234	1.1832367	0.10212336	0.61735773	2.3279639	-0.0385095
REACTOME_CD28_CO_STIMULATION	c2.CP_REACTOME_ Reactome gene sets	29	1.1445414	0.27089337	0.46007457	REACTOME_CD28_CO_STIMULATION	30	1.1281309	0.31616765	0.70856845	2.2726723	0.0164105
PID_SHP2_PATHWAY	c2.CP_ Canonical pathways	56	1.1444964	0.25869262	0.46011582	PID_SHP2_PATHWAY	56	1.3219106	0.07860262	0.41117984	2.466407	-0.1774142
GSE27786_BCELL_VS_MONO_MAC_DN	C7_ immunologic signatures	172	1.1444712	0.18226002	0.46009347	GSE27786_BCELL_VS_MONO_MAC_DN	177	1.1378877	0.18762678	0.6941593	2.2823589	0.0065835
UDAYAKUMAR_MED1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	211	1.1444377	0.174269	0.46010333	UDAYAKUMAR_MED1_TARGETS_DN	211	0.9463449	0.6417004	0.9857406	2.0907826	0.1980928
GO_ORGANOPHOSPHATE_ESTER_TRANSPORT	c5.BP_ GO biological process	74	1.144338	0.24291497	0.46030676	GO_ORGANOPHOSPHATE_ESTER_TRANSPORT	77	1.066571	0.37337664	0.81179523	2.210909	0.077767
GO_BETA_CATENIN_BINDING	c5.GO molecular function	76	1.1443263	0.23816156	0.4602509	GO_BETA_CATENIN_BINDING	78	0.74729455	0.8782051	1	1.89162085	0.39703175
REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL	c2.CP_REACTOME_ Reactome gene sets	123	1.1442739	0.21257861	0.46031752	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL	132	1.1991146	0.14153846	0.5933642	2.3433885	-0.0548407
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN	C7_ immunologic signatures	173	1.1441269	0.17550059	0.4606478	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN	173	1.1271936	0.21399595	0.7108821	2.2713205	0.0169333
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN	C7_ immunologic signatures	173	1.1440406	0.18106508	0.4608039	GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN	174	1.2948499	0.022357723	0.44927895	2.4388905	-0.1508093
GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP	C7_ immunologic signatures	166	1.144031	0.19668247	0.4607409	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP	174	1.1950309	0.124873094	0.5970847	2.3390619	-0.0509999
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	c2.CGP_ chemical and genetic perturbations	279	1.144026	0.15673289	0.46066156	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	279	1.4516948	0	0.2919838	2.5957208	-0.3076688
GNF2_RTN1	c4.CGN_ cancer gene neighborhoods	47	1.1439532	0.24856322	0.46078384	GNF2_RTN1	47	1.2407948	0.1557562	0.524484	2.384748	-0.0968416
IL2_UP.V1_DN	C6_ oncogenic signatures	151	1.1439521	0.20484848	0.4606947	IL2_UP.V1_DN	159	1.3099881	0.036697246	0.4257321	2.4539402	-0.166036
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA	c2.CP_REACTOME_ Reactome gene sets	19	1.143906	0.2801303	0.46073443	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA	19	-0.7599132	0.8375	0.93291175	0.3839928	1.9038192
GO_TEMPERATURE_HOMEOSTASIS	c5.BP_ GO biological process	21	1.1438702	0.30232558	0.46074495	GO_TEMPERATURE_HOMEOSTASIS	24	1.5222716	0.017412934	0.23432635	2.6661418	-0.3784014
DR3_Q4	c3.TFT_ transcription factor targets	124	1.1437825	0.20248447	0.46090737	DR3_Q4	128	0.8343719	0.82043344	1	1.9781544	0.3094106
MORF_MSH3	c4.CGN_ cancer gene neighborhoods	199	1.1436844	0.1774942	0.4611017	MORF_MSH3	213	1.1517454	0.15778895	0.6669714	2.2954298	-0.008061
GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	147	1.1435877	0.19588876	0.46129894	GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP	149	1.354779	0.019328587	0.38219532	2.4983667	-0.2111913
GO_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE	c5.BP_ GO biological process	81	1.1435078	0.244	0.46144527	GO_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE	86	0.864707	0.7418335	1	2.0082148	0.2788008
GO_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION	c5.BP_ GO biological process	24	1.1434624	0.27549466	0.46148825	GO_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION	26	0.6252324	0.9449761	1	1.7686948	0.51823
GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	C7_ immunologic signatures	121	1.1434612	0.19949812	0.46139985	GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	136	0.82248074	0.8329918	1	1.96594194	0.32098046
GO_PLASMA_MEMBRANE_ORGANIZATION	c5.BP_ GO biological process	191	1.1434156	0.19176471	0.46144125	GO_PLASMA_MEMBRANE_ORGANIZATION	190	1.2664574	0.050813008	0.48881456	2.409873	-0.1230418
GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP	C7_ immunologic signatures	148	1.1433578	0.20405728	0.46151352	GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP	155	1.1219876	0.25661916	0.72232413	2.2653454	0.0213702
GO_NEGATIVE_REGULATION_OF_COAGULATION	c5.BP_ GO biological process	39	1.1432372	0.27259684	0.4617722	GO_NEGATIVE_REGULATION_OF_COAGULATION	43	1.8326515	0	0.027171772	2.9758887	-0.6894143
GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP	C7_ immunologic signatures	162	1.1432046	0.1789976	0.46177062	GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP	164	1.2541318	0.06237219	0.5029343	2.3973364	-0.1109272
LMO2COM_02	c3.TFT_ transcription factor targets	209	1.1431879	0.18032786	0.4617246	LMO2COM_02	218	1.0750854	0.31626505	0.79629827	2.2182733	0.0681025
GO_REGULATION_OF_MULTI_ORGANISM_PROCESS	c5.BP_ GO biological process	378	1.143186	0.14162162	0.46163675	GO_REGULATION_OF_MULTI_ORGANISM_PROCESS	394	0.77965575	0.967	1	1.92284175	0.36353025
GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	C7_ immunologic signatures	166	1.1431264	0.18083832	0.46171412	GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	174	0.79552716	0.90194076	1	1.93865356	0.34759924
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	c2.CGP_ chemical and genetic perturbations	277	1.142652	0.16371681	0.46301973	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	330	1.4037561	0	0.3353296	2.5464081	-0.2611041
GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP	C7_ immunologic signatures	175	1.142576	0.18957347	0.4631581	GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP	176	0.9976918	0.49294356	0.92561346	2.1402678	0.1448842
GO_SPECIFICATION_OF_SYMMETRY	c5.BP_ GO biological process	100	1.142532	0.21788414	0.4631939	GO_SPECIFICATION_OF_SYMMETRY	111	1.129792	0.24793388	0.7058049	2.272324	0.01274
GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN	C7_ immunologic signatures	171	1.1423566	0.19902913	0.4636215	GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN	179	1.0608441	0.35569105	0.8221695	2.2032007	0.0815125
GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	C7_ immunologic signatures	181	1.1422471	0.19716647	0.46385637	GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	180	0.90580547	0.7279188	1	2.04805257	0.23644163
GO_EXTRACELLULAR_MATRIX_BINDING	c5.GO molecular function	44	1.1422393	0.25958702	0.46378574	GO_EXTRACELLULAR_MATRIX_BINDING	48	1.0362834	0.42643678	0.8656135	2.1785227	0.1059559
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	c2.CP_REACTOME_ Reactome gene sets	101	1.142175	0.1948718	0.46387616	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	103	0.69444734	0.9504219	1	1.83662234	0.44772766
GO_INNATE_IMMUNE_RESPONSE	c5.BP_ GO biological process	412	1.1421306	0.123667374	0.46391213	GO_INNATE_IMMUNE_RESPONSE	444	1.0494425	0.315	0.8408043	2.1915731	0.0926881
GO_LIPID_PHOSPHORYLATION	c5.BP_ GO biological process	92	1.1419996	0.21704394	0.46420106	GO_LIPID_PHOSPHORYLATION	95	1.0467741	0.4012539	0.8451247	2.1887737	0.0952255
GSE17721_CTRL_VS_CPG_6H_BMDC_DN	C7_ immunologic signatures	176	1.141983	0.19976635	0.46415138	GSE17721_CTRL_VS_CPG_6H_BMDC_DN	185	0.8641138	0.79695433	1	2.0060968	0.2778692
MODULE_362	c4.CM_ cancer modules	18	1.1418436	0.27480915	0.46446466	MODULE_362	17	0.86425036	0.65932643	1	2.00609396	0.27759324
ZIC2_01	c3.TFT_ transcription factor targets	224	1.1417904	0.16591422	0.4645293	ZIC2_01	232	0.861027	0.83484393	1	2.0028174	0.2807634
GO_SINGLE_STRANDED_DNA_BINDING	c5.GO molecular function	71	1.1416558	0.24078947	0.4648124	GO_SINGLE_STRANDED_DNA_BINDING	72	-1.7132803	0	0.052273672	-0.5716245	2.8549361
GTACTGT_MIR101	c3.MIR_ microRNA targets	235	1.1416106	0.16439909	0.46485597	GTACTGT_MIR101	241	0.73777145	0.9628514	1	1.87938205	0.40383915
KEGG_SMALL_CELL_LUNG_CANCER	c2.CP_BIOCARTA_ BioCarta gene sets	81	1.1416004	0.24191462	0.46478915	KEGG_SMALL_CELL_LUNG_CANCER	83	1.0274897	0.43501613	0.8803708	2.1690901	0.1141107
GO_REGULATION_OF_CELL_CELL_ADHESION	c5.BP_ GO biological process	301	1.141576	0.15638767	0.46477	GO_REGULATION_OF_CELL_CELL_ADHESION	321	1.121354	0.17151454	0.72169703	2.26293	0.020222
ATAGGAA_MIR202	c3.MIR_ microRNA targets	94	1.1414479	0.22109276	0.46505475	ATAGGAA_MIR202	94	1.0445064	0.4012605	0.8501877	2.1859543	0.0969415
GO_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING	c5.GO molecular function	38	1.141438	0.25608012	0.46498996	GO_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING	40	0.90790415	0.6251455	1	2.04934215	0.23353385
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	c2.CGP_ chemical and genetic perturbations	141	1.1414027	0.19497608	0.46500403	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	144	1.1639633	0.17213115	0.64745504	2.305366	-0.0225606
REACTOME_DIABETES_PATHWAYS	c2.CP_REACTOME_ Reactome gene sets	113	1.1412123	0.21744627	0.46546412	REACTOME_DIABETES_PATHWAYS	118	-1.1199664	0.18518518	0.48930055	0.0212459	2.2611787
GO_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT	c5.BP_ GO biological process	41	1.1410997	0.24680851	0.46571115	GO_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT	45	1.5183347	0.003412969	0.23556577	2.6594344	-0.377235
GO_REGULATION_OF_INTERLEUKIN_1_PRODUCTION	c5.BP_ GO biological process	40	1.1410643	0.24857955	0.46573415	GO_REGULATION_OF_INTERLEUKIN_1_PRODUCTION	47	1.2068262	0.19090909	0.5806035	2.3478905	-0.0657619
NFKB_C	c3.TFT_ transcription factor targets	240	1.1409779	0.17579909	0.4658895	NFKB_C	246	1.1112255	0.20582329	0.735651	2.2522034	0.0297524
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	c2.CGP_ chemical and genetic perturbations	54	1.1409408	0.22633745	0.4659119	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	69	1.2496035	0.12104689	0.5115004	2.3905443	-0.1086627
GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	C7_ immunologic signatures	171	1.1408429	0.17380953	0.4661163	GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	173	1.0298249	0.43232325	0.87586695	2.1706678	0.111018
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP	C7_ immunologic signatures	178	1.1407843	0.17917676	0.4662007	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP	179	0.9293959	0.6825076	0.9989061	2.0701802	0.2113884
GO_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING	c5.GO molecular function	28	1.1407635	0.28858024	0.46617162	GO_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING	29	1.3589258	0.07202881	0.37836725	2.4996893	-0.2181623
GSE15659_RESTING_VS_ACTIVATED_TREG_UP	C7_ immunologic signatures	121	1.1407027	0.21446384	0.4662617	GSE15659_RESTING_VS_ACTIVATED_TREG_UP	128	1.245521	0.0840249	0.5180207	2.3862237	-0.1048183
GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP	C7_ immunologic signatures	174	1.1406888	0.17177914	0.46621212	GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP	178	1.259808	0.051829267	0.49664325	2.4004968	-0.1191192
GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP	C7_ immunologic signatures	165	1.140635	0.20843373	0.46628883	GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP	171	1.2208029	0.09173387	0.5545985	2.3614379	-0.0801679
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	c2.CGP_ chemical and genetic perturbations	83	1.1406274	0.22807017	0.46621773	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	86	0.9841197	0.5318471	0.9424688	2.1247471	0.1565077
ATACTGT_MIR144	c3.MIR_ microRNA targets	187	1.1405972	0.1912114	0.46622077	ATACTGT_MIR144	188	-1.2630998	0	0.31303126	-0.1225026	2.403697
PID_TELOMERASE_PATHWAY	c2.CP_ Canonical pathways	63	1.1404774	0.24157304	0.4664814	PID_TELOMERASE_PATHWAY	63	0.6933778	0.9184123	1	1.8338552	0.4470996
KOHOUTEK_CCNT1_TARGETS	c2.CGP_ chemical and genetic perturbations	43	1.1403389	0.24539877	0.46679834	KOHOUTEK_CCNT1_TARGETS	45	1.5197233	0.006920415	0.23656224	2.6600622	-0.3793844
GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	C7_ immunologic signatures	159	1.140287	0.19636364	0.46685314	GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	161	0.99776006	0.51934826	0.92604923	2.13804706	0.14252694
CHRXQ26	C1: positional gene sets	28	1.1402292	0.27046785	0.46693447	CHRXQ26	34	0.7053027	0.8953771	1	1.8455319	0.4349265
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP	C7_ immunologic signatures	171	1.1400704	0.1886121	0.46732387	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP	177	1.0417911	0.4090909	0.85599726	2.1818615	0.0982793
GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	153	1.1399913	0.20669056	0.4674554	GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	156	1.3595148	0.011190234	0.37782502	2.4995061	-0.2195235
GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	C7_ immunologic signatures	153	1.1397232	0.20567375	0.46813738	GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	156	1.0411601	0.39347604	0.8572308	2.1808833	0.0985631
GO_REGULATION_OF_ACTIN_FILAMENT_LENGTH	c5.BP_ GO biological process	135	1.1397084	0.20710784	0.46808282	GO_REGULATION_OF_ACTIN_FILAMENT_LENGTH	139	0.86601394	0.7742268	1	2.00572234	0.27369446
RSRFC4_Q2	c3.TFT_ transcription factor targets	180	1.1396983	0.1745283	0.46801934	RSRFC4_Q2	186	1.1660559	0.15470172	0.6452675	2.3057542	-0.0263576
MODULE_18	c4.CM_ cancer modules	410	1.1395215	0.13490364	0.4684575	MODULE_18	410	0	0	0	1.1395215	1.1395215
NAKAYAMA_FRA2_TARGETS	c2.CGP_ chemical and genetic perturbations	38	1.1394455	0.2579666	0.46858358	NAKAYAMA_FRA2_TARGETS	38	0.75849366	0.8583043	1	1.89793916	0.38095184
CACBINDINGPROTEIN_Q6	c3.TFT_ transcription factor targets	223	1.1393976	0.18448883	0.46864405	CACBINDINGPROTEIN_Q6	225	0.7099713	0.97590363	1	1.8493689	0.4294263
GHANDHI_BYSTANDER_IRRADIATION_UP	c2.CGP_ chemical and genetic perturbations	64	1.1393894	0.24161074	0.46857405	GHANDHI_BYSTANDER_IRRADIATION_UP	65	1.4560341	0.019586507	0.28724036	2.5954235	-0.3166447
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN	C7_ immunologic signatures	116	1.1393257	0.21132076	0.4686752	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN	121	1.1697217	0.17757009	0.63851964	2.3090474	-0.030396
YAP1_UP	C6_ oncogenic signatures	38	1.139322	0.25985402	0.46859434	YAP1_UP	37	1.0531837	0.3995327	0.8361291	2.1925057	0.0861383
GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	C7_ immunologic signatures	147	1.1392765	0.20609756	0.46863768	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	154	1.1028792	0.26930895	0.7517188	2.2421557	0.0363973
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	c2.CGP_ chemical and genetic perturbations	42	1.1391851	0.26785713	0.46881732	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	44	0.9805037	0.5389755	0.948831	2.1196888	0.1586814
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN	C7_ immunologic signatures	175	1.1391846	0.19905214	0.46872628	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN	175	-1.2034513	0.1	0.37792832	-0.0642667	2.3426359
GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN	C7_ immunologic signatures	175	1.1389016	0.19397591	0.46948507	GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN	181	1.2504549	0.052525252	0.5092748	2.3893565	-0.1115533
GO_REGULATION_OF_NEUROTRANSMITTER_SECRETION	c5.BP_ GO biological process	45	1.1388346	0.26037195	0.4695822	GO_REGULATION_OF_NEUROTRANSMITTER_SECRETION	47	1.2979007	0.110738255	0.44537157	2.4367353	-0.1590661
GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_UP	C7_ immunologic signatures	179	1.1385754	0.19358669	0.4702383	GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_UP	179	0.7065368	0.9635996	1	1.8451122	0.4320386
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	c2.CGP_ chemical and genetic perturbations	60	1.1385674	0.26666668	0.47016767	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	61	0.85534656	0.73580784	1	1.99391396	0.28322084
TANG_SENESCENCE_TP53_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	28	1.138505	0.26246333	0.47025472	TANG_SENESCENCE_TP53_TARGETS_UP	31	0.84848464	0.706235	1	1.98698964	0.29002036
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	c2.CGP_ chemical and genetic perturbations	66	1.1384004	0.25680932	0.47047397	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	71	0.9985879	0.5021834	0.92521095	2.1369883	0.1398125
GO_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING	c5.BP_ GO biological process	20	1.1383777	0.3009554	0.47045192	GO_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING	19	1.3182337	0.10923277	0.41349474	2.4566114	-0.179856
THUM_SYSTOLIC_HEART_FAILURE_DN	c2.CGP_ chemical and genetic perturbations	193	1.1382772	0.18404908	0.4706443	THUM_SYSTOLIC_HEART_FAILURE_DN	197	1.1546048	0.15206446	0.6622211	2.292882	-0.0163276
ULE_SPLICING_VIA_NOVA2	c2.CGP_ chemical and genetic perturbations	43	1.138259	0.24057971	0.47060472	ULE_SPLICING_VIA_NOVA2	43	1.4152825	0.022522522	0.32187036	2.5535415	-0.2770235
GO_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS	c5.BP_ GO biological process	20	1.1381671	0.28315946	0.47077024	GO_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS	19	1.3651725	0.080976866	0.37186906	2.5033396	-0.2270054
GO_RESPONSE_TO_MUSCLE_ACTIVITY	c5.BP_ GO biological process	17	1.1381558	0.30541873	0.47071105	GO_RESPONSE_TO_MUSCLE_ACTIVITY	16	1.2329398	0.19770408	0.5362792	2.3710956	-0.094784
GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP	C7_ immunologic signatures	169	1.1381414	0.21269095	0.47066453	GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP	178	1.1515076	0.16986856	0.66755694	2.289649	-0.0133662
GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP	C7_ immunologic signatures	178	1.1380979	0.20598802	0.4706982	GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP	180	0.98789877	0.5423387	0.9381515	2.12599667	0.15019913
FOXO3_01	c3.TFT_ transcription factor targets	206	1.1380544	0.1823461	0.47073823	FOXO3_01	217	0.7156377	0.9717742	1	1.8536921	0.4224167
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP	C7_ immunologic signatures	149	1.1379952	0.22262774	0.47082284	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP	151	1.4034195	0.003051882	0.33610725	2.5414147	-0.2654243
GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	C7_ immunologic signatures	181	1.1379128	0.18957347	0.47097614	GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	181	1.3576269	0.008064516	0.37934038	2.4955397	-0.2197141
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	c2.CGP_ chemical and genetic perturbations	55	1.1378343	0.26420453	0.4711238	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	54	1.1072601	0.30357143	0.74246126	2.2450944	0.0305742
GO_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY	c5.BP_ GO biological process	29	1.1377693	0.28869048	0.47122586	GO_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY	29	0.88467425	0.6521197	1	2.02244355	0.25309505
GO_XENOPHAGY	c5.BP_ GO biological process	86	1.1377666	0.22703412	0.47114274	GO_XENOPHAGY	89	0.690612	0.95478445	1	1.8283786	0.4471546
MORF_FSHR	c4.CGN_ cancer gene neighborhoods	214	1.1376413	0.19392523	0.47141057	MORF_FSHR	226	1.3789792	0.005050505	0.35644233	2.5166205	-0.2413379
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	c2.CGP_ chemical and genetic perturbations	238	1.1375016	0.17727272	0.47173154	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	243	1.1152031	0.19396985	0.73019594	2.2527047	0.0222985
NRSF_01	c3.TFT_ transcription factor targets	82	1.1374625	0.24694708	0.47175622	NRSF_01	87	1.0064259	0.47463003	0.91319704	2.1438884	0.1310366
GACTGTT_MIR212_MIR132	c3.MIR_ microRNA targets	146	1.1374457	0.20357142	0.47171187	GACTGTT_MIR212_MIR132	147	-1.304766	0.07692308	0.27856714	-0.1673203	2.4422117
GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP	C7_ immunologic signatures	141	1.1373492	0.20204604	0.4719039	GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP	144	1.2657833	0.05629478	0.48963168	2.4031325	-0.1284341
GO_GLUTAMATE_RECEPTOR_BINDING	c5.GO molecular function	34	1.1373467	0.28030303	0.47182116	GO_GLUTAMATE_RECEPTOR_BINDING	36	1.2672684	0.1492891	0.4881798	2.4046151	-0.1299217
GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	C7_ immunologic signatures	174	1.1372768	0.19086652	0.47194138	GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	178	1.3142377	0.024217961	0.41926706	2.4515145	-0.1769609
GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP	C7_ immunologic signatures	134	1.1372362	0.22560975	0.47196606	GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP	140	0.9669045	0.56778795	0.9644781	2.1041407	0.1703317
GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP	C7_ immunologic signatures	172	1.1372186	0.19787987	0.47192594	GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP	176	1.1845465	0.13021363	0.61405575	2.3217651	-0.0473279
GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP	C7_ immunologic signatures	162	1.1370829	0.19179735	0.47222435	GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP	169	0.9495592	0.62068963	0.98275363	2.0866421	0.1875237
GSE339_CD4POS_VS_CD4CD8DN_DC_UP	C7_ immunologic signatures	176	1.1369857	0.20470588	0.47241834	GSE339_CD4POS_VS_CD4CD8DN_DC_UP	182	1.1223456	0.2241206	0.7212936	2.2593313	0.0146401
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	c2.CGP_ chemical and genetic perturbations	207	1.136932	0.1871345	0.47247612	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	232	1.3809754	0.001003009	0.35634288	2.5179074	-0.2440434
GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN	C7_ immunologic signatures	168	1.1368424	0.18073721	0.4726514	GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN	170	0.9818652	0.55172414	0.94645715	2.1187076	0.1549772
GO_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION	c5.BP_ GO biological process	56	1.1366315	0.2521127	0.4731702	GO_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION	55	1.0261331	0.4580067	0.88232845	2.1627646	0.1104984
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	c2.CGP_ chemical and genetic perturbations	23	1.1365193	0.29329172	0.47340587	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	24	1.3766103	0.06965174	0.3576023	2.5131296	-0.240091
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	c2.CGP_ chemical and genetic perturbations	126	1.1365055	0.22878228	0.47335255	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	132	1.0328121	0.43380857	0.8725156	2.1693176	0.1036934
GO_ANTEROGRADE_AXONAL_TRANSPORT	c5.BP_ GO biological process	21	1.1363915	0.28980893	0.4735831	GO_ANTEROGRADE_AXONAL_TRANSPORT	21	0.80286026	0.7422553	1	1.93925176	0.33353124
MODULE_354	c4.CM_ cancer modules	15	1.1363642	0.30323678	0.4735684	MODULE_354	17	0.8577577	0.6768617	1	1.9941219	0.2786065
GCATTTG_MIR105	c3.MIR_ microRNA targets	162	1.136286	0.20120482	0.4737024	GCATTTG_MIR105	163	0.7043233	0.97861505	1	1.8406093	0.4319627
PID_HDAC_CLASSIII_PATHWAY	c2.CP_ Canonical pathways	24	1.1361865	0.2602118	0.47391444	PID_HDAC_CLASSIII_PATHWAY	25	0.84437925	0.69296116	1	1.98056575	0.29180725
GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP	C7_ immunologic signatures	170	1.1361849	0.15990454	0.4738255	GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP	172	0.9262395	0.67439514	1	2.0624244	0.2099454
GO_CALCIUM_CHANNEL_REGULATOR_ACTIVITY	c5.GO molecular function	31	1.1361744	0.28721803	0.47375944	GO_CALCIUM_CHANNEL_REGULATOR_ACTIVITY	32	0.7502785	0.8416076	1	1.8864529	0.3858959
GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP	C7_ immunologic signatures	151	1.1360128	0.23150358	0.47415698	GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP	168	1.3436824	0.017171716	0.39104015	2.4796952	-0.2076696
GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	164	1.1360073	0.2026379	0.47407824	GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN	169	1.3273047	0.017258883	0.40447247	2.463312	-0.1912974
ZHAN_MULTIPLE_MYELOMA_PR_DN	c2.CGP_ chemical and genetic perturbations	41	1.1359973	0.25701624	0.47401524	ZHAN_MULTIPLE_MYELOMA_PR_DN	42	1.1561149	0.25170842	0.66025704	2.2921122	-0.0201176
GO_ORGANONITROGEN_COMPOUND_CATABOLIC_PROCESS	c5.BP_ GO biological process	302	1.1357825	0.15812431	0.47456154	GO_ORGANONITROGEN_COMPOUND_CATABOLIC_PROCESS	311	0.9960807	0.5200401	0.92942965	2.1318632	0.1397018
GO_REGULATION_OF_CYTOKINE_PRODUCTION	c5.BP_ GO biological process	460	1.1356882	0.13354701	0.47474012	GO_REGULATION_OF_CYTOKINE_PRODUCTION	485	1.16446	0.044	0.64620745	2.3001482	-0.0287718
GO_RESPONSE_TO_ETHANOL	c5.BP_ GO biological process	123	1.1356417	0.23350254	0.4747751	GO_RESPONSE_TO_ETHANOL	127	1.0191971	0.4443299	0.89195895	2.1548388	0.1164446
GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP	C7_ immunologic signatures	130	1.1356019	0.2009804	0.47479466	GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP	141	1.0734788	0.33983573	0.7997056	2.2090807	0.0621231
GO_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE	c5.BP_ GO biological process	31	1.1355598	0.2561151	0.47482163	GO_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE	38	1.4207138	0.033838972	0.3186081	2.5562736	-0.285154
GO_PHOSPHOLIPID_TRANSPORT	c5.BP_ GO biological process	48	1.1355046	0.255911	0.47488835	GO_PHOSPHOLIPID_TRANSPORT	51	1.0021234	0.49336284	0.9198602	2.137628	0.1333812
E2F_01	c3.TFT_ transcription factor targets	61	1.1354914	0.25439784	0.4748336	E2F_01	61	-1.4379114	0.012048192	0.18125466	-0.30242	2.5734028
TTGCCAA_MIR182	c3.MIR_ microRNA targets	299	1.1351535	0.1790393	0.4757617	TTGCCAA_MIR182	303	0.7016684	0.992	1	1.8368219	0.4334851
GO_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	18	1.1351268	0.28144655	0.4757444	GO_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE	16	0.5425757	0.9765625	1	1.6777025	0.5925511
GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	C7_ immunologic signatures	185	1.1349435	0.18961352	0.47617614	GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	185	0.9561662	0.59857726	0.97561437	2.0911097	0.1787773
GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP	C7_ immunologic signatures	179	1.1349415	0.19415204	0.47608796	GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP	179	0.9747142	0.5825735	0.9555651	2.1096557	0.1602273
DURCHDEWALD_SKIN_CARCINOGENESIS_UP	c2.CGP_ chemical and genetic perturbations	66	1.1349384	0.24931881	0.47600278	DURCHDEWALD_SKIN_CARCINOGENESIS_UP	69	0.8111808	0.78958786	1	1.9461192	0.3237576
GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN	C7_ immunologic signatures	144	1.1348224	0.22864321	0.47625437	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN	160	1.1415367	0.2071066	0.6874368	2.2763591	-0.0067143
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	178	1.134802	0.20645906	0.47622228	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	179	0.97672176	0.55375254	0.9533882	2.11152376	0.15808024
GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	160	1.1346856	0.20408164	0.4764668	GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN	169	0.99223024	0.5162272	0.9334966	2.12691584	0.14245536
JOHNSTONE_PARVB_TARGETS_2_DN	c2.CGP_ chemical and genetic perturbations	297	1.1346813	0.1638796	0.47638726	JOHNSTONE_PARVB_TARGETS_2_DN	298	0.7006804	0.99499	1	1.8353617	0.4340009
MORF_LCAT	c4.CGN_ cancer gene neighborhoods	107	1.1346345	0.22378516	0.4764363	MORF_LCAT	112	1.0131783	0.47673216	0.9010415	2.1478128	0.1214562
GO_CYCLIN_BINDING	c5.GO molecular function	19	1.1345834	0.29458597	0.47648498	GO_CYCLIN_BINDING	19	0.7533638	0.81439394	1	1.8879472	0.3812196
KEGG_DNA_REPLICATION	c2.CP_BIOCARTA_ BioCarta gene sets	34	1.1345606	0.2783505	0.4764576	KEGG_DNA_REPLICATION	34	-2.08638	0	0.003200736	-0.9518194	3.2209406
CROONQUIST_IL6_DEPRIVATION_UP	c2.CGP_ chemical and genetic perturbations	19	1.1344197	0.29153094	0.47676286	CROONQUIST_IL6_DEPRIVATION_UP	19	-1.0310676	0.40707964	0.638113	0.1033521	2.1654873
GATA1_05	c3.TFT_ transcription factor targets	239	1.1343827	0.16531792	0.47677946	GATA1_05	253	1.1022346	0.24172518	0.753553	2.2366173	0.0321481
GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	169	1.1343575	0.18343195	0.47676486	GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN	179	1.1760263	0.12537917	0.6281479	2.3103838	-0.0416688
GAVIN_FOXP3_TARGETS_CLUSTER_P2	c2.CGP_ chemical and genetic perturbations	67	1.1341512	0.25135136	0.47726938	GAVIN_FOXP3_TARGETS_CLUSTER_P2	69	1.139138	0.25494507	0.69108474	2.2732892	-0.0049868
IWANAGA_CARCINOGENESIS_BY_KRAS_DN	c2.CGP_ chemical and genetic perturbations	102	1.1339872	0.23821656	0.47766322	IWANAGA_CARCINOGENESIS_BY_KRAS_DN	108	1.2133987	0.14270833	0.5716688	2.3473859	-0.0794115
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN	C7_ immunologic signatures	178	1.1339455	0.2123369	0.47769147	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN	181	0.8435839	0.8294416	1	1.9775294	0.2903616
GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN	C7_ immunologic signatures	175	1.1338272	0.20097442	0.47793728	GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN	178	0.8559091	0.8154158	1	1.9897363	0.2779181
TGIF_01	c3.TFT_ transcription factor targets	213	1.1337997	0.1826484	0.4779268	TGIF_01	222	1.0284077	0.40643862	0.8784429	2.1622074	0.105392
GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP	C7_ immunologic signatures	162	1.1337523	0.20320196	0.47798216	GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP	173	1.2085145	0.09572301	0.5803238	2.3422668	-0.0747622
GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP	C7_ immunologic signatures	170	1.1336449	0.20598802	0.47821155	GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP	172	1.0947053	0.2719919	0.7655347	2.2283502	0.0389396
GO_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	c5.BP_ GO biological process	238	1.1335983	0.1860203	0.47825083	GO_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	258	1.088073	0.25125125	0.7736977	2.2216713	0.0455253
GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	C7_ immunologic signatures	161	1.1335976	0.20743406	0.4781607	GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	172	1.2728419	0.04356636	0.4821441	2.4064395	-0.1392443
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN	C7_ immunologic signatures	134	1.1335673	0.22100122	0.47815418	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN	141	1.3773116	0.010224949	0.3571944	2.5108789	-0.2437443
MISSIAGLIA_REGULATED_BY_METHYLATION_UP	c2.CGP_ chemical and genetic perturbations	104	1.1335449	0.21979435	0.47813168	MISSIAGLIA_REGULATED_BY_METHYLATION_UP	106	1.4582852	0.002089864	0.2830987	2.5918301	-0.3247403
REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	26	1.1335151	0.2963526	0.47812456	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	26	1.1156253	0.33168927	0.72980547	2.2491404	0.0178898
GO_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT	c5.BP_ GO biological process	23	1.1334463	0.31008902	0.47823218	GO_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT	29	1.316952	0.09569378	0.41522774	2.4503983	-0.1835057
GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP	C7_ immunologic signatures	179	1.1333596	0.18019094	0.47840026	GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP	183	1.3839492	0.003051882	0.35231975	2.5173088	-0.2505896
GO_RESPONSE_TO_INTERFERON_ALPHA	c5.BP_ GO biological process	18	1.1333215	0.27955273	0.47841898	GO_RESPONSE_TO_INTERFERON_ALPHA	18	0.8462579	0.68846154	1	1.9795794	0.2870636
WELCSH_BRCA1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	177	1.1333138	0.20543094	0.47834894	WELCSH_BRCA1_TARGETS_UP	181	0.86668646	0.7912867	1	2.00000026	0.26662734
CHR4Q13	C1: positional gene sets	19	1.133313	0.3121212	0.47825935	CHR4Q13	24	-1.5532627	0.014634146	0.11332437	-0.4199497	2.6865757
GO_DETECTION_OF_VISIBLE_LIGHT	c5.BP_ GO biological process	40	1.1332908	0.26323318	0.47824097	GO_DETECTION_OF_VISIBLE_LIGHT	36	-1.1768618	0.16233766	0.40808082	-0.043571	2.3101526
CHANG_IMMORTALIZED_BY_HPV31_UP	c2.CGP_ chemical and genetic perturbations	67	1.1332659	0.23174158	0.47822234	CHANG_IMMORTALIZED_BY_HPV31_UP	69	0.9348662	0.6	0.9951217	2.0681321	0.1983997
GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN	C7_ immunologic signatures	160	1.1332529	0.20577617	0.47817	GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN	161	0.7227826	0.95112014	1	1.8560355	0.4104703
TATA_C	c3.TFT_ transcription factor targets	233	1.1329485	0.18987341	0.47899023	TATA_C	248	1.218816	0.059236947	0.5572767	2.3517645	-0.0858675
GSE20366_TREG_VS_TCONV_DN	C7_ immunologic signatures	174	1.1329358	0.18377088	0.4789357	GSE20366_TREG_VS_TCONV_DN	179	1.0082735	0.507085	0.91156805	2.1412093	0.1246623
MEISSNER_NPC_HCP_WITH_H3K4ME2	c2.CGP_ chemical and genetic perturbations	443	1.132921	0.13912134	0.47888258	MEISSNER_NPC_HCP_WITH_H3K4ME2	457	1.5779389	0	0.18215075	2.7108599	-0.4450179
FAC1_01	c3.TFT_ transcription factor targets	189	1.1329073	0.2089915	0.47883156	FAC1_01	195	0.9295928	0.6841046	0.9994804	2.0625001	0.2033145
GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	124	1.1327419	0.2077597	0.47922617	GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN	140	0.94219553	0.62487257	0.9888338	2.07493743	0.19054637
GHO_ATF5_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	15	1.1326936	0.32171157	0.4792728	GHO_ATF5_TARGETS_DN	15	-1.2235605	0.19607843	0.35142553	-0.0908669	2.3562541
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	175	1.1326106	0.21488595	0.4794234	GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	181	0.6554667	0.9898888	1	1.7880773	0.4771439
KANG_AR_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	17	1.1324983	0.31181103	0.47965533	KANG_AR_TARGETS_DN	19	-0.89456385	0.6164383	0.82748145	0.23793445	2.02706215
GOZGIT_ESR1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	123	1.1324736	0.21631645	0.4796355	GOZGIT_ESR1_TARGETS_UP	127	1.14696	0.2037037	0.6738938	2.2794336	-0.0144864
GO_CORTICAL_CYTOSKELETON	c5.CC_ GO cellular component	71	1.1324216	0.25279328	0.4797061	GO_CORTICAL_CYTOSKELETON	75	1.1266491	0.2656748	0.71162254	2.2590707	0.0057725
GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP	C7_ immunologic signatures	173	1.1323246	0.20570749	0.47989148	GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP	176	1.2285099	0.07200811	0.54417366	2.3608345	-0.0961853
PASINI_SUZ12_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	97	1.1322902	0.22739018	0.47991195	PASINI_SUZ12_TARGETS_UP	100	1.4107057	0.011640212	0.3251848	2.5429959	-0.2784155
GO_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE	c5.BP_ GO biological process	118	1.1322854	0.2260982	0.4798315	GO_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE	125	0.82171893	0.8226804	1	1.95400433	0.31056647
GO_INTRACELLULAR_LIPID_TRANSPORT	c5.BP_ GO biological process	20	1.1321336	0.29467085	0.48019215	GO_INTRACELLULAR_LIPID_TRANSPORT	20	1.3019191	0.13290323	0.43843886	2.4340527	-0.1697855
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	c2.CGP_ chemical and genetic perturbations	19	1.1321307	0.30228758	0.4801108	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	20	0.63441586	0.92900854	1	1.76654656	0.49771484
GO_POSITIVE_REGULATION_OF_RECEPTOR_ACTIVITY	c5.BP_ GO biological process	40	1.1320738	0.2882883	0.48019248	GO_POSITIVE_REGULATION_OF_RECEPTOR_ACTIVITY	42	1.2478676	0.1489842	0.5144859	2.3799414	-0.1157938
GO_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION	c5.BP_ GO biological process	89	1.1320345	0.23468058	0.48022026	GO_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION	90	0.80847883	0.8229167	1	1.94051333	0.32355567
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP	C7_ immunologic signatures	174	1.1319858	0.21186441	0.48027292	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP	181	0.9846513	0.5282828	0.94214547	2.1166371	0.1473345
ATF2_S_UP.V1_UP	C6_ oncogenic signatures	150	1.1319112	0.21315469	0.48038924	ATF2_S_UP.V1_UP	157	1.0905682	0.29674795	0.7705077	2.2224794	0.041343
GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN	C7_ immunologic signatures	170	1.131888	0.21615201	0.48035923	GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN	173	1.3671399	0.008080808	0.3710323	2.4990279	-0.2352519
GO_ION_ANTIPORTER_ACTIVITY	c5.GO molecular function	40	1.1316066	0.2733711	0.48111185	GO_ION_ANTIPORTER_ACTIVITY	44	1.0326184	0.42791235	0.872456	2.164225	0.0989882
MILI_PSEUDOPODIA_CHEMOTAXIS_UP	c2.CGP_ chemical and genetic perturbations	68	1.131572	0.25	0.48111987	MILI_PSEUDOPODIA_CHEMOTAXIS_UP	68	-1.3240223	0.028985508	0.26180613	-0.1924503	2.4555943
GO_MAMMARY_GLAND_DEVELOPMENT	c5.BP_ GO biological process	107	1.1315395	0.24133663	0.48111555	GO_MAMMARY_GLAND_DEVELOPMENT	111	0.8236202	0.81884056	1	1.9551597	0.3079193
GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	133	1.1314522	0.21668743	0.48127982	GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN	135	1.3611798	0.013238289	0.37657928	2.492632	-0.2297276
CAGGTCC_MIR492	c3.MIR_ microRNA targets	54	1.1313328	0.26676384	0.48154452	CAGGTCC_MIR492	56	0.92793417	0.60850114	0.99986005	2.05926697	0.20339863
GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP	C7_ immunologic signatures	177	1.1312735	0.18615752	0.4816375	GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP	180	1.0501479	0.37525356	0.83981943	2.1814214	0.0811256
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN	C7_ immunologic signatures	104	1.131255	0.22467533	0.48160085	GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN	115	1.2052908	0.12796697	0.58270264	2.3365458	-0.0740358
TSAI_RESPONSE_TO_IONIZING_RADIATION	c2.CGP_ chemical and genetic perturbations	134	1.1312404	0.21871203	0.48155215	TSAI_RESPONSE_TO_IONIZING_RADIATION	137	0.9156332	0.6810256	1	2.0468736	0.2156072
AMIT_SERUM_RESPONSE_60_MCF10A	c2.CGP_ chemical and genetic perturbations	55	1.1310365	0.25633803	0.48206225	AMIT_SERUM_RESPONSE_60_MCF10A	56	1.2804204	0.10352423	0.47165143	2.4114569	-0.1493839
GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP	C7_ immunologic signatures	165	1.1310365	0.2089915	0.4819692	GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP	166	1.0039837	0.5010142	0.9170303	2.1350202	0.1270528
GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN	C7_ immunologic signatures	161	1.1310349	0.2086331	0.48187947	GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN	171	1.1896034	0.13030303	0.60586506	2.3206383	-0.0585685
GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP	C7_ immunologic signatures	180	1.1310136	0.20605356	0.48185128	GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP	182	1.140961	0.17878787	0.6887439	2.2719746	-0.0099474
GSE3039_CD4_TCELL_VS_NKT_CELL_UP	C7_ immunologic signatures	177	1.1310077	0.1964497	0.4817787	GSE3039_CD4_TCELL_VS_NKT_CELL_UP	178	0.8614455	0.7965587	1	1.9924532	0.2695622
GO_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	c5.BP_ GO biological process	32	1.1308569	0.30136988	0.48214522	GO_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	33	0.6973697	0.9026128	1	1.8282266	0.4334872
LEE_LIVER_CANCER_ACOX1_UP	c2.CGP_ chemical and genetic perturbations	54	1.1307912	0.24930362	0.4822414	LEE_LIVER_CANCER_ACOX1_UP	52	1.3566687	0.061659195	0.38021883	2.4874599	-0.2258775
GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP	C7_ immunologic signatures	161	1.1307654	0.2	0.48222774	GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP	164	0.8604462	0.803262	1	1.9912116	0.2703192
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	c2.CGP_ chemical and genetic perturbations	338	1.130722	0.171926	0.48226643	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	356	1.1688861	0.078	0.6391592	2.2996081	-0.0381641
REACTOME_CELL_JUNCTION_ORGANIZATION	c2.CP_REACTOME_ Reactome gene sets	62	1.1306752	0.2581081	0.4823196	REACTOME_CELL_JUNCTION_ORGANIZATION	68	1.1167414	0.31712708	0.72836566	2.2474166	0.0139338
GO_RESPONSE_TO_INORGANIC_SUBSTANCE	c5.BP_ GO biological process	415	1.1306365	0.14162162	0.48234266	GO_RESPONSE_TO_INORGANIC_SUBSTANCE	438	1.1697725	0.061	0.63864326	2.300409	-0.039136
GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN	C7_ immunologic signatures	170	1.1306204	0.19570406	0.4822951	GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN	175	0.7438818	0.93933266	1	1.8745022	0.3867386
GSE7852_TREG_VS_TCONV_LN_DN	C7_ immunologic signatures	170	1.1306155	0.20095694	0.48221564	GSE7852_TREG_VS_TCONV_LN_DN	178	1.4213368	0.003039514	0.3199964	2.5519523	-0.2907213
VERHAAK_GLIOBLASTOMA_PRONEURAL	c2.CGP_ chemical and genetic perturbations	149	1.1303836	0.20420793	0.48282364	VERHAAK_GLIOBLASTOMA_PRONEURAL	157	0.81753737	0.8729508	1	1.94792097	0.31284623
GSE8835_CD4_VS_CD8_TCELL_DN	C7_ immunologic signatures	151	1.1303667	0.22493887	0.48278174	GSE8835_CD4_VS_CD8_TCELL_DN	172	1.0446008	0.3839104	0.8502253	2.1749675	0.0857659
MODY_HIPPOCAMPUS_NEONATAL	c2.CGP_ chemical and genetic perturbations	35	1.1303303	0.28592375	0.48280194	MODY_HIPPOCAMPUS_NEONATAL	35	-0.98788387	0.4679487	0.7057309	0.14244643	2.11821417
FRASOR_RESPONSE_TO_ESTRADIOL_UP	c2.CGP_ chemical and genetic perturbations	35	1.1302724	0.29912025	0.48288235	FRASOR_RESPONSE_TO_ESTRADIOL_UP	36	1.3899845	0.059101656	0.34505415	2.5202569	-0.2597121
GO_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS	c5.BP_ GO biological process	62	1.1302571	0.24793388	0.4828354	GO_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS	67	1.3689438	0.03850385	0.36920333	2.4992009	-0.2386867
MCAATNNNNNGCG_UNKNOWN	c3.TFT_ transcription factor targets	78	1.1302108	0.25956285	0.4828793	MCAATNNNNNGCG_UNKNOWN	78	-1.1086308	0.24528302	0.5050721	0.02158	2.2388416
GO_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION	c5.BP_ GO biological process	27	1.1299585	0.28213167	0.48354927	GO_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION	28	1.1483557	0.2769784	0.6707855	2.2783142	-0.0183972
MARTINEZ_TP53_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	490	1.1299199	0.12710084	0.4835776	MARTINEZ_TP53_TARGETS_DN	490	0	0	0	1.1299199	1.1299199
GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN	C7_ immunologic signatures	184	1.1298168	0.19506463	0.4837844	GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN	185	0.61099	0.99696046	1	1.7408068	0.5188268
GO_POSITIVE_REGULATION_OF_STAT_CASCADE	c5.BP_ GO biological process	57	1.1296506	0.27486187	0.4841822	GO_POSITIVE_REGULATION_OF_STAT_CASCADE	62	-1.1447784	0.20987654	0.45023197	-0.0151278	2.274429
GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP	C7_ immunologic signatures	149	1.1296382	0.2180268	0.48412627	GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP	152	1.2576947	0.058762886	0.49950394	2.3873329	-0.1280565
TTGGAGA_MIR5155P_MIR519E	c3.MIR_ microRNA targets	130	1.1295409	0.22783251	0.4843293	TTGGAGA_MIR5155P_MIR519E	132	-1.092991	0.121212125	0.5296868	0.0365499	2.2225319
PHONG_TNF_RESPONSE_NOT_VIA_P38	c2.CGP_ chemical and genetic perturbations	310	1.1294026	0.17011996	0.48465976	PHONG_TNF_RESPONSE_NOT_VIA_P38	313	1.2282857	0.03206413	0.5435363	2.3576883	-0.0988831
GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN	C7_ immunologic signatures	169	1.1292565	0.20918985	0.4849882	GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN	172	1.0027641	0.48582995	0.91860414	2.1320206	0.1264924
GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP	C7_ immunologic signatures	180	1.1292344	0.20877817	0.48496294	GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP	179	-1.2694263	0	0.3098296	-0.1401919	2.3986607
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	c2.CGP_ chemical and genetic perturbations	312	1.1291734	0.15921482	0.48504862	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	317	0.97632754	0.56626505	0.9537254	2.10550094	0.15284586
SNACANNNYSYAGA_UNKNOWN	c3.TFT_ transcription factor targets	78	1.1291689	0.24119242	0.48497063	SNACANNNYSYAGA_UNKNOWN	78	0.73021024	0.9039488	1	1.85937914	0.39895866
MYB_Q3	c3.TFT_ transcription factor targets	211	1.1291656	0.20997679	0.48488602	MYB_Q3	219	0.79323846	0.9148297	1	1.92240406	0.33592714
GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN	C7_ immunologic signatures	173	1.12911	0.20971563	0.48495403	GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN	177	0.6819528	0.9847561	1	1.8110628	0.4471572
GO_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION	c5.BP_ GO biological process	132	1.1290165	0.25272068	0.48513868	GO_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION	137	0.85453	0.7780062	1	1.9835465	0.2744865
GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP	C7_ immunologic signatures	176	1.1289936	0.20833333	0.48511717	GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP	183	0.9747889	0.5558912	0.95583445	2.1037825	0.1542047
GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP	C7_ immunologic signatures	168	1.1289836	0.19929245	0.48505458	GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP	174	0.97443897	0.56838906	0.95628023	2.10342257	0.15454463
GO_POSITIVE_REGULATION_OF_CHROMATIN_MODIFICATION	c5.BP_ GO biological process	77	1.1289179	0.25201073	0.48515868	GO_POSITIVE_REGULATION_OF_CHROMATIN_MODIFICATION	80	-0.9261303	0.6111111	0.7884113	0.2027876	2.0550482
MORF_WNT1	c4.CGN_ cancer gene neighborhoods	85	1.1288993	0.23197903	0.48512322	MORF_WNT1	90	1.0719872	0.3614331	0.80276036	2.2008865	0.0569121
GO_METANEPHROS_DEVELOPMENT	c5.BP_ GO biological process	75	1.128853	0.26364848	0.48516512	GO_METANEPHROS_DEVELOPMENT	78	1.001649	0.48452508	0.9208679	2.130502	0.127204
GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP	C7_ immunologic signatures	177	1.1286612	0.21128452	0.48564723	GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP	179	0.9816336	0.55870444	0.9467683	2.1102948	0.1470276
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	c2.CGP_ chemical and genetic perturbations	42	1.1285502	0.2699115	0.4858843	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	42	0.67654	0.9249707	1	1.8050902	0.4520102
GO_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS	c5.BP_ GO biological process	87	1.1284782	0.24934725	0.48600054	GO_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS	92	1.1032448	0.29046088	0.75176954	2.231723	0.0252334
GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP	C7_ immunologic signatures	153	1.128426	0.23105134	0.48606634	GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP	165	1.0654217	0.35939085	0.8136084	2.1938477	0.0630043
GNF2_SNRK	c4.CGN_ cancer gene neighborhoods	24	1.1283813	0.2738654	0.4861065	GNF2_SNRK	23	0.83634144	0.72727275	1	1.96472274	0.29203986
GO_B_CELL_MEDIATED_IMMUNITY	c5.BP_ GO biological process	59	1.1283681	0.26756757	0.4860557	GO_B_CELL_MEDIATED_IMMUNITY	71	1.4247322	0.011956521	0.31897974	2.5531003	-0.2963641
GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN	C7_ immunologic signatures	170	1.1282626	0.20971563	0.48626274	GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN	170	0.90430325	0.7184959	1	2.03256585	0.22395935
MODULE_126	c4.CM_ cancer modules	164	1.1282192	0.21121718	0.48631427	MODULE_126	166	-1.2439296	0	0.33024368	-0.1157104	2.3721488
GO_REGULATION_OF_CYTOPLASMIC_TRANSPORT	c5.BP_ GO biological process	419	1.1282077	0.15778251	0.48625654	GO_REGULATION_OF_CYTOPLASMIC_TRANSPORT	433	0.8990162	0.8408408	1	2.0272239	0.2291915
GO_POSITIVE_CHEMOTAXIS	c5.BP_ GO biological process	30	1.1282047	0.2804878	0.4861733	GO_POSITIVE_CHEMOTAXIS	32	0.6831175	0.8976471	1	1.8113222	0.4450872
CHR7Q32	C1: positional gene sets	36	1.1280986	0.2673716	0.48640612	CHR7Q32	39	0.8079883	0.7747126	1	1.9360869	0.3201103
GO_ORGANELLE_ASSEMBLY	c5.BP_ GO biological process	423	1.1280947	0.14634146	0.48632428	GO_ORGANELLE_ASSEMBLY	435	1.017664	0.436	0.8937427	2.1457587	0.1104307
GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN	C7_ immunologic signatures	179	1.1280931	0.20435308	0.4862358	GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN	183	1.2224932	0.0801217	0.5524628	2.3505863	-0.0944001
TAL1ALPHAE47_01	c3.TFT_ transcription factor targets	214	1.1278393	0.2004662	0.48688725	TAL1ALPHAE47_01	223	1.1499184	0.15847543	0.6700125	2.2777577	-0.0220791
GSE3039_CD4_TCELL_VS_NKT_CELL_DN	C7_ immunologic signatures	179	1.1278137	0.21749409	0.4868751	GSE3039_CD4_TCELL_VS_NKT_CELL_DN	181	-1.2209918	0	0.35454178	-0.0931781	2.3488055
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN	C7_ immunologic signatures	169	1.1277744	0.20352942	0.4869014	GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN	170	1.1813868	0.12678936	0.6207796	2.3091612	-0.0536124
SANSOM_APC_TARGETS	c2.CGP_ chemical and genetic perturbations	176	1.1277704	0.22209166	0.48682016	SANSOM_APC_TARGETS	181	0.87764645	0.7721774	1	2.00541685	0.25012395
AACTGAC_MIR223	c3.MIR_ microRNA targets	88	1.1277417	0.26098534	0.48681465	AACTGAC_MIR223	87	0.96711695	0.5599152	0.96441877	2.09485865	0.16062475
GO_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY	c5.GO molecular function	184	1.1276925	0.18843931	0.48687306	GO_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY	186	0.6741176	0.979859	1	1.8018101	0.4535749
GO_POSITIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	49	1.1275859	0.26353276	0.48710153	GO_POSITIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS	52	1.1912974	0.1979405	0.6040818	2.3188833	-0.0637115
GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	156	1.1275059	0.22604422	0.48724636	GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP	162	0.9940349	0.5020325	0.9309812	2.1215408	0.133471
MODULE_123	c4.CM_ cancer modules	208	1.1274823	0.21412037	0.4872194	MODULE_123	218	-0.9170497	0.6666667	0.79909277	0.2104326	2.044532
GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN	C7_ immunologic signatures	165	1.1273267	0.206235	0.48757702	GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN	169	0.9654359	0.58971775	0.96486914	2.0927626	0.1618908
GSE14308_TH2_VS_TH17_UP	C7_ immunologic signatures	179	1.1272228	0.2117225	0.48780313	GSE14308_TH2_VS_TH17_UP	178	0.6936653	0.9747475	1	1.8208881	0.4335575
MYOGENIN_Q6	c3.TFT_ transcription factor targets	220	1.1272026	0.1948956	0.4877746	MYOGENIN_Q6	227	0.8453562	0.84762865	1	1.9725588	0.2818464
GO_PERIKARYON	c5.CC_ GO cellular component	88	1.1271781	0.23584905	0.4877535	GO_PERIKARYON	97	1.0247612	0.4572025	0.88441175	2.1519393	0.1024169
GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	183	1.1271327	0.22336769	0.48779476	GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN	185	0.75431323	0.9535354	1	1.88144593	0.37281947
HALLMARK_INFLAMMATORY_RESPONSE	H_ hallmark gene sets	178	1.1270599	0.2133646	0.48791444	HALLMARK_INFLAMMATORY_RESPONSE	182	1.1458441	0.18585859	0.67761475	2.272904	-0.0187842
GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	167	1.1270437	0.2362301	0.48787114	GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	168	1.0347761	0.42292088	0.8681621	2.1618198	0.0922676
GO_REGULATION_OF_RESPONSE_TO_WOUNDING	c5.BP_ GO biological process	337	1.1269339	0.17806731	0.48810643	GO_REGULATION_OF_RESPONSE_TO_WOUNDING	352	1.498338	0	0.25380647	2.6252719	-0.3714041
MODULE_164	c4.CM_ cancer modules	48	1.1268641	0.26433566	0.48821545	MODULE_164	54	1.2307013	0.16703786	0.53912425	2.3575654	-0.1038372
BIOCARTA_AMI_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	1.1268348	0.31198686	0.48820838	BIOCARTA_AMI_PATHWAY	16	1.7413667	0.002583979	0.06415542	2.8682015	-0.6145319
GO_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	c5.BP_ GO biological process	23	1.1268145	0.2922591	0.48817575	GO_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	24	0.954422	0.539823	0.9769595	2.0812365	0.1723925
ATGAAGG_MIR205	c3.MIR_ microRNA targets	147	1.1268114	0.20243903	0.48809215	ATGAAGG_MIR205	147	0.80526596	0.8604651	1	1.93207736	0.32154544
GSE3982_MAC_VS_NKCELL_UP	C7_ immunologic signatures	180	1.1267912	0.20642202	0.48805693	GSE3982_MAC_VS_NKCELL_UP	180	1.0807467	0.30121705	0.78595275	2.2075379	0.0460445
MODULE_312	c4.CM_ cancer modules	42	1.1267767	0.26609442	0.4880044	MODULE_312	45	1.0642515	0.4	0.8154817	2.1910282	0.0625252
GSE17721_CTRL_VS_LPS_4H_BMDC_DN	C7_ immunologic signatures	166	1.1267152	0.21595092	0.48809308	GSE17721_CTRL_VS_LPS_4H_BMDC_DN	175	1.1632112	0.17510122	0.64782184	2.2899264	-0.036496
WANG_NFKB_TARGETS	c2.CGP_ chemical and genetic perturbations	23	1.1267145	0.3015873	0.48800188	WANG_NFKB_TARGETS	22	0.7011424	0.8754717	1	1.8278569	0.4255721
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP	C7_ immunologic signatures	168	1.1266539	0.20487805	0.48808965	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP	175	1.2069621	0.0862069	0.58077216	2.333616	-0.0803082
CHR5Q21	C1: positional gene sets	20	1.1265823	0.3	0.48820776	CHR5Q21	22	-1.0187007	0.41538462	0.66113096	0.1078816	2.145283
GO_CELLULAR_RESPONSE_TO_STARVATION	c5.BP_ GO biological process	102	1.1265353	0.24088542	0.48825142	GO_CELLULAR_RESPONSE_TO_STARVATION	106	0.873429	0.74303406	1	1.9999643	0.2531063
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN	C7_ immunologic signatures	156	1.1262708	0.19656019	0.4889378	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN	171	1.1288233	0.23309788	0.70680445	2.2550941	-0.0025525
GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	C7_ immunologic signatures	180	1.1261882	0.20888355	0.4890932	GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	182	1.2459898	0.05050505	0.5174743	2.372178	-0.1198016
BERNARD_PPAPDC1B_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	36	1.12616	0.27718222	0.48908174	BERNARD_PPAPDC1B_TARGETS_UP	36	0.8307413	0.74385965	1	1.9569013	0.2954187
GO_A_BAND	c5.CC_ GO cellular component	26	1.1259245	0.30126184	0.4896994	GO_A_BAND	31	1.242919	0.17772512	0.5226366	2.3688435	-0.1169945
GO_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS	c5.BP_ GO biological process	29	1.125773	0.28462708	0.49005452	GO_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS	29	1.0801765	0.35499397	0.7868655	2.2059495	0.0455965
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	c2.CGP_ chemical and genetic perturbations	140	1.1257432	0.23048328	0.49005926	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	146	1.2366982	0.069815196	0.5309961	2.3624414	-0.110955
GSE3982_MAST_CELL_VS_TH2_DN	C7_ immunologic signatures	169	1.125722	0.21575758	0.49002805	GSE3982_MAST_CELL_VS_TH2_DN	174	-0.88886636	0.93333334	0.83674014	0.23685564	2.01458836
GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN	C7_ immunologic signatures	152	1.1257133	0.22407629	0.48996451	GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN	155	0.7619201	0.9143731	1	1.8876334	0.3637932
AGTCAGC_MIR345	c3.MIR_ microRNA targets	53	1.1256162	0.28431374	0.49016562	AGTCAGC_MIR345	55	0.73564124	0.88222224	1	1.86125744	0.38997496
GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP	C7_ immunologic signatures	162	1.1255804	0.21790342	0.49017996	GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP	162	0.8448119	0.8277268	1	1.9703923	0.2807685
GO_MEGAKARYOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	19	1.1255057	0.3176292	0.49031505	GO_MEGAKARYOCYTE_DIFFERENTIATION	19	0.8073063	0.75745785	1	1.932812	0.3181994
ACAACCT_MIR453	c3.MIR_ microRNA targets	37	1.1252323	0.2884058	0.49103338	ACAACCT_MIR453	38	0.97672117	0.5343602	0.9532544	2.10195347	0.14851113
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP	C7_ immunologic signatures	135	1.125214	0.23316708	0.4909887	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP	136	1.3223298	0.024640657	0.4112123	2.4475438	-0.1971158
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	C7_ immunologic signatures	183	1.1250275	0.21311475	0.4914333	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	183	-1.3787801	0	0.22131604	-0.2537526	2.5038076
GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP	C7_ immunologic signatures	158	1.1249526	0.20427553	0.49155906	GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP	161	1.2111901	0.091093116	0.57528305	2.3361427	-0.0862375
JAEGER_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	206	1.1249326	0.20476191	0.49152738	JAEGER_METASTASIS_DN	217	1.5571506	0	0.20149623	2.6820832	-0.432218
GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN	C7_ immunologic signatures	159	1.1248832	0.21589561	0.49158671	GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN	160	-1.1817948	0.05882353	0.40285975	-0.0569116	2.306678
GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN	C7_ immunologic signatures	177	1.1247491	0.21959858	0.49188864	GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN	184	1.1368247	0.1969697	0.6949292	2.2615738	-0.0120756
GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP	C7_ immunologic signatures	166	1.1247377	0.23444976	0.49183628	GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP	169	1.4408212	0.003045685	0.30287254	2.5655589	-0.3160835
GO_ENDOPEPTIDASE_ACTIVITY	c5.GO molecular function	330	1.124717	0.19176598	0.4917992	GO_ENDOPEPTIDASE_ACTIVITY	355	1.222749	0.024024025	0.5519097	2.347466	-0.098032
GSE7852_TREG_VS_TCONV_FAT_UP	C7_ immunologic signatures	183	1.1245466	0.2276029	0.49220696	GSE7852_TREG_VS_TCONV_FAT_UP	184	1.3855386	0.008048289	0.35067776	2.5100852	-0.260992
GO_UBIQUITIN_LIKE_PROTEIN_BINDING	c5.GO molecular function	111	1.1244158	0.22634271	0.492507	GO_UBIQUITIN_LIKE_PROTEIN_BINDING	111	0.8540444	0.76938987	1	1.9784602	0.2703714
GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	122	1.124395	0.24686716	0.49248028	GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	128	1.1054505	0.27604166	0.7463699	2.2298455	0.0189445
CCCNNGGGAR_OLF1_01	c3.TFT_ transcription factor targets	287	1.1243844	0.19235095	0.4924178	CCCNNGGGAR_OLF1_01	295	1.0298871	0.4084084	0.87604487	2.1542715	0.0944973
STAT3_02	c3.TFT_ transcription factor targets	130	1.1243838	0.2249691	0.49232766	STAT3_02	134	1.1535542	0.18209563	0.6626482	2.277938	-0.0291704
CHR4Q23	C1: positional gene sets	15	1.1241344	0.29552716	0.49298888	CHR4Q23	16	1.4740567	0.03761349	0.27476284	2.5981911	-0.3499223
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	C7_ immunologic signatures	171	1.124114	0.20286396	0.49295416	GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	173	0.87012506	0.7881874	1	1.99423906	0.25398894
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN	C7_ immunologic signatures	173	1.1241125	0.20332937	0.49286574	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN	178	0.9685799	0.5777778	0.96299094	2.0926924	0.1555326
GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP	C7_ immunologic signatures	170	1.1240462	0.22064057	0.49296567	GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP	175	1.170858	0.13981763	0.63720685	2.2949042	-0.0468118
GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	C7_ immunologic signatures	143	1.1240417	0.23300971	0.49288437	GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	147	0.79816175	0.877551	1	1.92220345	0.32587995
GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP	C7_ immunologic signatures	174	1.1240197	0.2114486	0.49285898	GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP	179	1.2203684	0.076612905	0.55511636	2.3443881	-0.0963487
GO_ATP_DEPENDENT_DNA_HELICASE_ACTIVITY	c5.GO molecular function	31	1.1239874	0.29970327	0.49286148	GO_ATP_DEPENDENT_DNA_HELICASE_ACTIVITY	31	-1.4075904	0.081871346	0.20172678	-0.283603	2.5315778
GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION	c5.BP_ GO biological process	428	1.123978	0.16190477	0.4927984	GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION	429	1.0573175	0.304	0.82856005	2.1812955	0.0666605
GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	140	1.1238741	0.22060606	0.4930113	GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN	149	0.9653167	0.5920651	0.96488076	2.0891908	0.1585574
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN	C7_ immunologic signatures	173	1.1238627	0.21563981	0.49295166	GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN	173	0.9089971	0.71198386	1	2.0328598	0.2148656
MODULE_111	c4.CM_ cancer modules	121	1.1236112	0.23964868	0.4936045	MODULE_111	134	1.1699404	0.17418033	0.6381949	2.2935516	-0.0463292
KRAS.LUNG_UP.V1_DN	C6_ oncogenic signatures	105	1.1234851	0.25480154	0.4938831	KRAS.LUNG_UP.V1_DN	108	1.249392	0.08872651	0.5117648	2.3728771	-0.1259069
GO_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION	c5.BP_ GO biological process	480	1.1233273	0.15271966	0.4942549	GO_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION	492	0.84338486	0.9289289	1	1.96671216	0.27994244
AML1_Q6	c3.TFT_ transcription factor targets	228	1.1233116	0.19173364	0.49421182	AML1_Q6	240	1.084124	0.27181545	0.77909386	2.2074356	0.0391876
GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP	C7_ immunologic signatures	155	1.1232579	0.21650718	0.4942713	GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP	156	1.3158591	0.035641547	0.41661838	2.439117	-0.1926012
GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP	C7_ immunologic signatures	172	1.1231874	0.23329425	0.49438763	GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP	173	-1.043187	0.33333334	0.617498	0.0800004	2.1663744
KEGG_PROSTATE_CANCER	c2.CP_BIOCARTA_ BioCarta gene sets	86	1.1231565	0.23927177	0.4943786	KEGG_PROSTATE_CANCER	87	0.94260585	0.6225026	0.98897564	2.06576235	0.18055065
MODULE_274	c4.CM_ cancer modules	70	1.12308	0.27297667	0.49451935	MODULE_274	78	1.1841433	0.20430107	0.6152029	2.3072233	-0.0610633
RASHI_RESPONSE_TO_IONIZING_RADIATION_1	c2.CGP_ chemical and genetic perturbations	39	1.1230048	0.2677515	0.49464783	RASHI_RESPONSE_TO_IONIZING_RADIATION_1	39	1.0998445	0.3284091	0.7574284	2.2228493	0.0231603
SIMBULAN_UV_RESPONSE_NORMAL_DN	c2.CGP_ chemical and genetic perturbations	33	1.1229588	0.2929746	0.49468812	SIMBULAN_UV_RESPONSE_NORMAL_DN	33	1.1738526	0.23970944	0.6315326	2.2968114	-0.0508938
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	c2.CGP_ chemical and genetic perturbations	109	1.1228395	0.247765	0.49496195	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	109	0.9945901	0.50103736	0.9305289	2.1174296	0.1282494
GO_PLASMA_MEMBRANE_RECEPTOR_COMPLEX	c5.CC_ GO cellular component	155	1.1228377	0.22115384	0.49487382	GO_PLASMA_MEMBRANE_RECEPTOR_COMPLEX	167	1.3814046	0.008121828	0.35655707	2.5042423	-0.2585669
GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP	C7_ immunologic signatures	158	1.1228238	0.21208385	0.49482808	GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP	171	1.0097564	0.4720812	0.9082118	2.1325802	0.1130674
MCCABE_BOUND_BY_HOXC6	c2.CGP_ chemical and genetic perturbations	340	1.1226832	0.19417475	0.49514478	MCCABE_BOUND_BY_HOXC6	341	1.2182842	0.029	0.55904084	2.3409674	-0.095601
WCAANNNYCAG_UNKNOWN	c3.TFT_ transcription factor targets	220	1.122682	0.2	0.49505556	WCAANNNYCAG_UNKNOWN	226	0.9084205	0.73742455	1	2.0311025	0.2142615
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	c2.CGP_ chemical and genetic perturbations	59	1.1226604	0.25240055	0.4950263	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	60	1.1652944	0.22320442	0.6461661	2.2879548	-0.042634
MODULE_277	c4.CM_ cancer modules	51	1.1224505	0.2839161	0.49557176	MODULE_277	51	0.5519348	0.9943757	1	1.6743853	0.5705157
GO_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY	c5.BP_ GO biological process	118	1.1223605	0.23241206	0.4957539	GO_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY	120	0.91668004	0.682243	1	2.03904054	0.20568046
GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	147	1.1222718	0.23325358	0.49592316	GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	153	1.2318685	0.07215447	0.5365978	2.3541403	-0.1095967
GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP	C7_ immunologic signatures	174	1.122188	0.22596154	0.49608514	GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP	176	1.0542829	0.39350912	0.8344356	2.1764709	0.0679051
LI_INDUCED_T_TO_NATURAL_KILLER_DN	c2.CGP_ chemical and genetic perturbations	104	1.1221654	0.24293059	0.49606195	LI_INDUCED_T_TO_NATURAL_KILLER_DN	107	1.1837264	0.16405433	0.61660266	2.3058918	-0.061561
YGACNNYACAR_UNKNOWN	c3.TFT_ transcription factor targets	77	1.122115	0.24804178	0.49612367	YGACNNYACAR_UNKNOWN	83	0.8000721	0.8342246	1	1.9221871	0.3220429
GSE3982_MAC_VS_NKCELL_DN	C7_ immunologic signatures	166	1.1217791	0.21133412	0.49704608	GSE3982_MAC_VS_NKCELL_DN	168	1.1730088	0.13360325	0.63348055	2.2947879	-0.0512297
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	C7_ immunologic signatures	175	1.1217313	0.21933962	0.49709895	GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	182	0.863603	0.7805864	1	1.9853343	0.2581283
GO_MYELOID_CELL_DEVELOPMENT	c5.BP_ GO biological process	39	1.1216283	0.30215827	0.49732283	GO_MYELOID_CELL_DEVELOPMENT	39	0.6679681	0.9167644	1	1.7895964	0.4536602
GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP	C7_ immunologic signatures	172	1.1216216	0.20689656	0.49724582	GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP	176	1.2126751	0.08989899	0.5729517	2.3342967	-0.0910535
MEDINA_SMARCA4_TARGETS	c2.CGP_ chemical and genetic perturbations	38	1.1215615	0.3026316	0.4973334	MEDINA_SMARCA4_TARGETS	39	0.7033451	0.8917051	1	1.8249066	0.4182164
GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	C7_ immunologic signatures	170	1.1213658	0.225731	0.49785095	GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	178	0.84362423	0.8388721	1	1.96499003	0.27774157
GO_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION	c5.BP_ GO biological process	44	1.1213593	0.28156748	0.4977743	GO_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION	45	1.1012008	0.3213873	0.7551674	2.2225601	0.0201585
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	c2.CGP_ chemical and genetic perturbations	69	1.1213546	0.2749658	0.49769387	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	71	0.8064246	0.8169935	1	1.9277792	0.31493
GO_KIDNEY_MORPHOGENESIS	c5.BP_ GO biological process	77	1.1213188	0.26412615	0.49771363	GO_KIDNEY_MORPHOGENESIS	80	0.9192646	0.64361703	1	2.0405834	0.2020542
IL15_UP.V1_DN	C6_ oncogenic signatures	142	1.1211408	0.24317913	0.49814957	IL15_UP.V1_DN	146	1.3793322	0.011258956	0.35597005	2.500473	-0.2581914
GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP	C7_ immunologic signatures	164	1.1211219	0.2284689	0.4981107	GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP	169	1.0706252	0.34153846	0.8038903	2.1917471	0.0504967
GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP	C7_ immunologic signatures	179	1.12108	0.23809524	0.498137	GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP	178	1.0879838	0.28973842	0.7736386	2.2090638	0.0330962
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP	C7_ immunologic signatures	164	1.1210327	0.22887324	0.49818695	GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP	167	1.0144614	0.46734694	0.8991694	2.1354941	0.1065713
GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING	c5.GO molecular function	206	1.1209251	0.21954022	0.49840733	GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING	220	0.88578457	0.78203833	1	2.00670967	0.23514053
HE_PTEN_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	15	1.1207049	0.32786885	0.4989655	HE_PTEN_TARGETS_UP	16	1.14238	0.301423	0.6862103	2.2630849	-0.0216751
GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	C7_ immunologic signatures	165	1.1206355	0.21936989	0.49907443	GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	167	1.3503994	0.011133603	0.3836413	2.4710349	-0.2297639
GO_KERATINIZATION	c5.BP_ GO biological process	20	1.1206024	0.30718955	0.49908662	GO_KERATINIZATION	19	1.1970007	0.2433121	0.59681326	2.3176031	-0.0763983
TIEN_INTESTINE_PROBIOTICS_6HR_DN	c2.CGP_ chemical and genetic perturbations	155	1.1205314	0.23222749	0.4992057	TIEN_INTESTINE_PROBIOTICS_6HR_DN	155	0.7220032	0.95607764	1	1.8425346	0.3985282
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN	C7_ immunologic signatures	149	1.1204482	0.23424494	0.49935517	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN	151	0.7608221	0.9125127	1	1.8812703	0.3596261
GO_CELLULAR_RESPONSE_TO_LIPID	c5.BP_ GO biological process	401	1.1203033	0.16506922	0.49969503	GO_CELLULAR_RESPONSE_TO_LIPID	417	0.92984694	0.759	0.99908495	2.05015024	0.19045636
HARRIS_BRAIN_CANCER_PROGENITORS	c2.CGP_ chemical and genetic perturbations	37	1.1202888	0.28652483	0.4996479	HARRIS_BRAIN_CANCER_PROGENITORS	39	1.4498897	0.02433372	0.29100737	2.5701785	-0.3296009
GO_REGULATION_OF_TOR_SIGNALING	c5.BP_ GO biological process	64	1.1202605	0.27412587	0.49963713	GO_REGULATION_OF_TOR_SIGNALING	65	0.89325386	0.66411376	1	2.01351436	0.22700664
GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN	C7_ immunologic signatures	180	1.1201367	0.20500596	0.49991494	GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN	179	1.4332244	0.002022245	0.31333393	2.5533611	-0.3130877
BMI1_DN.V1_DN	C6_ oncogenic signatures	118	1.1200337	0.22871046	0.5001295	BMI1_DN.V1_DN	124	1.1077546	0.28985506	0.74129164	2.2277883	0.0122791
GO_RESPONSE_TO_NUTRIENT	c5.BP_ GO biological process	176	1.1199559	0.21520467	0.5002677	GO_RESPONSE_TO_NUTRIENT	182	1.1121451	0.2355915	0.73421866	2.232101	0.0078108
GAANYNYGACNY_UNKNOWN	c3.TFT_ transcription factor targets	64	1.1198174	0.27125505	0.5005849	GAANYNYGACNY_UNKNOWN	64	1.1076224	0.3054348	0.74159026	2.2274398	0.012195
GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_DN	C7_ immunologic signatures	141	1.1197705	0.23751523	0.50063705	GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_DN	147	1.13252	0.2272262	0.7022342	2.2522905	-0.0127495
MODULE_346	c4.CM_ cancer modules	16	1.1196994	0.31096563	0.500752	MODULE_346	17	1.0250286	0.4400527	0.88374734	2.144728	0.0946708
CHR4Q12	C1: positional gene sets	22	1.1196566	0.3117284	0.5007888	CHR4Q12	24	0.6344653	0.93159205	1	1.7541219	0.4851913
LABBE_WNT3A_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	83	1.1195855	0.24864864	0.50091934	LABBE_WNT3A_TARGETS_DN	86	1.2635787	0.08760684	0.49133685	2.3831642	-0.1439932
GSE17721_CTRL_VS_LPS_2H_BMDC_DN	C7_ immunologic signatures	172	1.1195524	0.2370892	0.50093377	GSE17721_CTRL_VS_LPS_2H_BMDC_DN	175	1.1161935	0.23410696	0.7289695	2.2357459	0.0033589
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	c2.CP_BIOCARTA_ BioCarta gene sets	54	1.1195202	0.25879043	0.5009344	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	60	1.8245281	0	0.02629262	2.9440483	-0.7050079
GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN	C7_ immunologic signatures	178	1.1193411	0.22195704	0.50138545	GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN	180	0.99597776	0.52982813	0.9295499	2.11531886	0.12336334
GSE27786_CD4_TCELL_VS_NKCELL_DN	C7_ immunologic signatures	183	1.1193339	0.22261904	0.5013139	GSE27786_CD4_TCELL_VS_NKCELL_DN	184	0.80163115	0.8943089	1	1.92096505	0.31770275
MTOR_UP.N4.V1_DN	C6_ oncogenic signatures	137	1.1193153	0.24189526	0.50127536	MTOR_UP.N4.V1_DN	139	1.3624575	0.018442623	0.37583742	2.4817728	-0.2431422
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP	C7_ immunologic signatures	168	1.119276	0.23086269	0.5012987	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP	171	0.7652597	0.9361702	1	1.8845357	0.3540163
GO_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE	c5.BP_ GO biological process	58	1.1191367	0.29320112	0.50162774	GO_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE	60	0.7911457	0.820765	1	1.9102824	0.327991
PAX6_01	c3.TFT_ transcription factor targets	84	1.1191348	0.2542373	0.5015379	PAX6_01	88	0.71346545	0.9279661	1	1.83260025	0.40566935
KRAS.LUNG.BREAST_UP.V1_UP	C6_ oncogenic signatures	107	1.1189522	0.24585988	0.5020046	KRAS.LUNG.BREAST_UP.V1_UP	109	1.3944888	0.014644352	0.34583196	2.513441	-0.2755366
GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP	C7_ immunologic signatures	178	1.1188203	0.2317647	0.5023197	GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP	183	1.262685	0.04453441	0.49265194	2.3815053	-0.1438647
CHR18P11	C1: positional gene sets	48	1.1187551	0.30057803	0.50240785	CHR18P11	48	1.0624064	0.36659193	0.81869394	2.1811615	0.0563487
TBK1.DF_DN	C6_ oncogenic signatures	260	1.1186045	0.21618626	0.5027652	TBK1.DF_DN	261	0.66848963	0.9959799	1	1.78709413	0.45011487
MODULE_48	c4.CM_ cancer modules	273	1.118432	0.20022002	0.50318384	MODULE_48	290	1.4179455	0.00201005	0.320701	2.5363775	-0.2995135
GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_DN	C7_ immunologic signatures	118	1.1183848	0.25590062	0.5032379	GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_DN	127	1.4877609	0.002070393	0.26284304	2.6061457	-0.3693761
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN	C7_ immunologic signatures	180	1.1183507	0.23250297	0.503245	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN	180	-1.0346336	0.3	0.63057405	0.0837171	2.1529843
GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP	C7_ immunologic signatures	183	1.1183494	0.22541967	0.5031559	GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP	186	1.0968665	0.2782258	0.7614101	2.2152159	0.0214829
GO_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS	c5.BP_ GO biological process	179	1.1182961	0.23672055	0.50323236	GO_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS	190	0.9950086	0.51417005	0.9301748	2.1133047	0.1232875
MULLIGHAN_MLL_SIGNATURE_1_DN	c2.CGP_ chemical and genetic perturbations	203	1.1182797	0.20813954	0.5031832	MULLIGHAN_MLL_SIGNATURE_1_DN	211	1.0471507	0.37185928	0.8448111	2.1654304	0.071129
MORF_TNFRSF6	c4.CGN_ cancer gene neighborhoods	122	1.1182193	0.24871135	0.5032711	MORF_TNFRSF6	132	1.3950101	0.011235955	0.34634364	2.5132294	-0.2767908
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	c2.CGP_ chemical and genetic perturbations	22	1.117961	0.29575163	0.50394255	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	24	0.6971479	0.8644918	1	1.8151089	0.4208131
GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP	C7_ immunologic signatures	160	1.1178563	0.23267327	0.50416315	GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP	163	1.1204482	0.23987854	0.72279316	2.2383045	-0.0025919
GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN	C7_ immunologic signatures	165	1.1178536	0.22716346	0.5040765	GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN	181	1.2803959	0.042296074	0.47126532	2.3982495	-0.1625423
GO_POSITIVE_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	16	1.1178014	0.30990416	0.5041393	GO_POSITIVE_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION	18	1.366457	0.09542484	0.37178457	2.4842584	-0.2486556
GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	C7_ immunologic signatures	185	1.117719	0.23820755	0.5042954	GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	186	1.0781494	0.30382293	0.7912803	2.1958684	0.0395696
GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP	C7_ immunologic signatures	169	1.117673	0.22393365	0.5043391	GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP	180	1.4293342	0.003039514	0.31616926	2.5470072	-0.3116612
GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN	C7_ immunologic signatures	174	1.1175363	0.2301305	0.50466275	GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN	178	0.8863651	0.76012146	1	2.0039014	0.2311712
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP	C7_ immunologic signatures	152	1.1175086	0.22819594	0.5046488	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP	159	1.2738799	0.05010225	0.48185277	2.3913885	-0.1563713
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	C7_ immunologic signatures	173	1.1174897	0.23305589	0.5046105	GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	176	1.333966	0.019133938	0.3994	2.4514557	-0.2164763
GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP	C7_ immunologic signatures	175	1.1174284	0.23167849	0.5047126	GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP	179	-0.9762187	0.5714286	0.71911323	0.1412097	2.0936471
BIOCARTA_TNFR2_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	1.1174111	0.3218391	0.50466996	BIOCARTA_TNFR2_PATHWAY	17	1.2948786	0.14896373	0.44940734	2.4122897	-0.1774675
BIOCARTA_IGF1R_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	1.1171608	0.28810975	0.5053511	BIOCARTA_IGF1R_PATHWAY	22	-0.83434194	0.7765363	0.8786057	0.28281886	1.95150274
GSE3982_MAST_CELL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	163	1.1171054	0.24487334	0.5054154	GSE3982_MAST_CELL_VS_NEUTROPHIL_DN	169	1.0892718	0.30682978	0.7717941	2.2063772	0.0278336
GNCF_01	c3.TFT_ transcription factor targets	60	1.1170752	0.2457627	0.5054115	GNCF_01	67	1.1513395	0.24618736	0.66749525	2.2684147	-0.0342643
GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN	C7_ immunologic signatures	167	1.1170509	0.23627685	0.50539297	GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN	172	1.1829133	0.12893401	0.6181049	2.2999642	-0.0658624
AP4_Q6_01	c3.TFT_ transcription factor targets	221	1.1170093	0.22962113	0.5054194	AP4_Q6_01	225	1.0722839	0.2982811	0.80219233	2.1892932	0.0447254
MORF_MT4	c4.CGN_ cancer gene neighborhoods	208	1.1169937	0.2078978	0.5053704	MORF_MT4	223	1.3090597	0.013039118	0.42759392	2.4260534	-0.192066
GO_PHOSPHATIDYLSERINE_BINDING	c5.GO molecular function	28	1.1168463	0.3115727	0.50571424	GO_PHOSPHATIDYLSERINE_BINDING	29	1.1935873	0.22880372	0.59968734	2.3104336	-0.076741
GSE45365_BCELL_VS_CD8_TCELL_DN	C7_ immunologic signatures	125	1.1167902	0.24502487	0.50579137	GSE45365_BCELL_VS_CD8_TCELL_DN	130	1.1300664	0.23100616	0.7056509	2.2468566	-0.0132762
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	c2.CGP_ chemical and genetic perturbations	130	1.1167502	0.23815462	0.50582147	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	136	1.3920852	0.007179487	0.3469103	2.5088354	-0.275335
GO_CLATHRIN_MEDIATED_ENDOCYTOSIS	c5.BP_ GO biological process	35	1.1166778	0.30875576	0.50595	GO_CLATHRIN_MEDIATED_ENDOCYTOSIS	35	1.326465	0.102870815	0.40601856	2.4431428	-0.2097872
GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	C7_ immunologic signatures	163	1.1165998	0.24366707	0.50609136	GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	167	1.0053905	0.4969574	0.9140331	2.1219903	0.1112093
GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN	C7_ immunologic signatures	174	1.1165866	0.23104693	0.5060332	GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN	181	0.75483215	0.9320487	1	1.87141875	0.36175445
GO_FILAMENTOUS_ACTIN	c5.CC_ GO cellular component	19	1.1165718	0.32049307	0.505981	GO_FILAMENTOUS_ACTIN	19	0.9447423	0.5637319	0.98775387	2.0613141	0.1718295
GO_CELLULAR_SENESCENCE	c5.BP_ GO biological process	29	1.1164622	0.2879257	0.506212	GO_CELLULAR_SENESCENCE	29	0.7810317	0.80266345	1	1.8974939	0.3354305
TTTTGAG_MIR373	c3.MIR_ microRNA targets	207	1.1164358	0.21779859	0.50620234	TTTTGAG_MIR373	211	-1.2136045	0	0.3638302	-0.0971687	2.3300403
GO_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	252	1.1164341	0.22824858	0.50611424	GO_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS	255	0.7895237	0.93567836	1	1.9059578	0.3269104
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN	C7_ immunologic signatures	180	1.1164258	0.22444183	0.50604564	GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN	182	1.1495134	0.17748478	0.67037773	2.2659392	-0.0330876
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP	C7_ immunologic signatures	172	1.1164054	0.23356807	0.5060092	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP	177	1.4279712	0.001013171	0.31714484	2.5443766	-0.3115658
GO_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION	c5.BP_ GO biological process	27	1.1163317	0.29402515	0.5061354	GO_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION	28	1.032456	0.42630938	0.8728449	2.1487877	0.0838757
GO_POSITIVE_REGULATION_OF_INTERLEUKIN_1_SECRETION	c5.BP_ GO biological process	15	1.1162562	0.32427844	0.50626665	GO_POSITIVE_REGULATION_OF_INTERLEUKIN_1_SECRETION	18	1.3211639	0.10969388	0.41111016	2.4374201	-0.2049077
GO_REGULATION_OF_INCLUSION_BODY_ASSEMBLY	c5.BP_ GO biological process	16	1.1160934	0.32084692	0.50667876	GO_REGULATION_OF_INCLUSION_BODY_ASSEMBLY	16	1.5329462	0.025299601	0.21962315	2.6490396	-0.4168528
GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN	C7_ immunologic signatures	175	1.11608	0.22260669	0.50662255	GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN	177	1.1130425	0.24392712	0.7329835	2.2291225	0.0030375
MORF_BRCA1	c4.CGN_ cancer gene neighborhoods	217	1.1160214	0.21212122	0.50670904	MORF_BRCA1	233	0.92019475	0.7267267	1	2.03621615	0.19582665
FIRESTEIN_CTNNB1_PATHWAY	c2.CGP_ chemical and genetic perturbations	32	1.1160083	0.29925925	0.5066559	FIRESTEIN_CTNNB1_PATHWAY	32	1.3293177	0.09305065	0.40285683	2.445326	-0.2133094
GO_REGULATION_OF_LEUKOCYTE_PROLIFERATION	c5.BP_ GO biological process	160	1.1159797	0.24697337	0.5066517	GO_REGULATION_OF_LEUKOCYTE_PROLIFERATION	172	1.0939901	0.2833843	0.76725036	2.2099698	0.0219896
GO_T_CELL_MEDIATED_IMMUNITY	c5.BP_ GO biological process	23	1.1158569	0.32579187	0.50692135	GO_T_CELL_MEDIATED_IMMUNITY	24	1.0076746	0.49569497	0.9109452	2.1235315	0.1081823
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	c2.CP_REACTOME_ Reactome gene sets	28	1.1157004	0.30505952	0.5072969	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	30	-1.0440141	0.38333333	0.616113	0.0716863	2.1597145
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP	c2.CGP_ chemical and genetic perturbations	126	1.1156291	0.2455243	0.5074239	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP	129	1.4378097	0.003083248	0.30789724	2.5534388	-0.3221806
GO_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION	c5.BP_ GO biological process	70	1.1155769	0.27935222	0.50748706	GO_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION	76	1.1141291	0.29555085	0.73178756	2.229706	0.0014478
GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP	C7_ immunologic signatures	138	1.1155554	0.24878049	0.50745374	GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP	146	1.0378271	0.41337386	0.86230344	2.1533825	0.0777283
GSE3982_MAST_CELL_VS_TH2_UP	C7_ immunologic signatures	169	1.1155425	0.23815165	0.507398	GSE3982_MAST_CELL_VS_TH2_UP	169	1.191126	0.11983887	0.6041176	2.3066685	-0.0755835
GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN	C7_ immunologic signatures	173	1.1155269	0.24299066	0.5073523	GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN	177	1.083068	0.28614762	0.7820399	2.1985949	0.0324589
GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	148	1.1153742	0.23507462	0.5077201	GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	151	-0.95109165	0.65	0.75315773	0.16428255	2.06646585
GO_SEX_DIFFERENTIATION	c5.BP_ GO biological process	226	1.1153607	0.20761245	0.50766444	GO_SEX_DIFFERENTIATION	243	0.8632613	0.82530123	1	1.978622	0.2520994
GO_AMMONIUM_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	20	1.1152201	0.32171157	0.5079799	GO_AMMONIUM_TRANSMEMBRANE_TRANSPORT	24	0.7776904	0.7766749	1	1.8929105	0.3375297
DELASERNA_MYOD_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	52	1.1151973	0.28687415	0.5079508	DELASERNA_MYOD_TARGETS_DN	52	0.9902939	0.4982974	0.9353919	2.1054912	0.1249034
GO_MYOSIN_II_COMPLEX	c5.CC_ GO cellular component	18	1.1151432	0.32576984	0.5080198	GO_MYOSIN_II_COMPLEX	22	1.0654835	0.38745388	0.81348777	2.1806267	0.0496597
HAN_SATB1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	391	1.1151075	0.18240343	0.508032	HAN_SATB1_TARGETS_DN	396	1.3153255	0	0.4178893	2.430433	-0.200218
GO_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY	c5.GO molecular function	146	1.1150804	0.24792407	0.50801814	GO_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY	146	0.99020886	0.5292308	0.93529516	2.10528926	0.12487154
GO_REGULATION_OF_FATTY_ACID_OXIDATION	c5.BP_ GO biological process	26	1.1150599	0.3190184	0.50798935	GO_REGULATION_OF_FATTY_ACID_OXIDATION	27	1.3044398	0.11931119	0.4346115	2.4194997	-0.1893799
GO_ANDROGEN_RECEPTOR_BINDING	c5.GO molecular function	38	1.1149914	0.2929293	0.50809735	GO_ANDROGEN_RECEPTOR_BINDING	37	0.90881926	0.6207675	1	2.02381066	0.20617214
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	c2.CGP_ chemical and genetic perturbations	43	1.1149124	0.29885057	0.5082368	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	43	-0.8200516	0.8938053	0.8895662	0.2948608	1.934964
PID_P53_REGULATION_PATHWAY	c2.CP_ Canonical pathways	53	1.1147383	0.27700832	0.5086843	PID_P53_REGULATION_PATHWAY	53	-0.71911335	0.973913	0.95127916	0.39562495	1.83385165
GSE25087_TREG_VS_TCONV_FETUS_UP	C7_ immunologic signatures	164	1.1144902	0.21212122	0.5093319	GSE25087_TREG_VS_TCONV_FETUS_UP	166	1.0175827	0.45288754	0.89378375	2.1320729	0.0969075
AML1_01	c3.TFT_ transcription factor targets	228	1.1144694	0.21354765	0.50929564	AML1_01	240	1.0921482	0.2713568	0.7692298	2.2066176	0.0223212
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	66	1.1144005	0.2894376	0.509404	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	63	0.54364914	0.99335545	1	1.65804964	0.57075136
GO_SYNTAXIN_BINDING	c5.GO molecular function	80	1.1143994	0.26493508	0.50931305	GO_SYNTAXIN_BINDING	84	1.0658863	0.36949515	0.8127358	2.1802857	0.0485131
GO_GAMETE_GENERATION	c5.BP_ GO biological process	457	1.1143975	0.16892597	0.50922513	GO_GAMETE_GENERATION	489	1.2772853	0.003	0.47608766	2.3916828	-0.1628878
GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	C7_ immunologic signatures	165	1.11438	0.2482353	0.50918365	GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	166	1.2209342	0.08766565	0.5544176	2.3353142	-0.1065542
GSE13522_WT_VS_IFNAR_KO_SKIN_UP	C7_ immunologic signatures	169	1.1137849	0.22503008	0.51087683	GSE13522_WT_VS_IFNAR_KO_SKIN_UP	171	1.0397601	0.40202022	0.85906625	2.153545	0.0740248
STAT5A_03	c3.TFT_ transcription factor targets	219	1.113752	0.21993127	0.51088613	STAT5A_03	227	0.7664217	0.943662	1	1.8801737	0.3473303
CHR1Q25	C1: positional gene sets	55	1.1137146	0.28312412	0.5109078	CHR1Q25	55	1.3801672	0.04318937	0.35646856	2.4938818	-0.2664526
GO_RHO_GTPASE_BINDING	c5.GO molecular function	75	1.1135509	0.27140975	0.51130915	GO_RHO_GTPASE_BINDING	76	1.2896512	0.084142394	0.45836294	2.4032021	-0.1761003
GO_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	c5.BP_ GO biological process	27	1.1135427	0.31944445	0.51124054	GO_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	27	0.57917446	0.96359223	1	1.69271716	0.53436824
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN	c2.CGP_ chemical and genetic perturbations	15	1.1134963	0.32102728	0.511286	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN	16	1.4860841	0.027173912	0.2644125	2.5995804	-0.3725878
GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP	C7_ immunologic signatures	167	1.1134796	0.22888617	0.51124346	GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP	170	1.1643509	0.1632653	0.64655286	2.2778305	-0.0508713
GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	177	1.1134523	0.22479722	0.51123047	GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	179	1.2095935	0.0862069	0.5776174	2.3230458	-0.0961412
GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP	C7_ immunologic signatures	168	1.1130852	0.24521531	0.51223755	GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP	170	1.108343	0.24395162	0.7407753	2.2214282	0.0047422
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	159	1.1130319	0.2251497	0.5123048	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	160	1.0283837	0.43295804	0.8784026	2.1414156	0.0846482
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	c2.CGP_ chemical and genetic perturbations	32	1.1129988	0.3154671	0.51231414	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	35	1.2898506	0.12139423	0.45803216	2.4028494	-0.1768518
GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	172	1.1129673	0.24076281	0.5123178	GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	187	1.0859077	0.29685917	0.7760602	2.198875	0.0270596
TSENG_IRS1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	100	1.1129603	0.26496816	0.5122449	TSENG_IRS1_TARGETS_UP	101	0.8420415	0.7795031	1	1.9550018	0.2709188
PID_AMB2_NEUTROPHILS_PATHWAY	c2.CP_ Canonical pathways	36	1.1128931	0.29667148	0.5123637	PID_AMB2_NEUTROPHILS_PATHWAY	36	0.74554974	0.86839014	1	1.85844284	0.36734336
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	c2.CGP_ chemical and genetic perturbations	287	1.1128223	0.20744081	0.5124833	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	301	1.052904	0.34704113	0.83629537	2.1657263	0.0599183
CHR15Q26	C1: positional gene sets	54	1.1127423	0.2869081	0.51263446	CHR15Q26	54	1.2790234	0.11973392	0.4724115	2.3917657	-0.1662811
GSE2826_WT_VS_XID_BCELL_UP	C7_ immunologic signatures	178	1.1127161	0.22538553	0.5126207	GSE2826_WT_VS_XID_BCELL_UP	182	1.2458469	0.065789476	0.5172299	2.358563	-0.1331308
GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	C7_ immunologic signatures	181	1.1124154	0.23699422	0.51344824	GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	182	0.6564387	0.9919192	1	1.7688541	0.4559767
KEGG_WNT_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	136	1.1123875	0.2524272	0.5134389	KEGG_WNT_SIGNALING_PATHWAY	142	1.0165149	0.45020324	0.8949856	2.1289024	0.0958726
GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN	C7_ immunologic signatures	105	1.1123602	0.25252524	0.51342726	GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN	106	0.9534796	0.59143156	0.9777597	2.0658398	0.1588806
CEBP_Q2	c3.TFT_ transcription factor targets	197	1.1122952	0.2467986	0.5135266	CEBP_Q2	209	1.3200066	0.010060363	0.4121518	2.4323018	-0.2077114
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	c2.CGP_ chemical and genetic perturbations	20	1.1121975	0.33486238	0.513722	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	21	1.3788766	0.07673569	0.35540116	2.4910741	-0.2666791
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	c2.CGP_ chemical and genetic perturbations	15	1.1121248	0.3260135	0.5138574	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15	0.6307062	0.92506814	1	1.742831	0.4814186
GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN	C7_ immunologic signatures	177	1.1120425	0.24516909	0.514018	GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN	180	1.3204339	0.015228426	0.4115879	2.4324764	-0.2083914
GO_MACROMITOPHAGY	c5.BP_ GO biological process	117	1.111859	0.23027167	0.51447445	GO_MACROMITOPHAGY	119	0.9507163	0.60887516	0.9814331	2.0625753	0.1611427
IKEDA_MIR30_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	110	1.1118295	0.24438573	0.5144707	IKEDA_MIR30_TARGETS_UP	110	0.7667316	0.8869654	1	1.8785611	0.3450979
FOSTER_TOLERANT_MACROPHAGE_DN	c2.CGP_ chemical and genetic perturbations	368	1.1116505	0.19506967	0.51491684	FOSTER_TOLERANT_MACROPHAGE_DN	370	1.0819335	0.24424425	0.78368235	2.193584	0.029717
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	c2.CGP_ chemical and genetic perturbations	57	1.1115942	0.2994429	0.5149997	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	60	0.98268723	0.52135813	0.9446884	2.09428143	0.12890697
GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN	C7_ immunologic signatures	171	1.1114687	0.24561404	0.51528174	GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN	176	0.7360515	0.95723015	1	1.8475202	0.3754172
GO_SNARE_BINDING	c5.GO molecular function	113	1.1113697	0.27057356	0.51548785	GO_SNARE_BINDING	117	0.9775948	0.5412371	0.95198256	2.0889645	0.1337749
GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL	c5.BP_ GO biological process	17	1.1112965	0.33227345	0.5156199	GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL	18	1.4226153	0.049608354	0.31828222	2.5339118	-0.3113188
GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN	C7_ immunologic signatures	176	1.1112584	0.23842593	0.5156437	GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN	179	0.7769899	0.9106599	1	1.8882483	0.3342685
GO_RESPONSE_TO_INCREASED_OXYGEN_LEVELS	c5.BP_ GO biological process	21	1.1112256	0.31811264	0.5156471	GO_RESPONSE_TO_INCREASED_OXYGEN_LEVELS	23	1.0554959	0.40274313	0.83219796	2.1667215	0.0557297
GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP	C7_ immunologic signatures	131	1.111204	0.24171779	0.5156237	GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP	137	0.91506356	0.6895492	1	2.02626756	0.19614044
GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_UP	C7_ immunologic signatures	174	1.1111933	0.23159145	0.5155631	GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_UP	176	0.6922314	0.97267205	1	1.8034247	0.4189619
GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP	C7_ immunologic signatures	175	1.1109911	0.24669074	0.51607496	GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP	176	0.9776871	0.54352224	0.9520525	2.0886782	0.133304
RIZ_ERYTHROID_DIFFERENTIATION_6HR	c2.CGP_ chemical and genetic perturbations	35	1.1108323	0.31911764	0.51644814	RIZ_ERYTHROID_DIFFERENTIATION_6HR	37	1.5456873	0.006944445	0.20761898	2.6565196	-0.434855
RUIZ_TNC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	141	1.1108018	0.26049381	0.5164493	RUIZ_TNC_TARGETS_UP	142	1.2630142	0.054081634	0.4919276	2.373816	-0.1522124
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR	c2.CGP_ chemical and genetic perturbations	32	1.110707	0.3168909	0.5166484	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR	34	0.9516575	0.5478972	0.9804096	2.0623645	0.1590495
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP	C7_ immunologic signatures	179	1.1106203	0.22964764	0.51680756	GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP	181	0.84258693	0.8290946	1	1.95320723	0.26803337
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN	C7_ immunologic signatures	174	1.1103568	0.23481308	0.5175218	GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN	179	1.1193367	0.22482197	0.7237757	2.2296935	-0.0089799
CHR7Q33	C1: positional gene sets	16	1.110281	0.33172303	0.51766014	CHR7Q33	17	1.2509109	0.1882353	0.50927186	2.3611919	-0.1406299
GO_CHANNEL_REGULATOR_ACTIVITY	c5.GO molecular function	105	1.1102673	0.26982096	0.51760644	GO_CHANNEL_REGULATOR_ACTIVITY	117	1.0639328	0.3595855	0.8158476	2.1742001	0.0463345
GO_EPITHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	399	1.110235	0.19271949	0.5176128	GO_EPITHELIAL_CELL_DIFFERENTIATION	423	0.93552166	0.724	0.99426115	2.04575666	0.17471334
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP	C7_ immunologic signatures	148	1.1102254	0.24613555	0.517547	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP	159	1.3244877	0.019191919	0.4090593	2.4347131	-0.2142623
TATA_01	c3.TFT_ transcription factor targets	196	1.1101881	0.22860493	0.5175582	TATA_01	217	0.81556445	0.89145726	1	1.92575255	0.29462365
GSE2706_UNSTIM_VS_8H_R848_DC_UP	C7_ immunologic signatures	158	1.1101317	0.25516403	0.51764005	GSE2706_UNSTIM_VS_8H_R848_DC_UP	162	1.2561225	0.046795525	0.50096774	2.3662542	-0.1459908
GSE17721_CTRL_VS_LPS_1H_BMDC_UP	C7_ immunologic signatures	165	1.1100712	0.23955774	0.51773757	GSE17721_CTRL_VS_LPS_1H_BMDC_UP	169	-0.8595132	1	0.86102027	0.250558	1.9695844
GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN	C7_ immunologic signatures	154	1.1100581	0.23333333	0.51768285	GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN	159	1.1514984	0.17951319	0.66742396	2.2615565	-0.0414403
ZHU_CMV_24_HR_UP	c2.CGP_ chemical and genetic perturbations	85	1.1099998	0.27419356	0.51775956	ZHU_CMV_24_HR_UP	85	0.7885365	0.8568399	1	1.8985363	0.3214633
GO_CELL_SUBSTRATE_JUNCTION	c5.CC_ GO cellular component	367	1.1096907	0.18743229	0.51861876	GO_CELL_SUBSTRATE_JUNCTION	367	0.832564	0.91	1	1.9422547	0.2771267
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN	c2.CGP_ chemical and genetic perturbations	30	1.1096587	0.29640287	0.51862025	HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN	30	0.7921046	0.7747642	1	1.9017633	0.3175541
EGFR_UP.V1_DN	C6_ oncogenic signatures	156	1.1096407	0.25564805	0.51857895	EGFR_UP.V1_DN	161	1.1165118	0.2272262	0.7286199	2.2261525	-0.0068711
GO_REGULATION_OF_NEUROBLAST_PROLIFERATION	c5.BP_ GO biological process	26	1.1095972	0.3168168	0.51861835	GO_REGULATION_OF_NEUROBLAST_PROLIFERATION	28	-1.2952365	0.11956522	0.28834572	-0.1856393	2.4048337
GO_MIDBRAIN_DEVELOPMENT	c5.BP_ GO biological process	76	1.1095595	0.28903225	0.51863974	GO_MIDBRAIN_DEVELOPMENT	78	-1.3580679	0.010989011	0.2358245	-0.2485084	2.4676274
GO_REGULATION_OF_DNA_METHYLATION	c5.BP_ GO biological process	16	1.1094886	0.34597155	0.518755	GO_REGULATION_OF_DNA_METHYLATION	17	0.94638646	0.52516127	0.9858731	2.05587506	0.16310214
GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN	C7_ immunologic signatures	182	1.1093707	0.26491648	0.5190138	GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN	183	0.87385136	0.7928934	1	1.98322206	0.23551934
GNF2_CCNA1	c4.CGN_ cancer gene neighborhoods	46	1.1092829	0.29839882	0.5191865	GNF2_CCNA1	51	1.3886001	0.0396376	0.34816113	2.497883	-0.2793172
PKCA_DN.V1_DN	C6_ oncogenic signatures	135	1.1092293	0.24725944	0.51925087	PKCA_DN.V1_DN	149	0.87712055	0.76350665	1	1.98634985	0.23210875
GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN	C7_ immunologic signatures	170	1.1091886	0.23866348	0.5192751	GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN	174	1.269788	0.038306452	0.48527023	2.3789766	-0.1605994
BIOCARTA_BIOPEPTIDES_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	39	1.1091119	0.29885057	0.5194063	BIOCARTA_BIOPEPTIDES_PATHWAY	39	1.1371614	0.2672919	0.6948754	2.2462733	-0.0280495
GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP	C7_ immunologic signatures	167	1.1090893	0.24669074	0.51938254	GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP	168	1.1668804	0.13953489	0.64287126	2.2759697	-0.0577911
BIOCARTA_CSK_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	19	1.1090606	0.3474843	0.5193799	BIOCARTA_CSK_PATHWAY	20	0.8070634	0.75382656	1	1.916124	0.3019972
MODULE_169	c4.CM_ cancer modules	81	1.1090243	0.28225806	0.5194015	MODULE_169	84	1.1905632	0.16204691	0.60506016	2.2995875	-0.0815389
GO_CARBOHYDRATE_TRANSPORT	c5.BP_ GO biological process	77	1.1090122	0.2816167	0.51934236	GO_CARBOHYDRATE_TRANSPORT	83	0.86262953	0.7321998	1	1.97164173	0.24638267
GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN	C7_ immunologic signatures	142	1.1089642	0.23595506	0.51939404	GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN	141	0.7502324	0.92505133	1	1.8591966	0.3587318
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	43	1.108925	0.30113637	0.51941705	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	46	0.8421997	0.72632796	1	1.9511247	0.2667253
STAT6_02	c3.TFT_ transcription factor targets	224	1.1088547	0.22171946	0.5195361	STAT6_02	230	1.0170499	0.45390782	0.8939554	2.1259046	0.0918048
GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN	C7_ immunologic signatures	174	1.1088	0.2508918	0.5196127	GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN	175	0.7382305	0.94827586	1	1.8470305	0.3705695
GO_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX	c5.CC_ GO cellular component	38	1.1087242	0.30624092	0.5197398	GO_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX	38	0.63226277	0.94649225	1	1.74098697	0.47646143
GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING	c5.GO molecular function	47	1.108617	0.29149798	0.51997274	GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING	49	-1.2830311	0.048543688	0.2998965	-0.1744141	2.3916481
KYNG_RESPONSE_TO_H2O2	c2.CGP_ chemical and genetic perturbations	61	1.1085681	0.29224378	0.52003235	KYNG_RESPONSE_TO_H2O2	62	1.0308717	0.44323143	0.8738205	2.1394398	0.0776964
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	c2.CGP_ chemical and genetic perturbations	210	1.1084882	0.22540046	0.5201934	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	211	0.87774295	0.7887324	1	1.98623115	0.23074525
GO_ENDOPLASMIC_RETICULUM_LUMEN	c5.CC_ GO cellular component	168	1.1084838	0.23253012	0.5201114	GO_ENDOPLASMIC_RETICULUM_LUMEN	176	1.005678	0.49847716	0.9141698	2.1141618	0.1028058
GSE24210_TCONV_VS_TREG_DN	C7_ immunologic signatures	174	1.108439	0.25445896	0.5201567	GSE24210_TCONV_VS_TREG_DN	171	1.0067462	0.49190283	0.9126397	2.1151852	0.1016928
GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN	C7_ immunologic signatures	140	1.1083078	0.2622549	0.5204665	GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN	143	0.82678026	0.8335036	1	1.93508806	0.28152754
GO_LEUKOCYTE_MEDIATED_IMMUNITY	c5.BP_ GO biological process	129	1.1082789	0.2615572	0.52046597	GO_LEUKOCYTE_MEDIATED_IMMUNITY	147	1.1530015	0.19447288	0.66421705	2.2612804	-0.0447226
GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN	C7_ immunologic signatures	155	1.10826	0.24852072	0.5204309	GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN	157	1.1178379	0.24285714	0.72746193	2.2260979	-0.0095779
GO_TRACHEA_DEVELOPMENT	c5.BP_ GO biological process	20	1.1082193	0.3323217	0.5204578	GO_TRACHEA_DEVELOPMENT	20	0.7980167	0.75321335	1	1.906236	0.3102026
GO_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION	c5.BP_ GO biological process	97	1.1081305	0.265625	0.5206244	GO_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION	104	1.3378756	0.032563027	0.39783227	2.4460061	-0.2297451
GO_REGULATION_OF_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	27	1.1081024	0.32824427	0.5206188	GO_REGULATION_OF_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY	27	1.0677638	0.38546798	0.8093479	2.1758662	0.0403386
GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP	C7_ immunologic signatures	139	1.108069	0.24197531	0.52062416	GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP	141	0.7257775	0.9457523	1	1.8338465	0.3822915
GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN	C7_ immunologic signatures	173	1.1078739	0.23957092	0.52111584	GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN	176	1.5522395	0	0.20617628	2.6601134	-0.4443656
YAGI_AML_WITH_T_9_11_TRANSLOCATION	c2.CGP_ chemical and genetic perturbations	118	1.1078496	0.2631579	0.5210925	YAGI_AML_WITH_T_9_11_TRANSLOCATION	119	0.83654565	0.80908155	1	1.94439525	0.27130395
GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	C7_ immunologic signatures	170	1.1078445	0.25653207	0.52101433	GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	179	1.1853614	0.11425682	0.61321074	2.2932059	-0.0775169
GO_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	26	1.1076528	0.3287879	0.52150124	GO_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS	29	1.1705972	0.24183796	0.63732237	2.27825	-0.0629444
GO_RESPONSE_TO_LIPOPROTEIN_PARTICLE	c5.BP_ GO biological process	20	1.1076487	0.32258064	0.521418	GO_RESPONSE_TO_LIPOPROTEIN_PARTICLE	16	1.3369232	0.10411311	0.39846724	2.4445719	-0.2292745
GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	177	1.1075683	0.23122066	0.52157915	GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN	179	0.9573264	0.60160965	0.97465503	2.0648947	0.1502419
GO_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	104	1.1075356	0.25620916	0.52159095	GO_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS	107	1.0637503	0.38589212	0.8160517	2.1712859	0.0437853
GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP	C7_ immunologic signatures	178	1.107459	0.23943663	0.5217242	GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP	183	0.7961157	0.8973843	1	1.9035747	0.3113433
PID_IL2_1PATHWAY	c2.CP_ Canonical pathways	53	1.1074079	0.29608938	0.52177894	PID_IL2_1PATHWAY	54	1.0811775	0.352081	0.7855546	2.1885854	0.0262304
GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP	C7_ immunologic signatures	162	1.1073912	0.25360578	0.52173734	GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP	165	0.8517737	0.8130081	1	1.9591649	0.2556175
GO_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	33	1.1073847	0.30955994	0.5216633	GO_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY	33	1.0475519	0.42167255	0.84410435	2.1549366	0.0598328
GO_HIGH_DENSITY_LIPOPROTEIN_PARTICLE	c5.CC_ GO cellular component	18	1.1073343	0.31578946	0.52172256	GO_HIGH_DENSITY_LIPOPROTEIN_PARTICLE	22	-1.0665755	0.35682818	0.5758665	0.0407588	2.1739098
GO_MACROAUTOPHAGY	c5.BP_ GO biological process	236	1.1072034	0.23529412	0.5220321	GO_MACROAUTOPHAGY	240	0.8771366	0.7993982	1	1.98434	0.2300668
GO_TYPE_I_INTERFERON_RECEPTOR_BINDING	c5.GO molecular function	15	1.1071997	0.34713376	0.52194864	GO_TYPE_I_INTERFERON_RECEPTOR_BINDING	15	0	0	0	1.1071997	1.1071997
GSE30083_SP2_VS_SP4_THYMOCYTE_UP	C7_ immunologic signatures	170	1.1071903	0.25295508	0.52188027	GSE30083_SP2_VS_SP4_THYMOCYTE_UP	178	1.5339231	0	0.21769263	2.6411134	-0.4267328
MODULE_308	c4.CM_ cancer modules	65	1.106942	0.2956989	0.5225447	MODULE_308	67	0.6802785	0.9541485	1	1.7872205	0.4266635
GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP	C7_ immunologic signatures	174	1.106836	0.23905325	0.5227735	GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP	178	0.8794289	0.78622085	1	1.9862649	0.2274071
GO_ACTIN_FILAMENT_POLYMERIZATION	c5.BP_ GO biological process	21	1.1067536	0.32206118	0.5229223	GO_ACTIN_FILAMENT_POLYMERIZATION	21	0.8274657	0.71428573	1	1.9342193	0.2792879
TST1_01	c3.TFT_ transcription factor targets	214	1.1066171	0.23372093	0.5232563	TST1_01	227	0.8906693	0.774323	1	1.9972864	0.2159478
GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP	C7_ immunologic signatures	178	1.1066091	0.2358604	0.52318394	GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP	178	1.1019946	0.27505112	0.7535693	2.2086037	0.0046145
GO_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION	c5.BP_ GO biological process	22	1.1066036	0.33333334	0.52310604	GO_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION	22	1.1674407	0.26361385	0.6413263	2.2740443	-0.0608371
CHR2Q13	C1: positional gene sets	20	1.1065769	0.32594937	0.5230936	CHR2Q13	21	0.8691068	0.6705277	1	1.9756837	0.2374701
KEGG_PANCREATIC_CANCER	c2.CP_BIOCARTA_ BioCarta gene sets	66	1.1065013	0.2917251	0.5232244	KEGG_PANCREATIC_CANCER	66	1.2987566	0.07934783	0.4441164	2.4052579	-0.1922553
SRY_02	c3.TFT_ transcription factor targets	215	1.1064749	0.2301496	0.5232107	SRY_02	224	0.9256169	0.6871847	1	2.0320918	0.180858
BIOCARTA_IL6_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	1.1064733	0.346395	0.52312183	BIOCARTA_IL6_PATHWAY	22	0.8561365	0.68961036	1	1.9626098	0.2503368
GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP	C7_ immunologic signatures	181	1.1062298	0.24231678	0.52378035	GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP	187	0.877462	0.7850656	1	1.9836918	0.2287678
GSE339_CD4POS_VS_CD8POS_DC_UP	C7_ immunologic signatures	184	1.1062208	0.26303318	0.5237166	GSE339_CD4POS_VS_CD8POS_DC_UP	191	1.135232	0.19413549	0.6964993	2.2414528	-0.0290112
GO_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY	c5.GO molecular function	27	1.1061655	0.31357256	0.5237958	GO_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY	29	1.4273337	0.042908225	0.3179814	2.5334992	-0.3211682
KASLER_HDAC7_TARGETS_2_DN	c2.CGP_ chemical and genetic perturbations	31	1.1060671	0.32104453	0.5240068	KASLER_HDAC7_TARGETS_2_DN	31	1.0598768	0.3980344	0.8246592	2.1659439	0.0461903
GO_RECEPTOR_CLUSTERING	c5.BP_ GO biological process	41	1.1060319	0.3170391	0.52402323	GO_RECEPTOR_CLUSTERING	41	0.70726776	0.88141394	1	1.81329966	0.39876414
GO_CARBOHYDRATE_HOMEOSTASIS	c5.BP_ GO biological process	141	1.1060166	0.25120774	0.52397895	GO_CARBOHYDRATE_HOMEOSTASIS	154	1.1360538	0.2165475	0.6961871	2.2420704	-0.0300372
GSE360_CTRL_VS_L_MAJOR_MAC_DN	C7_ immunologic signatures	169	1.1059806	0.2451923	0.5239942	GSE360_CTRL_VS_L_MAJOR_MAC_DN	173	0.6981384	0.96747965	1	1.804119	0.4078422
ZHANG_PROLIFERATING_VS_QUIESCENT	c2.CGP_ chemical and genetic perturbations	45	1.1058595	0.30938417	0.5242624	ZHANG_PROLIFERATING_VS_QUIESCENT	45	0.9934984	0.4982857	0.9310762	2.0993579	0.1123611
GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP	C7_ immunologic signatures	158	1.1058079	0.24366707	0.5243256	GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP	166	1.3762754	0.009118541	0.3574232	2.4820833	-0.2704675
GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN	C7_ immunologic signatures	174	1.1058078	0.2564706	0.52423173	GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN	179	-1.102328	0.16666667	0.513803	0.0034798	2.2081358
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	c2.CGP_ chemical and genetic perturbations	410	1.1057981	0.18201284	0.52416515	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	417	0.87058467	0.884	1	1.97638277	0.23521343
GO_EARLY_ENDOSOME_MEMBRANE	c5.CC_ GO cellular component	93	1.1054553	0.26640928	0.5251198	GO_EARLY_ENDOSOME_MEMBRANE	96	1.0201311	0.465625	0.8914341	2.1255864	0.0853242
PID_SMAD2_3PATHWAY	c2.CP_ Canonical pathways	17	1.1054512	0.3338816	0.52503675	PID_SMAD2_3PATHWAY	17	0.74691564	0.8	1	1.85236684	0.35853556
GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	160	1.1054152	0.25802615	0.52505136	GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN	164	1.0416574	0.41271442	0.85627127	2.1470726	0.0637578
ATTCTTT_MIR186	c3.MIR_ microRNA targets	239	1.105348	0.23085715	0.52516377	ATTCTTT_MIR186	248	-0.85623467	1	0.8628257	0.24911333	1.96158267
GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP	C7_ immunologic signatures	180	1.1052654	0.24217844	0.5253204	GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP	183	1.0874754	0.27393076	0.77454704	2.1927408	0.01779
GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP	C7_ immunologic signatures	173	1.1052483	0.25659472	0.525279	GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP	176	1.1886675	0.11561866	0.6075791	2.2939158	-0.0834192
GO_NEPHRON_DEVELOPMENT	c5.BP_ GO biological process	109	1.1052246	0.26288658	0.52526236	GO_NEPHRON_DEVELOPMENT	112	1.1414512	0.23602484	0.68749374	2.2466758	-0.0362266
GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_BINDING	c5.GO molecular function	142	1.1051803	0.2526946	0.52530205	GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_BINDING	154	0.88306975	0.7555781	1	1.98825005	0.22211055
GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	C7_ immunologic signatures	109	1.1051216	0.27521792	0.5253862	GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	113	1.2416995	0.10031348	0.52327126	2.3468211	-0.1365779
MORF_KDR	c4.CGN_ cancer gene neighborhoods	72	1.1049788	0.3043478	0.5257307	MORF_KDR	78	1.3681127	0.04004329	0.37052023	2.4730915	-0.2631339
GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP	C7_ immunologic signatures	171	1.1049118	0.25058547	0.52585006	GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP	179	0.7034597	0.97876644	1	1.8083715	0.4014521
CHR4P12	C1: positional gene sets	18	1.104898	0.32126698	0.52579486	CHR4P12	20	0.77448386	0.78331256	1	1.87938186	0.33041414
CAHOY_NEURONAL	C6_ oncogenic signatures	84	1.1048906	0.2857143	0.5257214	CAHOY_NEURONAL	91	1.1817815	0.17916666	0.62022775	2.2866721	-0.0768909
GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	175	1.1047609	0.2413793	0.5260207	GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP	180	1.2017976	0.1023303	0.5888897	2.3065585	-0.0970367
GSE25677_MPL_VS_R848_STIM_BCELL_UP	C7_ immunologic signatures	157	1.1047485	0.25622776	0.52596366	GSE25677_MPL_VS_R848_STIM_BCELL_UP	161	1.3322076	0.015243903	0.40006265	2.4369561	-0.2274591
KEGG_COLORECTAL_CANCER	c2.CP_BIOCARTA_ BioCarta gene sets	61	1.1046711	0.29395974	0.5261	KEGG_COLORECTAL_CANCER	61	0.7973398	0.8116101	1	1.9020109	0.3073313
GO_POSTSYNAPTIC_MEMBRANE	c5.CC_ GO cellular component	177	1.1045454	0.25030228	0.52639425	GO_POSTSYNAPTIC_MEMBRANE	195	1.4564306	0	0.28696957	2.560976	-0.3518852
CHR3Q21	C1: positional gene sets	80	1.1045434	0.2763685	0.5263061	CHR3Q21	88	0.8874206	0.70053476	1	1.991964	0.2171228
GGCAGTG_MIR3243P	c3.MIR_ microRNA targets	90	1.1042601	0.28157896	0.52706915	GGCAGTG_MIR3243P	91	0.81223226	0.81751823	1	1.91649236	0.29202784
GO_14_3_3_PROTEIN_BINDING	c5.GO molecular function	19	1.1042198	0.33937398	0.52709943	GO_14_3_3_PROTEIN_BINDING	19	1.2331765	0.20258065	0.5356556	2.3373963	-0.1289567
HMGIY_Q6	c3.TFT_ transcription factor targets	208	1.1041793	0.23958333	0.527126	HMGIY_Q6	220	0.8628518	0.83951855	1	1.9670311	0.2413275
GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP	C7_ immunologic signatures	166	1.1040645	0.2381531	0.52739155	GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP	173	1.2074062	0.104568526	0.580693	2.3114707	-0.1033417
GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN	C7_ immunologic signatures	173	1.1040428	0.25622776	0.5273569	GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN	182	0.81366056	0.8734818	1	1.91770336	0.29038224
GO_PLASMA_MEMBRANE_PROTEIN_COMPLEX	c5.CC_ GO cellular component	430	1.1040395	0.20401691	0.5272715	GO_PLASMA_MEMBRANE_PROTEIN_COMPLEX	469	1.3240353	0	0.40914276	2.4280748	-0.2199958
GO_RESPONSE_TO_PEPTIDE	c5.BP_ GO biological process	356	1.1040105	0.20368364	0.5272684	GO_RESPONSE_TO_PEPTIDE	375	0.8745941	0.8518519	1	1.9786046	0.2294164
DELACROIX_RAR_BOUND_ES	c2.CGP_ chemical and genetic perturbations	406	1.1039901	0.19271949	0.527238	DELACROIX_RAR_BOUND_ES	414	0.99525094	0.5230461	0.930368	2.09924104	0.10873916
GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN	C7_ immunologic signatures	104	1.1039644	0.27122942	0.527225	GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN	113	0.9141283	0.67050207	1	2.0180927	0.1898361
MITSIADES_RESPONSE_TO_APLIDIN_UP	c2.CGP_ chemical and genetic perturbations	371	1.1039504	0.19783784	0.5271734	MITSIADES_RESPONSE_TO_APLIDIN_UP	379	0.8618903	0.879	1	1.9658407	0.2420601
MORI_MATURE_B_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	71	1.1038897	0.29403606	0.5272677	MORI_MATURE_B_LYMPHOCYTE_DN	71	-1.7365423	0	0.04689061	-0.6326526	2.840432
GSE28237_EARLY_VS_LATE_GC_BCELL_UP	C7_ immunologic signatures	172	1.1038706	0.26508877	0.52723455	GSE28237_EARLY_VS_LATE_GC_BCELL_UP	181	1.1856462	0.11382114	0.6135491	2.2895168	-0.0817756
GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	164	1.1038215	0.25437573	0.52729076	GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	165	0.91981184	0.6839959	1	2.02363334	0.18400966
GGCAGCT_MIR22	c3.MIR_ microRNA targets	209	1.1037544	0.2455516	0.52740085	GGCAGCT_MIR22	211	0.8790247	0.796576	1	1.9827791	0.2247297
GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP	C7_ immunologic signatures	173	1.1037247	0.25526932	0.5273942	GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP	173	-1.1868632	0	0.39742535	-0.0831385	2.2905879
KEGG_MISMATCH_REPAIR	c2.CP_BIOCARTA_ BioCarta gene sets	21	1.1036755	0.33226323	0.5274407	KEGG_MISMATCH_REPAIR	21	-1.5528572	0.023584906	0.113443136	-0.4491817	2.6565327
RYTGCNWTGGNR_UNKNOWN	c3.TFT_ transcription factor targets	98	1.1035863	0.2777778	0.5276157	RYTGCNWTGGNR_UNKNOWN	103	1.1333789	0.2610939	0.70042723	2.2369652	-0.0297926
GO_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION	c5.BP_ GO biological process	22	1.1034843	0.3529412	0.5278287	GO_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION	24	0.755247	0.8123457	1	1.8587313	0.3482373
GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP	C7_ immunologic signatures	173	1.1033833	0.24085006	0.5280383	GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP	172	1.0870074	0.31749243	0.77542883	2.1903907	0.0163759
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	c2.CGP_ chemical and genetic perturbations	57	1.1033049	0.30470914	0.5281901	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	57	0.8308346	0.7660754	1	1.9341395	0.2724703
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN	C7_ immunologic signatures	178	1.1032423	0.25087926	0.5283053	GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN	180	1.2575891	0.042769857	0.4997294	2.3608314	-0.1543468
GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	c5.BP_ GO biological process	170	1.103127	0.26595744	0.5285706	GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	176	1.0737865	0.32962587	0.7989226	2.1769135	0.0293405
GO_AMINOGLYCAN_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	96	1.1030251	0.2964427	0.5287888	GO_AMINOGLYCAN_BIOSYNTHETIC_PROCESS	101	1.2432082	0.09544008	0.523097	2.3462333	-0.1401831
GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	167	1.102932	0.25268176	0.5289707	GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	176	0.94242066	0.62449396	0.9891607	2.04535266	0.16051134
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP	C7_ immunologic signatures	133	1.1028761	0.26485148	0.52903926	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP	133	1.2221982	0.08748728	0.55297196	2.3250743	-0.1193221
GO_RECEPTOR_MEDIATED_ENDOCYTOSIS	c5.BP_ GO biological process	183	1.1028663	0.23900118	0.52897197	GO_RECEPTOR_MEDIATED_ENDOCYTOSIS	193	1.1213809	0.21392533	0.7218998	2.2242472	-0.0185146
GO_AMMONIUM_TRANSPORT	c5.BP_ GO biological process	49	1.1028416	0.2845304	0.5289516	GO_AMMONIUM_TRANSPORT	54	1.2231294	0.14893617	0.55161506	2.325971	-0.1202878
GO_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	32	1.102819	0.31571218	0.5289259	GO_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION	38	1.1803206	0.2150289	0.62354726	2.2831396	-0.0775016
IK2_01	c3.TFT_ transcription factor targets	236	1.10279	0.22095671	0.5289225	IK2_01	244	1.0269196	0.42211056	0.88111365	2.1297096	0.0758704
MODULE_13	c4.CM_ cancer modules	433	1.1027524	0.19103523	0.5289365	MODULE_13	470	1.1217898	0.131	0.7222853	2.2245422	-0.0190374
GO_FILOPODIUM	c5.CC_ GO cellular component	86	1.102737	0.28830084	0.5288929	GO_FILOPODIUM	87	1.3283305	0.049682874	0.40327486	2.4310675	-0.2255935
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	c2.CGP_ chemical and genetic perturbations	90	1.1025957	0.28516623	0.5292239	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	90	1.0042374	0.49367088	0.91672724	2.1068331	0.0983583
GO_RESPONSE_TO_EXTRACELLULAR_STIMULUS	c5.BP_ GO biological process	383	1.102468	0.21734476	0.52951396	GO_RESPONSE_TO_EXTRACELLULAR_STIMULUS	409	1.1369096	0.107	0.694859	2.2393776	-0.0344416
GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP	C7_ immunologic signatures	183	1.1023406	0.2671395	0.52981836	GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP	185	0.96763223	0.57878786	0.96399146	2.06997283	0.13470837
GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN	C7_ immunologic signatures	165	1.1022995	0.27251184	0.5298481	GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN	168	0.8448562	0.8351871	1	1.9471557	0.2574433
GO_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION	c5.BP_ GO biological process	19	1.1022481	0.32376397	0.5299197	GO_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION	20	0.8557044	0.7001287	1	1.9579525	0.2465437
GSE14308_TH2_VS_INDUCED_TREG_UP	C7_ immunologic signatures	179	1.1021206	0.2535545	0.53021944	GSE14308_TH2_VS_INDUCED_TREG_UP	180	1.1690207	0.15678392	0.6396229	2.2711413	-0.0669001
GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP	C7_ immunologic signatures	134	1.1021011	0.27543426	0.5301852	GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP	144	1.0634857	0.37183383	0.8166204	2.1655868	0.0386154
REACTOME_MYOGENESIS	c2.CP_REACTOME_ Reactome gene sets	24	1.1020925	0.3258595	0.5301185	REACTOME_MYOGENESIS	24	0.95131505	0.54392296	0.98061615	2.05340755	0.15077745
GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN	C7_ immunologic signatures	169	1.102019	0.25239235	0.5302576	GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN	173	1.1094344	0.25303644	0.73794174	2.2114534	-0.0074154
GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN	C7_ immunologic signatures	174	1.1019168	0.26586828	0.5304857	GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN	175	1.0132525	0.45757577	0.901029	2.1151693	0.0886643
GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP	C7_ immunologic signatures	168	1.1018791	0.24701671	0.53050715	GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP	175	0.64964515	0.9889001	1	1.75152425	0.45223395
GO_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION	c5.BP_ GO biological process	137	1.1018438	0.26449275	0.5305202	GO_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION	147	0.9822142	0.53846157	0.9457379	2.084058	0.1196296
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	c2.CGP_ chemical and genetic perturbations	212	1.1018326	0.24510932	0.53045964	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	213	1.168782	0.125502	0.63910806	2.2706146	-0.0669494
GO_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	c5.GO molecular function	275	1.1018305	0.23660715	0.53037	GO_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	279	1.4696206	0	0.27638736	2.5714511	-0.3677901
GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP	C7_ immunologic signatures	148	1.1016761	0.2669082	0.53074247	GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP	157	1.2577354	0.051934827	0.49955776	2.3594115	-0.1560593
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	C7_ immunologic signatures	165	1.1015238	0.25413713	0.53111744	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	166	1.0941292	0.27319062	0.7672376	2.195653	0.0073946
MYB_Q5_01	c3.TFT_ transcription factor targets	219	1.1013488	0.26279864	0.53155243	MYB_Q5_01	230	0.79740584	0.9164149	1	1.89875464	0.30394296
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_UP	C7_ immunologic signatures	175	1.1012888	0.25890738	0.5316336	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_UP	181	1.3896527	0.003045685	0.34544602	2.4909415	-0.2883639
GO_PROTEIN_DEGLYCOSYLATION	c5.BP_ GO biological process	20	1.1012505	0.30269414	0.53166693	GO_PROTEIN_DEGLYCOSYLATION	20	1.2324387	0.19770408	0.53701675	2.3336892	-0.1311882
GNF2_ZAP70	c4.CGN_ cancer gene neighborhoods	22	1.1011101	0.32872504	0.5319988	GNF2_ZAP70	22	0.9310655	0.5808458	0.9987135	2.0321756	0.1700446
GSE17721_LPS_VS_CPG_16H_BMDC_UP	C7_ immunologic signatures	172	1.1010619	0.25419664	0.53205585	GSE17721_LPS_VS_CPG_16H_BMDC_UP	178	0.9947702	0.50455004	0.9304024	2.0958321	0.1062917
GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP	C7_ immunologic signatures	161	1.1009581	0.25336596	0.53229344	GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP	176	1.4548025	0.002016129	0.28814414	2.5557606	-0.3538444
GO_DENDRITE	c5.CC_ GO cellular component	413	1.1007508	0.20149253	0.532838	GO_DENDRITE	426	1.2714874	0.007	0.48297492	2.3722382	-0.1707366
GSE360_CTRL_VS_L_MAJOR_DC_UP	C7_ immunologic signatures	172	1.1006011	0.26900584	0.53320664	GSE360_CTRL_VS_L_MAJOR_DC_UP	176	1.0501295	0.39068827	0.839753	2.1507306	0.0504716
FORTSCHEGGER_PHF8_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	229	1.1005698	0.23842593	0.5332109	FORTSCHEGGER_PHF8_TARGETS_UP	235	0.970048	0.5766129	0.96155965	2.0706178	0.1305218
GO_DORSAL_VENTRAL_AXIS_SPECIFICATION	c5.BP_ GO biological process	19	1.1005598	0.31447586	0.53314465	GO_DORSAL_VENTRAL_AXIS_SPECIFICATION	20	-1.0852951	0.3119266	0.5423322	0.0152647	2.1858549
GO_DORSAL_VENTRAL_PATTERN_FORMATION	c5.BP_ GO biological process	77	1.1005294	0.28940567	0.5331454	GO_DORSAL_VENTRAL_PATTERN_FORMATION	90	1.0346445	0.41489363	0.868004	2.1351739	0.0658849
KEGG_SPHINGOLIPID_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	35	1.1004792	0.31222385	0.53319925	KEGG_SPHINGOLIPID_METABOLISM	36	0.95355463	0.5648148	0.9777611	2.05403383	0.14692457
GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP	C7_ immunologic signatures	173	1.1004657	0.2449941	0.5331411	GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP	174	0.82756525	0.85309017	1	1.92803095	0.27290045
GO_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS	c5.BP_ GO biological process	57	1.1004592	0.28818443	0.53306556	GO_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS	64	0.97243196	0.5438787	0.958825	2.07289116	0.12802724
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	c2.CGP_ chemical and genetic perturbations	139	1.1004398	0.27173913	0.53302985	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	149	-1.0177201	0.45833334	0.6624747	0.0827197	2.1181599
MODULE_289	c4.CM_ cancer modules	92	1.1002505	0.29287598	0.533503	MODULE_289	109	1.2868637	0.06896552	0.46246198	2.3871142	-0.1866132
LEONARD_HYPOXIA	c2.CGP_ chemical and genetic perturbations	44	1.1001996	0.3206751	0.5335716	LEONARD_HYPOXIA	44	1.1547639	0.2739726	0.6620199	2.2549635	-0.0545643
SMAD4_Q6	c3.TFT_ transcription factor targets	210	1.1000841	0.22899885	0.5338408	SMAD4_Q6	217	1.1862453	0.093561366	0.61322725	2.2863294	-0.0861612
GO_REGULATION_OF_ATPASE_ACTIVITY	c5.BP_ GO biological process	54	1.1000073	0.28410688	0.53398865	GO_REGULATION_OF_ATPASE_ACTIVITY	56	0.9948268	0.50496143	0.9303229	2.0948341	0.1051805
GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP	C7_ immunologic signatures	170	1.1	0.24880952	0.53391814	GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP	174	0.851526	0.8311292	1	1.951526	0.248474
GO_LAMININ_BINDING	c5.GO molecular function	26	1.0999148	0.3477589	0.5340839	GO_LAMININ_BINDING	29	1.1188642	0.31472683	0.7244901	2.218779	-0.0189494
GO_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION	c5.BP_ GO biological process	178	1.0998842	0.2555686	0.53408784	GO_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION	178	1.242717	0.05959596	0.5224481	2.3426012	-0.1428328
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP	C7_ immunologic signatures	133	1.0998554	0.27450982	0.5340833	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP	139	1.4900725	0	0.2598066	2.5899279	-0.3902171
GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN	C7_ immunologic signatures	176	1.0995506	0.26271185	0.5349212	GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN	181	0.95956737	0.58739835	0.97095394	2.05911797	0.13998323
MODULE_105	c4.CM_ cancer modules	188	1.0995171	0.2697291	0.5349292	MODULE_105	192	-0.8565062	1	0.86334324	0.2430109	1.9560233
MODULE_576	c4.CM_ cancer modules	104	1.0994868	0.29671717	0.53492737	MODULE_576	104	0.5745781	0.99583334	1	1.6740649	0.5249087
GO_RESPONSE_TO_STEROL	c5.BP_ GO biological process	21	1.0992864	0.3323217	0.53543216	GO_RESPONSE_TO_STEROL	22	-1.1110597	0.2857143	0.5045586	-0.0117733	2.2103461
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	c2.CGP_ chemical and genetic perturbations	310	1.0989697	0.22271715	0.53630656	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	319	0.9512221	0.667	0.98066473	2.0501918	0.1477476
GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN	C7_ immunologic signatures	175	1.0988907	0.2677532	0.5364561	GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN	178	0.9104563	0.7255298	1	2.009347	0.1884344
GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN	C7_ immunologic signatures	168	1.0988206	0.2751196	0.53658026	GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN	175	0.7632983	0.9319106	1	1.8621189	0.3355223
GSE3982_EOSINOPHIL_VS_BCELL_UP	C7_ immunologic signatures	173	1.0988082	0.2669845	0.5365236	GSE3982_EOSINOPHIL_VS_BCELL_UP	181	1.4326156	0.001012146	0.3130471	2.5314238	-0.3338074
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN	C7_ immunologic signatures	177	1.0987926	0.25559482	0.5364804	GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN	180	0.9868645	0.52994925	0.93966717	2.0856571	0.1119281
GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP	C7_ immunologic signatures	175	1.0987588	0.2449941	0.53649503	GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP	177	1.298726	0.023162136	0.44398952	2.3974848	-0.1999672
GO_RETINA_LAYER_FORMATION	c5.BP_ GO biological process	20	1.098619	0.34562212	0.5368422	GO_RETINA_LAYER_FORMATION	21	1.2677747	0.16015132	0.48670325	2.3663937	-0.1691557
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	172	1.0985079	0.2606635	0.537099	GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP	180	0.9216849	0.69223005	1	2.0201928	0.176823
GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_DN	C7_ immunologic signatures	158	1.0984807	0.26900584	0.5370907	GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_DN	164	1.2374994	0.07426246	0.52997273	2.3359801	-0.1390187
GSE15767_MED_VS_SCS_MAC_LN_DN	C7_ immunologic signatures	177	1.0983777	0.2578763	0.53731966	GSE15767_MED_VS_SCS_MAC_LN_DN	180	0.5842716	0.99696356	1	1.6826493	0.5141061
GO_REGULATION_OF_T_CELL_MIGRATION	c5.BP_ GO biological process	17	1.0982624	0.3380503	0.537582	GO_REGULATION_OF_T_CELL_MIGRATION	20	1.0525194	0.40564826	0.8367878	2.1507818	0.045743
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP	C7_ immunologic signatures	169	1.0982608	0.27065867	0.53749347	GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP	171	1.4538732	0.001012146	0.28909147	2.552134	-0.3556124
GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN	C7_ immunologic signatures	177	1.098195	0.278169	0.5376066	GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN	182	1.4835356	0	0.26517144	2.5817306	-0.3853406
GSE31622_WT_VS_KLF3_KO_BCELL_UP	C7_ immunologic signatures	172	1.0981352	0.26650944	0.5376917	GSE31622_WT_VS_KLF3_KO_BCELL_UP	181	1.1438123	0.18548387	0.6832171	2.2419475	-0.0456771
GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367	c3.MIR_ microRNA targets	279	1.0981349	0.23867403	0.53759706	GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367	291	0.91251934	0.7387387	1	2.01065424	0.18561556
GO_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY	c5.BP_ GO biological process	78	1.0980747	0.31292516	0.5376876	GO_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY	82	1.0321124	0.4488273	0.87339705	2.1301871	0.0659623
GO_NEGATIVE_REGULATION_OF_BINDING	c5.BP_ GO biological process	118	1.0979611	0.27194068	0.5379363	GO_NEGATIVE_REGULATION_OF_BINDING	118	0.74790365	0.9113402	1	1.84586475	0.35005745
GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN	C7_ immunologic signatures	139	1.097916	0.2809816	0.5379712	GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN	143	0.75338066	0.9319797	1	1.85129666	0.34453534
STAEGE_EWING_FAMILY_TUMOR	c2.CGP_ chemical and genetic perturbations	28	1.0979074	0.32262996	0.5379016	STAEGE_EWING_FAMILY_TUMOR	30	1.2179161	0.18847539	0.56014556	2.3158235	-0.1200087
GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	C7_ immunologic signatures	167	1.0978956	0.26508877	0.53784263	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	168	1.2204638	0.08366936	0.5548789	2.3183594	-0.1225682
GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP	C7_ immunologic signatures	177	1.097856	0.2778429	0.5378685	GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP	175	1.120589	0.22301425	0.7232925	2.218445	-0.022733
GO_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS	c5.BP_ GO biological process	45	1.0978094	0.31654677	0.537921	GO_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS	46	0.8308762	0.7599094	1	1.9286856	0.2669332
MODULE_337	c4.CM_ cancer modules	56	1.0977364	0.32554945	0.5380504	MODULE_337	57	-1.7144976	0	0.052029107	-0.6167612	2.812234
GO_RESPONSE_TO_AMINO_ACID	c5.BP_ GO biological process	99	1.0977316	0.281491	0.5379703	GO_RESPONSE_TO_AMINO_ACID	102	0.76049036	0.8748686	1	1.85822196	0.33724124
REACTOME_TELOMERE_MAINTENANCE	c2.CP_REACTOME_ Reactome gene sets	45	1.0976764	0.31241083	0.53805524	REACTOME_TELOMERE_MAINTENANCE	46	0.8781159	0.69908464	1	1.9757923	0.2195605
GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	173	1.0976229	0.27942926	0.53811866	GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN	177	0.92622316	0.68490374	1	2.02384606	0.17139974
GO_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	259	1.0974216	0.24610245	0.5386384	GO_APOPTOTIC_SIGNALING_PATHWAY	261	0.9519351	0.6278837	0.97975737	2.0493567	0.1454865
GO_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS	c5.BP_ GO biological process	36	1.0973467	0.32977098	0.538775	GO_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS	36	-1.5151418	0.025641026	0.1338985	-0.4177951	2.6124885
GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN	C7_ immunologic signatures	178	1.0972321	0.25798815	0.5390393	GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN	179	1.0913535	0.28456104	0.76974034	2.1885856	0.0058786
GO_AXON	c5.CC_ GO cellular component	369	1.0972164	0.20427808	0.5389913	GO_AXON	389	1.2238477	0.021	0.55007255	2.3210641	-0.1266313
GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN	C7_ immunologic signatures	181	1.0970429	0.26932085	0.53940964	GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN	183	0.8833948	0.7744209	1	1.9804377	0.2136481
OLF1_01	c3.TFT_ transcription factor targets	239	1.0969995	0.23863636	0.539447	OLF1_01	246	0.813707	0.90571713	1	1.9107065	0.2832925
GROSS_ELK3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	27	1.096893	0.32740742	0.5396756	GROSS_ELK3_TARGETS_UP	27	1.2227066	0.19216646	0.55190015	2.3195996	-0.1258136
GO_FUCOSYLATION	c5.BP_ GO biological process	18	1.0967435	0.35054773	0.54004186	GO_FUCOSYLATION	19	0.75588953	0.8026144	1	1.85263303	0.34085397
GUO_HEX_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	78	1.0967118	0.28936744	0.54004645	GUO_HEX_TARGETS_UP	78	-0.8629061	0.8076923	0.8573842	0.2338057	1.9596179
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	169	1.0966038	0.26442307	0.5402734	GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	177	1.1679739	0.15564598	0.6407746	2.2645777	-0.0713701
PENG_LEUCINE_DEPRIVATION_UP	c2.CGP_ chemical and genetic perturbations	123	1.0965585	0.27965045	0.5403238	PENG_LEUCINE_DEPRIVATION_UP	127	-0.9674683	0.625	0.73320746	0.1290902	2.0640268
GO_POSITIVE_REGULATION_OF_PROTEIN_IMPORT	c5.BP_ GO biological process	90	1.0965425	0.2840617	0.540275	GO_POSITIVE_REGULATION_OF_PROTEIN_IMPORT	96	0.9117096	0.68387777	1	2.0082521	0.1848329
PID_PI3KCI_AKT_PATHWAY	c2.CP_ Canonical pathways	33	1.0965172	0.3127889	0.5402559	PID_PI3KCI_AKT_PATHWAY	33	-1.110383	0.26751593	0.5041487	-0.0138658	2.2069002
GO_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION	c5.BP_ GO biological process	499	1.0963701	0.20621762	0.5406121	GO_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION	499	0	0	0	1.0963701	1.0963701
GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP	C7_ immunologic signatures	174	1.0962623	0.27868852	0.5408555	GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP	177	1.1437591	0.1724138	0.68330973	2.2400214	-0.0474968
FXR_IR1_Q6	c3.TFT_ transcription factor targets	94	1.0962396	0.2750317	0.5408317	FXR_IR1_Q6	98	0.9764044	0.53951526	0.9537207	2.072644	0.1198352
DR4_Q2	c3.TFT_ transcription factor targets	220	1.0961374	0.25620767	0.5410537	DR4_Q2	234	0.9495133	0.6532258	0.9826503	2.0456507	0.1466241
ERB2_UP.V1_UP	C6_ oncogenic signatures	166	1.0960922	0.2778429	0.541102	ERB2_UP.V1_UP	170	1.384652	0.006116208	0.3516453	2.4807442	-0.2885598
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP	C7_ immunologic signatures	146	1.0960919	0.28345498	0.54100734	GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP	153	1.0143168	0.44557476	0.8993186	2.1104087	0.0817751
GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN	C7_ immunologic signatures	171	1.0960791	0.2645631	0.5409547	GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN	178	0.9000956	0.7419028	1	1.9961747	0.1959835
NKX25_01	c3.TFT_ transcription factor targets	101	1.0960357	0.29056603	0.54099625	NKX25_01	113	1.0552262	0.38906088	0.8327831	2.1512619	0.0408095
GO_MEMBRANE_LIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	165	1.0959531	0.26963657	0.54114884	GO_MEMBRANE_LIPID_METABOLIC_PROCESS	169	1.2591668	0.05279188	0.49716493	2.3551199	-0.1632137
GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP	C7_ immunologic signatures	146	1.0958912	0.27490997	0.5412407	GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP	151	0.8436954	0.8270215	1	1.9395866	0.2521958
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY	c2.CGP_ chemical and genetic perturbations	23	1.0958599	0.329927	0.5412346	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY	27	1.087746	0.36087486	0.7740983	2.1836059	0.0081139
GO_COA_HYDROLASE_ACTIVITY	c5.GO molecular function	18	1.0958376	0.32779455	0.5412149	GO_COA_HYDROLASE_ACTIVITY	20	1.0069019	0.48143566	0.9124376	2.1027395	0.0889357
GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT	c5.BP_ GO biological process	123	1.0958225	0.27664974	0.54116744	GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT	127	0.9219458	0.6738461	1	2.0177683	0.1738767
GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP	C7_ immunologic signatures	157	1.0957838	0.27703524	0.5411953	GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP	163	0.8429274	0.8259109	1	1.9387112	0.2528564
MODULE_372	c4.CM_ cancer modules	20	1.0957536	0.34126985	0.5411872	MODULE_372	21	-0.9197781	0.5675676	0.7959128	0.1759755	2.0155317
AGTTCTC_MIR146A_MIR146B	c3.MIR_ microRNA targets	55	1.0956644	0.2970297	0.5413632	AGTTCTC_MIR146A_MIR146B	55	1.024532	0.45011085	0.88435555	2.1201964	0.0711324
AAAGGGA_MIR204_MIR211	c3.MIR_ microRNA targets	204	1.0955591	0.27324915	0.5415949	AAAGGGA_MIR204_MIR211	208	0.766239	0.94076306	1	1.8617981	0.3293201
GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	C7_ immunologic signatures	167	1.0955424	0.25653207	0.5415571	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	172	1.127319	0.21319798	0.7108121	2.2228614	-0.0317766
GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP	C7_ immunologic signatures	137	1.0954723	0.27361962	0.5416683	GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP	135	1.2025161	0.11502591	0.58813334	2.2979884	-0.1070438
SAFFORD_T_LYMPHOCYTE_ANERGY	c2.CGP_ chemical and genetic perturbations	78	1.0954565	0.30388218	0.54162246	SAFFORD_T_LYMPHOCYTE_ANERGY	80	0.9595416	0.56052345	0.970911	2.0549981	0.1359149
GSE6875_WT_VS_FOXP3_KO_TREG_DN	C7_ immunologic signatures	176	1.0954415	0.25029516	0.541573	GSE6875_WT_VS_FOXP3_KO_TREG_DN	177	1.2450525	0.06490872	0.5190065	2.340494	-0.149611
GO_DEPHOSPHORYLATION	c5.BP_ GO biological process	243	1.0954401	0.25055432	0.54148203	GO_DEPHOSPHORYLATION	248	1.0263375	0.4275654	0.88219184	2.1217776	0.0691026
OSF2_Q6	c3.TFT_ transcription factor targets	236	1.0951836	0.25	0.5421622	OSF2_Q6	235	0.76673496	0.95266867	1	1.86191856	0.32844864
GO_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY	c5.GO molecular function	18	1.0951508	0.3286385	0.54216737	GO_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY	20	1.3076873	0.13399504	0.428965	2.4028381	-0.2125365
GO_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION	c5.BP_ GO biological process	107	1.0949376	0.2835443	0.5427145	GO_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION	115	1.1608622	0.2055785	0.6512169	2.2557998	-0.0659246
SENGUPTA_EBNA1_ANTICORRELATED	c2.CGP_ chemical and genetic perturbations	124	1.0949062	0.283715	0.54271686	SENGUPTA_EBNA1_ANTICORRELATED	128	1.3513908	0.016477859	0.3837063	2.446297	-0.2564846
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN	C7_ immunologic signatures	161	1.0946501	0.2874396	0.5434118	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN	163	1.1308622	0.22718053	0.70527786	2.2255123	-0.0362121
GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN	C7_ immunologic signatures	184	1.0946321	0.25686976	0.5433686	GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN	187	1.0078343	0.48335016	0.91087717	2.1024664	0.0867978
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	c2.CGP_ chemical and genetic perturbations	51	1.0946244	0.31101814	0.54329586	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	51	1.2989639	0.10426009	0.44382197	2.3935883	-0.2043395
TCF4_Q5	c3.TFT_ transcription factor targets	198	1.0945944	0.27116704	0.54329354	TCF4_Q5	208	1.1263362	0.18787879	0.7122688	2.2209306	-0.0317418
ZID_01	c3.TFT_ transcription factor targets	226	1.0945431	0.26160815	0.5433606	ZID_01	228	0.9154891	0.7342026	1	2.0100322	0.179054
GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN	C7_ immunologic signatures	168	1.094386	0.275	0.5437609	GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN	170	1.2657881	0.04883011	0.48984414	2.3601741	-0.1714021
CAHOY_OLIGODENDROCUTIC	C6_ oncogenic signatures	86	1.0943646	0.28229028	0.5437312	CAHOY_OLIGODENDROCUTIC	88	1.3611317	0.033369213	0.37643752	2.4554963	-0.2667671
GO_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	116	1.0943593	0.28712872	0.5436533	GO_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS	118	0.90797514	0.67184263	1	2.00233444	0.18638416
GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING	c5.GO molecular function	93	1.0942827	0.30078125	0.5437952	GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING	98	0.89573157	0.69012606	1	1.99001427	0.19855113
GO_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION	c5.BP_ GO biological process	180	1.0942825	0.2748815	0.54370034	GO_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION	194	0.9437419	0.6421371	0.9888693	2.0380244	0.1505406
GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP	C7_ immunologic signatures	108	1.0942298	0.28680202	0.54376495	GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP	112	1.3840531	0.02173913	0.3522889	2.4782829	-0.2898233
CHR16Q23	C1: positional gene sets	26	1.0940648	0.34177214	0.5441915	CHR16Q23	29	0.64674073	0.9375765	1	1.74080553	0.44732407
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN	C7_ immunologic signatures	185	1.0939437	0.27586207	0.5444679	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN	186	1.0741752	0.32560483	0.7980792	2.1681189	0.0197685
KEGG_VIRAL_MYOCARDITIS	c2.CP_BIOCARTA_ BioCarta gene sets	48	1.0939	0.32201087	0.5445076	KEGG_VIRAL_MYOCARDITIS	53	0.99172974	0.5066964	0.933872	2.08562974	0.10217026
WEBER_METHYLATED_HCP_IN_SPERM_DN	c2.CGP_ chemical and genetic perturbations	24	1.093884	0.34775642	0.54445726	WEBER_METHYLATED_HCP_IN_SPERM_DN	27	1.320202	0.09393579	0.41192734	2.414086	-0.226318
ZIC3_01	c3.TFT_ transcription factor targets	233	1.0936954	0.24858116	0.544947	ZIC3_01	236	0.91232896	0.7276382	1	2.00602436	0.18136644
RELA_DN.V1_UP	C6_ oncogenic signatures	121	1.0935574	0.27114427	0.5452598	RELA_DN.V1_UP	129	1.369558	0.016614746	0.36864576	2.4631154	-0.2760006
GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	C7_ immunologic signatures	120	1.0935236	0.28318584	0.54526526	GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	131	1.1088687	0.2711519	0.7397829	2.2023923	-0.0153451
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	c2.CGP_ chemical and genetic perturbations	42	1.0934501	0.3211679	0.545392	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	44	0.7727026	0.8306636	1	1.8661527	0.3207475
MATZUK_SPERMATOGONIA	c2.CGP_ chemical and genetic perturbations	21	1.0934432	0.3344	0.54531604	MATZUK_SPERMATOGONIA	23	1.0670452	0.39672545	0.81104887	2.1604884	0.026398
GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN	C7_ immunologic signatures	169	1.0933417	0.27085853	0.54553604	GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN	175	0.88122207	0.77212614	1	1.97456377	0.21211963
HOSHIDA_LIVER_CANCER_SUBCLASS_S1	c2.CGP_ chemical and genetic perturbations	212	1.0932614	0.25626424	0.54568005	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	220	0.95658153	0.6188069	0.9751562	2.04984293	0.13667987
GO_PEPTIDYL_TYROSINE_MODIFICATION	c5.BP_ GO biological process	172	1.0932447	0.2747909	0.54563355	GO_PEPTIDYL_TYROSINE_MODIFICATION	180	1.0799074	0.30364373	0.78746504	2.1731521	0.0133373
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN	C7_ immunologic signatures	140	1.0932363	0.26113862	0.54556346	GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN	144	1.0534402	0.36976507	0.8364895	2.1466765	0.0397961
BROWNE_HCMV_INFECTION_2HR_DN	c2.CGP_ chemical and genetic perturbations	48	1.0931945	0.34087694	0.5456045	BROWNE_HCMV_INFECTION_2HR_DN	48	1.1692405	0.2247446	0.63916945	2.262435	-0.076046
GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN	C7_ immunologic signatures	171	1.0931803	0.26168224	0.5455553	GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN	178	1.1832185	0.11290322	0.61707324	2.2763988	-0.0900382
SESTO_RESPONSE_TO_UV_C3	c2.CGP_ chemical and genetic perturbations	17	1.0931015	0.35225376	0.54569155	SESTO_RESPONSE_TO_UV_C3	18	1.3217298	0.11764706	0.4111045	2.4148313	-0.2286283
STAT6_01	c3.TFT_ transcription factor targets	223	1.0930735	0.25312147	0.5456838	STAT6_01	227	-0.9953373	0.5	0.6938459	0.0977362	2.0884108
CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I	c3.MIR_ microRNA targets	353	1.0929679	0.2248062	0.54591924	CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I	361	0.7968204	0.956	1	1.8897883	0.2961475
GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP	C7_ immunologic signatures	133	1.0929058	0.3031056	0.54601294	GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP	141	1.3396401	0.024514811	0.39648002	2.4325459	-0.2467343
GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN	C7_ immunologic signatures	164	1.0928437	0.27185628	0.5461082	GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN	171	0.9486969	0.62903225	0.9833352	2.0415406	0.1441468
GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP	C7_ immunologic signatures	184	1.0928382	0.27662036	0.5460289	GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP	185	0.891376	0.73939395	1	1.9842142	0.2014622
BASSO_CD40_SIGNALING_UP	c2.CGP_ chemical and genetic perturbations	86	1.0927953	0.31084657	0.54606044	BASSO_CD40_SIGNALING_UP	90	1.1878861	0.17578948	0.60899353	2.2806814	-0.0950908
GSE6259_BCELL_VS_CD4_TCELL_DN	C7_ immunologic signatures	160	1.0927685	0.28465346	0.5460464	GSE6259_BCELL_VS_CD4_TCELL_DN	166	0.6580717	0.98582995	1	1.7508402	0.4346968
GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP	C7_ immunologic signatures	172	1.0927652	0.27075812	0.5459612	GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP	179	1.1536375	0.16330644	0.66277283	2.2464027	-0.0608723
GO_REGULATION_OF_THYMOCYTE_AGGREGATION	c5.BP_ GO biological process	22	1.092763	0.34662578	0.54587394	GO_REGULATION_OF_THYMOCYTE_AGGREGATION	23	-1.2828306	0.12560387	0.29961404	-0.1900676	2.3755936
GO_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS	c5.BP_ GO biological process	19	1.0927355	0.33333334	0.5458646	GO_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS	20	1.1529527	0.30541238	0.66427535	2.2456882	-0.0602172
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN	C7_ immunologic signatures	174	1.0927298	0.26855123	0.54578674	GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN	178	1.2334458	0.06680162	0.53612185	2.3261756	-0.140716
GO_SMOOTH_ENDOPLASMIC_RETICULUM	c5.CC_ GO cellular component	31	1.0927019	0.326284	0.5457773	GO_SMOOTH_ENDOPLASMIC_RETICULUM	31	0.7931835	0.77668715	1	1.8858854	0.2995184
KRIEG_HYPOXIA_VIA_KDM3A	c2.CGP_ chemical and genetic perturbations	43	1.0925983	0.30962962	0.5460128	KRIEG_HYPOXIA_VIA_KDM3A	46	1.277403	0.12304251	0.47631082	2.3700013	-0.1848047
ATAACCT_MIR154	c3.MIR_ microRNA targets	57	1.0925503	0.3026874	0.54606384	ATAACCT_MIR154	57	0.7834787	0.83073497	1	1.876029	0.3090716
GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP	C7_ immunologic signatures	132	1.092508	0.27641279	0.54609185	GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP	140	1.1792871	0.16274309	0.6235168	2.2717951	-0.0867791
GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN	C7_ immunologic signatures	173	1.0924485	0.2811736	0.5461785	GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN	176	1.1587461	0.15035318	0.6551113	2.2511946	-0.0662976
GO_RESPONSE_TO_OSMOTIC_STRESS	c5.BP_ GO biological process	56	1.0923225	0.32290184	0.5464793	GO_RESPONSE_TO_OSMOTIC_STRESS	57	1.2915094	0.09709822	0.45546943	2.3838319	-0.1991869
GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP	C7_ immunologic signatures	156	1.0923089	0.2775061	0.54642683	GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP	165	1.324338	0.021363175	0.40937507	2.4166469	-0.2320291
GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	C7_ immunologic signatures	170	1.0922815	0.28399518	0.5464179	GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	177	0.99305624	0.5121951	0.9317644	2.08533774	0.09922526
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP	c2.CGP_ chemical and genetic perturbations	239	1.0922685	0.24856156	0.54636276	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP	252	1.2083352	0.055055056	0.58055043	2.3006037	-0.1160667
GSE27786_LSK_VS_LIN_NEG_CELL_UP	C7_ immunologic signatures	174	1.0922577	0.28554642	0.5463046	GSE27786_LSK_VS_LIN_NEG_CELL_UP	180	1.2807022	0.032388665	0.47122934	2.3729599	-0.1884445
GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP	C7_ immunologic signatures	170	1.092213	0.26914153	0.5463452	GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP	172	1.1636165	0.16028225	0.6482354	2.2558295	-0.0714035
CHR1P21	C1: positional gene sets	26	1.0921724	0.34626865	0.5463681	CHR1P21	26	0.9315327	0.5826087	0.99821526	2.0237051	0.1606397
BIOCARTA_MAL_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	1.0920974	0.33870968	0.5465143	BIOCARTA_MAL_PATHWAY	18	-1.6642938	0.010152284	0.06664849	-0.5721964	2.7563912
GO_RECEPTOR_INTERNALIZATION	c5.BP_ GO biological process	41	1.0920639	0.3259587	0.54652864	GO_RECEPTOR_INTERNALIZATION	43	-1.1227577	0.21768707	0.4845034	-0.0306938	2.2148216
GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	179	1.0920504	0.2661098	0.5464744	GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	182	0.80837655	0.879798	1	1.90042695	0.28367385
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP	C7_ immunologic signatures	154	1.0920451	0.2738239	0.54639727	GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP	159	1.2472035	0.060790274	0.5154582	2.3392486	-0.1551584
MODULE_3	c4.CM_ cancer modules	368	1.0918772	0.22258064	0.546817	MODULE_3	368	0.7511651	0.976977	1	1.8430423	0.3407121
GSE9037_WT_VS_IRAK4_KO_BMDM_UP	C7_ immunologic signatures	180	1.0918666	0.2662722	0.54675424	GSE9037_WT_VS_IRAK4_KO_BMDM_UP	182	1.0182363	0.46693796	0.8925653	2.1101029	0.0736303
GO_ATPASE_ACTIVITY_COUPLED	c5.GO molecular function	284	1.0917366	0.26361656	0.5470576	GO_ATPASE_ACTIVITY_COUPLED	293	0.9026107	0.779338	1	1.9943473	0.1891259
TERAO_AOX4_TARGETS_SKIN_DN	c2.CGP_ chemical and genetic perturbations	22	1.0916324	0.33802816	0.5472855	TERAO_AOX4_TARGETS_SKIN_DN	21	0.8924559	0.6427673	1	1.9840883	0.1991765
GO_MOLTING_CYCLE	c5.BP_ GO biological process	65	1.0915539	0.31571627	0.54742235	GO_MOLTING_CYCLE	74	1.1031243	0.30107528	0.7513806	2.1946782	-0.0115704
GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP	C7_ immunologic signatures	173	1.0915434	0.27639383	0.5473602	GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP	179	0.99696827	0.5025432	0.92726475	2.08851167	0.09457513
GSE11924_TFH_VS_TH17_CD4_TCELL_UP	C7_ immunologic signatures	174	1.091491	0.27514452	0.54742754	GSE11924_TFH_VS_TH17_CD4_TCELL_UP	176	0.9713664	0.55465585	0.96015245	2.0628574	0.1201246
ACTGTGA_MIR27A_MIR27B	c3.MIR_ microRNA targets	424	1.0914547	0.23248407	0.5474426	ACTGTGA_MIR27A_MIR27B	431	0.9350949	0.733	0.9949468	2.0265496	0.1563598
RUTELLA_RESPONSE_TO_HGF_DN	c2.CGP_ chemical and genetic perturbations	199	1.0913799	0.26588234	0.54757315	RUTELLA_RESPONSE_TO_HGF_DN	205	1.3575522	0.004040404	0.37930134	2.4489321	-0.2661723
GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	C7_ immunologic signatures	166	1.0913674	0.2773893	0.5475123	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	170	1.1078098	0.2573455	0.74118954	2.1991772	-0.0164424
YCATTAA_UNKNOWN	c3.TFT_ transcription factor targets	472	1.0913615	0.21549894	0.5474371	YCATTAA_UNKNOWN	487	1.1894089	0.028	0.60622746	2.2807704	-0.0980474
GSE13522_WT_VS_IFNG_KO_SKIN_UP	C7_ immunologic signatures	93	1.0913595	0.29614875	0.5473471	GSE13522_WT_VS_IFNG_KO_SKIN_UP	109	1.5191023	0.005175984	0.2368427	2.6104618	-0.4277428
GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_DN	C7_ immunologic signatures	97	1.0913225	0.30138713	0.54736286	GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_DN	102	-1.347178	0	0.24347308	-0.2558555	2.4385005
GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP	C7_ immunologic signatures	172	1.0913177	0.2905162	0.54728234	GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP	174	0.84610575	0.8228745	1	1.93742345	0.24521195
KEGG_CHRONIC_MYELOID_LEUKEMIA	c2.CP_BIOCARTA_ BioCarta gene sets	71	1.0913026	0.3137255	0.5472333	KEGG_CHRONIC_MYELOID_LEUKEMIA	71	0.8431208	0.7669173	1	1.9344234	0.2481818
HEN1_01	c3.TFT_ transcription factor targets	172	1.0912417	0.2804296	0.547323	HEN1_01	176	1.116073	0.23737374	0.7293615	2.2073147	-0.0248313
ATF3_Q6	c3.TFT_ transcription factor targets	211	1.0911329	0.26932085	0.5475683	ATF3_Q6	219	0.83600694	0.86653185	1	1.92713984	0.25512596
KRAS.LUNG_UP.V1_UP	C6_ oncogenic signatures	103	1.0910758	0.29262087	0.5476504	KRAS.LUNG_UP.V1_UP	113	1.3407049	0.025826447	0.39573386	2.4317807	-0.2496291
CHR2Q21	C1: positional gene sets	38	1.0910747	0.31034482	0.5475594	CHR2Q21	40	0.9180898	0.6062718	1	2.0091645	0.1729849
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP	c2.CGP_ chemical and genetic perturbations	17	1.0910579	0.34142396	0.54751384	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP	15	0.8505531	0.67374	1	1.941611	0.2405048
GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP	C7_ immunologic signatures	171	1.0910008	0.29131985	0.547584	GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP	178	0.9584616	0.60873985	0.9724346	2.0494624	0.1325392
DBP_Q6	c3.TFT_ transcription factor targets	210	1.0908526	0.2667464	0.54793817	DBP_Q6	225	1.0956995	0.25728643	0.76359254	2.1865521	-0.0048469
KOHOUTEK_CCNT2_TARGETS	c2.CGP_ chemical and genetic perturbations	48	1.0907813	0.32398316	0.5480735	KOHOUTEK_CCNT2_TARGETS	51	0.9605906	0.54555553	0.9709294	2.0513719	0.1301907
REACTOME_STEROID_HORMONES	c2.CP_REACTOME_ Reactome gene sets	20	1.0907431	0.34836704	0.54809827	REACTOME_STEROID_HORMONES	22	1.2639657	0.15547264	0.49108326	2.3547088	-0.1732226
MODULE_525	c4.CM_ cancer modules	56	1.090729	0.30727023	0.54804707	MODULE_525	57	-0.91480446	0.65625	0.8017313	0.17592454	2.00553346
MATZUK_SPERMATOZOA	c2.CGP_ chemical and genetic perturbations	99	1.0907115	0.2966208	0.5480085	MATZUK_SPERMATOZOA	102	0.9300222	0.6357069	0.9990773	2.0207337	0.1606893
GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN	C7_ immunologic signatures	189	1.0905733	0.27251995	0.54832965	GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN	188	0.76753956	0.94646466	1	1.85811286	0.32303374
GO_AMINO_ACID_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	60	1.09057	0.32054794	0.5482437	GO_AMINO_ACID_TRANSMEMBRANE_TRANSPORT	64	0.97476953	0.5371179	0.9557723	2.06533953	0.11580047
CHR1P33	C1: positional gene sets	29	1.0905676	0.34976888	0.5481552	CHR1P33	30	1.0898662	0.36407185	0.77138454	2.1804338	0.0007014
GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP	C7_ immunologic signatures	176	1.0904857	0.25851938	0.54833007	GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP	179	1.239076	0.045592707	0.52703774	2.3295617	-0.1485903
BIOCARTA_NGF_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	1.0904452	0.3423138	0.548359	BIOCARTA_NGF_PATHWAY	18	1.1271675	0.32241154	0.710843	2.2176127	-0.0367223
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	c2.CGP_ chemical and genetic perturbations	64	1.090265	0.29560587	0.548819	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	64	0.651247	0.96324325	1	1.741512	0.439018
GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN	C7_ immunologic signatures	173	1.0901662	0.2746988	0.5490265	GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN	174	1.0046867	0.49594322	0.91580063	2.0948529	0.0854795
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	c2.CGP_ chemical and genetic perturbations	97	1.0901484	0.3129771	0.5489844	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	97	-1.3066839	0	0.27694148	-0.2165355	2.3968323
GO_ORGAN_REGENERATION	c5.BP_ GO biological process	77	1.0901123	0.31299734	0.5490043	GO_ORGAN_REGENERATION	80	1.1875309	0.19251336	0.609907	2.2776432	-0.0974186
GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN	C7_ immunologic signatures	169	1.0899985	0.26328218	0.5492568	GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN	174	1.1707705	0.13434343	0.6368943	2.260769	-0.080772
CCCNNNNNNAAGWT_UNKNOWN	c3.TFT_ transcription factor targets	87	1.0899593	0.313394	0.5492782	CCCNNNNNNAAGWT_UNKNOWN	93	1.0459089	0.3938754	0.8470923	2.1358682	0.0440504
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_UP	C7_ immunologic signatures	131	1.0898179	0.29301745	0.54961985	GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_UP	131	1.1610129	0.18022656	0.6510551	2.2508308	-0.071195
GO_AMIDE_BINDING	c5.GO molecular function	214	1.0897857	0.26544622	0.5496178	GO_AMIDE_BINDING	227	0.9795406	0.5648241	0.95019233	2.0693263	0.1102451
ONO_AML1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	31	1.0897033	0.3440367	0.5497718	ONO_AML1_TARGETS_DN	32	-1.1388023	0.22222222	0.45866036	-0.049099	2.2285056
GO_ANAPHASE_PROMOTING_COMPLEX	c5.CC_ GO cellular component	19	1.0895472	0.3525741	0.55015	GO_ANAPHASE_PROMOTING_COMPLEX	19	1.1367447	0.30384615	0.6946426	2.2262919	-0.0471975
GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP	C7_ immunologic signatures	186	1.0895245	0.28	0.5501242	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP	187	0.97532386	0.56407666	0.9559504	2.06484836	0.11420064
GO_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE	c5.BP_ GO biological process	43	1.0895171	0.3314121	0.55005306	GO_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE	44	0.8590245	0.7037862	1	1.9485416	0.2304926
GO_POSITIVE_REGULATION_OF_CELL_GROWTH	c5.BP_ GO biological process	129	1.0895115	0.2920792	0.5499743	GO_POSITIVE_REGULATION_OF_CELL_GROWTH	137	1.0623993	0.35221422	0.8185763	2.1519108	0.0271122
MIKKELSEN_NPC_HCP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	267	1.0892156	0.2590909	0.5507855	MIKKELSEN_NPC_HCP_WITH_H3K27ME3	325	1.4618479	0	0.28140348	2.5510635	-0.3726323
GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP	C7_ immunologic signatures	178	1.0890044	0.28345498	0.55133677	GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP	180	1.0635189	0.34008098	0.8166234	2.1525233	0.0254855
GSE22886_TH1_VS_TH2_12H_ACT_DN	C7_ immunologic signatures	159	1.0888739	0.29236278	0.5516476	GSE22886_TH1_VS_TH2_12H_ACT_DN	163	1.1224037	0.21805274	0.7213541	2.2112776	-0.0335298
GNF2_MSH2	c4.CGN_ cancer gene neighborhoods	27	1.0887936	0.35693216	0.5517959	GNF2_MSH2	27	-1.809215	0	0.0316167	-0.7204214	2.8980086
GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN	C7_ immunologic signatures	114	1.0887485	0.28787878	0.5518393	GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN	128	1.0111974	0.48041236	0.9052766	2.0999459	0.0775511
PID_SYNDECAN_2_PATHWAY	c2.CP_ Canonical pathways	30	1.0886546	0.32114467	0.5520301	PID_SYNDECAN_2_PATHWAY	30	-0.81912875	0.8427673	0.8901223	0.26952585	1.90778335
DELYS_THYROID_CANCER_UP	c2.CGP_ chemical and genetic perturbations	398	1.0886526	0.23322684	0.55194074	DELYS_THYROID_CANCER_UP	411	1.1128367	0.146	0.7329682	2.2014893	-0.0241841
GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP	C7_ immunologic signatures	156	1.088545	0.2960761	0.55217415	GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP	167	1.3923056	0.005070994	0.34770882	2.4808506	-0.3037606
GO_DENDRITIC_SPINE_DEVELOPMENT	c5.BP_ GO biological process	19	1.0884348	0.35023043	0.5524142	GO_DENDRITIC_SPINE_DEVELOPMENT	19	-1.109004	0.31904763	0.5044475	-0.0205692	2.1974388
OCT1_01	c3.TFT_ transcription factor targets	221	1.0882983	0.28995433	0.55274135	OCT1_01	233	1.0251715	0.41883767	0.88344604	2.1134698	0.0631268
GO_POSITIVE_REGULATION_OF_CELL_ACTIVATION	c5.BP_ GO biological process	228	1.088289	0.28128588	0.5526731	GO_POSITIVE_REGULATION_OF_CELL_ACTIVATION	256	1.089368	0.2570281	0.7719785	2.177657	-0.001079
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	c2.CGP_ chemical and genetic perturbations	50	1.0881486	0.3218391	0.5530134	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	53	0.91767645	0.6272523	1	2.00582505	0.17047215
GO_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING	c5.GO molecular function	16	1.0881438	0.3378608	0.5529322	GO_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING	15	1.3906068	0.05745554	0.34584463	2.4787506	-0.302463
GO_POSITIVE_REGULATION_OF_CHEMOTAXIS	c5.BP_ GO biological process	93	1.0880302	0.29754204	0.5531866	GO_POSITIVE_REGULATION_OF_CHEMOTAXIS	99	1.4191782	0.009513742	0.31989777	2.5072084	-0.331148
GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP	C7_ immunologic signatures	159	1.0880135	0.28226778	0.5531472	GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP	167	1.0731432	0.3214649	0.8004395	2.1611567	0.0148703
GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN	C7_ immunologic signatures	165	1.0879623	0.2810219	0.55320716	GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN	168	0.839331	0.84615386	1	1.9272933	0.2486313
TTTNNANAGCYR_UNKNOWN	c3.TFT_ transcription factor targets	90	1.0877979	0.31362468	0.5536209	TTTNNANAGCYR_UNKNOWN	94	0.8799224	0.72146595	1	1.9677203	0.2078755
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	c2.CGP_ chemical and genetic perturbations	167	1.087751	0.2627824	0.5536738	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	167	0.99983007	0.49035534	0.92480034	2.08758107	0.08792093
PTEN_DN.V2_DN	C6_ oncogenic signatures	108	1.0877326	0.29726207	0.5536373	PTEN_DN.V2_DN	116	0.9068996	0.6966874	1	1.9946322	0.180833
GSE3039_NKT_CELL_VS_B2_BCELL_UP	C7_ immunologic signatures	181	1.0877087	0.26291078	0.5536142	GSE3039_NKT_CELL_VS_B2_BCELL_UP	188	0.9499459	0.6232323	0.98200786	2.0376546	0.1377628
GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN	C7_ immunologic signatures	136	1.087557	0.28908187	0.5539902	GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN	143	0.9977335	0.5280899	0.92601407	2.0852905	0.0898235
HALLMARK_APICAL_SURFACE	H_ hallmark gene sets	42	1.0875263	0.33524355	0.5539934	HALLMARK_APICAL_SURFACE	43	1.1681416	0.24449594	0.6406778	2.2556679	-0.0806153
GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN	C7_ immunologic signatures	175	1.0874544	0.2877527	0.5541196	GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN	181	1.0915877	0.2980866	0.76974684	2.1790421	-0.0041333
GO_MUSCLE_CELL_CELLULAR_HOMEOSTASIS	c5.BP_ GO biological process	16	1.0873653	0.3508772	0.55429906	GO_MUSCLE_CELL_CELLULAR_HOMEOSTASIS	16	0.8149313	0.74571806	1	1.9022966	0.272434
GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN	C7_ immunologic signatures	179	1.087187	0.29453683	0.5547277	GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN	187	0.9521657	0.62096775	0.9792681	2.0393527	0.1350213
MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED	c2.CGP_ chemical and genetic perturbations	435	1.0870662	0.22163309	0.5549988	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED	472	1.4604207	0	0.28309953	2.5474869	-0.3733545
HALLMARK_APICAL_JUNCTION	H_ hallmark gene sets	185	1.08689	0.29777256	0.5554537	HALLMARK_APICAL_JUNCTION	188	1.199273	0.08493428	0.593409	2.286163	-0.112383
GO_AUTOPHAGOSOME	c5.CC_ GO cellular component	73	1.0867529	0.33068782	0.5557751	GO_AUTOPHAGOSOME	74	1.2643772	0.08934338	0.490893	2.3511301	-0.1776243
GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	175	1.0866096	0.28621495	0.55613005	GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	177	1.2448947	0.057633974	0.5190832	2.3315043	-0.1582851
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP	C7_ immunologic signatures	171	1.0865315	0.29556075	0.55626774	GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP	183	1.0498579	0.39012095	0.84050554	2.1363894	0.0366736
GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP	C7_ immunologic signatures	175	1.0864564	0.28009534	0.5564155	GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP	180	0.9914165	0.5272727	0.934064	2.0778729	0.0950399
CREBP1_Q2	c3.TFT_ transcription factor targets	217	1.0863287	0.27771428	0.5567336	CREBP1_Q2	228	0.8016787	0.90625	1	1.8880074	0.28465
GO_ORGANELLE_MEMBRANE_FUSION	c5.BP_ GO biological process	83	1.0862843	0.31317204	0.55677587	GO_ORGANELLE_MEMBRANE_FUSION	84	1.2072909	0.15434083	0.5808283	2.2935752	-0.1210066
GO_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS	c5.BP_ GO biological process	106	1.0862372	0.29792747	0.5568245	GO_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS	122	0.9853992	0.537037	0.9413017	2.0716364	0.100838
GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN	C7_ immunologic signatures	147	1.0862286	0.28315413	0.55675477	GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN	154	1.0760474	0.3264887	0.79459524	2.162276	0.0101812
BRUECKNER_TARGETS_OF_MIRLET7A3_DN	c2.CGP_ chemical and genetic perturbations	64	1.0861856	0.308	0.5567916	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	65	1.1597394	0.2251951	0.6535231	2.245925	-0.0735538
GSE23695_CD57_POS_VS_NEG_NK_CELL_DN	C7_ immunologic signatures	182	1.0861001	0.2806604	0.5569578	GSE23695_CD57_POS_VS_NEG_NK_CELL_DN	183	0.6641964	0.9888325	1	1.7502965	0.4219037
GO_VENTRICULAR_SEPTUM_DEVELOPMENT	c5.BP_ GO biological process	49	1.086054	0.3154848	0.55700153	GO_VENTRICULAR_SEPTUM_DEVELOPMENT	51	1.0286634	0.43630216	0.87810785	2.1147174	0.0573906
GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN	C7_ immunologic signatures	128	1.0859991	0.28279182	0.55707973	GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN	130	1.3580345	0.016443988	0.3785078	2.4440336	-0.2720354
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	c2.CGP_ chemical and genetic perturbations	294	1.0859406	0.27262813	0.5571718	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	300	1.0600106	0.32532534	0.8245224	2.1459512	0.02593
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	123	1.0857133	0.3044586	0.55777985	GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	124	0.68663156	0.9670782	1	1.77234486	0.39908174
GSE6875_TCONV_VS_FOXP3_KO_TREG_DN	C7_ immunologic signatures	178	1.0856656	0.27981108	0.55783	GSE6875_TCONV_VS_FOXP3_KO_TREG_DN	181	1.0987052	0.26310483	0.75905055	2.1843708	-0.0130396
GO_CARBOXYPEPTIDASE_ACTIVITY	c5.GO molecular function	33	1.0855427	0.33578792	0.5581164	GO_CARBOXYPEPTIDASE_ACTIVITY	36	1.5219711	0.01836969	0.23371963	2.6075138	-0.4364284
MODULE_503	c4.CM_ cancer modules	106	1.0855228	0.29657796	0.55808055	MODULE_503	106	0.59616643	0.9947644	1	1.68168923	0.48935637
GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP	C7_ immunologic signatures	181	1.0853903	0.28437132	0.55838543	GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP	182	1.1199818	0.23636363	0.7231982	2.2053721	-0.0345915
GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	C7_ immunologic signatures	182	1.0852609	0.28150767	0.5586789	GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	182	1.2080075	0.09137056	0.5806699	2.2932684	-0.1227466
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	c2.CGP_ chemical and genetic perturbations	31	1.0851762	0.34638554	0.5588437	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	31	-1.0297979	0.40555555	0.63983035	0.0553783	2.1149741
RICKMAN_HEAD_AND_NECK_CANCER_E	c2.CGP_ chemical and genetic perturbations	63	1.0849118	0.33106267	0.5595736	RICKMAN_HEAD_AND_NECK_CANCER_E	70	1.7691926	0	0.056157343	2.8541044	-0.6842808
YTAAYNGCT_UNKNOWN	c3.TFT_ transcription factor targets	133	1.0848985	0.29611042	0.5595206	YTAAYNGCT_UNKNOWN	135	0.7385027	0.92362523	1	1.8234012	0.3463958
GO_ATP_HYDROLYSIS_COUPLED_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	27	1.08489	0.3598726	0.5594496	GO_ATP_HYDROLYSIS_COUPLED_TRANSMEMBRANE_TRANSPORT	31	0.6753465	0.9140436	1	1.7602365	0.4095435
WEIGEL_OXIDATIVE_STRESS_RESPONSE	c2.CGP_ chemical and genetic perturbations	33	1.0848597	0.32300884	0.5594413	WEIGEL_OXIDATIVE_STRESS_RESPONSE	33	1.022823	0.44678363	0.88679594	2.1076827	0.0620367
GO_RESPONSE_TO_OXIDATIVE_STRESS	c5.BP_ GO biological process	314	1.084858	0.26593408	0.5593514	GO_RESPONSE_TO_OXIDATIVE_STRESS	325	1.1353374	0.12112112	0.6966822	2.2201954	-0.0504794
GSE6875_TCONV_VS_TREG_UP	C7_ immunologic signatures	174	1.0848484	0.28755867	0.5592895	GSE6875_TCONV_VS_TREG_UP	179	0.9829737	0.54711246	0.94418097	2.0678221	0.1018747
GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP	C7_ immunologic signatures	167	1.084835	0.2917167	0.55923045	GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP	169	1.1232127	0.20913705	0.7196858	2.2080477	-0.0383777
GSE39864_WT_VS_GATA3_KO_TREG_UP	C7_ immunologic signatures	173	1.0847787	0.28438228	0.55932003	GSE39864_WT_VS_GATA3_KO_TREG_UP	179	1.3438928	0.010162601	0.39173838	2.4286715	-0.2591141
GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN	C7_ immunologic signatures	179	1.084737	0.29304448	0.5593561	GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN	179	-1.136366	0.125	0.46182793	-0.051629	2.221103
GSE22886_TCELL_VS_BCELL_NAIVE_DN	C7_ immunologic signatures	156	1.0846982	0.29839703	0.55938166	GSE22886_TCELL_VS_BCELL_NAIVE_DN	161	1.2949474	0.028629856	0.44960856	2.3796456	-0.2102492
GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN	C7_ immunologic signatures	124	1.084566	0.29671717	0.5597146	GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN	130	1.4732431	0.001027749	0.27573553	2.5578091	-0.3886771
GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP	C7_ immunologic signatures	141	1.0844712	0.28832117	0.5599092	GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP	143	0.7910944	0.8897959	1	1.8755656	0.2933768
GO_FEMALE_SEX_DIFFERENTIATION	c5.BP_ GO biological process	106	1.0844651	0.30949286	0.5598309	GO_FEMALE_SEX_DIFFERENTIATION	112	0.9403171	0.6349372	0.9898559	2.0247822	0.144148
GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP	C7_ immunologic signatures	171	1.084347	0.28363636	0.5600945	GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP	175	0.9069661	0.7296748	1	1.9913131	0.1773809
GO_RESPONSE_TO_PAIN	c5.BP_ GO biological process	21	1.0842499	0.36261982	0.560312	GO_RESPONSE_TO_PAIN	28	1.1931528	0.2180268	0.6001813	2.2774027	-0.1089029
GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN	C7_ immunologic signatures	176	1.0842109	0.26904762	0.5603388	GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN	179	1.2866737	0.03437816	0.4625216	2.3708846	-0.2024628
GO_NEURON_SPINE	c5.CC_ GO cellular component	113	1.0842012	0.32572877	0.5602737	GO_NEURON_SPINE	117	1.3505485	0.019709544	0.38401884	2.4347497	-0.2663473
CHR2P21	C1: positional gene sets	31	1.0841458	0.3312789	0.5603499	CHR2P21	33	0.65694445	0.92065346	1	1.74109025	0.42720135
GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	189	1.0840757	0.30865604	0.56047416	GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP	191	0.9468712	0.64568526	0.9857414	2.0309469	0.1372045
GO_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	36	1.084059	0.33086053	0.5604318	GO_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION	37	1.3796948	0.059453033	0.3567799	2.4637538	-0.2956358
MODULE_491	c4.CM_ cancer modules	73	1.0840006	0.30506155	0.5605154	MODULE_491	72	1.3944699	0.018599562	0.34513336	2.4784705	-0.3104693
JACKSON_DNMT1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	70	1.0839812	0.29697767	0.56048054	JACKSON_DNMT1_TARGETS_UP	69	1.0751463	0.36453745	0.79663813	2.1591275	0.0088349
FOXO1_02	c3.TFT_ transcription factor targets	212	1.0839553	0.28293243	0.5604653	FOXO1_02	219	0.9080889	0.73843056	1	1.9920442	0.1758664
YAMASHITA_LIVER_CANCER_STEM_CELL_UP	c2.CGP_ chemical and genetic perturbations	42	1.0839341	0.34463277	0.56043094	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	45	0.92476606	0.61079866	1	2.00870016	0.15916804
GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY	c5.BP_ GO biological process	461	1.0838832	0.22553192	0.56048805	GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY	476	1.0870178	0.186	0.77553844	2.170901	-0.0031346
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	c2.CGP_ chemical and genetic perturbations	30	1.0838748	0.34360555	0.5604188	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	29	0.834897	0.7172082	1	1.9187718	0.2489778
GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	166	1.083813	0.27651966	0.5605145	GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	168	0.88954884	0.7530488	1	1.97336184	0.19426416
REACTOME_GABA_B_RECEPTOR_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	36	1.0837445	0.31729323	0.56063306	REACTOME_GABA_B_RECEPTOR_ACTIVATION	37	1.1791177	0.22880372	0.6234053	2.2628622	-0.0953732
LIU_SOX4_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	122	1.0837109	0.30456853	0.5606423	LIU_SOX4_TARGETS_UP	122	1.1251585	0.24455959	0.7148116	2.2088694	-0.0414476
KIM_WT1_TARGETS_12HR_UP	c2.CGP_ chemical and genetic perturbations	148	1.0837109	0.272838	0.5605468	KIM_WT1_TARGETS_12HR_UP	149	1.1745057	0.15	0.63052595	2.2582166	-0.0907948
NAGASHIMA_NRG1_SIGNALING_DN	c2.CGP_ chemical and genetic perturbations	47	1.0837066	0.32217574	0.5604666	NAGASHIMA_NRG1_SIGNALING_DN	47	0.88503504	0.6770601	1	1.96874164	0.19867156
GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN	C7_ immunologic signatures	181	1.0835791	0.2970297	0.560765	GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN	184	1.487045	0	0.26326263	2.5706241	-0.4034659
REACTOME_AMYLOIDS	c2.CP_REACTOME_ Reactome gene sets	35	1.0835222	0.32670453	0.5608388	REACTOME_AMYLOIDS	40	1.336383	0.07373272	0.39766848	2.4199052	-0.2528608
GO_DENDRITE_DEVELOPMENT	c5.BP_ GO biological process	78	1.083361	0.30585107	0.5612428	GO_DENDRITE_DEVELOPMENT	79	1.0246838	0.44539616	0.88429177	2.1080448	0.0586772
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	c2.CP_REACTOME_ Reactome gene sets	15	1.0833598	0.34966215	0.56115055	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	15	-1.5747153	0.038135592	0.10232552	-0.4913555	2.6580751
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	131	1.0833373	0.29611042	0.5611229	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP	139	1.1457952	0.18628454	0.6776756	2.2291325	-0.0624579
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	c2.CGP_ chemical and genetic perturbations	30	1.0833272	0.3367647	0.56105894	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	28	1.3491096	0.07274969	0.38324845	2.4324368	-0.2657824
GO_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT	c5.BP_ GO biological process	23	1.0833235	0.3642072	0.56097615	GO_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT	23	1.1110984	0.33333334	0.735765	2.1944219	-0.0277749
CAIRO_LIVER_DEVELOPMENT_UP	c2.CGP_ chemical and genetic perturbations	150	1.083166	0.31332532	0.56136376	CAIRO_LIVER_DEVELOPMENT_UP	153	0.6992593	0.9672131	1	1.7824253	0.3839067
GO_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_CELL_FATE_COMMITMENT	c5.BP_ GO biological process	17	1.083058	0.3540587	0.5616049	GO_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_CELL_FATE_COMMITMENT	20	0.83021784	0.7061791	1	1.91327584	0.25284016
GO_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	90	1.0830238	0.3307888	0.5616214	GO_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY	91	1.0405213	0.41033757	0.8586311	2.1235451	0.0425025
GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP	C7_ immunologic signatures	160	1.082914	0.2904412	0.5618636	GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP	175	0.905012	0.71543896	1	1.987926	0.177902
GCCNNNWTAAR_UNKNOWN	c3.TFT_ transcription factor targets	131	1.0829033	0.2910628	0.5617996	GCCNNNWTAAR_UNKNOWN	133	-1.1458566	0.16666667	0.44911802	-0.0629533	2.2287599
MORF_ARL3	c4.CGN_ cancer gene neighborhoods	232	1.0828671	0.27314815	0.56181175	MORF_ARL3	258	1.1675421	0.108324975	0.6413748	2.2504092	-0.084675
GO_INSULIN_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	74	1.0828375	0.32392472	0.5618117	GO_INSULIN_RECEPTOR_SIGNALING_PATHWAY	77	0.8309141	0.7723404	1	1.9137516	0.2519234
GO_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	38	1.0828165	0.3393124	0.5617778	GO_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY	37	0.85469663	0.6879433	1	1.93751313	0.22811987
GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN	C7_ immunologic signatures	96	1.0828028	0.2996159	0.56172293	GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN	101	1.5785154	0.00105042	0.18168063	2.6613182	-0.4957126
GO_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS	c5.BP_ GO biological process	193	1.0827634	0.27240565	0.5617507	GO_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS	202	0.8667409	0.7993982	1	1.9495043	0.2160225
GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP	C7_ immunologic signatures	181	1.0827416	0.29556075	0.56172013	GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP	184	1.3759018	0.005045409	0.35739642	2.4586434	-0.2931602
GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP	C7_ immunologic signatures	179	1.0826833	0.28754365	0.5618027	GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP	181	1.2047464	0.1	0.58265644	2.2874297	-0.1220631
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	c2.CGP_ chemical and genetic perturbations	27	1.0826801	0.36619717	0.5617168	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	27	0.73598796	0.86240786	1	1.81866806	0.34669214
GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	C7_ immunologic signatures	137	1.08265	0.29202455	0.5617077	GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	149	1.1537312	0.18954918	0.6632118	2.2363812	-0.0710812
SNF5_DN.V1_DN	C6_ oncogenic signatures	141	1.0822082	0.27641279	0.56297547	SNF5_DN.V1_DN	141	1.49923	0	0.25490335	2.5814382	-0.4170218
GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_UP	C7_ immunologic signatures	133	1.082181	0.3090909	0.56296486	GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_UP	141	1.1242052	0.2324873	0.71715754	2.2063862	-0.0420242
MA_PITUITARY_FETAL_VS_ADULT_DN	c2.CGP_ chemical and genetic perturbations	16	1.0819468	0.3681592	0.56359607	MA_PITUITARY_FETAL_VS_ADULT_DN	17	-1.2672352	0.1682243	0.3094226	-0.1852884	2.349182
GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN	C7_ immunologic signatures	165	1.0819253	0.29988194	0.56356066	GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN	178	1.1817869	0.124117054	0.6203877	2.2637122	-0.0998616
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	c2.CGP_ chemical and genetic perturbations	39	1.0818356	0.32874617	0.5637371	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	40	-0.94608647	0.59504133	0.7607382	0.13574913	2.02792207
GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN	C7_ immunologic signatures	165	1.0818049	0.31132075	0.5637318	GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN	168	1.0141371	0.47160244	0.89975053	2.095942	0.0676678
GO_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS	c5.BP_ GO biological process	112	1.0817955	0.30844554	0.5636658	GO_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS	119	0.88018984	0.7283177	1	1.96198534	0.20160566
GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN	C7_ immunologic signatures	178	1.0817072	0.27553445	0.5638457	GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN	178	0.8309834	0.8460754	1	1.9126906	0.2507238
GO_CLATHRIN_BINDING	c5.GO molecular function	56	1.0816859	0.33049646	0.56381494	GO_CLATHRIN_BINDING	57	1.1958693	0.19269103	0.5972633	2.2775552	-0.1141834
GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN	C7_ immunologic signatures	176	1.0816063	0.31388566	0.5639626	GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN	180	1.0594975	0.35852912	0.8255844	2.1411038	0.0221088
GSE10325_MYELOID_VS_LUPUS_MYELOID_UP	C7_ immunologic signatures	150	1.0814039	0.29550827	0.56448084	GSE10325_MYELOID_VS_LUPUS_MYELOID_UP	163	1.2810823	0.044399597	0.4706416	2.3624862	-0.1996784
CHR16Q22	C1: positional gene sets	119	1.0813444	0.31082803	0.56456673	CHR16Q22	124	0.6068117	0.99481326	1	1.6881561	0.4745327
GO_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA	c5.BP_ GO biological process	19	1.0813435	0.36019737	0.5644727	GO_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA	19	1.0267607	0.44796956	0.88147503	2.1081042	0.0545828
GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN	C7_ immunologic signatures	179	1.0813295	0.2986111	0.56442297	GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN	176	1.0186111	0.4680851	0.8923358	2.0999406	0.0627184
GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	C7_ immunologic signatures	181	1.0810992	0.30227274	0.5650522	GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	186	1.1432474	0.19436052	0.68397886	2.2243466	-0.0621482
GTTRYCATRR_UNKNOWN	c3.TFT_ transcription factor targets	136	1.0810702	0.31459332	0.56504387	GTTRYCATRR_UNKNOWN	140	0.9166232	0.69152194	1	1.9976934	0.164447
GO_RESPONSE_TO_COLD	c5.BP_ GO biological process	38	1.0810425	0.3382353	0.56503975	GO_RESPONSE_TO_COLD	40	1.1565576	0.25465116	0.6592399	2.2376001	-0.0755151
MORF_RAD51L3	c4.CGN_ cancer gene neighborhoods	296	1.0810175	0.27461708	0.5650192	MORF_RAD51L3	320	1.2813689	0.014056225	0.47067058	2.3623864	-0.2003514
GO_NEURON_PROJECTION_TERMINUS	c5.CC_ GO cellular component	109	1.0810161	0.3005115	0.56492823	GO_NEURON_PROJECTION_TERMINUS	123	1.343841	0.022610484	0.39163256	2.4248571	-0.2628249
GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP	C7_ immunologic signatures	123	1.080942	0.30656934	0.56506115	GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP	127	1.2728822	0.062564105	0.48245662	2.3538242	-0.1919402
GO_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS	c5.BP_ GO biological process	362	1.0809137	0.2673913	0.56505096	GO_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS	371	0.9407275	0.6906907	0.9897209	2.0216412	0.1401862
GO_SPERM_MOTILITY	c5.BP_ GO biological process	35	1.0808874	0.36731634	0.5650298	GO_SPERM_MOTILITY	37	1.2061896	0.1842723	0.5821102	2.287077	-0.1253022
GO_POLYOL_TRANSPORT	c5.BP_ GO biological process	15	1.0808192	0.37815127	0.56515056	GO_POLYOL_TRANSPORT	16	0.7530139	0.80946124	1	1.8338331	0.3278053
GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN	C7_ immunologic signatures	161	1.0807973	0.29376498	0.5651233	GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN	167	0.79900706	0.89013225	1	1.87980436	0.28179024
GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	151	1.0807805	0.30381304	0.5650838	GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	155	1.0497518	0.39452332	0.8406609	2.1305323	0.0310287
MODULE_20	c4.CM_ cancer modules	73	1.0806471	0.31962866	0.5654031	MODULE_20	77	1.4396422	0.014893618	0.30432463	2.5202893	-0.3589951
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN	C7_ immunologic signatures	174	1.0806179	0.28857478	0.5653964	GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN	175	1.0686593	0.3401222	0.8076412	2.1492772	0.0119586
MODULE_45	c4.CM_ cancer modules	480	1.0806171	0.24130663	0.56530327	MODULE_45	500	1.2414817	0.008008008	0.5231295	2.3220988	-0.1608646
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	c2.CGP_ chemical and genetic perturbations	22	1.0805974	0.36495176	0.56526494	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	24	-0.806707	0.72625697	0.89953506	0.2738904	1.8873044
IWANAGA_CARCINOGENESIS_BY_KRAS_UP	c2.CGP_ chemical and genetic perturbations	148	1.0805824	0.3280098	0.5652179	IWANAGA_CARCINOGENESIS_BY_KRAS_UP	150	0.9939597	0.52953154	0.93098444	2.0745421	0.0866227
GO_POSITIVE_REGULATION_OF_DNA_REPLICATION	c5.BP_ GO biological process	77	1.0805655	0.3337766	0.56517464	GO_POSITIVE_REGULATION_OF_DNA_REPLICATION	80	1.0400345	0.4062165	0.8590991	2.1206	0.040531
GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP	C7_ immunologic signatures	181	1.0803936	0.3078759	0.5656151	GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP	184	1.1267267	0.2116349	0.7115919	2.2071203	-0.0463331
RICKMAN_HEAD_AND_NECK_CANCER_D	c2.CGP_ chemical and genetic perturbations	20	1.0802885	0.35967743	0.5658327	RICKMAN_HEAD_AND_NECK_CANCER_D	27	1.3459736	0.10169491	0.38765746	2.4262621	-0.2656851
CROMER_TUMORIGENESIS_DN	c2.CGP_ chemical and genetic perturbations	39	1.0802854	0.31864905	0.565748	CROMER_TUMORIGENESIS_DN	41	1.1135405	0.31633836	0.7319542	2.1938259	-0.0332551
REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS	c2.CP_REACTOME_ Reactome gene sets	37	1.080282	0.33564493	0.5656629	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS	40	0.961645	0.53294796	0.96920156	2.041927	0.118637
GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	C7_ immunologic signatures	173	1.0802504	0.2939068	0.56566036	GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	174	0.86177856	0.80425966	1	1.94202896	0.21847184
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES	c2.CP_ Canonical pathways	32	1.080233	0.34833091	0.5656182	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES	34	1.1491321	0.2723971	0.670263	2.2293651	-0.0688991
GSE29618_BCELL_VS_PDC_UP	C7_ immunologic signatures	158	1.0801327	0.2913669	0.56583154	GSE29618_BCELL_VS_PDC_UP	163	0.8761555	0.7651822	1	1.9562882	0.2039772
GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN	C7_ immunologic signatures	150	1.0799901	0.31400967	0.56618184	GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN	156	1.3380679	0.019427402	0.39769155	2.418058	-0.2580778
GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN	C7_ immunologic signatures	181	1.0799574	0.2983683	0.5661905	GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN	181	1.1707425	0.13508065	0.6368311	2.2506999	-0.0907851
CHR3Q29	C1: positional gene sets	33	1.0799109	0.36701337	0.5662382	CHR3Q29	35	-1.0872724	0.3146853	0.5393716	-0.0073615	2.1671833
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN	C7_ immunologic signatures	182	1.0798503	0.30359212	0.56633717	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN	179	1.021596	0.45674044	0.8897171	2.1014463	0.0582543
GO_MULTIVESICULAR_BODY_ORGANIZATION	c5.BP_ GO biological process	28	1.0798398	0.33594978	0.56627536	GO_MULTIVESICULAR_BODY_ORGANIZATION	28	0.7756249	0.78414637	1	1.8554647	0.3042149
AR_Q2	c3.TFT_ transcription factor targets	106	1.0797575	0.32337663	0.5664379	AR_Q2	111	1.0799521	0.3170478	0.7874261	2.1597096	-0.0001946
GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN	C7_ immunologic signatures	166	1.0797393	0.31490386	0.566394	GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN	173	1.2715377	0.038306452	0.48322704	2.351277	-0.1917984
GO_REGULATION_OF_FAT_CELL_DIFFERENTIATION	c5.BP_ GO biological process	96	1.0796129	0.3153745	0.56668824	GO_REGULATION_OF_FAT_CELL_DIFFERENTIATION	98	0.91983575	0.6554974	1	1.99944865	0.15977715
GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	127	1.0795885	0.3125	0.5666667	GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	128	0.71996826	0.947314	1	1.79955676	0.35962024
GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN	C7_ immunologic signatures	177	1.0795765	0.2899061	0.5666115	GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN	179	0.93416464	0.66935486	0.9955015	2.01374114	0.14541186
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN	C7_ immunologic signatures	169	1.0794584	0.31339714	0.5668756	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN	181	1.0880479	0.2926337	0.7736604	2.1675063	-0.0085895
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP	C7_ immunologic signatures	155	1.0794569	0.28846154	0.56678545	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP	167	1.1220219	0.22983871	0.7223277	2.2014788	-0.042565
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	160	1.0794224	0.30732292	0.56679237	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN	161	0.9552293	0.5983773	0.9757065	2.0346517	0.1241931
GO_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE	c5.BP_ GO biological process	122	1.0793467	0.31234258	0.5669294	GO_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE	125	1.1327083	0.22554068	0.7018617	2.212055	-0.0533616
GO_ANATOMICAL_STRUCTURE_MATURATION	c5.BP_ GO biological process	35	1.0793386	0.32697946	0.56685877	GO_ANATOMICAL_STRUCTURE_MATURATION	39	-1.081928	0.30597016	0.5481295	-0.0025894	2.1612666
BURTON_ADIPOGENESIS_12	c2.CGP_ chemical and genetic perturbations	30	1.079311	0.33679524	0.5668472	BURTON_ADIPOGENESIS_12	30	-1.5458776	0.03649635	0.1171889	-0.4665666	2.6251886
GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	C7_ immunologic signatures	154	1.0792923	0.30057803	0.5668101	GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	158	0.645618	0.99286443	1	1.7249103	0.4336743
GO_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS	c5.BP_ GO biological process	132	1.0792476	0.28710464	0.5668537	GO_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS	128	1.0764127	0.32304525	0.794341	2.1556603	0.0028349
GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN	C7_ immunologic signatures	181	1.0791945	0.28687572	0.5669165	GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN	179	0.9402906	0.6576032	0.9896752	2.0194851	0.1389039
TATCTGG_MIR488	c3.MIR_ microRNA targets	53	1.0790668	0.33707866	0.5672148	TATCTGG_MIR488	54	0.81974393	0.7785088	1	1.89881073	0.25932287
GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP	C7_ immunologic signatures	178	1.079062	0.29411766	0.5671365	GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP	181	0.8787752	0.76829267	1	1.9578372	0.2002868
GO_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION	c5.BP_ GO biological process	18	1.0789999	0.3775351	0.5672351	GO_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION	18	-0.74444544	0.875576	0.9403014	0.33455446	1.82344534
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	c2.CGP_ chemical and genetic perturbations	257	1.0789746	0.2858783	0.5672207	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	258	0.9732664	0.5927783	0.9578723	2.052241	0.1057082
GSE11924_TH1_VS_TH17_CD4_TCELL_UP	C7_ immunologic signatures	160	1.0789644	0.2961165	0.5671582	GSE11924_TH1_VS_TH17_CD4_TCELL_UP	173	0.93068033	0.6693712	0.9983529	2.00964473	0.14828407
MIKKELSEN_NPC_LCP_WITH_H3K4ME3	c2.CGP_ chemical and genetic perturbations	49	1.0789591	0.33053222	0.567083	MIKKELSEN_NPC_LCP_WITH_H3K4ME3	51	1.2021662	0.18510158	0.58874416	2.2811253	-0.1232071
BIOCARTA_MCALPAIN_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	1.0788956	0.35692307	0.5671892	BIOCARTA_MCALPAIN_PATHWAY	23	0.8629794	0.6889715	1	1.941875	0.2159162
GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS	c5.BP_ GO biological process	35	1.0788745	0.32803467	0.56716675	GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS	39	1.226289	0.18390805	0.547286	2.3051635	-0.1474145
MODULE_284	c4.CM_ cancer modules	43	1.0787812	0.35498488	0.56734854	MODULE_284	43	1.0626783	0.38310185	0.81841743	2.1414595	0.0161029
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN	C7_ immunologic signatures	168	1.0786798	0.29259694	0.56755626	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN	169	0.6290937	0.98677516	1	1.7077735	0.4495861
MODULE_208	c4.CM_ cancer modules	90	1.0786587	0.32692307	0.56752294	MODULE_208	92	1.3843079	0.030398322	0.35174906	2.4629666	-0.3056492
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN	C7_ immunologic signatures	146	1.0786076	0.3057644	0.5675904	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN	145	0.80948645	0.85350966	1	1.88809405	0.26912115
GO_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	24	1.0785366	0.35846153	0.5677171	GO_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY	25	-1.1470479	0.20975609	0.4472754	-0.0685113	2.2255845
CHEN_PDGF_TARGETS	c2.CGP_ chemical and genetic perturbations	17	1.0785358	0.3744076	0.56762385	CHEN_PDGF_TARGETS	17	-0.71995205	0.8908297	0.9516649	0.35858375	1.79848785
GO_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	22	1.0785295	0.3672496	0.5675475	GO_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS	23	1.4835787	0.024050632	0.26562178	2.5621082	-0.4050492
GSE17721_0.5H_VS_8H_LPS_BMDC_DN	C7_ immunologic signatures	175	1.0785098	0.2931442	0.5675154	GSE17721_0.5H_VS_8H_LPS_BMDC_DN	180	1.1635801	0.14111675	0.6478698	2.2420899	-0.0850703
BIOCARTA_CTCF_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	1.0784312	0.35285053	0.5676647	BIOCARTA_CTCF_PATHWAY	22	0.72450376	0.8697271	1	1.80293496	0.35392744
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP	C7_ immunologic signatures	142	1.0784156	0.28782287	0.5676184	GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP	147	1.0328108	0.42535788	0.87237495	2.1112264	0.0456048
GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP	C7_ immunologic signatures	182	1.0783169	0.2904762	0.5678251	GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP	185	1.025794	0.44949496	0.8830147	2.1041109	0.0525229
GO_EMBRYONIC_DIGIT_MORPHOGENESIS	c5.BP_ GO biological process	53	1.0782937	0.35497835	0.56780416	GO_EMBRYONIC_DIGIT_MORPHOGENESIS	57	0.7837734	0.82530797	1	1.8620671	0.2945203
GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	C7_ immunologic signatures	183	1.0781914	0.29234338	0.5680169	GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	188	1.2637775	0.04365482	0.49096674	2.3419689	-0.1855861
GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN	C7_ immunologic signatures	146	1.0781766	0.3091335	0.5679649	GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN	149	1.2869929	0.054136876	0.4621603	2.3651695	-0.2088163
GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN	C7_ immunologic signatures	163	1.0781683	0.28421053	0.56789726	GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN	176	1.2627608	0.053752534	0.49253413	2.3409291	-0.1845925
GO_REGULATION_OF_WNT_SIGNALING_PATHWAY	c5.BP_ GO biological process	284	1.0780022	0.2850877	0.5683051	GO_REGULATION_OF_WNT_SIGNALING_PATHWAY	293	0.7411397	0.9749499	1	1.8191419	0.3368625
GSE17721_POLYIC_VS_CPG_6H_BMDC_UP	C7_ immunologic signatures	185	1.0779842	0.2994083	0.56826717	GSE17721_POLYIC_VS_CPG_6H_BMDC_UP	188	-0.8937041	0.8	0.8280895	0.1842801	1.9716883
CREB_Q4	c3.TFT_ transcription factor targets	232	1.0779294	0.29411766	0.5683457	CREB_Q4	243	0.78178453	0.9286432	1	1.85971393	0.29614487
REACTOME_LIPOPROTEIN_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	21	1.0779119	0.3524721	0.56830657	REACTOME_LIPOPROTEIN_METABOLISM	25	-1.2612911	0.14070351	0.31386492	-0.1833792	2.339203
GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP	C7_ immunologic signatures	174	1.0778446	0.30409357	0.5684202	GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP	177	-1.0291173	0.3	0.6407204	0.0487273	2.1069619
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN	c2.CGP_ chemical and genetic perturbations	241	1.0778145	0.28683037	0.5684172	OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN	250	1.0528055	0.37111333	0.8362716	2.13062	0.025009
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	c2.CP_REACTOME_ Reactome gene sets	138	1.0778105	0.2959805	0.5683339	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	148	1.10161	0.2755102	0.75424016	2.1794205	-0.0237995
GO_LYMPHOCYTE_ACTIVATION	c5.BP_ GO biological process	291	1.0777911	0.27323008	0.5682987	GO_LYMPHOCYTE_ACTIVATION	311	0.9648913	0.61022043	0.965519	2.0426824	0.1128998
GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP	C7_ immunologic signatures	96	1.0777438	0.34526855	0.56834763	GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP	100	0.94588643	0.6008316	0.9862962	2.02363023	0.13185737
GO_REGULATION_OF_EXOSOMAL_SECRETION	c5.BP_ GO biological process	15	1.0777256	0.36564627	0.56830823	GO_REGULATION_OF_EXOSOMAL_SECRETION	15	0.8504627	0.6759259	1	1.9281883	0.2272629
GO_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS	c5.BP_ GO biological process	176	1.0776691	0.30806258	0.5683904	GO_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS	185	1.1566869	0.17272727	0.6589883	2.234356	-0.0790178
GSE25087_FETAL_VS_ADULT_TREG_DN	C7_ immunologic signatures	147	1.0775936	0.30960855	0.568536	GSE25087_FETAL_VS_ADULT_TREG_DN	150	1.0758222	0.33095723	0.79498196	2.1534158	0.0017714
GO_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION	c5.BP_ GO biological process	149	1.0775756	0.321513	0.56849825	GO_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION	154	0.75603074	0.93237704	1	1.83360634	0.32154486
GO_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS	c5.BP_ GO biological process	487	1.077435	0.2455216	0.5688284	GO_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS	487	0	0	0	1.077435	1.077435
GO_THYMUS_DEVELOPMENT	c5.BP_ GO biological process	43	1.0773925	0.33381712	0.5688657	GO_THYMUS_DEVELOPMENT	46	-1.4730854	0.015267176	0.1591345	-0.3956929	2.5504779
GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP	C7_ immunologic signatures	176	1.0773441	0.3101415	0.56891865	GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP	179	1.2782347	0.04733132	0.47429794	2.3555788	-0.2008906
GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN	C7_ immunologic signatures	176	1.0771763	0.3125	0.56933886	GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN	179	0.81187123	0.88301116	1	1.88904753	0.26530507
BIOCARTA_IGF1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	21	1.0771407	0.37239164	0.56935424	BIOCARTA_IGF1_PATHWAY	21	0.89049053	0.64881694	1	1.96763123	0.18665017
GO_LYTIC_VACUOLE_ORGANIZATION	c5.BP_ GO biological process	49	1.0770984	0.33524355	0.5693973	GO_LYTIC_VACUOLE_ORGANIZATION	49	1.1110668	0.31690928	0.7357524	2.1881652	-0.0339684
GO_REGULATION_OF_RECEPTOR_BINDING	c5.BP_ GO biological process	15	1.0770462	0.35934958	0.56946397	GO_REGULATION_OF_RECEPTOR_BINDING	16	1.1487709	0.31149733	0.67005926	2.2258171	-0.0717247
GSE17580_TREG_VS_TEFF_UP	C7_ immunologic signatures	175	1.0769967	0.30177516	0.56951535	GSE17580_TREG_VS_TEFF_UP	175	0.9301422	0.6686992	0.9989722	2.0071389	0.1468545
GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN	C7_ immunologic signatures	186	1.0769956	0.3073286	0.56942374	GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN	186	1.2373772	0.05662285	0.5302984	2.3143728	-0.1603816
KYNG_DNA_DAMAGE_DN	c2.CGP_ chemical and genetic perturbations	178	1.0768107	0.31695905	0.56990916	KYNG_DNA_DAMAGE_DN	180	0.7479846	0.9370558	1	1.8247953	0.3288261
ACAWYAAAG_UNKNOWN	c3.TFT_ transcription factor targets	84	1.076763	0.31406045	0.56995064	ACAWYAAAG_UNKNOWN	89	1.101165	0.31712472	0.7551762	2.177928	-0.024402
GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP	C7_ immunologic signatures	171	1.0766592	0.30997625	0.5701686	GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP	176	0.9992204	0.5237614	0.9248832	2.0758796	0.0774388
GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP	C7_ immunologic signatures	165	1.0766569	0.3005917	0.57008207	GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP	179	1.0842263	0.29061553	0.77908593	2.1608832	-0.0075694
GO_ISOPRENOID_METABOLIC_PROCESS	c5.BP_ GO biological process	109	1.0764492	0.3114754	0.57063	GO_ISOPRENOID_METABOLIC_PROCESS	110	1.1908222	0.14926931	0.6040222	2.2672714	-0.114373
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	153	1.0763236	0.3070588	0.5709181	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP	160	1.1815116	0.13171226	0.6207555	2.2578352	-0.105188
MODULE_408	c4.CM_ cancer modules	17	1.0760334	0.3630673	0.57169193	MODULE_408	18	0.98844886	0.49802372	0.93731433	2.06448226	0.08758454
GNF2_PTPRC	c4.CGN_ cancer gene neighborhoods	49	1.0759951	0.3537803	0.57170784	GNF2_PTPRC	51	1.2328775	0.15701559	0.53636426	2.3088726	-0.1568824
GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP	C7_ immunologic signatures	159	1.075963	0.29807693	0.57171094	GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP	167	0.9154618	0.70385396	1	1.9914248	0.1605012
GO_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION	c5.BP_ GO biological process	31	1.0758958	0.35545722	0.5718156	GO_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION	31	1.2312862	0.16306955	0.5379811	2.307182	-0.1553904
GREENBAUM_E2A_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	17	1.0758928	0.3623639	0.5717293	GREENBAUM_E2A_TARGETS_DN	18	1.2389605	0.19383825	0.52648556	2.3148533	-0.1630677
GO_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS	c5.BP_ GO biological process	45	1.0758843	0.34119278	0.5716599	GO_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS	45	0.82713133	0.7453704	1	1.90301563	0.24875297
MODULE_46	c4.CM_ cancer modules	291	1.0758222	0.27161863	0.57175845	MODULE_46	321	1.0690898	0.3083083	0.8071073	2.144912	0.0067324
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN	C7_ immunologic signatures	154	1.0757233	0.30306748	0.57196146	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN	154	1.4278657	0.001020408	0.31705987	2.503589	-0.3521424
PID_INSULIN_PATHWAY	c2.CP_ Canonical pathways	44	1.0756359	0.34733894	0.57213354	PID_INSULIN_PATHWAY	45	0.6560247	0.93840986	1	1.7316606	0.4196112
GSE3982_NKCELL_VS_TH1_DN	C7_ immunologic signatures	179	1.0755038	0.3198573	0.5724385	GSE3982_NKCELL_VS_TH1_DN	178	0.96005213	0.6106014	0.9711636	2.03555593	0.11545167
GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN	C7_ immunologic signatures	180	1.075361	0.30210772	0.57278	GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN	185	1.1498332	0.18850806	0.6702431	2.2251942	-0.0744722
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN	C7_ immunologic signatures	165	1.0752869	0.30331755	0.57290906	GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN	171	0.9937901	0.5091093	0.9310706	2.069077	0.0814968
MODULE_367	c4.CM_ cancer modules	25	1.0751932	0.3595679	0.5731102	MODULE_367	28	-1.5951872	0.02173913	0.09328213	-0.519994	2.6703804
GSE30083_SP3_VS_SP4_THYMOCYTE_DN	C7_ immunologic signatures	166	1.0750613	0.29905438	0.5734219	GSE30083_SP3_VS_SP4_THYMOCYTE_DN	170	1.3827341	0.006072875	0.35528433	2.4577954	-0.3076728
KEGG_ADHERENS_JUNCTION	c2.CP_BIOCARTA_ BioCarta gene sets	66	1.0750514	0.33684212	0.5733588	KEGG_ADHERENS_JUNCTION	66	1.1117123	0.29235882	0.73512316	2.1867637	-0.0366609
GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP	C7_ immunologic signatures	180	1.0750493	0.31698564	0.57327074	GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP	180	0.9377543	0.65555555	0.99297255	2.0128036	0.137295
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	154	1.0750397	0.32168674	0.57320845	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	167	1.3421474	0.014271152	0.39291993	2.4171871	-0.2671077
GO_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	109	1.0750016	0.31145433	0.5732384	GO_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION	119	1.1273141	0.24871	0.71066767	2.2023157	-0.0523125
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	c2.CGP_ chemical and genetic perturbations	101	1.0749962	0.33333334	0.573159	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	108	0.7523478	0.89490443	1	1.827344	0.3226484
GO_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY	c5.BP_ GO biological process	148	1.0749922	0.3050239	0.5730753	GO_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY	153	0.6985074	0.97040814	1	1.7734996	0.3764848
CHR11P15	C1: positional gene sets	209	1.0749866	0.2974239	0.57299906	CHR11P15	226	0.9920668	0.53420526	0.9334163	2.0670534	0.0829198
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	c2.CGP_ chemical and genetic perturbations	54	1.0748514	0.33653846	0.57332844	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	57	0.92892736	0.6156388	0.99878675	2.00377876	0.14592404
GO_REGULATION_OF_EXCRETION	c5.BP_ GO biological process	21	1.0746373	0.37519872	0.5738949	GO_REGULATION_OF_EXCRETION	25	1.3484362	0.09022556	0.38339046	2.4230735	-0.2737989
GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP	C7_ immunologic signatures	151	1.0745947	0.32851985	0.5739276	GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP	154	1.2251264	0.07942974	0.54882884	2.2997211	-0.1505317
MORF_BCL2L11	c4.CGN_ cancer gene neighborhoods	129	1.0745584	0.31885856	0.5739426	MORF_BCL2L11	145	1.2231246	0.09081633	0.55143416	2.297683	-0.1485662
GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	154	1.0745137	0.32600734	0.5739884	GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	162	1.0882027	0.30784914	0.77343434	2.1627164	-0.013689
GROSS_HYPOXIA_VIA_ELK3_DN	c2.CGP_ chemical and genetic perturbations	146	1.0743498	0.31716418	0.57439995	GROSS_HYPOXIA_VIA_ELK3_DN	142	0.80095667	0.872449	1	1.87530647	0.27339313
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	c2.CGP_ chemical and genetic perturbations	253	1.0742934	0.28295454	0.5744875	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	256	1.0378299	0.40220663	0.8624395	2.1121233	0.0364635
CCANNAGRKGGC_UNKNOWN	c3.TFT_ transcription factor targets	98	1.0740645	0.32005313	0.5751031	CCANNAGRKGGC_UNKNOWN	104	1.2963486	0.061116964	0.44742554	2.3704131	-0.2222841
GO_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	22	1.0739694	0.35222054	0.5753041	GO_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS	23	0.9115501	0.62138367	1	1.9855195	0.1624193
MODULE_480	c4.CM_ cancer modules	78	1.0739318	0.31299734	0.5753275	MODULE_480	79	1.3753471	0.026427062	0.35697114	2.4492789	-0.3014153
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	c2.CGP_ chemical and genetic perturbations	324	1.0737349	0.2813187	0.57583755	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	331	1.291137	0.002004008	0.45648062	2.3648719	-0.2174021
GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP	C7_ immunologic signatures	146	1.0737299	0.31878787	0.5757589	GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP	171	1.1628221	0.16262627	0.6487743	2.236552	-0.0890922
KESHELAVA_MULTIPLE_DRUG_RESISTANCE	c2.CGP_ chemical and genetic perturbations	70	1.0736426	0.33682832	0.5759365	KESHELAVA_MULTIPLE_DRUG_RESISTANCE	71	0.95551425	0.5714286	0.9758142	2.02915685	0.11812835
GO_EXOCYST	c5.CC_ GO cellular component	17	1.0735911	0.3993994	0.57600063	GO_EXOCYST	17	1.1012851	0.3493976	0.7550989	2.1748762	-0.027694
GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN	C7_ immunologic signatures	174	1.0733633	0.31672597	0.5765925	GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN	180	0.87396854	0.7945344	1	1.94733184	0.19939476
GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_DN	C7_ immunologic signatures	168	1.073331	0.3085366	0.5765997	GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_DN	179	0.9781872	0.5487805	0.9518656	2.0515182	0.0951438
GO_MITOCHONDRIAL_GENOME_MAINTENANCE	c5.BP_ GO biological process	20	1.0732204	0.36187398	0.57684225	GO_MITOCHONDRIAL_GENOME_MAINTENANCE	20	0.9925819	0.49433962	0.93274456	2.0658023	0.0806385
GO_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING	c5.GO molecular function	21	1.0731989	0.3767661	0.57681257	GO_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING	23	1.3460444	0.083847106	0.38770044	2.4192433	-0.2728455
AAGGGAT_MIR188	c3.MIR_ microRNA targets	70	1.0731949	0.33977902	0.57673126	AAGGGAT_MIR188	71	0.9270483	0.59956235	1	2.0002432	0.1461466
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP	C7_ immunologic signatures	178	1.073127	0.31257343	0.5768499	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP	180	0.9693593	0.5784708	0.9619863	2.0424863	0.1037677
GENTILE_UV_HIGH_DOSE_DN	c2.CGP_ chemical and genetic perturbations	292	1.0730296	0.2935378	0.5770605	GENTILE_UV_HIGH_DOSE_DN	293	-1.3394136	0	0.2494344	-0.266384	2.4124432
ROZANOV_MMP14_TARGETS_SUBSET	c2.CGP_ chemical and genetic perturbations	30	1.0729752	0.36476043	0.5771321	ROZANOV_MMP14_TARGETS_SUBSET	31	0.6993508	0.89369595	1	1.772326	0.3736244
GO_PSEUDOPODIUM	c5.CC_ GO cellular component	15	1.0729614	0.3793651	0.57707596	GO_PSEUDOPODIUM	15	0.82451206	0.73368144	1	1.89747346	0.24844934
PAX4_03	c3.TFT_ transcription factor targets	224	1.0726545	0.31729668	0.57793593	PAX4_03	230	-1.1732975	0	0.41371742	-0.100643	2.245952
GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN	C7_ immunologic signatures	144	1.072597	0.2792683	0.57800865	GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN	147	1.7443526	0	0.06400055	2.8169496	-0.6717556
GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP	C7_ immunologic signatures	187	1.0725565	0.2991755	0.5780412	GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP	190	1.2893274	0.031313132	0.45870665	2.3618839	-0.2167709
GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP	C7_ immunologic signatures	150	1.072523	0.32134292	0.57804936	GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP	160	1.282751	0.041751526	0.4680807	2.355274	-0.210228
MODULE_492	c4.CM_ cancer modules	16	1.0724994	0.38694268	0.57802397	MODULE_492	17	1.1633945	0.27973858	0.6480207	2.2358939	-0.0908951
GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP	C7_ immunologic signatures	170	1.0724722	0.3172497	0.5780132	GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP	171	1.3510071	0.012133468	0.38453773	2.4234793	-0.2785349
GO_CIRCADIAN_RHYTHM	c5.BP_ GO biological process	122	1.0723915	0.31513646	0.5781691	GO_CIRCADIAN_RHYTHM	129	0.87626696	0.75	1	1.94865846	0.19612454
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN	C7_ immunologic signatures	184	1.0723885	0.30565584	0.5780834	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN	184	0.6985972	0.96862346	1	1.7709857	0.3737913
CHR14Q12	C1: positional gene sets	18	1.0722967	0.3773292	0.57827103	CHR14Q12	19	-1.2648654	0.14159292	0.31097466	-0.1925687	2.3371621
GTCTTCC_MIR7	c3.MIR_ microRNA targets	152	1.0722882	0.31572482	0.5782041	GTCTTCC_MIR7	153	0.75636566	0.910387	1	1.82865386	0.31592254
ACACTGG_MIR199A_MIR199B	c3.MIR_ microRNA targets	143	1.0722438	0.32808718	0.5782484	ACACTGG_MIR199A_MIR199B	144	0.85608333	0.7991675	1	1.92832713	0.21616047
GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN	C7_ immunologic signatures	93	1.0720264	0.3148148	0.57883745	GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN	100	0.75075084	0.9020021	1	1.82277724	0.32127556
AAGCAAT_MIR137	c3.MIR_ microRNA targets	197	1.0720117	0.304142	0.5787869	AAGCAAT_MIR137	204	0.8649943	0.82092553	1	1.937006	0.2070174
GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP	C7_ immunologic signatures	188	1.0719845	0.3274648	0.57877165	GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP	189	0.6597903	0.9909091	1	1.7317748	0.4121942
PID_MYC_REPRESS_PATHWAY	c2.CP_ Canonical pathways	59	1.0719157	0.35285914	0.5788857	PID_MYC_REPRESS_PATHWAY	58	0.89975744	0.6659341	1	1.97167314	0.17215826
LIM_MAMMARY_LUMINAL_MATURE_UP	c2.CGP_ chemical and genetic perturbations	93	1.0718763	0.308094	0.57891536	LIM_MAMMARY_LUMINAL_MATURE_UP	100	1.2245653	0.12785862	0.5496869	2.2964416	-0.152689
GO_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION	c5.BP_ GO biological process	135	1.0718323	0.32439023	0.5789611	GO_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION	138	-0.8418921	0.85	0.8734798	0.2299402	1.9137244
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	c2.CGP_ chemical and genetic perturbations	196	1.071794	0.31321186	0.5789721	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	200	1.3204625	0.010050251	0.4117369	2.3922565	-0.2486685
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	176	1.0717901	0.31603774	0.5788881	GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN	177	0.61561596	0.9969481	1	1.68740606	0.45617414
CCTNTMAGA_UNKNOWN	c3.TFT_ transcription factor targets	108	1.0716991	0.32603094	0.5790676	CCTNTMAGA_UNKNOWN	109	1.1100762	0.27357513	0.73766404	2.1817753	-0.0383771
GO_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.BP_ GO biological process	37	1.0716503	0.3472023	0.5791252	GO_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	38	1.1080621	0.32908458	0.74111515	2.1797124	-0.0364118
GO_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES	c5.BP_ GO biological process	170	1.0715722	0.2995283	0.57927316	GO_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES	177	1.1018544	0.2611336	0.7539057	2.1734266	-0.0302822
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP	C7_ immunologic signatures	158	1.0715706	0.3158522	0.579181	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP	163	1.1072431	0.24493927	0.7422235	2.1788137	-0.0356725
MODULE_179	c4.CM_ cancer modules	383	1.0715537	0.29122055	0.5791395	MODULE_179	392	1.1754287	0.052	0.62821645	2.2469824	-0.103875
MODULE_427	c4.CM_ cancer modules	96	1.0715513	0.35826772	0.57904935	MODULE_427	97	1.3395121	0.03911205	0.39665633	2.4110634	-0.2679608
GO_SARCOPLASM	c5.CC_ GO cellular component	61	1.0714884	0.36565098	0.57915163	GO_SARCOPLASM	61	1.4467852	0.01748634	0.2946778	2.5182736	-0.3752968
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP	C7_ immunologic signatures	158	1.0714866	0.31976047	0.5790615	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP	170	1.1435399	0.18466195	0.6836516	2.2150265	-0.0720533
GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	C7_ immunologic signatures	167	1.0714846	0.30687204	0.5789731	GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	172	0.89405936	0.7390863	1	1.96554396	0.17742524
GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP	C7_ immunologic signatures	148	1.0713552	0.3265306	0.57926834	GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP	150	1.2112304	0.09155646	0.57529527	2.2825856	-0.1398752
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	122	1.0712767	0.3279503	0.57941425	GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP	127	1.2997869	0.034836065	0.4430382	2.3710636	-0.2285102
GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP	C7_ immunologic signatures	169	1.0711703	0.31917477	0.5796457	GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP	178	1.4331692	0.003042596	0.31305102	2.5043395	-0.3619989
GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP	C7_ immunologic signatures	183	1.071129	0.32619047	0.5796783	GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP	187	0.7214529	0.9707366	1	1.7925819	0.3496761
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	c2.CP_BIOCARTA_ BioCarta gene sets	71	1.0710821	0.3211382	0.57972664	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	72	1.6477005	0	0.1173848	2.7187826	-0.5766184
GO_AMINO_ACID_TRANSPORT	c5.BP_ GO biological process	112	1.0710075	0.31524548	0.5798625	GO_AMINO_ACID_TRANSPORT	119	1.1854333	0.16202271	0.61360806	2.2564408	-0.1144258
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	179	1.0709819	0.33333334	0.57985127	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	178	0.8112435	0.87436676	1	1.8822254	0.2597384
GO_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION	c5.BP_ GO biological process	46	1.0709759	0.33095577	0.5797727	GO_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION	48	-0.9735639	0.47272727	0.72349364	0.097412	2.0445398
GO_STRIATED_MUSCLE_CONTRACTION	c5.BP_ GO biological process	86	1.0709625	0.34185734	0.57971805	GO_STRIATED_MUSCLE_CONTRACTION	92	1.5787917	0	0.1827804	2.6497542	-0.5078292
GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP	C7_ immunologic signatures	182	1.0709157	0.31807512	0.579763	GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP	182	0.7214862	0.964539	1	1.7924019	0.3494295
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP	C7_ immunologic signatures	178	1.0706505	0.31680775	0.58049166	GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP	178	0.71573853	0.97067744	1	1.78638903	0.35491197
SENESE_HDAC1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	392	1.070554	0.2748663	0.5806833	SENESE_HDAC1_TARGETS_UP	398	0.6885853	0.998999	1	1.7591393	0.3819687
GSE3982_MAST_CELL_VS_MAC_DN	C7_ immunologic signatures	165	1.0705459	0.3261391	0.58061767	GSE3982_MAST_CELL_VS_MAC_DN	170	1.2193125	0.0841785	0.5562363	2.2898584	-0.1487666
GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN	C7_ immunologic signatures	168	1.0705324	0.32258064	0.580566	GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN	176	1.1900256	0.1177665	0.60507536	2.260558	-0.1194932
GO_RESPONSE_TO_LEAD_ION	c5.BP_ GO biological process	19	1.0704688	0.38841566	0.5806711	GO_RESPONSE_TO_LEAD_ION	18	0.79878485	0.7539267	1	1.86925365	0.27168395
GO_ORGANELLE_DISASSEMBLY	c5.BP_ GO biological process	162	1.0704594	0.31967214	0.5806052	GO_ORGANELLE_DISASSEMBLY	165	0.7905864	0.89847714	1	1.8610458	0.279873
GO_CORE_PROMOTER_PROXIMAL_REGION_DNA_BINDING	c5.GO molecular function	292	1.0704064	0.28932893	0.58067274	GO_CORE_PROMOTER_PROXIMAL_REGION_DNA_BINDING	317	0.859739	0.8588589	1	1.9301454	0.2106674
GSE17721_LPS_VS_CPG_1H_BMDC_DN	C7_ immunologic signatures	172	1.070066	0.3016627	0.5816278	GSE17721_LPS_VS_CPG_1H_BMDC_DN	180	1.185078	0.119796954	0.61343247	2.255144	-0.115012
GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP	C7_ immunologic signatures	163	1.0698271	0.32071006	0.58225924	GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP	168	1.3220977	0.021384928	0.4110102	2.3919248	-0.2522706
LABBE_TGFB1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	87	1.0698051	0.3453145	0.58223253	LABBE_TGFB1_TARGETS_DN	96	1.2451637	0.09384776	0.51894295	2.3149688	-0.1753586
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN	C7_ immunologic signatures	177	1.0697911	0.3200483	0.58218116	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN	178	0.711267	0.97154474	1	1.7810581	0.3585241
GO_LIPID_TRANSPORTER_ACTIVITY	c5.GO molecular function	90	1.0697465	0.332021	0.5822165	GO_LIPID_TRANSPORTER_ACTIVITY	94	1.1321377	0.23467231	0.7025033	2.2018842	-0.0623912
MORF_SUPT3H	c4.CGN_ cancer gene neighborhoods	255	1.0697062	0.2931229	0.5822468	MORF_SUPT3H	273	1.3663768	0.002006018	0.37107778	2.436083	-0.2966706
GSE30083_SP2_VS_SP3_THYMOCYTE_DN	C7_ immunologic signatures	174	1.0696474	0.30898204	0.58234215	GSE30083_SP2_VS_SP3_THYMOCYTE_DN	177	0.93073756	0.6855984	0.99843717	2.00038496	0.13890984
GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	143	1.0695236	0.3257485	0.5826283	GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	145	1.1535964	0.19348268	0.6626119	2.22312	-0.0840728
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	c2.CGP_ chemical and genetic perturbations	378	1.069486	0.28755364	0.5826535	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	391	1.479294	0	0.26996914	2.54878	-0.409808
GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN	C7_ immunologic signatures	180	1.0694224	0.3298611	0.58275586	GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN	182	0.89628726	0.73493975	1	1.96570966	0.17313514
GO_MONOOXYGENASE_ACTIVITY	c5.GO molecular function	67	1.0692123	0.36503497	0.5833329	GO_MONOOXYGENASE_ACTIVITY	73	1.4929836	0.01191766	0.25854892	2.5621959	-0.4237713
GYORFFY_DOXORUBICIN_RESISTANCE	c2.CGP_ chemical and genetic perturbations	44	1.0691518	0.37553343	0.583418	GYORFFY_DOXORUBICIN_RESISTANCE	44	1.5457385	0.008036739	0.20827523	2.6148903	-0.4765867
GO_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	1.068908	0.35893154	0.584067	GO_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS	15	-1.4493107	0.083333336	0.17395623	-0.3804027	2.5182187
MIKKELSEN_IPS_LCP_WITH_H3K4ME3	c2.CGP_ chemical and genetic perturbations	146	1.0688925	0.32552403	0.58401924	MIKKELSEN_IPS_LCP_WITH_H3K4ME3	154	1.5428265	0	0.21073121	2.611719	-0.473934
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	c2.CP_REACTOME_ Reactome gene sets	15	1.0688508	0.38202247	0.5840558	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	16	0.8734257	0.6763158	1	1.9422765	0.1954251
GO_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION	c5.BP_ GO biological process	35	1.0686083	0.36585367	0.5847184	GO_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION	39	1.4095459	0.045191195	0.32656127	2.4781542	-0.3409376
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	81	1.0685781	0.34640524	0.584717	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	86	1.2855424	0.08537887	0.46276265	2.3541205	-0.2169643
MODULE_287	c4.CM_ cancer modules	43	1.0683479	0.36312056	0.58533674	MODULE_287	47	1.0528588	0.41865757	0.83619094	2.1212067	0.0154891
GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP	C7_ immunologic signatures	157	1.0681688	0.32374102	0.5857913	GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP	178	1.3417925	0.009146341	0.39368048	2.4099613	-0.2736237
GCNP_SHH_UP_EARLY.V1_DN	C6_ oncogenic signatures	143	1.0679916	0.30666667	0.58623964	GCNP_SHH_UP_EARLY.V1_DN	149	1.1809751	0.13061224	0.6214171	2.2489667	-0.1129835
CHEBOTAEV_GR_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	70	1.0679888	0.34924966	0.58615243	CHEBOTAEV_GR_TARGETS_UP	73	0.9689241	0.5562841	0.9622977	2.0369129	0.0990647
GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN	C7_ immunologic signatures	165	1.0679878	0.32147095	0.58605987	GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN	173	1.3955833	0.001019368	0.34699512	2.4635711	-0.3275955
FREAC3_01	c3.TFT_ transcription factor targets	209	1.0679742	0.3148358	0.58600765	FREAC3_01	218	0.91714513	0.72004026	1	1.98511933	0.15082907
GSE17721_0.5H_VS_4H_LPS_BMDC_DN	C7_ immunologic signatures	173	1.0679615	0.32093024	0.5859481	GSE17721_0.5H_VS_4H_LPS_BMDC_DN	176	1.21905	0.08056395	0.5564438	2.2870115	-0.1510885
HALLMARK_NOTCH_SIGNALING	H_ hallmark gene sets	32	1.0677851	0.35338345	0.5864036	HALLMARK_NOTCH_SIGNALING	32	1.1600691	0.25339925	0.6521798	2.2278542	-0.092284
GSE22033_WT_VS_PPARG_KO_MEF_UP	C7_ immunologic signatures	167	1.0677395	0.3265306	0.5864515	GSE22033_WT_VS_PPARG_KO_MEF_UP	171	1.2072418	0.104462475	0.5806541	2.2749813	-0.1395023
GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN	C7_ immunologic signatures	173	1.0677001	0.2960688	0.5864738	GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN	173	1.0631492	0.34751773	0.81676626	2.1308493	0.0045509
DOANE_BREAST_CANCER_ESR1_UP	c2.CGP_ chemical and genetic perturbations	90	1.0676584	0.3559097	0.5865043	DOANE_BREAST_CANCER_ESR1_UP	98	1.1520272	0.21548118	0.6661553	2.2196856	-0.0843688
GO_LEUKOCYTE_ACTIVATION	c5.BP_ GO biological process	348	1.067638	0.29166666	0.5864691	GO_LEUKOCYTE_ACTIVATION	367	1.0499601	0.348	0.8403434	2.1175981	0.0176779
GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN	C7_ immunologic signatures	174	1.0675743	0.33413175	0.58657527	GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN	180	0.6558387	0.98778003	1	1.723413	0.4117356
GO_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS	c5.BP_ GO biological process	16	1.0675012	0.3789809	0.5867075	GO_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS	19	-1.4464036	0.078341015	0.17604026	-0.3789024	2.5139048
GU_PDEF_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	35	1.0674663	0.35302594	0.5867189	GU_PDEF_TARGETS_DN	36	0.9854532	0.5300926	0.94136757	2.0529195	0.0820131
GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN	C7_ immunologic signatures	166	1.0672528	0.3412604	0.58728033	GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN	172	0.85662156	0.8058943	1	1.92387436	0.21063124
REACTOME_DEVELOPMENTAL_BIOLOGY	c2.CP_REACTOME_ Reactome gene sets	363	1.0671736	0.28478965	0.58743507	REACTOME_DEVELOPMENTAL_BIOLOGY	366	0.94648457	0.68	0.9856816	2.01365817	0.12068903
MODULE_301	c4.CM_ cancer modules	123	1.0669754	0.32456142	0.58794415	MODULE_301	130	1.3389903	0.024973985	0.39683816	2.4059657	-0.2720149
ROME_INSULIN_TARGETS_IN_MUSCLE_DN	c2.CGP_ chemical and genetic perturbations	154	1.0669552	0.33210784	0.5879123	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	161	1.3854293	0.009118541	0.3502981	2.4523845	-0.3184741
CHR7Q34	C1: positional gene sets	33	1.0669342	0.35135135	0.5878846	CHR7Q34	40	0.85332024	0.70989764	1	1.92025444	0.21361396
GSE2706_R848_VS_LPS_8H_STIM_DC_UP	C7_ immunologic signatures	115	1.0669082	0.32010242	0.5878747	GSE2706_R848_VS_LPS_8H_STIM_DC_UP	125	1.196762	0.13669065	0.59695864	2.2636702	-0.1298538
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	c2.CP_REACTOME_ Reactome gene sets	77	1.0668566	0.34501347	0.58793	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	80	1.2481016	0.12179487	0.51456594	2.3149582	-0.181245
GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP	C7_ immunologic signatures	181	1.0668136	0.32164448	0.5879642	GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP	184	1.237008	0.062374245	0.5306817	2.3038216	-0.1701944
GO_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT	c5.BP_ GO biological process	241	1.0667135	0.3115693	0.58817303	GO_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT	253	1.011733	0.47047046	0.9042678	2.0784465	0.0549805
GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN	C7_ immunologic signatures	175	1.0665213	0.34389672	0.5886772	GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN	176	1.071141	0.33400604	0.8032141	2.1376623	-0.0046197
GRYDER_PAX3FOXO1_TOP_ENHANCERS	c2.CGP_ chemical and genetic perturbations	409	1.0661436	0.28898582	0.58979076	GRYDER_PAX3FOXO1_TOP_ENHANCERS	414	0.9596806	0.6416416	0.9708441	2.0258242	0.106463
LEE_DOUBLE_POLAR_THYMOCYTE	c2.CGP_ chemical and genetic perturbations	24	1.0660632	0.37597504	0.589944	LEE_DOUBLE_POLAR_THYMOCYTE	24	0.97394824	0.5205128	0.95678383	2.04001144	0.09211496
GO_PHOSPHOLIPASE_ACTIVITY	c5.GO molecular function	80	1.0659963	0.34794158	0.59005606	GO_PHOSPHOLIPASE_ACTIVITY	90	1.3755885	0.021119324	0.3568047	2.4415848	-0.3095922
GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	C7_ immunologic signatures	159	1.0659267	0.32159624	0.59018046	GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	162	0.92043227	0.6751269	1	1.98635897	0.14549443
ACTGTAG_MIR139	c3.MIR_ microRNA targets	116	1.0656265	0.3372093	0.5910069	ACTGTAG_MIR139	117	-1.1693504	0.1	0.41797268	-0.1037239	2.2349769
GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP	C7_ immunologic signatures	175	1.0656054	0.3254717	0.59097195	GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP	178	0.6829548	0.98785424	1	1.7485602	0.3826506
GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP	C7_ immunologic signatures	164	1.0656025	0.33530107	0.59088427	GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP	170	1.0977705	0.28600407	0.7594413	2.163373	-0.032168
AP4_01	c3.TFT_ transcription factor targets	220	1.0655798	0.31609195	0.5908544	AP4_01	232	1.1646577	0.12145749	0.64614457	2.2302375	-0.0990779
GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	C7_ immunologic signatures	171	1.0655686	0.32101616	0.5907933	GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	176	0.7274802	0.9447853	1	1.7930488	0.3380884
GO_GLOMERULUS_DEVELOPMENT	c5.BP_ GO biological process	48	1.0654792	0.35344827	0.5909703	GO_GLOMERULUS_DEVELOPMENT	47	1.2430904	0.14910313	0.5227628	2.3085696	-0.1776112
GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP	C7_ immunologic signatures	188	1.0654677	0.3270809	0.59090984	GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP	187	0.76713985	0.9344758	1	1.83260755	0.29832785
GO_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION	c5.BP_ GO biological process	32	1.0654466	0.37463126	0.5908795	GO_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION	34	-1.3516597	0.08163265	0.2416263	-0.2862131	2.4171063
GO_GAMMA_TUBULIN_BINDING	c5.GO molecular function	23	1.0654274	0.3718141	0.5908434	GO_GAMMA_TUBULIN_BINDING	23	1.1553606	0.27590513	0.6616877	2.220788	-0.0899332
DE_YY1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	87	1.065386	0.34889755	0.59087634	DE_YY1_TARGETS_DN	88	0.93231386	0.6246023	0.9977726	1.99769986	0.13307214
GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_CELLULAR_RESPONSE_TO_CHEMICAL_STIMULUS	c5.BP_ GO biological process	25	1.0652649	0.3798799	0.5911468	GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_CELLULAR_RESPONSE_TO_CHEMICAL_STIMULUS	25	0.71873283	0.85254025	1	1.78399773	0.34653207
GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP	C7_ immunologic signatures	147	1.0652615	0.30984205	0.59105986	GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP	152	1.2910142	0.034517765	0.4567292	2.3562757	-0.2257527
CTGTTAC_MIR194	c3.MIR_ microRNA targets	95	1.0652493	0.34862384	0.5910011	CTGTTAC_MIR194	96	0.91732985	0.65961945	1	1.98257915	0.14791945
GSE3982_BCELL_VS_BASOPHIL_DN	C7_ immunologic signatures	168	1.0652449	0.3262159	0.59091985	GSE3982_BCELL_VS_BASOPHIL_DN	169	1.0960981	0.27575758	0.7628591	2.161343	-0.0308532
GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN	C7_ immunologic signatures	178	1.0651797	0.32900944	0.5910231	GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN	179	0.8793388	0.77732795	1	1.9445185	0.1858409
GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP	C7_ immunologic signatures	160	1.065127	0.32762837	0.59109294	GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP	163	0.90499383	0.70385396	1	1.97012083	0.16013317
GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP	C7_ immunologic signatures	174	1.0649883	0.32619047	0.59142834	GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP	177	0.64006823	0.98985803	1	1.70505653	0.42492007
CTCTGGA_MIR520A_MIR525	c3.MIR_ microRNA targets	143	1.0649604	0.32023808	0.5914133	CTCTGGA_MIR520A_MIR525	144	0.8100983	0.8489796	1	1.8750587	0.2548621
GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN	C7_ immunologic signatures	171	1.0649549	0.34340993	0.5913321	GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN	177	1.0527128	0.38967612	0.83636844	2.1176677	0.0122421
GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN	C7_ immunologic signatures	181	1.0649085	0.33096084	0.5913836	GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN	182	1.0459955	0.3902932	0.84714997	2.110904	0.018913
GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN	C7_ immunologic signatures	170	1.0648966	0.3297619	0.59132516	GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN	176	0.7672802	0.93061227	1	1.8321768	0.2976164
GO_NEUROPEPTIDE_RECEPTOR_BINDING	c5.GO molecular function	16	1.064843	0.37616098	0.5913999	GO_NEUROPEPTIDE_RECEPTOR_BINDING	23	1.2954495	0.13151364	0.44909865	2.3602925	-0.2306065
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	131	1.0647703	0.33212122	0.5915276	GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP	136	1.0202669	0.4396728	0.89115584	2.0850372	0.0445034
GO_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS	c5.BP_ GO biological process	352	1.0647491	0.30576715	0.59149414	GO_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS	361	0.78679127	0.96693385	1	1.85154037	0.27795783
MODULE_41	c4.CM_ cancer modules	431	1.0647347	0.29049677	0.5914402	MODULE_41	479	1.3949665	0	0.3457185	2.4597012	-0.3302318
GATA6_01	c3.TFT_ transcription factor targets	221	1.0646243	0.33673468	0.5916839	GATA6_01	238	1.1932373	0.08165322	0.5999816	2.2578616	-0.128613
GO_LIMBIC_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	86	1.064196	0.3351135	0.59291	GO_LIMBIC_SYSTEM_DEVELOPMENT	95	0.7255952	0.93121696	1	1.7897912	0.3386008
CTGYNNCTYTAA_UNKNOWN	c3.TFT_ transcription factor targets	81	1.0641309	0.35900784	0.59301794	CTGYNNCTYTAA_UNKNOWN	80	0.97701514	0.53601694	0.952999	2.04114604	0.08711576
LEE_NEURAL_CREST_STEM_CELL_UP	c2.CGP_ chemical and genetic perturbations	130	1.0640962	0.33291772	0.5930296	LEE_NEURAL_CREST_STEM_CELL_UP	132	0.75392205	0.9154639	1	1.81801825	0.31017415
GCTNWTTGK_UNKNOWN	c3.TFT_ transcription factor targets	262	1.0640268	0.32881355	0.59314924	GCTNWTTGK_UNKNOWN	276	0.9442462	0.68405217	0.9880457	2.008273	0.1197806
CHR18Q21	C1: positional gene sets	61	1.0639255	0.3650568	0.59336823	CHR18Q21	67	1.0309932	0.43090317	0.87418085	2.0949187	0.0329323
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	c2.CGP_ chemical and genetic perturbations	149	1.063876	0.33333334	0.59342045	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	152	0.9571967	0.60223806	0.97455615	2.0210727	0.1066793
GSE360_CTRL_VS_L_MAJOR_DC_DN	C7_ immunologic signatures	170	1.0638261	0.31839624	0.5934789	GSE360_CTRL_VS_L_MAJOR_DC_DN	170	1.133496	0.21530612	0.70053726	2.1973221	-0.0696699
GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	95	1.0637954	0.36925098	0.59347063	GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN	97	1.0668876	0.36469343	0.8115981	2.130683	-0.0030922
GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP	C7_ immunologic signatures	169	1.0637497	0.33580247	0.59351903	GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP	170	0.6361788	0.99393326	1	1.6999285	0.4275709
GO_REGULATION_OF_FIBROBLAST_MIGRATION	c5.BP_ GO biological process	27	1.0635287	0.3723077	0.59410006	GO_REGULATION_OF_FIBROBLAST_MIGRATION	27	1.2208023	0.2094176	0.55440223	2.284331	-0.1572736
GO_POSITIVE_REGULATION_OF_LYASE_ACTIVITY	c5.BP_ GO biological process	43	1.0635101	0.36390102	0.5940632	GO_POSITIVE_REGULATION_OF_LYASE_ACTIVITY	50	1.6779464	0.001137656	0.093653284	2.7414565	-0.6144363
GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	180	1.0632817	0.3290993	0.59468436	GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN	181	0.88582224	0.76992935	1	1.94910394	0.17745946
BIOCARTA_P38MAPK_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	38	1.0630124	0.3903819	0.5954314	BIOCARTA_P38MAPK_PATHWAY	38	1.0035174	0.46690735	0.9173069	2.0665298	0.059495
GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN	C7_ immunologic signatures	148	1.0628896	0.32718328	0.5957171	GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN	156	1.2067509	0.10183299	0.580753	2.2696405	-0.1438613
GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN	C7_ immunologic signatures	176	1.0627717	0.3349001	0.5960007	GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN	178	1.1154221	0.23458038	0.72962576	2.1781938	-0.0526504
MODULE_113	c4.CM_ cancer modules	81	1.0627017	0.356	0.59611887	MODULE_113	95	1.223504	0.1328452	0.5507668	2.2862057	-0.1608023
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN	C7_ immunologic signatures	157	1.0626808	0.33491126	0.5960894	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN	164	1.1917434	0.11408016	0.6038825	2.2544242	-0.1290626
GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	C7_ immunologic signatures	167	1.062529	0.33524683	0.5964731	GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	173	0.85172486	0.81707317	1	1.91425386	0.21080414
WANG_CISPLATIN_RESPONSE_AND_XPC_DN	c2.CGP_ chemical and genetic perturbations	205	1.0624583	0.33449075	0.5966027	WANG_CISPLATIN_RESPONSE_AND_XPC_DN	208	0.72924536	0.96471775	1	1.79170366	0.33321294
GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP	C7_ immunologic signatures	162	1.0624378	0.34554335	0.59656626	GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP	170	1.0228333	0.45	0.8869014	2.0852711	0.0396045
GO_GLUCURONOSYLTRANSFERASE_ACTIVITY	c5.GO molecular function	21	1.0624088	0.3846154	0.5965654	GO_GLUCURONOSYLTRANSFERASE_ACTIVITY	22	0.4926837	0.9898219	1	1.5550925	0.5697251
GO_DIVALENT_INORGANIC_CATION_HOMEOSTASIS	c5.BP_ GO biological process	272	1.0624067	0.30596176	0.59647506	GO_DIVALENT_INORGANIC_CATION_HOMEOSTASIS	304	1.2541648	0.028056113	0.50323135	2.3165715	-0.1917581
PRC1_BMI_UP.V1_DN	C6_ oncogenic signatures	144	1.0623847	0.34170854	0.5964428	PRC1_BMI_UP.V1_DN	157	1.2319787	0.08213552	0.53672564	2.2943634	-0.169594
GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP	C7_ immunologic signatures	170	1.0623558	0.3345281	0.5964399	GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP	177	1.3920525	0.002028398	0.34627193	2.4544083	-0.3296967
GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	C7_ immunologic signatures	166	1.0622884	0.32634032	0.5965496	GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	178	1.0660336	0.3491903	0.8122167	2.128322	-0.0037452
BIOCARTA_NTHI_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	1.0621284	0.37019968	0.59695417	BIOCARTA_NTHI_PATHWAY	22	1.1337147	0.33123425	0.7005258	2.1958431	-0.0715863
DEMAGALHAES_AGING_UP	c2.CGP_ chemical and genetic perturbations	45	1.0621042	0.37175792	0.5969337	DEMAGALHAES_AGING_UP	47	1.0218711	0.45317918	0.8890212	2.0839753	0.0402331
GO_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS	c5.BP_ GO biological process	16	1.0620981	0.38618523	0.59685546	GO_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS	16	0.6190237	0.9265464	1	1.6811218	0.4430744
AR_02	c3.TFT_ transcription factor targets	32	1.0620679	0.37331334	0.59685415	AR_02	33	0.6901445	0.9020071	1	1.7522124	0.3719234
PAX4_02	c3.TFT_ transcription factor targets	199	1.0620286	0.33139536	0.5968804	PAX4_02	208	1.1289814	0.1875	0.70740575	2.19101	-0.0669528
GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	151	1.0620126	0.36773428	0.5968315	GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	154	0.97816485	0.53720695	0.95168024	2.04017745	0.08384775
GO_POSITIVE_REGULATION_OF_BEHAVIOR	c5.BP_ GO biological process	18	1.061781	0.37919462	0.59745514	GO_POSITIVE_REGULATION_OF_BEHAVIOR	19	0.82633466	0.7365662	1	1.88811566	0.23544634
GO_LIPASE_ACTIVITY	c5.GO molecular function	97	1.0617713	0.35558408	0.597389	GO_LIPASE_ACTIVITY	105	1.35095	0.029473685	0.38444275	2.4127213	-0.2891787
GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN	C7_ immunologic signatures	149	1.061654	0.33414045	0.5976547	GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN	154	1.0477736	0.38900203	0.84372073	2.1094276	0.0138804
MODULE_147	c4.CM_ cancer modules	101	1.061572	0.33846155	0.59780955	MODULE_147	101	0.70348305	0.945629	1	1.76505505	0.35808895
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	c2.CGP_ chemical and genetic perturbations	28	1.0614727	0.3797277	0.5980131	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	29	0.84293914	0.6972256	1	1.90441184	0.21853356
GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP	C7_ immunologic signatures	179	1.061389	0.31753555	0.5981759	GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP	178	0.7232335	0.9533941	1	1.7846225	0.3381555
SHI_SPARC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	22	1.0612925	0.3742236	0.5983829	SHI_SPARC_TARGETS_UP	24	1.4838388	0.023399014	0.26539236	2.5451313	-0.4225463
GSE39556_CD8A_DC_VS_NK_CELL_DN	C7_ immunologic signatures	172	1.0610697	0.32635468	0.59896713	GSE39556_CD8A_DC_VS_NK_CELL_DN	175	1.046494	0.3897281	0.8458879	2.1075637	0.0145757
GO_POSITIVE_REGULATION_OF_NEURON_DEATH	c5.BP_ GO biological process	61	1.0609202	0.3533424	0.59934086	GO_POSITIVE_REGULATION_OF_NEURON_DEATH	64	0.9024562	0.6552106	1	1.9633764	0.158464
MODULE_195	c4.CM_ cancer modules	138	1.0606282	0.34686348	0.600142	MODULE_195	140	0.48921394	1	1	1.54984214	0.57141426
KRAS.600.LUNG.BREAST_UP.V1_UP	C6_ oncogenic signatures	204	1.0605587	0.32400933	0.60025525	KRAS.600.LUNG.BREAST_UP.V1_UP	221	1.1929862	0.08459215	0.60038286	2.2535449	-0.1324275
GSE45365_CD8A_DC_VS_CD11B_DC_UP	C7_ immunologic signatures	161	1.0605103	0.32451922	0.60031295	GSE45365_CD8A_DC_VS_CD11B_DC_UP	165	0.86749977	0.7865854	1	1.92801007	0.19301053
GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN	C7_ immunologic signatures	167	1.0605035	0.34875444	0.60023695	GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN	171	0.9957705	0.52129817	0.9296376	2.056274	0.064733
GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP	C7_ immunologic signatures	172	1.060432	0.34241706	0.6003573	GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP	177	0.75708234	0.94153225	1	1.81751434	0.30334966
GO_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	1.0604056	0.38486314	0.6003396	GO_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS	15	-0.7838072	0.7804878	0.9183841	0.2765984	1.8442128
BIOCARTA_ARF_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	1.0603762	0.38449368	0.6003337	BIOCARTA_ARF_PATHWAY	16	0.9371663	0.5869281	0.9930967	1.9975425	0.1232099
RAMALHO_STEMNESS_DN	c2.CGP_ chemical and genetic perturbations	64	1.0602081	0.35397038	0.6007494	RAMALHO_STEMNESS_DN	64	1.4493397	0.014380531	0.29138133	2.5095478	-0.3891316
GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP	C7_ immunologic signatures	140	1.0601976	0.3585608	0.6006893	GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP	149	1.1461635	0.17802645	0.6765829	2.2063611	-0.0859659
DASU_IL6_SIGNALING_SCAR_DN	c2.CGP_ chemical and genetic perturbations	16	1.0601839	0.38658148	0.6006337	DASU_IL6_SIGNALING_SCAR_DN	16	0.7792442	0.7733161	1	1.8394281	0.2809397
GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN	C7_ immunologic signatures	168	1.0601628	0.3321513	0.60059834	GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN	172	1.2345067	0.06014271	0.53432107	2.2946695	-0.1743439
FOSTER_KDM1A_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	191	1.060139	0.3297619	0.600574	FOSTER_KDM1A_TARGETS_DN	193	0.794808	0.91129035	1	1.854947	0.265331
GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_UP	C7_ immunologic signatures	171	1.0600922	0.34642032	0.6006201	GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_UP	175	1.2896302	0.036437247	0.45821166	2.3497224	-0.229538
GO_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	53	1.0600739	0.37412095	0.600581	GO_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT	57	1.133035	0.28349945	0.7010037	2.1931089	-0.0729611
GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP	C7_ immunologic signatures	173	1.0599321	0.34204274	0.6009173	GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP	181	0.800258	0.9030303	1	1.8601901	0.2596741
SMITH_TERT_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	79	1.0598204	0.3355526	0.6011698	SMITH_TERT_TARGETS_DN	81	1.3387024	0.056902003	0.3967611	2.3985228	-0.278882
GSE27786_CD4_TCELL_VS_NKTCELL_UP	C7_ immunologic signatures	185	1.0598056	0.3236659	0.6011227	GSE27786_CD4_TCELL_VS_NKTCELL_UP	188	0.7103297	0.9678715	1	1.7701353	0.3494759
GO_REGULATION_OF_HORMONE_LEVELS	c5.BP_ GO biological process	377	1.0596716	0.32289416	0.6014392	GO_REGULATION_OF_HORMONE_LEVELS	416	1.1838094	0.036	0.61641645	2.243481	-0.1241378
GO_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	94	1.0596328	0.34895834	0.601459	GO_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS	94	0.8093826	0.8261328	1	1.8690154	0.2502502
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN	C7_ immunologic signatures	131	1.0596203	0.34188035	0.6014011	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN	136	1.4397335	0.002059732	0.3045262	2.4993538	-0.3801132
TTCYNRGAA_STAT5B_01	c3.TFT_ transcription factor targets	286	1.0595753	0.3107221	0.6014406	TTCYNRGAA_STAT5B_01	292	1.0977001	0.22244489	0.7594431	2.1572754	-0.0381248
GNF2_AF1Q	c4.CGN_ cancer gene neighborhoods	24	1.0595701	0.381317	0.601359	GNF2_AF1Q	24	1.1972358	0.21305418	0.5970583	2.2568059	-0.1376657
GO_NEGATIVE_REGULATION_OF_TRANSPORT	c5.BP_ GO biological process	376	1.0595279	0.3116883	0.6013962	GO_NEGATIVE_REGULATION_OF_TRANSPORT	409	1.1289545	0.11911912	0.70736295	2.1884824	-0.0694266
GO_ERROR_PRONE_TRANSLESION_SYNTHESIS	c5.BP_ GO biological process	18	1.0595219	0.3877551	0.6013176	GO_ERROR_PRONE_TRANSLESION_SYNTHESIS	18	-0.98902977	0.46636772	0.70368165	0.07049213	2.04855167
GO_POSITIVE_REGULATION_OF_VASODILATION	c5.BP_ GO biological process	23	1.0594577	0.37384614	0.60141057	GO_POSITIVE_REGULATION_OF_VASODILATION	29	1.4789349	0.023584906	0.26994544	2.5383926	-0.4194772
GSE17721_CTRL_VS_LPS_8H_BMDC_DN	C7_ immunologic signatures	175	1.0594444	0.352657	0.6013552	GSE17721_CTRL_VS_LPS_8H_BMDC_DN	179	1.0866851	0.2994924	0.77549946	2.1461295	-0.0272407
GRATIAS_RETINOBLASTOMA_16Q24	c2.CGP_ chemical and genetic perturbations	15	1.0594256	0.40286624	0.6013157	GRATIAS_RETINOBLASTOMA_16Q24	15	0.8208684	0.7168831	1	1.880294	0.2385572
GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN	C7_ immunologic signatures	185	1.0593216	0.34454757	0.60154086	GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN	186	0.7551389	0.93591046	1	1.8144605	0.3041827
JI_RESPONSE_TO_FSH_UP	c2.CGP_ chemical and genetic perturbations	66	1.0592504	0.36164382	0.601667	JI_RESPONSE_TO_FSH_UP	65	0.8298451	0.7772878	1	1.8890955	0.2294053
GSE16266_CTRL_VS_LPS_STIM_MEF_UP	C7_ immunologic signatures	176	1.0592424	0.32979977	0.60159856	GSE16266_CTRL_VS_LPS_STIM_MEF_UP	177	1.1137279	0.24570273	0.7318832	2.1729703	-0.0544855
GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN	C7_ immunologic signatures	176	1.059213	0.35714287	0.6015923	GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN	182	0.819526	0.8809766	1	1.878739	0.239687
GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	C7_ immunologic signatures	166	1.0590781	0.3413242	0.60192406	GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	169	1.2137946	0.09137056	0.5709038	2.2728727	-0.1547165
LI_LUNG_CANCER	c2.CGP_ chemical and genetic perturbations	37	1.0590597	0.3710145	0.6018849	LI_LUNG_CANCER	38	0.75701904	0.85150814	1	1.81607874	0.30204066
RUAN_RESPONSE_TO_TNF_DN	c2.CGP_ chemical and genetic perturbations	79	1.0590472	0.3587385	0.6018271	RUAN_RESPONSE_TO_TNF_DN	81	0.6821808	0.9432548	1	1.741228	0.3768664
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	c2.CGP_ chemical and genetic perturbations	47	1.0589625	0.36011478	0.6019918	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	47	0.7557798	0.82179344	1	1.8147423	0.3031827
BIOCARTA_P53HYPOXIA_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	21	1.0589542	0.3770739	0.60192215	BIOCARTA_P53HYPOXIA_PATHWAY	21	0.81349707	0.7427536	1	1.87245127	0.24545713
TSENG_ADIPOGENIC_POTENTIAL_UP	c2.CGP_ chemical and genetic perturbations	25	1.0589144	0.38109306	0.60194516	TSENG_ADIPOGENIC_POTENTIAL_UP	26	0.78057504	0.78855723	1	1.83948944	0.27833936
GO_RECEPTOR_COMPLEX	c5.CC_ GO cellular component	289	1.0588963	0.33147943	0.6019097	GO_RECEPTOR_COMPLEX	311	1.3731339	0.002008032	0.36323813	2.4320302	-0.3142376
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP	C7_ immunologic signatures	179	1.0588039	0.3598131	0.602097	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP	181	-1.0440956	0.2857143	0.6166417	0.0147083	2.1028995
GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	C7_ immunologic signatures	174	1.0587914	0.31919906	0.60204095	GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	175	0.57847345	0.9979716	1	1.63726485	0.48031795
GO_MULTICELLULAR_ORGANISMAL_MOVEMENT	c5.BP_ GO biological process	37	1.0587435	0.37668163	0.60210097	GO_MULTICELLULAR_ORGANISMAL_MOVEMENT	39	1.2831491	0.12922002	0.4673671	2.3418926	-0.2244056
GO_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	c5.BP_ GO biological process	21	1.0587406	0.39642325	0.6020126	GO_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	22	-0.83880675	0.7453704	0.8771759	0.21993385	1.89754735
GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	182	1.058682	0.34491017	0.6021075	GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	184	0.8696434	0.7995951	1	1.9283254	0.1890386
GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	C7_ immunologic signatures	142	1.0586196	0.34060606	0.6022049	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	152	1.3676937	0.014256619	0.37099415	2.4263133	-0.3090741
MURATA_VIRULENCE_OF_H_PILORI	c2.CGP_ chemical and genetic perturbations	18	1.0585724	0.38961038	0.60224795	MURATA_VIRULENCE_OF_H_PILORI	21	1.0298308	0.4318182	0.87598413	2.0884032	0.0287416
GSE3982_EOSINOPHIL_VS_DC_UP	C7_ immunologic signatures	160	1.058559	0.33653846	0.60219306	GSE3982_EOSINOPHIL_VS_DC_UP	165	1.2077553	0.10222672	0.5806645	2.2663143	-0.1491963
GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN	C7_ immunologic signatures	122	1.0585369	0.34596577	0.6021624	GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN	124	-1.0083265	0.44444445	0.6741294	0.0502104	2.0668634
GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP	C7_ immunologic signatures	174	1.0584886	0.33136094	0.60222083	GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP	176	1.2277294	0.07591093	0.54485816	2.286218	-0.1692408
GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	176	1.0584856	0.35495284	0.60213417	GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP	174	1.140881	0.20714286	0.68878096	2.1993666	-0.0823954
GSE45365_NK_CELL_VS_CD8A_DC_DN	C7_ immunologic signatures	151	1.0582827	0.35576922	0.60267645	GSE45365_NK_CELL_VS_CD8A_DC_DN	163	1.1558911	0.15768057	0.6606043	2.2141738	-0.0976084
GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP	C7_ immunologic signatures	162	1.0582509	0.3317647	0.60268116	GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP	167	0.90239555	0.7169043	1	1.96064645	0.15585535
GSE4142_NAIVE_VS_MEMORY_BCELL_DN	C7_ immunologic signatures	157	1.0582491	0.36848485	0.60259	GSE4142_NAIVE_VS_MEMORY_BCELL_DN	177	1.0576941	0.36150712	0.82810503	2.1159432	0.000555
GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN	C7_ immunologic signatures	119	1.0582209	0.3588761	0.60258245	GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN	124	0.75435555	0.90843624	1	1.81257645	0.30386535
GO_MICROTUBULE_BUNDLE_FORMATION	c5.BP_ GO biological process	53	1.057992	0.37146893	0.6031809	GO_MICROTUBULE_BUNDLE_FORMATION	55	1.2701331	0.12124583	0.48497477	2.3281251	-0.2121411
ATGCACG_MIR517B	c3.MIR_ microRNA targets	19	1.0579747	0.39349595	0.60313624	ATGCACG_MIR517B	19	-0.99598753	0.45454547	0.6928933	0.06198717	2.05396223
GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP	C7_ immunologic signatures	170	1.0579417	0.33568904	0.6031471	GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP	178	1.0651764	0.36142132	0.8137939	2.1231181	-0.0072347
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP	C7_ immunologic signatures	109	1.0579227	0.33376455	0.60310835	GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP	112	1.3600425	0.03212435	0.3775027	2.4179652	-0.3021198
GO_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	51	1.0578933	0.37730497	0.6031038	GO_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION	50	-1.1556422	0.18103448	0.43687278	-0.0977489	2.2135355
GO_COSTAMERE	c5.CC_ GO cellular component	18	1.0578654	0.40412045	0.6030948	GO_COSTAMERE	18	1.5002254	0.02541296	0.25314543	2.5580908	-0.44236
GO_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX	c5.CC_ GO cellular component	35	1.0578355	0.36725664	0.6030998	GO_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX	35	0.928985	0.6011765	0.9989944	1.9868205	0.1288505
GSE17721_CTRL_VS_LPS_6H_BMDC_DN	C7_ immunologic signatures	181	1.0577892	0.34131736	0.60314816	GSE17721_CTRL_VS_LPS_6H_BMDC_DN	180	0.8991908	0.7255298	1	1.95698	0.1585984
GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN	C7_ immunologic signatures	167	1.0577363	0.3534994	0.6032169	GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN	173	1.0974156	0.2816616	0.75997216	2.1551519	-0.0396793
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	c2.CGP_ chemical and genetic perturbations	68	1.0576631	0.38633195	0.6033442	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	69	-1.0792652	0.21176471	0.55316365	-0.0216021	2.1369283
GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	130	1.057563	0.34658384	0.6035641	GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	134	0.9734395	0.5451713	0.95779485	2.0310025	0.0841235
GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP	C7_ immunologic signatures	110	1.0575522	0.34256926	0.6035034	GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP	121	1.328547	0.042487048	0.4038186	2.3860992	-0.2709948
REACTOME_CA_DEPENDENT_EVENTS	c2.CP_REACTOME_ Reactome gene sets	25	1.0575438	0.3776435	0.6034333	REACTOME_CA_DEPENDENT_EVENTS	26	1.0521884	0.405	0.8368965	2.1097322	0.0053554
GO_CHROMOSOME_TELOMERIC_REGION	c5.CC_ GO cellular component	126	1.0574802	0.34375	0.6035416	GO_CHROMOSOME_TELOMERIC_REGION	128	-1.0657785	0.3	0.5771042	-0.0082983	2.1232587
GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN	C7_ immunologic signatures	183	1.0574671	0.3372503	0.6034876	GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN	186	0.938463	0.66327566	0.9923111	1.9959301	0.1190041
GO_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE	c5.BP_ GO biological process	18	1.0574036	0.36682615	0.60358524	GO_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE	20	-1.2763717	0.1042654	0.30537787	-0.2189681	2.3337753
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN	C7_ immunologic signatures	154	1.0573962	0.34528077	0.6035095	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN	154	1.1054981	0.2706002	0.74630636	2.1628943	-0.0481019
GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN	C7_ immunologic signatures	97	1.0573132	0.34496123	0.60366887	GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN	104	0.96691567	0.57566136	0.9645719	2.02422887	0.09039753
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	c2.CGP_ chemical and genetic perturbations	73	1.0572318	0.34731323	0.6038245	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	78	0.7762835	0.85531914	1	1.8335153	0.2809483
GO_REGULATION_OF_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS	c5.BP_ GO biological process	16	1.057145	0.39541984	0.6040064	GO_REGULATION_OF_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS	16	-1.5511824	0.045643155	0.11418397	-0.4940374	2.6083274
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	c2.CGP_ chemical and genetic perturbations	35	1.0571351	0.36486486	0.60393757	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	34	0.67986	0.9257075	1	1.7369951	0.3772751
GO_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	23	1.0569528	0.3671875	0.60440266	GO_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS	25	1.1946223	0.25	0.597624	2.2515751	-0.1376695
MODULE_533	c4.CM_ cancer modules	41	1.0569521	0.36998513	0.60430825	MODULE_533	42	1.2473106	0.16455697	0.5152308	2.3042627	-0.1903585
GSE3982_EOSINOPHIL_VS_TH1_UP	C7_ immunologic signatures	157	1.0565085	0.33932853	0.60560924	GSE3982_EOSINOPHIL_VS_TH1_UP	169	1.0652404	0.34817815	0.81381255	2.1217489	-0.0087319
GGTGAAG_MIR412	c3.MIR_ microRNA targets	55	1.0563917	0.37860084	0.6058825	GGTGAAG_MIR412	56	0.6756007	0.93072623	1	1.7319924	0.380791
GSE42724_MEMORY_VS_B1_BCELL_UP	C7_ immunologic signatures	167	1.0563712	0.33413753	0.6058494	GSE42724_MEMORY_VS_B1_BCELL_UP	173	0.67857337	0.98065174	1	1.73494457	0.37779783
TGCTTTG_MIR330	c3.MIR_ microRNA targets	292	1.0562794	0.33333334	0.60603565	TGCTTTG_MIR330	305	0.811795	0.9349349	1	1.8680744	0.2444844
GO_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY	c5.GO molecular function	27	1.0562705	0.37147334	0.6059648	GO_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY	27	-0.8189961	0.8066667	0.8899703	0.2372744	1.8752666
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	174	1.0562594	0.35990623	0.60590416	GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	175	0.72809076	0.9645749	1	1.78435016	0.32816864
GO_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS	c5.BP_ GO biological process	124	1.0562515	0.35301507	0.6058322	GO_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS	128	0.77722025	0.8885481	1	1.83347175	0.27903125
GO_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC	c5.BP_ GO biological process	69	1.0562257	0.36997318	0.605816	GO_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC	76	0.7279131	0.9146868	1	1.7841388	0.3283126
GO_REGULATION_OF_BODY_FLUID_LEVELS	c5.BP_ GO biological process	423	1.0561928	0.31779662	0.6058256	GO_REGULATION_OF_BODY_FLUID_LEVELS	448	1.2546989	0.006	0.5026726	2.3108917	-0.1985061
OSMAN_BLADDER_CANCER_UP	c2.CGP_ chemical and genetic perturbations	363	1.0561178	0.33836207	0.6059624	OSMAN_BLADDER_CANCER_UP	363	0	0	0	1.0561178	1.0561178
GO_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	17	1.0560815	0.38870433	0.6059795	GO_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY	17	1.0008976	0.5	0.922857	2.0569791	0.0551839
GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING	c5.BP_ GO biological process	22	1.0560688	0.39384118	0.6059254	GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING	22	-1.0308113	0.3938053	0.63859266	0.0252575	2.0868801
SUNG_METASTASIS_STROMA_UP	c2.CGP_ chemical and genetic perturbations	98	1.0560523	0.36305732	0.60587704	SUNG_METASTASIS_STROMA_UP	98	0.98151606	0.529595	0.94692504	2.03756836	0.07453624
GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN	C7_ immunologic signatures	101	1.0559189	0.35416666	0.6061968	GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN	111	1.1617625	0.18775934	0.65105534	2.2176814	-0.1058436
GO_REGULATION_OF_CIRCADIAN_RHYTHM	c5.BP_ GO biological process	87	1.0556334	0.36481243	0.6069794	GO_REGULATION_OF_CIRCADIAN_RHYTHM	92	-1.0741384	0.25925925	0.5631942	-0.018505	2.1297718
GO_CALCIUM_ION_REGULATED_EXOCYTOSIS_OF_NEUROTRANSMITTER	c5.BP_ GO biological process	29	1.0556049	0.3773292	0.6069697	GO_CALCIUM_ION_REGULATED_EXOCYTOSIS_OF_NEUROTRANSMITTER	30	1.2215407	0.19327731	0.55372524	2.2771456	-0.1659358
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	c2.CGP_ chemical and genetic perturbations	149	1.0555937	0.34610778	0.6069106	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	155	0.9725824	0.5652174	0.9584099	2.0281761	0.0830113
GO_PLASMA_MEMBRANE_RAFT	c5.CC_ GO cellular component	77	1.055535	0.3598901	0.60699505	GO_PLASMA_MEMBRANE_RAFT	81	1.2386799	0.12137487	0.52755266	2.2942149	-0.1831449
MODULE_188	c4.CM_ cancer modules	114	1.0554221	0.35516372	0.60725075	MODULE_188	120	1.3138341	0.045454547	0.42001835	2.3692562	-0.258412
GO_POSITIVE_REGULATION_OF_CELL_ADHESION	c5.BP_ GO biological process	305	1.0553124	0.3228261	0.60749733	GO_POSITIVE_REGULATION_OF_CELL_ADHESION	326	1.0762919	0.26526526	0.79458344	2.1316043	-0.0209795
GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN	C7_ immunologic signatures	170	1.0552458	0.3408019	0.6076058	GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN	174	-0.9713045	0.5833333	0.7262631	0.0839413	2.0265503
GSE29618_BCELL_VS_MDC_UP	C7_ immunologic signatures	152	1.0551399	0.3325359	0.60783803	GSE29618_BCELL_VS_MDC_UP	160	0.9519816	0.6363636	0.97973776	2.0071215	0.1031583
GO_REGULATION_OF_VASODILATION	c5.BP_ GO biological process	36	1.0551375	0.39792898	0.60774887	GO_REGULATION_OF_VASODILATION	43	1.5873526	0.005694761	0.17701991	2.6424901	-0.5322151
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM	c2.CGP_ chemical and genetic perturbations	270	1.054916	0.3325792	0.60832536	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM	278	1.3993949	0.00201005	0.3406369	2.4543109	-0.3444789
BIOCARTA_STATHMIN_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	1.0548677	0.37886178	0.60837823	BIOCARTA_STATHMIN_PATHWAY	17	1.2606593	0.18613607	0.4952983	2.315527	-0.2057916
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP	C7_ immunologic signatures	152	1.0547934	0.36121213	0.60851544	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP	162	0.73676527	0.92346936	1	1.79155867	0.31802813
GO_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	47	1.0547506	0.38252148	0.60855025	GO_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION	48	1.3996958	0.049943246	0.3403596	2.4544464	-0.3449452
MORF_ESPL1	c4.CGN_ cancer gene neighborhoods	56	1.0546764	0.3837535	0.60868615	MORF_ESPL1	56	-1.3273199	0.036036037	0.25950253	-0.2726435	2.3819963
GAGCTGG_MIR337	c3.MIR_ microRNA targets	142	1.0546204	0.35167465	0.6087708	GAGCTGG_MIR337	145	1.0720087	0.33944955	0.80281454	2.1266291	-0.0173883
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP	c2.CGP_ chemical and genetic perturbations	64	1.0546088	0.37753722	0.60871375	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP	65	0.7479668	0.8784946	1	1.8025756	0.306642
GO_POSITIVE_REGULATION_OF_AUTOPHAGY	c5.BP_ GO biological process	73	1.0545048	0.37533155	0.608942	GO_POSITIVE_REGULATION_OF_AUTOPHAGY	73	1.1282961	0.2837109	0.7084503	2.1828009	-0.0737913
GO_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_PROTEASE_ACTIVITY	c5.GO molecular function	91	1.0543253	0.36447367	0.60939294	GO_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_PROTEASE_ACTIVITY	92	0.6657987	0.97178686	1	1.720124	0.3885266
GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP	C7_ immunologic signatures	176	1.0542835	0.3647343	0.609422	GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP	176	0.94158196	0.6409736	0.9893645	1.99586546	0.11270154
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	180	1.0541949	0.34241706	0.6096101	GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	185	1.2726462	0.03156823	0.48203492	2.3268411	-0.2184513
GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP	C7_ immunologic signatures	169	1.0541238	0.34564957	0.6097378	GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP	172	1.4209325	0	0.31870374	2.4750563	-0.3668087
BOYLAN_MULTIPLE_MYELOMA_C_D_UP	c2.CGP_ chemical and genetic perturbations	124	1.0539966	0.36430317	0.61002916	BOYLAN_MULTIPLE_MYELOMA_C_D_UP	126	-0.9467186	0.62068963	0.76073533	0.107278	2.0007152
GO_B_CELL_ACTIVATION	c5.BP_ GO biological process	118	1.0539747	0.35913706	0.6100009	GO_B_CELL_ACTIVATION	121	1.0129459	0.47417355	0.9018278	2.0669206	0.0410288
GO_NUCLEAR_MATRIX	c5.CC_ GO cellular component	91	1.0538781	0.36316472	0.6102148	GO_NUCLEAR_MATRIX	91	-1.2923821	0	0.28978136	-0.238504	2.3462602
BRCA1_DN.V1_DN	C6_ oncogenic signatures	101	1.0538642	0.3624511	0.6101603	BRCA1_DN.V1_DN	108	1.1790181	0.16823407	0.62332463	2.2328823	-0.1251539
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	c2.CGP_ chemical and genetic perturbations	239	1.0537204	0.34195724	0.6105139	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	239	1.0922012	0.25551102	0.7691542	2.1459216	-0.0384808
GO_HORMONE_METABOLIC_PROCESS	c5.BP_ GO biological process	122	1.0533409	0.35532996	0.61159873	GO_HORMONE_METABOLIC_PROCESS	131	1.0910761	0.31410918	0.76962364	2.144417	-0.0377352
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	C7_ immunologic signatures	184	1.0532526	0.35314685	0.61178404	GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	186	1.2684772	0.04048583	0.48669717	2.3217298	-0.2152246
GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP	C7_ immunologic signatures	169	1.0532469	0.33653846	0.6117041	GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP	171	1.2055877	0.09775967	0.58212143	2.2588346	-0.1523408
GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP	C7_ immunologic signatures	160	1.0532167	0.36439666	0.61169666	GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP	174	0.9346176	0.66362715	0.99538004	1.9878343	0.1185991
GO_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING	c5.GO molecular function	92	1.0531055	0.34649682	0.611947	GO_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING	98	-0.764512	0.9791667	0.9304247	0.2885935	1.8176175
GO_INTRACELLULAR_CALCIUM_ACTIVATED_CHLORIDE_CHANNEL_ACTIVITY	c5.GO molecular function	15	1.0531001	0.3923445	0.61186695	GO_INTRACELLULAR_CALCIUM_ACTIVATED_CHLORIDE_CHANNEL_ACTIVITY	16	1.1200532	0.32934928	0.7231825	2.1731533	-0.0669531
CEBP_Q2_01	c3.TFT_ transcription factor targets	234	1.0529985	0.35689852	0.61209327	CEBP_Q2_01	241	1.3051199	0.013052209	0.43345895	2.3581184	-0.2521214
GO_MOTOR_NEURON_AXON_GUIDANCE	c5.BP_ GO biological process	27	1.0529048	0.3900156	0.61228585	GO_MOTOR_NEURON_AXON_GUIDANCE	27	1.0002682	0.49390244	0.9240699	2.053173	0.0526366
BURTON_ADIPOGENESIS_1	c2.CGP_ chemical and genetic perturbations	32	1.0528367	0.39879155	0.6124028	BURTON_ADIPOGENESIS_1	32	-0.9149913	0.6564417	0.8016164	0.1378454	1.967828
GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	C7_ immunologic signatures	178	1.0528102	0.33890215	0.61239	GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	177	1.1603525	0.15307151	0.6520801	2.2131627	-0.1075423
GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP	C7_ immunologic signatures	158	1.0527403	0.35436893	0.6125167	GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP	160	0.87004304	0.76102567	1	1.92278334	0.18269726
GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN	C7_ immunologic signatures	106	1.052674	0.38029924	0.61263037	GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN	112	1.1858822	0.171875	0.6130209	2.2385562	-0.1332082
GO_INNERVATION	c5.BP_ GO biological process	22	1.0525659	0.38778627	0.6128623	GO_INNERVATION	22	1.0344914	0.43296432	0.8680608	2.0870573	0.0180745
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_DN	C7_ immunologic signatures	162	1.0524663	0.35844472	0.6130692	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_DN	179	0.8157328	0.8753799	1	1.8681991	0.2367335
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	c2.CGP_ chemical and genetic perturbations	257	1.0524455	0.34151787	0.6130333	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	260	1.0744017	0.2893145	0.79797673	2.1268472	-0.0219562
GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_UP	C7_ immunologic signatures	172	1.0521413	0.35756853	0.6139089	GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_UP	176	0.6910888	0.982706	1	1.7432301	0.3610525
GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_UP	C7_ immunologic signatures	162	1.0521355	0.3492823	0.6138326	GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_UP	167	1.0758781	0.33537832	0.7951887	2.1280136	-0.0237426
GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	C7_ immunologic signatures	177	1.0521222	0.33651552	0.6137788	GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	182	0.8966009	0.73662966	1	1.9487231	0.1555213
GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN	C7_ immunologic signatures	174	1.052094	0.34478673	0.6137738	GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN	176	1.1300194	0.20665322	0.7053709	2.1821134	-0.0779254
GO_EMBRYO_IMPLANTATION	c5.BP_ GO biological process	34	1.0520804	0.4003021	0.61371875	GO_EMBRYO_IMPLANTATION	38	1.5397168	0.010404624	0.21109045	2.5917972	-0.4876364
GO_REGULATION_OF_ORGANIC_ACID_TRANSPORT	c5.BP_ GO biological process	42	1.0519884	0.37777779	0.6139157	GO_REGULATION_OF_ORGANIC_ACID_TRANSPORT	44	1.4989308	0.018018018	0.2538864	2.5509192	-0.4469424
REACTOME_AXON_GUIDANCE	c2.CP_REACTOME_ Reactome gene sets	231	1.0518184	0.35754824	0.6143573	REACTOME_AXON_GUIDANCE	230	1.1236818	0.20682731	0.7184666	2.1755002	-0.0718634
GGAMTNNNNNTCCY_UNKNOWN	c3.TFT_ transcription factor targets	101	1.0517777	0.37408313	0.6143906	GGAMTNNNNNTCCY_UNKNOWN	101	-1.067531	0.19354838	0.57420045	-0.0157533	2.1193087
GSE19512_NAUTRAL_VS_INDUCED_TREG_UP	C7_ immunologic signatures	151	1.051766	0.3534994	0.61432767	GSE19512_NAUTRAL_VS_INDUCED_TREG_UP	170	1.3262129	0.019367991	0.40564036	2.3779789	-0.2744469
GO_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE	c5.BP_ GO biological process	18	1.0517457	0.39096573	0.61429673	GO_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE	17	0.9225414	0.58210945	1	1.9742871	0.1292043
MANTOVANI_VIRAL_GPCR_SIGNALING_UP	c2.CGP_ chemical and genetic perturbations	76	1.0515013	0.39324325	0.61495715	MANTOVANI_VIRAL_GPCR_SIGNALING_UP	76	1.0402348	0.42032087	0.8589731	2.0917361	0.0112665
GO_PROTEASE_BINDING	c5.GO molecular function	88	1.0514545	0.36103895	0.6150152	GO_PROTEASE_BINDING	93	1.2320745	0.110526316	0.5369483	2.283529	-0.18062
GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	147	1.0512356	0.3579202	0.6156081	GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN	148	0.80128586	0.87216496	1	1.85252146	0.24994974
MODULE_255	c4.CM_ cancer modules	366	1.0512314	0.33116177	0.61552715	MODULE_255	375	1.1508979	0.076	0.6680204	2.2021293	-0.0996665
GNF2_CD53	c4.CGN_ cancer gene neighborhoods	45	1.0511141	0.3963068	0.61577946	GNF2_CD53	48	1.184706	0.21118721	0.61387455	2.2358201	-0.1335919
GO_PEPTIDASE_ACTIVITY	c5.GO molecular function	498	1.0511081	0.32809225	0.6157005	GO_PEPTIDASE_ACTIVITY	498	0	0	0	1.0511081	1.0511081
CTTTGTA_MIR524	c3.MIR_ microRNA targets	391	1.0509261	0.3315734	0.6161691	CTTTGTA_MIR524	403	-0.98638725	1	0.70680696	0.06453885	2.03731335
GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN	C7_ immunologic signatures	157	1.0508418	0.37228915	0.6163289	GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN	157	0.98489976	0.53690594	0.9416445	2.03574156	0.06594204
KIM_ALL_DISORDERS_CALB1_CORR_DN	c2.CGP_ chemical and genetic perturbations	25	1.0508265	0.38139534	0.6162763	KIM_ALL_DISORDERS_CALB1_CORR_DN	29	0.8324982	0.717233	1	1.8833247	0.2183283
GO_NEGATIVE_REGULATION_OF_HORMONE_SECRETION	c5.BP_ GO biological process	56	1.0507363	0.36197183	0.61645204	GO_NEGATIVE_REGULATION_OF_HORMONE_SECRETION	68	1.3040218	0.078688525	0.4352247	2.3547581	-0.2532855
GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN	C7_ immunologic signatures	171	1.0506846	0.3642857	0.61650616	GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN	178	0.6795609	0.97160244	1	1.7302455	0.3711237
GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN	C7_ immunologic signatures	172	1.0506737	0.349642	0.61643976	GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN	178	1.1492112	0.18044356	0.6705778	2.1998849	-0.0985375
GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP	C7_ immunologic signatures	130	1.050595	0.36561742	0.6165798	GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP	133	1.2263027	0.1015544	0.54741824	2.2768977	-0.1757077
GO_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	41	1.0505677	0.38101983	0.61657125	GO_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS	44	1.290905	0.10300926	0.45695326	2.3414727	-0.2403373
GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	C7_ immunologic signatures	147	1.0505514	0.35411766	0.6165283	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	150	1.515942	0.00204918	0.23483582	2.5664934	-0.4653906
MORF_PTPRB	c4.CGN_ cancer gene neighborhoods	196	1.0503211	0.34597155	0.6171506	MORF_PTPRB	207	1.359281	0.003015075	0.3780169	2.4096021	-0.3089599
GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN	C7_ immunologic signatures	165	1.0501773	0.3566265	0.6174949	GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN	169	0.8621827	0.81395346	1	1.91236	0.1879946
GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	C7_ immunologic signatures	177	1.0499853	0.3755924	0.6179809	GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	177	0.7414912	0.9291498	1	1.7914765	0.3084941
GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN	C7_ immunologic signatures	169	1.0499779	0.36966825	0.6179069	GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN	171	1.3917942	0.006103764	0.34639674	2.4417721	-0.3418163
GO_INTERCELLULAR_BRIDGE	c5.CC_ GO cellular component	38	1.0499668	0.3729569	0.61784154	GO_INTERCELLULAR_BRIDGE	38	0.9777893	0.52068967	0.95209324	2.0277561	0.0721775
HAHTOLA_SEZARY_SYNDROM_UP	c2.CGP_ chemical and genetic perturbations	79	1.0497092	0.38582677	0.6185338	HAHTOLA_SEZARY_SYNDROM_UP	82	1.2697242	0.080213904	0.48485425	2.3194334	-0.220015
GSE27859_MACROPHAGE_VS_DC_UP	C7_ immunologic signatures	152	1.0497044	0.35330072	0.6184517	GSE27859_MACROPHAGE_VS_DC_UP	153	-1.0557137	0.14285715	0.5952419	-0.0060093	2.1054181
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	c2.CGP_ chemical and genetic perturbations	17	1.0496944	0.407767	0.61838746	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	18	0.8924905	0.6287879	1	1.9421849	0.1572039
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP	C7_ immunologic signatures	171	1.0496639	0.37529412	0.6183877	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP	172	1.0423017	0.39473686	0.8548331	2.0919656	0.0073622
GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	178	1.049571	0.36038187	0.6185811	GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	179	0.9372138	0.66497976	0.993076	1.9867848	0.1123572
GSE14350_IL2RB_KO_VS_WT_TREG_UP	C7_ immunologic signatures	178	1.0493448	0.3527316	0.619194	GSE14350_IL2RB_KO_VS_WT_TREG_UP	182	1.2213596	0.07825203	0.5535085	2.2707044	-0.1720148
AMUNDSON_GENOTOXIC_SIGNATURE	c2.CGP_ chemical and genetic perturbations	91	1.0492858	0.35138705	0.61928815	AMUNDSON_GENOTOXIC_SIGNATURE	93	1.1493345	0.22655427	0.6705167	2.1986203	-0.1000487
GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP	C7_ immunologic signatures	182	1.0492829	0.3569794	0.6192005	GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP	183	0.8372625	0.8482412	1	1.8865454	0.2120204
GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP	C7_ immunologic signatures	170	1.0492754	0.3690476	0.6191252	GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP	179	0.98356664	0.5568983	0.94339186	2.03284204	0.06570876
GO_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	20	1.0492617	0.39375	0.6190739	GO_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION	22	1.0563644	0.4125	0.8306372	2.1056261	-0.0071027
GO_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	88	1.0492333	0.3672391	0.6190601	GO_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS	89	1.1658214	0.205074	0.6458316	2.2150547	-0.1165881
GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN	C7_ immunologic signatures	170	1.0491611	0.35272726	0.6191913	GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN	175	0.7494702	0.9441624	1	1.7986313	0.2996909
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	c2.CGP_ chemical and genetic perturbations	22	1.0491449	0.40127388	0.61914706	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	22	1.1920813	0.25	0.602882	2.2412262	-0.1429364
PAX_Q6	c3.TFT_ transcription factor targets	218	1.049138	0.3671783	0.6190701	PAX_Q6	227	0.9752703	0.5633803	0.95587534	2.0244083	0.0738677
HIF1_Q3	c3.TFT_ transcription factor targets	199	1.049052	0.36511627	0.61923313	HIF1_Q3	207	0.62626916	0.9929578	1	1.67532116	0.42278284
LIM_MAMMARY_LUMINAL_PROGENITOR_UP	c2.CGP_ chemical and genetic perturbations	50	1.0488496	0.3909465	0.6197602	LIM_MAMMARY_LUMINAL_PROGENITOR_UP	50	1.1021249	0.3265766	0.7534304	2.1509745	-0.0532753
GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN	C7_ immunologic signatures	152	1.0488472	0.375	0.6196719	GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN	155	1.1197294	0.22685656	0.7233983	2.1685766	-0.0708822
GRESHOCK_CANCER_COPY_NUMBER_UP	c2.CGP_ chemical and genetic perturbations	290	1.0488117	0.34602463	0.61968565	GRESHOCK_CANCER_COPY_NUMBER_UP	299	0.76146257	0.971	1	1.81027427	0.28734913
CACTGTG_MIR128A_MIR128B	c3.MIR_ microRNA targets	305	1.0488026	0.3325967	0.6196181	CACTGTG_MIR128A_MIR128B	308	0.81147045	0.928	1	1.86027305	0.23733215
GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN	C7_ immunologic signatures	172	1.0487854	0.3535109	0.61957574	GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN	176	1.168444	0.15609264	0.6396168	2.2172294	-0.1196586
YIH_RESPONSE_TO_ARSENITE_C1	c2.CGP_ chemical and genetic perturbations	23	1.0487221	0.3906977	0.61967975	YIH_RESPONSE_TO_ARSENITE_C1	23	0.6654553	0.90806043	1	1.7141774	0.3832668
GO_REGULATION_OF_CELL_PROJECTION_ASSEMBLY	c5.BP_ GO biological process	129	1.0487155	0.3686747	0.6196024	GO_REGULATION_OF_CELL_PROJECTION_ASSEMBLY	137	1.0869052	0.3183214	0.7755863	2.1356207	-0.0381897
GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP	C7_ immunologic signatures	171	1.0485932	0.36267605	0.6198701	GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP	172	-0.80178106	0.95652175	0.9041618	0.24681214	1.85037426
GO_CELL_VOLUME_HOMEOSTASIS	c5.BP_ GO biological process	25	1.0485648	0.40865386	0.61986136	GO_CELL_VOLUME_HOMEOSTASIS	26	1.0253872	0.43757576	0.88355625	2.073952	0.0231776
GO_CHOLESTEROL_EFFLUX	c5.BP_ GO biological process	22	1.0485287	0.40350878	0.6198734	GO_CHOLESTEROL_EFFLUX	25	0.74506867	0.83913565	1	1.79359737	0.30346003
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	C7_ immunologic signatures	171	1.0484759	0.3447016	0.619936	GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	174	0.8133062	0.8651116	1	1.8617821	0.2351697
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	c2.CGP_ chemical and genetic perturbations	113	1.0484393	0.36585367	0.6199518	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	111	0.8485263	0.8002103	1	1.8969656	0.199913
GO_CELLULAR_RESPONSE_TO_PEPTIDE	c5.BP_ GO biological process	245	1.0484307	0.3539519	0.61987954	GO_CELLULAR_RESPONSE_TO_PEPTIDE	257	0.824761	0.8947896	1	1.8731917	0.2236697
GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	112	1.0483855	0.37150127	0.61992335	GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	116	1.0257413	0.43834198	0.88294464	2.0741268	0.0226442
GO_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION	c5.BP_ GO biological process	16	1.0483153	0.4067524	0.62004507	GO_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION	16	0.70648193	0.8632258	1	1.75479723	0.34183337
GTTAAAG_MIR302B	c3.MIR_ microRNA targets	62	1.0482643	0.37857142	0.62010455	GTTAAAG_MIR302B	65	0.964249	0.55222225	0.966394	2.0125133	0.0840153
GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP	C7_ immunologic signatures	177	1.0481874	0.3708134	0.62025255	GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP	183	1.2044823	0.08181818	0.5833166	2.2526697	-0.1562949
GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN	C7_ immunologic signatures	167	1.0481482	0.3494687	0.6202784	GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN	170	1.1471033	0.1673428	0.6735705	2.1952515	-0.0989551
GO_B_CELL_DIFFERENTIATION	c5.BP_ GO biological process	81	1.0481067	0.3707124	0.62031364	GO_B_CELL_DIFFERENTIATION	81	0.9402676	0.61587983	0.98948336	1.9883743	0.1078391
GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN	C7_ immunologic signatures	174	1.04799	0.36561742	0.6205791	GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN	175	-0.8796839	0.85714287	0.84547156	0.1683061	1.9276739
GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP	C7_ immunologic signatures	144	1.0478197	0.35472155	0.62100494	GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP	147	0.9664081	0.580348	0.9647291	2.0142278	0.0814116
MODULE_69	c4.CM_ cancer modules	438	1.047785	0.33507854	0.62102425	MODULE_69	448	1.1094708	0.148	0.7380839	2.1572558	-0.0616858
GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN	C7_ immunologic signatures	169	1.0477155	0.34772182	0.62116	GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN	171	0.5801339	1	1	1.6278494	0.4675816
GSE9037_WT_VS_IRAK4_KO_BMDM_DN	C7_ immunologic signatures	156	1.0476943	0.36439666	0.62112635	GSE9037_WT_VS_IRAK4_KO_BMDM_DN	162	0.94457513	0.6327569	0.987507	1.99226943	0.10311917
GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	C7_ immunologic signatures	176	1.0476838	0.36147442	0.6210619	GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	176	1.1196539	0.22502522	0.72325075	2.1673377	-0.0719701
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	c2.CGP_ chemical and genetic perturbations	66	1.0476289	0.38744885	0.62114644	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	68	1.0560359	0.38345864	0.8313126	2.1036648	-0.008407
CRX_DN.V1_UP	C6_ oncogenic signatures	119	1.0474287	0.37247476	0.6216747	CRX_DN.V1_UP	122	1.1320974	0.22590673	0.7025239	2.1795261	-0.0846687
OSADA_ASCL1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	23	1.0473138	0.4031008	0.62194294	OSADA_ASCL1_TARGETS_DN	23	-0.6929696	0.9402174	0.9637727	0.3543442	1.7402834
GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP	C7_ immunologic signatures	156	1.04726	0.38188493	0.6220062	GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP	160	0.96094376	0.5934959	0.9699953	2.00820376	0.08631624
VDR_Q6	c3.TFT_ transcription factor targets	220	1.0472229	0.369515	0.6220252	VDR_Q6	236	1.0543275	0.35005015	0.83454126	2.1015504	-0.0071046
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	c2.CGP_ chemical and genetic perturbations	17	1.0472192	0.40449437	0.62193906	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	16	0.7758564	0.77559054	1	1.8230756	0.2713628
GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	45	1.0469965	0.3891273	0.6225198	GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION	52	1.1315024	0.2821388	0.703794	2.1784989	-0.0845059
GO_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	325	1.0469916	0.34711644	0.6224368	GO_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY	333	0.75812113	0.967	1	1.80511273	0.28887047
GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP	C7_ immunologic signatures	175	1.0469754	0.35808384	0.6223842	GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP	176	0.6986334	0.9685917	1	1.7456088	0.348342
GO_REPLISOME	c5.CC_ GO cellular component	26	1.0467365	0.39935064	0.6230323	GO_REPLISOME	26	-1.7605286	0	0.041270252	-0.7137921	2.8072651
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	167	1.0466881	0.3520958	0.6230862	GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	172	0.71175665	0.9697276	1	1.75844475	0.33493145
PETROVA_PROX1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	58	1.0466748	0.37714285	0.62303126	PETROVA_PROX1_TARGETS_DN	60	1.1711532	0.22320442	0.6365686	2.217828	-0.1244784
GO_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	107	1.0466348	0.36835444	0.6230613	GO_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	124	1.1788222	0.15621789	0.62385345	2.225457	-0.1321874
SMTTTTGT_UNKNOWN	c3.TFT_ transcription factor targets	349	1.0465597	0.35675675	0.6232035	SMTTTTGT_UNKNOWN	368	0.7211927	0.98897797	1	1.7677524	0.325367
GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP	C7_ immunologic signatures	152	1.0463804	0.37751478	0.6236557	GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP	155	0.8608618	0.7765306	1	1.9072422	0.1855186
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN	C7_ immunologic signatures	169	1.0462289	0.37170264	0.624029	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN	171	0.8115765	0.8786952	1	1.8578054	0.2346524
GSE4142_NAIVE_VS_GC_BCELL_UP	C7_ immunologic signatures	174	1.0461289	0.35480094	0.62424016	GSE4142_NAIVE_VS_GC_BCELL_UP	180	1.1791108	0.14604463	0.62325144	2.2252397	-0.1329819
LU_AGING_BRAIN_DN	c2.CGP_ chemical and genetic perturbations	136	1.0458915	0.36835748	0.6248782	LU_AGING_BRAIN_DN	139	0.79213476	0.8780488	1	1.83802626	0.25375674
GSE3982_BASOPHIL_VS_NKCELL_UP	C7_ immunologic signatures	162	1.0458764	0.3689904	0.62482595	GSE3982_BASOPHIL_VS_NKCELL_UP	165	0.88668084	0.7390863	1	1.93255724	0.15919556
GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP	C7_ immunologic signatures	184	1.0457882	0.37662336	0.6249965	GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP	185	0.8572719	0.82525253	1	1.9030601	0.1885163
GO_REPRODUCTIVE_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	362	1.045743	0.36842105	0.6250477	GO_REPRODUCTIVE_SYSTEM_DEVELOPMENT	383	0.93215185	0.714	0.9978769	1.97789485	0.11359115
GSE17721_CTRL_VS_CPG_24H_BMDC_DN	C7_ immunologic signatures	174	1.0457302	0.38168848	0.6249897	GSE17721_CTRL_VS_CPG_24H_BMDC_DN	181	-0.878266	1	0.8465421	0.1674642	1.9239962
GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP	C7_ immunologic signatures	146	1.0455985	0.36263737	0.6253001	GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP	148	1.1370506	0.21522842	0.6945438	2.1826491	-0.0914521
GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	C7_ immunologic signatures	180	1.0455911	0.36804733	0.6252242	GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	181	0.761943	0.94135493	1	1.8075341	0.2836481
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN	C7_ immunologic signatures	179	1.0455878	0.36374697	0.6251361	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN	179	0.85865885	0.816616	1	1.90424665	0.18692895
GO_GLIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	123	1.0455784	0.37943697	0.62506783	GO_GLIAL_CELL_DIFFERENTIATION	128	-1.4194163	0	0.19416742	-0.3738379	2.4649947
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	c2.CGP_ chemical and genetic perturbations	38	1.0455492	0.3823954	0.62506455	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	38	-1.1947922	0.14723927	0.38807106	-0.149243	2.2403414
BIOCARTA_CREB_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	25	1.0455133	0.39808917	0.62507653	BIOCARTA_CREB_PATHWAY	25	0.91887796	0.5977723	1	1.96439126	0.12663534
GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP	C7_ immunologic signatures	176	1.0455098	0.37906978	0.6249899	GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP	180	0.8170643	0.8836032	1	1.8625741	0.2284455
GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	C7_ immunologic signatures	186	1.0454643	0.36690646	0.62503177	GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	188	1.1135722	0.23427992	0.73212284	2.1590365	-0.0681079
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	c2.CP_REACTOME_ Reactome gene sets	59	1.0454546	0.3877551	0.62496537	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	59	-1.2713352	0.048543688	0.3085415	-0.2258806	2.3167898
TGAYRTCA_ATF3_Q6	c3.TFT_ transcription factor targets	448	1.0454527	0.34398296	0.6248745	TGAYRTCA_ATF3_Q6	464	0.8788643	0.882	1	1.924317	0.1665884
ROPERO_HDAC2_TARGETS	c2.CGP_ chemical and genetic perturbations	86	1.0452831	0.37601078	0.625315	ROPERO_HDAC2_TARGETS	92	1.1030892	0.3132275	0.7513815	2.1483723	-0.0578061
GSE17721_LPS_VS_CPG_6H_BMDC_UP	C7_ immunologic signatures	181	1.0451322	0.35928145	0.6256954	GSE17721_LPS_VS_CPG_6H_BMDC_UP	179	0.86952376	0.8123108	1	1.91465596	0.17560844
GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP	C7_ immunologic signatures	172	1.0450763	0.37880632	0.62577355	GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP	177	0.7771416	0.9215292	1	1.8222179	0.2679347
PID_FCER1_PATHWAY	c2.CP_ Canonical pathways	56	1.045063	0.38418078	0.62571853	PID_FCER1_PATHWAY	59	1.4594252	0.019955654	0.2836604	2.5044882	-0.4143622
GO_TRANSCRIPTIONALLY_ACTIVE_CHROMATIN	c5.CC_ GO cellular component	16	1.0450315	0.39593115	0.6257224	GO_TRANSCRIPTIONALLY_ACTIVE_CHROMATIN	16	-1.1383575	0.27705628	0.45901656	-0.093326	2.183389
GO_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	25	1.0450294	0.40402478	0.6256305	GO_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS	27	1.0494126	0.43811882	0.84063864	2.094442	-0.0043832
GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	158	1.0449502	0.3673966	0.62578964	GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN	162	0.92302734	0.6744659	1	1.96797754	0.12192286
GO_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	60	1.0447135	0.40220386	0.62643754	GO_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT	65	0.8403326	0.7529666	1	1.8850461	0.2043809
CREB_Q2	c3.TFT_ transcription factor targets	230	1.044678	0.37311703	0.62645566	CREB_Q2	240	0.8556604	0.8370221	1	1.9003384	0.1890176
GO_OLIGOSACCHARIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	62	1.0446751	0.4028169	0.6263674	GO_OLIGOSACCHARIDE_METABOLIC_PROCESS	62	1.3783053	0.036916394	0.35606116	2.4229804	-0.3336302
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN	c2.CGP_ chemical and genetic perturbations	16	1.0446669	0.4040404	0.6262957	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN	16	0.8144089	0.7277628	1	1.8590758	0.230258
GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN	C7_ immunologic signatures	174	1.0444564	0.36150235	0.6268376	GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN	179	0.9329056	0.6823289	0.99728364	1.977362	0.1115508
GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN	C7_ immunologic signatures	164	1.0443696	0.3800475	0.62702006	GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN	165	0.9192635	0.68367344	1	1.9636331	0.1251061
GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	168	1.0442014	0.37159765	0.6274526	GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP	176	0.98075175	0.55172414	0.94835484	2.02495315	0.06344965
GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP	C7_ immunologic signatures	177	1.0441082	0.3846154	0.6276482	GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP	176	0.9894689	0.5241935	0.9355579	2.0335771	0.0546393
GO_STEROID_HORMONE_RECEPTOR_ACTIVITY	c5.GO molecular function	53	1.0439581	0.38655463	0.62801784	GO_STEROID_HORMONE_RECEPTOR_ACTIVITY	57	1.2110438	0.18312986	0.5757605	2.2550019	-0.1670857
LINDSTEDT_DENDRITIC_CELL_MATURATION_A	c2.CGP_ chemical and genetic perturbations	55	1.0439489	0.3835022	0.6279501	LINDSTEDT_DENDRITIC_CELL_MATURATION_A	53	1.0562438	0.39485458	0.8308674	2.1001927	-0.0122949
BIOCARTA_RACCYCD_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	26	1.0437468	0.41001564	0.62846667	BIOCARTA_RACCYCD_PATHWAY	26	-0.80401266	0.80898875	0.9022601	0.23973414	1.84775946
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	c2.CGP_ chemical and genetic perturbations	49	1.0437466	0.3867792	0.62836957	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	51	0.774337	0.8354143	1	1.8180836	0.2694096
GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP	C7_ immunologic signatures	173	1.0437188	0.3828033	0.62835634	GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP	176	0.7332872	0.9504049	1	1.777006	0.3104316
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	c2.CGP_ chemical and genetic perturbations	30	1.0437123	0.3849624	0.6282801	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	31	0.9427785	0.5808824	0.98881155	1.9864908	0.1009338
GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	189	1.0436097	0.3764706	0.62850386	GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	190	0.6996066	0.9726997	1	1.7432163	0.3440031
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	c2.CGP_ chemical and genetic perturbations	168	1.0435894	0.36651054	0.628462	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	172	0.8736895	0.7923387	1	1.9172789	0.1698999
ATF_B	c3.TFT_ transcription factor targets	166	1.0435102	0.35928145	0.62860703	ATF_B	169	0.8359826	0.83231086	1	1.8794928	0.2075276
GO_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING	c5.BP_ GO biological process	104	1.0434502	0.36036035	0.62870544	GO_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING	109	0.9874608	0.5176715	0.9389661	2.030911	0.0559894
GNF2_MYL3	c4.CGN_ cancer gene neighborhoods	27	1.0433437	0.38990825	0.62893915	GNF2_MYL3	29	1.2886045	0.12876053	0.46066612	2.3319482	-0.2452608
GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN	C7_ immunologic signatures	146	1.0432986	0.36630037	0.6289775	GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN	146	1.1880455	0.13571429	0.60880566	2.2313441	-0.1447469
GO_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION	c5.BP_ GO biological process	57	1.0432273	0.39942113	0.6291091	GO_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION	59	1.06949	0.37416482	0.8063658	2.1127173	-0.0262627
GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN	C7_ immunologic signatures	130	1.0431794	0.3762255	0.62915516	GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN	137	1.1285456	0.2507772	0.7077984	2.171725	-0.0853662
GO_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS	c5.BP_ GO biological process	340	1.0430995	0.3304253	0.6293093	GO_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS	359	0.9997551	0.4964965	0.92452437	2.0428546	0.0433444
GO_LONG_TERM_SYNAPTIC_POTENTIATION	c5.BP_ GO biological process	35	1.0430733	0.40177253	0.629294	GO_LONG_TERM_SYNAPTIC_POTENTIATION	37	1.4758104	0.027251184	0.27264145	2.5188837	-0.4327371
CHIBA_RESPONSE_TO_TSA_DN	c2.CGP_ chemical and genetic perturbations	21	1.043073	0.3984252	0.62919706	CHIBA_RESPONSE_TO_TSA_DN	21	0.9950722	0.49107143	0.9304987	2.0381452	0.0480008
GO_AMINO_SUGAR_METABOLIC_PROCESS	c5.BP_ GO biological process	33	1.0430248	0.40469208	0.62925035	GO_AMINO_SUGAR_METABOLIC_PROCESS	34	0.89634866	0.6285377	1	1.93937346	0.14667614
GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN	C7_ immunologic signatures	165	1.0429809	0.3839713	0.6292899	GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN	177	1.2487609	0.05177665	0.5127913	2.2917418	-0.20578
REACTOME_CELL_CELL_COMMUNICATION	c2.CP_REACTOME_ Reactome gene sets	97	1.0429287	0.3953186	0.6293555	REACTOME_CELL_CELL_COMMUNICATION	104	1.2177838	0.12513034	0.5601541	2.2607125	-0.1748551
BROWNE_HCMV_INFECTION_20HR_UP	c2.CGP_ chemical and genetic perturbations	212	1.0425577	0.37689614	0.6304168	BROWNE_HCMV_INFECTION_20HR_UP	217	0.75716794	0.9453994	1	1.79972564	0.28538976
GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN	C7_ immunologic signatures	180	1.042382	0.37336504	0.63085836	GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN	179	1.123653	0.21830986	0.71843046	2.166035	-0.081271
GO_ALPHA_TUBULIN_BINDING	c5.GO molecular function	22	1.0422944	0.4014706	0.6310393	GO_ALPHA_TUBULIN_BINDING	23	1.0492787	0.4131227	0.84106636	2.0915731	-0.0069843
GRUETZMANN_PANCREATIC_CANCER_DN	c2.CGP_ chemical and genetic perturbations	181	1.0421613	0.3696408	0.6313655	GRUETZMANN_PANCREATIC_CANCER_DN	186	1.100149	0.2617108	0.756652	2.1423103	-0.0579877
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	c2.CGP_ chemical and genetic perturbations	257	1.0420997	0.36971048	0.63145286	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	257	-1.2251776	0	0.3499866	-0.1830779	2.2672773
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP	C7_ immunologic signatures	178	1.0420958	0.37885985	0.6313668	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP	184	1.156853	0.1564694	0.65874124	2.1989488	-0.1147572
KHETCHOUMIAN_TRIM24_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	46	1.0420055	0.3847242	0.6315423	KHETCHOUMIAN_TRIM24_TARGETS_UP	45	0.9137059	0.638106	1	1.9557114	0.1282996
CAGCCTC_MIR4855P	c3.MIR_ microRNA targets	129	1.0419797	0.3631841	0.63152725	CAGCCTC_MIR4855P	132	0.61194706	0.9948507	1	1.65392676	0.43003264
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	c2.CGP_ chemical and genetic perturbations	144	1.0419725	0.3833747	0.63145196	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	147	-1.5424498	0	0.119275086	-0.5004773	2.5844223
GO_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS	c5.BP_ GO biological process	145	1.0419626	0.39740565	0.6313869	GO_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS	145	0.9429263	0.6129363	0.98848057	1.9848889	0.0990363
GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN	C7_ immunologic signatures	162	1.0418617	0.38166046	0.63160676	GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN	173	0.82948107	0.8411405	1	1.87134277	0.21238063
ZWANG_EGF_INTERVAL_DN	c2.CGP_ chemical and genetic perturbations	173	1.0418085	0.387471	0.6316881	ZWANG_EGF_INTERVAL_DN	176	1.010631	0.46963564	0.90627116	2.0524395	0.0311775
MATSUDA_NATURAL_KILLER_DIFFERENTIATION	c2.CGP_ chemical and genetic perturbations	424	1.0417893	0.3567625	0.6316487	MATSUDA_NATURAL_KILLER_DIFFERENTIATION	436	0.84255064	0.937	1	1.88433994	0.19923866
CDP_01	c3.TFT_ transcription factor targets	76	1.041712	0.3989704	0.6317975	CDP_01	78	0.7314141	0.9027778	1	1.7731261	0.3102979
GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP	C7_ immunologic signatures	138	1.0416688	0.37220845	0.6318346	GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP	139	1.1450403	0.19709544	0.678988	2.1867091	-0.1033715
GO_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ER	c5.BP_ GO biological process	72	1.041373	0.38896188	0.63267595	GO_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ER	73	0.9864955	0.5281768	0.94036126	2.0278685	0.0548775
GO_EXPLORATION_BEHAVIOR	c5.BP_ GO biological process	18	1.0413269	0.41666666	0.63272387	GO_EXPLORATION_BEHAVIOR	21	1.0384893	0.42678347	0.8611079	2.0798162	0.0028376
GO_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	37	1.0412567	0.41125542	0.63284475	GO_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY	41	1.2873713	0.11007026	0.462098	2.328628	-0.2461146
GO_POSITIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION	c5.BP_ GO biological process	20	1.0412326	0.40359476	0.63282603	GO_POSITIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION	21	1.1600726	0.28800988	0.6523364	2.2013052	-0.11884
GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN	C7_ immunologic signatures	159	1.0412111	0.39320388	0.6328009	GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN	164	1.4501787	0	0.29097083	2.4913898	-0.4089676
GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	142	1.0411341	0.3778858	0.63293225	GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	148	-0.86756945	0.9354839	0.8547427	0.17356465	1.90870355
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN	C7_ immunologic signatures	164	1.0410625	0.37275985	0.6330657	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN	168	0.8333565	0.8427419	1	1.874419	0.207706
MODULE_121	c4.CM_ cancer modules	85	1.0410165	0.37218544	0.633103	MODULE_121	90	1.0942135	0.3228181	0.76701087	2.13523	-0.053197
GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	150	1.0409449	0.3738426	0.6332325	GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN	153	1.287792	0.040041067	0.4615899	2.3287369	-0.2468471
REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	c2.CP_REACTOME_ Reactome gene sets	24	1.0409265	0.4114202	0.6331969	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	26	1.1027914	0.3466334	0.75195885	2.1437179	-0.0618649
PID_EPHRINB_REV_PATHWAY	c2.CP_ Canonical pathways	27	1.0407904	0.4058642	0.6335395	PID_EPHRINB_REV_PATHWAY	28	0.91297865	0.60239524	1	1.95376905	0.12781175
GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP	C7_ immunologic signatures	150	1.0407442	0.39739028	0.6335903	GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP	154	0.8269379	0.8415742	1	1.8676821	0.2138063
LU_TUMOR_ANGIOGENESIS_UP	c2.CGP_ chemical and genetic perturbations	25	1.0407249	0.4171875	0.63355327	LU_TUMOR_ANGIOGENESIS_UP	25	1.0445133	0.41191068	0.85030586	2.0852382	-0.0037884
GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN	C7_ immunologic signatures	159	1.0407095	0.38077858	0.63350105	GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN	163	0.7497615	0.9359756	1	1.790471	0.290948
GO_NEGATIVE_REGULATION_OF_NEURON_DEATH	c5.BP_ GO biological process	153	1.0406513	0.39419588	0.6335749	GO_NEGATIVE_REGULATION_OF_NEURON_DEATH	159	0.83810216	0.847561	1	1.87875346	0.20254914
HALLMARK_KRAS_SIGNALING_UP	H_ hallmark gene sets	180	1.0406022	0.36638454	0.6336331	HALLMARK_KRAS_SIGNALING_UP	185	1.0772682	0.30342743	0.7929494	2.1178704	-0.036666
GO_ERYTHROCYTE_HOMEOSTASIS	c5.BP_ GO biological process	64	1.0405667	0.4063361	0.6336474	GO_ERYTHROCYTE_HOMEOSTASIS	65	0.57573617	0.99137	1	1.61630287	0.46483053
GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN	C7_ immunologic signatures	178	1.0405633	0.37951106	0.6335603	GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN	179	1.2925109	0.020263424	0.45408458	2.3330742	-0.2519476
GO_PEPTIDYL_LYSINE_METHYLATION	c5.BP_ GO biological process	53	1.0405449	0.3884993	0.6335217	GO_PEPTIDYL_LYSINE_METHYLATION	55	0.7505973	0.8674699	1	1.7911422	0.2899476
GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP	C7_ immunologic signatures	158	1.04038	0.37939394	0.6339455	GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP	159	1.113668	0.26434427	0.7320001	2.154048	-0.073288
GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	C7_ immunologic signatures	167	1.0403426	0.379717	0.6339666	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	173	0.79912716	0.89126015	1	1.83946976	0.24121544
GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP	C7_ immunologic signatures	176	1.040337	0.35900474	0.6338848	GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP	176	0.8566677	0.83739835	1	1.8970047	0.1836693
GO_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET	c5.BP_ GO biological process	40	1.0403236	0.39942938	0.6338274	GO_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET	40	-1.0404744	0.36036035	0.6212835	-0.0001508	2.080798
GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN	C7_ immunologic signatures	164	1.0403057	0.3764988	0.6337855	GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN	179	1.3469726	0.010090818	0.3857319	2.3872783	-0.3066669
GO_HEMOSTASIS	c5.BP_ GO biological process	264	1.0402329	0.38365495	0.63392216	GO_HEMOSTASIS	274	1.2512702	0.025100403	0.5088516	2.2915031	-0.2110373
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	c2.CP_BIOCARTA_ BioCarta gene sets	203	1.0401855	0.38207546	0.63396746	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	234	1.4050831	0.001005025	0.33309567	2.4452686	-0.3648976
GO_RECEPTOR_ACTIVATOR_ACTIVITY	c5.GO molecular function	29	1.0401355	0.41229385	0.63402784	GO_RECEPTOR_ACTIVATOR_ACTIVITY	32	1.2430192	0.18870193	0.5226382	2.2831547	-0.2028837
GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN	C7_ immunologic signatures	146	1.03997	0.37405542	0.63445544	GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN	144	0.7768853	0.90233976	1	1.8168553	0.2630847
MORF_IL9	c4.CGN_ cancer gene neighborhoods	80	1.0398875	0.392	0.63461864	MORF_IL9	84	0.9601289	0.55579174	0.97143996	2.0000164	0.0797586
GO_REGULATION_OF_BINDING	c5.BP_ GO biological process	257	1.0398713	0.3683616	0.6345709	GO_REGULATION_OF_BINDING	262	1.0252805	0.42168674	0.8834152	2.0651518	0.0145908
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN	C7_ immunologic signatures	167	1.0398164	0.3782506	0.63463974	GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN	173	1.1391617	0.20887992	0.69131076	2.1789781	-0.0993453
GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	C7_ immunologic signatures	179	1.0397441	0.38882282	0.6347663	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	182	1.0472562	0.38196555	0.84465003	2.0870003	-0.0075121
GSE13229_IMM_VS_INTMATURE_NKCELL_DN	C7_ immunologic signatures	177	1.0397224	0.38151658	0.63473725	GSE13229_IMM_VS_INTMATURE_NKCELL_DN	178	1.2538859	0.051671732	0.50311786	2.2936083	-0.2141635
GO_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT	c5.BP_ GO biological process	309	1.0397182	0.3839384	0.6346523	GO_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT	322	1.0613284	0.3103103	0.8213837	2.1010466	-0.0216102
GO_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION	c5.BP_ GO biological process	180	1.039661	0.37756333	0.63474286	GO_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION	190	1.1333579	0.20766129	0.7003574	2.1730189	-0.0936969
GO_SPLEEN_DEVELOPMENT	c5.BP_ GO biological process	35	1.0395921	0.39821693	0.634863	GO_SPLEEN_DEVELOPMENT	36	1.1475284	0.2609209	0.67275286	2.1871205	-0.1079363
GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	145	1.0395523	0.38787878	0.63488513	GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN	147	1.2708771	0.055384614	0.48342144	2.3104294	-0.2313248
MODULE_37	c4.CM_ cancer modules	394	1.0392917	0.36655948	0.63558984	MODULE_37	400	1.0722291	0.263	0.80228716	2.1115208	-0.0329374
GSE11057_PBMC_VS_MEM_CD4_TCELL_UP	C7_ immunologic signatures	155	1.039259	0.3861145	0.6355946	GSE11057_PBMC_VS_MEM_CD4_TCELL_UP	166	1.2817451	0.036511157	0.47004512	2.3210041	-0.2424861
KONDO_PROSTATE_CANCER_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	124	1.0391579	0.38567838	0.63580537	KONDO_PROSTATE_CANCER_WITH_H3K27ME3	136	1.0778672	0.34355828	0.7916372	2.1170251	-0.0387093
GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	C7_ immunologic signatures	172	1.0389701	0.37744534	0.63629246	GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	180	0.9618352	0.5784114	0.96883345	2.0008053	0.0771349
GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP	C7_ immunologic signatures	163	1.0389278	0.38190365	0.63631934	GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP	166	1.3352777	0.015151516	0.3977884	2.3742055	-0.2963499
MORF_JAK3	c4.CGN_ cancer gene neighborhoods	78	1.0389193	0.3768116	0.6362511	MORF_JAK3	84	1.2031578	0.16594827	0.5867136	2.2420771	-0.1642385
GO_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES	c5.BP_ GO biological process	94	1.0389105	0.38794234	0.6361824	GO_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES	97	0.83893275	0.8211297	1	1.87784325	0.19997775
GO_REGULATION_OF_PROTEIN_POLYMERIZATION	c5.BP_ GO biological process	151	1.0389065	0.4	0.6360977	GO_REGULATION_OF_PROTEIN_POLYMERIZATION	156	0.81802255	0.86761713	1	1.85692905	0.22088395
GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	C7_ immunologic signatures	180	1.0388714	0.37919074	0.63610256	GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	186	1.4052231	0.002020202	0.33338472	2.4440945	-0.3663517
GO_DICARBOXYLIC_ACID_TRANSPORT	c5.BP_ GO biological process	64	1.0388381	0.39716312	0.63610923	GO_DICARBOXYLIC_ACID_TRANSPORT	68	1.1726961	0.19146608	0.63293356	2.2115342	-0.133858
CUI_GLUCOSE_DEPRIVATION	c2.CGP_ chemical and genetic perturbations	54	1.038836	0.39385474	0.6360186	CUI_GLUCOSE_DEPRIVATION	54	0.8150136	0.7783903	1	1.8538496	0.2238224
REACTOME_REGULATION_OF_IFNA_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	24	1.0388259	0.4027565	0.6359519	REACTOME_REGULATION_OF_IFNA_SIGNALING	23	0.5177565	0.9812968	1	1.5565824	0.5210694
PID_ER_NONGENOMIC_PATHWAY	c2.CP_ Canonical pathways	40	1.038796	0.3882353	0.6359481	PID_ER_NONGENOMIC_PATHWAY	40	0.80562323	0.7719298	1	1.84441923	0.23317277
GO_REGULATION_OF_ENDOCRINE_PROCESS	c5.BP_ GO biological process	38	1.038767	0.40861812	0.63594145	GO_REGULATION_OF_ENDOCRINE_PROCESS	43	0.85753	0.7058824	1	1.896297	0.181237
GCM_CALM1	c4.CGN_ cancer gene neighborhoods	95	1.0387515	0.38303342	0.6358878	GCM_CALM1	95	0.84195185	0.7787144	1	1.88070335	0.19679965
GO_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS	c5.BP_ GO biological process	156	1.0387359	0.40598804	0.6358408	GO_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS	160	0.8203272	0.8546571	1	1.8590631	0.2184087
GO_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	240	1.0387304	0.36191538	0.63575906	GO_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS	244	0.84836936	0.85844284	1	1.88709976	0.19036104
EHLERS_ANEUPLOIDY_UP	c2.CGP_ chemical and genetic perturbations	37	1.0385624	0.38540146	0.63617694	EHLERS_ANEUPLOIDY_UP	37	-1.6664106	0.013605442	0.066494524	-0.6278482	2.704973
GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP	C7_ immunologic signatures	148	1.0384655	0.3857143	0.63637555	GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP	154	1.2497057	0.060081467	0.51124465	2.2881712	-0.2112402
MORF_RAP1A	c4.CGN_ cancer gene neighborhoods	125	1.0381955	0.37752524	0.6371122	MORF_RAP1A	133	0.6172717	0.9969419	1	1.6554672	0.4209238
GO_EMBRYONIC_AXIS_SPECIFICATION	c5.BP_ GO biological process	31	1.0381749	0.4077381	0.637083	GO_EMBRYONIC_AXIS_SPECIFICATION	32	0.57856363	0.96634614	1	1.61673853	0.45961127
GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP	C7_ immunologic signatures	177	1.0381484	0.37799042	0.6370706	GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP	182	1.0563363	0.364467	0.8306097	2.0944847	-0.0181879
GO_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY	c5.BP_ GO biological process	45	1.0381316	0.41029206	0.6370273	GO_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY	45	0.7796407	0.81359905	1	1.8177723	0.2584909
GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP	C7_ immunologic signatures	176	1.0381033	0.38255814	0.6370213	GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP	181	1.3150219	0.022380468	0.41776252	2.3531252	-0.2769186
MORI_MATURE_B_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	74	1.0380903	0.3811421	0.6369691	MORI_MATURE_B_LYMPHOCYTE_UP	80	1.3493919	0.04710921	0.3831265	2.3874822	-0.3113016
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	c2.CGP_ chemical and genetic perturbations	117	1.0379744	0.3893696	0.6372357	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	117	0.69598967	0.9657676	1	1.73396407	0.34198473
STREICHER_LSM1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	42	1.0378146	0.3943662	0.6376375	STREICHER_LSM1_TARGETS_UP	42	1.1163361	0.3122886	0.72879493	2.1541507	-0.0785215
GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	136	1.0377796	0.41442543	0.637646	GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	141	0.86877304	0.76185566	1	1.90655264	0.16900656
WIERENGA_STAT5A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	177	1.0377777	0.39568347	0.63755435	WIERENGA_STAT5A_TARGETS_UP	180	1.0923959	0.28064844	0.7685787	2.1301736	-0.0546182
GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN	C7_ immunologic signatures	175	1.0376315	0.3903302	0.6379071	GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN	177	0.8554414	0.82573456	1	1.8930729	0.1821901
IPF1_Q4	c3.TFT_ transcription factor targets	216	1.0375222	0.38056207	0.63814294	IPF1_Q4	222	0.77629054	0.9294355	1	1.81381274	0.26123166
GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP	C7_ immunologic signatures	164	1.0374159	0.37032568	0.6383749	GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP	168	1.0408406	0.40243903	0.8580132	2.0782565	-0.0034247
GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP	C7_ immunologic signatures	105	1.0373886	0.4	0.6383632	GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP	119	0.8407947	0.8119219	1	1.8781833	0.1965939
GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN	C7_ immunologic signatures	172	1.0372123	0.38717338	0.63881737	GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN	175	1.1826439	0.13171226	0.61842674	2.2198562	-0.1454316
GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	158	1.0371176	0.37181044	0.63900477	GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP	173	1.3529019	0.011167512	0.38288727	2.3900195	-0.3157843
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	28	1.0370812	0.4224924	0.6390205	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	28	-1.2657954	0.123595506	0.3109584	-0.2287142	2.3028766
REACTOME_PI3K_AKT_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	36	1.0370485	0.39642325	0.63902557	REACTOME_PI3K_AKT_ACTIVATION	36	1.0756389	0.36866903	0.79517984	2.1126874	-0.0385904
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN	C7_ immunologic signatures	176	1.037008	0.37294117	0.63905454	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN	181	0.7028155	0.97067744	1	1.7398235	0.3341925
GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	C7_ immunologic signatures	174	1.0369127	0.379717	0.63925225	GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	181	0.9186581	0.7001013	1	1.9555708	0.1182546
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	c2.CP_REACTOME_ Reactome gene sets	24	1.0369028	0.41500765	0.63918203	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	27	1.6915257	0.003740648	0.08498717	2.7284285	-0.6546229
CAGNWMCNNNGAC_UNKNOWN	c3.TFT_ transcription factor targets	70	1.0368919	0.41712707	0.63911647	CAGNWMCNNNGAC_UNKNOWN	73	1.0552719	0.4069264	0.8327356	2.0921638	-0.01838
AACTGGA_MIR145	c3.MIR_ microRNA targets	213	1.0368329	0.39211136	0.63920325	AACTGGA_MIR145	214	0.96376735	0.58971775	0.96714544	2.00060025	0.07306555
GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_UP	C7_ immunologic signatures	168	1.036812	0.38666666	0.63917273	GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_UP	175	1.0295092	0.41971543	0.87601537	2.0663212	0.0073028
GO_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS	c5.BP_ GO biological process	43	1.0367904	0.40783745	0.6391393	GO_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS	46	1.3097279	0.11047836	0.42629737	2.3465183	-0.2729375
BROWNE_HCMV_INFECTION_1HR_DN	c2.CGP_ chemical and genetic perturbations	188	1.0367732	0.39526626	0.63909525	BROWNE_HCMV_INFECTION_1HR_DN	192	0.91821474	0.70879674	1	1.95498794	0.11855846
GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	148	1.0367441	0.38713592	0.6390889	GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	151	0.9302985	0.6734486	0.9987485	1.9670426	0.1064456
GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN	C7_ immunologic signatures	158	1.0367416	0.3809524	0.63899964	GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN	160	-1.0358273	0.3125	0.62922597	0.0009143	2.0725689
PID_DNA_PK_PATHWAY	c2.CP_ Canonical pathways	15	1.036654	0.4156051	0.6391708	PID_DNA_PK_PATHWAY	15	0.9040983	0.60897434	1	1.9407523	0.1325557
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	c2.CGP_ chemical and genetic perturbations	81	1.0366386	0.40136054	0.63912356	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	84	1.5502418	0.001059322	0.20839861	2.5868804	-0.5136032
GO_RESPONSE_TO_GAMMA_RADIATION	c5.BP_ GO biological process	47	1.0365769	0.40606937	0.63920695	GO_RESPONSE_TO_GAMMA_RADIATION	46	1.0200298	0.467279	0.89141613	2.0566067	0.0165471
GO_REGULATION_OF_LYASE_ACTIVITY	c5.BP_ GO biological process	61	1.0365766	0.41274238	0.63911104	GO_REGULATION_OF_LYASE_ACTIVITY	73	1.4474113	0.013043478	0.29409328	2.4839879	-0.4108347
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP	C7_ immunologic signatures	177	1.0364008	0.38586327	0.63954645	GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP	179	0.9354424	0.65858585	0.99437773	1.9718432	0.1009584
GO_HYALURONIC_ACID_BINDING	c5.GO molecular function	20	1.0362711	0.4254317	0.6398546	GO_HYALURONIC_ACID_BINDING	20	1.0953431	0.3478261	0.7642877	2.1316142	-0.059072
KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP	C7_ immunologic signatures	176	1.036268	0.39027283	0.639767	KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP	175	0.77965987	0.91093117	1	1.81592787	0.25660813
GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP	C7_ immunologic signatures	174	1.0362301	0.39975992	0.6397814	GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP	180	0.94782794	0.6297787	0.9842045	1.98405804	0.08840216
MODULE_453	c4.CM_ cancer modules	36	1.0362256	0.39253733	0.63969773	MODULE_453	39	1.3540679	0.081871346	0.38327834	2.3902935	-0.3178423
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP	C7_ immunologic signatures	178	1.0360501	0.38968825	0.64014304	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP	183	0.8459839	0.8408862	1	1.882034	0.1900662
CTCAGGG_MIR125B_MIR125A	c3.MIR_ microRNA targets	303	1.035997	0.37037036	0.6402107	CTCAGGG_MIR125B_MIR125A	304	0.9880773	0.5300601	0.93775594	2.0240743	0.0479197
GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP	C7_ immunologic signatures	169	1.0358529	0.38443395	0.64055485	GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP	168	0.5212916	1	1	1.5571445	0.5145613
GO_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL	c5.BP_ GO biological process	256	1.0358464	0.37853107	0.6404795	GO_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL	259	0.86165047	0.8314945	1	1.89749687	0.17419593
GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	C7_ immunologic signatures	170	1.0357811	0.37724552	0.6405825	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	175	0.9789178	0.550856	0.95055896	2.0146989	0.0568633
GO_CELL_LEADING_EDGE	c5.CC_ GO cellular component	324	1.0357454	0.375803	0.64060086	GO_CELL_LEADING_EDGE	326	1.1018158	0.1971972	0.75393283	2.1375612	-0.0660704
GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP	C7_ immunologic signatures	168	1.035729	0.38388625	0.64055324	GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP	170	1.3110243	0.023279352	0.42445055	2.3467533	-0.2752953
ATCATGA_MIR433	c3.MIR_ microRNA targets	103	1.0357285	0.40891218	0.6404585	ATCATGA_MIR433	104	0.6731461	0.9573805	1	1.7088746	0.3625824
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	c2.CGP_ chemical and genetic perturbations	15	1.0357018	0.40746754	0.64044404	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	17	0.54440325	0.9714286	1	1.58010505	0.49129855
GSE17721_CTRL_VS_CPG_24H_BMDC_UP	C7_ immunologic signatures	175	1.035646	0.41575757	0.64051217	GSE17721_CTRL_VS_CPG_24H_BMDC_UP	180	1.0904756	0.2880161	0.770626	2.1261216	-0.0548296
PID_HEDGEHOG_2PATHWAY	c2.CP_ Canonical pathways	20	1.0356451	0.4348485	0.6404175	PID_HEDGEHOG_2PATHWAY	21	-0.90274966	0.5970149	0.8175672	0.13289544	1.93839476
GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP	C7_ immunologic signatures	170	1.0355555	0.3988304	0.6406042	GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP	177	1.0857775	0.3030303	0.77633065	2.121333	-0.050222
TBP_01	c3.TFT_ transcription factor targets	210	1.0354053	0.38488373	0.6409732	TBP_01	219	0.83271456	0.88531184	1	1.86811986	0.20269074
GSE3982_EOSINOPHIL_VS_NKCELL_UP	C7_ immunologic signatures	167	1.0353559	0.39073634	0.6410162	GSE3982_EOSINOPHIL_VS_NKCELL_UP	172	0.9357817	0.63195145	0.99385804	1.9711376	0.0995742
GO_ACTIVATION_OF_MAPK_ACTIVITY	c5.BP_ GO biological process	122	1.03534	0.38060606	0.64097166	GO_ACTIVATION_OF_MAPK_ACTIVITY	128	1.3314748	0.024590164	0.40028337	2.3668148	-0.2961348
ACTGCAG_MIR173P	c3.MIR_ microRNA targets	94	1.035339	0.37239584	0.6408776	ACTGCAG_MIR173P	97	-0.72675556	1	0.9481536	0.30858344	1.76209456
MORF_PTPRR	c4.CGN_ cancer gene neighborhoods	70	1.0352935	0.3909091	0.64093554	MORF_PTPRR	77	1.3425823	0.052406415	0.39272016	2.3778758	-0.3072888
PID_BETA_CATENIN_NUC_PATHWAY	c2.CP_ Canonical pathways	69	1.0352067	0.38718292	0.6410993	PID_BETA_CATENIN_NUC_PATHWAY	72	0.73216975	0.90172786	1	1.76737645	0.30303695
GSE24210_IL35_TREATED_VS_RESTING_TREG_UP	C7_ immunologic signatures	164	1.0350919	0.38617402	0.64136213	GSE24210_IL35_TREATED_VS_RESTING_TREG_UP	168	1.2650259	0.04883011	0.4906236	2.3001178	-0.229934
GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	C7_ immunologic signatures	179	1.0350603	0.40636042	0.641363	GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	187	1.2565542	0.038422648	0.500665	2.2916145	-0.2214939
GO_RESPONSE_TO_XENOBIOTIC_STIMULUS	c5.BP_ GO biological process	78	1.0349627	0.4029451	0.64156044	GO_RESPONSE_TO_XENOBIOTIC_STIMULUS	82	1.3523484	0.023630505	0.38304165	2.3873111	-0.3173857
GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP	C7_ immunologic signatures	181	1.0348377	0.40140846	0.64184713	GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP	182	0.8481279	0.8319838	1	1.8829656	0.1867098
GSE557_WT_VS_CIITA_KO_DC_DN	C7_ immunologic signatures	180	1.0347534	0.38915664	0.6420065	GSE557_WT_VS_CIITA_KO_DC_DN	182	0.81620866	0.88145894	1	1.85096206	0.21854474
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	c2.CP_REACTOME_ Reactome gene sets	20	1.0347122	0.43290734	0.6420369	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	23	1.1523824	0.27909887	0.6657214	2.1870946	-0.1176702
GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN	C7_ immunologic signatures	177	1.0346986	0.38106796	0.64198315	GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN	176	1.3371166	0.017102616	0.39864835	2.3718152	-0.302418
GO_NEURON_MIGRATION	c5.BP_ GO biological process	93	1.034586	0.38642296	0.6422451	GO_NEURON_MIGRATION	101	1.1727958	0.19037656	0.6330138	2.2073818	-0.1382098
REACTOME_SIGNALING_BY_EGFR_IN_CANCER	c2.CP_REACTOME_ Reactome gene sets	98	1.0342184	0.39344263	0.64329195	REACTOME_SIGNALING_BY_EGFR_IN_CANCER	99	1.1537671	0.20991561	0.6632077	2.1879855	-0.1195487
GNF2_FOS	c4.CGN_ cancer gene neighborhoods	31	1.0341932	0.42684767	0.64327806	GNF2_FOS	32	1.4773096	0.015348288	0.2708829	2.5115028	-0.4431164
GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP	C7_ immunologic signatures	176	1.0340854	0.3937198	0.64351666	GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP	177	0.56683815	1	1	1.60092355	0.46724725
GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN	C7_ immunologic signatures	174	1.0340723	0.3931624	0.643455	GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN	174	0.90927124	0.7153061	1	1.94334354	0.12480106
GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP	C7_ immunologic signatures	160	1.0340483	0.4185766	0.643433	GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP	166	1.1174977	0.2494929	0.72758114	2.151546	-0.0834494
GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP	C7_ immunologic signatures	137	1.034009	0.39141414	0.6434584	GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP	143	1.0230457	0.45325205	0.8867305	2.0570547	0.0109633
RIZKI_TUMOR_INVASIVENESS_3D_DN	c2.CGP_ chemical and genetic perturbations	237	1.0339729	0.4004525	0.6434706	RIZKI_TUMOR_INVASIVENESS_3D_DN	240	0.92515844	0.6931589	1	1.95913134	0.10881446
GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN	C7_ immunologic signatures	173	1.0337828	0.4011905	0.6439598	GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN	175	0.92138886	0.6864919	1	1.95517166	0.11239394
GO_NEURON_APOPTOTIC_PROCESS	c5.BP_ GO biological process	33	1.0336921	0.42857143	0.64413434	GO_NEURON_APOPTOTIC_PROCESS	34	1.170096	0.2482353	0.63819313	2.2037881	-0.1364039
GO_CEREBELLAR_CORTEX_FORMATION	c5.BP_ GO biological process	21	1.0336546	0.41744548	0.6441527	GO_CEREBELLAR_CORTEX_FORMATION	22	-0.90316176	0.6130653	0.8172718	0.13049284	1.93681636
GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP	C7_ immunologic signatures	150	1.0335783	0.40024784	0.64429915	GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP	153	1.40066	0.002034588	0.33861026	2.4342383	-0.3670817
GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN	C7_ immunologic signatures	168	1.0335357	0.3838973	0.64433324	GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN	169	1.2140253	0.08004053	0.5700412	2.247561	-0.1804896
GO_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY	c5.BP_ GO biological process	18	1.0334789	0.4274062	0.6444183	GO_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY	18	-0.85869646	0.65	0.86167955	0.17478244	1.89217536
GO_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY	c5.BP_ GO biological process	20	1.0332575	0.42121685	0.64499617	GO_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY	22	1.047814	0.41108248	0.84383464	2.0810715	-0.0145565
GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	147	1.0332496	0.39412484	0.64492124	GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN	147	0.8161389	0.8596311	1	1.8493885	0.2171107
RORA1_01	c3.TFT_ transcription factor targets	216	1.0332131	0.39285713	0.64493006	RORA1_01	220	0.7924421	0.9155779	1	1.8256552	0.240771
GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN	C7_ immunologic signatures	180	1.0330648	0.39764705	0.64529413	GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN	178	1.0949619	0.27327934	0.7648051	2.1280267	-0.0618971
GO_CARGO_RECEPTOR_ACTIVITY	c5.GO molecular function	53	1.0330112	0.41086352	0.6453539	GO_CARGO_RECEPTOR_ACTIVITY	53	1.4187394	0.026578072	0.3200966	2.4517506	-0.3857282
GO_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY	c5.BP_ GO biological process	207	1.0329155	0.3892694	0.6455478	GO_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY	215	1.0368384	0.41330644	0.8641675	2.0697539	-0.0039229
GRABARCZYK_BCL11B_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	50	1.0327972	0.4011065	0.6458176	GRABARCZYK_BCL11B_TARGETS_DN	50	0.8917223	0.6592675	1	1.9245195	0.1410749
YAGI_AML_FAB_MARKERS	c2.CGP_ chemical and genetic perturbations	170	1.0327387	0.38199514	0.6458977	YAGI_AML_FAB_MARKERS	174	0.95401865	0.61094224	0.9771326	1.98675735	0.07872005
GO_REGULATION_OF_MEMBRANE_DEPOLARIZATION	c5.BP_ GO biological process	36	1.0327283	0.41339156	0.64582855	GO_REGULATION_OF_MEMBRANE_DEPOLARIZATION	38	1.3955685	0.047235023	0.346662	2.4282968	-0.3628402
GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP	C7_ immunologic signatures	168	1.0327024	0.38307872	0.645813	GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP	175	1.0709603	0.3255578	0.8034287	2.1036627	-0.0382579
LU_TUMOR_VASCULATURE_UP	c2.CGP_ chemical and genetic perturbations	26	1.0326457	0.4128167	0.6458869	LU_TUMOR_VASCULATURE_UP	26	1.1083617	0.32880098	0.74084187	2.1410074	-0.075716
GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	149	1.0325637	0.40316686	0.64605117	GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	149	1.1567975	0.1709054	0.6586544	2.1893612	-0.1242338
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	c2.CGP_ chemical and genetic perturbations	21	1.0324064	0.41835147	0.64644426	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	21	-1.1191124	0.29107982	0.48973227	-0.086706	2.1515188
GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN	C7_ immunologic signatures	157	1.0323113	0.3933254	0.6466319	GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN	156	0.626011	0.99390864	1	1.6583223	0.4063003
GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN	C7_ immunologic signatures	177	1.0322666	0.38968825	0.6466667	GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN	184	0.88566995	0.7578521	1	1.91793655	0.14659665
CRX_Q4	c3.TFT_ transcription factor targets	220	1.0321683	0.3951049	0.6468804	CRX_Q4	239	0.8626823	0.8373494	1	1.8948506	0.169486
GO_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION	c5.BP_ GO biological process	22	1.0321618	0.41290322	0.6468032	GO_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION	22	1.1401147	0.28109452	0.6902863	2.1722765	-0.1079529
GCM_RAP2A	c4.CGN_ cancer gene neighborhoods	34	1.0321417	0.41549295	0.6467662	GCM_RAP2A	34	0.58749086	0.96766466	1	1.61963256	0.44465084
CHR4Q21	C1: positional gene sets	65	1.0321274	0.39112905	0.6467103	CHR4Q21	69	1.0035459	0.4946581	0.917482	2.0356733	0.0285815
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP	C7_ immunologic signatures	92	1.0321021	0.41230366	0.646688	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP	105	1.1527039	0.20145379	0.6645765	2.184806	-0.1206018
GO_CELL_RECOGNITION	c5.BP_ GO biological process	99	1.0320063	0.39846742	0.6468806	GO_CELL_RECOGNITION	117	0.9670049	0.5812757	0.96440816	1.9990112	0.0650014
GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN	C7_ immunologic signatures	171	1.0319104	0.3893491	0.6470822	GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN	173	1.1709727	0.14038657	0.6372322	2.2028831	-0.1390623
VERHAAK_GLIOBLASTOMA_CLASSICAL	c2.CGP_ chemical and genetic perturbations	140	1.031886	0.4	0.64706224	VERHAAK_GLIOBLASTOMA_CLASSICAL	144	1.1630527	0.19008264	0.6480319	2.1949387	-0.1311667
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP	C7_ immunologic signatures	172	1.0318235	0.4055944	0.64715576	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP	178	1.2732952	0.039634146	0.48214528	2.3051187	-0.2414717
GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP	C7_ immunologic signatures	150	1.0317665	0.39540508	0.6472402	GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP	158	1.1168588	0.2392638	0.7286403	2.1486253	-0.0850923
AMIT_EGF_RESPONSE_480_HELA	c2.CGP_ chemical and genetic perturbations	149	1.0314984	0.3889556	0.6479664	AMIT_EGF_RESPONSE_480_HELA	152	0.83554983	0.8331627	1	1.86704823	0.19594857
GSE42021_TREG_VS_TCONV_PLN_DN	C7_ immunologic signatures	180	1.0313543	0.41079813	0.6482926	GSE42021_TREG_VS_TCONV_PLN_DN	184	1.3315921	0.015166835	0.40039733	2.3629464	-0.3002378
GO_PLATELET_DENSE_GRANULE	c5.CC_ GO cellular component	16	1.0313054	0.41680396	0.64834446	GO_PLATELET_DENSE_GRANULE	17	1.1308242	0.31225806	0.70529735	2.1621296	-0.0995188
GO_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS	c5.BP_ GO biological process	15	1.0312604	0.42246836	0.6483876	GO_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS	17	1.3105499	0.13298565	0.4255886	2.3418103	-0.2792895
GO_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE	c5.BP_ GO biological process	15	1.0312308	0.42389524	0.6483825	GO_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE	15	0.5448087	0.9660131	1	1.5760395	0.4864221
ONO_AML1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	19	1.0311048	0.40465117	0.6486781	ONO_AML1_TARGETS_UP	21	0.97751325	0.51492536	0.95187694	2.00861805	0.05359155
GO_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	40	1.0311034	0.4068768	0.64858425	GO_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY	40	0.75029695	0.8472064	1	1.78140035	0.28080645
GO_NODE_OF_RANVIER	c5.CC_ GO cellular component	15	1.0310901	0.42319277	0.6485271	GO_NODE_OF_RANVIER	15	1.3093302	0.13020134	0.4268162	2.3404203	-0.2782401
GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN	C7_ immunologic signatures	167	1.0309951	0.41190475	0.64872	GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN	169	0.93736565	0.635996	0.9931294	1.96836075	0.09362945
GO_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY	c5.BP_ GO biological process	19	1.030768	0.43349755	0.6493229	GO_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY	23	1.1822684	0.24535316	0.6194354	2.2130364	-0.1515004
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	175	1.0307331	0.3960047	0.6493338	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN	176	1.4555525	0.001010101	0.2866251	2.4862856	-0.4248194
GCAAGGA_MIR502	c3.MIR_ microRNA targets	69	1.0306963	0.4100529	0.6493484	GCAAGGA_MIR502	70	0.97157145	0.53721684	0.96010447	2.00226775	0.05912485
GO_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION	c5.BP_ GO biological process	50	1.0306242	0.42291373	0.64947706	GO_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION	52	-0.96802795	0.5102041	0.7330679	0.06259625	1.99865215
GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP	C7_ immunologic signatures	172	1.0306109	0.39012927	0.6494237	GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP	179	0.92054385	0.6898288	1	1.95115475	0.11006705
GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN	C7_ immunologic signatures	112	1.0306082	0.39745224	0.64933455	GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN	120	1.0164357	0.45987654	0.89517194	2.0470439	0.0141725
GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP	C7_ immunologic signatures	174	1.0305988	0.4051095	0.64927	GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP	179	1.0168248	0.46707192	0.89457923	2.0474236	0.013774
GO_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT	c5.BP_ GO biological process	105	1.0305328	0.40102172	0.6493804	GO_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT	107	0.72698253	0.9384776	1	1.75751533	0.30355027
GO_REGULATION_OF_PROTEIN_BINDING	c5.BP_ GO biological process	158	1.0304788	0.40047675	0.649456	GO_REGULATION_OF_PROTEIN_BINDING	161	1.2416021	0.05852674	0.5228339	2.2720809	-0.2111233
GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN	C7_ immunologic signatures	138	1.0304639	0.40072638	0.6494036	GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN	138	0.9625033	0.5961343	0.9685445	1.9929672	0.0679606
GO_CELLULAR_COMPONENT_MAINTENANCE	c5.BP_ GO biological process	17	1.0303931	0.4192	0.6495256	GO_CELLULAR_COMPONENT_MAINTENANCE	17	1.1964902	0.24934037	0.59669095	2.2268833	-0.1660971
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	c2.CGP_ chemical and genetic perturbations	40	1.0303359	0.40981242	0.6495992	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	41	-1.5287473	0.016393442	0.12621562	-0.4984114	2.5590832
GSE12366_NAIVE_VS_MEMORY_BCELL_UP	C7_ immunologic signatures	150	1.0302804	0.40391678	0.6496759	GSE12366_NAIVE_VS_MEMORY_BCELL_UP	154	1.1596977	0.18274112	0.65353674	2.1899781	-0.1294173
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN	C7_ immunologic signatures	155	1.0302234	0.4004884	0.6497557	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN	160	1.2822603	0.043610547	0.46911788	2.3124837	-0.2520369
GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP	C7_ immunologic signatures	157	1.0302191	0.40193704	0.64967096	GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP	167	1.047011	0.39126018	0.84497195	2.0772301	-0.0167919
PR_01	c3.TFT_ transcription factor targets	123	1.0301362	0.40667492	0.6498221	PR_01	128	0.840891	0.8221303	1	1.8710272	0.1892452
GO_SECRETORY_GRANULE_MEMBRANE	c5.CC_ GO cellular component	64	1.0300711	0.44	0.649936	GO_SECRETORY_GRANULE_MEMBRANE	71	1.4149733	0.022459893	0.32254663	2.4450444	-0.3849022
BROWNE_HCMV_INFECTION_18HR_DN	c2.CGP_ chemical and genetic perturbations	156	1.030059	0.41148326	0.64987814	BROWNE_HCMV_INFECTION_18HR_DN	159	1.2135082	0.10873984	0.5717456	2.2435672	-0.1834492
GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP	C7_ immunologic signatures	165	1.0299941	0.40141678	0.6499816	GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP	170	1.1289167	0.20591234	0.7068624	2.1589108	-0.0989226
MORF_JAG1	c4.CGN_ cancer gene neighborhoods	78	1.0299746	0.41099477	0.6499447	MORF_JAG1	84	1.4544457	0.008547009	0.2882575	2.4844203	-0.4244711
REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	c2.CP_REACTOME_ Reactome gene sets	22	1.0299649	0.42903227	0.64987534	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	27	-1.0099128	0.39130434	0.67267215	0.0200521	2.0398777
HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	c2.CGP_ chemical and genetic perturbations	148	1.0299342	0.39657283	0.6498698	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	150	-1.1523734	0.05	0.43966457	-0.1224392	2.1823076
AR_03	c3.TFT_ transcription factor targets	50	1.0299019	0.41446453	0.649874	AR_03	51	0.8368522	0.72883296	1	1.8667541	0.1930497
GO_MICROVILLUS_ORGANIZATION	c5.BP_ GO biological process	18	1.0298588	0.40454546	0.6499031	GO_MICROVILLUS_ORGANIZATION	18	-0.6426411	0.9213974	0.97767586	0.3872177	1.6724999
CAGCAGG_MIR370	c3.MIR_ microRNA targets	135	1.0298377	0.399754	0.64986897	CAGCAGG_MIR370	140	0.92271155	0.6663276	1	1.95254925	0.10712615
GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP	C7_ immunologic signatures	166	1.0298126	0.4138756	0.6498484	GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP	175	1.1115474	0.24186991	0.7352445	2.14136	-0.0817348
YTTCCNNNGGAMR_UNKNOWN	c3.TFT_ transcription factor targets	42	1.0297279	0.4180791	0.65001345	YTTCCNNNGGAMR_UNKNOWN	45	0.8355895	0.7325056	1	1.8653174	0.1941384
GO_NEUROBLAST_PROLIFERATION	c5.BP_ GO biological process	23	1.0296857	0.44785276	0.6500482	GO_NEUROBLAST_PROLIFERATION	27	0.8230388	0.743309	1	1.8527245	0.2066469
GO_NEURON_PROJECTION_MEMBRANE	c5.CC_ GO cellular component	32	1.0296015	0.43883792	0.65020645	GO_NEURON_PROJECTION_MEMBRANE	34	-0.98580724	0.47741935	0.70662355	0.04379426	2.01540874
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	c2.CGP_ chemical and genetic perturbations	30	1.0294425	0.42563292	0.65059227	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	33	1.1617347	0.2674556	0.6510093	2.1911772	-0.1322922
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	162	1.0293763	0.3907767	0.65070075	GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN	172	0.989912	0.52077	0.935279	2.0192883	0.0394643
GSE14308_TH2_VS_TH1_DN	C7_ immunologic signatures	177	1.0293661	0.39880952	0.6506348	GSE14308_TH2_VS_TH1_DN	182	1.1201808	0.22087133	0.72325337	2.1495469	-0.0908147
TERAMOTO_OPN_TARGETS_CLUSTER_6	c2.CGP_ chemical and genetic perturbations	25	1.0291896	0.43267778	0.6510729	TERAMOTO_OPN_TARGETS_CLUSTER_6	25	0.82419884	0.74438906	1	1.85338844	0.20499076
GSE29618_MONOCYTE_VS_PDC_UP	C7_ immunologic signatures	165	1.0290432	0.39504716	0.651419	GSE29618_MONOCYTE_VS_PDC_UP	167	1.1655596	0.14863499	0.64579344	2.1946028	-0.1365164
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	c2.CGP_ chemical and genetic perturbations	472	1.0289376	0.4050633	0.65164715	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	472	0	0	0	1.0289376	1.0289376
KTGGYRSGAA_UNKNOWN	c3.TFT_ transcription factor targets	70	1.0288681	0.4021739	0.65177125	KTGGYRSGAA_UNKNOWN	71	-1.6040988	0	0.0895774	-0.5752307	2.6329669
GO_ERROR_FREE_TRANSLESION_SYNTHESIS	c5.BP_ GO biological process	16	1.0287557	0.43387097	0.6520257	GO_ERROR_FREE_TRANSLESION_SYNTHESIS	16	-1.0568724	0.3625498	0.5940283	-0.0281167	2.0856281
PID_SYNDECAN_4_PATHWAY	c2.CP_ Canonical pathways	31	1.0286311	0.4287879	0.65231484	PID_SYNDECAN_4_PATHWAY	29	1.207518	0.21568628	0.5803707	2.2361491	-0.1788869
PRAMOONJAGO_SOX4_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	48	1.0285914	0.41678727	0.65233856	PRAMOONJAGO_SOX4_TARGETS_UP	49	1.1758448	0.2240991	0.6280758	2.2044362	-0.1472534
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN	C7_ immunologic signatures	160	1.0285676	0.4155194	0.6523132	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN	171	1.0620747	0.3506626	0.8191157	2.0906423	-0.0335071
GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN	C7_ immunologic signatures	174	1.0285172	0.39294118	0.65237015	GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN	177	0.7273875	0.958502	1	1.7559047	0.3011297
GO_REGULATION_OF_NEURON_APOPTOTIC_PROCESS	c5.BP_ GO biological process	175	1.028385	0.39458185	0.6526845	GO_REGULATION_OF_NEURON_APOPTOTIC_PROCESS	182	0.8264092	0.8592965	1	1.8547942	0.2019758
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	c2.CGP_ chemical and genetic perturbations	21	1.0282986	0.42512077	0.65284806	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	20	1.0175614	0.4537389	0.8935871	2.04586	0.0107372
CHR7Q21	C1: positional gene sets	64	1.0280463	0.404	0.6535367	CHR7Q21	67	1.2155912	0.1471536	0.5651123	2.2436375	-0.1875449
GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN	C7_ immunologic signatures	107	1.0279804	0.41353384	0.6536357	GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN	110	1.1932698	0.14403293	0.60039675	2.2212502	-0.1652894
HAN_JNK_SINGALING_DN	c2.CGP_ chemical and genetic perturbations	37	1.0279455	0.41531664	0.65364313	HAN_JNK_SINGALING_DN	36	-1.2301893	0.12162162	0.34559992	-0.2022438	2.2581348
GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP	C7_ immunologic signatures	162	1.0279351	0.39083233	0.6535783	GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP	169	0.80428666	0.8922457	1	1.83222176	0.22364844
GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	180	1.0278554	0.39166668	0.65372235	GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	183	0.93030417	0.6596386	0.9988591	1.95815957	0.09755123
MORF_ESR1	c4.CGN_ cancer gene neighborhoods	132	1.0278246	0.40892193	0.6537284	MORF_ESR1	149	1.0724069	0.31836733	0.80254847	2.1002315	-0.0445823
SRC_UP.V1_DN	C6_ oncogenic signatures	125	1.0278022	0.42610836	0.6536974	SRC_UP.V1_DN	133	0.9358889	0.63766634	0.9940512	1.9636911	0.0919133
MODULE_378	c4.CM_ cancer modules	355	1.0277437	0.39583334	0.6537815	MODULE_378	361	1.1833435	0.062	0.6175988	2.2110872	-0.1555998
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP	C7_ immunologic signatures	175	1.0275942	0.430622	0.65414405	GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP	178	1.1075506	0.25	0.741587	2.1351448	-0.0799564
EGR2_01	c3.TFT_ transcription factor targets	175	1.0274987	0.41197184	0.65434164	EGR2_01	181	0.91813534	0.69727546	1	1.94563404	0.10936336
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP	C7_ immunologic signatures	180	1.0274535	0.38842976	0.65437895	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP	180	0.68802136	0.98689514	1	1.71547486	0.33943214
GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN	C7_ immunologic signatures	145	1.0273832	0.39177752	0.6544936	GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN	148	1.2125067	0.11597151	0.57350445	2.2398899	-0.1851235
GALE_APL_WITH_FLT3_MUTATED_UP	c2.CGP_ chemical and genetic perturbations	48	1.0273768	0.40145984	0.6544167	GALE_APL_WITH_FLT3_MUTATED_UP	48	-0.9245586	0.5660377	0.789746	0.1028182	1.9519354
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP	C7_ immunologic signatures	153	1.0273322	0.39783654	0.6544583	GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP	156	1.2646607	0.051072523	0.49059215	2.2919929	-0.2373285
GYORFFY_MITOXANTRONE_RESISTANCE	c2.CGP_ chemical and genetic perturbations	45	1.0272518	0.406657	0.65459937	GYORFFY_MITOXANTRONE_RESISTANCE	47	1.1730934	0.22095671	0.6336347	2.2003452	-0.1458416
GO_ENDOSOME_TO_LYSOSOME_TRANSPORT	c5.BP_ GO biological process	38	1.0272294	0.4237037	0.65457076	GO_ENDOSOME_TO_LYSOSOME_TRANSPORT	39	1.0541213	0.40850058	0.83499646	2.0813507	-0.0268919
SANSOM_APC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	108	1.0272133	0.4117647	0.6545262	SANSOM_APC_TARGETS_UP	113	0.7887349	0.8732984	1	1.8159482	0.2384784
GO_PEPTIDYL_LYSINE_MODIFICATION	c5.BP_ GO biological process	266	1.0270777	0.39417693	0.6548438	GO_PEPTIDYL_LYSINE_MODIFICATION	269	-0.94730943	0.8	0.76005447	0.07976827	1.97438713
KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	173	1.0270319	0.41824645	0.65488255	KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP	178	1.0961399	0.2704339	0.76282215	2.1231718	-0.069108
GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN	C7_ immunologic signatures	159	1.0269382	0.4097561	0.65507835	GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN	167	1.0958552	0.28134558	0.7633562	2.1227934	-0.068917
GGGGCCC_MIR296	c3.MIR_ microRNA targets	64	1.0268904	0.43949932	0.6551234	GGGGCCC_MIR296	68	-1.0526874	0.31506848	0.6006041	-0.025797	2.0795778
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	c2.CGP_ chemical and genetic perturbations	116	1.02687	0.4125786	0.65508604	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	117	0.8560005	0.77743274	1	1.8828705	0.1708695
GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP	C7_ immunologic signatures	170	1.0268564	0.4129111	0.6550316	GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP	169	1.044388	0.40890688	0.8498062	2.0712444	-0.0175316
MODULE_7	c4.CM_ cancer modules	194	1.0268517	0.39372823	0.6549486	MODULE_7	205	1.4253309	0.001015229	0.3187178	2.4521826	-0.3984792
GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP	C7_ immunologic signatures	177	1.0267646	0.40584797	0.6551159	GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP	179	1.4051132	0.001014199	0.33339545	2.4318778	-0.3783486
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP	C7_ immunologic signatures	172	1.0267024	0.41190198	0.65521604	GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP	175	1.1218755	0.21849594	0.7225374	2.1485779	-0.0951731
GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN	C7_ immunologic signatures	178	1.0265926	0.4084014	0.6554532	GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN	182	0.6945228	0.9726444	1	1.7211154	0.3320698
BASAKI_YBX1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	324	1.0265472	0.4067245	0.65548927	BASAKI_YBX1_TARGETS_DN	324	1.2256813	0.0250501	0.5481844	2.2522285	-0.1991341
GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN	C7_ immunologic signatures	149	1.0265324	0.39783654	0.65543604	GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN	152	0.9269222	0.6642857	1	1.9534546	0.0996102
GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN	C7_ immunologic signatures	170	1.0264052	0.4177671	0.655721	GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN	174	1.3161123	0.024242423	0.4164393	2.3425175	-0.2897071
AATGTGA_MIR23A_MIR23B	c3.MIR_ microRNA targets	376	1.0261717	0.40648648	0.65633786	AATGTGA_MIR23A_MIR23B	380	0.8374221	0.9218437	1	1.8635938	0.1887496
GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	170	1.0261308	0.39786223	0.65636957	GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN	179	0.69216055	0.9676441	1	1.71829135	0.33397025
GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN	C7_ immunologic signatures	161	1.0260862	0.4066339	0.6564123	GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN	168	1.0896008	0.2936428	0.7716807	2.115687	-0.0635146
PID_GMCSF_PATHWAY	c2.CP_ Canonical pathways	35	1.0260838	0.40963855	0.6563246	PID_GMCSF_PATHWAY	34	1.6116991	0.003597122	0.14753929	2.6377829	-0.5856153
AP2_Q6_01	c3.TFT_ transcription factor targets	242	1.0259767	0.4061086	0.6565566	AP2_Q6_01	249	0.72300106	0.9809045	1	1.74897776	0.30297564
GO_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST	c5.BP_ GO biological process	107	1.0259154	0.40436456	0.65665036	GO_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST	110	0.83687437	0.8096234	1	1.86278977	0.18904103
CHR19P13	C1: positional gene sets	401	1.0258973	0.4032258	0.65660566	CHR19P13	410	0.7569332	0.982	1	1.7828305	0.2689641
GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP	C7_ immunologic signatures	185	1.025892	0.40956825	0.6565246	GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP	185	0.88188034	0.7660643	1	1.90777234	0.14401166
GO_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT	c5.BP_ GO biological process	45	1.0257859	0.41759777	0.6567578	GO_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT	45	-1.0966188	0.26771653	0.5228141	-0.0708329	2.1224047
GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP	C7_ immunologic signatures	153	1.0257148	0.42092457	0.65688264	GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP	155	1.3710021	0.008163265	0.36709157	2.3967169	-0.3452873
GO_N_ACYLTRANSFERASE_ACTIVITY	c5.GO molecular function	88	1.0256411	0.41329858	0.6570135	GO_N_ACYLTRANSFERASE_ACTIVITY	89	0.49444252	0.9989452	1	1.52008362	0.53119858
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	c2.CGP_ chemical and genetic perturbations	21	1.0256107	0.44816586	0.657008	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	22	1.1430058	0.3080873	0.6842611	2.1686165	-0.1173951
GSE7460_TREG_VS_TCONV_ACT_DN	C7_ immunologic signatures	164	1.0251536	0.41079813	0.6583285	GSE7460_TREG_VS_TCONV_ACT_DN	168	1.3400078	0.01010101	0.39688176	2.3651614	-0.3148542
GO_REGULATION_OF_CHOLESTEROL_EFFLUX	c5.BP_ GO biological process	18	1.0249962	0.41204438	0.6587078	GO_REGULATION_OF_CHOLESTEROL_EFFLUX	18	-1.0500436	0.3991228	0.6061305	-0.0250474	2.0750398
GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP	C7_ immunologic signatures	167	1.0249336	0.4192771	0.6588007	GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP	169	0.77676946	0.9066937	1	1.80170306	0.24816414
PID_FAS_PATHWAY	c2.CP_ Canonical pathways	36	1.024804	0.44283646	0.6591045	PID_FAS_PATHWAY	37	0.79284126	0.79696614	1	1.81764526	0.23196274
GSE27786_LIN_NEG_VS_NKCELL_DN	C7_ immunologic signatures	180	1.0247681	0.40692124	0.6591056	GSE27786_LIN_NEG_VS_NKCELL_DN	181	0.7159365	0.9595551	1	1.7407046	0.3088316
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	c2.CGP_ chemical and genetic perturbations	81	1.0247475	0.40620783	0.65906364	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	88	1.4806752	0.007478633	0.26809004	2.5054227	-0.4559277
GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP	C7_ immunologic signatures	180	1.0245086	0.40998837	0.6596978	GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP	182	1.135991	0.20304568	0.69614875	2.1604996	-0.1114824
WEI_MIR34A_TARGETS	c2.CGP_ chemical and genetic perturbations	131	1.0244188	0.4092664	0.65987885	WEI_MIR34A_TARGETS	134	0.73613346	0.930824	1	1.76055226	0.28828534
GO_MHC_PROTEIN_BINDING	c5.GO molecular function	17	1.0244014	0.41747573	0.6598422	GO_MHC_PROTEIN_BINDING	19	1.4695492	0.047741935	0.27550188	2.4939506	-0.4451478
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP	C7_ immunologic signatures	142	1.0243002	0.41041163	0.660058	GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP	146	1.1860182	0.11716341	0.61334103	2.2103184	-0.161718
CEBPDELTA_Q6	c3.TFT_ transcription factor targets	210	1.0242776	0.4238259	0.6600317	CEBPDELTA_Q6	217	0.9530154	0.6232465	0.97807616	1.977293	0.0712622
GSE14308_TH2_VS_TH1_UP	C7_ immunologic signatures	179	1.0242367	0.39836448	0.6600638	GSE14308_TH2_VS_TH1_UP	181	0.51340425	1	1	1.53764095	0.51083245
CHR6Q16	C1: positional gene sets	20	1.0242019	0.42438272	0.6600784	CHR6Q16	21	-1.0216866	0.39655173	0.65698296	0.0025153	2.0458885
GO_KINESIN_BINDING	c5.GO molecular function	29	1.0241748	0.42684767	0.66006094	GO_KINESIN_BINDING	29	1.2112601	0.2053463	0.5755642	2.2354349	-0.1870853
GO_PROTEIN_DNA_COMPLEX_SUBUNIT_ORGANIZATION	c5.BP_ GO biological process	169	1.0239372	0.4128655	0.66070604	GO_PROTEIN_DNA_COMPLEX_SUBUNIT_ORGANIZATION	171	0.8945318	0.7613751	1	1.918469	0.1294054
GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN	C7_ immunologic signatures	163	1.023835	0.40639812	0.66093034	GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN	166	0.98209417	0.54247695	0.9458987	2.00592917	0.04174083
GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN	C7_ immunologic signatures	169	1.023728	0.4318182	0.66116124	GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN	181	1.0890254	0.27547932	0.7724712	2.1127534	-0.0652974
GO_TRANSPORTER_COMPLEX	c5.CC_ GO cellular component	263	1.0237237	0.42117116	0.66107774	GO_TRANSPORTER_COMPLEX	297	1.3180989	0.005015045	0.41350353	2.3418226	-0.2943752
MURAKAMI_UV_RESPONSE_6HR_UP	c2.CGP_ chemical and genetic perturbations	32	1.0236964	0.43255132	0.6610615	MURAKAMI_UV_RESPONSE_6HR_UP	34	0.8097341	0.76337695	1	1.8334305	0.2139623
GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN	C7_ immunologic signatures	173	1.0236398	0.40669855	0.66113997	GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN	174	-0.99046355	0.5555556	0.7014369	0.03317625	2.01410335
GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP	C7_ immunologic signatures	172	1.0236335	0.4225352	0.6610641	GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP	181	1.0687255	0.34141415	0.8079436	2.092359	-0.045092
GSE14350_IL2RB_KO_VS_WT_TEFF_DN	C7_ immunologic signatures	174	1.0235773	0.42009684	0.66114557	GSE14350_IL2RB_KO_VS_WT_TEFF_DN	180	-1.3950098	0	0.21096021	-0.3714325	2.4185871
GSE20715_0H_VS_48H_OZONE_LUNG_UP	C7_ immunologic signatures	183	1.0235736	0.4097788	0.6610591	GSE20715_0H_VS_48H_OZONE_LUNG_UP	187	0.84145296	0.8546922	1	1.86502656	0.18212064
GO_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION	c5.BP_ GO biological process	34	1.0235659	0.43703705	0.66098374	GO_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION	38	1.2032555	0.20967741	0.5864667	2.2268214	-0.1796896
GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN	C7_ immunologic signatures	172	1.023518	0.4177671	0.6610373	GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN	174	0.8999557	0.734879	1	1.9234737	0.1235623
HNF4_Q6	c3.TFT_ transcription factor targets	234	1.0234072	0.41271678	0.6612777	HNF4_Q6	239	1.0499402	0.3671013	0.8402843	2.0733474	-0.026533
GO_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	35	1.0233369	0.43396226	0.6614043	GO_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION	39	1.2275248	0.17437722	0.54558706	2.2508617	-0.2041879
GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN	C7_ immunologic signatures	160	1.0233295	0.42840096	0.6613334	GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN	162	1.207216	0.1023303	0.5805761	2.2305455	-0.1838865
GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN	C7_ immunologic signatures	171	1.0233161	0.42227662	0.6612773	GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN	174	0.9243419	0.7076613	1	1.947658	0.0989742
HALLMARK_UV_RESPONSE_UP	H_ hallmark gene sets	149	1.0233088	0.4232614	0.6612035	HALLMARK_UV_RESPONSE_UP	149	0.90557534	0.72008115	1	1.92888414	0.11773346
GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	20	1.023253	0.43730888	0.661276	GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT	24	1.0330178	0.4404015	0.87195	2.0562708	-0.0097648
LAIHO_COLORECTAL_CANCER_SERRATED_UP	c2.CGP_ chemical and genetic perturbations	102	1.0230376	0.43427834	0.6618429	LAIHO_COLORECTAL_CANCER_SERRATED_UP	103	0.7276061	0.9217119	1	1.7506437	0.2954315
GO_REGULATION_OF_MICROTUBULE_POLYMERIZATION	c5.BP_ GO biological process	30	1.0229867	0.42581603	0.6618978	GO_REGULATION_OF_MICROTUBULE_POLYMERIZATION	31	0.60800344	0.9583333	1	1.63099014	0.41498326
GO_REGULATION_OF_NOTCH_SIGNALING_PATHWAY	c5.BP_ GO biological process	59	1.0229253	0.4011065	0.6619942	GO_REGULATION_OF_NOTCH_SIGNALING_PATHWAY	62	1.1337494	0.279558	0.7005254	2.1566747	-0.1108241
GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	181	1.0228642	0.4049881	0.6620873	GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	184	1.0313339	0.44016227	0.8744937	2.0541981	-0.0084697
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	c2.CGP_ chemical and genetic perturbations	46	1.0227687	0.4348442	0.6622808	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	54	1.6208211	0.003293084	0.14085132	2.6435898	-0.5980524
GO_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE	c5.BP_ GO biological process	81	1.0227321	0.4165536	0.66229135	GO_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE	86	0.99048847	0.52063495	0.93520623	2.01322057	0.03224363
GO_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY	c5.BP_ GO biological process	17	1.0226638	0.4496124	0.66240406	GO_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY	18	1.0929108	0.35257214	0.7682476	2.1155746	-0.070247
GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN	C7_ immunologic signatures	139	1.0226421	0.43811882	0.662375	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN	144	1.072362	0.3476923	0.8022967	2.0950041	-0.0497199
GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN	C7_ immunologic signatures	176	1.0224533	0.42736077	0.6628467	GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN	177	-0.95389044	0.7058824	0.7519232	0.06856286	1.97634374
CATRRAGC_UNKNOWN	c3.TFT_ transcription factor targets	109	1.0224315	0.40693197	0.6628135	CATRRAGC_UNKNOWN	120	1.0787954	0.32438016	0.78977036	2.1012269	-0.0563639
GO_POSITIVE_REGULATION_OF_TELOMERE_CAPPING	c5.BP_ GO biological process	15	1.0224268	0.42607313	0.6627294	GO_POSITIVE_REGULATION_OF_TELOMERE_CAPPING	15	0.9731217	0.53367877	0.9577083	1.9955485	0.0493051
CCAWNWWNNNGGC_UNKNOWN	c3.TFT_ transcription factor targets	72	1.0223949	0.42168674	0.66273373	CCAWNWWNNNGGC_UNKNOWN	76	0.740948	0.8825431	1	1.7633429	0.2814469
GO_DEVELOPMENTAL_PROGRAMMED_CELL_DEATH	c5.BP_ GO biological process	22	1.022214	0.4456869	0.66320074	GO_DEVELOPMENTAL_PROGRAMMED_CELL_DEATH	25	0.7618372	0.810219	1	1.7840512	0.2603768
GO_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION	c5.BP_ GO biological process	24	1.0220478	0.42153847	0.6636148	GO_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION	26	1.4307278	0.045918368	0.3133311	2.4527756	-0.40868
GO_REGULATION_OF_HOMEOSTATIC_PROCESS	c5.BP_ GO biological process	385	1.0220346	0.42110875	0.66355866	GO_REGULATION_OF_HOMEOSTATIC_PROCESS	404	1.3072058	0.003	0.4293169	2.3292404	-0.2851712
GCM_PRKCG	c4.CGN_ cancer gene neighborhoods	53	1.0220288	0.4127907	0.66347635	GCM_PRKCG	56	0.7047759	0.9038031	1	1.7268047	0.3172529
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP	C7_ immunologic signatures	180	1.0220262	0.4177363	0.6633868	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP	182	0.9663877	0.5886525	0.96452874	1.9884139	0.0556385
MODULE_317	c4.CM_ cancer modules	359	1.0220112	0.4089422	0.6633327	MODULE_317	366	1.1825589	0.062	0.61845016	2.2045701	-0.1605477
GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN	C7_ immunologic signatures	162	1.0219928	0.42735043	0.66329217	GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN	164	0.6142579	0.99490833	1	1.6362507	0.4077349
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP	C7_ immunologic signatures	175	1.0219615	0.4259928	0.6632953	GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP	180	0.97564614	0.5709939	0.9554696	1.99760764	0.04631536
GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	136	1.0217516	0.43341404	0.66385466	GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP	138	1.0313948	0.4240571	0.8743843	2.0531464	-0.0096432
TENEDINI_MEGAKARYOCYTE_MARKERS	c2.CGP_ chemical and genetic perturbations	58	1.0217302	0.44337016	0.6638199	TENEDINI_MEGAKARYOCYTE_MARKERS	58	0.9115989	0.6211111	1	1.9333291	0.1101313
ZHAN_MULTIPLE_MYELOMA_UP	c2.CGP_ chemical and genetic perturbations	54	1.0215496	0.42956764	0.664265	ZHAN_MULTIPLE_MYELOMA_UP	53	0.73670477	0.8806818	1	1.75825437	0.28484483
GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	168	1.0215214	0.41666666	0.6642551	GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP	178	1.2353227	0.05757576	0.5330318	2.2568441	-0.2138013
GO_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE	c5.BP_ GO biological process	25	1.0214884	0.4307458	0.6642599	GO_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE	23	-0.57968706	0.9950739	0.988036	0.44180134	1.60117546
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	177	1.0214853	0.41141498	0.66416985	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN	181	0.7057083	0.96180904	1	1.7271936	0.315777
XU_GH1_EXOGENOUS_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	66	1.0214437	0.43502825	0.6642014	XU_GH1_EXOGENOUS_TARGETS_UP	69	1.1031492	0.32717392	0.75142395	2.1245929	-0.0817055
GSE42724_NAIVE_VS_B1_BCELL_UP	C7_ immunologic signatures	175	1.0213636	0.4152941	0.66435057	GSE42724_NAIVE_VS_B1_BCELL_UP	175	0.75529087	0.9445565	1	1.77665447	0.26607273
SCHEIDEREIT_IKK_INTERACTING_PROTEINS	c2.CGP_ chemical and genetic perturbations	54	1.0213592	0.42817295	0.66426617	SCHEIDEREIT_IKK_INTERACTING_PROTEINS	56	1.0516274	0.3960396	0.8368082	2.0729866	-0.0302682
GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	162	1.0213478	0.41805226	0.66420203	GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	167	0.8744352	0.7621951	1	1.895783	0.1469126
GNF2_HLA_C	c4.CGN_ cancer gene neighborhoods	33	1.0213053	0.4259542	0.6642284	GNF2_HLA_C	35	1.2615267	0.1475797	0.4942249	2.282832	-0.2402214
KIM_WT1_TARGETS_8HR_DN	c2.CGP_ chemical and genetic perturbations	102	1.0212598	0.42635658	0.664274	KIM_WT1_TARGETS_8HR_DN	102	1.0180851	0.47406638	0.8926037	2.0393449	0.0031747
GO_NUCLEOPHAGY	c5.BP_ GO biological process	17	1.0212106	0.45	0.66432387	GO_NUCLEOPHAGY	17	0.61983126	0.93324775	1	1.64104186	0.40137934
PAL_PRMT5_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	188	1.0212013	0.42142856	0.66425294	PAL_PRMT5_TARGETS_UP	188	-1.6873642	0	0.05895145	-0.6661629	2.7085655
GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN	C7_ immunologic signatures	117	1.0211754	0.42709678	0.6642407	GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN	120	1.6010824	0	0.15672593	2.6222578	-0.579907
GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	C7_ immunologic signatures	177	1.0211638	0.41239572	0.6641742	GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	178	0.6071221	0.9949444	1	1.6282859	0.4140417
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN	C7_ immunologic signatures	162	1.0211383	0.44208038	0.6641547	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN	171	0.9216101	0.6905242	1	1.9427484	0.0995282
GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP	C7_ immunologic signatures	144	1.0210674	0.42098767	0.664277	GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP	147	1.3498588	0.019447288	0.3832302	2.3709262	-0.3287914
GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN	C7_ immunologic signatures	147	1.0209547	0.43764988	0.6645102	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN	159	1.1501495	0.18209563	0.6694475	2.1711042	-0.1291948
GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN	C7_ immunologic signatures	184	1.0208665	0.41463414	0.6646793	GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN	186	1.0441357	0.38640973	0.85046613	2.0650022	-0.0232692
GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP	C7_ immunologic signatures	180	1.0208235	0.41408116	0.66471106	GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP	182	0.89419407	0.7611336	1	1.91501757	0.12662943
GO_PHOSPHOPROTEIN_BINDING	c5.GO molecular function	54	1.0207375	0.4338843	0.6648776	GO_PHOSPHOPROTEIN_BINDING	56	0.76179194	0.85650724	1	1.78252944	0.25894556
GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	179	1.0207165	0.42193088	0.6648402	GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	179	0.692013	0.97286433	1	1.7127295	0.3287035
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP	C7_ immunologic signatures	172	1.0206882	0.41595092	0.6648355	GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP	174	0.8168882	0.8800813	1	1.8375764	0.2038
REACTOME_SIGNALING_BY_ERBB2	c2.CP_REACTOME_ Reactome gene sets	90	1.0206461	0.425	0.66486216	REACTOME_SIGNALING_BY_ERBB2	92	1.1296295	0.24762908	0.7062226	2.1502756	-0.1089834
CAHOY_ASTROCYTIC	C6_ oncogenic signatures	89	1.0206217	0.42125985	0.66484	CAHOY_ASTROCYTIC	91	1.0911938	0.32706374	0.7695485	2.1118155	-0.0705721
GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN	C7_ immunologic signatures	144	1.0204024	0.40556902	0.6654154	GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN	146	0.83850247	0.8109504	1	1.85890487	0.18189993
GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP	C7_ immunologic signatures	172	1.0203869	0.41916168	0.6653607	GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP	174	1.3486266	0.004052685	0.3829488	2.3690135	-0.3282397
GO_CYTOPLASMIC_MICROTUBULE_ORGANIZATION	c5.BP_ GO biological process	39	1.0203568	0.41364297	0.6653516	GO_CYTOPLASMIC_MICROTUBULE_ORGANIZATION	39	1.1490347	0.25546604	0.6698458	2.1693915	-0.1286779
GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP	C7_ immunologic signatures	175	1.0203061	0.4185766	0.66540134	GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP	178	1.0761732	0.31675127	0.79465437	2.0964793	-0.0558671
CDC5_01	c3.TFT_ transcription factor targets	208	1.0202898	0.4247685	0.6653591	CDC5_01	226	0.98578256	0.5532129	0.9412338	2.00607236	0.03450724
PID_IFNG_PATHWAY	c2.CP_ Canonical pathways	37	1.0202751	0.43534482	0.6653076	PID_IFNG_PATHWAY	37	0.5511962	0.98946136	1	1.5714713	0.4690789
GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	177	1.0201778	0.42180094	0.6655159	GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN	180	0.71255505	0.97258884	1	1.73273285	0.30762275
GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN	C7_ immunologic signatures	158	1.0200845	0.42736077	0.66570085	GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN	160	0.8702302	0.76703966	1	1.8903147	0.1498543
CREBP1CJUN_01	c3.TFT_ transcription factor targets	225	1.0199494	0.42531356	0.6660164	CREBP1CJUN_01	230	0.81411266	0.9072581	1	1.83406206	0.20583674
GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN	C7_ immunologic signatures	182	1.0197203	0.43645084	0.6666332	GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN	182	1.0542914	0.37676767	0.83454895	2.0740117	-0.0345711
GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING	c5.GO molecular function	76	1.0196261	0.44021025	0.6668294	GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING	78	-1.2751757	0.035714287	0.3064954	-0.2555496	2.2948018
GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	C7_ immunologic signatures	165	1.0195143	0.41716328	0.6670776	GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	176	1.2350497	0.06471183	0.5329602	2.254564	-0.2155354
GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP	C7_ immunologic signatures	178	1.0194806	0.42307693	0.6670786	GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP	184	0.8505303	0.8266129	1	1.8700109	0.1689503
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	162	1.0194685	0.4297719	0.66701597	GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	165	0.9322084	0.6592065	0.99783945	1.9516769	0.0872601
GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP	C7_ immunologic signatures	150	1.019455	0.4278788	0.66695976	GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP	153	1.2698528	0.054081634	0.48569024	2.2893078	-0.2503978
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN	C7_ immunologic signatures	169	1.019429	0.42270532	0.66694224	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN	183	0.8382618	0.8249497	1	1.8576908	0.1811672
GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP	C7_ immunologic signatures	176	1.0193746	0.42550656	0.66701835	GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP	176	0.8042198	0.87906504	1	1.8235944	0.2151548
GRADE_COLON_CANCER_DN	c2.CGP_ chemical and genetic perturbations	29	1.0191563	0.4691358	0.667573	GRADE_COLON_CANCER_DN	30	0.8010255	0.7458234	1	1.8201818	0.2181308
GO_TRANSCRIPTION_FACTOR_ACTIVITY_DIRECT_LIGAND_REGULATED_SEQUENCE_SPECIFIC_DNA_BINDING	c5.GO molecular function	41	1.0190377	0.43722305	0.6678365	GO_TRANSCRIPTION_FACTOR_ACTIVITY_DIRECT_LIGAND_REGULATED_SEQUENCE_SPECIFIC_DNA_BINDING	45	1.2843324	0.11595867	0.46534592	2.3033701	-0.2652947
GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP	C7_ immunologic signatures	181	1.0189756	0.43728018	0.66793084	GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP	188	0.8055069	0.89979756	1	1.8244825	0.2134687
GSE11057_CD4_CENT_MEM_VS_PBMC_DN	C7_ immunologic signatures	168	1.0189708	0.4161782	0.66784656	GSE11057_CD4_CENT_MEM_VS_PBMC_DN	172	1.1958392	0.103975534	0.59703463	2.21481	-0.1768684
OXFORD_RALA_OR_RALB_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	22	1.0189595	0.4392971	0.66778153	OXFORD_RALA_OR_RALB_TARGETS_DN	23	1.3317649	0.11196911	0.4002957	2.3507244	-0.3128054
GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP	C7_ immunologic signatures	126	1.0189319	0.43349755	0.66776747	GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP	135	1.1353183	0.2147303	0.69659454	2.1542502	-0.1163864
GSE27786_NKCELL_VS_NKTCELL_UP	C7_ immunologic signatures	182	1.0188603	0.41550925	0.6678889	GSE27786_NKCELL_VS_NKTCELL_UP	183	0.7906555	0.90816325	1	1.8095158	0.2282048
GO_METALLOCARBOXYPEPTIDASE_ACTIVITY	c5.GO molecular function	21	1.0187303	0.4187898	0.6681941	GO_METALLOCARBOXYPEPTIDASE_ACTIVITY	24	1.568344	0.015056462	0.19027197	2.5870743	-0.5496137
REACTOME_G_PROTEIN_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	25	1.0185715	0.44283414	0.6685899	REACTOME_G_PROTEIN_ACTIVATION	26	-0.97260994	0.46192893	0.7245359	0.04596156	1.99118144
GO_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT	c5.BP_ GO biological process	323	1.0185493	0.42810458	0.66856587	GO_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT	331	0.7926278	0.9448898	1	1.8111771	0.2259215
GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN	C7_ immunologic signatures	154	1.0184867	0.42142856	0.6686765	GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN	156	1.1141536	0.23684211	0.7318326	2.1326403	-0.0956669
GSE30083_SP2_VS_SP4_THYMOCYTE_DN	C7_ immunologic signatures	171	1.0183976	0.4205379	0.6688573	GSE30083_SP2_VS_SP4_THYMOCYTE_DN	174	1.33277	0.018274112	0.39961967	2.3511676	-0.3143724
GO_PROTEIN_LIPID_COMPLEX_BINDING	c5.GO molecular function	23	1.0182904	0.42331287	0.6690956	GO_PROTEIN_LIPID_COMPLEX_BINDING	21	0.7564801	0.8094629	1	1.7747705	0.2618103
GO_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT	c5.BP_ GO biological process	56	1.0182599	0.41517243	0.66909385	GO_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT	60	1.2431731	0.12087912	0.5225986	2.261433	-0.2249132
GO_LIGAND_GATED_CHANNEL_ACTIVITY	c5.GO molecular function	111	1.0182462	0.40811154	0.6690384	GO_LIGAND_GATED_CHANNEL_ACTIVITY	130	1.435936	0.002059732	0.30937275	2.4541822	-0.4176898
GO_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE	c5.BP_ GO biological process	40	1.0182086	0.42793462	0.66905594	GO_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE	42	-0.93448424	0.58677685	0.77872396	0.08372436	1.95269284
MEISSNER_BRAIN_HCP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	203	1.0182002	0.4372093	0.66898215	MEISSNER_BRAIN_HCP_WITH_H3K27ME3	252	1.1032256	0.2248996	0.7515441	2.1214258	-0.0850254
LIU_PROSTATE_CANCER_UP	c2.CGP_ chemical and genetic perturbations	83	1.0181588	0.44908616	0.66901773	LIU_PROSTATE_CANCER_UP	85	1.4547457	0.010626992	0.28782648	2.4729045	-0.4365869
AAGCACT_MIR520F	c3.MIR_ microRNA targets	218	1.018139	0.43676814	0.6689773	AAGCACT_MIR520F	219	1.2240337	0.05858586	0.5504569	2.2421727	-0.2058947
CACTGCC_MIR34A_MIR34C_MIR449	c3.MIR_ microRNA targets	254	1.0180459	0.43148357	0.66917074	CACTGCC_MIR34A_MIR34C_MIR449	258	0.8570143	0.8388721	1	1.8750602	0.1610316
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP	C7_ immunologic signatures	146	1.0180364	0.41066998	0.66910404	GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP	159	0.84545547	0.8200409	1	1.86349187	0.17258093
GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN	C7_ immunologic signatures	184	1.017916	0.42857143	0.66938275	GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN	188	0.7351205	0.95035464	1	1.7530365	0.2827955
GO_MACROPHAGE_ACTIVATION	c5.BP_ GO biological process	26	1.0178492	0.4526814	0.6694788	GO_MACROPHAGE_ACTIVATION	27	1.3996708	0.05896806	0.34004802	2.41752	-0.3818216
GO_PROTEIN_DESTABILIZATION	c5.BP_ GO biological process	31	1.0178391	0.4160363	0.6694125	GO_PROTEIN_DESTABILIZATION	32	1.2792171	0.14183553	0.47302622	2.2970562	-0.261378
GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP	C7_ immunologic signatures	154	1.017692	0.43589744	0.6697744	GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP	162	1.0119013	0.48373982	0.9043103	2.0295933	0.0057907
DELPUECH_FOXO3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	66	1.0176816	0.42817295	0.6697069	DELPUECH_FOXO3_TARGETS_UP	66	1.5118725	0.00874317	0.24019918	2.5295541	-0.4941909
GO_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	24	1.0176351	0.43562874	0.669749	GO_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS	24	-0.7901305	0.82608694	0.9136907	0.2275046	1.8077656
GO_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION	c5.BP_ GO biological process	26	1.0175767	0.44270015	0.6698319	GO_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION	28	0.8082343	0.7532467	1	1.825811	0.2093424
GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	109	1.0175455	0.43198994	0.66982824	GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP	119	0.8128873	0.84090906	1	1.8304328	0.2046582
LIN_NPAS4_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	145	1.0174774	0.42604297	0.66994005	LIN_NPAS4_TARGETS_UP	145	0.6419203	0.9836233	1	1.6593977	0.3755571
GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	172	1.0174564	0.43095237	0.66990554	GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP	175	0.74356794	0.94641054	1	1.76102434	0.27388846
OCT1_Q6	c3.TFT_ transcription factor targets	217	1.0174559	0.4300578	0.66980934	OCT1_Q6	225	1.0626458	0.34545454	0.8184082	2.0801017	-0.0451899
GO_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	31	1.0174556	0.45550528	0.6697125	GO_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS	33	1.279138	0.11785714	0.47264358	2.2965936	-0.2616824
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN	C7_ immunologic signatures	170	1.017442	0.43779343	0.6696534	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN	171	0.9212882	0.6859756	1	1.9387302	0.0961538
SU_PANCREAS	c2.CGP_ chemical and genetic perturbations	40	1.0173839	0.44144145	0.66973543	SU_PANCREAS	40	0.6118137	0.9560185	1	1.6291976	0.4055702
GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN	C7_ immunologic signatures	160	1.0173659	0.44591346	0.66969067	GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN	168	1.0811561	0.31072876	0.78550166	2.098522	-0.0637902
CSR_LATE_UP.V1_DN	C6_ oncogenic signatures	143	1.0173458	0.42601433	0.6696551	CSR_LATE_UP.V1_DN	142	0.9619922	0.5899795	0.96869624	1.979338	0.0553536
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN	C7_ immunologic signatures	148	1.0172466	0.41475213	0.6698645	GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN	147	-1.3649468	0	0.23074955	-0.3477002	2.3821934
GO_CHROMATIN_MODIFICATION	c5.BP_ GO biological process	458	1.0172181	0.41932058	0.6698588	GO_CHROMATIN_MODIFICATION	458	0	0	0	1.0172181	1.0172181
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	c2.CGP_ chemical and genetic perturbations	68	1.0171514	0.42465752	0.66995525	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	68	1.2013414	0.17931794	0.58957654	2.2184928	-0.18419
GO_REGULATION_OF_HORMONE_SECRETION	c5.BP_ GO biological process	207	1.017142	0.42725173	0.6698837	GO_REGULATION_OF_HORMONE_SECRETION	234	1.1888556	0.08416834	0.6070903	2.2059976	-0.1717136
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP	C7_ immunologic signatures	168	1.0170854	0.4309724	0.6699599	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP	171	0.68016595	0.97553515	1	1.69725135	0.33691945
GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP	C7_ immunologic signatures	178	1.0170372	0.42857143	0.67000467	GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP	188	1.1558958	0.15539859	0.6607571	2.172933	-0.1388586
GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	C7_ immunologic signatures	152	1.0170186	0.44228432	0.6699601	GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	154	1.1378706	0.2034588	0.6940729	2.1548892	-0.120852
GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	174	1.017013	0.42243436	0.6698797	GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	177	0.98143363	0.56693715	0.9466814	1.99844663	0.03557937
GO_BASAL_PART_OF_CELL	c5.CC_ GO cellular component	44	1.0168737	0.4389881	0.67020667	GO_BASAL_PART_OF_CELL	46	1.1514525	0.23515981	0.66747713	2.1683262	-0.1345788
GO_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY	c5.BP_ GO biological process	23	1.0168104	0.46212122	0.67030525	GO_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY	22	0.8509797	0.697733	1	1.8677901	0.1658307
GO_RESPONSE_TO_EXOGENOUS_DSRNA	c5.BP_ GO biological process	41	1.0167451	0.44379562	0.67041117	GO_RESPONSE_TO_EXOGENOUS_DSRNA	40	-0.44680312	1	0.99113953	0.56994198	1.46354822
GO_PROTEIN_HOMOTRIMERIZATION	c5.BP_ GO biological process	19	1.016618	0.43009117	0.67071426	GO_PROTEIN_HOMOTRIMERIZATION	19	1.1041938	0.3494133	0.74917394	2.1208118	-0.0875758
GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_DN	C7_ immunologic signatures	173	1.0164859	0.42753622	0.6710228	GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_DN	177	1.035073	0.43800813	0.86764127	2.0515589	-0.0185871
MORF_ARAF1	c4.CGN_ cancer gene neighborhoods	70	1.0163882	0.43676662	0.6712221	MORF_ARAF1	71	0.91371316	0.642015	1	1.93010136	0.10267504
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	C7_ immunologic signatures	170	1.0163823	0.43309858	0.6711409	GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	174	0.79431653	0.91356784	1	1.81069883	0.22206577
GO_RESPONSE_TO_AMPHETAMINE	c5.BP_ GO biological process	25	1.0163772	0.45801526	0.6710574	GO_RESPONSE_TO_AMPHETAMINE	28	0.9132741	0.6140777	1	1.9296513	0.1031031
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	c2.CGP_ chemical and genetic perturbations	66	1.0161945	0.45231608	0.67152584	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	71	1.065207	0.37096775	0.8138105	2.0814015	-0.0490125
GO_THYMIC_T_CELL_SELECTION	c5.BP_ GO biological process	15	1.0161474	0.44217688	0.6715858	GO_THYMIC_T_CELL_SELECTION	19	1.4196439	0.053097345	0.31961957	2.4357913	-0.4034965
GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	26	1.0161325	0.4414003	0.67153656	GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY	26	-1.1441038	0.2752809	0.45078272	-0.1279713	2.1602363
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP	C7_ immunologic signatures	149	1.015927	0.4213075	0.6720622	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP	156	1.541008	0.001014199	0.20976357	2.556935	-0.525081
GO_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	320	1.0158241	0.42546245	0.67228	GO_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION	326	1.1040477	0.19438878	0.74952745	2.1198718	-0.0882236
GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP	C7_ immunologic signatures	177	1.0158056	0.44032446	0.6722402	GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP	181	1.3376602	0.012108981	0.39776924	2.3534658	-0.3218546
GO_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT	c5.BP_ GO biological process	31	1.0156772	0.43465045	0.6725391	GO_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT	32	-1.0977712	0.29139072	0.52251565	-0.082094	2.1134484
CEBPB_01	c3.TFT_ transcription factor targets	226	1.0155038	0.4416185	0.6729813	CEBPB_01	232	0.973958	0.56683415	0.9568866	1.9894618	0.0415458
AMIT_EGF_RESPONSE_40_MCF10A	c2.CGP_ chemical and genetic perturbations	19	1.0153816	0.46019107	0.67324895	AMIT_EGF_RESPONSE_40_MCF10A	19	1.2838906	0.15025906	0.46624476	2.2992722	-0.268509
MYOD_Q6	c3.TFT_ transcription factor targets	211	1.0151615	0.4385965	0.6738344	MYOD_Q6	224	0.9282673	0.6770624	0.99924725	1.9434288	0.0868942
MODULE_497	c4.CM_ cancer modules	26	1.0149618	0.44620255	0.67435044	MODULE_497	27	-0.8377173	0.7283237	0.8766096	0.1772445	1.8526791
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	c2.CGP_ chemical and genetic perturbations	82	1.0149438	0.42761394	0.6743098	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	88	0.92302674	0.6359743	1	1.93797054	0.09191706
TAGGTCA_MIR192_MIR215	c3.MIR_ microRNA targets	43	1.0148875	0.42670536	0.6743838	TAGGTCA_MIR192_MIR215	43	-1.2089417	0.1570248	0.36874402	-0.1940542	2.2238292
GO_RESPONSE_TO_AUDITORY_STIMULUS	c5.BP_ GO biological process	19	1.0148841	0.4604651	0.67429835	GO_RESPONSE_TO_AUDITORY_STIMULUS	22	-0.92602104	0.5786802	0.78833324	0.08886306	1.94090514
GO_BONE_CELL_DEVELOPMENT	c5.BP_ GO biological process	20	1.0148455	0.44603175	0.6743171	GO_BONE_CELL_DEVELOPMENT	20	0.6553773	0.9088639	1	1.6702228	0.3594682
SHEN_SMARCA2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	401	1.014827	0.4378321	0.67427695	SHEN_SMARCA2_TARGETS_UP	401	-1.1056027	0	0.5086713	-0.0907757	2.1204297
GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP	C7_ immunologic signatures	184	1.0148085	0.43187067	0.6742351	GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP	185	0.6394822	0.9919273	1	1.6542907	0.3753263
GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP	C7_ immunologic signatures	174	1.0147252	0.41824645	0.6743747	GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP	175	1.2510574	0.049445003	0.5088995	2.2657826	-0.2363322
GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	153	1.0146842	0.4471446	0.67440706	GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP	158	1.0952126	0.25993884	0.76443183	2.1098968	-0.0805284
GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP	C7_ immunologic signatures	154	1.0146557	0.43008226	0.67440176	GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP	167	1.0672631	0.37131232	0.8106606	2.0819188	-0.0526074
GSE22886_DC_VS_MONOCYTE_UP	C7_ immunologic signatures	178	1.0145361	0.41676646	0.6746805	GSE22886_DC_VS_MONOCYTE_UP	179	0.94191945	0.625	0.98892736	1.95645555	0.07261665
SA_TRKA_RECEPTOR	c2.CP_ Canonical pathways	17	1.0145355	0.44267517	0.67458475	SA_TRKA_RECEPTOR	17	1.3868688	0.07435898	0.34847134	2.4014043	-0.3723333
GO_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	c5.BP_ GO biological process	19	1.0144947	0.45397815	0.67461765	GO_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	22	1.235216	0.18922305	0.53266716	2.2497107	-0.2207213
HSIAO_LIVER_SPECIFIC_GENES	c2.CGP_ chemical and genetic perturbations	193	1.0144691	0.44417766	0.6746055	HSIAO_LIVER_SPECIFIC_GENES	211	1.2791198	0.029204432	0.47248882	2.2935889	-0.2646507
MODULE_134	c4.CM_ cancer modules	26	1.0144435	0.44444445	0.67458546	MODULE_134	26	-1.1857042	0.20652173	0.3985496	-0.1712607	2.2001477
GO_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY	c5.BP_ GO biological process	31	1.0143569	0.42057487	0.67474955	GO_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY	33	-1.299744	0.10526316	0.2839072	-0.2853871	2.3141009
WENG_POR_DOSAGE	c2.CGP_ chemical and genetic perturbations	19	1.0143155	0.42879745	0.6747835	WENG_POR_DOSAGE	19	0.8709722	0.657289	1	1.8852877	0.1433433
CCTGAGT_MIR510	c3.MIR_ microRNA targets	38	1.014302	0.44206008	0.67472464	CCTGAGT_MIR510	39	0.55480665	0.99196327	1	1.56910865	0.45949535
ZHAN_MULTIPLE_MYELOMA_HP_DN	c2.CGP_ chemical and genetic perturbations	41	1.0142881	0.45386904	0.6746725	ZHAN_MULTIPLE_MYELOMA_HP_DN	42	-0.9484016	0.53913045	0.7588232	0.0658865	1.9626897
GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	C7_ immunologic signatures	175	1.0141505	0.45072114	0.6749933	GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	175	0.94127905	0.6433637	0.98953676	1.95542955	0.07287145
GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	C7_ immunologic signatures	164	1.0141349	0.44166666	0.6749419	GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	166	1.0159702	0.46666667	0.89578223	2.0301051	-0.0018353
GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP	C7_ immunologic signatures	179	1.0141287	0.4341637	0.6748636	GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP	183	1.1304934	0.21928935	0.70583445	2.1446221	-0.1163647
GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP	C7_ immunologic signatures	176	1.0141187	0.43890867	0.6747939	GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP	178	0.9991848	0.5	0.92488277	2.0133035	0.0149339
GENTILE_UV_RESPONSE_CLUSTER_D1	c2.CGP_ chemical and genetic perturbations	16	1.0141065	0.45101088	0.67473245	GENTILE_UV_RESPONSE_CLUSTER_D1	16	0.7398478	0.81646425	1	1.7539543	0.2742587
GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP	C7_ immunologic signatures	177	1.0140951	0.43187067	0.67466736	GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP	178	0.78461397	0.90899897	1	1.79870907	0.22948113
GO_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	92	1.0140738	0.434492	0.6746334	GO_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT	97	1.0099229	0.47539267	0.9078187	2.0239967	0.0041509
GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN	C7_ immunologic signatures	173	1.0140659	0.42648846	0.67456305	GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN	183	1.4732685	0.001015229	0.2762284	2.4873344	-0.4592026
GO_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	70	1.0140587	0.43962008	0.6744887	GO_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	76	1.0612508	0.38709676	0.8215962	2.0753095	-0.0471921
REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	35	1.013914	0.43712574	0.67482954	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	36	0.9705296	0.52781063	0.96106064	1.9844436	0.0433844
GSE7509_DC_VS_MONOCYTE_DN	C7_ immunologic signatures	178	1.0137655	0.43040934	0.67518014	GSE7509_DC_VS_MONOCYTE_DN	177	0.76239204	0.9322548	1	1.77615754	0.25137346
GSE11057_CD4_EFF_MEM_VS_PBMC_UP	C7_ immunologic signatures	171	1.013735	0.4352392	0.6751758	GSE11057_CD4_EFF_MEM_VS_PBMC_UP	178	1.3073535	0.027327936	0.4289994	2.3210885	-0.2936185
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP	C7_ immunologic signatures	117	1.0135368	0.44010088	0.6756885	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP	119	1.3066964	0.040123455	0.43059766	2.3202332	-0.2931596
GO_POLYOL_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	24	1.0134915	0.45230263	0.67572224	GO_POLYOL_BIOSYNTHETIC_PROCESS	26	0.6854436	0.89351285	1	1.6989351	0.3280479
GO_HORMONE_TRANSPORT	c5.BP_ GO biological process	65	1.0134679	0.42465752	0.67570084	GO_HORMONE_TRANSPORT	73	1.0548407	0.38643703	0.83315945	2.0683086	-0.0413728
GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP	C7_ immunologic signatures	175	1.0131661	0.44138756	0.67652744	GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP	177	0.83277607	0.85714287	1	1.84594217	0.18039003
GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	C7_ immunologic signatures	146	1.0131499	0.43200964	0.6764795	GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	150	1.0761368	0.32418698	0.79435825	2.0892867	-0.0629869
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP	C7_ immunologic signatures	128	1.0130776	0.43451652	0.6766007	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP	133	1.0821613	0.3148148	0.78324735	2.0952389	-0.0690837
GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	C7_ immunologic signatures	181	1.0129416	0.43099272	0.6769098	GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	187	0.8622085	0.7993921	1	1.8751501	0.1507331
GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	171	1.0129228	0.44200245	0.6768688	GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP	172	1.0896262	0.29757085	0.7717191	2.102549	-0.0767034
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN	C7_ immunologic signatures	166	1.0128272	0.4664179	0.6770639	GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN	177	1.0864625	0.2923387	0.77542454	2.0992897	-0.0736353
GO_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION	c5.BP_ GO biological process	296	1.0127841	0.4411441	0.677094	GO_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION	319	1.1201429	0.1544634	0.7232658	2.132927	-0.1073588
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS	c5.BP_ GO biological process	45	1.0127571	0.41116005	0.67707616	GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS	45	0.8533179	0.70181406	1	1.866075	0.1594392
GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	151	1.0127503	0.43398532	0.67699665	GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN	155	0.94685966	0.6180344	0.9856443	1.95960996	0.06589064
GO_ORGANELLE_FUSION	c5.BP_ GO biological process	112	1.0127085	0.43209878	0.6770258	GO_ORGANELLE_FUSION	113	1.2302175	0.11510792	0.5402663	2.242926	-0.217509
GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP	C7_ immunologic signatures	168	1.0126936	0.44457832	0.67696834	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP	172	0.6191976	0.9949135	1	1.6318912	0.393496
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	165	1.0126245	0.43421054	0.6770714	GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	182	0.95805013	0.59816885	0.9734135	1.97067463	0.05457437
GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN	C7_ immunologic signatures	170	1.0125219	0.42774567	0.6772823	GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN	181	0.9924294	0.52337396	0.9330398	2.0049513	0.0200925
CHR6P24	C1: positional gene sets	20	1.0125129	0.45253164	0.67721546	CHR6P24	22	0.90546775	0.6175	1	1.91798065	0.10704515
GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II	c5.BP_ GO biological process	75	1.0124843	0.42759562	0.67720354	GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II	79	1.2458752	0.13333334	0.5173124	2.2583595	-0.2333909
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	c2.CGP_ chemical and genetic perturbations	107	1.0124538	0.45922208	0.67719984	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	121	0.8801496	0.73966944	1	1.8926034	0.1323042
GGCACAT_MIR455	c3.MIR_ microRNA targets	56	1.0124369	0.43600562	0.67715013	GGCACAT_MIR455	57	0.734326	0.8895089	1	1.7467629	0.2781109
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN	C7_ immunologic signatures	180	1.012433	0.43660286	0.67706394	GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN	180	0.9184664	0.70558375	1	1.9308994	0.0939666
GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	161	1.0124182	0.44430992	0.6770122	GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP	169	0.7823247	0.91979694	1	1.7947429	0.2300935
MYOGNF1_01	c3.TFT_ transcription factor targets	40	1.0123967	0.43527737	0.6769823	MYOGNF1_01	42	1.1547639	0.23950057	0.66219354	2.1671606	-0.1423672
GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP	C7_ immunologic signatures	120	1.0123425	0.44585988	0.6770509	GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP	126	1.1781164	0.15930113	0.62479913	2.1904589	-0.1657739
REACTOME_NEURONAL_SYSTEM	c2.CP_REACTOME_ Reactome gene sets	240	1.0122813	0.44847113	0.67714417	REACTOME_NEURONAL_SYSTEM	269	1.2082596	0.055165496	0.5803044	2.2205409	-0.1959783
GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN	C7_ immunologic signatures	174	1.0122707	0.44065806	0.67708176	GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN	177	1.0304836	0.42131978	0.87457365	2.0427543	-0.0182129
GO_CHANNEL_INHIBITOR_ACTIVITY	c5.GO molecular function	29	1.0122378	0.42835596	0.67708296	GO_CHANNEL_INHIBITOR_ACTIVITY	34	1.0941054	0.3552169	0.7671839	2.1063432	-0.0818676
GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP	C7_ immunologic signatures	172	1.0121257	0.44191617	0.67733425	GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP	175	0.8025648	0.8821138	1	1.8146905	0.2095609
GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN	C7_ immunologic signatures	165	1.0121148	0.42737094	0.6772679	GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN	170	1.0947905	0.27547932	0.7654441	2.1069053	-0.0826757
GO_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING	c5.GO molecular function	241	1.0120443	0.44310722	0.67738587	GO_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING	244	0.5134063	1	1	1.5254506	0.498638
GO_REGULATION_OF_INTERLEUKIN_8_PRODUCTION	c5.BP_ GO biological process	47	1.0120355	0.44396552	0.6773195	GO_REGULATION_OF_INTERLEUKIN_8_PRODUCTION	52	1.5139272	0.00792752	0.23849492	2.5259627	-0.5018917
GGGATGC_MIR3245P	c3.MIR_ microRNA targets	44	1.0120175	0.4478261	0.67727447	GGGATGC_MIR3245P	45	1.0570734	0.38586327	0.8287424	2.0690909	-0.0450559
GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN	C7_ immunologic signatures	182	1.0120077	0.42532855	0.6772088	GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN	182	0.88356495	0.7532729	1	1.89557265	0.12844275
GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP	C7_ immunologic signatures	166	1.0118437	0.45421246	0.6775953	GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP	175	1.1545441	0.16950853	0.6623202	2.1663878	-0.1427004
GSE3982_MAC_VS_BASOPHIL_DN	C7_ immunologic signatures	158	1.0118225	0.4524669	0.67756635	GSE3982_MAC_VS_BASOPHIL_DN	155	0.91188544	0.68986696	1	1.92370794	0.09993706
GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN	C7_ immunologic signatures	145	1.0118207	0.43658537	0.67747396	GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN	150	1.1867517	0.12729125	0.6121997	2.1985724	-0.174931
ST_INTEGRIN_SIGNALING_PATHWAY	c2.CP_ Canonical pathways	79	1.0116771	0.42818427	0.67780465	ST_INTEGRIN_SIGNALING_PATHWAY	79	0.78464997	0.8434505	1	1.79632707	0.22702713
REACTOME_SIGNALING_BY_FGFR1_MUTANTS	c2.CP_REACTOME_ Reactome gene sets	29	1.0116632	0.45565748	0.6777461	REACTOME_SIGNALING_BY_FGFR1_MUTANTS	28	1.0571519	0.41475213	0.82883453	2.0688151	-0.0454887
GSE20727_CTRL_VS_H2O2_TREATED_DC_UP	C7_ immunologic signatures	167	1.0115848	0.44925743	0.67789423	GSE20727_CTRL_VS_H2O2_TREATED_DC_UP	169	1.1847206	0.12600806	0.61399096	2.1963054	-0.1731358
ENK_UV_RESPONSE_EPIDERMIS_DN	c2.CGP_ chemical and genetic perturbations	462	1.0115837	0.44889358	0.6777996	ENK_UV_RESPONSE_EPIDERMIS_DN	467	1.1267489	0.11	0.7116517	2.1383326	-0.1151652
GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP	C7_ immunologic signatures	177	1.0115827	0.42617047	0.6777058	GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP	184	0.78096515	0.9200405	1	1.79254785	0.23061755
GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	171	1.011515	0.44471446	0.6778189	GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP	174	1.242782	0.053698074	0.52302146	2.254297	-0.231267
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN	C7_ immunologic signatures	175	1.0114961	0.44079718	0.67778707	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN	178	0.8628653	0.8020202	1	1.8743614	0.1486308
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN	C7_ immunologic signatures	183	1.0114492	0.45942858	0.67782646	GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN	187	1.2582315	0.04632427	0.4985462	2.2696807	-0.2467823
GO_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	29	1.0113833	0.45333335	0.6779249	GO_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS	30	1.195862	0.22689076	0.5971115	2.2072453	-0.1844787
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	c2.CGP_ chemical and genetic perturbations	242	1.0113368	0.4542334	0.6779657	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	259	0.89260185	0.80020183	1	1.90393865	0.11873495
GNF2_DDX5	c4.CGN_ cancer gene neighborhoods	57	1.0113027	0.44011143	0.67796975	GNF2_DDX5	57	0.51942426	0.9966481	1	1.53072696	0.49187844
GO_REGULATION_OF_CILIUM_ASSEMBLY	c5.BP_ GO biological process	45	1.0111228	0.4556962	0.67841893	GO_REGULATION_OF_CILIUM_ASSEMBLY	46	1.1422788	0.28128588	0.68652683	2.1534016	-0.131156
GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP	C7_ immunologic signatures	158	1.0110905	0.43559718	0.67841697	GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP	162	0.92906797	0.65408164	0.9989985	1.94015847	0.08202253
GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN	C7_ immunologic signatures	178	1.0110761	0.4354644	0.6783625	GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN	180	1.3723694	0.008097166	0.3646187	2.3834455	-0.3612933
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	c2.CGP_ chemical and genetic perturbations	177	1.0110382	0.4640754	0.67837596	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	179	0.9729608	0.57723576	0.95773077	1.983999	0.0380774
NIELSEN_GIST	c2.CGP_ chemical and genetic perturbations	89	1.0109912	0.44942382	0.67842495	NIELSEN_GIST	89	1.0851504	0.33832976	0.7770292	2.0961416	-0.0741592
GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN	C7_ immunologic signatures	155	1.010981	0.45868263	0.67835534	GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN	156	0.87658525	0.75308645	1	1.88756625	0.13439575
MORF_PML	c4.CGN_ cancer gene neighborhoods	126	1.0109247	0.44956413	0.6784269	MORF_PML	132	1.0732089	0.3568507	0.80044174	2.0841336	-0.0622842
GCM_MAP1B	c4.CGN_ cancer gene neighborhoods	59	1.0109206	0.4454023	0.6783413	GCM_MAP1B	59	0.7694561	0.8495575	1	1.7803767	0.2414645
GO_LYTIC_VACUOLE	c5.CC_ GO cellular component	455	1.0108752	0.46526316	0.6783771	GO_LYTIC_VACUOLE	470	1.3257625	0	0.40606257	2.3366377	-0.3148873
GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN	C7_ immunologic signatures	177	1.0106646	0.44868734	0.67891246	GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN	181	0.7383242	0.95445347	1	1.7489888	0.2723404
GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	112	1.0106612	0.433291	0.678826	GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	131	0.9781861	0.5555556	0.9517329	1.9888473	0.0324751
GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN	C7_ immunologic signatures	149	1.0105144	0.45235223	0.67918575	GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN	152	1.2570955	0.052040815	0.49942198	2.2676099	-0.2465811
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP	C7_ immunologic signatures	172	1.0104803	0.44366196	0.67919034	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP	177	1.1021706	0.26241136	0.7536905	2.1126509	-0.0916903
GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	186	1.0104134	0.45616114	0.6793005	GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP	188	-1.0926328	0	0.53032947	-0.0822194	2.1030462
GSE22886_NAIVE_VS_MEMORY_TCELL_DN	C7_ immunologic signatures	182	1.0103405	0.44626167	0.6794304	GSE22886_NAIVE_VS_MEMORY_TCELL_DN	183	-0.9831511	0.45454547	0.7103288	0.0271894	1.9934916
GO_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN	c5.BP_ GO biological process	32	1.0102566	0.4698795	0.6795958	GO_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN	43	1.6843864	0	0.08861275	2.694643	-0.6741298
ONDER_CDH1_TARGETS_3_DN	c2.CGP_ chemical and genetic perturbations	37	1.0102553	0.44705883	0.6795025	ONDER_CDH1_TARGETS_3_DN	42	1.3865542	0.05510907	0.3492213	2.3968095	-0.3762989
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN	C7_ immunologic signatures	136	1.0102366	0.45068663	0.67946213	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN	140	1.0633894	0.38124362	0.8165884	2.073626	-0.0531528
GO_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY	c5.GO molecular function	106	1.0101571	0.4614379	0.6796064	GO_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY	113	1.1632578	0.18834548	0.647772	2.1734149	-0.1531007
GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP	C7_ immunologic signatures	171	1.0101193	0.43962485	0.67961997	GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP	170	1.1835656	0.13414635	0.61714655	2.1936849	-0.1734463
GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	159	1.010078	0.44951922	0.679647	GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	162	1.093866	0.28629443	0.76766163	2.103944	-0.083788
GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP	C7_ immunologic signatures	174	1.0100057	0.45738295	0.67976916	GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP	177	1.0278428	0.4287169	0.8794538	2.0378485	-0.0178371
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	c2.CP_REACTOME_ Reactome gene sets	87	1.0100045	0.46013072	0.67967546	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	88	1.0957656	0.32142857	0.7634455	2.1057701	-0.0857611
GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN	C7_ immunologic signatures	147	1.0099887	0.43956044	0.67962235	GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN	149	1.0290837	0.45417514	0.876925	2.0390724	-0.019095
GO_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	29	1.0098447	0.4489465	0.67995465	GO_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS	29	1.1940212	0.23058543	0.5991997	2.2038659	-0.1841765
E2F_Q2	c3.TFT_ transcription factor targets	156	1.0098294	0.44915253	0.67990494	E2F_Q2	158	-1.0672798	0.23809524	0.57452875	-0.0574504	2.0771092
GSE14350_TREG_VS_TEFF_DN	C7_ immunologic signatures	178	1.009741	0.44902635	0.6800777	GSE14350_TREG_VS_TEFF_DN	184	0.91709006	0.701417	1	1.92683106	0.09265094
GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP	C7_ immunologic signatures	179	1.0096519	0.4533493	0.68025166	GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP	183	1.08231	0.30527383	0.7832082	2.0919619	-0.0726581
VERHAAK_AML_WITH_NPM1_MUTATED_UP	c2.CGP_ chemical and genetic perturbations	141	1.0095255	0.44074073	0.6805355	VERHAAK_AML_WITH_NPM1_MUTATED_UP	142	1.1334163	0.2174359	0.70041865	2.1429418	-0.1238908
GSE27786_BCELL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	178	1.009449	0.4398585	0.68066865	GSE27786_BCELL_VS_NEUTROPHIL_DN	183	1.3027196	0.032388665	0.43679956	2.3121686	-0.2932706
GO_INSULIN_RECEPTOR_BINDING	c5.GO molecular function	30	1.0094328	0.4544073	0.6806208	GO_INSULIN_RECEPTOR_BINDING	31	1.1510067	0.2921212	0.66854084	2.1604395	-0.1415739
CHR1P34	C1: positional gene sets	133	1.0093015	0.42944038	0.6809146	CHR1P34	137	-0.96146625	0.5217391	0.74140537	0.04783525	1.97076775
GO_BLASTOCYST_DEVELOPMENT	c5.BP_ GO biological process	56	1.0092515	0.45254472	0.6809672	GO_BLASTOCYST_DEVELOPMENT	60	-0.84317666	0.875	0.8735526	0.16607484	1.85242816
GCM_ZNF198	c4.CGN_ cancer gene neighborhoods	109	1.0092477	0.45148772	0.68088144	GCM_ZNF198	109	-0.9873746	0.5	0.7053832	0.0218731	1.9966223
WYAAANNRNNNGCG_UNKNOWN	c3.TFT_ transcription factor targets	58	1.009177	0.44335663	0.68100494	WYAAANNRNNNGCG_UNKNOWN	61	-1.0556803	0.3478261	0.5949747	-0.0465033	2.0648573
GO_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY	c5.BP_ GO biological process	42	1.0090494	0.46627566	0.6812875	GO_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY	42	1.1484778	0.24487472	0.6705693	2.1575272	-0.1394284
GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN	C7_ immunologic signatures	135	1.0089245	0.43287328	0.68156946	GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN	136	0.93310004	0.63429755	0.9972136	1.94202454	0.07582446
ACATATC_MIR190	c3.MIR_ microRNA targets	57	1.008897	0.46944445	0.6815528	ACATATC_MIR190	59	0.7479714	0.8778878	1	1.7568684	0.2609256
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	c2.CGP_ chemical and genetic perturbations	61	1.0088824	0.43658212	0.6814989	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	66	1.156479	0.24096386	0.6594481	2.1653614	-0.1475966
CHICAS_RB1_TARGETS_LOW_SERUM	c2.CGP_ chemical and genetic perturbations	69	1.008881	0.44532278	0.6814063	CHICAS_RB1_TARGETS_LOW_SERUM	69	-1.2599428	0.04819277	0.3154341	-0.2510618	2.2688238
BENPORATH_ES_2	c2.CGP_ chemical and genetic perturbations	39	1.0088469	0.45193687	0.6814125	BENPORATH_ES_2	40	-1.7251399	0	0.049316045	-0.716293	2.7339868
GSE27859_MACROPHAGE_VS_DC_DN	C7_ immunologic signatures	161	1.0088056	0.45421687	0.6814396	GSE27859_MACROPHAGE_VS_DC_DN	163	1.198517	0.09470469	0.5957179	2.2073226	-0.1897114
GO_ANTIGEN_BINDING	c5.GO molecular function	46	1.0087845	0.4446043	0.6814046	GO_ANTIGEN_BINDING	58	0.78110427	0.8329646	1	1.78988877	0.22768023
JIANG_HYPOXIA_CANCER	c2.CGP_ chemical and genetic perturbations	73	1.0087787	0.45392954	0.681325	JIANG_HYPOXIA_CANCER	75	-0.9570042	0.61538464	0.7464124	0.0517745	1.9657829
GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP	C7_ immunologic signatures	139	1.0087616	0.45707375	0.6812813	GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP	155	1.1771529	0.13394684	0.6263383	2.1859145	-0.1683913
MORF_CD8A	c4.CGN_ cancer gene neighborhoods	92	1.00856	0.4685864	0.6818078	MORF_CD8A	100	1.3634609	0.022821577	0.37478688	2.3720209	-0.3549009
GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP	C7_ immunologic signatures	175	1.0085377	0.4384525	0.6817768	GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP	179	1.002601	0.47283703	0.91868824	2.0111387	0.0059367
GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN	C7_ immunologic signatures	175	1.0084833	0.45058823	0.681847	GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN	177	0.8520479	0.8130081	1	1.8605312	0.1564354
GSE40273_GATA1_KO_VS_WT_TREG_DN	C7_ immunologic signatures	178	1.0080667	0.45344618	0.6829945	GSE40273_GATA1_KO_VS_WT_TREG_DN	182	1.1917715	0.10372608	0.60394	2.1998382	-0.1837048
GCM_TINF2	c4.CGN_ cancer gene neighborhoods	37	1.0080034	0.4524887	0.6831009	GCM_TINF2	37	-0.76558024	0.90909094	0.9306286	0.24242316	1.77358364
GSE14308_TH17_VS_NATURAL_TREG_DN	C7_ immunologic signatures	177	1.0079498	0.45	0.68316865	GSE14308_TH17_VS_NATURAL_TREG_DN	177	0.9894918	0.54259634	0.935612	1.9974416	0.018458
GSE17721_LPS_VS_POLYIC_2H_BMDC_UP	C7_ immunologic signatures	184	1.0078738	0.4608076	0.68330306	GSE17721_LPS_VS_POLYIC_2H_BMDC_UP	186	0.745743	0.9444444	1	1.7536168	0.2621308
GO_METANEPHROS_MORPHOGENESIS	c5.BP_ GO biological process	25	1.0077815	0.43962848	0.6834856	GO_METANEPHROS_MORPHOGENESIS	27	0.7938826	0.78467155	1	1.8016641	0.2138989
GSE557_WT_VS_CIITA_KO_DC_UP	C7_ immunologic signatures	175	1.0077448	0.45011875	0.6834997	GSE557_WT_VS_CIITA_KO_DC_UP	175	1.0107538	0.47148675	0.90619504	2.0184986	-0.003009
GO_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM	c5.BP_ GO biological process	24	1.0077116	0.45859873	0.68349946	GO_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM	26	1.2367496	0.19578686	0.5311799	2.2444612	-0.229038
GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN	C7_ immunologic signatures	154	1.0076708	0.45676005	0.68352145	GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN	163	1.190055	0.11639676	0.60513204	2.1977258	-0.1823842
GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP	C7_ immunologic signatures	180	1.0075258	0.4617225	0.6838627	GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP	184	0.9699618	0.57186234	0.9614596	1.9774876	0.037564
GO_NUCLEAR_PERIPHERY	c5.CC_ GO cellular component	113	1.0075182	0.44908616	0.68378747	GO_NUCLEAR_PERIPHERY	113	-1.4296141	0	0.18743494	-0.4220959	2.4371323
GSE14308_INDUCED_VS_NATURAL_TREG_DN	C7_ immunologic signatures	186	1.0074364	0.44536817	0.68393105	GSE14308_INDUCED_VS_NATURAL_TREG_DN	185	1.1394905	0.19172554	0.6913171	2.1469269	-0.1320541
GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN	C7_ immunologic signatures	159	1.0073677	0.44430992	0.68403596	GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN	166	1.2023945	0.102746695	0.588083	2.2097622	-0.1950268
GO_ANION_CATION_SYMPORTER_ACTIVITY	c5.GO molecular function	45	1.0072716	0.45918366	0.68422586	GO_ANION_CATION_SYMPORTER_ACTIVITY	50	1.2016288	0.18510158	0.58904386	2.2089004	-0.1943572
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR	c2.CGP_ chemical and genetic perturbations	470	1.0070386	0.4618644	0.6848459	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR	470	0	0	0	1.0070386	1.0070386
GO_S_ACYLTRANSFERASE_ACTIVITY	c5.GO molecular function	27	1.007021	0.45454547	0.684801	GO_S_ACYLTRANSFERASE_ACTIVITY	27	0.5443749	0.98329353	1	1.5513959	0.4626461
AAGTCCA_MIR422B_MIR422A	c3.MIR_ microRNA targets	63	1.0069448	0.4507979	0.6849381	AAGTCCA_MIR422B_MIR422A	63	1.0389339	0.42378378	0.8599463	2.0458787	-0.0319891
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	27	1.0069402	0.45063695	0.6848527	REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM	26	1.0701007	0.38733253	0.80486876	2.0770409	-0.0631605
GO_EMBRYONIC_HEART_TUBE_DEVELOPMENT	c5.BP_ GO biological process	64	1.0067345	0.45391062	0.68539697	GO_EMBRYONIC_HEART_TUBE_DEVELOPMENT	71	0.9536959	0.58324385	0.97767663	1.9604304	0.0530386
GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP	C7_ immunologic signatures	143	1.0066168	0.4626683	0.68565345	GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP	146	1.513483	0	0.23833014	2.5200998	-0.5068662
GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN	C7_ immunologic signatures	142	1.006541	0.45781636	0.68579584	GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN	163	1.1641104	0.15805471	0.6469409	2.1706514	-0.1575694
GSE3982_EOSINOPHIL_VS_BASOPHIL_UP	C7_ immunologic signatures	161	1.0063597	0.44621027	0.6862714	GSE3982_EOSINOPHIL_VS_BASOPHIL_UP	167	1.1311415	0.24487706	0.7048104	2.1375012	-0.1247818
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN	C7_ immunologic signatures	179	1.0063381	0.45828438	0.6862393	GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN	184	1.2380906	0.056737587	0.5286536	2.2444287	-0.2317525
NADLER_OBESITY_UP	c2.CGP_ chemical and genetic perturbations	52	1.0063329	0.45601174	0.68615717	NADLER_OBESITY_UP	55	-0.8639551	0.6976744	0.85773706	0.1423778	1.870288
MODULE_332	c4.CM_ cancer modules	39	1.0063132	0.44245142	0.6861231	MODULE_332	39	-1.5662885	0.02027027	0.1063609	-0.5599753	2.5726017
PID_ALK1_PATHWAY	c2.CP_ Canonical pathways	24	1.0062263	0.46293494	0.6862826	PID_ALK1_PATHWAY	24	0.78890663	0.7997543	1	1.79513293	0.21731967
REACTOME_CELL_CYCLE_CHECKPOINTS	c2.CP_REACTOME_ Reactome gene sets	105	1.0061433	0.45038167	0.6864322	REACTOME_CELL_CYCLE_CHECKPOINTS	106	-1.7694064	0	0.039481573	-0.7632631	2.7755497
HOEBEKE_LYMPHOID_STEM_CELL_UP	c2.CGP_ chemical and genetic perturbations	82	1.0061232	0.46061414	0.6863938	HOEBEKE_LYMPHOID_STEM_CELL_UP	84	1.0105189	0.4771033	0.90642923	2.0166421	-0.0043957
GO_LAMELLIPODIUM	c5.CC_ GO cellular component	162	1.0060203	0.47469878	0.68661416	GO_LAMELLIPODIUM	162	1.2758489	0.04781282	0.47976816	2.2818692	-0.2698286
GO_TRANSMISSION_OF_NERVE_IMPULSE	c5.BP_ GO biological process	47	1.0060017	0.4420904	0.6865736	GO_TRANSMISSION_OF_NERVE_IMPULSE	51	-1.1221282	0.21649484	0.48578438	-0.1161265	2.1281299
GO_CELLULAR_PIGMENTATION	c5.BP_ GO biological process	40	1.005928	0.44186047	0.6866966	GO_CELLULAR_PIGMENTATION	42	0.9206515	0.624424	1	1.9265795	0.0852765
GO_POSITIVE_REGULATION_OF_VASOCONSTRICTION	c5.BP_ GO biological process	27	1.0058619	0.4477848	0.686803	GO_POSITIVE_REGULATION_OF_VASOCONSTRICTION	31	1.1300784	0.29318735	0.7057638	2.1359403	-0.1242165
GO_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION	c5.BP_ GO biological process	40	1.0057493	0.45360824	0.68702936	GO_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION	43	1.3356675	0.088435374	0.39832437	2.3414168	-0.3299182
GO_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION	c5.BP_ GO biological process	21	1.0056844	0.44801223	0.6871266	GO_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION	22	1.4174128	0.054945055	0.32078344	2.4230972	-0.4117284
GSE17580_TREG_VS_TEFF_DN	C7_ immunologic signatures	183	1.0056164	0.46171966	0.68724024	GSE17580_TREG_VS_TEFF_DN	185	0.922524	0.68048537	1	1.9281404	0.0830924
GSE3982_BCELL_VS_TH1_UP	C7_ immunologic signatures	157	1.0055605	0.4599761	0.6873109	GSE3982_BCELL_VS_TH1_UP	161	1.1579983	0.17418033	0.6574199	2.1635588	-0.1524378
GO_GTPASE_BINDING	c5.GO molecular function	277	1.0055338	0.47655398	0.68728715	GO_GTPASE_BINDING	279	1.2130287	0.050301813	0.5719414	2.2185625	-0.2074949
GO_POLYOL_METABOLIC_PROCESS	c5.BP_ GO biological process	84	1.0055078	0.4473342	0.68726945	GO_POLYOL_METABOLIC_PROCESS	89	1.0104676	0.4676564	0.9064965	2.0159754	-0.0049598
BENPORATH_ES_1	c2.CGP_ chemical and genetic perturbations	336	1.005446	0.4517203	0.6873634	BENPORATH_ES_1	340	-1.4698517	0	0.16177455	-0.4644057	2.4752977
GO_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN	c5.BP_ GO biological process	53	1.005443	0.45156696	0.6872739	GO_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN	60	-1.2297697	0.07526882	0.3459932	-0.2243267	2.2352127
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	c2.CGP_ chemical and genetic perturbations	50	1.0054272	0.46551725	0.68722254	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	49	1.07086	0.35542858	0.8037368	2.0762872	-0.0654328
GO_REGULATION_OF_LEUKOCYTE_MIGRATION	c5.BP_ GO biological process	111	1.0054218	0.47887325	0.6871421	GO_REGULATION_OF_LEUKOCYTE_MIGRATION	120	1.3354881	0.024691358	0.39813828	2.3409099	-0.3300663
GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	168	1.0053724	0.45760745	0.68719685	GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP	171	0.75178784	0.9359756	1	1.75716024	0.25358456
GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN	C7_ immunologic signatures	181	1.0053161	0.45433527	0.6872799	GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN	184	1.0767168	0.31578946	0.79465485	2.0820329	-0.0714007
REACTOME_ARMS_MEDIATED_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	17	1.0052751	0.44391027	0.687307	REACTOME_ARMS_MEDIATED_ACTIVATION	17	0.9633434	0.5503876	0.9675322	1.9686185	0.0419317
BARRIER_COLON_CANCER_RECURRENCE_DN	c2.CGP_ chemical and genetic perturbations	17	1.005226	0.4572785	0.68735015	BARRIER_COLON_CANCER_RECURRENCE_DN	17	1.2397197	0.19816273	0.52569276	2.2449457	-0.2344937
GSE11924_TH1_VS_TH17_CD4_TCELL_DN	C7_ immunologic signatures	177	1.0052022	0.45584726	0.6873284	GSE11924_TH1_VS_TH17_CD4_TCELL_DN	176	1.2176093	0.07113821	0.5605227	2.2228115	-0.2124071
RFX1_02	c3.TFT_ transcription factor targets	234	1.0051998	0.4624146	0.68723726	RFX1_02	238	0.8815232	0.7865732	1	1.886723	0.1236766
GO_PROTEIN_C_TERMINUS_BINDING	c5.GO molecular function	178	1.0051993	0.45680472	0.687142	GO_PROTEIN_C_TERMINUS_BINDING	181	0.79094934	0.8992879	1	1.79614864	0.21424996
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP	C7_ immunologic signatures	166	1.0051364	0.47199047	0.6872431	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP	173	1.0718372	0.33502537	0.80251986	2.0769736	-0.0667008
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	c2.CGP_ chemical and genetic perturbations	44	1.0050671	0.48175183	0.68736583	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	46	1.4715978	0.016949153	0.2751784	2.4766649	-0.4665307
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	114	1.0049521	0.4568528	0.68762165	GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN	124	1.1999916	0.110195674	0.5920332	2.2049437	-0.1950395
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN	C7_ immunologic signatures	184	1.0047432	0.48156956	0.68817586	GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN	185	1.0367216	0.41170534	0.86435926	2.0414648	-0.0319784
GO_STEREOCILIUM_BUNDLE	c5.CC_ GO cellular component	33	1.0044838	0.45	0.6888707	GO_STEREOCILIUM_BUNDLE	37	1.0905527	0.35052755	0.77042586	2.0950365	-0.0860689
GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_UP	C7_ immunologic signatures	179	1.0043571	0.45878136	0.6891532	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_UP	185	1.2244767	0.07591093	0.54968107	2.2288338	-0.2201196
GO_INCLUSION_BODY	c5.CC_ GO cellular component	61	1.0043328	0.44228095	0.6891306	GO_INCLUSION_BODY	63	1.1188593	0.29327452	0.72434914	2.1231921	-0.1145265
REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS	c2.CP_REACTOME_ Reactome gene sets	191	1.0042281	0.46922183	0.6893458	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS	215	1.1641573	0.12877263	0.64690614	2.1683854	-0.1599292
GNF2_HAT1	c4.CGN_ cancer gene neighborhoods	47	1.0041689	0.46280992	0.689429	GNF2_HAT1	47	-2.0078478	0	0.007685809	-1.0036789	3.0120167
GO_MEMORY	c5.BP_ GO biological process	87	1.0040064	0.44137022	0.6898202	GO_MEMORY	91	0.9225693	0.6397906	1	1.9265757	0.0814371
CATGTAA_MIR496	c3.MIR_ microRNA targets	161	1.0039766	0.46570396	0.68981075	CATGTAA_MIR496	165	-0.9274158	0.8666667	0.7874162	0.0765608	1.9313924
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP	C7_ immunologic signatures	153	1.0039506	0.46967897	0.6897955	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP	159	0.9189034	0.68565613	1	1.922854	0.0850472
GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN	C7_ immunologic signatures	165	1.0038542	0.46424243	0.6899781	GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN	167	0.64018637	0.99696356	1	1.64404057	0.36366783
GO_CALCIUM_MEDIATED_SIGNALING	c5.BP_ GO biological process	70	1.0036774	0.44813278	0.69041824	GO_CALCIUM_MEDIATED_SIGNALING	74	1.2725217	0.09090909	0.48185027	2.2761991	-0.2688443
GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	C7_ immunologic signatures	148	1.0035695	0.4716526	0.69063294	GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	151	1.530814	0	0.2211385	2.5343835	-0.5272445
MALONEY_RESPONSE_TO_17AAG_UP	c2.CGP_ chemical and genetic perturbations	37	1.0035518	0.4352574	0.6905899	MALONEY_RESPONSE_TO_17AAG_UP	37	1.0010563	0.48390806	0.92237663	2.0046081	0.0024955
GO_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS	c5.BP_ GO biological process	25	1.0035112	0.47670808	0.6906139	GO_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS	33	0.6581849	0.93421054	1	1.6616961	0.3453263
GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN	C7_ immunologic signatures	184	1.0034776	0.46225318	0.690624	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN	186	1.0082407	0.4994965	0.91141075	2.0117183	-0.0047631
YIH_RESPONSE_TO_ARSENITE_C4	c2.CGP_ chemical and genetic perturbations	15	1.0033939	0.4824281	0.69077456	YIH_RESPONSE_TO_ARSENITE_C4	16	1.0411756	0.42480212	0.85730845	2.0445695	-0.0377817
KENNY_CTNNB1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	48	1.003372	0.45494187	0.69074684	KENNY_CTNNB1_TARGETS_DN	48	-0.98105216	0.5338983	0.71328485	0.02231984	1.98442416
AMIT_DELAYED_EARLY_GENES	c2.CGP_ chemical and genetic perturbations	18	1.003316	0.4639017	0.69081527	AMIT_DELAYED_EARLY_GENES	18	0.80206484	0.75125	1	1.80538084	0.20125116
GO_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	31	1.0032794	0.47727272	0.69082725	GO_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	32	0.7139055	0.88383234	1	1.7171849	0.2893739
REACTOME_ADP_SIGNALLING_THROUGH_P2RY12	c2.CP_REACTOME_ Reactome gene sets	19	1.003241	0.4564184	0.69084585	REACTOME_ADP_SIGNALLING_THROUGH_P2RY12	19	-0.9952106	0.46086955	0.69347715	0.0080304	1.9984516
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	c2.CGP_ chemical and genetic perturbations	220	1.0032171	0.4692483	0.6908221	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	230	1.1700065	0.11334002	0.63805807	2.1732236	-0.1667894
GO_RESPONSE_TO_PROGESTERONE	c5.BP_ GO biological process	46	1.0032156	0.4320458	0.6907283	GO_RESPONSE_TO_PROGESTERONE	46	1.0666965	0.38117108	0.81152874	2.0699121	-0.0634809
LEF1_Q6	c3.TFT_ transcription factor targets	223	1.0032036	0.46900585	0.690665	LEF1_Q6	234	0.92697537	0.6864322	1	1.93017897	0.07622823
GO_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION	c5.BP_ GO biological process	22	1.0030249	0.46575344	0.69110554	GO_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION	20	1.020652	0.44543147	0.89129204	2.0236769	-0.0176271
SA_B_CELL_RECEPTOR_COMPLEXES	c2.CP_ Canonical pathways	23	1.0030017	0.4665676	0.69108176	SA_B_CELL_RECEPTOR_COMPLEXES	24	1.1786177	0.25438598	0.6237386	2.1816194	-0.175616
SMAD_Q6	c3.TFT_ transcription factor targets	218	1.0028596	0.47607934	0.69140726	SMAD_Q6	229	0.9358364	0.68108654	0.9939509	1.938696	0.0670232
GO_RESPONSE_TO_ANTIBIOTIC	c5.BP_ GO biological process	43	1.0028123	0.4516129	0.6914513	GO_RESPONSE_TO_ANTIBIOTIC	43	0.8808289	0.6757679	1	1.8836412	0.1219834
GO_REGULATION_OF_MACROPHAGE_CHEMOTAXIS	c5.BP_ GO biological process	15	1.0027994	0.45723686	0.6913893	GO_REGULATION_OF_MACROPHAGE_CHEMOTAXIS	15	0	0	0	1.0027994	1.0027994
GO_NEGATIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL	c5.BP_ GO biological process	16	1.0027978	0.47900465	0.69129735	GO_NEGATIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL	16	0.93265915	0.57727873	0.9972607	1.93545695	0.07013865
GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN	C7_ immunologic signatures	142	1.0026153	0.46699876	0.6917562	GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN	145	0.89671457	0.7306911	1	1.89932987	0.10590073
GO_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY	c5.BP_ GO biological process	16	1.0025831	0.4716981	0.6917544	GO_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY	16	0.45941645	0.99202126	1	1.46199955	0.54316665
GO_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION	c5.BP_ GO biological process	19	1.002558	0.47507787	0.6917275	GO_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION	21	-1.2655896	0.123222746	0.3109804	-0.2630316	2.2681476
CHYLA_CBFA2T3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	333	1.0023702	0.47939262	0.6921855	CHYLA_CBFA2T3_TARGETS_UP	335	1.4709884	0	0.27475852	2.4733586	-0.4686182
GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	166	1.0023183	0.4658019	0.6922378	GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_UP	169	0.6137002	0.9969231	1	1.6160185	0.3886181
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP	C7_ immunologic signatures	161	1.0022806	0.4939173	0.69225436	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP	162	-1.4100537	0	0.20020242	-0.4077731	2.4123343
PARK_HSC_MARKERS	c2.CGP_ chemical and genetic perturbations	42	1.002249	0.42753622	0.6922465	PARK_HSC_MARKERS	43	0.94255173	0.57767546	0.9890146	1.94480073	0.05969727
GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	C7_ immunologic signatures	157	1.0022364	0.4654321	0.6921913	GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	157	-1.1718681	0.0625	0.41422242	-0.1696317	2.1741045
GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN	C7_ immunologic signatures	177	1.0021883	0.4737456	0.6922456	GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN	179	0.90212345	0.7217125	1	1.90431175	0.10006485
KEGG_LINOLEIC_ACID_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	22	1.0021777	0.47145188	0.69217545	KEGG_LINOLEIC_ACID_METABOLISM	26	1.3386925	0.09765142	0.39650944	2.3408702	-0.3365148
TSENG_IRS1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	126	1.0021474	0.44857496	0.69216055	TSENG_IRS1_TARGETS_DN	129	1.0794636	0.32610938	0.78810513	2.081611	-0.0773162
GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN	C7_ immunologic signatures	161	1.0020858	0.45818183	0.69224274	GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN	171	1.1936045	0.109644674	0.59979147	2.1956903	-0.1915187
GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	178	1.0020587	0.46415982	0.6922248	GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN	179	1.2279793	0.07497467	0.54394615	2.230038	-0.2259206
GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP	C7_ immunologic signatures	159	1.002057	0.45734596	0.6921319	GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP	164	0.9486945	0.6591607	0.98321325	1.9507515	0.0533625
GO_ATPASE_COMPLEX	c5.CC_ GO cellular component	22	1.0019981	0.4453125	0.6922185	GO_ATPASE_COMPLEX	22	0.8583109	0.7001239	1	1.860309	0.1436872
MEK_UP.V1_DN	C6_ oncogenic signatures	155	1.0019726	0.46200243	0.69220144	MEK_UP.V1_DN	158	1.1972467	0.11099899	0.5971934	2.1992193	-0.1952741
GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP	C7_ immunologic signatures	185	1.0018774	0.46753246	0.6923921	GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP	185	0.708145	0.97672063	1	1.7100224	0.2937324
OCT1_B	c3.TFT_ transcription factor targets	221	1.0018505	0.4665127	0.6923784	OCT1_B	233	1.1802315	0.096871845	0.6235758	2.182082	-0.178381
MODULE_361	c4.CM_ cancer modules	112	1.0017428	0.47116566	0.69261485	MODULE_361	119	1.1653891	0.18461539	0.6460653	2.1671319	-0.1636463
REACTOME_SIGNALING_BY_NODAL	c2.CP_REACTOME_ Reactome gene sets	18	1.0016854	0.47516558	0.69269085	REACTOME_SIGNALING_BY_NODAL	18	0.81977266	0.73358583	1	1.82145806	0.18191274
GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	C7_ immunologic signatures	185	1.0016518	0.45614034	0.6926997	GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	185	0.8878972	0.7593152	1	1.889549	0.1137546
MODULE_192	c4.CM_ cancer modules	100	1.0015116	0.43582886	0.6930227	MODULE_192	99	1.2334677	0.12184874	0.536229	2.2349793	-0.2319561
GO_EPHRIN_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	80	1.0014126	0.46524063	0.693214	GO_EPHRIN_RECEPTOR_SIGNALING_PATHWAY	81	1.0087783	0.48335123	0.9104143	2.0101909	-0.0073657
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP	c2.CGP_ chemical and genetic perturbations	35	1.0013179	0.46686304	0.6934	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP	40	1.064715	0.37558138	0.81464267	2.0660329	-0.0633971
GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN	C7_ immunologic signatures	162	1.0012662	0.4770318	0.6934613	GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN	163	0.8262821	0.8452869	1	1.8275483	0.1749841
CHR2Q24	C1: positional gene sets	37	1.0012659	0.48153618	0.69336563	CHR2Q24	37	0.9710546	0.5263158	0.9602968	1.9723205	0.0302113
GO_PHOSPHATASE_COMPLEX	c5.CC_ GO cellular component	40	1.001214	0.47474748	0.693426	GO_PHOSPHATASE_COMPLEX	40	-1.2516586	0.104347825	0.32172856	-0.2504446	2.2528726
MODULE_568	c4.CM_ cancer modules	68	1.0011151	0.45640326	0.6936162	MODULE_568	67	1.4270052	0.014317181	0.3176773	2.4281203	-0.4258901
CAMPS_COLON_CANCER_COPY_NUMBER_UP	c2.CGP_ chemical and genetic perturbations	69	1.0011148	0.4512195	0.6935195	CAMPS_COLON_CANCER_COPY_NUMBER_UP	63	0.94476694	0.5869324	0.98780924	1.94588174	0.05634786
GO_ADENYLYLTRANSFERASE_ACTIVITY	c5.GO molecular function	21	1.0009942	0.45288754	0.6937903	GO_ADENYLYLTRANSFERASE_ACTIVITY	21	1.0360183	0.45956355	0.8658519	2.0370125	-0.0350241
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_DN	C7_ immunologic signatures	174	1.000946	0.47086248	0.69383085	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_DN	177	0.9402687	0.6393939	0.98960924	1.9412147	0.0606773
CHR12Q23	C1: positional gene sets	53	1.0009447	0.45529574	0.6937377	CHR12Q23	57	1.1605409	0.22135706	0.651883	2.1614856	-0.1595962
GAVIN_FOXP3_TARGETS_CLUSTER_P3	c2.CGP_ chemical and genetic perturbations	141	1.0009344	0.4640682	0.69367325	GAVIN_FOXP3_TARGETS_CLUSTER_P3	147	1.2582965	0.06026558	0.49870148	2.2592309	-0.2573621
GO_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY	c5.BP_ GO biological process	23	1.0008032	0.46964857	0.6939696	GO_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY	24	1.1169546	0.31823745	0.7286613	2.1177578	-0.1161514
MORF_BNIP1	c4.CGN_ cancer gene neighborhoods	150	1.0008019	0.45676005	0.693877	MORF_BNIP1	169	1.1104982	0.2479757	0.7367991	2.1113001	-0.1096963
RAO_BOUND_BY_SALL4	c2.CGP_ chemical and genetic perturbations	203	1.0007606	0.47051886	0.69390017	RAO_BOUND_BY_SALL4	210	1.0140947	0.47336683	0.8997765	2.0148553	-0.0133341
RAGHAVACHARI_PLATELET_SPECIFIC_GENES	c2.CGP_ chemical and genetic perturbations	58	1.0005926	0.45762712	0.69430256	RAGHAVACHARI_PLATELET_SPECIFIC_GENES	57	1.0279669	0.43791574	0.87952405	2.0285595	-0.0273743
GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP	C7_ immunologic signatures	171	1.0005093	0.4683393	0.69446725	GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP	179	0.58373255	1	1	1.58424185	0.41677675
BIOCARTA_TEL_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	1.0004121	0.45859873	0.69466186	BIOCARTA_TEL_PATHWAY	17	0.979724	0.5173745	0.95007634	1.9801361	0.0206881
GO_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	153	1.0002675	0.48870394	0.6949941	GO_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY	158	0.9272832	0.6907426	1	1.9275507	0.0729843
GO_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY	c5.BP_ GO biological process	180	1.0002079	0.47387174	0.69507533	GO_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY	184	0.9414428	0.6565041	0.98954	1.9416507	0.0587651
AMUNDSON_RESPONSE_TO_ARSENITE	c2.CGP_ chemical and genetic perturbations	194	1.000083	0.46261683	0.6953628	AMUNDSON_RESPONSE_TO_ARSENITE	197	0.9073974	0.7287449	1	1.9074804	0.0926856
MODULE_327	c4.CM_ cancer modules	18	1.0000614	0.47191012	0.6953318	MODULE_327	18	0.93967956	0.5647208	0.99004596	1.93974096	0.06038184
TGCTGAY_UNKNOWN	c3.TFT_ transcription factor targets	449	0.9999298	0.4921301	0.6956308	TGCTGAY_UNKNOWN	470	0.9231178	0.762	1	1.9230476	0.076812
CEBPA_01	c3.TFT_ transcription factor targets	212	0.99987805	0.46682188	0.6956894	CEBPA_01	217	1.2853097	0.027135678	0.46301985	2.28518775	-0.28543165
BROWNE_HCMV_INFECTION_48HR_DN	c2.CGP_ chemical and genetic perturbations	435	0.9997639	0.48155954	0.6959434	BROWNE_HCMV_INFECTION_48HR_DN	453	1.063726	0.3	0.81600815	2.0634899	-0.0639621
GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP	C7_ immunologic signatures	115	0.99973565	0.46270543	0.6959296	GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP	118	1.0982782	0.2826087	0.75882065	2.09801385	-0.09854255
GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN	C7_ immunologic signatures	173	0.9995996	0.46776083	0.6962489	GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN	175	0.8042859	0.8765182	1	1.8038855	0.1953137
GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP	C7_ immunologic signatures	160	0.9993251	0.4763033	0.69699895	GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP	164	0.77500015	0.8982706	1	1.77432525	0.22432495
GO_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY	c5.GO molecular function	58	0.9992882	0.46488765	0.69702125	GO_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY	71	1.4442073	0.01835853	0.2986621	2.4434955	-0.4449191
GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	179	0.99926233	0.46946108	0.6970029	GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	181	1.1760188	0.13306452	0.6280036	2.17528113	-0.17675647
CHR20Q12	C1: positional gene sets	31	0.9991577	0.4505988	0.697208	CHR20Q12	31	1.397696	0.073619634	0.3445089	2.3968537	-0.3985383
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	C7_ immunologic signatures	160	0.99913013	0.46052632	0.6971884	GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	161	1.1181886	0.23147207	0.7266359	2.11731873	-0.11905847
GO_LYMPHOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	187	0.9990312	0.4717887	0.69739103	GO_LYMPHOCYTE_DIFFERENTIATION	194	0.94680995	0.64444447	0.98567903	1.94584115	0.05222125
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	c2.CGP_ chemical and genetic perturbations	46	0.99899787	0.46216217	0.6973916	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	46	1.5168898	0.011534025	0.23553857	2.51588767	-0.51789193
MODULE_418	c4.CM_ cancer modules	54	0.9989937	0.4756447	0.69730884	MODULE_418	56	0.97905743	0.52568305	0.9504543	1.97805113	0.01993627
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	c2.CGP_ chemical and genetic perturbations	56	0.9989697	0.46185285	0.69728	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	58	-0.8217987	0.8842105	0.8888011	0.177171	1.8207684
GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP	C7_ immunologic signatures	171	0.99895763	0.4922711	0.6972192	GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP	172	1.3558156	0.007049345	0.3805492	2.35477323	-0.35685797
GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_DN	C7_ immunologic signatures	134	0.99884975	0.48592412	0.6974493	GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_DN	137	0.9321507	0.6395112	0.9977518	1.93100045	0.06669905
GO_MALE_GENITALIA_DEVELOPMENT	c5.BP_ GO biological process	18	0.99878424	0.48604268	0.69754446	GO_MALE_GENITALIA_DEVELOPMENT	21	0.8390295	0.70870113	1	1.83781374	0.15975474
CHR2P12	C1: positional gene sets	18	0.99876523	0.4591195	0.69750154	CHR2P12	19	1.0919449	0.34296483	0.7692187	2.09071013	-0.09317967
GSE11057_PBMC_VS_MEM_CD4_TCELL_DN	C7_ immunologic signatures	164	0.9987157	0.46690735	0.6975503	GSE11057_PBMC_VS_MEM_CD4_TCELL_DN	167	1.29693	0.034552846	0.4470716	2.2956457	-0.2982143
VERNOCHET_ADIPOGENESIS	c2.CGP_ chemical and genetic perturbations	18	0.99861664	0.46299213	0.6977409	VERNOCHET_ADIPOGENESIS	16	0.60129446	0.9460526	1	1.5999111	0.39732218
STK33_DN	C6_ oncogenic signatures	231	0.998581	0.45933563	0.69774777	STK33_DN	238	1.1312704	0.18236473	0.7045613	2.1298514	-0.1326894
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN	C7_ immunologic signatures	148	0.9985227	0.48317307	0.6978163	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN	168	1.0581731	0.37104994	0.82750463	2.0566958	-0.0596504
GO_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT	c5.BP_ GO biological process	105	0.99849045	0.4644737	0.6978072	GO_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT	105	1.2017013	0.14933059	0.5891252	2.20019175	-0.20321085
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS	c5.BP_ GO biological process	29	0.998486	0.47409734	0.6977251	GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS	31	0.7378722	0.8574822	1	1.7363582	0.2606138
GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP	C7_ immunologic signatures	179	0.9984705	0.48174322	0.6976729	GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP	179	-1.0320112	0.2631579	0.6364152	-0.0335407	2.0304817
GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	141	0.99829316	0.4595588	0.6981232	GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	147	1.2689117	0.05900305	0.4862312	2.26720486	-0.27061854
KAYO_AGING_MUSCLE_UP	c2.CGP_ chemical and genetic perturbations	208	0.99821186	0.46432748	0.69825834	KAYO_AGING_MUSCLE_UP	214	0.9842037	0.54435486	0.94242615	1.98241556	0.01400816
GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN	C7_ immunologic signatures	166	0.99814785	0.47100592	0.69835186	GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN	173	0.7710819	0.9222222	1	1.76922975	0.22706595
GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN	C7_ immunologic signatures	160	0.9980929	0.48284313	0.69842196	GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN	169	1.1350269	0.2082912	0.6971168	2.1331198	-0.136934
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	c2.CGP_ chemical and genetic perturbations	48	0.99802154	0.45056498	0.6985336	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	50	1.1901215	0.20156775	0.60539144	2.18814304	-0.19209996
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP	C7_ immunologic signatures	172	0.99790394	0.45686513	0.69877625	GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP	174	1.0240499	0.45096058	0.8851987	2.02195384	-0.02614596
MODULE_16	c4.CM_ cancer modules	444	0.9978478	0.49428868	0.6988472	MODULE_16	459	0.75099003	0.991	1	1.74883783	0.24685777
GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN	C7_ immunologic signatures	152	0.9978187	0.4601227	0.69883674	GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN	156	1.2117724	0.10493827	0.5750345	2.2095911	-0.2139537
GO_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION	c5.BP_ GO biological process	37	0.99780256	0.46573427	0.69878703	GO_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION	39	0.7882661	0.80760366	1	1.78606866	0.20953646
GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP	C7_ immunologic signatures	160	0.99776715	0.47710842	0.69880164	GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP	161	0.91578794	0.69207317	1	1.91355509	0.08197921
GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP	C7_ immunologic signatures	131	0.9976938	0.4809348	0.69892323	GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP	135	1.584408	0	0.17554349	2.5821018	-0.5867142
GO_GLIAL_CELL_DEVELOPMENT	c5.BP_ GO biological process	70	0.99766713	0.4688347	0.6989075	GO_GLIAL_CELL_DEVELOPMENT	71	-1.3952622	0	0.21092814	-0.39759507	2.39292933
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	c2.CGP_ chemical and genetic perturbations	24	0.99762803	0.4673913	0.69893456	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	26	1.0296491	0.42269325	0.8758765	2.02727713	-0.03202107
GTGTGAG_MIR342	c3.MIR_ microRNA targets	57	0.9976092	0.46443516	0.69889224	GTGTGAG_MIR342	57	0.9413026	0.5948661	0.98959076	1.9389118	0.0563066
GRADE_COLON_AND_RECTAL_CANCER_DN	c2.CGP_ chemical and genetic perturbations	86	0.99749684	0.48548812	0.6991401	GRADE_COLON_AND_RECTAL_CANCER_DN	91	1.1945279	0.18037975	0.5978572	2.19202474	-0.19703106
GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN	C7_ immunologic signatures	107	0.9974903	0.4659091	0.69906485	GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN	114	1.2942588	0.07157677	0.45095173	2.2917491	-0.2967685
GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP	C7_ immunologic signatures	184	0.99746466	0.45086706	0.6990423	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP	188	1.3370761	0.018181818	0.3984943	2.33454076	-0.33961144
HALLMARK_HYPOXIA	H_ hallmark gene sets	182	0.9974015	0.46528623	0.6991269	HALLMARK_HYPOXIA	187	1.3042964	0.020325202	0.4348867	2.3016979	-0.3068949
GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN	C7_ immunologic signatures	164	0.9973917	0.47310513	0.6990588	GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN	167	0.77378005	0.9104781	1	1.77117175	0.22361165
GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN	C7_ immunologic signatures	172	0.99738646	0.48028675	0.6989803	GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN	175	0.67599034	0.9856997	1	1.6733768	0.32139612
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	c2.CGP_ chemical and genetic perturbations	27	0.99738204	0.47158217	0.69889575	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	28	1.0250661	0.44296116	0.8837412	2.02244814	-0.02768406
GO_PEPTIDYL_THREONINE_MODIFICATION	c5.BP_ GO biological process	42	0.9972552	0.48090523	0.69917035	GO_PEPTIDYL_THREONINE_MODIFICATION	42	1.1361467	0.2986111	0.69610286	2.1334019	-0.1388915
MODULE_238	c4.CM_ cancer modules	128	0.9972531	0.4827586	0.69907856	MODULE_238	135	1.3212084	0.03469388	0.4114805	2.3184615	-0.3239553
GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP	C7_ immunologic signatures	181	0.99709505	0.49654377	0.69945824	GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP	182	0.7136299	0.9676441	1	1.71072495	0.28346515
GSE27786_LIN_NEG_VS_BCELL_UP	C7_ immunologic signatures	174	0.9970153	0.48210025	0.6996075	GSE27786_LIN_NEG_VS_BCELL_UP	180	0.98302966	0.5568983	0.9442552	1.98004496	0.01398564
ELLWOOD_MYC_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	37	0.99701065	0.46892655	0.69952416	ELLWOOD_MYC_TARGETS_DN	37	1.0425462	0.41485715	0.85436255	2.03955685	-0.04553555
GO_ADAPTIVE_IMMUNE_RESPONSE	c5.BP_ GO biological process	199	0.99689674	0.48635826	0.6997719	GO_ADAPTIVE_IMMUNE_RESPONSE	220	1.2385582	0.05125628	0.5276602	2.23545494	-0.24166146
HSF_Q6	c3.TFT_ transcription factor targets	169	0.9968096	0.46642685	0.6999301	HSF_Q6	175	1.1300501	0.21796165	0.70556307	2.1268597	-0.1332405
MORF_MAGEA8	c4.CGN_ cancer gene neighborhoods	195	0.99674416	0.4691502	0.70003563	MORF_MAGEA8	208	1.3150816	0.019133938	0.41804585	2.31182576	-0.31833744
GSE13522_WT_VS_IFNAR_KO_SKIN_DN	C7_ immunologic signatures	160	0.9967196	0.4939904	0.7000123	GSE13522_WT_VS_IFNAR_KO_SKIN_DN	164	1.3116777	0.026342452	0.42268753	2.3083973	-0.3149581
PLASARI_NFIC_TARGETS_BASAL_DN	c2.CGP_ chemical and genetic perturbations	17	0.9966529	0.45547944	0.700129	PLASARI_NFIC_TARGETS_BASAL_DN	17	-0.861772	0.6418605	0.8586974	0.1348809	1.8584249
GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP	C7_ immunologic signatures	170	0.9965089	0.4549763	0.7004616	GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP	172	0.92957646	0.6622584	0.9993995	1.92608536	0.06693244
CAAGGAT_MIR362	c3.MIR_ microRNA targets	61	0.99641937	0.4640434	0.70063865	CAAGGAT_MIR362	63	1.0935296	0.34606987	0.7684097	2.08994897	-0.09711023
GO_CORECEPTOR_ACTIVITY	c5.GO molecular function	31	0.9963021	0.47465438	0.7008889	GO_CORECEPTOR_ACTIVITY	33	0.747269	0.8505338	1	1.7435711	0.2490331
GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN	C7_ immunologic signatures	105	0.9960315	0.47522235	0.7016018	GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN	113	1.0550715	0.3809524	0.8328715	2.051103	-0.05904
CHR15Q15	C1: positional gene sets	58	0.99596095	0.45804676	0.7017105	CHR15Q15	58	1.2201128	0.15503876	0.55547166	2.21607375	-0.22415185
GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	C7_ immunologic signatures	180	0.99585986	0.4823113	0.701918	GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	181	0.5672801	0.9989909	1	1.56313996	0.42857976
GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_DN	C7_ immunologic signatures	149	0.99578565	0.47411764	0.7020356	GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_DN	151	0.6579403	0.9887984	1	1.65372595	0.33784535
GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	C7_ immunologic signatures	160	0.9957555	0.46764347	0.7020312	GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	164	0.8070239	0.8792221	1	1.8027794	0.1887316
GO_PROTEIN_MONOUBIQUITINATION	c5.BP_ GO biological process	49	0.99574274	0.46958983	0.7019735	GO_PROTEIN_MONOUBIQUITINATION	49	-0.9955052	0.4509804	0.6937054	0.00023754	1.99124794
GO_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION	c5.BP_ GO biological process	22	0.9956553	0.4654088	0.7021286	GO_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION	24	0.7985746	0.78	1	1.7942299	0.1970807
GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	181	0.9956386	0.4778443	0.70208305	GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP	180	1.0702327	0.34109312	0.8045761	2.0658713	-0.0745941
GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN	C7_ immunologic signatures	169	0.9956131	0.4846698	0.70206636	GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN	173	0.8285352	0.8423746	1	1.8241483	0.1670779
HNF4_01	c3.TFT_ transcription factor targets	228	0.9955923	0.48791716	0.70203483	HNF4_01	241	1.0228652	0.43473896	0.88691217	2.0184575	-0.0272729
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	c2.CGP_ chemical and genetic perturbations	161	0.9955514	0.4868735	0.7020569	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	163	1.1582639	0.1632653	0.6563652	2.1538153	-0.1627125
GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN	C7_ immunologic signatures	156	0.99545383	0.4835966	0.70224583	GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN	164	1.501942	0.001015229	0.2513961	2.49739583	-0.50648817
KEGG_STEROID_HORMONE_BIOSYNTHESIS	c2.CP_BIOCARTA_ BioCarta gene sets	33	0.9954369	0.46811596	0.70220006	KEGG_STEROID_HORMONE_BIOSYNTHESIS	35	1.1322324	0.29036003	0.70239764	2.1276693	-0.1367955
GO_RAB_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	c5.GO molecular function	26	0.9954281	0.4992343	0.7021285	GO_RAB_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	26	1.2880266	0.12773722	0.4611122	2.2834547	-0.2925985
GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION	c5.BP_ GO biological process	36	0.9951824	0.48024315	0.70274895	GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION	38	1.3214971	0.08045977	0.4114688	2.3166795	-0.3263147
GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	C7_ immunologic signatures	169	0.9951345	0.47831327	0.70279866	GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	173	0.995833	0.5151515	0.92982674	1.9909675	-0.0006985
GO_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION	c5.BP_ GO biological process	25	0.99511343	0.4628752	0.70276225	GO_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION	28	0.7330216	0.84710234	1	1.72813503	0.26209183
GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP	C7_ immunologic signatures	177	0.9950681	0.48349056	0.70279366	GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP	180	1.2731998	0.037525356	0.48184007	2.2682679	-0.2781317
GO_NUCLEOTIDE_TRANSPORT	c5.BP_ GO biological process	23	0.9950136	0.4830247	0.70286655	GO_NUCLEOTIDE_TRANSPORT	23	1.0681272	0.38902438	0.8089417	2.0631408	-0.0731136
GO_ESCRT_COMPLEX	c5.CC_ GO cellular component	23	0.9949436	0.47662142	0.7029731	GO_ESCRT_COMPLEX	23	0.67905617	0.89312977	1	1.67399977	0.31588743
STAT5A_04	c3.TFT_ transcription factor targets	180	0.9949365	0.47805455	0.7028982	STAT5A_04	188	1.2203629	0.06747231	0.55494034	2.2152994	-0.2254264
GO_RESPONSE_TO_STARVATION	c5.BP_ GO biological process	135	0.9949329	0.46859902	0.70281136	GO_RESPONSE_TO_STARVATION	143	0.9141114	0.67934227	1	1.9090443	0.0808215
GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN	C7_ immunologic signatures	182	0.99485207	0.48943663	0.70295286	GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN	181	-1.192214	0.07692308	0.39176345	-0.19736193	2.18706607
GO_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY	c5.GO molecular function	16	0.9948445	0.47704917	0.702874	GO_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY	15	0.8592074	0.66622865	1	1.8540519	0.1356371
GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN	C7_ immunologic signatures	170	0.9947804	0.48356807	0.70296997	GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN	173	1.2137343	0.08044807	0.5709475	2.2085147	-0.2189539
LBP1_Q6	c3.TFT_ transcription factor targets	193	0.994731	0.4946108	0.7030172	LBP1_Q6	201	0.99638075	0.51008064	0.9288366	1.99111175	-0.00164975
GSE10325_MYELOID_VS_LUPUS_MYELOID_DN	C7_ immunologic signatures	167	0.9946313	0.45357144	0.7032152	GSE10325_MYELOID_VS_LUPUS_MYELOID_DN	168	1.1672473	0.14646465	0.64171493	2.1618786	-0.172616
PXR_Q2	c3.TFT_ transcription factor targets	220	0.9946123	0.48741418	0.70317525	PXR_Q2	234	1.0714717	0.30753767	0.80310655	2.066084	-0.0768594
LIAN_LIPA_TARGETS_6M	c2.CGP_ chemical and genetic perturbations	55	0.99455374	0.47083926	0.70325077	LIAN_LIPA_TARGETS_6M	60	1.0891031	0.33406836	0.7724269	2.08365684	-0.09454936
GO_REPRESSING_TRANSCRIPTION_FACTOR_BINDING	c5.GO molecular function	52	0.9945299	0.4563107	0.70322376	GO_REPRESSING_TRANSCRIPTION_FACTOR_BINDING	54	-1.2289331	0.13829787	0.34723476	-0.2344032	2.223463
GO_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION	c5.BP_ GO biological process	21	0.99452174	0.4744186	0.7031541	GO_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION	21	1.1538517	0.28176102	0.663321	2.14837344	-0.15932996
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP	C7_ immunologic signatures	174	0.9945141	0.46698114	0.7030786	GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP	176	1.1476005	0.1802444	0.6727683	2.1421146	-0.1530864
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP	C7_ immunologic signatures	174	0.9944427	0.4839477	0.70319194	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP	176	0.83274055	0.8440367	1	1.82718325	0.16170215
GO_REGULATION_OF_NEURON_DEATH	c5.BP_ GO biological process	227	0.99412006	0.4726426	0.70408225	GO_REGULATION_OF_NEURON_DEATH	236	0.93119365	0.7015075	0.9987202	1.92531371	0.06292641
GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN	C7_ immunologic signatures	167	0.9939181	0.48156956	0.7045844	GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN	173	1.0674299	0.33805668	0.81021196	2.061348	-0.0735118
GSE1460_DP_VS_CD4_THYMOCYTE_DN	C7_ immunologic signatures	162	0.99385196	0.49095297	0.7046869	GSE1460_DP_VS_CD4_THYMOCYTE_DN	169	1.255387	0.045638945	0.50258476	2.24923896	-0.26153504
GSE7852_TREG_VS_TCONV_DN	C7_ immunologic signatures	173	0.99381506	0.48108748	0.70470005	GSE7852_TREG_VS_TCONV_DN	175	1.2971479	0.024242423	0.44719744	2.29096296	-0.30333284
GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	C7_ immunologic signatures	184	0.9937843	0.48390943	0.7046948	GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	187	0.7188638	0.9555106	1	1.7126481	0.2749205
GO_MYELOID_LEUKOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	84	0.9937594	0.48192772	0.7046682	GO_MYELOID_LEUKOCYTE_DIFFERENTIATION	85	1.2078909	0.1695279	0.5804282	2.2016503	-0.2141315
GCM_LTK	c4.CGN_ cancer gene neighborhoods	39	0.99375826	0.45808384	0.7045741	GCM_LTK	40	0.77441996	0.80846065	1	1.76817822	0.2193383
GSE17721_POLYIC_VS_CPG_2H_BMDC_UP	C7_ immunologic signatures	182	0.99369425	0.4730679	0.70466346	GSE17721_POLYIC_VS_CPG_2H_BMDC_UP	183	0.57555073	1	1	1.56924498	0.41814352
GO_RESPONSE_TO_TOXIC_SUBSTANCE	c5.BP_ GO biological process	205	0.9935283	0.49045345	0.7050627	GO_RESPONSE_TO_TOXIC_SUBSTANCE	213	1.2513342	0.03939394	0.5090114	2.2448625	-0.2578059
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	169	0.99346524	0.48910412	0.7051567	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	170	0.86827856	0.78723407	1	1.8617438	0.12518668
AMIT_SERUM_RESPONSE_240_MCF10A	c2.CGP_ chemical and genetic perturbations	52	0.99332297	0.47316384	0.7054705	AMIT_SERUM_RESPONSE_240_MCF10A	52	1.0710022	0.3748622	0.8033922	2.06432517	-0.07767923
MULLIGHAN_NPM1_SIGNATURE_3_DN	c2.CGP_ chemical and genetic perturbations	142	0.99317104	0.47757575	0.70582694	MULLIGHAN_NPM1_SIGNATURE_3_DN	144	1.1223532	0.23421589	0.7214222	2.11552424	-0.12918216
MORF_PDCD1	c4.CGN_ cancer gene neighborhoods	54	0.99314755	0.46241134	0.7057984	MORF_PDCD1	59	1.3435766	0.063053094	0.39111388	2.33672415	-0.35042905
GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN	C7_ immunologic signatures	166	0.99311143	0.49031478	0.7058096	GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN	168	1.3288033	0.022244692	0.40394965	2.32191473	-0.33569187
GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN	C7_ immunologic signatures	178	0.9931048	0.48609433	0.7057337	GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN	179	1.4237663	0.001014199	0.31828666	2.4168711	-0.4306615
KEGG_RETINOL_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	46	0.99309725	0.47954866	0.7056589	KEGG_RETINOL_METABOLISM	47	1.550864	0.006802721	0.20757058	2.54396125	-0.55776675
GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	C7_ immunologic signatures	169	0.99304146	0.4903846	0.70573026	GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	182	0.79927695	0.8987854	1	1.79231841	0.19376451
BRCA1_DN.V1_UP	C6_ oncogenic signatures	95	0.9929736	0.45501286	0.7058266	BRCA1_DN.V1_UP	106	0.8537733	0.7790339	1	1.8467469	0.1392003
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN	C7_ immunologic signatures	175	0.9929179	0.5017626	0.7059073	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN	176	0.8262322	0.86018234	1	1.8191501	0.1666857
TAGAACC_MIR182	c3.MIR_ microRNA targets	37	0.9928936	0.47303542	0.7058823	TAGAACC_MIR182	37	-1.0978585	0.2580645	0.5230419	-0.1049649	2.0907521
GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN	C7_ immunologic signatures	177	0.9928837	0.48284024	0.70581293	GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN	180	1.0080203	0.49746707	0.91071975	2.000904	-0.0151366
NADLER_HYPERGLYCEMIA_AT_OBESITY	c2.CGP_ chemical and genetic perturbations	53	0.9928051	0.4807418	0.70595205	NADLER_HYPERGLYCEMIA_AT_OBESITY	54	0.58170784	0.99115044	1	1.57451294	0.41109726
GO_NUCLEUS_LOCALIZATION	c5.BP_ GO biological process	18	0.9927904	0.48932678	0.70589757	GO_NUCLEUS_LOCALIZATION	18	1.1647351	0.26973686	0.6463281	2.1575255	-0.1719447
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP	C7_ immunologic signatures	167	0.9927773	0.5064782	0.70583797	GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP	174	0.70722276	0.9654471	1	1.70000006	0.28555454
GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN	C7_ immunologic signatures	162	0.9925445	0.47889024	0.70644057	GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN	171	0.9722515	0.56723964	0.9591896	1.964796	0.020293
GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	155	0.9923639	0.48099762	0.7068957	GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN	166	1.1195462	0.22244692	0.7235902	2.1119101	-0.1271823
GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN	C7_ immunologic signatures	173	0.9923482	0.47800237	0.7068458	GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN	172	-0.969848	0.54545456	0.7297089	0.0225002	1.9621962
GO_GLYCEROLIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	194	0.9922364	0.49886364	0.70706886	GO_GLYCEROLIPID_BIOSYNTHETIC_PROCESS	201	1.1067971	0.2522613	0.7428445	2.0990335	-0.1145607
GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	C7_ immunologic signatures	178	0.992224	0.47675803	0.7070104	GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	177	1.0352743	0.4207317	0.86722004	2.0274983	-0.0430503
MORF_HEAB	c4.CGN_ cancer gene neighborhoods	75	0.9921208	0.48128343	0.7072167	MORF_HEAB	77	0.719411	0.92167383	1	1.7115318	0.2727098
GO_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	44	0.9920954	0.48079658	0.7071987	GO_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT	43	-1.0604308	0.35820895	0.58771735	-0.0683354	2.0525262
GSE29949_MICROGLIA_VS_DC_BRAIN_DN	C7_ immunologic signatures	162	0.9920186	0.48967195	0.70734423	GSE29949_MICROGLIA_VS_DC_BRAIN_DN	168	1.3917463	0.00508647	0.34621182	2.3837649	-0.3997277
GLI1_UP.V1_UP	C6_ oncogenic signatures	23	0.99194396	0.4617737	0.70747143	GLI1_UP.V1_UP	24	0.70292467	0.881761	1	1.69486863	0.28901929
GSE27786_LIN_NEG_VS_NKTCELL_UP	C7_ immunologic signatures	182	0.9919162	0.4994233	0.70745796	GSE27786_LIN_NEG_VS_NKTCELL_UP	182	0.88794214	0.7512639	1	1.87985834	0.10397406
GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP	C7_ immunologic signatures	116	0.9917524	0.4713376	0.70786756	GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP	126	1.3664097	0.016511869	0.37129924	2.3581621	-0.3746573
GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN	C7_ immunologic signatures	153	0.9917364	0.49459785	0.70781446	GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN	156	1.046045	0.38617885	0.84709084	2.0377814	-0.0543086
BROWNE_HCMV_INFECTION_16HR_UP	c2.CGP_ chemical and genetic perturbations	204	0.9917263	0.48591548	0.7077461	BROWNE_HCMV_INFECTION_16HR_UP	207	0.74648297	0.94752777	1	1.73820927	0.24524333
GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	181	0.9916811	0.4800937	0.7077849	GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP	181	1.1111605	0.24162437	0.73580635	2.1028416	-0.1194794
GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN	C7_ immunologic signatures	179	0.9916615	0.47820964	0.70774543	GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN	179	0.9658432	0.58645093	0.96480376	1.9575047	0.0258183
PR_02	c3.TFT_ transcription factor targets	115	0.991613	0.48685858	0.70779777	PR_02	121	0.6974142	0.9601259	1	1.6890272	0.2941988
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN	C7_ immunologic signatures	175	0.99157304	0.49168646	0.70781744	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN	180	1.2009969	0.11099899	0.59076583	2.19256994	-0.20942386
BIOCARTA_CARDIACEGF_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	0.9915685	0.47867298	0.7077311	BIOCARTA_CARDIACEGF_PATHWAY	18	1.3376908	0.12597403	0.398233	2.3292593	-0.3461223
GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN	C7_ immunologic signatures	139	0.99148417	0.48242423	0.7078846	GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN	147	0.7982004	0.8799593	1	1.78968457	0.19328377
GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP	C7_ immunologic signatures	133	0.99138695	0.49066	0.70808154	GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP	141	-0.7191601	1	0.9515989	0.27222685	1.71054705
GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN	C7_ immunologic signatures	174	0.99133384	0.50998825	0.7081511	GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN	178	0.9083249	0.73030305	1	1.89965874	0.08300894
BIDUS_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	135	0.99129206	0.4903846	0.70816785	BIDUS_METASTASIS_DN	137	1.5958606	0	0.16512378	2.58715266	-0.60456854
GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP	C7_ immunologic signatures	174	0.9912453	0.5083333	0.708212	GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP	176	1.1481813	0.18016194	0.6710868	2.1394266	-0.156936
MODULE_9	c4.CM_ cancer modules	105	0.9912175	0.4826701	0.7081969	MODULE_9	110	1.2860105	0.060228452	0.4625455	2.277228	-0.294793
GO_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION	c5.BP_ GO biological process	19	0.99100727	0.45859873	0.7087289	GO_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION	20	1.2487587	0.18773946	0.51258487	2.23976597	-0.25775143
GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP	C7_ immunologic signatures	178	0.99100447	0.48920864	0.70863956	GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP	180	0.8248163	0.8704454	1	1.81582077	0.16618817
BIOCARTA_EGF_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	31	0.99088943	0.49697885	0.7088836	BIOCARTA_EGF_PATHWAY	31	1.331822	0.08669109	0.4006592	2.32271143	-0.34093257
GO_SOMATIC_CELL_DNA_RECOMBINATION	c5.BP_ GO biological process	30	0.9908727	0.4941349	0.7088369	GO_SOMATIC_CELL_DNA_RECOMBINATION	30	-1.6839409	0.018404908	0.060132854	-0.6930682	2.6748136
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	C7_ immunologic signatures	154	0.990759	0.5079559	0.70908034	GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	160	0.8996367	0.72199595	1	1.8903957	0.0911223
GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	C7_ immunologic signatures	176	0.990749	0.486747	0.7090127	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	177	0.73991114	0.9477459	1	1.73066014	0.25083786
KEGG_TIGHT_JUNCTION	c2.CP_BIOCARTA_ BioCarta gene sets	111	0.99072546	0.49553	0.7089826	KEGG_TIGHT_JUNCTION	118	0.96852577	0.5647182	0.9629037	1.95925123	0.02219969
GO_ENDOSOMAL_PART	c5.CC_ GO cellular component	368	0.9906131	0.5239651	0.7092282	GO_ENDOSOMAL_PART	375	0.9852758	0.55667	0.9414835	1.9758889	0.0053373
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	c2.CGP_ chemical and genetic perturbations	36	0.99051917	0.49082568	0.70942473	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	39	0.96678007	0.5277136	0.9643757	1.95729924	0.0237391
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	c2.CGP_ chemical and genetic perturbations	188	0.99051446	0.5	0.709342	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	194	0.9658475	0.59574467	0.96492314	1.95636196	0.02466696
GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	C7_ immunologic signatures	180	0.9902964	0.46989375	0.7099138	GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	183	1.1758044	0.11425682	0.6279006	2.1661008	-0.185508
GSE22033_WT_VS_PPARG_KO_MEF_DN	C7_ immunologic signatures	169	0.9902645	0.4830918	0.70991224	GSE22033_WT_VS_PPARG_KO_MEF_DN	171	0.7930862	0.8978766	1	1.7833507	0.1971783
GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP	C7_ immunologic signatures	163	0.9901922	0.48165682	0.7100199	GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP	164	1.0650824	0.34556574	0.8140569	2.0552746	-0.0748902
GO_PROTEIN_SELF_ASSOCIATION	c5.GO molecular function	39	0.99019	0.49854228	0.7099279	GO_PROTEIN_SELF_ASSOCIATION	39	1.1740638	0.21077283	0.6312841	2.1642538	-0.1838738
GO_4_IRON_4_SULFUR_CLUSTER_BINDING	c5.GO molecular function	38	0.9901769	0.4751067	0.70987344	GO_4_IRON_4_SULFUR_CLUSTER_BINDING	39	-0.7711413	0.8863636	0.92697877	0.2190356	1.7613182
GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	160	0.99015296	0.47894102	0.70985186	GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP	171	1.1117367	0.24848485	0.7351744	2.10188966	-0.12158374
LEE_LIVER_CANCER_CIPROFIBRATE_DN	c2.CGP_ chemical and genetic perturbations	50	0.9901452	0.46861926	0.7097791	LEE_LIVER_CANCER_CIPROFIBRATE_DN	49	0.7166586	0.8875	1	1.7068038	0.2734866
GO_DEFENSE_RESPONSE_TO_FUNGUS	c5.BP_ GO biological process	27	0.9901401	0.48765433	0.70969725	GO_DEFENSE_RESPONSE_TO_FUNGUS	28	0.686066	0.9014778	1	1.6762061	0.3040741
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	c2.CGP_ chemical and genetic perturbations	20	0.9900936	0.47694755	0.7097407	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	20	1.1994706	0.23994975	0.59347594	2.1895642	-0.209377
GO_PALMITOYLTRANSFERASE_ACTIVITY	c5.GO molecular function	32	0.9899999	0.48562783	0.7099262	GO_PALMITOYLTRANSFERASE_ACTIVITY	34	0.75692946	0.8294931	1	1.74692936	0.23307044
GO_G_PROTEIN_COUPLED_RECEPTOR_BINDING	c5.GO molecular function	190	0.98999476	0.4902411	0.70984524	GO_G_PROTEIN_COUPLED_RECEPTOR_BINDING	212	1.1657679	0.14859438	0.6459024	2.15576266	-0.17577314
GO_CYTOKINE_PRODUCTION	c5.BP_ GO biological process	95	0.98997897	0.4967825	0.70979464	GO_CYTOKINE_PRODUCTION	101	1.0446328	0.41151834	0.8503828	2.03461177	-0.05465383
GO_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION	c5.BP_ GO biological process	23	0.98996884	0.475976	0.70972943	GO_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION	25	1.4556987	0.042944785	0.2872134	2.44566754	-0.46572986
GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP	C7_ immunologic signatures	174	0.9898393	0.49760765	0.7100259	GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP	177	0.8229213	0.86336035	1	1.8127606	0.166918
GO_LEARNING	c5.BP_ GO biological process	110	0.98983854	0.4810606	0.70993125	GO_LEARNING	119	1.1908879	0.14639175	0.6044717	2.18072644	-0.20104936
GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN	C7_ immunologic signatures	160	0.9898263	0.48502994	0.70987296	GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN	174	0.88041615	0.76214576	1	1.87024245	0.10941015
MORF_PDPK1	c4.CGN_ cancer gene neighborhoods	63	0.9898203	0.48396096	0.7097963	MORF_PDPK1	65	0.8353967	0.7684783	1	1.825217	0.1544236
VEGF_A_UP.V1_DN	C6_ oncogenic signatures	179	0.9897935	0.49584815	0.709777	VEGF_A_UP.V1_DN	182	-1.3859541	0	0.2155884	-0.3961606	2.3757476
GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN	C7_ immunologic signatures	170	0.9897518	0.4858156	0.7098034	GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN	170	1.125582	0.21052632	0.7133384	2.1153338	-0.1358302
IK3_01	c3.TFT_ transcription factor targets	195	0.9896725	0.47938752	0.70994925	IK3_01	197	0.9661511	0.59778225	0.9648131	1.9558236	0.0235214
GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP	C7_ immunologic signatures	171	0.9896072	0.4876325	0.71004516	GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP	185	1.3215904	0.011201629	0.41138035	2.3111976	-0.3319832
GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN	C7_ immunologic signatures	137	0.98952585	0.47809762	0.71019155	GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN	142	0.6954306	0.96118486	1	1.68495645	0.29409525
MCDOWELL_ACUTE_LUNG_INJURY_DN	c2.CGP_ chemical and genetic perturbations	42	0.9894149	0.48358208	0.7104172	MCDOWELL_ACUTE_LUNG_INJURY_DN	43	1.3701012	0.06370876	0.36865678	2.3595161	-0.3806863
GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	176	0.98939896	0.4918415	0.71036553	GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP	181	1.1719861	0.13709678	0.6348329	2.16138506	-0.18258714
GO_HISTONE_LYSINE_N_METHYLTRANSFERASE_ACTIVITY	c5.GO molecular function	29	0.9893606	0.47166923	0.7103803	GO_HISTONE_LYSINE_N_METHYLTRANSFERASE_ACTIVITY	31	0.69659454	0.86851627	1	1.68595514	0.29276606
ONKEN_UVEAL_MELANOMA_DN	c2.CGP_ chemical and genetic perturbations	474	0.98925436	0.5205479	0.7105912	ONKEN_UVEAL_MELANOMA_DN	476	0.95029503	0.687	0.98190653	1.93954939	0.03895933
GO_MYELOID_CELL_HOMEOSTASIS	c5.BP_ GO biological process	78	0.989227	0.4959893	0.7105782	GO_MYELOID_CELL_HOMEOSTASIS	78	0.6847912	0.94186044	1	1.6740182	0.3044358
MODULE_145	c4.CM_ cancer modules	95	0.9891898	0.4864865	0.7105994	MODULE_145	100	1.1370473	0.23584905	0.69439137	2.1262371	-0.1478575
GO_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS_PHOSPHORYLATIVE_MECHANISM	c5.GO molecular function	29	0.9891194	0.48955223	0.7107146	GO_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS_PHOSPHORYLATIVE_MECHANISM	33	0.9775157	0.51118964	0.9520026	1.9666351	0.0116037
AKL_HTLV1_INFECTION_DN	c2.CGP_ chemical and genetic perturbations	60	0.9891172	0.49717513	0.7106243	AKL_HTLV1_INFECTION_DN	61	0.89602834	0.6724701	1	1.88514554	0.09308886
GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN	C7_ immunologic signatures	135	0.9890826	0.49758455	0.71062905	GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN	140	1.1322329	0.20204082	0.7025626	2.1213155	-0.1431503
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	c2.CGP_ chemical and genetic perturbations	20	0.98906267	0.49923664	0.7105907	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	19	0.6612245	0.9042821	1	1.65028717	0.32783817
GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP	C7_ immunologic signatures	171	0.9890471	0.48557693	0.7105401	GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP	171	0.9206764	0.6885743	1	1.9097235	0.0683707
GO_INTERACTION_WITH_HOST	c5.BP_ GO biological process	115	0.9889812	0.5051414	0.71064	GO_INTERACTION_WITH_HOST	116	0.64781576	0.97619045	1	1.63679696	0.34116544
GSE3982_BASOPHIL_VS_NKCELL_DN	C7_ immunologic signatures	158	0.9889655	0.4909964	0.71059227	GSE3982_BASOPHIL_VS_NKCELL_DN	167	1.1854366	0.13414635	0.613783	2.1744021	-0.1964711
RIZKI_TUMOR_INVASIVENESS_3D_UP	c2.CGP_ chemical and genetic perturbations	177	0.988919	0.51913875	0.7106302	RIZKI_TUMOR_INVASIVENESS_3D_UP	183	1.013282	0.4701719	0.90119547	2.002201	-0.024363
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	c2.CGP_ chemical and genetic perturbations	229	0.9889154	0.5017065	0.71054655	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	240	0.9978692	0.5150905	0.92590714	1.9867846	-0.0089538
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP	C7_ immunologic signatures	175	0.98888576	0.4747596	0.71054155	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP	177	-1.004104	0.45454547	0.67812544	-0.01521824	1.99298976
GO_RESPONSE_TO_AMINE	c5.BP_ GO biological process	42	0.98886234	0.46554148	0.71051633	GO_RESPONSE_TO_AMINE	46	1.0482583	0.4171364	0.84295225	2.03712064	-0.05939596
GO_HEART_TRABECULA_MORPHOGENESIS	c5.BP_ GO biological process	24	0.988827	0.4680187	0.71051663	GO_HEART_TRABECULA_MORPHOGENESIS	25	-0.9068115	0.5697674	0.81415594	0.0820155	1.8956385
PENG_GLUCOSE_DEPRIVATION_DN	c2.CGP_ chemical and genetic perturbations	148	0.98878914	0.50477326	0.7105324	PENG_GLUCOSE_DEPRIVATION_DN	155	0.70314544	0.95607764	1	1.69193458	0.2856437
ST_WNT_CA2_CYCLIC_GMP_PATHWAY	c2.CP_ Canonical pathways	17	0.9886963	0.4617737	0.71071875	ST_WNT_CA2_CYCLIC_GMP_PATHWAY	18	0.89974463	0.6189225	1	1.88844093	0.08895167
DAZARD_UV_RESPONSE_CLUSTER_G24	c2.CGP_ chemical and genetic perturbations	19	0.9885635	0.48863637	0.7110167	DAZARD_UV_RESPONSE_CLUSTER_G24	19	1.2935703	0.13359788	0.45249602	2.2821338	-0.3050068
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	c2.CGP_ chemical and genetic perturbations	284	0.9883905	0.5016358	0.7114378	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	285	-1.4112818	0	0.19910048	-0.4228913	2.3996723
ER_Q6_01	c3.TFT_ transcription factor targets	225	0.98833686	0.4960452	0.7115065	ER_Q6_01	236	0.90036404	0.76185673	1	1.8887009	0.08797282
BROWNE_HCMV_INFECTION_24HR_UP	c2.CGP_ chemical and genetic perturbations	130	0.98828363	0.50799507	0.71156543	BROWNE_HCMV_INFECTION_24HR_UP	131	-0.858285	0.8636364	0.86180264	0.12999863	1.84656863
GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN	C7_ immunologic signatures	180	0.9879811	0.49707603	0.7123699	GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN	181	0.9140271	0.70475227	1	1.9020082	0.073954
GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	176	0.9879458	0.49639422	0.7123787	GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	181	0.9056365	0.7284701	1	1.8935823	0.0823093
GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP	C7_ immunologic signatures	177	0.9879118	0.5018007	0.71238273	GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP	181	0.87283564	0.7882472	1	1.86074744	0.11507616
MAHAJAN_RESPONSE_TO_IL1A_DN	c2.CGP_ chemical and genetic perturbations	69	0.9877516	0.45702592	0.7127615	MAHAJAN_RESPONSE_TO_IL1A_DN	69	0.9009288	0.64699334	1	1.8886804	0.0868228
GO_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE	c5.BP_ GO biological process	93	0.9877043	0.48101267	0.71280307	GO_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE	94	1.2019765	0.15800416	0.5884436	2.1896808	-0.2142722
AP1FJ_Q2	c3.TFT_ transcription factor targets	235	0.98747784	0.4875	0.7133874	AP1FJ_Q2	246	1.2609025	0.03121853	0.49468336	2.24838034	-0.27342466
GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	112	0.98746485	0.48214287	0.7133263	GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN	116	0.9996935	0.4881321	0.92447364	1.98715835	-0.01222865
GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	169	0.98742545	0.5115473	0.71334267	GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN	172	0.7729229	0.90789473	1	1.76034835	0.21450255
STK33_NOMO_DN	C6_ oncogenic signatures	221	0.987424	0.50341684	0.7132505	STK33_NOMO_DN	232	1.1165444	0.20703517	0.7286299	2.1039684	-0.1291204
GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_DN	C7_ immunologic signatures	174	0.9874145	0.49636805	0.71318126	GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_DN	179	0.8423155	0.8414634	1	1.82973	0.145099
GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	155	0.9873986	0.4903846	0.7131321	GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN	155	0.614422	0.9959184	1	1.6018206	0.3729766
PID_ARF6_PATHWAY	c2.CP_ Canonical pathways	33	0.987318	0.47858196	0.71327883	PID_ARF6_PATHWAY	34	1.3698379	0.068445474	0.36862907	2.3571559	-0.3825199
GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP	C7_ immunologic signatures	172	0.9870518	0.5023148	0.7139788	GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP	175	0.9072272	0.7023209	1	1.894279	0.0798246
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	c2.CGP_ chemical and genetic perturbations	173	0.98704624	0.51465416	0.7138968	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	203	1.4690768	0	0.2763344	2.45612304	-0.48203056
GSE27786_LIN_NEG_VS_MONO_MAC_DN	C7_ immunologic signatures	170	0.98702365	0.5	0.7138651	GSE27786_LIN_NEG_VS_MONO_MAC_DN	177	0.86504656	0.8054711	1	1.85207021	0.12197709
GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN	C7_ immunologic signatures	162	0.9869189	0.5066829	0.71408767	GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN	170	1.3585743	0.006066734	0.37842318	2.3454932	-0.3716554
GCM_USP6	c4.CGN_ cancer gene neighborhoods	66	0.9868663	0.5020408	0.71415174	GCM_USP6	66	1.2068709	0.16261062	0.5807893	2.1937372	-0.2200046
GO_ANION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	210	0.986839	0.5137931	0.7141369	GO_ANION_TRANSMEMBRANE_TRANSPORT	231	1.1648201	0.1307847	0.6464352	2.1516591	-0.1779811
COATES_MACROPHAGE_M1_VS_M2_UP	c2.CGP_ chemical and genetic perturbations	69	0.9868195	0.48965517	0.7140974	COATES_MACROPHAGE_M1_VS_M2_UP	70	1.3850304	0.029157666	0.35066903	2.3718499	-0.3982109
GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN	C7_ immunologic signatures	167	0.9867519	0.5053892	0.714202	GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN	175	1.1613549	0.16902834	0.6512233	2.1481068	-0.174603
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN	C7_ immunologic signatures	156	0.98670673	0.48371533	0.7142468	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN	155	0.69238114	0.96636087	1	1.67908787	0.29432559
GO_NEURON_FATE_SPECIFICATION	c5.BP_ GO biological process	26	0.9866826	0.4857143	0.71422404	GO_NEURON_FATE_SPECIFICATION	31	1.1489464	0.26618704	0.6697533	2.135629	-0.1622638
GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN	C7_ immunologic signatures	174	0.986503	0.49635923	0.7146589	GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN	176	1.3329111	0.015182186	0.39965108	2.3194141	-0.3464081
GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN	C7_ immunologic signatures	174	0.98645526	0.5	0.7147105	GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN	180	1.0920173	0.28846154	0.769359	2.07847256	-0.10556204
GO_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT	c5.BP_ GO biological process	15	0.9863648	0.49131122	0.7148859	GO_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT	16	1.3335588	0.12945838	0.39979625	2.3199236	-0.347194
GO_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION	c5.BP_ GO biological process	34	0.9863129	0.47887325	0.71494216	GO_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION	35	-0.8462468	0.72670805	0.8719905	0.1400661	1.8325597
GSE3982_NEUTROPHIL_VS_TH1_UP	C7_ immunologic signatures	163	0.98627895	0.4994012	0.7149519	GSE3982_NEUTROPHIL_VS_TH1_UP	166	0.92311186	0.6811741	1	1.90939081	0.06316709
LEI_MYB_TARGETS	c2.CGP_ chemical and genetic perturbations	281	0.98627096	0.50727886	0.7148825	LEI_MYB_TARGETS	289	1.0885472	0.24624625	0.77309597	2.07481816	-0.10227624
GSE17721_LPS_VS_CPG_24H_BMDC_UP	C7_ immunologic signatures	173	0.98620856	0.51425177	0.7149716	GSE17721_LPS_VS_CPG_24H_BMDC_UP	173	0.9396857	0.6555218	0.9901562	1.92589426	0.04652286
GO_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX	c5.CC_ GO cellular component	18	0.98613864	0.4869707	0.71508116	GO_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX	18	-1.348859	0.10358566	0.24300967	-0.36272036	2.33499764
GO_CELLULAR_RESPONSE_TO_CYTOKINE_STIMULUS	c5.BP_ GO biological process	486	0.9861157	0.5203337	0.7150592	GO_CELLULAR_RESPONSE_TO_CYTOKINE_STIMULUS	486	0	0	0	0.9861157	0.9861157
GSE15330_WT_VS_IKAROS_KO_HSC_DN	C7_ immunologic signatures	179	0.9861043	0.495283	0.7149966	GSE15330_WT_VS_IKAROS_KO_HSC_DN	183	0.9440031	0.65489405	0.98869413	1.9301074	0.0421012
GO_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	92	0.98607147	0.49802372	0.7149987	GO_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY	96	0.7666776	0.88376963	1	1.75274907	0.21939387
GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN	C7_ immunologic signatures	174	0.9860126	0.49759614	0.715085	GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN	173	0.7119118	0.9653415	1	1.6979244	0.2741008
GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP	C7_ immunologic signatures	158	0.98592144	0.5	0.71525735	GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP	154	1.0082535	0.47005075	0.9115016	1.99417494	-0.02233206
PID_ILK_PATHWAY	c2.CP_ Canonical pathways	43	0.9859093	0.49418604	0.7151978	PID_ILK_PATHWAY	43	0.8979319	0.6488992	1	1.8838412	0.0879774
GO_CELLULAR_RESPONSE_TO_AMINO_ACID_STIMULUS	c5.BP_ GO biological process	48	0.98586816	0.48028168	0.7152222	GO_CELLULAR_RESPONSE_TO_AMINO_ACID_STIMULUS	47	-0.95585877	0.51785713	0.74795586	0.03000939	1.94172693
REACTOME_GAB1_SIGNALOSOME	c2.CP_REACTOME_ Reactome gene sets	36	0.9858635	0.47226387	0.71514064	REACTOME_GAB1_SIGNALOSOME	36	1.3199301	0.10095012	0.41192538	2.3057936	-0.3340666
GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	C7_ immunologic signatures	152	0.98562205	0.49036145	0.71575946	GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	155	0.5421484	1	1	1.52777045	0.44347365
GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN	C7_ immunologic signatures	172	0.9856116	0.49710312	0.7156956	GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN	177	0.9956241	0.51417005	0.9299272	1.9812357	-0.0100125
TGCACTG_MIR148A_MIR152_MIR148B	c3.MIR_ microRNA targets	278	0.9855916	0.50339365	0.7156601	TGCACTG_MIR148A_MIR152_MIR148B	281	0.77736366	0.9429429	1	1.76295526	0.20822794
DOANE_RESPONSE_TO_ANDROGEN_UP	c2.CGP_ chemical and genetic perturbations	151	0.9855592	0.51918465	0.71565974	DOANE_RESPONSE_TO_ANDROGEN_UP	157	1.1728067	0.13455658	0.6331351	2.1583659	-0.1872475
GSE42724_NAIVE_VS_MEMORY_BCELL_DN	C7_ immunologic signatures	173	0.9855527	0.5140187	0.71558106	GSE42724_NAIVE_VS_MEMORY_BCELL_DN	176	0.82066226	0.8606061	1	1.80621496	0.16489044
GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP	C7_ immunologic signatures	156	0.9855203	0.48907766	0.71558297	GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP	160	0.87716067	0.7798165	1	1.86268097	0.10835963
GO_REGULATION_OF_SYNAPSE_ORGANIZATION	c5.BP_ GO biological process	95	0.9854109	0.48831168	0.7158077	GO_REGULATION_OF_SYNAPSE_ORGANIZATION	101	0.7594732	0.8871636	1	1.7448841	0.2259377
GO_POSITIVE_REGULATION_OF_PROTEIN_BINDING	c5.BP_ GO biological process	69	0.9853865	0.48644987	0.71578807	GO_POSITIVE_REGULATION_OF_PROTEIN_BINDING	71	1.350241	0.048806943	0.38393477	2.3356275	-0.3648545
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP	C7_ immunologic signatures	154	0.98537296	0.49882075	0.71572876	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP	162	0.9117031	0.71311474	1	1.89707606	0.07366986
GO_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN	c5.BP_ GO biological process	274	0.9853383	0.5147059	0.71573126	GO_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN	282	1.0557694	0.33266333	0.8316008	2.0411077	-0.0704311
GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN	C7_ immunologic signatures	176	0.9852889	0.5140187	0.71577805	GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN	176	0.50943524	1	1	1.49472414	0.47585366
GO_EARLY_ENDOSOME	c5.CC_ GO cellular component	252	0.98515123	0.53599113	0.71607774	GO_EARLY_ENDOSOME	260	0.9864221	0.55265796	0.9403588	1.97157333	-0.00127087
GSE22886_NEUTROPHIL_VS_DC_UP	C7_ immunologic signatures	144	0.98513764	0.4819427	0.7160229	GSE22886_NEUTROPHIL_VS_DC_UP	151	1.3770325	0.009100101	0.35751155	2.36217014	-0.39189486
GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP	C7_ immunologic signatures	159	0.9851113	0.5120101	0.71599984	GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP	177	1.1401093	0.1923077	0.69014376	2.1252206	-0.154998
SENESE_HDAC1_AND_HDAC2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	199	0.9850942	0.5065089	0.71595615	SENESE_HDAC1_AND_HDAC2_TARGETS_UP	206	0.8491755	0.8388721	1	1.8342697	0.1359187
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	c2.CGP_ chemical and genetic perturbations	123	0.98505515	0.48992443	0.71597314	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	123	-0.9899607	0.5	0.7026256	-0.00490555	1.97501585
GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP	C7_ immunologic signatures	168	0.9850305	0.5059952	0.7159488	GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP	180	0.75050247	0.93515706	1	1.73553297	0.23452803
PROVENZANI_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	122	0.98502105	0.5160051	0.7158796	PROVENZANI_METASTASIS_DN	123	1.2591971	0.0674974	0.49726078	2.24421815	-0.27417605
GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN	C7_ immunologic signatures	165	0.9849827	0.49280575	0.7158922	GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN	165	0.62146306	0.9949546	1	1.60644576	0.36351964
GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	C7_ immunologic signatures	181	0.98497486	0.514758	0.71581554	GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	181	1.0707281	0.33534744	0.80418515	2.05570296	-0.08575324
MORF_CDH4	c4.CGN_ cancer gene neighborhoods	96	0.9848277	0.49932706	0.7161568	MORF_CDH4	108	1.2855265	0.069574244	0.46234304	2.2703542	-0.3006988
GO_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	98	0.9848132	0.5006337	0.716105	GO_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS	99	1.1285341	0.26137567	0.7076878	2.1133473	-0.1437209
HALLMARK_IL2_STAT5_SIGNALING	H_ hallmark gene sets	180	0.9847678	0.5203837	0.7161402	HALLMARK_IL2_STAT5_SIGNALING	185	1.1323076	0.2	0.70254946	2.1170754	-0.1475398
GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP	C7_ immunologic signatures	176	0.984699	0.49880952	0.7162518	GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP	182	1.1232493	0.22548029	0.7196834	2.1079483	-0.1385503
TCCAGAG_MIR518C	c3.MIR_ microRNA targets	134	0.98466325	0.48525798	0.71626216	TCCAGAG_MIR518C	134	0.93923634	0.62153846	0.9909251	1.92389959	0.04542691
GO_TRANSCRIPTION_COREPRESSOR_ACTIVITY	c5.GO molecular function	204	0.98465294	0.5079909	0.7161975	GO_TRANSCRIPTION_COREPRESSOR_ACTIVITY	210	0.5528628	1	1	1.53751574	0.43179014
STANELLE_E2F1_TARGETS	c2.CGP_ chemical and genetic perturbations	28	0.9846161	0.4969419	0.7162012	STANELLE_E2F1_TARGETS	28	-1.50408	0.019354839	0.1402772	-0.5194639	2.4886961
GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	C7_ immunologic signatures	156	0.9845991	0.4964029	0.71615005	GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	161	0.81579804	0.8720812	1	1.80039714	0.16880106
GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP	C7_ immunologic signatures	171	0.98448026	0.50591016	0.71640056	GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP	180	1.073634	0.34114054	0.79946584	2.05811426	-0.08915374
MA_PITUITARY_FETAL_VS_ADULT_UP	c2.CGP_ chemical and genetic perturbations	25	0.9843965	0.49223602	0.7165496	MA_PITUITARY_FETAL_VS_ADULT_UP	28	0.94217014	0.5633456	0.9887851	1.92656664	0.04222636
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	c2.CGP_ chemical and genetic perturbations	255	0.98436797	0.5311111	0.7165409	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	255	-0.9069628	1	0.81413746	0.07740517	1.89133077
GO_BODY_FLUID_SECRETION	c5.BP_ GO biological process	59	0.98434055	0.4979647	0.71652937	GO_BODY_FLUID_SECRETION	63	0.61325324	0.9800664	1	1.59759379	0.37108731
DELACROIX_RAR_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	43	0.9843188	0.50613916	0.7164948	DELACROIX_RAR_TARGETS_UP	46	1.2932055	0.0974478	0.45196807	2.2775243	-0.3088867
GO_REGULATION_OF_B_CELL_ACTIVATION	c5.BP_ GO biological process	88	0.9842521	0.4973822	0.716601	GO_REGULATION_OF_B_CELL_ACTIVATION	103	1.0517552	0.37934667	0.8371475	2.0360073	-0.0675031
GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	C7_ immunologic signatures	171	0.9841535	0.50835323	0.71678597	GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	180	1.1380622	0.17730497	0.6938516	2.1222157	-0.1539087
LY_AGING_PREMATURE_DN	c2.CGP_ chemical and genetic perturbations	27	0.98413205	0.47943038	0.7167531	LY_AGING_PREMATURE_DN	27	0.9372138	0.5807645	0.99320537	1.92134585	0.04691825
GO_RESPONSE_TO_GLUCAGON	c5.BP_ GO biological process	42	0.9841075	0.482066	0.7167315	GO_RESPONSE_TO_GLUCAGON	46	0.9053208	0.63461536	1	1.8894283	0.0787867
GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	184	0.9840298	0.5186916	0.7168571	GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP	186	1.0736097	0.298583	0.79942155	2.0576395	-0.0895799
GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP	C7_ immunologic signatures	174	0.9837722	0.48870394	0.71751845	GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP	177	0.73267597	0.94848484	1	1.71644817	0.25109623
GO_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS	c5.BP_ GO biological process	66	0.9837378	0.47879618	0.71751565	GO_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS	64	0.76188487	0.8644252	1	1.74562267	0.22185293
GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	C7_ immunologic signatures	179	0.98372716	0.5047059	0.71744907	GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	178	-1.0357424	0.41666666	0.62912965	-0.05201524	2.01946956
LEE_DIFFERENTIATING_T_LYMPHOCYTE	c2.CGP_ chemical and genetic perturbations	164	0.98371476	0.5119617	0.71738434	LEE_DIFFERENTIATING_T_LYMPHOCYTE	171	1.233522	0.07077856	0.5361993	2.21723676	-0.24980724
GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP	C7_ immunologic signatures	151	0.98353285	0.50603867	0.7178253	GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP	162	0.90430737	0.7306122	1	1.88784022	0.07922548
GGTGTGT_MIR329	c3.MIR_ microRNA targets	97	0.98339593	0.5148771	0.7181336	GGTGTGT_MIR329	103	0.9433262	0.608377	0.9886385	1.92672213	0.04006973
GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	179	0.98337406	0.5172825	0.71809727	GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	180	0.8971264	0.7372709	1	1.88050046	0.08624766
REACTOME_NETRIN1_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	36	0.9833723	0.48424068	0.7180054	REACTOME_NETRIN1_SIGNALING	36	1.1053298	0.3317757	0.7459818	2.0887021	-0.1219575
GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN	C7_ immunologic signatures	180	0.9833238	0.4913694	0.71804535	GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN	179	1.081178	0.31428573	0.78570354	2.0645018	-0.0978542
MORF_CASP10	c4.CGN_ cancer gene neighborhoods	92	0.9832279	0.50700635	0.71823275	MORF_CASP10	105	1.2763956	0.07024793	0.478621	2.2596235	-0.2931677
MODULE_439	c4.CM_ cancer modules	19	0.9828745	0.48330683	0.7191729	MODULE_439	20	1.1171061	0.32967034	0.72813505	2.0999806	-0.1342316
GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP	C7_ immunologic signatures	185	0.9828204	0.49882904	0.71923864	GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP	185	1.1357396	0.18567105	0.69582456	2.11856	-0.1529192
GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP	C7_ immunologic signatures	157	0.9827623	0.50540215	0.7193105	GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP	158	-1.0225981	0.26666668	0.6556832	-0.0398358	2.0053604
LINDVALL_IMMORTALIZED_BY_TERT_UP	c2.CGP_ chemical and genetic perturbations	70	0.98274136	0.4908377	0.719278	LINDVALL_IMMORTALIZED_BY_TERT_UP	71	0.9062859	0.68675995	1	1.88902726	0.07645546
ROSS_AML_OF_FAB_M7_TYPE	c2.CGP_ chemical and genetic perturbations	61	0.9826728	0.48998666	0.71938515	ROSS_AML_OF_FAB_M7_TYPE	64	0.87535095	0.70581895	1	1.85802375	0.10732185
GO_LEADING_EDGE_MEMBRANE	c5.CC_ GO cellular component	121	0.98264533	0.50567466	0.7193686	GO_LEADING_EDGE_MEMBRANE	124	1.0522444	0.38779733	0.8369483	2.03488973	-0.06959907
GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP	C7_ immunologic signatures	172	0.9825211	0.5169082	0.71962553	GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP	175	0.6320021	0.9929648	1	1.6145232	0.350519
GO_MICROVILLUS	c5.CC_ GO cellular component	66	0.9824631	0.52667576	0.7196946	GO_MICROVILLUS	70	0.9745952	0.5511551	0.9558505	1.9570583	0.0078679
QI_PLASMACYTOMA_UP	c2.CGP_ chemical and genetic perturbations	230	0.9823751	0.5211913	0.71985954	QI_PLASMACYTOMA_UP	239	0.876384	0.8028169	1	1.8587591	0.1059911
GO_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS	c5.BP_ GO biological process	136	0.98236656	0.5055215	0.7197862	GO_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS	140	0.66769326	0.96813977	1	1.65005982	0.3146733
GO_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS	c5.BP_ GO biological process	24	0.9823253	0.4888889	0.71980166	GO_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS	25	0.9506792	0.5645161	0.9814295	1.9330045	0.0316461
GO_REGULATION_OF_CYTOKINE_SECRETION	c5.BP_ GO biological process	110	0.98230493	0.49683943	0.7197625	GO_REGULATION_OF_CYTOKINE_SECRETION	122	1.2759845	0.052361395	0.47943535	2.25828943	-0.29367957
GSE3982_NEUTROPHIL_VS_BASOPHIL_UP	C7_ immunologic signatures	166	0.98227924	0.51892555	0.7197422	GSE3982_NEUTROPHIL_VS_BASOPHIL_UP	165	0.94828147	0.6330275	0.98391366	1.93056071	0.03399777
GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	C7_ immunologic signatures	179	0.98220134	0.5145858	0.71987444	GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	185	1.1944999	0.10253807	0.59779483	2.17670124	-0.21229856
GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN	C7_ immunologic signatures	172	0.9819849	0.51387215	0.7204233	GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN	173	1.2222058	0.06910569	0.553146	2.2041907	-0.2402209
GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP	C7_ immunologic signatures	161	0.9819811	0.51042944	0.72033554	GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP	168	0.66957784	0.9857868	1	1.65155894	0.31240326
GSE17721_LPS_VS_POLYIC_1H_BMDC_DN	C7_ immunologic signatures	175	0.9819445	0.50934577	0.7203494	GSE17721_LPS_VS_POLYIC_1H_BMDC_DN	179	0.8078786	0.8978766	1	1.7898231	0.1740659
GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN	C7_ immunologic signatures	183	0.9817484	0.51431984	0.7208204	GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN	189	1.0713468	0.33433735	0.80292463	2.0530952	-0.0895984
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	c2.CGP_ chemical and genetic perturbations	23	0.98171616	0.4945055	0.7208204	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	24	1.0035365	0.47625	0.91737837	1.98525266	-0.02182034
GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP	C7_ immunologic signatures	165	0.98170084	0.51465416	0.72077185	GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP	168	1.3674362	0.008154944	0.37026864	2.34913704	-0.38573536
GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN	C7_ immunologic signatures	173	0.9816758	0.5184744	0.72074664	GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN	171	1.2756212	0.036548223	0.479538	2.257297	-0.2939454
BROWNE_HCMV_INFECTION_10HR_UP	c2.CGP_ chemical and genetic perturbations	83	0.98163754	0.49336872	0.72076756	BROWNE_HCMV_INFECTION_10HR_UP	83	-1.7987291	0	0.033077765	-0.81709156	2.78036664
HALLMARK_ESTROGEN_RESPONSE_EARLY	H_ hallmark gene sets	188	0.9816336	0.5132948	0.72068137	HALLMARK_ESTROGEN_RESPONSE_EARLY	190	1.3534843	0.008080808	0.38322484	2.3351179	-0.3718507
GTGCCAT_MIR183	c3.MIR_ microRNA targets	157	0.98155284	0.50298685	0.7208288	GTGCCAT_MIR183	158	0.7281324	0.94040406	1	1.70968524	0.25342044
GO_SODIUM_CHANNEL_ACTIVITY	c5.GO molecular function	27	0.9814486	0.48142415	0.72103477	GO_SODIUM_CHANNEL_ACTIVITY	31	1.6685573	0.00118624	0.09762674	2.6500059	-0.6871087
FAELT_B_CLL_WITH_VH3_21_DN	c2.CGP_ chemical and genetic perturbations	44	0.981292	0.5119887	0.7213958	FAELT_B_CLL_WITH_VH3_21_DN	44	-0.74951804	0.9189189	0.93905693	0.23177396	1.73081004
GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	147	0.9810553	0.50560397	0.72199106	GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN	149	1.0014715	0.48582995	0.92142516	1.9825268	-0.0204162
GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP	C7_ immunologic signatures	179	0.980994	0.5139733	0.7220761	GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP	179	-1.2154768	0	0.36085618	-0.2344828	2.1964708
GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	C7_ immunologic signatures	182	0.98073584	0.51543945	0.72275746	GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	182	0.5371836	1	1	1.51791944	0.44355224
GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	174	0.9807337	0.5094787	0.72266686	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN	176	-0.72023976	1	0.9517723	0.26049394	1.70097346
GSE11386_NAIVE_VS_MEMORY_BCELL_DN	C7_ immunologic signatures	146	0.9804478	0.5127582	0.7234076	GSE11386_NAIVE_VS_MEMORY_BCELL_DN	148	1.3663633	0.015368853	0.37046197	2.3468111	-0.3859155
KEGG_ABC_TRANSPORTERS	c2.CP_BIOCARTA_ BioCarta gene sets	40	0.9804289	0.51293105	0.7233661	KEGG_ABC_TRANSPORTERS	42	1.5559227	0.005714286	0.20129326	2.5363516	-0.5754938
HEN1_02	c3.TFT_ transcription factor targets	176	0.9803605	0.5239808	0.7234681	HEN1_02	179	0.9558408	0.6082996	0.97578025	1.9362013	0.0245197
USF_02	c3.TFT_ transcription factor targets	249	0.9802734	0.52619845	0.7236158	USF_02	253	0.8856029	0.7854985	1	1.8658763	0.0946705
WWTAAGGC_UNKNOWN	c3.TFT_ transcription factor targets	124	0.9800381	0.50061053	0.72420895	WWTAAGGC_UNKNOWN	130	0.88952374	0.72417355	1	1.86956184	0.09051436
MARTINEZ_RESPONSE_TO_TRABECTEDIN	c2.CGP_ chemical and genetic perturbations	44	0.9800167	0.51014495	0.7241769	MARTINEZ_RESPONSE_TO_TRABECTEDIN	44	1.2241852	0.18360277	0.55037975	2.2042019	-0.2441685
GO_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE	c5.BP_ GO biological process	36	0.9799497	0.47851852	0.72427845	GO_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE	38	0.9152908	0.6114422	1	1.8952405	0.0646589
GSE13229_IMM_VS_MATURE_NKCELL_UP	C7_ immunologic signatures	178	0.97986937	0.5232558	0.7244125	GSE13229_IMM_VS_MATURE_NKCELL_UP	179	1.1149398	0.2426396	0.7306087	2.09480917	-0.13507043
GO_GABA_RECEPTOR_BINDING	c5.GO molecular function	15	0.97982115	0.5070422	0.724453	GO_GABA_RECEPTOR_BINDING	15	0.8572278	0.6573333	1	1.83704895	0.12259335
GO_FEAR_RESPONSE	c5.BP_ GO biological process	26	0.9798207	0.47013783	0.7243577	GO_FEAR_RESPONSE	27	-0.42568254	1	0.9910258	0.55413816	1.40550324
GO_GLYCEROLIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	317	0.97975856	0.54385966	0.7244441	GO_GLYCEROLIPID_METABOLIC_PROCESS	332	1.0768659	0.27027026	0.7941404	2.05662446	-0.09710734
WINNEPENNINCKX_MELANOMA_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	33	0.9796234	0.5088235	0.72473407	WINNEPENNINCKX_MELANOMA_METASTASIS_DN	35	1.1088505	0.31170335	0.7397093	2.0884739	-0.1292271
MORF_FDXR	c4.CGN_ cancer gene neighborhoods	199	0.9796228	0.50762016	0.72463894	MORF_FDXR	206	0.9088209	0.72883064	1	1.8884437	0.0708019
GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_DN	C7_ immunologic signatures	170	0.979563	0.5148987	0.72472656	GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_DN	178	1.089346	0.2909461	0.77191997	2.068909	-0.109783
GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP	C7_ immunologic signatures	143	0.97955465	0.5018821	0.72465366	GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP	147	1.1969125	0.12742099	0.5966568	2.17646715	-0.21735785
GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	134	0.9793064	0.5145631	0.7252905	GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP	143	1.020982	0.4564995	0.89069253	2.0002884	-0.0416756
GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	167	0.97925663	0.53223914	0.72534317	GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN	178	0.65226704	0.98677516	1	1.63152367	0.32698959
GO_REGULATION_OF_LEUKOCYTE_DEGRANULATION	c5.BP_ GO biological process	35	0.97908926	0.4750378	0.72574246	GO_REGULATION_OF_LEUKOCYTE_DEGRANULATION	37	0.8496815	0.72350794	1	1.82877076	0.12940776
GO_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	40	0.9789499	0.50140846	0.7260659	GO_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS	41	-1.1456453	0.18656716	0.4492869	-0.1666954	2.1245952
GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN	C7_ immunologic signatures	177	0.9789336	0.5278766	0.7260156	GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN	181	0.82022697	0.86807656	1	1.79916057	0.15870663
GO_TETRAHYDROFOLATE_METABOLIC_PROCESS	c5.BP_ GO biological process	18	0.9788945	0.48412699	0.72603804	GO_TETRAHYDROFOLATE_METABOLIC_PROCESS	18	-1.5836934	0.029661017	0.09772609	-0.6047989	2.5625879
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	c2.CGP_ chemical and genetic perturbations	69	0.9788807	0.50945944	0.725984	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	69	0.6865118	0.9492441	1	1.6653925	0.2923689
GO_RIBONUCLEASE_ACTIVITY	c5.GO molecular function	80	0.9788367	0.49610388	0.7260181	GO_RIBONUCLEASE_ACTIVITY	83	-0.7993156	0.93650794	0.90668225	0.1795211	1.7781523
GO_REGULATION_OF_PROTEIN_DEACETYLATION	c5.BP_ GO biological process	30	0.97864866	0.4871407	0.726473	GO_REGULATION_OF_PROTEIN_DEACETYLATION	31	0.64337987	0.9380952	1	1.62202853	0.33526879
GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	122	0.97863895	0.5151899	0.7264069	GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	127	1.0095111	0.4663909	0.90834546	1.98815005	-0.03087215
CHR12Q21	C1: positional gene sets	38	0.9786347	0.50147927	0.72632253	CHR12Q21	37	-0.8865103	0.64	0.8383478	0.0921244	1.865145
GO_LIPID_MODIFICATION	c5.BP_ GO biological process	186	0.97859275	0.5005834	0.72635156	GO_LIPID_MODIFICATION	190	1.0505307	0.37044534	0.83904284	2.02912345	-0.07193795
GO_REGULATION_OF_FATTY_ACID_TRANSPORT	c5.BP_ GO biological process	22	0.97855276	0.5048701	0.72637784	GO_REGULATION_OF_FATTY_ACID_TRANSPORT	24	1.5282495	0.016229713	0.22477941	2.50680226	-0.54969674
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN	C7_ immunologic signatures	178	0.9785404	0.5382775	0.72631866	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN	182	1.268037	0.032193158	0.4864948	2.2465774	-0.2894966
HNF6_Q6	c3.TFT_ transcription factor targets	200	0.9784467	0.5303551	0.7265088	HNF6_Q6	211	0.86000216	0.83987916	1	1.83844886	0.11844454
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	c2.CGP_ chemical and genetic perturbations	161	0.97837347	0.50542825	0.72661835	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	162	0.7251726	0.9522843	1	1.70354607	0.25320087
KANG_AR_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	16	0.9783725	0.48508635	0.7265232	KANG_AR_TARGETS_UP	17	1.388048	0.07225806	0.34757465	2.3664205	-0.4096755
GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN	C7_ immunologic signatures	184	0.97835827	0.5415677	0.7264656	GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN	185	-1.2207414	0.055555556	0.35435838	-0.24238313	2.19909967
LU_IL4_SIGNALING	c2.CGP_ chemical and genetic perturbations	87	0.97830373	0.5026316	0.7265288	LU_IL4_SIGNALING	85	1.0411085	0.42010581	0.85731447	2.01941223	-0.06280477
GO_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT	c5.BP_ GO biological process	401	0.97826964	0.5409483	0.72653335	GO_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT	424	1.1341083	0.107	0.6991986	2.11237794	-0.15583866
GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP	C7_ immunologic signatures	162	0.9782405	0.5165094	0.726525	GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP	169	1.2449399	0.07005076	0.5193069	2.2231804	-0.2666994
CHR1P35	C1: positional gene sets	82	0.97815317	0.49731183	0.72668576	CHR1P35	83	0.68637806	0.94074076	1	1.66453123	0.29177511
GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN	C7_ immunologic signatures	89	0.9780606	0.51884425	0.726852	GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN	98	1.1612847	0.21256545	0.6510222	2.1393453	-0.1832241
GO_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	267	0.9780552	0.54977375	0.7267689	GO_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	279	1.1595266	0.11322645	0.653466	2.1375818	-0.1814714
ZWANG_EGF_PERSISTENTLY_DN	c2.CGP_ chemical and genetic perturbations	51	0.97791564	0.5028653	0.7270868	ZWANG_EGF_PERSISTENTLY_DN	51	0.91550225	0.6265193	1	1.89341789	0.06241339
GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP	C7_ immunologic signatures	174	0.9778384	0.51345026	0.72721153	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP	175	0.7522185	0.9401623	1	1.7300569	0.2256199
GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN	C7_ immunologic signatures	176	0.9777934	0.50961536	0.72724754	GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN	171	0.9264941	0.66836214	1	1.9042875	0.0512993
HALLMARK_ANGIOGENESIS	H_ hallmark gene sets	33	0.9777677	0.4962742	0.727225	HALLMARK_ANGIOGENESIS	32	0.9335568	0.589525	0.9965923	1.9113245	0.0442109
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	c2.CP_REACTOME_ Reactome gene sets	42	0.9776671	0.47851852	0.7274229	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	46	1.191484	0.2095672	0.6041631	2.1691511	-0.2138169
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	c2.CGP_ chemical and genetic perturbations	69	0.9776374	0.51551956	0.7274136	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	71	1.5677705	0.00326087	0.19100201	2.5454079	-0.5901331
PEART_HDAC_PROLIFERATION_CLUSTER_DN	c2.CGP_ chemical and genetic perturbations	71	0.9775338	0.4972826	0.7276061	PEART_HDAC_PROLIFERATION_CLUSTER_DN	72	-1.3669302	0	0.2293651	-0.3893964	2.344464
GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP	C7_ immunologic signatures	149	0.9774265	0.50487804	0.7278235	GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP	154	0.9583014	0.6042945	0.97271454	1.9357279	0.0191251
MODULE_119	c4.CM_ cancer modules	120	0.97741556	0.51672864	0.7277546	MODULE_119	122	0.9289621	0.6340469	0.99880487	1.90637766	0.04845346
GNF2_ATM	c4.CGN_ cancer gene neighborhoods	25	0.9773774	0.4890625	0.72776926	GNF2_ATM	26	1.0842963	0.36384976	0.7789075	2.0616737	-0.1069189
GO_SPHINGOLIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	69	0.9773751	0.5154778	0.7276795	GO_SPHINGOLIPID_BIOSYNTHETIC_PROCESS	71	1.1802515	0.19562842	0.6236682	2.1576266	-0.2028764
GO_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR	c5.BP_ GO biological process	26	0.9773706	0.50080776	0.72759664	GO_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR	26	0.78698575	0.7809406	1	1.76435635	0.19038485
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP	C7_ immunologic signatures	155	0.9773317	0.53477216	0.72761923	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP	167	1.4817421	0.00101626	0.26770267	2.4590738	-0.5044104
GO_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION	c5.BP_ GO biological process	55	0.97726095	0.4876033	0.727721	GO_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION	58	1.1688224	0.23942094	0.6391	2.14608335	-0.19156145
GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION	c5.BP_ GO biological process	26	0.97715217	0.49310872	0.7279419	GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION	26	0.8224982	0.7305315	1	1.79965037	0.15465397
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	C7_ immunologic signatures	179	0.9770603	0.53801167	0.72811455	GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	180	1.0796127	0.31813577	0.7881902	2.056673	-0.1025524
PID_TGFBR_PATHWAY	c2.CP_ Canonical pathways	53	0.977054	0.5140056	0.72803545	PID_TGFBR_PATHWAY	53	-0.92652214	0.65625	0.78804505	0.05053186	1.90357614
MODULE_455	c4.CM_ cancer modules	35	0.97696584	0.47806355	0.72819114	MODULE_455	37	1.0611476	0.3950178	0.82144684	2.03811344	-0.08418176
SMITH_TERT_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	135	0.97694653	0.5160142	0.7281493	SMITH_TERT_TARGETS_UP	136	0.70452815	0.95820594	1	1.68147468	0.27241838
GO_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY	c5.GO molecular function	22	0.97693765	0.5130168	0.72807455	GO_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY	22	0.8919904	0.6420382	1	1.86892805	0.08494725
GO_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	82	0.9768963	0.51398134	0.7280957	GO_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	85	-0.8215857	0.8923077	0.8884517	0.1553106	1.798482
MORF_FRK	c4.CGN_ cancer gene neighborhoods	86	0.97685665	0.5134788	0.72811073	MORF_FRK	90	1.2432451	0.11217949	0.52314717	2.22010175	-0.26638845
GGGACCA_MIR133A_MIR133B	c3.MIR_ microRNA targets	181	0.9768236	0.51976746	0.7281142	GGGACCA_MIR133A_MIR133B	181	0.74891484	0.95266867	1	1.72573844	0.22790876
GTGTTGA_MIR505	c3.MIR_ microRNA targets	92	0.97681355	0.5078125	0.72804743	GTGTTGA_MIR505	95	-0.9520052	0.6122449	0.7526392	0.02480835	1.92881875
GO_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING	c5.GO molecular function	15	0.9767221	0.5063898	0.7282126	GO_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING	15	0.8490873	0.68205804	1	1.8258094	0.1276348
GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP	C7_ immunologic signatures	127	0.9766189	0.52625	0.7283989	GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP	131	1.0930283	0.29856852	0.767858	2.0696472	-0.1164094
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN	C7_ immunologic signatures	139	0.9764335	0.5109489	0.72884136	GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN	141	0.8748265	0.7627291	1	1.85126	0.101607
WESTON_VEGFA_TARGETS_3HR	c2.CGP_ chemical and genetic perturbations	61	0.97631186	0.50617284	0.72911	WESTON_VEGFA_TARGETS_3HR	63	1.0646285	0.36800894	0.81485903	2.04094036	-0.08831664
COLLIS_PRKDC_REGULATORS	c2.CGP_ chemical and genetic perturbations	15	0.97619194	0.5103668	0.7293537	COLLIS_PRKDC_REGULATORS	15	-0.936747	0.53174603	0.77558964	0.03944494	1.91293894
GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	C7_ immunologic signatures	150	0.97605115	0.5036408	0.72966635	GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	153	1.2710025	0.046558704	0.48384824	2.24705365	-0.29495135
JIANG_AGING_CEREBRAL_CORTEX_UP	c2.CGP_ chemical and genetic perturbations	30	0.97599274	0.50834596	0.72974825	JIANG_AGING_CEREBRAL_CORTEX_UP	30	-1.7296085	0	0.048520442	-0.75361576	2.70560124
ALONSO_METASTASIS_EMT_UP	c2.CGP_ chemical and genetic perturbations	35	0.9759874	0.49269006	0.7296673	ALONSO_METASTASIS_EMT_UP	35	1.13996	0.29590642	0.6906572	2.1159474	-0.1639726
GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP	C7_ immunologic signatures	176	0.97555304	0.53090906	0.73083633	GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP	179	1.1136471	0.2563323	0.731928	2.08920014	-0.13809406
VANTVEER_BREAST_CANCER_ESR1_DN	c2.CGP_ chemical and genetic perturbations	212	0.9754193	0.53667057	0.7311291	VANTVEER_BREAST_CANCER_ESR1_DN	215	0.98961097	0.53420526	0.9353077	1.96503027	-0.01419167
GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_UP	C7_ immunologic signatures	176	0.97523004	0.5351609	0.7315652	GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_UP	180	-1.4417632	0	0.17845882	-0.46653316	2.41699324
GO_REGULATION_OF_FEEDING_BEHAVIOR	c5.BP_ GO biological process	16	0.9752033	0.4968652	0.73154527	GO_REGULATION_OF_FEEDING_BEHAVIOR	20	1.234625	0.19587629	0.5339992	2.2098283	-0.2594217
GSE8835_CD4_VS_CD8_TCELL_UP	C7_ immunologic signatures	179	0.9752015	0.5293427	0.73145294	GSE8835_CD4_VS_CD8_TCELL_UP	177	0.6516948	0.9888438	1	1.6268963	0.3235067
GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	130	0.97517544	0.5402726	0.7314315	GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN	134	1.101013	0.29345602	0.75557023	2.07618844	-0.12583756
GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP	C7_ immunologic signatures	164	0.9751666	0.5259434	0.73136455	GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP	169	0.9020687	0.7350254	1	1.8772353	0.0730979
GNF2_CEBPA	c4.CGN_ cancer gene neighborhoods	50	0.97516465	0.5041783	0.7312754	GNF2_CEBPA	57	1.3357683	0.060674157	0.3988009	2.31093295	-0.36060365
CHR17Q21	C1: positional gene sets	217	0.975156	0.5304248	0.7312052	CHR17Q21	229	0.96466243	0.6014056	0.9653597	1.93981843	0.01049357
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN	C7_ immunologic signatures	147	0.97504085	0.53349876	0.7314447	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN	153	0.78573525	0.8943089	1	1.7607761	0.1893056
GO_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION	c5.BP_ GO biological process	24	0.9748028	0.50766873	0.7320488	GO_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION	24	0.97484666	0.5339088	0.9557669	1.94964946	-4.39E-05
GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP	C7_ immunologic signatures	156	0.9747268	0.51937044	0.73217225	GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP	158	0.9065444	0.7118126	1	1.8812712	0.0681824
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	172	0.97470725	0.5289941	0.73213005	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN	177	0.91134125	0.7092199	1	1.8860485	0.063366
GO_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION	c5.BP_ GO biological process	17	0.97463363	0.4913928	0.7322558	GO_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION	20	1.168864	0.26289308	0.63907975	2.14349763	-0.19423037
GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP	C7_ immunologic signatures	164	0.97460085	0.5358025	0.7322521	GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP	166	-0.9523888	0.625	0.75410527	0.02221205	1.92698965
GO_GPI_ANCHOR_METABOLIC_PROCESS	c5.BP_ GO biological process	31	0.97459656	0.49772382	0.73216724	GO_GPI_ANCHOR_METABOLIC_PROCESS	32	0.5221161	0.9917453	1	1.49671266	0.45248046
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	c2.CGP_ chemical and genetic perturbations	138	0.9745418	0.5236318	0.7322245	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	144	1.1522433	0.17784552	0.6661873	2.1267851	-0.1777015
GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP	C7_ immunologic signatures	172	0.9745416	0.52834743	0.73212796	GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP	174	1.0181884	0.47720364	0.89246017	1.99273	-0.0436468
GO_REGULATION_OF_PROTEIN_TARGETING	c5.BP_ GO biological process	258	0.9745191	0.53469855	0.73209614	GO_REGULATION_OF_PROTEIN_TARGETING	266	0.7946043	0.9318637	1	1.7691234	0.1799148
BIOCARTA_FAS_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	28	0.97437656	0.49022555	0.73240834	BIOCARTA_FAS_PATHWAY	29	0.5919513	0.9662651	1	1.56632786	0.38242526
GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN	C7_ immunologic signatures	135	0.9743588	0.5266344	0.73236144	GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN	141	1.1155151	0.25614753	0.7298387	2.0898739	-0.1411563
GSE3982_EOSINOPHIL_VS_TH2_DN	C7_ immunologic signatures	173	0.9743546	0.5462287	0.732276	GSE3982_EOSINOPHIL_VS_TH2_DN	176	0.6648975	0.99696046	1	1.6392521	0.3094571
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP	C7_ immunologic signatures	175	0.9742687	0.53846157	0.7324243	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP	177	1.1548868	0.15415822	0.661964	2.1291555	-0.1806181
GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP	C7_ immunologic signatures	178	0.9742331	0.5155131	0.7324314	GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP	181	0.76563144	0.9264854	1	1.73986454	0.20860166
GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	163	0.9741895	0.5318396	0.73246664	GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN	167	0.966299	0.5792129	0.9645704	1.9404885	0.0078905
GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP	C7_ immunologic signatures	165	0.9741628	0.51720047	0.73244613	GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP	175	0.66903484	0.97461927	1	1.64319764	0.30512796
TING_SILENCED_BY_DICER	c2.CGP_ chemical and genetic perturbations	23	0.974098	0.49768162	0.73254275	TING_SILENCED_BY_DICER	23	0.89349204	0.64223605	1	1.86759004	0.08060596
GO_1_PHOSPHATIDYLINOSITOL_BINDING	c5.GO molecular function	18	0.9740954	0.5031746	0.7324521	GO_1_PHOSPHATIDYLINOSITOL_BINDING	18	1.249274	0.1851369	0.5120576	2.2233694	-0.2751786
GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN	C7_ immunologic signatures	184	0.97399384	0.5558167	0.7326572	GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN	187	0.9202504	0.6952573	1	1.89424424	0.05374344
GENTILE_UV_HIGH_DOSE_UP	c2.CGP_ chemical and genetic perturbations	21	0.9738937	0.49621785	0.732845	GENTILE_UV_HIGH_DOSE_UP	22	1.0706301	0.38957816	0.80402	2.0445238	-0.0967364
GO_SENSORY_PERCEPTION_OF_TASTE	c5.BP_ GO biological process	33	0.97378576	0.51363635	0.7330622	GO_SENSORY_PERCEPTION_OF_TASTE	32	0.94326884	0.5862884	0.988566	1.9170546	0.03051692
GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	162	0.9737671	0.5234192	0.73301697	GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN	159	1.1168158	0.25918368	0.72852194	2.0905829	-0.1430487
GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_DN	C7_ immunologic signatures	174	0.97372264	0.5294811	0.7330484	GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_DN	182	1.1074198	0.25888324	0.7420459	2.08114244	-0.13369716
HOSHIDA_LIVER_CANCER_SURVIVAL_UP	c2.CGP_ chemical and genetic perturbations	62	0.9737123	0.5212038	0.7329842	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	68	1.2532648	0.1154273	0.50441897	2.2269771	-0.2795525
LEE_LIVER_CANCER_SURVIVAL_DN	c2.CGP_ chemical and genetic perturbations	149	0.97359806	0.5259901	0.7332244	LEE_LIVER_CANCER_SURVIVAL_DN	150	-1.542049	0	0.11939422	-0.56845094	2.51564706
BROWNE_HCMV_INFECTION_14HR_UP	c2.CGP_ chemical and genetic perturbations	141	0.973402	0.5340633	0.7336955	BROWNE_HCMV_INFECTION_14HR_UP	143	-1.4317783	0	0.18577474	-0.4583763	2.4051803
GO_MAIN_AXON	c5.CC_ GO cellular component	52	0.97338307	0.5131195	0.7336483	GO_MAIN_AXON	55	1.2792617	0.10645527	0.47330508	2.25264477	-0.30587863
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN	C7_ immunologic signatures	164	0.97322726	0.5329341	0.733998	GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN	170	1.1696686	0.13981763	0.63858587	2.14289586	-0.19644134
ZEMBUTSU_SENSITIVITY_TO_CISPLATIN	c2.CGP_ chemical and genetic perturbations	16	0.97321916	0.5172956	0.7339266	ZEMBUTSU_SENSITIVITY_TO_CISPLATIN	18	1.1231232	0.31942633	0.7199528	2.09634236	-0.14990404
MODULE_136	c4.CM_ cancer modules	406	0.97314584	0.5726588	0.73404515	MODULE_136	415	1.1771909	0.047	0.6266969	2.15033674	-0.20404506
GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP	C7_ immunologic signatures	174	0.9731039	0.5508982	0.7340782	GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP	175	1.0446266	0.40899795	0.8502641	2.0177305	-0.0715227
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	c2.CP_REACTOME_ Reactome gene sets	19	0.973097	0.5294118	0.733999	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	19	0.98180145	0.50449294	0.94641304	1.95489845	-0.00870445
GO_CERAMIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	72	0.973019	0.5139073	0.73413396	GO_CERAMIDE_METABOLIC_PROCESS	72	1.1963077	0.17716116	0.59639525	2.1693267	-0.2232887
GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN	C7_ immunologic signatures	121	0.9730094	0.5062035	0.73406667	GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN	125	0.7719144	0.8907217	1	1.7449238	0.201095
GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN	C7_ immunologic signatures	177	0.97293556	0.5348028	0.7341816	GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN	181	1.0142776	0.47052845	0.899328	1.98721316	-0.04134204
REACTOME_GABA_RECEPTOR_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	47	0.97293377	0.4964937	0.7340906	REACTOME_GABA_RECEPTOR_ACTIVATION	51	0.9919102	0.50793654	0.9336048	1.96484397	-0.01897643
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	C7_ immunologic signatures	171	0.97290057	0.52	0.73408794	GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	172	0.7916871	0.90345526	1	1.76458767	0.18121347
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	31	0.9728011	0.47913447	0.734272	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	32	1.3431848	0.08830549	0.39108038	2.3159859	-0.3703837
GO_GLIAL_CELL_MIGRATION	c5.BP_ GO biological process	32	0.9727284	0.5	0.73439205	GO_GLIAL_CELL_MIGRATION	32	0.82053846	0.7523585	1	1.79326686	0.15218994
GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN	C7_ immunologic signatures	168	0.97267294	0.5435294	0.7344622	GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN	169	0.75571775	0.9392097	1	1.72839069	0.21695519
GO_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT	c5.BP_ GO biological process	32	0.97255	0.47767857	0.7347246	GO_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT	34	0.91717213	0.6079812	1	1.88972213	0.05537787
GO_NEGATIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY	c5.BP_ GO biological process	15	0.9724514	0.51026857	0.73492074	GO_NEGATIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY	16	1.036921	0.44791666	0.86424303	2.0093724	-0.0644696
PID_HES_HEY_PATHWAY	c2.CP_ Canonical pathways	43	0.9724417	0.49579832	0.73485094	PID_HES_HEY_PATHWAY	46	0.7397279	0.8751432	1	1.7121696	0.2327138
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	c2.CGP_ chemical and genetic perturbations	34	0.97242683	0.48230088	0.7347947	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	34	0.7922452	0.79072535	1	1.76467203	0.18018163
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	c2.CGP_ chemical and genetic perturbations	135	0.9723059	0.52832514	0.7350555	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	140	0.9544382	0.59589744	0.97703665	1.9267441	0.0178677
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP	C7_ immunologic signatures	114	0.97228825	0.51625	0.7350089	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP	127	1.0700163	0.3574338	0.80478364	2.04230455	-0.09772805
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN	C7_ immunologic signatures	176	0.9722489	0.51990634	0.73502785	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN	179	0.69249254	0.9676113	1	1.66474144	0.27975636
GSE20366_TREG_VS_TCONV_UP	C7_ immunologic signatures	170	0.97217536	0.54025674	0.7351479	GSE20366_TREG_VS_TCONV_UP	176	1.2283533	0.06639428	0.54342836	2.20052866	-0.25617794
REACTOME_SEMAPHORIN_INTERACTIONS	c2.CP_REACTOME_ Reactome gene sets	61	0.9721033	0.52638704	0.7352584	REACTOME_SEMAPHORIN_INTERACTIONS	61	0.77443975	0.85682577	1	1.74654305	0.19766355
GO_ENDOCRINE_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	104	0.9718948	0.5068836	0.7357737	GO_ENDOCRINE_SYSTEM_DEVELOPMENT	119	-1.1308945	0.16	0.47036615	-0.1589997	2.1027893
GO_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION	c5.BP_ GO biological process	28	0.9718839	0.5015015	0.73570764	GO_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION	28	0.5269055	0.980344	1	1.4987894	0.4449784
GO_CERAMIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	43	0.9718762	0.481982	0.7356323	GO_CERAMIDE_BIOSYNTHETIC_PROCESS	43	1.2399652	0.16857798	0.52587795	2.2118414	-0.268089
MIKKELSEN_NPC_ICP_WITH_H3K4ME3	c2.CGP_ chemical and genetic perturbations	383	0.97174835	0.562635	0.735899	MIKKELSEN_NPC_ICP_WITH_H3K4ME3	388	1.064507	0.268	0.8152595	2.03625535	-0.09275865
GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP	C7_ immunologic signatures	154	0.97171193	0.5411043	0.73590636	GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP	156	-0.9211697	0.7	0.79387933	0.05054223	1.89288163
GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	178	0.9716359	0.5294118	0.73603433	GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	182	1.160289	0.14676113	0.65202385	2.1319249	-0.1886531
TBK1.DN.48HRS_DN	C6_ oncogenic signatures	50	0.9716292	0.51424503	0.7359584	TBK1.DN.48HRS_DN	50	1.1481833	0.2625	0.67124677	2.1198125	-0.1765541
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	c2.CGP_ chemical and genetic perturbations	61	0.97160804	0.5179558	0.7359241	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	61	0.8198723	0.7866521	1	1.79148034	0.15173574
GO_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS	c5.BP_ GO biological process	30	0.971434	0.49455675	0.7363376	GO_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS	30	1.2491485	0.16062802	0.5121534	2.2205825	-0.2777145
GO_CATION_CHANNEL_COMPLEX	c5.CC_ GO cellular component	137	0.9714321	0.5169492	0.73624563	GO_CATION_CHANNEL_COMPLEX	155	1.3786759	0.014256619	0.35546082	2.350108	-0.4072438
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	c2.CP_REACTOME_ Reactome gene sets	29	0.9713132	0.5131376	0.7364955	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	30	1.1585302	0.2669845	0.65580386	2.1298434	-0.187217
GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	159	0.9711577	0.54146343	0.73685175	GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	159	0.9547261	0.63357216	0.9765884	1.9258838	0.0164316
GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP	C7_ immunologic signatures	127	0.9711452	0.51995015	0.7367933	GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP	138	1.2912393	0.037793666	0.45629448	2.2623845	-0.3200941
TBK1.DF_UP	C6_ oncogenic signatures	254	0.9711196	0.5422222	0.7367713	TBK1.DF_UP	254	0.9644201	0.61022043	0.96606225	1.9355397	0.0066995
GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN	C7_ immunologic signatures	181	0.9711069	0.55892646	0.73671013	GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN	179	1.1268994	0.2296748	0.71160257	2.0980063	-0.1557925
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN	C7_ immunologic signatures	167	0.97108954	0.5527273	0.7366635	GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN	169	0.9106307	0.7076613	1	1.88172024	0.06045884
CGCTGCT_MIR503	c3.MIR_ microRNA targets	22	0.9710612	0.50693375	0.73664933	CGCTGCT_MIR503	22	0.7998154	0.7571965	1	1.7708766	0.1712458
GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP	C7_ immunologic signatures	167	0.9709802	0.5354994	0.736793	GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP	174	1.3225971	0.018237082	0.41202283	2.2935773	-0.3516169
ATCTTGC_MIR31	c3.MIR_ microRNA targets	64	0.97084314	0.5083333	0.73710644	ATCTTGC_MIR31	64	-1.3040574	0.057471264	0.27899784	-0.33321426	2.27490054
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP	C7_ immunologic signatures	167	0.9708175	0.54038006	0.7370875	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP	171	1.1983632	0.11585366	0.5954798	2.1691807	-0.2275457
APRELIKOVA_BRCA1_TARGETS	c2.CGP_ chemical and genetic perturbations	45	0.97076356	0.5	0.7371531	APRELIKOVA_BRCA1_TARGETS	46	-1.1553845	0.18095239	0.43714443	-0.18462094	2.12614806
GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	142	0.97072023	0.5487805	0.73718756	GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	148	1.0745643	0.3404689	0.79771125	2.04528453	-0.10384407
GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP	C7_ immunologic signatures	149	0.970692	0.53614455	0.73717266	GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP	157	1.0933709	0.28893444	0.76834774	2.0640629	-0.1226789
GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN	C7_ immunologic signatures	181	0.9706831	0.54151624	0.73710245	GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN	185	0.8785051	0.78014183	1	1.8491882	0.092178
GATA1_03	c3.TFT_ transcription factor targets	210	0.9705984	0.5522388	0.73726183	GATA1_03	220	0.9747432	0.57085425	0.9557335	1.9453416	-0.0041448
WATANABE_COLON_CANCER_MSI_VS_MSS_UP	c2.CGP_ chemical and genetic perturbations	23	0.9705944	0.49235475	0.73717606	WATANABE_COLON_CANCER_MSI_VS_MSS_UP	25	1.0622628	0.39237392	0.8187358	2.0328572	-0.0916684
RIGGINS_TAMOXIFEN_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	58	0.970587	0.50339216	0.73710334	RIGGINS_TAMOXIFEN_RESISTANCE_UP	61	1.2004833	0.179402	0.5915228	2.1710703	-0.2298963
REACTOME_IL_2_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	39	0.97053134	0.506383	0.7371633	REACTOME_IL_2_SIGNALING	39	1.2391574	0.17559864	0.52691156	2.20968874	-0.26862606
GSE17721_0.5H_VS_24H_LPS_BMDC_UP	C7_ immunologic signatures	174	0.9702428	0.53394705	0.7379152	GSE17721_0.5H_VS_24H_LPS_BMDC_UP	179	1.0055797	0.49292928	0.91342294	1.9758225	-0.0353369
GO_REGULATION_OF_ANION_TRANSPORT	c5.BP_ GO biological process	114	0.9701624	0.54591197	0.7380484	GO_REGULATION_OF_ANION_TRANSPORT	122	1.3102636	0.049689442	0.42539504	2.280426	-0.3401012
GO_HISTONE_DEACETYLASE_BINDING	c5.GO molecular function	98	0.9700241	0.5150327	0.7383464	GO_HISTONE_DEACETYLASE_BINDING	97	0.67418194	0.95652175	1	1.64420604	0.29584216
MARTINEZ_RB1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	448	0.9699904	0.585162	0.73834777	MARTINEZ_RB1_TARGETS_DN	457	1.0176638	0.43643644	0.8936009	1.9876542	-0.0476734
GO_POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING	c5.BP_ GO biological process	160	0.96986216	0.5167464	0.7386225	GO_POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING	160	1.0570885	0.36912066	0.82882655	2.02695066	-0.08722634
GO_ENDOCRINE_PANCREAS_DEVELOPMENT	c5.BP_ GO biological process	33	0.9696816	0.51937985	0.73905355	GO_ENDOCRINE_PANCREAS_DEVELOPMENT	40	0.9699743	0.5407578	0.96168786	1.9396559	-0.0002927
SERVITJA_LIVER_HNF1A_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	121	0.96961635	0.5349127	0.7391486	SERVITJA_LIVER_HNF1A_TARGETS_DN	136	1.5473486	0	0.20712103	2.51696495	-0.57773225
GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN	C7_ immunologic signatures	169	0.9694915	0.53429604	0.7394207	GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN	178	0.982204	0.54416245	0.9456363	1.9516955	-0.0127125
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	177	0.96948683	0.5474795	0.73933864	GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	179	0.7353957	0.9512195	1	1.70488253	0.23409113
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP	C7_ immunologic signatures	174	0.9694029	0.5566265	0.739487	GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP	184	1.1537083	0.16717635	0.66262466	2.1231112	-0.1843054
GO_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	c5.BP_ GO biological process	52	0.9693953	0.4943182	0.7394107	GO_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	54	0.84363383	0.74279124	1	1.81302913	0.12576147
GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	C7_ immunologic signatures	180	0.96927726	0.545018	0.739661	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	180	1.0959114	0.28109202	0.76325744	2.06518866	-0.12663414
GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN	C7_ immunologic signatures	181	0.9692709	0.5299043	0.7395826	GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN	184	-1.4197415	0	0.19414319	-0.4504706	2.3890124
TGACGTCA_ATF3_Q6	c3.TFT_ transcription factor targets	201	0.9692286	0.5507585	0.7396045	TGACGTCA_ATF3_Q6	205	0.82694715	0.8795181	1	1.79617575	0.14228145
GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN	C7_ immunologic signatures	180	0.9691972	0.5436554	0.73959506	GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN	183	1.0875171	0.28904665	0.7745078	2.0567143	-0.1183199
GO_HYDROGEN_EXPORTING_ATPASE_ACTIVITY	c5.GO molecular function	20	0.96919274	0.5178295	0.739512	GO_HYDROGEN_EXPORTING_ATPASE_ACTIVITY	21	1.0330887	0.44981414	0.8719595	2.00228144	-0.06389596
GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_BINDING	c5.GO molecular function	282	0.9691372	0.54910713	0.7395735	GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_BINDING	307	0.81439865	0.9358717	1	1.78353585	0.15473855
GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP	C7_ immunologic signatures	128	0.9691291	0.54691356	0.73949856	GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP	138	0.8700283	0.78417265	1	1.8391574	0.0991008
GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP	C7_ immunologic signatures	174	0.9690767	0.567696	0.73955613	GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP	179	0.75736195	0.9369278	1	1.72643865	0.21171475
GO_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE	c5.BP_ GO biological process	29	0.96893597	0.5131783	0.73986864	GO_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE	30	1.1538522	0.2596154	0.6634923	2.12278817	-0.18491623
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	c2.CGP_ chemical and genetic perturbations	44	0.9688755	0.5254491	0.73995143	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	45	-1.0298862	0.37068966	0.63994485	-0.0610107	1.9987617
GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP	C7_ immunologic signatures	180	0.96881074	0.5532934	0.740046	GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP	182	-0.999615	0.5	0.6860744	-0.03080426	1.96842574
GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN	C7_ immunologic signatures	159	0.96878004	0.5406061	0.74003875	GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN	170	1.2036254	0.115306124	0.5851458	2.17240544	-0.23484536
ACCAATC_MIR509	c3.MIR_ microRNA targets	38	0.96873105	0.50073636	0.7400873	ACCAATC_MIR509	43	0.7800358	0.81	1	1.74876685	0.18869525
GO_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS	c5.BP_ GO biological process	22	0.96856457	0.51445967	0.74046904	GO_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS	24	0.9605626	0.5354523	0.97088504	1.92912717	0.00800197
GO_AMMONIUM_ION_METABOLIC_PROCESS	c5.BP_ GO biological process	142	0.9685271	0.528416	0.7404734	GO_AMMONIUM_ION_METABOLIC_PROCESS	153	0.98920506	0.5219612	0.93613464	1.95773216	-0.02067796
GO_MALE_GAMETE_GENERATION	c5.BP_ GO biological process	365	0.96846	0.56842107	0.74057835	GO_MALE_GAMETE_GENERATION	388	1.2268016	0.018	0.54680604	2.1952616	-0.2583416
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	c2.CP_REACTOME_ Reactome gene sets	28	0.96841085	0.51044774	0.74063015	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	28	-1.5986997	0.01604278	0.091344245	-0.63028885	2.56711055
CHR10P15	C1: positional gene sets	30	0.96835107	0.5022556	0.74070436	CHR10P15	30	0.7677381	0.8112306	1	1.73608917	0.20061297
GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN	C7_ immunologic signatures	180	0.9683191	0.52403283	0.74070793	GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN	182	0.6200902	0.9959596	1	1.5884093	0.3482289
GSE3039_NKT_CELL_VS_B1_BCELL_UP	C7_ immunologic signatures	158	0.96819925	0.5207317	0.7409545	GSE3039_NKT_CELL_VS_B1_BCELL_UP	166	1.0715988	0.31504065	0.8029892	2.03979805	-0.10339955
HUTTMANN_B_CLL_POOR_SURVIVAL_DN	c2.CGP_ chemical and genetic perturbations	54	0.9679706	0.52580196	0.741526	HUTTMANN_B_CLL_POOR_SURVIVAL_DN	51	1.0385258	0.42727274	0.86109716	2.0064964	-0.0705552
GO_REGULATION_OF_MYOTUBE_DIFFERENTIATION	c5.BP_ GO biological process	51	0.96787566	0.5246377	0.7417011	GO_REGULATION_OF_MYOTUBE_DIFFERENTIATION	52	0.93441516	0.5887743	0.9956237	1.90229082	0.0334605
GO_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION	c5.BP_ GO biological process	19	0.96781224	0.504717	0.7417987	GO_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION	19	-0.8648538	0.65486723	0.8579906	0.10295844	1.83266604
PID_RHOA_REG_PATHWAY	c2.CP_ Canonical pathways	43	0.9677636	0.52149	0.74184644	PID_RHOA_REG_PATHWAY	45	1.6454479	0.003452244	0.11913143	2.6132115	-0.6776843
GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	181	0.9677351	0.5369285	0.74183303	GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	181	0.9761322	0.5465587	0.95414454	1.9438673	-0.0083971
GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP	C7_ immunologic signatures	174	0.96767914	0.55699176	0.7418946	GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP	179	0.8958027	0.7429435	1	1.86348184	0.07187644
GO_RIBONUCLEOSIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	19	0.96766144	0.513302	0.74185145	GO_RIBONUCLEOSIDE_CATABOLIC_PROCESS	19	0.89642894	0.6316472	1	1.86409038	0.0712325
GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP	C7_ immunologic signatures	152	0.96755534	0.52294683	0.74205846	GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP	154	-0.9175202	0.8333333	0.79856884	0.05003514	1.88507554
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	c2.CGP_ chemical and genetic perturbations	21	0.9675035	0.50693375	0.7421099	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	20	-0.80126774	0.7644231	0.90458906	0.16623576	1.76877124
GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP	C7_ immunologic signatures	174	0.9674012	0.54285717	0.7423044	GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP	177	0.75788593	0.94219065	1	1.72528713	0.20951527
GO_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION	c5.BP_ GO biological process	26	0.96737814	0.50678736	0.7422715	GO_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION	27	-0.87046033	0.7234042	0.85381615	0.09691781	1.83783847
LYF1_01	c3.TFT_ transcription factor targets	223	0.9671351	0.55530477	0.7428711	LYF1_01	231	1.0887457	0.27482447	0.7732636	2.0558808	-0.1216106
GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP	C7_ immunologic signatures	162	0.9670361	0.5457876	0.7430595	GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP	163	0.91747785	0.68711656	1	1.88451395	0.04955825
GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN	C7_ immunologic signatures	170	0.96702087	0.5631769	0.74300665	GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN	175	0.7171612	0.9656218	1	1.68418207	0.24985967
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	c2.CGP_ chemical and genetic perturbations	345	0.9670148	0.5940919	0.74292624	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	353	0.9245017	0.748	1	1.8915165	0.0425131
GO_SOMATIC_STEM_CELL_DIVISION	c5.BP_ GO biological process	19	0.9669514	0.525268	0.74301594	GO_SOMATIC_STEM_CELL_DIVISION	20	-1.2676116	0.14418605	0.30908602	-0.3006602	2.234563
MEIS1_01	c3.TFT_ transcription factor targets	211	0.9669508	0.5532164	0.7429204	MEIS1_01	219	0.86905575	0.80220884	1	1.83600655	0.09789505
GO_IN_UTERO_EMBRYONIC_DEVELOPMENT	c5.BP_ GO biological process	289	0.9668695	0.5837004	0.7430559	GO_IN_UTERO_EMBRYONIC_DEVELOPMENT	303	0.8625816	0.8707415	1	1.8294511	0.1042879
GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	C7_ immunologic signatures	149	0.9667513	0.56585366	0.74329036	GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	149	0.8271886	0.8474059	1	1.7939399	0.1395627
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	c2.CGP_ chemical and genetic perturbations	74	0.96645826	0.53557044	0.7440414	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	79	1.0353223	0.4348762	0.86716396	2.00178056	-0.06886404
MADAN_DPPA4_TARGETS	c2.CGP_ chemical and genetic perturbations	32	0.966269	0.51775146	0.744482	MADAN_DPPA4_TARGETS	42	1.8419304	0	0.028045252	2.8081994	-0.8756614
GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	C7_ immunologic signatures	158	0.9662453	0.5409638	0.7444602	GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	164	0.8006083	0.88301116	1	1.7668536	0.165637
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	182	0.9661457	0.5520581	0.7446404	GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	184	0.6530484	0.99088144	1	1.6191941	0.3130973
GO_ION_CHANNEL_BINDING	c5.GO molecular function	92	0.96611613	0.5379494	0.74462396	GO_ION_CHANNEL_BINDING	100	1.2618586	0.079792745	0.49372965	2.22797473	-0.29574247
GO_TELOMERE_CAPPING	c5.BP_ GO biological process	16	0.9660811	0.5277778	0.74463344	GO_TELOMERE_CAPPING	16	0.88961697	0.63109356	1	1.85569807	0.07646413
NOTCH_DN.V1_DN	C6_ oncogenic signatures	136	0.9660129	0.5592186	0.7447332	NOTCH_DN.V1_DN	146	1.4170482	0.002038736	0.32039097	2.3830611	-0.4510353
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP	C7_ immunologic signatures	176	0.96578753	0.535109	0.74529463	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP	179	1.1615925	0.1490433	0.65117157	2.12738003	-0.19580497
GO_SULFOTRANSFERASE_ACTIVITY	c5.GO molecular function	38	0.9657444	0.52873564	0.7453244	GO_SULFOTRANSFERASE_ACTIVITY	42	1.4315339	0.03733032	0.3133342	2.3972783	-0.4657895
MORF_PRKACA	c4.CGN_ cancer gene neighborhoods	94	0.96572703	0.54342103	0.74528104	MORF_PRKACA	104	1.3351672	0.035940804	0.39763245	2.30089423	-0.36944017
KIM_WT1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	205	0.9655148	0.55288464	0.74580455	KIM_WT1_TARGETS_UP	203	0.9436783	0.65120965	0.98855597	1.9091931	0.0218365
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	c2.CGP_ chemical and genetic perturbations	31	0.9653927	0.53061223	0.74605596	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	31	0.93109876	0.5954923	0.9988727	1.89649146	0.03429394
GO_DRUG_BINDING	c5.GO molecular function	94	0.9652919	0.5409623	0.7462479	GO_DRUG_BINDING	99	1.1301771	0.2416318	0.70580393	2.095469	-0.1648852
GSE27786_BCELL_VS_NKCELL_DN	C7_ immunologic signatures	181	0.96528393	0.55971897	0.7461748	GSE27786_BCELL_VS_NKCELL_DN	180	1.0609444	0.3710819	0.8218809	2.02622833	-0.09566047
GO_VASCULOGENESIS	c5.BP_ GO biological process	53	0.96516556	0.53252035	0.7464241	GO_VASCULOGENESIS	54	-1.1104455	0.21428572	0.5043334	-0.14527994	2.07561106
GO_MOVEMENT_IN_ENVIRONMENT_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION	c5.BP_ GO biological process	75	0.9651061	0.5190039	0.74649376	GO_MOVEMENT_IN_ENVIRONMENT_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION	77	-0.856079	0.779661	0.8624131	0.1090271	1.8211851
GERHOLD_ADIPOGENESIS_DN	c2.CGP_ chemical and genetic perturbations	63	0.96509635	0.5334207	0.74642456	GERHOLD_ADIPOGENESIS_DN	59	1.0237219	0.45154184	0.8858303	1.98881825	-0.05862555
GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP	C7_ immunologic signatures	174	0.96505594	0.55581945	0.74644345	GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP	179	1.1156332	0.21580547	0.72993255	2.08068914	-0.15057726
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP	C7_ immunologic signatures	151	0.96501255	0.53956836	0.74647784	GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP	157	1.189227	0.12309258	0.6064858	2.15423955	-0.22421445
MODULE_459	c4.CM_ cancer modules	351	0.9649158	0.59032255	0.74665916	MODULE_459	357	1.1787095	0.06406406	0.62384635	2.1436253	-0.2137937
GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP	C7_ immunologic signatures	177	0.9649046	0.56557375	0.74659663	GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP	178	1.0265574	0.44129553	0.88171804	1.991462	-0.0616528
GO_STEROL_TRANSPORT	c5.BP_ GO biological process	42	0.96466345	0.52623904	0.74720925	GO_STEROL_TRANSPORT	43	1.0304942	0.4186851	0.87467575	1.99515765	-0.06583075
REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS	c2.CP_REACTOME_ Reactome gene sets	56	0.9645169	0.5221113	0.74753785	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS	57	1.851624	0	0.024553407	2.8161409	-0.8871071
GO_HOMEOSTASIS_OF_NUMBER_OF_CELLS	c5.BP_ GO biological process	154	0.9645094	0.5470086	0.7474608	GO_HOMEOSTASIS_OF_NUMBER_OF_CELLS	162	0.87366915	0.76243657	1	1.83817855	0.09084025
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	c2.CGP_ chemical and genetic perturbations	18	0.964438	0.5152	0.74756634	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	18	1.05376	0.4107143	0.8359874	2.018198	-0.089322
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	c2.CGP_ chemical and genetic perturbations	89	0.96431804	0.5316947	0.7478105	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	91	1.2030598	0.15539113	0.586977	2.16737784	-0.23874176
GO_MAGNESIUM_ION_BINDING	c5.GO molecular function	177	0.9643054	0.56759906	0.7477513	GO_MAGNESIUM_ION_BINDING	185	0.85550517	0.8186424	1	1.81981057	0.10880023
GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN	C7_ immunologic signatures	174	0.9642998	0.5519713	0.7476701	GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN	177	1.1700281	0.13908629	0.6381368	2.1343279	-0.2057283
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	c2.CGP_ chemical and genetic perturbations	63	0.96427876	0.5156038	0.74763197	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	62	-0.9224611	0.7012987	0.7926964	0.04181766	1.88673986
GO_IMMUNOGLOBULIN_BINDING	c5.GO molecular function	15	0.9642455	0.5085537	0.74763036	GO_IMMUNOGLOBULIN_BINDING	16	1.0288026	0.44046095	0.8776792	1.9930481	-0.0645571
CHR6Q24	C1: positional gene sets	33	0.964188	0.49854228	0.74770004	CHR6Q24	34	0.9772804	0.5280199	0.9523156	1.9414684	-0.0130924
GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN	C7_ immunologic signatures	169	0.9641238	0.53173655	0.7477853	GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN	175	0.923596	0.6765005	1	1.8877198	0.0405278
GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP	C7_ immunologic signatures	181	0.9641011	0.5530922	0.7477556	GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP	187	0.7825799	0.92532796	1	1.746681	0.1815212
MODULE_340	c4.CM_ cancer modules	19	0.964098	0.5143312	0.7476674	MODULE_340	21	0.962474	0.54385966	0.96851003	1.926572	0.001624
GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN	C7_ immunologic signatures	158	0.96409655	0.5253012	0.7475744	GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN	166	1.301742	0.030241935	0.43867555	2.26583855	-0.33764545
GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	C7_ immunologic signatures	176	0.963961	0.5493612	0.7478648	GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	180	1.4105839	0.00708502	0.3247877	2.3745449	-0.4466229
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	C7_ immunologic signatures	164	0.96390384	0.56848484	0.7479275	GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	172	1.2915472	0.03137652	0.45555693	2.25545104	-0.32764336
GO_DNA_GEOMETRIC_CHANGE	c5.BP_ GO biological process	73	0.9637966	0.5272244	0.7481411	GO_DNA_GEOMETRIC_CHANGE	73	-1.4008944	0.013888889	0.20586936	-0.4370978	2.364691
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	C7_ immunologic signatures	178	0.96376824	0.55490655	0.7481259	GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	183	1.2060031	0.09706774	0.5821705	2.16977134	-0.24223486
GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP	C7_ immunologic signatures	125	0.9637351	0.54424244	0.7481195	GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP	133	1.1160344	0.26002055	0.72906446	2.0797695	-0.1522993
TTGGGAG_MIR150	c3.MIR_ microRNA targets	86	0.96369797	0.5488621	0.7481342	TTGGGAG_MIR150	86	0.7230577	0.9260824	1	1.68675567	0.24064027
GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_UP	C7_ immunologic signatures	184	0.9636059	0.5609195	0.7482934	GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_UP	184	0.99064606	0.5252525	0.93501025	1.95425196	-0.02704016
GSE17721_LPS_VS_POLYIC_12H_BMDC_DN	C7_ immunologic signatures	173	0.9635052	0.54066986	0.7484867	GSE17721_LPS_VS_POLYIC_12H_BMDC_DN	178	0.859335	0.8117409	1	1.8228402	0.1041702
GO_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	349	0.9632934	0.5734494	0.74901575	GO_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	394	1.3160347	0.002002002	0.4162063	2.2793281	-0.3527413
GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	145	0.9632309	0.54885405	0.74910176	GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN	145	1.0583385	0.38071066	0.8275185	2.0215694	-0.0951076
GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP	C7_ immunologic signatures	161	0.96315485	0.5326087	0.74922764	GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP	160	1.1247264	0.21572581	0.7157113	2.08788125	-0.16157155
SYATTGTG_UNKNOWN	c3.TFT_ transcription factor targets	195	0.9630459	0.56941175	0.7494384	SYATTGTG_UNKNOWN	206	0.8501997	0.8160804	1	1.8132456	0.1128462
GO_PROTEIN_KINASE_A_BINDING	c5.GO molecular function	39	0.9629984	0.5148368	0.7494756	GO_PROTEIN_KINASE_A_BINDING	39	0.6571994	0.9390805	1	1.6201978	0.305799
GO_CELLULAR_RESPONSE_TO_INTERLEUKIN_1	c5.BP_ GO biological process	65	0.9628985	0.53908354	0.74966615	GO_CELLULAR_RESPONSE_TO_INTERLEUKIN_1	68	1.1216899	0.2944384	0.7222418	2.0845884	-0.1587914
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1	c2.CP_REACTOME_ Reactome gene sets	39	0.9627837	0.5180897	0.74989754	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1	40	1.1432357	0.2612198	0.68385977	2.1060194	-0.180452
ETF_Q6	c3.TFT_ transcription factor targets	102	0.96268606	0.55484694	0.75006604	ETF_Q6	105	-1.0145307	0.3783784	0.66784894	-0.05184464	1.97721676
GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN	C7_ immunologic signatures	176	0.9625363	0.5641932	0.7504005	GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN	178	1.2511874	0.044444446	0.50877905	2.2137237	-0.2886511
PID_VEGFR1_PATHWAY	c2.CP_ Canonical pathways	24	0.9625285	0.5313936	0.75032574	PID_VEGFR1_PATHWAY	24	1.0638052	0.40569395	0.8161082	2.0263337	-0.1012767
MODULE_356	c4.CM_ cancer modules	140	0.96227574	0.56332934	0.75092936	MODULE_356	142	-0.7652282	1	0.92996824	0.19704754	1.72750394
GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	C7_ immunologic signatures	159	0.96226716	0.5733333	0.75085497	GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	169	1.2258812	0.07817259	0.5482895	2.18814836	-0.26361404
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	168	0.96222836	0.56453556	0.75086814	GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	179	1.27267	0.03430878	0.48241138	2.23489836	-0.31044164
GO_PCG_PROTEIN_COMPLEX	c5.CC_ GO cellular component	43	0.96222776	0.5188953	0.7507727	GO_PCG_PROTEIN_COMPLEX	43	-0.8861355	0.7285714	0.8384755	0.07609226	1.84836326
TCTGATA_MIR361	c3.MIR_ microRNA targets	78	0.9620571	0.5249344	0.75115836	TCTGATA_MIR361	82	-1.1873671	0.12987013	0.39711344	-0.22531	2.1494242
GSE13229_MATURE_VS_INTMATURE_NKCELL_DN	C7_ immunologic signatures	177	0.9619555	0.55962217	0.75135285	GSE13229_MATURE_VS_INTMATURE_NKCELL_DN	179	0.7838513	0.9084435	1	1.7458068	0.1781042
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	C7_ immunologic signatures	182	0.9619273	0.5736342	0.75132793	GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	184	0.75101864	0.93509126	1	1.71294594	0.21090866
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN	C7_ immunologic signatures	171	0.961926	0.5652695	0.75123364	GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN	173	1.0471612	0.40657085	0.84491783	2.0090872	-0.0852352
GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN	C7_ immunologic signatures	179	0.9619052	0.57109284	0.7511971	GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN	184	1.1078391	0.25506073	0.7412084	2.0697443	-0.1459339
GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	C7_ immunologic signatures	157	0.96176535	0.57056695	0.7515115	GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	159	0.6820219	0.97636175	1	1.64378725	0.27974345
GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP	C7_ immunologic signatures	182	0.9617454	0.56568044	0.7514735	GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP	183	1.0884143	0.30142567	0.7733821	2.0501597	-0.1266689
GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP	C7_ immunologic signatures	176	0.96173644	0.56395346	0.75140065	GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP	180	1.2734952	0.037336025	0.48155752	2.23523164	-0.31175876
GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP	C7_ immunologic signatures	167	0.9617	0.55741626	0.7514026	GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP	170	0.8570623	0.8123732	1	1.8187623	0.1046377
GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	C7_ immunologic signatures	164	0.96163565	0.5456702	0.75149155	GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	170	0.95947737	0.60365856	0.97100157	1.92111302	0.00215828
GO_FRIZZLED_BINDING	c5.GO molecular function	31	0.9616335	0.53073466	0.75140023	GO_FRIZZLED_BINDING	36	0.8924458	0.63170165	1	1.8540793	0.0691877
OHGUCHI_LIVER_HNF4A_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	117	0.96159434	0.53643215	0.75140655	OHGUCHI_LIVER_HNF4A_TARGETS_DN	126	1.1802132	0.1590909	0.6234718	2.14180754	-0.21861886
GSE17721_LPS_VS_CPG_24H_BMDC_DN	C7_ immunologic signatures	169	0.9615139	0.5611765	0.7515337	GSE17721_LPS_VS_CPG_24H_BMDC_DN	173	-0.9585558	0.7058824	0.7439892	0.0029581	1.9200697
GSE29618_MONOCYTE_VS_MDC_UP	C7_ immunologic signatures	162	0.96137196	0.5719468	0.75185686	GSE29618_MONOCYTE_VS_MDC_UP	165	1.4562072	0.004060914	0.28725094	2.41757916	-0.49483524
GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP	C7_ immunologic signatures	175	0.96137166	0.5534442	0.75176066	GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP	176	0.8875157	0.76151484	1	1.84888736	0.07385596
GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP	C7_ immunologic signatures	152	0.9613689	0.57194245	0.7516712	GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP	160	1.1508852	0.18274112	0.6679077	2.1122541	-0.1895163
KIM_WT1_TARGETS_12HR_DN	c2.CGP_ chemical and genetic perturbations	194	0.9613554	0.5584416	0.7516126	KIM_WT1_TARGETS_12HR_DN	194	0.91883427	0.70665324	1	1.88018967	0.04252113
GO_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	15	0.9612867	0.53453946	0.75170493	GO_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORT	16	0.7011231	0.86451614	1	1.6624098	0.2601636
TTTGTAG_MIR520D	c3.MIR_ microRNA targets	301	0.96119857	0.5968992	0.7518611	TTTGTAG_MIR520D	311	0.85934615	0.869	1	1.82054472	0.10185242
GR_01	c3.TFT_ transcription factor targets	176	0.96119845	0.5511432	0.75176424	GR_01	179	0.7217642	0.9605662	1	1.68296265	0.23943425
ZUCCHI_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	34	0.9611576	0.51874065	0.75178444	ZUCCHI_METASTASIS_DN	35	0.82136625	0.7544274	1	1.78252385	0.13979135
BIOCARTA_41BB_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	0.96103257	0.53451043	0.75205344	BIOCARTA_41BB_PATHWAY	16	1.1090208	0.34366578	0.7394061	2.07005337	-0.14798823
GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	151	0.9608976	0.5683453	0.7523498	GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	155	0.90084887	0.72131145	1	1.86174647	0.06004873
IRF1_Q6	c3.TFT_ transcription factor targets	213	0.96087426	0.56497175	0.75232047	IRF1_Q6	229	0.8209432	0.8864322	1	1.78181746	0.13993106
GO_SNARE_COMPLEX	c5.CC_ GO cellular component	47	0.9608479	0.52045137	0.75229216	GO_SNARE_COMPLEX	48	0.76523775	0.8526682	1	1.72608565	0.19561015
PID_P38_MK2_PATHWAY	c2.CP_ Canonical pathways	20	0.96083075	0.5079618	0.7522405	PID_P38_MK2_PATHWAY	20	-0.9811717	0.5121951	0.7136863	-0.02034095	1.94200245
GO_REGULATION_OF_SYNAPSE_ASSEMBLY	c5.BP_ GO biological process	65	0.9607767	0.5353805	0.7522992	GO_REGULATION_OF_SYNAPSE_ASSEMBLY	70	0.97695434	0.53405404	0.9530903	1.93773104	-0.01617764
GSE10325_CD4_TCELL_VS_MYELOID_UP	C7_ immunologic signatures	175	0.9607543	0.57109004	0.75226563	GSE10325_CD4_TCELL_VS_MYELOID_UP	181	1.0677375	0.32290617	0.8093091	2.0284918	-0.1069832
GSE17721_LPS_VS_CPG_8H_BMDC_UP	C7_ immunologic signatures	174	0.96074396	0.56294537	0.7521966	GSE17721_LPS_VS_CPG_8H_BMDC_UP	182	0.92706233	0.6757576	1	1.88780629	0.03368163
GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP	C7_ immunologic signatures	160	0.9607439	0.5603345	0.75209993	GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP	164	0.7779604	0.91700405	1	1.7387043	0.1827835
GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	167	0.9607381	0.57210964	0.7520195	GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN	172	1.065267	0.36455187	0.8139919	2.0260051	-0.1045289
GO_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT	c5.BP_ GO biological process	27	0.96060294	0.5022762	0.7523034	GO_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT	28	1.1140705	0.3321256	0.73173684	2.07467344	-0.15346756
MODULE_488	c4.CM_ cancer modules	25	0.9605533	0.50832075	0.75235385	MODULE_488	25	1.3015195	0.12423124	0.43882132	2.2620728	-0.3409662
GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	C7_ immunologic signatures	179	0.9605117	0.5707491	0.7523795	GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	180	1.0331073	0.42611337	0.872031	1.993619	-0.0725956
GO_PROTEIN_TYROSINE_KINASE_BINDING	c5.GO molecular function	51	0.96043885	0.52890176	0.75249094	GO_PROTEIN_TYROSINE_KINASE_BINDING	51	1.323046	0.0815155	0.4108085	2.28348485	-0.36260715
MAZ_Q6	c3.TFT_ transcription factor targets	168	0.960421	0.5505351	0.7524449	MAZ_Q6	174	-1.1123636	0.11764706	0.5022621	-0.1519426	2.0727846
GO_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION	c5.BP_ GO biological process	29	0.96039283	0.50625	0.7524278	GO_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION	31	1.0310403	0.45169082	0.8745628	1.99143313	-0.07064747
YIH_RESPONSE_TO_ARSENITE_C3	c2.CGP_ chemical and genetic perturbations	33	0.9603535	0.52387846	0.7524473	YIH_RESPONSE_TO_ARSENITE_C3	33	-0.862486	0.7421384	0.8579147	0.0978675	1.8228395
CAGCACT_MIR5123P	c3.MIR_ microRNA targets	137	0.9603488	0.5707317	0.75236267	CAGCACT_MIR5123P	141	1.1298825	0.23391216	0.7058704	2.0902313	-0.1695337
GO_PEPTIDE_SECRETION	c5.BP_ GO biological process	49	0.96032244	0.5155367	0.7523442	GO_PEPTIDE_SECRETION	55	1.0254124	0.44345897	0.8835946	1.98573484	-0.06508996
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP	C7_ immunologic signatures	176	0.9602744	0.5665083	0.75238365	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP	183	0.8242354	0.86876905	1	1.7845098	0.136039
GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	183	0.9602497	0.5700599	0.75235784	GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	185	0.768547	0.910387	1	1.7287967	0.1917027
GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN	C7_ immunologic signatures	137	0.9602153	0.5470297	0.75235724	GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN	145	0.7307054	0.94111675	1	1.6909207	0.2295099
GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN	C7_ immunologic signatures	178	0.9602134	0.5634638	0.75226605	GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN	182	1.0658296	0.33434343	0.8126891	2.026043	-0.1056162
GSE2585_CTEC_VS_MTEC_THYMUS_UP	C7_ immunologic signatures	162	0.9601525	0.5598086	0.7523384	GSE2585_CTEC_VS_MTEC_THYMUS_UP	165	1.0758649	0.33230454	0.7950982	2.0360174	-0.1157124
GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN	C7_ immunologic signatures	161	0.9601032	0.5519324	0.7523855	GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN	171	1.0192919	0.4450102	0.8917144	1.9793951	-0.0591887
WNT_UP.V1_DN	C6_ oncogenic signatures	148	0.96005976	0.56674755	0.752408	WNT_UP.V1_DN	151	1.2557812	0.070408165	0.50152564	2.21584096	-0.29572144
PDGF_UP.V1_DN	C6_ oncogenic signatures	90	0.96001405	0.5600522	0.7524411	PDGF_UP.V1_DN	97	1.418735	0.010504202	0.31925794	2.37874905	-0.45872095
GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN	C7_ immunologic signatures	176	0.9600108	0.5530393	0.7523531	GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN	177	0.79564834	0.89137053	1	1.75565914	0.16436246
GO_REGULATION_OF_RENAL_SODIUM_EXCRETION	c5.BP_ GO biological process	17	0.9600023	0.5222734	0.7522808	GO_REGULATION_OF_RENAL_SODIUM_EXCRETION	20	1.1787713	0.25888324	0.6239228	2.1387736	-0.218769
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN	C7_ immunologic signatures	168	0.9596363	0.56904763	0.7532212	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN	169	1.3136172	0.027300304	0.42006692	2.2732535	-0.3539809
GO_COGNITION	c5.BP_ GO biological process	214	0.9595034	0.5723982	0.7534976	GO_COGNITION	229	1.1595178	0.13232324	0.65332913	2.1190212	-0.2000144
SERVITJA_ISLET_HNF1A_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	86	0.95949775	0.54545456	0.7534186	SERVITJA_ISLET_HNF1A_TARGETS_DN	95	1.2319448	0.115588546	0.53666985	2.19144255	-0.27244705
GO_NUCLEIC_ACID_PHOSPHODIESTER_BOND_HYDROLYSIS	c5.BP_ GO biological process	218	0.9594303	0.571263	0.75351447	GO_NUCLEIC_ACID_PHOSPHODIESTER_BOND_HYDROLYSIS	223	-0.86427295	1	0.8577587	0.09515735	1.82370325
GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	C7_ immunologic signatures	180	0.9594189	0.5556872	0.7534492	GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	185	0.7932258	0.8989899	1	1.7526447	0.1661931
GO_RUFFLE_ORGANIZATION	c5.BP_ GO biological process	18	0.959254	0.52747256	0.75382584	GO_RUFFLE_ORGANIZATION	20	0.6977345	0.8517588	1	1.6569885	0.2615195
GO_AMIDE_TRANSPORT	c5.BP_ GO biological process	83	0.9591664	0.5548303	0.75398046	GO_AMIDE_TRANSPORT	88	0.9126702	0.658147	1	1.8718366	0.0464962
PID_AP1_PATHWAY	c2.CP_ Canonical pathways	63	0.95911324	0.5235457	0.7540351	PID_AP1_PATHWAY	62	0.68358636	0.9335548	1	1.6426996	0.27552688
GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN	C7_ immunologic signatures	181	0.95902604	0.54534745	0.7541918	GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN	181	1.120305	0.22018349	0.7229759	2.07933104	-0.16127896
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	c2.CP_REACTOME_ Reactome gene sets	15	0.95901066	0.52845526	0.75414115	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	15	0.8532612	0.660105	1	1.81227186	0.10574946
GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN	C7_ immunologic signatures	183	0.95878255	0.5747939	0.7546946	GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN	183	0.7062364	0.9656912	1	1.66501895	0.25254615
GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN	C7_ immunologic signatures	174	0.9587002	0.5656214	0.7548386	GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN	184	0.9357299	0.652834	0.9937529	1.8944301	0.0229703
GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN	C7_ immunologic signatures	158	0.95862037	0.5625745	0.7549634	GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN	165	0.5574586	1	1	1.51607897	0.40116177
TAXCREB_01	c3.TFT_ transcription factor targets	121	0.9585074	0.5744681	0.75517935	TAXCREB_01	123	0.8372336	0.82043344	1	1.795741	0.1212738
GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	C7_ immunologic signatures	174	0.9583768	0.56287426	0.75545627	GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	179	0.8942335	0.74418604	1	1.8526103	0.0641433
GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP	C7_ immunologic signatures	156	0.95836914	0.59006214	0.7553805	GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP	160	1.1605654	0.16004078	0.65195054	2.11893454	-0.20219626
GSE27786_NKCELL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	164	0.958284	0.5767878	0.75552696	GSE27786_NKCELL_VS_NEUTROPHIL_DN	174	0.9196931	0.68186426	1	1.8779771	0.0385909
GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	C7_ immunologic signatures	171	0.95816976	0.5547703	0.7557531	GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	170	0.73683614	0.9531091	1	1.6950059	0.22133362
CMYB_01	c3.TFT_ transcription factor targets	218	0.95815265	0.5753425	0.75570583	CMYB_01	224	0.5687005	0.99899596	1	1.52685315	0.38945215
MORF_IFNA1	c4.CGN_ cancer gene neighborhoods	157	0.95811933	0.55764705	0.7557046	MORF_IFNA1	168	1.4126664	0.006042296	0.32422224	2.37078573	-0.45454707
GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP	C7_ immunologic signatures	151	0.95801747	0.562954	0.75590074	GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP	157	1.4502069	0.00305499	0.29187304	2.40822437	-0.49218943
GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN	C7_ immunologic signatures	187	0.9579968	0.55942374	0.75586367	GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN	190	0.9348446	0.6744422	0.9950537	1.8928414	0.0231522
BIOCARTA_MET_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	37	0.95799124	0.5478645	0.7557816	BIOCARTA_MET_PATHWAY	37	0.8931084	0.6441281	1	1.85109964	0.06488284
GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP	C7_ immunologic signatures	172	0.95767164	0.57227486	0.75659335	GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP	178	0.7210335	0.9758065	1	1.67870514	0.23663814
GO_WNT_SIGNALING_PATHWAY	c5.BP_ GO biological process	313	0.957619	0.5883002	0.7566557	GO_WNT_SIGNALING_PATHWAY	325	0.71951616	0.990991	1	1.67713516	0.23810284
GSE17721_LPS_VS_CPG_0.5H_BMDC_UP	C7_ immunologic signatures	178	0.95760894	0.55594003	0.7565862	GSE17721_LPS_VS_CPG_0.5H_BMDC_UP	181	1.0451835	0.38900203	0.84903634	2.00279244	-0.08757456
GSE45365_NK_CELL_VS_CD8A_DC_UP	C7_ immunologic signatures	181	0.9574698	0.6051402	0.756878	GSE45365_NK_CELL_VS_CD8A_DC_UP	182	0.77347136	0.92950654	1	1.73094116	0.18399844
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	c2.CGP_ chemical and genetic perturbations	51	0.95738906	0.5325444	0.7570171	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	54	0.6352045	0.95730335	1	1.59259356	0.32218456
GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	133	0.9571939	0.5813665	0.75746524	GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	135	1.3203968	0.026639344	0.4114676	2.2775907	-0.3632029
MORF_THPO	c4.CGN_ cancer gene neighborhoods	92	0.9571375	0.54615384	0.75752354	MORF_THPO	98	1.2791455	0.077405855	0.47308502	2.236283	-0.322008
DELACROIX_RAR_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	23	0.9569488	0.53282446	0.7579617	DELACROIX_RAR_TARGETS_DN	24	-0.8645254	0.6960784	0.8575833	0.0924234	1.8214742
REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	c2.CP_REACTOME_ Reactome gene sets	31	0.95693034	0.51713395	0.7579154	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	34	1.1178266	0.3057554	0.727354	2.07475694	-0.16089626
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	c2.CGP_ chemical and genetic perturbations	19	0.9567979	0.5008104	0.7581923	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	19	-0.96500903	0.48372093	0.7356652	-0.00821113	1.92180693
GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP	C7_ immunologic signatures	169	0.95671976	0.55962217	0.75831795	GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP	178	1.1754813	0.13109756	0.62833637	2.13220106	-0.21876154
GO_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION	c5.BP_ GO biological process	17	0.95671844	0.5451713	0.7582243	GO_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION	20	1.2237028	0.20368098	0.550511	2.18042124	-0.26698436
GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	176	0.95671195	0.611976	0.7581444	GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN	176	0.8600413	0.79776424	1	1.81675325	0.09667065
GO_RESPONSE_TO_TRANSITION_METAL_NANOPARTICLE	c5.BP_ GO biological process	122	0.9566986	0.54950494	0.7580862	GO_RESPONSE_TO_TRANSITION_METAL_NANOPARTICLE	128	1.2560233	0.0743034	0.50094837	2.2127219	-0.2993247
TITF1_Q3	c3.TFT_ transcription factor targets	196	0.9566739	0.571934	0.75806195	TITF1_Q3	211	1.1335312	0.18473895	0.7007211	2.0902051	-0.1768573
MODULE_177	c4.CM_ cancer modules	91	0.9566233	0.54342103	0.75811017	MODULE_177	92	0.8045808	0.8343882	1	1.7612041	0.1520425
GCM_PTPRD	c4.CGN_ cancer gene neighborhoods	53	0.9565769	0.5300546	0.75814325	GCM_PTPRD	53	0.681572	0.9345898	1	1.6381489	0.2750049
GO_POSITIVE_T_CELL_SELECTION	c5.BP_ GO biological process	19	0.95656586	0.5184615	0.7580757	GO_POSITIVE_T_CELL_SELECTION	21	0.84578925	0.69174755	1	1.80235511	0.11077661
GO_TONGUE_DEVELOPMENT	c5.BP_ GO biological process	16	0.9564878	0.5322314	0.7582094	GO_TONGUE_DEVELOPMENT	18	-0.8120535	0.7546296	0.8957011	0.1444343	1.7685413
GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	C7_ immunologic signatures	176	0.95641327	0.56788665	0.7583238	GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	181	1.0530609	0.38046795	0.8360657	2.00947417	-0.09664763
STEGER_ADIPOGENESIS_UP	c2.CGP_ chemical and genetic perturbations	20	0.9561711	0.5273556	0.75891125	STEGER_ADIPOGENESIS_UP	19	-1.0080515	0.38709676	0.67423135	-0.0518804	1.9642226
GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP	C7_ immunologic signatures	165	0.9560807	0.5903188	0.7590756	GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP	167	0.6669321	0.98170733	1	1.6230128	0.2891486
E47_01	c3.TFT_ transcription factor targets	231	0.95604783	0.59158134	0.7590752	E47_01	234	1.1855321	0.09045226	0.61371565	2.14157993	-0.22948427
GSE22886_TH1_VS_TH2_12H_ACT_UP	C7_ immunologic signatures	169	0.95593494	0.5748503	0.75929415	GSE22886_TH1_VS_TH2_12H_ACT_UP	175	0.9298423	0.66362715	0.9989717	1.88577724	0.02609264
GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	C7_ immunologic signatures	178	0.95583946	0.56391877	0.7594653	GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	179	1.2805648	0.030395137	0.47131404	2.23640426	-0.32472534
MAYBURD_RESPONSE_TO_L663536_DN	c2.CGP_ chemical and genetic perturbations	46	0.9557887	0.544808	0.7595075	MAYBURD_RESPONSE_TO_L663536_DN	47	0.96993583	0.53415453	0.96128523	1.92572453	-0.01414713
GO_VESICLE_ORGANIZATION	c5.BP_ GO biological process	246	0.9557862	0.5854214	0.759416	GO_VESICLE_ORGANIZATION	248	1.0026191	0.5030303	0.91875863	1.9584053	-0.0468329
GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP	C7_ immunologic signatures	178	0.95574045	0.5729412	0.7594498	GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP	178	1.127669	0.222334	0.7097216	2.08340945	-0.17192855
GO_POSITIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING	c5.BP_ GO biological process	69	0.95572394	0.5304233	0.7594004	GO_POSITIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING	74	1.0291913	0.43167028	0.8769018	1.98491524	-0.07346736
GSE27786_CD4_TCELL_VS_NKCELL_UP	C7_ immunologic signatures	168	0.9556746	0.5667075	0.7594504	GSE27786_CD4_TCELL_VS_NKCELL_UP	171	0.8562246	0.82204247	1	1.8118992	0.09945
NOUZOVA_METHYLATED_IN_APL	c2.CGP_ chemical and genetic perturbations	53	0.9555234	0.5557103	0.75977194	NOUZOVA_METHYLATED_IN_APL	57	0.86087596	0.7261641	1	1.81639936	0.09464744
GO_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY	c5.BP_ GO biological process	123	0.9553777	0.5499383	0.7600866	GO_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY	130	0.90254277	0.71413934	1	1.85792047	0.05283493
GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP	C7_ immunologic signatures	127	0.9552472	0.5721455	0.7603669	GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP	135	1.1902674	0.1399177	0.60605276	2.1455146	-0.2350202
GO_MEGAKARYOCYTE_DEVELOPMENT	c5.BP_ GO biological process	15	0.955129	0.5285481	0.7606049	GO_MEGAKARYOCYTE_DEVELOPMENT	15	-0.71009403	0.85365856	0.95544136	0.24503497	1.66522303
GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_UP	C7_ immunologic signatures	170	0.95504874	0.5971223	0.76073706	GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_UP	170	1.1392155	0.18431772	0.6917361	2.09426424	-0.18416676
GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP	C7_ immunologic signatures	173	0.9548993	0.57431626	0.7610681	GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP	180	1.0959529	0.27963525	0.7632224	2.0508522	-0.1410536
REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	c2.CP_REACTOME_ Reactome gene sets	30	0.9548241	0.5124224	0.76118153	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	30	0.8766763	0.66424245	1	1.8315004	0.0781478
CADWELL_ATG16L1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	69	0.95456237	0.5358127	0.76182246	CADWELL_ATG16L1_TARGETS_UP	79	1.1221253	0.28709677	0.722006	2.07668767	-0.16756293
GO_AGGRESOME	c5.CC_ GO cellular component	28	0.95453316	0.5550661	0.7618079	GO_AGGRESOME	29	0.9431662	0.5766509	0.9886402	1.89769936	0.01136696
GO_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS	c5.BP_ GO biological process	46	0.9545268	0.54479766	0.7617267	GO_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS	52	1.1305033	0.2625	0.7059537	2.0850301	-0.1759765
GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN	C7_ immunologic signatures	113	0.9545252	0.5670498	0.7616353	GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN	129	1.4311926	0.005208334	0.31318036	2.3857178	-0.4766674
GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN	C7_ immunologic signatures	163	0.954463	0.56698567	0.7617185	GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN	165	0.9038364	0.7218274	1	1.8582994	0.0506266
GO_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT	c5.BP_ GO biological process	24	0.9543307	0.5332326	0.76199716	GO_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT	26	1.6251067	0.002430134	0.13667135	2.5794374	-0.670776
GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP	C7_ immunologic signatures	140	0.9542867	0.5777234	0.7620262	GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP	147	1.0717764	0.34615386	0.80264175	2.0260631	-0.1174897
CCAATNNSNNNGCG_UNKNOWN	c3.TFT_ transcription factor targets	57	0.95425284	0.5443038	0.76202095	CCAATNNSNNNGCG_UNKNOWN	57	0.770492	0.83573806	1	1.72474484	0.18376084
GO_COBALAMIN_METABOLIC_PROCESS	c5.BP_ GO biological process	20	0.95424944	0.5340557	0.7619322	GO_COBALAMIN_METABOLIC_PROCESS	20	0.9940997	0.50324255	0.9310067	1.94834914	-0.03985026
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP	c2.CGP_ chemical and genetic perturbations	97	0.9542408	0.5613577	0.7618605	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP	104	1.0906093	0.32979852	0.77047735	2.0448501	-0.1363685
GSE3982_MAC_VS_NEUTROPHIL_UP	C7_ immunologic signatures	170	0.95420545	0.5809179	0.7618658	GSE3982_MAC_VS_NEUTROPHIL_UP	170	0.8647487	0.79141104	1	1.81895415	0.08945675
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	c2.CGP_ chemical and genetic perturbations	93	0.9541743	0.5882353	0.7618531	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	97	1.1025891	0.29102167	0.75256616	2.0567634	-0.1484148
GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP	C7_ immunologic signatures	141	0.954011	0.5691158	0.7622242	GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP	143	1.2939293	0.039014373	0.45175788	2.2479403	-0.3399183
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP	C7_ immunologic signatures	151	0.95384955	0.56763285	0.7625838	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP	155	0.8841554	0.74771106	1	1.83800495	0.06969415
GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP	C7_ immunologic signatures	158	0.9538416	0.5766509	0.7625069	GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP	164	0.94009125	0.6454265	0.98965126	1.89393285	0.01375035
GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP	C7_ immunologic signatures	178	0.9536906	0.5877503	0.76283586	GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP	180	1.1303445	0.1902834	0.70585823	2.0840351	-0.1766539
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	c2.CGP_ chemical and genetic perturbations	60	0.95351666	0.56241614	0.7632234	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	61	0.82442164	0.7809633	1	1.7779383	0.12909502
GSE17721_LPS_VS_POLYIC_4H_BMDC_UP	C7_ immunologic signatures	183	0.9534785	0.57108724	0.763234	GSE17721_LPS_VS_POLYIC_4H_BMDC_UP	190	0.753169	0.93353474	1	1.7066475	0.2003095
GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN	C7_ immunologic signatures	173	0.95331997	0.5712575	0.7635879	GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN	178	1.0196368	0.4579534	0.89157313	1.97295677	-0.06631683
GO_KERATIN_FILAMENT	c5.CC_ GO cellular component	22	0.95328104	0.535061	0.7635975	GO_KERATIN_FILAMENT	29	1.0309589	0.43757576	0.87403333	1.98423994	-0.07767786
GO_LYMPHOCYTE_HOMEOSTASIS	c5.BP_ GO biological process	46	0.9531847	0.5401662	0.76376885	GO_LYMPHOCYTE_HOMEOSTASIS	50	1.0265933	0.43771043	0.88185924	1.979778	-0.0734086
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	c2.CGP_ chemical and genetic perturbations	131	0.95312786	0.5663391	0.7638234	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	132	0.9797379	0.5474227	0.95030135	1.93286576	-0.02661004
GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN	C7_ immunologic signatures	174	0.953113	0.58253586	0.7637712	GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN	178	0.7610165	0.9180991	1	1.7141295	0.1920965
GO_BICARBONATE_TRANSPORT	c5.BP_ GO biological process	39	0.95310986	0.5231214	0.76368165	GO_BICARBONATE_TRANSPORT	41	1.1824092	0.22916667	0.6189858	2.13551906	-0.22929934
GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP	C7_ immunologic signatures	182	0.9530231	0.5885168	0.76382834	GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP	187	0.98843557	0.5110664	0.9372279	1.94145867	-0.03541247
GO_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	17	0.9529557	0.53355706	0.763926	GO_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	16	0.615565	0.93041235	1	1.5685207	0.3373907
GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP	C7_ immunologic signatures	143	0.9529094	0.57678354	0.76396614	GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP	147	0.8822666	0.74002045	1	1.835176	0.0706428
GNF2_CD14	c4.CGN_ cancer gene neighborhoods	24	0.9528553	0.5449102	0.76402134	GNF2_CD14	26	1.4622762	0.03606965	0.28104234	2.4151315	-0.5094209
REACTOME_SIGNALING_BY_HIPPO	c2.CP_REACTOME_ Reactome gene sets	19	0.95279616	0.53858024	0.76409066	REACTOME_SIGNALING_BY_HIPPO	19	0.6539334	0.9128205	1	1.60672956	0.29886276
GO_DNA_POLYMERASE_ACTIVITY	c5.GO molecular function	28	0.95262456	0.525641	0.7644742	GO_DNA_POLYMERASE_ACTIVITY	28	0.9292864	0.5859564	0.99909705	1.88191096	0.02333816
GSE24142_DN2_VS_DN3_THYMOCYTE_DN	C7_ immunologic signatures	187	0.9526089	0.5950992	0.7644154	GSE24142_DN2_VS_DN3_THYMOCYTE_DN	189	1.169575	0.12977867	0.6384814	2.1221839	-0.2169661
WORSCHECH_TUMOR_REJECTION_UP	c2.CGP_ chemical and genetic perturbations	41	0.95252436	0.54344624	0.7645593	WORSCHECH_TUMOR_REJECTION_UP	43	0.915742	0.62045455	1	1.86826636	0.03678236
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP	C7_ immunologic signatures	170	0.95250607	0.5797619	0.76451224	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP	179	1.2036896	0.09219858	0.5850446	2.15619567	-0.25118353
REACTOME_PIP3_ACTIVATES_AKT_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	27	0.9522293	0.5419162	0.7652047	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING	27	0.96413404	0.5376214	0.96665794	1.91636334	-0.01190474
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN	C7_ immunologic signatures	175	0.9521805	0.59928656	0.76524955	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN	181	0.9765723	0.5652174	0.9533804	1.9287528	-0.0243918
GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP	C7_ immunologic signatures	118	0.95216584	0.5693904	0.76519316	GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP	123	0.82343966	0.84008306	1	1.7756055	0.12872618
GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP	C7_ immunologic signatures	122	0.95216244	0.5708861	0.7651055	GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP	125	1.1835271	0.16943868	0.6171287	2.13568954	-0.23136466
GO_VENTRICULAR_SEPTUM_MORPHOGENESIS	c5.BP_ GO biological process	25	0.952133	0.5468278	0.7650904	GO_VENTRICULAR_SEPTUM_MORPHOGENESIS	26	-1.4778311	0.024691358	0.15577829	-0.5256981	2.4299641
GO_PANCREAS_DEVELOPMENT	c5.BP_ GO biological process	61	0.9519445	0.54520166	0.7655198	GO_PANCREAS_DEVELOPMENT	69	0.8436565	0.74509805	1	1.795601	0.108288
GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN	C7_ immunologic signatures	177	0.95178485	0.6064982	0.76588356	GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN	183	1.0909022	0.27365208	0.7697747	2.04268705	-0.13911735
GO_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	25	0.951691	0.5195936	0.7660621	GO_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS	31	1.2470498	0.16666667	0.5156734	2.1987408	-0.2953588
IGARASHI_ATF4_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	79	0.95163196	0.55440414	0.76613986	IGARASHI_ATF4_TARGETS_DN	78	1.0332298	0.42857143	0.8716529	1.98486176	-0.08159784
REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	c2.CP_REACTOME_ Reactome gene sets	358	0.9516004	0.6212121	0.7661328	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	387	0.97525495	0.5905906	0.9557955	1.92685535	-0.02365455
GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN	C7_ immunologic signatures	170	0.9514988	0.59134614	0.76631874	GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN	171	0.6745962	0.98176295	1	1.626095	0.2769026
MODULE_94	c4.CM_ cancer modules	315	0.9514427	0.6173246	0.76638263	MODULE_94	330	1.2340516	0.017017016	0.53506565	2.1854943	-0.2826089
GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN	C7_ immunologic signatures	178	0.95143896	0.59166664	0.7662955	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN	181	1.0166417	0.46928498	0.8950315	1.96808066	-0.06520274
GSE27786_LSK_VS_BCELL_UP	C7_ immunologic signatures	173	0.9513971	0.5864124	0.7663129	GSE27786_LSK_VS_BCELL_UP	176	0.8449168	0.8284264	1	1.7963139	0.1064803
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP	C7_ immunologic signatures	153	0.9513791	0.5683453	0.7662649	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP	153	1.2133654	0.11190965	0.57162386	2.1647445	-0.2619863
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	c2.CGP_ chemical and genetic perturbations	17	0.9513631	0.5299838	0.7662143	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	17	-1.0062516	0.41558442	0.67596835	-0.0548885	1.9576147
WANG_HCP_PROSTATE_CANCER	c2.CGP_ chemical and genetic perturbations	96	0.9513057	0.5625	0.76627845	WANG_HCP_PROSTATE_CANCER	96	1.1619126	0.19409283	0.6505293	2.1132183	-0.2106069
GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN	C7_ immunologic signatures	157	0.95127225	0.5538642	0.7662744	GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN	161	1.1817657	0.15055951	0.62011063	2.13303795	-0.23049345
GO_ATPASE_COUPLED_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	55	0.9512482	0.55586594	0.76624155	GO_ATPASE_COUPLED_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	62	1.1784663	0.20989011	0.624281	2.1297145	-0.2272181
GO_REGULATION_OF_EPIDERMIS_DEVELOPMENT	c5.BP_ GO biological process	52	0.95122045	0.55413103	0.7662252	GO_REGULATION_OF_EPIDERMIS_DEVELOPMENT	55	1.0926652	0.3507795	0.7684382	2.04388565	-0.14144475
GO_CRANIAL_NERVE_MORPHOGENESIS	c5.BP_ GO biological process	21	0.9511191	0.539039	0.7664065	GO_CRANIAL_NERVE_MORPHOGENESIS	23	-1.4467049	0.04347826	0.1759601	-0.4955858	2.397824
GSE17721_12H_VS_24H_PAM3CSK4_BMDC_UP	C7_ immunologic signatures	182	0.95110863	0.58023256	0.76633805	GSE17721_12H_VS_24H_PAM3CSK4_BMDC_UP	183	0.6498805	0.9878665	1	1.60098913	0.30122813
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN	C7_ immunologic signatures	99	0.9510967	0.5749674	0.76627624	GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN	108	0.9587938	0.591858	0.9721101	1.9098905	-0.0076971
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP	C7_ immunologic signatures	142	0.9510371	0.5714286	0.76634437	GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP	150	1.1403011	0.20773931	0.6901115	2.0913382	-0.189264
GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP	C7_ immunologic signatures	172	0.9508551	0.60379595	0.766774	GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP	172	-0.7763927	1	0.9235177	0.1744624	1.7272478
GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_DN	C7_ immunologic signatures	154	0.9507576	0.5940476	0.76694095	GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_DN	154	0.6352824	0.99591005	1	1.58604	0.3154752
GO_N_ACETYLTRANSFERASE_ACTIVITY	c5.GO molecular function	73	0.9507287	0.55870444	0.766928	GO_N_ACETYLTRANSFERASE_ACTIVITY	74	0.5346789	0.9923581	1	1.4854076	0.4160498
GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	C7_ immunologic signatures	172	0.9507058	0.58676654	0.76689315	GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	179	1.0589432	0.37917086	0.8264945	2.009649	-0.1082374
GATA_Q6	c3.TFT_ transcription factor targets	168	0.9506898	0.57806915	0.7668404	GATA_Q6	180	0.8738801	0.8056395	1	1.8245699	0.0768097
GO_JNK_CASCADE	c5.BP_ GO biological process	73	0.95053715	0.5387701	0.7671862	GO_JNK_CASCADE	74	1.2598184	0.09743041	0.4968235	2.21035555	-0.30928125
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	41	0.9504439	0.5373563	0.7673591	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	42	1.176249	0.23367697	0.6274893	2.1266929	-0.2258051
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	134	0.9504413	0.5793358	0.7672696	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN	145	1.3525578	0.019427402	0.3835266	2.3029991	-0.4021165
GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP	C7_ immunologic signatures	154	0.9504266	0.5782396	0.76721144	GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP	157	1.0886071	0.29989868	0.773128	2.0390337	-0.1381805
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP	C7_ immunologic signatures	176	0.9503791	0.6	0.7672476	GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP	179	0.9230176	0.700611	1	1.8733967	0.0273615
ATGTCAC_MIR489	c3.MIR_ microRNA targets	80	0.9503644	0.5655527	0.76719075	ATGTCAC_MIR489	81	1.0972781	0.30719656	0.76028186	2.0476425	-0.1469137
GO_NUCLEAR_MEMBRANE	c5.CC_ GO cellular component	243	0.95029306	0.60366553	0.7672886	GO_NUCLEAR_MEMBRANE	243	0.9430829	0.6589769	0.9885128	1.89337596	0.00721016
GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP	C7_ immunologic signatures	164	0.9502575	0.5954382	0.7672944	GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP	167	0.90613395	0.7309237	1	1.85639145	0.04412355
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN	C7_ immunologic signatures	161	0.9501853	0.5938242	0.7674062	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN	167	0.8778664	0.775076	1	1.8280517	0.0723189
GO_KERATAN_SULFATE_METABOLIC_PROCESS	c5.BP_ GO biological process	30	0.95009804	0.5532234	0.76757014	GO_KERATAN_SULFATE_METABOLIC_PROCESS	29	1.1521803	0.2741738	0.66613287	2.10227834	-0.20208226
GO_ANCHORED_COMPONENT_OF_PLASMA_MEMBRANE	c5.CC_ GO cellular component	35	0.95002395	0.54689753	0.767683	GO_ANCHORED_COMPONENT_OF_PLASMA_MEMBRANE	39	1.5447565	0.00814901	0.20859358	2.49478045	-0.59473255
GO_ANDROGEN_METABOLIC_PROCESS	c5.BP_ GO biological process	24	0.9499781	0.5416667	0.7677174	GO_ANDROGEN_METABOLIC_PROCESS	25	-1.0058882	0.43455496	0.6763364	-0.0559101	1.9558663
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	c2.CGP_ chemical and genetic perturbations	220	0.94992965	0.60928655	0.76775056	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	223	1.4313897	0	0.31292257	2.38131935	-0.48146005
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	c2.CGP_ chemical and genetic perturbations	137	0.94982547	0.5694618	0.7679385	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	139	0.6840378	0.96102566	1	1.63386327	0.26578767
GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN	C7_ immunologic signatures	132	0.9497094	0.57716435	0.76816565	GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN	137	1.4420071	0.004085802	0.30043718	2.3917165	-0.4922977
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	139	0.9496954	0.5992736	0.7681075	GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	145	0.9866115	0.5462869	0.9402032	1.9363069	-0.0369161
GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN	C7_ immunologic signatures	174	0.94950134	0.59880954	0.76855415	GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN	182	-1.1647338	0	0.42454332	-0.21523246	2.11423514
JOHNSTONE_PARVB_TARGETS_3_UP	c2.CGP_ chemical and genetic perturbations	379	0.94942117	0.633547	0.7686799	JOHNSTONE_PARVB_TARGETS_3_UP	381	1.4076946	0	0.32892475	2.35711577	-0.45827343
YAGI_AML_WITH_INV_16_TRANSLOCATION	c2.CGP_ chemical and genetic perturbations	362	0.94942003	0.6386192	0.7685862	YAGI_AML_WITH_INV_16_TRANSLOCATION	375	0.9322878	0.7067067	0.997722	1.88170783	0.01713223
GO_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION	c5.BP_ GO biological process	23	0.9494125	0.52710843	0.7685125	GO_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION	23	1.4485899	0.044720497	0.29186752	2.3980024	-0.4991774
GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	171	0.9492986	0.5870348	0.7687297	GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	176	1.2392085	0.069838054	0.52690494	2.1885071	-0.2899099
GO_NEUROPEPTIDE_SIGNALING_PATHWAY	c5.BP_ GO biological process	58	0.9491795	0.56378603	0.7689675	GO_NEUROPEPTIDE_SIGNALING_PATHWAY	75	1.0920993	0.3215434	0.7692903	2.0412788	-0.1429198
GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP	C7_ immunologic signatures	167	0.9491749	0.57347673	0.7688835	GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP	170	1.2196804	0.075987846	0.555776	2.1688553	-0.2705055
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP	C7_ immunologic signatures	163	0.9491639	0.60807604	0.76881796	GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP	166	1.1456723	0.20020534	0.67791283	2.0948362	-0.1965084
GO_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	76	0.94913805	0.564753	0.76879984	GO_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS	76	1.3463802	0.043431055	0.3873727	2.29551825	-0.39724215
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	165	0.9491286	0.5824561	0.7687269	GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN	167	0.9467466	0.6134283	0.9852303	1.8958752	0.002382
GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN	C7_ immunologic signatures	180	0.9490827	0.60260975	0.76875967	GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN	182	0.85828745	0.8248988	1	1.80737015	0.09079525
JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP	c2.CGP_ chemical and genetic perturbations	101	0.9489929	0.57653064	0.76891315	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP	102	1.0397925	0.42436975	0.85921985	1.9887854	-0.0907996
GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN	C7_ immunologic signatures	164	0.94894046	0.59518075	0.7689642	GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN	168	0.8681648	0.7965587	1	1.81710526	0.08077566
CREB_01	c3.TFT_ transcription factor targets	229	0.94890755	0.6181818	0.768962	CREB_01	234	0.8103461	0.891129	1	1.75925365	0.13856145
ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY	c2.CP_ Canonical pathways	34	0.94879794	0.5337331	0.76916564	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY	34	1.0036433	0.49707603	0.91737086	1.95244124	-0.05484536
GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP	C7_ immunologic signatures	177	0.94872403	0.5959953	0.76928204	GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP	177	1.1229844	0.21558705	0.72010577	2.07170843	-0.17426037
GO_NEUROTRANSMITTER_RECEPTOR_ACTIVITY	c5.GO molecular function	50	0.94865763	0.56772333	0.7693704	GO_NEUROTRANSMITTER_RECEPTOR_ACTIVITY	59	1.37809	0.03490991	0.3564879	2.32674763	-0.42943237
MODULE_261	c4.CM_ cancer modules	90	0.94860375	0.5714286	0.76942325	MODULE_261	92	-0.9026326	0.76744187	0.8174781	0.04597115	1.85123635
GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	175	0.9485437	0.5833333	0.7695009	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	173	1.057539	0.36558044	0.8283453	2.0060827	-0.1089953
KRAS.AMP.LUNG_UP.V1_UP	C6_ oncogenic signatures	96	0.9484828	0.5792839	0.7695749	KRAS.AMP.LUNG_UP.V1_UP	109	1.2348701	0.10412371	0.5335405	2.1833529	-0.2863873
GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN	C7_ immunologic signatures	179	0.9484055	0.60023177	0.7696952	GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN	181	0.87777597	0.7654196	1	1.82618147	0.07062953
GO_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	15	0.9483838	0.5264847	0.76965755	GO_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION	16	-1.2995328	0.12653062	0.28358316	-0.351149	2.2479166
PPAR_DR1_Q2	c3.TFT_ transcription factor targets	227	0.9483	0.61627907	0.7697895	PPAR_DR1_Q2	238	0.64403397	0.99497485	1	1.59233397	0.30426603
DAIRKEE_CANCER_PRONE_RESPONSE_BPA	c2.CGP_ chemical and genetic perturbations	49	0.9481848	0.5520111	0.77000624	DAIRKEE_CANCER_PRONE_RESPONSE_BPA	48	-1.0389194	0.37762237	0.6244682	-0.0907346	1.9871042
LEE_EARLY_T_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	40	0.94818336	0.52905196	0.7699128	LEE_EARLY_T_LYMPHOCYTE_DN	43	1.3730112	0.050847456	0.36333793	2.32119456	-0.42482784
GO_ERYTHROCYTE_DEVELOPMENT	c5.BP_ GO biological process	21	0.94784474	0.5451761	0.7707536	GO_ERYTHROCYTE_DEVELOPMENT	21	0.4607769	0.99496853	1	1.40862164	0.48706784
ROSS_AML_WITH_CBFB_MYH11_FUSION	c2.CGP_ chemical and genetic perturbations	43	0.9478329	0.53846157	0.770689	ROSS_AML_WITH_CBFB_MYH11_FUSION	45	1.0350108	0.44036698	0.8677573	1.9828437	-0.0871779
GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	C7_ immunologic signatures	179	0.94781584	0.5896835	0.77063835	GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	179	0.92804664	0.6811741	0.9996487	1.87586248	0.0197692
SANSOM_APC_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	305	0.9477311	0.62080175	0.7707743	SANSOM_APC_TARGETS_DN	326	1.17733	0.072	0.6269519	2.1250611	-0.2295989
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN	c2.CGP_ chemical and genetic perturbations	16	0.9477082	0.5415282	0.7707416	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN	17	1.6137515	0.010471204	0.14702754	2.5614597	-0.6660433
GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	154	0.9476613	0.5817073	0.77077323	GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN	160	0.97360027	0.56908906	0.9573503	1.92126157	-0.02593897
MANTOVANI_NFKB_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	36	0.94759977	0.5532234	0.77085143	MANTOVANI_NFKB_TARGETS_UP	36	0.8036585	0.78846157	1	1.75125827	0.14394127
GCM_ATM	c4.CGN_ cancer gene neighborhoods	21	0.9475356	0.54388714	0.77092874	GCM_ATM	23	1.1106588	0.33959898	0.7363707	2.0581944	-0.1631232
GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP	C7_ immunologic signatures	183	0.94750506	0.59741783	0.7709127	GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP	185	0.76368886	0.9360406	1	1.71119392	0.1838162
GO_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	19	0.9474921	0.53605014	0.7708516	GO_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	20	1.1751498	0.26641884	0.6290011	2.1226419	-0.2276577
IK1_01	c3.TFT_ transcription factor targets	244	0.9473936	0.59438205	0.7710256	IK1_01	244	0.89131933	0.79338014	1	1.83871293	0.05607427
GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	C7_ immunologic signatures	176	0.9473673	0.59043175	0.7710014	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	178	0.5526061	0.9989858	1	1.4999734	0.3947612
GO_NERVE_DEVELOPMENT	c5.BP_ GO biological process	64	0.9473546	0.54633474	0.77093923	GO_NERVE_DEVELOPMENT	66	-1.0004512	0.4	0.68505275	-0.0530966	1.9478058
ATTACAT_MIR3803P	c3.MIR_ microRNA targets	96	0.9473541	0.56416774	0.77084434	ATTACAT_MIR3803P	96	1.0421996	0.42335767	0.8549714	1.9895537	-0.0948455
WIERENGA_STAT5A_TARGETS_GROUP1	c2.CGP_ chemical and genetic perturbations	111	0.9472198	0.57974684	0.77112025	WIERENGA_STAT5A_TARGETS_GROUP1	112	0.9975849	0.5057232	0.9257403	1.9448047	-0.0503651
WINTER_HYPOXIA_METAGENE	c2.CGP_ chemical and genetic perturbations	209	0.94714624	0.5912744	0.7712255	WINTER_HYPOXIA_METAGENE	217	1.10904	0.22512563	0.739475	2.05618624	-0.16189376
GSE3982_MAST_CELL_VS_DC_UP	C7_ immunologic signatures	158	0.9471138	0.5809179	0.77121395	GSE3982_MAST_CELL_VS_DC_UP	162	1.0801537	0.33128205	0.7868128	2.0272675	-0.1330399
GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN	C7_ immunologic signatures	163	0.9470444	0.6	0.7713073	GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN	168	0.93587756	0.6426396	0.99395365	1.88292196	0.01116684
GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	163	0.94697976	0.59836066	0.7713866	GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP	162	1.0104221	0.4979757	0.9062565	1.95740186	-0.06344234
ZF5_01	c3.TFT_ transcription factor targets	216	0.9469347	0.6125	0.7714142	ZF5_01	224	-0.943095	0.85714287	0.7663556	0.0038397	1.8900297
GO_LIPOSACCHARIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	102	0.94684994	0.58236057	0.77156043	GO_LIPOSACCHARIDE_METABOLIC_PROCESS	104	1.3630426	0.020191286	0.3756818	2.30989254	-0.41619266
GO_CYTOKINE_RECEPTOR_BINDING	c5.GO molecular function	212	0.94682086	0.5978898	0.7715414	GO_CYTOKINE_RECEPTOR_BINDING	222	1.1169286	0.19879518	0.72846425	2.06374946	-0.17010774
GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	177	0.9467443	0.58830696	0.7716651	GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	179	0.5491369	1	1	1.4958812	0.3976074
JIANG_AGING_HYPOTHALAMUS_DN	c2.CGP_ chemical and genetic perturbations	39	0.9465398	0.5549133	0.77212846	JIANG_AGING_HYPOTHALAMUS_DN	39	-0.752148	0.8881579	0.9379701	0.1943918	1.6986878
REACTOME_ADP_SIGNALLING_THROUGH_P2RY1	c2.CP_REACTOME_ Reactome gene sets	23	0.94638795	0.53384614	0.77246356	REACTOME_ADP_SIGNALLING_THROUGH_P2RY1	23	0.8930334	0.6477987	1	1.83942135	0.05335455
GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	168	0.9463844	0.58553386	0.7723788	GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_UP	175	1.0215775	0.43380857	0.8896533	1.9679619	-0.0751931
GO_PROTEIN_PHOSPHATASE_BINDING	c5.GO molecular function	111	0.94634163	0.5884615	0.7724023	GO_PROTEIN_PHOSPHATASE_BINDING	114	0.59048826	0.996888	1	1.53682989	0.35585337
GNF2_PAK2	c4.CGN_ cancer gene neighborhoods	24	0.94622815	0.52923536	0.7726108	GNF2_PAK2	26	0.8011252	0.7815231	1	1.74735335	0.14510295
GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP	C7_ immunologic signatures	163	0.9461824	0.5980861	0.77263665	GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP	167	0.873508	0.7820774	1	1.8196904	0.0726744
MORF_DDX11	c4.CGN_ cancer gene neighborhoods	139	0.94616723	0.5935564	0.7725816	MORF_DDX11	144	0.73773646	0.93679917	1	1.68390369	0.20843077
GO_SIGNALING_ADAPTOR_ACTIVITY	c5.GO molecular function	70	0.94603264	0.5649264	0.7728618	GO_SIGNALING_ADAPTOR_ACTIVITY	71	1.137308	0.25	0.6950391	2.08334064	-0.19127536
GO_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	55	0.94599783	0.5674157	0.77285635	GO_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS	56	1.4517685	0.019736841	0.29222587	2.39776633	-0.50577067
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP	C7_ immunologic signatures	150	0.94566	0.615942	0.77371824	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP	152	1.0911299	0.29357797	0.76968	2.0367899	-0.1454699
SP3_Q3	c3.TFT_ transcription factor targets	205	0.945616	0.61437124	0.7737465	SP3_Q3	215	0.8273093	0.87751	1	1.7729253	0.1183067
GO_POLYUBIQUITIN_BINDING	c5.GO molecular function	36	0.9455783	0.54585797	0.7737531	GO_POLYUBIQUITIN_BINDING	36	0.83167243	0.738975	1	1.77725073	0.11390587
GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN	C7_ immunologic signatures	181	0.94556165	0.6064815	0.77370054	GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN	185	1.295614	0.024340771	0.44891262	2.24117565	-0.35005235
GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN	C7_ immunologic signatures	112	0.9455185	0.5726817	0.77372533	GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN	122	0.92183924	0.6638918	1	1.86735774	0.02367926
GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_UP	C7_ immunologic signatures	112	0.9454258	0.5730479	0.7738858	GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_UP	120	1.0406504	0.4084362	0.85838354	1.9860762	-0.0952246
CHR3Q26	C1: positional gene sets	45	0.9453973	0.56458634	0.77386737	CHR3Q26	53	0.9383643	0.5986471	0.992487	1.8837616	0.007033
GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP	C7_ immunologic signatures	156	0.94539255	0.59667856	0.77378416	GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP	173	1.1427689	0.17914979	0.68470234	2.08816145	-0.19737635
GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	C7_ immunologic signatures	176	0.94537455	0.6128641	0.7737391	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	178	1.4108925	0.003064351	0.32491058	2.35626705	-0.46551795
CHIN_BREAST_CANCER_COPY_NUMBER_UP	c2.CGP_ chemical and genetic perturbations	24	0.9453674	0.53220856	0.7736579	CHIN_BREAST_CANCER_COPY_NUMBER_UP	25	1.2738708	0.13186814	0.48165116	2.2192382	-0.3285034
GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	148	0.9453343	0.60831237	0.77364844	GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP	156	1.0061982	0.4827935	0.9135139	1.9515325	-0.0608639
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	c2.CGP_ chemical and genetic perturbations	82	0.9453063	0.5939948	0.77363384	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	82	0.79829705	0.8393617	1	1.74360335	0.14700925
GO_RESPIRATORY_GASEOUS_EXCHANGE	c5.BP_ GO biological process	41	0.9452891	0.5498534	0.7735822	GO_RESPIRATORY_GASEOUS_EXCHANGE	44	1.4595369	0.022883296	0.28383175	2.404826	-0.5142478
GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	C7_ immunologic signatures	172	0.945243	0.6016847	0.7736154	GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	178	0.9587742	0.6164802	0.97191316	1.9040172	-0.0135312
GO_NEGATIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING	c5.BP_ GO biological process	48	0.94507915	0.5394191	0.77398247	GO_NEGATIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING	48	0.838957	0.7514253	1	1.78403615	0.10612215
GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP	C7_ immunologic signatures	121	0.9450731	0.58343947	0.77390087	GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP	123	1.2291191	0.08939709	0.54306453	2.1741922	-0.284046
BILD_HRAS_ONCOGENIC_SIGNATURE	c2.CGP_ chemical and genetic perturbations	216	0.9450253	0.61899316	0.77394325	BILD_HRAS_ONCOGENIC_SIGNATURE	222	1.3587922	0.004024145	0.377924	2.3038175	-0.4137669
GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP	C7_ immunologic signatures	174	0.9448284	0.6059524	0.7743933	GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP	176	0.69308823	0.97973657	1	1.63791663	0.25174017
PID_DELTA_NP63_PATHWAY	c2.CP_ Canonical pathways	42	0.9448231	0.53586495	0.7743112	PID_DELTA_NP63_PATHWAY	43	1.1779094	0.22576967	0.6253944	2.1227325	-0.2330863
GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN	C7_ immunologic signatures	177	0.9448203	0.58117646	0.77422005	GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN	180	0.7507238	0.9348269	1	1.6955441	0.1940965
GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN	C7_ immunologic signatures	170	0.9447267	0.5980975	0.7743803	GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN	173	1.1624388	0.16666667	0.64951015	2.1071655	-0.2177121
GSE2706_R848_VS_LPS_2H_STIM_DC_UP	C7_ immunologic signatures	120	0.94470537	0.5914787	0.7743442	GSE2706_R848_VS_LPS_2H_STIM_DC_UP	124	1.0610616	0.35493827	0.8215325	2.00576697	-0.11635623
GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP	C7_ immunologic signatures	184	0.94470376	0.6034483	0.7742513	GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP	186	1.2749189	0.03538928	0.4805741	2.21962266	-0.33021514
ST_MYOCYTE_AD_PATHWAY	c2.CP_ Canonical pathways	22	0.9445126	0.56630266	0.77468926	ST_MYOCYTE_AD_PATHWAY	22	0.6948661	0.8879203	1	1.6393787	0.2496465
LAIHO_COLORECTAL_CANCER_SERRATED_DN	c2.CGP_ chemical and genetic perturbations	74	0.94436765	0.56208277	0.7749975	LAIHO_COLORECTAL_CANCER_SERRATED_DN	75	0.9223912	0.6378378	1	1.86675885	0.02197645
GO_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION	c5.BP_ GO biological process	65	0.9443211	0.55433285	0.77502435	GO_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION	67	0.7200711	0.89935064	1	1.6643922	0.22425
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	c2.CGP_ chemical and genetic perturbations	30	0.94417834	0.5450311	0.7753163	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	30	-1.7642215	0.00621118	0.04047881	-0.82004316	2.70839984
EPPERT_LSC_R	c2.CGP_ chemical and genetic perturbations	34	0.9441732	0.55274886	0.77523094	EPPERT_LSC_R	34	1.0189518	0.43966547	0.8918216	1.963125	-0.0747786
GO_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	38	0.9440812	0.5488506	0.7753897	GO_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY	38	0.9613155	0.54	0.9696595	1.9053967	-0.0172343
GSE7852_THYMUS_VS_FAT_TREG_UP	C7_ immunologic signatures	176	0.94402075	0.6159251	0.7754592	GSE7852_THYMUS_VS_FAT_TREG_UP	177	-0.903116	0.90909094	0.8170083	0.04090475	1.84713675
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP	C7_ immunologic signatures	169	0.943877	0.6158324	0.7757618	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP	174	1.4702933	0	0.2759413	2.4141703	-0.5264163
GO_INORGANIC_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	466	0.94386184	0.67834395	0.7757096	GO_INORGANIC_ION_TRANSMEMBRANE_TRANSPORT	466	0	0	0	0.94386184	0.94386184
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	c2.CGP_ chemical and genetic perturbations	60	0.94385755	0.56633383	0.7756237	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	60	1.2000785	0.17463848	0.5920327	2.14393605	-0.25622095
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	57	0.94383985	0.5511596	0.77557415	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	67	0.8842638	0.6941432	1	1.82810365	0.05957605
GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN	C7_ immunologic signatures	168	0.94382447	0.5876043	0.77551794	GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN	167	0.8745451	0.75914633	1	1.81836957	0.06927937
CHR7Q11	C1: positional gene sets	68	0.9436797	0.57104194	0.7758179	CHR7Q11	67	1.1349206	0.26438054	0.6972716	2.0786003	-0.1912409
GO_EXOCYTIC_VESICLE	c5.CC_ GO cellular component	133	0.9436324	0.5833333	0.7758539	GO_EXOCYTIC_VESICLE	138	1.3049521	0.044852193	0.43387255	2.2485845	-0.3613197
DARWICHE_PAPILLOMA_RISK_LOW_DN	c2.CGP_ chemical and genetic perturbations	140	0.9435412	0.5683192	0.7760005	DARWICHE_PAPILLOMA_RISK_LOW_DN	145	0.8499713	0.8244898	1	1.7935125	0.0935699
HAMAI_APOPTOSIS_VIA_TRAIL_DN	c2.CGP_ chemical and genetic perturbations	151	0.9434993	0.5923719	0.77601624	HAMAI_APOPTOSIS_VIA_TRAIL_DN	159	0.8566627	0.7886179	1	1.800162	0.0868366
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP	C7_ immunologic signatures	167	0.9434799	0.6167883	0.77597594	GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP	174	1.1865731	0.11967546	0.6124561	2.130053	-0.2430932
GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP	C7_ immunologic signatures	177	0.9434717	0.6052319	0.77590054	GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP	182	-1.1500652	0	0.44285968	-0.2065935	2.0935369
GO_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	117	0.9433863	0.58867925	0.7760421	GO_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY	122	0.96408874	0.57348406	0.96667504	1.90747504	-0.02070244
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN	C7_ immunologic signatures	167	0.94335186	0.5835294	0.776043	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN	170	0.9567329	0.6163968	0.9751841	1.90008476	-0.01338104
GO_ENDORIBONUCLEASE_ACTIVITY	c5.GO molecular function	44	0.9433476	0.5553936	0.7759582	GO_ENDORIBONUCLEASE_ACTIVITY	44	0.55764747	0.9885714	1	1.50099507	0.38570013
GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP	C7_ immunologic signatures	174	0.94333255	0.60188454	0.7759048	GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP	178	0.6991543	0.9807107	1	1.64248685	0.24417825
GSE6259_33D1_POS_DC_VS_BCELL_UP	C7_ immunologic signatures	131	0.94315434	0.5894608	0.7763041	GSE6259_33D1_POS_DC_VS_BCELL_UP	137	1.3487699	0.020491803	0.38330686	2.29192424	-0.40561556
GO_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE	c5.BP_ GO biological process	16	0.94314224	0.5502392	0.77624065	GO_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE	16	0.94059896	0.5652742	0.98973167	1.8837412	0.00254328
GO_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS	c5.CC_ GO cellular component	116	0.9430248	0.59292036	0.7764672	GO_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS	125	1.3047267	0.04106776	0.4339969	2.2477515	-0.3617019
GSE27786_LSK_VS_NKCELL_UP	C7_ immunologic signatures	170	0.9429744	0.61725396	0.7765122	GSE27786_LSK_VS_NKCELL_UP	173	0.84562874	0.8311292	1	1.78860314	0.09734566
REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	c2.CP_REACTOME_ Reactome gene sets	21	0.9429604	0.5469697	0.7764532	REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	21	0.7061934	0.8614232	1	1.6491538	0.236767
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP	C7_ immunologic signatures	179	0.94293123	0.6030445	0.7764418	GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP	178	1.0578289	0.37195122	0.8276514	2.00076013	-0.11489767
GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	C7_ immunologic signatures	139	0.9428173	0.58902436	0.7766673	GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	140	1.1154413	0.2533062	0.7296911	2.0582586	-0.172624
GO_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION	c5.BP_ GO biological process	419	0.94279915	0.6631356	0.77662235	GO_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION	446	0.87076217	0.883	1	1.81356132	0.07203698
HOX13_01	c3.TFT_ transcription factor targets	37	0.94278735	0.5362963	0.7765581	HOX13_01	41	0.76150894	0.83372366	1	1.70429629	0.18127841
GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP	C7_ immunologic signatures	167	0.9427638	0.6014235	0.77652806	GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP	174	1.3874261	0.003067485	0.34834367	2.3301899	-0.4446623
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	C7_ immunologic signatures	179	0.94276106	0.61393154	0.77643913	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	184	1.3368691	0.01010101	0.39842138	2.27963016	-0.39410804
GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN	C7_ immunologic signatures	183	0.942708	0.6159251	0.77648866	GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN	182	0.60808253	0.99496984	1	1.55079053	0.33462547
CHR6Q21	C1: positional gene sets	47	0.94259036	0.56657225	0.7767166	CHR6Q21	48	0.69577056	0.9158249	1	1.63836092	0.2468198
GO_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION	c5.BP_ GO biological process	99	0.9425385	0.56081945	0.7767659	GO_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION	99	1.0163493	0.46949327	0.8952252	1.9588878	-0.0738108
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP	C7_ immunologic signatures	175	0.9423671	0.6004728	0.7771455	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP	179	1.229539	0.059898477	0.5416181	2.1719061	-0.2871719
GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN	C7_ immunologic signatures	176	0.94233006	0.59181285	0.77715355	GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN	177	0.7460512	0.94147325	1	1.68838126	0.19627886
REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	c2.CP_REACTOME_ Reactome gene sets	18	0.9422778	0.5516129	0.7771992	REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	18	-0.7975651	0.7635468	0.9086502	0.1447127	1.7398429
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	c2.CGP_ chemical and genetic perturbations	23	0.94223595	0.5443235	0.7772263	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	25	1.1376746	0.30506328	0.6943305	2.07991055	-0.19543865
GO_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS	c5.BP_ GO biological process	42	0.94221234	0.55972224	0.777196	GO_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS	43	0.6846303	0.9063927	1	1.62684264	0.25758204
GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN	C7_ immunologic signatures	179	0.9421616	0.6143868	0.777241	GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN	179	0.7538845	0.93340063	1	1.6960461	0.1882771
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	c2.CGP_ chemical and genetic perturbations	32	0.94200224	0.551263	0.77760273	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	35	1.4460132	0.03087886	0.29519933	2.38801544	-0.50401096
GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP	C7_ immunologic signatures	132	0.9419442	0.5873606	0.7776679	GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP	136	1.1374974	0.21627188	0.69466126	2.0794416	-0.1955532
GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN	C7_ immunologic signatures	176	0.9418545	0.6044864	0.77781886	GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN	178	0.9431899	0.6579213	0.98869365	1.8850444	-0.0013354
CHR3P26	C1: positional gene sets	18	0.9418132	0.54140127	0.7778382	CHR3P26	17	-0.9847389	0.4347826	0.7069179	-0.0429257	1.9265521
MEL18_DN.V1_UP	C6_ oncogenic signatures	126	0.9416772	0.6138614	0.7781193	MEL18_DN.V1_UP	125	1.4948645	0.002042901	0.25673828	2.4365417	-0.5531873
GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN	C7_ immunologic signatures	178	0.941643	0.6151122	0.77812237	GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN	181	0.740166	0.94624746	1	1.681809	0.201477
YANG_BREAST_CANCER_ESR1_UP	c2.CGP_ chemical and genetic perturbations	30	0.94160104	0.55192876	0.77814215	YANG_BREAST_CANCER_ESR1_UP	32	1.4949938	0.016887818	0.2576203	2.43659484	-0.55339276
GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN	C7_ immunologic signatures	162	0.9414291	0.6085366	0.7785258	GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN	168	1.2991647	0.029471545	0.44353917	2.2405938	-0.3577356
TTF1_Q6	c3.TFT_ transcription factor targets	226	0.94133514	0.6310345	0.7786903	TTF1_Q6	240	1.0805432	0.28772637	0.7861244	2.02187834	-0.13920806
GSE20715_0H_VS_24H_OZONE_LUNG_UP	C7_ immunologic signatures	173	0.9413261	0.6085366	0.77861995	GSE20715_0H_VS_24H_OZONE_LUNG_UP	177	1.1731763	0.12841254	0.63361084	2.1145024	-0.2318502
GR_Q6_01	c3.TFT_ transcription factor targets	232	0.9411855	0.62782806	0.7788996	GR_Q6_01	244	0.88756526	0.7895267	1	1.82875076	0.05362024
GNF2_TM4SF2	c4.CGN_ cancer gene neighborhoods	26	0.9410772	0.5455927	0.7791016	GNF2_TM4SF2	26	1.3957402	0.055350553	0.34799507	2.3368174	-0.454663
GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	175	0.9410443	0.5855646	0.7790927	GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN	176	0.9454152	0.63259107	0.98689485	1.8864595	-0.0043709
GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN	C7_ immunologic signatures	182	0.9409238	0.6120092	0.7793198	GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN	183	0.8784109	0.79376256	1	1.8193347	0.0625129
GO_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT	c5.BP_ GO biological process	33	0.9408256	0.55709875	0.7794877	GO_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT	33	0.89707154	0.6386256	1	1.83789714	0.04375406
GO_ENSHEATHMENT_OF_NEURONS	c5.BP_ GO biological process	82	0.94072187	0.5795756	0.77968055	GO_ENSHEATHMENT_OF_NEURONS	84	1.0081459	0.47821465	0.9112158	1.94886777	-0.06742403
GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP	C7_ immunologic signatures	143	0.9407179	0.59681374	0.7795933	GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP	143	0.8350306	0.8201439	1	1.7757485	0.1056873
PID_CONE_PATHWAY	c2.CP_ Canonical pathways	19	0.9406784	0.5541601	0.7796078	PID_CONE_PATHWAY	20	1.13334	0.30628273	0.70009786	2.0740184	-0.1926616
GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_UP	C7_ immunologic signatures	170	0.9406542	0.5985748	0.7795765	GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_UP	175	1.1004688	0.2565923	0.75632566	2.041123	-0.1598146
GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	C7_ immunologic signatures	168	0.9402716	0.62216926	0.7805241	GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	171	1.0261676	0.44399184	0.88232315	1.9664392	-0.085896
GO_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	138	0.9402421	0.5845411	0.7805101	GO_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	139	0.8958349	0.7109295	1	1.836077	0.0444072
MORF_CDC2L5	c4.CGN_ cancer gene neighborhoods	127	0.9402057	0.60150373	0.7805094	MORF_CDC2L5	132	0.9001014	0.7107438	1	1.8403071	0.0401043
GO_DETECTION_OF_STIMULUS	c5.BP_ GO biological process	418	0.94018716	0.6680988	0.7804647	GO_DETECTION_OF_STIMULUS	436	0.8228141	0.942	1	1.76300126	0.11737306
GO_REGULATION_OF_PROTEIN_STABILITY	c5.BP_ GO biological process	198	0.94015735	0.6127865	0.78044915	GO_REGULATION_OF_PROTEIN_STABILITY	202	0.8464695	0.8508065	1	1.78662685	0.09368785
GSE339_CD4POS_VS_CD4CD8DN_DC_DN	C7_ immunologic signatures	180	0.9399613	0.61241215	0.7809012	GSE339_CD4POS_VS_CD4CD8DN_DC_DN	181	-0.9257324	0.7	0.7887472	0.0142289	1.8656937
POS_HISTAMINE_RESPONSE_NETWORK	c2.CGP_ chemical and genetic perturbations	31	0.9399311	0.557971	0.780886	POS_HISTAMINE_RESPONSE_NETWORK	31	0.9340022	0.5954654	0.99586654	1.8739333	0.0059289
WIKMAN_ASBESTOS_LUNG_CANCER_DN	c2.CGP_ chemical and genetic perturbations	26	0.93988615	0.548048	0.7809204	WIKMAN_ASBESTOS_LUNG_CANCER_DN	26	-1.2619843	0.08024691	0.3136893	-0.32209815	2.20187045
GSE13493_DP_VS_CD8POS_THYMOCYTE_UP	C7_ immunologic signatures	170	0.939768	0.6254459	0.78115577	GSE13493_DP_VS_CD8POS_THYMOCYTE_UP	172	1.2337832	0.07250755	0.53544945	2.1735512	-0.2940152
GO_AMELOGENESIS	c5.BP_ GO biological process	15	0.9394767	0.55948555	0.7818494	GO_AMELOGENESIS	19	0.9997372	0.48458692	0.92444557	1.9392139	-0.0602605
GO_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION	c5.BP_ GO biological process	17	0.9394471	0.5398374	0.78182906	GO_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION	17	-0.91063374	0.6098655	0.8073618	0.02881336	1.85008084
GNF2_PTX3	c4.CGN_ cancer gene neighborhoods	34	0.9393617	0.55419844	0.7819658	GNF2_PTX3	34	-1.5900708	0	0.09432789	-0.6507091	2.5294325
GO_THIOL_DEPENDENT_UBIQUITIN_SPECIFIC_PROTEASE_ACTIVITY	c5.GO molecular function	68	0.9391551	0.5590231	0.782432	GO_THIOL_DEPENDENT_UBIQUITIN_SPECIFIC_PROTEASE_ACTIVITY	69	0.8344851	0.77861774	1	1.7736402	0.10467
GO_ACTIN_FILAMENT_BUNDLE_ORGANIZATION	c5.BP_ GO biological process	43	0.9391049	0.5693215	0.7824776	GO_ACTIN_FILAMENT_BUNDLE_ORGANIZATION	43	1.0410478	0.41550925	0.8574205	1.9801527	-0.1019429
KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN	C7_ immunologic signatures	173	0.9390056	0.60726845	0.7826525	KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN	174	-1.1141794	0.14285715	0.4990502	-0.1751738	2.053185
GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	153	0.93887293	0.62317073	0.7829242	GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	154	0.7224259	0.9521872	1	1.66129883	0.21644703
GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP	C7_ immunologic signatures	159	0.9388574	0.6038186	0.78286916	GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP	158	1.2021658	0.11414141	0.5885507	2.1410232	-0.2633084
CHR7P13	C1: positional gene sets	30	0.93880326	0.5657492	0.7829286	CHR7P13	31	0.72989434	0.85103786	1	1.6686976	0.20890892
CHR2Q11	C1: positional gene sets	46	0.93879193	0.5934844	0.7828626	CHR2Q11	50	1.1840315	0.225	0.61555237	2.12282343	-0.24523957
GO_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	26	0.93875456	0.56672156	0.78286326	GO_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS	28	0.84999883	0.6997549	1	1.78875339	0.08875573
GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	C7_ immunologic signatures	172	0.9386827	0.6079137	0.78296727	GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	179	1.0234814	0.44186047	0.8858224	1.9621641	-0.0847987
GO_GLYCOSYL_COMPOUND_CATABOLIC_PROCESS	c5.BP_ GO biological process	32	0.93854636	0.585736	0.7832514	GO_GLYCOSYL_COMPOUND_CATABOLIC_PROCESS	34	1.0518051	0.4035294	0.8370882	1.99035146	-0.11325874
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A	c2.CGP_ chemical and genetic perturbations	15	0.93852735	0.5395189	0.78321093	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A	17	1.289989	0.1608301	0.45771068	2.22851635	-0.35146165
GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP	C7_ immunologic signatures	166	0.93851256	0.61648744	0.78315294	GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP	176	0.928605	0.66935486	0.9993798	1.86711756	0.00990756
GO_RESPONSE_TO_FUNGUS	c5.BP_ GO biological process	38	0.9384252	0.55789477	0.7832872	GO_RESPONSE_TO_FUNGUS	41	0.6401696	0.95133257	1	1.5785948	0.2982556
GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP	C7_ immunologic signatures	124	0.9383263	0.60299623	0.7834659	GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP	132	0.9284222	0.66117406	0.99929273	1.8667485	0.0099041
YAGI_AML_WITH_11Q23_REARRANGED	c2.CGP_ chemical and genetic perturbations	310	0.9383177	0.63585746	0.7833946	YAGI_AML_WITH_11Q23_REARRANGED	315	1.0853858	0.24573721	0.777185	2.0237035	-0.1470681
BROWNE_HCMV_INFECTION_14HR_DN	c2.CGP_ chemical and genetic perturbations	255	0.93800014	0.62806237	0.7841709	BROWNE_HCMV_INFECTION_14HR_DN	259	1.1578279	0.11770624	0.65768325	2.09582804	-0.21982776
KEGG_CARDIAC_MUSCLE_CONTRACTION	c2.CP_BIOCARTA_ BioCarta gene sets	64	0.9378938	0.5735695	0.7843654	KEGG_CARDIAC_MUSCLE_CONTRACTION	71	0.9198243	0.64399576	1	1.8577181	0.0180695
GO_POSITIVE_REGULATION_OF_PROTEIN_SECRETION	c5.BP_ GO biological process	162	0.93784904	0.6070133	0.7843927	GO_POSITIVE_REGULATION_OF_PROTEIN_SECRETION	182	0.93684167	0.652439	0.99318975	1.87469071	0.00100737
MODULE_532	c4.CM_ cancer modules	331	0.9378429	0.6565547	0.7843131	MODULE_532	336	1.2546982	0.015015015	0.50245583	2.1925411	-0.3168553
GCM_PTK2	c4.CGN_ cancer gene neighborhoods	133	0.9378328	0.6143552	0.78424644	GCM_PTK2	133	0.7533994	0.9101124	1	1.6912322	0.1844334
GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP	C7_ immunologic signatures	175	0.9378147	0.6073113	0.78419554	GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP	180	1.12796	0.21291624	0.70888036	2.0657747	-0.1901453
OZEN_MIR125B1_TARGETS	c2.CGP_ chemical and genetic perturbations	25	0.9377007	0.5474339	0.78440577	OZEN_MIR125B1_TARGETS	25	1.1096562	0.33043477	0.73801684	2.0473569	-0.1719555
GO_MELANOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	16	0.9375747	0.5490506	0.78465587	GO_MELANOCYTE_DIFFERENTIATION	17	0.9298585	0.5893536	0.99917984	1.8674332	0.0077162
GO_RECEPTOR_METABOLIC_PROCESS	c5.BP_ GO biological process	69	0.93750906	0.5766129	0.7847359	GO_RECEPTOR_METABOLIC_PROCESS	70	-1.1601552	0.15492958	0.43012092	-0.22264614	2.09766426
GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN	C7_ immunologic signatures	154	0.9374762	0.61445785	0.7847344	GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN	158	0.9238258	0.6703854	1	1.861302	0.0136504
GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN	C7_ immunologic signatures	169	0.93724346	0.62765956	0.78526604	GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN	174	0.82150877	0.871066	1	1.75875223	0.11573469
GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	C7_ immunologic signatures	175	0.9371724	0.6214623	0.7853589	GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	179	0.99433094	0.5276382	0.93082666	1.93150334	-0.05715854
GSE6681_DELETED_FOXP3_VS_WT_TREG_DN	C7_ immunologic signatures	176	0.93713754	0.62352943	0.7853588	GSE6681_DELETED_FOXP3_VS_WT_TREG_DN	177	0.7223007	0.9674134	1	1.65943824	0.21483684
GO_GUANYL_NUCLEOTIDE_BINDING	c5.GO molecular function	333	0.93712294	0.6666667	0.7853017	GO_GUANYL_NUCLEOTIDE_BINDING	342	0.6859984	0.99098194	1	1.62312134	0.25112454
GSE360_L_MAJOR_VS_T_GONDII_MAC_UP	C7_ immunologic signatures	163	0.9370965	0.6267943	0.7852734	GSE360_L_MAJOR_VS_T_GONDII_MAC_UP	174	1.1129166	0.24516785	0.7332377	2.0500131	-0.1758201
GO_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING	c5.GO molecular function	52	0.9370809	0.56882024	0.785221	GO_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING	54	1.1167864	0.3006536	0.7283278	2.0538673	-0.1797055
GO_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT	c5.BP_ GO biological process	29	0.9370164	0.5493171	0.7852953	GO_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT	29	1.1071556	0.32682925	0.7421582	2.044172	-0.1701392
GSE360_L_DONOVANI_VS_T_GONDII_DC_UP	C7_ immunologic signatures	162	0.9369833	0.62085307	0.7852979	GSE360_L_DONOVANI_VS_T_GONDII_DC_UP	171	1.3192885	0.015136226	0.41279194	2.2562718	-0.3823052
MCCLUNG_CREB1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	51	0.9369831	0.5736544	0.78520113	MCCLUNG_CREB1_TARGETS_DN	53	0.69541943	0.9033708	1	1.63240253	0.24156367
GO_MAP_KINASE_KINASE_KINASE_ACTIVITY	c5.GO molecular function	19	0.93693787	0.551447	0.7852324	GO_MAP_KINASE_KINASE_KINASE_ACTIVITY	19	1.6085397	0.013020833	0.14953123	2.54547757	-0.67160183
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	158	0.9369231	0.62235296	0.7851716	GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	163	0.8517045	0.8168871	1	1.7886276	0.0852186
GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	180	0.93678004	0.6364706	0.78545856	GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP	181	0.96734643	0.57735085	0.96390086	1.90412647	-0.03056639
GNF2_CYP2B6	c4.CGN_ cancer gene neighborhoods	36	0.93660563	0.56911767	0.7858527	GNF2_CYP2B6	42	1.562244	0.006928407	0.1985083	2.49884963	-0.62563837
GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN	C7_ immunologic signatures	177	0.93659997	0.62665063	0.78577125	GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN	176	1.4528176	0.003036437	0.29141223	2.38941757	-0.51621763
CHR3P22	C1: positional gene sets	51	0.9365967	0.5706371	0.78568256	CHR3P22	52	1.1796633	0.2259887	0.62399775	2.11626	-0.2430666
GO_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	31	0.9365527	0.54137444	0.78570294	GO_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	32	1.1114396	0.33211678	0.7355897	2.0479923	-0.1748869
GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN	C7_ immunologic signatures	170	0.9364663	0.6347518	0.7858399	GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN	173	0.9562713	0.61654896	0.9756592	1.8927376	-0.019805
REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE	c2.CP_REACTOME_ Reactome gene sets	15	0.9363306	0.56666666	0.78612775	REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE	15	0.6199686	0.9332425	1	1.5562992	0.316362
CREL_01	c3.TFT_ transcription factor targets	233	0.9363113	0.61694914	0.7860857	CREL_01	241	1.0798293	0.28672034	0.78764766	2.0161406	-0.143518
ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS	c2.CP_ Canonical pathways	40	0.93623155	0.5661218	0.7862075	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS	42	0.8970136	0.65945333	1	1.83324515	0.03921795
ALFANO_MYC_TARGETS	c2.CGP_ chemical and genetic perturbations	220	0.9361424	0.63383543	0.7863601	ALFANO_MYC_TARGETS	222	-1.0030261	0.6666667	0.67954063	-0.0668837	1.9391685
GO_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	25	0.93604714	0.5621212	0.78652114	GO_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	26	1.1516578	0.2921212	0.66719425	2.08770494	-0.21561066
GO_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	17	0.93596375	0.53960395	0.7866533	GO_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS	20	1.3843303	0.07197943	0.35202667	2.32029405	-0.44836655
NAGASHIMA_EGF_SIGNALING_UP	c2.CGP_ chemical and genetic perturbations	55	0.9359513	0.5840336	0.7865896	NAGASHIMA_EGF_SIGNALING_UP	55	0.7433756	0.85524863	1	1.6793269	0.1925757
GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN	C7_ immunologic signatures	153	0.9359372	0.6164053	0.78653336	GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN	156	0.9732706	0.5407332	0.9579945	1.9092078	-0.0373334
GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN	C7_ immunologic signatures	171	0.9356569	0.6173285	0.78720194	GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN	179	0.6555531	0.9919436	1	1.59121	0.2801038
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	173	0.9355254	0.62184876	0.78745586	GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	177	1.1901728	0.11054767	0.6055397	2.1256982	-0.2546474
GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP	C7_ immunologic signatures	172	0.9355247	0.6175772	0.7873603	GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP	178	0.8281991	0.84969324	1	1.7637238	0.1073256
STAT_01	c3.TFT_ transcription factor targets	219	0.9354534	0.65086704	0.7874652	STAT_01	224	1.0546433	0.37349397	0.83388335	1.9900967	-0.1191899
GO_CAMP_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	0.93544114	0.57050246	0.7874015	GO_CAMP_BIOSYNTHETIC_PROCESS	16	0.9679383	0.5360963	0.9640037	1.90337944	-0.03249716
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	c2.CGP_ chemical and genetic perturbations	36	0.93535334	0.55686855	0.7875395	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	38	-1.0492947	0.37012988	0.60686666	-0.11394136	1.98464804
GO_LYSINE_N_METHYLTRANSFERASE_ACTIVITY	c5.GO molecular function	35	0.9349259	0.58832115	0.78860366	GO_LYSINE_N_METHYLTRANSFERASE_ACTIVITY	37	0.980299	0.49535963	0.94892454	1.9152249	-0.0453731
STAT_Q6	c3.TFT_ transcription factor targets	221	0.934896	0.63625866	0.7885844	STAT_Q6	228	1.1528885	0.15725806	0.6644044	2.0877845	-0.2179925
GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP	C7_ immunologic signatures	184	0.9348947	0.612529	0.78849053	GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP	185	0.763415	0.93414384	1	1.6983097	0.1714797
GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN	C7_ immunologic signatures	175	0.93473345	0.62439615	0.788827	GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN	178	1.094985	0.27383366	0.76485616	2.02971845	-0.16025155
GO_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING	c5.GO molecular function	47	0.9347205	0.5761317	0.78876454	GO_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING	49	1.539947	0.007847534	0.21121585	2.4746675	-0.6052265
GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN	C7_ immunologic signatures	181	0.93468213	0.6274971	0.7887743	GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN	185	0.9330655	0.65858585	0.99718606	1.86774763	0.00161663
GO_SYNCYTIUM_FORMATION	c5.BP_ GO biological process	22	0.93461674	0.5580645	0.78886324	GO_SYNCYTIUM_FORMATION	23	0.95276475	0.54879594	0.9786249	1.88738149	-0.01814801
GO_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS	c5.BP_ GO biological process	187	0.93456	0.61565423	0.7889235	GO_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS	195	0.788772	0.90332323	1	1.723332	0.145788
GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP	C7_ immunologic signatures	178	0.93452954	0.60438293	0.7889168	GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP	180	0.93430054	0.65015167	0.99559426	1.86883008	0.000229
GO_STAT_CASCADE	c5.BP_ GO biological process	42	0.93439406	0.5761194	0.78919584	GO_STAT_CASCADE	46	-1.2136922	0.08888889	0.3639642	-0.27929814	2.14808626
GO_REGULATION_OF_CELLULAR_EXTRAVASATION	c5.BP_ GO biological process	17	0.93438095	0.5696595	0.78913784	GO_REGULATION_OF_CELLULAR_EXTRAVASATION	20	0.7155322	0.8629243	1	1.64991315	0.21884875
GO_RESPONSE_TO_NITRIC_OXIDE	c5.BP_ GO biological process	17	0.93420035	0.5707472	0.78952944	GO_RESPONSE_TO_NITRIC_OXIDE	20	1.0011187	0.49422336	0.92227536	1.93531905	-0.06691835
WANG_TUMOR_INVASIVENESS_DN	c2.CGP_ chemical and genetic perturbations	191	0.9340567	0.625731	0.7898272	WANG_TUMOR_INVASIVENESS_DN	191	-1.0562344	0.42857143	0.59440947	-0.1221777	1.9902911
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	175	0.93399626	0.60454005	0.78989273	GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP	177	0.9118271	0.70273006	1	1.84582336	0.02216916
GCM_RBM8A	c4.CGN_ cancer gene neighborhoods	73	0.9338541	0.6	0.7901785	GCM_RBM8A	73	-0.80928904	0.9402985	0.89692765	0.12456506	1.74314314
CHANDRAN_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	173	0.93381995	0.62289155	0.7901745	CHANDRAN_METASTASIS_UP	177	-0.8550157	0.875	0.86137944	0.07880425	1.78883565
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	c2.CGP_ chemical and genetic perturbations	45	0.93365365	0.584058	0.79053336	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	49	1.3624587	0.055235904	0.37649322	2.29611235	-0.42880505
ESC_J1_UP_LATE.V1_DN	C6_ oncogenic signatures	169	0.933536	0.6172986	0.79075944	ESC_J1_UP_LATE.V1_DN	176	-1.0651027	0.14285715	0.57833517	-0.1315667	1.9986387
GO_CELLULAR_CHEMICAL_HOMEOSTASIS	c5.BP_ GO biological process	465	0.93350726	0.683106	0.79073924	GO_CELLULAR_CHEMICAL_HOMEOSTASIS	465	0	0	0	0.93350726	0.93350726
GSE3982_EOSINOPHIL_VS_MAC_UP	C7_ immunologic signatures	162	0.93339866	0.6319703	0.7909328	GSE3982_EOSINOPHIL_VS_MAC_UP	165	0.9801337	0.55284554	0.94911367	1.91353236	-0.04673504
GO_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY	c5.GO molecular function	35	0.93328524	0.5755396	0.7911422	GO_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY	42	1.0421623	0.42923433	0.8549869	1.97544754	-0.10887706
NFKAPPAB_01	c3.TFT_ transcription factor targets	222	0.93321866	0.61849713	0.7912278	NFKAPPAB_01	228	1.1883805	0.093561366	0.6080031	2.12159916	-0.25516184
GO_SOLUTE_CATION_ANTIPORTER_ACTIVITY	c5.GO molecular function	24	0.93317807	0.5630769	0.7912322	GO_SOLUTE_CATION_ANTIPORTER_ACTIVITY	27	0.7840881	0.7892157	1	1.71726617	0.14908997
GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP	C7_ immunologic signatures	120	0.9331178	0.61710036	0.7913004	GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP	125	1.2106825	0.11958763	0.5764393	2.1438003	-0.2775647
GSE11057_CD4_EFF_MEM_VS_PBMC_DN	C7_ immunologic signatures	172	0.9330437	0.62396204	0.79141474	GSE11057_CD4_EFF_MEM_VS_PBMC_DN	176	1.2547607	0.051987767	0.5028499	2.1878044	-0.321717
GO_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING	c5.BP_ GO biological process	22	0.9327767	0.584127	0.79204404	GO_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING	22	-0.8716541	0.67171717	0.85332423	0.0611226	1.8044308
WHN_B	c3.TFT_ transcription factor targets	227	0.9327611	0.6505747	0.7919886	WHN_B	235	0.8093265	0.918593	1	1.7420876	0.1234346
GO_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION	c5.BP_ GO biological process	18	0.93273574	0.553719	0.79195935	GO_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION	19	1.227267	0.2	0.5461443	2.16000274	-0.29453126
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP	C7_ immunologic signatures	170	0.9326724	0.62068963	0.7920287	GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP	175	1.256345	0.041624367	0.50068027	2.1890174	-0.3236726
GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN	C7_ immunologic signatures	168	0.93251914	0.6288783	0.7923475	GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN	170	1.2283913	0.07785642	0.5434649	2.16091044	-0.29587216
GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN	C7_ immunologic signatures	176	0.93249345	0.6414201	0.7923197	GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN	182	0.9541292	0.6143001	0.9768911	1.88662265	-0.02163575
GO_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	250	0.9323959	0.6735871	0.7924864	GO_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS	254	0.619967	0.997992	1	1.5523629	0.3124289
GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN	C7_ immunologic signatures	167	0.93237644	0.6259169	0.7924397	GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN	171	1.1092787	0.24621594	0.73851144	2.04165514	-0.17690226
GO_GOLGI_CISTERNA_MEMBRANE	c5.CC_ GO cellular component	67	0.93237174	0.5994475	0.79235506	GO_GOLGI_CISTERNA_MEMBRANE	68	0.80385536	0.79617834	1	1.7362271	0.12851638
GO_LATE_ENDOSOME	c5.CC_ GO cellular component	185	0.93236464	0.6280702	0.792276	GO_LATE_ENDOSOME	186	1.053377	0.3569262	0.836321	1.98574164	-0.12101236
GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN	C7_ immunologic signatures	176	0.9322365	0.63069546	0.7925313	GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN	178	0.52623105	1	1	1.45846755	0.40600545
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	c2.CGP_ chemical and genetic perturbations	15	0.9321676	0.5665102	0.7926208	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	15	-0.89589477	0.6025641	0.8266909	0.03627283	1.82806237
HUPER_BREAST_BASAL_VS_LUMINAL_DN	c2.CGP_ chemical and genetic perturbations	50	0.932101	0.601683	0.7927053	HUPER_BREAST_BASAL_VS_LUMINAL_DN	49	0.93622494	0.5977401	0.99393344	1.86832594	-0.00412394
LINSLEY_MIR16_TARGETS	c2.CGP_ chemical and genetic perturbations	184	0.9320712	0.6189349	0.79268885	LINSLEY_MIR16_TARGETS	184	0.81735575	0.87462085	1	1.74942695	0.11471545
GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP	C7_ immunologic signatures	172	0.9320638	0.6203593	0.7926132	GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP	172	-1.162025	0	0.4273386	-0.2299612	2.0940888
BAE_BRCA1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	68	0.93201953	0.5751366	0.79263574	BAE_BRCA1_TARGETS_UP	69	0.9024313	0.66703296	1	1.83445083	0.02958823
GO_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	20	0.932019	0.5849057	0.7925402	GO_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	20	1.2796046	0.15064935	0.47285205	2.2116236	-0.3475856
GO_NEGATIVE_REGULATION_OF_HEART_CONTRACTION	c5.BP_ GO biological process	19	0.9317279	0.56296295	0.7932331	GO_NEGATIVE_REGULATION_OF_HEART_CONTRACTION	18	0.9983528	0.48425198	0.92556566	1.9300807	-0.0666249
GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP	C7_ immunologic signatures	172	0.93167627	0.6389549	0.7932757	GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP	180	0.9509349	0.6256307	0.98120975	1.88261117	-0.01925863
BIOCARTA_HIVNEF_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	57	0.9315243	0.57438016	0.79359615	BIOCARTA_HIVNEF_PATHWAY	57	0.77459127	0.8427948	1	1.70611557	0.15693303
TIEN_INTESTINE_PROBIOTICS_2HR_DN	c2.CGP_ chemical and genetic perturbations	82	0.9314831	0.6018767	0.7936177	TIEN_INTESTINE_PROBIOTICS_2HR_DN	82	0.8126424	0.80576307	1	1.7441255	0.1188407
ZUCCHI_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	35	0.9314671	0.5924812	0.7935654	ZUCCHI_METASTASIS_UP	36	-0.96624446	0.47945204	0.7346359	-0.03477736	1.89771156
LEE_LIVER_CANCER	c2.CGP_ chemical and genetic perturbations	36	0.9313604	0.58515286	0.7937568	LEE_LIVER_CANCER	38	1.1347144	0.2945285	0.6980462	2.0660748	-0.203354
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	c2.CGP_ chemical and genetic perturbations	53	0.9313427	0.5892351	0.79370683	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	55	0.70105714	0.9185022	1	1.63239984	0.23028556
GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN	C7_ immunologic signatures	178	0.93133026	0.61301774	0.79364294	GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN	180	0.61861545	0.99798995	1	1.54994571	0.31271481
GO_BONE_GROWTH	c5.BP_ GO biological process	19	0.93113726	0.5765625	0.7940715	GO_BONE_GROWTH	20	1.0210719	0.45363408	0.8910384	1.95220916	-0.08993464
GTTATAT_MIR410	c3.MIR_ microRNA targets	84	0.93113655	0.60742706	0.7939757	GTTATAT_MIR410	86	0.80671555	0.82078475	1	1.7378521	0.124421
GENTILE_UV_RESPONSE_CLUSTER_D9	c2.CGP_ chemical and genetic perturbations	27	0.9311282	0.586727	0.79389966	GENTILE_UV_RESPONSE_CLUSTER_D9	27	0.5304555	0.99281436	1	1.4615837	0.4006727
JACKSON_DNMT1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	24	0.9309596	0.54858935	0.79425436	JACKSON_DNMT1_TARGETS_DN	24	-1.8261651	0.010050251	0.028445855	-0.8952055	2.7571247
GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN	C7_ immunologic signatures	177	0.9309592	0.6285047	0.79415876	GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN	182	0.7920971	0.90973634	1	1.7230563	0.1388621
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	c2.CGP_ chemical and genetic perturbations	65	0.93090045	0.58945906	0.79421765	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	62	0.7522351	0.87862515	1	1.68313555	0.17866535
GO_RESPONSE_TO_ISCHEMIA	c5.BP_ GO biological process	25	0.9308597	0.56856704	0.7942321	GO_RESPONSE_TO_ISCHEMIA	27	-0.7741522	0.83589745	0.92500067	0.1567075	1.7050119
MODULE_334	c4.CM_ cancer modules	146	0.930852	0.6223022	0.79415673	MODULE_334	146	1.3170868	0.03058104	0.41494715	2.2479388	-0.3862348
GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP	C7_ immunologic signatures	181	0.9307302	0.6446759	0.7943841	GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP	182	1.0580754	0.36703742	0.82762635	1.9888056	-0.1273452
MODULE_294	c4.CM_ cancer modules	16	0.9306884	0.56902355	0.7943949	MODULE_294	18	1.2619029	0.1618799	0.4937401	2.1925913	-0.3312145
GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP	C7_ immunologic signatures	162	0.93062866	0.63280296	0.7944589	GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP	162	1.3130745	0.03469388	0.4203871	2.24370316	-0.38244584
HOXA9_DN.V1_DN	C6_ oncogenic signatures	167	0.93060607	0.61813843	0.7944259	HOXA9_DN.V1_DN	168	-1.2964236	0	0.2874945	-0.36581753	2.22702967
MULLIGHAN_MLL_SIGNATURE_1_UP	c2.CGP_ chemical and genetic perturbations	332	0.9305968	0.68335146	0.7943528	MULLIGHAN_MLL_SIGNATURE_1_UP	334	1.067085	0.299	0.811023	1.9976818	-0.1364882
GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	169	0.9305781	0.6537998	0.79430574	GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	183	1.2020389	0.09817814	0.58835435	2.132617	-0.2714608
GO_REGULATION_OF_CELL_FATE_COMMITMENT	c5.BP_ GO biological process	21	0.93054384	0.5936508	0.7943006	GO_REGULATION_OF_CELL_FATE_COMMITMENT	25	-1.2916688	0.14948453	0.29061833	-0.36112496	2.22221264
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	c2.CGP_ chemical and genetic perturbations	297	0.93047273	0.67475194	0.79439455	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	302	0.86245763	0.8557114	1	1.79293036	0.0680151
GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	C7_ immunologic signatures	176	0.9304114	0.6315789	0.794459	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	177	0.8444404	0.84040403	1	1.7748518	0.085971
GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP	C7_ immunologic signatures	164	0.9302153	0.62484777	0.79489887	GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP	171	0.9870977	0.54462475	0.93922967	1.917313	-0.0568824
CHR5Q14	C1: positional gene sets	32	0.9301606	0.5767511	0.794941	CHR5Q14	33	0.7295455	0.85680753	1	1.6597061	0.2006151
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	c2.CGP_ chemical and genetic perturbations	51	0.9301064	0.57977206	0.7949947	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	55	1.0655487	0.36633664	0.8134952	1.9956551	-0.1354423
GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP	C7_ immunologic signatures	169	0.92996746	0.6376812	0.79527456	GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP	181	1.0202923	0.45	0.8913335	1.95025976	-0.09032484
GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN	C7_ immunologic signatures	154	0.9299316	0.61630696	0.7952691	GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN	157	1.1635176	0.17484662	0.6479896	2.0934492	-0.233586
GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP	C7_ immunologic signatures	174	0.92981154	0.629717	0.79549056	GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP	178	0.79180366	0.90253806	1	1.7216152	0.13800788
GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN	C7_ immunologic signatures	173	0.9296463	0.6238208	0.79584396	GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN	178	0.7609093	0.937247	1	1.6905556	0.168737
RUTELLA_RESPONSE_TO_HGF_UP	c2.CGP_ chemical and genetic perturbations	357	0.92961633	0.68172044	0.79582995	RUTELLA_RESPONSE_TO_HGF_UP	365	0.9472812	0.675	0.98506516	1.87689753	-0.01766487
GO_PRESYNAPSE	c5.CC_ GO cellular component	252	0.9295745	0.63901347	0.79584336	GO_PRESYNAPSE	271	1.3251548	0.005025126	0.40704036	2.2547293	-0.3955803
LU_TUMOR_ENDOTHELIAL_MARKERS_UP	c2.CGP_ chemical and genetic perturbations	20	0.92955345	0.56309146	0.79580116	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	20	1.200502	0.22779922	0.59163004	2.13005545	-0.27094855
GO_METAL_ION_TRANSPORT	c5.BP_ GO biological process	476	0.9294365	0.7082896	0.7960183	GO_METAL_ION_TRANSPORT	476	0	0	0	0.9294365	0.9294365
GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	C7_ immunologic signatures	179	0.92941236	0.6340326	0.7959867	GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	180	0.85549897	0.8090909	1	1.78491133	0.07391339
GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN	C7_ immunologic signatures	164	0.9294122	0.6384248	0.7958901	GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN	167	1.1311266	0.19269776	0.70471287	2.0605388	-0.2017144
GO_LEUKOCYTE_HOMEOSTASIS	c5.BP_ GO biological process	54	0.9293163	0.56726766	0.7960598	GO_LEUKOCYTE_HOMEOSTASIS	58	0.9904501	0.5027686	0.9352146	1.9197664	-0.0611338
AUNG_GASTRIC_CANCER	c2.CGP_ chemical and genetic perturbations	44	0.92930853	0.57309943	0.7959825	AUNG_GASTRIC_CANCER	46	0.8395849	0.75691247	1	1.76889343	0.08972363
GO_PARTURITION	c5.BP_ GO biological process	17	0.92910546	0.56709266	0.796426	GO_PARTURITION	18	1.4757686	0.037453182	0.27220392	2.40487406	-0.54666314
GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP	C7_ immunologic signatures	186	0.9290906	0.65303737	0.79636925	GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP	186	0.81454825	0.8753799	1	1.74363885	0.11454235
GO_SERINE_HYDROLASE_ACTIVITY	c5.GO molecular function	167	0.9290296	0.63484484	0.7964397	GO_SERINE_HYDROLASE_ACTIVITY	186	1.4399452	0	0.30434555	2.3689748	-0.5109156
GO_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	179	0.92900026	0.64897466	0.7964219	GO_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS	181	0.91864294	0.72441745	1	1.8476432	0.01035732
GO_POSITIVE_REGULATION_OF_PROTEOLYSIS	c5.BP_ GO biological process	323	0.92891943	0.6928879	0.79654545	GO_POSITIVE_REGULATION_OF_PROTEOLYSIS	328	0.88097376	0.8276553	1	1.80989319	0.04794567
GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN	C7_ immunologic signatures	167	0.9288511	0.6545454	0.796633	GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN	171	0.8791259	0.76649743	1	1.807977	0.0497252
SCHRAMM_INHBA_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	23	0.9288492	0.5613208	0.7965404	SCHRAMM_INHBA_TARGETS_DN	23	-1.1205206	0.2722513	0.48838836	-0.1916714	2.0493698
GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN	C7_ immunologic signatures	169	0.92884135	0.6334895	0.796465	GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN	173	1.4157726	0.003058104	0.32135096	2.34461395	-0.48693125
GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP	C7_ immunologic signatures	178	0.9286354	0.6423445	0.7969304	GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP	181	1.121515	0.22755101	0.7222458	2.0501504	-0.1928796
GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP	C7_ immunologic signatures	178	0.9285252	0.62266356	0.7971282	GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP	178	1.3544892	0.010070493	0.3829746	2.2830144	-0.425964
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN	C7_ immunologic signatures	181	0.928469	0.6324582	0.7971766	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN	181	0.8130272	0.86598986	1	1.7414962	0.1154418
GO_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY	c5.BP_ GO biological process	178	0.9284546	0.635054	0.7971188	GO_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY	185	0.72116494	0.9684318	1	1.64961954	0.20728966
GO_THYMOCYTE_AGGREGATION	c5.BP_ GO biological process	41	0.92843914	0.56577086	0.7970638	GO_THYMOCYTE_AGGREGATION	45	1.2621406	0.12328767	0.49360198	2.19057974	-0.33370146
GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP	C7_ immunologic signatures	179	0.92840064	0.6650831	0.79706794	GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP	181	1.1182623	0.23045686	0.7264484	2.04666294	-0.18986166
GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	163	0.92832875	0.6489104	0.7971692	GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP	167	1.1023647	0.2744898	0.7531178	2.03069345	-0.17403595
GO_INDOLALKYLAMINE_METABOLIC_PROCESS	c5.BP_ GO biological process	16	0.92825484	0.57281554	0.79727733	GO_INDOLALKYLAMINE_METABOLIC_PROCESS	16	-1.0554526	0.3982684	0.5948722	-0.12719776	1.98370744
GO_VESICLE_MEDIATED_TRANSPORT_BETWEEN_ENDOSOMAL_COMPARTMENTS	c5.BP_ GO biological process	19	0.9282107	0.57717043	0.79730034	GO_VESICLE_MEDIATED_TRANSPORT_BETWEEN_ENDOSOMAL_COMPARTMENTS	19	0.5989507	0.94683546	1	1.5271614	0.32926
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	c2.CGP_ chemical and genetic perturbations	59	0.92817396	0.5958042	0.7973002	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	59	-1.0278352	0.3655914	0.64353055	-0.09966124	1.95600916
GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN	C7_ immunologic signatures	161	0.9281237	0.6224612	0.7973426	GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN	166	1.1728275	0.13030303	0.63323045	2.1009512	-0.2447038
EVI1_03	c3.TFT_ transcription factor targets	52	0.9278477	0.5771905	0.79798776	EVI1_03	54	0.8408659	0.73318386	1	1.7687136	0.0869818
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	c2.CGP_ chemical and genetic perturbations	16	0.92781526	0.56401944	0.7979789	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17	1.2317106	0.20451528	0.5371038	2.15952586	-0.30389534
ZHAN_MULTIPLE_MYELOMA_CD2_UP	c2.CGP_ chemical and genetic perturbations	41	0.92775685	0.58487874	0.7980486	ZHAN_MULTIPLE_MYELOMA_CD2_UP	40	1.2446525	0.16300578	0.5195297	2.17240935	-0.31689565
GO_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING	c5.BP_ GO biological process	31	0.9277454	0.5695067	0.7979824	GO_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING	31	0.7999113	0.763789	1	1.7276567	0.1278341
MTOR_UP.V1_UP	C6_ oncogenic signatures	139	0.92773336	0.6555024	0.7979168	MTOR_UP.V1_UP	145	1.1032317	0.27805865	0.7516746	2.03096506	-0.17549834
GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN	C7_ immunologic signatures	157	0.9275999	0.62422746	0.7981764	GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN	163	1.2193105	0.081275724	0.5560505	2.1469104	-0.2917106
GO_CATION_CHANNEL_ACTIVITY	c5.GO molecular function	238	0.9275663	0.66039824	0.79816556	GO_CATION_CHANNEL_ACTIVITY	273	1.5252552	0	0.23029095	2.4528215	-0.5976889
GO_REGULATION_OF_PROTEIN_SECRETION	c5.BP_ GO biological process	309	0.9275332	0.6896175	0.7981577	GO_REGULATION_OF_PROTEIN_SECRETION	341	1.1629461	0.08717435	0.6483681	2.0904793	-0.2354129
GO_DNA_METHYLATION_INVOLVED_IN_GAMETE_GENERATION	c5.BP_ GO biological process	16	0.92749137	0.55500823	0.7981716	GO_DNA_METHYLATION_INVOLVED_IN_GAMETE_GENERATION	18	1.6937059	0.001321004	0.08309664	2.62119727	-0.76621453
GO_HUMORAL_IMMUNE_RESPONSE	c5.BP_ GO biological process	110	0.9274551	0.6227848	0.79817593	GO_HUMORAL_IMMUNE_RESPONSE	129	1.2992449	0.048453607	0.44396263	2.2267	-0.3717898
GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN	C7_ immunologic signatures	143	0.9273567	0.64276886	0.7983529	GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN	147	0.91904086	0.67755103	1	1.84639756	0.00831584
GO_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	23	0.92723197	0.5904	0.79859895	GO_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY	24	1.0195681	0.4530457	0.8914152	1.94680007	-0.09233613
GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN	C7_ immunologic signatures	166	0.9272184	0.64449817	0.79853636	GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN	165	0.6899583	0.97766495	1	1.6171767	0.2372601
GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	C7_ immunologic signatures	174	0.92720604	0.6401425	0.7984725	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	174	1.1799977	0.12903225	0.62355095	2.10720374	-0.25279166
GGGNRMNNYCAT_UNKNOWN	c3.TFT_ transcription factor targets	69	0.92720324	0.58446866	0.7983853	GGGNRMNNYCAT_UNKNOWN	72	0.8790206	0.6983957	1	1.80622384	0.04818264
GNF2_MCM5	c4.CGN_ cancer gene neighborhoods	59	0.92716914	0.6191117	0.7983773	GNF2_MCM5	59	-2.2630632	0	0.000414596	-1.33589406	3.19023234
MORF_FANCG	c4.CGN_ cancer gene neighborhoods	153	0.92693955	0.62064826	0.7988873	MORF_FANCG	155	0.7743772	0.904908	1	1.70131675	0.15256235
GO_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY	c5.GO molecular function	15	0.92680955	0.57735246	0.79914236	GO_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY	16	1.2969002	0.14844805	0.44695136	2.22370975	-0.37009065
GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	C7_ immunologic signatures	182	0.92679954	0.6469194	0.79907084	GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	180	1.0912775	0.28311425	0.7696276	2.01807704	-0.16447796
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN	C7_ immunologic signatures	184	0.92667943	0.6299766	0.7993111	GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN	184	1.2002431	0.10150754	0.59225976	2.12692253	-0.27356367
GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	C7_ immunologic signatures	173	0.92657167	0.64481527	0.7995056	GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	182	1.1736486	0.13682093	0.6322907	2.10022027	-0.24707693
GO_CANONICAL_WNT_SIGNALING_PATHWAY	c5.BP_ GO biological process	83	0.9265214	0.6165803	0.7995431	GO_CANONICAL_WNT_SIGNALING_PATHWAY	89	-1.0818224	0.2777778	0.5480347	-0.155301	2.0083438
GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP	C7_ immunologic signatures	173	0.92644477	0.630303	0.799649	GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP	177	0.9192864	0.6798379	1	1.84573117	0.00715837
GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	175	0.9263175	0.6551724	0.79990095	GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	174	0.8923226	0.7389113	1	1.8186401	0.0339949
GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	182	0.92628175	0.63678694	0.7999051	GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN	183	1.1410118	0.18052739	0.6886808	2.06729355	-0.21473005
GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN	C7_ immunologic signatures	176	0.9261948	0.6366864	0.8000467	GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN	180	0.6083486	0.9979757	1	1.5345434	0.3178462
GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	64	0.9261484	0.5978407	0.8000695	GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION	69	0.791144	0.84083426	1	1.7172924	0.1350044
GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN	C7_ immunologic signatures	158	0.9260951	0.65636146	0.8001163	GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN	165	1.0093948	0.47923	0.9086657	1.9354899	-0.0832997
GSE28408_LY6G_POS_VS_NEG_DC_UP	C7_ immunologic signatures	165	0.9260582	0.6426036	0.8001143	GSE28408_LY6G_POS_VS_NEG_DC_UP	168	1.2088946	0.10510204	0.5791966	2.1349528	-0.2828364
GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP	C7_ immunologic signatures	180	0.9260541	0.6674556	0.8000272	GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP	178	1.1163222	0.2444219	0.7286975	2.0423763	-0.1902681
GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP	C7_ immunologic signatures	181	0.9260538	0.6485207	0.79993093	GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP	181	-1.0642742	0.33333334	0.5800246	-0.1382204	1.990328
GO_PROTEIN_K48_LINKED_UBIQUITINATION	c5.BP_ GO biological process	44	0.9259963	0.59297216	0.79998636	GO_PROTEIN_K48_LINKED_UBIQUITINATION	44	0.87398255	0.6834862	1	1.79997885	0.05201375
SP1_Q6	c3.TFT_ transcription factor targets	231	0.92597884	0.6666667	0.79993415	SP1_Q6	233	0.58340955	0.99899495	1	1.50938839	0.34256929
PTEN_DN.V2_UP	C6_ oncogenic signatures	102	0.92594475	0.6286439	0.7999289	PTEN_DN.V2_UP	109	1.1289465	0.27130976	0.7072284	2.05489125	-0.20300175
GSE3039_CD4_TCELL_VS_B1_BCELL_UP	C7_ immunologic signatures	177	0.9258878	0.6631579	0.7999822	GSE3039_CD4_TCELL_VS_B1_BCELL_UP	183	0.70860213	0.96833503	1	1.63448993	0.21728567
PID_AR_NONGENOMIC_PATHWAY	c2.CP_ Canonical pathways	30	0.92578024	0.5761194	0.8001688	PID_AR_NONGENOMIC_PATHWAY	30	0.89923805	0.6433649	1	1.82501829	0.02654219
GO_AU_RICH_ELEMENT_BINDING	c5.GO molecular function	23	0.9257746	0.58371043	0.80008596	GO_AU_RICH_ELEMENT_BINDING	23	-1.7099687	0.009950249	0.053052407	-0.7841941	2.6357433
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP	C7_ immunologic signatures	178	0.92570347	0.63445866	0.80018103	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP	182	1.4242641	0.003027245	0.31750533	2.34996757	-0.49856063
GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	C7_ immunologic signatures	163	0.9256921	0.649635	0.8001138	GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	165	1.0594348	0.36852792	0.82555854	1.9851269	-0.1337427
MORF_PSMF1	c4.CGN_ cancer gene neighborhoods	147	0.9256839	0.6407767	0.8000395	MORF_PSMF1	154	0.9603664	0.5934627	0.9714106	1.8860503	-0.0346825
GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN	C7_ immunologic signatures	183	0.9255809	0.65105385	0.8002261	GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN	186	0.8846423	0.7700101	1	1.8102232	0.0409386
GSE11057_CD4_CENT_MEM_VS_PBMC_UP	C7_ immunologic signatures	179	0.92557704	0.64893615	0.80013895	GSE11057_CD4_CENT_MEM_VS_PBMC_UP	181	1.1528322	0.16868687	0.66449773	2.07840924	-0.22725516
GSE3982_NEUTROPHIL_VS_TH2_UP	C7_ immunologic signatures	164	0.9254641	0.6528926	0.8003405	GSE3982_NEUTROPHIL_VS_TH2_UP	168	1.0146382	0.46286878	0.89886695	1.9401023	-0.0891741
GO_BINDING_BRIDGING	c5.GO molecular function	163	0.9253308	0.6498195	0.8006015	GO_BINDING_BRIDGING	163	1.0191698	0.4497462	0.89178777	1.9445006	-0.093839
MA_MYELOID_DIFFERENTIATION_UP	c2.CGP_ chemical and genetic perturbations	34	0.9253028	0.60240966	0.8005762	MA_MYELOID_DIFFERENTIATION_UP	34	0.7048265	0.8938679	1	1.6301293	0.2204763
GSE25087_TREG_VS_TCONV_FETUS_DN	C7_ immunologic signatures	150	0.9252753	0.652439	0.8005545	GSE25087_TREG_VS_TCONV_FETUS_DN	155	1.0437429	0.3987854	0.8515678	1.9690182	-0.1184676
VALK_AML_CLUSTER_7	c2.CGP_ chemical and genetic perturbations	24	0.92511433	0.5579937	0.800892	VALK_AML_CLUSTER_7	25	0.8768454	0.64868104	1	1.80195973	0.04826893
LEE_AGING_CEREBELLUM_UP	c2.CGP_ chemical and genetic perturbations	69	0.9249592	0.60461956	0.80120856	LEE_AGING_CEREBELLUM_UP	76	1.1992223	0.17161018	0.59343606	2.1241815	-0.2742631
GO_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS	c5.BP_ GO biological process	44	0.92495596	0.6085106	0.80112	GO_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS	47	1.296587	0.09568261	0.44745973	2.22154296	-0.37163104
GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP	C7_ immunologic signatures	166	0.9249449	0.64310956	0.8010519	GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP	173	1.1955022	0.104781285	0.5970433	2.1204471	-0.2705573
GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_UP	C7_ immunologic signatures	170	0.92488676	0.6591716	0.80110675	GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_UP	174	1.1896899	0.11303462	0.60602987	2.11457666	-0.26480314
GO_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION	c5.BP_ GO biological process	25	0.9247296	0.58449614	0.8014426	GO_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION	23	1.3448477	0.09935484	0.38939095	2.2695773	-0.4201181
GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP	C7_ immunologic signatures	170	0.9246186	0.6526442	0.8016415	GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP	173	0.92518914	0.6869301	1	1.84980774	-0.00057054
GO_RETINAL_GANGLION_CELL_AXON_GUIDANCE	c5.BP_ GO biological process	17	0.92458016	0.57301587	0.8016555	GO_RETINAL_GANGLION_CELL_AXON_GUIDANCE	18	1.2393363	0.21400778	0.5267829	2.16391646	-0.31475614
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	C7_ immunologic signatures	165	0.9245539	0.65625	0.80163157	GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	176	1.1334703	0.20282543	0.7004903	2.0580242	-0.2089164
GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN	C7_ immunologic signatures	166	0.92452115	0.6501767	0.8016162	GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN	173	1.1537102	0.15720081	0.6627866	2.07823135	-0.22918905
GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	171	0.92442524	0.6370107	0.80177504	GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	174	1.0789438	0.3097166	0.7895535	2.00336904	-0.15451856
GO_RESPONSE_TO_COPPER_ION	c5.BP_ GO biological process	24	0.9243533	0.57294834	0.8018629	GO_RESPONSE_TO_COPPER_ION	25	0.87133497	0.6683047	1	1.79568827	0.05301833
GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP	C7_ immunologic signatures	141	0.92419887	0.6404358	0.8021788	GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP	145	1.0396357	0.40826613	0.8589996	1.96383457	-0.11543683
GO_RESPONSE_TO_CARBOHYDRATE	c5.BP_ GO biological process	148	0.9239935	0.6538937	0.80262184	GO_RESPONSE_TO_CARBOHYDRATE	159	1.1464297	0.1839431	0.6755099	2.0704232	-0.2224362
REACTOME_CIRCADIAN_CLOCK	c2.CP_REACTOME_ Reactome gene sets	48	0.9239887	0.60481584	0.802538	REACTOME_CIRCADIAN_CLOCK	48	0.89916736	0.6553738	1	1.82315606	0.02482134
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP	c2.CGP_ chemical and genetic perturbations	26	0.9239799	0.5861027	0.80246377	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP	26	1.2547319	0.1670823	0.5027567	2.1787118	-0.330752
GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	173	0.92388004	0.63757575	0.8026362	GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	176	1.0137991	0.48016277	0.9002627	1.93767914	-0.08991906
GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP	C7_ immunologic signatures	179	0.9238412	0.6627358	0.8026435	GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP	183	1.0313169	0.42741936	0.87427044	1.9551581	-0.1074757
GO_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS	c5.BP_ GO biological process	74	0.92372984	0.59477127	0.80284715	GO_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS	78	1.8401213	0	0.024332419	2.76385114	-0.91639146
GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP	C7_ immunologic signatures	174	0.92365366	0.63614744	0.80294657	GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP	186	1.0953971	0.24772498	0.76419127	2.01905076	-0.17174344
GO_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION	c5.BP_ GO biological process	20	0.9235363	0.5746753	0.80316037	GO_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION	20	1.1217338	0.3193384	0.7222141	2.0452701	-0.1981975
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	c2.CGP_ chemical and genetic perturbations	53	0.9235286	0.582744	0.80308443	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	55	1.2593397	0.12445415	0.4975254	2.1828683	-0.3358111
GO_EPITHELIAL_CELL_MORPHOGENESIS	c5.BP_ GO biological process	39	0.9234856	0.58615613	0.8031021	GO_EPITHELIAL_CELL_MORPHOGENESIS	39	0.7863734	0.7893519	1	1.709859	0.1371122
GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP	C7_ immunologic signatures	164	0.9234232	0.6505441	0.8031721	GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP	177	1.0930687	0.29614604	0.7679859	2.0164919	-0.1696455
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	c2.CGP_ chemical and genetic perturbations	365	0.923347	0.69438446	0.8032774	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	379	1.0886543	0.226	0.7730691	2.0120013	-0.1653073
GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	173	0.923335	0.6432818	0.8032136	GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP	178	1.043283	0.3993964	0.8531243	1.966618	-0.119948
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX	c2.CP_REACTOME_ Reactome gene sets	59	0.923302	0.6	0.8032007	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX	59	-0.88300365	0.7352941	0.84067804	0.04029835	1.80630565
GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN	C7_ immunologic signatures	158	0.9232409	0.63755983	0.80326253	GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN	161	0.8455172	0.822335	1	1.7687581	0.0777237
REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	c2.CP_REACTOME_ Reactome gene sets	15	0.9230649	0.5786062	0.80364114	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	15	1.4670887	0.030383091	0.2766172	2.3901536	-0.5440238
COREBINDINGFACTOR_Q6	c3.TFT_ transcription factor targets	224	0.9229334	0.6579546	0.8039023	COREBINDINGFACTOR_Q6	243	0.9756267	0.56713426	0.95540196	1.8985601	-0.0526933
CHR1Q24	C1: positional gene sets	33	0.92290515	0.5736434	0.80387914	CHR1Q24	37	1.3123916	0.1002331	0.42222723	2.23529675	-0.38948645
GSE3982_BCELL_VS_TH2_UP	C7_ immunologic signatures	153	0.92284846	0.6469136	0.803932	GSE3982_BCELL_VS_TH2_UP	157	1.0818607	0.31878173	0.7835569	2.00470916	-0.15901224
GO_ENDOTHELIUM_DEVELOPMENT	c5.BP_ GO biological process	82	0.9228421	0.6199214	0.8038508	GO_ENDOTHELIUM_DEVELOPMENT	85	0.95743287	0.5705196	0.97470087	1.88027497	-0.03459077
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	c2.CGP_ chemical and genetic perturbations	32	0.9228317	0.5808937	0.80378467	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	33	0.98505706	0.5140187	0.9417474	1.90788876	-0.06222536
ATGCTGC_MIR103_MIR107	c3.MIR_ microRNA targets	201	0.92273253	0.65925056	0.8039566	ATGCTGC_MIR103_MIR107	204	0.8084739	0.8879919	1	1.73120643	0.11425863
GSE3039_NKT_CELL_VS_B1_BCELL_DN	C7_ immunologic signatures	175	0.9224941	0.6391509	0.8045059	GSE3039_NKT_CELL_VS_B1_BCELL_DN	175	0.61515284	0.9959514	1	1.53764694	0.30734126
REACTOME_SIGNALING_BY_SCF_KIT	c2.CP_REACTOME_ Reactome gene sets	74	0.9224823	0.60686016	0.80443954	REACTOME_SIGNALING_BY_SCF_KIT	74	1.0844989	0.32371795	0.77843755	2.0069812	-0.1620166
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN	C7_ immunologic signatures	173	0.9224649	0.64835167	0.80438554	GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN	178	1.0195482	0.45213848	0.8913533	1.9420131	-0.0970833
GO_ENDOCYTOSIS	c5.BP_ GO biological process	428	0.92242825	0.72186834	0.8043851	GO_ENDOCYTOSIS	447	1.1038295	0.15715715	0.749887	2.02625775	-0.18140125
GO_3_5_EXONUCLEASE_ACTIVITY	c5.GO molecular function	43	0.92235404	0.5875	0.80449307	GO_3_5_EXONUCLEASE_ACTIVITY	44	-0.91655093	0.6097561	0.8001274	0.00580311	1.83890497
GO_LIPID_LOCALIZATION	c5.BP_ GO biological process	221	0.9221973	0.6751152	0.80482435	GO_LIPID_LOCALIZATION	233	1.1696501	0.11222445	0.63849044	2.0918474	-0.2474528
YGCGYRCGC_UNKNOWN	c3.TFT_ transcription factor targets	284	0.9220794	0.69560313	0.8050417	YGCGYRCGC_UNKNOWN	288	-1.1581275	0	0.43260187	-0.2360481	2.0802069
GO_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS	c5.BP_ GO biological process	208	0.9218554	0.6708861	0.80553764	GO_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS	214	1.2176704	0.07738694	0.560439	2.1395258	-0.295815
GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN	C7_ immunologic signatures	179	0.9218485	0.6540732	0.8054583	GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN	182	0.89438957	0.74493927	1	1.81623807	0.02745893
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN	C7_ immunologic signatures	160	0.9218471	0.6603774	0.8053655	GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN	165	1.3071065	0.025176235	0.42946196	2.2289536	-0.3852594
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN	C7_ immunologic signatures	174	0.9218246	0.66121495	0.80532205	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN	175	0.8354473	0.8503055	1	1.7572719	0.0863773
LEE_AGING_MUSCLE_DN	c2.CGP_ chemical and genetic perturbations	42	0.92176825	0.57471263	0.8053752	LEE_AGING_MUSCLE_DN	43	-0.9794479	0.45454547	0.71484363	-0.05767965	1.90121615
PID_PS1_PATHWAY	c2.CP_ Canonical pathways	45	0.92173827	0.6305278	0.8053626	PID_PS1_PATHWAY	45	-0.9791727	0.4649123	0.7153796	-0.05743443	1.90091097
GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	C7_ immunologic signatures	166	0.9215127	0.65096617	0.8058701	GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	175	0.9630981	0.5769231	0.9674279	1.8846108	-0.0415854
GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN	C7_ immunologic signatures	165	0.921381	0.6469194	0.80613893	GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN	178	0.7822185	0.91028225	1	1.7035995	0.1391625
SYED_ESTRADIOL_RESPONSE	c2.CGP_ chemical and genetic perturbations	18	0.92131	0.568254	0.80622625	SYED_ESTRADIOL_RESPONSE	18	0.78152275	0.78515625	1	1.70283275	0.13978725
GO_NEGATIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT	c5.BP_ GO biological process	25	0.92116654	0.58518517	0.8065038	GO_NEGATIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT	26	0.71920294	0.8484108	1	1.64036948	0.2019636
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP	c2.CGP_ chemical and genetic perturbations	33	0.9211319	0.5987934	0.8065015	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP	34	-0.95382285	0.51265824	0.7517429	-0.03269095	1.87495475
GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN	C7_ immunologic signatures	174	0.92111605	0.6604651	0.8064486	GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN	179	0.7930854	0.8946302	1	1.71420145	0.12803065
GO_BLOOD_MICROPARTICLE	c5.CC_ GO cellular component	82	0.92104846	0.6151798	0.8065348	GO_BLOOD_MICROPARTICLE	98	1.2288865	0.11654527	0.54326564	2.14993496	-0.30783804
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN	C7_ immunologic signatures	173	0.9210352	0.67286247	0.8064705	GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN	184	1.0766144	0.3131313	0.79420596	1.9976496	-0.1555792
GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	C7_ immunologic signatures	151	0.9210069	0.64425427	0.8064543	GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	150	0.6897065	0.9805726	1	1.6107134	0.2313004
GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP	C7_ immunologic signatures	168	0.9209721	0.6465721	0.80644447	GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP	169	0.8106661	0.8774063	1	1.7316382	0.110306
GO_PROTEIN_LIPID_COMPLEX_SUBUNIT_ORGANIZATION	c5.BP_ GO biological process	30	0.9209602	0.5825545	0.80637676	GO_PROTEIN_LIPID_COMPLEX_SUBUNIT_ORGANIZATION	34	-1.1801708	0.15972222	0.40405113	-0.2592106	2.101131
GO_MIDDLE_EAR_MORPHOGENESIS	c5.BP_ GO biological process	19	0.9209433	0.58551615	0.80632824	GO_MIDDLE_EAR_MORPHOGENESIS	20	-1.5931238	0.03883495	0.09352561	-0.6721805	2.5140671
GO_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY	c5.BP_ GO biological process	16	0.920903	0.5665584	0.8063387	GO_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY	16	0.6969655	0.8669302	1	1.6178685	0.2239375
GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP	C7_ immunologic signatures	163	0.92073154	0.66069293	0.8066795	GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP	166	0.97780174	0.5679513	0.9521884	1.89853328	-0.0570702
GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP	C7_ immunologic signatures	171	0.920551	0.6638756	0.8070548	GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP	174	1.2263745	0.07467205	0.54750466	2.1469255	-0.3058235
ROVERSI_GLIOMA_COPY_NUMBER_DN	c2.CGP_ chemical and genetic perturbations	46	0.92053413	0.5881482	0.8070054	ROVERSI_GLIOMA_COPY_NUMBER_DN	48	0.7973625	0.8026756	1	1.71789663	0.12317163
GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP	C7_ immunologic signatures	138	0.920504	0.6460606	0.8069927	GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP	139	1.1755431	0.14343846	0.6282215	2.0960471	-0.2550391
GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	167	0.92047155	0.6594982	0.80698407	GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN	176	1.4375008	0.001015229	0.3075375	2.35797235	-0.51702925
GO_CELL_PROJECTION_ASSEMBLY	c5.BP_ GO biological process	230	0.92037565	0.66292137	0.80714196	GO_CELL_PROJECTION_ASSEMBLY	232	1.2104305	0.060240965	0.5763673	2.13080615	-0.29005485
GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	150	0.9203012	0.6551313	0.80724096	GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	153	1.1139376	0.2466735	0.7318848	2.0342388	-0.1936364
GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP	C7_ immunologic signatures	188	0.9200812	0.63947994	0.80774105	GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP	188	0.81177896	0.8800813	1	1.73186016	0.10830224
GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP	C7_ immunologic signatures	175	0.9200796	0.674144	0.8076487	GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP	180	1.1621382	0.1680162	0.65001625	2.0822178	-0.2420586
GO_EXOPEPTIDASE_ACTIVITY	c5.GO molecular function	89	0.9200707	0.6277851	0.8075759	GO_EXOPEPTIDASE_ACTIVITY	95	1.4361444	0.009574468	0.3096138	2.3562151	-0.5160737
CUI_TCF21_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	28	0.92006177	0.57799673	0.8075039	CUI_TCF21_TARGETS_DN	28	1.1948057	0.21664627	0.5971666	2.11486747	-0.27474393
GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN	C7_ immunologic signatures	169	0.92000556	0.641844	0.8075558	GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN	172	0.9597158	0.59412956	0.97099274	1.87972136	-0.03971024
OCT1_Q5_01	c3.TFT_ transcription factor targets	220	0.91994226	0.67235494	0.80762565	OCT1_Q5_01	233	0.91020626	0.7243461	1	1.83014852	0.009736
PENG_RAPAMYCIN_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	169	0.9198265	0.6517647	0.80783206	PENG_RAPAMYCIN_RESPONSE_UP	177	0.9544678	0.6148374	0.9770696	1.8742943	-0.0346413
GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	C7_ immunologic signatures	178	0.9197893	0.6591981	0.8078336	GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	179	0.7987584	0.8958544	1	1.7185477	0.1210309
GO_RHO_PROTEIN_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	46	0.91977763	0.58485276	0.8077675	GO_RHO_PROTEIN_SIGNAL_TRANSDUCTION	46	1.1008779	0.32560834	0.75586575	2.02065553	-0.18110027
GO_EMBRYONIC_PLACENTA_DEVELOPMENT	c5.BP_ GO biological process	77	0.9196592	0.62381595	0.80799246	GO_EMBRYONIC_PLACENTA_DEVELOPMENT	81	0.88321614	0.7035865	1	1.80287534	0.03644306
GO_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	18	0.919621	0.57735246	0.80799806	GO_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	18	0.59938115	0.96456695	1	1.51900215	0.32023985
GSE360_CTRL_VS_T_GONDII_DC_UP	C7_ immunologic signatures	167	0.91961175	0.6642157	0.8079245	GSE360_CTRL_VS_T_GONDII_DC_UP	178	1.1962527	0.11425682	0.596449	2.11586445	-0.27664095
GO_REGULATION_OF_LYMPHOCYTE_MIGRATION	c5.BP_ GO biological process	26	0.91957676	0.581761	0.80792004	GO_REGULATION_OF_LYMPHOCYTE_MIGRATION	28	1.2215985	0.19682151	0.5536603	2.14117526	-0.30202174
GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP	C7_ immunologic signatures	178	0.91953284	0.6674528	0.80793613	GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP	180	0.6149663	0.9959391	1	1.53449914	0.30456654
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP	C7_ immunologic signatures	171	0.91942406	0.66504854	0.80813044	GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP	176	0.96533227	0.58592963	0.96495813	1.88475633	-0.04590821
OCT_Q6	c3.TFT_ transcription factor targets	214	0.9193848	0.6666667	0.80813104	OCT_Q6	225	1.0321016	0.42237905	0.87329656	1.9514864	-0.1127168
GO_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT	c5.BP_ GO biological process	17	0.9193792	0.5468227	0.808049	GO_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT	16	1.279257	0.16347381	0.47308695	2.1986362	-0.3598778
BIOCARTA_DEATH_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	30	0.9193697	0.5825826	0.8079786	BIOCARTA_DEATH_PATHWAY	30	0.6538386	0.9273608	1	1.5732083	0.2655311
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN	C7_ immunologic signatures	130	0.91927713	0.6363636	0.80812806	GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN	130	1.161038	0.1791967	0.65112126	2.08031513	-0.24176087
GSE27786_BCELL_VS_NKTCELL_DN	C7_ immunologic signatures	171	0.91915005	0.6718377	0.80837184	GSE27786_BCELL_VS_NKTCELL_DN	175	1.0934708	0.289181	0.76837105	2.01262085	-0.17432075
GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP	C7_ immunologic signatures	171	0.91910446	0.6405152	0.8083927	GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP	173	1.2551293	0.052578364	0.50237876	2.17423376	-0.33602484
ACTACCT_MIR196A_MIR196B	c3.MIR_ microRNA targets	129	0.919073	0.63773584	0.80837804	ACTACCT_MIR196A_MIR196B	130	-1.1463451	0.10526316	0.44829452	-0.2272721	2.0654181
GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP	C7_ immunologic signatures	171	0.91895777	0.6670673	0.80858994	GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP	172	0.83872515	0.8363821	1	1.75768292	0.08023262
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP	C7_ immunologic signatures	162	0.9189437	0.65789473	0.80853444	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP	165	0.99584997	0.5178754	0.9298968	1.91479367	-0.07690627
GO_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS	c5.BP_ GO biological process	39	0.91869795	0.59940654	0.8090918	GO_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS	42	-1.158214	0.17829457	0.4327815	-0.23951605	2.07691195
GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN	C7_ immunologic signatures	166	0.9186923	0.6852071	0.80900913	GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN	170	0.7670425	0.93068296	1	1.6857348	0.1516498
GO_CHROMATIN_REMODELING	c5.BP_ GO biological process	123	0.9186529	0.63821656	0.8090208	GO_CHROMATIN_REMODELING	126	-1.0126969	0.41666666	0.66981494	-0.094044	1.9313498
REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	c2.CP_REACTOME_ Reactome gene sets	24	0.91848034	0.596463	0.80939674	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	24	0.5642026	0.9727723	1	1.48268294	0.35427774
GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	154	0.91847295	0.6551313	0.809318	GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN	159	0.86688244	0.7857868	1	1.78535539	0.05159051
GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN	C7_ immunologic signatures	154	0.9184538	0.64880955	0.80926883	GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN	158	0.7193057	0.9625127	1	1.6377595	0.1991481
GO_REGULATION_OF_GLUCONEOGENESIS	c5.BP_ GO biological process	26	0.9184408	0.5786164	0.8092117	GO_REGULATION_OF_GLUCONEOGENESIS	32	1.2420824	0.17793594	0.5232988	2.1605232	-0.3236416
WU_ALZHEIMER_DISEASE_DN	c2.CGP_ chemical and genetic perturbations	17	0.91840076	0.57355374	0.8092202	WU_ALZHEIMER_DISEASE_DN	18	1.0369736	0.4348404	0.8641696	1.95537436	-0.11857284
GNF2_MYL2	c4.CGN_ cancer gene neighborhoods	28	0.9182564	0.58912385	0.809505	GNF2_MYL2	30	1.573955	0.008413462	0.18661854	2.4922114	-0.6556986
GO_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT	c5.BP_ GO biological process	19	0.91806704	0.5805369	0.80990714	GO_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT	18	1.1718063	0.28030303	0.6349405	2.08987334	-0.25373926
GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	135	0.9180233	0.66625464	0.80992734	GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	139	0.6149941	0.9927983	1	1.5330174	0.3030292
GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN	C7_ immunologic signatures	172	0.91796607	0.6761566	0.8099823	GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN	177	1.3486923	0.014198783	0.38330677	2.26665837	-0.43072623
GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP	C7_ immunologic signatures	183	0.91795766	0.64135516	0.80990887	GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP	187	0.89288616	0.7432024	1	1.81084382	0.0250715
SHEN_SMARCA2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	248	0.91795194	0.66327685	0.80982834	SHEN_SMARCA2_TARGETS_DN	274	1.1158739	0.18136272	0.72965294	2.03382584	-0.19792196
PU1_Q6	c3.TFT_ transcription factor targets	203	0.9177792	0.6945755	0.81019217	PU1_Q6	213	1.0123421	0.47474748	0.9035451	1.9301213	-0.0945629
GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP	C7_ immunologic signatures	166	0.9176652	0.6619883	0.8104031	GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP	175	0.8682954	0.7909091	1	1.7859606	0.0493698
GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP	C7_ immunologic signatures	176	0.9176553	0.6662708	0.810331	GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP	185	1.0902505	0.29048583	0.7710274	2.0079058	-0.1725952
GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN	C7_ immunologic signatures	170	0.9176397	0.6601705	0.81027883	GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN	172	1.0167038	0.4450102	0.8949252	1.9343435	-0.0990641
TRACEY_RESISTANCE_TO_IFNA2_DN	c2.CGP_ chemical and genetic perturbations	27	0.9175901	0.57984495	0.81030667	TRACEY_RESISTANCE_TO_IFNA2_DN	27	0.9908516	0.49285713	0.93477947	1.9084417	-0.0732615
GO_REGULATION_OF_COFACTOR_METABOLIC_PROCESS	c5.BP_ GO biological process	46	0.9174907	0.6172107	0.81046945	GO_REGULATION_OF_COFACTOR_METABOLIC_PROCESS	48	1.0806986	0.35135135	0.7858724	1.9981893	-0.1632079
GO_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	16	0.91748446	0.591195	0.8103902	GO_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY	17	0.91801965	0.6093144	1	1.83550411	-0.00053519
GO_HISTONE_H3_K4_METHYLATION	c5.BP_ GO biological process	23	0.91746527	0.5738204	0.8103443	GO_HISTONE_H3_K4_METHYLATION	24	-1.1632016	0.18691589	0.42676204	-0.24573633	2.08066687
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	c2.CGP_ chemical and genetic perturbations	67	0.9174593	0.59383756	0.8102654	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	65	0.757994	0.87135136	1	1.6754533	0.1594653
GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	C7_ immunologic signatures	175	0.917293	0.66865313	0.81060183	GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	178	0.52383846	1	1	1.44113146	0.39345454
GSE17721_CTRL_VS_POLYIC_4H_BMDC_UP	C7_ immunologic signatures	177	0.9172235	0.66824645	0.8106895	GSE17721_CTRL_VS_POLYIC_4H_BMDC_UP	179	0.5862145	1	1	1.503438	0.331009
MORF_CASP2	c4.CGN_ cancer gene neighborhoods	85	0.9172009	0.6347942	0.8106557	MORF_CASP2	89	0.58315754	0.99682873	1	1.50035844	0.33404336
GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP	C7_ immunologic signatures	173	0.9170475	0.67176473	0.81096697	GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP	180	0.9598812	0.6089159	0.9710862	1.8769287	-0.0428337
GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP	C7_ immunologic signatures	152	0.9169487	0.6622114	0.81112367	GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP	153	0.9526107	0.5969543	0.9786016	1.8695594	-0.035662
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	64	0.91694695	0.63064295	0.8110313	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	66	0.9814482	0.5348066	0.94676334	1.89839515	-0.06450125
LEE_LIVER_CANCER_SURVIVAL_UP	c2.CGP_ chemical and genetic perturbations	147	0.91693586	0.6577993	0.8109617	LEE_LIVER_CANCER_SURVIVAL_UP	156	1.264601	0.058645096	0.490397	2.18153686	-0.34766514
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN	C7_ immunologic signatures	114	0.9169264	0.6572529	0.8108896	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN	116	1.1393007	0.23913044	0.6916785	2.0562271	-0.2223743
RODRIGUES_NTN1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	15	0.9168929	0.5883257	0.8108842	RODRIGUES_NTN1_TARGETS_UP	16	-1.2525263	0.19642857	0.32116106	-0.3356334	2.1694192
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	c2.CGP_ chemical and genetic perturbations	81	0.9168874	0.64986736	0.8108029	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	81	0.9373953	0.6345339	0.99342793	1.8542827	-0.0205079
GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	173	0.9168528	0.6559524	0.8107983	GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP	173	0.76159936	0.93819654	1	1.67845216	0.15525344
EIF4E_DN	C6_ oncogenic signatures	87	0.9167444	0.606536	0.8109846	EIF4E_DN	89	1.2291536	0.119667016	0.5431053	2.145898	-0.3124092
GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP	C7_ immunologic signatures	148	0.91658217	0.6698565	0.8113004	GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP	154	0.97487897	0.56880736	0.95606583	1.89146114	-0.0582968
GO_REGULATION_OF_ARF_PROTEIN_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	15	0.9165704	0.5645161	0.81123596	GO_REGULATION_OF_ARF_PROTEIN_SIGNAL_TRANSDUCTION	15	1.3882489	0.08792651	0.34830785	2.3048193	-0.4716785
BRUINS_UVC_RESPONSE_MIDDLE	c2.CGP_ chemical and genetic perturbations	81	0.9165524	0.6485084	0.8111884	BRUINS_UVC_RESPONSE_MIDDLE	82	0.80579185	0.81104034	1	1.72234425	0.11076055
NAKAMURA_CANCER_MICROENVIRONMENT_UP	c2.CGP_ chemical and genetic perturbations	19	0.9165389	0.5825397	0.81112605	NAKAMURA_CANCER_MICROENVIRONMENT_UP	21	0.69478124	0.87723786	1	1.61132014	0.22175766
GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN	C7_ immunologic signatures	168	0.9165338	0.66384524	0.8110413	GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN	171	1.219948	0.07886754	0.5553655	2.1364818	-0.3034142
MORF_RBM8A	c4.CGN_ cancer gene neighborhoods	72	0.916418	0.60461956	0.81124324	MORF_RBM8A	76	0.69655764	0.9337607	1	1.61297564	0.21986036
GSE3039_NKT_CELL_VS_B2_BCELL_DN	C7_ immunologic signatures	168	0.9162999	0.6549637	0.8114519	GSE3039_NKT_CELL_VS_B2_BCELL_DN	169	1.3593837	0.00814664	0.3779795	2.2756836	-0.4430838
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN	C7_ immunologic signatures	168	0.91625136	0.65483475	0.8114833	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN	173	1.051712	0.38485157	0.83718735	1.96796336	-0.13546064
GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS	c5.BP_ GO biological process	102	0.9162012	0.65300894	0.8115204	GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS	112	0.93972296	0.624355	0.9902981	1.85592416	-0.02352176
MARSON_FOXP3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	57	0.9161074	0.6053748	0.8116628	MARSON_FOXP3_TARGETS_UP	58	1.0455179	0.41144115	0.84801304	1.9616253	-0.1294105
GO_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT	c5.BP_ GO biological process	214	0.9160991	0.69624573	0.81158876	GO_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT	221	0.776654	0.92028254	1	1.6927531	0.1394451
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	c2.CGP_ chemical and genetic perturbations	99	0.9159873	0.62828535	0.81177926	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	100	0.8705515	0.74058574	1	1.7865388	0.0454358
STEARMAN_TUMOR_FIELD_EFFECT_UP	c2.CGP_ chemical and genetic perturbations	31	0.9159429	0.56838906	0.8118026	STEARMAN_TUMOR_FIELD_EFFECT_UP	32	1.1558613	0.25536993	0.6605749	2.0718042	-0.2399184
GO_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES	c5.BP_ GO biological process	30	0.91578853	0.58125	0.81210816	GO_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES	30	0.92634946	0.5788235	1	1.84213799	-0.01056093
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	c2.CP_BIOCARTA_ BioCarta gene sets	50	0.9157643	0.60851645	0.81207544	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	51	0.94756395	0.57079154	0.98455125	1.86332825	-0.03179965
PID_TRAIL_PATHWAY	c2.CP_ Canonical pathways	23	0.9157625	0.58384144	0.811984	PID_TRAIL_PATHWAY	23	0.81608325	0.7351077	1	1.73184575	0.09967925
GO_CYTOKINE_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	351	0.9157496	0.73513514	0.8119234	GO_CYTOKINE_MEDIATED_SIGNALING_PATHWAY	374	0.9236115	0.762	1	1.8393611	-0.0078619
GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP	C7_ immunologic signatures	143	0.9156289	0.6570352	0.8121441	GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP	148	1.2956579	0.03033367	0.44898945	2.2112868	-0.380029
GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN	C7_ immunologic signatures	179	0.91532004	0.6721698	0.8128505	GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN	180	0.8874834	0.76697063	1	1.80280344	0.02783664
GO_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING	c5.BP_ GO biological process	211	0.91531205	0.6563218	0.8127762	GO_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING	211	1.0936011	0.26405624	0.7682488	2.00891315	-0.17828905
GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	169	0.9150941	0.67176473	0.81325215	GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN	174	0.76224893	0.9284995	1	1.67734303	0.15284517
LE_EGR2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	102	0.9150517	0.6289474	0.81327313	LE_EGR2_TARGETS_DN	103	0.8867088	0.72129434	1	1.8017605	0.0283429
GO_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION	c5.BP_ GO biological process	37	0.9149633	0.6119186	0.81341434	GO_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION	41	-1.0335083	0.38345864	0.63261485	-0.118545	1.9484716
GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN	C7_ immunologic signatures	114	0.9148963	0.6449935	0.8134963	GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN	121	0.9318689	0.631038	0.997589	1.8467652	-0.0169726
CAGCTTT_MIR320	c3.MIR_ microRNA targets	227	0.9148621	0.6797688	0.81348974	CAGCTTT_MIR320	233	-0.83868843	1	0.87665576	0.07617367	1.75355053
GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	160	0.9147663	0.6735187	0.81364673	GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP	163	0.83167106	0.83144915	1	1.74643736	0.08309524
GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP	C7_ immunologic signatures	156	0.91475475	0.6682521	0.8135786	GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP	155	-0.85532844	0.84615386	0.8614646	0.05942631	1.77008319
MANN_RESPONSE_TO_AMIFOSTINE_UP	c2.CGP_ chemical and genetic perturbations	19	0.91472214	0.62025315	0.8135668	MANN_RESPONSE_TO_AMIFOSTINE_UP	19	-0.7868419	0.81900454	0.9167534	0.12788024	1.70156404
GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP	C7_ immunologic signatures	120	0.9146774	0.66582596	0.8135875	GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP	129	1.0459315	0.40454078	0.84713626	1.9606089	-0.1312541
GO_PHOSPHOLIPID_DEPHOSPHORYLATION	c5.BP_ GO biological process	21	0.91454554	0.5880503	0.8138329	GO_PHOSPHOLIPID_DEPHOSPHORYLATION	21	1.0863127	0.35741445	0.77564394	2.00085824	-0.17176716
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	c2.CGP_ chemical and genetic perturbations	269	0.9145308	0.6908691	0.8137741	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	270	0.96896666	0.6136136	0.9622759	1.88349746	-0.05443586
GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN	C7_ immunologic signatures	174	0.9144896	0.66349584	0.8137855	GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN	174	0.90580535	0.7152989	1	1.82029495	0.00868425
GO_MITOCHONDRION_LOCALIZATION	c5.BP_ GO biological process	32	0.9144275	0.57787484	0.81384385	GO_MITOCHONDRION_LOCALIZATION	32	0.8471431	0.70665085	1	1.7615706	0.0672844
GO_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION	c5.BP_ GO biological process	106	0.9143315	0.6286439	0.81400305	GO_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION	107	1.135977	0.23371251	0.6960482	2.0503085	-0.2216455
MODULE_511	c4.CM_ cancer modules	31	0.91429484	0.6075188	0.8140024	MODULE_511	33	1.2062943	0.20443925	0.58221	2.12058914	-0.29199946
GO_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	21	0.91429234	0.58877087	0.81391346	GO_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS	20	0.7323841	0.83625	1	1.64667644	0.18190824
GO_ACROSOMAL_VESICLE	c5.CC_ GO cellular component	70	0.91428965	0.6239554	0.8138237	GO_ACROSOMAL_VESICLE	80	0.9777817	0.53961456	0.9519827	1.89207135	-0.06349205
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN	C7_ immunologic signatures	163	0.9141445	0.6638955	0.81410444	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN	167	1.081267	0.30808082	0.7857572	1.9954115	-0.1671225
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	C7_ immunologic signatures	162	0.914055	0.6646116	0.8142487	GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	162	1.1639094	0.15939087	0.6473598	2.0779644	-0.2498544
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	65	0.9140212	0.6032609	0.8142455	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	67	1.098563	0.31487513	0.7585963	2.0125842	-0.1845418
LEI_HOXC8_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	16	0.91400945	0.5779221	0.81417793	LEI_HOXC8_TARGETS_DN	16	0.71600586	0.86996096	1	1.63001531	0.19800359
GO_REGULATION_OF_PEPTIDE_SECRETION	c5.BP_ GO biological process	162	0.9139988	0.6703567	0.81410867	GO_REGULATION_OF_PEPTIDE_SECRETION	185	1.2473722	0.06363636	0.5151708	2.161371	-0.3333734
GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	179	0.91397315	0.67734283	0.81407785	GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP	180	0.73900914	0.95573443	1	1.65298229	0.17496401
GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP	C7_ immunologic signatures	133	0.9139474	0.6526946	0.8140493	GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP	140	1.2018492	0.119266056	0.5888568	2.1157966	-0.2879018
WONG_IFNA2_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	15	0.9138911	0.59090906	0.8140999	WONG_IFNA2_RESISTANCE_UP	15	1.1154549	0.3368146	0.7297889	2.029346	-0.2015638
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	c2.CGP_ chemical and genetic perturbations	73	0.9138711	0.6128609	0.8140552	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	72	0.8851489	0.69372296	1	1.79902	0.0287222
GSE27896_HDAC6_KO_VS_WT_TREG_UP	C7_ immunologic signatures	159	0.9138693	0.67980886	0.81396246	GSE27896_HDAC6_KO_VS_WT_TREG_UP	161	1.203466	0.11032388	0.5856915	2.1173353	-0.2895967
GO_CELL_PROJECTION_MEMBRANE	c5.CC_ GO cellular component	258	0.9138203	0.69777775	0.81399524	GO_CELL_PROJECTION_MEMBRANE	267	1.1500602	0.13453816	0.66968817	2.0638805	-0.2362399
GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	153	0.9138111	0.67527676	0.8139218	GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	157	1.1801627	0.14939025	0.6235216	2.0939738	-0.2663516
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	c2.CGP_ chemical and genetic perturbations	27	0.9137537	0.58435583	0.8139713	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	27	1.0017943	0.48488513	0.9205882	1.915548	-0.0880406
GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	C7_ immunologic signatures	177	0.91367984	0.69069767	0.81406343	GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	177	0.86110425	0.7912867	1	1.77478409	0.05257559
GNF2_TST	c4.CGN_ cancer gene neighborhoods	80	0.91364646	0.6359946	0.8140508	GNF2_TST	91	1.1996189	0.16435432	0.5931642	2.11326536	-0.28597244
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	C7_ immunologic signatures	182	0.91357493	0.6837806	0.8141491	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	183	1.0691786	0.33808553	0.80701	1.98275353	-0.15560367
GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	178	0.91350317	0.6750299	0.81424654	GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	178	0.9435798	0.6447368	0.98859966	1.85708297	-0.03007663
GO_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	33	0.9133879	0.58656716	0.8144452	GO_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS	33	-1.3664362	0.050632913	0.22974616	-0.4530483	2.2798241
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI	c2.CP_REACTOME_ Reactome gene sets	16	0.9133844	0.5925926	0.8143582	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI	16	1.339428	0.100391135	0.39611223	2.2528124	-0.4260436
GO_RESPONSE_TO_ANGIOTENSIN	c5.BP_ GO biological process	16	0.9133284	0.59410805	0.81441164	GO_RESPONSE_TO_ANGIOTENSIN	16	0.5980386	0.9420103	1	1.511367	0.3152898
GO_PEPTIDYL_LYSINE_TRIMETHYLATION	c5.BP_ GO biological process	18	0.9132538	0.5796875	0.81451225	GO_PEPTIDYL_LYSINE_TRIMETHYLATION	18	-1.6215888	0.036036037	0.08373115	-0.708335	2.5348426
GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	161	0.91320765	0.6674787	0.8145395	GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	165	1.1304569	0.20951417	0.705832	2.04366455	-0.21724925
PID_WNT_CANONICAL_PATHWAY	c2.CP_ Canonical pathways	18	0.9131227	0.5644654	0.8146639	PID_WNT_CANONICAL_PATHWAY	19	-0.6624798	0.9073171	0.9739053	0.2506429	1.5756025
GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN	C7_ immunologic signatures	177	0.9130605	0.69129914	0.81472856	GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN	177	-1.0731686	0.13333334	0.5636495	-0.1601081	1.9862291
GO_ESTABLISHMENT_OR_MAINTENANCE_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY	c5.BP_ GO biological process	25	0.9129469	0.5975422	0.8149337	GO_ESTABLISHMENT_OR_MAINTENANCE_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY	27	-1.2083119	0.13855422	0.36967123	-0.295365	2.1212588
GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP	C7_ immunologic signatures	185	0.91292924	0.6853147	0.81488144	GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP	188	1.1240349	0.20647773	0.7174793	2.03696414	-0.21110566
GO_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE	c5.BP_ GO biological process	51	0.91283387	0.6167582	0.81502885	GO_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE	51	0.95526254	0.5535098	0.97599185	1.86809641	-0.04242867
LABBE_TGFB1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	95	0.9128299	0.64438504	0.8149443	LABBE_TGFB1_TARGETS_UP	96	1.1195356	0.2761506	0.7234809	2.0323655	-0.2067057
HEB_Q6	c3.TFT_ transcription factor targets	231	0.91278094	0.7147689	0.81497985	HEB_Q6	233	1.1113821	0.21005026	0.73554015	2.02416304	-0.19860116
GO_NUCLEAR_CHROMOSOME_TELOMERIC_REGION	c5.CC_ GO cellular component	100	0.9126828	0.6521197	0.81513846	GO_NUCLEAR_CHROMOSOME_TELOMERIC_REGION	101	-1.1867588	0.060606062	0.3973093	-0.274076	2.0994416
GO_GTPASE_ACTIVITY	c5.GO molecular function	212	0.91268116	0.7122807	0.81504655	GO_GTPASE_ACTIVITY	218	0.7367778	0.9667339	1	1.64945896	0.17590336
GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	188	0.91262	0.682783	0.81510174	GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	188	-1.2681288	0	0.3093964	-0.3555088	2.1807488
LUI_THYROID_CANCER_CLUSTER_2	c2.CGP_ chemical and genetic perturbations	39	0.91233695	0.58557284	0.8157487	LUI_THYROID_CANCER_CLUSTER_2	40	1.1060511	0.33094385	0.74488544	2.01838805	-0.19371415
KEGG_INSULIN_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	126	0.91228807	0.6516854	0.8157788	KEGG_INSULIN_SIGNALING_PATHWAY	130	0.8407443	0.79408765	1	1.75303237	0.07154377
GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN	C7_ immunologic signatures	155	0.91227925	0.66906476	0.8157038	GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN	161	0.8195486	0.8753799	1	1.73182785	0.09273065
GO_METALLOEXOPEPTIDASE_ACTIVITY	c5.GO molecular function	42	0.9122791	0.6167147	0.81560755	GO_METALLOEXOPEPTIDASE_ACTIVITY	46	1.5542226	0.004494382	0.2042035	2.4665017	-0.6419435
GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN	C7_ immunologic signatures	167	0.91220874	0.6967509	0.81570095	GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN	171	1.0265843	0.45445344	0.8817532	1.93879304	-0.11437556
GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP	C7_ immunologic signatures	115	0.9122014	0.65592784	0.8156237	GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP	119	1.36595	0.020746889	0.37125865	2.2781514	-0.4537486
YUAN_ZNF143_PARTNERS	c2.CGP_ chemical and genetic perturbations	21	0.91201496	0.63479626	0.8160141	YUAN_ZNF143_PARTNERS	21	0.7283871	0.83354676	1	1.64040206	0.18362786
GO_TRANS_GOLGI_NETWORK	c5.CC_ GO cellular component	163	0.9118215	0.67108434	0.8164098	GO_TRANS_GOLGI_NETWORK	167	1.0667698	0.34346506	0.8118036	1.9785913	-0.1549483
GSE6259_DEC205_POS_DC_VS_BCELL_DN	C7_ immunologic signatures	155	0.9117871	0.6767554	0.81640047	GSE6259_DEC205_POS_DC_VS_BCELL_DN	155	0.8561835	0.8138352	1	1.7679706	0.0556036
GO_PROTEIN_LIPID_COMPLEX	c5.CC_ GO cellular component	30	0.91175735	0.6023055	0.8163803	GO_PROTEIN_LIPID_COMPLEX	33	0.7501233	0.8393285	1	1.66188065	0.16163405
GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN	C7_ immunologic signatures	180	0.91164476	0.67266184	0.8165716	GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN	181	-1.196687	0.083333336	0.38565275	-0.28504224	2.10833176
GO_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS	c5.BP_ GO biological process	196	0.911616	0.67548907	0.8165466	GO_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS	200	0.79704076	0.9001009	1	1.70865676	0.11457524
CREB_Q3	c3.TFT_ transcription factor targets	219	0.91156226	0.7108295	0.8165875	CREB_Q3	222	0.76533675	0.9495459	1	1.67689901	0.14622551
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	C7_ immunologic signatures	169	0.91155684	0.7046005	0.8165027	GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	171	1.0932686	0.26464647	0.7680248	2.00482544	-0.18171176
GO_REGULATION_OF_HISTONE_DEACETYLATION	c5.BP_ GO biological process	21	0.91153467	0.58401304	0.8164652	GO_REGULATION_OF_HISTONE_DEACETYLATION	22	0.5188759	0.97850823	1	1.43041057	0.39265877
GO_FLUID_TRANSPORT	c5.BP_ GO biological process	23	0.911467	0.60413355	0.8165405	GO_FLUID_TRANSPORT	23	-0.9423121	0.52820516	0.7664027	-0.0308451	1.8537791
GO_BRUSH_BORDER	c5.CC_ GO cellular component	88	0.9114315	0.6154822	0.8165405	GO_BRUSH_BORDER	94	1.3281331	0.042689435	0.40353447	2.2395646	-0.4167016
GSE557_WT_VS_I_AB_KO_DC_DN	C7_ immunologic signatures	175	0.911379	0.6801427	0.8165834	GSE557_WT_VS_I_AB_KO_DC_DN	178	-1.6843884	0	0.06004915	-0.7730094	2.5957674
GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING	c5.GO molecular function	17	0.91134876	0.6064	0.8165646	GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING	17	0.97154903	0.5433673	0.96005	1.88289779	-0.06020027
GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	166	0.91134167	0.68838865	0.8164874	GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	167	0.7267119	0.94848484	1	1.63805357	0.18462977
REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	c2.CP_REACTOME_ Reactome gene sets	100	0.9112129	0.65447664	0.8167131	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	101	0.9132883	0.66071427	1	1.8245012	-0.0020754
WAGNER_APO2_SENSITIVITY	c2.CGP_ chemical and genetic perturbations	17	0.911099	0.60392797	0.816912	WAGNER_APO2_SENSITIVITY	18	1.3901218	0.09018568	0.3449219	2.3012208	-0.4790228
GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN	C7_ immunologic signatures	151	0.91101843	0.6764706	0.81702596	GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN	154	1.1356938	0.21596725	0.6958748	2.04671223	-0.22467537
GO_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION	c5.BP_ GO biological process	30	0.91094625	0.61024845	0.81711847	GO_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION	31	0.538474	0.9857651	1	1.44942025	0.37247225
GO_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE	c5.BP_ GO biological process	23	0.9109062	0.6047619	0.81712395	GO_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE	23	0.8253956	0.7247475	1	1.7363018	0.0855106
GO_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	28	0.9107834	0.5987934	0.81733936	GO_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS	33	1.2431786	0.15539739	0.522797	2.153962	-0.3323952
GO_RHYTHMIC_BEHAVIOR	c5.BP_ GO biological process	17	0.9107549	0.618442	0.81731606	GO_RHYTHMIC_BEHAVIOR	17	0.8656928	0.6706349	1	1.7764477	0.0450621
GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	178	0.91071266	0.6809015	0.81732917	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP	181	0.646866	0.9898888	1	1.55757866	0.26384666
GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN	C7_ immunologic signatures	177	0.9106662	0.6805721	0.81735957	GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN	181	0.7312277	0.95564514	1	1.6418939	0.1794385
MORF_TFDP2	c4.CGN_ cancer gene neighborhoods	183	0.9106606	0.7034483	0.8172799	MORF_TFDP2	204	1.1914912	0.08713272	0.60431564	2.1021518	-0.2808306
DAZARD_RESPONSE_TO_UV_SCC_DN	c2.CGP_ chemical and genetic perturbations	114	0.9106512	0.6795866	0.81721133	DAZARD_RESPONSE_TO_UV_SCC_DN	114	0.9180425	0.6680412	1	1.8286937	-0.0073913
SA_CASPASE_CASCADE	c2.CP_ Canonical pathways	17	0.9106427	0.6044304	0.8171386	SA_CASPASE_CASCADE	18	0.83222324	0.7235669	1	1.74286594	0.07841946
SASSON_RESPONSE_TO_GONADOTROPHINS_UP	c2.CGP_ chemical and genetic perturbations	79	0.9106269	0.6408545	0.8170802	SASSON_RESPONSE_TO_GONADOTROPHINS_UP	80	1.031535	0.41339	0.87409	1.9421619	-0.1209081
DOANE_BREAST_CANCER_CLASSES_DN	c2.CGP_ chemical and genetic perturbations	30	0.91054744	0.6038864	0.81719494	DOANE_BREAST_CANCER_CLASSES_DN	33	1.2692391	0.14074074	0.48552427	2.17978654	-0.35869166
GNF2_DNM1	c4.CGN_ cancer gene neighborhoods	70	0.9103355	0.6341128	0.8176413	GNF2_DNM1	73	1.1820552	0.20581897	0.61969936	2.0923907	-0.2717197
GO_STEROL_BINDING	c5.GO molecular function	37	0.9102763	0.61086637	0.8177006	GO_STEROL_BINDING	39	1.1052098	0.32613635	0.7460542	2.0154861	-0.1949335
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN	C7_ immunologic signatures	178	0.91026586	0.6694118	0.8176309	GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN	180	1.281894	0.034587994	0.46967453	2.19215986	-0.37162814
GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN	C7_ immunologic signatures	180	0.9102274	0.6818182	0.8176359	GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN	181	-0.83413523	1	0.87864375	0.07609217	1.74436263
GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN	C7_ immunologic signatures	175	0.9102124	0.6801854	0.8175777	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN	180	1.1143432	0.24647887	0.73128515	2.0245556	-0.2041308
GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	169	0.91017705	0.68439716	0.8175732	GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	170	0.8709578	0.79939514	1	1.78113485	0.03921925
GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP	C7_ immunologic signatures	133	0.9101621	0.6633663	0.817516	GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP	137	0.7577109	0.9169231	1	1.667873	0.1524512
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	c2.CGP_ chemical and genetic perturbations	231	0.91005874	0.6993007	0.81769025	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	235	1.0606971	0.32696176	0.8225148	1.97075584	-0.15063836
GO_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS	c5.BP_ GO biological process	30	0.9099002	0.5996979	0.81799823	GO_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS	30	0.8112071	0.7609223	1	1.7211073	0.0986931
GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP	C7_ immunologic signatures	173	0.9098537	0.681764	0.818024	GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP	173	-0.8358527	0.93333334	0.8771711	0.074001	1.7457064
GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN	C7_ immunologic signatures	189	0.90974814	0.6952842	0.818197	GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN	190	-0.921314	0.6	0.79462475	-0.01156586	1.83106214
GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	171	0.90971303	0.6967113	0.81819534	GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	174	1.012442	0.4702321	0.9032778	1.92215503	-0.10272897
BIOCARTA_MCM_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	0.909411	0.59193546	0.8188797	BIOCARTA_MCM_PATHWAY	18	-2.0420647	0.004149378	0.005393769	-1.1326537	2.9514757
GO_SINGLE_ORGANISM_MEMBRANE_FUSION	c5.BP_ GO biological process	102	0.9093752	0.6735484	0.8188792	GO_SINGLE_ORGANISM_MEMBRANE_FUSION	105	1.1981415	0.1388601	0.59592927	2.1075167	-0.2887663
GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP	C7_ immunologic signatures	179	0.9091467	0.68235296	0.81936646	GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP	177	0.94459206	0.65858585	0.9875844	1.85373876	-0.03544536
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP	C7_ immunologic signatures	176	0.9089542	0.68578255	0.819766	GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP	179	0.8311588	0.852077	1	1.740113	0.0777954
BIOCARTA_FCER1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	35	0.9089257	0.63505745	0.8197448	BIOCARTA_FCER1_PATHWAY	36	1.5416251	0.005834306	0.21039459	2.4505508	-0.6326994
GSE15215_CD2_POS_VS_NEG_PDC_UP	C7_ immunologic signatures	164	0.9089195	0.6686747	0.8196632	GSE15215_CD2_POS_VS_NEG_PDC_UP	175	0.96276516	0.6062753	0.9680556	1.87168466	-0.05384566
GO_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY	c5.BP_ GO biological process	56	0.90888804	0.6126761	0.81964177	GO_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY	57	1.0721922	0.37041157	0.80230373	1.98108024	-0.16330416
GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP	C7_ immunologic signatures	167	0.90886587	0.6807229	0.8196021	GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP	170	0.9636294	0.5855397	0.96709245	1.87249527	-0.05476353
GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	142	0.9087989	0.67478687	0.81967556	GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	142	1.1774402	0.16786818	0.6266239	2.0862391	-0.2686413
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP	C7_ immunologic signatures	181	0.9086709	0.6866029	0.81991494	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP	182	0.5543115	1	1	1.4629824	0.3543594
GO_MULTI_ORGANISM_MEMBRANE_ORGANIZATION	c5.BP_ GO biological process	27	0.9086655	0.59875584	0.8198331	GO_MULTI_ORGANISM_MEMBRANE_ORGANIZATION	27	-0.7787695	0.8369565	0.92298794	0.129896	1.687435
AP1_Q2_01	c3.TFT_ transcription factor targets	237	0.90862	0.7034091	0.8198544	AP1_Q2_01	250	1.1771866	0.116582915	0.6265326	2.0858066	-0.2685666
MORF_MYST2	c4.CGN_ cancer gene neighborhoods	60	0.90851635	0.61538464	0.8200293	MORF_MYST2	62	0.7641811	0.8527808	1	1.67269745	0.14433525
MODULE_248	c4.CM_ cancer modules	116	0.9084699	0.67412937	0.82005525	MODULE_248	122	1.2149626	0.11971104	0.5669906	2.1234325	-0.3064927
GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP	C7_ immunologic signatures	174	0.90846694	0.676611	0.81996536	GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP	174	0.80667835	0.8799193	1	1.71514529	0.10178859
AREB6_01	c3.TFT_ transcription factor targets	234	0.9084256	0.69780856	0.8199839	AREB6_01	247	1.0122494	0.47088355	0.9036373	1.920675	-0.1038238
CAR_WBSCR22	c4.CGN_ cancer gene neighborhoods	25	0.90834886	0.625	0.82008564	CAR_WBSCR22	29	1.0862182	0.35160905	0.7757527	1.99456706	-0.17786934
GO_LAMIN_BINDING	c5.GO molecular function	16	0.90826946	0.58478606	0.82018995	GO_LAMIN_BINDING	16	0.80798215	0.75812745	1	1.71625161	0.10028731
GO_MANGANESE_ION_BINDING	c5.GO molecular function	41	0.9081946	0.6309696	0.82028645	GO_MANGANESE_ION_BINDING	43	0.6303805	0.967366	1	1.5385751	0.2778141
GO_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION	c5.BP_ GO biological process	308	0.9081805	0.71460426	0.8202265	GO_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION	317	0.8061492	0.9329329	1	1.7143297	0.1020313
GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN	C7_ immunologic signatures	185	0.90817994	0.6953405	0.8201314	GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN	186	1.1622646	0.16008106	0.6497837	2.07044454	-0.25408466
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	c2.CGP_ chemical and genetic perturbations	73	0.90804535	0.64435697	0.8203759	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	74	-1.0946946	0.29411766	0.52593	-0.18664925	2.00273995
GSE22886_NAIVE_CD4_TCELL_VS_DC_UP	C7_ immunologic signatures	160	0.90789944	0.68149036	0.82064104	GSE22886_NAIVE_CD4_TCELL_VS_DC_UP	165	0.8628786	0.76876265	1	1.77077804	0.04502084
GO_PHOTOPERIODISM	c5.BP_ GO biological process	22	0.9078824	0.6028481	0.82058597	GO_PHOTOPERIODISM	23	0.6331511	0.9254808	1	1.5410335	0.2747313
GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP	C7_ immunologic signatures	174	0.9078624	0.6851415	0.8205409	GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP	176	0.8294337	0.8718466	1	1.7372961	0.0784287
MODULE_485	c4.CM_ cancer modules	43	0.9077267	0.61167884	0.82079077	MODULE_485	44	-1.235381	0.1328125	0.34008613	-0.3276543	2.1431077
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	c2.CGP_ chemical and genetic perturbations	220	0.90769774	0.705951	0.8207682	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	221	1.254327	0.03222558	0.502754	2.16202474	-0.34662926
WENG_POR_TARGETS_LIVER_DN	c2.CGP_ chemical and genetic perturbations	17	0.9076886	0.623839	0.82069594	WENG_POR_TARGETS_LIVER_DN	16	1.0208514	0.45743328	0.8909353	1.92854	-0.1131628
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	c2.CGP_ chemical and genetic perturbations	148	0.9076209	0.6863905	0.8207754	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	148	0.8053648	0.8755102	1	1.7129857	0.1022561
GO_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS	c5.BP_ GO biological process	38	0.90730715	0.6255639	0.8214902	GO_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS	37	0.72956926	0.8824228	1	1.63687641	0.17773789
CHR2Q23	C1: positional gene sets	21	0.9071136	0.58320373	0.82189995	CHR2Q23	21	1.0310789	0.43308082	0.87454826	1.9381925	-0.1239653
MYOD_Q6_01	c3.TFT_ transcription factor targets	226	0.9070979	0.7137891	0.82184345	MYOD_Q6_01	229	0.82340086	0.89447236	1	1.73049876	0.08369704
MODULE_206	c4.CM_ cancer modules	132	0.90708315	0.68578553	0.82178795	MODULE_206	133	1.0887169	0.30610135	0.77308756	1.99580005	-0.18163375
GSE27786_LSK_VS_NEUTROPHIL_UP	C7_ immunologic signatures	173	0.90705836	0.69739956	0.8217542	GSE27786_LSK_VS_NEUTROPHIL_UP	174	0.77051663	0.9264113	1	1.67757499	0.13654173
MORI_PRE_BI_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	63	0.90705127	0.6361072	0.8216771	MORI_PRE_BI_LYMPHOCYTE_DN	67	1.281014	0.0867679	0.47068113	2.18806527	-0.37396273
GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	152	0.9069017	0.6944785	0.82195276	GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP	154	0.8314619	0.8356998	1	1.7383636	0.0754398
GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	175	0.90666276	0.70665085	0.8224759	GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP	182	0.9651508	0.5892495	0.96518135	1.87181356	-0.05848804
GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_DN	C7_ immunologic signatures	156	0.90650076	0.6845966	0.8227995	GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_DN	160	1.0950843	0.28150406	0.7647133	2.00158506	-0.18858354
GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN	C7_ immunologic signatures	146	0.90640503	0.69193155	0.8229502	GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN	148	0.8659421	0.7878476	1	1.77234713	0.04046293
GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_UP	C7_ immunologic signatures	169	0.9062932	0.6875769	0.8231405	GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_UP	176	0.87065905	0.7959596	1	1.77695225	0.03563415
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN	C7_ immunologic signatures	166	0.9062627	0.6867612	0.8231231	GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN	174	1.1352654	0.18255578	0.69650996	2.0415281	-0.2290027
BYSTROEM_CORRELATED_WITH_IL5_DN	c2.CGP_ chemical and genetic perturbations	63	0.9060121	0.6341789	0.82367045	BYSTROEM_CORRELATED_WITH_IL5_DN	63	0.6849286	0.9402174	1	1.5909407	0.2210835
GSE7764_NKCELL_VS_SPLENOCYTE_DN	C7_ immunologic signatures	179	0.90595526	0.7110849	0.82371897	GSE7764_NKCELL_VS_SPLENOCYTE_DN	186	0.86834425	0.7891019	1	1.77429951	0.03761101
RICKMAN_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	286	0.9058033	0.7185355	0.8240105	RICKMAN_METASTASIS_UP	289	0.68341833	0.993988	1	1.58922163	0.22238497
GO_MYELOID_LEUKOCYTE_ACTIVATION	c5.BP_ GO biological process	80	0.90562856	0.6351531	0.82435745	GO_MYELOID_LEUKOCYTE_ACTIVATION	82	1.4236529	0.012779553	0.318218	2.32928146	-0.51802434
HUMMEL_BURKITTS_LYMPHOMA_UP	c2.CGP_ chemical and genetic perturbations	35	0.9056171	0.61078715	0.82428557	HUMMEL_BURKITTS_LYMPHOMA_UP	35	0.7127319	0.89285713	1	1.618349	0.1928852
GSE18893_TCONV_VS_TREG_2H_CULTURE_UP	C7_ immunologic signatures	172	0.90557355	0.68757397	0.8243012	GSE18893_TCONV_VS_TREG_2H_CULTURE_UP	175	0.94706017	0.6395939	0.98539054	1.85263372	-0.04148662
GO_POSITIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS	c5.BP_ GO biological process	134	0.9054535	0.6811955	0.82451004	GO_POSITIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS	138	-0.91304344	0.8	0.80303806	-0.00758994	1.81849694
CYCLIN_D1_UP.V1_UP	C6_ oncogenic signatures	152	0.90540624	0.70710784	0.82452863	CYCLIN_D1_UP.V1_UP	163	1.2429241	0.056737587	0.5228323	2.14833034	-0.33751786
GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN	C7_ immunologic signatures	186	0.90529644	0.7152941	0.8247152	GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN	186	-1.0369161	0.22222222	0.6273909	-0.13161966	1.94221254
GO_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION	c5.BP_ GO biological process	25	0.9051558	0.60983104	0.82497525	GO_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION	25	1.3914405	0.06993865	0.34693515	2.2965963	-0.4862847
STAT1_01	c3.TFT_ transcription factor targets	54	0.90513396	0.6402778	0.82493305	STAT1_01	58	0.93322605	0.6036717	0.99694973	1.83836001	-0.02809209
GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP	C7_ immunologic signatures	156	0.9051237	0.68421054	0.82486165	GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP	165	1.1646876	0.16514692	0.6461892	2.0698113	-0.2595639
GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP	C7_ immunologic signatures	185	0.9050562	0.6942149	0.8249374	GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP	185	0.7490283	0.94827586	1	1.6540845	0.1560279
GO_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION	c5.CC_ GO cellular component	30	0.90502095	0.6046176	0.82493514	GO_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION	30	1.5057843	0.015815085	0.24591206	2.41080525	-0.60076335
GSE6875_TCONV_VS_TREG_DN	C7_ immunologic signatures	169	0.90501326	0.6693736	0.824859	GSE6875_TCONV_VS_TREG_DN	177	0.900601	0.7484725	1	1.80561426	0.00441226
GSE45365_NK_CELL_VS_BCELL_DN	C7_ immunologic signatures	113	0.9048193	0.656925	0.82525545	GSE45365_NK_CELL_VS_BCELL_DN	121	1.1929404	0.1458118	0.6004103	2.0977597	-0.2881211
ZAMORA_NOS2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	81	0.9047363	0.65039575	0.8253663	ZAMORA_NOS2_TARGETS_DN	84	0.91987914	0.63897765	1	1.82461544	-0.01514284
GO_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION	c5.BP_ GO biological process	15	0.9047058	0.60547507	0.82534015	GO_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION	15	0.9829926	0.5161725	0.94425285	1.8876984	-0.0782868
GO_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION	c5.BP_ GO biological process	16	0.9046491	0.6131045	0.8253893	GO_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION	16	-1.0086508	0.4296875	0.6743294	-0.1040017	1.9132999
GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP	C7_ immunologic signatures	171	0.9045302	0.706235	0.82559294	GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP	176	1.0296155	0.43407708	0.87586975	1.9341457	-0.1250853
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	C7_ immunologic signatures	170	0.9045029	0.68327403	0.82557195	GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	176	1.425238	0	0.31861252	2.3297409	-0.5207351
GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN	C7_ immunologic signatures	157	0.9043788	0.70160294	0.82579434	GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN	162	1.0313296	0.40609136	0.8743645	1.9357084	-0.1269508
LI_ADIPOGENESIS_BY_ACTIVATED_PPARG	c2.CGP_ chemical and genetic perturbations	16	0.9042939	0.6042345	0.8259107	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG	17	0.67102534	0.8893333	1	1.57531924	0.23326856
GCM_CRKL	c4.CGN_ cancer gene neighborhoods	58	0.9040404	0.6506365	0.8264461	GCM_CRKL	58	0.66318256	0.9597765	1	1.56722296	0.24085784
GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP	C7_ immunologic signatures	177	0.9039977	0.69014084	0.8264522	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP	179	0.6919572	0.97876644	1	1.5959549	0.2120405
GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN	C7_ immunologic signatures	128	0.90398127	0.67245656	0.82640076	GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN	130	1.2885481	0.05035971	0.46016756	2.19252937	-0.38456683
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	c2.CGP_ chemical and genetic perturbations	262	0.90387416	0.71235955	0.8265793	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	270	1.1369025	0.163142	0.6947244	2.04077666	-0.23302834
WANG_LMO4_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	306	0.90387374	0.74861574	0.8264844	WANG_LMO4_TARGETS_UP	310	0.5964334	1	1	1.50030714	0.30744034
GO_CYTOKINE_METABOLIC_PROCESS	c5.BP_ GO biological process	17	0.903686	0.59197325	0.82686186	GO_CYTOKINE_METABOLIC_PROCESS	15	-1.0159836	0.42723006	0.6647769	-0.1122976	1.9196696
GO_NUCLEAR_INNER_MEMBRANE	c5.CC_ GO cellular component	42	0.9036701	0.6122449	0.82680434	GO_NUCLEAR_INNER_MEMBRANE	41	0.7043784	0.90207374	1	1.6080485	0.1992917
GO_INTRINSIC_COMPONENT_OF_GOLGI_MEMBRANE	c5.CC_ GO cellular component	49	0.90366095	0.62674093	0.8267291	GO_INTRINSIC_COMPONENT_OF_GOLGI_MEMBRANE	49	1.1973356	0.20022753	0.59735805	2.10099655	-0.29367465
GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN	C7_ immunologic signatures	135	0.903621	0.6846626	0.8267329	GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN	144	1.1478268	0.18069816	0.67239547	2.0514478	-0.2442058
GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP	C7_ immunologic signatures	163	0.90343416	0.695599	0.82711667	GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP	165	1.4587336	0.002038736	0.28385267	2.36216776	-0.55529944
GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	166	0.9033793	0.70560193	0.8271552	GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	175	-0.9602001	0.6666667	0.74209917	-0.0568208	1.8635794
AHR_01	c3.TFT_ transcription factor targets	55	0.90336514	0.62184876	0.8270979	AHR_01	57	-1.1682959	0.16666667	0.4189925	-0.26493076	2.07166104
MORF_PPP2R5B	c4.CGN_ cancer gene neighborhoods	133	0.90328825	0.682266	0.8271942	MORF_PPP2R5B	147	1.2706175	0.055271238	0.4838129	2.17390575	-0.36732925
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	c2.CGP_ chemical and genetic perturbations	16	0.90326124	0.6066879	0.82716674	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	17	1.2238901	0.19300517	0.55029005	2.12715134	-0.32062886
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN	C7_ immunologic signatures	164	0.90292126	0.68779343	0.82792735	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN	164	1.2802043	0.045918368	0.47180992	2.18312556	-0.37728304
MORF_ATF2	c4.CGN_ cancer gene neighborhoods	254	0.9029016	0.7339346	0.827879	MORF_ATF2	270	1.32414	0.006018054	0.40928978	2.2270416	-0.4212384
GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN	C7_ immunologic signatures	174	0.90283513	0.6839623	0.82795554	GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN	179	1.254032	0.04761905	0.50291353	2.15686713	-0.35119687
GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN	C7_ immunologic signatures	164	0.9027835	0.7009685	0.8279911	GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN	172	0.98392445	0.5478349	0.94277203	1.88670795	-0.08114095
GO_SCAFFOLD_PROTEIN_BINDING	c5.GO molecular function	42	0.90274215	0.60567373	0.8280032	GO_SCAFFOLD_PROTEIN_BINDING	42	0.8327329	0.7579318	1	1.73547505	0.07000925
GSE31082_DN_VS_DP_THYMOCYTE_DN	C7_ immunologic signatures	184	0.90264654	0.6952842	0.8281566	GSE31082_DN_VS_DP_THYMOCYTE_DN	184	1.0919806	0.28816986	0.76921815	1.99462714	-0.18933406
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	186	0.90261036	0.7175926	0.82814664	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP	184	0.99209636	0.5365112	0.9335826	1.89470672	-0.089486
BROWNE_HCMV_INFECTION_30MIN_DN	c2.CGP_ chemical and genetic perturbations	123	0.90248346	0.6683481	0.82837665	BROWNE_HCMV_INFECTION_30MIN_DN	127	1.0062108	0.4661191	0.9137504	1.90869426	-0.10372734
GO_EPITHELIAL_CELL_DEVELOPMENT	c5.BP_ GO biological process	171	0.90240353	0.71340716	0.8284833	GO_EPITHELIAL_CELL_DEVELOPMENT	176	0.93646544	0.64300203	0.993959	1.83886897	-0.03406191
RASHI_RESPONSE_TO_IONIZING_RADIATION_6	c2.CGP_ chemical and genetic perturbations	70	0.90234	0.6551265	0.8285505	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	69	-0.9056111	0.73913044	0.81430054	-0.0032711	1.8079511
GO_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL	c5.BP_ GO biological process	49	0.9022206	0.6181556	0.8287586	GO_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL	55	1.4275492	0.03374578	0.31768098	2.3297698	-0.5253286
GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP	C7_ immunologic signatures	166	0.90214384	0.7104946	0.82886004	GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP	177	0.9696515	0.570273	0.9616222	1.87179534	-0.06750766
GO_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION	c5.BP_ GO biological process	47	0.9021203	0.6255319	0.82882476	GO_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION	47	1.4676284	0.020713463	0.27652568	2.3697487	-0.5655081
GO_PROTEIN_DEALKYLATION	c5.BP_ GO biological process	26	0.90202934	0.5972222	0.8289555	GO_PROTEIN_DEALKYLATION	26	0.5931189	0.97051597	1	1.49514824	0.30891044
GSE11924_TFH_VS_TH2_CD4_TCELL_UP	C7_ immunologic signatures	179	0.9019656	0.69186044	0.82901174	GSE11924_TFH_VS_TH2_CD4_TCELL_UP	180	1.2871376	0.03147208	0.462044	2.1891032	-0.385172
GSE3982_CTRL_VS_LPS_4H_MAC_UP	C7_ immunologic signatures	172	0.9018989	0.699284	0.8290848	GSE3982_CTRL_VS_LPS_4H_MAC_UP	174	0.70514554	0.96435845	1	1.60704444	0.19675336
VERHAAK_GLIOBLASTOMA_NEURAL	c2.CGP_ chemical and genetic perturbations	107	0.901823	0.6700637	0.8291763	VERHAAK_GLIOBLASTOMA_NEURAL	113	0.90784764	0.6943867	1	1.80967064	-0.00602464
GSE18281_CORTEX_VS_MEDULLA_THYMUS_UP	C7_ immunologic signatures	144	0.90179944	0.7064555	0.8291403	GSE18281_CORTEX_VS_MEDULLA_THYMUS_UP	149	0.7855855	0.9003052	1	1.68738494	0.11621394
MORF_EPHA7	c4.CGN_ cancer gene neighborhoods	112	0.9017631	0.67948717	0.8291327	MORF_EPHA7	116	1.2734956	0.06542056	0.4817911	2.1752587	-0.3717325
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP	c2.CGP_ chemical and genetic perturbations	17	0.9017529	0.6057234	0.82906115	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP	17	0.97922814	0.5013123	0.9502467	1.88098104	-0.07747524
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	c2.CGP_ chemical and genetic perturbations	17	0.9015605	0.5901899	0.82946116	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	17	-1.1430943	0.24019608	0.45208386	-0.2415338	2.0446548
GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	172	0.9014547	0.7131429	0.82963216	GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP	175	0.93596405	0.6437247	0.9942031	1.83741875	-0.03450935
GENTILE_RESPONSE_CLUSTER_D3	c2.CGP_ chemical and genetic perturbations	58	0.90141875	0.64344263	0.8296267	GENTILE_RESPONSE_CLUSTER_D3	58	-1.7128872	0	0.052319564	-0.81146845	2.61430595
GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN	C7_ immunologic signatures	174	0.9013619	0.67995167	0.82966983	GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN	174	1.0163512	0.46544716	0.8953588	1.9177131	-0.1149893
MORF_DMPK	c4.CGN_ cancer gene neighborhoods	136	0.9013616	0.6916462	0.8295742	MORF_DMPK	144	1.4622835	0.001023541	0.2815394	2.3636451	-0.5609219
GO_RESPONSE_TO_FLUID_SHEAR_STRESS	c5.BP_ GO biological process	34	0.901235	0.64036417	0.8298058	GO_RESPONSE_TO_FLUID_SHEAR_STRESS	34	0.9611394	0.5432243	0.9697265	1.8623744	-0.0599044
GO_ANTIMICROBIAL_HUMORAL_RESPONSE	c5.BP_ GO biological process	26	0.9012316	0.5936556	0.8297167	GO_ANTIMICROBIAL_HUMORAL_RESPONSE	28	-1.084307	0.33742332	0.5435938	-0.1830754	1.9855386
GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP	C7_ immunologic signatures	169	0.90118015	0.70202625	0.82975274	GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP	169	0.80573606	0.89216685	1	1.70691621	0.09544409
GO_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	96	0.90112376	0.6662404	0.8297964	GO_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION	108	1.1556606	0.21079959	0.66100013	2.05678436	-0.25453684
GO_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS	c5.BP_ GO biological process	23	0.9008509	0.5784615	0.83038217	GO_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS	23	-1.0043186	0.43809524	0.6778316	-0.1034677	1.9051695
GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	C7_ immunologic signatures	169	0.9008051	0.7072019	0.8304084	GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	170	0.79362166	0.90456855	1	1.69442676	0.10718344
GO_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING	c5.GO molecular function	19	0.9007827	0.6045381	0.8303677	GO_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING	19	0.8439344	0.69419354	1	1.7447171	0.0568483
GO_REGULATION_OF_MRNA_3_END_PROCESSING	c5.BP_ GO biological process	26	0.90071696	0.6125574	0.8304349	GO_REGULATION_OF_MRNA_3_END_PROCESSING	26	0.56398606	0.96666664	1	1.46470302	0.3367309
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN	C7_ immunologic signatures	169	0.9006677	0.7124413	0.8304653	GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN	177	1.0186132	0.4568528	0.8924695	1.9192809	-0.1179455
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN	C7_ immunologic signatures	178	0.90048796	0.7021531	0.8308146	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN	182	0.8492843	0.8145897	1	1.74977226	0.05120366
GO_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS	c5.BP_ GO biological process	18	0.90036255	0.6092504	0.83104	GO_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS	18	0.61580575	0.92975736	1	1.5161683	0.2845568
GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP	C7_ immunologic signatures	165	0.9002101	0.71497005	0.8313333	GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP	175	1.1866924	0.112804875	0.6120853	2.0869025	-0.2864823
OXFORD_RALA_OR_RALB_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	45	0.9001428	0.64876634	0.8314084	OXFORD_RALA_OR_RALB_TARGETS_UP	45	-1.3890132	0.046875	0.21454974	-0.4888704	2.289156
GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN	C7_ immunologic signatures	174	0.9000739	0.7134434	0.831486	GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN	173	0.87254167	0.7857868	1	1.77261557	0.02753223
PID_S1P_META_PATHWAY	c2.CP_ Canonical pathways	20	0.9000164	0.61671925	0.8315358	PID_S1P_META_PATHWAY	20	0.93350005	0.56840795	0.9966296	1.83351645	-0.03348365
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN	c2.CGP_ chemical and genetic perturbations	34	0.8999271	0.62481534	0.83167225	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN	35	0.64733136	0.9442467	1	1.54725846	0.25259574
MODULE_279	c4.CM_ cancer modules	124	0.8999172	0.6662453	0.83160156	MODULE_279	123	1.3595293	0.021716649	0.37808967	2.2594465	-0.4596121
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN	C7_ immunologic signatures	120	0.89976984	0.6773399	0.83187306	GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN	126	1.075806	0.32404542	0.7947526	1.97557584	-0.17603616
BIOCARTA_ETS_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	0.8997556	0.60883284	0.83181185	BIOCARTA_ETS_PATHWAY	18	0.9241976	0.5679172	1	1.8239532	-0.024442
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP	C7_ immunologic signatures	181	0.8997297	0.7257683	0.83178014	GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP	181	0.63997865	0.9918367	1	1.53970835	0.25975105
ZWANG_EGF_INTERVAL_UP	c2.CGP_ chemical and genetic perturbations	66	0.8996727	0.62657344	0.83183324	ZWANG_EGF_INTERVAL_UP	71	0.823973	0.79787236	1	1.7236457	0.0756997
GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_UP	C7_ immunologic signatures	110	0.89957017	0.6958128	0.83198935	GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_UP	111	1.2089019	0.14656964	0.5793634	2.10847207	-0.30933173
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	163	0.89939976	0.6951807	0.83232576	GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP	173	0.9918746	0.5354251	0.93359995	1.89127436	-0.09247484
GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	C7_ immunologic signatures	173	0.89933336	0.6925754	0.8323952	GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	178	0.82352936	0.8791878	1	1.72286272	0.075804
CAMP_UP.V1_DN	C6_ oncogenic signatures	184	0.8992063	0.7204176	0.83261645	CAMP_UP.V1_DN	184	1.0586284	0.37688443	0.8268503	1.9578347	-0.1594221
MODULE_350	c4.CM_ cancer modules	51	0.89918643	0.6290098	0.8325699	MODULE_350	52	0.83417743	0.75310034	1	1.73336386	0.065009
DARWICHE_PAPILLOMA_RISK_HIGH_DN	c2.CGP_ chemical and genetic perturbations	151	0.8989066	0.6988095	0.83317685	DARWICHE_PAPILLOMA_RISK_HIGH_DN	155	0.953392	0.61749744	0.9777815	1.8522986	-0.0544854
GSE17721_POLYIC_VS_CPG_12H_BMDC_UP	C7_ immunologic signatures	174	0.8988338	0.6909518	0.83326036	GSE17721_POLYIC_VS_CPG_12H_BMDC_UP	176	1.0359339	0.38680202	0.86592454	1.9347677	-0.1371001
VALK_AML_CLUSTER_8	c2.CGP_ chemical and genetic perturbations	23	0.89881384	0.6534181	0.8332142	VALK_AML_CLUSTER_8	25	-0.846525	0.7107843	0.8718107	0.05228884	1.74533884
GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	C7_ immunologic signatures	153	0.8985177	0.71480143	0.8338563	GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	152	0.87193614	0.76703966	1	1.77045384	0.02658156
GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN	C7_ immunologic signatures	152	0.8985176	0.6979294	0.83376	GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN	150	1.2246077	0.092573754	0.5497071	2.1231253	-0.3260901
GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP	C7_ immunologic signatures	160	0.89851636	0.7019231	0.83366686	GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP	165	1.093079	0.29513183	0.7682533	1.99159536	-0.19456264
GO_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION	c5.BP_ GO biological process	16	0.8983403	0.6056572	0.8340061	GO_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION	16	1.2520558	0.19550858	0.5083512	2.1503961	-0.3537155
GSE27786_LIN_NEG_VS_CD8_TCELL_UP	C7_ immunologic signatures	188	0.89825654	0.72202593	0.83412164	GSE27786_LIN_NEG_VS_CD8_TCELL_UP	187	0.98730993	0.5266868	0.93899316	1.88556647	-0.08905339
GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN	C7_ immunologic signatures	173	0.89808947	0.7156287	0.83444965	GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN	173	0.8014604	0.88438135	1	1.69954987	0.09662907
GSE2706_2H_VS_8H_LPS_STIM_DC_UP	C7_ immunologic signatures	170	0.8980824	0.70858526	0.834372	GSE2706_2H_VS_8H_LPS_STIM_DC_UP	175	1.1147163	0.25757575	0.7311873	2.0127987	-0.2166339
GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	C7_ immunologic signatures	183	0.89806616	0.70441	0.83431816	GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	183	1.0794164	0.30816326	0.78817254	1.97748256	-0.18135024
GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN	C7_ immunologic signatures	173	0.8980433	0.7278106	0.83427835	GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN	175	1.071908	0.31983805	0.80266124	1.9699513	-0.1738647
GO_PROTEIN_INSERTION_INTO_MEMBRANE	c5.BP_ GO biological process	21	0.89804	0.62776023	0.83419114	GO_PROTEIN_INSERTION_INTO_MEMBRANE	20	0.96578604	0.5481386	0.9647288	1.86382604	-0.06774604
SPZ1_01	c3.TFT_ transcription factor targets	202	0.89788485	0.74590164	0.8345015	SPZ1_01	207	-1.1525958	0.16666667	0.43983653	-0.25471095	2.05048065
GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_UP	C7_ immunologic signatures	175	0.897706	0.7151442	0.8348533	GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_UP	178	0.9135983	0.69828457	1	1.8113043	-0.0158923
GO_REGULATION_OF_AUTOPHAGY	c5.BP_ GO biological process	228	0.8976272	0.7212742	0.83495355	GO_REGULATION_OF_AUTOPHAGY	229	0.817903	0.9001009	1	1.7155302	0.0797242
GO_PROTEIN_K63_LINKED_DEUBIQUITINATION	c5.BP_ GO biological process	21	0.8973392	0.5940902	0.8355802	GO_PROTEIN_K63_LINKED_DEUBIQUITINATION	21	0.9964279	0.49120602	0.92906916	1.8937671	-0.0990887
GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	176	0.89727	0.7107143	0.8356525	GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN	177	0.89174867	0.7642276	1	1.78901867	0.00552133
GO_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	63	0.89721787	0.6446837	0.8356889	GO_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT	75	1.0782936	0.34471717	0.79078084	1.97551147	-0.18107573
GO_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	69	0.8970975	0.65821093	0.83588433	GO_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS	73	0.9557396	0.5709607	0.9758565	1.8528371	-0.0586421
CRX_NRL_DN.V1_DN	C6_ oncogenic signatures	109	0.89703095	0.68846154	0.8359528	CRX_NRL_DN.V1_DN	112	0.9361779	0.63503647	0.9939545	1.83320885	-0.03914695
GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	177	0.896947	0.7056075	0.8360685	GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	178	-0.82572603	0.9230769	0.8857133	0.07122097	1.72267303
ROSS_AML_WITH_PML_RARA_FUSION	c2.CGP_ chemical and genetic perturbations	68	0.89690405	0.6581197	0.83608127	ROSS_AML_WITH_PML_RARA_FUSION	69	1.0980474	0.33261803	0.75942177	1.99495145	-0.20114335
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN	C7_ immunologic signatures	158	0.89688635	0.720339	0.8360299	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN	165	0.7908262	0.8851626	1	1.68771255	0.10606015
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	C7_ immunologic signatures	107	0.8967061	0.6833977	0.83638626	GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	116	1.0585725	0.3825641	0.8269442	1.9552786	-0.1618664
GO_SPHINGOLIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	121	0.8966842	0.6897856	0.83634555	GO_SPHINGOLIPID_METABOLIC_PROCESS	124	1.3651245	0.018518519	0.37172443	2.2618087	-0.4684403
GO_EXTRINSIC_COMPONENT_OF_MEMBRANE	c5.CC_ GO cellular component	229	0.8965582	0.72839504	0.8365778	GO_EXTRINSIC_COMPONENT_OF_MEMBRANE	236	1.1459167	0.16197184	0.6774393	2.0424749	-0.2493585
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN	C7_ immunologic signatures	144	0.8964022	0.69554454	0.83686554	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN	154	1.0632614	0.340143	0.8165503	1.9596636	-0.1668592
GO_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION	c5.BP_ GO biological process	48	0.89629704	0.6388889	0.8370202	GO_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION	50	0.67470604	0.9368542	1	1.57100308	0.221591
GO_CRANIAL_SKELETAL_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	54	0.896274	0.64450866	0.8369791	GO_CRANIAL_SKELETAL_SYSTEM_DEVELOPMENT	55	0.80158	0.8046615	1	1.697854	0.094694
LEE_AGING_CEREBELLUM_DN	c2.CGP_ chemical and genetic perturbations	74	0.8958806	0.6720648	0.83785886	LEE_AGING_CEREBELLUM_DN	76	1.4477274	0.013963481	0.29360068	2.343608	-0.5518468
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	c2.CGP_ chemical and genetic perturbations	24	0.89569694	0.6194145	0.83821905	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	25	-0.76547545	0.8756219	0.9303895	0.13022149	1.66117239
MMS_MOUSE_LYMPH_HIGH_4HRS_UP	c2.CGP_ chemical and genetic perturbations	30	0.8956315	0.6352584	0.838285	MMS_MOUSE_LYMPH_HIGH_4HRS_UP	30	-1.7409327	0	0.045778986	-0.8453012	2.6365642
GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP	C7_ immunologic signatures	177	0.8956175	0.7352246	0.83822066	GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP	183	1.3617578	0.006066734	0.37611237	2.2573753	-0.4661403
GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN	C7_ immunologic signatures	182	0.8955461	0.7151442	0.8382981	GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN	189	0.85582536	0.8169014	1	1.75137146	0.03972074
GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP	C7_ immunologic signatures	171	0.8955212	0.72749394	0.83826214	GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP	172	0.7877805	0.889002	1	1.6833017	0.1077407
GO_CELLULAR_RESPONSE_TO_AMINO_ACID_STARVATION	c5.BP_ GO biological process	23	0.8954632	0.63067293	0.8383135	GO_CELLULAR_RESPONSE_TO_AMINO_ACID_STARVATION	23	0.67774504	0.882939	1	1.57320824	0.21771816
GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN	C7_ immunologic signatures	182	0.8954539	0.7297297	0.83823955	GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN	179	0.94262004	0.63109756	0.98905766	1.83807394	-0.04716614
SCHRAETS_MLL_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	29	0.8954336	0.595679	0.8381896	SCHRAETS_MLL_TARGETS_DN	29	0.94340956	0.56687117	0.9887662	1.83884316	-0.04797596
GO_SULFUR_COMPOUND_TRANSPORT	c5.BP_ GO biological process	28	0.8953883	0.6544586	0.83820707	GO_SULFUR_COMPOUND_TRANSPORT	30	1.4589875	0.03199052	0.28354815	2.3543758	-0.5635992
WANG_BARRETTS_ESOPHAGUS_UP	c2.CGP_ chemical and genetic perturbations	40	0.89507985	0.6647482	0.83887315	WANG_BARRETTS_ESOPHAGUS_UP	43	1.1933081	0.21191294	0.6004115	2.08838795	-0.29822825
GO_NEUROTRANSMITTER_BINDING	c5.GO molecular function	17	0.895072	0.6314935	0.8387953	GO_NEUROTRANSMITTER_BINDING	26	1.2416286	0.18048781	0.5231491	2.1367006	-0.3465566
CCAGGGG_MIR331	c3.MIR_ microRNA targets	82	0.89496225	0.6603295	0.8389794	CCAGGGG_MIR331	82	1.2063394	0.15539113	0.58220506	2.10130165	-0.31137715
GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN	C7_ immunologic signatures	178	0.89490396	0.7134434	0.8390272	GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN	180	1.0762646	0.3147208	0.7943998	1.97116856	-0.18136064
GO_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY	c5.GO molecular function	41	0.8948811	0.6462197	0.83898675	GO_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY	44	1.0220187	0.45610034	0.88868934	1.9168998	-0.1271376
VALK_AML_CLUSTER_15	c2.CGP_ chemical and genetic perturbations	29	0.89475566	0.6246291	0.83920276	VALK_AML_CLUSTER_15	31	-0.9783557	0.47368422	0.7156359	-0.08360004	1.87311136
GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	173	0.89470303	0.70898205	0.8392342	GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP	177	0.93987876	0.6468813	0.990059	1.83458179	-0.04517573
GO_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL	c5.BP_ GO biological process	107	0.89469075	0.7013802	0.8391684	GO_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL	108	0.6376774	0.985447	1	1.53236815	0.25701335
BIOCARTA_MTA3_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	0.8946879	0.6015873	0.83907825	BIOCARTA_MTA3_PATHWAY	18	1.4682882	0.027925532	0.27718052	2.3629761	-0.5736003
GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN	C7_ immunologic signatures	168	0.8945568	0.72357726	0.83930075	GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN	168	-0.903321	0.84615386	0.8172499	-0.0087642	1.7978778
CAR_TNFRSF25	c4.CGN_ cancer gene neighborhoods	26	0.8944814	0.62032884	0.83938473	CAR_TNFRSF25	27	1.2547913	0.16206482	0.5031669	2.1492727	-0.3603099
REACTOME_COMPLEMENT_CASCADE	c2.CP_REACTOME_ Reactome gene sets	20	0.894457	0.627451	0.83935076	REACTOME_COMPLEMENT_CASCADE	23	1.6967881	0.00129199	0.080963664	2.5912451	-0.8023311
GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	170	0.89439833	0.7294686	0.83939743	GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	172	0.62709916	0.9908257	1	1.52149749	0.26729917
GO_COENZYME_A_METABOLIC_PROCESS	c5.BP_ GO biological process	17	0.89403677	0.62171054	0.8402117	GO_COENZYME_A_METABOLIC_PROCESS	17	1.0263511	0.45609435	0.88228136	1.92038787	-0.13231433
GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP	C7_ immunologic signatures	182	0.89370054	0.73348784	0.8409551	GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP	181	0.9288758	0.6764706	0.998813	1.82257634	-0.03517526
GO_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE	c5.BP_ GO biological process	15	0.8935998	0.6224	0.84110355	GO_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE	17	0.60397464	0.94703656	1	1.49757444	0.28962516
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	c2.CGP_ chemical and genetic perturbations	45	0.8935932	0.670977	0.841023	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	45	1.0533268	0.4074074	0.8360932	1.94692	-0.1597336
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	42	0.89357877	0.6375358	0.8409637	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	44	0.7017251	0.9014723	1	1.59530387	0.19185367
GO_CHROMATIN	c5.CC_ GO cellular component	356	0.8935541	0.7796791	0.8409281	GO_CHROMATIN	356	0	0	0	0.8935541	0.8935541
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	c2.CP_BIOCARTA_ BioCarta gene sets	21	0.8933934	0.613924	0.84123373	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	22	1.2523527	0.17048346	0.5075284	2.1457461	-0.3589593
GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	180	0.8932875	0.7245509	0.8414023	GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP	182	-0.8847611	0.6666667	0.83881706	0.0085264	1.7780486
GO_ASTROCYTE_DIFFERENTIATION	c5.BP_ GO biological process	36	0.8932157	0.6364985	0.8414858	GO_ASTROCYTE_DIFFERENTIATION	35	-1.3484187	0.06428572	0.24310489	-0.455203	2.2416344
BASSO_CD40_SIGNALING_DN	c2.CGP_ chemical and genetic perturbations	57	0.8932042	0.6563815	0.841415	BASSO_CD40_SIGNALING_DN	59	1.3525379	0.063403785	0.3832806	2.2457421	-0.4593337
BARIS_THYROID_CANCER_DN	c2.CGP_ chemical and genetic perturbations	56	0.8931585	0.66288954	0.8414269	BARIS_THYROID_CANCER_DN	56	1.0581441	0.39597315	0.8274781	1.9513026	-0.1649856
GO_CARBOHYDRATE_BINDING	c5.GO molecular function	198	0.89315605	0.7415991	0.8413367	GO_CARBOHYDRATE_BINDING	210	1.2024318	0.078470826	0.5881129	2.09558785	-0.30927575
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN	c2.CGP_ chemical and genetic perturbations	16	0.8931454	0.6196721	0.8412662	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN	16	1.0834838	0.38138926	0.7807647	1.9766292	-0.1903384
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	c2.CGP_ chemical and genetic perturbations	97	0.8930572	0.6968912	0.8413912	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	104	1.2834133	0.064075634	0.46674478	2.1764705	-0.3903561
GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN	C7_ immunologic signatures	172	0.89292634	0.70622796	0.8416093	GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN	175	1.0490655	0.38680202	0.8417061	1.94199184	-0.15613916
GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	C7_ immunologic signatures	175	0.89288193	0.72738236	0.84162295	GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	179	1.1895359	0.12296748	0.60580164	2.08241783	-0.29665397
ALONSO_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	20	0.89282876	0.6125	0.84165424	ALONSO_METASTASIS_DN	22	-1.0636482	0.30733946	0.5811951	-0.17081944	1.95647696
GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP	C7_ immunologic signatures	185	0.8928244	0.7291169	0.84156936	GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP	180	0.9774099	0.5660949	0.95198125	1.8702343	-0.0845855
GO_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY	c5.BP_ GO biological process	112	0.89279324	0.68925834	0.84154946	GO_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY	114	0.646922	0.9740664	1	1.53971524	0.24587124
GSE27786_LSK_VS_MONO_MAC_DN	C7_ immunologic signatures	174	0.8927584	0.7	0.84153664	GSE27786_LSK_VS_MONO_MAC_DN	175	1.069217	0.33097166	0.8069918	1.9619754	-0.1764586
GO_TELOMERIC_DNA_BINDING	c5.GO molecular function	28	0.8927434	0.6282642	0.8414765	GO_TELOMERIC_DNA_BINDING	28	0.76512736	0.82095003	1	1.65787076	0.12761604
GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP	C7_ immunologic signatures	166	0.89269125	0.7227603	0.8415087	GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP	169	0.8656489	0.80730224	1	1.75834015	0.02704235
GO_PROXIMAL_DISTAL_PATTERN_FORMATION	c5.BP_ GO biological process	31	0.89268404	0.6287879	0.84142977	GO_PROXIMAL_DISTAL_PATTERN_FORMATION	32	0.9466981	0.5590278	0.9852559	1.83938214	-0.05401406
GO_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	44	0.89259225	0.64	0.8415592	GO_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS	45	1.428024	0.027210884	0.3174204	2.32061625	-0.53543175
CHR18Q11	C1: positional gene sets	27	0.89253753	0.6393189	0.8415995	CHR18Q11	28	0.9081146	0.6237981	1	1.80065213	-0.01557707
GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP	C7_ immunologic signatures	171	0.8924859	0.72289157	0.8416308	GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP	175	1.1650697	0.1321897	0.64615893	2.0575556	-0.2725838
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	c2.CGP_ chemical and genetic perturbations	31	0.89247113	0.62222224	0.8415677	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	34	1.3885568	0.05995204	0.34792614	2.28102793	-0.49608567
GO_MEMBRANE_FUSION	c5.BP_ GO biological process	127	0.8924623	0.68472904	0.84149224	GO_MEMBRANE_FUSION	130	1.1261442	0.2581967	0.7121838	2.0186065	-0.2336819
GO_PROTEIN_K63_LINKED_UBIQUITINATION	c5.BP_ GO biological process	31	0.8923988	0.6377025	0.8415482	GO_PROTEIN_K63_LINKED_UBIQUITINATION	31	0.489904	0.9964706	1	1.3823028	0.4024948
CHANG_IMMORTALIZED_BY_HPV31_DN	c2.CGP_ chemical and genetic perturbations	48	0.89208186	0.66571426	0.84224087	CHANG_IMMORTALIZED_BY_HPV31_DN	49	1.508891	0.011325029	0.24421734	2.40097286	-0.61680914
GSE17721_LPS_VS_POLYIC_6H_BMDC_DN	C7_ immunologic signatures	180	0.8920283	0.7294118	0.84227496	GSE17721_LPS_VS_POLYIC_6H_BMDC_DN	180	0.90719604	0.7184959	1	1.79922434	-0.01516774
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	c2.CGP_ chemical and genetic perturbations	207	0.89178723	0.7372593	0.8427672	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	204	0.8455221	0.82723576	1	1.73730933	0.04626513
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	c2.CGP_ chemical and genetic perturbations	58	0.89161813	0.65254235	0.8430951	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	60	0.8676028	0.7202186	1	1.75922093	0.02401533
CHR2P13	C1: positional gene sets	64	0.8915643	0.6721763	0.8431312	CHR2P13	68	1.2651374	0.110278375	0.4906002	2.1567017	-0.3735731
GO_RESPONSE_TO_INTERFERON_BETA	c5.BP_ GO biological process	21	0.89152807	0.6134585	0.84312385	GO_RESPONSE_TO_INTERFERON_BETA	20	1.1433538	0.3065134	0.6836642	2.03488187	-0.25182573
GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN	C7_ immunologic signatures	167	0.8914845	0.7033493	0.84313667	GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN	169	0.6251768	0.99390244	1	1.5166613	0.2663077
REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	c2.CP_REACTOME_ Reactome gene sets	27	0.89146316	0.62611276	0.84309053	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	27	0.88163686	0.6593407	1	1.77310002	0.0098263
RB_DN.V1_DN	C6_ oncogenic signatures	109	0.89145976	0.6855346	0.84300125	RB_DN.V1_DN	111	0.87431365	0.73117155	1	1.76577341	0.01714611
GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP	C7_ immunologic signatures	173	0.89139855	0.7389791	0.8430483	GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP	175	1.1422278	0.20447609	0.6865981	2.03362635	-0.25082925
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP	C7_ immunologic signatures	159	0.89130443	0.70998794	0.8431856	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP	158	0.82585186	0.8329918	1	1.71715629	0.06545257
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP	C7_ immunologic signatures	182	0.89109105	0.7176196	0.8436127	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP	181	1.0336102	0.4200405	0.87092805	1.92470125	-0.14251915
GSE17721_CTRL_VS_LPS_24H_BMDC_UP	C7_ immunologic signatures	173	0.89089775	0.7376655	0.8440122	GSE17721_CTRL_VS_LPS_24H_BMDC_UP	180	0.99956435	0.5090909	0.92441136	1.8904621	-0.1086666
GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	172	0.89086574	0.7091776	0.84399426	GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN	178	1.414722	0.004060914	0.3225807	2.30558774	-0.52385626
GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN	C7_ immunologic signatures	178	0.89078087	0.7146312	0.8441033	GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN	180	1.0510064	0.36868685	0.83817786	1.94178727	-0.16022553
GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN	C7_ immunologic signatures	176	0.89075327	0.73396677	0.84407395	GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN	178	0.69403917	0.9776195	1	1.58479244	0.1967141
GSE3982_BCELL_VS_BASOPHIL_UP	C7_ immunologic signatures	156	0.8907308	0.71308523	0.84403086	GSE3982_BCELL_VS_BASOPHIL_UP	162	1.1564636	0.1653144	0.6593486	2.0471944	-0.2657328
GSE37532_WT_VS_PPARG_KO_LN_TREG_UP	C7_ immunologic signatures	159	0.8905676	0.7146254	0.8443423	GSE37532_WT_VS_PPARG_KO_LN_TREG_UP	159	0.93211824	0.66327566	0.9975924	1.82268584	-0.04155064
KYNG_DNA_DAMAGE_BY_UV	c2.CGP_ chemical and genetic perturbations	59	0.8905223	0.6759388	0.844352	KYNG_DNA_DAMAGE_BY_UV	60	-0.8624714	0.8181818	0.8575739	0.0280509	1.7529937
GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN	C7_ immunologic signatures	169	0.8904746	0.72494173	0.84436965	GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN	169	-0.98501116	0.6666667	0.7068533	-0.09453656	1.87548576
PARK_APL_PATHOGENESIS_DN	c2.CGP_ chemical and genetic perturbations	43	0.890396	0.6380814	0.84446585	PARK_APL_PATHOGENESIS_DN	41	1.2220129	0.18160652	0.5532148	2.1124089	-0.3316169
PID_CD8_TCR_DOWNSTREAM_PATHWAY	c2.CP_ Canonical pathways	60	0.8902597	0.6522949	0.84470034	PID_CD8_TCR_DOWNSTREAM_PATHWAY	62	1.4917306	0.012141281	0.2579004	2.3819903	-0.6014709
GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	160	0.8901775	0.7300242	0.84481364	GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP	168	0.81431454	0.86192894	1	1.70449204	0.07586296
REACTOME_RNA_POL_I_PROMOTER_OPENING	c2.CP_REACTOME_ Reactome gene sets	24	0.8900712	0.63826364	0.8449866	REACTOME_RNA_POL_I_PROMOTER_OPENING	25	1.0787739	0.3858561	0.78956527	1.9688451	-0.1887027
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	c2.CGP_ chemical and genetic perturbations	17	0.8900079	0.6396104	0.84504944	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	16	1.062452	0.38671875	0.8186495	1.9524599	-0.1724441
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	c2.CGP_ chemical and genetic perturbations	15	0.8899885	0.60777956	0.84499925	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	16	0.72248286	0.83506495	1	1.61247136	0.16750564
ONDER_CDH1_TARGETS_3_UP	c2.CGP_ chemical and genetic perturbations	16	0.88998395	0.6255778	0.8449149	ONDER_CDH1_TARGETS_3_UP	16	1.1939654	0.24901704	0.59926337	2.08394935	-0.30398145
MORF_PRKCA	c4.CGN_ cancer gene neighborhoods	137	0.88996905	0.72503084	0.8448541	MORF_PRKCA	142	1.4040122	0.006103764	0.33479404	2.29398125	-0.51404315
GSE27786_NKCELL_VS_MONO_MAC_DN	C7_ immunologic signatures	167	0.8898949	0.7508813	0.8449371	GSE27786_NKCELL_VS_MONO_MAC_DN	177	0.9334443	0.67411166	0.99641556	1.8233392	-0.0435494
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	c2.CP_BIOCARTA_ BioCarta gene sets	39	0.8898213	0.6414286	0.8450243	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	40	1.2231216	0.18786465	0.5512476	2.1129429	-0.3333003
GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN	C7_ immunologic signatures	178	0.88979065	0.72836536	0.8450031	GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN	181	1.1106764	0.23302938	0.73644733	2.00046705	-0.22088575
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	C7_ immunologic signatures	163	0.88976306	0.725944	0.8449728	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	166	0.8855686	0.75306123	1	1.77533166	0.00419446
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN	C7_ immunologic signatures	184	0.88973707	0.7364621	0.84494215	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN	182	0.90755916	0.7336024	1	1.79729623	-0.01782209
GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	165	0.8897002	0.7260921	0.8449367	GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	165	0.9572169	0.61094224	0.97461784	1.8469171	-0.0675167
GO_RESPONSE_TO_INTERLEUKIN_1	c5.BP_ GO biological process	89	0.8896861	0.6901042	0.8448719	GO_RESPONSE_TO_INTERLEUKIN_1	93	1.2337397	0.113247864	0.53544337	2.1234258	-0.3440536
GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	166	0.8896476	0.73123485	0.84487426	GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN	165	0.8275824	0.8410931	1	1.71723	0.0620652
GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	C7_ immunologic signatures	164	0.88961464	0.72389793	0.8448544	GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	174	1.1594574	0.16008106	0.65325576	2.04907204	-0.26984276
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	C7_ immunologic signatures	175	0.8895838	0.7309524	0.8448287	GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	174	1.0285614	0.43895057	0.8780809	1.9181452	-0.1389776
GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_UP	C7_ immunologic signatures	172	0.8895514	0.73333335	0.8448108	GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_UP	174	0.58284444	0.9979737	1	1.47239584	0.30670696
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP	C7_ immunologic signatures	164	0.88951564	0.71532845	0.84480006	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP	163	0.7822974	0.90194076	1	1.67181304	0.10721824
GO_CELL_DIFFERENTIATION_IN_SPINAL_CORD	c5.BP_ GO biological process	45	0.8895092	0.65	0.84471846	GO_CELL_DIFFERENTIATION_IN_SPINAL_CORD	53	0.7714168	0.8280394	1	1.660926	0.1180924
GO_NUCLEOCYTOPLASMIC_TRANSPORTER_ACTIVITY	c5.GO molecular function	22	0.88949394	0.6018377	0.8446601	GO_NUCLEOCYTOPLASMIC_TRANSPORTER_ACTIVITY	23	-1.2155055	0.20652173	0.36111805	-0.32601156	2.10499944
BIOCARTA_PDGF_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	32	0.8894458	0.6498516	0.8446844	BIOCARTA_PDGF_PATHWAY	32	1.1748501	0.22840236	0.63002837	2.0642959	-0.2854043
PID_IL12_STAT4_PATHWAY	c2.CP_ Canonical pathways	28	0.88933	0.6283988	0.84487575	PID_IL12_STAT4_PATHWAY	31	-1.0117873	0.374269	0.67022514	-0.1224573	1.9011173
GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP	C7_ immunologic signatures	173	0.8891219	0.72596157	0.84528583	GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP	176	0.7613482	0.92097265	1	1.6504701	0.1277737
GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	C7_ immunologic signatures	172	0.8891087	0.71923536	0.84522164	GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	177	0.96605045	0.58358663	0.9648816	1.85515915	-0.07694175
GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP	C7_ immunologic signatures	173	0.88909626	0.7278106	0.84515977	GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP	177	1.2560731	0.05172414	0.5009478	2.14516936	-0.36697684
MORF_IL16	c4.CGN_ cancer gene neighborhoods	179	0.8890658	0.74601364	0.84514165	MORF_IL16	197	1.2776942	0.030241935	0.47537118	2.16676	-0.3886284
GCM_NCAM1	c4.CGN_ cancer gene neighborhoods	115	0.8890054	0.6852792	0.84520704	GCM_NCAM1	116	0.7399294	0.91701245	1	1.6289348	0.149076
GSE14308_TH17_VS_NATURAL_TREG_UP	C7_ immunologic signatures	177	0.88894016	0.73081464	0.8452696	GSE14308_TH17_VS_NATURAL_TREG_UP	178	0.970259	0.5750507	0.9613515	1.85919916	-0.08131884
GSE17721_LPS_VS_CPG_12H_BMDC_DN	C7_ immunologic signatures	169	0.888879	0.73641616	0.8453191	GSE17721_LPS_VS_CPG_12H_BMDC_DN	170	0.8044479	0.8877654	1	1.6933269	0.0844311
GO_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	75	0.88882756	0.6662144	0.8453489	GO_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS	83	1.0865335	0.34364995	0.7754056	1.97536106	-0.19770594
YU_MYC_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	43	0.8886373	0.6622222	0.8457218	YU_MYC_TARGETS_DN	46	1.4302703	0.026467204	0.31400132	2.3189076	-0.541633
GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN	C7_ immunologic signatures	159	0.8886068	0.7354037	0.84570104	GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN	162	1.0950904	0.27805865	0.7648417	1.9836972	-0.2064836
VALK_AML_CLUSTER_16	c2.CGP_ chemical and genetic perturbations	20	0.88848627	0.6304348	0.8459056	VALK_AML_CLUSTER_16	22	1.0974586	0.3490099	0.7599336	1.98594487	-0.20897233
GSE7852_LN_VS_FAT_TCONV_UP	C7_ immunologic signatures	172	0.88840204	0.7327081	0.84601444	GSE7852_LN_VS_FAT_TCONV_UP	173	0.97775674	0.5464646	0.95193595	1.86615878	-0.0893547
GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP	C7_ immunologic signatures	118	0.8883878	0.7017544	0.8459521	GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP	129	0.83552337	0.80618554	1	1.72391117	0.05286443
GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP	C7_ immunologic signatures	180	0.8882767	0.7352941	0.84612775	GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP	180	1.0926421	0.26923078	0.76838577	1.9809188	-0.2043654
GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP	C7_ immunologic signatures	148	0.8881653	0.70660144	0.8462996	GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP	152	0.567917	1	1	1.4560823	0.3202483
MYOD_01	c3.TFT_ transcription factor targets	227	0.88812524	0.7453488	0.846303	MYOD_01	233	1.2726758	0.021148037	0.48262495	2.16080104	-0.38455056
GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN	C7_ immunologic signatures	184	0.8878621	0.73616016	0.8468516	GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN	186	0.7770179	0.9175992	1	1.66488	0.1108442
GO_RECYCLING_ENDOSOME_MEMBRANE	c5.CC_ GO cellular component	38	0.88784397	0.6571856	0.84679884	GO_RECYCLING_ENDOSOME_MEMBRANE	37	0.60943496	0.9506463	1	1.49727893	0.27840901
GO_METANEPHRIC_NEPHRON_MORPHOGENESIS	c5.BP_ GO biological process	19	0.88765585	0.63355047	0.84717315	GO_METANEPHRIC_NEPHRON_MORPHOGENESIS	21	-0.96510273	0.509009	0.7357378	-0.07744688	1.85275858
GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	C7_ immunologic signatures	139	0.88765323	0.71536523	0.84708375	GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	148	0.9849229	0.5189355	0.9418341	1.87257613	-0.09726967
GO_REGULATION_OF_SYNAPTIC_PLASTICITY	c5.BP_ GO biological process	130	0.88757664	0.72141117	0.84717095	GO_REGULATION_OF_SYNAPTIC_PLASTICITY	134	1.1810379	0.14959016	0.6215059	2.06861454	-0.29346126
GSE7831_1H_VS_4H_CPG_STIM_PDC_UP	C7_ immunologic signatures	180	0.887481	0.715311	0.84730726	GSE7831_1H_VS_4H_CPG_STIM_PDC_UP	183	1.1971527	0.103517585	0.59686565	2.0846337	-0.3096717
REACTOME_S_PHASE	c2.CP_REACTOME_ Reactome gene sets	101	0.8874471	0.70477384	0.8472962	REACTOME_S_PHASE	102	-2.296681	0	0.000311569	-1.4092339	3.1841281
HIF1_Q5	c3.TFT_ transcription factor targets	214	0.887444	0.7685185	0.8472069	HIF1_Q5	222	0.6822704	0.9879639	1	1.5697144	0.2051736
CCTGCTG_MIR214	c3.MIR_ microRNA targets	217	0.8873886	0.7456847	0.84724313	CCTGCTG_MIR214	218	1.049455	0.36958712	0.8411907	1.9368436	-0.1620664
GO_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES	c5.GO molecular function	79	0.8872625	0.69437	0.84745485	GO_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES	79	0.80222154	0.82599354	1	1.68948404	0.08504096
GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	139	0.8871827	0.6916462	0.8475582	GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	143	1.0872959	0.315519	0.7748939	1.9744786	-0.2001132
GSE2706_2H_VS_8H_R848_STIM_DC_UP	C7_ immunologic signatures	162	0.8870354	0.73365617	0.8478172	GSE2706_2H_VS_8H_R848_STIM_DC_UP	165	1.2051649	0.104462475	0.5823134	2.0922003	-0.3181295
GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP	C7_ immunologic signatures	171	0.88691515	0.735363	0.8480156	GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP	176	0.88149756	0.77620965	1	1.76841271	0.00541759
GO_BROWN_FAT_CELL_DIFFERENTIATION	c5.BP_ GO biological process	26	0.8868968	0.658805	0.84796417	GO_BROWN_FAT_CELL_DIFFERENTIATION	28	1.3027745	0.11070999	0.43708938	2.1896713	-0.4158777
GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	C7_ immunologic signatures	122	0.88681895	0.7169118	0.8480601	GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	128	1.1489623	0.22765073	0.6698474	2.03578125	-0.26214335
BIOCARTA_CALCINEURIN_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	0.8867833	0.6374172	0.84805274	BIOCARTA_CALCINEURIN_PATHWAY	16	1.3989869	0.077225134	0.34157583	2.2857702	-0.5122036
GO_DNA_ALKYLATION	c5.BP_ GO biological process	41	0.8867452	0.65129685	0.84805024	GO_DNA_ALKYLATION	43	1.5502338	0.009184845	0.2075895	2.436979	-0.6634886
LEE_LIVER_CANCER_MYC_DN	c2.CGP_ chemical and genetic perturbations	53	0.88662356	0.65522176	0.8482408	LEE_LIVER_CANCER_MYC_DN	52	1.1876026	0.18686296	0.60994154	2.07422616	-0.30097904
COLLIS_PRKDC_SUBSTRATES	c2.CGP_ chemical and genetic perturbations	18	0.8865595	0.6295707	0.8482931	COLLIS_PRKDC_SUBSTRATES	18	-0.87502134	0.64634144	0.8493213	0.01153816	1.76158084
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	30	0.88644147	0.65140325	0.84848434	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	35	-1.2160145	0.14379086	0.3607774	-0.32957303	2.10245597
MORF_ERCC2	c4.CGN_ cancer gene neighborhoods	94	0.8864293	0.69401044	0.8484139	MORF_ERCC2	96	0.7900607	0.85427666	1	1.67649	0.0963686
GSE10325_CD4_TCELL_VS_MYELOID_DN	C7_ immunologic signatures	168	0.8864073	0.74761903	0.8483734	GSE10325_CD4_TCELL_VS_MYELOID_DN	174	1.0972753	0.2628918	0.76014197	1.9836826	-0.210868
GSE3982_MAST_CELL_VS_DC_DN	C7_ immunologic signatures	169	0.88633245	0.73170733	0.8484568	GSE3982_MAST_CELL_VS_DC_DN	173	1.295441	0.026422765	0.44887733	2.18177345	-0.40910855
HANSON_HRAS_SIGNALING_VIA_NFKB	c2.CGP_ chemical and genetic perturbations	19	0.88624734	0.640553	0.8485654	HANSON_HRAS_SIGNALING_VIA_NFKB	21	1.149631	0.28767124	0.6703378	2.03587834	-0.26338366
GSE27786_LSK_VS_NEUTROPHIL_DN	C7_ immunologic signatures	169	0.88593477	0.7372881	0.84924537	GSE27786_LSK_VS_NEUTROPHIL_DN	175	0.84432733	0.8343496	1	1.7302621	0.04160744
MORF_DCC	c4.CGN_ cancer gene neighborhoods	87	0.8859313	0.70657897	0.84915715	MORF_DCC	92	1.2207985	0.1341853	0.5542176	2.1067298	-0.3348672
GSE14308_TH1_VS_INDUCED_TREG_DN	C7_ immunologic signatures	167	0.88591635	0.7379808	0.8491004	GSE14308_TH1_VS_INDUCED_TREG_DN	174	-0.8950004	0.85714287	0.82672656	-0.00908405	1.78091675
CHR2P23	C1: positional gene sets	60	0.88553345	0.67808217	0.84992975	CHR2P23	63	0.8072345	0.79718006	1	1.69276795	0.07829895
GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP	C7_ immunologic signatures	163	0.8854743	0.7295673	0.84998024	GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP	174	1.179683	0.14708887	0.6242794	2.0651573	-0.2942087
GO_PHAGOSOME_MATURATION	c5.BP_ GO biological process	34	0.88539886	0.64653903	0.85006857	GO_PHAGOSOME_MATURATION	36	0.9009175	0.64123005	1	1.78631636	-0.01551864
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP	C7_ immunologic signatures	154	0.88528407	0.7231504	0.85026467	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP	161	1.0573643	0.3809524	0.8286504	1.94264837	-0.17208023
GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	181	0.8852621	0.7526627	0.85022354	GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	182	0.7818913	0.9108409	1	1.6671534	0.1033708
CYCLIN_D1_KE_.V1_DN	C6_ oncogenic signatures	155	0.8852424	0.7635054	0.8501764	CYCLIN_D1_KE_.V1_DN	168	0.97656864	0.548583	0.95325816	1.86181104	-0.09132624
GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	177	0.88520265	0.7464623	0.85017556	GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP	182	0.98236996	0.5570131	0.9453069	1.86757261	-0.09716731
GO_RECEPTOR_REGULATOR_ACTIVITY	c5.GO molecular function	41	0.8851694	0.6440922	0.85016084	GO_RECEPTOR_REGULATOR_ACTIVITY	42	1.1609724	0.25373134	0.6510635	2.0461418	-0.275803
GSE27786_CD4_TCELL_VS_NKTCELL_DN	C7_ immunologic signatures	181	0.88510203	0.73609465	0.8502268	GSE27786_CD4_TCELL_VS_NKTCELL_DN	180	0.6846544	0.9692938	1	1.56975643	0.20044763
GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN	C7_ immunologic signatures	188	0.88491887	0.77438307	0.85058135	GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN	190	0.9915316	0.5180723	0.9341987	1.87645047	-0.10661273
GO_CHLORIDE_CHANNEL_COMPLEX	c5.CC_ GO cellular component	39	0.8848654	0.64511496	0.8506185	GO_CHLORIDE_CHANNEL_COMPLEX	47	0.802297	0.79298645	1	1.6871624	0.0825684
GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN	C7_ immunologic signatures	176	0.8845428	0.73772454	0.8512836	GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN	183	0.9636215	0.5821501	0.96684927	1.8481643	-0.0790787
GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN	C7_ immunologic signatures	165	0.88443714	0.744325	0.85144335	GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN	166	0.8239005	0.85989845	1	1.70833764	0.06053664
GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP	C7_ immunologic signatures	173	0.88430065	0.75178146	0.85166365	GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP	176	0.6935992	0.9726166	1	1.57789985	0.19070145
GO_ROUGH_ENDOPLASMIC_RETICULUM	c5.CC_ GO cellular component	64	0.8842437	0.69460225	0.8517051	GO_ROUGH_ENDOPLASMIC_RETICULUM	67	1.1172258	0.2784272	0.7285371	2.0014695	-0.2329821
GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP	C7_ immunologic signatures	161	0.8841085	0.737819	0.8519302	GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP	163	0.8757498	0.76291794	1	1.7598583	0.0083587
GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP	C7_ immunologic signatures	176	0.8838366	0.7491082	0.8524881	GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP	177	0.76533145	0.9283552	1	1.64916805	0.11850515
GSE29618_BCELL_VS_PDC_DN	C7_ immunologic signatures	178	0.883812	0.73772454	0.8524512	GSE29618_BCELL_VS_PDC_DN	180	-0.90567386	0.84615386	0.8148836	-0.02186186	1.78948586
GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN	C7_ immunologic signatures	182	0.883721	0.75326216	0.85257316	GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN	184	0.70942014	0.96443087	1	1.59314114	0.17430086
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN	c2.CGP_ chemical and genetic perturbations	17	0.88369805	0.6267716	0.85252863	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN	17	1.4453385	0.043766577	0.29690436	2.32903655	-0.56164045
GO_GATED_CHANNEL_ACTIVITY	c5.GO molecular function	263	0.8836786	0.7737962	0.85248053	GO_GATED_CHANNEL_ACTIVITY	303	1.4271216	0.001002004	0.31823525	2.3108002	-0.543443
ST_GA13_PATHWAY	c2.CP_ Canonical pathways	33	0.88363343	0.6763359	0.8524935	ST_GA13_PATHWAY	33	0.7196484	0.86127865	1	1.60328183	0.16398503
GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP	C7_ immunologic signatures	130	0.88329315	0.7181706	0.85322076	GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP	133	1.4043603	0.008188332	0.33402666	2.28765345	-0.52106715
GSE27786_BCELL_VS_NKCELL_UP	C7_ immunologic signatures	176	0.88325214	0.7544274	0.8532273	GSE27786_BCELL_VS_NKCELL_UP	179	0.64451665	0.9898477	1	1.52776879	0.23873549
MZF1_02	c3.TFT_ transcription factor targets	207	0.88311654	0.758465	0.8534544	MZF1_02	215	0.8424991	0.8546922	1	1.72561564	0.04061744
NFKB_Q6_01	c3.TFT_ transcription factor targets	211	0.8831103	0.7525424	0.8533753	NFKB_Q6_01	214	0.9230411	0.695171	1	1.8061514	-0.0399308
GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP	C7_ immunologic signatures	178	0.8826896	0.7445521	0.8542741	GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP	178	1.053707	0.3437816	0.8360901	1.9363966	-0.1710174
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	171	0.8826645	0.7505995	0.8542467	GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP	176	0.9359687	0.6517767	0.9943186	1.8186332	-0.0533042
ACTWSNACTNY_UNKNOWN	c3.TFT_ transcription factor targets	95	0.8826088	0.6798419	0.8542786	ACTWSNACTNY_UNKNOWN	96	0.76300377	0.88092726	1	1.64561257	0.11960503
GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	167	0.882551	0.7472119	0.85432625	GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN	170	0.6321162	0.994929	1	1.5146672	0.2504348
GO_NUCLEAR_ENVELOPE	c5.CC_ GO cellular component	363	0.88237077	0.81060606	0.85466653	GO_NUCLEAR_ENVELOPE	364	0.87560385	0.8476954	1	1.75797462	0.00676692
GO_CATION_CATION_ANTIPORTER_ACTIVITY	c5.GO molecular function	22	0.8822561	0.65384614	0.8548419	GO_CATION_CATION_ANTIPORTER_ACTIVITY	24	0.7033861	0.86533666	1	1.5856422	0.17887
KEGG_JAK_STAT_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	126	0.882252	0.7310087	0.85475415	KEGG_JAK_STAT_SIGNALING_PATHWAY	138	0.85786706	0.7942682	1	1.74011906	0.02438494
GSE360_L_DONOVANI_VS_T_GONDII_DC_DN	C7_ immunologic signatures	167	0.8822088	0.75386447	0.8547585	GSE360_L_DONOVANI_VS_T_GONDII_DC_DN	172	0.7582402	0.93509126	1	1.640449	0.1239686
GO_REGULATION_OF_CELL_MATURATION	c5.BP_ GO biological process	17	0.88212216	0.6323987	0.8548709	GO_REGULATION_OF_CELL_MATURATION	17	1.008084	0.48865154	0.9110322	1.89020616	-0.12596184
GCM_AQP4	c4.CGN_ cancer gene neighborhoods	43	0.8819996	0.66525424	0.8550669	GCM_AQP4	43	0.7287968	0.88242006	1	1.6107964	0.1532028
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN	C7_ immunologic signatures	173	0.88194793	0.73653394	0.8550935	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN	176	1.1515981	0.15510204	0.6672986	2.03354603	-0.26965017
GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP	C7_ immunologic signatures	180	0.88183755	0.7375297	0.8552571	GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP	180	0.93573296	0.6659919	0.99387354	1.81757051	-0.05389541
GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP	C7_ immunologic signatures	182	0.88181937	0.7456446	0.85520077	GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP	183	0.7559974	0.937247	1	1.63781677	0.12582197
GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP	C7_ immunologic signatures	169	0.8818042	0.73031026	0.8551412	GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP	177	1.1206335	0.21428572	0.72325	2.0024377	-0.2388293
GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	C7_ immunologic signatures	167	0.88169795	0.7529274	0.855301	GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	174	0.71459377	0.96555215	1	1.59629172	0.16710418
KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	183	0.88159126	0.75476193	0.85544866	KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN	184	0.86859447	0.77878785	1	1.75018573	0.01299679
GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP	C7_ immunologic signatures	176	0.88148224	0.76839566	0.8556093	GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP	179	1.316861	0.018237082	0.41506928	2.19834324	-0.43537876
MODULE_131	c4.CM_ cancer modules	27	0.8813448	0.64803624	0.8558272	MODULE_131	28	1.6071652	0.007281554	0.14879528	2.48851	-0.7258204
GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP	C7_ immunologic signatures	177	0.8812654	0.73672056	0.8559254	GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP	185	0.9555962	0.613198	0.975807	1.8368616	-0.0743308
GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN	C7_ immunologic signatures	179	0.88124764	0.7383721	0.85587144	GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN	177	0.99267954	0.5267407	0.9325137	1.87392718	-0.1114319
GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN	C7_ immunologic signatures	170	0.8812462	0.7467145	0.8557778	GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN	181	1.1202755	0.21774194	0.7229458	2.0015217	-0.2390293
NRL_DN.V1_DN	C6_ oncogenic signatures	117	0.88119507	0.72186285	0.85580176	NRL_DN.V1_DN	121	1.0804201	0.31113425	0.786381	1.96161517	-0.19922503
TCCCCAC_MIR491	c3.MIR_ microRNA targets	55	0.8811537	0.68413794	0.85580295	TCCCCAC_MIR491	55	0.9487244	0.5771812	0.98350644	1.8298781	-0.0675707
GO_REGULATION_OF_CELL_KILLING	c5.BP_ GO biological process	43	0.8811349	0.66466165	0.85575193	GO_REGULATION_OF_CELL_KILLING	47	1.0002544	0.47914317	0.92398614	1.8813893	-0.1191195
GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	165	0.8811094	0.7306317	0.85571736	GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP	165	0.7598763	0.9357798	1	1.6409857	0.1212331
LAMB_CCND1_TARGETS	c2.CGP_ chemical and genetic perturbations	18	0.8810543	0.64603174	0.855756	LAMB_CCND1_TARGETS	18	0.8990795	0.643038	1	1.7801338	-0.0180252
GO_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION	c5.BP_ GO biological process	18	0.88090086	0.6365079	0.8560288	GO_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION	18	0.7425651	0.8202824	1	1.62346596	0.13833576
YY1_01	c3.TFT_ transcription factor targets	210	0.88087714	0.76869965	0.85599416	YY1_01	220	-0.8539976	0.875	0.86275554	0.02687954	1.73487474
GO_RESPONSE_TO_HEAT	c5.BP_ GO biological process	74	0.88086945	0.71216214	0.85591507	GO_RESPONSE_TO_HEAT	77	1.6002375	0.002162162	0.15749839	2.48110695	-0.71936805
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	210	0.88079816	0.76131225	0.8559912	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	225	1.0225078	0.42467138	0.8870962	1.90330596	-0.14170964
GSE3982_CTRL_VS_LPS_48H_DC_UP	C7_ immunologic signatures	160	0.8806222	0.7294398	0.85631734	GSE3982_CTRL_VS_LPS_48H_DC_UP	165	1.0058806	0.48367348	0.91393054	1.8865028	-0.1252584
GO_EUCHROMATIN	c5.CC_ GO cellular component	28	0.88059205	0.6459627	0.85629237	GO_EUCHROMATIN	28	-1.6905732	0.005882353	0.05856042	-0.80998115	2.57116525
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	c2.CGP_ chemical and genetic perturbations	20	0.88047636	0.63929147	0.8564776	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	21	0.99375165	0.5069886	0.9310802	1.87422801	-0.11327529
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	57	0.8803381	0.68690956	0.8567128	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	56	0.83166414	0.76222223	1	1.71200224	0.04867396
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	c2.CGP_ chemical and genetic perturbations	208	0.88024074	0.76639813	0.8568515	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	209	0.67836106	0.9919598	1	1.5586018	0.20187968
BROCKE_APOPTOSIS_REVERSED_BY_IL6	c2.CGP_ chemical and genetic perturbations	133	0.88022655	0.7394015	0.8567906	BROCKE_APOPTOSIS_REVERSED_BY_IL6	133	0.85795397	0.78512394	1	1.73818052	0.02227258
GO_FERROUS_IRON_BINDING	c5.GO molecular function	22	0.8802045	0.65898615	0.8567487	GO_FERROUS_IRON_BINDING	22	0.7399953	0.8331194	1	1.6201998	0.1402092
PID_S1P_S1P2_PATHWAY	c2.CP_ Canonical pathways	22	0.8801003	0.63338536	0.8569027	PID_S1P_S1P2_PATHWAY	23	0.7889942	0.77351487	1	1.6690945	0.0911061
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	c2.CGP_ chemical and genetic perturbations	15	0.88006735	0.6285266	0.85688615	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	15	0	0	0	0.88006735	0.88006735
GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN	C7_ immunologic signatures	183	0.87998253	0.7797203	0.8569871	GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN	182	-1.1621963	0	0.42729735	-0.28221377	2.04217883
JOHNSTONE_PARVB_TARGETS_1_DN	c2.CGP_ chemical and genetic perturbations	53	0.87995124	0.67777777	0.85696894	JOHNSTONE_PARVB_TARGETS_1_DN	53	0.971419	0.5472127	0.9601049	1.85137024	-0.09146776
GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN	C7_ immunologic signatures	154	0.87992686	0.7625459	0.8569323	GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN	155	0.73892355	0.9450661	1	1.61885041	0.14100331
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN	C7_ immunologic signatures	171	0.87983674	0.7520564	0.8570462	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN	174	0.9174663	0.68463886	1	1.79730304	-0.03762956
GO_NEGATIVE_REGULATION_OF_SECRETION	c5.BP_ GO biological process	159	0.87969404	0.7487923	0.857299	GO_NEGATIVE_REGULATION_OF_SECRETION	174	1.3602885	0.00810537	0.37754932	2.23998254	-0.48059446
REACTOME_INNATE_IMMUNE_SYSTEM	c2.CP_REACTOME_ Reactome gene sets	209	0.879667	0.7666291	0.8572668	REACTOME_INNATE_IMMUNE_SYSTEM	218	1.0913675	0.2669363	0.7698336	1.9710345	-0.2117005
GO_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS	c5.BP_ GO biological process	44	0.87958	0.6661721	0.85737705	GO_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS	48	0.8563633	0.7266436	1	1.7359433	0.0232167
CHR5Q31	C1: positional gene sets	166	0.8795096	0.7370283	0.8574485	CHR5Q31	176	1.1851262	0.11573604	0.6133891	2.0646358	-0.3056166
GSE24142_DN2_VS_DN3_THYMOCYTE_UP	C7_ immunologic signatures	178	0.87948	0.75729287	0.857424	GSE24142_DN2_VS_DN3_THYMOCYTE_UP	184	0.9492904	0.6336032	0.98310345	1.8287704	-0.0698104
OUYANG_PROSTATE_CANCER_PROGRESSION_DN	c2.CGP_ chemical and genetic perturbations	18	0.87929803	0.63054186	0.8577606	OUYANG_PROSTATE_CANCER_PROGRESSION_DN	19	-0.9406946	0.5515695	0.769136	-0.06139657	1.81999263
GSE17721_CTRL_VS_LPS_12H_BMDC_UP	C7_ immunologic signatures	168	0.8792845	0.74813896	0.85769844	GSE17721_CTRL_VS_LPS_12H_BMDC_UP	170	0.9501644	0.63184583	0.9818107	1.8294489	-0.0708799
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN	C7_ immunologic signatures	156	0.87915176	0.7667464	0.8579154	GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN	162	1.100965	0.27954778	0.7556194	1.98011676	-0.22181324
GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	C7_ immunologic signatures	171	0.87910396	0.76610976	0.85793424	GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	179	0.76702935	0.92028254	1	1.64613331	0.11207461
HU_GENOTOXIC_DAMAGE_24HR	c2.CGP_ chemical and genetic perturbations	30	0.8790831	0.65673983	0.857887	HU_GENOTOXIC_DAMAGE_24HR	30	0.6494692	0.93136096	1	1.5285523	0.2296139
GO_VESICLE_LOCALIZATION	c5.BP_ GO biological process	204	0.8790316	0.77764976	0.8579113	GO_VESICLE_LOCALIZATION	206	1.141253	0.15477388	0.6879017	2.0202846	-0.2622214
AGGTGCA_MIR500	c3.MIR_ microRNA targets	90	0.87899923	0.71229404	0.8578873	AGGTGCA_MIR500	93	1.0711296	0.36430833	0.803115	1.95012883	-0.19213037
GO_BRAIN_MORPHOGENESIS	c5.BP_ GO biological process	31	0.87855846	0.652648	0.8588506	GO_BRAIN_MORPHOGENESIS	33	0.94467473	0.5579196	0.98757875	1.82323319	-0.06611627
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	c2.CP_BIOCARTA_ BioCarta gene sets	100	0.8784201	0.71811223	0.8590745	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	105	0.9787545	0.5336091	0.9507428	1.8571746	-0.1003344
GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN	C7_ immunologic signatures	167	0.8784107	0.74078476	0.8590027	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN	175	1.3286424	0.009137056	0.40401644	2.2070531	-0.4502317
GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP	C7_ immunologic signatures	158	0.87834215	0.73431736	0.85907304	GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP	170	0.94977605	0.6236012	0.98243487	1.8281182	-0.0714339
GO_ENDOTHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	65	0.8783008	0.6942149	0.859068	GO_ENDOTHELIAL_CELL_DIFFERENTIATION	67	0.80856097	0.802589	1	1.68686177	0.06973983
HOFMANN_CELL_LYMPHOMA_UP	c2.CGP_ chemical and genetic perturbations	45	0.8782608	0.68758917	0.859063	HOFMANN_CELL_LYMPHOMA_UP	47	0.75347835	0.8373425	1	1.63173915	0.12478245
GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP	C7_ immunologic signatures	173	0.8780631	0.7422062	0.8594383	GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP	177	0.9966092	0.5035318	0.92851377	1.8746723	-0.1185461
GO_PHOSPHOLIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	320	0.87794536	0.8047404	0.8596205	GO_PHOSPHOLIPID_METABOLIC_PROCESS	333	1.0997291	0.20841683	0.75732046	1.97767446	-0.22178374
GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP	C7_ immunologic signatures	179	0.87765455	0.76449704	0.86020285	GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP	180	0.74470884	0.9317023	1	1.62236339	0.13294571
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	C7_ immunologic signatures	163	0.8775715	0.7633136	0.86030304	GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	162	1.181029	0.14184397	0.6213568	2.0586005	-0.3034575
GO_CELLULAR_RESPONSE_TO_HEAT	c5.BP_ GO biological process	31	0.87739146	0.6606607	0.86063194	GO_CELLULAR_RESPONSE_TO_HEAT	31	1.6637452	0.001212121	0.099057555	2.54113666	-0.78635374
GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP	C7_ immunologic signatures	180	0.8771306	0.7696827	0.86113983	GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP	183	1.0997624	0.2695829	0.7573249	1.976893	-0.2226318
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	c2.CGP_ chemical and genetic perturbations	214	0.87709224	0.7596811	0.8611352	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	215	0.7342947	0.95665324	1	1.61138694	0.14279754
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP	C7_ immunologic signatures	174	0.8770697	0.7494005	0.86109287	GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP	173	-0.93849987	0.73333335	0.7723657	-0.06143017	1.81556957
PID_IGF1_PATHWAY	c2.CP_ Canonical pathways	28	0.8769686	0.6605505	0.86123556	PID_IGF1_PATHWAY	28	-0.6496814	0.9705882	0.9768956	0.2272872	1.52665
GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	158	0.87695277	0.7258454	0.86117655	GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP	161	0.91332775	0.7193516	1	1.79028052	-0.03637498
GO_CHROMATIN_DNA_BINDING	c5.GO molecular function	70	0.876928	0.6894665	0.86113423	GO_CHROMATIN_DNA_BINDING	75	-0.90472347	0.71428573	0.81507736	-0.02779547	1.78165147
GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	C7_ immunologic signatures	186	0.87687546	0.7558962	0.86116225	GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	187	-1.1347079	0.09090909	0.46561146	-0.25783244	2.01158336
CHR3Q23	C1: positional gene sets	18	0.8767557	0.67363346	0.86135083	CHR3Q23	20	1.1069231	0.3358396	0.7427309	1.9836788	-0.2301674
KYNG_NORMAL_AGING_DN	c2.CGP_ chemical and genetic perturbations	24	0.87668246	0.6335878	0.86142164	KYNG_NORMAL_AGING_DN	25	0.6845323	0.8784933	1	1.56121476	0.19215016
GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	171	0.87664807	0.7580071	0.8614069	GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP	175	0.8359643	0.8439716	1	1.71261237	0.04068377
GO_NEGATIVE_REGULATION_OF_ANOIKIS	c5.BP_ GO biological process	16	0.8766135	0.6420722	0.8613921	GO_NEGATIVE_REGULATION_OF_ANOIKIS	16	0.84992725	0.6929134	1	1.72654075	0.02668625
XBP1_01	c3.TFT_ transcription factor targets	121	0.87657815	0.7385204	0.86138254	XBP1_01	123	0.9622285	0.5836777	0.96868175	1.83880665	-0.08565035
GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP	C7_ immunologic signatures	156	0.87651074	0.74970484	0.8614427	GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP	155	0.8941772	0.72764647	1	1.77068794	-0.01766646
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	23	0.8764285	0.6546311	0.8615428	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	23	1.5203818	0.01972873	0.23611544	2.3968103	-0.6439533
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN	c2.CGP_ chemical and genetic perturbations	63	0.87640816	0.69486827	0.861495	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN	67	0.9459856	0.59447515	0.9862384	1.82239376	-0.06957744
GSE2706_UNSTIM_VS_8H_LPS_DC_UP	C7_ immunologic signatures	162	0.87629807	0.7635054	0.8616585	GSE2706_UNSTIM_VS_8H_LPS_DC_UP	164	0.7245119	0.95555556	1	1.60080997	0.15178617
GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN	C7_ immunologic signatures	178	0.87621284	0.75757575	0.8617611	GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN	185	0.62666655	0.9959514	1	1.50287939	0.24954629
GO_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS	c5.BP_ GO biological process	27	0.8761728	0.6707132	0.8617654	GO_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS	28	-0.9323855	0.5483871	0.78097945	-0.0562127	1.8085583
GO_CELLULAR_COMPONENT_DISASSEMBLY	c5.BP_ GO biological process	462	0.8761422	0.8512221	0.86174154	GO_CELLULAR_COMPONENT_DISASSEMBLY	473	0.7118998	0.996	1	1.588042	0.1642424
GO_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS	c5.BP_ GO biological process	20	0.87612003	0.6482982	0.8616951	GO_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS	20	0.64122015	0.9208543	1	1.51734018	0.23489988
WONG_ENDMETRIUM_CANCER_UP	c2.CGP_ chemical and genetic perturbations	18	0.8758581	0.66507936	0.8622297	WONG_ENDMETRIUM_CANCER_UP	21	0.9666025	0.52820516	0.9643178	1.8424606	-0.0907444
GO_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY	c5.GO molecular function	38	0.87569475	0.6886931	0.86252105	GO_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY	39	1.1541455	0.25608343	0.66263485	2.02984025	-0.27845075
DR1_Q3	c3.TFT_ transcription factor targets	220	0.8756116	0.79445726	0.8626281	DR1_Q3	231	0.7407341	0.9698492	1	1.6163457	0.1348775
GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP	C7_ immunologic signatures	128	0.87560916	0.7555283	0.862537	GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP	136	1.0849458	0.33744857	0.777334	1.96055496	-0.20933664
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	139	0.87556225	0.7389163	0.86255574	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP	144	1.1027589	0.2791411	0.7519453	1.97832115	-0.22719665
ACAGGGT_MIR10A_MIR10B	c3.MIR_ microRNA targets	116	0.8755191	0.74462706	0.86256474	ACAGGGT_MIR10A_MIR10B	119	-0.9829369	0.4814815	0.71022874	-0.1074178	1.858456
TCCATTKW_UNKNOWN	c3.TFT_ transcription factor targets	204	0.87549216	0.7714286	0.8625287	TCCATTKW_UNKNOWN	214	1.0253437	0.4511581	0.88358766	1.90083586	-0.14985154
GSE14308_TH2_VS_NATURAL_TREG_UP	C7_ immunologic signatures	176	0.8753675	0.74820143	0.8627255	GSE14308_TH2_VS_NATURAL_TREG_UP	178	0.72006226	0.9705882	1	1.59542976	0.15530524
CHOW_RASSF1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	25	0.87532264	0.67281103	0.86273116	CHOW_RASSF1_TARGETS_UP	24	-1.1883091	0.17277487	0.39579955	-0.31298646	2.06363174
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP	C7_ immunologic signatures	175	0.87523884	0.7631258	0.86283153	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP	174	0.6861244	0.9797571	1	1.56136324	0.18911444
GO_SIGNAL_TRANSDUCTION_BY_PROTEIN_PHOSPHORYLATION	c5.BP_ GO biological process	368	0.8752172	0.8331504	0.8627873	GO_SIGNAL_TRANSDUCTION_BY_PROTEIN_PHOSPHORYLATION	377	1.0057248	0.486	0.9141313	1.880942	-0.1305076
ATGTAGC_MIR221_MIR222	c3.MIR_ microRNA targets	123	0.87506235	0.7441285	0.8630628	ATGTAGC_MIR221_MIR222	130	0.8528041	0.79468846	1	1.72786645	0.02225825
GO_TRANSPORT_VESICLE	c5.CC_ GO cellular component	286	0.8749286	0.7934426	0.8632744	GO_TRANSPORT_VESICLE	299	1.0520608	0.35005015	0.8370122	1.9269894	-0.1771322
GO_POSITIVE_REGULATION_OF_BINDING	c5.BP_ GO biological process	114	0.8747481	0.73417723	0.8635941	GO_POSITIVE_REGULATION_OF_BINDING	119	1.1016095	0.27829698	0.7540856	1.9763576	-0.2268614
GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	126	0.8746509	0.72959185	0.86372614	GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN	130	1.0220723	0.45790553	0.88875365	1.8967232	-0.1474214
GO_HEART_VALVE_DEVELOPMENT	c5.BP_ GO biological process	31	0.8744916	0.66096425	0.86400115	GO_HEART_VALVE_DEVELOPMENT	31	1.0483141	0.41342756	0.8432971	1.9228057	-0.1738225
POU3F2_01	c3.TFT_ transcription factor targets	87	0.8744567	0.71984434	0.86399055	POU3F2_01	95	1.0954533	0.3005291	0.764245	1.96991	-0.2209966
LI_CYTIDINE_ANALOG_PATHWAY	c2.CGP_ chemical and genetic perturbations	15	0.8744106	0.64638156	0.8640039	LI_CYTIDINE_ANALOG_PATHWAY	15	-1.4780236	0.06198347	0.15617734	-0.603613	2.3524342
GO_POSITIVE_REGULATION_OF_HOMEOSTATIC_PROCESS	c5.BP_ GO biological process	179	0.87426805	0.7639535	0.86424047	GO_POSITIVE_REGULATION_OF_HOMEOSTATIC_PROCESS	190	1.2605733	0.044399597	0.49544218	2.13484135	-0.38630525
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	c2.CGP_ chemical and genetic perturbations	106	0.87423116	0.7386216	0.86422855	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	108	0.9490407	0.60479665	0.9832694	1.82327186	-0.07480954
GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN	C7_ immunologic signatures	176	0.8741515	0.76749706	0.8643188	GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN	179	1.1655601	0.14503042	0.6459699	2.0397116	-0.2914086
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	c2.CGP_ chemical and genetic perturbations	34	0.8740197	0.69253296	0.8645375	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	35	-0.949296	0.57236844	0.7569636	-0.0752763	1.8233157
MODULE_318	c4.CM_ cancer modules	24	0.87395805	0.66199374	0.8645846	MODULE_318	25	-0.8784801	0.6826923	0.84643537	-0.00452205	1.75243815
GO_RESPONSE_TO_CORTICOSTERONE	c5.BP_ GO biological process	24	0.87393045	0.66172105	0.86455435	GO_RESPONSE_TO_CORTICOSTERONE	24	0.84719193	0.70595694	1	1.72112238	0.02673852
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	17	0.87391657	0.6634921	0.86448985	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	17	1.0761403	0.3783784	0.7944939	1.95005687	-0.20222373
GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	C7_ immunologic signatures	180	0.8739075	0.78748524	0.86441356	GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	185	1.1370668	0.18635438	0.6946309	2.0109743	-0.2631593
GO_HIPPO_SIGNALING	c5.BP_ GO biological process	26	0.8738908	0.6676876	0.86435527	GO_HIPPO_SIGNALING	26	-1.1094915	0.2819149	0.50539327	-0.2356007	1.9833823
CHR2P16	C1: positional gene sets	28	0.87377846	0.67018074	0.864525	CHR2P16	28	0.7305343	0.85408807	1	1.60431276	0.14324416
BIOCARTA_IL7_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	0.8735721	0.6471519	0.8649165	BIOCARTA_IL7_PATHWAY	17	1.1725688	0.2767624	0.6331657	2.0461409	-0.2989967
PID_IL3_PATHWAY	c2.CP_ Canonical pathways	23	0.87351453	0.6379585	0.8649566	PID_IL3_PATHWAY	25	1.1678413	0.26190478	0.6406615	2.04135583	-0.29432677
PID_RAC1_REG_PATHWAY	c2.CP_ Canonical pathways	36	0.87347025	0.68162084	0.8649613	PID_RAC1_REG_PATHWAY	38	1.5728654	0.005787037	0.18733516	2.44633565	-0.69939515
GSE17721_12H_VS_24H_POLYIC_BMDC_DN	C7_ immunologic signatures	177	0.87328243	0.7720329	0.8653155	GSE17721_12H_VS_24H_POLYIC_BMDC_DN	177	0.8642437	0.7975708	1	1.73752613	0.00903873
GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	169	0.8732503	0.7768496	0.86529565	GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP	173	1.081097	0.30645162	0.7854488	1.9543473	-0.2078467
MCCABE_HOXC6_TARGETS_CANCER_DN	c2.CGP_ chemical and genetic perturbations	20	0.87318826	0.6393189	0.8653466	MCCABE_HOXC6_TARGETS_CANCER_DN	20	0.6450819	0.9255456	1	1.51827016	0.22810636
GO_RNA_POLYMERASE_II_REPRESSING_TRANSCRIPTION_FACTOR_BINDING	c5.GO molecular function	25	0.87311316	0.65625	0.86542517	GO_RNA_POLYMERASE_II_REPRESSING_TRANSCRIPTION_FACTOR_BINDING	27	-1.2240758	0.15675676	0.35080558	-0.35096264	2.09718896
GO_ENTRAINMENT_OF_CIRCADIAN_CLOCK	c5.BP_ GO biological process	23	0.87307036	0.66720515	0.8654282	GO_ENTRAINMENT_OF_CIRCADIAN_CLOCK	24	0.6999017	0.88627934	1	1.57297206	0.17316866
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	c2.CGP_ chemical and genetic perturbations	26	0.87306696	0.65384614	0.8653384	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	26	-1.5483902	0.024390243	0.11633461	-0.67532324	2.42145716
REACTOME_SIGNAL_AMPLIFICATION	c2.CP_REACTOME_ Reactome gene sets	28	0.8730654	0.657228	0.86524683	REACTOME_SIGNAL_AMPLIFICATION	28	0.8896441	0.6408364	1	1.7627095	-0.0165787
GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP	C7_ immunologic signatures	153	0.8730446	0.76710683	0.86520314	GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP	156	1.1289277	0.21501014	0.70714533	2.0019723	-0.2558831
GO_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING	c5.BP_ GO biological process	33	0.8729451	0.66765577	0.86534333	GO_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING	35	0.62319267	0.9462617	1	1.49613777	0.24975243
GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN	C7_ immunologic signatures	174	0.87293386	0.75	0.8652737	GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN	180	0.5806073	0.9989858	1	1.45354116	0.29232656
GENTILE_UV_RESPONSE_CLUSTER_D5	c2.CGP_ chemical and genetic perturbations	37	0.8727908	0.68532526	0.865514	GENTILE_UV_RESPONSE_CLUSTER_D5	37	-1.2422457	0.12592593	0.33227164	-0.3694549	2.1150365
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	153	0.8727057	0.75507766	0.8656115	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP	156	0.79763216	0.87385553	1	1.67033786	0.07507354
GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN	C7_ immunologic signatures	179	0.8726737	0.7569767	0.8655897	GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN	180	0.75179183	0.9505051	1	1.62446553	0.12088187
MORF_MAP3K14	c4.CGN_ cancer gene neighborhoods	95	0.8726446	0.72619045	0.8655642	MORF_MAP3K14	98	1.0438176	0.4043659	0.8514134	1.9164622	-0.171173
GO_ORGANOPHOSPHATE_CATABOLIC_PROCESS	c5.BP_ GO biological process	107	0.8725902	0.72243345	0.8656028	GO_ORGANOPHOSPHATE_CATABOLIC_PROCESS	107	0.84734446	0.78115183	1	1.71993466	0.02524574
GALLUZZI_PERMEABILIZE_MITOCHONDRIA	c2.CGP_ chemical and genetic perturbations	37	0.8725054	0.68421054	0.86570525	GALLUZZI_PERMEABILIZE_MITOCHONDRIA	38	-1.5685346	0	0.10548864	-0.6960292	2.44104
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	c2.CGP_ chemical and genetic perturbations	20	0.8725026	0.640625	0.8656149	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	20	-0.7438905	0.8545455	0.9404592	0.1286121	1.6163931
TTGCWCAAY_CEBPB_02	c3.TFT_ transcription factor targets	56	0.8725023	0.7213578	0.86551905	TTGCWCAAY_CEBPB_02	58	0.9808621	0.5033557	0.94809705	1.8533644	-0.1083598
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	c2.CGP_ chemical and genetic perturbations	69	0.87249917	0.6963563	0.86543095	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	71	-1.8713944	0	0.021265404	-0.99889523	2.74389357
GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	C7_ immunologic signatures	184	0.8724893	0.76913875	0.8653581	GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	188	0.89758337	0.74772954	1	1.77007267	-0.02509407
GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN	C7_ immunologic signatures	164	0.8724326	0.7595694	0.8653935	GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN	163	1.1214614	0.23279352	0.721841	1.993894	-0.2490288
GSE29618_MONOCYTE_VS_PDC_DN	C7_ immunologic signatures	173	0.8724212	0.7809868	0.8653261	GSE29618_MONOCYTE_VS_PDC_DN	177	-1.2551025	0	0.31981677	-0.3826813	2.1275237
REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS	c2.CP_REACTOME_ Reactome gene sets	15	0.8723959	0.66292137	0.8652928	REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS	15	0.9666026	0.5370121	0.9644524	1.8389985	-0.0942067
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP	C7_ immunologic signatures	175	0.87232184	0.778043	0.8653638	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP	182	1.0485665	0.37487334	0.8426572	1.92088834	-0.17624466
GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN	C7_ immunologic signatures	142	0.8722451	0.7539586	0.8654428	GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN	147	1.2689049	0.06294416	0.48602343	2.14115	-0.3966598
GO_NONMOTILE_PRIMARY_CILIUM_ASSEMBLY	c5.BP_ GO biological process	22	0.8722414	0.6872111	0.8653566	GO_NONMOTILE_PRIMARY_CILIUM_ASSEMBLY	22	1.0552231	0.41863355	0.8326477	1.9274645	-0.1829817
MODULE_157	c4.CM_ cancer modules	88	0.8721263	0.70721924	0.8655294	MODULE_157	94	1.2575086	0.0844773	0.49917847	2.1296349	-0.3853823
GO_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING	c5.BP_ GO biological process	23	0.872068	0.65409833	0.8655708	GO_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING	22	1.2163879	0.20901126	0.5633151	2.0884559	-0.3443199
GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN	C7_ immunologic signatures	172	0.8720136	0.7608173	0.8656092	GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN	174	1.051693	0.3743642	0.83697134	1.9237066	-0.1796794
URS_ADIPOCYTE_DIFFERENTIATION_DN	c2.CGP_ chemical and genetic perturbations	29	0.87201333	0.6699858	0.86551404	URS_ADIPOCYTE_DIFFERENTIATION_DN	29	1.0008081	0.48296836	0.92306316	1.87282143	-0.12879477
MAZR_01	c3.TFT_ transcription factor targets	204	0.87173295	0.7766204	0.86605924	MAZR_01	207	-1.097355	0.2857143	0.5229972	-0.22562205	1.96908795
GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	C7_ immunologic signatures	110	0.87166893	0.7487374	0.86611146	GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	111	1.155322	0.1822863	0.6613424	2.02699093	-0.28365307
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	c2.CGP_ chemical and genetic perturbations	26	0.87156063	0.65625	0.86626136	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	28	1.2297864	0.1941032	0.5413532	2.10134703	-0.35822577
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	175	0.8715601	0.7708082	0.8661665	GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	178	1.0061288	0.4868421	0.9136435	1.8776889	-0.1345687
GSE43955_1H_VS_60H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	178	0.8712942	0.7608173	0.8666849	GSE43955_1H_VS_60H_ACT_CD4_TCELL_UP	182	0.7582971	0.9319106	1	1.6295913	0.1129971
GO_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING	c5.GO molecular function	32	0.87120146	0.66101694	0.8667984	GO_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING	33	1.2824354	0.12941177	0.46889666	2.15363686	-0.41123394
KRAS.BREAST_UP.V1_UP	C6_ oncogenic signatures	98	0.8711648	0.7315522	0.8667824	KRAS.BREAST_UP.V1_UP	104	1.4165286	0.016563147	0.32088625	2.2876934	-0.5453638
CREB_Q4_01	c3.TFT_ transcription factor targets	182	0.87106216	0.784267	0.8669219	CREB_Q4_01	185	0.8713144	0.78498983	1	1.74237656	-0.00025224
GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP	C7_ immunologic signatures	151	0.8710554	0.74969476	0.8668412	GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP	157	1.2265913	0.074489795	0.54732996	2.0976467	-0.3555359
GGCAGAC_MIR346	c3.MIR_ microRNA targets	37	0.8709527	0.6676783	0.86697525	GGCAGAC_MIR346	37	1.1140043	0.32585597	0.731886	1.984957	-0.2430516
GO_PROTEIN_LIPID_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	18	0.87089354	0.65097404	0.867017	GO_PROTEIN_LIPID_COMPLEX_ASSEMBLY	20	-0.74978113	0.83653843	0.93909097	0.12111241	1.62067467
GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP	C7_ immunologic signatures	177	0.8708308	0.7721822	0.8670626	GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP	182	0.9912659	0.53698075	0.934355	1.8620967	-0.1204351
GSE20727_CTRL_VS_H2O2_TREATED_DC_DN	C7_ immunologic signatures	161	0.8707551	0.7709091	0.8671393	GSE20727_CTRL_VS_H2O2_TREATED_DC_DN	165	1.3406929	0.01928934	0.3954795	2.211448	-0.4699378
GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN	C7_ immunologic signatures	185	0.8707453	0.7709049	0.867064	GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN	186	-1.1826493	0	0.4023439	-0.311904	2.0533946
MORF_RBBP8	c4.CGN_ cancer gene neighborhoods	185	0.8706273	0.7920561	0.86723566	MORF_RBBP8	194	0.9468048	0.63370335	0.9855651	1.8174321	-0.0761775
VILIMAS_NOTCH1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	16	0.87039465	0.6496815	0.8676857	VILIMAS_NOTCH1_TARGETS_DN	17	1.3603134	0.08397933	0.37777573	2.23070805	-0.48991875
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	21	0.87035197	0.6527778	0.86769056	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	21	0.66930187	0.8929471	1	1.53965384	0.2010501
GO_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY	c5.GO molecular function	16	0.8703018	0.6401945	0.8677077	GO_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY	16	-0.8473183	0.68442625	0.8708643	0.0229835	1.7176201
GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP	C7_ immunologic signatures	138	0.87026	0.7345679	0.86771125	GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP	143	0.58307797	0.99794024	1	1.45333797	0.28718203
GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	C7_ immunologic signatures	153	0.87023884	0.7732342	0.86766547	GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	154	0.99287647	0.52085453	0.93190116	1.86311531	-0.12263763
GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN	C7_ immunologic signatures	173	0.87016654	0.77068555	0.86773264	GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN	178	1.3033482	0.020181635	0.43612468	2.17351474	-0.43318166
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP	C7_ immunologic signatures	175	0.86998713	0.75688624	0.86804414	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP	177	0.91641957	0.70938444	1	1.7864067	-0.04643244
MORF_MAP2K7	c4.CGN_ cancer gene neighborhoods	138	0.8697108	0.75731707	0.8685841	MORF_MAP2K7	150	1.2795566	0.039795917	0.47280592	2.1492674	-0.4098458
GSE27786_LIN_NEG_VS_CD4_TCELL_DN	C7_ immunologic signatures	178	0.8695758	0.774269	0.86879903	GSE27786_LIN_NEG_VS_CD4_TCELL_DN	180	1.386924	0.006072875	0.34863707	2.2564998	-0.5173482
LIAN_LIPA_TARGETS_3M	c2.CGP_ chemical and genetic perturbations	41	0.86948705	0.6719653	0.86891556	LIAN_LIPA_TARGETS_3M	47	0.90841603	0.6300448	1	1.77790308	-0.03892898
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP	C7_ immunologic signatures	183	0.86938876	0.8027523	0.869045	GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP	183	1.0262367	0.42296073	0.88247263	1.89562546	-0.15684794
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	c2.CGP_ chemical and genetic perturbations	28	0.86926615	0.65898615	0.869233	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	28	1.2603463	0.158831	0.49593756	2.12961245	-0.39108015
GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	182	0.8692516	0.7815951	0.8691723	GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP	181	-1.4178177	0	0.19517511	-0.5485661	2.2870693
GAVIN_FOXP3_TARGETS_CLUSTER_T4	c2.CGP_ chemical and genetic perturbations	82	0.8692241	0.7432258	0.86914593	GAVIN_FOXP3_TARGETS_CLUSTER_T4	84	0.8760652	0.7250531	1	1.7452893	-0.0068411
GO_ANTIGEN_PROCESSING_AND_PRESENTATION	c5.BP_ GO biological process	173	0.8691306	0.7899263	0.86925644	GO_ANTIGEN_PROCESSING_AND_PRESENTATION	177	1.0228186	0.4249493	0.8866706	1.8919492	-0.153688
GO_ACTIN_CYTOSKELETON_REORGANIZATION	c5.BP_ GO biological process	53	0.8691089	0.7070423	0.8692047	GO_ACTIN_CYTOSKELETON_REORGANIZATION	53	1.3308039	0.07821229	0.4008515	2.1999128	-0.461695
GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	C7_ immunologic signatures	175	0.8691	0.76251453	0.86912876	GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	176	-1.2547628	0.1	0.31977725	-0.3856628	2.1238628
BROWNE_HCMV_INFECTION_10HR_DN	c2.CGP_ chemical and genetic perturbations	51	0.8689875	0.68	0.8692966	BROWNE_HCMV_INFECTION_10HR_DN	51	0.9396192	0.60088205	0.9901024	1.8086067	-0.0706317
GO_HEPATICOBILIARY_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	118	0.8688088	0.7667526	0.8696044	GO_HEPATICOBILIARY_SYSTEM_DEVELOPMENT	125	0.864126	0.78328174	1	1.7329348	0.0046828
GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP	C7_ immunologic signatures	125	0.8687844	0.74626863	0.86955976	GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP	136	0.91140926	0.6930185	1	1.78019366	-0.04262486
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	177	0.8687581	0.77698696	0.8695194	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP	179	0.66501075	0.9848332	1	1.53376885	0.20374735
GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	138	0.8687398	0.76695436	0.869466	GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	142	0.705824	0.960041	1	1.5745638	0.1629158
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN	C7_ immunologic signatures	174	0.86873263	0.7794994	0.86938906	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN	173	0.62551236	0.9959473	1	1.49424499	0.24322027
GO_CHROMATIN_BINDING	c5.GO molecular function	385	0.8686825	0.84439605	0.86940616	GO_CHROMATIN_BINDING	406	0.6298848	1	1	1.4985673	0.2387977
GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP	C7_ immunologic signatures	179	0.8686489	0.7723005	0.8693855	GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP	183	0.68141115	0.9817444	1	1.55006005	0.18723775
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	171	0.8685646	0.7826603	0.86948514	GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	176	1.2519758	0.05792683	0.50825554	2.1205404	-0.3834112
GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN	C7_ immunologic signatures	183	0.86837786	0.79710144	0.86980695	GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN	184	-1.275573	0	0.3064761	-0.40719514	2.14395086
GO_MONOAMINE_TRANSPORT	c5.BP_ GO biological process	17	0.86835223	0.6536585	0.86976993	GO_MONOAMINE_TRANSPORT	19	1.2385844	0.17948718	0.527763	2.10693663	-0.37023217
YGCANTGCR_UNKNOWN	c3.TFT_ transcription factor targets	109	0.8683417	0.7221511	0.86969763	YGCANTGCR_UNKNOWN	115	0.8749994	0.74843425	1	1.7433411	-0.0066577
GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN	C7_ immunologic signatures	173	0.8683323	0.77288944	0.8696221	GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN	173	0.9171859	0.67918783	1	1.7855182	-0.0488536
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN	C7_ immunologic signatures	177	0.8681947	0.7717004	0.86983544	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN	171	1.0092747	0.4898374	0.90900266	1.8774694	-0.14108
GO_ALCOHOL_BINDING	c5.GO molecular function	84	0.86808366	0.7298013	0.869999	GO_ALCOHOL_BINDING	93	1.3655206	0.02763018	0.3722062	2.23360426	-0.49743694
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	170	0.8680671	0.7669789	0.8699446	GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP	175	1.1808226	0.13866396	0.6219456	2.0488897	-0.3127555
STARK_HYPPOCAMPUS_22Q11_DELETION_UP	c2.CGP_ chemical and genetic perturbations	46	0.8680322	0.6891334	0.8699265	STARK_HYPPOCAMPUS_22Q11_DELETION_UP	47	-0.9337273	0.5948276	0.7786991	-0.0656951	1.8017595
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	c2.CGP_ chemical and genetic perturbations	21	0.8679736	0.6181534	0.86996424	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	22	0.7239887	0.8546366	1	1.5919623	0.1439849
GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	137	0.8678479	0.7731707	0.8701624	GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP	143	1.4441693	0.001014199	0.29783496	2.3120172	-0.5763214
GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP	C7_ immunologic signatures	169	0.86781067	0.7810219	0.8701527	GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP	175	1.2572013	0.03340081	0.49917722	2.12501197	-0.38939063
GO_REGULATION_OF_WATER_LOSS_VIA_SKIN	c5.BP_ GO biological process	15	0.8677874	0.68113524	0.87010926	GO_REGULATION_OF_WATER_LOSS_VIA_SKIN	18	1.3760763	0.09727626	0.3574559	2.2438637	-0.5082889
GO_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE	c5.BP_ GO biological process	26	0.8675314	0.657277	0.87061405	GO_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE	26	0.8126026	0.7530414	1	1.680134	0.0549288
GO_PROTEIN_HETEROOLIGOMERIZATION	c5.BP_ GO biological process	88	0.8674388	0.7289235	0.87073004	GO_PROTEIN_HETEROOLIGOMERIZATION	90	0.8942726	0.68869936	1	1.7617114	-0.0268338
GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN	C7_ immunologic signatures	180	0.86725116	0.7720504	0.8710564	GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN	182	0.6680516	0.98985803	1	1.53530276	0.19919956
MODULE_49	c4.CM_ cancer modules	224	0.8669994	0.8002296	0.8715363	MODULE_49	236	1.3089645	0.014070352	0.42769605	2.1759639	-0.4419651
GO_MULTIVESICULAR_BODY	c5.CC_ GO cellular component	31	0.866915	0.6666667	0.87163687	GO_MULTIVESICULAR_BODY	32	1.0004587	0.46778044	0.92344344	1.8673737	-0.1335437
RB_P130_DN.V1_DN	C6_ oncogenic signatures	119	0.86670727	0.7608426	0.87201166	RB_P130_DN.V1_DN	121	1.0927116	0.3125649	0.76853013	1.95941887	-0.22600433
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN	c2.CGP_ chemical and genetic perturbations	211	0.86665833	0.7831603	0.872025	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN	214	0.6920707	0.97981834	1	1.55872903	0.17458763
GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN	C7_ immunologic signatures	177	0.86661196	0.78690475	0.8720347	GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN	178	1.2020797	0.09979633	0.5887495	2.06869166	-0.33546774
GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP	C7_ immunologic signatures	164	0.8665925	0.7656805	0.871986	GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP	168	-0.9817038	0.5625	0.7125366	-0.1151113	1.8482963
GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP	C7_ immunologic signatures	148	0.86648136	0.75060827	0.87214607	GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP	156	1.1902236	0.12729125	0.6058654	2.05670496	-0.32374224
GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP	C7_ immunologic signatures	170	0.86638343	0.77304965	0.8722715	GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP	174	0.8653433	0.78809285	1	1.73172673	0.00104013
GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	C7_ immunologic signatures	162	0.8662636	0.77261907	0.8724548	GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	161	1.0234967	0.44771573	0.8859006	1.8897603	-0.1572331
CAR_MYST2	c4.CGN_ cancer gene neighborhoods	23	0.86624783	0.6827372	0.8723936	CAR_MYST2	24	0.58279014	0.96350366	1	1.44903797	0.28345769
GO_M_BAND	c5.CC_ GO cellular component	17	0.8662163	0.67701864	0.87236613	GO_M_BAND	19	1.2047127	0.23148148	0.58262616	2.070929	-0.3384964
GSE15330_HSC_VS_PRO_BCELL_UP	C7_ immunologic signatures	174	0.8662095	0.79811096	0.8722828	GSE15330_HSC_VS_PRO_BCELL_UP	176	-0.74467707	1	0.94080544	0.12153243	1.61088657
GO_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_EXONUCLEOLYTIC	c5.BP_ GO biological process	33	0.8661463	0.669219	0.8723296	GO_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_EXONUCLEOLYTIC	33	-1.4955909	0.023121387	0.14537096	-0.6294446	2.3617372
GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP	C7_ immunologic signatures	172	0.8660934	0.78502417	0.87235224	GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP	175	0.7108953	0.96875	1	1.5769887	0.1551981
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN	C7_ immunologic signatures	176	0.86609304	0.7887155	0.87225676	GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN	176	1.0871404	0.28311425	0.775115	1.95323344	-0.22104736
RELA_DN.V1_DN	C6_ oncogenic signatures	108	0.8659629	0.74529487	0.8724576	RELA_DN.V1_DN	114	1.2804048	0.06256517	0.47147614	2.1463677	-0.4144419
GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN	C7_ immunologic signatures	165	0.86586934	0.76	0.87256634	GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN	170	1.0829138	0.31338742	0.7824582	1.94878314	-0.21704446
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	165	0.8658218	0.78317535	0.8725774	GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN	175	0.93816245	0.64032423	0.9927324	1.80398425	-0.07234065
GO_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE	c5.BP_ GO biological process	28	0.865632	0.69491524	0.87290674	GO_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE	29	1.1111318	0.32853717	0.73577833	1.9767638	-0.2454998
GO_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS	c5.BP_ GO biological process	29	0.8655127	0.6741405	0.8730847	GO_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS	30	1.377744	0.072792366	0.357047	2.2432567	-0.5122313
GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN	C7_ immunologic signatures	173	0.8654909	0.77454543	0.87303853	GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN	180	0.907901	0.720202	1	1.7733919	-0.0424101
GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP	C7_ immunologic signatures	168	0.8654779	0.7792521	0.8729719	GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP	169	1.0189806	0.44579533	0.89198154	1.8844585	-0.1535027
MORF_ZNF10	c4.CGN_ cancer gene neighborhoods	39	0.8654529	0.66852367	0.8729323	MORF_ZNF10	41	1.1763887	0.22004609	0.6273822	2.0418416	-0.3109358
GSE22886_NAIVE_BCELL_VS_DC_DN	C7_ immunologic signatures	183	0.8654192	0.76802886	0.87291044	GSE22886_NAIVE_BCELL_VS_DC_DN	183	0.9230278	0.68085104	1	1.788447	-0.0576086
CREB_Q2_01	c3.TFT_ transcription factor targets	194	0.8652752	0.8020955	0.8731351	CREB_Q2_01	198	0.99731946	0.4969819	0.926197	1.86259466	-0.13204426
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	c2.CGP_ chemical and genetic perturbations	46	0.8652473	0.70544916	0.87309927	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	46	1.2116992	0.16838488	0.5749882	2.0769465	-0.3464519
GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP	C7_ immunologic signatures	147	0.86512923	0.7609756	0.87328035	GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP	152	0.94119143	0.62487257	0.9895555	1.80632066	-0.0760622
CHR5Q22	C1: positional gene sets	18	0.86511904	0.6455696	0.87320423	CHR5Q22	18	-1.1369188	0.24166666	0.4621676	-0.27179976	2.00203784
BOYLAN_MULTIPLE_MYELOMA_D_UP	c2.CGP_ chemical and genetic perturbations	78	0.86510676	0.73015875	0.8731369	BOYLAN_MULTIPLE_MYELOMA_D_UP	81	1.1327825	0.25792813	0.70168537	1.99788926	-0.26767574
GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN	C7_ immunologic signatures	161	0.865085	0.771327	0.8730903	GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN	169	0.73334146	0.953252	1	1.59842646	0.13174354
GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP	C7_ immunologic signatures	180	0.86501896	0.7882775	0.8731445	GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP	182	0.8742049	0.7758621	1	1.73922386	-0.00918594
GO_ORGANELLE_SUBCOMPARTMENT	c5.CC_ GO cellular component	268	0.8649958	0.8388195	0.87310123	GO_ORGANELLE_SUBCOMPARTMENT	273	0.9486641	0.6616617	0.9831824	1.8136599	-0.0836683
GO_ANION_TRANSPORT	c5.BP_ GO biological process	416	0.86497074	0.85287845	0.87305874	GO_ANION_TRANSPORT	459	1.2553161	0.003	0.5019945	2.12028684	-0.39034536
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	c2.CGP_ chemical and genetic perturbations	28	0.864963	0.6942393	0.8729794	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	29	0.76986885	0.8231707	1	1.63483185	0.09509415
GO_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	53	0.8648228	0.71174866	0.87320495	GO_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS	58	1.1801043	0.2196468	0.623411	2.0449271	-0.3152815
ATCMNTCCGY_UNKNOWN	c3.TFT_ transcription factor targets	47	0.86480594	0.6782107	0.8731481	ATCMNTCCGY_UNKNOWN	48	0.7992434	0.79223746	1	1.66404934	0.06556254
GO_CYTOLYSIS	c5.BP_ GO biological process	18	0.86472696	0.6585366	0.87323403	GO_CYTOLYSIS	17	1.4977542	0.025974026	0.2530185	2.36248116	-0.63302724
CRX_NRL_DN.V1_UP	C6_ oncogenic signatures	129	0.8647026	0.7777778	0.87319183	CRX_NRL_DN.V1_UP	130	1.0653906	0.38055843	0.81360096	1.9300932	-0.200688
GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN	c5.BP_ GO biological process	17	0.86428374	0.6540362	0.8740614	GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN	20	0.7455276	0.8089172	1	1.60981134	0.11875614
GO_APOPTOTIC_NUCLEAR_CHANGES	c5.BP_ GO biological process	21	0.8640478	0.6761006	0.87450147	GO_APOPTOTIC_NUCLEAR_CHANGES	24	-1.0138117	0.4556213	0.6678107	-0.1497639	1.8778595
GTATGAT_MIR154_MIR487	c3.MIR_ microRNA targets	66	0.86395663	0.72801083	0.87460995	GTATGAT_MIR154_MIR487	67	-0.85703015	0.8064516	0.86262095	0.00692648	1.72098678
SP1_Q2_01	c3.TFT_ transcription factor targets	227	0.8638363	0.7988439	0.8747844	SP1_Q2_01	230	0.87349826	0.8026052	1	1.73733456	-0.00966196
CHR6Q23	C1: positional gene sets	36	0.86382896	0.6886228	0.87470406	CHR6Q23	36	1.0658749	0.37633136	0.81263757	1.92970386	-0.20204594
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G	c2.CGP_ chemical and genetic perturbations	90	0.8638236	0.7480211	0.8746214	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G	90	-0.9141076	0.7258065	0.80173296	-0.050284	1.7779312
GO_SIGNAL_PEPTIDE_PROCESSING	c5.BP_ GO biological process	22	0.8638121	0.67346936	0.87455034	GO_SIGNAL_PEPTIDE_PROCESSING	22	1.3437009	0.091925465	0.39126584	2.207513	-0.4798888
REACTOME_BOTULINUM_NEUROTOXICITY	c2.CP_REACTOME_ Reactome gene sets	17	0.8636144	0.660596	0.8749039	REACTOME_BOTULINUM_NEUROTOXICITY	17	1.1141194	0.33687	0.73166996	1.9777338	-0.250505
GENTILE_UV_RESPONSE_CLUSTER_D8	c2.CGP_ chemical and genetic perturbations	38	0.8635429	0.67518795	0.8749748	GENTILE_UV_RESPONSE_CLUSTER_D8	38	0.7288129	0.8672986	1	1.5923558	0.13473
GO_REGULATION_OF_CHROMATIN_ORGANIZATION	c5.BP_ GO biological process	138	0.8634815	0.7772277	0.8750173	GO_REGULATION_OF_CHROMATIN_ORGANIZATION	143	-0.9229869	0.85	0.7919676	-0.0595054	1.7864684
GO_ORGANIC_ANION_TRANSPORT	c5.BP_ GO biological process	316	0.8634377	0.83515286	0.8750147	GO_ORGANIC_ANION_TRANSPORT	346	1.2466706	0.012012012	0.5166699	2.1101083	-0.3832329
GO_VENTRAL_SPINAL_CORD_DEVELOPMENT	c5.BP_ GO biological process	41	0.8632835	0.6907994	0.8752813	GO_VENTRAL_SPINAL_CORD_DEVELOPMENT	46	-1.1315798	0.20560747	0.46936175	-0.2682963	1.9948633
GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN	C7_ immunologic signatures	177	0.8632127	0.77606636	0.8753406	GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN	184	0.9621851	0.60427266	0.9686948	1.8253978	-0.0989724
GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN	C7_ immunologic signatures	146	0.8631722	0.7751196	0.87533456	GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN	162	1.02421	0.44827586	0.8849783	1.8873822	-0.1610378
GSE16385_MONOCYTE_VS_MACROPHAGE_UP	C7_ immunologic signatures	166	0.86308146	0.7747318	0.8754347	GSE16385_MONOCYTE_VS_MACROPHAGE_UP	174	1.0746411	0.3242148	0.7976827	1.93772256	-0.21155964
GO_REGULATION_OF_SYMBIOSIS_ENCOMPASSING_MUTUALISM_THROUGH_PARASITISM	c5.BP_ GO biological process	166	0.8629871	0.7826603	0.8755419	GO_REGULATION_OF_SYMBIOSIS_ENCOMPASSING_MUTUALISM_THROUGH_PARASITISM	168	0.7379993	0.94624746	1	1.6009864	0.1249878
GO_CELLULAR_RESPONSE_TO_DSRNA	c5.BP_ GO biological process	30	0.86280483	0.65909094	0.87584305	GO_CELLULAR_RESPONSE_TO_DSRNA	29	0.66648644	0.9219331	1	1.52929127	0.19631839
GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP	C7_ immunologic signatures	174	0.86280125	0.786052	0.87575597	GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP	173	1.0154325	0.46435845	0.8965394	1.87823375	-0.15263125
GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN	C7_ immunologic signatures	176	0.8627914	0.7708831	0.8756824	GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN	179	1.2771308	0.044624746	0.4764954	2.1399222	-0.4143394
GO_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL	c5.BP_ GO biological process	177	0.8626504	0.7850356	0.875905	GO_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL	179	0.8867253	0.75733066	1	1.7493757	-0.0240749
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	c2.CGP_ chemical and genetic perturbations	147	0.8626475	0.76626503	0.87581754	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	153	0.80023646	0.8700508	1	1.66288396	0.06241104
TCATCTC_MIR143	c3.MIR_ microRNA targets	136	0.86255604	0.7803681	0.87593275	TCATCTC_MIR143	140	0.807472	0.84473956	1	1.67002804	0.05508404
GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN	C7_ immunologic signatures	185	0.8625124	0.8051948	0.87593114	GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN	186	-1.1298782	0.09090909	0.4714374	-0.2673658	1.9923906
KIM_GERMINAL_CENTER_T_HELPER_UP	c2.CGP_ chemical and genetic perturbations	54	0.86243564	0.7054598	0.8760027	KIM_GERMINAL_CENTER_T_HELPER_UP	58	1.135901	0.27628636	0.695904	1.99833664	-0.27346536
GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN	C7_ immunologic signatures	182	0.8623994	0.76705885	0.8759864	GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN	185	0.93612176	0.6424242	0.99398625	1.79852116	-0.07372236
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP	C7_ immunologic signatures	167	0.86238956	0.7818182	0.87591106	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP	168	0.82639617	0.8469388	1	1.68878573	0.03599339
GO_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	0.86238474	0.66062605	0.8758248	GO_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS	16	1.2745742	0.16481994	0.4806198	2.13695894	-0.41218946
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN	C7_ immunologic signatures	180	0.8623672	0.77790695	0.8757655	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN	181	-1.3311359	0	0.25537968	-0.4687687	2.1935031
TTCYRGAA_UNKNOWN	c3.TFT_ transcription factor targets	286	0.8623421	0.8434004	0.87572825	TTCYRGAA_UNKNOWN	299	1.0028919	0.502008	0.91866124	1.865234	-0.1405498
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN	C7_ immunologic signatures	171	0.8621266	0.7762073	0.8761239	GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN	176	0.7583937	0.9221436	1	1.6205203	0.1037329
GO_FIBRINOLYSIS	c5.BP_ GO biological process	16	0.86209136	0.6644951	0.876106	GO_FIBRINOLYSIS	18	1.6041695	0.003870968	0.15272957	2.46626086	-0.74207814
GO_AROMATIC_AMINO_ACID_FAMILY_METABOLIC_PROCESS	c5.BP_ GO biological process	24	0.86203206	0.6713178	0.8761453	GO_AROMATIC_AMINO_ACID_FAMILY_METABOLIC_PROCESS	27	-1.442395	0.04347826	0.17855649	-0.58036294	2.30442706
GCTGAGT_MIR5125P	c3.MIR_ microRNA targets	46	0.8619037	0.6766382	0.8763417	GCTGAGT_MIR5125P	47	1.3918376	0.042577676	0.34663698	2.2537413	-0.5299339
PAX4_01	c3.TFT_ transcription factor targets	231	0.8618964	0.81395346	0.87626094	PAX4_01	241	0.67715603	0.99297893	1	1.53905243	0.18474037
CTACTAG_MIR325	c3.MIR_ microRNA targets	17	0.86171526	0.66450566	0.8765718	CTACTAG_MIR325	17	0.8012763	0.7565543	1	1.66299156	0.06043896
XU_CREBBP_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	39	0.8616894	0.7090643	0.876532	XU_CREBBP_TARGETS_DN	40	-1.2698438	0.10948905	0.30935103	-0.4081544	2.1315332
GO_NUCLEAR_CHROMATIN	c5.CC_ GO cellular component	237	0.8616546	0.8240741	0.8765113	GO_NUCLEAR_CHROMATIN	244	-1.1573075	0	0.43405533	-0.2956529	2.0189621
GSE6875_WT_VS_FOXP3_KO_TREG_UP	C7_ immunologic signatures	168	0.8615748	0.7926102	0.8765967	GSE6875_WT_VS_FOXP3_KO_TREG_UP	171	0.8733529	0.78840286	1	1.7349277	-0.0117781
BIOCARTA_BAD_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	23	0.8615714	0.7040971	0.8765071	BIOCARTA_BAD_PATHWAY	24	0.4822999	0.99507993	1	1.3438713	0.3792715
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN	C7_ immunologic signatures	185	0.86156553	0.78878284	0.8764256	GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN	188	0.8849456	0.7586207	1	1.74651113	-0.02338007
GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	C7_ immunologic signatures	134	0.8615384	0.7924757	0.87639266	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	139	1.1723616	0.15250768	0.6339493	2.0339	-0.3108232
GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN	C7_ immunologic signatures	183	0.86144716	0.7882353	0.8764929	GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN	185	0.82030135	0.8699187	1	1.68174851	0.04114581
GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN	C7_ immunologic signatures	154	0.8609135	0.79450417	0.877578	GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN	160	1.268862	0.046605878	0.48574758	2.1297755	-0.4079485
GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_UP	C7_ immunologic signatures	166	0.8608336	0.7990599	0.8776594	GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_UP	167	1.0311867	0.42030457	0.87438756	1.8920203	-0.1703531
GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	C7_ immunologic signatures	167	0.8607843	0.79623085	0.8776759	GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	171	0.9781321	0.5385395	0.9516584	1.8389164	-0.1173478
GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS	c5.BP_ GO biological process	21	0.8607465	0.6713396	0.8776655	GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS	21	-1.2388828	0.18721461	0.33578706	-0.3781363	2.0996293
CHR4Q31	C1: positional gene sets	52	0.8606999	0.70014143	0.87766933	CHR4Q31	55	1.0532181	0.40133038	0.8361272	1.913918	-0.1925182
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN	C7_ immunologic signatures	150	0.86062396	0.7636139	0.87773955	GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN	152	0.88313425	0.7494929	1	1.74375821	-0.02251029
GO_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY	c5.BP_ GO biological process	16	0.8605246	0.70225567	0.8778717	GO_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY	16	0.58083075	0.95564514	1	1.44135535	0.27969385
GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN	C7_ immunologic signatures	174	0.86031973	0.77882355	0.87823737	GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN	180	1.0391243	0.40609136	0.8595706	1.89944403	-0.17880457
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN	C7_ immunologic signatures	165	0.860311	0.78631455	0.8781598	GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN	165	0.96926785	0.57575756	0.9620332	1.82957885	-0.10895685
GO_ACETYLCHOLINE_RECEPTOR_ACTIVITY	c5.GO molecular function	19	0.86020905	0.66452646	0.8782928	GO_ACETYLCHOLINE_RECEPTOR_ACTIVITY	24	1.2793924	0.14035088	0.47299692	2.13960145	-0.41918335
GO_ION_HOMEOSTASIS	c5.BP_ GO biological process	466	0.86004233	0.88092726	0.8785729	GO_ION_HOMEOSTASIS	466	0	0	0	0.86004233	0.86004233
GO_COPPER_ION_BINDING	c5.GO molecular function	45	0.8598892	0.69822484	0.8788181	GO_COPPER_ION_BINDING	48	1.0199931	0.4490022	0.8912782	1.8798823	-0.1601039
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	c2.CGP_ chemical and genetic perturbations	103	0.8598143	0.7559449	0.87887967	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	104	-0.9316196	0.7105263	0.7823851	-0.0718053	1.7914339
MCCLUNG_CREB1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	90	0.8596568	0.7473545	0.87914526	MCCLUNG_CREB1_TARGETS_UP	92	0.9096567	0.65608466	1	1.7693135	-0.0499999
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN	C7_ immunologic signatures	165	0.85963994	0.78244746	0.87908185	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN	166	0.82643205	0.84473956	1	1.68607199	0.03320789
REACTOME_EXTENSION_OF_TELOMERES	c2.CP_REACTOME_ Reactome gene sets	26	0.8595808	0.6661608	0.87911904	REACTOME_EXTENSION_OF_TELOMERES	26	-1.6243755	0.022857143	0.0827071	-0.7647947	2.4839563
GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN	C7_ immunologic signatures	163	0.85945916	0.8040621	0.8793029	GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN	171	1.1718793	0.15206446	0.6349679	2.03133846	-0.31242014
TTCNRGNNNNTTC_HSF_Q6	c3.TFT_ transcription factor targets	130	0.8594105	0.75980395	0.87931603	TTCNRGNNNNTTC_HSF_Q6	136	0.71570927	0.9608247	1	1.57511977	0.14370123
GSE45365_NK_CELL_VS_CD8_TCELL_DN	C7_ immunologic signatures	128	0.8593891	0.76220274	0.87926483	GSE45365_NK_CELL_VS_CD8_TCELL_DN	136	1.2462459	0.08171604	0.5170054	2.105635	-0.3868568
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	c2.CGP_ chemical and genetic perturbations	24	0.8593248	0.6744186	0.87931275	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	24	-1.6408246	0.017045455	0.07623085	-0.7814998	2.5001494
GO_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	27	0.8593188	0.67835367	0.8792296	GO_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS	32	-1.1542213	0.24390244	0.43818602	-0.2949025	2.0135401
GO_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	104	0.859081	0.75788146	0.8796568	GO_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	117	1.0901583	0.32919255	0.7709807	1.9492393	-0.2310773
GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	C7_ immunologic signatures	157	0.85898995	0.7802469	0.87977034	GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	158	1.1971687	0.1180061	0.5971822	2.05615865	-0.33817875
BCAT_GDS748_UP	C6_ oncogenic signatures	43	0.8589805	0.70646065	0.8796949	BCAT_GDS748_UP	43	-1.0924426	0.29007635	0.5305094	-0.2334621	1.9514231
GO_ENTEROENDOCRINE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	17	0.85888046	0.67670363	0.87982166	GO_ENTEROENDOCRINE_CELL_DIFFERENTIATION	19	1.0326021	0.44770408	0.87238085	1.89148256	-0.17372164
KEGG_GLYCEROLIPID_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	39	0.8587496	0.6944046	0.8800119	KEGG_GLYCEROLIPID_METABOLISM	39	1.2265186	0.15028901	0.5474588	2.0852682	-0.367769
GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING	c5.GO molecular function	23	0.85873824	0.69352293	0.87993807	GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING	23	0.6605976	0.91523343	1	1.51933584	0.19814064
GNF2_CD33	c4.CGN_ cancer gene neighborhoods	39	0.8587192	0.7092511	0.87988263	GNF2_CD33	39	1.5101017	0.013824885	0.24335642	2.3688209	-0.6513825
GO_EXONUCLEASE_ACTIVITY	c5.GO molecular function	68	0.858685	0.7431694	0.879866	GO_EXONUCLEASE_ACTIVITY	69	-0.83276355	0.8636364	0.88015956	0.02592145	1.69144855
GO_STEROID_HORMONE_RECEPTOR_BINDING	c5.GO molecular function	76	0.8586609	0.7375505	0.8798237	GO_STEROID_HORMONE_RECEPTOR_BINDING	77	-0.85043824	0.81395346	0.867101	0.00822266	1.70909914
PID_P38_ALPHA_BETA_PATHWAY	c2.CP_ Canonical pathways	28	0.8586537	0.6750369	0.87974334	PID_P38_ALPHA_BETA_PATHWAY	29	-0.9361876	0.54651165	0.7764614	-0.0775339	1.7948413
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN	C7_ immunologic signatures	166	0.85862017	0.8088942	0.8797213	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN	174	1.0520463	0.380182	0.8369271	1.91066647	-0.19342613
MODULE_333	c4.CM_ cancer modules	24	0.8586073	0.6553846	0.87965417	MODULE_333	24	0.7369183	0.84811664	1	1.5955256	0.121689
GENTILE_UV_RESPONSE_CLUSTER_D7	c2.CGP_ chemical and genetic perturbations	36	0.8585837	0.69929075	0.8796087	GENTILE_UV_RESPONSE_CLUSTER_D7	36	-0.89177215	0.6666667	0.8306255	-0.03318845	1.75035585
GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN	C7_ immunologic signatures	164	0.8584392	0.8021454	0.8798292	GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN	178	1.2350914	0.05882353	0.53299975	2.0935306	-0.3766522
PIGF_UP.V1_UP	C6_ oncogenic signatures	166	0.85837054	0.7947179	0.87989044	PIGF_UP.V1_UP	171	-1.2496251	0.083333336	0.32360068	-0.39125456	2.10799564
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	180	0.8583452	0.80396736	0.879853	GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN	182	1.1197368	0.23022312	0.7236908	1.978082	-0.2613916
GSE7852_LN_VS_FAT_TREG_UP	C7_ immunologic signatures	181	0.8581407	0.8055222	0.880219	GSE7852_LN_VS_FAT_TREG_UP	183	-0.83686197	1	0.87748384	0.02127873	1.69500267
GO_SH3_SH2_ADAPTOR_ACTIVITY	c5.GO molecular function	49	0.8580339	0.7294282	0.8803568	GO_SH3_SH2_ADAPTOR_ACTIVITY	50	1.0523046	0.40111113	0.83684146	1.9103385	-0.1942707
GO_GOLGI_ORGANIZATION	c5.BP_ GO biological process	81	0.8580226	0.7369127	0.88028604	GO_GOLGI_ORGANIZATION	81	0.6015508	0.98702705	1	1.4595734	0.2564718
CHR20Q13	C1: positional gene sets	131	0.8579654	0.75123763	0.88032126	CHR20Q13	141	1.397717	0.005102041	0.34484076	2.2556824	-0.5397516
GO_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY	c5.BP_ GO biological process	20	0.85782903	0.6787975	0.8805341	GO_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY	23	1.17303	0.24387255	0.63356376	2.03085903	-0.31520097
GSE15215_CD2_POS_VS_NEG_PDC_DN	C7_ immunologic signatures	177	0.8577348	0.79689366	0.88064736	GSE15215_CD2_POS_VS_NEG_PDC_DN	179	0.8694258	0.7791287	1	1.7271606	-0.011691
GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_DN	C7_ immunologic signatures	174	0.8576954	0.8136792	0.8806383	GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_DN	177	0.7511668	0.9452888	1	1.6088622	0.1065286
PID_EPHA_FWDPATHWAY	c2.CP_ Canonical pathways	31	0.85769206	0.7010622	0.88055015	PID_EPHA_FWDPATHWAY	33	0.8243228	0.7377831	1	1.68201486	0.03336926
GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP	C7_ immunologic signatures	173	0.8576153	0.7864897	0.88062775	GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP	175	0.9508311	0.6504065	0.9813001	1.8084464	-0.0932158
GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN	C7_ immunologic signatures	145	0.85749537	0.79151946	0.8808138	GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN	154	0.9700962	0.571282	0.9616584	1.82759157	-0.11260083
GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN	C7_ immunologic signatures	183	0.8574381	0.80588233	0.880847	GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN	187	0.86116874	0.80668014	1	1.71860684	-0.00373064
GO_OMEGA_PEPTIDASE_ACTIVITY	c5.GO molecular function	15	0.85741323	0.68225807	0.8808081	GO_OMEGA_PEPTIDASE_ACTIVITY	16	1.3818179	0.08632138	0.35640854	2.23923113	-0.52440467
GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_UP	C7_ immunologic signatures	101	0.85736626	0.74545455	0.8808186	GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_UP	103	1.0934889	0.31145832	0.76844007	1.95085516	-0.23612264
GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP	C7_ immunologic signatures	170	0.8571811	0.7886659	0.88112015	GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP	175	1.2105919	0.08879919	0.5760319	2.067773	-0.3534108
ATF4_Q2	c3.TFT_ transcription factor targets	225	0.8570857	0.8156109	0.88123477	ATF4_Q2	233	0.92189527	0.70896274	1	1.77898097	-0.06480957
GO_AMINE_CATABOLIC_PROCESS	c5.BP_ GO biological process	20	0.8568875	0.6993865	0.8815752	GO_AMINE_CATABOLIC_PROCESS	20	-1.3240185	0.08372093	0.2615047	-0.467131	2.180906
GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN	C7_ immunologic signatures	163	0.85686713	0.79151946	0.881522	GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN	166	0.9674727	0.57259715	0.9638724	1.82433983	-0.11060557
GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP	C7_ immunologic signatures	129	0.8568448	0.7972466	0.88147753	GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP	135	1.2889485	0.049029622	0.45976147	2.1457933	-0.4321037
GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN	C7_ immunologic signatures	157	0.8567852	0.80269605	0.88151014	GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN	159	1.2906748	0.030612245	0.45663324	2.14746	-0.4338896
GO_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION	c5.BP_ GO biological process	54	0.8562462	0.7208633	0.8825993	GO_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION	56	1.4033483	0.03218646	0.3359711	2.2595945	-0.5471021
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	23	0.85612446	0.6656489	0.8827663	REACTOME_KERATAN_SULFATE_BIOSYNTHESIS	22	0.9543958	0.53673726	0.97691375	1.81052026	-0.09827134
GO_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	378	0.855995	0.8780749	0.8829604	GO_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	426	1.3337862	0	0.39951265	2.1897812	-0.4777912
MODULE_375	c4.CM_ cancer modules	66	0.85583854	0.73719674	0.88321066	MODULE_375	78	1.1949133	0.18614718	0.5974368	2.05075184	-0.33907476
MARSHALL_VIRAL_INFECTION_RESPONSE_DN	c2.CGP_ chemical and genetic perturbations	27	0.8555443	0.70319635	0.88375914	MARSHALL_VIRAL_INFECTION_RESPONSE_DN	27	-1.46248	0.02631579	0.16502176	-0.6069357	2.3180243
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP	C7_ immunologic signatures	178	0.85539484	0.79265404	0.8839841	GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP	180	1.1417086	0.17997977	0.68767166	1.99710344	-0.28631376
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	c2.CGP_ chemical and genetic perturbations	41	0.85536575	0.7007092	0.88395166	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	43	0.70235014	0.9130435	1	1.55771589	0.15301561
GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	152	0.8553598	0.80455637	0.88387096	GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN	154	1.0399891	0.4117043	0.8588421	1.8953489	-0.1846293
CHANDRAN_METASTASIS_TOP50_DN	c2.CGP_ chemical and genetic perturbations	40	0.85524845	0.71365637	0.8840138	CHANDRAN_METASTASIS_TOP50_DN	40	1.0444348	0.4128655	0.8498977	1.89968325	-0.18918635
LASTOWSKA_COAMPLIFIED_WITH_MYCN	c2.CGP_ chemical and genetic perturbations	33	0.85515296	0.6843658	0.8841307	LASTOWSKA_COAMPLIFIED_WITH_MYCN	36	0.6838293	0.90119046	1	1.53898226	0.17132366
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN	C7_ immunologic signatures	184	0.8551039	0.8317865	0.8841485	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN	185	0.61957324	0.99797773	1	1.47467714	0.23553066
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	c2.CP_BIOCARTA_ BioCarta gene sets	72	0.85493743	0.7503392	0.88440686	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	74	1.4573432	0.015053763	0.2850187	2.31228063	-0.60240577
GSE13887_RESTING_VS_ACT_CD4_TCELL_DN	C7_ immunologic signatures	116	0.85491467	0.78728926	0.88435906	GSE13887_RESTING_VS_ACT_CD4_TCELL_DN	116	0.78998923	0.8648649	1	1.6449039	0.06492544
GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP	C7_ immunologic signatures	171	0.8547863	0.8104496	0.8845436	GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP	180	1.1038065	0.2505071	0.7498333	1.9585928	-0.2490202
GO_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY	c5.BP_ GO biological process	320	0.854612	0.84375	0.884828	GO_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY	335	1.1133771	0.16216215	0.73239136	1.9679891	-0.2587651
GRABARCZYK_BCL11B_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	62	0.85457176	0.7396529	0.8848206	GRABARCZYK_BCL11B_TARGETS_UP	65	-0.85639375	0.74358976	0.86322325	-0.00182199	1.71096551
GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP	C7_ immunologic signatures	165	0.854506	0.8221437	0.8848639	GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP	164	1.2360795	0.06605691	0.53137517	2.0905855	-0.3815735
GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP	C7_ immunologic signatures	177	0.8544791	0.80548924	0.8848239	GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP	184	0.68663293	0.98582995	1	1.54111203	0.16784617
GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP	C7_ immunologic signatures	174	0.8544182	0.8082353	0.8848689	GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP	175	0.69059694	0.97267205	1	1.54501514	0.16382126
GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN	C7_ immunologic signatures	152	0.85437894	0.8084337	0.88485265	GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN	155	1.1689445	0.16683726	0.6392515	2.02332344	-0.31456556
GO_NEUROPEPTIDE_HORMONE_ACTIVITY	c5.GO molecular function	17	0.8543121	0.6834416	0.88490444	GO_NEUROPEPTIDE_HORMONE_ACTIVITY	22	1.1005734	0.3438287	0.7563233	1.9548855	-0.2462613
KEGG_ENDOCYTOSIS	c2.CP_BIOCARTA_ BioCarta gene sets	163	0.8542679	0.80169284	0.88490105	KEGG_ENDOCYTOSIS	163	1.2590984	0.053807106	0.49723276	2.1133663	-0.4048305
GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_DN	C7_ immunologic signatures	112	0.8542074	0.7670886	0.8849343	GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_DN	126	1.3710966	0.010245902	0.3674256	2.225304	-0.5168892
GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP	C7_ immunologic signatures	172	0.8541407	0.81454545	0.8849838	GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP	174	0.84560996	0.82275933	1	1.69975066	0.00853074
GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN	C7_ immunologic signatures	162	0.85412467	0.8112981	0.8849209	GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN	169	1.1128719	0.2431611	0.7329609	1.96699657	-0.25874723
YOKOE_CANCER_TESTIS_ANTIGENS	c2.CGP_ chemical and genetic perturbations	29	0.8540041	0.70030123	0.885091	YOKOE_CANCER_TESTIS_ANTIGENS	31	1.279767	0.15632458	0.47263974	2.1337711	-0.4257629
GO_STEM_CELL_DIVISION	c5.BP_ GO biological process	26	0.85399276	0.6912851	0.885021	GO_STEM_CELL_DIVISION	27	-1.515686	0.01898734	0.13393575	-0.66169324	2.36967876
GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	169	0.85387343	0.81272084	0.88518447	GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP	169	1.2356313	0.07411168	0.5323153	2.08950473	-0.38175787
REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	c2.CP_REACTOME_ Reactome gene sets	16	0.8536368	0.6791531	0.8856109	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	16	0.7252687	0.8356868	1	1.5789055	0.1283681
GSE360_DC_VS_MAC_L_MAJOR_DN	C7_ immunologic signatures	166	0.85359114	0.8041872	0.885612	GSE360_DC_VS_MAC_L_MAJOR_DN	171	0.9979603	0.50557244	0.92568964	1.85155144	-0.14436916
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	c2.CGP_ chemical and genetic perturbations	85	0.8535809	0.75065273	0.8855373	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	92	1.0081257	0.46990496	0.9111505	1.8617066	-0.1545448
GO_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION	c5.BP_ GO biological process	28	0.85352033	0.69170576	0.8855779	GO_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION	28	1.3611282	0.09950249	0.37612367	2.21464853	-0.50760787
KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	175	0.8534488	0.8177458	0.8856384	KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP	179	0.9126668	0.71095335	1	1.7661156	-0.059218
MARTENS_BOUND_BY_PML_RARA_FUSION	c2.CGP_ chemical and genetic perturbations	392	0.85344493	0.8695187	0.8855489	MARTENS_BOUND_BY_PML_RARA_FUSION	398	1.1316855	0.117117114	0.7036191	1.98513043	-0.27824057
GO_MEMBRANE_BIOGENESIS	c5.BP_ GO biological process	29	0.8534144	0.68049157	0.88552016	GO_MEMBRANE_BIOGENESIS	29	0.904442	0.64755076	1	1.7578564	-0.0510276
GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP	C7_ immunologic signatures	178	0.85334235	0.82091343	0.88557816	GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP	177	1.4697264	0.00101626	0.27663088	2.32306875	-0.61638405
GO_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS	c5.GO molecular function	34	0.8533094	0.7032641	0.8855529	GO_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS	34	-1.2396301	0.13207547	0.3354502	-0.3863207	2.0929395
GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	161	0.85330355	0.7937274	0.88547033	GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN	166	0.8660324	0.7892604	1	1.71933595	-0.01272885
GO_CYTOSOLIC_TRANSPORT	c5.BP_ GO biological process	184	0.85328406	0.8035503	0.8854144	GO_CYTOSOLIC_TRANSPORT	186	1.0044192	0.49344096	0.91643846	1.85770326	-0.15113514
GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	C7_ immunologic signatures	179	0.8531341	0.80980164	0.8856433	GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	180	0.86252594	0.8	1	1.71566004	-0.00939184
ATGGYGGA_UNKNOWN	c3.TFT_ transcription factor targets	89	0.8530008	0.75239396	0.88584024	ATGGYGGA_UNKNOWN	93	0.5787585	0.9957939	1	1.4317593	0.2742423
PID_TNF_PATHWAY	c2.CP_ Canonical pathways	45	0.85287285	0.7186147	0.8860276	PID_TNF_PATHWAY	44	0.9603386	0.56556445	0.9713712	1.81321145	-0.10746575
GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	181	0.8528285	0.8278302	0.88602847	GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	183	1.2815038	0.02535497	0.47058198	2.1343323	-0.4286753
PDGF_ERK_DN.V1_UP	C6_ oncogenic signatures	118	0.8527758	0.7739899	0.88605016	PDGF_ERK_DN.V1_UP	126	0.85362965	0.7840083	1	1.70640545	-0.00085385
REACTOME_ENOS_ACTIVATION_AND_REGULATION	c2.CP_REACTOME_ Reactome gene sets	17	0.85276663	0.6767516	0.88597393	REACTOME_ENOS_ACTIVATION_AND_REGULATION	17	-1.047286	0.36554623	0.6119376	-0.19451937	1.90005263
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	30	0.85255694	0.6886503	0.88633686	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	30	-0.8980706	0.6418919	0.8239789	-0.04551366	1.75062754
BCAT_GDS748_DN	C6_ oncogenic signatures	38	0.8525272	0.6877698	0.8863047	BCAT_GDS748_DN	39	-1.0731783	0.32413793	0.56400084	-0.2206511	1.9257055
GO_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION	c5.BP_ GO biological process	16	0.8524334	0.6693679	0.8864153	GO_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION	16	1.0456997	0.42105263	0.84740466	1.8981331	-0.1932663
GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	168	0.8522342	0.80582523	0.88674605	GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	166	1.0138344	0.46897253	0.90026754	1.8660686	-0.1616002
GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN	C7_ immunologic signatures	181	0.8522255	0.8122786	0.88666797	GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN	181	0.95877033	0.59795916	0.9717927	1.81099583	-0.10654483
NOJIMA_SFRP2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	21	0.85203207	0.68421054	0.88698375	NOJIMA_SFRP2_TARGETS_DN	21	0.9844857	0.50252527	0.942208	1.83651777	-0.13245363
GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN	C7_ immunologic signatures	168	0.85195017	0.8125	0.8870683	GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN	169	0.5362076	1	1	1.38815777	0.31574257
GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP	C7_ immunologic signatures	166	0.8517887	0.81265205	0.88732	GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP	174	1.0564698	0.36345178	0.83063066	1.9082585	-0.2046811
GO_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY	c5.GO molecular function	17	0.85174584	0.6602564	0.8873113	GO_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY	19	-1.4546292	0.05940594	0.17015848	-0.60288336	2.30637504
GO_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	23	0.8516157	0.6936508	0.88750106	GO_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS	23	0.75184155	0.82625	1	1.60345725	0.09977415
GO_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM	c5.BP_ GO biological process	16	0.851587	0.6743044	0.88746756	GO_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM	16	-0.9188414	0.5611814	0.79764026	-0.0672544	1.7704284
ACTAYRNNNCCCR_UNKNOWN	c3.TFT_ transcription factor targets	397	0.85149026	0.9012739	0.88758206	ACTAYRNNNCCCR_UNKNOWN	397	0.520397	1	1	1.37188726	0.33109326
GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN	C7_ immunologic signatures	158	0.85135436	0.8115246	0.8877897	GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN	160	1.0780708	0.30324543	0.7913333	1.92942516	-0.22671644
GO_RESPONSE_TO_ACTIVITY	c5.BP_ GO biological process	63	0.85114324	0.71703297	0.8881481	GO_RESPONSE_TO_ACTIVITY	61	1.3076962	0.07158352	0.42919022	2.15883944	-0.45655296
GSE36095_WT_VS_HDAC9_KO_TREG_DN	C7_ immunologic signatures	97	0.85114074	0.7559055	0.8880584	GSE36095_WT_VS_HDAC9_KO_TREG_DN	107	0.9542853	0.59707725	0.97715586	1.80542604	-0.10314456
GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP	C7_ immunologic signatures	174	0.8510808	0.8142857	0.8880932	GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP	180	1.1976923	0.11144883	0.5968477	2.0487731	-0.3466115
MIKKELSEN_MEF_HCP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	424	0.85100585	0.8875928	0.88816357	MIKKELSEN_MEF_HCP_WITH_H3K27ME3	424	0	0	0	0.85100585	0.85100585
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	c2.CP_BIOCARTA_ BioCarta gene sets	15	0.85095906	0.6712538	0.88817036	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	15	1.3871297	0.071801566	0.3486404	2.23808876	-0.53617064
GSE17721_CTRL_VS_CPG_2H_BMDC_UP	C7_ immunologic signatures	177	0.85079044	0.80764633	0.8884311	GSE17721_CTRL_VS_CPG_2H_BMDC_UP	180	-0.88652396	0.8333333	0.8386957	-0.03573352	1.7373144
GO_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT	c5.BP_ GO biological process	15	0.8506673	0.6772655	0.8886058	GO_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT	17	-1.0430331	0.35526314	0.617564	-0.1923658	1.8937004
PID_THROMBIN_PAR1_PATHWAY	c2.CP_ Canonical pathways	40	0.8506598	0.6988131	0.88852644	PID_THROMBIN_PAR1_PATHWAY	41	1.181595	0.22169812	0.62054044	2.0322548	-0.3309352
GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN	C7_ immunologic signatures	155	0.85064834	0.80778587	0.8884554	GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN	160	0.95452696	0.60873985	0.9769974	1.8051753	-0.10387862
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN	C7_ immunologic signatures	177	0.85045815	0.82002383	0.88878167	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN	183	1.2601773	0.047426842	0.49596956	2.11063545	-0.40971915
GO_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS	c5.BP_ GO biological process	19	0.8503637	0.6796875	0.8888892	GO_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS	19	1.1951342	0.22646311	0.5971935	2.0454979	-0.3447705
GO_REGULATION_OF_DOPAMINE_SECRETION	c5.BP_ GO biological process	16	0.8501922	0.6768	0.8891734	GO_REGULATION_OF_DOPAMINE_SECRETION	20	1.4637204	0.03606965	0.2823627	2.3139126	-0.6135282
GO_GLYCOPROTEIN_METABOLIC_PROCESS	c5.BP_ GO biological process	302	0.85018617	0.844519	0.88909006	GO_GLYCOPROTEIN_METABOLIC_PROCESS	316	1.1399181	0.13540623	0.690691	1.99010427	-0.28973193
GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	170	0.8501409	0.8023952	0.88908774	GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN	174	0.8046472	0.8780488	1	1.6547881	0.0454937
GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP	C7_ immunologic signatures	159	0.8500221	0.8033573	0.88925207	GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP	167	1.0833073	0.30173293	0.7812759	1.9333294	-0.2332852
GTCAGGA_MIR378	c3.MIR_ microRNA targets	50	0.84982973	0.75139666	0.88957244	GTCAGGA_MIR378	51	1.2464795	0.14285715	0.51708287	2.09630923	-0.39664977
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN	c2.CGP_ chemical and genetic perturbations	27	0.8497273	0.6915052	0.88969177	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN	27	1.1672632	0.26537997	0.64181423	2.0169905	-0.3175359
GO_PEPTIDE_RECEPTOR_ACTIVITY	c5.GO molecular function	90	0.84970313	0.75949365	0.8896535	GO_PEPTIDE_RECEPTOR_ACTIVITY	103	1.0899965	0.31606767	0.77109	1.93969963	-0.24029337
GSE22886_NAIVE_VS_MEMORY_TCELL_UP	C7_ immunologic signatures	169	0.8497023	0.815534	0.8895594	GSE22886_NAIVE_VS_MEMORY_TCELL_UP	173	1.0968567	0.2776089	0.7612961	1.946559	-0.2471544
GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP	C7_ immunologic signatures	172	0.84963906	0.8402861	0.8896011	GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP	178	1.1755891	0.13346815	0.6283674	2.02522816	-0.32595004
GSE3982_NEUTROPHIL_VS_BCELL_UP	C7_ immunologic signatures	164	0.8495995	0.82402915	0.88958925	GSE3982_NEUTROPHIL_VS_BCELL_UP	168	1.0861714	0.30527383	0.7758189	1.9357709	-0.2365719
CGTSACG_PAX3_B	c3.TFT_ transcription factor targets	130	0.84959036	0.7863354	0.889513	CGTSACG_PAX3_B	135	0.8534005	0.8053007	1	1.70299086	-0.00381014
MORF_PTPN9	c4.CGN_ cancer gene neighborhoods	53	0.84951794	0.73653567	0.88957334	MORF_PTPN9	55	-0.9121678	0.66964287	0.8049973	-0.06264986	1.76168574
GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN	C7_ immunologic signatures	169	0.84928274	0.8016529	0.88996565	GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN	170	0.77593756	0.91260165	1	1.6252203	0.07334518
CHR2P25	C1: positional gene sets	39	0.8490696	0.71428573	0.8903264	CHR2P25	43	-0.9056717	0.6859504	0.81451535	-0.0566021	1.7547413
GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP	C7_ immunologic signatures	182	0.8490145	0.8144208	0.8903473	GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP	183	0.7887909	0.9060606	1	1.6378054	0.0602236
GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP	C7_ immunologic signatures	177	0.84891194	0.82721895	0.8904727	GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP	181	0.80758554	0.89725333	1	1.65649748	0.0413264
HEIDENBLAD_AMPLICON_8Q24_UP	c2.CGP_ chemical and genetic perturbations	32	0.84882295	0.714939	0.890575	HEIDENBLAD_AMPLICON_8Q24_UP	31	0.6569656	0.93124247	1	1.50578855	0.19185735
GCM_VAV1	c4.CGN_ cancer gene neighborhoods	41	0.84877956	0.73478264	0.8905698	GCM_VAV1	42	0.55486786	0.9894737	1	1.40364742	0.2939117
GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP	C7_ immunologic signatures	173	0.848579	0.83040935	0.89088863	GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP	173	0.8116155	0.87753034	1	1.6601945	0.0369635
REACTOME_GLYCOSPHINGOLIPID_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	30	0.8485051	0.72408295	0.8909516	REACTOME_GLYCOSPHINGOLIPID_METABOLISM	31	1.4824106	0.025974026	0.26633105	2.3309157	-0.6339055
GO_DNA_CATABOLIC_PROCESS_ENDONUCLEOLYTIC	c5.BP_ GO biological process	15	0.8484168	0.6677966	0.89103967	GO_DNA_CATABOLIC_PROCESS_ENDONUCLEOLYTIC	17	-1.4631206	0.052208837	0.16548847	-0.6147038	2.3115374
GSE29949_MICROGLIA_VS_DC_BRAIN_UP	C7_ immunologic signatures	176	0.8481177	0.84241706	0.8915917	GSE29949_MICROGLIA_VS_DC_BRAIN_UP	183	0.78937775	0.90716445	1	1.63749545	0.05873995
GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN	C7_ immunologic signatures	156	0.8481005	0.80236685	0.8915326	GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN	162	-0.92760354	0.8125	0.7872703	-0.07950304	1.77570404
GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP	C7_ immunologic signatures	169	0.8480367	0.8211284	0.8915694	GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP	168	1.2117012	0.09154929	0.57517725	2.0597379	-0.3636645
BAKKER_FOXO3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	155	0.84803563	0.81939393	0.89147586	BAKKER_FOXO3_TARGETS_DN	161	0.6304333	0.98882115	1	1.47846893	0.21760233
GO_PROTEIN_POLYUBIQUITINATION	c5.BP_ GO biological process	227	0.84802324	0.84931505	0.8914057	GO_PROTEIN_POLYUBIQUITINATION	229	0.63651574	0.99496984	1	1.48453898	0.2115075
GTAAGAT_MIR200A	c3.MIR_ microRNA targets	47	0.8479527	0.72830725	0.89146036	GTAAGAT_MIR200A	47	-1.4875256	0	0.15054803	-0.6395729	2.3354783
GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	C7_ immunologic signatures	179	0.8479525	0.83273166	0.89136475	GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	179	-1.0083585	0.42857143	0.6744291	-0.160406	1.856311
GSE27786_LIN_NEG_VS_NKTCELL_DN	C7_ immunologic signatures	183	0.84781265	0.827791	0.8915559	GSE27786_LIN_NEG_VS_NKTCELL_DN	183	1.1953156	0.11290322	0.59656626	2.04312825	-0.34750295
CHR16P11	C1: positional gene sets	78	0.847806	0.7522698	0.8914741	CHR16P11	80	0.75967383	0.86002123	1	1.60747983	0.08813217
GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	166	0.8477792	0.8291815	0.89143234	GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP	168	0.85623735	0.80404043	1	1.70401655	-0.00845815
GNF2_GSTM1	c4.CGN_ cancer gene neighborhoods	85	0.8477758	0.75686276	0.89134353	GNF2_GSTM1	95	1.15076	0.22350472	0.6676584	1.9985358	-0.3029842
GSE27786_BCELL_VS_CD8_TCELL_DN	C7_ immunologic signatures	168	0.8477367	0.8138425	0.89133215	GSE27786_BCELL_VS_CD8_TCELL_DN	174	0.9243102	0.6782431	1	1.7720469	-0.0765735
GO_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION	c5.BP_ GO biological process	32	0.8477089	0.67518795	0.89129657	GO_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION	35	1.1389031	0.2719715	0.69189095	1.986612	-0.2911942
GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN	C7_ immunologic signatures	102	0.8477085	0.77344704	0.8912013	GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN	106	0.8098872	0.8348813	1	1.6575957	0.0378213
MODULE_323	c4.CM_ cancer modules	53	0.8476219	0.7232525	0.89128435	MODULE_323	53	-0.89410377	0.6636364	0.82827866	-0.04648187	1.74172567
MORF_CNTN1	c4.CGN_ cancer gene neighborhoods	91	0.84761	0.7647815	0.89121497	MORF_CNTN1	95	0.76319206	0.8834746	1	1.61080206	0.08441794
GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	169	0.8475547	0.839372	0.8912307	GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP	171	0.86302614	0.8050505	1	1.71058084	-0.01547144
GO_RESPONSE_TO_DEXAMETHASONE	c5.BP_ GO biological process	28	0.8474052	0.71493214	0.89145184	GO_RESPONSE_TO_DEXAMETHASONE	27	0.9145604	0.6176116	1	1.7619656	-0.0671552
GO_GROWTH_FACTOR_RECEPTOR_BINDING	c5.GO molecular function	116	0.84739196	0.7939317	0.89138263	GO_GROWTH_FACTOR_RECEPTOR_BINDING	119	1.0985473	0.3003096	0.75851005	1.94593926	-0.25115534
GO_ACYLGLYCEROL_HOMEOSTASIS	c5.BP_ GO biological process	21	0.8472656	0.70046085	0.8915518	GO_ACYLGLYCEROL_HOMEOSTASIS	26	-1.0000079	0.46022728	0.6848804	-0.1527423	1.8472735
GO_RESPONSE_TO_THYROID_HORMONE	c5.BP_ GO biological process	18	0.8472524	0.677116	0.89148384	GO_RESPONSE_TO_THYROID_HORMONE	20	0.91459	0.5971686	1	1.7618424	-0.0673376
GSE10325_BCELL_VS_MYELOID_DN	C7_ immunologic signatures	167	0.84716076	0.8162291	0.89157677	GSE10325_BCELL_VS_MYELOID_DN	168	1.1722952	0.14765784	0.6340892	2.01945596	-0.32513444
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	c2.CGP_ chemical and genetic perturbations	21	0.8470889	0.6873016	0.89163303	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	22	0.9844516	0.5111663	0.9421954	1.8315405	-0.1373627
MORF_PPP5C	c4.CGN_ cancer gene neighborhoods	85	0.84684986	0.7792732	0.8920497	MORF_PPP5C	85	0.5568682	0.9967983	1	1.40371806	0.28998166
CHR12P11	C1: positional gene sets	28	0.8466692	0.72138554	0.8923389	CHR12P11	28	0.706129	0.877551	1	1.5527982	0.1405402
GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN	C7_ immunologic signatures	184	0.84665537	0.81615925	0.8922726	GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN	187	-0.8227391	1	0.8879199	0.02391627	1.66939447
GO_COVALENT_CHROMATIN_MODIFICATION	c5.BP_ GO biological process	297	0.84657556	0.873743	0.8923457	GO_COVALENT_CHROMATIN_MODIFICATION	309	-0.89747775	1	0.8247268	-0.05090219	1.74405331
VALK_AML_CLUSTER_11	c2.CGP_ chemical and genetic perturbations	35	0.84652007	0.69207776	0.89237034	VALK_AML_CLUSTER_11	36	0.7364495	0.8693116	1	1.58296957	0.11007057
MORF_MLLT10	c4.CGN_ cancer gene neighborhoods	233	0.8462812	0.8607595	0.892785	MORF_MLLT10	249	1.3233696	0.010050251	0.41037858	2.1696508	-0.4770884
NFKB_Q6	c3.TFT_ transcription factor targets	232	0.84625006	0.8335234	0.892754	NFKB_Q6	235	1.0825702	0.26834172	0.7829536	1.92882026	-0.23632014
GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN	C7_ immunologic signatures	176	0.84616745	0.82211536	0.8928295	GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN	175	-1.4090494	0	0.20105162	-0.56288195	2.25521685
GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP	C7_ immunologic signatures	165	0.8461557	0.8097561	0.89275724	GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP	170	1.2672466	0.04800817	0.48804486	2.1134023	-0.4210909
AACYNNNNTTCCS_UNKNOWN	c3.TFT_ transcription factor targets	85	0.8459796	0.77956986	0.8930328	AACYNNNNTTCCS_UNKNOWN	87	-0.84286475	0.86153847	0.87378645	0.00311485	1.68884435
LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES	c2.CGP_ chemical and genetic perturbations	29	0.8459581	0.7020649	0.89297825	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES	30	0.8064256	0.7535377	1	1.6523837	0.0395325
GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN	C7_ immunologic signatures	176	0.8458977	0.8361045	0.8930084	GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN	180	0.73952943	0.95871097	1	1.58542713	0.10636827
GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP	C7_ immunologic signatures	155	0.84578466	0.81785285	0.8931528	GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP	160	1.0073706	0.49848023	0.91186213	1.85315526	-0.16158594
GO_HETEROTYPIC_CELL_CELL_ADHESION	c5.BP_ GO biological process	23	0.84577787	0.6918336	0.89306945	GO_HETEROTYPIC_CELL_CELL_ADHESION	24	1.3906897	0.06393245	0.34591645	2.23646757	-0.54491183
GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP	C7_ immunologic signatures	174	0.84573925	0.80714285	0.89305645	GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP	176	0.64517355	0.99489796	1	1.4909128	0.2005657
GO_CYTOPLASMIC_SIDE_OF_MEMBRANE	c5.CC_ GO cellular component	157	0.84540147	0.7978469	0.8936664	GO_CYTOPLASMIC_SIDE_OF_MEMBRANE	162	1.0917411	0.30010173	0.7696746	1.93714257	-0.24633963
HOLLMANN_APOPTOSIS_VIA_CD40_UP	c2.CGP_ chemical and genetic perturbations	179	0.84538287	0.8212617	0.8936106	HOLLMANN_APOPTOSIS_VIA_CD40_UP	180	-0.85558	0.9444444	0.86167884	-0.01019713	1.70096287
GSE27786_LSK_VS_NKTCELL_DN	C7_ immunologic signatures	163	0.8452976	0.85194176	0.8936864	GSE27786_LSK_VS_NKTCELL_DN	166	1.0240505	0.44297352	0.88534063	1.8693481	-0.1787529
GO_PROTEIN_OLIGOMERIZATION	c5.BP_ GO biological process	370	0.84483004	0.8725702	0.8945786	GO_PROTEIN_OLIGOMERIZATION	388	1.0924668	0.2	0.7685596	1.93729684	-0.24763676
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	c2.CGP_ chemical and genetic perturbations	45	0.84482557	0.73661363	0.89449173	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	45	-1.4159471	0.036363635	0.19580941	-0.57112153	2.26077267
GO_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	25	0.8448188	0.6919431	0.89441055	GO_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	26	0.9889047	0.5134474	0.936433	1.8337235	-0.1440859
GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN	C7_ immunologic signatures	179	0.844726	0.8296122	0.89451164	GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN	180	-1.172768	0.06666667	0.41389582	-0.328042	2.017494
AP2GAMMA_01	c3.TFT_ transcription factor targets	221	0.84472394	0.8594104	0.8944203	AP2GAMMA_01	228	0.7982605	0.91549295	1	1.64298444	0.04646344
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	c2.CGP_ chemical and genetic perturbations	22	0.844721	0.6978193	0.8943304	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	22	-0.8321633	0.7659575	0.8808701	0.0125577	1.6768843
BIOCARTA_TNFR1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	29	0.84470075	0.7207891	0.89427483	BIOCARTA_TNFR1_PATHWAY	28	-1.107377	0.24561404	0.506832	-0.26267625	1.95207775
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN	C7_ immunologic signatures	180	0.844624	0.8451688	0.8943387	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN	183	0.90238047	0.71865445	1	1.74700447	-0.05775647
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP	C7_ immunologic signatures	176	0.84442306	0.8219833	0.89466834	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP	183	1.3116875	0.016161617	0.42290685	2.15611056	-0.46726444
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	C7_ immunologic signatures	168	0.8443432	0.84023666	0.8947455	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	172	1.3274969	0.016161617	0.4045559	2.1718401	-0.4831537
GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN	C7_ immunologic signatures	167	0.8443165	0.82494	0.8947068	GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN	168	0.7792189	0.90899897	1	1.6235354	0.0650976
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	c2.CGP_ chemical and genetic perturbations	21	0.84431404	0.7049442	0.89461625	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	21	-1.2526243	0.13989638	0.32132384	-0.40831026	2.09693834
GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP	C7_ immunologic signatures	185	0.8442384	0.84223014	0.8946777	GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP	185	0.7655559	0.92828286	1	1.6097943	0.0786825
RODWELL_AGING_KIDNEY_NO_BLOOD_DN	c2.CGP_ chemical and genetic perturbations	123	0.8442379	0.7942643	0.8945828	RODWELL_AGING_KIDNEY_NO_BLOOD_DN	128	0.9668809	0.578675	0.9642883	1.8111188	-0.122643
AMIT_EGF_RESPONSE_120_HELA	c2.CGP_ chemical and genetic perturbations	61	0.8442315	0.75418997	0.89450026	AMIT_EGF_RESPONSE_120_HELA	60	1.1129109	0.29934925	0.7331003	1.9571424	-0.2686794
CHR20P11	C1: positional gene sets	36	0.8441268	0.71428573	0.894621	CHR20P11	35	-0.92370534	0.6086956	0.7910373	-0.07957854	1.76783214
GO_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY	c5.GO molecular function	16	0.8439779	0.68976897	0.89484346	GO_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY	20	0.61812776	0.9362809	1	1.46210566	0.22585014
GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP	C7_ immunologic signatures	178	0.84385157	0.84136313	0.8950101	GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP	176	1.140781	0.1678463	0.6889103	1.98463257	-0.29692943
GO_HIPPOCAMPUS_DEVELOPMENT	c5.BP_ GO biological process	66	0.84382814	0.7366985	0.89496595	GO_HIPPOCAMPUS_DEVELOPMENT	71	0.7716216	0.85604393	1	1.61544974	0.07220654
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP	C7_ immunologic signatures	173	0.84373736	0.83157897	0.8950664	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP	172	0.9487094	0.6093591	0.9834261	1.79244676	-0.10497204
GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP	C7_ immunologic signatures	167	0.84373224	0.8076923	0.8949794	GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP	168	0.9413604	0.64837396	0.9895394	1.78509264	-0.09762816
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	c2.CGP_ chemical and genetic perturbations	60	0.843717	0.7461213	0.89491796	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	62	1.1401376	0.2414175	0.6905247	1.9838546	-0.2964206
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP	C7_ immunologic signatures	159	0.843559	0.82121575	0.8951492	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP	162	0.72451186	0.9613035	1	1.56807086	0.11904714
GO_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY	c5.GO molecular function	40	0.84351224	0.7374631	0.8951513	GO_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY	41	1.2070403	0.19279908	0.58060485	2.05055254	-0.36352806
REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	c2.CP_REACTOME_ Reactome gene sets	126	0.843335	0.8	0.8954264	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	129	1.069976	0.35825545	0.80465955	1.913311	-0.226641
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP	C7_ immunologic signatures	157	0.84324837	0.8019802	0.89550304	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP	168	0.68452346	0.97373736	1	1.52777183	0.15872491
GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP	C7_ immunologic signatures	181	0.84321177	0.8367347	0.89548165	GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP	180	1.0034618	0.49593496	0.91738874	1.84667357	-0.16025003
GO_CILIUM	c5.CC_ GO cellular component	395	0.843173	0.9016913	0.8954689	GO_CILIUM	402	1.2244328	0.022	0.5496728	2.0676058	-0.3812598
WOTTON_RUNX_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	27	0.8430179	0.709531	0.89569455	WOTTON_RUNX_TARGETS_DN	26	0.6410716	0.9368932	1	1.4840895	0.2019463
GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN	C7_ immunologic signatures	183	0.8430163	0.83429897	0.8956018	GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN	182	0.9871645	0.5242424	0.93926454	1.8301808	-0.1441482
SPIRA_SMOKERS_LUNG_CANCER_UP	c2.CGP_ chemical and genetic perturbations	34	0.8429501	0.7259684	0.8956514	SPIRA_SMOKERS_LUNG_CANCER_UP	33	1.0694128	0.3942993	0.8065553	1.9123629	-0.2264627
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	c2.CGP_ chemical and genetic perturbations	276	0.84280664	0.8671875	0.895851	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	277	-0.93134266	1	0.78247195	-0.08853602	1.7741493
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP	C7_ immunologic signatures	175	0.8427857	0.8343057	0.8957953	GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP	180	0.8832576	0.76214576	1	1.7260433	-0.0404719
GSE27434_WT_VS_DNMT1_KO_TREG_DN	C7_ immunologic signatures	182	0.8427488	0.8354726	0.895778	GSE27434_WT_VS_DNMT1_KO_TREG_DN	182	0.7366001	0.95131844	1	1.5793489	0.1061487
GO_ESTROGEN_METABOLIC_PROCESS	c5.BP_ GO biological process	15	0.8427322	0.7102362	0.89571816	GO_ESTROGEN_METABOLIC_PROCESS	16	0.65395075	0.9012987	1	1.49668295	0.18878145
GO_REGULATION_OF_LIGASE_ACTIVITY	c5.BP_ GO biological process	117	0.84270465	0.7987578	0.89568096	GO_REGULATION_OF_LIGASE_ACTIVITY	119	0.7454165	0.90544707	1	1.58812115	0.09728815
GO_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE	c5.BP_ GO biological process	29	0.842417	0.7155425	0.8961674	GO_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE	29	0.8544658	0.6873508	1	1.6968828	-0.0120488
GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	169	0.84234434	0.8278788	0.89622456	GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	171	0.80464727	0.8677518	1	1.64699161	0.03769707
GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	178	0.8419947	0.82130176	0.8968499	GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN	181	1.0613706	0.34008098	0.8213533	1.9033653	-0.2193759
REACTOME_SYNTHESIS_OF_DNA	c2.CP_REACTOME_ Reactome gene sets	85	0.8419637	0.7856192	0.8968174	REACTOME_SYNTHESIS_OF_DNA	86	-2.071261	0	0.003844472	-1.2292973	2.9132247
T3R_Q6	c3.TFT_ transcription factor targets	208	0.841945	0.8437133	0.8967617	T3R_Q6	222	0.941687	0.673716	0.9891578	1.783632	-0.099742
GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	173	0.8416512	0.8140948	0.8972821	GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	176	0.7235858	0.95010185	1	1.565237	0.1180654
GSE27786_NEUTROPHIL_VS_MONO_MAC_UP	C7_ immunologic signatures	175	0.84158516	0.8449704	0.8973211	GSE27786_NEUTROPHIL_VS_MONO_MAC_UP	175	0.8639673	0.7951564	1	1.70555246	-0.02238214
DE_YY1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	15	0.8413157	0.68576103	0.8977853	DE_YY1_TARGETS_UP	16	0.8977929	0.6111111	1	1.7391086	-0.0564772
GSE22045_TREG_VS_TCONV_DN	C7_ immunologic signatures	143	0.8410739	0.83374083	0.89819276	GSE22045_TREG_VS_TCONV_DN	147	1.1471232	0.18106996	0.6738206	1.9881971	-0.3060493
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP	C7_ immunologic signatures	180	0.84105414	0.8307873	0.89813936	GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP	182	0.7580101	0.9346076	1	1.59906424	0.08304404
BIOCARTA_HCMV_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	0.8410067	0.7089202	0.8981417	BIOCARTA_HCMV_PATHWAY	17	0.5496672	0.97354496	1	1.3906739	0.2913395
BIOCARTA_TPO_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	23	0.8409963	0.70353305	0.89807254	BIOCARTA_TPO_PATHWAY	24	1.3294919	0.11851852	0.40273935	2.1704882	-0.4884956
REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	c2.CP_REACTOME_ Reactome gene sets	77	0.84095955	0.7623498	0.8980579	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	77	0.64343685	0.96666664	1	1.4843964	0.1975227
GO_ESTABLISHMENT_OF_LOCALIZATION_BY_MOVEMENT_ALONG_MICROTUBULE	c5.BP_ GO biological process	87	0.8409497	0.7752957	0.89798254	GO_ESTABLISHMENT_OF_LOCALIZATION_BY_MOVEMENT_ALONG_MICROTUBULE	87	0.98963493	0.506383	0.9356373	1.83058463	-0.14868523
GO_PHAGOCYTIC_VESICLE_MEMBRANE	c5.CC_ GO cellular component	46	0.8408843	0.72571427	0.8980214	GO_PHAGOCYTIC_VESICLE_MEMBRANE	48	0.6966077	0.91051453	1	1.537492	0.1442766
GSE17721_LPS_VS_POLYIC_2H_BMDC_DN	C7_ immunologic signatures	181	0.84085417	0.8627907	0.8979865	GSE17721_LPS_VS_POLYIC_2H_BMDC_DN	183	-0.86400974	1	0.857997	-0.02315557	1.70486391
GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN	C7_ immunologic signatures	153	0.84082896	0.823389	0.89794374	GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN	154	0.670649	0.9776876	1	1.51147796	0.17017996
TACTTGA_MIR26A_MIR26B	c3.MIR_ microRNA targets	277	0.8408018	0.87222224	0.89790565	TACTTGA_MIR26A_MIR26B	277	0.9717841	0.5863454	0.96001816	1.8125859	-0.1309823
LU_EZH2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	231	0.8403879	0.84108967	0.89866143	LU_EZH2_TARGETS_UP	237	0.92523134	0.6914573	1	1.76561924	-0.08484344
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	c2.CGP_ chemical and genetic perturbations	82	0.84029955	0.77483445	0.89874774	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	84	1.0257481	0.4368932	0.8830618	1.86604765	-0.18544855
GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP	C7_ immunologic signatures	184	0.8401085	0.83411765	0.8990564	GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP	184	0.8428566	0.8424242	1	1.6829651	-0.0027481
GO_MEMBRANE_ASSEMBLY	c5.BP_ GO biological process	24	0.84007674	0.7050473	0.89902693	GO_MEMBRANE_ASSEMBLY	24	1.1095815	0.33039093	0.7381972	1.94965824	-0.26950476
GO_DETECTION_OF_LIGHT_STIMULUS	c5.BP_ GO biological process	52	0.8400123	0.73278236	0.8990663	GO_DETECTION_OF_LIGHT_STIMULUS	49	0.7958435	0.8006719	1	1.6358558	0.0441688
GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP	C7_ immunologic signatures	176	0.8400032	0.82520807	0.8989884	GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP	179	0.75843424	0.9369919	1	1.59843744	0.08156896
GO_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT	c5.BP_ GO biological process	54	0.8398567	0.74657536	0.8991974	GO_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT	54	0.9265452	0.6158129	1	1.7664019	-0.0866885
GO_MUSCLE_CELL_PROLIFERATION	c5.BP_ GO biological process	18	0.8398293	0.68327975	0.8991574	GO_MUSCLE_CELL_PROLIFERATION	18	-0.8694636	0.6363636	0.8541889	-0.0296343	1.7092929
WALLACE_JAK2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	24	0.83978814	0.6909938	0.89914376	WALLACE_JAK2_TARGETS_UP	24	0.48827162	0.9937811	1	1.32805976	0.35151652
GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN	C7_ immunologic signatures	186	0.83957905	0.8337292	0.8994895	GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN	186	0.8001288	0.8894472	1	1.63970785	0.03945025
GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN	C7_ immunologic signatures	141	0.8394849	0.81898737	0.8995887	GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN	146	1.1955763	0.12563322	0.59708947	2.0350612	-0.3560914
GO_RESPONSE_TO_GROWTH_HORMONE	c5.BP_ GO biological process	25	0.8394809	0.71450615	0.8995014	GO_RESPONSE_TO_GROWTH_HORMONE	29	1.0203819	0.4729892	0.89140075	1.8598628	-0.180901
BIOCARTA_NOS1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	19	0.83941394	0.68453294	0.89954394	BIOCARTA_NOS1_PATHWAY	19	1.3762378	0.09857328	0.35721576	2.21565174	-0.53682386
TGCGCANK_UNKNOWN	c3.TFT_ transcription factor targets	479	0.83931476	0.92690676	0.8996539	TGCGCANK_UNKNOWN	483	0.58991635	1	1	1.42923111	0.24939841
GO_EMBRYONIC_HINDLIMB_MORPHOGENESIS	c5.BP_ GO biological process	27	0.8391429	0.7112782	0.89991105	GO_EMBRYONIC_HINDLIMB_MORPHOGENESIS	28	-1.776468	0	0.037779406	-0.9373251	2.6156109
MODULE_17	c4.CM_ cancer modules	331	0.83898926	0.8816504	0.90013456	MODULE_17	331	0	0	0	0.83898926	0.83898926
KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP	C7_ immunologic signatures	173	0.83889836	0.8317647	0.90022373	KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP	176	1.130958	0.20486815	0.70499957	1.96985636	-0.29205964
ST_GRANULE_CELL_SURVIVAL_PATHWAY	c2.CP_ Canonical pathways	23	0.83887315	0.720679	0.90017813	ST_GRANULE_CELL_SURVIVAL_PATHWAY	24	0.97438884	0.49621212	0.9561885	1.81326199	-0.13551569
GO_CELL_PROJECTION_CYTOPLASM	c5.CC_ GO cellular component	47	0.8388554	0.7443182	0.90011996	GO_CELL_PROJECTION_CYTOPLASM	47	0.91736597	0.64050055	1	1.75622137	-0.07851057
GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN	C7_ immunologic signatures	178	0.83885366	0.8370457	0.900028	GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN	184	0.9119392	0.71802616	1	1.75079286	-0.07308554
GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	C7_ immunologic signatures	139	0.8388522	0.82120836	0.89993536	GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	145	1.0272148	0.43163267	0.88048905	1.866067	-0.1883626
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	184	0.83862793	0.83587337	0.9003044	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	185	0.8622598	0.8030303	1	1.70088773	-0.02363187
BIOCARTA_PTDINS_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	23	0.8385478	0.70542634	0.90036887	BIOCARTA_PTDINS_PATHWAY	23	0.9410978	0.5678392	0.98958457	1.7796456	-0.10255
GO_HISTONE_DEMETHYLASE_ACTIVITY	c5.GO molecular function	23	0.8384412	0.6943574	0.90048844	GO_HISTONE_DEMETHYLASE_ACTIVITY	23	1.0747447	0.37333333	0.7976625	1.9131859	-0.2363035
REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	c2.CP_REACTOME_ Reactome gene sets	26	0.8383987	0.713615	0.9004782	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	26	1.3400345	0.0862069	0.39707145	2.1784332	-0.5016358
MODULE_204	c4.CM_ cancer modules	69	0.8383491	0.779452	0.90048385	MODULE_204	72	1.0155451	0.45347592	0.89651066	1.8538942	-0.177196
HELLER_SILENCED_BY_METHYLATION_DN	c2.CGP_ chemical and genetic perturbations	91	0.8382997	0.8049096	0.9004835	HELLER_SILENCED_BY_METHYLATION_DN	93	1.0375642	0.404837	0.86312294	1.8758639	-0.1992645
GO_OLIGODENDROCYTE_DIFFERENTIATION	c5.BP_ GO biological process	53	0.8382941	0.739011	0.9004002	GO_OLIGODENDROCYTE_DIFFERENTIATION	58	-1.3132935	0.04040404	0.2717325	-0.4749994	2.1515876
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	c2.CGP_ chemical and genetic perturbations	16	0.8381232	0.6944	0.9006613	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	16	-1.1596444	0.25523013	0.43058112	-0.3215212	1.9977676
PID_ERBB1_INTERNALIZATION_PATHWAY	c2.CP_ Canonical pathways	40	0.83809334	0.7385057	0.90062696	PID_ERBB1_INTERNALIZATION_PATHWAY	40	1.2104288	0.1923077	0.57617354	2.04852214	-0.37233546
GO_CELLULAR_RESPONSE_TO_MECHANICAL_STIMULUS	c5.BP_ GO biological process	72	0.8380747	0.77459013	0.90056735	GO_CELLULAR_RESPONSE_TO_MECHANICAL_STIMULUS	74	0.84686905	0.76759064	1	1.68494375	-0.00879435
GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP	C7_ immunologic signatures	179	0.8379509	0.8556213	0.9007312	GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP	184	0.985629	0.5323887	0.9414011	1.8235799	-0.1476781
GCM_BMPR2	c4.CGN_ cancer gene neighborhoods	73	0.8379322	0.7366362	0.9006722	GCM_BMPR2	73	0.6322178	0.97746783	1	1.47015	0.2057144
GO_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	170	0.83791804	0.8275449	0.90060437	GO_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY	171	0.8340273	0.8314721	1	1.67194534	0.00389074
GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP	C7_ immunologic signatures	136	0.83789444	0.8060606	0.9005581	GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP	141	1.0730776	0.32073545	0.8005725	1.91097204	-0.23518316
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	C7_ immunologic signatures	174	0.8378927	0.84093565	0.9004654	GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	178	1.0869201	0.2816616	0.7756668	1.9248128	-0.2490274
GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP	C7_ immunologic signatures	176	0.8378527	0.8370457	0.90045726	GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP	184	0.7243492	0.95770395	1	1.5622019	0.1135035
AHR_Q5	c3.TFT_ transcription factor targets	188	0.8378036	0.8480278	0.90046084	AHR_Q5	195	-1.4191917	0	0.19417341	-0.5813881	2.2569953
BIOCARTA_ERK_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	28	0.83776635	0.6912851	0.90043813	BIOCARTA_ERK_PATHWAY	28	-0.9142887	0.6234568	0.8023455	-0.07652235	1.75205505
GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	C7_ immunologic signatures	162	0.8376659	0.84197533	0.90054184	GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	163	0.5870954	0.9959225	1	1.4247613	0.2505705
GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN	C7_ immunologic signatures	152	0.83763134	0.80815345	0.90051484	GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN	151	0.6777489	0.9745417	1	1.51538024	0.15988244
GO_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	22	0.8375902	0.71003133	0.90050334	GO_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY	25	1.4524848	0.029113924	0.29201853	2.290075	-0.6148946
GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN	C7_ immunologic signatures	174	0.83744496	0.8458781	0.9006952	GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN	178	1.2530723	0.049395163	0.5050537	2.09051726	-0.41562734
GO_CELLULAR_PROTEIN_COMPLEX_LOCALIZATION	c5.BP_ GO biological process	21	0.8373188	0.7210366	0.9008605	GO_CELLULAR_PROTEIN_COMPLEX_LOCALIZATION	21	0.76697755	0.7916137	1	1.60429635	0.07034125
GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	176	0.8372212	0.84375	0.9009637	GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP	178	1.1575791	0.15191147	0.65795666	1.9948003	-0.3203579
GO_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY	c5.BP_ GO biological process	36	0.83717245	0.7022222	0.90096545	GO_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY	39	1.3305796	0.09331797	0.40112177	2.16775205	-0.49340715
GTTTGTT_MIR495	c3.MIR_ microRNA targets	229	0.8371378	0.8506271	0.9009379	GTTTGTT_MIR495	236	0.6898258	0.9889669	1	1.5269636	0.147312
RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2	c2.CGP_ chemical and genetic perturbations	21	0.837083	0.7169811	0.9009494	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2	22	1.4495964	0.043586552	0.29146713	2.2866794	-0.6125134
GSE22886_NAIVE_BCELL_VS_DC_UP	C7_ immunologic signatures	147	0.83688456	0.8235995	0.90125823	GSE22886_NAIVE_BCELL_VS_DC_UP	153	1.1510181	0.18172589	0.6686621	1.98790266	-0.31413354
GO_CELLULAR_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS	c5.BP_ GO biological process	81	0.8368141	0.77671236	0.90130466	GO_CELLULAR_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS	88	0.8277194	0.80275714	1	1.6645335	0.0090947
GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN	C7_ immunologic signatures	168	0.83640987	0.8266509	0.9020271	GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN	167	0.75215894	0.9276249	1	1.58856881	0.08425093
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	c2.CGP_ chemical and genetic perturbations	24	0.83635217	0.71271586	0.9020489	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	24	1.4899963	0.034440346	0.2594287	2.32634847	-0.65364413
GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP	C7_ immunologic signatures	155	0.83630264	0.8319328	0.90205175	GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP	155	-1.6549907	0	0.07016797	-0.81868806	2.49129334
P300_01	c3.TFT_ transcription factor targets	213	0.83627856	0.8543578	0.9020053	P300_01	226	0.93982714	0.67474747	0.99009556	1.7761057	-0.10354858
YYCATTCAWW_UNKNOWN	c3.TFT_ transcription factor targets	165	0.83618265	0.853717	0.9021121	YYCATTCAWW_UNKNOWN	171	0.8639983	0.7975708	1	1.70018095	-0.02781565
GO_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING	c5.BP_ GO biological process	15	0.83608806	0.6888519	0.90220803	GO_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING	15	0.7554538	0.80474937	1	1.59154186	0.08063426
GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN	C7_ immunologic signatures	164	0.83567506	0.8463385	0.9029519	GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN	170	0.84923166	0.8299595	1	1.68490672	-0.0135566
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP	C7_ immunologic signatures	150	0.83566743	0.8335287	0.9028718	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP	151	-1.8204311	0	0.02945419	-0.98476367	2.65609853
GO_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	17	0.83555233	0.70598006	0.90300494	GO_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	17	1.1406853	0.30253166	0.6891845	1.97623763	-0.30513297
GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN	C7_ immunologic signatures	155	0.8352948	0.84455323	0.90342826	GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN	153	0.9228132	0.67622954	1	1.758108	-0.0875184
GO_STEROID_DEHYDROGENASE_ACTIVITY	c5.GO molecular function	18	0.8351066	0.7067308	0.90370756	GO_STEROID_DEHYDROGENASE_ACTIVITY	19	0.9380519	0.58681875	0.99282885	1.7731585	-0.1029453
GO_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING	c5.GO molecular function	16	0.8349173	0.6813187	0.90399384	GO_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING	16	1.0302391	0.45526317	0.8751512	1.8651564	-0.1953218
MODULE_257	c4.CM_ cancer modules	150	0.83487386	0.8239521	0.903982	MODULE_257	150	1.0432168	0.40895218	0.85311043	1.87809066	-0.20834294
GO_DNA_METHYLATION_OR_DEMETHYLATION	c5.BP_ GO biological process	52	0.8347998	0.7466863	0.90404105	GO_DNA_METHYLATION_OR_DEMETHYLATION	54	1.4801694	0.008762322	0.2684812	2.3149692	-0.6453696
GO_NITROGEN_COMPOUND_TRANSPORT	c5.BP_ GO biological process	438	0.83462274	0.90851736	0.9043134	GO_NITROGEN_COMPOUND_TRANSPORT	461	0.98387057	0.562	0.942703	1.81849331	-0.14924783
GGGNNTTTCC_NFKB_Q6_01	c3.TFT_ transcription factor targets	123	0.8345786	0.8154235	0.90431017	GGGNNTTTCC_NFKB_Q6_01	126	1.0933112	0.30340558	0.76814455	1.9278898	-0.2587326
GSE17721_LPS_VS_POLYIC_24H_BMDC_DN	C7_ immunologic signatures	181	0.8344969	0.83818394	0.9043796	GSE17721_LPS_VS_POLYIC_24H_BMDC_DN	183	1.1024624	0.26064909	0.75299037	1.9369593	-0.2679655
GSE27786_LSK_VS_NKCELL_DN	C7_ immunologic signatures	171	0.83446145	0.8506024	0.9043567	GSE27786_LSK_VS_NKCELL_DN	176	1.2430316	0.059898477	0.5228008	2.07749305	-0.40857015
GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN	C7_ immunologic signatures	163	0.83444154	0.84378844	0.9043023	GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN	167	0.9259507	0.6730964	1	1.76039224	-0.09150916
KEGG_DRUG_METABOLISM_OTHER_ENZYMES	c2.CP_BIOCARTA_ BioCarta gene sets	40	0.83443135	0.7288401	0.9042253	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	42	0.9706061	0.53579676	0.96119756	1.80503745	-0.13617475
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	c2.CGP_ chemical and genetic perturbations	164	0.83437866	0.84498835	0.90423834	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	170	-0.8693855	0.875	0.85399324	-0.03500684	1.70376416
GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP	C7_ immunologic signatures	158	0.83412963	0.8295858	0.90464854	GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP	160	1.0069954	0.4974464	0.912201	1.84112503	-0.17286577
GO_PIGMENT_GRANULE_ORGANIZATION	c5.BP_ GO biological process	17	0.83397377	0.709062	0.9048612	GO_PIGMENT_GRANULE_ORGANIZATION	19	-0.90521604	0.63981044	0.8149732	-0.07124227	1.73918981
AMIT_EGF_RESPONSE_240_HELA	c2.CGP_ chemical and genetic perturbations	57	0.83374965	0.7559944	0.9052152	AMIT_EGF_RESPONSE_240_HELA	57	0.6154407	0.98566705	1	1.44919035	0.21830895
GO_NEGATIVE_REGULATION_OF_JNK_CASCADE	c5.BP_ GO biological process	28	0.83366305	0.7275495	0.90528935	GO_NEGATIVE_REGULATION_OF_JNK_CASCADE	30	1.176874	0.24548736	0.6265572	2.01053705	-0.34321095
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	43	0.83362997	0.7507553	0.9052578	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN	45	0.75679	0.8525714	1	1.59041997	0.07683997
GSE17721_CTRL_VS_CPG_2H_BMDC_DN	C7_ immunologic signatures	172	0.83343005	0.82762694	0.90556306	GSE17721_CTRL_VS_CPG_2H_BMDC_DN	179	1.225515	0.07497467	0.5485264	2.05894505	-0.39208495
SUNG_METASTASIS_STROMA_DN	c2.CGP_ chemical and genetic perturbations	44	0.8334111	0.74127907	0.9055051	SUNG_METASTASIS_STROMA_DN	43	-1.3351835	0.04895105	0.25229156	-0.5017724	2.1685946
NRF1_Q6	c3.TFT_ transcription factor targets	223	0.83325946	0.8733032	0.9057156	NRF1_Q6	223	0.53849155	1	1	1.37175101	0.29476791
GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP	C7_ immunologic signatures	162	0.8329974	0.8583235	0.9061367	GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP	174	0.9506061	0.6238625	0.98141074	1.7836035	-0.1176087
RODRIGUES_NTN1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	140	0.8326595	0.83495146	0.906718	RODRIGUES_NTN1_TARGETS_DN	141	1.1853889	0.15621789	0.613448	2.0180484	-0.3527294
GO_NEGATIVE_REGULATION_OF_AUTOPHAGY	c5.BP_ GO biological process	46	0.83264136	0.76293105	0.9066615	GO_NEGATIVE_REGULATION_OF_AUTOPHAGY	47	0.810101	0.7799316	1	1.64274236	0.02254036
GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP	C7_ immunologic signatures	168	0.83259165	0.84994	0.90667194	GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP	173	0.98564196	0.5457317	0.9414893	1.81823361	-0.15305031
GO_ATPASE_ACTIVATOR_ACTIVITY	c5.GO molecular function	15	0.8324672	0.6827697	0.9068293	GO_ATPASE_ACTIVATOR_ACTIVITY	16	-0.9917349	0.44017094	0.6996641	-0.1592677	1.8242021
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	c2.CGP_ chemical and genetic perturbations	60	0.8323821	0.7730978	0.9069042	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	61	-1.3331784	0.07777778	0.2534159	-0.5007963	2.1655605
REACTOME_ACTIVATED_TLR4_SIGNALLING	c2.CP_REACTOME_ Reactome gene sets	86	0.83237857	0.79818887	0.9068137	REACTOME_ACTIVATED_TLR4_SIGNALLING	86	0.70346457	0.92782426	1	1.53584314	0.128914
GSE17186_MEMORY_VS_NAIVE_BCELL_UP	C7_ immunologic signatures	168	0.8320684	0.8501742	0.90734816	GSE17186_MEMORY_VS_NAIVE_BCELL_UP	174	0.9004203	0.72690356	1	1.7324887	-0.0683519
GO_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION	c5.BP_ GO biological process	36	0.8319775	0.7406297	0.9074287	GO_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION	38	1.1568563	0.2491269	0.65889794	1.9888338	-0.3248788
GO_REGULATION_OF_MESONEPHROS_DEVELOPMENT	c5.BP_ GO biological process	23	0.8315005	0.74503815	0.9082642	GO_REGULATION_OF_MESONEPHROS_DEVELOPMENT	25	-1.2998914	0.08866995	0.2839711	-0.4683909	2.1313919
GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN	C7_ immunologic signatures	149	0.8314915	0.8304455	0.9081867	GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN	155	0.97164804	0.577823	0.96024096	1.80313954	-0.14015654
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN	C7_ immunologic signatures	135	0.83142495	0.82758623	0.90822387	GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN	144	1.012175	0.4717369	0.90378535	1.84359995	-0.18075005
GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP	C7_ immunologic signatures	174	0.8314107	0.8473373	0.9081579	GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP	177	0.7752894	0.9248731	1	1.6067001	0.0561213
GO_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	56	0.8313677	0.78206897	0.908155	GO_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS	56	1.1127917	0.3114754	0.7330198	1.9441594	-0.281424
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP	C7_ immunologic signatures	180	0.83126485	0.84633297	0.9082694	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP	182	1.1127408	0.24467005	0.7330976	1.94400565	-0.28147595
GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP	C7_ immunologic signatures	174	0.8312481	0.8551069	0.90820664	GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP	177	0.9536201	0.6172589	0.97780097	1.7848682	-0.122372
GO_NUCLEAR_BODY	c5.CC_ GO cellular component	322	0.8312353	0.8942203	0.90813565	GO_NUCLEAR_BODY	324	-1.1338376	0	0.46700644	-0.3026023	1.9650729
GO_THIOLESTER_HYDROLASE_ACTIVITY	c5.GO molecular function	29	0.8311748	0.7162367	0.90816224	GO_THIOLESTER_HYDROLASE_ACTIVITY	32	1.0632764	0.3774912	0.8166303	1.8944512	-0.2321016
GO_REGULATION_OF_HAIR_CYCLE	c5.BP_ GO biological process	21	0.8311131	0.7014218	0.9081881	GO_REGULATION_OF_HAIR_CYCLE	20	0.9060191	0.6174583	1	1.7371322	-0.074906
GO_MACROMOLECULAR_COMPLEX_REMODELING	c5.BP_ GO biological process	18	0.8310987	0.7087228	0.90812206	GO_MACROMOLECULAR_COMPLEX_REMODELING	22	-1.1905311	0.22	0.3932761	-0.3594324	2.0216298
GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	C7_ immunologic signatures	173	0.83106124	0.8481308	0.9081028	GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	176	0.9315638	0.66700715	0.99825305	1.76262504	-0.10050256
KASLER_HDAC7_TARGETS_1_UP	c2.CGP_ chemical and genetic perturbations	178	0.8310125	0.8482676	0.90810287	KASLER_HDAC7_TARGETS_1_UP	182	1.0162187	0.4663951	0.89533013	1.8472312	-0.1852062
HALLMARK_HEME_METABOLISM	H_ hallmark gene sets	183	0.83095855	0.88061464	0.9081124	HALLMARK_HEME_METABOLISM	187	0.81545174	0.86903554	1	1.64641029	0.01550681
VALK_AML_CLUSTER_1	c2.CGP_ chemical and genetic perturbations	22	0.8309029	0.73570323	0.9081298	VALK_AML_CLUSTER_1	26	-0.8458509	0.72820514	0.87237394	-0.014948	1.6767538
GO_PROTEIN_LOCALIZATION_TO_NUCLEUS	c5.BP_ GO biological process	145	0.83076364	0.85908526	0.9082989	GO_PROTEIN_LOCALIZATION_TO_NUCLEUS	146	-1.2582442	0	0.3156454	-0.42748056	2.08900784
KEGG_BASE_EXCISION_REPAIR	c2.CP_BIOCARTA_ BioCarta gene sets	32	0.8306919	0.74440897	0.90834403	KEGG_BASE_EXCISION_REPAIR	32	-1.0401736	0.3918919	0.62180895	-0.2094817	1.8708655
GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN	C7_ immunologic signatures	183	0.8305275	0.86288416	0.9085731	GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN	187	-0.9861997	0.6923077	0.70626616	-0.1556722	1.8167272
TTTGCAG_MIR518A2	c3.MIR_ microRNA targets	189	0.83044976	0.86470586	0.9086346	TTTGCAG_MIR518A2	193	0.6165871	0.9959718	1	1.44703686	0.21386266
GO_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	426	0.83042014	0.93333334	0.9085984	GO_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	477	1.2639401	0.007	0.49096957	2.09436024	-0.43351996
GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	173	0.83037	0.85915494	0.90860355	GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP	176	0.5910336	0.9979716	1	1.4214036	0.2393364
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	19	0.8302603	0.71824104	0.9087276	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	20	-0.9083228	0.59447	0.8120033	-0.0780625	1.7385831
GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	158	0.8301865	0.87046003	0.90877235	GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN	159	0.84936285	0.80827445	1	1.67954935	-0.01917635
LIM_MAMMARY_STEM_CELL_DN	c2.CGP_ chemical and genetic perturbations	382	0.8300159	0.90780914	0.9090125	LIM_MAMMARY_STEM_CELL_DN	388	1.262225	0.006	0.49369505	2.0922409	-0.4322091
GO_NEGATIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	117	0.8298674	0.8170581	0.909206	GO_NEGATIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS	118	-1.0595162	0.3	0.5885841	-0.2296488	1.8893836
GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN	C7_ immunologic signatures	153	0.82979745	0.85354143	0.9092507	GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN	156	0.8291108	0.8269231	1	1.65890825	0.00068665
GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP	C7_ immunologic signatures	162	0.8297737	0.842615	0.9092015	GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP	177	1.2648522	0.046605878	0.49091235	2.0946259	-0.4350785
GO_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY	c5.BP_ GO biological process	50	0.82955784	0.7713068	0.9095254	GO_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY	56	1.2075254	0.18579236	0.5805374	2.03708324	-0.37796756
GO_NEURAL_RETINA_DEVELOPMENT	c5.BP_ GO biological process	45	0.8295176	0.73495704	0.9095064	GO_NEURAL_RETINA_DEVELOPMENT	47	0.9093089	0.6181411	1	1.7388265	-0.0797913
PID_TOLL_ENDOGENOUS_PATHWAY	c2.CP_ Canonical pathways	22	0.82939225	0.6975684	0.90966064	PID_TOLL_ENDOGENOUS_PATHWAY	22	-0.78259975	0.825	0.9189228	0.0467925	1.611992
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP	C7_ immunologic signatures	174	0.8293366	0.86785716	0.90967596	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP	172	0.73796093	0.95131844	1	1.56729753	0.09137567
TCTATGA_MIR376A_MIR376B	c3.MIR_ microRNA targets	71	0.82930183	0.77388966	0.9096515	TCTATGA_MIR376A_MIR376B	73	0.6669368	0.94972676	1	1.49623863	0.16236503
GO_VESICLE_CYTOSKELETAL_TRAFFICKING	c5.BP_ GO biological process	34	0.8291553	0.7453237	0.9098481	GO_VESICLE_CYTOSKELETAL_TRAFFICKING	34	0.9053316	0.63763064	1	1.7344869	-0.0761763
GO_RAB_GTPASE_BINDING	c5.GO molecular function	109	0.82898676	0.84093714	0.91007805	GO_RAB_GTPASE_BINDING	110	1.388141	0.01863354	0.34797627	2.21712776	-0.55915424
GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP	C7_ immunologic signatures	166	0.8287971	0.8353222	0.9103521	GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP	179	0.9020946	0.7411527	1	1.7308917	-0.0732975
GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	173	0.8287823	0.85865724	0.91028565	GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP	174	0.65993094	0.9788093	1	1.48871324	0.16885136
GO_DEATH_RECEPTOR_ACTIVITY	c5.GO molecular function	19	0.8286659	0.7292645	0.9104143	GO_DEATH_RECEPTOR_ACTIVITY	19	1.4063286	0.06408545	0.33157715	2.2349945	-0.5776627
GO_ONE_CARBON_METABOLIC_PROCESS	c5.BP_ GO biological process	31	0.82865226	0.74821174	0.9103432	GO_ONE_CARBON_METABOLIC_PROCESS	33	-1.1530828	0.20253165	0.44008568	-0.32443054	1.98173506
VERRECCHIA_RESPONSE_TO_TGFB1_C2	c2.CGP_ chemical and genetic perturbations	25	0.8285958	0.71178347	0.910351	VERRECCHIA_RESPONSE_TO_TGFB1_C2	25	-1.0169388	0.38202247	0.6626269	-0.188343	1.8455346
GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	158	0.82831746	0.8568047	0.91080403	GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN	157	1.2000016	0.11577869	0.59218246	2.02831906	-0.37168414
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR	c2.CGP_ chemical and genetic perturbations	27	0.82817423	0.7389985	0.9109875	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR	27	1.050665	0.4105642	0.8387554	1.87883923	-0.22249077
GO_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY	c5.GO molecular function	15	0.8281243	0.71428573	0.91098857	GO_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY	15	0.63438827	0.9116883	1	1.46251257	0.19373603
NFKAPPAB65_01	c3.TFT_ transcription factor targets	214	0.82804424	0.87398845	0.911049	NFKAPPAB65_01	220	1.1582885	0.12562814	0.6565986	1.98633274	-0.33024426
GO_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	38	0.82783395	0.7627119	0.9113583	GO_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS	41	1.5501221	0.011848342	0.20703697	2.37795605	-0.72228815
CHR3Q12	C1: positional gene sets	25	0.8276205	0.7385103	0.91168237	CHR3Q12	28	-1.1333961	0.22651933	0.46740416	-0.3057756	1.9610166
GO_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	74	0.82744306	0.78457445	0.91194	GO_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	81	1.082176	0.34044823	0.7833396	1.90961906	-0.25473294
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	71	0.82701606	0.8	0.9126707	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	76	1.4959114	0.003285871	0.256024	2.32292746	-0.66889534
GSE14308_TH2_VS_INDUCED_TREG_DN	C7_ immunologic signatures	175	0.82698864	0.86190474	0.9126281	GSE14308_TH2_VS_INDUCED_TREG_DN	179	1.1525711	0.15470172	0.6650333	1.97955974	-0.32558246
GO_REGULATION_OF_STEROID_HORMONE_SECRETION	c5.BP_ GO biological process	15	0.8269488	0.71941274	0.9126118	GO_REGULATION_OF_STEROID_HORMONE_SECRETION	17	-1.0134339	0.41304347	0.6681888	-0.1864851	1.8403827
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP	C7_ immunologic signatures	124	0.82688516	0.84138787	0.9126403	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP	132	0.9791892	0.5576132	0.95025355	1.80607436	-0.15230404
GO_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY	c5.BP_ GO biological process	86	0.8267359	0.7987013	0.91283506	GO_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY	91	0.96545374	0.5694737	0.96507776	1.79218964	-0.13871784
AP2_Q3	c3.TFT_ transcription factor targets	220	0.8267014	0.8912281	0.91280156	AP2_Q3	233	0.61301947	0.9969849	1	1.43972087	0.21368193
GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	155	0.82638377	0.8578554	0.9133117	GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	163	0.7283217	0.96032554	1	1.55470547	0.09806207
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	189	0.8263159	0.8605991	0.9133551	GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	189	0.96988523	0.5714286	0.96133107	1.79620113	-0.14356933
PID_IL1_PATHWAY	c2.CP_ Canonical pathways	31	0.82629347	0.71806854	0.9133019	PID_IL1_PATHWAY	31	0.9648492	0.5418139	0.96539134	1.79114267	-0.13855573
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	c2.CP_REACTOME_ Reactome gene sets	30	0.82620955	0.7647059	0.91336834	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	31	0.83907276	0.7172583	1	1.66528231	-0.01286321
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN	C7_ immunologic signatures	114	0.8261199	0.8190955	0.9134493	GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN	119	1.0000191	0.49264705	0.9244753	1.826139	-0.1738992
GO_REGULATION_OF_HISTONE_METHYLATION	c5.BP_ GO biological process	48	0.82608455	0.76846594	0.9134201	GO_REGULATION_OF_HISTONE_METHYLATION	51	-0.9478509	0.5809524	0.76004016	-0.12176635	1.77393545
TFIII_Q6	c3.TFT_ transcription factor targets	193	0.8260559	0.87078	0.9133807	TFIII_Q6	198	-1.1989572	0	0.3827527	-0.3729013	2.0250131
GO_NEURAL_TUBE_PATTERNING	c5.BP_ GO biological process	28	0.8255856	0.75113124	0.91416746	GO_NEURAL_TUBE_PATTERNING	33	-1.3869367	0.045454547	0.21498223	-0.5613511	2.2125223
GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS	c5.BP_ GO biological process	43	0.8255004	0.7567568	0.9142389	GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS	45	1.0795635	0.3552781	0.7881096	1.9050639	-0.2540631
SILIGAN_BOUND_BY_EWS_FLT1_FUSION	c2.CGP_ chemical and genetic perturbations	40	0.825458	0.7518248	0.91422635	SILIGAN_BOUND_BY_EWS_FLT1_FUSION	42	1.3978475	0.049142856	0.34518462	2.2233055	-0.5723895
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	c2.CP_BIOCARTA_ BioCarta gene sets	124	0.8254298	0.8128797	0.91418594	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	125	0.5223395	0.99793816	1	1.3477693	0.3030903
VALK_AML_CLUSTER_2	c2.CGP_ chemical and genetic perturbations	23	0.8254111	0.69664633	0.91412413	VALK_AML_CLUSTER_2	23	1.391358	0.063197024	0.3464598	2.2167691	-0.5659469
GO_NEUROTRANSMITTER_TRANSPORT	c5.BP_ GO biological process	136	0.82524675	0.8562259	0.9143411	GO_NEUROTRANSMITTER_TRANSPORT	145	1.2102978	0.09766022	0.5759421	2.03554455	-0.38505105
GO_WATER_HOMEOSTASIS	c5.BP_ GO biological process	54	0.82523793	0.7830986	0.9142615	GO_WATER_HOMEOSTASIS	60	1.3192747	0.06298342	0.41258177	2.14451263	-0.49403677
SP1_Q4_01	c3.TFT_ transcription factor targets	231	0.82513785	0.9001135	0.9143524	SP1_Q4_01	232	-0.977716	0.625	0.7171846	-0.15257815	1.80285385
GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	173	0.8250445	0.8590203	0.9144279	GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP	178	0.9997639	0.5	0.9246304	1.8248084	-0.1747194
GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	C7_ immunologic signatures	169	0.8248186	0.8463385	0.91476935	GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	169	0.6596043	0.98985803	1	1.4844229	0.1652143
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP	C7_ immunologic signatures	150	0.82479525	0.85272276	0.9147202	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP	151	1.02206	0.45528457	0.8886583	1.84685525	-0.19726475
GO_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY	c5.GO molecular function	25	0.8247481	0.70864946	0.9147144	GO_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY	25	1.013721	0.47455472	0.9001512	1.8384691	-0.1889729
COUP_DR1_Q6	c3.TFT_ transcription factor targets	215	0.8246382	0.8891429	0.9148266	COUP_DR1_Q6	221	0.78181154	0.9273461	1	1.60644974	0.04282666
PEA3_Q6	c3.TFT_ transcription factor targets	223	0.82459104	0.8797251	0.9148202	PEA3_Q6	228	1.2474488	0.04036327	0.5150506	2.07203984	-0.42285776
GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN	C7_ immunologic signatures	180	0.8245431	0.8798587	0.9148194	GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN	182	-1.6112174	0	0.087711275	-0.7866743	2.4357605
GO_CILIARY_PLASM	c5.CC_ GO cellular component	75	0.8245006	0.787717	0.91480434	GO_CILIARY_PLASM	76	1.248726	0.105882354	0.51251197	2.0732266	-0.4242254
WENDT_COHESIN_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	32	0.8244135	0.7532656	0.91487885	WENDT_COHESIN_TARGETS_UP	32	-0.7558331	0.90140843	0.93608946	0.0685804	1.5802466
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	c2.CGP_ chemical and genetic perturbations	69	0.8243516	0.8026144	0.914897	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	73	1.3496063	0.04623656	0.38261655	2.1739579	-0.5252547
GO_TRANSLATION_REPRESSOR_ACTIVITY	c5.GO molecular function	19	0.8241714	0.73322934	0.9151452	GO_TRANSLATION_REPRESSOR_ACTIVITY	19	-1.3905691	0.0945946	0.21403359	-0.5663977	2.2147405
GSE14308_INDUCED_VS_NATURAL_TREG_UP	C7_ immunologic signatures	179	0.82416975	0.8654292	0.9150526	GSE14308_INDUCED_VS_NATURAL_TREG_UP	178	0.7854528	0.89137053	1	1.60962255	0.03871695
KIM_LRRC3B_TARGETS	c2.CGP_ chemical and genetic perturbations	20	0.8240057	0.7265861	0.9152624	KIM_LRRC3B_TARGETS	19	1.498099	0.032745592	0.25326034	2.3221047	-0.6740933
GO_MULTICELLULAR_ORGANISMAL_WATER_HOMEOSTASIS	c5.BP_ GO biological process	44	0.8239461	0.7548006	0.91527814	GO_MULTICELLULAR_ORGANISMAL_WATER_HOMEOSTASIS	51	1.4585133	0.017660044	0.28350243	2.2824594	-0.6345672
GO_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION	c5.BP_ GO biological process	15	0.82378584	0.7095238	0.91549385	GO_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION	18	1.4138943	0.058748405	0.32380632	2.23768014	-0.59010846
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	c2.CGP_ chemical and genetic perturbations	18	0.8237549	0.71086264	0.9154551	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	18	1.1804565	0.27248678	0.6234756	2.0042114	-0.3567016
GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	166	0.82372725	0.8523002	0.9154089	GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP	169	0.8672499	0.7834525	1	1.69097715	-0.04352265
GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN	C7_ immunologic signatures	173	0.8236922	0.8673709	0.91537815	GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN	177	0.98634046	0.5303644	0.94025564	1.81003266	-0.16264826
GO_KERATAN_SULFATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	25	0.82357776	0.74164134	0.9155017	GO_KERATAN_SULFATE_BIOSYNTHETIC_PROCESS	24	1.117177	0.33079848	0.7284409	1.94075476	-0.29359924
BIOCARTA_AT1R_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	30	0.823544	0.7300151	0.91547316	BIOCARTA_AT1R_PATHWAY	30	1.2553699	0.16270784	0.5022164	2.0789139	-0.4318259
GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP	C7_ immunologic signatures	156	0.8234516	0.85594237	0.91555405	GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP	164	0.99869424	0.50051075	0.9252285	1.82214584	-0.17524264
ELF1_Q6	c3.TFT_ transcription factor targets	211	0.82320285	0.88337183	0.9159287	ELF1_Q6	219	0.93237877	0.66498995	0.9977161	1.75558162	-0.10917592
GO_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY	c5.BP_ GO biological process	43	0.8231942	0.76617646	0.915849	GO_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY	42	0.6854036	0.9150623	1	1.5085978	0.1377906
GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_UP	C7_ immunologic signatures	163	0.8230651	0.85234094	0.91600287	GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_UP	162	0.99416965	0.52240324	0.93115807	1.81723475	-0.17110455
GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	182	0.823054	0.8813161	0.9159276	GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP	183	0.9152374	0.70385396	1	1.7382914	-0.0921834
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP	C7_ immunologic signatures	169	0.8228711	0.86634845	0.91617924	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP	172	0.90913826	0.71095335	1	1.73200936	-0.08626716
CAFFAREL_RESPONSE_TO_THC_UP	c2.CGP_ chemical and genetic perturbations	29	0.8227275	0.7488922	0.9163522	CAFFAREL_RESPONSE_TO_THC_UP	29	-1.1844503	0.19161677	0.3990584	-0.3617228	2.0071778
GNF2_CD48	c4.CGN_ cancer gene neighborhoods	23	0.82266855	0.72897196	0.9163669	GNF2_CD48	26	0.82979554	0.73690623	1	1.65246409	-0.00712699
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP	C7_ immunologic signatures	163	0.82257915	0.8590203	0.9164434	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP	165	1.202058	0.11077236	0.58865166	2.02463715	-0.37947885
GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP	C7_ immunologic signatures	178	0.82255805	0.87410927	0.9163853	GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP	179	-0.9208207	0.75	0.7937575	-0.09826265	1.74337875
GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP	C7_ immunologic signatures	176	0.82255256	0.85354143	0.9162998	GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP	176	1.3331051	0.016145308	0.40005645	2.15565766	-0.51055254
GO_ENTRAINMENT_OF_CIRCADIAN_CLOCK_BY_PHOTOPERIOD	c5.BP_ GO biological process	18	0.8223948	0.72195125	0.91650486	GO_ENTRAINMENT_OF_CIRCADIAN_CLOCK_BY_PHOTOPERIOD	18	0.4978341	0.9875312	1	1.3202289	0.3245607
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	c2.CGP_ chemical and genetic perturbations	51	0.8222633	0.77011496	0.91665447	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	54	0.63915336	0.9742441	1	1.46141666	0.18310994
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	C7_ immunologic signatures	171	0.82225764	0.8633177	0.91657	GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	178	1.1543092	0.14489795	0.6625607	1.97656684	-0.33205156
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	c2.CGP_ chemical and genetic perturbations	16	0.82205856	0.71172637	0.91684955	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	15	-0.9025598	0.6042553	0.8172761	-0.08050124	1.72461836
AGGAGTG_MIR483	c3.MIR_ microRNA targets	62	0.821873	0.79073036	0.91711307	AGGAGTG_MIR483	63	0.94198287	0.5869324	0.98885363	1.76385587	-0.12010987
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	c2.CGP_ chemical and genetic perturbations	60	0.82185924	0.7885154	0.91704243	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	61	-1.5821546	0	0.098337285	-0.76029536	2.40401384
GSE18148_CBFB_KO_VS_WT_TREG_UP	C7_ immunologic signatures	151	0.82183033	0.8464419	0.91699743	GSE18148_CBFB_KO_VS_WT_TREG_UP	166	1.3191967	0.019250253	0.41232035	2.14102703	-0.49736637
GSE34515_CD16_POS_MONOCYTE_VS_DC_UP	C7_ immunologic signatures	189	0.8218128	0.88783944	0.91693616	GSE34515_CD16_POS_MONOCYTE_VS_DC_UP	189	0.8497891	0.82929295	1	1.6716019	-0.0279763
PAX5_01	c3.TFT_ transcription factor targets	133	0.8218101	0.84138787	0.9168451	PAX5_01	139	0.9949947	0.51428574	0.9300863	1.8168048	-0.1731846
CHR1Q44	C1: positional gene sets	35	0.8217321	0.7439545	0.9168916	CHR1Q44	34	1.2464564	0.17257683	0.5169643	2.0681885	-0.4247243
AGTCTAG_MIR151	c3.MIR_ microRNA targets	21	0.82168704	0.72897196	0.9168825	AGTCTAG_MIR151	21	0.6408603	0.9309045	1	1.46254734	0.18082674
MILI_PSEUDOPODIA_CHEMOTAXIS_DN	c2.CGP_ chemical and genetic perturbations	422	0.8216149	0.9469122	0.91693145	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	422	0.98450667	0.5755756	0.9422655	1.80612157	-0.16289177
GO_V_D_J_RECOMBINATION	c5.BP_ GO biological process	15	0.8215635	0.7199367	0.9169317	GO_V_D_J_RECOMBINATION	15	-1.3724029	0.09055118	0.22511338	-0.5508394	2.1939664
GO_NUCLEAR_EUCHROMATIN	c5.CC_ GO cellular component	21	0.8214516	0.7261346	0.91704434	GO_NUCLEAR_EUCHROMATIN	21	-1.5681251	0.033333335	0.10548073	-0.7466735	2.3895767
GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN	C7_ immunologic signatures	163	0.8214495	0.86121	0.9169517	GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN	164	1.2270637	0.092385784	0.5466275	2.0485132	-0.4056142
GO_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS	c5.BP_ GO biological process	85	0.82137185	0.8229167	0.917003	GO_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS	86	0.9750443	0.5279831	0.9557496	1.79641615	-0.15367245
GSE27786_LSK_VS_CD4_TCELL_UP	C7_ immunologic signatures	177	0.8212518	0.86914766	0.9171321	GSE27786_LSK_VS_CD4_TCELL_UP	181	0.8969832	0.7461929	1	1.718235	-0.0757314
GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	168	0.82112324	0.8601645	0.91728187	GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN	176	0.91580695	0.7076613	1	1.73693019	-0.09468371
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	c2.CGP_ chemical and genetic perturbations	135	0.82107836	0.85268414	0.91727275	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	135	-0.8955727	0.88461536	0.8267612	-0.07449434	1.71665106
GSE2585_THYMIC_DC_VS_MTEC_UP	C7_ immunologic signatures	163	0.82105255	0.8696742	0.91722506	GSE2585_THYMIC_DC_VS_MTEC_UP	170	0.87319297	0.77800405	1	1.69424552	-0.05214042
GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	C7_ immunologic signatures	144	0.8207799	0.85540706	0.9176425	GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	152	1.1521702	0.17997977	0.6660074	1.9729501	-0.3313903
GSE14308_TH2_VS_TH17_DN	C7_ immunologic signatures	177	0.82077813	0.8685446	0.9175492	GSE14308_TH2_VS_TH17_DN	177	0.89813364	0.7380711	1	1.71891177	-0.07735551
GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	137	0.82074183	0.84662575	0.91752625	GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP	139	0.5901307	0.99486125	1	1.41087253	0.23061113
GO_PROTEIN_TARGETING_TO_PLASMA_MEMBRANE	c5.BP_ GO biological process	21	0.8206768	0.73824453	0.9175603	GO_PROTEIN_TARGETING_TO_PLASMA_MEMBRANE	21	1.3129294	0.12113721	0.42040977	2.1336062	-0.4922526
MAINA_VHL_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	18	0.8206625	0.7245696	0.9174947	MAINA_VHL_TARGETS_DN	18	1.1037042	0.34854245	0.74998885	1.9243667	-0.2830417
GO_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL	c5.BP_ GO biological process	21	0.82047147	0.7324841	0.91775954	GO_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL	23	1.1108483	0.3379397	0.7361199	1.93131977	-0.29037683
BIOCARTA_BARRESTIN_SRC_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	0.82039106	0.7389163	0.9178183	BIOCARTA_BARRESTIN_SRC_PATHWAY	15	1.007704	0.47218454	0.9109667	1.82809506	-0.18731294
GO_RETINA_HOMEOSTASIS	c5.BP_ GO biological process	51	0.82020366	0.7911932	0.9180658	GO_RETINA_HOMEOSTASIS	54	0.9570787	0.5612472	0.9746785	1.77728236	-0.13687504
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	175	0.82019085	0.8789659	0.9179921	GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN	175	-0.99957645	0.42857143	0.68542415	-0.1793856	1.8197673
GOLUB_ALL_VS_AML_UP	c2.CGP_ chemical and genetic perturbations	24	0.8201316	0.74766356	0.91800225	GOLUB_ALL_VS_AML_UP	24	-1.4800351	0.05670103	0.15505412	-0.6599035	2.3001667
GSE7460_CD8_TCELL_VS_TREG_ACT_UP	C7_ immunologic signatures	177	0.81991893	0.8729412	0.9183037	GSE7460_CD8_TCELL_VS_TREG_ACT_UP	181	1.2079536	0.08897877	0.5803322	2.02787253	-0.38803467
GO_REGULATION_OF_DENDRITE_DEVELOPMENT	c5.BP_ GO biological process	114	0.81980145	0.8496894	0.918428	GO_REGULATION_OF_DENDRITE_DEVELOPMENT	115	1.0732212	0.34583333	0.80054224	1.89302265	-0.25341975
GO_RUFFLE	c5.CC_ GO cellular component	144	0.81940395	0.86009735	0.9190841	GO_RUFFLE	144	0.9731483	0.5446154	0.9577469	1.79255225	-0.15374435
GCM_DDX11	c4.CGN_ cancer gene neighborhoods	42	0.81928587	0.76268655	0.91919905	GCM_DDX11	43	0.9211439	0.60839957	1	1.74042977	-0.10185803
PDGF_UP.V1_UP	C6_ oncogenic signatures	135	0.8189784	0.8548185	0.91966337	PDGF_UP.V1_UP	136	-1.0287396	0.33333334	0.6414451	-0.2097612	1.847718
GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP	C7_ immunologic signatures	158	0.8187113	0.8874251	0.9200783	GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP	161	1.1319155	0.22335026	0.70306706	1.9506268	-0.3132042
GO_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	31	0.8181901	0.7322239	0.92095023	GO_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	33	-0.9518895	0.5176471	0.7522441	-0.1336994	1.7700796
GO_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION	c5.BP_ GO biological process	33	0.81806505	0.7348837	0.9210886	GO_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION	34	0.8911582	0.6437198	1	1.70922325	-0.07309315
GO_MULTI_ORGANISM_ORGANELLE_ORGANIZATION	c5.BP_ GO biological process	21	0.8180423	0.7411402	0.92103165	GO_MULTI_ORGANISM_ORGANELLE_ORGANIZATION	21	0.77124286	0.80856425	1	1.58928516	0.04679944
GO_WW_DOMAIN_BINDING	c5.GO molecular function	25	0.81801206	0.712627	0.9209924	GO_WW_DOMAIN_BINDING	27	1.3852487	0.08033573	0.35022494	2.20326076	-0.56723664
PID_CDC42_PATHWAY	c2.CP_ Canonical pathways	66	0.81799906	0.80921054	0.92092264	PID_CDC42_PATHWAY	68	0.7456504	0.8622951	1	1.56364946	0.07234866
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	c2.CGP_ chemical and genetic perturbations	34	0.8179288	0.7716418	0.9209566	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	34	0.8265613	0.7431953	1	1.6444901	-0.0086325
GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	183	0.81781757	0.88402367	0.9210642	GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	184	-1.3560132	0	0.23735042	-0.53819563	2.17383077
GO_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY	c5.BP_ GO biological process	80	0.8178059	0.81865287	0.9209903	GO_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY	78	0.83055997	0.77224576	1	1.64836587	-0.01275407
GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN	C7_ immunologic signatures	182	0.81777906	0.87910795	0.9209412	GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN	185	0.6759786	0.9848024	1	1.49375766	0.14180046
GO_LEUKOCYTE_CELL_CELL_ADHESION	c5.BP_ GO biological process	215	0.8177343	0.89675176	0.92092615	GO_LEUKOCYTE_CELL_CELL_ADHESION	230	0.91050637	0.73380566	1	1.72824067	-0.09277207
CCACACA_MIR147	c3.MIR_ microRNA targets	57	0.8177231	0.76237625	0.92085034	CCACACA_MIR147	57	0.9920426	0.4889868	0.9333712	1.8097657	-0.1743195
CREB_02	c3.TFT_ transcription factor targets	213	0.81769586	0.90650886	0.920802	CREB_02	220	0.78813404	0.91356784	1	1.6058299	0.02956182
GO_NEGATIVE_REGULATION_OF_HOMEOSTATIC_PROCESS	c5.BP_ GO biological process	104	0.8172697	0.8403576	0.9214921	GO_NEGATIVE_REGULATION_OF_HOMEOSTATIC_PROCESS	114	1.3081901	0.049382716	0.42851105	2.1254598	-0.4909204
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	c2.CGP_ chemical and genetic perturbations	462	0.8170857	0.95132273	0.9217325	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	464	-1.1298656	0	0.47111484	-0.3127799	1.9469513
GO_REGULATION_OF_CAMP_MEDIATED_SIGNALING	c5.BP_ GO biological process	19	0.81690943	0.7232704	0.92196304	GO_REGULATION_OF_CAMP_MEDIATED_SIGNALING	21	0.992316	0.4974811	0.9333296	1.80922543	-0.17540657
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN	C7_ immunologic signatures	166	0.8169028	0.87764704	0.9218789	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN	167	0.60378957	0.9959267	1	1.42069237	0.21311323
GO_ARF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	c5.GO molecular function	23	0.81683254	0.7453125	0.92191017	GO_ARF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	23	1.3193651	0.11001236	0.4130526	2.13619764	-0.50253256
GO_PROTEIN_COMPLEX_SCAFFOLD	c5.GO molecular function	60	0.8168325	0.78206897	0.9218142	GO_PROTEIN_COMPLEX_SCAFFOLD	62	1.2220012	0.17271727	0.5530681	2.0388337	-0.4051687
GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN	C7_ immunologic signatures	114	0.816612	0.85264486	0.9221243	GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN	114	-0.9984907	0.4117647	0.68766713	-0.1818787	1.8151027
GO_RNA_STABILIZATION	c5.BP_ GO biological process	28	0.8165782	0.7579425	0.9220891	GO_RNA_STABILIZATION	28	-2.0388005	0	0.005592078	-1.2222223	2.8553787
GSE27786_BCELL_VS_CD4_TCELL_DN	C7_ immunologic signatures	167	0.816543	0.8574879	0.92206	GSE27786_BCELL_VS_CD4_TCELL_DN	171	0.8784078	0.7656566	1	1.6949508	-0.0618648
REACTOME_SIGNALLING_BY_NGF	c2.CP_REACTOME_ Reactome gene sets	200	0.8164546	0.8895349	0.9221345	REACTOME_SIGNALLING_BY_NGF	204	1.1543585	0.15879397	0.6624932	1.9708131	-0.3379039
HINATA_NFKB_TARGETS_KERATINOCYTE_UP	c2.CGP_ chemical and genetic perturbations	81	0.81634563	0.81958765	0.92223823	HINATA_NFKB_TARGETS_KERATINOCYTE_UP	81	1.135868	0.25135428	0.69572216	1.95221363	-0.31952237
GO_VITAMIN_D_RECEPTOR_BINDING	c5.GO molecular function	16	0.8163335	0.7095238	0.9221648	GO_VITAMIN_D_RECEPTOR_BINDING	16	-0.9517926	0.5144033	0.7521311	-0.1354591	1.7681261
GO_SEX_DETERMINATION	c5.BP_ GO biological process	18	0.816087	0.71608835	0.9225253	GO_SEX_DETERMINATION	21	-0.8455984	0.70535713	0.87175924	-0.0295114	1.6616854
GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	150	0.81606334	0.8699387	0.9224718	GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	153	0.82189304	0.85350966	1	1.63795638	-0.0058297
BIOCARTA_IL1R_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	32	0.81605715	0.744012	0.92238694	BIOCARTA_IL1R_PATHWAY	31	1.0036657	0.47841728	0.9174246	1.81972285	-0.18760855
GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP	C7_ immunologic signatures	167	0.8158784	0.86819834	0.92262155	GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP	172	0.8687167	0.79027355	1	1.6845951	-0.0528383
GSE3039_CD4_TCELL_VS_B1_BCELL_DN	C7_ immunologic signatures	164	0.8158499	0.8730159	0.92258245	GSE3039_CD4_TCELL_VS_B1_BCELL_DN	166	1.0965117	0.2847011	0.7617695	1.9123616	-0.2806618
HASLINGER_B_CLL_WITH_11Q23_DELETION	c2.CGP_ chemical and genetic perturbations	21	0.8158463	0.75579596	0.92249376	HASLINGER_B_CLL_WITH_11Q23_DELETION	21	0.5127279	0.9896507	1	1.3285742	0.3031184
GO_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS	c5.GO molecular function	35	0.8158121	0.7721894	0.9224574	GO_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS	37	0.6902998	0.9097222	1	1.5061119	0.1255123
BRIDEAU_IMPRINTED_GENES	c2.CGP_ chemical and genetic perturbations	54	0.81568295	0.80497926	0.92258966	BRIDEAU_IMPRINTED_GENES	57	1.0273036	0.44983461	0.8805508	1.84298655	-0.21162065
GO_T_CELL_HOMEOSTASIS	c5.BP_ GO biological process	32	0.8156125	0.75835866	0.9226254	GO_T_CELL_HOMEOSTASIS	34	0.92227507	0.5971395	1	1.73788757	-0.10666257
GO_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	218	0.8153063	0.91402715	0.9230863	GO_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS	225	1.049148	0.38546923	0.8414978	1.8644543	-0.2338417
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	c2.CGP_ chemical and genetic perturbations	78	0.8152661	0.8283093	0.9230628	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	81	0.7785861	0.8557895	1	1.5938522	0.03668
SREBP1_02	c3.TFT_ transcription factor targets	78	0.81518006	0.82463187	0.92311954	SREBP1_02	81	0.87840873	0.69957983	1	1.69358879	-0.06322867
GO_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	25	0.8147403	0.719685	0.9238159	GO_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE	27	1.2053486	0.22248521	0.58264923	2.0200889	-0.3906083
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_UP	C7_ immunologic signatures	171	0.8147263	0.8793911	0.9237444	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_UP	179	0.8501504	0.8397566	1	1.6648767	-0.0354241
GO_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	45	0.814722	0.7846821	0.92365646	GO_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	45	0.91296124	0.6069429	1	1.72768324	-0.09823924
TCTGATC_MIR383	c3.MIR_ microRNA targets	44	0.8145636	0.8008596	0.9238439	TCTGATC_MIR383	45	-1.0776857	0.34437087	0.555692	-0.2631221	1.8922493
GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN	C7_ immunologic signatures	180	0.8145594	0.89429927	0.92375475	GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN	181	1.0458229	0.39311042	0.84730697	1.8603823	-0.2312635
GO_HELICASE_ACTIVITY	c5.GO molecular function	140	0.81453985	0.8585248	0.9236945	GO_HELICASE_ACTIVITY	142	-1.2633412	0.05263158	0.31294152	-0.44880135	2.07788105
CHR7P21	C1: positional gene sets	28	0.814447	0.75191426	0.92376345	CHR7P21	28	0.8232087	0.74247897	1	1.6376557	-0.0087617
GO_LIPID_CATABOLIC_PROCESS	c5.BP_ GO biological process	211	0.81442803	0.8926887	0.9237016	GO_LIPID_CATABOLIC_PROCESS	221	1.274692	0.028282829	0.48058987	2.08912003	-0.46026397
GO_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION	c5.BP_ GO biological process	15	0.8143155	0.73752016	0.92380863	GO_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION	15	0	0	0	0.8143155	0.8143155
STAMBOLSKY_BOUND_BY_MUTATED_TP53	c2.CGP_ chemical and genetic perturbations	15	0.8142559	0.721875	0.9238226	STAMBOLSKY_BOUND_BY_MUTATED_TP53	16	-1.4233979	0.0875	0.19217128	-0.609142	2.2376538
GO_MAINTENANCE_OF_LOCATION	c5.BP_ GO biological process	129	0.8140232	0.8706468	0.9241547	GO_MAINTENANCE_OF_LOCATION	127	0.84949714	0.80123585	1	1.66352034	-0.03547394
GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP	C7_ immunologic signatures	165	0.81378967	0.8863636	0.92447907	GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP	165	0.9004524	0.73197967	1	1.71424207	-0.08666273
GO_R_SMAD_BINDING	c5.GO molecular function	21	0.8137575	0.73393124	0.92444324	GO_R_SMAD_BINDING	21	-0.8090365	0.7685185	0.89697903	0.004721	1.622794
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP	C7_ immunologic signatures	171	0.8137062	0.88221437	0.9244401	GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP	174	0.6331094	0.9919028	1	1.4468156	0.1805968
MELLMAN_TUT1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	43	0.8136819	0.78757226	0.9243867	MELLMAN_TUT1_TARGETS_DN	43	-1.0958632	0.22047244	0.5238733	-0.2821813	1.9095451
ST_P38_MAPK_PATHWAY	c2.CP_ Canonical pathways	36	0.8135329	0.7521994	0.92455524	ST_P38_MAPK_PATHWAY	36	0.8323427	0.7216981	1	1.6458756	-0.0188098
DARWICHE_PAPILLOMA_PROGRESSION_RISK	c2.CGP_ chemical and genetic perturbations	64	0.8135007	0.80325645	0.92452025	DARWICHE_PAPILLOMA_PROGRESSION_RISK	65	0.7701698	0.85452586	1	1.5836705	0.0433309
CYCLIN_D1_UP.V1_DN	C6_ oncogenic signatures	159	0.81347287	0.875	0.92447346	CYCLIN_D1_UP.V1_DN	169	0.90428436	0.73454916	1	1.71775723	-0.09081149
GO_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND	c5.BP_ GO biological process	43	0.8133922	0.7716312	0.92452735	GO_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND	42	1.1290244	0.29898074	0.7078642	1.9424166	-0.3156322
GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN	C7_ immunologic signatures	144	0.81338704	0.8465228	0.9244411	GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN	153	0.86681616	0.77959186	1	1.6802032	-0.05342912
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	c2.CGP_ chemical and genetic perturbations	97	0.813358	0.8586252	0.9244012	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	98	1.1796697	0.17709439	0.6241536	1.9930277	-0.3663117
GO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	68	0.81325585	0.811749	0.92448705	GO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	68	1.2164618	0.17067833	0.5635508	2.02971765	-0.40320595
WANG_BARRETTS_ESOPHAGUS_DN	c2.CGP_ chemical and genetic perturbations	21	0.8132295	0.7430769	0.9244396	WANG_BARRETTS_ESOPHAGUS_DN	20	-1.2630509	0.1559633	0.312827	-0.4498214	2.0762804
GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN	C7_ immunologic signatures	175	0.81305367	0.87244284	0.9246645	GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN	185	0.75726366	0.93939394	1	1.57031733	0.05579001
GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN	C7_ immunologic signatures	147	0.8130198	0.86552566	0.9246322	GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN	153	1.0193228	0.4489796	0.891731	1.8323426	-0.206303
VANASSE_BCL2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	31	0.8128843	0.7665663	0.9247899	VANASSE_BCL2_TARGETS_UP	32	1.1264906	0.30769232	0.7116913	1.9393749	-0.3136063
TBK1.DN.48HRS_UP	C6_ oncogenic signatures	46	0.81274766	0.7869081	0.9249443	TBK1.DN.48HRS_UP	46	0.5676254	0.9842342	1	1.38037306	0.24512226
GO_LATE_ENDOSOME_MEMBRANE	c5.CC_ GO cellular component	88	0.8126378	0.8435463	0.9250477	GO_LATE_ENDOSOME_MEMBRANE	88	1.0723953	0.35555556	0.80245274	1.8850331	-0.2597575
REACTOME_BIOLOGICAL_OXIDATIONS	c2.CP_REACTOME_ Reactome gene sets	102	0.81257194	0.8486005	0.925069	REACTOME_BIOLOGICAL_OXIDATIONS	104	1.6898074	0	0.08391921	2.50237934	-0.87723546
LIU_COMMON_CANCER_GENES	c2.CGP_ chemical and genetic perturbations	61	0.8124651	0.8115108	0.9251662	LIU_COMMON_CANCER_GENES	62	0.9559426	0.56736034	0.9759753	1.7684077	-0.1434775
GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	108	0.8122605	0.837388	0.9254404	GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP	112	1.1893718	0.15271966	0.6062081	2.0016323	-0.3771113
GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN	C7_ immunologic signatures	174	0.8121941	0.91314554	0.92545825	GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN	173	0.8316382	0.8603239	1	1.6438323	-0.0194441
MORF_ORC1L	c4.CGN_ cancer gene neighborhoods	62	0.81216013	0.81216216	0.92542535	MORF_ORC1L	64	-0.836596	0.8552632	0.87726325	-0.02443587	1.64875613
ROSS_LEUKEMIA_WITH_MLL_FUSIONS	c2.CGP_ chemical and genetic perturbations	71	0.81207067	0.8360882	0.9254877	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	71	0.8533481	0.754329	1	1.66541877	-0.04127743
STEIN_ESR1_TARGETS	c2.CGP_ chemical and genetic perturbations	76	0.81206024	0.82384104	0.92541075	STEIN_ESR1_TARGETS	80	-1.5329953	0	0.12374094	-0.72093506	2.34505554
HINATA_NFKB_TARGETS_KERATINOCYTE_DN	c2.CGP_ chemical and genetic perturbations	20	0.812034	0.72624797	0.9253629	HINATA_NFKB_TARGETS_KERATINOCYTE_DN	21	1.0588969	0.4053367	0.82625484	1.8709309	-0.2468629
GO_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	89	0.81194675	0.8266494	0.92541957	GO_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	88	0.85006016	0.77439666	1	1.66200691	-0.03811341
KEGG_MTOR_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	50	0.81194603	0.7819225	0.92532563	KEGG_MTOR_SIGNALING_PATHWAY	51	0.83196014	0.7586981	1	1.64390617	-0.02001411
GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN	C7_ immunologic signatures	178	0.8117913	0.87914693	0.9255115	GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN	181	1.4048159	0.008080808	0.33280522	2.2166072	-0.5930246
GO_ACROSOMAL_MEMBRANE	c5.CC_ GO cellular component	16	0.8117759	0.73432344	0.9254452	GO_ACROSOMAL_MEMBRANE	19	0.8723441	0.68961036	1	1.68412	-0.0605682
GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN	C7_ immunologic signatures	151	0.81162786	0.8599752	0.9256229	GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN	155	1.1416817	0.17802645	0.6874557	1.95330956	-0.33005384
GO_ENDOCARDIAL_CUSHION_MORPHOGENESIS	c5.BP_ GO biological process	22	0.81160855	0.741433	0.92556006	GO_ENDOCARDIAL_CUSHION_MORPHOGENESIS	22	1.1099677	0.33249685	0.737697	1.92157625	-0.29835915
GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	177	0.8115342	0.8926887	0.9255948	GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN	176	0.8140094	0.879798	1	1.6255436	-0.0024752
GO_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS	c5.BP_ GO biological process	37	0.8115262	0.78814816	0.92551255	GO_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS	38	0.7273736	0.8676123	1	1.5388998	0.0841526
GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	19	0.81151456	0.7576244	0.92543745	GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS	20	1.0934113	0.35376757	0.7683227	1.90492586	-0.28189674
GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP	C7_ immunologic signatures	172	0.8112806	0.88861984	0.9257626	GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP	177	1.349751	0.008064516	0.38302937	2.1610316	-0.5384704
GO_POSITIVE_REGULATION_OF_HORMONE_SECRETION	c5.BP_ GO biological process	90	0.81123906	0.82157123	0.9257398	GO_POSITIVE_REGULATION_OF_HORMONE_SECRETION	104	0.9154288	0.656701	1	1.72666786	-0.10418974
GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN	C7_ immunologic signatures	179	0.81118125	0.8851894	0.9257499	GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN	180	0.9591426	0.6006067	0.9713375	1.77032385	-0.14796135
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	c2.CGP_ chemical and genetic perturbations	61	0.81115603	0.80779946	0.92569876	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	64	1.0626258	0.38931298	0.81834304	1.87378183	-0.25146977
GO_CLATHRIN_COATED_VESICLE	c5.CC_ GO cellular component	136	0.8108714	0.8760736	0.9261008	GO_CLATHRIN_COATED_VESICLE	141	0.95704	0.5798146	0.9746784	1.7679114	-0.1461686
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR	c5.GO molecular function	16	0.81083035	0.7395498	0.9260765	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR	16	-1.0547912	0.37130803	0.59612405	-0.24396085	1.86562155
GO_RAC_GTPASE_BINDING	c5.GO molecular function	37	0.81067747	0.77951634	0.92624706	GO_RAC_GTPASE_BINDING	38	1.0811231	0.36489606	0.78548974	1.89180057	-0.27044563
RACCACAR_AML_Q6	c3.TFT_ transcription factor targets	221	0.8106271	0.9072165	0.9262405	RACCACAR_AML_Q6	230	0.92345583	0.71142286	1	1.73408293	-0.11282873
GO_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS	c5.GO molecular function	21	0.8106153	0.7424961	0.9261683	GO_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS	22	0.6736061	0.8893035	1	1.4842214	0.1370092
GO_METANEPHRIC_EPITHELIUM_DEVELOPMENT	c5.BP_ GO biological process	16	0.81039125	0.7208589	0.9264671	GO_METANEPHRIC_EPITHELIUM_DEVELOPMENT	19	-0.7539026	0.8465116	0.9367638	0.05648865	1.56429385
CCTGTGA_MIR513	c3.MIR_ microRNA targets	111	0.8100939	0.84263957	0.92687863	CCTGTGA_MIR513	114	1.0047114	0.49126413	0.91584504	1.8148053	-0.1946175
BRUECKNER_TARGETS_OF_MIRLET7A3_UP	c2.CGP_ chemical and genetic perturbations	97	0.81008065	0.8487614	0.9268044	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	98	1.4008554	0.01371308	0.3387193	2.21093605	-0.59077475
MORF_CTSB	c4.CGN_ cancer gene neighborhoods	142	0.81006074	0.86683106	0.9267448	MORF_CTSB	150	1.2101902	0.100712106	0.57585645	2.02025094	-0.40012946
GO_ANION_CHANNEL_ACTIVITY	c5.GO molecular function	74	0.8099728	0.8221925	0.9267999	GO_ANION_CHANNEL_ACTIVITY	85	0.97762936	0.52709883	0.9519973	1.78760216	-0.16765656
CHR16Q13	C1: positional gene sets	27	0.80989945	0.74846625	0.9268353	CHR16Q13	29	1.1794313	0.25214198	0.6243497	1.98933075	-0.36953185
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	c2.CP_BIOCARTA_ BioCarta gene sets	40	0.8098352	0.77286136	0.9268507	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	42	0.7663115	0.8235294	1	1.5761467	0.0435237
CHR10P13	C1: positional gene sets	24	0.80980235	0.75834656	0.9268158	CHR10P13	25	-1.6318543	0.005208334	0.07926035	-0.82205195	2.44165665
BAKER_HEMATOPOIESIS_STAT3_TARGETS	c2.CGP_ chemical and genetic perturbations	16	0.8095856	0.7131661	0.9270967	BAKER_HEMATOPOIESIS_STAT3_TARGETS	16	1.1048406	0.34961438	0.74761987	1.9144262	-0.295255
TCANNTGAY_SREBP1_01	c3.TFT_ transcription factor targets	417	0.80939656	0.9510117	0.92733526	TCANNTGAY_SREBP1_01	431	0.97957736	0.576	0.95032847	1.78897392	-0.1701808
GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP	C7_ immunologic signatures	144	0.80934656	0.8834721	0.92732656	GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP	148	1.1472235	0.18321392	0.6735241	1.95657006	-0.33787694
VERNELL_RETINOBLASTOMA_PATHWAY_DN	c2.CGP_ chemical and genetic perturbations	19	0.8092185	0.7386364	0.92744976	VERNELL_RETINOBLASTOMA_PATHWAY_DN	19	1.1228983	0.2951654	0.7203458	1.9321168	-0.3136798
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN	C7_ immunologic signatures	168	0.8090247	0.8710434	0.92769414	GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN	169	1.0472777	0.38321537	0.8447003	1.8563024	-0.238253
CTACTGT_MIR199A	c3.MIR_ microRNA targets	166	0.8089206	0.89097303	0.92778355	CTACTGT_MIR199A	171	0.6489781	0.99086297	1	1.4578987	0.1599425
GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN	C7_ immunologic signatures	182	0.8086263	0.89097303	0.9281996	GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN	182	-0.9557908	0.6363636	0.74775666	-0.1471645	1.7644171
GO_TERMINAL_BOUTON	c5.CC_ GO cellular component	56	0.8084933	0.80111265	0.92833537	GO_TERMINAL_BOUTON	63	1.3444176	0.05875952	0.3900989	2.1529109	-0.5359243
DALESSIO_TSA_RESPONSE	c2.CGP_ chemical and genetic perturbations	21	0.8082774	0.7380952	0.9286217	DALESSIO_TSA_RESPONSE	22	1.29368	0.12376238	0.4523067	2.1019574	-0.4854026
GSE27786_LSK_VS_CD4_TCELL_DN	C7_ immunologic signatures	169	0.8082354	0.89320385	0.92859745	GSE27786_LSK_VS_CD4_TCELL_DN	176	1.1346424	0.21095334	0.6980387	1.9428778	-0.326407
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN	C7_ immunologic signatures	95	0.80809754	0.847769	0.92873996	GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN	109	1.6553923	0	0.110844664	2.46348984	-0.84729476
GO_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE	c5.BP_ GO biological process	17	0.8080575	0.7568	0.9287156	GO_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE	18	1.1985054	0.22908624	0.59557414	2.0065629	-0.3904479
MCCLUNG_DELTA_FOSB_TARGETS_8WK	c2.CGP_ chemical and genetic perturbations	46	0.8079622	0.7942857	0.9287868	MCCLUNG_DELTA_FOSB_TARGETS_8WK	46	0.97555476	0.5257143	0.9555219	1.78351696	-0.16759256
GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN	C7_ immunologic signatures	169	0.8079304	0.8920863	0.928747	GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN	170	0.702336	0.9675456	1	1.5102664	0.1055944
GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	157	0.8078349	0.89975846	0.9288197	GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP	157	1.1278553	0.21252567	0.709033	1.9356902	-0.3200204
GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	C7_ immunologic signatures	178	0.8078052	0.89605737	0.9287778	GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	179	0.76691806	0.93819654	1	1.57472326	0.04088714
GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_UP	C7_ immunologic signatures	174	0.8077443	0.90150636	0.9287852	GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_UP	173	0.7289451	0.95329946	1	1.5366894	0.0787992
GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	C7_ immunologic signatures	139	0.8076575	0.88723665	0.92883325	GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	146	0.8645552	0.76796716	1	1.6722127	-0.0568977
GATA1_01	c3.TFT_ transcription factor targets	213	0.8073457	0.9074941	0.9292853	GATA1_01	220	-0.9764547	0.41666666	0.7191224	-0.169109	1.7838004
IKEDA_MIR30_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	26	0.8073449	0.74849397	0.9291904	IKEDA_MIR30_TARGETS_DN	26	0.7962491	0.77553594	1	1.603594	0.0110958
GO_VIRUS_RECEPTOR_ACTIVITY	c5.GO molecular function	60	0.807311	0.8068493	0.92915004	GO_VIRUS_RECEPTOR_ACTIVITY	62	-0.94657135	0.5813953	0.76040286	-0.13926035	1.75388235
GO_TETRAPYRROLE_BINDING	c5.GO molecular function	97	0.80714667	0.844473	0.92933184	GO_TETRAPYRROLE_BINDING	104	1.5410501	0.001049318	0.21041682	2.34819677	-0.73390343
GO_REGULATION_OF_B_CELL_PROLIFERATION	c5.BP_ GO biological process	45	0.8070901	0.8079179	0.92933375	GO_REGULATION_OF_B_CELL_PROLIFERATION	52	1.2354445	0.14666666	0.53270435	2.0425346	-0.4283544
GO_ADRENAL_GLAND_DEVELOPMENT	c5.BP_ GO biological process	20	0.8068188	0.74299836	0.9297127	GO_ADRENAL_GLAND_DEVELOPMENT	22	0.61931854	0.94199246	1	1.42613734	0.18750026
GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP	C7_ immunologic signatures	170	0.80654156	0.9017544	0.9301005	GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP	179	1.2020437	0.09118541	0.58852226	2.00858526	-0.39550214
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP	C7_ immunologic signatures	161	0.80643016	0.8903614	0.9301883	GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP	164	1.131739	0.21916412	0.70353615	1.93816916	-0.32530884
GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP	C7_ immunologic signatures	179	0.80638134	0.9015421	0.9301709	GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP	183	1.3559029	0.00810537	0.38086554	2.16228424	-0.54952156
GSE27786_NKCELL_VS_NKTCELL_DN	C7_ immunologic signatures	174	0.8059334	0.8954704	0.9308504	GSE27786_NKCELL_VS_NKTCELL_DN	181	0.99933	0.50506073	0.9247507	1.8052634	-0.1933966
GSE14000_UNSTIM_VS_4H_LPS_DC_UP	C7_ immunologic signatures	167	0.80582273	0.885514	0.93094325	GSE14000_UNSTIM_VS_4H_LPS_DC_UP	167	-0.9337926	0.71428573	0.7788824	-0.12796987	1.73961533
WALLACE_PROSTATE_CANCER_RACE_DN	c2.CGP_ chemical and genetic perturbations	66	0.8057315	0.8187919	0.93100643	WALLACE_PROSTATE_CANCER_RACE_DN	69	0.8427413	0.77022654	1	1.6484728	-0.0370098
GSE3982_DC_VS_TH1_UP	C7_ immunologic signatures	166	0.8056141	0.8807556	0.9311132	GSE3982_DC_VS_TH1_UP	171	1.1862979	0.12386707	0.61317563	1.991912	-0.3806838
WATANABE_COLON_CANCER_MSI_VS_MSS_DN	c2.CGP_ chemical and genetic perturbations	59	0.80561256	0.8	0.9310205	WATANABE_COLON_CANCER_MSI_VS_MSS_DN	70	1.3707845	0.035164837	0.3668171	2.17639706	-0.56517194
BIOCARTA_AKT_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	19	0.8051837	0.71359223	0.93167174	BIOCARTA_AKT_PATHWAY	21	-0.819281	0.7804878	0.8902062	-0.0140973	1.6244647
CHR3Q25	C1: positional gene sets	41	0.8049928	0.7983075	0.9319019	CHR3Q25	42	-1.1682606	0.16239317	0.41872752	-0.3632678	1.9732534
GENTILE_UV_RESPONSE_CLUSTER_D2	c2.CGP_ chemical and genetic perturbations	40	0.8048145	0.8011364	0.9321076	GENTILE_UV_RESPONSE_CLUSTER_D2	40	-1.4553343	0.013793103	0.16997764	-0.6505198	2.2601488
GO_REGULATION_OF_VASCULAR_PERMEABILITY	c5.BP_ GO biological process	28	0.8046798	0.75829387	0.9322429	GO_REGULATION_OF_VASCULAR_PERMEABILITY	29	1.2756499	0.14060606	0.47965622	2.0803297	-0.4709701
GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	C7_ immunologic signatures	178	0.8045864	0.8977408	0.9323071	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	180	1.2116526	0.0840081	0.5750029	2.016239	-0.4070662
GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	C7_ immunologic signatures	166	0.8045782	0.89548695	0.93222594	GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	170	0.93299913	0.66161615	0.9972571	1.73757733	-0.12842093
GO_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	34	0.8045426	0.7674074	0.9321947	GO_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY	35	1.2200283	0.20500596	0.5554188	2.0245709	-0.4154857
GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN	C7_ immunologic signatures	174	0.80452746	0.89917934	0.9321264	GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN	176	-0.8144847	0.9285714	0.89311266	-0.00995724	1.61901216
MODULE_331	c4.CM_ cancer modules	67	0.8044782	0.83597887	0.9321168	MODULE_331	67	0.66960126	0.95185995	1	1.47407946	0.13487694
GO_REGULATION_OF_MITOCHONDRIAL_FISSION	c5.BP_ GO biological process	15	0.8044241	0.73572594	0.9321106	GO_REGULATION_OF_MITOCHONDRIAL_FISSION	15	1.1879907	0.24661246	0.6088765	1.9924148	-0.3835666
BROWN_MYELOID_CELL_DEVELOPMENT_UP	c2.CGP_ chemical and genetic perturbations	136	0.8042777	0.89375	0.93226904	BROWN_MYELOID_CELL_DEVELOPMENT_UP	138	1.2009768	0.12295082	0.59045756	2.0052545	-0.3966991
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	21	0.80427545	0.7420382	0.93217695	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	22	1.1003575	0.3548387	0.7566695	1.90463295	-0.29608205
GSE557_WT_VS_I_AB_KO_DC_UP	C7_ immunologic signatures	174	0.80412775	0.91240877	0.9323224	GSE557_WT_VS_I_AB_KO_DC_UP	177	1.1899309	0.12867275	0.6051144	1.99405865	-0.38580315
GSE17721_LPS_VS_POLYIC_8H_BMDC_DN	C7_ immunologic signatures	176	0.803936	0.9	0.93255544	GSE17721_LPS_VS_POLYIC_8H_BMDC_DN	177	0.70136666	0.97461927	1	1.50530266	0.10256934
GO_ION_GATED_CHANNEL_ACTIVITY	c5.GO molecular function	37	0.8037535	0.7708333	0.93276304	GO_ION_GATED_CHANNEL_ACTIVITY	40	1.3560935	0.07479862	0.38080004	2.159847	-0.55234
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	c2.CGP_ chemical and genetic perturbations	16	0.8036373	0.75911254	0.9328707	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	17	0.78219384	0.76578945	1	1.58583114	0.02144346
GO_TRANSFERASE_ACTIVITY_TRANSFERRING_PENTOSYL_GROUPS	c5.GO molecular function	48	0.8034699	0.8313783	0.93305916	GO_TRANSFERASE_ACTIVITY_TRANSFERRING_PENTOSYL_GROUPS	49	0.895381	0.6495434	1	1.6988509	-0.0919111
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP	C7_ immunologic signatures	144	0.80338323	0.8931677	0.93310666	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP	148	0.89392126	0.73748726	1	1.69730449	-0.09053803
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN	c2.CGP_ chemical and genetic perturbations	15	0.80336356	0.7471637	0.9330443	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN	15	0	0	0	0.80336356	0.80336356
AIYAR_COBRA1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	27	0.80322754	0.7846154	0.93318	AIYAR_COBRA1_TARGETS_DN	28	-1.425791	0.02793296	0.19128937	-0.62256346	2.22901854
BILANGES_SERUM_SENSITIVE_VIA_TSC1	c2.CGP_ chemical and genetic perturbations	18	0.80318415	0.74763405	0.9331591	BILANGES_SERUM_SENSITIVE_VIA_TSC1	21	-0.82479626	0.7397959	0.88619703	-0.02161211	1.62798041
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	c2.CGP_ chemical and genetic perturbations	160	0.80303144	0.89903843	0.9333157	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	164	0.58635503	0.9979757	1	1.38938647	0.21667641
GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	146	0.80303144	0.8888889	0.9332198	GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	151	1.1322634	0.22413793	0.70259076	1.93529484	-0.32923196
GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP	C7_ immunologic signatures	157	0.8027164	0.89045936	0.93366605	GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP	160	1.0946877	0.28730965	0.7653094	1.8974041	-0.2919713
GO_TRANS_GOLGI_NETWORK_MEMBRANE	c5.CC_ GO cellular component	67	0.80271053	0.8388889	0.9335801	GO_TRANS_GOLGI_NETWORK_MEMBRANE	68	0.78847915	0.83457845	1	1.59118968	0.01423138
GO_RUFFLE_MEMBRANE	c5.CC_ GO cellular component	73	0.8024945	0.8380567	0.93385726	GO_RUFFLE_MEMBRANE	74	1.0808746	0.33836207	0.7858427	1.8833691	-0.2783801
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	c2.CGP_ chemical and genetic perturbations	30	0.80244976	0.771261	0.93383765	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	30	-1.7977782	0	0.03327629	-0.99532844	2.60022796
GO_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY	c5.BP_ GO biological process	21	0.80214906	0.7483871	0.9342634	GO_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY	26	0.93283886	0.57228917	0.9973588	1.73498792	-0.1306898
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP	C7_ immunologic signatures	170	0.80209297	0.8860606	0.934262	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP	183	0.6953362	0.9819277	1	1.49742917	0.10675677
GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP	C7_ immunologic signatures	168	0.8020676	0.8948598	0.93420815	GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP	168	0.5497329	1	1	1.3518005	0.2523347
GO_MODULATION_BY_HOST_OF_VIRAL_PROCESS	c5.BP_ GO biological process	15	0.80202717	0.7399679	0.93418026	GO_MODULATION_BY_HOST_OF_VIRAL_PROCESS	15	0.8811517	0.6331522	1	1.68317887	-0.07912453
GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP	C7_ immunologic signatures	171	0.8019634	0.90834314	0.93418497	GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP	176	0.9929456	0.5267407	0.93191797	1.794909	-0.1909822
GO_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	17	0.80191636	0.7527559	0.9341659	GO_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT	17	-1.3487138	0.072961375	0.24293736	-0.54679744	2.15063016
GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	166	0.8018754	0.9074519	0.9341422	GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN	181	1.2101126	0.09090909	0.57601327	2.011988	-0.4082372
GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	157	0.80176026	0.8856799	0.93423384	GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	164	0.781389	0.91472083	1	1.58314926	0.02037126
WONG_PROTEASOME_GENE_MODULE	c2.CGP_ chemical and genetic perturbations	48	0.801703	0.7994269	0.9342387	WONG_PROTEASOME_GENE_MODULE	48	-1.3916438	0.01904762	0.21416555	-0.5899408	2.1933468
WHITFIELD_CELL_CYCLE_M_G1	c2.CGP_ chemical and genetic perturbations	129	0.8016966	0.87531173	0.93415374	WHITFIELD_CELL_CYCLE_M_G1	130	-0.9989487	0.4375	0.6869518	-0.1972521	1.8006453
PAX3_01	c3.TFT_ transcription factor targets	19	0.801664	0.75236595	0.9341127	PAX3_01	19	-0.85221636	0.7070707	0.8642552	-0.05055236	1.65388036
GO_PATTERNING_OF_BLOOD_VESSELS	c5.BP_ GO biological process	28	0.8016471	0.7890625	0.9340404	GO_PATTERNING_OF_BLOOD_VESSELS	29	0.95650536	0.5587879	0.9750137	1.75815246	-0.15485826
GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP	C7_ immunologic signatures	155	0.8014391	0.9	0.9342986	GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP	158	1.1408882	0.1989899	0.68891776	1.9423273	-0.3394491
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	c2.CGP_ chemical and genetic perturbations	51	0.8013694	0.8038943	0.9343174	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	51	0.76403606	0.84538376	1	1.56540546	0.03733334
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	65	0.80131227	0.8266494	0.9343228	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	70	1.1967156	0.19068256	0.5967909	1.99802787	-0.39540333
GO_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION	c5.BP_ GO biological process	34	0.8011943	0.79883385	0.934419	GO_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION	35	0.59732074	0.96195006	1	1.39851504	0.20387356
GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP	C7_ immunologic signatures	182	0.8009917	0.91734576	0.934657	GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP	189	0.8288145	0.8646465	1	1.6298062	-0.0278228
GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	C7_ immunologic signatures	176	0.8009542	0.89424205	0.9346233	GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	181	0.84994507	0.84615386	1	1.65089927	-0.04899087
GO_TRANSCRIPTIONAL_REPRESSOR_COMPLEX	c5.CC_ GO cellular component	70	0.8007673	0.83879423	0.93483984	GO_TRANSCRIPTIONAL_REPRESSOR_COMPLEX	70	-1.1134824	0.22340426	0.50020415	-0.3127151	1.9142497
GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP	C7_ immunologic signatures	159	0.80062485	0.8892774	0.93498063	GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP	160	-0.866112	0.8235294	0.85604084	-0.06548715	1.66673685
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP	C7_ immunologic signatures	138	0.8005337	0.88929003	0.9350327	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP	141	1.0519961	0.37270877	0.8369948	1.8525298	-0.2514624
GSE3982_DC_VS_BASOPHIL_DN	C7_ immunologic signatures	168	0.800403	0.8911483	0.93514526	GSE3982_DC_VS_BASOPHIL_DN	169	0.7653014	0.92260695	1	1.5657044	0.0351016
GO_VIRAL_GENOME_REPLICATION	c5.BP_ GO biological process	17	0.8003927	0.7234042	0.9350674	GO_VIRAL_GENOME_REPLICATION	16	-0.8739327	0.6270492	0.850334	-0.07354	1.6743254
GNF2_ITGB2	c4.CGN_ cancer gene neighborhoods	48	0.80028933	0.8148148	0.93514454	GNF2_ITGB2	49	0.977588	0.51839465	0.9518735	1.77787733	-0.17729867
GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP	C7_ immunologic signatures	176	0.80026174	0.91278374	0.93509656	GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP	179	1.0928193	0.2851365	0.7681907	1.89308104	-0.29255756
GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP	C7_ immunologic signatures	162	0.80011874	0.90082645	0.935247	GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP	167	1.0967554	0.27558258	0.7612889	1.89687414	-0.29663666
BEIER_GLIOMA_STEM_CELL_DN	c2.CGP_ chemical and genetic perturbations	54	0.8000814	0.828816	0.9352158	BEIER_GLIOMA_STEM_CELL_DN	56	1.3891907	0.04480874	0.34633055	2.1892721	-0.5891093
GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	C7_ immunologic signatures	176	0.79993004	0.903423	0.93537354	GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	177	-1.1019098	0.16666667	0.5135231	-0.30197976	1.90183984
ANDERSEN_CHOLANGIOCARCINOMA_CLASS1	c2.CGP_ chemical and genetic perturbations	51	0.79992276	0.824417	0.93528986	ANDERSEN_CHOLANGIOCARCINOMA_CLASS1	52	1.3643867	0.057174888	0.37272426	2.16430946	-0.56446394
GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN	C7_ immunologic signatures	177	0.79986346	0.90527576	0.9352946	GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN	180	0.6242836	0.99389625	1	1.42414706	0.17557986
GO_GOLGI_CISTERNA	c5.CC_ GO cellular component	83	0.7998329	0.8413333	0.9352538	GO_GOLGI_CISTERNA	84	0.91900617	0.6390658	1	1.71883907	-0.11917327
ROESSLER_LIVER_CANCER_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	43	0.7996188	0.81120944	0.935503	ROESSLER_LIVER_CANCER_METASTASIS_DN	43	0.78937066	0.79157174	1	1.58898946	0.01024814
DARWICHE_SKIN_TUMOR_PROMOTER_DN	c2.CGP_ chemical and genetic perturbations	149	0.79960436	0.8864469	0.93543166	DARWICHE_SKIN_TUMOR_PROMOTER_DN	155	0.9862836	0.5325866	0.94020116	1.78588796	-0.18667924
BROWNE_HCMV_INFECTION_4HR_DN	c2.CGP_ chemical and genetic perturbations	221	0.7993663	0.9212329	0.93573004	BROWNE_HCMV_INFECTION_4HR_DN	229	0.80286425	0.9204431	1	1.60223055	-0.00349795
GO_CELLULAR_GLUCOSE_HOMEOSTASIS	c5.BP_ GO biological process	64	0.7993599	0.8361955	0.93564606	GO_CELLULAR_GLUCOSE_HOMEOSTASIS	69	1.2106712	0.17627856	0.5760844	2.0100311	-0.4113113
GO_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	27	0.7991527	0.7621861	0.9358959	GO_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	27	1.0273335	0.44759557	0.8805758	1.8264862	-0.2281808
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	c2.CGP_ chemical and genetic perturbations	25	0.79890245	0.779661	0.9362096	WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	25	0.7112386	0.8569682	1	1.51014105	0.08766385
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	c2.CGP_ chemical and genetic perturbations	57	0.7987518	0.8394366	0.93637115	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	59	1.0934552	0.3248337	0.76828	1.892207	-0.2947034
CROMER_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	70	0.79861534	0.8518024	0.9365062	CROMER_METASTASIS_UP	70	0.7651359	0.85714287	1	1.56375124	0.03347944
GO_T_CELL_DIFFERENTIATION	c5.BP_ GO biological process	110	0.7986074	0.8686131	0.9364236	GO_T_CELL_DIFFERENTIATION	118	0.94890034	0.62408376	0.983458	1.74750774	-0.15029294
GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	C7_ immunologic signatures	167	0.79833764	0.9078341	0.93677014	GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	174	1.0172114	0.46868688	0.8938639	1.81554904	-0.21887376
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP	C7_ immunologic signatures	166	0.79829895	0.9160671	0.9367345	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP	178	0.9650324	0.5995976	0.9653108	1.76333135	-0.16673345
WOO_LIVER_CANCER_RECURRENCE_DN	c2.CGP_ chemical and genetic perturbations	66	0.79823714	0.832664	0.9367434	WOO_LIVER_CANCER_RECURRENCE_DN	73	1.361623	0.029032258	0.37596044	2.15986014	-0.56338586
GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN	C7_ immunologic signatures	181	0.7980794	0.9198565	0.93691057	GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN	186	-0.95835274	0.6875	0.74423033	-0.16027334	1.75643214
GO_DOPAMINE_RECEPTOR_BINDING	c5.GO molecular function	15	0.7979998	0.75490195	0.9369435	GO_DOPAMINE_RECEPTOR_BINDING	17	0.7275181	0.84237075	1	1.5255179	0.0704817
GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP	C7_ immunologic signatures	176	0.79791147	0.89429927	0.93699193	GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP	177	0.84712404	0.83282363	1	1.64503551	-0.04921257
GO_PROTEIN_STABILIZATION	c5.BP_ GO biological process	116	0.79787	0.8919598	0.9369663	GO_PROTEIN_STABILIZATION	119	0.584073	0.9989637	1	1.381943	0.213797
GO_BASE_EXCISION_REPAIR	c5.BP_ GO biological process	38	0.797506	0.7835498	0.9374563	GO_BASE_EXCISION_REPAIR	38	-1.3523289	0.047945205	0.24098472	-0.5548229	2.1498349
GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	184	0.79744893	0.9064748	0.93745244	GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN	182	1.0877383	0.2848423	0.77397776	1.88518723	-0.29028937
GO_SH3_DOMAIN_BINDING	c5.GO molecular function	109	0.79738414	0.87580025	0.937464	GO_SH3_DOMAIN_BINDING	111	1.2703128	0.071428575	0.48440093	2.06769694	-0.47292866
GO_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	153	0.79727274	0.9042424	0.9375572	GO_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY	154	0.9162053	0.70951414	1	1.71347804	-0.11893256
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN	C7_ immunologic signatures	170	0.7972625	0.9093079	0.9374798	GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN	180	1.0886804	0.28700906	0.77310556	1.8859429	-0.2914179
GO_POLYOL_CATABOLIC_PROCESS	c5.BP_ GO biological process	15	0.7971814	0.736	0.9375122	GO_POLYOL_CATABOLIC_PROCESS	17	0.8075401	0.74869794	1	1.6047215	-0.0103587
GTCAACC_MIR3805P	c3.MIR_ microRNA targets	17	0.7971368	0.7564935	0.9374954	GTCAACC_MIR3805P	18	1.1095217	0.3680203	0.7379967	1.9066585	-0.3123849
MODULE_325	c4.CM_ cancer modules	49	0.7970624	0.8216833	0.93752354	MODULE_325	49	1.071097	0.37992832	0.803106	1.8681594	-0.2740346
GO_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY	c5.BP_ GO biological process	31	0.797045	0.7710487	0.93745697	GO_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY	33	0.7043733	0.89069766	1	1.5014183	0.0926717
GO_DNA_N_GLYCOSYLASE_ACTIVITY	c5.GO molecular function	15	0.7969117	0.74433655	0.93757164	GO_DNA_N_GLYCOSYLASE_ACTIVITY	15	-1.2098173	0.21132076	0.36800665	-0.4129056	2.006729
REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	c2.CP_REACTOME_ Reactome gene sets	75	0.7968888	0.83648646	0.9375134	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	83	1.066706	0.36893204	0.81163454	1.8635948	-0.2698172
GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	155	0.7968132	0.9133089	0.9375394	GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN	166	0.84764415	0.8171717	1	1.64445735	-0.05083095
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	c2.CGP_ chemical and genetic perturbations	16	0.7965987	0.78434503	0.93778795	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	16	1.2712617	0.16601816	0.48345247	2.0678604	-0.474663
GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN	C7_ immunologic signatures	172	0.7965973	0.9270335	0.93769515	GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN	174	1.2533014	0.047474746	0.5044962	2.0498987	-0.4567041
MORF_IKBKG	c4.CGN_ cancer gene neighborhoods	124	0.79655874	0.89302886	0.93765885	MORF_IKBKG	125	0.7525536	0.9064748	1	1.54911234	0.04400514
KEGG_CHEMOKINE_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	147	0.7964381	0.8907767	0.93776196	KEGG_CHEMOKINE_SIGNALING_PATHWAY	156	0.91216916	0.69300914	1	1.70860726	-0.11573106
GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	105	0.7962627	0.8657289	0.937947	GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP	108	1.1193427	0.25467774	0.724074	1.9156054	-0.32308
GO_ORGANIC_HYDROXY_COMPOUND_TRANSPORT	c5.BP_ GO biological process	130	0.7959348	0.8948686	0.93838507	GO_ORGANIC_HYDROXY_COMPOUND_TRANSPORT	137	1.0361987	0.4094166	0.86582786	1.8321335	-0.2402639
BIOCARTA_IL2_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	0.7957938	0.7727975	0.93851435	BIOCARTA_IL2_PATHWAY	22	0.8600707	0.64734894	1	1.6558645	-0.0642769
PID_CDC42_REG_PATHWAY	c2.CP_ Canonical pathways	28	0.7955226	0.7706422	0.93884957	PID_CDC42_REG_PATHWAY	28	1.3909364	0.054413542	0.34686205	2.186459	-0.5954138
GO_PROTEIN_KINASE_COMPLEX	c5.CC_ GO cellular component	85	0.7952211	0.8582575	0.9392321	GO_PROTEIN_KINASE_COMPLEX	85	0.9158084	0.64338624	1	1.7110295	-0.1205873
KEGG_GLIOMA	c2.CP_BIOCARTA_ BioCarta gene sets	60	0.7949764	0.8221906	0.9395305	KEGG_GLIOMA	60	1.4904385	0.009771987	0.2593414	2.2854149	-0.6954621
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	c2.CGP_ chemical and genetic perturbations	32	0.79497325	0.76820207	0.93943995	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	32	-0.83190185	0.77070063	0.8809776	-0.0369286	1.6268751
GO_REGULATION_OF_RESPONSE_TO_INTERFERON_GAMMA	c5.BP_ GO biological process	21	0.7946229	0.7678301	0.93991077	GO_REGULATION_OF_RESPONSE_TO_INTERFERON_GAMMA	21	0.54683936	0.978882	1	1.34146226	0.24778354
REACTOME_IL_RECEPTOR_SHC_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	25	0.7944917	0.78193146	0.94003475	REACTOME_IL_RECEPTOR_SHC_SIGNALING	25	1.1928153	0.22885571	0.6002152	1.987307	-0.3983236
GO_ECTODERM_DEVELOPMENT	c5.BP_ GO biological process	20	0.79440767	0.7543036	0.9400715	GO_ECTODERM_DEVELOPMENT	20	-1.0304508	0.4185022	0.6393463	-0.23604313	1.82485847
GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	128	0.7941518	0.889029	0.94038445	GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN	129	0.9211393	0.6701031	1	1.7152911	-0.1269875
GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN	C7_ immunologic signatures	170	0.79409224	0.90700483	0.94038	GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN	177	1.2025594	0.08713272	0.5881331	1.99665164	-0.40846716
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN	C7_ immunologic signatures	165	0.7940321	0.90843374	0.94037753	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN	167	-1.2679408	0	0.30913976	-0.4739087	2.0619729
GO_CHLORIDE_TRANSPORT	c5.BP_ GO biological process	84	0.7937551	0.85224277	0.940727	GO_CHLORIDE_TRANSPORT	95	1.0913985	0.31751055	0.7701582	1.8851536	-0.2976434
BIOCARTA_TCR_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	41	0.7935423	0.806735	0.9409661	BIOCARTA_TCR_PATHWAY	43	1.377608	0.04457143	0.35717636	2.1711503	-0.5840657
SUMI_HNF4A_TARGETS	c2.CGP_ chemical and genetic perturbations	23	0.7934992	0.78431374	0.94093865	SUMI_HNF4A_TARGETS	26	1.2664576	0.17761557	0.48904338	2.0599568	-0.4729584
GSE17721_4_VS_24H_CPG_BMDC_DN	C7_ immunologic signatures	180	0.7934728	0.9165673	0.9408891	GSE17721_4_VS_24H_CPG_BMDC_DN	178	0.82603633	0.8577236	1	1.61950913	-0.03256353
GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP	C7_ immunologic signatures	173	0.793455	0.92627823	0.9408238	GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP	173	0.62352353	0.99075973	1	1.41697853	0.16993147
GO_HETEROCHROMATIN	c5.CC_ GO cellular component	61	0.7932823	0.8335553	0.9410043	GO_HETEROCHROMATIN	62	-1.3806392	0.05	0.219397	-0.5873569	2.1739215
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	C7_ immunologic signatures	174	0.7931808	0.9182692	0.94106907	GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	179	0.7698478	0.91700405	1	1.5630286	0.023333
GO_SNAP_RECEPTOR_ACTIVITY	c5.GO molecular function	35	0.7931804	0.8005997	0.9409736	GO_SNAP_RECEPTOR_ACTIVITY	35	0.9170648	0.6390187	1	1.7102452	-0.1238844
GO_TRANSCRIPTION_FACTOR_COMPLEX	c5.CC_ GO cellular component	270	0.79317886	0.9297052	0.9408799	GO_TRANSCRIPTION_FACTOR_COMPLEX	284	0.8951596	0.7937938	1	1.68833846	-0.10198074
GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP	C7_ immunologic signatures	176	0.79312307	0.9238095	0.94087684	GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP	177	0.7325463	0.95854396	1	1.52566937	0.06057677
MODULE_366	c4.CM_ cancer modules	31	0.79306	0.7917282	0.9408822	MODULE_366	31	1.1892134	0.2169697	0.6061718	1.9822734	-0.3961534
MAF_Q6	c3.TFT_ transcription factor targets	230	0.7930264	0.9357061	0.9408387	MAF_Q6	236	0.8497725	0.85584676	1	1.6427989	-0.0567461
CTAGGAA_MIR384	c3.MIR_ microRNA targets	59	0.7929671	0.83168316	0.94083923	CTAGGAA_MIR384	60	0.82411766	0.76169264	1	1.61708476	-0.03115056
CACGTTT_MIR302A	c3.MIR_ microRNA targets	28	0.79266685	0.8033033	0.94120324	CACGTTT_MIR302A	29	-1.1040001	0.2822086	0.51112634	-0.31133325	1.89666695
GO_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY	c5.BP_ GO biological process	19	0.79225856	0.79153097	0.94175744	GO_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY	19	0.7726847	0.78463477	1	1.56494326	0.01957386
GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP	C7_ immunologic signatures	168	0.792199	0.9002375	0.9417531	GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP	170	1.0867919	0.28672746	0.77533776	1.8789909	-0.2945929
GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	C7_ immunologic signatures	154	0.7921332	0.8996328	0.9417625	GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	158	0.63210726	0.9928789	1	1.42424046	0.16002594
GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP	C7_ immunologic signatures	178	0.7920786	0.9380316	0.94175166	GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP	182	0.8255817	0.85482234	1	1.6176603	-0.0335031
GO_POSITIVE_REGULATION_OF_GLIOGENESIS	c5.BP_ GO biological process	43	0.79192185	0.81065917	0.94189924	GO_POSITIVE_REGULATION_OF_GLIOGENESIS	46	1.1260581	0.29820627	0.712252	1.91797995	-0.33413625
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP	C7_ immunologic signatures	147	0.79147375	0.9129902	0.9425157	GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP	156	-0.9071041	0.73913044	0.8141347	-0.11563035	1.69857785
GO_ENDOTHELIAL_CELL_DEVELOPMENT	c5.BP_ GO biological process	41	0.79142916	0.80143887	0.9424848	GO_ENDOTHELIAL_CELL_DEVELOPMENT	41	0.72906667	0.86285716	1	1.52049583	0.06236249
GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN	C7_ immunologic signatures	177	0.7911247	0.920522	0.9428647	GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN	179	0.7613266	0.9329949	1	1.5524513	0.0297981
GO_DEVELOPMENTAL_PIGMENTATION	c5.BP_ GO biological process	31	0.7911186	0.78700906	0.94277656	GO_DEVELOPMENTAL_PIGMENTATION	34	-1.3760355	0.05732484	0.22355919	-0.5849169	2.1671541
KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN	C7_ immunologic signatures	168	0.79109627	0.92261183	0.942716	KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN	172	1.2445606	0.060851928	0.51952416	2.03565687	-0.45346433
GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN	C7_ immunologic signatures	105	0.7910754	0.8745198	0.9426535	GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN	121	0.87470776	0.7610711	1	1.66578316	-0.08363236
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN	C7_ immunologic signatures	186	0.79107463	0.9271445	0.94255924	GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN	184	0.7299346	0.95348835	1	1.52100923	0.06114003
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	c2.CGP_ chemical and genetic perturbations	22	0.79102653	0.78504676	0.9425339	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	23	1.245453	0.19454771	0.51810926	2.03647953	-0.45442647
AGGCACT_MIR5153P	c3.MIR_ microRNA targets	81	0.7910064	0.86973685	0.94246733	AGGCACT_MIR5153P	81	0.7828721	0.8524763	1	1.5738785	0.0081343
GO_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	297	0.79098636	0.9524862	0.9424033	GO_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	324	1.2732238	0.01	0.4822098	2.06421016	-0.48223744
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	c2.CGP_ chemical and genetic perturbations	54	0.79097885	0.8489011	0.94231784	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	54	-1.2946084	0.068627454	0.28846353	-0.50362955	2.08558725
GO_LIGASE_ACTIVITY	c5.GO molecular function	368	0.7908852	0.9592712	0.9423704	GO_LIGASE_ACTIVITY	376	0.8033254	0.944	1	1.5942106	-0.0124402
MODULE_567	c4.CM_ cancer modules	86	0.7908387	0.88204455	0.9423531	MODULE_567	90	-0.96252644	0.6666667	0.7388644	-0.17168774	1.75336514
CHR2Q37	C1: positional gene sets	84	0.7906468	0.86934024	0.9425561	CHR2Q37	92	1.2295588	0.13431269	0.5417315	2.0202056	-0.438912
YGTCCTTGR_UNKNOWN	c3.TFT_ transcription factor targets	86	0.7905091	0.8548387	0.94267833	YGTCCTTGR_UNKNOWN	90	0.88800454	0.7080214	1	1.67851364	-0.09749544
GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	183	0.7903786	0.9229858	0.94277817	GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN	184	1.0750968	0.3043478	0.7964025	1.8654754	-0.2847182
HTF_01	c3.TFT_ transcription factor targets	64	0.79034305	0.84966445	0.9427354	HTF_01	66	1.1382201	0.26615554	0.6937487	1.92856315	-0.34787705
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	178	0.79026383	0.9208973	0.9427619	GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP	179	0.6573958	0.99080694	1	1.44765963	0.13286803
GO_POSITIVE_REGULATION_OF_MRNA_3_END_PROCESSING	c5.BP_ GO biological process	16	0.78992116	0.7507886	0.943194	GO_POSITIVE_REGULATION_OF_MRNA_3_END_PROCESSING	16	0.8364506	0.71391755	1	1.62637176	-0.04652944
GO_ANATOMICAL_STRUCTURE_ARRANGEMENT	c5.BP_ GO biological process	16	0.78983116	0.77446103	0.9432435	GO_ANATOMICAL_STRUCTURE_ARRANGEMENT	17	-0.85776794	0.6336207	0.8614296	-0.06793678	1.6475991
ENK_UV_RESPONSE_KERATINOCYTE_DN	c2.CGP_ chemical and genetic perturbations	454	0.7895977	0.9796137	0.94351333	ENK_UV_RESPONSE_KERATINOCYTE_DN	454	0	0	0	0.7895977	0.7895977
GO_DNA_DEALKYLATION	c5.BP_ GO biological process	17	0.7894835	0.75980395	0.9435944	GO_DNA_DEALKYLATION	17	0.8409356	0.7096774	1	1.6304191	-0.0514521
GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	C7_ immunologic signatures	189	0.7893619	0.9150718	0.9436848	GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	190	1.1114215	0.21906693	0.7355159	1.9007834	-0.3220596
GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	111	0.7892448	0.8886108	0.94377023	GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	112	0.94151175	0.6257796	0.98945385	1.73075655	-0.15226695
GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	C7_ immunologic signatures	146	0.78919864	0.90865386	0.9437434	GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	150	0.8660935	0.7750511	1	1.65529214	-0.07689486
GSE2826_XID_VS_BTK_KO_BCELL_UP	C7_ immunologic signatures	174	0.7890509	0.89791185	0.9438765	GSE2826_XID_VS_BTK_KO_BCELL_UP	182	0.655742	0.9959637	1	1.4447929	0.1333089
GO_PHOSPHOLIPASE_BINDING	c5.GO molecular function	16	0.7888767	0.77597404	0.9440498	GO_PHOSPHOLIPASE_BINDING	17	0.66627526	0.89615387	1	1.45515196	0.12260144
LEE_AGING_NEOCORTEX_UP	c2.CGP_ chemical and genetic perturbations	77	0.7887481	0.86266667	0.94414294	LEE_AGING_NEOCORTEX_UP	81	0.90626055	0.6673706	1	1.69500865	-0.11751245
TAXCREB_02	c3.TFT_ transcription factor targets	23	0.7887194	0.7949527	0.94408876	TAXCREB_02	24	0.81277525	0.75060827	1	1.60149465	-0.02405585
GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP	C7_ immunologic signatures	168	0.7886782	0.92874396	0.9440582	GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP	172	0.7271767	0.9521385	1	1.5158549	0.0615015
GO_CARBOHYDRATE_TRANSPORTER_ACTIVITY	c5.GO molecular function	36	0.7886504	0.8054363	0.9440014	GO_CARBOHYDRATE_TRANSPORTER_ACTIVITY	37	0.78387517	0.81058824	1	1.57252557	0.00477523
GO_SIN3_TYPE_COMPLEX	c5.CC_ GO cellular component	15	0.78861517	0.7718447	0.9439578	GO_SIN3_TYPE_COMPLEX	15	-1.0956486	0.3237705	0.52410495	-0.30703343	1.88426377
GO_CELLULAR_LIPID_CATABOLIC_PROCESS	c5.BP_ GO biological process	138	0.788448	0.9067485	0.9441194	GO_CELLULAR_LIPID_CATABOLIC_PROCESS	143	1.1205704	0.25586137	0.7230519	1.9090184	-0.3321224
MODULE_78	c4.CM_ cancer modules	18	0.7884057	0.745283	0.9440917	MODULE_78	20	0.66623294	0.89460474	1	1.45463864	0.12217276
GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	165	0.78831303	0.9170616	0.9441367	GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN	170	0.98640054	0.5304878	0.9401599	1.77471357	-0.19808751
EFC_Q6	c3.TFT_ transcription factor targets	228	0.7881927	0.9377124	0.94421995	EFC_Q6	238	0.85453737	0.8482412	1	1.64273007	-0.06634467
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	c2.CGP_ chemical and genetic perturbations	18	0.78806597	0.784252	0.9443187	SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	18	-0.92149204	0.59210527	0.79496324	-0.13342607	1.70955801
YY1_02	c3.TFT_ transcription factor targets	216	0.78805864	0.9421296	0.9442328	YY1_02	216	0.53665096	1	1	1.3247096	0.25140768
KUMAR_AUTOPHAGY_NETWORK	c2.CGP_ chemical and genetic perturbations	57	0.7878419	0.8317107	0.9444616	KUMAR_AUTOPHAGY_NETWORK	56	1.0764711	0.35897437	0.7943793	1.864313	-0.2886292
ACACTCC_MIR122A	c3.MIR_ microRNA targets	65	0.7877795	0.8597734	0.9444618	ACACTCC_MIR122A	66	-1.0109539	0.44047618	0.6705629	-0.2231744	1.7987334
GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP	C7_ immunologic signatures	179	0.78752506	0.9216152	0.94476104	GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP	180	0.7566758	0.95459133	1	1.54420086	0.03084926
GO_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS	c5.BP_ GO biological process	39	0.78725004	0.8136095	0.94507015	GO_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS	41	-1.0968709	0.28947368	0.5232418	-0.30962086	1.88412094
GCM_HMGA2	c4.CGN_ cancer gene neighborhoods	96	0.7872077	0.8694517	0.9450397	GCM_HMGA2	106	1.0494303	0.39422086	0.8407112	1.836638	-0.2622226
GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP	C7_ immunologic signatures	182	0.7870162	0.92520136	0.9452298	GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP	185	0.96686834	0.586802	0.96419924	1.75388454	-0.17985214
YAN_ESCAPE_FROM_ANOIKIS	c2.CGP_ chemical and genetic perturbations	21	0.7866921	0.76506954	0.94563746	YAN_ESCAPE_FROM_ANOIKIS	22	0.7683444	0.80625	1	1.5550365	0.0183477
GO_SERTOLI_CELL_DIFFERENTIATION	c5.BP_ GO biological process	16	0.78660953	0.75816995	0.94566464	GO_SERTOLI_CELL_DIFFERENTIATION	17	0.9864013	0.51428574	0.94029564	1.77301083	-0.19979177
GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP	C7_ immunologic signatures	183	0.786487	0.9207459	0.94574684	GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP	183	0.94740146	0.62828285	0.984808	1.73388846	-0.16091446
GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN	C7_ immunologic signatures	177	0.7864418	0.9166667	0.9457126	GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN	181	0.7428819	0.93794507	1	1.5293237	0.0435599
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP	c2.CGP_ chemical and genetic perturbations	52	0.7860644	0.8567493	0.946186	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP	55	0.935819	0.606264	0.9938767	1.7218834	-0.1497546
REACTOME_ADAPTIVE_IMMUNE_SYSTEM	c2.CP_REACTOME_ Reactome gene sets	444	0.78590894	0.9726316	0.9463255	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	461	0.86085117	0.905	1	1.64676011	-0.07494223
REACTOME_SIGNALING_BY_ILS	c2.CP_REACTOME_ Reactome gene sets	102	0.7858817	0.8984375	0.9462715	REACTOME_SIGNALING_BY_ILS	103	0.8792653	0.72119343	1	1.665147	-0.0933836
GO_NEGATIVE_REGULATION_OF_HISTONE_METHYLATION	c5.BP_ GO biological process	16	0.7847871	0.7710652	0.947829	GO_NEGATIVE_REGULATION_OF_HISTONE_METHYLATION	16	0.8089627	0.7335958	1	1.5937498	-0.0241756
GRADE_COLON_VS_RECTAL_CANCER_DN	c2.CGP_ chemical and genetic perturbations	45	0.78471285	0.83404255	0.94784	GRADE_COLON_VS_RECTAL_CANCER_DN	48	1.2463185	0.13461539	0.5171245	2.03103135	-0.46160565
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN	C7_ immunologic signatures	167	0.7846412	0.92610836	0.9478553	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN	172	0.9351196	0.6585613	0.9949999	1.7197608	-0.1504784
GSE42724_NAIVE_VS_MEMORY_BCELL_UP	C7_ immunologic signatures	168	0.78445596	0.91817087	0.9480372	GSE42724_NAIVE_VS_MEMORY_BCELL_UP	171	0.8619225	0.8172589	1	1.64637846	-0.07746654
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP	C7_ immunologic signatures	158	0.7839715	0.9240349	0.9486671	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP	165	0.9130926	0.7038934	1	1.6970641	-0.1291211
GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN	C7_ immunologic signatures	147	0.78395486	0.912154	0.9485966	GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN	149	0.6074851	0.995872	1	1.39143996	0.17646976
GO_PHOSPHOLIPID_CATABOLIC_PROCESS	c5.BP_ GO biological process	29	0.78388643	0.77709925	0.94860476	GO_PHOSPHOLIPID_CATABOLIC_PROCESS	30	0.99860436	0.48104265	0.92529297	1.78249079	-0.21471793
TCCCRNNRTGC_UNKNOWN	c3.TFT_ transcription factor targets	194	0.7837676	0.9442509	0.9486919	TCCCRNNRTGC_UNKNOWN	194	-1.2529867	0	0.32125425	-0.4692191	2.0367543
REACTOME_REGULATION_OF_SIGNALING_BY_CBL	c2.CP_REACTOME_ Reactome gene sets	17	0.7836799	0.7863105	0.9487196	REACTOME_REGULATION_OF_SIGNALING_BY_CBL	18	0.97132367	0.5181818	0.95989084	1.75500357	-0.18764377
MCCABE_HOXC6_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	19	0.783498	0.7725806	0.9488923	MCCABE_HOXC6_TARGETS_DN	19	0.9074411	0.6159696	1	1.6909391	-0.1239431
GO_PROTEIN_HOMOOLIGOMERIZATION	c5.BP_ GO biological process	220	0.78344697	0.9461009	0.9488739	GO_PROTEIN_HOMOOLIGOMERIZATION	234	1.1428354	0.17795753	0.6847327	1.92628237	-0.35938843
GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP	C7_ immunologic signatures	173	0.78343856	0.9234393	0.94879025	GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP	177	-1.202375	0.04761905	0.3788331	-0.41893644	1.98581356
PID_ERBB2_ERBB3_PATHWAY	c2.CP_ Canonical pathways	43	0.78328085	0.81962484	0.94893986	PID_ERBB2_ERBB3_PATHWAY	43	0.7229062	0.8828932	1	1.50618705	0.06037465
KMCATNNWGGA_UNKNOWN	c3.TFT_ transcription factor targets	79	0.783222	0.86973685	0.94892806	KMCATNNWGGA_UNKNOWN	79	-0.76319265	0.9714286	0.93016243	0.02002935	1.54641465
USF_Q6	c3.TFT_ transcription factor targets	234	0.78316236	0.96444446	0.94892293	USF_Q6	238	0.6913168	0.9809237	1	1.47447916	0.09184556
GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN	C7_ immunologic signatures	186	0.78291947	0.93924665	0.9491768	GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN	185	-0.89393926	0.75	0.82829607	-0.11101979	1.67685873
GO_NEURAL_NUCLEUS_DEVELOPMENT	c5.BP_ GO biological process	55	0.7828927	0.83903134	0.94912267	GO_NEURAL_NUCLEUS_DEVELOPMENT	56	-1.462633	0.009090909	0.16542226	-0.6797403	2.2455257
BIOCARTA_EDG1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	27	0.78265715	0.77952754	0.94936746	BIOCARTA_EDG1_PATHWAY	27	1.0473956	0.41028708	0.84463584	1.83005275	-0.26473845
GO_CORNIFIED_ENVELOPE	c5.CC_ GO cellular component	16	0.7824937	0.78571427	0.9495044	GO_CORNIFIED_ENVELOPE	16	0	0	0	0.7824937	0.7824937
GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	C7_ immunologic signatures	156	0.782254	0.9227053	0.94975907	GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	155	1.0718626	0.331307	0.8025578	1.8541166	-0.2896086
GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	175	0.7821123	0.922626	0.949866	GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	177	0.6814374	0.9817998	1	1.4635497	0.1006749
GO_BRUSH_BORDER_MEMBRANE	c5.CC_ GO cellular component	43	0.7820881	0.83457524	0.94980794	GO_BRUSH_BORDER_MEMBRANE	48	1.4969687	0.017877094	0.2546685	2.2790568	-0.7148806
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP	C7_ immunologic signatures	174	0.7820738	0.93124247	0.94973177	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP	176	-0.8119222	1	0.89558077	-0.0298484	1.593996
CHR7P22	C1: positional gene sets	58	0.7819853	0.8623595	0.94977105	CHR7P22	61	1.0229307	0.44567627	0.88678247	1.804916	-0.2409454
GO_RESPONSE_TO_CAFFEINE	c5.BP_ GO biological process	17	0.781954	0.8055556	0.94972193	GO_RESPONSE_TO_CAFFEINE	17	1.2580233	0.18181819	0.4989984	2.0399773	-0.4760693
GO_PROTEIN_SECRETION	c5.BP_ GO biological process	92	0.78191364	0.8841699	0.94968003	GO_PROTEIN_SECRETION	99	1.0335479	0.41033757	0.8710304	1.81546154	-0.25163426
PID_IL6_7_PATHWAY	c2.CP_ Canonical pathways	45	0.7818173	0.8189655	0.94972724	PID_IL6_7_PATHWAY	47	0.97134554	0.5403226	0.95994973	1.75316284	-0.18952824
GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN	C7_ immunologic signatures	155	0.7817686	0.93058825	0.9497031	GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN	158	1.1319773	0.21084954	0.7029401	1.9137459	-0.3502087
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	128	0.7814893	0.92250925	0.9500049	GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP	133	1.1533445	0.2008155	0.6629435	1.9348338	-0.3718552
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN	C7_ immunologic signatures	178	0.7812843	0.9432624	0.95020723	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN	179	0.96281946	0.6024341	0.9681395	1.74410376	-0.18153516
GO_ENERGY_RESERVE_METABOLIC_PROCESS	c5.BP_ GO biological process	59	0.78121114	0.8286908	0.950214	GO_ENERGY_RESERVE_METABOLIC_PROCESS	63	1.0155914	0.44759825	0.89675045	1.79680254	-0.23438026
GCM_RING1	c4.CGN_ cancer gene neighborhoods	91	0.78110796	0.88874346	0.9502693	GCM_RING1	98	0.8333464	0.8198758	1	1.61445436	-0.05223844
GSE11924_TFH_VS_TH1_CD4_TCELL_DN	C7_ immunologic signatures	167	0.78102213	0.91697645	0.95029616	GSE11924_TFH_VS_TH1_CD4_TCELL_DN	177	-1.1649691	0.071428575	0.42438477	-0.38394697	1.94599123
GNF2_PECAM1	c4.CGN_ cancer gene neighborhoods	43	0.7808886	0.8385714	0.95038944	GNF2_PECAM1	45	1.3549353	0.07727797	0.38222352	2.1358239	-0.5740467
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	c2.CGP_ chemical and genetic perturbations	24	0.7808283	0.7800312	0.9503801	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	24	0.6443592	0.9398977	1	1.4251875	0.1364691
GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	179	0.7807056	0.9471831	0.9504613	GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP	179	-1.0368757	0.23529412	0.6271166	-0.2561701	1.8175813
MODULE_120	c4.CM_ cancer modules	64	0.7804714	0.8746667	0.9507175	MODULE_120	67	1.3610046	0.04673913	0.37623993	2.141476	-0.5805332
GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN	C7_ immunologic signatures	178	0.7804643	0.92865634	0.95063305	GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN	179	0.72948956	0.94832826	1	1.50995386	0.05097474
MORF_RRM1	c4.CGN_ cancer gene neighborhoods	94	0.7804445	0.8845655	0.95056534	MORF_RRM1	94	-2.0129893	0	0.007399192	-1.2325448	2.7934338
GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN	C7_ immunologic signatures	175	0.7803421	0.9302046	0.95061827	GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN	179	0.69071114	0.97676766	1	1.47105324	0.08963096
GO_CATION_SUGAR_SYMPORTER_ACTIVITY	c5.GO molecular function	15	0.7802729	0.7668919	0.9506195	GO_CATION_SUGAR_SYMPORTER_ACTIVITY	15	1.0133902	0.46944082	0.90089774	1.7936631	-0.2331173
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS	c5.BP_ GO biological process	23	0.7799306	0.7990581	0.95101035	GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS	23	0.66755784	0.89369595	1	1.44748844	0.11237276
CHR4P14	C1: positional gene sets	19	0.77989787	0.7744	0.95096165	CHR4P14	20	1.3148862	0.13748379	0.41774198	2.09478407	-0.53498833
CP2_01	c3.TFT_ transcription factor targets	233	0.77965224	0.9537246	0.95121086	CP2_01	239	0.89816344	0.7588295	1	1.67781568	-0.1185112
GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP	C7_ immunologic signatures	179	0.77962595	0.9477521	0.95115423	GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP	183	0.73823565	0.9524773	1	1.5178616	0.0413903
GSE27786_LSK_VS_BCELL_DN	C7_ immunologic signatures	167	0.7795792	0.93911004	0.95112497	GSE27786_LSK_VS_BCELL_DN	175	0.9218405	0.70600206	1	1.7014197	-0.1422613
GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP	C7_ immunologic signatures	173	0.77944213	0.94383395	0.9512257	GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP	179	0.78149605	0.9131313	1	1.56093818	-0.00205392
GO_REGULATION_OF_CELL_SHAPE	c5.BP_ GO biological process	130	0.7793179	0.91531754	0.95130765	GO_REGULATION_OF_CELL_SHAPE	130	0.7166496	0.9495885	1	1.4959675	0.0626683
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	c2.CGP_ chemical and genetic perturbations	37	0.77925336	0.82905984	0.9513018	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	38	0.67624754	0.9193182	1	1.4555009	0.10300582
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	c2.CGP_ chemical and genetic perturbations	28	0.77878076	0.7818182	0.95188767	MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	29	0.94508034	0.5623472	0.9875795	1.7238611	-0.16629958
GO_PROTEIN_N_TERMINUS_BINDING	c5.GO molecular function	95	0.7780075	0.90088946	0.95290047	GO_PROTEIN_N_TERMINUS_BINDING	98	0.64169544	0.9853403	1	1.41970294	0.13631206
PID_VEGFR1_2_PATHWAY	c2.CP_ Canonical pathways	65	0.777981	0.8646409	0.95284086	PID_VEGFR1_2_PATHWAY	67	0.95139134	0.59513277	0.9806288	1.72937234	-0.17341034
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	118	0.7779299	0.9185464	0.9528182	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	119	0.8243182	0.8243243	1	1.6022481	-0.0463883
PID_IL2_STAT5_PATHWAY	c2.CP_ Canonical pathways	29	0.7778987	0.8081571	0.95276403	PID_IL2_STAT5_PATHWAY	30	0.8469668	0.7159904	1	1.6248655	-0.0690681
GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	C7_ immunologic signatures	177	0.77787054	0.9461988	0.9527083	GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	181	0.6756545	0.9878665	1	1.45352504	0.10221604
GO_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING	c5.GO molecular function	50	0.77783656	0.84822696	0.9526614	GO_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING	53	-0.7779921	0.8909091	0.92331606	-0.00015554	1.55582866
GO_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION	c5.BP_ GO biological process	24	0.77768654	0.8135095	0.9527761	GO_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION	29	1.0275288	0.4311815	0.8803553	1.80521534	-0.24984226
GGTAACC_MIR4095P	c3.MIR_ microRNA targets	28	0.77763593	0.7882353	0.9527485	GGTAACC_MIR4095P	29	-0.8872453	0.6084337	0.83806705	-0.10960937	1.66488123
GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP	C7_ immunologic signatures	178	0.7771689	0.9338061	0.9532985	GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP	181	1.0312153	0.42598188	0.8744054	1.8083842	-0.2540464
GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN	C7_ immunologic signatures	176	0.77713627	0.93720376	0.95324546	GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN	175	-1.26767	0	0.3093053	-0.49053373	2.04480627
GO_CHROMATIN_SILENCING	c5.BP_ GO biological process	52	0.7771293	0.8472222	0.95315915	GO_CHROMATIN_SILENCING	59	0.89130515	0.68524593	1	1.66843445	-0.11417585
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	20	0.7770331	0.815873	0.95319605	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING	20	-0.8789809	0.672043	0.8463434	-0.1019478	1.656014
GO_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION	c5.BP_ GO biological process	30	0.7765259	0.82843894	0.9538062	GO_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION	32	1.2299252	0.18384075	0.54113686	2.0064511	-0.4533993
GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS	c5.GO molecular function	184	0.77651	0.9401611	0.95373493	GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS	188	-0.72881514	1	0.9474181	0.04769486	1.50532514
GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	C7_ immunologic signatures	179	0.7763354	0.93373495	0.95388204	GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	183	0.6472358	0.9899092	1	1.4235712	0.1290996
PPARA_01	c3.TFT_ transcription factor targets	32	0.776213	0.8305847	0.95396	PPARA_01	32	1.3819206	0.08070175	0.35639027	2.1581336	-0.6057076
GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN	C7_ immunologic signatures	182	0.77587	0.9470656	0.95433795	GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN	184	1.2284392	0.07583418	0.54366446	2.0043092	-0.4525692
GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP	C7_ immunologic signatures	159	0.7756043	0.93454546	0.95461375	GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP	162	0.9727643	0.5653061	0.95816565	1.7483686	-0.19716
YWATTWNNRGCT_UNKNOWN	c3.TFT_ transcription factor targets	57	0.77559704	0.87339973	0.95452714	YWATTWNNRGCT_UNKNOWN	62	-1.0969204	0.25287357	0.52345616	-0.32132336	1.87251744
MODULE_416	c4.CM_ cancer modules	19	0.7754687	0.79591835	0.95460314	MODULE_416	19	1.1289874	0.30314466	0.707546	1.9044561	-0.3535187
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	c2.CGP_ chemical and genetic perturbations	62	0.77546036	0.8632011	0.95451885	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	61	-1.3038087	0.04950495	0.27874264	-0.52834834	2.07926906
GCM_RAN	c4.CGN_ cancer gene neighborhoods	173	0.77545434	0.95459974	0.9544289	GCM_RAN	173	-0.9524432	0.6923077	0.7543058	-0.17698886	1.72789754
MOOTHA_GLYCOGEN_METABOLISM	c2.CGP_ chemical and genetic perturbations	18	0.7754535	0.784689	0.95433444	MOOTHA_GLYCOGEN_METABOLISM	18	1.2846563	0.1574904	0.4645189	2.0601098	-0.5092028
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN	C7_ immunologic signatures	177	0.7753928	0.94947124	0.954323	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN	177	0.7173889	0.9625127	1	1.4927817	0.0580039
GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP	C7_ immunologic signatures	177	0.7753062	0.9307049	0.9543442	GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP	177	0.6793723	0.98084676	1	1.4546785	0.0959339
GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	C7_ immunologic signatures	176	0.77474225	0.9367682	0.9550259	GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	176	-0.8556245	0.8666667	0.8623157	-0.08088225	1.63036675
GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN	C7_ immunologic signatures	180	0.7747162	0.93372095	0.9549685	GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN	181	0.9523512	0.6270161	0.97893006	1.7270674	-0.177635
GO_DEMETHYLATION	c5.BP_ GO biological process	46	0.774553	0.8335704	0.9550974	GO_DEMETHYLATION	46	0.94595927	0.56744707	0.9861948	1.72051227	-0.17140627
GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP	C7_ immunologic signatures	173	0.77454704	0.9468085	0.9550101	GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP	178	1.0793295	0.30738118	0.7882508	1.85387654	-0.30478246
GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP	C7_ immunologic signatures	166	0.77448523	0.9485924	0.95499814	GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP	168	1.0777776	0.3076142	0.7915754	1.85226283	-0.30329237
ROVERSI_GLIOMA_COPY_NUMBER_UP	c2.CGP_ chemical and genetic perturbations	81	0.7742304	0.8816326	0.955246	ROVERSI_GLIOMA_COPY_NUMBER_UP	88	0.7173392	0.91525424	1	1.4915696	0.0568912
PETRETTO_HEART_MASS_QTL_CIS_UP	c2.CGP_ chemical and genetic perturbations	26	0.7742214	0.807267	0.9551637	PETRETTO_HEART_MASS_QTL_CIS_UP	26	0.85082465	0.6966427	1	1.62504605	-0.07660325
GO_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS	c5.BP_ GO biological process	20	0.77410233	0.8113497	0.95523137	GO_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS	20	0.82031375	0.7276215	1	1.59441608	-0.04621142
GO_ENDOCYTIC_VESICLE_MEMBRANE	c5.CC_ GO cellular component	125	0.77399397	0.9299124	0.9552777	GO_ENDOCYTIC_VESICLE_MEMBRANE	128	1.0395693	0.41128206	0.8591343	1.81356327	-0.26557533
GSE17721_CTRL_VS_LPS_6H_BMDC_UP	C7_ immunologic signatures	176	0.7737792	0.941247	0.9554718	GSE17721_CTRL_VS_LPS_6H_BMDC_UP	178	0.83756375	0.85859615	1	1.61134295	-0.06378455
GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP	C7_ immunologic signatures	166	0.7737165	0.93779343	0.9554601	GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP	170	0.7326862	0.9460834	1	1.5064027	0.0410303
GSE3982_DC_VS_MAC_LPS_STIM_UP	C7_ immunologic signatures	172	0.77364916	0.9404762	0.9554541	GSE3982_DC_VS_MAC_LPS_STIM_UP	175	0.7686844	0.9332659	1	1.54233356	0.00496476
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN	C7_ immunologic signatures	179	0.7733395	0.9348079	0.9557676	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN	182	0.9752339	0.55263156	0.9557363	1.7485734	-0.2018944
KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	172	0.77329594	0.94242066	0.9557299	KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN	176	0.8995897	0.7315096	1	1.67288564	-0.12629376
GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP	C7_ immunologic signatures	174	0.773264	0.9400705	0.9556753	GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP	175	1.0502001	0.3814329	0.8397421	1.8234641	-0.2769361
GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN	C7_ immunologic signatures	177	0.77314377	0.9343864	0.95574045	GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN	177	-0.98537284	0.3846154	0.7072302	-0.21222907	1.75851661
GO_RAC_PROTEIN_SIGNAL_TRANSDUCTION	c5.BP_ GO biological process	18	0.7730302	0.7635783	0.95580256	GO_RAC_PROTEIN_SIGNAL_TRANSDUCTION	18	0.68952525	0.86725664	1	1.46255545	0.08350495
GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN	C7_ immunologic signatures	164	0.7729338	0.94096386	0.9558357	GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN	165	-0.9765682	0.47058824	0.71956486	-0.2036344	1.749502
KEGG_TASTE_TRANSDUCTION	c2.CP_BIOCARTA_ BioCarta gene sets	28	0.77277046	0.8271787	0.9559617	KEGG_TASTE_TRANSDUCTION	28	0.94705325	0.5585366	0.9852813	1.71982371	-0.17428279
GSE11924_TH1_VS_TH2_CD4_TCELL_UP	C7_ immunologic signatures	172	0.77273184	0.94430995	0.9559195	GSE11924_TH1_VS_TH2_CD4_TCELL_UP	182	0.89305305	0.74262464	1	1.66578489	-0.12032121
GNF2_PCAF	c4.CGN_ cancer gene neighborhoods	28	0.7724434	0.80930233	0.95622003	GNF2_PCAF	32	0.70140433	0.8798587	1	1.47384773	0.07103907
GAJATE_RESPONSE_TO_TRABECTEDIN_DN	c2.CGP_ chemical and genetic perturbations	17	0.77242166	0.77544427	0.9561523	GAJATE_RESPONSE_TO_TRABECTEDIN_DN	17	-0.7676791	0.83739835	0.92913455	0.00474256	1.54010076
RFX1_01	c3.TFT_ transcription factor targets	213	0.77241087	0.9561707	0.95607096	RFX1_01	225	0.89902544	0.74048096	1	1.67143631	-0.12661457
GCM_PRKAG1	c4.CGN_ cancer gene neighborhoods	42	0.772152	0.8445079	0.9563192	GCM_PRKAG1	44	0.6531434	0.9433526	1	1.4252954	0.1190086
GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN	C7_ immunologic signatures	171	0.771961	0.9451074	0.9564804	GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN	171	-1.2810084	0	0.30092064	-0.5090474	2.0529694
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	c2.CGP_ chemical and genetic perturbations	36	0.77171636	0.83381504	0.95670545	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	36	0.7564855	0.8337292	1	1.52820186	0.01523086
GO_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS	c5.GO molecular function	128	0.7716926	0.9260173	0.95664054	GO_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS	130	0.9841394	0.53347063	0.942529	1.755832	-0.2124468
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	182	0.7716411	0.947245	0.9566087	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	182	1.1247771	0.22030456	0.71579254	1.8964182	-0.353136
STEIN_ESRRA_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	91	0.77163017	0.88282293	0.956527	STEIN_ESRRA_TARGETS_DN	92	0.7590675	0.886196	1	1.53069767	0.01256267
GSE27786_NEUTROPHIL_VS_MONO_MAC_DN	C7_ immunologic signatures	178	0.7713788	0.9527187	0.95676374	GSE27786_NEUTROPHIL_VS_MONO_MAC_DN	182	-1.1367517	0.07692308	0.4618952	-0.3653729	1.9081305
GCM_ERCC4	c4.CGN_ cancer gene neighborhoods	23	0.77098006	0.81191224	0.95718086	GCM_ERCC4	25	1.0062021	0.48101267	0.9136411	1.77718216	-0.23522204
GO_REGULATION_OF_MEMBRANE_PERMEABILITY	c5.BP_ GO biological process	64	0.77080715	0.8658192	0.9573174	GO_REGULATION_OF_MEMBRANE_PERMEABILITY	64	0.8683296	0.71397614	1	1.63913675	-0.09752245
CCGNMNNTNACG_UNKNOWN	c3.TFT_ transcription factor targets	69	0.770623	0.88461536	0.9574677	CCGNMNNTNACG_UNKNOWN	69	-1.2802645	0.072289154	0.30147222	-0.5096415	2.0508875
GO_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	23	0.770424	0.8202247	0.9576346	GO_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY	25	0.9793212	0.5085784	0.9500346	1.7497452	-0.2088972
GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	C7_ immunologic signatures	178	0.7702809	0.9533799	0.95773184	GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	185	0.90894866	0.71442986	1	1.67922956	-0.13866776
GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN	C7_ immunologic signatures	187	0.77012336	0.9557945	0.95784307	GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN	191	0.71484506	0.9748491	1	1.48496842	0.0552783
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP	C7_ immunologic signatures	126	0.76986706	0.93772894	0.95808995	GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP	129	1.2638782	0.052029137	0.49078205	2.03374526	-0.49401114
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP	C7_ immunologic signatures	174	0.7697754	0.950237	0.9581139	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP	175	-0.81002665	1	0.8968059	-0.04025125	1.57980205
GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP	C7_ immunologic signatures	166	0.7696631	0.9324645	0.958157	GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP	175	1.2786056	0.048730966	0.47321483	2.0482687	-0.5089425
CHR16Q12	C1: positional gene sets	33	0.7696482	0.82008994	0.9580803	CHR16Q12	34	0.7089949	0.8804734	1	1.4786431	0.0606533
REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	c2.CP_REACTOME_ Reactome gene sets	17	0.7695208	0.79771614	0.95814806	REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	17	0.5445352	0.9741602	1	1.314056	0.2249856
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES	c2.CP_ Canonical pathways	60	0.76913774	0.86849314	0.95856047	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES	62	0.64919233	0.9557032	1	1.41833007	0.11994541
GO_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION	c5.BP_ GO biological process	36	0.76909053	0.84393066	0.95852727	GO_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION	44	1.2924188	0.10932106	0.45421013	2.06150933	-0.52332827
GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	C7_ immunologic signatures	172	0.7682838	0.9357143	0.9594748	GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	175	0.9567899	0.595117	0.97525966	1.7250737	-0.1885061
GO_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS	c5.BP_ GO biological process	40	0.7681605	0.8539493	0.95953685	GO_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS	47	0.8510728	0.7295455	1	1.6192333	-0.0829123
MODULE_243	c4.CM_ cancer modules	73	0.7680122	0.86880857	0.95963585	MODULE_243	73	-0.82623637	0.8961039	0.88555515	-0.05822417	1.59424857
GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP	C7_ immunologic signatures	136	0.76795834	0.93282634	0.9596096	GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP	138	0.9239576	0.6557377	1	1.69191594	-0.15599926
AMUNDSON_GAMMA_RADIATION_RESISTANCE	c2.CGP_ chemical and genetic perturbations	17	0.7678255	0.76650566	0.9596864	AMUNDSON_GAMMA_RADIATION_RESISTANCE	18	1.3788903	0.08132147	0.35605612	2.1467158	-0.6110648
LXR_Q3	c3.TFT_ transcription factor targets	66	0.7677865	0.88813096	0.95964223	LXR_Q3	69	0.64604956	0.9676026	1	1.41383606	0.12173694
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	c2.CGP_ chemical and genetic perturbations	32	0.7675533	0.82666665	0.9598406	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	34	1.3193506	0.09601874	0.4128477	2.0869039	-0.5517973
GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP	C7_ immunologic signatures	163	0.76748145	0.942757	0.9598342	GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP	165	1.1733232	0.13880445	0.6336332	1.94080465	-0.40584175
ONDER_CDH1_TARGETS_1_DN	c2.CGP_ chemical and genetic perturbations	137	0.76731026	0.93942994	0.9599519	ONDER_CDH1_TARGETS_1_DN	142	-1.3246343	0	0.2612265	-0.55732404	2.09194456
GO_POSITIVE_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING	c5.BP_ GO biological process	27	0.7672276	0.81575036	0.9599614	GO_POSITIVE_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING	26	0.7260158	0.84413964	1	1.4932434	0.0412118
GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	C7_ immunologic signatures	182	0.7672124	0.9555035	0.959884	GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	184	0.80573183	0.89101917	1	1.57294423	-0.03851943
GO_HORMONE_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	143	0.767124	0.93583536	0.9598926	GO_HORMONE_MEDIATED_SIGNALING_PATHWAY	150	0.9090068	0.71120244	1	1.6761308	-0.1418828
PID_ERBB1_DOWNSTREAM_PATHWAY	c2.CP_ Canonical pathways	103	0.7668792	0.9071518	0.9601137	PID_ERBB1_DOWNSTREAM_PATHWAY	103	0.95097834	0.58	0.98119617	1.71785754	-0.18409914
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP	C7_ immunologic signatures	175	0.7668552	0.948503	0.96005183	GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP	175	1.0445693	0.3985873	0.85020715	1.8114245	-0.2777141
GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN	C7_ immunologic signatures	175	0.7668497	0.9520468	0.9599636	GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN	179	0.97330374	0.5714286	0.9581495	1.74015344	-0.20645404
GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	C7_ immunologic signatures	174	0.7667621	0.9465558	0.95997536	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	177	0.9364363	0.65587044	0.99392015	1.7031984	-0.1696742
GO_ADP_BINDING	c5.GO molecular function	29	0.7667425	0.8143275	0.95990413	GO_ADP_BINDING	30	1.0590734	0.4060241	0.8265161	1.8258159	-0.2923309
GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	145	0.76665145	0.93195623	0.95992017	GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP	146	0.9753342	0.5658836	0.9560463	1.74198565	-0.20868275
GTCNYYATGR_UNKNOWN	c3.TFT_ transcription factor targets	93	0.7665694	0.9095541	0.95992845	GTCNYYATGR_UNKNOWN	93	1.0227127	0.4573235	0.88683194	1.7892821	-0.2561433
GO_LOCALIZATION_WITHIN_MEMBRANE	c5.BP_ GO biological process	113	0.7664567	0.9202059	0.9599698	GO_LOCALIZATION_WITHIN_MEMBRANE	114	0.600223	0.996888	1	1.3666797	0.1662337
GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	172	0.76644605	0.93682957	0.95988685	GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	172	0.76558	0.9223007	1	1.53202605	0.00086605
GO_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS	c5.BP_ GO biological process	28	0.7664405	0.8356164	0.95979846	GO_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS	28	0.79407185	0.7771011	1	1.56051235	-0.02763135
GO_RESPONSE_TO_INSULIN	c5.BP_ GO biological process	188	0.766225	0.9521028	0.9599786	GO_RESPONSE_TO_INSULIN	193	0.7820631	0.919598	1	1.5482881	-0.0158381
DAZARD_RESPONSE_TO_UV_SCC_UP	c2.CGP_ chemical and genetic perturbations	101	0.76609606	0.9197995	0.9600517	DAZARD_RESPONSE_TO_UV_SCC_UP	103	0.8045508	0.84199584	1	1.57064686	-0.03845474
TOMIDA_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	17	0.7656313	0.7939297	0.96053267	TOMIDA_METASTASIS_DN	17	-1.0002741	0.45595855	0.68518144	-0.2346428	1.7659054
KYNG_NORMAL_AGING_UP	c2.CGP_ chemical and genetic perturbations	16	0.76543516	0.8	0.9606757	KYNG_NORMAL_AGING_UP	16	1.3337092	0.12702702	0.3995145	2.09914436	-0.56827404
GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN	C7_ immunologic signatures	87	0.76534605	0.8744993	0.9606849	GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN	100	1.3507485	0.031479537	0.3842391	2.11609455	-0.58540245
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	176	0.76512736	0.960761	0.96086645	GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	177	0.5998928	0.9989899	1	1.36502016	0.16523456
REACTOME_PHOSPHOLIPID_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	176	0.765038	0.9489311	0.96088636	REACTOME_PHOSPHOLIPID_METABOLISM	183	1.3021635	0.02123357	0.4382447	2.0672015	-0.5371255
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	c2.CGP_ chemical and genetic perturbations	102	0.7649511	0.9322917	0.96089864	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	103	1.0525786	0.38998958	0.83681285	1.8175297	-0.2876275
GO_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT	c5.BP_ GO biological process	30	0.7646583	0.8412463	0.9611611	GO_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT	29	-1.0761328	0.33136094	0.55930984	-0.3114745	1.8407911
LIU_BREAST_CANCER	c2.CGP_ chemical and genetic perturbations	24	0.7645813	0.8172043	0.9611657	LIU_BREAST_CANCER	24	1.1044368	0.34857848	0.74837035	1.8690181	-0.3398555
ACTGCCT_MIR34B	c3.MIR_ microRNA targets	202	0.7643607	0.96740395	0.9613419	ACTGCCT_MIR34B	206	0.96211225	0.6060606	0.96868306	1.72647295	-0.19775155
GCGSCMNTTT_UNKNOWN	c3.TFT_ transcription factor targets	64	0.7641916	0.87603307	0.9614516	GCGSCMNTTT_UNKNOWN	65	-1.2475492	0.10526316	0.3258622	-0.4833576	2.0117408
GO_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE	c5.CC_ GO cellular component	127	0.76395637	0.9229798	0.961652	GO_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE	130	1.1428921	0.2073922	0.68463105	1.90684847	-0.37893573
BIOCARTA_PTEN_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	0.7637046	0.8229665	0.96186656	BIOCARTA_PTEN_PATHWAY	18	0.99737793	0.4961637	0.9261245	1.76108253	-0.23367333
CHR17P13	C1: positional gene sets	176	0.7636947	0.93862814	0.96178067	CHR17P13	188	1.0706824	0.33705583	0.8040823	1.8343771	-0.3069877
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	148	0.7636766	0.9498164	0.9617072	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP	150	1.3316486	0.02042901	0.4004683	2.0953252	-0.567972
GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP	C7_ immunologic signatures	177	0.7636563	0.96103895	0.9616357	GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP	177	0.6803749	0.98373985	1	1.4440312	0.0832814
GO_NEPHRON_TUBULE_FORMATION	c5.BP_ GO biological process	15	0.7635435	0.8067633	0.9616814	GO_NEPHRON_TUBULE_FORMATION	18	-1.209491	0.21717171	0.36827427	-0.4459475	1.9730345
SIG_BCR_SIGNALING_PATHWAY	c2.CP_ Canonical pathways	44	0.7631512	0.8618705	0.9620648	SIG_BCR_SIGNALING_PATHWAY	46	1.4403636	0.027149322	0.3039203	2.2035148	-0.6772124
GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	164	0.7630448	0.94416875	0.9620991	GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	170	0.9480749	0.62222224	0.98419064	1.7111197	-0.1850301
DANG_MYC_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	26	0.7629426	0.8173653	0.96213263	DANG_MYC_TARGETS_DN	26	0.9890911	0.5054678	0.936141	1.7520337	-0.2261485
GO_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	321	0.7628865	0.97228384	0.96210736	GO_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY	325	0.85357153	0.87374747	1	1.61645803	-0.09068503
GO_RNA_POLYMERASE_II_TRANSCRIPTION_COACTIVATOR_ACTIVITY	c5.GO molecular function	32	0.7627987	0.84897363	0.96211797	GO_RNA_POLYMERASE_II_TRANSCRIPTION_COACTIVATOR_ACTIVITY	32	-0.9983696	0.44970414	0.68765295	-0.2355709	1.7611683
GO_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING	c5.GO molecular function	24	0.7626901	0.8015873	0.9621533	GO_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING	26	1.1192274	0.29652604	0.72380507	1.8819175	-0.3565373
GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	C7_ immunologic signatures	179	0.7626386	0.94145197	0.962122	GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	183	0.8627829	0.8181818	1	1.6254215	-0.1001443
BIOCARTA_GCR_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	0.76244193	0.8132045	0.9622712	BIOCARTA_GCR_PATHWAY	17	1.4339072	0.035714287	0.31243697	2.19634913	-0.67146527
GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP	C7_ immunologic signatures	115	0.7623895	0.92414665	0.9622389	GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP	127	0.9203235	0.6714727	1	1.682713	-0.157934
GCM_FCGR2B	c4.CGN_ cancer gene neighborhoods	31	0.7622262	0.8363636	0.9623314	GCM_FCGR2B	34	-0.9374875	0.5660377	0.7742264	-0.1752613	1.6997137
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP	C7_ immunologic signatures	125	0.7620514	0.9376528	0.96244615	GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP	134	1.1912757	0.11848825	0.6039973	1.9533271	-0.4292243
GO_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION	c5.BP_ GO biological process	27	0.7618773	0.84090906	0.9625673	GO_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION	27	1.1054226	0.3409091	0.7463425	1.8672999	-0.3435453
GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	C7_ immunologic signatures	167	0.76180565	0.9601874	0.9625557	GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	168	-1.4150642	0	0.1963624	-0.65325855	2.17686985
GUILLAUMOND_KLF10_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	26	0.76139957	0.81039757	0.9629494	GUILLAUMOND_KLF10_TARGETS_DN	27	-0.96429324	0.48850575	0.73635316	-0.20289367	1.72569281
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	c2.CGP_ chemical and genetic perturbations	44	0.7613364	0.8557692	0.9629318	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	46	1.2991664	0.11061452	0.44378412	2.0605028	-0.53783
PID_CERAMIDE_PATHWAY	c2.CP_ Canonical pathways	48	0.7613156	0.86	0.9628613	PID_CERAMIDE_PATHWAY	47	-0.8252175	0.8545455	0.8858448	-0.0639019	1.5865331
GNF2_TYK2	c4.CGN_ cancer gene neighborhoods	31	0.7609029	0.85602504	0.96324307	GNF2_TYK2	32	0.56095934	0.9811098	1	1.32186224	0.19994356
GO_GOLGI_VESICLE_TRANSPORT	c5.BP_ GO biological process	287	0.7608935	0.9865922	0.9631584	GO_GOLGI_VESICLE_TRANSPORT	288	0.94778186	0.6559679	0.98423105	1.70867536	-0.18688836
GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN	C7_ immunologic signatures	163	0.76073676	0.9642432	0.9632495	GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN	164	0.9637602	0.59939146	0.9670352	1.72449696	-0.20302344
GO_REGULATION_OF_PH	c5.BP_ GO biological process	77	0.7601276	0.90412784	0.9638706	GO_REGULATION_OF_PH	84	1.0297915	0.44444445	0.87571275	1.7899191	-0.2696639
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP	C7_ immunologic signatures	169	0.7600218	0.949825	0.9639089	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP	171	1.1722156	0.14242424	0.634095	1.9322374	-0.4121938
PID_EPO_PATHWAY	c2.CP_ Canonical pathways	33	0.7595994	0.84162897	0.96431935	PID_EPO_PATHWAY	34	1.0530275	0.3943662	0.83590674	1.8126269	-0.2934281
GO_SKELETAL_MUSCLE_CONTRACTION	c5.BP_ GO biological process	29	0.75943613	0.85289747	0.96441203	GO_SKELETAL_MUSCLE_CONTRACTION	29	1.4483387	0.041769043	0.29210952	2.20777483	-0.68890257
PID_TRKR_PATHWAY	c2.CP_ Canonical pathways	59	0.759332	0.88812155	0.96444136	PID_TRKR_PATHWAY	60	1.2210585	0.16164994	0.5540759	1.9803905	-0.4617265
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN	C7_ immunologic signatures	154	0.75929064	0.9564692	0.96439505	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN	158	0.73739284	0.93737376	1	1.49668348	0.0218978
PID_CASPASE_PATHWAY	c2.CP_ Canonical pathways	49	0.75927913	0.8699301	0.96431214	PID_CASPASE_PATHWAY	47	-1.2320958	0.13084112	0.34376967	-0.47281667	1.99137493
GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	C7_ immunologic signatures	177	0.75919265	0.96445495	0.9643198	GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	184	0.6568468	0.9828802	1	1.41603945	0.10234585
BIOCARTA_TID_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	0.75901866	0.79591835	0.9644303	BIOCARTA_TID_PATHWAY	17	1.1509857	0.28404668	0.6681126	1.91000436	-0.39196704
ERR1_Q2	c3.TFT_ transcription factor targets	230	0.75899976	0.97602737	0.964358	ERR1_Q2	238	0.74292165	0.9658977	1	1.50192141	0.01607811
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP	C7_ immunologic signatures	172	0.7589815	0.9519906	0.9642833	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP	173	-1.1973354	0.11111111	0.3852997	-0.4383539	1.9563169
GO_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	28	0.75876975	0.82731557	0.96443367	GO_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	28	0.9125338	0.59205776	1	1.67130355	-0.15376405
GNF2_CD1D	c4.CGN_ cancer gene neighborhoods	34	0.75872713	0.853211	0.96438694	GNF2_CD1D	35	1.4618179	0.026995305	0.28096214	2.22054503	-0.70309077
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	c2.CP_REACTOME_ Reactome gene sets	37	0.75851756	0.86053413	0.9645404	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	37	1.1864761	0.21538462	0.6127167	1.94499366	-0.42795854
GO_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION	c5.BP_ GO biological process	33	0.75840944	0.84650457	0.9645734	GO_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION	35	0.64091885	0.9486874	1	1.39932829	0.11749059
GO_NUCLEAR_ENVELOPE_ORGANIZATION	c5.BP_ GO biological process	74	0.7583072	0.9121447	0.96459454	GO_NUCLEAR_ENVELOPE_ORGANIZATION	74	0.8609582	0.7472885	1	1.6192654	-0.102651
GO_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	63	0.7576374	0.88308114	0.96526945	GO_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	66	1.1181427	0.2945055	0.72667533	1.8757801	-0.3605053
BIOCARTA_GPCR_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	31	0.7575969	0.85090363	0.9652186	BIOCARTA_GPCR_PATHWAY	31	1.4492254	0.026128266	0.29130384	2.2068223	-0.6916285
GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP	C7_ immunologic signatures	172	0.7573506	0.963615	0.96540546	GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP	174	1.1367762	0.1891348	0.6946604	1.8941268	-0.3794256
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	c2.CGP_ chemical and genetic perturbations	165	0.7571154	0.95749706	0.96557033	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	167	0.8679932	0.7766498	1	1.6251086	-0.1108778
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN	C7_ immunologic signatures	176	0.7569356	0.9531616	0.9656751	GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN	176	0.877651	0.79492384	1	1.6345866	-0.1207154
GO_VESICLE_MEMBRANE	c5.CC_ GO cellular component	443	0.756829	0.9935414	0.9657015	GO_VESICLE_MEMBRANE	462	1.1373774	0.082	0.6948862	1.8942064	-0.3805484
GO_TRANSFERASE_ACTIVITY_TRANSFERRING_AMINO_ACYL_GROUPS	c5.GO molecular function	21	0.7561506	0.82439023	0.9663699	GO_TRANSFERASE_ACTIVITY_TRANSFERRING_AMINO_ACYL_GROUPS	22	1.2449006	0.20174347	0.5192709	2.0010512	-0.48875
GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN	C7_ immunologic signatures	182	0.7561048	0.9620853	0.96632576	GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN	185	0.60962456	0.99798185	1	1.36572936	0.14648024
GO_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING	c5.GO molecular function	97	0.75541526	0.9194805	0.9670155	GO_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING	101	1.0179827	0.4523305	0.8928825	1.77339796	-0.26256744
GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP	C7_ immunologic signatures	154	0.7553905	0.95226437	0.9669454	GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP	154	0.7230373	0.95146614	1	1.4784278	0.0323532
GO_PHOTORECEPTOR_CELL_DEVELOPMENT	c5.BP_ GO biological process	37	0.755342	0.84126985	0.966905	GO_PHOTORECEPTOR_CELL_DEVELOPMENT	37	-0.9696994	0.5	0.7293669	-0.2143574	1.7250414
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	c2.CGP_ chemical and genetic perturbations	219	0.7552297	0.9666283	0.96693665	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	221	0.9212767	0.71097684	1	1.6765064	-0.166047
GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP	C7_ immunologic signatures	177	0.75521314	0.9533493	0.96685994	GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP	178	0.7974077	0.90678823	1	1.55262084	-0.04219456
GO_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY	c5.GO molecular function	40	0.7550829	0.877292	0.96690637	GO_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY	42	0.9188096	0.599768	1	1.6738925	-0.1637267
GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	C7_ immunologic signatures	151	0.755035	0.9563636	0.9668647	GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	152	0.8487566	0.8040816	1	1.6037916	-0.0937216
GO_QUATERNARY_AMMONIUM_GROUP_TRANSPORT	c5.BP_ GO biological process	16	0.75461453	0.78664494	0.96724236	GO_QUATERNARY_AMMONIUM_GROUP_TRANSPORT	18	0.8667054	0.67612904	1	1.62131993	-0.11209087
AMIT_SERUM_RESPONSE_480_MCF10A	c2.CGP_ chemical and genetic perturbations	28	0.75459474	0.8549849	0.9671671	AMIT_SERUM_RESPONSE_480_MCF10A	29	0.4914305	0.99278843	1	1.24602524	0.26316424
GO_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	96	0.75452363	0.9203085	0.9671494	GO_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY	98	1.028296	0.4475891	0.8784785	1.78281963	-0.27377237
GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN	C7_ immunologic signatures	177	0.75400966	0.96117646	0.9676169	GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN	181	0.68423855	0.9787234	1	1.43824821	0.06977111
GO_INNER_EAR_RECEPTOR_STEREOCILIUM_ORGANIZATION	c5.BP_ GO biological process	18	0.75397336	0.81311476	0.9675599	GO_INNER_EAR_RECEPTOR_STEREOCILIUM_ORGANIZATION	19	0.8121244	0.7425	1	1.56609776	-0.05815104
WANG_CLIM2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	160	0.7538213	0.9537713	0.9676265	WANG_CLIM2_TARGETS_DN	161	-0.8521424	0.8	0.86402637	-0.0983211	1.6059637
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	c2.CGP_ chemical and genetic perturbations	15	0.7537836	0.821192	0.9675727	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	15	-1.5298858	0.03984064	0.1253856	-0.7761022	2.2836694
REACTOME_ERK_MAPK_TARGETS	c2.CP_REACTOME_ Reactome gene sets	20	0.75355744	0.8181818	0.96773654	REACTOME_ERK_MAPK_TARGETS	20	-1.5763525	0.015075377	0.10186043	-0.82279506	2.32990994
GO_KINASE_ACTIVATOR_ACTIVITY	c5.GO molecular function	55	0.7533737	0.8706537	0.9678396	GO_KINASE_ACTIVATOR_ACTIVITY	55	0.7354667	0.8880266	1	1.4888404	0.017907
GO_NECROTIC_CELL_DEATH	c5.BP_ GO biological process	26	0.75331557	0.8404908	0.9678062	GO_NECROTIC_CELL_DEATH	25	1.1268903	0.31272727	0.7114795	1.88020587	-0.37357473
GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN	C7_ immunologic signatures	155	0.7532953	0.9465371	0.96773213	GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN	157	1.6592699	0	0.10481636	2.4125652	-0.9059746
GO_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	43	0.7532651	0.8590705	0.9676694	GO_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY	42	1.3346508	0.08229989	0.3979246	2.0879159	-0.5813857
GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP	C7_ immunologic signatures	179	0.75307155	0.9589202	0.9677916	GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP	184	1.0704801	0.32326284	0.80422455	1.82355165	-0.31740855
GO_LYTIC_VACUOLE_MEMBRANE	c5.CC_ GO cellular component	236	0.753048	0.97303635	0.96772224	GO_LYTIC_VACUOLE_MEMBRANE	240	1.3552982	0.003024194	0.38180554	2.1083462	-0.6022502
GO_VACUOLE_FUSION	c5.BP_ GO biological process	21	0.7525287	0.8428571	0.968196	GO_VACUOLE_FUSION	21	1.2062246	0.24317618	0.58214545	1.9587533	-0.4536959
TOMLINS_PROSTATE_CANCER_UP	c2.CGP_ chemical and genetic perturbations	36	0.7525266	0.85672516	0.9681024	TOMLINS_PROSTATE_CANCER_UP	36	-0.86632633	0.7315436	0.8559458	-0.11379973	1.61885293
GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP	C7_ immunologic signatures	155	0.75236195	0.9533742	0.9681848	GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP	156	-1.7222481	0	0.050023835	-0.96988615	2.47461005
GO_DENDRITIC_SPINE_ORGANIZATION	c5.BP_ GO biological process	17	0.75232047	0.81072557	0.96813494	GO_DENDRITIC_SPINE_ORGANIZATION	17	-0.87929624	0.61603373	0.8459738	-0.12697577	1.63161671
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	162	0.75231004	0.95980513	0.96805036	GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN	163	0.5974259	0.9969574	1	1.34973594	0.15488414
GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP	C7_ immunologic signatures	185	0.75167334	0.9744483	0.9686525	GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP	187	0.73698694	0.95963675	1	1.48866028	0.0146864
GO_SPINAL_CORD_DEVELOPMENT	c5.BP_ GO biological process	94	0.7516214	0.9230769	0.96861464	GO_SPINAL_CORD_DEVELOPMENT	104	0.72772425	0.9412998	1	1.47934565	0.02389715
REACTOME_RECYCLING_PATHWAY_OF_L1	c2.CP_REACTOME_ Reactome gene sets	25	0.7514632	0.8311307	0.9686947	REACTOME_RECYCLING_PATHWAY_OF_L1	25	0.68303764	0.8913309	1	1.43450084	0.06842556
GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN	C7_ immunologic signatures	171	0.7511353	0.97727275	0.9689577	GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN	173	0.98373914	0.5388548	0.9430407	1.73487444	-0.23260384
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	c2.CGP_ chemical and genetic perturbations	15	0.750866	0.83753943	0.96915585	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	16	0.56813806	0.95652175	1	1.31900406	0.18272794
AIYAR_COBRA1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	36	0.7508573	0.8607407	0.96906954	AIYAR_COBRA1_TARGETS_UP	35	0.8409365	0.7345751	1	1.5917938	-0.0900792
GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_UP	C7_ immunologic signatures	175	0.7507048	0.9687875	0.96913505	GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_UP	179	0.96757066	0.5857868	0.96393573	1.71827546	-0.21686586
GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	C7_ immunologic signatures	163	0.75045484	0.96167666	0.9693109	GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	165	-0.8380692	0.93333334	0.87671477	-0.08761436	1.58852404
CHR12P12	C1: positional gene sets	38	0.7503646	0.8708752	0.9693119	CHR12P12	41	1.1534208	0.2434881	0.6627601	1.9037854	-0.4030562
GO_LONG_TERM_MEMORY	c5.BP_ GO biological process	27	0.75036186	0.85	0.96921885	GO_LONG_TERM_MEMORY	28	0.8296865	0.72296476	1	1.58004836	-0.07932464
GO_STEROID_BINDING	c5.GO molecular function	76	0.7502179	0.9023067	0.969268	GO_STEROID_BINDING	81	1.053624	0.39055794	0.8361504	1.8038419	-0.3034061
GSE17721_LPS_VS_POLYIC_1H_BMDC_UP	C7_ immunologic signatures	178	0.7501575	0.97044915	0.96923846	GSE17721_LPS_VS_POLYIC_1H_BMDC_UP	174	0.93282056	0.6511156	0.9972816	1.68297806	-0.18266306
GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	C7_ immunologic signatures	183	0.74979097	0.96370023	0.9695281	GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	186	0.63281053	0.99493927	1	1.3826015	0.11698044
GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP	C7_ immunologic signatures	180	0.74958193	0.97261906	0.96965283	GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP	181	1.0000132	0.5071283	0.9243593	1.74959513	-0.25043127
GO_HISTONE_H3_ACETYLATION	c5.BP_ GO biological process	40	0.74908197	0.8880707	0.97008574	GO_HISTONE_H3_ACETYLATION	41	0.4494649	0.99770904	1	1.19854687	0.29961707
GO_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	87	0.74894685	0.92348284	0.9701343	GO_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	88	-1.0847759	0.21666667	0.5430373	-0.33582905	1.83372275
GSE27786_LSK_VS_CD8_TCELL_DN	C7_ immunologic signatures	169	0.7488798	0.96480584	0.9701088	GSE27786_LSK_VS_CD8_TCELL_DN	172	0.6763799	0.98378927	1	1.4252597	0.0724999
GO_EMBRYONIC_PLACENTA_MORPHOGENESIS	c5.BP_ GO biological process	20	0.7487456	0.8315133	0.9701503	GO_EMBRYONIC_PLACENTA_MORPHOGENESIS	21	1.0954366	0.3472222	0.7641659	1.8441822	-0.346691
MARCHINI_TRABECTEDIN_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	17	0.74849105	0.82222223	0.97032493	MARCHINI_TRABECTEDIN_RESISTANCE_UP	17	0.8880785	0.6509804	1	1.63656955	-0.13958745
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	15	0.7479991	0.81054366	0.97073597	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	15	1.3490311	0.10857909	0.38323748	2.0970302	-0.601032
GSE17721_POLYIC_VS_CPG_1H_BMDC_DN	C7_ immunologic signatures	179	0.74766266	0.9659367	0.97099423	GSE17721_POLYIC_VS_CPG_1H_BMDC_DN	185	0.9748521	0.5747475	0.9558864	1.72251476	-0.22718944
GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN	C7_ immunologic signatures	180	0.74765486	0.9775414	0.9709065	GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN	185	0.6450838	0.99088144	1	1.39273866	0.10257106
GO_OSTEOCLAST_DIFFERENTIATION	c5.BP_ GO biological process	27	0.74765027	0.8562691	0.97081584	GO_OSTEOCLAST_DIFFERENTIATION	26	1.4474039	0.04767726	0.2936189	2.19505417	-0.69975363
LEE_LIVER_CANCER_MYC_E2F1_DN	c2.CGP_ chemical and genetic perturbations	55	0.7475466	0.90616244	0.9708303	LEE_LIVER_CANCER_MYC_E2F1_DN	55	0.80018365	0.79845816	1	1.54773025	-0.05263705
ACACTAC_MIR1423P	c3.MIR_ microRNA targets	118	0.7473177	0.9475032	0.97096914	ACACTAC_MIR1423P	122	-1.1969622	0	0.3854342	-0.4496445	1.9442799
EGR_Q6	c3.TFT_ transcription factor targets	244	0.7472263	0.9718785	0.97096604	EGR_Q6	250	0.74498886	0.96884423	1	1.49221516	0.00223744
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY	c2.CP_ Canonical pathways	37	0.746967	0.8846715	0.9711428	PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY	38	1.0582676	0.39657143	0.827379	1.8052346	-0.3113006
GO_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE	c5.BP_ GO biological process	20	0.74661237	0.8323263	0.9714063	GO_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE	22	0.87983143	0.6520651	1	1.6264438	-0.13321906
GO_NECROPTOTIC_PROCESS	c5.BP_ GO biological process	19	0.74651	0.8274268	0.97142035	GO_NECROPTOTIC_PROCESS	19	1.1497816	0.2878981	0.67030984	1.8962916	-0.4032716
GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	C7_ immunologic signatures	175	0.74644774	0.95813954	0.97138596	GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	176	0.7485414	0.94159114	1	1.49498914	-0.00209366
GO_CELLULAR_PROTEIN_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	299	0.74553156	0.99335545	0.9722177	GO_CELLULAR_PROTEIN_COMPLEX_ASSEMBLY	302	0.86846054	0.8458458	1	1.6139921	-0.12292898
GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_UP	C7_ immunologic signatures	183	0.74508953	0.9669031	0.9725802	GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_UP	181	0.91500735	0.7145749	1	1.66009688	-0.16991782
CHR8Q11	C1: positional gene sets	18	0.7450568	0.8248408	0.97251767	CHR8Q11	19	1.0599465	0.39821884	0.8245068	1.8050033	-0.3148897
GO_SH2_DOMAIN_BINDING	c5.GO molecular function	27	0.7448319	0.8595166	0.9726515	GO_SH2_DOMAIN_BINDING	27	1.1794096	0.25786924	0.6242574	1.9242415	-0.4345777
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN	C7_ immunologic signatures	136	0.7446938	0.96329117	0.9726989	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN	144	0.8860701	0.7571138	1	1.6307639	-0.1413763
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	c2.CGP_ chemical and genetic perturbations	92	0.744582	0.94598156	0.9727089	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	95	0.6457532	0.97899157	1	1.3903352	0.0988288
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	c2.CGP_ chemical and genetic perturbations	16	0.7444851	0.8300971	0.97271353	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	17	0.9840423	0.5019608	0.9426186	1.7285274	-0.2395572
GO_REGULATION_OF_VACUOLAR_TRANSPORT	c5.BP_ GO biological process	28	0.74448293	0.84917045	0.9726196	GO_REGULATION_OF_VACUOLAR_TRANSPORT	28	0.64550495	0.9209581	1	1.38998788	0.09897798
GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS	c5.BP_ GO biological process	59	0.74431014	0.909465	0.9726978	GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS	60	0.6515197	0.96043956	1	1.39582984	0.09279044
GSE3982_MAC_VS_TH2_DN	C7_ immunologic signatures	172	0.7442396	0.96856105	0.9726741	GSE3982_MAC_VS_TH2_DN	178	0.60240006	0.9989858	1	1.34663966	0.14183954
GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN	C7_ immunologic signatures	178	0.7440476	0.9726516	0.9727662	GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN	180	-0.9635476	0.46666667	0.7374993	-0.2195	1.7075952
CHR8Q13	C1: positional gene sets	28	0.7434829	0.875	0.9732277	CHR8Q13	31	1.0058508	0.48329356	0.9139085	1.7493337	-0.2623679
SCIBETTA_KDM5B_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	17	0.7430491	0.8328076	0.97356194	SCIBETTA_KDM5B_TARGETS_UP	17	0.71771383	0.84514433	1	1.46076293	0.02533527
GENTILE_UV_RESPONSE_CLUSTER_D6	c2.CGP_ chemical and genetic perturbations	35	0.74303555	0.84870315	0.9734796	GENTILE_UV_RESPONSE_CLUSTER_D6	35	0.6018234	0.9680473	1	1.34485895	0.14121215
GO_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	21	0.7428746	0.81388015	0.97354525	GO_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY	20	0.6302437	0.94353825	1	1.3731183	0.1126309
GO_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY	c5.GO molecular function	20	0.7426268	0.8317308	0.97369397	GO_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY	20	0.8882905	0.6328321	1	1.6309173	-0.1456637
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	c2.CGP_ chemical and genetic perturbations	30	0.742626	0.8646154	0.97359896	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	30	-0.76854306	0.92896175	0.92875856	-0.02591706	1.51116906
GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN	C7_ immunologic signatures	176	0.74260116	0.97199535	0.9735285	GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN	179	0.8522734	0.81945837	1	1.59487456	-0.10967224
GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP	C7_ immunologic signatures	185	0.7424547	0.9752066	0.9735703	GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP	185	-1.1449192	0	0.4502536	-0.4024645	1.8873739
CHEOK_RESPONSE_TO_HD_MTX_UP	c2.CGP_ chemical and genetic perturbations	15	0.7424148	0.79931974	0.97351354	CHEOK_RESPONSE_TO_HD_MTX_UP	17	0.87772447	0.6526316	1	1.62013927	-0.13530967
GO_MITOCHONDRION_MORPHOGENESIS	c5.BP_ GO biological process	19	0.7416185	0.84663534	0.9741959	GO_MITOCHONDRION_MORPHOGENESIS	19	-0.6791753	0.91121495	0.96871364	0.0624432	1.4207938
GO_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS	c5.BP_ GO biological process	55	0.74159276	0.8888889	0.97412807	GO_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS	60	1.1137403	0.31712708	0.7319865	1.85533306	-0.37214754
CHR11Q14	C1: positional gene sets	32	0.741444	0.8569343	0.9741754	CHR11Q14	35	-0.8387011	0.76	0.87699586	-0.0972571	1.5801451
MODULE_239	c4.CM_ cancer modules	111	0.7412233	0.94900495	0.97429407	MODULE_239	111	-1.3582603	0.057142857	0.23584539	-0.617037	2.0994836
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	c2.CGP_ chemical and genetic perturbations	44	0.74087924	0.8741059	0.97453445	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	45	-0.8039506	0.852459	0.90197855	-0.06307136	1.54482984
GCM_MYST2	c4.CGN_ cancer gene neighborhoods	158	0.7406406	0.9654321	0.97467	GCM_MYST2	158	-0.98532504	0.45454547	0.7070038	-0.24468444	1.72596564
GSE27786_NKCELL_VS_MONO_MAC_UP	C7_ immunologic signatures	174	0.7397713	0.9720874	0.9754097	GSE27786_NKCELL_VS_MONO_MAC_UP	173	-0.95204973	0.6666667	0.7540006	-0.21227843	1.69182103
GCM_DLG1	c4.CGN_ cancer gene neighborhoods	67	0.739364	0.9104895	0.9756952	GCM_DLG1	67	0.70096815	0.9191257	1	1.44033215	0.03839585
GO_LYSOSOMAL_TRANSPORT	c5.BP_ GO biological process	61	0.73867697	0.9149233	0.976247	GO_LYSOSOMAL_TRANSPORT	62	0.9234398	0.6198257	1	1.66211677	-0.18476283
GO_LABYRINTHINE_LAYER_DEVELOPMENT	c5.BP_ GO biological process	39	0.7386432	0.87683284	0.976182	GO_LABYRINTHINE_LAYER_DEVELOPMENT	43	0.8111747	0.7625	1	1.5498179	-0.0725315
REACTOME_GLOBAL_GENOMIC_NER_GG_NER	c2.CP_REACTOME_ Reactome gene sets	30	0.7386317	0.86153847	0.97609556	REACTOME_GLOBAL_GENOMIC_NER_GG_NER	30	-1.0912732	0.2857143	0.53151906	-0.3526415	1.8299049
MORI_PLASMA_CELL_DN	c2.CGP_ chemical and genetic perturbations	27	0.7385441	0.83994126	0.9760826	MORI_PLASMA_CELL_DN	28	0.7546602	0.83413464	1	1.4932043	-0.0161161
GO_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	28	0.7384956	0.8530735	0.97603184	GO_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS	29	0.8587637	0.70740306	1	1.5972593	-0.1202681
GO_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	124	0.73830414	0.957638	0.97611755	GO_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	134	1.2427555	0.08213552	0.522712	1.98105964	-0.50445136
GO_FEMALE_GENITALIA_DEVELOPMENT	c5.BP_ GO biological process	16	0.73814005	0.84006464	0.97617096	GO_FEMALE_GENITALIA_DEVELOPMENT	16	1.1100951	0.35449734	0.73774064	1.84823515	-0.37195505
GO_POSITIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY	c5.BP_ GO biological process	205	0.7380865	0.974537	0.97612804	GO_POSITIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY	212	1.1991153	0.088709675	0.5935547	1.9372018	-0.4610288
GSE27786_LIN_NEG_VS_NEUTROPHIL_DN	C7_ immunologic signatures	177	0.7380709	0.9799528	0.9760469	GSE27786_LIN_NEG_VS_NEUTROPHIL_DN	179	0.7712127	0.9328586	1	1.5092836	-0.0331418
CHEN_ETV5_TARGETS_SERTOLI	c2.CGP_ chemical and genetic perturbations	17	0.7376514	0.8409836	0.97634876	CHEN_ETV5_TARGETS_SERTOLI	16	1.205187	0.22351421	0.58240515	1.9428384	-0.4675356
GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	C7_ immunologic signatures	135	0.73754364	0.9572864	0.97635394	GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	134	0.7835759	0.90408164	1	1.52111954	-0.04603226
GO_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS	c5.GO molecular function	22	0.7375297	0.8359375	0.97627205	GO_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS	22	-1.0060682	0.44392523	0.6761771	-0.2685385	1.7435979
GSE11818_WT_VS_DICER_KO_TREG_DN	C7_ immunologic signatures	134	0.73742056	0.95477384	0.97627664	GSE11818_WT_VS_DICER_KO_TREG_DN	139	0.77132654	0.9238683	1	1.5087471	-0.03390598
GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	C7_ immunologic signatures	172	0.7374038	0.96449023	0.97619534	GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	172	0.99323916	0.51117885	0.9313495	1.73064296	-0.25583536
GSE27786_CD8_TCELL_VS_NKTCELL_DN	C7_ immunologic signatures	183	0.73735195	0.97290933	0.97614497	GSE27786_CD8_TCELL_VS_NKTCELL_DN	186	1.2108811	0.0881459	0.57591695	1.94823305	-0.47352915
RRCCGTTA_UNKNOWN	c3.TFT_ transcription factor targets	79	0.73725414	0.9286694	0.97613883	RRCCGTTA_UNKNOWN	80	-1.4571307	0	0.1685395	-0.71987656	2.19438484
GO_MEMBRANE_LIPID_CATABOLIC_PROCESS	c5.BP_ GO biological process	22	0.73723775	0.86129034	0.9760572	GO_MEMBRANE_LIPID_CATABOLIC_PROCESS	23	0.82625824	0.73651195	1	1.56349599	-0.08902049
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN	C7_ immunologic signatures	106	0.7370916	0.95171535	0.9760917	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN	115	1.1971669	0.13584118	0.5969964	1.9342585	-0.4600753
GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN	C7_ immunologic signatures	176	0.7368051	0.97940505	0.97626126	GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN	176	0.63144857	0.9919028	1	1.36825367	0.10535653
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	c2.CGP_ chemical and genetic perturbations	41	0.7367801	0.87847733	0.9761896	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	41	-0.95201993	0.5588235	0.75335246	-0.21523983	1.68880003
ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE	c2.CGP_ chemical and genetic perturbations	15	0.73646533	0.83495146	0.97636884	ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE	16	0.94296455	0.5732648	0.988624	1.67942988	-0.20649922
GO_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS	c5.BP_ GO biological process	46	0.73639387	0.89244187	0.9763385	GO_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS	48	0.8815091	0.6769406	1	1.61790297	-0.14511523
GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP	C7_ immunologic signatures	174	0.73635316	0.9713604	0.9762777	GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP	176	1.1832664	0.112804875	0.61740315	1.91961956	-0.44691324
HALLMARK_BILE_ACID_METABOLISM	H_ hallmark gene sets	101	0.7359871	0.9666239	0.97651285	HALLMARK_BILE_ACID_METABOLISM	103	0.9765874	0.553125	0.953467	1.7125745	-0.2406003
GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN	C7_ immunologic signatures	181	0.7359461	0.9669811	0.9764514	GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN	182	0.7645204	0.93756294	1	1.5004665	-0.0285743
GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN	C7_ immunologic signatures	130	0.73584616	0.9641975	0.97644615	GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN	129	0.62059295	0.9937759	1	1.35643911	0.11525321
GO_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	174	0.735809	0.98224854	0.97638315	GO_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY	176	0.90320224	0.72959185	1	1.63901124	-0.16739324
GO_INTERMEDIATE_FILAMENT_CYTOSKELETON	c5.CC_ GO cellular component	112	0.7357947	0.94494236	0.97630024	GO_INTERMEDIATE_FILAMENT_CYTOSKELETON	126	1.0561259	0.36485097	0.83122677	1.7919206	-0.3203312
GNF2_ANP32B	c4.CGN_ cancer gene neighborhoods	34	0.7357186	0.88335705	0.97627157	GNF2_ANP32B	34	-2.3504038	0	0.000111137	-1.6146852	3.0861224
GO_NUCLEUS_ORGANIZATION	c5.BP_ GO biological process	117	0.7356533	0.95535713	0.97623485	GO_NUCLEUS_ORGANIZATION	123	0.7230509	0.9346473	1	1.4587042	0.0126024
GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN	C7_ immunologic signatures	147	0.73560655	0.9676617	0.9761843	GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN	149	1.0683312	0.33981577	0.8086325	1.80393775	-0.33272465
GO_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING	c5.BP_ GO biological process	38	0.7353348	0.9077599	0.97634137	GO_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING	38	0.66878444	0.9351415	1	1.40411924	0.06655036
GO_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE	c5.BP_ GO biological process	29	0.7349329	0.86873156	0.97660697	GO_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE	29	0.76056796	0.83312577	1	1.49550086	-0.02563506
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP	C7_ immunologic signatures	176	0.7348298	0.96740395	0.9766031	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP	177	0.8709098	0.79352224	1	1.6057396	-0.13608
GO_REGULATION_OF_FILOPODIUM_ASSEMBLY	c5.BP_ GO biological process	30	0.7344521	0.8834356	0.9768388	GO_REGULATION_OF_FILOPODIUM_ASSEMBLY	33	1.160875	0.24009603	0.6513314	1.8953271	-0.4264229
GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN	C7_ immunologic signatures	184	0.73423237	0.98490125	0.97694033	GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN	186	1.0383993	0.40040445	0.8610404	1.77263167	-0.30416693
GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP	C7_ immunologic signatures	180	0.73421174	0.977327	0.9768624	GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP	182	-1.4168307	0	0.19521531	-0.68261896	2.15104244
SASSON_RESPONSE_TO_FORSKOLIN_UP	c2.CGP_ chemical and genetic perturbations	79	0.73343545	0.9348958	0.97745514	SASSON_RESPONSE_TO_FORSKOLIN_UP	80	1.0165387	0.48526317	0.8951698	1.74997415	-0.28310325
GO_RESPONSE_TO_VITAMIN_A	c5.BP_ GO biological process	16	0.7333535	0.8356589	0.9774329	GO_RESPONSE_TO_VITAMIN_A	18	1.4488693	0.045393858	0.2919171	2.1822228	-0.7155158
GSE19512_NAUTRAL_VS_INDUCED_TREG_DN	C7_ immunologic signatures	166	0.73313475	0.9787736	0.9775266	GSE19512_NAUTRAL_VS_INDUCED_TREG_DN	170	1.0704097	0.3343465	0.8042258	1.80354445	-0.33727495
GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	C7_ immunologic signatures	174	0.7326939	0.98313254	0.9778098	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	174	1.0332842	0.43680486	0.8717115	1.7659781	-0.3005903
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_UP	C7_ immunologic signatures	158	0.7323842	0.9677419	0.9779855	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_UP	171	1.0377992	0.40141556	0.8622735	1.7701834	-0.305415
PID_NFAT_3PATHWAY	c2.CP_ Canonical pathways	52	0.73215514	0.9257642	0.97809017	PID_NFAT_3PATHWAY	52	1.2339592	0.1513453	0.5352852	1.96611434	-0.50180406
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	c2.CP_REACTOME_ Reactome gene sets	42	0.7321429	0.9047619	0.9780045	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	43	1.5692863	0.008064516	0.19041105	2.3014292	-0.8371434
GO_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION	c5.BP_ GO biological process	19	0.73188627	0.8537736	0.9781323	GO_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION	20	0.75724494	0.8002611	1	1.48913121	-0.02535867
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	c2.CGP_ chemical and genetic perturbations	16	0.73129004	0.8314425	0.9785513	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16	1.0323738	0.4457216	0.87288505	1.76366384	-0.30108376
GO_NEUROTRANSMITTER_METABOLIC_PROCESS	c5.BP_ GO biological process	22	0.73128563	0.85603714	0.9784603	GO_NEUROTRANSMITTER_METABOLIC_PROCESS	24	1.089469	0.3726708	0.7718293	1.82075463	-0.35818337
ST_TUMOR_NECROSIS_FACTOR_PATHWAY	c2.CP_ Canonical pathways	29	0.7312045	0.881203	0.97843194	ST_TUMOR_NECROSIS_FACTOR_PATHWAY	28	0.672071	0.8926417	1	1.4032755	0.0591335
GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN	C7_ immunologic signatures	179	0.7310699	0.98190594	0.97845405	GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN	183	0.6853547	0.98785424	1	1.4164246	0.0457152
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN	C7_ immunologic signatures	176	0.7309724	0.9760192	0.9784416	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN	178	0.5930985	1	1	1.3240709	0.1378739
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	c2.CP_REACTOME_ Reactome gene sets	35	0.73080873	0.8688047	0.97848797	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	42	0.75940406	0.8352535	1	1.49021279	-0.02859533
GSE15659_RESTING_VS_ACTIVATED_TREG_DN	C7_ immunologic signatures	164	0.73070145	0.9786223	0.9784786	GSE15659_RESTING_VS_ACTIVATED_TREG_DN	165	1.0642376	0.3628049	0.81524473	1.79493905	-0.33353615
GO_PIGMENT_GRANULE_LOCALIZATION	c5.BP_ GO biological process	22	0.73061615	0.8374613	0.97845125	GO_PIGMENT_GRANULE_LOCALIZATION	23	1.031008	0.4340796	0.8742672	1.76162415	-0.30039185
GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING	c5.GO molecular function	122	0.7305553	0.9677819	0.9784089	GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING	124	-1.1447226	0.11111111	0.4500052	-0.4141673	1.8752779
REACTOME_DOWNSTREAM_TCR_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	28	0.73014086	0.87900877	0.9786609	REACTOME_DOWNSTREAM_TCR_SIGNALING	30	1.0297154	0.44717446	0.87588507	1.75985626	-0.29957454
GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN	C7_ immunologic signatures	183	0.7290231	0.98088413	0.9795035	GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN	187	0.9695449	0.5861027	0.9617306	1.698568	-0.2405218
GO_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY	c5.BP_ GO biological process	44	0.72897255	0.9026549	0.9794499	GO_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY	45	0.72521716	0.8891429	1	1.45418971	0.00375539
GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	C7_ immunologic signatures	173	0.7285065	0.9753521	0.97973484	GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	176	1.130983	0.21175279	0.7052213	1.8594895	-0.4024765
LIN_MELANOMA_COPY_NUMBER_DN	c2.CGP_ chemical and genetic perturbations	36	0.7281589	0.88081396	0.97992575	LIN_MELANOMA_COPY_NUMBER_DN	36	0.8946527	0.6373494	1	1.6228116	-0.1664938
GO_PHOTOTRANSDUCTION_VISIBLE_LIGHT	c5.BP_ GO biological process	18	0.72780395	0.86245954	0.98012155	GO_PHOTOTRANSDUCTION_VISIBLE_LIGHT	18	-1.0204014	0.40888888	0.65786654	-0.29259745	1.74820535
GO_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE	c5.CC_ GO cellular component	93	0.72771287	0.9528178	0.9800998	GO_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE	95	1.1204938	0.27916667	0.72290903	1.84820667	-0.39278093
TAANNYSGCG_UNKNOWN	c3.TFT_ transcription factor targets	73	0.72734034	0.94165534	0.980304	TAANNYSGCG_UNKNOWN	75	-1.1123366	0.1875	0.501955	-0.38499626	1.83967694
BIOCARTA_VEGF_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	28	0.72689325	0.8763693	0.9805739	BIOCARTA_VEGF_PATHWAY	28	0.92044437	0.59592324	1	1.64733762	-0.19355112
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	c2.CP_BIOCARTA_ BioCarta gene sets	98	0.7267855	0.9617347	0.9805663	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	102	1.237051	0.11030177	0.5307065	1.9638365	-0.5102655
GO_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT	c5.CC_ GO cellular component	92	0.726533	0.9550706	0.9806794	GO_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT	93	0.70292485	0.93993676	1	1.42945785	0.02360815
STAT1_03	c3.TFT_ transcription factor targets	215	0.7262233	0.9849711	0.9808298	STAT1_03	218	0.6661989	0.9949495	1	1.3924222	0.0600244
GO_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT	c5.BP_ GO biological process	37	0.7261799	0.8955882	0.98076826	GO_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT	37	0.9377889	0.6023392	0.99338377	1.6639688	-0.211609
GO_INTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE	c5.CC_ GO cellular component	221	0.725859	0.9908257	0.9809366	GO_INTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE	225	1.1612998	0.12714429	0.6512999	1.8871588	-0.4354408
GO_MAINTENANCE_OF_LOCATION_IN_CELL	c5.BP_ GO biological process	91	0.72582394	0.95646435	0.9808698	GO_MAINTENANCE_OF_LOCATION_IN_CELL	91	0.8731735	0.7251586	1	1.59899744	-0.14734956
GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP	C7_ immunologic signatures	188	0.7256847	0.99311924	0.98088306	GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP	189	-0.8907796	0.9166667	0.8323803	-0.1650949	1.6164643
GO_PIGMENTATION	c5.BP_ GO biological process	74	0.72505206	0.94736844	0.9812921	GO_PIGMENTATION	78	0.76594704	0.86199576	1	1.4909991	-0.04089498
GO_MEMBRANE_DISASSEMBLY	c5.BP_ GO biological process	44	0.7249221	0.90960455	0.981303	GO_MEMBRANE_DISASSEMBLY	44	0.8178459	0.7650463	1	1.542768	-0.0929238
GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP	C7_ immunologic signatures	149	0.724369	0.98685783	0.9816418	GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP	154	-1.2941264	0	0.28892058	-0.5697574	2.0184954
GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN	C7_ immunologic signatures	187	0.7240565	0.98472387	0.98179615	GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN	190	0.9150936	0.6985887	1	1.6391501	-0.1910371
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	c2.CP_REACTOME_ Reactome gene sets	15	0.72370344	0.84375	0.9819685	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	17	1.1915088	0.25492772	0.60461026	1.91521224	-0.46780536
GCM_FANCL	c4.CGN_ cancer gene neighborhoods	22	0.723656	0.86175114	0.9819116	GCM_FANCL	22	-0.8721692	0.6486486	0.8536446	-0.1485132	1.5958252
GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP	C7_ immunologic signatures	169	0.72350764	0.9820144	0.981931	GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP	171	0.7418501	0.9574468	1	1.46535774	-0.01834246
GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN	C7_ immunologic signatures	164	0.7233484	0.9842041	0.9819608	GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN	169	0.86077327	0.7905544	1	1.58412167	-0.13742487
GO_REGULATION_OF_VESICLE_FUSION	c5.BP_ GO biological process	53	0.7230587	0.92362094	0.982092	GO_REGULATION_OF_VESICLE_FUSION	54	1.5728654	0.003314917	0.18642578	2.2959241	-0.8498067
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	c2.CGP_ chemical and genetic perturbations	144	0.7228026	0.9732685	0.98219085	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	145	-1.6665229	0	0.06661753	-0.9437203	2.3893255
PID_TCPTP_PATHWAY	c2.CP_ Canonical pathways	42	0.7224691	0.8938714	0.9823466	PID_TCPTP_PATHWAY	43	1.3789607	0.06101695	0.35615525	2.1014298	-0.6564916
GO_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	25	0.72238445	0.87738854	0.98231417	GO_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS	26	-1.1706465	0.19339623	0.41580898	-0.44826205	1.89303095
GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	C7_ immunologic signatures	169	0.7223673	0.97973776	0.9822308	GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	170	0.7801496	0.92166835	1	1.5025169	-0.0577823
CHANGOLKAR_H2AFY_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	34	0.7221528	0.8854626	0.9823004	CHANGOLKAR_H2AFY_TARGETS_DN	34	0.8263078	0.75555557	1	1.5484606	-0.104155
GNF2_TNFRSF1B	c4.CGN_ cancer gene neighborhoods	47	0.7219717	0.92083335	0.9823423	GNF2_TNFRSF1B	50	1.0702361	0.367713	0.8047144	1.7922078	-0.3482644
GSE14308_TH1_VS_TH17_DN	C7_ immunologic signatures	175	0.72127855	0.9893743	0.9827716	GSE14308_TH1_VS_TH17_DN	176	0.9168764	0.7112462	1	1.63815495	-0.19559785
NIELSEN_LEIOMYOSARCOMA_CNN1_DN	c2.CGP_ chemical and genetic perturbations	19	0.7211057	0.86541474	0.9828102	NIELSEN_LEIOMYOSARCOMA_CNN1_DN	20	-1.0124621	0.40930232	0.6697263	-0.2913564	1.7335678
GO_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION	c5.BP_ GO biological process	15	0.7208348	0.8429752	0.9829167	GO_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION	18	1.4003855	0.07095926	0.33913332	2.1212203	-0.6795507
GSE17721_CTRL_VS_LPS_2H_BMDC_UP	C7_ immunologic signatures	177	0.72056526	0.9843562	0.98302966	GSE17721_CTRL_VS_LPS_2H_BMDC_UP	181	0.71752137	0.958502	1	1.43808663	0.00304389
GO_IRON_ION_BINDING	c5.GO molecular function	121	0.720546	0.97384804	0.9829491	GO_IRON_ION_BINDING	123	1.3881961	0.014418126	0.34813482	2.1087421	-0.6676501
GO_PRE_AUTOPHAGOSOMAL_STRUCTURE	c5.CC_ GO cellular component	28	0.72034746	0.88736683	0.9829975	GO_PRE_AUTOPHAGOSOMAL_STRUCTURE	28	0.89481944	0.63325185	1	1.6151669	-0.17447198
GO_SECONDARY_METABOLIC_PROCESS	c5.BP_ GO biological process	40	0.7202897	0.9030837	0.98294336	GO_SECONDARY_METABOLIC_PROCESS	41	0.7606856	0.8335274	1	1.4809753	-0.0403959
GO_REGULATION_OF_PROTEIN_ACETYLATION	c5.BP_ GO biological process	59	0.7199752	0.9256662	0.9830734	GO_REGULATION_OF_PROTEIN_ACETYLATION	60	-0.8496573	0.8041237	0.8683382	-0.1296821	1.5696325
GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN	C7_ immunologic signatures	165	0.71964675	0.9808383	0.98322505	GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN	169	0.8281298	0.86598986	1	1.54777655	-0.10848305
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	153	0.718755	0.98431844	0.983792	GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	162	1.103754	0.24671385	0.749913	1.822509	-0.384999
MODULE_218	c4.CM_ cancer modules	17	0.71863395	0.86862445	0.9837852	MODULE_218	19	0.8671393	0.67794484	1	1.58577325	-0.14850535
WU_HBX_TARGETS_1_DN	c2.CGP_ chemical and genetic perturbations	21	0.71845233	0.8649469	0.98381746	WU_HBX_TARGETS_1_DN	21	-0.77717704	0.80203044	0.92322683	-0.05872471	1.49562937
GO_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_BINDING	c5.GO molecular function	21	0.71808505	0.8701923	0.98399985	GO_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_BINDING	22	-1.0002521	0.43010753	0.684876	-0.28216705	1.71833715
GSE360_CTRL_VS_L_MAJOR_MAC_UP	C7_ immunologic signatures	171	0.71789753	0.97906977	0.98403937	GSE360_CTRL_VS_L_MAJOR_MAC_UP	176	0.96512306	0.595117	0.9651442	1.68302059	-0.24722553
FINETTI_BREAST_CANCER_KINOME_GREEN	c2.CGP_ chemical and genetic perturbations	15	0.7178714	0.8452769	0.9839634	FINETTI_BREAST_CANCER_KINOME_GREEN	16	1.2369989	0.1904762	0.53051376	1.9548703	-0.5191275
GO_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY	c5.GO molecular function	27	0.71785766	0.8836858	0.983878	GO_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY	30	1.0823667	0.38270143	0.7831127	1.80022436	-0.36450904
CHR11P13	C1: positional gene sets	34	0.71777	0.9040698	0.98384666	CHR11P13	35	0.67229486	0.9138135	1	1.39006486	0.04547514
BIOCARTA_NFKB_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	23	0.71740115	0.88080496	0.9840152	BIOCARTA_NFKB_PATHWAY	22	1.4066312	0.048029557	0.33100083	2.12403235	-0.68923005
GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN	C7_ immunologic signatures	171	0.717168	0.9866667	0.98408484	GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN	171	0.9897729	0.5298886	0.9355354	1.7069409	-0.2726049
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	169	0.7171534	0.98671496	0.9839994	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN	169	-1.1106645	0.13333334	0.50448155	-0.3935111	1.8278179
AAGWWRNYGGC_UNKNOWN	c3.TFT_ transcription factor targets	111	0.71714634	0.97834396	0.9839084	AAGWWRNYGGC_UNKNOWN	110	-0.899958	0.88461536	0.8214184	-0.18281166	1.61710434
GO_POSITIVE_REGULATION_OF_STEROL_TRANSPORT	c5.BP_ GO biological process	16	0.71680045	0.8532258	0.9840635	GO_POSITIVE_REGULATION_OF_STEROL_TRANSPORT	16	0.7851343	0.7702703	1	1.50193475	-0.06833385
GO_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY	c5.BP_ GO biological process	19	0.7166826	0.8844376	0.9840521	GO_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY	19	0.4671316	0.9934037	1	1.1838142	0.249551
CHR17Q24	C1: positional gene sets	28	0.7164989	0.8768769	0.98408943	CHR17Q24	31	1.1626805	0.2555012	0.64887846	1.8791794	-0.4461816
DORMOY_ELAVL1_TARGETS	c2.CGP_ chemical and genetic perturbations	16	0.71592724	0.8516746	0.984401	DORMOY_ELAVL1_TARGETS	15	0.54664826	0.96675533	1	1.2625755	0.16927898
KEGG_PRIMARY_IMMUNODEFICIENCY	c2.CP_BIOCARTA_ BioCarta gene sets	30	0.71571857	0.8786482	0.98444897	KEGG_PRIMARY_IMMUNODEFICIENCY	34	0.95494044	0.56973994	0.97628224	1.67065901	-0.23922187
GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP	C7_ immunologic signatures	174	0.71511817	0.9919262	0.98477244	GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP	176	0.8468186	0.8326572	1	1.56193677	-0.13170043
WU_HBX_TARGETS_2_UP	c2.CGP_ chemical and genetic perturbations	18	0.7150117	0.8637084	0.98475087	WU_HBX_TARGETS_2_UP	18	0.74263173	0.8174905	1	1.45764343	-0.02762003
GO_UTERUS_DEVELOPMENT	c5.BP_ GO biological process	16	0.7149687	0.8685065	0.98468274	GO_UTERUS_DEVELOPMENT	18	0.99619776	0.4830287	0.92926294	1.71116646	-0.28122906
GO_ATRIOVENTRICULAR_VALVE_MORPHOGENESIS	c5.BP_ GO biological process	16	0.71494555	0.8612521	0.98460424	GO_ATRIOVENTRICULAR_VALVE_MORPHOGENESIS	16	0.77316827	0.7899604	1	1.48811382	-0.05822272
GO_REGULATION_OF_NUCLEASE_ACTIVITY	c5.BP_ GO biological process	22	0.7143069	0.8508634	0.9849561	GO_REGULATION_OF_NUCLEASE_ACTIVITY	21	-0.9909667	0.43939394	0.70140517	-0.2766598	1.7052736
GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN	C7_ immunologic signatures	157	0.71412313	0.9915561	0.98498726	GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN	164	0.7331053	0.9438776	1	1.44722843	-0.01898217
MILI_PSEUDOPODIA_HAPTOTAXIS_UP	c2.CGP_ chemical and genetic perturbations	460	0.71406794	0.99893844	0.9849297	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	460	0	0	0	0.71406794	0.71406794
GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP	C7_ immunologic signatures	166	0.7139129	0.9880096	0.984938	GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP	168	0.7882089	0.8872105	1	1.5021218	-0.074296
GO_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR	c5.BP_ GO biological process	25	0.71389467	0.8765625	0.9848539	GO_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR	25	0.993488	0.49388754	0.9309752	1.70738267	-0.27959333
GO_RESPONSE_TO_SALT_STRESS	c5.BP_ GO biological process	15	0.71364385	0.8529887	0.984932	GO_RESPONSE_TO_SALT_STRESS	15	1.5859193	0.005148005	0.1778171	2.29956315	-0.87227545
GSE7852_TREG_VS_TCONV_THYMUS_DN	C7_ immunologic signatures	170	0.7130505	0.99525505	0.98525584	GSE7852_TREG_VS_TCONV_THYMUS_DN	172	1.4211155	0	0.31899083	2.134166	-0.708065
GO_PHOSPHATIDYLSERINE_METABOLIC_PROCESS	c5.BP_ GO biological process	24	0.71272266	0.87835705	0.98538154	GO_PHOSPHATIDYLSERINE_METABOLIC_PROCESS	28	1.2134143	0.20731707	0.5717996	1.92613696	-0.50069164
CAGNYGKNAAA_UNKNOWN	c3.TFT_ transcription factor targets	64	0.71269643	0.9427374	0.9853052	CAGNYGKNAAA_UNKNOWN	64	1.1200818	0.2771739	0.7233787	1.83277823	-0.40738537
GO_CLATHRIN_COAT	c5.CC_ GO cellular component	44	0.71243644	0.92565596	0.98539245	GO_CLATHRIN_COAT	45	1.0461164	0.40160182	0.8470718	1.75855284	-0.33367996
GO_PIGMENT_CELL_DIFFERENTIATION	c5.BP_ GO biological process	22	0.71206015	0.88095236	0.98554796	GO_PIGMENT_CELL_DIFFERENTIATION	24	0.68330026	0.88029927	1	1.39536041	0.02875989
SCHLOSSER_SERUM_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	121	0.7120088	0.9778598	0.9854849	SCHLOSSER_SERUM_RESPONSE_UP	121	0.91531175	0.66803277	1	1.62732055	-0.20330295
GO_P53_BINDING	c5.GO molecular function	63	0.7113752	0.9398085	0.9858144	GO_P53_BINDING	63	0.96145993	0.5582418	0.9696979	1.67283513	-0.25008473
GO_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE	c5.CC_ GO cellular component	55	0.7106329	0.93635076	0.9862102	GO_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE	55	0.8346351	0.75389755	1	1.545268	-0.1240022
GO_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION	c5.BP_ GO biological process	16	0.7103462	0.86292833	0.98629487	GO_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION	17	-1.0566248	0.40243903	0.5940058	-0.3462786	1.766971
BIOCARTA_MAPK_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	86	0.7092884	0.9593909	0.9868832	BIOCARTA_MAPK_PATHWAY	86	0.91909075	0.6516736	1	1.62837915	-0.20980235
GO_B_CELL_HOMEOSTASIS	c5.BP_ GO biological process	19	0.7091731	0.86743045	0.98686385	GO_B_CELL_HOMEOSTASIS	21	0.7992626	0.7465668	1	1.5084357	-0.0900895
BIOCARTA_TOLL_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	36	0.7091566	0.9034175	0.98677963	BIOCARTA_TOLL_PATHWAY	36	1.2319885	0.17912218	0.53688926	1.9411451	-0.5228319
GO_LAMELLIPODIUM_ASSEMBLY	c5.BP_ GO biological process	28	0.70905435	0.8806202	0.9867526	GO_LAMELLIPODIUM_ASSEMBLY	28	1.3811007	0.07168894	0.3565942	2.09015505	-0.67204635
GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN	C7_ immunologic signatures	145	0.70896703	0.9814815	0.9867165	GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN	152	-0.9263902	0.6666667	0.7880573	-0.21742317	1.63535723
CHR15Q13	C1: positional gene sets	25	0.70877105	0.8929712	0.98675007	CHR15Q13	27	1.4393401	0.05185185	0.30478415	2.14811115	-0.73056905
GO_PROTEIN_ACYLATION	c5.BP_ GO biological process	139	0.7081937	0.9863184	0.987011	GO_PROTEIN_ACYLATION	140	-0.8523396	0.8965517	0.86471355	-0.1441459	1.5605333
GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN	C7_ immunologic signatures	128	0.7081819	0.97903824	0.9869225	GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN	128	0.95851094	0.5873837	0.97239846	1.66669284	-0.25032904
GO_COPPER_ION_HOMEOSTASIS	c5.BP_ GO biological process	15	0.7075076	0.8582677	0.9872685	GO_COPPER_ION_HOMEOSTASIS	15	1.1061369	0.36133334	0.7446521	1.8136445	-0.3986293
GO_CARBOHYDRATE_DERIVATIVE_TRANSPORTER_ACTIVITY	c5.GO molecular function	32	0.7074727	0.8930636	0.9871954	GO_CARBOHYDRATE_DERIVATIVE_TRANSPORTER_ACTIVITY	32	1.162775	0.25238097	0.64880437	1.8702477	-0.4553023
GO_RENAL_WATER_HOMEOSTASIS	c5.BP_ GO biological process	26	0.70724523	0.8914027	0.9872494	GO_RENAL_WATER_HOMEOSTASIS	29	1.0605928	0.38875306	0.82252026	1.76783803	-0.35334757
GO_CORTICAL_CYTOSKELETON_ORGANIZATION	c5.BP_ GO biological process	34	0.7072364	0.9007752	0.98715883	GO_CORTICAL_CYTOSKELETON_ORGANIZATION	33	1.2907116	0.12930012	0.45698088	1.997948	-0.5834752
BIOCARTA_CCR3_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	19	0.7071094	0.85736924	0.98713714	BIOCARTA_CCR3_PATHWAY	21	0.827049	0.73057646	1	1.5341584	-0.1199396
GO_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT	c5.BP_ GO biological process	16	0.707075	0.8552632	0.9870632	GO_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT	16	-1.3769301	0.0945946	0.2230491	-0.6698551	2.0840051
BIOCARTA_PYK2_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	26	0.7069011	0.89442813	0.98707765	BIOCARTA_PYK2_PATHWAY	26	1.0361569	0.43636364	0.86555904	1.743058	-0.3292558
GO_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS	c5.BP_ GO biological process	19	0.7067951	0.88244516	0.98704845	GO_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS	20	1.2080717	0.22535211	0.5805695	1.9148668	-0.5012766
CHEN_LIVER_METABOLISM_QTL_CIS	c2.CGP_ chemical and genetic perturbations	80	0.70645607	0.9673913	0.9871586	CHEN_LIVER_METABOLISM_QTL_CIS	83	0.9633005	0.5593583	0.96741027	1.66975657	-0.25684443
WANG_RECURRENT_LIVER_CANCER_UP	c2.CGP_ chemical and genetic perturbations	18	0.7064487	0.8910569	0.9870674	WANG_RECURRENT_LIVER_CANCER_UP	20	0.96906984	0.5160462	0.96219045	1.67551854	-0.26262114
GO_LIPID_STORAGE	c5.BP_ GO biological process	25	0.7064114	0.87931037	0.9869947	GO_LIPID_STORAGE	24	0.9583264	0.5556886	0.97276187	1.6647378	-0.251915
GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN	C7_ immunologic signatures	183	0.70603365	0.9918415	0.9871406	GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN	185	0.9128009	0.7116935	1	1.61883455	-0.20676725
MEISSNER_ES_ICP_WITH_H3K4ME3	c2.CGP_ chemical and genetic perturbations	27	0.7058939	0.8916914	0.9871303	MEISSNER_ES_ICP_WITH_H3K4ME3	28	0.8955829	0.6385542	1	1.6014768	-0.189689
GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	174	0.7055606	0.9823113	0.9872424	GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN	174	0.82677156	0.85136503	1	1.53233216	-0.12121096
LOPES_METHYLATED_IN_COLON_CANCER_DN	c2.CGP_ chemical and genetic perturbations	23	0.7054509	0.8768997	0.98720944	LOPES_METHYLATED_IN_COLON_CANCER_DN	24	0.82875824	0.7379135	1	1.53420914	-0.12330734
BLUM_RESPONSE_TO_SALIRASIB_UP	c2.CGP_ chemical and genetic perturbations	228	0.7051573	0.996614	0.9872987	BLUM_RESPONSE_TO_SALIRASIB_UP	228	-0.93149006	0.75	0.7824095	-0.22633276	1.63664736
GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	C7_ immunologic signatures	175	0.70508605	0.99065423	0.98724324	GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	176	-1.0803074	0.16666667	0.5514423	-0.37522135	1.78539345
GSE36009_UNSTIM_VS_LPS_STIM_DC_DN	C7_ immunologic signatures	173	0.70477194	0.9918224	0.987338	GSE36009_UNSTIM_VS_LPS_STIM_DC_DN	173	-0.951539	0.8	0.752163	-0.24676706	1.65631094
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	c2.CGP_ chemical and genetic perturbations	21	0.7046822	0.8855326	0.98729783	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	21	-1.0544144	0.38990825	0.59612453	-0.3497322	1.7590966
GO_DYNEIN_COMPLEX	c5.CC_ GO cellular component	40	0.7046618	0.9186047	0.98721653	GO_DYNEIN_COMPLEX	41	1.1852177	0.20876586	0.6131364	1.8898795	-0.4805559
GO_REGULATION_OF_RECEPTOR_RECYCLING	c5.BP_ GO biological process	19	0.704382	0.8658147	0.98728526	GO_REGULATION_OF_RECEPTOR_RECYCLING	19	-0.6057936	0.977169	0.98473585	0.0985884	1.3101756
PID_RETINOIC_ACID_PATHWAY	c2.CP_ Canonical pathways	30	0.7038129	0.90468985	0.9875379	PID_RETINOIC_ACID_PATHWAY	30	0.90659237	0.63550293	1	1.61040527	-0.20277947
PID_IL2_PI3K_PATHWAY	c2.CP_ Canonical pathways	33	0.70369595	0.9102941	0.98751116	PID_IL2_PI3K_PATHWAY	33	0.723506	0.8803828	1	1.42720195	-0.01981005
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	c2.CP_REACTOME_ Reactome gene sets	42	0.70357245	0.9382184	0.9874866	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	42	1.1532372	0.2511574	0.6632677	1.85680965	-0.44966475
GO_SOLUTE_CATION_SYMPORTER_ACTIVITY	c5.GO molecular function	85	0.7034847	0.97463286	0.9874467	GO_SOLUTE_CATION_SYMPORTER_ACTIVITY	94	1.0928472	0.31354168	0.76822364	1.7963319	-0.3893625
GNF2_CBFB	c4.CGN_ cancer gene neighborhoods	27	0.70298505	0.8831563	0.9876586	GNF2_CBFB	28	-1.2937367	0.09090909	0.2891988	-0.59075165	1.99672175
REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS	c2.CP_REACTOME_ Reactome gene sets	18	0.70236135	0.8720749	0.98792756	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS	18	1.0555052	0.43450883	0.83230966	1.75786655	-0.35314385
GO_GLUCAN_METABOLIC_PROCESS	c5.BP_ GO biological process	49	0.7020016	0.9468391	0.9880448	GO_GLUCAN_METABOLIC_PROCESS	51	1.0160291	0.44481236	0.8959661	1.7180307	-0.3140275
LEE_AGING_NEOCORTEX_DN	c2.CGP_ chemical and genetic perturbations	70	0.7018027	0.954039	0.988058	LEE_AGING_NEOCORTEX_DN	71	0.84335226	0.7603037	1	1.54515496	-0.14154956
GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN	C7_ immunologic signatures	158	0.70176303	0.99150485	0.98798627	GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN	163	0.96930784	0.5730223	0.96202534	1.67107087	-0.26754481
GO_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	18	0.7016472	0.87341774	0.9879582	GO_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS	18	-1.3854686	0.06696428	0.21529175	-0.6838214	2.0871158
GO_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY	c5.BP_ GO biological process	119	0.7016291	0.9878049	0.9878757	GO_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY	121	1.3527598	0.025826447	0.383071	2.0543889	-0.6511307
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	68	0.7013876	0.95594126	0.9879275	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	67	-0.83352816	0.8867925	0.87942296	-0.13214056	1.53491576
KEGG_APOPTOSIS	c2.CP_BIOCARTA_ BioCarta gene sets	75	0.7012777	0.9620596	0.9878944	KEGG_APOPTOSIS	77	1.1568016	0.21636169	0.6588089	1.8580793	-0.4555239
GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN	C7_ immunologic signatures	168	0.7005974	0.9964371	0.9881845	GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN	173	1.1813495	0.12753037	0.62077576	1.8819469	-0.4807521
NAKAJIMA_EOSINOPHIL	c2.CGP_ chemical and genetic perturbations	19	0.699833	0.86949927	0.988533	NAKAJIMA_EOSINOPHIL	23	0.8922579	0.64646465	1	1.5920909	-0.1924249
GNF2_MYD88	c4.CGN_ cancer gene neighborhoods	51	0.69967437	0.93029875	0.9885266	GNF2_MYD88	51	0.8892656	0.6504525	1	1.58893997	-0.18959123
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN	C7_ immunologic signatures	165	0.69965345	0.9917744	0.98844373	GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN	166	0.62992907	0.99088144	1	1.32958252	0.06972438
GO_BETA_CATENIN_DESTRUCTION_COMPLEX_DISASSEMBLY	c5.BP_ GO biological process	18	0.69926685	0.85825545	0.98857236	GO_BETA_CATENIN_DESTRUCTION_COMPLEX_DISASSEMBLY	20	-1.2268292	0.2	0.3485415	-0.52756235	1.92609605
MODULE_288	c4.CM_ cancer modules	29	0.6992563	0.90342677	0.9884831	MODULE_288	31	-1.3396648	0.08982036	0.24937674	-0.6404085	2.0389211
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	168	0.69911796	0.9904535	0.9884683	GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	169	-1.1922014	0.09090909	0.39145127	-0.49308344	1.89131936
MODULE_186	c4.CM_ cancer modules	18	0.69834554	0.92258066	0.9888048	MODULE_186	19	1.0894562	0.36139897	0.7717268	1.78780174	-0.39111066
GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_DN	C7_ immunologic signatures	159	0.69828767	0.99172574	0.98873883	GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_DN	168	1.2612002	0.04205128	0.49495012	1.95948787	-0.56291253
PID_TXA2PATHWAY	c2.CP_ Canonical pathways	52	0.69792485	0.93274856	0.98883796	PID_TXA2PATHWAY	53	1.1485839	0.2488889	0.6705908	1.84650875	-0.45065905
AGTCTTA_MIR499	c3.MIR_ microRNA targets	65	0.69787407	0.94956774	0.9887689	AGTCTTA_MIR499	68	-1.3516204	0.038961038	0.24136487	-0.65374633	2.04949447
GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP	C7_ immunologic signatures	133	0.6977657	0.9888476	0.9887327	GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP	139	0.8974186	0.71472394	1	1.5951843	-0.1996529
PID_REELIN_PATHWAY	c2.CP_ Canonical pathways	29	0.6974296	0.9142442	0.9888258	PID_REELIN_PATHWAY	29	-0.8253781	0.8278146	0.8859613	-0.1279485	1.5228077
GO_POSITIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION	c5.BP_ GO biological process	142	0.69680333	0.98674697	0.98908013	GO_POSITIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION	144	0.9711116	0.5571284	0.96023065	1.66791493	-0.27430827
BIOCARTA_RELA_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	0.69679004	0.88387096	0.988992	BIOCARTA_RELA_PATHWAY	15	1.1507924	0.29372495	0.6676722	1.84758244	-0.45400236
GO_SODIUM_ION_TRANSPORT	c5.BP_ GO biological process	118	0.69673145	0.98729354	0.9889281	GO_SODIUM_ION_TRANSPORT	130	1.2852356	0.058581706	0.46310225	1.98196705	-0.58850415
GO_ENDORIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS	c5.GO molecular function	26	0.69612116	0.9078125	0.989167	GO_ENDORIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS	26	-1.014338	0.4032258	0.66803586	-0.31821684	1.71045916
GO_RESPONSE_TO_PH	c5.BP_ GO biological process	33	0.69446063	0.9100295	0.98995376	GO_RESPONSE_TO_PH	36	0.9088526	0.61927146	1	1.60331323	-0.21439197
SA_PTEN_PATHWAY	c2.CP_ Canonical pathways	17	0.69416744	0.91653544	0.9900071	SA_PTEN_PATHWAY	17	1.1352721	0.29792747	0.6966457	1.82943954	-0.44110466
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	c2.CP_REACTOME_ Reactome gene sets	70	0.6939554	0.9535519	0.9900207	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	69	-0.8780485	0.8	0.8466796	-0.1840931	1.5720039
GO_PROTEIN_O_LINKED_GLYCOSYLATION	c5.BP_ GO biological process	75	0.69390804	0.9659864	0.9899487	GO_PROTEIN_O_LINKED_GLYCOSYLATION	82	1.1666905	0.21985058	0.6433834	1.86059854	-0.47278246
BURTON_ADIPOGENESIS_10	c2.CGP_ chemical and genetic perturbations	28	0.69388866	0.9255952	0.9898625	BURTON_ADIPOGENESIS_10	28	0.64218163	0.9499404	1	1.33607029	0.05170703
PID_NETRIN_PATHWAY	c2.CP_ Canonical pathways	31	0.69381756	0.92825115	0.9898043	PID_NETRIN_PATHWAY	31	-0.7968415	0.82098764	0.90899134	-0.10302394	1.49065906
CHR20Q11	C1: positional gene sets	83	0.69345134	0.96899223	0.98989445	CHR20Q11	90	0.90782964	0.64126986	1	1.60128098	-0.2143783
PID_REG_GR_PATHWAY	c2.CP_ Canonical pathways	72	0.69342905	0.96414346	0.98980993	PID_REG_GR_PATHWAY	76	0.83615106	0.7700422	1	1.52958011	-0.14272201
GO_OXYGEN_BINDING	c5.GO molecular function	31	0.6932811	0.92877907	0.98978966	GO_OXYGEN_BINDING	31	1.5602249	0.010804322	0.19848987	2.253506	-0.8669438
DORSAM_HOXA9_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	30	0.69275993	0.91955835	0.9899669	DORSAM_HOXA9_TARGETS_DN	30	-0.8649765	0.7218935	0.8581464	-0.17221657	1.55773643
GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN	C7_ immunologic signatures	144	0.6921066	0.9890244	0.99021053	GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN	145	-0.8861059	0.9411765	0.8381806	-0.1939993	1.5782125
GO_REGULATION_OF_INTERLEUKIN_2_PRODUCTION	c5.BP_ GO biological process	39	0.6917019	0.9461427	0.9903181	GO_REGULATION_OF_INTERLEUKIN_2_PRODUCTION	44	1.091332	0.34204546	0.76968217	1.7830339	-0.3996301
GO_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES	c5.BP_ GO biological process	17	0.69148976	0.87874013	0.99032867	GO_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES	18	0.90348315	0.61746615	1	1.59497291	-0.21199339
GO_MODULATION_BY_VIRUS_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY	c5.BP_ GO biological process	33	0.69107795	0.9208955	0.99044114	GO_MODULATION_BY_VIRUS_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY	33	-1.2721053	0.118421055	0.3088281	-0.58102735	1.96318325
PID_AR_PATHWAY	c2.CP_ Canonical pathways	58	0.69093955	0.95921236	0.9904166	PID_AR_PATHWAY	58	0.5765188	0.983462	1	1.26745835	0.11442075
GO_REGULATION_OF_CHROMATIN_SILENCING	c5.BP_ GO biological process	19	0.6907713	0.8883333	0.9904064	GO_REGULATION_OF_CHROMATIN_SILENCING	19	-1.5821998	0.03181818	0.098501645	-0.8914285	2.2729711
GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP	C7_ immunologic signatures	169	0.6907613	0.9928315	0.99031645	GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP	170	1.0197835	0.44343436	0.89155006	1.7105448	-0.3290222
GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_DN	C7_ immunologic signatures	182	0.68989104	0.99658316	0.99064606	GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_DN	181	0.7035939	0.97373736	1	1.39348494	-0.01370286
REACTOME_IL1_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	38	0.68986183	0.94640124	0.9905655	REACTOME_IL1_SIGNALING	39	0.65616125	0.9356725	1	1.34602308	0.03370058
PID_BCR_5PATHWAY	c2.CP_ Canonical pathways	64	0.68960905	0.95454544	0.99059236	PID_BCR_5PATHWAY	65	1.1440583	0.25082147	0.6824265	1.83366735	-0.45444925
BIOCARTA_CASPASE_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	21	0.6894211	0.9052795	0.99059063	BIOCARTA_CASPASE_PATHWAY	20	-1.1414243	0.25454545	0.45507163	-0.4520032	1.8308454
GCM_RAB10	c4.CGN_ cancer gene neighborhoods	156	0.68862027	0.9919725	0.99088913	GCM_RAB10	157	-1.1669441	0.083333336	0.421312	-0.47832383	1.85556437
GO_DNA_MODIFICATION	c5.BP_ GO biological process	68	0.68851274	0.96486485	0.99084324	GO_DNA_MODIFICATION	70	1.3083234	0.057608694	0.42874235	1.99683614	-0.61981066
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS	c2.CP_REACTOME_ Reactome gene sets	26	0.6881216	0.9035608	0.9909414	REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS	26	0.59424615	0.9607362	1	1.28236775	0.09387545
GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	C7_ immunologic signatures	180	0.6877516	0.99417925	0.99102396	GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	180	0.8500614	0.81781375	1	1.537813	-0.1623098
GO_ENDOSOME_LUMEN	c5.CC_ GO cellular component	18	0.68722755	0.8770226	0.9911663	GO_ENDOSOME_LUMEN	21	0.8564164	0.6890547	1	1.54364395	-0.16918885
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	c2.CGP_ chemical and genetic perturbations	26	0.68705034	0.90639627	0.9911551	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	26	0.887529	0.6319613	1	1.57457934	-0.20047866
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	23	0.6870205	0.9009288	0.99107385	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	23	-1.7230518	0.005319149	0.04983611	-1.0360313	2.4100723
REACTOME_IL_3_5_AND_GM_CSF_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	40	0.6862544	0.9393064	0.9913372	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING	41	1.1832291	0.22576833	0.6172107	1.8694835	-0.4969747
MODULE_448	c4.CM_ cancer modules	39	0.6859684	0.9331437	0.9913781	MODULE_448	41	-0.95747894	0.5826772	0.7461526	-0.27151054	1.64344734
GO_NEGATIVE_REGULATION_OF_HISTONE_ACETYLATION	c5.BP_ GO biological process	15	0.6850893	0.8888889	0.9916966	GO_NEGATIVE_REGULATION_OF_HISTONE_ACETYLATION	15	-0.97183096	0.48046875	0.7250002	-0.28674166	1.65692026
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	c2.CGP_ chemical and genetic perturbations	28	0.6848503	0.9251497	0.9917151	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	28	-1.0952098	0.29447854	0.5249142	-0.4103595	1.7800601
GO_DRUG_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	16	0.6842968	0.9	0.9918736	GO_DRUG_TRANSMEMBRANE_TRANSPORT	17	1.4611324	0.03576159	0.28192338	2.1454292	-0.7768356
KEGG_NON_SMALL_CELL_LUNG_CANCER	c2.CP_BIOCARTA_ BioCarta gene sets	52	0.6842324	0.95708156	0.9918111	KEGG_NON_SMALL_CELL_LUNG_CANCER	53	1.2811527	0.08906426	0.47084513	1.9653851	-0.5969203
GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN	C7_ immunologic signatures	175	0.683706	0.9940048	0.99195683	GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN	175	-1.1759399	0	0.40978187	-0.4922339	1.8596459
GNF2_ITGAL	c4.CGN_ cancer gene neighborhoods	44	0.68365437	0.9397759	0.9918845	GNF2_ITGAL	46	1.1012464	0.3204983	0.7551194	1.78490077	-0.41759203
GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN	C7_ immunologic signatures	174	0.68364793	0.99299884	0.99179155	GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN	177	0.6637629	0.98587286	1	1.34741083	0.01988503
GO_LAMELLIPODIUM_ORGANIZATION	c5.BP_ GO biological process	34	0.6836385	0.9161765	0.99170035	GO_LAMELLIPODIUM_ORGANIZATION	34	1.2801054	0.1450654	0.47196087	1.9637439	-0.5964669
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN	C7_ immunologic signatures	171	0.6835415	0.99532163	0.99165094	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN	175	1.1548346	0.173428	0.66201985	1.8383761	-0.4712931
MODULE_153	c4.CM_ cancer modules	26	0.6834856	0.9235474	0.9915805	MODULE_153	28	1.0868899	0.36707318	0.77550393	1.7703755	-0.4034043
MODULE_162	c4.CM_ cancer modules	16	0.6829117	0.903937	0.99175036	MODULE_162	18	-0.88437223	0.6504065	0.83933055	-0.20146053	1.56728393
BIOCARTA_GLEEVEC_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	23	0.6820472	0.91691846	0.99204075	BIOCARTA_GLEEVEC_PATHWAY	23	0.6990094	0.8839506	1	1.3810566	-0.0169622
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	c2.CP_REACTOME_ Reactome gene sets	29	0.68183666	0.9132353	0.99204004	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	29	-1.2509421	0.13259669	0.32257757	-0.56910544	1.93277876
GO_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	52	0.68183154	0.95780593	0.99194705	GO_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY	51	-0.94780624	0.6036036	0.75979114	-0.2659747	1.62963778
ONO_FOXP3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	17	0.6817189	0.86906713	0.9918999	ONO_FOXP3_TARGETS_UP	18	-1.0319192	0.40182647	0.63629943	-0.3502003	1.7136381
GO_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	68	0.681696	0.9732977	0.99181443	GO_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY	69	0.7715621	0.85513514	1	1.4532581	-0.0898661
GO_VACUOLAR_TRANSPORT	c5.BP_ GO biological process	212	0.68166524	0.99657536	0.991733	GO_VACUOLAR_TRANSPORT	214	0.9159281	0.7039275	1	1.59759334	-0.23426286
PID_NFKAPPAB_CANONICAL_PATHWAY	c2.CP_ Canonical pathways	23	0.68155223	0.92197454	0.9916831	PID_NFKAPPAB_CANONICAL_PATHWAY	22	1.0988303	0.36940297	0.7586208	1.78038253	-0.41727807
SUZUKI_RESPONSE_TO_TSA	c2.CGP_ chemical and genetic perturbations	15	0.6815219	0.89261746	0.9915993	SUZUKI_RESPONSE_TO_TSA	16	-1.0554715	0.35042736	0.59520584	-0.3739496	1.7369934
GO_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT	c5.BP_ GO biological process	16	0.6812301	0.894081	0.99163437	GO_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT	18	0.51356447	0.9842313	1	1.19479457	0.16766563
GO_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	22	0.6810878	0.9126506	0.9916051	GO_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION	23	1.5446036	0.020782396	0.20824723	2.2256914	-0.8635158
GO_MICROBODY_LUMEN	c5.CC_ GO cellular component	42	0.6800522	0.94372296	0.99196	GO_MICROBODY_LUMEN	43	0.8177116	0.778291	1	1.4977638	-0.1376594
GO_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	17	0.6796761	0.91143316	0.99202734	GO_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS	17	1.1469557	0.2951031	0.67374134	1.8266318	-0.4672796
GO_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING	c5.GO molecular function	32	0.67948645	0.93053544	0.9920127	GO_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING	33	-0.55442834	1	0.98910624	0.12505811	1.23391479
GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN	C7_ immunologic signatures	167	0.67926073	0.995283	0.9920113	GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN	167	0.72491175	0.9531568	1	1.40417248	-0.04565102
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	c2.CGP_ chemical and genetic perturbations	31	0.67904615	0.9225251	0.992012	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	31	0.96525174	0.53956836	0.9649716	1.64429789	-0.28620559
PID_PI3K_PLC_TRK_PATHWAY	c2.CP_ Canonical pathways	35	0.67863137	0.9447592	0.9920977	PID_PI3K_PLC_TRK_PATHWAY	35	1.0638543	0.38198403	0.8160321	1.74248567	-0.38522293
BIOCARTA_PPARA_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	50	0.67847484	0.94882435	0.99206656	BIOCARTA_PPARA_PATHWAY	52	0.9320484	0.6218679	0.99755377	1.61052324	-0.25357356
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	159	0.67844546	0.99279714	0.9919818	GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	161	0.6996222	0.96239835	1	1.37806766	-0.02117674
GO_CYTOKINE_SECRETION	c5.BP_ GO biological process	27	0.67749816	0.93712574	0.99229	GO_CYTOKINE_SECRETION	30	0.7962016	0.77093023	1	1.47369976	-0.11870344
HASLINGER_B_CLL_WITH_17P13_DELETION	c2.CGP_ chemical and genetic perturbations	18	0.67723554	0.9213836	0.99230856	HASLINGER_B_CLL_WITH_17P13_DELETION	18	0.95477855	0.5429326	0.97668046	1.63201409	-0.27754301
GO_DEMETHYLASE_ACTIVITY	c5.GO molecular function	31	0.6770846	0.9470499	0.9922775	GO_DEMETHYLASE_ACTIVITY	31	1.1820841	0.24378698	0.61974263	1.8591687	-0.5049995
GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP	C7_ immunologic signatures	178	0.67686254	0.9976443	0.9922789	GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP	177	-1.1299509	0.14285715	0.4716427	-0.45308836	1.80681344
GO_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND	c5.BP_ GO biological process	29	0.67662615	0.9304734	0.9922776	GO_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND	28	1.0255456	0.45783132	0.88346344	1.70217175	-0.34891945
GO_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC	c5.BP_ GO biological process	177	0.67654234	0.99647474	0.99221724	GO_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC	184	-1.0300821	0.46666667	0.6401393	-0.35353976	1.70662444
GO_APOPTOTIC_MITOCHONDRIAL_CHANGES	c5.BP_ GO biological process	50	0.6763131	0.96033996	0.9922169	GO_APOPTOTIC_MITOCHONDRIAL_CHANGES	51	0.8901912	0.6854566	1	1.5665043	-0.2138781
MIKKELSEN_MEF_ICP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	149	0.6763116	0.99254656	0.9921223	MIKKELSEN_MEF_ICP_WITH_H3K27ME3	180	1.2455312	0.048879836	0.5181896	1.9218428	-0.5692196
GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP	C7_ immunologic signatures	146	0.6761705	0.99875	0.9920834	GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP	147	1.2737662	0.05067218	0.4816071	1.9499367	-0.5975957
GO_PROTEIN_LOCALIZATION_TO_VACUOLE	c5.BP_ GO biological process	41	0.6751092	0.94650817	0.99242276	GO_PROTEIN_LOCALIZATION_TO_VACUOLE	41	1.0742608	0.36489606	0.7981525	1.74937	-0.3991516
MODULE_400	c4.CM_ cancer modules	15	0.6743419	0.8993174	0.9926332	MODULE_400	17	-1.0657382	0.36625513	0.5768609	-0.3913963	1.7400801
GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN	C7_ immunologic signatures	180	0.6742962	0.9963548	0.9925548	GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN	180	-0.7630586	1	0.9299773	-0.0887624	1.4373548
GSE17721_CTRL_VS_LPS_24H_BMDC_DN	C7_ immunologic signatures	183	0.6741444	0.998818	0.9925198	GSE17721_CTRL_VS_LPS_24H_BMDC_DN	181	-1.1267774	0	0.47697273	-0.452633	1.8009218
GNF2_VAV1	c4.CGN_ cancer gene neighborhoods	27	0.6737049	0.92690516	0.9925966	GNF2_VAV1	30	1.0859194	0.36646706	0.77615815	1.7596243	-0.4122145
REACTOME_SIGNALING_BY_ERBB4	c2.CP_REACTOME_ Reactome gene sets	82	0.6735295	0.981208	0.9925738	REACTOME_SIGNALING_BY_ERBB4	85	0.6601619	0.9678801	1	1.3336914	0.0133676
REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR	c2.CP_REACTOME_ Reactome gene sets	15	0.67348486	0.89102566	0.9924959	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR	15	1.111233	0.33684212	0.7357745	1.78471786	-0.43774814
TERAMOTO_OPN_TARGETS_CLUSTER_7	c2.CGP_ chemical and genetic perturbations	18	0.67236716	0.9040881	0.9928515	TERAMOTO_OPN_TARGETS_CLUSTER_7	19	-0.8849821	0.5845411	0.8386215	-0.21261494	1.55734926
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	c2.CP_REACTOME_ Reactome gene sets	16	0.6723304	0.91446346	0.99277157	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	16	0.97676605	0.51915455	0.95349574	1.64909645	-0.30443565
GNF2_STAT6	c4.CGN_ cancer gene neighborhoods	63	0.6721209	0.9701493	0.99276036	GNF2_STAT6	64	0.86681503	0.7149123	1	1.53893593	-0.19469413
GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	185	0.6719426	0.9964243	0.9927331	GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP	186	-0.8367184	1	0.8773923	-0.1647758	1.508661
GO_NEGATIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS	c5.BP_ GO biological process	17	0.67185426	0.9044586	0.99267167	GO_NEGATIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS	17	0.75650966	0.82533336	1	1.42836392	-0.0846554
REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS	c2.CP_REACTOME_ Reactome gene sets	23	0.6717499	0.92319506	0.992619	REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS	25	1.1293625	0.31990233	0.70713127	1.8011124	-0.4576126
GO_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY	c5.GO molecular function	60	0.671699	0.9639889	0.9925416	GO_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY	62	0.77589566	0.83668905	1	1.44759466	-0.10419666
GO_REGULATION_OF_HORMONE_METABOLIC_PROCESS	c5.BP_ GO biological process	23	0.6711799	0.92802453	0.99263936	GO_REGULATION_OF_HORMONE_METABOLIC_PROCESS	23	1.403126	0.055900622	0.33633164	2.0743059	-0.7319461
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	c2.CGP_ chemical and genetic perturbations	26	0.67071885	0.91950464	0.9927199	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	26	1.27003	0.15432099	0.485164	1.94074885	-0.59931115
GO_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER	c5.BP_ GO biological process	145	0.6702524	0.9975155	0.9928003	GO_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER	149	1.0017127	0.50051177	0.9207682	1.6719651	-0.3314603
CHR6Q27	C1: positional gene sets	22	0.67008895	0.9044776	0.9927674	CHR6Q27	22	0.75951993	0.8066502	1	1.42960888	-0.08943098
GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	163	0.6694681	1	0.9929024	GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	163	-1.0096462	0.3529412	0.67316157	-0.3401781	1.6791143
GO_MANNOSYLATION	c5.BP_ GO biological process	26	0.6691384	0.92701864	0.99293125	GO_MANNOSYLATION	27	0.5722144	0.96821517	1	1.2413528	0.096924
MAYBURD_RESPONSE_TO_L663536_UP	c2.CGP_ chemical and genetic perturbations	26	0.6690823	0.938326	0.9928555	MAYBURD_RESPONSE_TO_L663536_UP	27	0.76255774	0.7956731	1	1.43164004	-0.09347544
SEIDEN_ONCOGENESIS_BY_MET	c2.CGP_ chemical and genetic perturbations	78	0.6687069	0.97889185	0.99289644	SEIDEN_ONCOGENESIS_BY_MET	78	-1.0470629	0.38709676	0.6110512	-0.378356	1.7157698
GO_DNA_DAMAGE_RESPONSE_DETECTION_OF_DNA_DAMAGE	c5.BP_ GO biological process	33	0.668583	0.9551375	0.9928481	GO_DNA_DAMAGE_RESPONSE_DETECTION_OF_DNA_DAMAGE	33	-1.3060324	0.10666667	0.27764985	-0.6374494	1.9746154
GO_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS	c5.BP_ GO biological process	37	0.6684647	0.9370629	0.99279785	GO_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS	40	-0.94696677	0.5588235	0.7603551	-0.27850207	1.61543147
GO_DSRNA_FRAGMENTATION	c5.BP_ GO biological process	17	0.6683301	0.9009434	0.99274963	GO_DSRNA_FRAGMENTATION	17	-0.73334765	0.88584477	0.94493395	-0.06501755	1.40167775
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	c2.CGP_ chemical and genetic perturbations	35	0.66785413	0.9631902	0.99283725	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	39	1.4769989	0.022144523	0.2712678	2.14485303	-0.80914477
ST_ERK1_ERK2_MAPK_PATHWAY	c2.CP_ Canonical pathways	32	0.66779846	0.9389881	0.9927636	ST_ERK1_ERK2_MAPK_PATHWAY	32	-0.8921725	0.675	0.8300437	-0.22437404	1.55997096
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP	c2.CGP_ chemical and genetic perturbations	21	0.6675254	0.9133127	0.99276435	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP	21	-0.9254341	0.58638746	0.78840744	-0.2579087	1.5929595
GO_PROTEIN_PHOSPHATASE_1_BINDING	c5.GO molecular function	17	0.6671054	0.904	0.992827	GO_PROTEIN_PHOSPHATASE_1_BINDING	17	0.7505385	0.8191214	1	1.4176439	-0.0834331
GO_LYSINE_ACETYLATED_HISTONE_BINDING	c5.GO molecular function	16	0.66682273	0.9232	0.9928334	GO_LYSINE_ACETYLATED_HISTONE_BINDING	16	-1.5370201	0.0349345	0.12229906	-0.87019737	2.20384283
REACTOME_TCR_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	44	0.6663967	0.9567723	0.9928935	REACTOME_TCR_SIGNALING	46	1.0358775	0.44175318	0.86586416	1.7022742	-0.3694808
GCM_DFFA	c4.CGN_ cancer gene neighborhoods	114	0.66605145	0.99246234	0.99292463	GCM_DFFA	114	-1.3462298	0.025	0.24354897	-0.68017835	2.01228125
GO_DEOXYRIBOSE_PHOSPHATE_CATABOLIC_PROCESS	c5.BP_ GO biological process	21	0.6649463	0.9450727	0.9932219	GO_DEOXYRIBOSE_PHOSPHATE_CATABOLIC_PROCESS	21	-0.820371	0.7209302	0.88975006	-0.1554247	1.4853173
GO_VACUOLAR_ACIDIFICATION	c5.BP_ GO biological process	15	0.6648272	0.9111111	0.9931679	GO_VACUOLAR_ACIDIFICATION	15	0.71884906	0.8458445	1	1.38367626	-0.05402186
REACTOME_SHC_RELATED_EVENTS	c2.CP_REACTOME_ Reactome gene sets	15	0.6647926	0.9096672	0.9930861	REACTOME_SHC_RELATED_EVENTS	16	0.89742583	0.6146789	1	1.56221843	-0.23263323
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	c2.CGP_ chemical and genetic perturbations	18	0.6645991	0.9216	0.993058	CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	24	1.3476733	0.08260325	0.38461456	2.0122724	-0.6830742
BIOCARTA_HER2_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	21	0.6643574	0.93075687	0.9930491	BIOCARTA_HER2_PATHWAY	22	1.2044067	0.22929937	0.58347696	1.8687641	-0.5400493
KEGG_RENAL_CELL_CARCINOMA	c2.CP_BIOCARTA_ BioCarta gene sets	64	0.6634945	0.96270716	0.9932525	KEGG_RENAL_CELL_CARCINOMA	64	0.71704787	0.90642	1	1.38054237	-0.05355337
CTCAAGA_MIR526B	c3.MIR_ microRNA targets	63	0.6631762	0.97705805	0.993268	CTCAAGA_MIR526B	64	1.0253209	0.45751634	0.883537	1.6884971	-0.3621447
GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP	C7_ immunologic signatures	176	0.6625109	1	0.9933981	GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP	179	0.8547362	0.82678753	1	1.5172471	-0.1922253
HALLMARK_PI3K_AKT_MTOR_SIGNALING	H_ hallmark gene sets	100	0.66164595	0.99461645	0.9935945	HALLMARK_PI3K_AKT_MTOR_SIGNALING	101	0.7976635	0.8520462	1	1.45930945	-0.13601755
GO_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION	c5.BP_ GO biological process	31	0.6607367	0.94977844	0.993816	GO_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION	32	0.8393831	0.7184466	1	1.5001198	-0.1786464
BIOCARTA_IL10_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	0.65925366	0.92635024	0.99421585	BIOCARTA_IL10_PATHWAY	15	1.1235884	0.32804233	0.71856993	1.78284206	-0.46433474
GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN	C7_ immunologic signatures	171	0.65873003	0.99765533	0.99428135	GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN	175	-0.73680794	1	0.9431368	-0.07807791	1.39553797
CHR5Q33	C1: positional gene sets	41	0.6573117	0.94387	0.9946371	CHR5Q33	45	0.81903756	0.75949365	1	1.47634926	-0.16172586
GO_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY	c5.BP_ GO biological process	21	0.6572156	0.93607306	0.9945718	GO_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY	23	0.78394955	0.7948084	1	1.44116515	-0.12673395
BIOCARTA_CERAMIDE_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	0.65717655	0.9526066	0.99448675	BIOCARTA_CERAMIDE_PATHWAY	22	-1.2739362	0.11792453	0.30704626	-0.61675965	1.93111275
REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	c2.CP_REACTOME_ Reactome gene sets	48	0.6566114	0.9676471	0.99457043	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	48	-0.8132753	0.8561644	0.8944326	-0.1566639	1.4698867
GO_SOLUTE_PROTON_SYMPORTER_ACTIVITY	c5.GO molecular function	24	0.6565809	0.93968254	0.99448454	GO_SOLUTE_PROTON_SYMPORTER_ACTIVITY	26	0.9291941	0.60459495	0.999251	1.585775	-0.2726132
GO_FATTY_ACYL_COA_BINDING	c5.GO molecular function	30	0.65593976	0.9552906	0.9945972	GO_FATTY_ACYL_COA_BINDING	31	0.94009924	0.58922154	0.98975724	1.596039	-0.28415948
GO_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	16	0.6556964	0.925	0.9945749	GO_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS	16	1.0230738	0.4660804	0.8867568	1.6787702	-0.3673774
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	c2.CP_REACTOME_ Reactome gene sets	35	0.65480345	0.94325155	0.9947503	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	35	-0.66168785	0.9722222	0.9735698	-0.0068844	1.3164913
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION	c2.CP_REACTOME_ Reactome gene sets	24	0.6546125	0.9257576	0.9947119	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION	24	-0.6576576	0.94418603	0.97475386	-0.0030451	1.3122701
PECE_MAMMARY_STEM_CELL_DN	c2.CGP_ chemical and genetic perturbations	123	0.65416175	0.9923858	0.99475324	PECE_MAMMARY_STEM_CELL_DN	124	0.70864433	0.946114	1	1.36280608	-0.05448258
GO_AXONEME_ASSEMBLY	c5.BP_ GO biological process	31	0.65315646	0.9504505	0.9949647	GO_AXONEME_ASSEMBLY	33	1.1068512	0.33010882	0.74274987	1.76000766	-0.45369474
GTAAACC_MIR2995P	c3.MIR_ microRNA targets	47	0.65263706	0.9594406	0.9950201	GTAAACC_MIR2995P	47	-1.342407	0.07258064	0.2471075	-0.68976994	1.99504406
PID_NEPHRIN_NEPH1_PATHWAY	c2.CP_ Canonical pathways	30	0.6525419	0.96	0.9949511	PID_NEPHRIN_NEPH1_PATHWAY	30	0.8162818	0.7547847	1	1.4688237	-0.1637399
GO_MULTI_ORGANISM_LOCALIZATION	c5.BP_ GO biological process	61	0.65147614	0.9886364	0.9951665	GO_MULTI_ORGANISM_LOCALIZATION	61	-0.93415684	0.6419753	0.7785334	-0.2826807	1.58563298
PID_WNT_NONCANONICAL_PATHWAY	c2.CP_ Canonical pathways	31	0.6502108	0.9580838	0.99542993	PID_WNT_NONCANONICAL_PATHWAY	31	0.80121225	0.78337234	1	1.45142305	-0.15100145
GO_NATURAL_KILLER_CELL_ACTIVATION	c5.BP_ GO biological process	44	0.6493364	0.96938777	0.9955851	GO_NATURAL_KILLER_CELL_ACTIVATION	46	-1.0405841	0.38931298	0.6213293	-0.3912477	1.6899205
GCM_GSPT1	c4.CGN_ cancer gene neighborhoods	148	0.64895713	1	0.9955979	GCM_GSPT1	148	-0.8693134	0.93333334	0.8537997	-0.22035627	1.51827053
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	c2.CGP_ chemical and genetic perturbations	18	0.6478565	0.9380952	0.99581397	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	18	0.54167694	0.98207426	1	1.18953344	0.10617956
GO_HISTONE_METHYLTRANSFERASE_COMPLEX	c5.CC_ GO cellular component	60	0.64784926	0.98214287	0.99572074	GO_HISTONE_METHYLTRANSFERASE_COMPLEX	61	-1.2777379	0.07954545	0.30430254	-0.62988864	1.92558716
GO_DNA_CATABOLIC_PROCESS	c5.BP_ GO biological process	23	0.6469393	0.9447853	0.99586844	GO_DNA_CATABOLIC_PROCESS	25	-1.5349023	0.020408163	0.122505374	-0.887963	2.1818416
GO_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	23	0.6458316	0.92036754	0.9960656	GO_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS	24	1.0245564	0.44938272	0.8843965	1.670388	-0.3787248
GO_BAF_TYPE_COMPLEX	c5.CC_ GO cellular component	22	0.64538795	0.9423676	0.99609536	GO_BAF_TYPE_COMPLEX	22	0.47654623	0.9896104	1	1.12193418	0.16884172
GO_DEACETYLASE_ACTIVITY	c5.GO molecular function	53	0.6434468	0.98233694	0.9965146	GO_DEACETYLASE_ACTIVITY	54	0.52352566	0.99671054	1	1.16697246	0.11992114
MORF_REV3L	c4.CGN_ cancer gene neighborhoods	55	0.6425823	0.9803647	0.9966374	MORF_REV3L	55	-1.0524783	0.32967034	0.6004858	-0.409896	1.6950606
GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN	C7_ immunologic signatures	173	0.6419547	1	0.99669755	GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN	173	-1.0579289	0.2	0.5922695	-0.4159742	1.6998836
GO_THYROID_HORMONE_RECEPTOR_BINDING	c5.GO molecular function	28	0.64017224	0.9580093	0.99705106	GO_THYROID_HORMONE_RECEPTOR_BINDING	29	0.6126292	0.95	1	1.25280144	0.02754304
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	c2.CGP_ chemical and genetic perturbations	16	0.6382977	0.9398374	0.9974175	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	16	0.5313492	0.9831388	1	1.1696469	0.1069485
GO_REGULATION_OF_GENE_SILENCING	c5.BP_ GO biological process	42	0.6371409	0.9847856	0.99760246	GO_REGULATION_OF_GENE_SILENCING	42	-1.3850783	0.03816794	0.21546397	-0.7479374	2.0222192
GO_C21_STEROID_HORMONE_METABOLIC_PROCESS	c5.BP_ GO biological process	16	0.63579965	0.91764706	0.9978204	GO_C21_STEROID_HORMONE_METABOLIC_PROCESS	17	0.69945234	0.8663239	1	1.33525199	-0.06365269
BIOCARTA_RARRXR_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	0.6346751	0.9206349	0.99799204	BIOCARTA_RARRXR_PATHWAY	15	0.6928895	0.86863273	1	1.3275646	-0.0582144
REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN	c2.CP_REACTOME_ Reactome gene sets	18	0.6314814	0.94154817	0.99861884	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN	19	-0.76035416	0.8818182	0.93275166	-0.12887276	1.39183556
GO_EXECUTION_PHASE_OF_APOPTOSIS	c5.BP_ GO biological process	47	0.6312068	0.9827834	0.9985877	GO_EXECUTION_PHASE_OF_APOPTOSIS	51	-1.194349	0.15966387	0.38864958	-0.5631422	1.8255558
BIOCARTA_ERK5_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	0.63071716	0.93247586	0.99859625	BIOCARTA_ERK5_PATHWAY	17	0.89852834	0.63372856	1	1.5292455	-0.26781118
GO_PROTEIN_ALKYLATION	c5.BP_ GO biological process	89	0.630425	0.99207395	0.99856335	GO_PROTEIN_ALKYLATION	94	0.7357474	0.9117647	1	1.3661724	-0.1053224
GO_MODULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL	c5.BP_ GO biological process	27	0.6299969	0.9681335	0.99856406	GO_MODULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL	28	0.83206576	0.74264705	1	1.46206266	-0.20206886
GO_CLATHRIN_COATED_ENDOCYTIC_VESICLE	c5.CC_ GO cellular component	51	0.6293378	0.9790795	0.9986051	GO_CLATHRIN_COATED_ENDOCYTIC_VESICLE	53	1.2249414	0.15934066	0.54902816	1.8542792	-0.5956036
BIOCARTA_IL2RB_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	36	0.62855077	0.962963	0.9986757	BIOCARTA_IL2RB_PATHWAY	38	-0.99606067	0.5104895	0.6930105	-0.3675099	1.62461144
GO_REGULATION_OF_SULFUR_METABOLIC_PROCESS	c5.BP_ GO biological process	19	0.6284094	0.9595202	0.9986103	GO_REGULATION_OF_SULFUR_METABOLIC_PROCESS	19	0.7711165	0.7789337	1	1.3995259	-0.1427071
GO_COMPLEMENT_BINDING	c5.GO molecular function	18	0.6267793	0.94392526	0.9988604	GO_COMPLEMENT_BINDING	18	1.3082892	0.1318822	0.42863506	1.9350685	-0.6815099
NIELSEN_SYNOVIAL_SARCOMA_DN	c2.CGP_ chemical and genetic perturbations	15	0.6267414	0.94392526	0.99877286	NIELSEN_SYNOVIAL_SARCOMA_DN	16	1.4200602	0.05284016	0.31951293	2.0468016	-0.7933188
GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA	c5.BP_ GO biological process	27	0.6255348	0.9654135	0.9989223	GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA	28	0.8975675	0.6348247	1	1.5231023	-0.2720327
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	c2.CGP_ chemical and genetic perturbations	23	0.6255145	0.9344512	0.99883145	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	23	-1.121428	0.24390244	0.48676974	-0.4959135	1.7469425
GO_MANNOSYLTRANSFERASE_ACTIVITY	c5.GO molecular function	22	0.6246164	0.9640625	0.99892265	GO_MANNOSYLTRANSFERASE_ACTIVITY	23	0.5950754	0.9626401	1	1.2196918	0.029541
PID_MAPK_TRK_PATHWAY	c2.CP_ Canonical pathways	33	0.62391937	0.9773414	0.99895877	PID_MAPK_TRK_PATHWAY	34	-0.9297465	0.5974026	0.7843216	-0.30582713	1.55366587
GCTTGAA_MIR498	c3.MIR_ microRNA targets	104	0.62388617	0.99743587	0.9988714	GCTTGAA_MIR498	104	-1.086556	0.30555555	0.5398591	-0.46266983	1.71044217
PID_P75_NTR_PATHWAY	c2.CP_ Canonical pathways	65	0.6231459	0.9932705	0.9989145	PID_P75_NTR_PATHWAY	64	-0.7370375	0.9886364	0.9432764	-0.1138916	1.3601834
REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK	c2.CP_REACTOME_ Reactome gene sets	17	0.62290865	0.9601329	0.99886316	REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK	17	-0.41459933	1	0.9903952	0.20830932	1.03750798
GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN	C7_ immunologic signatures	175	0.62268037	1	0.9988129	GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN	176	0.6941995	0.9684959	1	1.31687987	-0.07151913
GO_PHOSPHATASE_REGULATOR_ACTIVITY	c5.GO molecular function	75	0.6219749	0.9946524	0.9988578	GO_PHOSPHATASE_REGULATOR_ACTIVITY	75	0.68094665	0.95043105	1	1.30292155	-0.05897175
GO_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY	c5.BP_ GO biological process	28	0.62129056	0.9591195	0.9988923	GO_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY	29	-1.3072606	0.105960265	0.27635315	-0.68597004	1.92855116
PID_HIV_NEF_PATHWAY	c2.CP_ Canonical pathways	34	0.62079453	0.97293234	0.9988894	PID_HIV_NEF_PATHWAY	34	0.69438964	0.9063981	1	1.31518417	-0.07359511
YANG_MUC2_TARGETS_DUODENUM_3MO_DN	c2.CGP_ chemical and genetic perturbations	15	0.6207891	0.9365609	0.9987955	YANG_MUC2_TARGETS_DUODENUM_3MO_DN	15	1.2964889	0.1411917	0.44738692	1.917278	-0.6756998
GO_GASTRULATION_WITH_MOUTH_FORMING_SECOND	c5.BP_ GO biological process	22	0.6205234	0.9479495	0.9987502	GO_GASTRULATION_WITH_MOUTH_FORMING_SECOND	23	0.6751351	0.91325897	1	1.2956585	-0.0546117
GO_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	22	0.62007076	0.9629057	0.9987348	GO_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	26	0.8783598	0.6578313	1	1.49843056	-0.25828904
GO_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING	c5.GO molecular function	19	0.6194212	0.9512987	0.9987616	GO_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING	19	-1.1624613	0.22553192	0.42741615	-0.5430401	1.7818825
PID_ERBB4_PATHWAY	c2.CP_ Canonical pathways	37	0.6178305	0.9744361	0.9989586	PID_ERBB4_PATHWAY	38	0.69919556	0.8929412	1	1.31702606	-0.08136506
PID_INSULIN_GLUCOSE_PATHWAY	c2.CP_ Canonical pathways	24	0.61745507	0.9643411	0.99893165	PID_INSULIN_GLUCOSE_PATHWAY	24	-1.1410624	0.24561404	0.45489845	-0.52360733	1.75851747
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	c2.CGP_ chemical and genetic perturbations	56	0.6171697	0.9930748	0.9988856	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	56	0.6435689	0.9624724	1	1.2607386	-0.0263992
GO_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS	c5.GO molecular function	40	0.61699873	0.9941945	0.9988195	GO_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS	41	-1.3587968	0.046153847	0.23566857	-0.74179807	1.97579553
GO_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	26	0.6167692	0.9703125	0.9987664	GO_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS	26	1.0448179	0.4269802	0.8500275	1.6615871	-0.4280487
MORF_CSNK1D	c4.CGN_ cancer gene neighborhoods	68	0.6167092	0.9958506	0.99868256	MORF_CSNK1D	68	0.5615951	0.9935553	1	1.1783043	0.0551141
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	c2.CGP_ chemical and genetic perturbations	23	0.61661375	0.95267177	0.99860483	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	23	1.1950564	0.23019803	0.59716076	1.81167015	-0.57844265
BIOCARTA_MITOCHONDRIA_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	21	0.6161168	0.9564541	0.9985939	BIOCARTA_MITOCHONDRIA_PATHWAY	21	-0.6996145	0.91943127	0.96104616	-0.0834977	1.3157313
BIOCARTA_PML_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	0.61540014	0.9375	0.9986248	BIOCARTA_PML_PATHWAY	15	-0.7588755	0.81632656	0.93374854	-0.14347536	1.37427564
GO_HISTONE_METHYLATION	c5.BP_ GO biological process	65	0.6144864	0.9943182	0.9986896	GO_HISTONE_METHYLATION	69	-0.82456285	0.8873239	0.8859087	-0.21007645	1.43904925
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	c2.CP_REACTOME_ Reactome gene sets	24	0.6140596	0.97579426	0.9986693	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	24	0.5642845	0.97979796	1	1.1783441	0.0497751
SU_THYMUS	c2.CGP_ chemical and genetic perturbations	17	0.6126133	0.9708738	0.99881625	SU_THYMUS	16	-1.3495584	0.09090909	0.24269786	-0.7369451	1.9621717
GNF2_CD97	c4.CGN_ cancer gene neighborhoods	28	0.6117108	0.98253274	0.99887604	GNF2_CD97	31	0.9208633	0.6252983	1	1.5325741	-0.3091525
GO_NEGATIVE_REGULATION_OF_HISTONE_MODIFICATION	c5.BP_ GO biological process	34	0.6110479	0.9734121	0.9988877	GO_NEGATIVE_REGULATION_OF_HISTONE_MODIFICATION	35	0.62934196	0.96190476	1	1.24038986	-0.01829406
GO_ERBB2_SIGNALING_PATHWAY	c5.BP_ GO biological process	35	0.61093235	0.9770642	0.99881226	GO_ERBB2_SIGNALING_PATHWAY	36	0.9990857	0.48090693	0.92470795	1.61001805	-0.38815335
BIOCARTA_RAS_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	0.6106422	0.9540582	0.9987673	BIOCARTA_RAS_PATHWAY	22	0.7168985	0.8329208	1	1.3275407	-0.1062563
GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER	c5.BP_ GO biological process	18	0.61052674	0.9665605	0.9986905	GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER	18	0.79491436	0.76344085	1	1.4054411	-0.18438762
GO_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE	c5.BP_ GO biological process	24	0.6100918	0.96	0.99866194	GO_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE	25	0.54897475	0.98132	1	1.15906655	0.06111705
HOWLIN_CITED1_TARGETS_2_DN	c2.CGP_ chemical and genetic perturbations	16	0.6093633	0.94258374	0.9986863	HOWLIN_CITED1_TARGETS_2_DN	16	0.8547797	0.67185473	1	1.464143	-0.2454164
BIOCARTA_EPO_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	0.60928494	0.95510834	0.99860513	BIOCARTA_EPO_PATHWAY	19	0.7198311	0.85214007	1	1.32911604	-0.11054616
GO_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX	c5.CC_ GO cellular component	23	0.6092058	0.9717426	0.9985227	GO_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX	23	0.92744184	0.59292036	1	1.53664764	-0.31823604
GO_DORSAL_SPINAL_CORD_DEVELOPMENT	c5.BP_ GO biological process	15	0.60850286	0.95106035	0.99853945	GO_DORSAL_SPINAL_CORD_DEVELOPMENT	20	1.0910723	0.38077402	0.76948524	1.69957516	-0.48256944
GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING	c5.GO molecular function	16	0.6050856	0.96854305	0.99896395	GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING	16	0.9728532	0.54353565	0.9579803	1.5779388	-0.3677676
GO_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING	c5.GO molecular function	21	0.60487986	0.9657321	0.9988984	GO_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING	22	-0.9660031	0.504717	0.7345845	-0.36112324	1.57088296
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	c2.CGP_ chemical and genetic perturbations	26	0.6045515	0.96153843	0.9988506	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	25	0.8848916	0.6529851	1	1.4894431	-0.2803401
GCM_ING1	c4.CGN_ cancer gene neighborhoods	59	0.6037515	0.99316007	0.99887514	GCM_ING1	59	0.59723973	0.9856512	1	1.20099123	0.00651177
GO_CLATHRIN_COATED_VESICLE_MEMBRANE	c5.CC_ GO cellular component	67	0.60370314	0.9931319	0.99878764	GO_CLATHRIN_COATED_VESICLE_MEMBRANE	70	0.9994495	0.50108695	0.9245754	1.60315264	-0.39574636
GO_NEGATIVE_REGULATION_OF_CHROMATIN_MODIFICATION	c5.BP_ GO biological process	42	0.60247254	0.99127907	0.99886954	GO_NEGATIVE_REGULATION_OF_CHROMATIN_MODIFICATION	43	-0.77379525	0.9078014	0.92509127	-0.17132271	1.37626779
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES	c2.CP_ Canonical pathways	27	0.60149693	0.9769585	0.9989153	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES	27	0.9370809	0.5831325	0.99310553	1.53857783	-0.33558397
PID_MET_PATHWAY	c2.CP_ Canonical pathways	77	0.6008824	0.9973615	0.9989073	PID_MET_PATHWAY	78	0.7595433	0.87159956	1	1.3604257	-0.1586609
GO_LONG_CHAIN_FATTY_ACID_TRANSPORT	c5.BP_ GO biological process	32	0.6001724	0.9775449	0.9989116	GO_LONG_CHAIN_FATTY_ACID_TRANSPORT	39	1.5137523	0.01734104	0.23828538	2.1139247	-0.9135799
KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	c2.CP_BIOCARTA_ BioCarta gene sets	34	0.5997993	0.9865471	0.9988727	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	34	0.8631738	0.69249105	1	1.4629731	-0.2633745
GO_CLATHRIN_VESICLE_COAT	c5.CC_ GO cellular component	22	0.59940356	0.9580745	0.9988324	GO_CLATHRIN_VESICLE_COAT	22	0.8417713	0.6983931	1	1.44117486	-0.24236774
BIOCARTA_CHEMICAL_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	22	0.598741	0.97301584	0.9988318	BIOCARTA_CHEMICAL_PATHWAY	22	0.8559686	0.68578553	1	1.4547096	-0.2572276
MORF_RFC1	c4.CGN_ cancer gene neighborhoods	99	0.59675986	1	0.9990042	MORF_RFC1	100	-0.8212979	0.975	0.88854903	-0.22453804	1.41805776
VISALA_AGING_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	17	0.59525204	0.9519231	0.99910825	VISALA_AGING_LYMPHOCYTE_DN	17	1.1358678	0.29705507	0.6955548	1.73111984	-0.54061576
GO_PODOSOME	c5.CC_ GO cellular component	23	0.5949513	0.97205883	0.99905336	GO_PODOSOME	23	1.1519295	0.28858218	0.6664339	1.7468808	-0.5569782
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	c2.CGP_ chemical and genetic perturbations	19	0.5941697	0.95859873	0.9990556	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	19	-1.1477219	0.25358853	0.44593745	-0.5535522	1.7418916
GLI1_UP.V1_DN	C6_ oncogenic signatures	26	0.59413296	0.96240604	0.99896604	GLI1_UP.V1_DN	26	-0.9344046	0.57731956	0.7781932	-0.34027164	1.52853756
GO_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	30	0.59332246	0.98662704	0.99897355	GO_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY	30	0.94580245	0.55839413	0.986303	1.53912491	-0.35247999
GGCNNMSMYNTTG_UNKNOWN	c3.TFT_ transcription factor targets	68	0.5929546	0.99310344	0.9989242	GGCNNMSMYNTTG_UNKNOWN	68	-0.7832677	0.9459459	0.9187601	-0.1903131	1.3762223
KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	c2.CP_BIOCARTA_ BioCarta gene sets	18	0.59143543	0.9625585	0.999024	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	19	1.0102363	0.48244473	0.90672195	1.60167173	-0.41880087
PAL_PRMT5_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	22	0.5911446	0.9732704	0.99896926	PAL_PRMT5_TARGETS_DN	24	0.9081078	0.6129442	1	1.4992524	-0.3169632
LEE_CALORIE_RESTRICTION_MUSCLE_DN	c2.CGP_ chemical and genetic perturbations	48	0.5910468	0.99285716	0.9988869	LEE_CALORIE_RESTRICTION_MUSCLE_DN	49	0.78173167	0.8269231	1	1.37277847	-0.19068487
GCM_GSTA4	c4.CGN_ cancer gene neighborhoods	56	0.5876301	0.99167824	0.9992181	GCM_GSTA4	57	0.7580349	0.86237514	1	1.345665	-0.1704048
GO_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	16	0.58570886	0.95106035	0.9993448	GO_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS	16	-1.6070241	0.039473683	0.08889475	-1.02131524	2.19273296
GCM_MLL	c4.CGN_ cancer gene neighborhoods	155	0.58522516	1	0.99930567	GCM_MLL	155	-1.0107409	0.41379312	0.6708431	-0.42551574	1.59596606
GO_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER	c5.BP_ GO biological process	20	0.5812159	0.9690403	0.9996607	GO_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER	20	-1.4643778	0.052380953	0.16511072	-0.8831619	2.0455937
GCM_CSNK1A1	c4.CGN_ cancer gene neighborhoods	35	0.57825154	0.9866469	0.99987304	GCM_CSNK1A1	35	-1.0034323	0.4362416	0.67868316	-0.42518076	1.58168384
GO_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS	c5.BP_ GO biological process	31	0.57807225	0.9890966	0.9997984	GO_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS	31	1.0021899	0.48463356	0.9198803	1.58026215	-0.42411765
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP	C7_ immunologic signatures	150	0.57777363	1	0.9997322	GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP	154	0.74070877	0.96363634	1	1.3184824	-0.16293514
GO_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS	c5.BP_ GO biological process	25	0.5755078	0.98018295	0.99986	GO_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS	27	0.93705267	0.5859951	0.9929311	1.51256047	-0.36154487
GO_PLATELET_MORPHOGENESIS	c5.BP_ GO biological process	18	0.5729412	0.97839504	1	GO_PLATELET_MORPHOGENESIS	18	-1.4232877	0.099585064	0.19200571	-0.8503465	1.9962289
GO_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION	c5.BP_ GO biological process	37	0.5721599	0.98835516	0.99998856	GO_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION	40	-0.8767144	0.75	0.84688973	-0.3045545	1.4488743
HATADA_METHYLATED_IN_LUNG_CANCER_DN	c2.CGP_ chemical and genetic perturbations	21	0.5712438	0.9830247	0.9999784	HATADA_METHYLATED_IN_LUNG_CANCER_DN	24	0.902822	0.6352201	1	1.4740658	-0.3315782
MARSON_FOXP3_CORE_DIRECT_TARGETS	c2.CGP_ chemical and genetic perturbations	16	0.5711417	0.97492164	0.9998928	MARSON_FOXP3_CORE_DIRECT_TARGETS	19	1.249717	0.2007722	0.5114237	1.8208587	-0.6785753
GO_PROTEIN_K48_LINKED_DEUBIQUITINATION	c5.BP_ GO biological process	19	0.57051903	0.98202616	0.99985087	GO_PROTEIN_K48_LINKED_DEUBIQUITINATION	19	1.1385101	0.32484075	0.6930652	1.70902913	-0.56799107
GO_PROTEIN_LOCALIZATION_TO_CILIUM	c5.BP_ GO biological process	23	0.5702391	0.9818182	0.9997804	GO_PROTEIN_LOCALIZATION_TO_CILIUM	23	0.976349	0.50879395	0.9537822	1.5465881	-0.4061099
GCM_NF2	c4.CGN_ cancer gene neighborhoods	260	0.56956893	1	0.9997481	GCM_NF2	260	-0.79176736	1	0.91353977	-0.22219843	1.36133629
GO_VIRION_ASSEMBLY	c5.BP_ GO biological process	33	0.5691508	0.98502994	0.9996886	GO_VIRION_ASSEMBLY	33	0.87914693	0.6682578	1	1.44829773	-0.30999613
GO_PLASMA_MEMBRANE_FUSION	c5.BP_ GO biological process	17	0.56858486	0.9813875	0.999645	GO_PLASMA_MEMBRANE_FUSION	19	0.9547601	0.5513308	0.97660893	1.52334496	-0.38617524
GO_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING	c5.GO molecular function	19	0.5682339	0.96507937	0.9995798	GO_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING	19	1.0482593	0.41318125	0.84309536	1.6164932	-0.4800254
REACTOME_DARPP_32_EVENTS	c2.CP_REACTOME_ Reactome gene sets	22	0.5650958	0.98888886	0.99975383	REACTOME_DARPP_32_EVENTS	22	0.7227509	0.8368883	1	1.2878467	-0.1576551
GO_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS	c5.GO molecular function	17	0.5644052	0.9789644	0.99971557	GO_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS	17	-0.81251335	0.7443946	0.8952884	-0.24810815	1.37691855
GCM_CASP2	c4.CGN_ cancer gene neighborhoods	23	0.5626695	0.9835082	0.9997666	GCM_CASP2	23	-0.7445561	0.90555555	0.94054925	-0.1818866	1.3072256
GO_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	52	0.5626282	0.99723756	0.9996754	GO_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	52	1.1647607	0.23007856	0.64655817	1.7273889	-0.6021325
REACTOME_APOPTOTIC_EXECUTION_PHASE	c2.CP_REACTOME_ Reactome gene sets	49	0.5613609	0.99862635	0.9996804	REACTOME_APOPTOTIC_EXECUTION_PHASE	49	-1.3152274	0.060344826	0.27090928	-0.7538665	1.8765883
GO_HISTONE_MONOUBIQUITINATION	c5.BP_ GO biological process	23	0.5595824	0.9799692	0.9997236	GO_HISTONE_MONOUBIQUITINATION	23	-1.2579399	0.14141414	0.31585842	-0.6983575	1.8175223
GO_BILE_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	29	0.55572045	0.98660713	0.99990964	GO_BILE_ACID_METABOLIC_PROCESS	33	1.0980242	0.3459268	0.7593763	1.65374465	-0.54230375
GO_PROTEIN_DEACETYLASE_ACTIVITY	c5.GO molecular function	43	0.5538456	0.9971347	0.9999538	GO_PROTEIN_DEACETYLASE_ACTIVITY	43	0.5238824	0.9896074	1	1.077728	0.0299632
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	c2.CP_REACTOME_ Reactome gene sets	21	0.55189484	0.9888712	0.9999905	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	21	0.9977249	0.47782004	0.92562747	1.54961974	-0.44583006
GO_DETECTION_OF_BIOTIC_STIMULUS	c5.BP_ GO biological process	21	0.5510814	0.985623	0.99994934	GO_DETECTION_OF_BIOTIC_STIMULUS	22	1.4332951	0.046307884	0.31357482	1.9843765	-0.8822137
GO_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	21	0.5503894	0.98740155	0.99989927	GO_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS	20	0.9173475	0.60205394	1	1.4677369	-0.3669581
GO_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	17	0.54996717	0.9809524	0.999834	GO_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS	17	1.0417447	0.4283854	0.85604894	1.59171187	-0.49177753
REACTOME_GLUCOSE_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	33	0.54882145	0.9897511	0.9998126	REACTOME_GLUCOSE_TRANSPORT	34	-1.2865524	0.11728395	0.29636085	-0.73773095	1.83537385
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	c2.CP_REACTOME_ Reactome gene sets	25	0.53795964	0.98452014	1	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	26	-1.2818022	0.13089006	0.30034295	-0.74384256	1.81976184
MARSON_FOXP3_TARGETS_STIMULATED_UP	c2.CGP_ chemical and genetic perturbations	22	0.5353218	0.99375975	1	MARSON_FOXP3_TARGETS_STIMULATED_UP	28	1.2754788	0.16904762	0.47941393	1.8108006	-0.740157
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	c2.CGP_ chemical and genetic perturbations	17	0.53524727	0.97284347	1	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	17	0.5884673	0.9539919	1	1.12371457	-0.05322003
GO_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION	c5.BP_ GO biological process	21	0.5349971	0.9890625	1	GO_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION	21	-0.55720484	0.9782609	0.98941463	-0.02220774	1.09220194
GO_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	66	0.53441405	1	1	GO_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY	73	0.7966028	0.81847477	1	1.33101685	-0.26218875
REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	c2.CP_REACTOME_ Reactome gene sets	26	0.5338664	0.98170733	1	REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	26	-1.8449144	0.005128205	0.025211288	-1.311048	2.3787808
GCM_SUFU	c4.CGN_ cancer gene neighborhoods	68	0.5328945	1	1	GCM_SUFU	68	0.6912245	0.94438386	1	1.224119	-0.15833
BCAT_BILD_ET_AL_DN	C6_ oncogenic signatures	41	0.52929264	0.9985337	1	BCAT_BILD_ET_AL_DN	41	1.2321494	0.16741572	0.5368249	1.76144204	-0.70285676
GO_PEROXISOMAL_TRANSPORT	c5.BP_ GO biological process	18	0.52895194	0.98435056	1	GO_PEROXISOMAL_TRANSPORT	18	1.1323773	0.29522613	0.7025602	1.66132924	-0.60342536
GCM_DEAF1	c4.CGN_ cancer gene neighborhoods	26	0.5240498	0.993865	1	GCM_DEAF1	26	-0.75054574	0.83505154	0.93899006	-0.22649594	1.27459554
GCM_UBE2N	c4.CGN_ cancer gene neighborhoods	141	0.5211207	1	1	GCM_UBE2N	141	-1.0158931	0.4074074	0.66466683	-0.4947724	1.5370138
REACTOME_PEROXISOMAL_LIPID_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	19	0.51550126	0.98883575	1	REACTOME_PEROXISOMAL_LIPID_METABOLISM	20	0.6593323	0.9157373	1	1.17483356	-0.14383104
CHEOK_RESPONSE_TO_HD_MTX_DN	c2.CGP_ chemical and genetic perturbations	22	0.5142684	0.98299843	1	CHEOK_RESPONSE_TO_HD_MTX_DN	22	-1.2682908	0.12820514	0.30977148	-0.7540224	1.7825592
GO_ENDOCYTIC_RECYCLING	c5.BP_ GO biological process	23	0.51353693	0.9937304	1	GO_ENDOCYTIC_RECYCLING	23	0.91829765	0.6037267	1	1.43183458	-0.40476072
GO_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS	c5.BP_ GO biological process	280	0.5075136	1	1	GO_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS	295	0.31705025	1	1	0.82456385	0.19046335
GO_GOLGI_TO_VACUOLE_TRANSPORT	c5.BP_ GO biological process	23	0.49757943	0.99198717	1	GO_GOLGI_TO_VACUOLE_TRANSPORT	23	0.6802195	0.88916254	1	1.17779893	-0.18264007
REACTOME_INSULIN_RECEPTOR_RECYCLING	c2.CP_REACTOME_ Reactome gene sets	21	0.49455106	0.99539876	1	REACTOME_INSULIN_RECEPTOR_RECYCLING	23	0.9911829	0.49938196	0.9342542	1.48573396	-0.49663184
GO_NAD_DEPENDENT_PROTEIN_DEACETYLASE_ACTIVITY	c5.GO molecular function	17	0.49438494	0.99198717	1	GO_NAD_DEPENDENT_PROTEIN_DEACETYLASE_ACTIVITY	17	0.9843209	0.53594774	0.9422672	1.47870584	-0.48993596
GO_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX	c5.CC_ GO cellular component	26	0.49400276	0.9940916	1	GO_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX	27	0.9444585	0.5579078	0.9876187	1.43846126	-0.45045574
REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION	c2.CP_REACTOME_ Reactome gene sets	15	0.48673213	0.99343187	1	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION	15	-2.0838857	0	0.003205561	-1.59715357	2.57061783
GO_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	16	0.4817095	0.9966942	1	GO_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS	16	-1.1092391	0.3114035	0.5056358	-0.6275296	1.5909486
SANDERSON_PPARA_TARGETS	c2.CGP_ chemical and genetic perturbations	15	0.47790816	0.99833053	1	SANDERSON_PPARA_TARGETS	15	0	0	0	0.47790816	0.47790816
GO_ENDOPLASMIC_RETICULUM_ORGANIZATION	c5.BP_ GO biological process	35	0.47779015	0.99850076	1	GO_ENDOPLASMIC_RETICULUM_ORGANIZATION	35	0.72815824	0.87738097	1	1.20594839	-0.25036809
GO_OLFACTORY_RECEPTOR_ACTIVITY	c5.GO molecular function	228	0.46578494	1	1	GO_OLFACTORY_RECEPTOR_ACTIVITY	239	-0.4741523	1	0.99081457	-0.00836736	0.93993724
REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	c2.CP_REACTOME_ Reactome gene sets	26	0.46366933	0.99846625	1	REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	26	-1.7841907	0.006134969	0.036334958	-1.32052137	2.24786003
GO_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION	c5.BP_ GO biological process	18	0.4569457	0.99678975	1	GO_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION	19	0.8421339	0.70191085	1	1.2990796	-0.3851882
GO_RNA_POLYMERASE_II_CARBOXY_TERMINAL_DOMAIN_KINASE_ACTIVITY	c5.GO molecular function	16	0.4541603	0.9950331	1	GO_RNA_POLYMERASE_II_CARBOXY_TERMINAL_DOMAIN_KINASE_ACTIVITY	16	0.7488489	0.82376504	1	1.2030092	-0.2946886
GO_HSP90_PROTEIN_BINDING	c5.GO molecular function	25	0.45122346	0.9984733	1	GO_HSP90_PROTEIN_BINDING	26	1.0365868	0.42236024	0.86464596	1.48781026	-0.58536334
REACTOME_OLFACTORY_SIGNALING_PATHWAY	c2.CP_REACTOME_ Reactome gene sets	187	0.4459953	1	1	REACTOME_OLFACTORY_SIGNALING_PATHWAY	196	-0.48499933	1	0.9915053	-0.03900403	0.93099463
MODULE_352	c4.CM_ cancer modules	17	0.44237134	0.99841017	1	MODULE_352	17	-1.968586	0	0.010563188	-1.52621466	2.41095734
GO_GOLGI_TO_ENDOSOME_TRANSPORT	c5.BP_ GO biological process	15	0.4415528	0.9950083	0.99997956	GO_GOLGI_TO_ENDOSOME_TRANSPORT	15	0.74633986	0.80266666	1	1.18789266	-0.30478706
KEGG_OLFACTORY_TRANSDUCTION	c2.CP_BIOCARTA_ BioCarta gene sets	227	0.42328668	1	1	KEGG_OLFACTORY_TRANSDUCTION	241	0.24794649	1	1	0.67123317	0.17534019
GO_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS	c5.GO molecular function	18	0.41930255	0.9953416	0.99994594	GO_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS	18	0.60804355	0.9572539	1	1.0273461	-0.188741
GO_NUCLEAR_NUCLEOSOME	c5.CC_ GO cellular component	15	0.38712278	1	0.9999563	GO_NUCLEAR_NUCLEOSOME	16	1.4887079	0.02734375	0.261143	1.87583068	-1.10158512
GNF2_EIF3S6	c4.CGN_ cancer gene neighborhoods	93	-2.9762714	0	0	GNF2_EIF3S6	93	-0.70192814	1	0.9596806	-3.67819954	-2.27434326
REACTOME_TRANSLATION	c2.CP_REACTOME_ Reactome gene sets	115	-2.974046	0	0	REACTOME_TRANSLATION	115	-0.9424229	0.6315789	0.7671981	-3.9164689	-2.0316231
REACTOME_PEPTIDE_CHAIN_ELONGATION	c2.CP_REACTOME_ Reactome gene sets	56	-2.9629986	0	0	REACTOME_PEPTIDE_CHAIN_ELONGATION	56	1.0994072	0.32444444	0.7578438	-1.8635914	-4.0624058
REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE	c2.CP_REACTOME_ Reactome gene sets	79	-2.9538293	0	0	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE	79	0.47976136	1	1	-2.47406794	-3.43359066
REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX	c2.CP_REACTOME_ Reactome gene sets	78	-2.951598	0	0	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX	78	0.64209956	0.9700214	1	-2.30949844	-3.59369756
REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION	c2.CP_REACTOME_ Reactome gene sets	77	-2.9478626	0	0	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION	77	-0.8002947	0.90625	0.9056505	-3.7481573	-2.1475679
REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION	c2.CP_REACTOME_ Reactome gene sets	72	-2.9358306	0	0	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION	72	0.59016645	0.99356914	1	-2.34566415	-3.52599705
KEGG_RIBOSOME	c2.CP_BIOCARTA_ BioCarta gene sets	60	-2.93525	0	0	KEGG_RIBOSOME	60	0.95130664	0.5844298	0.98051196	-1.98394336	-3.88655664
MORF_NPM1	c4.CGN_ cancer gene neighborhoods	129	-2.915144	0	0	MORF_NPM1	129	-1.3910735	0	0.21372654	-4.3062175	-1.5240705
GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM	c5.BP_ GO biological process	75	-2.8962333	0	0	GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM	75	0.814813	0.80456024	1	-2.0814203	-3.7110463
GCM_TPT1	c4.CGN_ cancer gene neighborhoods	47	-2.8857877	0	0	GCM_TPT1	47	0.8092076	0.77130044	1	-2.0765801	-3.6949953
GO_TRANSLATIONAL_INITIATION	c5.BP_ GO biological process	114	-2.8702624	0	0	GO_TRANSLATIONAL_INITIATION	114	-0.83129424	0.8611111	0.8809802	-3.70155664	-2.03896816
GO_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM	c5.BP_ GO biological process	94	-2.8525984	0	0	GO_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM	94	0.654634	0.973262	1	-2.1979644	-3.5072324
GCM_NPM1	c4.CGN_ cancer gene neighborhoods	92	-2.8497033	0	0	GCM_NPM1	92	-1.4087241	0	0.20117165	-4.2584274	-1.4409792
GNF2_ST13	c4.CGN_ cancer gene neighborhoods	51	-2.8302057	0	0	GNF2_ST13	51	-0.5704064	1	0.9883679	-3.4006121	-2.2597993
GO_RRNA_METABOLIC_PROCESS	c5.BP_ GO biological process	205	-2.814558	0	0	GO_RRNA_METABOLIC_PROCESS	207	-1.3915539	0	0.21335068	-4.2061119	-1.4230041
GO_CYTOSOLIC_RIBOSOME	c5.CC_ GO cellular component	79	-2.8104756	0	0	GO_CYTOSOLIC_RIBOSOME	79	0.7718554	0.85959274	1	-2.0386202	-3.582331
GO_RIBOSOMAL_SUBUNIT	c5.CC_ GO cellular component	127	-2.7940023	0	0	GO_RIBOSOMAL_SUBUNIT	127	-0.7467516	1	0.9397797	-3.5407539	-2.0472507
GO_RIBOSOME_BIOGENESIS	c5.BP_ GO biological process	249	-2.7769268	0	0	GO_RIBOSOME_BIOGENESIS	250	-1.5553454	0	0.11219416	-4.3322722	-1.2215814
MORF_TPT1	c4.CGN_ cancer gene neighborhoods	77	-2.7721717	0	0	MORF_TPT1	77	0.5249615	0.99892473	1	-2.2472102	-3.2971332
MORF_ACTG1	c4.CGN_ cancer gene neighborhoods	110	-2.766556	0	0	MORF_ACTG1	110	-0.87087023	0.82857144	0.8547589	-3.63742623	-1.89568577
GO_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT	c5.CC_ GO cellular component	42	-2.7634933	0	0	GO_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT	42	0.80468893	0.7566321	1	-1.95880437	-3.56818223
GO_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY	c5.BP_ GO biological process	89	-2.762119	0	0	GO_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY	89	0.5596858	0.99785405	1	-2.2024332	-3.3218048
GNF2_FBL	c4.CGN_ cancer gene neighborhoods	126	-2.7472136	0	0	GNF2_FBL	126	-1.8988879	0	0.018001497	-4.6461015	-0.8483257
REACTOME_INFLUENZA_LIFE_CYCLE	c2.CP_REACTOME_ Reactome gene sets	105	-2.7459972	0	0	REACTOME_INFLUENZA_LIFE_CYCLE	105	-0.95328254	0.6136364	0.7525873	-3.69927974	-1.79271466
MORF_NME2	c4.CGN_ cancer gene neighborhoods	129	-2.725548	0	0	MORF_NME2	129	-0.85525215	0.96428573	0.86126643	-3.58080015	-1.87029585
GO_RIBOSOME	c5.CC_ GO cellular component	182	-2.7135227	0	0	GO_RIBOSOME	183	-0.94152975	0.8666667	0.7671619	-3.65505245	-1.77199295
GO_MULTI_ORGANISM_METABOLIC_PROCESS	c5.BP_ GO biological process	108	-2.7102165	0	0	GO_MULTI_ORGANISM_METABOLIC_PROCESS	108	-0.84574354	0.9347826	0.87221265	-3.55596004	-1.86447296
GO_LARGE_RIBOSOMAL_SUBUNIT	c5.CC_ GO cellular component	74	-2.683296	0	0	GO_LARGE_RIBOSOMAL_SUBUNIT	74	-0.64201057	1	0.9775944	-3.32530657	-2.04128543
GO_PRERIBOSOME	c5.CC_ GO cellular component	54	-2.6728601	0	0	GO_PRERIBOSOME	55	-1.8298767	0	0.027803076	-4.5027368	-0.8429834
GO_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS	c5.BP_ GO biological process	369	-2.6499012	0	0	GO_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS	369	0	0	0	-2.6499012	-2.6499012
REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX	c2.CP_REACTOME_ Reactome gene sets	36	-2.631301	0	0	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX	36	-0.74921584	0.9300699	0.9389973	-3.38051684	-1.88208516
GO_STRUCTURAL_CONSTITUENT_OF_RIBOSOME	c5.GO molecular function	172	-2.5956945	0	0	GO_STRUCTURAL_CONSTITUENT_OF_RIBOSOME	173	0.42998943	1	1	-2.16570507	-3.02568393
MORF_RAN	c4.CGN_ cancer gene neighborhoods	237	-2.5707893	0	0	MORF_RAN	237	-2.2121205	0	0.000800321	-4.7829098	-0.3586688
GO_NCRNA_PROCESSING	c5.BP_ GO biological process	319	-2.5660632	0	0	GO_NCRNA_PROCESSING	320	-1.5068206	0	0.13807678	-4.0728838	-1.0592426
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	c2.CGP_ chemical and genetic perturbations	47	-2.5595312	0	0	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	48	1.1476461	0.24631101	0.6727263	-1.4118851	-3.7071773
GNF2_NPM1	c4.CGN_ cancer gene neighborhoods	63	-2.5562165	0	0	GNF2_NPM1	63	-2.2692719	0	0.000395427	-4.8254884	-0.2869446
GNF2_GLTSCR2	c4.CGN_ cancer gene neighborhoods	25	-2.5458486	0	0	GNF2_GLTSCR2	25	0.8535414	0.6886675	1	-1.6923072	-3.39939
REACTOME_METABOLISM_OF_MRNA	c2.CP_REACTOME_ Reactome gene sets	176	-2.544454	0	0	REACTOME_METABOLISM_OF_MRNA	177	-1.0709693	0.18181819	0.56856406	-3.6154233	-1.4734847
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S	c2.CP_REACTOME_ Reactome gene sets	44	-2.539027	0	0	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S	44	-0.93726724	0.5952381	0.7744888	-3.47629424	-1.60175976
MODULE_83	c4.CM_ cancer modules	262	-2.530652	0	0	MODULE_83	263	-1.1165035	0	0.4940102	-3.6471555	-1.4141485
GO_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS	c5.BP_ GO biological process	41	-2.506223	0	0	GO_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS	41	-0.85593677	0.720339	0.8623686	-3.36215977	-1.65028623
MORF_EIF3S6	c4.CGN_ cancer gene neighborhoods	107	-2.4964466	0	0	MORF_EIF3S6	107	-1.9749476	0	0.01017171	-4.4713942	-0.521499
GNF2_TPT1	c4.CGN_ cancer gene neighborhoods	25	-2.4820833	0	0	GNF2_TPT1	25	0.8265006	0.7325	1	-1.6555827	-3.3085839
GCM_ACTG1	c4.CGN_ cancer gene neighborhoods	104	-2.477028	0	0	GCM_ACTG1	104	-2.3135781	0	0.000289461	-4.7906061	-0.1634499
GO_CYTOSOLIC_PART	c5.CC_ GO cellular component	163	-2.4698074	0	0	GO_CYTOSOLIC_PART	164	0.6548775	0.9887984	1	-1.8149299	-3.1246849
MORF_UBE2I	c4.CGN_ cancer gene neighborhoods	215	-2.4659276	0	0	MORF_UBE2I	215	-1.9428513	0	0.01309459	-4.4087789	-0.5230763
GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP	C7_ immunologic signatures	175	-2.4494622	0	0	GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP	177	-1.7034432	0	0.05436753	-4.1529054	-0.746019
REACTOME_METABOLISM_OF_RNA	c2.CP_REACTOME_ Reactome gene sets	219	-2.445706	0	0	REACTOME_METABOLISM_OF_RNA	220	-1.3725492	0	0.22519888	-3.8182552	-1.0731568
GO_OXIDATIVE_PHOSPHORYLATION	c5.BP_ GO biological process	74	-2.424947	0	0	GO_OXIDATIVE_PHOSPHORYLATION	75	0.42574248	1	1	-1.99920452	-2.85068948
REACTOME_METABOLISM_OF_PROTEINS	c2.CP_REACTOME_ Reactome gene sets	360	-2.419832	0	0	REACTOME_METABOLISM_OF_PROTEINS	365	0.64712375	0.997998	1	-1.77270825	-3.06695575
GO_NUCLEOLAR_PART	c5.CC_ GO cellular component	58	-2.4109814	0	0	GO_NUCLEOLAR_PART	59	-1.9190044	0	0.01583169	-4.3299858	-0.491977
GNF2_DAP3	c4.CGN_ cancer gene neighborhoods	96	-2.4054825	0	0	GNF2_DAP3	96	-1.9751675	0	0.010179265	-4.38065	-0.430315
MORF_JUND	c4.CGN_ cancer gene neighborhoods	51	-2.388171	0	0	MORF_JUND	51	-0.87663573	0.75238097	0.8467039	-3.26480673	-1.51153527
GO_NCRNA_METABOLIC_PROCESS	c5.BP_ GO biological process	453	-2.3762152	0	0	GO_NCRNA_METABOLIC_PROCESS	453	0	0	0	-2.3762152	-2.3762152
MORF_G22P1	c4.CGN_ cancer gene neighborhoods	159	-2.3715847	0	0	MORF_G22P1	159	-2.451246	0	0	-4.8228307	0.0796613
PENG_RAPAMYCIN_RESPONSE_DN	c2.CGP_ chemical and genetic perturbations	220	-2.371497	0	0	PENG_RAPAMYCIN_RESPONSE_DN	220	-1.8104961	0	0.031454492	-4.1819931	-0.5610009
GO_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS	c5.BP_ GO biological process	47	-2.367426	0	0	GO_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS	47	-1.464222	0.009009009	0.16499364	-3.831648	-0.903204
MORF_ANP32B	c4.CGN_ cancer gene neighborhoods	179	-2.3661757	0	0	MORF_ANP32B	179	-2.1077433	0	0.002556973	-4.473919	-0.2584324
GNF2_UBE2I	c4.CGN_ cancer gene neighborhoods	36	-2.3643353	0	0	GNF2_UBE2I	36	-1.7921783	0.00625	0.034369845	-4.1565136	-0.572157
MODULE_151	c4.CM_ cancer modules	259	-2.358591	0	0	MODULE_151	260	-0.9612071	0.6666667	0.7414571	-3.3197981	-1.3973839
GCM_CSNK2B	c4.CGN_ cancer gene neighborhoods	88	-2.3581724	0	0	GCM_CSNK2B	88	-1.9551163	0	0.01167116	-4.3132887	-0.4030561
GO_MITOCHONDRIAL_TRANSLATION	c5.BP_ GO biological process	104	-2.3559139	0	0	GO_MITOCHONDRIAL_TRANSLATION	104	-1.6932627	0	0.058195774	-4.0491766	-0.6626512
MORF_DAP3	c4.CGN_ cancer gene neighborhoods	181	-2.3533447	0	0	MORF_DAP3	181	-1.9408063	0	0.013249716	-4.294151	-0.4125384
GO_ELECTRON_TRANSPORT_CHAIN	c5.BP_ GO biological process	88	-2.3488116	0	0	GO_ELECTRON_TRANSPORT_CHAIN	89	0.46939284	1	1	-1.87941876	-2.81820444
GCM_APEX1	c4.CGN_ cancer gene neighborhoods	101	-2.3343604	0	0	GCM_APEX1	101	-2.4689257	0	0	-4.8032861	0.1345653
MODULE_114	c4.CM_ cancer modules	276	-2.3331528	0	0	MODULE_114	277	-0.88804734	1	0.83722866	-3.22120014	-1.44510546
GO_PROTEIN_TARGETING_TO_MEMBRANE	c5.BP_ GO biological process	124	-2.3279934	0	0	GO_PROTEIN_TARGETING_TO_MEMBRANE	123	0.79128045	0.869207	1	-1.53671295	-3.11927385
GO_RIBOSOME_ASSEMBLY	c5.BP_ GO biological process	44	-2.324756	0	0	GO_RIBOSOME_ASSEMBLY	44	-0.8807162	0.6885246	0.84370625	-3.2054722	-1.4440398
GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	C7_ immunologic signatures	158	-2.3222206	0	0	GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	161	-0.7291071	1	0.9478624	-3.0513277	-1.5931135
GO_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT	c5.CC_ GO cellular component	30	-2.318331	0	0	GO_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT	30	0.5793794	0.971864	1	-1.7389516	-2.8977104
GO_RIBONUCLEOPROTEIN_COMPLEX_SUBUNIT_ORGANIZATION	c5.BP_ GO biological process	177	-2.310805	0	0	GO_RIBONUCLEOPROTEIN_COMPLEX_SUBUNIT_ORGANIZATION	177	-1.4170765	0	0.1952229	-3.7278815	-0.8937285
COLLER_MYC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	25	-2.3073668	0	0	COLLER_MYC_TARGETS_UP	25	-1.3949566	0.061904762	0.2107316	-3.7023234	-0.9124102
GO_SMALL_RIBOSOMAL_SUBUNIT	c5.CC_ GO cellular component	53	-2.3072696	0	0	GO_SMALL_RIBOSOMAL_SUBUNIT	53	-0.7636075	0.95327103	0.93003774	-3.0708771	-1.5436621
GO_TRANSLATIONAL_ELONGATION	c5.BP_ GO biological process	106	-2.3047488	0	0	GO_TRANSLATIONAL_ELONGATION	105	-1.704785	0	0.054573994	-4.0095338	-0.5999638
HALLMARK_MYC_TARGETS_V2	H_ hallmark gene sets	54	-2.30047	0	0	HALLMARK_MYC_TARGETS_V2	54	-1.6325798	0	0.07907505	-3.9330498	-0.6678902
BURTON_ADIPOGENESIS_5	c2.CGP_ chemical and genetic perturbations	111	-2.2965145	0	0	BURTON_ADIPOGENESIS_5	111	-0.8155361	0.8518519	0.892895	-3.1120506	-1.4809784
GO_RNA_CATABOLIC_PROCESS	c5.BP_ GO biological process	180	-2.293378	0	0	GO_RNA_CATABOLIC_PROCESS	183	-0.89684325	0.8	0.82591236	-3.19022125	-1.39653475
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	62	-2.2904797	0	0	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT	62	-0.72767216	0.989011	0.9480566	-3.01815186	-1.56280754
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_	c2.CP_REACTOME_ Reactome gene sets	64	-2.290327	0	0	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_	65	-0.7544396	0.9285714	0.93693584	-3.0447666	-1.5358874
CHR22Q13	C1: positional gene sets	140	-2.285636	0	0	CHR22Q13	151	1.0825756	0.3082401	0.7830821	-1.2030604	-3.3682116
MORF_SART1	c4.CGN_ cancer gene neighborhoods	56	-2.285152	0	0	MORF_SART1	56	-1.8894132	0	0.018871542	-4.1745652	-0.3957388
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	c2.CGP_ chemical and genetic perturbations	42	-2.2810414	0	0	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	42	-0.65340716	0.9722222	0.97597426	-2.93444856	-1.62763424
GO_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX	c5.CC_ GO cellular component	76	-2.2796748	0	0	GO_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX	77	0.58633775	0.9924973	1	-1.69333705	-2.86601255
GCM_PSME1	c4.CGN_ cancer gene neighborhoods	73	-2.2784247	0	0	GCM_PSME1	73	-2.1796832	0	0.001095257	-4.4581079	-0.0987415
GO_MATURATION_OF_SSU_RRNA	c5.BP_ GO biological process	35	-2.269982	0	0	GO_MATURATION_OF_SSU_RRNA	35	-1.6304567	0.01369863	0.079660565	-3.9004387	-0.6395253
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	c2.CP_REACTOME_ Reactome gene sets	41	-2.268796	0	0	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	41	-0.6665083	0.99248123	0.9733108	-2.9353043	-1.6022877
MODULE_29	c4.CM_ cancer modules	17	-2.2653494	0	0	MODULE_29	17	0.6818506	0.8778523	1	-1.5834988	-2.9472
GO_TRANSLATIONAL_TERMINATION	c5.BP_ GO biological process	91	-2.2653227	0	0	GO_TRANSLATIONAL_TERMINATION	91	-1.8462969	0	0.024977544	-4.1116196	-0.4190258
GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	C7_ immunologic signatures	156	-2.2620492	0	0	GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	158	-1.3498478	0	0.2428809	-3.611897	-0.9122014
HALLMARK_MYC_TARGETS_V1	H_ hallmark gene sets	179	-2.2570388	0	0	HALLMARK_MYC_TARGETS_V1	179	-2.6938424	0	0	-4.9508812	0.4368036
GO_AMIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	446	-2.2542386	0	0	GO_AMIDE_BIOSYNTHETIC_PROCESS	446	0	0	0	-2.2542386	-2.2542386
MODULE_32	c4.CM_ cancer modules	210	-2.2538083	0	0	MODULE_32	210	-1.8741558	0	0.0210244	-4.1279641	-0.3796525
MORF_PPP1CA	c4.CGN_ cancer gene neighborhoods	151	-2.247712	0	0	MORF_PPP1CA	151	-2.0038223	0	0.00781551	-4.2515343	-0.2438897
MORF_CSNK2B	c4.CGN_ cancer gene neighborhoods	255	-2.244558	0	0	MORF_CSNK2B	255	-2.1369057	0	0.001817366	-4.3814637	-0.1076523
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	c2.CGP_ chemical and genetic perturbations	65	-2.2426481	0	0	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	65	-1.13302	0.21686748	0.46725887	-3.3756681	-1.1096281
GSE24210_RESTING_TREG_VS_TCONV_DN	C7_ immunologic signatures	172	-2.2375207	0	0	GSE24210_RESTING_TREG_VS_TCONV_DN	174	-1.4361606	0	0.1828962	-3.6736813	-0.8013601
MORF_FBL	c4.CGN_ cancer gene neighborhoods	126	-2.2295475	0	1.19E-05	MORF_FBL	126	-2.2252533	0	0.000667137	-4.4548008	-0.0042942
REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	99	-2.2268143	0	1.18E-05	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT	100	-0.65486073	1	0.9756935	-2.88167503	-1.57195357
GO_SMALL_SUBUNIT_PROCESSOME	c5.CC_ GO cellular component	29	-2.2251887	0	1.17E-05	GO_SMALL_SUBUNIT_PROCESSOME	30	-1.9049888	0	0.017486122	-4.1301775	-0.3201999
MORF_AP2M1	c4.CGN_ cancer gene neighborhoods	198	-2.2245705	0	1.15E-05	MORF_AP2M1	198	-1.6072805	0	0.08896504	-3.831851	-0.61729
MORF_CCNI	c4.CGN_ cancer gene neighborhoods	77	-2.210535	0	1.14E-05	MORF_CCNI	77	-1.960055	0	0.01134397	-4.17059	-0.25048
GCM_PFN1	c4.CGN_ cancer gene neighborhoods	46	-2.2066927	0	2.28E-05	GCM_PFN1	46	-1.6586807	0	0.06870049	-3.8653734	-0.548012
GO_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR	c5.CC_ GO cellular component	19	-2.2061424	0	2.26E-05	GO_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR	19	-1.3626349	0.10222222	0.23225802	-3.5687773	-0.8435075
TIEN_INTESTINE_PROBIOTICS_6HR_UP	c2.CGP_ chemical and genetic perturbations	40	-2.2046292	0	2.24E-05	TIEN_INTESTINE_PROBIOTICS_6HR_UP	40	-0.7424224	0.95238096	0.9407844	-2.9470516	-1.4622068
WONG_MITOCHONDRIA_GENE_MODULE	c2.CGP_ chemical and genetic perturbations	197	-2.200067	0	2.22E-05	WONG_MITOCHONDRIA_GENE_MODULE	199	-0.7695191	1	0.92827386	-2.9695861	-1.4305479
LUI_THYROID_CANCER_CLUSTER_3	c2.CGP_ chemical and genetic perturbations	26	-2.1998682	0	2.20E-05	LUI_THYROID_CANCER_CLUSTER_3	26	-0.72522956	0.8947368	0.9487797	-2.92509776	-1.47463864
MORF_SOD1	c4.CGN_ cancer gene neighborhoods	247	-2.1983588	0	2.18E-05	MORF_SOD1	247	0	0	0	-2.1983588	-2.1983588
GO_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_	c5.BP_ GO biological process	28	-2.1935444	0	2.16E-05	GO_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_	28	-1.5182798	0.04945055	0.13231538	-3.7118242	-0.6752646
MODULE_91	c4.CM_ cancer modules	35	-2.1865528	0	2.14E-05	MODULE_91	35	-2.1196284	0	0.002214998	-4.3061812	-0.0669244
GO_MITOCHONDRIAL_PROTEIN_COMPLEX	c5.CC_ GO cellular component	103	-2.185497	0	2.12E-05	GO_MITOCHONDRIAL_PROTEIN_COMPLEX	104	0.44119105	1	1	-1.74430595	-2.62668805
GO_CYTOPLASMIC_TRANSLATION	c5.BP_ GO biological process	31	-2.1822178	0	3.19E-05	GO_CYTOPLASMIC_TRANSLATION	31	-1.3039802	0.084337346	0.2787875	-3.486198	-0.8782376
GCM_ANP32B	c4.CGN_ cancer gene neighborhoods	34	-2.177232	0	5.25E-05	GCM_ANP32B	34	-2.0124276	0	0.00741062	-4.1896596	-0.1648044
GO_MITOCHONDRIAL_MEMBRANE_PART	c5.CC_ GO cellular component	129	-2.167329	0	6.26E-05	GO_MITOCHONDRIAL_MEMBRANE_PART	131	0.5602446	0.9979592	1	-1.6070844	-2.7275736
MORF_EIF4A2	c4.CGN_ cancer gene neighborhoods	120	-2.1645923	0	6.20E-05	MORF_EIF4A2	120	-1.3356959	0	0.2521487	-3.5002882	-0.8288964
LUI_TARGETS_OF_PAX8_PPARG_FUSION	c2.CGP_ chemical and genetic perturbations	31	-2.1600075	0	7.19E-05	LUI_TARGETS_OF_PAX8_PPARG_FUSION	31	-0.7290469	0.92777777	0.94755363	-2.8890544	-1.4309606
MODULE_28	c4.CM_ cancer modules	30	-2.1579206	0	7.13E-05	MODULE_28	30	-1.9930947	0	0.00873927	-4.1510153	-0.1648259
MORF_ERH	c4.CGN_ cancer gene neighborhoods	102	-2.1549358	0	9.10E-05	MORF_ERH	102	-2.4484143	0	0	-4.6033501	0.2934785
MODULE_149	c4.CM_ cancer modules	35	-2.154688	0	9.02E-05	MODULE_149	35	-1.5135878	0.014084507	0.13475443	-3.6682758	-0.6411002
MORF_EIF3S2	c4.CGN_ cancer gene neighborhoods	222	-2.1539738	0	8.95E-05	MORF_EIF3S2	222	-2.1437798	0	0.001737188	-4.2977536	-0.010194
MYC_UP.V1_UP	C6_ oncogenic signatures	147	-2.146286	0	9.83E-05	MYC_UP.V1_UP	148	0.8863444	0.7456588	1	-1.2599416	-3.0326304
GNF2_G22P1	c4.CGN_ cancer gene neighborhoods	31	-2.1462224	0	9.75E-05	GNF2_G22P1	31	-2.0722804	0	0.003857453	-4.2185028	-0.073942
REACTOME_MRNA_SPLICING_MINOR_PATHWAY	c2.CP_REACTOME_ Reactome gene sets	39	-2.143614	0	0.000106614	REACTOME_MRNA_SPLICING_MINOR_PATHWAY	39	-2.0857825	0	0.003193643	-4.2293965	-0.0578315
HORTON_SREBF_TARGETS	c2.CGP_ chemical and genetic perturbations	23	-2.1353307	0	0.000154147	HORTON_SREBF_TARGETS	23	-2.0710523	0	0.003813468	-4.206383	-0.0642784
MORF_ACP1	c4.CGN_ cancer gene neighborhoods	192	-2.1338131	0	0.000152914	MORF_ACP1	192	-2.0271952	0	0.006224667	-4.1610083	-0.1066179
CHR11Q13	C1: positional gene sets	219	-2.1316774	0	0.00016135	CHR11Q13	221	0.78521305	0.9336683	1	-1.34646435	-2.91689045
GO_RRNA_BINDING	c5.GO molecular function	50	-2.1295323	0	0.00016008	GO_RRNA_BINDING	50	-0.6490581	0.99	0.9760975	-2.7785904	-1.4804742
GO_MONOCYTE_CHEMOTAXIS	c5.BP_ GO biological process	21	-2.1291275	0	0.000158829	GO_MONOCYTE_CHEMOTAXIS	25	1.5870003	0.01	0.17694321	-0.5421272	-3.7161278
REACTOME_MRNA_SPLICING	c2.CP_REACTOME_ Reactome gene sets	99	-2.1284823	0	0.000157598	REACTOME_MRNA_SPLICING	99	-2.3381364	0	0.000136305	-4.4666187	0.2096541
PENG_GLUTAMINE_DEPRIVATION_DN	c2.CGP_ chemical and genetic perturbations	314	-2.1284294	0	0.000156386	PENG_GLUTAMINE_DEPRIVATION_DN	316	-1.9037007	0	0.01749415	-4.0321301	-0.2247287
MORF_HDAC1	c4.CGN_ cancer gene neighborhoods	234	-2.126007	0	0.000164499	MORF_HDAC1	234	-2.5282874	0	0	-4.6542944	0.4022804
MOOTHA_HUMAN_MITODB_6_2002	c2.CGP_ chemical and genetic perturbations	386	-2.1241274	0	0.000163252	MOOTHA_HUMAN_MITODB_6_2002	386	0	0	0	-2.1241274	-2.1241274
MENSSEN_MYC_TARGETS	c2.CGP_ chemical and genetic perturbations	45	-2.1225655	0	0.000170723	MENSSEN_MYC_TARGETS	44	-1.3077155	0.062015504	0.2766061	-3.430281	-0.81485
IRITANI_MAD1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	42	-2.1124728	0	0.000231829	IRITANI_MAD1_TARGETS_DN	42	-1.6647848	0	0.0669552	-3.7772576	-0.447688
HSIAO_HOUSEKEEPING_GENES	c2.CGP_ chemical and genetic perturbations	339	-2.1088157	0	0.000247923	HSIAO_HOUSEKEEPING_GENES	342	0.5029046	1	1	-1.6059111	-2.6117203
GO_90S_PRERIBOSOME	c5.CC_ GO cellular component	23	-2.1087184	0	0.0002461	GO_90S_PRERIBOSOME	23	-1.6884881	0	0.0589223	-3.7972065	-0.4202303
GO_PROTEIN_TARGETING_TO_MITOCHONDRION	c5.BP_ GO biological process	43	-2.1066277	0	0.000244304	GO_PROTEIN_TARGETING_TO_MITOCHONDRION	43	-0.6396271	0.99236643	0.97782856	-2.7462548	-1.4670006
GO_ORGANELLAR_RIBOSOME	c5.CC_ GO cellular component	67	-2.1005552	0	0.000259953	GO_ORGANELLAR_RIBOSOME	67	-1.5108209	0	0.1363504	-3.6113761	-0.5897343
GO_PEPTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	486	-2.0968647	0	0.000283888	GO_PEPTIDE_METABOLIC_PROCESS	495	0.5237708	1	1	-1.5730939	-2.6206355
GO_RESPIRATORY_CHAIN	c5.CC_ GO cellular component	73	-2.0966659	0	0.000281861	GO_RESPIRATORY_CHAIN	75	0.58866036	0.9935345	1	-1.50800554	-2.68532626
MORF_SKP1A	c4.CGN_ cancer gene neighborhoods	181	-2.094533	0	0.000288438	MORF_SKP1A	181	-2.1919448	0	0.000845513	-4.2864778	0.0974118
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR	c5.GO molecular function	46	-2.090071	0	0.000336514	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR	46	0.9438991	0.5810502	0.98863566	-1.1461719	-3.0339701
SCHUHMACHER_MYC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	77	-2.0899377	0	0.000334161	SCHUHMACHER_MYC_TARGETS_UP	77	-2.217149	0	0.000752977	-4.3070867	0.1272113
GO_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY	c5.BP_ GO biological process	21	-2.0868587	0	0.000356593	GO_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY	21	-0.7434351	0.89893615	0.9401679	-2.8302938	-1.3434236
GO_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	201	-2.0865564	0	0.000354133	GO_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS	206	0.5384166	1	1	-1.5481398	-2.624973
BILANGES_SERUM_RESPONSE_TRANSLATION	c2.CGP_ chemical and genetic perturbations	27	-2.0850897	0	0.000367978	BILANGES_SERUM_RESPONSE_TRANSLATION	27	0.7464313	0.8404385	1	-1.3386584	-2.831521
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	43	-2.081797	0	0.000422165	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	43	-1.0471679	0.37190083	0.6111081	-3.1289649	-1.0346291
HALLMARK_OXIDATIVE_PHOSPHORYLATION	H_ hallmark gene sets	177	-2.081102	0	0.000427325	HALLMARK_OXIDATIVE_PHOSPHORYLATION	177	-0.50426626	1	0.9915927	-2.58536826	-1.57683574
REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	c2.CP_REACTOME_ Reactome gene sets	45	-2.0787532	0	0.000456758	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	46	-1.6884372	0	0.058782734	-3.7671904	-0.390316
GAURNIER_PSMD4_TARGETS	c2.CGP_ chemical and genetic perturbations	40	-2.0783405	0	0.000469654	GAURNIER_PSMD4_TARGETS	46	0.9072303	0.6388262	1	-1.1711102	-2.9855708
GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN	C7_ immunologic signatures	177	-2.073171	0	0.000505972	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN	177	-1.0494715	0.22222222	0.60670483	-3.1226425	-1.0236995
GNF2_APEX1	c4.CGN_ cancer gene neighborhoods	85	-2.0695043	0	0.000541939	GNF2_APEX1	85	-2.6359391	0	0	-4.7054434	0.5664348
MOOTHA_VOXPHOS	c2.CGP_ chemical and genetic perturbations	67	-2.0651858	0	0.00056988	MOOTHA_VOXPHOS	67	-0.84414786	0.86764705	0.87279046	-2.90933366	-1.22103794
GO_DNA_DIRECTED_RNA_POLYMERASE_III_COMPLEX	c5.CC_ GO cellular component	16	-2.06115	0	0.000620556	GO_DNA_DIRECTED_RNA_POLYMERASE_III_COMPLEX	16	-0.62614924	0.92771083	0.9806118	-2.68729924	-1.43500076
GO_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	62	-2.060446	0	0.000616552	GO_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY	62	0.6795998	0.9394273	1	-1.3808462	-2.7400458
GO_CELLULAR_RESPIRATION	c5.BP_ GO biological process	130	-2.0551193	0	0.000674053	GO_CELLULAR_RESPIRATION	134	-0.5102088	1	0.9915614	-2.5653281	-1.5449105
GO_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	189	-2.0519152	0	0.000692612	GO_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS	192	0.778761	0.91834676	1	-1.2731542	-2.8306762
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	c2.CGP_ chemical and genetic perturbations	22	-2.0458097	0	0.000808864	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	22	0.62892884	0.9390402	1	-1.41688086	-2.67473854
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	c2.CGP_ chemical and genetic perturbations	24	-2.0375621	0	0.000901386	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	24	-1.2344182	0.15151516	0.34135202	-3.2719803	-0.8031439
MODULE_432	c4.CM_ cancer modules	15	-2.0353425	0	0.000970811	MODULE_432	15	-1.9109906	0.007843138	0.016854951	-3.9463331	-0.1243519
GO_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	39	-2.0328493	0	0.001002141	GO_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS	39	-1.0085709	0.47761193	0.6741833	-3.0414202	-1.0242784
GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	C7_ immunologic signatures	177	-2.03282	0	0.000995955	GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	179	-1.4218163	0	0.19239475	-3.4546363	-0.6110037
PENG_LEUCINE_DEPRIVATION_DN	c2.CGP_ chemical and genetic perturbations	175	-2.032053	0	0.000997325	PENG_LEUCINE_DEPRIVATION_DN	176	-2.06057	0	0.004311337	-4.092623	0.028517
MORF_MTA1	c4.CGN_ cancer gene neighborhoods	95	-2.0308437	0	0.001020606	MORF_MTA1	95	-1.9229941	0	0.015385579	-3.9538378	-0.1078496
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP	C7_ immunologic signatures	166	-2.0200663	0	0.001282629	GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP	169	-1.3679918	0	0.22826025	-3.3880581	-0.6520745
KEGG_OXIDATIVE_PHOSPHORYLATION	c2.CP_BIOCARTA_ BioCarta gene sets	93	-2.0196345	0	0.001281971	KEGG_OXIDATIVE_PHOSPHORYLATION	98	0.6800407	0.9570681	1	-1.3395938	-2.6996752
GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN	C7_ immunologic signatures	179	-2.0184891	0	0.001281403	GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN	180	-1.4939468	0	0.14648956	-3.5124359	-0.5245423
GO_NADH_DEHYDROGENASE_COMPLEX	c5.CC_ GO cellular component	41	-2.0176713	0	0.001316012	GO_NADH_DEHYDROGENASE_COMPLEX	41	0.8456109	0.71981776	1	-1.1720604	-2.8632822
MORF_RAD21	c4.CGN_ cancer gene neighborhoods	159	-2.013957	0	0.001428781	MORF_RAD21	159	-2.2110105	0	0.000791807	-4.2249675	0.1970535
MODULE_263	c4.CM_ cancer modules	26	-2.011464	0	0.001469747	MODULE_263	28	0.8847391	0.65939397	1	-1.1267249	-2.8962031
GO_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY	c5.GO molecular function	27	-2.009926	0	0.00149631	GO_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY	34	1.2624962	0.14233129	0.49274507	-0.7474298	-3.2724222
GO_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX	c5.BP_ GO biological process	20	-2.0093555	0	0.001535802	GO_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX	20	-1.5940194	0.023148147	0.0933883	-3.6033749	-0.4153361
GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	177	-2.0058267	0	0.001637527	GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN	177	-1.3124884	0	0.2719877	-3.3183151	-0.6933383
GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	146	-2.003676	0	0.001703798	GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP	146	0.59401333	0.99593085	1	-1.40966267	-2.59768933
GO_MITOCHONDRIAL_RNA_METABOLIC_PROCESS	c5.BP_ GO biological process	22	-2.002	0	0.00176264	GO_MITOCHONDRIAL_RNA_METABOLIC_PROCESS	22	-0.7160127	0.875	0.9524472	-2.7180127	-1.2859873
MOOTHA_MITOCHONDRIA	c2.CGP_ chemical and genetic perturbations	396	-2.001002	0	0.001772984	MOOTHA_MITOCHONDRIA	403	-0.80242014	1	0.9039399	-2.80342214	-1.19858186
REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	35	-2.0009084	0	0.001762966	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	36	0.92711693	0.5946262	1	-1.07379147	-2.92802533
DANG_MYC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	128	-2.00047	0	0.001766615	DANG_MYC_TARGETS_UP	129	-1.6539103	0	0.07036101	-3.6543803	-0.3465597
MODULE_115	c4.CM_ cancer modules	26	-1.9999813	0	0.001756746	MODULE_115	26	-1.3572536	0.102564104	0.23661625	-3.3572349	-0.6427277
GO_NADH_METABOLIC_PROCESS	c5.BP_ GO biological process	31	-1.9989787	0	0.001786808	GO_NADH_METABOLIC_PROCESS	32	0.5800837	0.9708029	1	-1.418895	-2.5790624
PECE_MAMMARY_STEM_CELL_UP	c2.CGP_ chemical and genetic perturbations	110	-1.9989756	0	0.001776936	PECE_MAMMARY_STEM_CELL_UP	113	0.8709597	0.74948025	1	-1.1280159	-2.8699353
GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	173	-1.9974308	0	0.001793489	GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP	177	-1.2975004	0	0.28602555	-3.2949312	-0.6999304
MORF_RAD23B	c4.CGN_ cancer gene neighborhoods	159	-1.9947987	0	0.001829355	MORF_RAD23B	159	-1.9407872	0	0.01317528	-3.9355859	-0.0540115
GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	155	-1.9946084	0	0.001832273	GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP	161	0.72627354	0.95837563	1	-1.26833486	-2.72088194
GCM_PPP1CC	c4.CGN_ cancer gene neighborhoods	50	-1.9919472	0	0.001938656	GCM_PPP1CC	50	-2.3221421	0	0.000198288	-4.3140893	0.3301949
GNF2_DENR	c4.CGN_ cancer gene neighborhoods	49	-1.9914515	0	0.001940871	GNF2_DENR	49	-2.3898015	0	0	-4.381253	0.39835
GO_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX	c5.CC_ GO cellular component	16	-1.9910245	0	0.001936953	GO_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX	17	-1.9028819	0.008130081	0.017566526	-3.8939064	-0.0881426
LI_DCP2_BOUND_MRNA	c2.CGP_ chemical and genetic perturbations	80	-1.9885327	0	0.001977848	LI_DCP2_BOUND_MRNA	81	0.4826194	1	1	-1.5059133	-2.4711521
GO_ORGANELLAR_LARGE_RIBOSOMAL_SUBUNIT	c5.CC_ GO cellular component	30	-1.9815941	0	0.002144495	GO_ORGANELLAR_LARGE_RIBOSOMAL_SUBUNIT	30	-1.3056619	0.073446326	0.27783528	-3.287256	-0.6759322
KEGG_SPLICEOSOME	c2.CP_BIOCARTA_ BioCarta gene sets	116	-1.9787837	0	0.002265382	KEGG_SPLICEOSOME	116	-2.1911495	0	0.000836796	-4.1699332	0.2123658
REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G	c2.CP_REACTOME_ Reactome gene sets	42	-1.978542	0	0.002259895	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G	43	-1.6873674	0.007575758	0.05911521	-3.6659094	-0.2911746
KEGG_RNA_POLYMERASE	c2.CP_BIOCARTA_ BioCarta gene sets	25	-1.9760411	0	0.002341443	KEGG_RNA_POLYMERASE	25	-1.0450298	0.37185928	0.61415267	-3.0210709	-0.9310113
GNF2_XRCC5	c4.CGN_ cancer gene neighborhoods	68	-1.9758762	0	0.002329311	GNF2_XRCC5	68	-2.6049924	0	0	-4.5808686	0.6291162
KEGG_PENTOSE_PHOSPHATE_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	23	-1.9753332	0	0.002342137	KEGG_PENTOSE_PHOSPHATE_PATHWAY	25	1.3481078	0.102402024	0.38397494	-0.6272254	-3.323441
GO_LYMPHOCYTE_MIGRATION	c5.BP_ GO biological process	28	-1.967426	0	0.002656502	GO_LYMPHOCYTE_MIGRATION	36	1.4172965	0.037647057	0.32035723	-0.5501295	-3.3847225
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H	c5.GO molecular function	82	-1.9647985	0	0.002723009	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H	82	0.91684157	0.654661	1	-1.04795693	-2.88164007
MORF_PRKAR1A	c4.CGN_ cancer gene neighborhoods	133	-1.9646591	0	0.002715076	MORF_PRKAR1A	133	-1.1523602	0.1724138	0.43934652	-3.1170193	-0.8122989
MODULE_108	c4.CM_ cancer modules	34	-1.9617171	0	0.002863922	MODULE_108	37	0.8461941	0.7391813	1	-1.115523	-2.8079112
GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN	C7_ immunologic signatures	177	-1.9587874	0	0.002981951	GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN	176	-1.6155802	0	0.085962445	-3.5743676	-0.3432072
MORF_PSMC1	c4.CGN_ cancer gene neighborhoods	167	-1.9580889	0	0.003002869	MORF_PSMC1	167	-1.5709338	0	0.104460716	-3.5290227	-0.3871551
BIOCARTA_PROTEASOME_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	26	-1.9561068	0	0.003088426	BIOCARTA_PROTEASOME_PATHWAY	26	-1.9254216	0	0.01506108	-3.8815284	-0.0306852
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	c2.CGP_ chemical and genetic perturbations	132	-1.9541041	0	0.003179763	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	133	-1.4971378	0	0.1443875	-3.4512419	-0.4569663
GO_TRANSLATION_PREINITIATION_COMPLEX	c5.CC_ GO cellular component	16	-1.952146	0	0.003252889	GO_TRANSLATION_PREINITIATION_COMPLEX	16	-1.7462949	0.007968128	0.044591095	-3.6984409	-0.2058511
GO_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	61	-1.9521424	0	0.003236943	GO_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS	63	-1.1521275	0.14814815	0.43959427	-3.1042699	-0.8000149
GO_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I_BIOGENESIS	c5.BP_ GO biological process	50	-1.9518945	0	0.003232915	GO_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I_BIOGENESIS	50	0.7857542	0.8111111	1	-1.1661403	-2.7376487
GO_PROTEASOME_ACCESSORY_COMPLEX	c5.CC_ GO cellular component	23	-1.9483235	0	0.003437178	GO_PROTEASOME_ACCESSORY_COMPLEX	23	-2.029475	0	0.006087755	-3.9777985	0.0811515
MORF_AATF	c4.CGN_ cancer gene neighborhoods	196	-1.9462196	0	0.003541761	MORF_AATF	196	-2.008562	0	0.007739556	-3.9547816	0.0623424
GO_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX	c5.CC_ GO cellular component	16	-1.9456377	0.002427185	0.003536428	GO_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX	16	-1.8090117	0.004132231	0.03151868	-3.7546494	-0.136626
MODULE_43	c4.CM_ cancer modules	85	-1.9449	0	0.003588507	MODULE_43	88	1.0185347	0.47102213	0.89235777	-0.9263653	-2.9634347
WENG_POR_TARGETS_GLOBAL_UP	c2.CGP_ chemical and genetic perturbations	16	-1.9445304	0	0.003600123	WENG_POR_TARGETS_GLOBAL_UP	17	0.8361353	0.685112	1	-1.1083951	-2.7806657
GO_SPLICEOSOMAL_SNRNP_ASSEMBLY	c5.BP_ GO biological process	36	-1.9390846	0	0.003883359	GO_SPLICEOSOMAL_SNRNP_ASSEMBLY	36	-1.732025	0	0.047788814	-3.6711096	-0.2070596
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	c2.CP_REACTOME_ Reactome gene sets	44	-1.936679	0	0.003983574	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	45	-1.4590408	0.007407407	0.16723657	-3.3957198	-0.4776382
REACTOME_REGULATION_OF_APOPTOSIS	c2.CP_REACTOME_ Reactome gene sets	52	-1.9347008	0	0.004032138	REACTOME_REGULATION_OF_APOPTOSIS	53	-1.2950758	0.084745765	0.28800043	-3.2297766	-0.639625
MORF_RAD23A	c4.CGN_ cancer gene neighborhoods	316	-1.9329692	0	0.004080104	MORF_RAD23A	317	-2.2582335	0	0.000403966	-4.1912027	0.3252643
GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP	C7_ immunologic signatures	156	-1.9325321	0	0.004078163	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP	156	-1.5940328	0	0.09358242	-3.5265649	-0.3384993
REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS	c2.CP_REACTOME_ Reactome gene sets	56	-1.9269987	0	0.004391414	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS	58	0.7562013	0.8692221	1	-1.1707974	-2.6832
KEGG_PROTEASOME	c2.CP_BIOCARTA_ BioCarta gene sets	39	-1.9254719	0	0.004513937	KEGG_PROTEASOME	40	-1.6020654	0.016806724	0.090115815	-3.5275373	-0.3234065
GNF2_ELAC2	c4.CGN_ cancer gene neighborhoods	44	-1.9243286	0	0.004542369	GNF2_ELAC2	44	-2.6518059	0	0	-4.5761345	0.7274773
MORF_PSMC2	c4.CGN_ cancer gene neighborhoods	107	-1.9241757	0	0.00452707	MORF_PSMC2	107	-1.7339458	0	0.047455285	-3.6581215	-0.1902299
REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	c2.CP_REACTOME_ Reactome gene sets	46	-1.9205145	0	0.004740325	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	47	-1.3149276	0.06603774	0.27074862	-3.2354421	-0.6055869
GSE369_IFNG_KO_VS_WT_LIVER_DN	C7_ immunologic signatures	176	-1.9171005	0	0.004935386	GSE369_IFNG_KO_VS_WT_LIVER_DN	179	-1.5270952	0	0.12624805	-3.4441957	-0.3900053
REACTOME_CHOLESTEROL_BIOSYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	20	-1.9105942	0.002710027	0.005338782	REACTOME_CHOLESTEROL_BIOSYNTHESIS	20	-2.1124122	0	0.002460155	-4.0230064	0.201818
GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE	c5.BP_ GO biological process	301	-1.9090309	0	0.005416861	GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE	302	0.53617096	1	1	-1.37285994	-2.44520186
SWEET_KRAS_ONCOGENIC_SIGNATURE	c2.CGP_ chemical and genetic perturbations	80	-1.9087273	0	0.00541424	SWEET_KRAS_ONCOGENIC_SIGNATURE	81	0.6174952	0.97983015	1	-1.2912321	-2.5262225
GO_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	48	-1.9075325	0	0.00543827	GO_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS	51	0.8510226	0.74124295	1	-1.0565099	-2.7585551
MORF_DEK	c4.CGN_ cancer gene neighborhoods	241	-1.9069022	0	0.005450974	MORF_DEK	241	-2.2547572	0	0.000529973	-4.1616594	0.347855
YAGI_AML_RELAPSE_PROGNOSIS	c2.CGP_ chemical and genetic perturbations	30	-1.9050169	0	0.005611987	YAGI_AML_RELAPSE_PROGNOSIS	30	-0.83092153	0.77380955	0.88127875	-2.73593843	-1.07409537
GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	154	-1.9045193	0	0.005608415	GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP	156	-1.4145104	0	0.1964337	-3.3190297	-0.4900089
MORF_PPP2CA	c4.CGN_ cancer gene neighborhoods	119	-1.9014022	0	0.00586697	MORF_PPP2CA	119	-2.255009	0	0.000536598	-4.1564112	0.3536068
MORF_UNG	c4.CGN_ cancer gene neighborhoods	70	-1.90106	0	0.005909083	MORF_UNG	70	-2.1420343	0	0.001766275	-4.0430943	0.2409743
REACTOME_SIGNALING_BY_WNT	c2.CP_REACTOME_ Reactome gene sets	57	-1.8972732	0	0.006236211	REACTOME_SIGNALING_BY_WNT	58	-1.8827194	0	0.019671174	-3.7799926	-0.0145538
REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	c2.CP_REACTOME_ Reactome gene sets	32	-1.8944979	0	0.006425558	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	41	1.3698891	0.0661157	0.3687846	-0.5246088	-3.264387
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN	C7_ immunologic signatures	159	-1.8933381	0	0.006479529	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN	164	-1.1805993	0.0952381	0.40347576	-3.0739374	-0.7127388
GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_UP	C7_ immunologic signatures	181	-1.893121	0	0.0064774	GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_UP	182	-1.7277389	0	0.04885208	-3.6208599	-0.1653821
GO_MITOCHONDRIAL_MATRIX	c5.CC_ GO cellular component	359	-1.8913774	0	0.006643993	GO_MITOCHONDRIAL_MATRIX	366	0.50120234	1	1	-1.39017506	-2.39257974
GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP	C7_ immunologic signatures	182	-1.8913201	0	0.006620892	GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP	185	-1.1514298	0	0.44068843	-3.0427499	-0.7398903
XU_CREBBP_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	22	-1.890945	0.002890173	0.006613182	XU_CREBBP_TARGETS_UP	23	0.6140731	0.9394673	1	-1.2768719	-2.5050181
MORF_ATOX1	c4.CGN_ cancer gene neighborhoods	71	-1.8902417	0	0.006651035	MORF_ATOX1	71	-1.3347121	0.027777778	0.2520538	-3.2249538	-0.5555296
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	c2.CGP_ chemical and genetic perturbations	61	-1.889865	0	0.006668282	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	61	-1.9367862	0	0.013554705	-3.8266512	0.0469212
MORF_MAP2K2	c4.CGN_ cancer gene neighborhoods	120	-1.8885136	0	0.006795029	MORF_MAP2K2	120	-1.5118918	0	0.13557844	-3.4004054	-0.3766218
KEGG_GLYCOLYSIS_GLUCONEOGENESIS	c2.CP_BIOCARTA_ BioCarta gene sets	51	-1.8854023	0	0.007079696	KEGG_GLYCOLYSIS_GLUCONEOGENESIS	55	1.4780065	0.021134594	0.2705181	-0.4073958	-3.3634088
GO_TRANSLATION_INITIATION_FACTOR_ACTIVITY	c5.GO molecular function	48	-1.8850907	0	0.007050441	GO_TRANSLATION_INITIATION_FACTOR_ACTIVITY	48	-1.704218	0.007633588	0.05456646	-3.5893087	-0.1808727
GCM_HDAC1	c4.CGN_ cancer gene neighborhoods	37	-1.8846717	0	0.007055567	GCM_HDAC1	37	-1.8970437	0	0.017899709	-3.7817154	0.012372
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	c2.CP_BIOCARTA_ BioCarta gene sets	43	-1.8829471	0	0.007203274	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	43	1.0026287	0.50641775	0.91900045	-0.8803184	-2.8855758
GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	169	-1.8817137	0	0.007271283	GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	169	0.6858717	0.97379035	1	-1.195842	-2.5675854
MORF_DAP	c4.CGN_ cancer gene neighborhoods	72	-1.8773205	0	0.007776438	MORF_DAP	72	-1.2250634	0.106796116	0.3498783	-3.1023839	-0.6522571
GSE22886_NEUTROPHIL_VS_MONOCYTE_DN	C7_ immunologic signatures	174	-1.8743278	0	0.008049898	GSE22886_NEUTROPHIL_VS_MONOCYTE_DN	177	-0.88733006	0.875	0.8382106	-2.76165786	-0.98699774
GO_HEXOSE_CATABOLIC_PROCESS	c5.BP_ GO biological process	43	-1.8743017	0	0.008022225	GO_HEXOSE_CATABOLIC_PROCESS	44	0.90415186	0.65202314	1	-0.97014984	-2.77845356
GO_GLUCOSE_CATABOLIC_PROCESS	c5.BP_ GO biological process	26	-1.8739866	0	0.008004639	GO_GLUCOSE_CATABOLIC_PROCESS	27	0.88830376	0.66021764	1	-0.98568284	-2.76229036
GO_U12_TYPE_SPLICEOSOMAL_COMPLEX	c5.CC_ GO cellular component	23	-1.8736907	0.002941177	0.007982293	GO_U12_TYPE_SPLICEOSOMAL_COMPLEX	23	-1.481191	0.04368932	0.15424876	-3.3548817	-0.3924997
KEGG_PROTEIN_EXPORT	c2.CP_BIOCARTA_ BioCarta gene sets	22	-1.8728672	0	0.00808448	KEGG_PROTEIN_EXPORT	22	-1.5390494	0.048387095	0.12109324	-3.4119166	-0.3338178
MORF_CTBP1	c4.CGN_ cancer gene neighborhoods	155	-1.8723137	0	0.008090688	MORF_CTBP1	155	-2.2541442	0	0.00052351	-4.1264579	0.3818305
GO_NUCLEOTIDE_PHOSPHORYLATION	c5.BP_ GO biological process	54	-1.8695079	0	0.008371883	GO_NUCLEOTIDE_PHOSPHORYLATION	54	0.70741665	0.9062147	1	-1.16209125	-2.57692455
CHR10Q24	C1: positional gene sets	83	-1.8694267	0	0.008343683	CHR10Q24	87	1.5712334	0.001066098	0.18791632	-0.2981933	-3.4406601
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	c2.CP_REACTOME_ Reactome gene sets	127	-1.8692937	0	0.008325066	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	127	-2.523894	0	0	-4.3931877	0.6546003
CHRXP11	C1: positional gene sets	113	-1.8685782	0	0.008376895	CHRXP11	116	0.9253223	0.64675593	1	-0.9432559	-2.7939005
REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	c2.CP_REACTOME_ Reactome gene sets	19	-1.8658259	0.002770083	0.00863668	REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	19	-1.6100272	0.01923077	0.0882288	-3.4758531	-0.2557987
MODULE_42	c4.CM_ cancer modules	24	-1.8656722	0	0.008635893	MODULE_42	24	0.68472886	0.89902675	1	-1.18094334	-2.55040106
REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	c2.CP_REACTOME_ Reactome gene sets	42	-1.8654767	0	0.008620905	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	43	-1.6237059	0.007194245	0.0829021	-3.4891826	-0.2417708
GNF2_RBBP6	c4.CGN_ cancer gene neighborhoods	61	-1.8651408	0	0.008619993	GNF2_RBBP6	61	-2.1318848	0	0.001948714	-3.9970256	0.266744
REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	c2.CP_REACTOME_ Reactome gene sets	42	-1.8627748	0	0.00884815	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	43	-1.7480462	0	0.044448882	-3.610821	-0.1147286
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	c2.CGP_ chemical and genetic perturbations	32	-1.8540186	0	0.009824424	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	32	0.38667378	1	1	-1.46734482	-2.24069238
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	c2.CGP_ chemical and genetic perturbations	440	-1.8531816	0	0.009878228	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	440	0	0	0	-1.8531816	-1.8531816
GAVIN_FOXP3_TARGETS_CLUSTER_T7	c2.CGP_ chemical and genetic perturbations	87	-1.8526545	0	0.009904677	GAVIN_FOXP3_TARGETS_CLUSTER_T7	88	-1.2687207	0.039215688	0.31002706	-3.1213752	-0.5839338
GSE31082_DN_VS_DP_THYMOCYTE_UP	C7_ immunologic signatures	179	-1.8525537	0	0.009889945	GSE31082_DN_VS_DP_THYMOCYTE_UP	179	-1.4483168	0	0.17447953	-3.3008705	-0.4042369
GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN	C7_ immunologic signatures	175	-1.8512219	0	0.010059582	GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN	176	0.8451088	0.83061224	1	-1.0061131	-2.6963307
GO_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE	c5.BP_ GO biological process	85	-1.8508556	0	0.010053119	GO_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE	90	1.3437573	0.03965702	0.3913519	-0.5070983	-3.1946129
GO_ORGANELLE_INNER_MEMBRANE	c5.CC_ GO cellular component	445	-1.8504754	0	0.01005102	GO_ORGANELLE_INNER_MEMBRANE	449	0.5955278	1	1	-1.2549476	-2.4460032
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	c2.CP_REACTOME_ Reactome gene sets	76	-1.8502566	0	0.010026951	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	77	-1.5643488	0	0.107327834	-3.4146054	-0.2859078
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	c2.CGP_ chemical and genetic perturbations	34	-1.8497952	0	0.010047484	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	34	-1.0455661	0.3918919	0.6132945	-2.8953613	-0.8042291
CHR8Q24	C1: positional gene sets	111	-1.8493612	0	0.010072293	CHR8Q24	116	0.9118624	0.6777202	1	-0.9374988	-2.7612236
GNF2_RAN	c4.CGN_ cancer gene neighborhoods	77	-1.8490274	0	0.010074774	GNF2_RAN	77	-2.4754345	0	0	-4.3244619	0.6264071
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	c2.CP_REACTOME_ Reactome gene sets	107	-1.8470751	0	0.010322345	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	109	-1.7360785	0	0.046907324	-3.5831536	-0.1109966
BARIS_THYROID_CANCER_UP	c2.CGP_ chemical and genetic perturbations	22	-1.8464885	0.005167959	0.010359002	BARIS_THYROID_CANCER_UP	22	1.031974	0.4274809	0.8733902	-0.8145145	-2.8784625
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	c2.CGP_ chemical and genetic perturbations	22	-1.844658	0	0.010517541	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	25	0.8317541	0.73200995	1	-1.0129039	-2.6764121
MORF_RAC1	c4.CGN_ cancer gene neighborhoods	199	-1.8439442	0	0.010592521	MORF_RAC1	199	-1.2315276	0	0.34458184	-3.0754718	-0.6124166
GO_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING	c5.GO molecular function	80	-1.8424715	0	0.010748753	GO_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING	80	-1.7698804	0	0.039485767	-3.6123519	-0.0725911
GO_SPERM_EGG_RECOGNITION	c5.BP_ GO biological process	33	-1.8420073	0	0.010775023	GO_SPERM_EGG_RECOGNITION	37	0.78288907	0.815759	1	-1.05911823	-2.62489637
GO_CATALYTIC_STEP_2_SPLICEOSOME	c5.CC_ GO cellular component	76	-1.8392907	0	0.011203746	GO_CATALYTIC_STEP_2_SPLICEOSOME	76	-2.234993	0	0.00058508	-4.0742837	0.3957023
MORF_AP3D1	c4.CGN_ cancer gene neighborhoods	120	-1.8383882	0	0.011249405	MORF_AP3D1	120	-2.0971382	0	0.002967534	-3.9355264	0.25875
RAHMAN_TP53_TARGETS_PHOSPHORYLATED	c2.CGP_ chemical and genetic perturbations	19	-1.8380862	0.005524862	0.011252238	RAHMAN_TP53_TARGETS_PHOSPHORYLATED	19	-1.5223515	0.074074075	0.12906322	-3.3604377	-0.3157347
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN	C7_ immunologic signatures	164	-1.8357487	0	0.011612009	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN	167	1.1387943	0.19653767	0.6922302	-0.6969544	-2.974543
LUI_THYROID_CANCER_PAX8_PPARG_DN	c2.CGP_ chemical and genetic perturbations	43	-1.8356241	0	0.011579474	LUI_THYROID_CANCER_PAX8_PPARG_DN	43	-0.63575256	0.9851852	0.9786148	-2.47137666	-1.19987154
GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	182	-1.8352332	0	0.011623079	GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP	182	0.8596497	0.8195565	1	-0.9755835	-2.6948829
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	c2.CGP_ chemical and genetic perturbations	47	-1.8341221	0	0.011717027	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	47	-0.9742498	0.51666665	0.7232621	-2.8083719	-0.8598723
MORF_USP5	c4.CGN_ cancer gene neighborhoods	47	-1.8333896	0	0.011797532	MORF_USP5	47	-1.5274411	0.009009009	0.12668054	-3.3608307	-0.3059485
MORF_CUL1	c4.CGN_ cancer gene neighborhoods	65	-1.829751	0	0.012324114	MORF_CUL1	65	-2.2697861	0	0.000400844	-4.0995371	0.4400351
GO_CELL_CELL_RECOGNITION	c5.BP_ GO biological process	42	-1.8289241	0.003246753	0.012422726	GO_CELL_CELL_RECOGNITION	50	0.9028736	0.6529933	1	-0.9260505	-2.7317977
GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	179	-1.8284163	0	0.012433615	GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	179	-1.5462022	0	0.1173333	-3.3746185	-0.2822141
GNF2_NS	c4.CGN_ cancer gene neighborhoods	37	-1.8281335	0.003076923	0.012415249	GNF2_NS	37	-2.2142856	0	0.000785274	-4.0424191	0.3861521
GO_ADP_METABOLIC_PROCESS	c5.BP_ GO biological process	42	-1.8265038	0	0.012623918	GO_ADP_METABOLIC_PROCESS	43	0.7783108	0.8180778	1	-1.048193	-2.6048146
GSE45837_WT_VS_GFI1_KO_PDC_DN	C7_ immunologic signatures	182	-1.825749	0	0.0127528	GSE45837_WT_VS_GFI1_KO_PDC_DN	184	-0.77477115	1	0.9249436	-2.60052015	-1.05097785
MODULE_152	c4.CM_ cancer modules	104	-1.8254894	0	0.012766479	MODULE_152	106	0.39592418	1	1	-1.42956522	-2.22141358
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	c2.CGP_ chemical and genetic perturbations	45	-1.8218374	0	0.01332863	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	45	-1.7875124	0	0.035488773	-3.6093498	-0.034325
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_	c2.CP_REACTOME_ Reactome gene sets	35	-1.8214488	0	0.013356436	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_	35	-1.7573516	0.013986014	0.041941144	-3.5788004	-0.0640972
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	c2.CGP_ chemical and genetic perturbations	23	-1.8212075	0.005763689	0.0133481	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	22	-1.1194801	0.2904762	0.48993874	-2.9406876	-0.7017274
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	174	-1.8211668	0	0.013307196	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_DN	179	0.7099927	0.9604863	1	-1.1111741	-2.5311595
GO_RNA_CAPPING	c5.BP_ GO biological process	33	-1.8206468	0.002777778	0.013334852	GO_RNA_CAPPING	33	-1.6163025	0.013422819	0.085719705	-3.4369493	-0.2043443
GO_VIRAL_LIFE_CYCLE	c5.BP_ GO biological process	240	-1.8205792	0	0.013298302	GO_VIRAL_LIFE_CYCLE	241	0.5661331	1	1	-1.2544461	-2.3867123
REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX	c2.CP_REACTOME_ Reactome gene sets	28	-1.8204848	0	0.013265775	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX	28	-1.5900267	0.005050505	0.09415118	-3.4105115	-0.2304581
WANG_TUMOR_INVASIVENESS_UP	c2.CGP_ chemical and genetic perturbations	334	-1.8199651	0	0.013269449	WANG_TUMOR_INVASIVENESS_UP	338	-1.4730444	0	0.15888928	-3.2930095	-0.3469207
TAKAO_RESPONSE_TO_UVB_RADIATION_UP	c2.CGP_ chemical and genetic perturbations	75	-1.8195299	0	0.013308315	TAKAO_RESPONSE_TO_UVB_RADIATION_UP	74	0.52521825	0.9967811	1	-1.29431165	-2.34474815
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	c2.CGP_ chemical and genetic perturbations	148	-1.8162018	0	0.013865387	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	148	-0.807829	1	0.8984088	-2.6240308	-1.0083728
GO_TRNA_METHYLATION	c5.BP_ GO biological process	18	-1.8156772	0.005540166	0.013882308	GO_TRNA_METHYLATION	18	-1.1817384	0.23766816	0.4026447	-2.9974156	-0.6339388
GO_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA	c5.BP_ GO biological process	24	-1.8145359	0	0.014041088	GO_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA	29	-0.8787692	0.6502732	0.84645003	-2.6933051	-0.9357667
GO_CCR_CHEMOKINE_RECEPTOR_BINDING	c5.GO molecular function	17	-1.8145359	0	0.013995201	GO_CCR_CHEMOKINE_RECEPTOR_BINDING	21	-1.2547631	0.1542056	0.32009014	-3.069299	-0.5597728
GO_ORGANELLAR_SMALL_RIBOSOMAL_SUBUNIT	c5.CC_ GO cellular component	25	-1.8142967	0	0.013969237	GO_ORGANELLAR_SMALL_RIBOSOMAL_SUBUNIT	25	-1.1332837	0.2777778	0.46695527	-2.9475804	-0.681013
GO_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS	c5.BP_ GO biological process	80	-1.8137734	0	0.014017116	GO_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS	84	-0.9379667	0.6315789	0.77356267	-2.7517401	-0.8758067
GO_OXIDOREDUCTASE_COMPLEX	c5.CC_ GO cellular component	88	-1.8134778	0	0.014025724	GO_OXIDOREDUCTASE_COMPLEX	89	-0.6603011	1	0.97387224	-2.4737789	-1.1531767
GO_GLYCOSYL_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	301	-1.812277	0	0.014119498	GO_GLYCOSYL_COMPOUND_METABOLIC_PROCESS	309	0.77494097	0.957958	1	-1.03733603	-2.58721797
GCM_CBFB	c4.CGN_ cancer gene neighborhoods	65	-1.8109417	0	0.014308593	GCM_CBFB	65	-2.3413477	0	0.000105844	-4.1522894	0.530406
GO_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX	c5.CC_ GO cellular component	58	-1.8096539	0	0.014511603	GO_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX	58	-1.8823026	0	0.019674594	-3.6919565	0.0726487
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	c2.CP_REACTOME_ Reactome gene sets	61	-1.808323	0	0.014734043	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	62	0.69171494	0.9360529	1	-1.11660806	-2.50003794
ANDERSEN_LIVER_CANCER_KRT19_UP	c2.CGP_ chemical and genetic perturbations	28	-1.8082399	0	0.014690867	ANDERSEN_LIVER_CANCER_KRT19_UP	28	-0.8562339	0.6890244	0.8624639	-2.6644738	-0.952006
GO_REGULATION_OF_TRANSLATIONAL_INITIATION	c5.BP_ GO biological process	78	-1.8074176	0	0.014784863	GO_REGULATION_OF_TRANSLATIONAL_INITIATION	76	-1.062713	0.32467532	0.58322084	-2.8701306	-0.7447046
GO_GUANOSINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	42	-1.807338	0.003194888	0.0147532	GO_GUANOSINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	42	0.94125545	0.58545035	0.9894819	-0.86608255	-2.74859345
BURTON_ADIPOGENESIS_2	c2.CGP_ chemical and genetic perturbations	70	-1.8041083	0	0.015210344	BURTON_ADIPOGENESIS_2	69	0.7918337	0.82900435	1	-1.0122746	-2.595942
GO_POSITIVE_REGULATION_OF_TISSUE_REMODELING	c5.BP_ GO biological process	22	-1.8034095	0	0.015308847	GO_POSITIVE_REGULATION_OF_TISSUE_REMODELING	25	1.3863465	0.07701711	0.34958762	-0.417063	-3.189756
GO_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER	c5.BP_ GO biological process	34	-1.8033855	0	0.015268445	GO_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER	34	-1.3182946	0.07333333	0.26848292	-3.1216801	-0.4850909
GO_PEPTIDYL_ARGININE_MODIFICATION	c5.BP_ GO biological process	18	-1.8019164	0.002590674	0.01547795	GO_PEPTIDYL_ARGININE_MODIFICATION	18	1.2274568	0.20754717	0.5457034	-0.5744596	-3.0293732
GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	C7_ immunologic signatures	180	-1.801866	0	0.015429732	GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	180	0.5630473	1	1	-1.2388187	-2.3649133
PID_MYC_ACTIV_PATHWAY	c2.CP_ Canonical pathways	75	-1.8008143	0	0.015560238	PID_MYC_ACTIV_PATHWAY	76	-1.1716874	0.17333333	0.41426036	-2.9725017	-0.6291269
CHR10Q25	C1: positional gene sets	37	-1.7988658	0	0.015897	CHR10Q25	40	1.3590292	0.06643757	0.37829864	-0.4398366	-3.157895
GO_STEROL_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	37	-1.7988143	0	0.015862893	GO_STEROL_BIOSYNTHETIC_PROCESS	39	-1.2595264	0.08571429	0.31490326	-3.0583407	-0.5392879
REACTOME_ER_PHAGOSOME_PATHWAY	c2.CP_REACTOME_ Reactome gene sets	49	-1.7967939	0.003436426	0.0161829	REACTOME_ER_PHAGOSOME_PATHWAY	50	0.69610137	0.9211712	1	-1.10069253	-2.49289527
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	c2.CGP_ chemical and genetic perturbations	127	-1.7963867	0	0.016173318	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	132	0.84808755	0.8008256	1	-0.94829915	-2.64447425
GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP	C7_ immunologic signatures	183	-1.7961717	0	0.016179115	GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP	184	-1.4665282	0	0.16352291	-3.2626999	-0.3296435
GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I	c5.BP_ GO biological process	54	-1.7949063	0	0.01630465	GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I	54	-1.1784925	0.16363636	0.40594828	-2.9733988	-0.6164138
MORF_UBE2N	c4.CGN_ cancer gene neighborhoods	85	-1.792927	0	0.0166834	MORF_UBE2N	85	-2.5567167	0	0	-4.3496437	0.7637897
GO_CHEMOKINE_ACTIVITY	c5.GO molecular function	23	-1.7902352	0.00265252	0.0171017	GO_CHEMOKINE_ACTIVITY	26	1.4246078	0.06004902	0.31852803	-0.3656274	-3.214843
GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN	C7_ immunologic signatures	171	-1.788412	0	0.01740451	GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN	172	0.6469851	0.9959596	1	-1.1414269	-2.4353971
MODULE_77	c4.CM_ cancer modules	27	-1.7858814	0.005830904	0.017795712	MODULE_77	27	-0.6982715	0.9388889	0.96162665	-2.4841529	-1.0876099
GO_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER	c5.BP_ GO biological process	36	-1.7856811	0.006349206	0.017774528	GO_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER	36	-0.6510718	0.97959185	0.9766347	-2.4367529	-1.1346093
REACTOME_ELONGATION_ARREST_AND_RECOVERY	c2.CP_REACTOME_ Reactome gene sets	24	-1.7850518	0.008474576	0.017832436	REACTOME_ELONGATION_ARREST_AND_RECOVERY	24	-1.6647146	0.005376344	0.06679727	-3.4497664	-0.1203372
GO_RNA_POLYMERASE_ACTIVITY	c5.GO molecular function	39	-1.7844559	0	0.017893821	GO_RNA_POLYMERASE_ACTIVITY	39	-1.0433987	0.375	0.61764336	-2.8278546	-0.7410572
GO_PROTEIN_TRANSPORT_ALONG_MICROTUBULE	c5.BP_ GO biological process	26	-1.783031	0	0.018125951	GO_PROTEIN_TRANSPORT_ALONG_MICROTUBULE	26	0.8918672	0.6292683	1	-0.8911638	-2.6748982
MOOTHA_GLUCONEOGENESIS	c2.CGP_ chemical and genetic perturbations	29	-1.7773453	0.005509642	0.019323248	MOOTHA_GLUCONEOGENESIS	31	0.9506563	0.5644769	0.98136806	-0.826689	-2.7280016
GROSS_HIF1A_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	20	-1.7767746	0	0.019361721	GROSS_HIF1A_TARGETS_DN	21	-0.92880464	0.5471698	0.7857945	-2.70557924	-0.84796996
GO_NIK_NF_KAPPAB_SIGNALING	c5.BP_ GO biological process	77	-1.776748	0	0.019304607	GO_NIK_NF_KAPPAB_SIGNALING	78	0.4965474	0.9989418	1	-1.2802006	-2.2732954
GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP	C7_ immunologic signatures	181	-1.7759044	0	0.019403286	GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP	189	0.6772571	0.9849095	1	-1.0986473	-2.4531615
MODULE_306	c4.CM_ cancer modules	23	-1.775406	0	0.019461852	MODULE_306	23	-1.0642338	0.29268292	0.57975674	-2.8396398	-0.7111722
MORF_RAB1A	c4.CGN_ cancer gene neighborhoods	182	-1.773726	0	0.019799862	MORF_RAB1A	182	-1.2934166	0	0.28940332	-3.0671426	-0.4803094
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN	C7_ immunologic signatures	178	-1.7731538	0	0.01987783	GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN	180	0.85716873	0.8194726	1	-0.91598507	-2.63032253
GO_POLYSOME	c5.CC_ GO cellular component	35	-1.7731228	0	0.019826954	GO_POLYSOME	36	0.6447205	0.95053005	1	-1.1284023	-2.4178433
MODULE_388	c4.CM_ cancer modules	15	-1.7699667	0	0.020512417	MODULE_388	15	-1.8664438	0.008264462	0.021873122	-3.6364105	0.0964771
MODULE_62	c4.CM_ cancer modules	73	-1.7695864	0	0.02056018	MODULE_62	74	-0.82797354	0.9206349	0.883951	-2.59755994	-0.94161286
GO_PROTEIN_LOCALIZATION_TO_MITOCHONDRION	c5.BP_ GO biological process	59	-1.7678765	0	0.020860406	GO_PROTEIN_LOCALIZATION_TO_MITOCHONDRION	59	-0.57862234	1	0.987881	-2.34649884	-1.18925416
REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT	c2.CP_REACTOME_ Reactome gene sets	44	-1.766344	0	0.02113413	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT	45	-1.8475521	0	0.024910087	-3.6138961	0.0812081
GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN	C7_ immunologic signatures	179	-1.7660086	0	0.021165894	GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN	179	-1.4669508	0	0.16338246	-3.2329594	-0.2990578
SANA_RESPONSE_TO_IFNG_DN	c2.CGP_ chemical and genetic perturbations	75	-1.7635344	0	0.021692459	SANA_RESPONSE_TO_IFNG_DN	76	0.7930565	0.83226496	1	-0.9704779	-2.5565909
GO_GTP_METABOLIC_PROCESS	c5.BP_ GO biological process	21	-1.7632282	0.008333334	0.021671427	GO_GTP_METABOLIC_PROCESS	20	1.1496634	0.29426435	0.67035776	-0.6135648	-2.9128916
GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP	C7_ immunologic signatures	180	-1.7621752	0	0.02191285	GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP	183	0.7627247	0.9283552	1	-0.9994505	-2.5248999
REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1	c2.CP_REACTOME_ Reactome gene sets	45	-1.7603152	0.003278689	0.022268085	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1	46	-1.7031164	0	0.054413103	-3.4634316	-0.0571988
GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_UP	C7_ immunologic signatures	170	-1.7584332	0	0.022572983	GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_UP	169	0.5590252	1	1	-1.199408	-2.3174584
MORF_BUB3	c4.CGN_ cancer gene neighborhoods	251	-1.7565362	0	0.022977993	MORF_BUB3	251	-2.743788	0	0	-4.5003242	0.9872518
GO_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	27	-1.7564187	0.005988024	0.022923559	GO_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS	26	0.77761936	0.80609757	1	-0.97879934	-2.53403806
GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP	C7_ immunologic signatures	174	-1.7563354	0	0.022875993	GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP	175	-1.0524591	0.5	0.60015076	-2.8087945	-0.7038763
MORF_PCNA	c4.CGN_ cancer gene neighborhoods	76	-1.7541004	0	0.023377683	MORF_PCNA	76	-2.2647622	0	0.000390155	-4.0188626	0.5106618
GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	178	-1.7531449	0	0.023518527	GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP	177	-1.6037679	0	0.08962043	-3.3569128	-0.149377
REACTOME_HIV_INFECTION	c2.CP_REACTOME_ Reactome gene sets	173	-1.7525063	0	0.023566268	REACTOME_HIV_INFECTION	175	-1.8777618	0	0.020382542	-3.6302681	0.1252555
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	c2.CGP_ chemical and genetic perturbations	124	-1.7508942	0	0.023859069	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	128	0.8371246	0.814475	1	-0.9137696	-2.5880188
CHR12Q12	C1: positional gene sets	48	-1.7498462	0	0.024064416	CHR12Q12	51	1.1716491	0.23404256	0.63497055	-0.5781971	-2.9214953
GO_MONOSACCHARIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	52	-1.7490867	0	0.024159526	GO_MONOSACCHARIDE_CATABOLIC_PROCESS	53	1.1118525	0.31543624	0.73495644	-0.6372342	-2.8609392
PID_NFAT_TFPATHWAY	c2.CP_ Canonical pathways	38	-1.748853	0.003322259	0.024149321	PID_NFAT_TFPATHWAY	41	1.3927221	0.057208236	0.3481801	-0.3561309	-3.1415751
MORF_GPX4	c4.CGN_ cancer gene neighborhoods	51	-1.7465143	0.003546099	0.024698481	MORF_GPX4	51	-0.6981918	0.95	0.9613282	-2.4447061	-1.0483225
MORF_XPC	c4.CGN_ cancer gene neighborhoods	55	-1.7453482	0	0.024960643	MORF_XPC	55	-0.9230203	0.61165047	0.79226524	-2.6683685	-0.8223279
GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP	C7_ immunologic signatures	148	-1.745101	0	0.02496782	GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP	151	-1.7149282	0	0.052071467	-3.4600292	-0.0301728
GO_CELLULAR_ALDEHYDE_METABOLIC_PROCESS	c5.BP_ GO biological process	70	-1.7448742	0.003846154	0.024957966	GO_CELLULAR_ALDEHYDE_METABOLIC_PROCESS	69	0.85961866	0.7456522	1	-0.88525554	-2.60449286
GO_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION	c5.BP_ GO biological process	94	-1.7429879	0	0.025449978	GO_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION	94	-1.9827406	0	0.009678267	-3.7257285	0.2397527
MORF_RAB6A	c4.CGN_ cancer gene neighborhoods	61	-1.7408428	0.003831418	0.025924344	MORF_RAB6A	61	-1.2164596	0.11827957	0.36028796	-2.9573024	-0.5243832
GO_ORGANIC_CYCLIC_COMPOUND_CATABOLIC_PROCESS	c5.BP_ GO biological process	352	-1.7378063	0	0.026717775	GO_ORGANIC_CYCLIC_COMPOUND_CATABOLIC_PROCESS	364	-0.75813675	1	0.93421173	-2.49594305	-0.97966955
GO_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY	c5.BP_ GO biological process	252	-1.7370185	0	0.026841437	GO_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY	261	0.55847067	1	1	-1.17854783	-2.29548917
MORF_BAG5	c4.CGN_ cancer gene neighborhoods	54	-1.7369645	0	0.026782414	MORF_BAG5	54	-1.7571172	0	0.041746676	-3.4940817	0.0201527
GSE3039_CD4_TCELL_VS_B2_BCELL_DN	C7_ immunologic signatures	176	-1.7369641	0	0.026710805	GSE3039_CD4_TCELL_VS_B2_BCELL_DN	175	0.734137	0.96036583	1	-1.0028271	-2.4711011
GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE	c5.BP_ GO biological process	225	-1.7369318	0	0.026642732	GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE	223	0.7865232	0.9344758	1	-0.9504086	-2.523455
GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP	C7_ immunologic signatures	182	-1.7355752	0	0.026957331	GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP	184	-0.88372004	0.8181818	0.8397567	-2.61929524	-0.85185516
REACTOME_PURINE_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	32	-1.7347893	0.00310559	0.027155954	REACTOME_PURINE_METABOLISM	31	-1.4979779	0.042168673	0.14399856	-3.2327672	-0.2368114
GO_ATP_GENERATION_FROM_ADP	c5.BP_ GO biological process	34	-1.7333486	0	0.027498977	GO_ATP_GENERATION_FROM_ADP	35	0.67783237	0.91785717	1	-1.05551623	-2.41118097
GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN	C7_ immunologic signatures	180	-1.7331389	0	0.027492493	GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN	179	-1.6856403	0	0.059651475	-3.4187792	-0.0474986
REACTOME_MRNA_CAPPING	c2.CP_REACTOME_ Reactome gene sets	28	-1.7311867	0	0.02801818	REACTOME_MRNA_CAPPING	28	-1.7037313	0.018404908	0.05440743	-3.434918	-0.0274554
GO_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS	c5.BP_ GO biological process	21	-1.7309532	0.00295858	0.028057799	GO_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS	22	1.2448857	0.19263804	0.51891047	-0.4860675	-2.9758389
GO_U2_SNRNP	c5.CC_ GO cellular component	17	-1.7303939	0.002717391	0.02817221	GO_U2_SNRNP	17	-1.8079746	0.008333334	0.031538203	-3.5383685	0.0775807
GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	138	-1.7299043	0	0.028229976	GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP	137	0.6248388	0.98870635	1	-1.1050655	-2.3547431
GO_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	62	-1.7283529	0.003731343	0.028580472	GO_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS	62	-0.8289711	0.87058824	0.8832974	-2.557324	-0.8993818
GO_TRANSLATION_ELONGATION_FACTOR_ACTIVITY	c5.GO molecular function	17	-1.7272398	0.019178081	0.028878924	GO_TRANSLATION_ELONGATION_FACTOR_ACTIVITY	17	-0.96576804	0.49115044	0.73495	-2.69300784	-0.76147176
GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN	C7_ immunologic signatures	162	-1.7267184	0	0.02897496	GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN	163	-0.9759259	0.61538464	0.7192227	-2.7026443	-0.7507925
MORF_PRKAG1	c4.CGN_ cancer gene neighborhoods	207	-1.7264501	0	0.028990246	MORF_PRKAG1	207	-1.3733994	0	0.22463371	-3.0998495	-0.3530507
HONMA_DOCETAXEL_RESISTANCE	c2.CGP_ chemical and genetic perturbations	28	-1.7258075	0.002824859	0.029125134	HONMA_DOCETAXEL_RESISTANCE	28	-0.9310272	0.5595238	0.78224444	-2.6568347	-0.7947803
GO_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	19	-1.7231375	0.008645534	0.029856602	GO_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	20	-1.2105317	0.16585366	0.36761037	-2.9336692	-0.5126058
GO_NAD_BINDING	c5.GO molecular function	51	-1.7224256	0	0.029979646	GO_NAD_BINDING	51	0.8403553	0.73279816	1	-0.8820703	-2.5627809
GO_PROTEASOME_COMPLEX	c5.CC_ GO cellular component	70	-1.7222098	0	0.029970458	GO_PROTEASOME_COMPLEX	71	-1.3351376	0.0625	0.2520561	-3.0573474	-0.3870722
GO_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	58	-1.7220935	0	0.029955141	GO_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS	60	0.92361885	0.6350762	1	-0.79847465	-2.64571235
BURTON_ADIPOGENESIS_4	c2.CGP_ chemical and genetic perturbations	42	-1.7219774	0.003344482	0.029927624	BURTON_ADIPOGENESIS_4	42	-1.2380347	0.14615385	0.33709198	-2.9600121	-0.4839427
MUNSHI_MULTIPLE_MYELOMA_UP	c2.CGP_ chemical and genetic perturbations	74	-1.7207137	0	0.030219028	MUNSHI_MULTIPLE_MYELOMA_UP	73	0.7374801	0.8987069	1	-0.9832336	-2.4581938
GROSS_HYPOXIA_VIA_HIF1A_UP	c2.CGP_ chemical and genetic perturbations	72	-1.7191236	0	0.030637039	GROSS_HYPOXIA_VIA_HIF1A_UP	72	-1.3438317	0.013888889	0.2460852	-3.0629553	-0.3752919
REACTOME_GLUCONEOGENESIS	c2.CP_REACTOME_ Reactome gene sets	27	-1.7184609	0.011428571	0.030771257	REACTOME_GLUCONEOGENESIS	29	0.67489076	0.91805226	1	-1.04357014	-2.39335166
REACTOME_GLYCOLYSIS	c2.CP_REACTOME_ Reactome gene sets	25	-1.7162302	0.005319149	0.031320315	REACTOME_GLYCOLYSIS	25	0.38479915	1	1	-1.33143105	-2.10102935
GO_TRNA_METABOLIC_PROCESS	c5.BP_ GO biological process	162	-1.715873	0	0.031349823	GO_TRNA_METABOLIC_PROCESS	163	-1.4944311	0	0.14625585	-3.2103041	-0.2214419
GO_TELOMERASE_HOLOENZYME_COMPLEX	c5.CC_ GO cellular component	18	-1.7157336	0.002754821	0.031316254	GO_TELOMERASE_HOLOENZYME_COMPLEX	18	-0.8447007	0.7016129	0.8724554	-2.5604343	-0.8710329
GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP	C7_ immunologic signatures	137	-1.7153547	0	0.03132474	GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP	140	0.7110758	0.954779	1	-1.0042789	-2.4264305
WELCSH_BRCA1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	133	-1.7149639	0	0.031386774	WELCSH_BRCA1_TARGETS_DN	133	-2.0001688	0	0.008074684	-3.7151327	0.2852049
GCM_RAD21	c4.CGN_ cancer gene neighborhoods	36	-1.7128842	0	0.031913668	GCM_RAD21	36	-2.3781805	0	3.87E-05	-4.0910647	0.6652963
MOOTHA_FFA_OXYDATION	c2.CGP_ chemical and genetic perturbations	22	-1.7123817	0.002631579	0.032015845	MOOTHA_FFA_OXYDATION	22	0.5347491	0.9848101	1	-1.1776326	-2.2471308
GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_DN	C7_ immunologic signatures	181	-1.7107412	0	0.03241382	GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_DN	180	-1.7153823	0	0.052066065	-3.4261235	0.0046411
GSE22886_NAIVE_TCELL_VS_DC_UP	C7_ immunologic signatures	156	-1.709334	0	0.032842606	GSE22886_NAIVE_TCELL_VS_DC_UP	161	1.1895478	0.12601626	0.60593593	-0.5197862	-2.8988818
MODULE_102	c4.CM_ cancer modules	18	-1.7084529	0.00862069	0.03300916	MODULE_102	18	-1.5025439	0.03292181	0.14084113	-3.2109968	-0.205909
GO_SPLICEOSOMAL_COMPLEX	c5.CC_ GO cellular component	147	-1.7072015	0	0.033383988	GO_SPLICEOSOMAL_COMPLEX	147	-2.200312	0	0.000807898	-3.9075135	0.4931105
GO_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS	c5.BP_ GO biological process	16	-1.7069559	0.007712083	0.03338456	GO_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS	21	1.4025372	0.071428575	0.33715257	-0.3044187	-3.1094931
GO_AEROBIC_RESPIRATION	c5.BP_ GO biological process	46	-1.7069023	0	0.03332049	GO_AEROBIC_RESPIRATION	49	-0.9800184	0.5212766	0.7135006	-2.6869207	-0.7268839
GO_INTRAMOLECULAR_TRANSFERASE_ACTIVITY	c5.GO molecular function	27	-1.7047979	0.011764706	0.033942714	GO_INTRAMOLECULAR_TRANSFERASE_ACTIVITY	27	-0.6191613	0.9895833	0.9818746	-2.3239592	-1.0856366
GSE22886_CTRL_VS_LPS_24H_DC_UP	C7_ immunologic signatures	179	-1.7047927	0	0.03386013	GSE22886_CTRL_VS_LPS_24H_DC_UP	179	0.84879893	0.83469385	1	-0.85599377	-2.55359163
GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_DN	C7_ immunologic signatures	175	-1.7040645	0	0.033975113	GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_DN	179	0.7437598	0.94129556	1	-0.9603047	-2.4478243
GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	182	-1.703406	0	0.03407248	GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP	181	-1.633595	0	0.07873806	-3.337001	-0.069811
GO_POLY_PYRIMIDINE_TRACT_BINDING	c5.GO molecular function	16	-1.7029176	0.013227513	0.034160476	GO_POLY_PYRIMIDINE_TRACT_BINDING	16	0.9897413	0.5096525	0.9355124	-0.7131763	-2.6926589
GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	C7_ immunologic signatures	176	-1.7000917	0	0.0350701	GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	181	-1.6724566	0	0.064474516	-3.3725483	-0.0276351
GO_PROTEIN_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	48	-1.698495	0.003367003	0.03552618	GO_PROTEIN_TRANSMEMBRANE_TRANSPORT	48	0.52150226	0.99328107	1	-1.17699274	-2.21999726
ENK_UV_RESPONSE_KERATINOCYTE_UP	c2.CGP_ chemical and genetic perturbations	468	-1.6958886	0	0.036287863	ENK_UV_RESPONSE_KERATINOCYTE_UP	476	0.6822345	0.999	1	-1.0136541	-2.3781231
AMIT_SERUM_RESPONSE_20_MCF10A	c2.CGP_ chemical and genetic perturbations	19	-1.6952825	0.012084592	0.03639613	AMIT_SERUM_RESPONSE_20_MCF10A	20	0.7176006	0.85895807	1	-0.9776819	-2.4128831
GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP	C7_ immunologic signatures	147	-1.6938816	0	0.0367957	GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP	150	-0.7813602	1	0.92028934	-2.4752418	-0.9125214
LI_AMPLIFIED_IN_LUNG_CANCER	c2.CGP_ chemical and genetic perturbations	158	-1.6928134	0	0.037061278	LI_AMPLIFIED_IN_LUNG_CANCER	160	0.6796857	0.977459	1	-1.0131277	-2.3724991
KRAS.300_UP.V1_UP	C6_ oncogenic signatures	108	-1.6926148	0	0.037029933	KRAS.300_UP.V1_UP	117	1.1981803	0.1427094	0.5959379	-0.4944345	-2.8907951
GSE369_SOCS3_KO_VS_WT_LIVER_UP	C7_ immunologic signatures	182	-1.6924239	0	0.037050135	GSE369_SOCS3_KO_VS_WT_LIVER_UP	182	-1.3809533	0	0.21932632	-3.0733772	-0.3114706
GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP	C7_ immunologic signatures	169	-1.6921959	0	0.037081268	GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP	171	0.57083845	0.99898785	1	-1.12135745	-2.26303435
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	c2.CGP_ chemical and genetic perturbations	166	-1.6914638	0	0.037281875	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	166	-1.4512504	0	0.17269906	-3.1427142	-0.2402134
GO_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS	c5.BP_ GO biological process	245	-1.6912835	0	0.037255917	GO_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS	245	-2.4050539	0	0	-4.0963374	0.7137704
GO_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS	c5.BP_ GO biological process	190	-1.6892425	0	0.03789664	GO_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS	198	0.54908067	0.99898475	1	-1.14016183	-2.23832317
GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	C7_ immunologic signatures	178	-1.688505	0	0.038090892	GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	177	-1.3863908	0	0.21527575	-3.0748958	-0.3021142
GO_MATURATION_OF_5_8S_RRNA	c5.BP_ GO biological process	27	-1.6872058	0.002890173	0.038507376	GO_MATURATION_OF_5_8S_RRNA	27	-1.778722	0.005524862	0.03711761	-3.4659278	0.0915162
REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION	c2.CP_REACTOME_ Reactome gene sets	19	-1.683301	0.013888889	0.03980625	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION	19	-1.0180174	0.40182647	0.6623679	-2.7013184	-0.6652836
KARLSSON_TGFB1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	114	-1.682841	0	0.03986697	KARLSSON_TGFB1_TARGETS_UP	114	-1.7674749	0	0.03986394	-3.4503159	0.0846339
GO_GLUTATHIONE_DERIVATIVE_METABOLIC_PROCESS	c5.BP_ GO biological process	16	-1.6822041	0.007751938	0.03998273	GO_GLUTATHIONE_DERIVATIVE_METABOLIC_PROCESS	16	1.2427077	0.20050761	0.52227867	-0.4394964	-2.9249118
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	c2.CGP_ chemical and genetic perturbations	48	-1.6812958	0.00330033	0.04029726	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	48	0.7852338	0.8272727	1	-0.896062	-2.4665296
GO_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	76	-1.6812854	0.003745318	0.04020973	GO_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS	77	0.77877647	0.84871244	1	-0.90250893	-2.46006187
REACTOME_MRNA_PROCESSING	c2.CP_REACTOME_ Reactome gene sets	145	-1.6795341	0	0.040794563	REACTOME_MRNA_PROCESSING	146	-2.3391252	0	0.000138435	-4.0186593	0.6595911
GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	140	-1.6791335	0	0.04082971	GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	141	-1.1930213	0.055555556	0.39074266	-2.8721548	-0.4861122
REACTOME_MICRORNA_MIRNA_BIOGENESIS	c2.CP_REACTOME_ Reactome gene sets	18	-1.678076	0.011204482	0.041159518	REACTOME_MICRORNA_MIRNA_BIOGENESIS	18	-1.2755035	0.15196079	0.306271	-2.9535795	-0.4025725
GO_RNA_SPLICING	c5.BP_ GO biological process	323	-1.6772622	0	0.041349903	GO_RNA_SPLICING	323	0	0	0	-1.6772622	-1.6772622
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	158	-1.6743166	0	0.042495534	GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP	159	0.6729363	0.9826707	1	-1.0013803	-2.3472529
GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN	C7_ immunologic signatures	180	-1.6735233	0	0.04266574	GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN	180	-0.9212095	0.84615386	0.7941626	-2.5947328	-0.7523138
MODULE_81	c4.CM_ cancer modules	20	-1.6728687	0.010471204	0.042794414	MODULE_81	20	-1.3756486	0.0959596	0.22373149	-3.0485173	-0.2972201
GO_CARBOHYDRATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	105	-1.6726018	0	0.042781454	GO_CARBOHYDRATE_BIOSYNTHETIC_PROCESS	113	0.8970518	0.7055731	1	-0.77555	-2.5696536
GO_LIPID_DIGESTION	c5.BP_ GO biological process	19	-1.6703451	0.010989011	0.043488726	GO_LIPID_DIGESTION	16	1.1266446	0.3271028	0.7114792	-0.5437005	-2.7969897
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP	C7_ immunologic signatures	169	-1.670204	0	0.043436535	GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP	173	0.9404822	0.65015167	0.98984337	-0.7297218	-2.6106862
GO_COPPER_ION_TRANSPORT	c5.BP_ GO biological process	18	-1.6701932	0.019021738	0.043338705	GO_COPPER_ION_TRANSPORT	20	1.2013803	0.22857143	0.5895966	-0.4688129	-2.8715735
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	c2.CGP_ chemical and genetic perturbations	131	-1.6672814	0	0.044486072	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	133	-1.1954136	0.03846154	0.38707465	-2.862695	-0.4718678
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	44	-1.6656802	0.006578947	0.045061447	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	44	-1.727373	0	0.048833176	-3.3930532	0.0616928
MODULE_183	c4.CM_ cancer modules	60	-1.6637075	0	0.045795344	MODULE_183	60	-2.001379	0	0.00799091	-3.6650865	0.3376715
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	c2.CGP_ chemical and genetic perturbations	145	-1.6635846	0	0.04574677	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	145	-2.0672386	0	0.003954557	-3.7308232	0.403654
GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN	C7_ immunologic signatures	175	-1.6626583	0	0.046025474	GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN	178	-1.5448189	0	0.11778639	-3.2074772	-0.1178394
GO_OXIDOREDUCTION_COENZYME_METABOLIC_PROCESS	c5.BP_ GO biological process	93	-1.6626458	0	0.045925867	GO_OXIDOREDUCTION_COENZYME_METABOLIC_PROCESS	93	-0.80550796	0.9285714	0.9007043	-2.46815376	-0.85713784
GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP	C7_ immunologic signatures	171	-1.6618059	0	0.04621859	GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP	175	1.2401518	0.05775076	0.5261243	-0.4216541	-2.9019577
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	c2.CGP_ chemical and genetic perturbations	360	-1.6616036	0	0.04621676	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	361	-0.9738369	1	0.7237808	-2.6354405	-0.6877667
GGAANCGGAANY_UNKNOWN	c3.TFT_ transcription factor targets	99	-1.6614115	0	0.046206757	GGAANCGGAANY_UNKNOWN	100	-0.9048935	0.8	0.8154069	-2.566305	-0.756518
GO_TRICARBOXYLIC_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	33	-1.6609342	0.006622517	0.046334285	GO_TRICARBOXYLIC_ACID_METABOLIC_PROCESS	35	-0.9730528	0.48051947	0.7243402	-2.633987	-0.6878814
VIETOR_IFRD1_TARGETS	c2.CGP_ chemical and genetic perturbations	20	-1.659661	0.013661202	0.046737727	VIETOR_IFRD1_TARGETS	20	-1.484723	0.042735044	0.15149598	-3.144384	-0.174938
GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN	C7_ immunologic signatures	182	-1.6592969	0	0.046768997	GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN	182	-1.205136	0.1	0.37535813	-2.8644329	-0.4541609
GRADE_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	40	-1.6581144	0.002985075	0.047159594	GRADE_METASTASIS_DN	40	-1.696712	0	0.05702198	-3.3548264	0.0385976
GO_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	37	-1.6568161	0.009404388	0.047644403	GO_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY	43	-1.1389017	0.17605634	0.45873463	-2.7957178	-0.5179144
RODRIGUES_NTN1_AND_DCC_TARGETS	c2.CGP_ chemical and genetic perturbations	26	-1.6564386	0.005524862	0.047689106	RODRIGUES_NTN1_AND_DCC_TARGETS	26	1.2397441	0.18988903	0.52579886	-0.4166945	-2.8961827
MORF_GMPS	c4.CGN_ cancer gene neighborhoods	46	-1.6561978	0.00621118	0.04767367	MORF_GMPS	46	-1.8238574	0	0.028595997	-3.4800552	0.1676596
GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN	C7_ immunologic signatures	132	-1.6553336	0	0.047903024	GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN	134	0.5184476	1	1	-1.136886	-2.1737812
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	74	-1.6546187	0	0.048107345	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	75	0.6269325	0.97334754	1	-1.0276862	-2.2815512
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP	C7_ immunologic signatures	167	-1.6539875	0	0.04826473	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP	168	0.9477006	0.6143725	0.9843737	-0.7062869	-2.6016881
MODULE_310	c4.CM_ cancer modules	16	-1.6532336	0.015831135	0.048500918	MODULE_310	16	1.4315062	0.054304637	0.31296805	-0.2217274	-3.0847398
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	c2.CGP_ chemical and genetic perturbations	26	-1.6515008	0.005988024	0.049188353	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	27	0.91280735	0.6302521	1	-0.73869345	-2.56430815
REACTOME_REGULATORY_RNA_PATHWAYS	c2.CP_REACTOME_ Reactome gene sets	21	-1.6490395	0.011204482	0.05024438	REACTOME_REGULATORY_RNA_PATHWAYS	21	-0.76829183	0.8069307	0.92872435	-2.41733133	-0.88074767
GO_PROTEIN_TARGETING	c5.BP_ GO biological process	343	-1.648135	0	0.050574217	GO_PROTEIN_TARGETING	343	0.5495449	1	1	-1.0985901	-2.1976799
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	c2.CGP_ chemical and genetic perturbations	106	-1.6466174	0	0.051253043	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	107	1.0327528	0.43396226	0.87232804	-0.6138646	-2.6793702
GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP	C7_ immunologic signatures	179	-1.6464064	0	0.051230237	GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP	185	-1.1888834	0.1	0.3953353	-2.8352898	-0.457523
GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN	C7_ immunologic signatures	173	-1.6462448	0	0.051197197	GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN	175	0.86397237	0.8018293	1	-0.78227243	-2.51021717
GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN	C7_ immunologic signatures	171	-1.6459063	0	0.051231027	GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN	170	-1.6370856	0	0.07727717	-3.2829919	-0.0088207
GO_COFACTOR_METABOLIC_PROCESS	c5.BP_ GO biological process	293	-1.6456442	0	0.05122916	GO_COFACTOR_METABOLIC_PROCESS	299	0.69001365	0.99297893	1	-0.95563055	-2.33565785
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP	C7_ immunologic signatures	171	-1.6452447	0	0.051310673	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP	182	0.94186974	0.6507614	0.9889583	-0.70337496	-2.58711444
KEGG_PYRUVATE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	36	-1.6440508	0.017857144	0.051719874	KEGG_PYRUVATE_METABOLISM	37	1.0104535	0.46604216	0.9064129	-0.6335973	-2.6545043
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	c2.CGP_ chemical and genetic perturbations	23	-1.6428896	0.005847953	0.052197527	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	23	0.5477055	0.97279793	1	-1.0951841	-2.1905951
GO_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	23	-1.6424145	0.005747126	0.052291308	GO_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS	23	0.7439782	0.8556962	1	-0.8984363	-2.3863927
GO_MICROVILLUS_MEMBRANE	c5.CC_ GO cellular component	16	-1.6422142	0.015665796	0.052302446	GO_MICROVILLUS_MEMBRANE	18	1.1826394	0.2506427	0.61826473	-0.4595748	-2.8248536
GO_2_OXOGLUTARATE_METABOLIC_PROCESS	c5.BP_ GO biological process	17	-1.641041	0.01923077	0.052739065	GO_2_OXOGLUTARATE_METABOLIC_PROCESS	18	-1.3462521	0.14102565	0.24382167	-2.9872931	-0.2947889
GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP	C7_ immunologic signatures	170	-1.6408874	0	0.05269617	GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP	172	0.9179646	0.69137055	1	-0.7229228	-2.558852
GO_CONNEXON_COMPLEX	c5.CC_ GO cellular component	16	-1.6392277	0.019444445	0.05334852	GO_CONNEXON_COMPLEX	18	-1.0049111	0.42051283	0.6770941	-2.6441388	-0.6343166
KEGG_PARKINSONS_DISEASE	c2.CP_BIOCARTA_ BioCarta gene sets	92	-1.6391411	0	0.05328001	KEGG_PARKINSONS_DISEASE	95	0.798556	0.85146445	1	-0.8405851	-2.4376971
REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C	c2.CP_REACTOME_ Reactome gene sets	52	-1.638471	0.003378379	0.053476688	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C	52	-1.3736471	0.03508772	0.2246366	-3.0121181	-0.2648239
GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN	C7_ immunologic signatures	168	-1.6377915	0	0.053700164	GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN	172	0.7330586	0.9614213	1	-0.9047329	-2.3708501
GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	150	-1.6372815	0	0.05381378	GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP	152	0.68707687	0.9664293	1	-0.95020463	-2.32435837
GO_NAD_METABOLIC_PROCESS	c5.BP_ GO biological process	47	-1.6372219	0	0.05373219	GO_NAD_METABOLIC_PROCESS	47	-1.0038829	0.3773585	0.67799705	-2.6411048	-0.633339
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	25	-1.6372076	0.009375	0.05362408	REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	25	0.6004083	0.9616307	1	-1.0367993	-2.2376159
GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP	C7_ immunologic signatures	177	-1.6363446	0	0.053933	GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP	178	-1.4057055	0	0.20246176	-3.0420501	-0.2306391
MORF_PPP2R4	c4.CGN_ cancer gene neighborhoods	44	-1.6357375	0.006430868	0.054124277	MORF_PPP2R4	44	-0.9690495	0.5	0.73060423	-2.604787	-0.666688
GO_COENZYME_METABOLIC_PROCESS	c5.BP_ GO biological process	234	-1.6346583	0	0.05454224	GO_COENZYME_METABOLIC_PROCESS	239	0.63287634	1	1	-1.00178196	-2.26753464
GSE42724_NAIVE_VS_B1_BCELL_DN	C7_ immunologic signatures	161	-1.6331812	0	0.055068113	GSE42724_NAIVE_VS_B1_BCELL_DN	161	0.53633016	1	1	-1.09685104	-2.16951136
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN	c2.CGP_ chemical and genetic perturbations	92	-1.6312971	0	0.05590773	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN	95	-1.052432	0.2962963	0.5998569	-2.6837291	-0.5788651
REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX	c2.CP_REACTOME_ Reactome gene sets	27	-1.6310927	0.011904762	0.05588877	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX	27	-0.7761936	0.83243245	0.923422	-2.4072863	-0.8548991
GO_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	60	-1.630024	0.003448276	0.056273818	GO_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS	59	-1.0564	0.26548672	0.59428555	-2.686424	-0.573624
GO_RRNA_MODIFICATION	c5.BP_ GO biological process	22	-1.6294918	0.01312336	0.056433875	GO_RRNA_MODIFICATION	23	-1.035111	0.41489363	0.62984216	-2.6646028	-0.5943808
GO_DNA_DIRECTED_RNA_POLYMERASE_II_CORE_COMPLEX	c5.CC_ GO cellular component	15	-1.6293807	0.02739726	0.0563754	GO_DNA_DIRECTED_RNA_POLYMERASE_II_CORE_COMPLEX	15	0.6758906	0.87189543	1	-0.9534901	-2.3052713
MORF_EI24	c4.CGN_ cancer gene neighborhoods	131	-1.6291848	0	0.0563487	MORF_EI24	131	-1.7639434	0	0.040425647	-3.3931282	0.1347586
GO_PURINE_NUCLEOBASE_METABOLIC_PROCESS	c5.BP_ GO biological process	16	-1.6264056	0.023498695	0.057516098	GO_PURINE_NUCLEOBASE_METABOLIC_PROCESS	17	1.1175015	0.33464566	0.727727	-0.5089041	-2.7439071
GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	164	-1.6262858	0	0.057470348	GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	169	0.9175434	0.69908816	1	-0.7087424	-2.5438292
KEGG_ARGININE_AND_PROLINE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	47	-1.626285	0.003194888	0.057355177	KEGG_ARGININE_AND_PROLINE_METABOLISM	49	0.9984459	0.50056756	0.92548335	-0.6278391	-2.6247309
KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	c2.CP_BIOCARTA_ BioCarta gene sets	15	-1.6262507	0.020460358	0.057259656	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	15	-1.1852845	0.236	0.3980254	-2.8115352	-0.4409662
GO_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION	c5.BP_ GO biological process	16	-1.6262467	0.022727273	0.057150222	GO_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION	16	0.88895226	0.6353093	1	-0.73729444	-2.51519896
GO_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN	c5.BP_ GO biological process	18	-1.625296	0.02688172	0.05750302	GO_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN	17	0.73952186	0.8298701	1	-0.88577414	-2.36481786
GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	136	-1.6245772	0	0.057760485	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN	139	0.7887224	0.8710338	1	-0.8358548	-2.4132996
KIM_MYC_AMPLIFICATION_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	175	-1.6231072	0	0.05839584	KIM_MYC_AMPLIFICATION_TARGETS_UP	177	0.68911505	0.98887765	1	-0.93399215	-2.31222225
MODULE_184	c4.CM_ cancer modules	26	-1.6227099	0.017045455	0.0584672	MODULE_184	28	1.228202	0.19117647	0.5437207	-0.3945079	-2.8509119
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	c2.CGP_ chemical and genetic perturbations	52	-1.6222442	0.006644518	0.05853388	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	51	-0.9361471	0.63793105	0.7761898	-2.5583913	-0.6860971
GO_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS	c5.BP_ GO biological process	26	-1.6220875	0.005602241	0.05848927	GO_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS	29	1.6427242	0.003579952	0.12244127	0.0206367	-3.2648117
GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP	C7_ immunologic signatures	184	-1.6211479	0	0.05882657	GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP	186	0.8126322	0.87158746	1	-0.8085157	-2.4337801
REACTOME_GLUCOSE_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	56	-1.6187711	0.003322259	0.059963115	REACTOME_GLUCOSE_METABOLISM	59	0.8697202	0.698324	1	-0.7490509	-2.4884913
MORF_HAT1	c4.CGN_ cancer gene neighborhoods	156	-1.6177882	0	0.060349625	MORF_HAT1	156	-2.4516835	0	0	-4.0694717	0.8338953
GO_SMN_SM_PROTEIN_COMPLEX	c5.CC_ GO cellular component	16	-1.6169392	0.023622047	0.0606552	GO_SMN_SM_PROTEIN_COMPLEX	16	-1.646519	0.017699115	0.07366051	-3.2634582	0.0295798
GO_RESPONSE_TO_WATER	c5.BP_ GO biological process	17	-1.6168253	0.032697547	0.060588125	GO_RESPONSE_TO_WATER	17	1.0355127	0.45198464	0.8665222	-0.5813126	-2.652338
MORF_HDAC2	c4.CGN_ cancer gene neighborhoods	254	-1.6156697	0	0.06105783	MORF_HDAC2	255	-2.3833907	0	0	-3.9990604	0.767721
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	c2.CP_REACTOME_ Reactome gene sets	170	-1.6143688	0	0.061607894	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	179	0.67781526	0.9797776	1	-0.93655354	-2.29218406
GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	C7_ immunologic signatures	168	-1.6110685	0	0.06328575	GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	177	0.5467654	1	1	-1.0643031	-2.1578339
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP	C7_ immunologic signatures	181	-1.6078606	0	0.06475278	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP	182	0.9219301	0.7020202	1	-0.6859305	-2.5297907
GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN	C7_ immunologic signatures	152	-1.6072603	0	0.064942494	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN	153	-0.97750133	0.6	0.7170889	-2.58476163	-0.62975897
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	180	-1.6071837	0	0.06485881	GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN	180	-1.342108	0	0.24718902	-2.9492917	-0.2650757
REACTOME_RNA_POL_III_CHAIN_ELONGATION	c2.CP_REACTOME_ Reactome gene sets	16	-1.6061913	0.013404826	0.065254524	REACTOME_RNA_POL_III_CHAIN_ELONGATION	16	-0.79238963	0.7383177	0.91336334	-2.39858093	-0.81380167
GO_REGULATION_OF_INTERLEUKIN_5_PRODUCTION	c5.BP_ GO biological process	15	-1.6057324	0.017857144	0.065373376	GO_REGULATION_OF_INTERLEUKIN_5_PRODUCTION	17	1.2921714	0.13403417	0.45373207	-0.313561	-2.8979038
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX	c2.CP_REACTOME_ Reactome gene sets	50	-1.6045951	0.010380623	0.06586583	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX	51	-2.0677414	0	0.003967803	-3.6723365	0.4631463
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	c2.CGP_ chemical and genetic perturbations	61	-1.6043608	0	0.06586333	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	62	-0.88847905	0.73333335	0.8369171	-2.49283985	-0.71588175
GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	C7_ immunologic signatures	141	-1.6041094	0	0.065878876	GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	142	0.66304886	0.9805924	1	-0.94106054	-2.26715826
GO_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	94	-1.6033444	0	0.0661681	GO_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY	97	0.69677633	0.95679665	1	-0.90656807	-2.30012073
GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP	C7_ immunologic signatures	168	-1.6020888	0	0.066710636	GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP	170	0.850822	0.81116754	1	-0.7512668	-2.4529108
GO_DIGESTION	c5.BP_ GO biological process	92	-1.6006892	0	0.06738417	GO_DIGESTION	103	1.0051789	0.4831579	0.9145783	-0.5955103	-2.6058681
MORF_DDB1	c4.CGN_ cancer gene neighborhoods	231	-1.5995976	0	0.06787822	MORF_DDB1	231	-1.285123	0	0.29770985	-2.8847206	-0.3144746
REACTOME_METABOLISM_OF_NUCLEOTIDES	c2.CP_REACTOME_ Reactome gene sets	68	-1.5989031	0	0.06817803	REACTOME_METABOLISM_OF_NUCLEOTIDES	67	-1.061888	0.31944445	0.5844848	-2.6607911	-0.5370151
GO_SNRNA_PROCESSING	c5.BP_ GO biological process	19	-1.598707	0.0265252	0.06815067	GO_SNRNA_PROCESSING	19	-1.3727443	0.067961164	0.22523311	-2.9714513	-0.2259627
GO_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	24	-1.5981305	0.014044944	0.0683447	GO_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS	24	1.4183445	0.05	0.31978816	-0.179786	-3.016475
ZHANG_RESPONSE_TO_CANTHARIDIN_DN	c2.CGP_ chemical and genetic perturbations	60	-1.5981168	0.003484321	0.06822496	ZHANG_RESPONSE_TO_CANTHARIDIN_DN	61	-1.4296671	0.03409091	0.18766984	-3.0277839	-0.1684497
GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	C7_ immunologic signatures	186	-1.5977572	0	0.0682724	GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	185	-1.8314303	0	0.027711386	-3.4291875	0.2336731
GO_LIPID_PARTICLE	c5.CC_ GO cellular component	55	-1.5975807	0.003344482	0.06825453	GO_LIPID_PARTICLE	56	-0.9572152	0.5504587	0.74617994	-2.5547959	-0.6403655
GO_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS	c5.GO molecular function	15	-1.5963981	0.012987013	0.06879948	GO_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS	17	1.4602293	0.048239894	0.2832172	-0.1361688	-3.0566274
GO_TRNA_BINDING	c5.GO molecular function	40	-1.5947181	0.013468013	0.06958122	GO_TRNA_BINDING	40	-1.4762902	0.028985508	0.15678993	-3.0710083	-0.1184279
GSE40443_INDUCED_VS_TOTAL_TREG_UP	C7_ immunologic signatures	186	-1.5943052	0	0.069674015	GSE40443_INDUCED_VS_TOTAL_TREG_UP	187	0.9802956	0.53955376	0.9487997	-0.6140096	-2.5746008
GO_POSITIVE_REGULATION_OF_VIRAL_TRANSCRIPTION	c5.BP_ GO biological process	34	-1.5918231	0.015923567	0.07102153	GO_POSITIVE_REGULATION_OF_VIRAL_TRANSCRIPTION	34	-0.8645718	0.7051282	0.85785455	-2.4563949	-0.7272513
GO_NEURONAL_CELL_BODY_MEMBRANE	c5.CC_ GO cellular component	17	-1.5917554	0.018666666	0.07091621	GO_NEURONAL_CELL_BODY_MEMBRANE	19	1.1896416	0.24870466	0.60607153	-0.4021138	-2.781397
MODULE_440	c4.CM_ cancer modules	17	-1.5916548	0.018041236	0.07083809	MODULE_440	17	1.0848395	0.36739975	0.77736366	-0.5068153	-2.6764943
GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	146	-1.59158	0	0.07076475	GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	148	-1.2928531	0.04761905	0.28962702	-2.8844331	-0.2987269
GO_PSEUDOURIDINE_SYNTHESIS	c5.BP_ GO biological process	17	-1.5915638	0.021377672	0.0706406	GO_PSEUDOURIDINE_SYNTHESIS	17	-1.1878511	0.20175439	0.39647186	-2.7794149	-0.4037127
GCM_RAF1	c4.CGN_ cancer gene neighborhoods	39	-1.5906667	0.013559322	0.071045004	GCM_RAF1	39	-1.9891878	0	0.008998808	-3.5798545	0.3985211
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS	c5.GO molecular function	20	-1.5897834	0.018918918	0.07145889	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS	22	0.8027018	0.7443038	1	-0.7870816	-2.3924852
GO_RETINOIC_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	21	-1.5896672	0.020231213	0.0713934	GO_RETINOIC_ACID_METABOLIC_PROCESS	21	1.1635967	0.27120823	0.6481488	-0.4260705	-2.7532639
CHR22Q12	C1: positional gene sets	82	-1.5885388	0.004081633	0.07195818	CHR22Q12	85	0.8849552	0.7172996	1	-0.7035836	-2.473494
GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN	C7_ immunologic signatures	192	-1.5882031	0	0.072027706	GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN	191	-1.2906711	0	0.29147023	-2.8788742	-0.297532
GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP	C7_ immunologic signatures	178	-1.5872501	0	0.0724345	GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP	182	-1.1770983	0.18181819	0.40794373	-2.7643484	-0.4101518
GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN	C7_ immunologic signatures	153	-1.5868682	0	0.07250528	GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN	154	0.8170503	0.8575758	1	-0.7698179	-2.4039185
HILLION_HMGA1B_TARGETS	c2.CGP_ chemical and genetic perturbations	76	-1.5867827	0	0.072429806	HILLION_HMGA1B_TARGETS	78	0.63466257	0.9762162	1	-0.95212013	-2.22144527
JISON_SICKLE_CELL_DISEASE_DN	c2.CGP_ chemical and genetic perturbations	152	-1.5862863	0	0.07259606	JISON_SICKLE_CELL_DISEASE_DN	156	0.65379447	0.9867482	1	-0.93249183	-2.24008077
GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	C7_ immunologic signatures	174	-1.5855486	0	0.072889395	GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	178	-1.0903989	0.25	0.53328526	-2.6759475	-0.4951497
GO_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE	c5.BP_ GO biological process	22	-1.585512	0.02247191	0.07278544	GO_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE	25	1.0980039	0.35588974	0.7593124	-0.4875081	-2.6835159
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM	c2.CP_REACTOME_ Reactome gene sets	17	-1.584822	0.024861878	0.07305448	REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM	17	0.93592525	0.5682119	0.994064	-0.64889675	-2.52074725
GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN	C7_ immunologic signatures	127	-1.5842453	0.005263158	0.0732053	GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN	134	0.6083223	0.99593085	1	-0.975923	-2.1925676
MORF_PRDX3	c4.CGN_ cancer gene neighborhoods	71	-1.5838994	0	0.07324793	MORF_PRDX3	71	-1.8066572	0	0.031725205	-3.3905566	0.2227578
MOOTHA_TCA	c2.CGP_ chemical and genetic perturbations	15	-1.5838121	0.03166227	0.073172025	MOOTHA_TCA	15	-0.6493691	0.9195402	0.97667783	-2.2331812	-0.934443
GO_CYTOCHROME_COMPLEX	c5.CC_ GO cellular component	16	-1.583453	0.024657534	0.073251076	GO_CYTOCHROME_COMPLEX	18	0.91232973	0.6069142	1	-0.67112327	-2.49578273
MATZUK_IMPLANTATION_AND_UTERINE	c2.CGP_ chemical and genetic perturbations	21	-1.5814006	0.027855154	0.07429792	MATZUK_IMPLANTATION_AND_UTERINE	22	1.1002772	0.37050804	0.75671464	-0.4811234	-2.6816778
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	c2.CGP_ chemical and genetic perturbations	96	-1.5797281	0.004255319	0.07524324	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	95	-1.4416972	0.027027028	0.17822991	-3.0214253	-0.1380309
GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN	C7_ immunologic signatures	175	-1.5794821	0	0.07525625	GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN	178	0.77025694	0.9200405	1	-0.80922516	-2.34973904
HALLMARK_ADIPOGENESIS	H_ hallmark gene sets	184	-1.5789816	0	0.075423166	HALLMARK_ADIPOGENESIS	185	0.76189005	0.9392713	1	-0.81709155	-2.34087165
GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN	C7_ immunologic signatures	178	-1.5786564	0	0.07549327	GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN	179	-1.3252025	0	0.26106852	-2.9038589	-0.2534539
GO_GABA_RECEPTOR_ACTIVITY	c5.GO molecular function	17	-1.5780107	0.016304348	0.07572429	GO_GABA_RECEPTOR_ACTIVITY	22	1.1046892	0.33756346	0.7475182	-0.4733215	-2.6826999
GO_RNA_MODIFICATION	c5.BP_ GO biological process	99	-1.5778878	0	0.07568323	GO_RNA_MODIFICATION	101	-0.88343745	0.754717	0.8400615	-2.46132525	-0.69445035
GO_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION	c5.BP_ GO biological process	84	-1.577489	0.003984064	0.07577126	GO_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION	84	-1.3145927	0.032258064	0.27094847	-2.8920817	-0.2628963
GO_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE	c5.BP_ GO biological process	18	-1.5771202	0.03561644	0.07587163	GO_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE	20	-1.2368479	0.17030568	0.33849993	-2.8139681	-0.3402723
BURTON_ADIPOGENESIS_PEAK_AT_8HR	c2.CGP_ chemical and genetic perturbations	38	-1.5752473	0.009345794	0.07683589	BURTON_ADIPOGENESIS_PEAK_AT_8HR	38	-1.216878	0.14	0.3599303	-2.7921253	-0.3583693
GO_MRNA_PROCESSING	c5.BP_ GO biological process	375	-1.5745413	0	0.077096306	GO_MRNA_PROCESSING	375	0	0	0	-1.5745413	-1.5745413
GO_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING	c5.GO molecular function	15	-1.5741112	0.027568921	0.07722394	GO_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING	16	-0.6926838	0.8995434	0.9636049	-2.266795	-0.8814274
GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN	C7_ immunologic signatures	184	-1.5738908	0	0.0772229	GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN	183	-0.74596155	1	0.9398916	-2.31985235	-0.82792925
GO_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION	c5.BP_ GO biological process	20	-1.5721828	0.027548209	0.07810113	GO_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION	20	-1.3847785	0.09049774	0.21560314	-2.9569613	-0.1874043
MOOTHA_GLYCOLYSIS	c2.CGP_ chemical and genetic perturbations	17	-1.5717158	0.024324324	0.078299426	MOOTHA_GLYCOLYSIS	19	0.9686664	0.5122265	0.962953	-0.6030494	-2.5403822
WILENSKY_RESPONSE_TO_DARAPLADIB	c2.CGP_ chemical and genetic perturbations	24	-1.571284	0.016528925	0.07842976	WILENSKY_RESPONSE_TO_DARAPLADIB	24	0.9654963	0.5324357	0.9653277	-0.6057877	-2.5367803
GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP	C7_ immunologic signatures	152	-1.5711405	0	0.07839731	GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP	157	0.92145663	0.6584867	1	-0.64968387	-2.49259713
GO_TRNA_MODIFICATION	c5.BP_ GO biological process	51	-1.5703815	0.021582734	0.078742445	GO_TRNA_MODIFICATION	51	-1.3136266	0.047169812	0.27177066	-2.8840081	-0.2567549
GO_TRNA_PROCESSING	c5.BP_ GO biological process	102	-1.5696796	0	0.07905482	GO_TRNA_PROCESSING	103	-1.1623905	0.14705883	0.42722675	-2.7320701	-0.4072891
GO_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE	c5.BP_ GO biological process	15	-1.5694195	0.033333335	0.07909597	GO_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE	15	0	0	0	-1.5694195	-1.5694195
PID_IL23_PATHWAY	c2.CP_ Canonical pathways	30	-1.569027	0.00931677	0.079222284	PID_IL23_PATHWAY	30	0.93057096	0.5747266	0.99829334	-0.63845604	-2.49959796
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	c2.CP_REACTOME_ Reactome gene sets	29	-1.5681323	0.022408964	0.079637185	REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	33	-1.2190812	0.14	0.3568849	-2.7872135	-0.3490511
GO_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY	c5.GO molecular function	25	-1.5678307	0.020895522	0.07968358	GO_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY	25	0.7990436	0.7512563	1	-0.7687871	-2.3668743
GNF2_HDAC1	c4.CGN_ cancer gene neighborhoods	101	-1.567425	0	0.07983893	GNF2_HDAC1	101	-2.333285	0	0.000168926	-3.90071	0.76586
GO_ISOPRENOID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	24	-1.5662185	0.02710027	0.08044246	GO_ISOPRENOID_BIOSYNTHETIC_PROCESS	24	0.7181437	0.8725	1	-0.8480748	-2.2843622
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	c2.CGP_ chemical and genetic perturbations	42	-1.5660937	0.009375	0.08037835	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	42	-1.2265195	0.09848485	0.3488177	-2.7926132	-0.3395742
MORF_MBD4	c4.CGN_ cancer gene neighborhoods	77	-1.565569	0.004	0.0805956	MORF_MBD4	77	-1.5794402	0	0.09992031	-3.1450092	0.0138712
MORF_RPA1	c4.CGN_ cancer gene neighborhoods	59	-1.5642173	0.010638298	0.08119016	MORF_RPA1	59	-2.5319834	0	0	-4.0962007	0.9677661
VANDESLUIS_NORMAL_EMBRYOS_DN	c2.CGP_ chemical and genetic perturbations	19	-1.5639346	0.022113021	0.08123752	VANDESLUIS_NORMAL_EMBRYOS_DN	20	-0.8776753	0.6292683	0.8468312	-2.4416099	-0.6862593
GO_QUINONE_METABOLIC_PROCESS	c5.BP_ GO biological process	22	-1.5638355	0.014124294	0.08116448	GO_QUINONE_METABOLIC_PROCESS	22	1.2478733	0.18158568	0.51489407	-0.3159622	-2.8117088
MODULE_159	c4.CM_ cancer modules	76	-1.5637997	0.01171875	0.08105079	MODULE_159	76	-1.4629009	0.016949153	0.16541515	-3.0267006	-0.1008988
GO_ISOMERASE_ACTIVITY	c5.GO molecular function	138	-1.5633848	0	0.08119371	GO_ISOMERASE_ACTIVITY	138	-0.8717338	0.84615386	0.85391194	-2.4351186	-0.691651
GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	179	-1.5616562	0	0.08219998	GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	181	-0.8488824	0.8947368	0.86951566	-2.4105386	-0.7127738
GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP	C7_ immunologic signatures	171	-1.5597814	0	0.08318518	GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP	172	-0.9878671	0.5833333	0.7054011	-2.5476485	-0.5719143
GO_THREONINE_TYPE_PEPTIDASE_ACTIVITY	c5.GO molecular function	18	-1.5589699	0.04225352	0.083553776	GO_THREONINE_TYPE_PEPTIDASE_ACTIVITY	19	0.72768503	0.84818065	1	-0.83128487	-2.28665493
GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN	C7_ immunologic signatures	180	-1.5583242	0	0.08380954	GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN	177	0.75529444	0.93832153	1	-0.80302976	-2.31361864
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE	c2.CP_REACTOME_ Reactome gene sets	18	-1.5582037	0.027855154	0.08373469	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE	18	-0.8523098	0.67906976	0.8644127	-2.4105135	-0.7058939
GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP	C7_ immunologic signatures	151	-1.557386	0	0.08413862	GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP	153	0.8744812	0.7663934	1	-0.6829048	-2.4318672
GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE	c5.CC_ GO cellular component	41	-1.5570631	0.01724138	0.08420839	GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE	41	-0.47625262	1	0.9910968	-2.03331572	-1.08081048
MOREIRA_RESPONSE_TO_TSA_UP	c2.CGP_ chemical and genetic perturbations	26	-1.555667	0.027777778	0.085051954	MOREIRA_RESPONSE_TO_TSA_UP	27	-0.9630841	0.47457626	0.7374852	-2.5187511	-0.5925829
GO_U2_TYPE_SPLICEOSOMAL_COMPLEX	c5.CC_ GO cellular component	27	-1.5553683	0.023952097	0.08512399	GO_U2_TYPE_SPLICEOSOMAL_COMPLEX	27	-1.1486733	0.22459893	0.44551185	-2.7040416	-0.406695
GO_CHEMOKINE_RECEPTOR_BINDING	c5.GO molecular function	32	-1.553994	0.016483517	0.08596019	GO_CHEMOKINE_RECEPTOR_BINDING	35	1.1421044	0.28354725	0.6868545	-0.4118896	-2.6960984
GRADE_COLON_AND_RECTAL_CANCER_UP	c2.CGP_ chemical and genetic perturbations	262	-1.5532365	0	0.086307175	GRADE_COLON_AND_RECTAL_CANCER_UP	262	-1.4240422	0	0.19199985	-2.9772787	-0.1291943
GNF2_TDG	c4.CGN_ cancer gene neighborhoods	33	-1.5529015	0.009230769	0.08639051	GNF2_TDG	33	-2.5017939	0	0	-4.0546954	0.9488924
GSE17721_0.5H_VS_8H_CPG_BMDC_UP	C7_ immunologic signatures	180	-1.5521113	0	0.086810045	GSE17721_0.5H_VS_8H_CPG_BMDC_UP	181	1.0322962	0.44040403	0.8729152	-0.5198151	-2.5844075
ZHAN_MULTIPLE_MYELOMA_DN	c2.CGP_ chemical and genetic perturbations	32	-1.5491095	0.022508038	0.088774614	ZHAN_MULTIPLE_MYELOMA_DN	33	1.1508713	0.27744982	0.66779894	-0.3982382	-2.6999808
HUNSBERGER_EXERCISE_REGULATED_GENES	c2.CGP_ chemical and genetic perturbations	25	-1.5484573	0.028089888	0.08904725	HUNSBERGER_EXERCISE_REGULATED_GENES	29	-1.1892992	0.19298245	0.39482063	-2.7377565	-0.3591581
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP	C7_ immunologic signatures	168	-1.5483804	0	0.08895526	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP	168	-0.9213321	0.6923077	0.79496336	-2.4697125	-0.6270483
PID_AJDISS_2PATHWAY	c2.CP_ Canonical pathways	46	-1.5466782	0.01655629	0.08989498	PID_AJDISS_2PATHWAY	46	1.0429171	0.44570136	0.85351497	-0.5037611	-2.5895953
GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	C7_ immunologic signatures	170	-1.5456212	0.005319149	0.090426736	GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	178	0.7082974	0.964467	1	-0.8373238	-2.2539186
KEGG_STEROID_BIOSYNTHESIS	c2.CP_BIOCARTA_ BioCarta gene sets	15	-1.5456121	0.045212764	0.090283796	KEGG_STEROID_BIOSYNTHESIS	15	-1.4635735	0.08032128	0.16534308	-3.0091856	-0.0820386
GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP	C7_ immunologic signatures	171	-1.5454359	0	0.09027305	GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP	174	0.78014284	0.9032587	1	-0.76529306	-2.32557874
GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN	C7_ immunologic signatures	177	-1.5452527	0	0.090243	GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN	177	-1.7221164	0	0.0498908	-3.2673691	0.1768637
KEGG_CITRATE_CYCLE_TCA_CYCLE	c2.CP_BIOCARTA_ BioCarta gene sets	28	-1.5449533	0.014836796	0.090279266	KEGG_CITRATE_CYCLE_TCA_CYCLE	29	-0.9922211	0.45806453	0.69890594	-2.5371744	-0.5527322
GO_ELECTRON_CARRIER_ACTIVITY	c5.GO molecular function	99	-1.5445229	0.004273505	0.09040925	GO_ELECTRON_CARRIER_ACTIVITY	101	0.83536166	0.7941484	1	-0.70916124	-2.37988456
MODULE_305	c4.CM_ cancer modules	17	-1.5438256	0.033426184	0.090743504	MODULE_305	17	1.1420771	0.2872629	0.6868151	-0.4017485	-2.6859027
GCM_DDX5	c4.CGN_ cancer gene neighborhoods	62	-1.5437323	0.007782101	0.09064443	GCM_DDX5	62	-2.409514	0	0	-3.9532463	0.8657817
GO_INO80_TYPE_COMPLEX	c5.CC_ GO cellular component	21	-1.5435164	0.029891305	0.09065628	GO_INO80_TYPE_COMPLEX	21	-1.3891135	0.082474224	0.21470016	-2.9326299	-0.1544029
MODULE_221	c4.CM_ cancer modules	27	-1.5434433	0.005797102	0.090554014	MODULE_221	29	1.204364	0.2025	0.5834745	-0.3390793	-2.7478073
MORF_GSPT1	c4.CGN_ cancer gene neighborhoods	48	-1.543204	0.010676157	0.09055812	MORF_GSPT1	48	-1.6458288	0	0.07380625	-3.1890328	0.1026248
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	c2.CP_REACTOME_ Reactome gene sets	77	-1.5425141	0.007117438	0.09090938	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	77	-0.687246	1	0.96642125	-2.2297601	-0.8552681
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP	C7_ immunologic signatures	164	-1.5422857	0	0.090928495	GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP	164	1.0616543	0.37183383	0.8203933	-0.4806314	-2.60394
GO_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	15	-1.5419636	0.018518519	0.09102867	GO_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION	15	1.3142936	0.13072777	0.41956943	-0.22767	-2.8562572
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	22	-1.5409966	0.023746701	0.09157244	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	22	-0.8238551	0.72680414	0.886395	-2.3648517	-0.7171415
GO_RNA_POLYMERASE_COMPLEX	c5.CC_ GO cellular component	112	-1.5407281	0	0.09161566	GO_RNA_POLYMERASE_COMPLEX	112	0.64201397	0.98229164	1	-0.89871413	-2.18274207
GO_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	332	-1.5402883	0	0.09180658	GO_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS	338	0.8402415	0.911	1	-0.7000468	-2.3805298
GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_UP	C7_ immunologic signatures	177	-1.5398473	0	0.09196803	GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_UP	178	-1.7050971	0	0.054620124	-3.2449444	0.1652498
REACTOME_GAP_JUNCTION_TRAFFICKING	c2.CP_REACTOME_ Reactome gene sets	22	-1.5398434	0.011594203	0.091824725	REACTOME_GAP_JUNCTION_TRAFFICKING	24	0.71323156	0.85194176	1	-0.82661184	-2.25307496
MODULE_61	c4.CM_ cancer modules	45	-1.5397978	0.003322259	0.09172382	MODULE_61	45	-1.9068115	0	0.017352317	-3.4466093	0.3670137
GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP	C7_ immunologic signatures	141	-1.5390363	0	0.092155956	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP	143	0.687018	0.9732785	1	-0.8520183	-2.2260543
GO_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION	c5.BP_ GO biological process	19	-1.5387504	0.035326086	0.092229865	GO_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION	18	1.32539	0.12057667	0.40640423	-0.2133604	-2.8641404
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	c2.CP_REACTOME_ Reactome gene sets	22	-1.5384426	0.024024025	0.092314795	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	22	-0.67241234	0.9368421	0.9711389	-2.21085494	-0.86603026
GNF2_KPNB1	c4.CGN_ cancer gene neighborhoods	69	-1.5382521	0.007380074	0.09235049	GNF2_KPNB1	69	-2.5354333	0	0	-4.0736854	0.9971812
MORF_XRCC5	c4.CGN_ cancer gene neighborhoods	215	-1.5381684	0	0.09225364	MORF_XRCC5	216	-2.3847227	0	0	-3.9228911	0.8465543
MOOTHA_PGC	c2.CGP_ chemical and genetic perturbations	383	-1.5380512	0	0.092187114	MOOTHA_PGC	385	0.55654496	1	1	-0.98150624	-2.09459616
GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	168	-1.5375363	0.006097561	0.09239375	GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN	167	0.64392936	0.99187815	1	-0.89360694	-2.18146566
RB_P107_DN.V1_DN	C6_ oncogenic signatures	119	-1.5366324	0	0.09287263	RB_P107_DN.V1_DN	117	0.79203975	0.8597748	1	-0.74459265	-2.32867215
GO_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING	c5.GO molecular function	19	-1.5363076	0.052478135	0.0929525	GO_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING	21	0.7116011	0.8594937	1	-0.8247065	-2.2479087
GO_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	35	-1.5361227	0.00974026	0.092941605	GO_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS	39	1.7473298	0	0.06418419	0.2112071	-3.2834525
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	31	-1.5354866	0.018126888	0.09323136	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	33	0.9741248	0.52606636	0.9568446	-0.5613618	-2.5096114
CHRXQ21	C1: positional gene sets	29	-1.5345365	0.014836796	0.09375075	CHRXQ21	32	1.0107472	0.4609005	0.9060784	-0.5237893	-2.5452837
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE	c2.CP_REACTOME_ Reactome gene sets	39	-1.5337818	0.015576324	0.09415987	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE	39	-1.0351088	0.3525641	0.6294632	-2.5688906	-0.498673
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	C7_ immunologic signatures	178	-1.5336037	0	0.094141744	GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	186	-1.0115069	0.45454547	0.67069817	-2.5451106	-0.5220968
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	c2.CGP_ chemical and genetic perturbations	215	-1.5336012	0	0.09399669	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	218	0.6088773	0.99596775	1	-0.9247239	-2.1424785
BILD_MYC_ONCOGENIC_SIGNATURE	c2.CGP_ chemical and genetic perturbations	176	-1.533434	0	0.093963705	BILD_MYC_ONCOGENIC_SIGNATURE	177	0.6877445	0.9777778	1	-0.8456895	-2.2211785
GO_STEROID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	86	-1.5329235	0.004237288	0.09418483	GO_STEROID_BIOSYNTHETIC_PROCESS	93	0.85417724	0.77282375	1	-0.67874626	-2.38710074
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	18	-1.5321847	0.02972973	0.09457195	REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS	18	-1.2409775	0.20171674	0.3339697	-2.7731622	-0.2912072
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	30	-1.531978	0.015060241	0.09455688	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	31	0.67576545	0.919708	1	-0.85621255	-2.20774345
GNF2_BUB3	c4.CGN_ cancer gene neighborhoods	26	-1.5311505	0.026392963	0.095015	GNF2_BUB3	26	-1.8731213	0	0.021200879	-3.4042718	0.3419708
GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN	C7_ immunologic signatures	189	-1.5309929	0	0.09499366	GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN	189	-1.7798157	0	0.037047207	-3.3108086	0.2488228
GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN	C7_ immunologic signatures	162	-1.5307121	0	0.09504637	GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN	162	0.78108233	0.8942014	1	-0.74962977	-2.31179443
CHR1Q21	C1: positional gene sets	175	-1.5306101	0	0.09498659	CHR1Q21	177	0.7134501	0.96277666	1	-0.81716	-2.2440602
GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN	C7_ immunologic signatures	178	-1.5305018	0	0.09492698	GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN	176	1.1482024	0.1715439	0.67132217	-0.3822994	-2.6787042
MCLACHLAN_DENTAL_CARIES_UP	c2.CGP_ chemical and genetic perturbations	186	-1.5300611	0	0.09508832	MCLACHLAN_DENTAL_CARIES_UP	196	1.213064	0.07272727	0.5721803	-0.3169971	-2.7431251
GO_RESPONSE_TO_MANGANESE_ION	c5.BP_ GO biological process	16	-1.5297316	0.041436464	0.0951811	GO_RESPONSE_TO_MANGANESE_ION	16	1.1846368	0.24441524	0.6138155	-0.3450948	-2.7143684
TIEN_INTESTINE_PROBIOTICS_2HR_UP	c2.CGP_ chemical and genetic perturbations	24	-1.5275754	0.028735632	0.09653659	TIEN_INTESTINE_PROBIOTICS_2HR_UP	24	1.1726158	0.25761423	0.63313526	-0.3549596	-2.7001912
GO_AMINE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	18	-1.5272421	0.042666666	0.09661252	GO_AMINE_BIOSYNTHETIC_PROCESS	18	0.90919745	0.6039216	1	-0.61804465	-2.43643955
GO_SPLICEOSOMAL_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	51	-1.5262029	0.020338982	0.09728092	GO_SPLICEOSOMAL_COMPLEX_ASSEMBLY	51	-1.5590117	0.027777778	0.110211186	-3.0852146	0.0328088
KEGG_FATTY_ACID_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	39	-1.5251119	0.012345679	0.097985506	KEGG_FATTY_ACID_METABOLISM	39	1.3394449	0.08568075	0.39634535	-0.185667	-2.8645568
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	156	-1.5250883	0	0.09785274	GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP	160	0.6031843	0.9939148	1	-0.921904	-2.1282726
VANLOO_SP3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	74	-1.5248337	0.004081633	0.097882256	VANLOO_SP3_TARGETS_DN	76	1.0517066	0.40413943	0.83706295	-0.4731271	-2.5765403
GO_RIBOSOME_BINDING	c5.GO molecular function	42	-1.5245826	0.018404908	0.09792824	GO_RIBOSOME_BINDING	42	-1.7290815	0	0.04839288	-3.2536641	0.2044989
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR	c5.GO molecular function	94	-1.5245259	0.008810572	0.09783058	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR	97	1.2659948	0.09224319	0.4898611	-0.2585311	-2.7905207
MAEKAWA_ATF2_TARGETS	c2.CGP_ chemical and genetic perturbations	18	-1.5244377	0.021333333	0.09773692	MAEKAWA_ATF2_TARGETS	20	-1.2394904	0.17961165	0.3350301	-2.7639281	-0.2849473
GO_CHROMATIN_DISASSEMBLY	c5.BP_ GO biological process	15	-1.5242946	0.053299494	0.097706884	GO_CHROMATIN_DISASSEMBLY	17	1.0177697	0.46357617	0.8936131	-0.5065249	-2.5420643
GSE17721_LPS_VS_POLYIC_8H_BMDC_UP	C7_ immunologic signatures	180	-1.5235778	0	0.09804311	GSE17721_LPS_VS_POLYIC_8H_BMDC_UP	178	0.7494944	0.93655586	1	-0.7740834	-2.2730722
GO_SNRNA_BINDING	c5.GO molecular function	33	-1.5233964	0.029411765	0.09802136	GO_SNRNA_BINDING	33	-1.9261075	0	0.014981994	-3.4495039	0.4027111
GO_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY	c5.BP_ GO biological process	24	-1.5231414	0.031073445	0.0980633	GO_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY	30	0.97131085	0.53170735	0.9598012	-0.55183055	-2.49445225
MODULE_404	c4.CM_ cancer modules	22	-1.5228214	0.02	0.09816286	MODULE_404	22	1.090181	0.37800252	0.77102655	-0.4326404	-2.6130024
GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP	C7_ immunologic signatures	179	-1.5225906	0	0.09818245	GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP	178	-0.85259575	0.9166667	0.86457145	-2.37518635	-0.66999485
GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN	C7_ immunologic signatures	178	-1.5197935	0	0.10014977	GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN	180	-0.82472605	1	0.88597053	-2.34451955	-0.69506745
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	c2.CP_REACTOME_ Reactome gene sets	25	-1.5193264	0.021021022	0.10037283	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	25	-0.82942885	0.7771429	0.88288766	-2.34875525	-0.68989755
GO_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC	c5.BP_ GO biological process	15	-1.5185	0.056657225	0.10087785	GO_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC	17	1.3598481	0.08894536	0.3775731	-0.1586519	-2.8783481
GCM_DPF2	c4.CGN_ cancer gene neighborhoods	27	-1.5170256	0.027190333	0.10187632	GCM_DPF2	29	0.36597183	1	1	-1.15105377	-1.88299743
GO_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS	c5.BP_ GO biological process	20	-1.517023	0.04945055	0.101728275	GO_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS	19	1.159561	0.2826087	0.65382296	-0.357462	-2.676584
GO_LYMPHOCYTE_CHEMOTAXIS	c5.BP_ GO biological process	19	-1.5140785	0.036723163	0.10385213	GO_LYMPHOCYTE_CHEMOTAXIS	25	1.1439981	0.28229666	0.6825272	-0.3700804	-2.6580766
GO_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	88	-1.5140746	0	0.10370335	GO_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS	89	0.6788644	0.95415777	1	-0.8352102	-2.192939
GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	187	-1.5140451	0.006849315	0.10356389	GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP	187	-1.3915621	0	0.21364483	-2.9056072	-0.122483
GO_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	45	-1.513087	0.037414964	0.10411413	GO_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS	49	1.548376	0.006726457	0.20688707	0.035289	-3.061463
GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN	C7_ immunologic signatures	180	-1.511814	0.00621118	0.10497874	GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN	180	0.6976821	0.9696663	1	-0.8141319	-2.2094961
GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I	c5.BP_ GO biological process	77	-1.5114576	0.008928572	0.105067685	GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I	77	0.94371414	0.600432	0.98857033	-0.56774346	-2.45517174
JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN	c2.CGP_ chemical and genetic perturbations	78	-1.5100446	0.011363637	0.10601543	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN	82	-1.454221	0	0.17027728	-2.9642656	-0.0558236
GO_PYRUVATE_METABOLIC_PROCESS	c5.BP_ GO biological process	57	-1.5099097	0.010416667	0.10595818	GO_PYRUVATE_METABOLIC_PROCESS	60	0.7622968	0.87236404	1	-0.7476129	-2.2722065
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS	c5.GO molecular function	111	-1.5098912	0.004975124	0.10581313	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS	113	1.2401375	0.09508882	0.52597547	-0.2697537	-2.7500287
GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_UP	C7_ immunologic signatures	175	-1.5094587	0	0.10598615	GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_UP	174	-1.4428083	0	0.17841652	-2.952267	-0.0666504
GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP	C7_ immunologic signatures	183	-1.5080891	0	0.10687842	GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP	183	-1.3299935	0	0.25643912	-2.8380826	-0.1780956
REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS	c2.CP_REACTOME_ Reactome gene sets	50	-1.5070999	0.017985612	0.10755108	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS	50	-1.8922005	0	0.018487317	-3.3993004	0.3851006
BYSTROEM_CORRELATED_WITH_IL5_UP	c2.CGP_ chemical and genetic perturbations	40	-1.5069298	0.013201321	0.10755454	BYSTROEM_CORRELATED_WITH_IL5_UP	42	-0.9423343	0.5833333	0.7670988	-2.4492641	-0.5645955
USF_C	c3.TFT_ transcription factor targets	249	-1.5068879	0	0.10743639	USF_C	256	1.0394603	0.39537224	0.8591632	-0.4674276	-2.5463482
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	37	-1.5058019	0.034985423	0.10814971	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	37	-0.70731014	0.9548387	0.9572026	-2.21311204	-0.79849176
GO_REGULATION_OF_NEUTROPHIL_MIGRATION	c5.BP_ GO biological process	19	-1.50578	0.036111113	0.108015075	GO_REGULATION_OF_NEUTROPHIL_MIGRATION	26	1.453756	0.027295286	0.28893864	-0.052024	-2.959536
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	33	-1.5055596	0.025559105	0.108061396	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	31	0.8238371	0.74415886	1	-0.6817225	-2.3293967
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	c2.CP_REACTOME_ Reactome gene sets	27	-1.5051728	0.03405573	0.10819475	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	29	1.109669	0.31363088	0.7384408	-0.3955038	-2.6148418
GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN	C7_ immunologic signatures	184	-1.504454	0	0.108663544	GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN	183	0.8492699	0.83704454	1	-0.6551841	-2.3537239
GO_SNORNA_BINDING	c5.GO molecular function	24	-1.5040748	0.02631579	0.108786225	GO_SNORNA_BINDING	24	-1.9895635	0	0.009043357	-3.4936383	0.4854887
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	c2.CP_REACTOME_ Reactome gene sets	26	-1.5040603	0.036931816	0.10864134	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	26	-1.1811281	0.1741573	0.4030247	-2.6851884	-0.3229322
GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP	C7_ immunologic signatures	150	-1.503901	0	0.108612254	GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP	158	1.0360703	0.4182741	0.8657748	-0.4678307	-2.5399713
GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP	C7_ immunologic signatures	181	-1.5037836	0	0.108531855	GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP	185	-1.1970583	0	0.38557985	-2.7008419	-0.3067253
GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN	C7_ immunologic signatures	175	-1.5036558	0	0.10845489	GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN	177	-1.5894388	0	0.094317086	-3.0930946	0.085783
GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	C7_ immunologic signatures	190	-1.5030962	0	0.10874197	GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	192	0.936957	0.68479353	0.9929639	-0.5661392	-2.4400532
GO_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE	c5.BP_ GO biological process	53	-1.5029975	0.020408163	0.10866338	GO_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE	53	-1.0088965	0.48039216	0.6743071	-2.511894	-0.494101
GO_U5_SNRNP	c5.CC_ GO cellular component	15	-1.5025612	0.051813472	0.10883127	GO_U5_SNRNP	15	-1.6710374	0.021645023	0.06504483	-3.1735986	0.1684762
MORF_DEAF1	c4.CGN_ cancer gene neighborhoods	50	-1.5024012	0.017006803	0.10883124	MORF_DEAF1	51	-1.6901067	0	0.058529835	-3.1925079	0.1877055
GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN	C7_ immunologic signatures	185	-1.5020022	0	0.10896475	GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN	185	-1.0789157	0.22222222	0.553738	-2.5809179	-0.4230865
GO_CILIARY_TIP	c5.CC_ GO cellular component	41	-1.5019641	0.019543974	0.10884001	GO_CILIARY_TIP	42	0.7925804	0.79466355	1	-0.7093837	-2.2945445
GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER	c5.BP_ GO biological process	17	-1.501164	0.034666665	0.10936043	GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER	17	-1.9888825	0	0.009013691	-3.4900465	0.4877185
CHRXQ28	C1: positional gene sets	69	-1.4992487	0.00729927	0.110746354	CHRXQ28	72	1.6967363	0	0.07989572	0.1974876	-3.195985
WINTER_HYPOXIA_UP	c2.CGP_ chemical and genetic perturbations	86	-1.4991032	0	0.110699214	WINTER_HYPOXIA_UP	87	0.83490217	0.78533477	1	-0.66420103	-2.33400537
GO_MRNA_CLEAVAGE_FACTOR_COMPLEX	c5.CC_ GO cellular component	16	-1.4986612	0.04347826	0.11091688	GO_MRNA_CLEAVAGE_FACTOR_COMPLEX	16	-1.4342144	0.069565214	0.18385167	-2.9328756	-0.0644468
GO_U1_SNRNP	c5.CC_ GO cellular component	16	-1.4974824	0.056603774	0.11171287	GO_U1_SNRNP	16	-1.2275794	0.17916666	0.34813026	-2.7250618	-0.269903
KEGG_GLUTATHIONE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	41	-1.4967883	0.024169184	0.11210976	KEGG_GLUTATHIONE_METABOLISM	43	1.177865	0.22284435	0.62541306	-0.3189233	-2.6746533
GO_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND	c5.BP_ GO biological process	31	-1.4953014	0.021276595	0.11318665	GO_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND	32	-1.3663886	0.08108108	0.22950806	-2.86169	-0.1289128
KEGG_PROPANOATE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	30	-1.4951564	0.022292994	0.113148205	KEGG_PROPANOATE_METABOLISM	30	1.5093607	0.015681544	0.2441333	0.0142043	-3.0045171
GO_RIBONUCLEOPROTEIN_COMPLEX_BINDING	c5.GO molecular function	85	-1.4949713	0.01754386	0.11314877	GO_RIBONUCLEOPROTEIN_COMPLEX_BINDING	85	-1.5939407	0	0.0932457	-3.088912	0.0989694
LEE_METASTASIS_AND_RNA_PROCESSING_UP	c2.CGP_ chemical and genetic perturbations	17	-1.4946252	0.051679585	0.11328361	LEE_METASTASIS_AND_RNA_PROCESSING_UP	17	-1.4441283	0.065789476	0.1776417	-2.9387535	-0.0504969
REACTOME_TRNA_AMINOACYLATION	c2.CP_REACTOME_ Reactome gene sets	42	-1.494453	0.012383901	0.113280445	REACTOME_TRNA_AMINOACYLATION	42	-1.5704829	0	0.104565956	-3.0649359	0.0760299
GO_VITAMIN_TRANSPORTER_ACTIVITY	c5.GO molecular function	17	-1.4932781	0.050139274	0.1140826	GO_VITAMIN_TRANSPORTER_ACTIVITY	19	1.1760011	0.25688073	0.6279032	-0.317277	-2.6692792
GSE27786_CD4_VS_CD8_TCELL_DN	C7_ immunologic signatures	173	-1.4932675	0	0.11393312	GSE27786_CD4_VS_CD8_TCELL_DN	179	0.7940081	0.896236	1	-0.6992594	-2.2872756
REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION	c2.CP_REACTOME_ Reactome gene sets	18	-1.4924959	0.03504043	0.11445128	REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION	18	-1.0798035	0.33920705	0.55207235	-2.5722994	-0.4126924
GO_SINGLE_STRANDED_RNA_BINDING	c5.GO molecular function	59	-1.4920156	0.017605634	0.11468556	GO_SINGLE_STRANDED_RNA_BINDING	60	-0.9422951	0.5595238	0.7660853	-2.4343107	-0.5497205
GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP	C7_ immunologic signatures	174	-1.4918212	0.00625	0.11468251	GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP	175	-1.8115216	0	0.031310137	-3.3033428	0.3197004
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	c2.CGP_ chemical and genetic perturbations	67	-1.4914553	0.012048192	0.11480904	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	68	0.8394687	0.75213677	1	-0.6519866	-2.330924
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN	C7_ immunologic signatures	173	-1.4908855	0	0.115097314	GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN	173	0.664904	0.97887325	1	-0.8259815	-2.1557895
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	c2.CGP_ chemical and genetic perturbations	21	-1.4908845	0.051136363	0.11493768	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	22	-1.5308123	0.038647342	0.12479747	-3.0216968	0.0399278
CHR10Q21	C1: positional gene sets	39	-1.4896555	0.03313253	0.115826085	CHR10Q21	40	0.86657906	0.7010551	1	-0.62307644	-2.35623456
KEGG_HUNTINGTONS_DISEASE	c2.CP_BIOCARTA_ BioCarta gene sets	147	-1.4887804	0.005747126	0.11635854	KEGG_HUNTINGTONS_DISEASE	150	0.54747045	1	1	-0.94130995	-2.03625085
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN	C7_ immunologic signatures	181	-1.4882967	0	0.11662457	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN	182	-0.9656807	0.5	0.7348278	-2.4539774	-0.522616
KEGG_PYRIMIDINE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	89	-1.4859916	0.004201681	0.118509375	KEGG_PYRIMIDINE_METABOLISM	90	-0.96308625	0.5813953	0.7378631	-2.44907785	-0.52290535
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	c2.CGP_ chemical and genetic perturbations	307	-1.4854857	0	0.11875651	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	315	0.7158111	0.991992	1	-0.7696746	-2.2012968
GO_SPLICEOSOMAL_TRI_SNRNP_COMPLEX	c5.CC_ GO cellular component	25	-1.4849917	0.028818443	0.11900479	GO_SPLICEOSOMAL_TRI_SNRNP_COMPLEX	25	-1.7573483	0.005586592	0.04179751	-3.24234	0.2723566
GO_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_	c5.BP_ GO biological process	19	-1.484903	0.057894737	0.118928656	GO_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_	19	-1.5094783	0.03524229	0.13673075	-2.9943813	0.0245753
GSE29618_MONOCYTE_VS_MDC_DN	C7_ immunologic signatures	159	-1.4841889	0	0.119353406	GSE29618_MONOCYTE_VS_MDC_DN	162	-1.0662111	0.23529412	0.5762054	-2.5504	-0.4179778
GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_DN	C7_ immunologic signatures	129	-1.4838136	0	0.11955824	GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_DN	133	0.80301446	0.8606557	1	-0.68079914	-2.28682806
MORF_PHB	c4.CGN_ cancer gene neighborhoods	117	-1.4832728	0.014778325	0.119843215	MORF_PHB	117	-0.8635121	0.9130435	0.8575801	-2.3467849	-0.6197607
LEE_CALORIE_RESTRICTION_MUSCLE_UP	c2.CGP_ chemical and genetic perturbations	37	-1.4829481	0.03821656	0.11996684	LEE_CALORIE_RESTRICTION_MUSCLE_UP	40	1.0386859	0.43939394	0.860554	-0.4442622	-2.521634
GO_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY	c5.GO molecular function	17	-1.4828861	0.048295453	0.11985201	GO_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY	18	1.3968384	0.06258149	0.34678197	-0.0860477	-2.8797245
SMID_BREAST_CANCER_ERBB2_UP	c2.CGP_ chemical and genetic perturbations	119	-1.4827214	0.005617978	0.119828746	SMID_BREAST_CANCER_ERBB2_UP	122	1.2749197	0.0661157	0.4808105	-0.2078017	-2.7576411
GO_ACUTE_PHASE_RESPONSE	c5.BP_ GO biological process	30	-1.4823587	0.045045044	0.120009504	GO_ACUTE_PHASE_RESPONSE	40	1.2362412	0.16724738	0.53152055	-0.2461175	-2.7185999
REACTOME_REGULATION_OF_KIT_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	16	-1.4821771	0.048843186	0.11999603	REACTOME_REGULATION_OF_KIT_SIGNALING	16	-0.8870319	0.6117647	0.83781284	-2.369209	-0.5951452
GSE27786_LSK_VS_MONO_MAC_UP	C7_ immunologic signatures	167	-1.4817861	0	0.12020201	GSE27786_LSK_VS_MONO_MAC_UP	169	0.66025525	0.9837728	1	-0.82153085	-2.14204135
MORF_RAF1	c4.CGN_ cancer gene neighborhoods	105	-1.4816973	0.004545454	0.120105594	MORF_RAF1	105	-1.969773	0	0.010649921	-3.4514703	0.4880757
GNF2_LYN	c4.CGN_ cancer gene neighborhoods	25	-1.4806322	0.030555556	0.12087963	GNF2_LYN	25	1.4462451	0.04385965	0.29485393	-0.0343871	-2.9268773
NRF2_01	c3.TFT_ transcription factor targets	244	-1.480624	0	0.12072269	NRF2_01	247	-0.7898077	1	0.9137537	-2.2704317	-0.6908163
MORF_SP3	c4.CGN_ cancer gene neighborhoods	75	-1.4804754	0.003937008	0.120661534	MORF_SP3	75	-2.0735343	0	0.003851458	-3.5540097	0.5930589
HILLION_HMGA1_TARGETS	c2.CGP_ chemical and genetic perturbations	71	-1.4803675	0.011627907	0.120581254	HILLION_HMGA1_TARGETS	76	0.6492455	0.9505908	1	-0.831122	-2.129613
GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	182	-1.4802521	0	0.12052343	GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN	182	-1.8049312	0	0.03219045	-3.2851833	0.3246791
GO_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA	c5.BP_ GO biological process	15	-1.48001	0.06410257	0.12056565	GO_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA	15	-0.8856887	0.60944206	0.838043	-2.3656987	-0.5943213
GSE29618_BCELL_VS_MDC_DN	C7_ immunologic signatures	175	-1.4793719	0.005714286	0.12101317	GSE29618_BCELL_VS_MDC_DN	177	0.9014464	0.72690356	1	-0.5779255	-2.3808183
KOBAYASHI_EGFR_SIGNALING_6HR_DN	c2.CGP_ chemical and genetic perturbations	17	-1.4790823	0.04568528	0.1211215	KOBAYASHI_EGFR_SIGNALING_6HR_DN	17	1.1433675	0.30052492	0.68377036	-0.3357148	-2.6224498
GO_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS	c5.GO molecular function	34	-1.4788655	0.018867925	0.12114022	GO_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS	36	0.8893645	0.65344226	1	-0.589501	-2.36823
GO_LEUKOTRIENE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	16	-1.47886	0.060759492	0.120986246	GO_LEUKOTRIENE_BIOSYNTHETIC_PROCESS	19	1.6107486	0.007633588	0.14750722	0.1318886	-3.0896086
GNF2_MSH6	c4.CGN_ cancer gene neighborhoods	31	-1.4776127	0.041666668	0.12191093	GNF2_MSH6	31	-2.3593652	0	3.74E-05	-3.8369779	0.8817525
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN	C7_ immunologic signatures	164	-1.4768647	0.005747126	0.12236751	GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN	173	0.7181455	0.9605263	1	-0.7587192	-2.1950102
INGRAM_SHH_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	57	-1.476132	0.014440433	0.122891225	INGRAM_SHH_TARGETS_DN	57	-1.2703756	0.078947365	0.30913344	-2.7465076	-0.2057564
FARMER_BREAST_CANCER_CLUSTER_3	c2.CGP_ chemical and genetic perturbations	15	-1.4758686	0.06870229	0.122983865	FARMER_BREAST_CANCER_CLUSTER_3	15	0.64031446	0.9256308	1	-0.83555414	-2.11618306
CHR1P13	C1: positional gene sets	77	-1.4756465	0.008849558	0.12303517	CHR1P13	83	0.6998352	0.9339723	1	-0.7758113	-2.1754817
GO_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE	c5.BP_ GO biological process	18	-1.4747971	0.049723756	0.12359366	GO_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE	18	1.0240222	0.47759283	0.8851745	-0.4507749	-2.4988193
GO_PROTEIN_TRANSPORTER_ACTIVITY	c5.GO molecular function	89	-1.4743989	0.022988506	0.12377952	GO_PROTEIN_TRANSPORTER_ACTIVITY	90	-0.84522647	0.8363636	0.87175184	-2.31962537	-0.62917243
GO_VENTRICULAR_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	26	-1.4742221	0.03763441	0.123764366	GO_VENTRICULAR_SYSTEM_DEVELOPMENT	26	1.039272	0.43309003	0.85909075	-0.4349501	-2.5134941
GO_ORGANELLE_ENVELOPE_LUMEN	c5.CC_ GO cellular component	68	-1.4739871	0	0.123821795	GO_ORGANELLE_ENVELOPE_LUMEN	70	0.8347139	0.77133477	1	-0.6392732	-2.308701
NUTT_GBM_VS_AO_GLIOMA_DN	c2.CGP_ chemical and genetic perturbations	39	-1.4735881	0.035947714	0.124005735	NUTT_GBM_VS_AO_GLIOMA_DN	41	0.7508492	0.8553241	1	-0.7227389	-2.2244373
ELVIDGE_HYPOXIA_DN	c2.CGP_ chemical and genetic perturbations	132	-1.4717101	0.005714286	0.12551832	ELVIDGE_HYPOXIA_DN	132	-1.5076883	0	0.1375414	-2.9793984	0.0359782
GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	C7_ immunologic signatures	179	-1.4713571	0	0.12566641	GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	179	0.6693864	0.98373985	1	-0.8019707	-2.1407435
GSE22886_NEUTROPHIL_VS_DC_DN	C7_ immunologic signatures	180	-1.4712534	0	0.12559074	GSE22886_NEUTROPHIL_VS_DC_DN	179	-1.0702096	0.18181819	0.57038563	-2.541463	-0.4010438
GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN	C7_ immunologic signatures	180	-1.4710475	0.006578947	0.12560955	GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN	180	-1.7686827	0	0.03952523	-3.2397302	0.2976352
BHATTACHARYA_EMBRYONIC_STEM_CELL	c2.CGP_ chemical and genetic perturbations	77	-1.4708643	0.010830325	0.12560646	BHATTACHARYA_EMBRYONIC_STEM_CELL	78	-1.2157447	0.08571429	0.36095837	-2.686609	-0.2551196
GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN	C7_ immunologic signatures	178	-1.4705535	0	0.12573628	GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN	176	-0.76405394	1	0.93060434	-2.23460744	-0.70649956
GSE25087_FETAL_VS_ADULT_TREG_UP	C7_ immunologic signatures	173	-1.4703968	0	0.1256971	GSE25087_FETAL_VS_ADULT_TREG_UP	174	0.9430134	0.6284264	0.9886001	-0.5273834	-2.4134102
GO_NEGATIVE_REGULATION_OF_RNA_SPLICING	c5.BP_ GO biological process	24	-1.4695698	0.05202312	0.12620789	GO_NEGATIVE_REGULATION_OF_RNA_SPLICING	24	-1.6510901	0.005050505	0.07136563	-3.1206599	0.1815203
GO_TRNA_METHYLTRANSFERASE_ACTIVITY	c5.GO molecular function	16	-1.4692564	0.048843186	0.1263425	GO_TRNA_METHYLTRANSFERASE_ACTIVITY	16	-0.7464	0.7782427	0.9397799	-2.2156564	-0.7228564
GNF2_PA2G4	c4.CGN_ cancer gene neighborhoods	74	-1.4691666	0.003521127	0.1262527	GNF2_PA2G4	74	-2.3608525	0	3.80E-05	-3.8300191	0.8916859
GO_MYELOID_LEUKOCYTE_MIGRATION	c5.BP_ GO biological process	62	-1.4690962	0.003968254	0.12613365	GO_MYELOID_LEUKOCYTE_MIGRATION	72	1.5424541	0.005464481	0.21026188	0.0733579	-3.0115503
KEGG_BUTANOATE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	29	-1.468613	0.05357143	0.1263926	KEGG_BUTANOATE_METABOLISM	31	0.7852596	0.79196215	1	-0.6833534	-2.2538726
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN	C7_ immunologic signatures	187	-1.468431	0	0.1263794	GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN	187	0.7249556	0.9737639	1	-0.7434754	-2.1933866
GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN	C7_ immunologic signatures	155	-1.4682738	0	0.12634262	GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN	155	1.0558662	0.37142858	0.8316175	-0.4124076	-2.52414
GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP	C7_ immunologic signatures	183	-1.4680417	0	0.12634757	GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP	185	-1.059646	0.25	0.58855635	-2.5276877	-0.4083957
GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP	C7_ immunologic signatures	167	-1.4676476	0	0.1265812	GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP	169	-0.86773705	0.9230769	0.85513765	-2.33538465	-0.59991055
GO_RNA_METHYLATION	c5.BP_ GO biological process	41	-1.4674245	0.03	0.1266045	GO_RNA_METHYLATION	42	-0.89980114	0.675	0.82145125	-2.36722564	-0.56762336
GO_GMP_METABOLIC_PROCESS	c5.BP_ GO biological process	18	-1.4670104	0.04481793	0.12679447	GO_GMP_METABOLIC_PROCESS	19	0.6606949	0.89659685	1	-0.8063155	-2.1277053
GO_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY	c5.GO molecular function	15	-1.4669118	0.060367454	0.12670343	GO_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY	15	0	0	0	-1.4669118	-1.4669118
GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP	C7_ immunologic signatures	170	-1.4663538	0	0.12704687	GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP	171	-1.0465934	0.5	0.6116967	-2.5129472	-0.4197604
GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP	C7_ immunologic signatures	136	-1.4654676	0.005376344	0.12772366	GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP	140	1.1611165	0.17846154	0.65128857	-0.3043511	-2.6265841
GSE13493_DP_VS_CD8POS_THYMOCYTE_DN	C7_ immunologic signatures	178	-1.464655	0	0.12827517	GSE13493_DP_VS_CD8POS_THYMOCYTE_DN	180	0.9527319	0.61150354	0.9784675	-0.5119231	-2.4173869
DOANE_BREAST_CANCER_ESR1_DN	c2.CGP_ chemical and genetic perturbations	37	-1.4637667	0.03154574	0.12888937	DOANE_BREAST_CANCER_ESR1_DN	39	1.1750933	0.23130842	0.62907755	-0.2886734	-2.63886
GO_ENDORIBONUCLEASE_COMPLEX	c5.CC_ GO cellular component	17	-1.4637309	0.053299494	0.1287659	GO_ENDORIBONUCLEASE_COMPLEX	17	-0.7380937	0.83842796	0.94295305	-2.2018246	-0.7256372
GO_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	39	-1.4632912	0.018382354	0.12894057	GO_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS	38	0.84232616	0.73448277	1	-0.62096504	-2.30561736
KRAS.50_UP.V1_UP	C6_ oncogenic signatures	42	-1.4622397	0.025236594	0.12973903	KRAS.50_UP.V1_UP	41	1.3076483	0.08660508	0.42860338	-0.1545914	-2.769888
GSE17721_0.5H_VS_24H_CPG_BMDC_UP	C7_ immunologic signatures	179	-1.4621001	0	0.12971845	GSE17721_0.5H_VS_24H_CPG_BMDC_UP	181	1.0274007	0.43188697	0.8805894	-0.4346994	-2.4895008
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION	c2.CGP_ chemical and genetic perturbations	39	-1.4617788	0.023809524	0.12983333	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION	41	-0.9397532	0.55921054	0.7710629	-2.401532	-0.5220256
GO_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	52	-1.4615368	0.013245033	0.12991013	GO_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	57	1.0913934	0.32855567	0.77002466	-0.3701434	-2.5529302
CHR11Q12	C1: positional gene sets	109	-1.4609694	0	0.13026798	CHR11Q12	116	0.8137831	0.8405797	1	-0.6471863	-2.2747525
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	c2.CGP_ chemical and genetic perturbations	42	-1.4607829	0.037037037	0.13027698	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	40	1.376742	0.052083332	0.35748458	-0.0840409	-2.8375249
GNF2_SERPINI2	c4.CGN_ cancer gene neighborhoods	20	-1.4607757	0.06371191	0.1301151	GNF2_SERPINI2	20	1.2632923	0.17258883	0.49164364	-0.1974834	-2.724068
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	c2.CP_REACTOME_ Reactome gene sets	24	-1.4606125	0.041322313	0.13007611	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	24	-2.160602	0	0.00132812	-3.6212145	0.6999895
HOLLERN_PAPILLARY_BREAST_TUMOR	c2.CGP_ chemical and genetic perturbations	15	-1.4604517	0.0656168	0.13007495	HOLLERN_PAPILLARY_BREAST_TUMOR	15	0	0	0	-1.4604517	-1.4604517
GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP	C7_ immunologic signatures	167	-1.4602139	0	0.13009344	GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP	167	-1.3900477	0	0.21409293	-2.8502616	-0.0701662
GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP	C7_ immunologic signatures	186	-1.4591187	0.006711409	0.13090718	GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP	185	0.5913491	1	1	-0.8677696	-2.0504678
TIAN_TNF_SIGNALING_VIA_NFKB	c2.CGP_ chemical and genetic perturbations	23	-1.458906	0.02688172	0.1309154	TIAN_TNF_SIGNALING_VIA_NFKB	24	1.3045537	0.11097257	0.43443322	-0.1543523	-2.7634597
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN	C7_ immunologic signatures	179	-1.458526	0	0.13110264	GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN	184	1.0132067	0.4579534	0.9010738	-0.4453193	-2.4717327
FARMER_BREAST_CANCER_CLUSTER_7	c2.CGP_ chemical and genetic perturbations	19	-1.4580147	0.043715846	0.13142024	FARMER_BREAST_CANCER_CLUSTER_7	19	-1.3572019	0.0720339	0.23640727	-2.8152166	-0.1008128
REACTOME_POTASSIUM_CHANNELS	c2.CP_REACTOME_ Reactome gene sets	79	-1.4573774	0.019455252	0.13184735	REACTOME_POTASSIUM_CHANNELS	94	1.3047882	0.06414301	0.4340131	-0.1525892	-2.7621656
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	c2.CGP_ chemical and genetic perturbations	32	-1.4573635	0.03975535	0.1316928	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	32	0.7114259	0.8827751	1	-0.7459376	-2.1687894
RYCACNNRNNRNCAG_UNKNOWN	c3.TFT_ transcription factor targets	60	-1.456521	0.014814815	0.13231222	RYCACNNRNNRNCAG_UNKNOWN	63	1.4382906	0.019823788	0.3067175	-0.0182304	-2.8948116
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	c2.CGP_ chemical and genetic perturbations	34	-1.455902	0.034582134	0.13273096	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	35	-0.8951819	0.6946108	0.8269943	-2.3510839	-0.5607201
GSE3982_NEUTROPHIL_VS_BCELL_DN	C7_ immunologic signatures	174	-1.4551859	0	0.13322456	GSE3982_NEUTROPHIL_VS_BCELL_DN	177	-1.0464559	0.25	0.61173415	-2.5016418	-0.40873
TERAO_AOX4_TARGETS_SKIN_UP	c2.CGP_ chemical and genetic perturbations	33	-1.4549406	0.044444446	0.13329427	TERAO_AOX4_TARGETS_SKIN_UP	33	-0.9254029	0.58278143	0.7881213	-2.3803435	-0.5295377
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN	C7_ immunologic signatures	185	-1.4525439	0	0.13537802	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN	186	-2.0450842	0	0.005159473	-3.4976281	0.5925403
GO_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING	c5.BP_ GO biological process	19	-1.4523029	0.03753351	0.1354536	GO_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING	19	-1.6129758	0.014705882	0.08707261	-3.0652787	0.1606729
GO_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR	c5.GO molecular function	36	-1.4518671	0.03076923	0.13573812	GO_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR	36	0.64529765	0.94089836	1	-0.80656945	-2.09716475
GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN	C7_ immunologic signatures	164	-1.4509779	0.006369427	0.1364632	GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN	162	0.6262502	0.9969543	1	-0.8247277	-2.0772281
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	47	-1.4506185	0.016891891	0.1366443	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	44	1.0104148	0.47332576	0.90614355	-0.4402037	-2.4610333
GO_TRIGLYCERIDE_LIPASE_ACTIVITY	c5.GO molecular function	15	-1.4499252	0.06684492	0.13715883	GO_TRIGLYCERIDE_LIPASE_ACTIVITY	15	0	0	0	-1.4499252	-1.4499252
GO_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH	c5.BP_ GO biological process	40	-1.449652	0.033557046	0.13727683	GO_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH	42	-0.9515875	0.6118421	0.7523952	-2.4012395	-0.4980645
MODULE_40	c4.CM_ cancer modules	72	-1.4492471	0.011494253	0.13747914	MODULE_40	77	1.1031523	0.31495228	0.7515659	-0.3460948	-2.5523994
GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_DUPLEX_UNWINDING	c5.BP_ GO biological process	21	-1.4492307	0.057142857	0.13732317	GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_DUPLEX_UNWINDING	21	0.43848723	0.99491096	1	-1.01074347	-1.88771793
GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN	C7_ immunologic signatures	104	-1.4492112	0.01010101	0.13717194	GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN	113	1.3643993	0.016580312	0.37301478	-0.0848119	-2.8136105
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN	C7_ immunologic signatures	171	-1.4484482	0	0.13775952	GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN	174	-1.1103557	0.13333334	0.5038569	-2.5588039	-0.3380925
LIN_APC_TARGETS	c2.CGP_ chemical and genetic perturbations	71	-1.448277	0.007067138	0.13776618	LIN_APC_TARGETS	73	-1.1858982	0.11764706	0.3984905	-2.6341752	-0.2623788
GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP	C7_ immunologic signatures	170	-1.4482367	0	0.13765009	GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP	173	0.73266244	0.96153843	1	-0.71557426	-2.18089914
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	c2.CGP_ chemical and genetic perturbations	103	-1.4482241	0.009174312	0.13749635	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	105	-0.83795047	0.8787879	0.8765679	-2.28617457	-0.61027363
REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION	c2.CP_REACTOME_ Reactome gene sets	16	-1.4481779	0.044155844	0.13737062	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION	20	0.5227244	0.9859155	1	-0.9254535	-1.9709023
OSMAN_BLADDER_CANCER_DN	c2.CGP_ chemical and genetic perturbations	317	-1.4478476	0	0.13750504	OSMAN_BLADDER_CANCER_DN	318	0.72174805	0.983984	1	-0.72609955	-2.16959565
GO_CELLULAR_PROTEIN_COMPLEX_DISASSEMBLY	c5.BP_ GO biological process	119	-1.4469634	0.010526316	0.13815998	GO_CELLULAR_PROTEIN_COMPLEX_DISASSEMBLY	119	-1.2129214	0.1	0.36452913	-2.6598848	-0.234042
GO_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS	c5.BP_ GO biological process	452	-1.4462079	0	0.13874812	GO_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS	458	0.7657177	0.983984	1	-0.6804902	-2.2119256
GO_REGULATION_OF_RNA_STABILITY	c5.BP_ GO biological process	130	-1.4458387	0.014354067	0.13893853	GO_REGULATION_OF_RNA_STABILITY	131	-1.5907705	0	0.09476395	-3.0366092	0.1449318
GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP	C7_ immunologic signatures	185	-1.4448109	0	0.13975462	GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP	187	-0.9995802	0.53333336	0.6857992	-2.4443911	-0.4452307
GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP	C7_ immunologic signatures	166	-1.4443878	0.006060606	0.13997829	GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP	168	-1.3889174	0	0.21436204	-2.8333052	-0.0554704
PID_UPA_UPAR_PATHWAY	c2.CP_ Canonical pathways	37	-1.4440141	0.022151899	0.14014313	PID_UPA_UPAR_PATHWAY	36	0.98836887	0.5029308	0.93720657	-0.45564523	-2.43238297
LIU_NASOPHARYNGEAL_CARCINOMA	c2.CGP_ chemical and genetic perturbations	61	-1.4434482	0.017985612	0.14054793	LIU_NASOPHARYNGEAL_CARCINOMA	61	0.70158184	0.9248619	1	-0.74186636	-2.14503004
GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN	C7_ immunologic signatures	183	-1.4429221	0.007042253	0.14089315	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN	183	-1.8516158	0	0.024493478	-3.2945379	0.4086937
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S	c2.CP_REACTOME_ Reactome gene sets	41	-1.4427024	0.048780486	0.14094682	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S	41	-1.0077873	0.4	0.67428046	-2.4504897	-0.4349151
GO_POSITIVE_REGULATION_OF_PHAGOCYTOSIS	c5.BP_ GO biological process	39	-1.4418048	0.038922157	0.1416252	GO_POSITIVE_REGULATION_OF_PHAGOCYTOSIS	40	1.4569715	0.02739726	0.2857046	0.0151667	-2.8987763
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	c2.CGP_ chemical and genetic perturbations	65	-1.4412696	0.016064256	0.14195506	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	65	-1.0690339	0.3493976	0.5721366	-2.5103035	-0.3722357
GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN	C7_ immunologic signatures	184	-1.4410704	0	0.14196418	GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN	186	0.5343477	1	1	-0.9067227	-1.9754181
GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP	C7_ immunologic signatures	177	-1.4410453	0	0.1418178	GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP	180	0.6476505	0.98888886	1	-0.7933948	-2.0886958
MODULE_154	c4.CM_ cancer modules	53	-1.4388514	0.02631579	0.14378063	MODULE_154	58	1.7275047	0	0.07167804	0.2886533	-3.1663561
GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE	c5.CC_ GO cellular component	15	-1.4376473	0.063360885	0.1448378	GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE	15	0.9165126	0.594702	1	-0.5211347	-2.3541599
GO_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	40	-1.4371315	0.024844721	0.14519942	GO_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION	41	1.0488348	0.40344828	0.84211886	-0.3882967	-2.4859663
GO_B_CELL_PROLIFERATION	c5.BP_ GO biological process	32	-1.4368676	0.046195652	0.14529015	GO_B_CELL_PROLIFERATION	32	-1.1797366	0.2	0.4042835	-2.6166042	-0.257131
GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_DN	C7_ immunologic signatures	175	-1.4365968	0	0.14540957	GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_DN	178	-0.86003697	0.875	0.86027044	-2.29663377	-0.57655983
GO_HSP70_PROTEIN_BINDING	c5.GO molecular function	28	-1.4364487	0.041533545	0.14538898	GO_HSP70_PROTEIN_BINDING	28	0.6103419	0.9459784	1	-0.8261068	-2.0467906
GO_CHAPERONE_MEDIATED_PROTEIN_FOLDING	c5.BP_ GO biological process	43	-1.4358314	0.026755853	0.14584406	GO_CHAPERONE_MEDIATED_PROTEIN_FOLDING	44	1.1364061	0.29298642	0.6954046	-0.2994253	-2.5722375
MODULE_297	c4.CM_ cancer modules	58	-1.435669	0.034843206	0.14581145	MODULE_297	62	1.7295085	0	0.070603944	0.2938395	-3.1651775
GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP	C7_ immunologic signatures	129	-1.4351858	0	0.14612213	GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP	133	0.9078504	0.69502074	1	-0.5273354	-2.3430362
GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_DAMAGE_RECOGNITION	c5.BP_ GO biological process	22	-1.4350752	0.065395094	0.1460414	GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_DAMAGE_RECOGNITION	22	-0.7212669	0.91237116	0.9512637	-2.1563421	-0.7138083
GO_SNRNA_METABOLIC_PROCESS	c5.BP_ GO biological process	72	-1.434278	0.015384615	0.14672388	GO_SNRNA_METABOLIC_PROCESS	72	-1.6701872	0	0.065242484	-3.1044652	0.2359092
GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	150	-1.4340974	0	0.14675313	GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN	152	-0.95874524	0.6111111	0.7438216	-2.39284264	-0.47535216
GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN	C7_ immunologic signatures	169	-1.4340488	0	0.14662349	GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN	171	0.7175429	0.95854396	1	-0.7165059	-2.1515917
GO_AMINO_ACID_ACTIVATION	c5.BP_ GO biological process	51	-1.4332623	0.025179856	0.14727603	GO_AMINO_ACID_ACTIVATION	51	-1.546465	0.018018018	0.117380984	-2.9797273	0.1132027
MODULE_76	c4.CM_ cancer modules	61	-1.4331486	0.021352313	0.14722088	MODULE_76	68	1.2622006	0.13282937	0.4935853	-0.170948	-2.6953492
GO_REGULATION_OF_INTERLEUKIN_17_PRODUCTION	c5.BP_ GO biological process	19	-1.4328929	0.048780486	0.1472703	GO_REGULATION_OF_INTERLEUKIN_17_PRODUCTION	19	1.1100411	0.33846155	0.7376712	-0.3228518	-2.542934
GO_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	17	-1.4319725	0.072164945	0.14808305	GO_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS	18	0.8696203	0.68066156	1	-0.5623522	-2.3015928
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	c2.CGP_ chemical and genetic perturbations	27	-1.4318036	0.05965909	0.1480763	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	26	-1.0459995	0.34183672	0.6124072	-2.4778031	-0.3858041
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP	C7_ immunologic signatures	180	-1.4313816	0	0.14837883	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP	185	0.9165347	0.7011145	1	-0.5148469	-2.3479163
GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	C7_ immunologic signatures	148	-1.4311161	0	0.1484673	GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	153	0.9248732	0.66530615	1	-0.5062429	-2.3559893
MODY_HIPPOCAMPUS_POSTNATAL	c2.CGP_ chemical and genetic perturbations	59	-1.4309484	0.014285714	0.14846744	MODY_HIPPOCAMPUS_POSTNATAL	59	1.184249	0.21696036	0.6148799	-0.2466994	-2.6151974
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	C7_ immunologic signatures	179	-1.4303417	0	0.14889926	GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	184	0.5594294	1	1	-0.8709123	-1.9897711
GO__DE_NOVO_PROTEIN_FOLDING	c5.BP_ GO biological process	17	-1.4288248	0.08563536	0.15031302	GO__DE_NOVO_PROTEIN_FOLDING	17	-0.7438035	0.8267148	0.9401833	-2.1726283	-0.6850213
GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_DN	C7_ immunologic signatures	178	-1.4280212	0	0.15099676	GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_DN	179	0.7494061	0.9332659	1	-0.6786151	-2.1774273
REACTOME_RNA_POL_III_TRANSCRIPTION	c2.CP_REACTOME_ Reactome gene sets	32	-1.4277023	0.053977273	0.1511487	REACTOME_RNA_POL_III_TRANSCRIPTION	32	-0.8676987	0.72727275	0.85484064	-2.295401	-0.5600036
MODULE_22	c4.CM_ cancer modules	33	-1.4271017	0.061349694	0.15156153	MODULE_22	33	0.94397926	0.56878614	0.9886413	-0.48312244	-2.37108096
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN	C7_ immunologic signatures	166	-1.427053	0.006802721	0.15143387	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN	167	-1.2338761	0	0.34171224	-2.6609291	-0.1931769
GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP	C7_ immunologic signatures	183	-1.4270246	0	0.15127578	GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP	185	-1.620201	0	0.08421182	-3.0472256	0.1931764
GO_CELLULAR_IRON_ION_HOMEOSTASIS	c5.BP_ GO biological process	39	-1.4259686	0.03631285	0.15218948	GO_CELLULAR_IRON_ION_HOMEOSTASIS	39	1.0690935	0.37149534	0.80724293	-0.3568751	-2.4950621
GO_PHOTORECEPTOR_CONNECTING_CILIUM	c5.CC_ GO cellular component	27	-1.4257836	0.059347183	0.15220186	GO_PHOTORECEPTOR_CONNECTING_CILIUM	28	-0.98784834	0.47540984	0.7050641	-2.41363194	-0.43793526
GO_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR	c5.BP_ GO biological process	69	-1.424872	0.013986014	0.15302432	GO_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR	69	-1.0208976	0.4057971	0.6579223	-2.4457696	-0.4039744
LINDSTEDT_DENDRITIC_CELL_MATURATION_D	c2.CGP_ chemical and genetic perturbations	61	-1.4236805	0.013513514	0.15410498	LINDSTEDT_DENDRITIC_CELL_MATURATION_D	63	0.65436816	0.969163	1	-0.76931234	-2.07804866
REACTOME_ACYL_CHAIN_REMODELLING_OF_PC	c2.CP_REACTOME_ Reactome gene sets	18	-1.4232932	0.074666664	0.15433827	REACTOME_ACYL_CHAIN_REMODELLING_OF_PC	22	1.0689299	0.39443743	0.80735105	-0.3543633	-2.4922231
GO_INTRACILIARY_TRANSPORT_PARTICLE	c5.CC_ GO cellular component	29	-1.4230101	0.06306306	0.15448037	GO_INTRACILIARY_TRANSPORT_PARTICLE	29	0.96186954	0.5434243	0.9688462	-0.46114056	-2.38487964
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	c2.CGP_ chemical and genetic perturbations	180	-1.422369	0.005555556	0.15504555	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	182	0.9011136	0.73011076	1	-0.5212554	-2.3234826
GO_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	15	-1.4221876	0.062337663	0.1550588	GO_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS	15	1.1793132	0.250646	0.62376314	-0.2428744	-2.6015008
SHIN_B_CELL_LYMPHOMA_CLUSTER_9	c2.CGP_ chemical and genetic perturbations	15	-1.4221803	0.084033616	0.15489136	SHIN_B_CELL_LYMPHOMA_CLUSTER_9	17	0.6680085	0.91383815	1	-0.7541718	-2.0901888
GSE21033_1H_VS_24H_POLYIC_STIM_DC_DN	C7_ immunologic signatures	143	-1.421915	0	0.15499045	GSE21033_1H_VS_24H_POLYIC_STIM_DC_DN	149	0.7162559	0.9510703	1	-0.7056591	-2.1381709
BROWN_MYELOID_CELL_DEVELOPMENT_DN	c2.CGP_ chemical and genetic perturbations	109	-1.4214872	0.00896861	0.15523829	BROWN_MYELOID_CELL_DEVELOPMENT_DN	113	0.71927243	0.93511844	1	-0.70221477	-2.14075963
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	c2.CP_REACTOME_ Reactome gene sets	87	-1.4213061	0.016949153	0.1552261	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	89	0.7364573	0.9130435	1	-0.6848488	-2.1577634
HALLMARK_ANDROGEN_RESPONSE	H_ hallmark gene sets	91	-1.4204226	0.008547009	0.15595996	HALLMARK_ANDROGEN_RESPONSE	93	0.6478466	0.9723698	1	-0.772576	-2.0682692
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	c2.CP_REACTOME_ Reactome gene sets	113	-1.4203504	0.004830918	0.1558526	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	116	0.94707805	0.6116803	0.98546624	-0.47327235	-2.36742845
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	168	-1.4202853	0	0.15574524	GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	172	0.8091633	0.8869654	1	-0.611122	-2.2294486
WONG_EMBRYONIC_STEM_CELL_CORE	c2.CGP_ chemical and genetic perturbations	317	-1.4200015	0	0.1558842	WONG_EMBRYONIC_STEM_CELL_CORE	318	-1.8320603	0	0.027803339	-3.2520618	0.4120588
GO_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	36	-1.419992	0.036253776	0.15571325	GO_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT	36	0.5941295	0.9639423	1	-0.8258625	-2.0141215
REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	c2.CP_REACTOME_ Reactome gene sets	59	-1.4197903	0.02749141	0.1557471	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	60	-2.2316146	0	0.000624046	-3.6514049	0.8118243
GSE3982_EOSINOPHIL_VS_MAST_CELL_DN	C7_ immunologic signatures	170	-1.4188608	0.012738854	0.15652703	GSE3982_EOSINOPHIL_VS_MAST_CELL_DN	171	0.73717666	0.9494439	1	-0.68168414	-2.15603746
GO_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	383	-1.418026	0	0.1572526	GO_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS	402	0.87387794	0.857	1	-0.54414806	-2.29190394
GO_ENDOCARDIAL_CUSHION_FORMATION	c5.BP_ GO biological process	15	-1.417884	0.080729164	0.15723427	GO_ENDOCARDIAL_CUSHION_FORMATION	15	0.5844396	0.95710456	1	-0.8334444	-2.0023236
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	96	-1.4174924	0.013574661	0.15749924	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	99	1.0382404	0.42259413	0.86141795	-0.379252	-2.4557328
GO_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR	c5.BP_ GO biological process	31	-1.4159217	0.065476194	0.15900101	GO_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR	31	-0.78028244	0.8742515	0.92134875	-2.19620414	-0.63563926
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	C7_ immunologic signatures	169	-1.4158316	0	0.15893218	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	173	-1.6358508	0	0.07778871	-3.0516824	0.2200192
TOMLINS_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	17	-1.4149961	0.08638743	0.1596803	TOMLINS_METASTASIS_DN	17	0.8365401	0.68133336	1	-0.578456	-2.2515362
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	c2.CGP_ chemical and genetic perturbations	86	-1.4143586	0.008658009	0.16013046	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	88	0.64175904	0.982851	1	-0.77259956	-2.05611764
GO_PRECATALYTIC_SPLICEOSOME	c5.CC_ GO cellular component	19	-1.4135445	0.07486631	0.16086175	GO_PRECATALYTIC_SPLICEOSOME	19	-1.4757398	0.038961038	0.1570839	-2.8892843	0.0621953
GO_THIOESTER_METABOLIC_PROCESS	c5.BP_ GO biological process	72	-1.4128283	0.02745098	0.16141507	GO_THIOESTER_METABOLIC_PROCESS	75	0.77227944	0.8652174	1	-0.64054886	-2.18510774
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	176	-1.4121122	0	0.16201088	GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_UP	175	-0.8471716	0.9230769	0.87083095	-2.2592838	-0.5649406
GSE22886_IL2_VS_IL15_STIM_NKCELL_DN	C7_ immunologic signatures	164	-1.4116839	0.005524862	0.1623284	GSE22886_IL2_VS_IL15_STIM_NKCELL_DN	164	-0.80952317	1	0.8969249	-2.22120707	-0.60216073
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	C7_ immunologic signatures	171	-1.4113027	0.005988024	0.16255067	GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	178	0.84338474	0.84412956	1	-0.56791796	-2.25468744
MODULE_357	c4.CM_ cancer modules	58	-1.4112272	0.014492754	0.16243808	MODULE_357	62	1.7376242	0	0.06581151	0.326397	-3.1488514
GO_BASAL_TRANSCRIPTION_MACHINERY_BINDING	c5.GO molecular function	21	-1.4105691	0.05970149	0.16302222	GO_BASAL_TRANSCRIPTION_MACHINERY_BINDING	21	-0.71522844	0.8986175	0.9527451	-2.12579754	-0.69534066
GO_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	152	-1.410329	0	0.16309948	GO_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY	164	1.24521	0.06530612	0.5189582	-0.165119	-2.655539
GO_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY	c5.GO molecular function	45	-1.4088978	0.028571429	0.16454585	GO_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY	45	-0.72679967	0.9745763	0.9484697	-2.13569747	-0.68209813
WU_CELL_MIGRATION	c2.CGP_ chemical and genetic perturbations	151	-1.4087026	0.00591716	0.16458133	WU_CELL_MIGRATION	161	1.4656966	0.002030457	0.27940178	0.056994	-2.8743992
GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN	C7_ immunologic signatures	144	-1.4083103	0	0.16486752	GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN	154	0.7696519	0.9247202	1	-0.6386584	-2.1779622
GO_PROTEIN_LOCALIZATION_TO_MEMBRANE	c5.BP_ GO biological process	331	-1.4079214	0	0.16511591	GO_PROTEIN_LOCALIZATION_TO_MEMBRANE	330	0.8186746	0.9218437	1	-0.5892468	-2.226596
GO_PROSTANOID_METABOLIC_PROCESS	c5.BP_ GO biological process	22	-1.4072295	0.06738544	0.16570029	GO_PROSTANOID_METABOLIC_PROCESS	23	1.5298795	0.012406948	0.22151315	0.12265	-2.937109
GO_RNA_SECONDARY_STRUCTURE_UNWINDING	c5.BP_ GO biological process	37	-1.4068954	0.048850574	0.16584726	GO_RNA_SECONDARY_STRUCTURE_UNWINDING	37	-1.4847654	0.03816794	0.1517104	-2.8916608	0.07787
GO_MITOCHONDRIAL_TRANSPORT	c5.BP_ GO biological process	136	-1.40678	0.004878049	0.16576669	GO_MITOCHONDRIAL_TRANSPORT	137	0.6653585	0.9805128	1	-0.7414215	-2.0721385
CHR10Q23	C1: positional gene sets	63	-1.4059689	0.01923077	0.16650556	CHR10Q23	66	0.8310709	0.77826566	1	-0.574898	-2.2370398
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	c2.CGP_ chemical and genetic perturbations	32	-1.4052715	0.061433446	0.16712825	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	34	1.5493044	0.007058824	0.20598276	0.1440329	-2.9545759
GSE6269_FLU_VS_E_COLI_INF_PBMC_DN	C7_ immunologic signatures	115	-1.4049175	0.004608295	0.16736718	GSE6269_FLU_VS_E_COLI_INF_PBMC_DN	127	1.159044	0.18022656	0.65444523	-0.2458735	-2.5639615
GO_IRON_ION_HOMEOSTASIS	c5.BP_ GO biological process	60	-1.4039683	0.03180212	0.16831847	GO_IRON_ION_HOMEOSTASIS	61	1.2373581	0.13861386	0.5299652	-0.1666102	-2.6413264
GO_RECEPTOR_CATABOLIC_PROCESS	c5.BP_ GO biological process	16	-1.4035108	0.088541664	0.16861597	GO_RECEPTOR_CATABOLIC_PROCESS	16	0.88677496	0.64933336	1	-0.51673584	-2.29028576
GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP	C7_ immunologic signatures	110	-1.4029286	0.025252525	0.16906476	GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP	116	1.0206326	0.45898235	0.8910828	-0.382296	-2.4235612
GSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN	C7_ immunologic signatures	182	-1.4017223	0	0.17030993	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN	182	1.2846227	0.035282258	0.46441746	-0.1170996	-2.686345
GO_REGULATION_OF_RNA_SPLICING	c5.BP_ GO biological process	87	-1.4015226	0	0.17038709	GO_REGULATION_OF_RNA_SPLICING	90	-0.9141815	0.73770493	0.80226225	-2.3157041	-0.4873411
GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	170	-1.4006414	0	0.17126247	GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN	172	0.6714219	0.97160244	1	-0.7292195	-2.0720633
HALLMARK_FATTY_ACID_METABOLISM	H_ hallmark gene sets	145	-1.4002806	0.011111111	0.17147988	HALLMARK_FATTY_ACID_METABOLISM	146	0.7810461	0.8994872	1	-0.6192345	-2.1813267
TOMIDA_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	25	-1.4001644	0.053097345	0.17143495	TOMIDA_METASTASIS_UP	25	0.85579395	0.6920245	1	-0.54437045	-2.25595835
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP	C7_ immunologic signatures	159	-1.3999602	0	0.1714751	GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP	160	1.2327988	0.07995951	0.5364957	-0.1671614	-2.632759
GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP	C7_ immunologic signatures	168	-1.399867	0.005291005	0.17139913	GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP	172	0.8655798	0.79313827	1	-0.5342872	-2.2654468
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN	C7_ immunologic signatures	174	-1.3992198	0.006802721	0.17190598	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN	180	0.9003094	0.7316583	1	-0.4989104	-2.2995292
MODULE_275	c4.CM_ cancer modules	16	-1.3992023	0.08695652	0.1717327	MODULE_275	16	1.1698085	0.28292048	0.63865215	-0.2293938	-2.5690108
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	c2.CGP_ chemical and genetic perturbations	76	-1.3989317	0.021008404	0.17184693	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	76	0.7908024	0.8394004	1	-0.6081293	-2.1897341
GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP	C7_ immunologic signatures	129	-1.3983886	0.013636364	0.17232366	GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP	132	1.224902	0.09700722	0.5489964	-0.1734866	-2.6232906
MODULE_223	c4.CM_ cancer modules	110	-1.3983848	0.013157895	0.17214002	MODULE_223	117	1.0413516	0.41649485	0.8570006	-0.3570332	-2.4397364
GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP	C7_ immunologic signatures	172	-1.3976939	0.006802721	0.17279929	GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP	176	-1.9021428	0	0.017546006	-3.2998367	0.5044489
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	c2.CGP_ chemical and genetic perturbations	20	-1.3974926	0.07799443	0.17283653	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	23	-0.8318271	0.72511846	0.88075125	-2.2293197	-0.5656655
GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP	C7_ immunologic signatures	158	-1.3973569	0.011299435	0.17280458	GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP	157	1.1168382	0.24387754	0.72857827	-0.2805187	-2.5141951
GO_RNA_3_END_PROCESSING	c5.BP_ GO biological process	90	-1.3971037	0.01843318	0.1729267	GO_RNA_3_END_PROCESSING	91	-1.9798076	0	0.009798914	-3.3769113	0.5827039
GO_WIDE_PORE_CHANNEL_ACTIVITY	c5.GO molecular function	21	-1.3970405	0.06887052	0.17282109	GO_WIDE_PORE_CHANNEL_ACTIVITY	22	-1.4282161	0.035532996	0.18878847	-2.8252566	0.0311756
REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING	c2.CP_REACTOME_ Reactome gene sets	38	-1.396968	0.041401275	0.17273523	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING	38	-1.5881493	0.027586207	0.09473839	-2.9851173	0.1911813
BENPORATH_MYC_TARGETS_WITH_EBOX	c2.CGP_ chemical and genetic perturbations	195	-1.3964442	0.013422819	0.17313725	BENPORATH_MYC_TARGETS_WITH_EBOX	201	0.7107358	0.9657258	1	-0.6857084	-2.10718
LEE_INTRATHYMIC_T_PROGENITOR	c2.CGP_ chemical and genetic perturbations	15	-1.3960918	0.09660574	0.17337397	LEE_INTRATHYMIC_T_PROGENITOR	16	0.7516605	0.8051282	1	-0.6444313	-2.1477523
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	c2.CGP_ chemical and genetic perturbations	120	-1.395018	0.01	0.1744202	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	120	-0.95728445	0.59574467	0.7463401	-2.35230245	-0.43773355
REACTOME_RNA_POL_II_TRANSCRIPTION	c2.CP_REACTOME_ Reactome gene sets	90	-1.3946922	0.013274336	0.17461339	REACTOME_RNA_POL_II_TRANSCRIPTION	90	-2.1231387	0	0.00213445	-3.5178309	0.7284465
GO_POTASSIUM_CHANNEL_ACTIVITY	c5.GO molecular function	95	-1.3945671	0.025	0.17455935	GO_POTASSIUM_CHANNEL_ACTIVITY	114	1.2500278	0.09034268	0.5107249	-0.1445393	-2.6445949
TONG_INTERACT_WITH_PTTG1	c2.CGP_ chemical and genetic perturbations	46	-1.3944848	0.04658385	0.17447203	TONG_INTERACT_WITH_PTTG1	46	0.9111395	0.64685714	1	-0.4833453	-2.3056243
GO_SMALL_MOLECULE_CATABOLIC_PROCESS	c5.BP_ GO biological process	294	-1.3936068	0	0.17530659	GO_SMALL_MOLECULE_CATABOLIC_PROCESS	303	1.1754321	0.075075075	0.6283836	-0.2181747	-2.5690389
GO_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT	c5.BP_ GO biological process	27	-1.3925447	0.065902576	0.17644596	GO_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT	27	0.97304	0.5197531	0.9578585	-0.4195047	-2.3655847
GO_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION	c5.BP_ GO biological process	24	-1.3918983	0.042735044	0.17700727	GO_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION	24	-1.3870202	0.08597285	0.2151666	-2.7789185	-0.0048781
GO_PROTEIN_LOCALIZATION_TO_ORGANELLE	c5.BP_ GO biological process	475	-1.3909956	0	0.17788956	GO_PROTEIN_LOCALIZATION_TO_ORGANELLE	475	0.70126015	0.998999	1	-0.68973545	-2.09225575
GO_CELLULAR_KETONE_METABOLIC_PROCESS	c5.BP_ GO biological process	53	-1.3909811	0.0528169	0.17771742	GO_CELLULAR_KETONE_METABOLIC_PROCESS	54	1.072967	0.3715909	0.80077577	-0.3180141	-2.4639481
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	c2.CGP_ chemical and genetic perturbations	21	-1.3909206	0.05865922	0.17760204	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	21	1.3728312	0.074165635	0.36364868	-0.0180894	-2.7637518
GO_POLY_PURINE_TRACT_BINDING	c5.GO molecular function	18	-1.3907672	0.07105263	0.17761436	GO_POLY_PURINE_TRACT_BINDING	18	0.96954906	0.5215124	0.9618522	-0.42121814	-2.36031626
GO_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION	c5.BP_ GO biological process	26	-1.3906194	0.064327486	0.17760123	GO_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION	28	0.91183895	0.6130592	1	-0.47878045	-2.30245835
KIM_HYPOXIA	c2.CGP_ chemical and genetic perturbations	24	-1.3905624	0.07584269	0.17747603	KIM_HYPOXIA	24	0.97802395	0.52135676	0.9516374	-0.41253845	-2.36858635
KEGG_PURINE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	142	-1.3904312	0.01183432	0.17743252	KEGG_PURINE_METABOLISM	143	0.7850207	0.88612837	1	-0.6054105	-2.1754519
GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN	C7_ immunologic signatures	130	-1.38984	0.009852217	0.17789422	GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN	131	0.75520384	0.92937565	1	-0.63463616	-2.14504384
GO_ISOPRENOID_BINDING	c5.GO molecular function	31	-1.3890625	0.05414013	0.17859383	GO_ISOPRENOID_BINDING	33	1.2648304	0.14235294	0.4907742	-0.1242321	-2.6538929
GO_TRANSLATION_INITIATION_FACTOR_BINDING	c5.GO molecular function	24	-1.3888997	0.08454811	0.1785867	GO_TRANSLATION_INITIATION_FACTOR_BINDING	25	-1.4879253	0.027472528	0.15041868	-2.876825	0.0990256
GO_MUSCLE_CELL_MIGRATION	c5.BP_ GO biological process	17	-1.3881165	0.07945205	0.17938387	GO_MUSCLE_CELL_MIGRATION	18	0.9444785	0.5613577	0.9876844	-0.443638	-2.332595
SHIPP_DLBCL_CURED_VS_FATAL_DN	c2.CGP_ chemical and genetic perturbations	40	-1.387581	0.03164557	0.17983282	SHIPP_DLBCL_CURED_VS_FATAL_DN	40	1.0477859	0.4032634	0.84381425	-0.3397951	-2.4353669
LI_WILMS_TUMOR	c2.CGP_ chemical and genetic perturbations	20	-1.3874208	0.09090909	0.17984506	LI_WILMS_TUMOR	22	0.9235522	0.5883807	1	-0.4638686	-2.310973
GO_PROTEIN_COMPLEX_LOCALIZATION	c5.BP_ GO biological process	50	-1.3865566	0.045296166	0.18075244	GO_PROTEIN_COMPLEX_LOCALIZATION	50	0.656018	0.9474886	1	-0.7305386	-2.0425746
MYC_Q2	c3.TFT_ transcription factor targets	162	-1.3864211	0	0.18072492	MYC_Q2	167	0.92723894	0.6864754	1	-0.45918216	-2.31366004
GO_CELL_REDOX_HOMEOSTASIS	c5.BP_ GO biological process	56	-1.3859689	0.041666668	0.18111789	GO_CELL_REDOX_HOMEOSTASIS	57	-0.69680494	0.99115044	0.9618979	-2.08277384	-0.68916396
YE_METASTATIC_LIVER_CANCER	c2.CGP_ chemical and genetic perturbations	21	-1.3854393	0.07853403	0.18159002	YE_METASTATIC_LIVER_CANCER	22	0.83401954	0.7174178	1	-0.55141976	-2.21945884
GO_LEUKOCYTE_MIGRATION	c5.BP_ GO biological process	200	-1.3848467	0.006410257	0.18210298	GO_LEUKOCYTE_MIGRATION	219	1.237267	0.046277665	0.52995867	-0.1475797	-2.6221137
REACTOME_MEMBRANE_TRAFFICKING	c2.CP_REACTOME_ Reactome gene sets	112	-1.3837504	0.004694836	0.18327068	REACTOME_MEMBRANE_TRAFFICKING	114	0.8564482	0.79050565	1	-0.5273022	-2.2401986
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN	C7_ immunologic signatures	165	-1.3836547	0	0.18318905	GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN	169	0.8729539	0.80223125	1	-0.5107008	-2.2566086
GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN	C7_ immunologic signatures	170	-1.3833047	0.006410257	0.18341202	GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN	168	0.63423145	0.9908257	1	-0.74907325	-2.01753615
CHR2P22	C1: positional gene sets	34	-1.3830571	0.05414013	0.18352188	CHR2P22	35	-0.85629874	0.7152318	0.86305785	-2.23935584	-0.52675836
MODULE_93	c4.CM_ cancer modules	156	-1.3820745	0.021582734	0.18447916	MODULE_93	159	1.105557	0.25614753	0.74636936	-0.2765175	-2.4876315
HALLMARK_UNFOLDED_PROTEIN_RESPONSE	H_ hallmark gene sets	106	-1.3820693	0.004237288	0.18429656	HALLMARK_UNFOLDED_PROTEIN_RESPONSE	106	-1.420021	0	0.19410509	-2.8020903	0.0379517
GO_LEUKOCYTE_CHEMOTAXIS	c5.BP_ GO biological process	76	-1.3819214	0.03265306	0.18428674	GO_LEUKOCYTE_CHEMOTAXIS	86	1.2512698	0.107368425	0.508635	-0.1306516	-2.6331912
GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP	C7_ immunologic signatures	175	-1.3815386	0	0.1845783	GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP	183	0.69461167	0.97168857	1	-0.68692693	-2.07615027
GO_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	115	-1.381277	0.018018018	0.18472148	GO_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY	125	1.0865436	0.32024795	0.7755126	-0.2947334	-2.4678206
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	c2.CGP_ chemical and genetic perturbations	40	-1.381258	0.05970149	0.18455184	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	41	-1.1320096	0.23076923	0.46867478	-2.5132676	-0.2492484
REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE	c2.CP_REACTOME_ Reactome gene sets	48	-1.380945	0.05	0.18474737	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE	49	-1.6212052	0	0.08374808	-3.0021502	0.2402602
GO_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS	c5.BP_ GO biological process	48	-1.3808678	0.051903114	0.18464267	GO_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS	47	-0.9349868	0.62184876	0.778374	-2.3158546	-0.445881
BURTON_ADIPOGENESIS_6	c2.CGP_ chemical and genetic perturbations	173	-1.380761	0.01183432	0.18458523	BURTON_ADIPOGENESIS_6	174	-1.0018433	0.6	0.6824795	-2.3826043	-0.3789177
FARDIN_HYPOXIA_11	c2.CGP_ chemical and genetic perturbations	30	-1.380072	0.071207434	0.1852356	FARDIN_HYPOXIA_11	30	0.8673398	0.6698113	1	-0.5127322	-2.2474118
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_UP	C7_ immunologic signatures	157	-1.3795824	0	0.18563145	GSE21670_STAT3_KO_VS_WT_CD4_TCELL_UP	162	1.3160621	0.031408306	0.4163665	-0.0635203	-2.6956445
GO_REGULATION_OF_CLATHRIN_MEDIATED_ENDOCYTOSIS	c5.BP_ GO biological process	15	-1.3795358	0.10103627	0.18550037	GO_REGULATION_OF_CLATHRIN_MEDIATED_ENDOCYTOSIS	16	1.0323722	0.4228792	0.87274593	-0.3471636	-2.411908
GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	C7_ immunologic signatures	174	-1.3794484	0	0.1854198	GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	174	0.99097705	0.5379171	0.93446416	-0.38847135	-2.37042545
GO_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	434	-1.37914	0	0.18563537	GO_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS	444	1.075558	0.239	0.79509413	-0.303582	-2.454698
GO_RNA_HELICASE_ACTIVITY	c5.GO molecular function	62	-1.3788896	0.032608695	0.18575852	GO_RNA_HELICASE_ACTIVITY	63	-0.98836887	0.4431818	0.70536053	-2.36725847	-0.39052073
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN	C7_ immunologic signatures	154	-1.3787844	0.005681818	0.18570419	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN	162	1.241347	0.06477733	0.52350706	-0.1374374	-2.6201314
EIF4E_UP	C6_ oncogenic signatures	83	-1.378528	0.023166023	0.18579856	EIF4E_UP	83	0.71067435	0.92879915	1	-0.66785365	-2.08920235
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP	C7_ immunologic signatures	167	-1.37821	0.00621118	0.18602398	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP	172	0.9591403	0.61178863	0.97121483	-0.4190697	-2.3373503
HOUSTIS_ROS	c2.CGP_ chemical and genetic perturbations	31	-1.3779153	0.08529412	0.18618535	HOUSTIS_ROS	30	0.9648048	0.5311751	0.9654089	-0.4131105	-2.3427201
REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21	c2.CP_REACTOME_ Reactome gene sets	50	-1.3773301	0.039473683	0.18671754	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21	50	-1.8719615	0	0.021259697	-3.2492916	0.4946314
GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	C7_ immunologic signatures	180	-1.3761705	0.005952381	0.18798402	GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	178	0.90887415	0.7023209	1	-0.46729635	-2.28504465
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP	C7_ immunologic signatures	116	-1.3756981	0.009569378	0.18839452	GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP	119	0.8883293	0.7252862	1	-0.4873688	-2.2640274
GO_DIGESTIVE_SYSTEM_PROCESS	c5.BP_ GO biological process	48	-1.3756385	0.057507988	0.18827675	GO_DIGESTIVE_SYSTEM_PROCESS	54	0.87840885	0.68357223	1	-0.49722965	-2.25404735
GO_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	17	-1.3754592	0.0867347	0.18827647	GO_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS	16	0.51392865	0.98598725	1	-0.86153055	-1.88938785
GO_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION	c5.BP_ GO biological process	16	-1.3753152	0.07853403	0.18824074	GO_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION	22	1.6137068	0.011349306	0.1461118	0.2383916	-2.989022
GO_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	100	-1.3745255	0.019900497	0.1890343	GO_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY	105	1.1131097	0.27320126	0.7329883	-0.2614158	-2.4876352
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	c2.CGP_ chemical and genetic perturbations	37	-1.3742126	0.042813454	0.18919164	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	37	-1.2470676	0.12650603	0.3260827	-2.6212802	-0.127145
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP	C7_ immunologic signatures	179	-1.3735449	0.00729927	0.18982899	GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP	181	0.770682	0.9188641	1	-0.6028629	-2.1442269
MORF_PRKDC	c4.CGN_ cancer gene neighborhoods	176	-1.3734622	0	0.1897686	MORF_PRKDC	177	-2.2146862	0	0.000793904	-3.5881484	0.841224
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	c2.CGP_ chemical and genetic perturbations	69	-1.3728756	0.027888447	0.19030525	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	70	0.79262006	0.83063644	1	-0.58025554	-2.16549566
GO_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION	c5.BP_ GO biological process	21	-1.3726363	0.04973822	0.19041722	GO_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION	19	0.6174884	0.93147206	1	-0.7551479	-1.9901247
GSE22886_NAIVE_TCELL_VS_NKCELL_UP	C7_ immunologic signatures	164	-1.3719456	0	0.19106102	GSE22886_NAIVE_TCELL_VS_NKCELL_UP	168	0.83548486	0.8615071	1	-0.53646074	-2.20743046
GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	C7_ immunologic signatures	169	-1.371542	0	0.19137675	GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	171	0.9105101	0.70374113	1	-0.4610319	-2.2820521
GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN	C7_ immunologic signatures	170	-1.371532	0.00617284	0.19119316	GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN	171	-0.9452079	0.6666667	0.7622354	-2.3167399	-0.4263241
KIM_ALL_DISORDERS_DURATION_CORR_DN	c2.CGP_ chemical and genetic perturbations	132	-1.3713601	0.005747126	0.19125012	KIM_ALL_DISORDERS_DURATION_CORR_DN	133	0.6048128	0.9948507	1	-0.7665473	-1.9761729
GO_COFACTOR_TRANSPORTER_ACTIVITY	c5.GO molecular function	21	-1.3713241	0.086592175	0.1910982	GO_COFACTOR_TRANSPORTER_ACTIVITY	21	1.2361548	0.17293233	0.531477	-0.1351693	-2.6074789
PRAMOONJAGO_SOX4_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	48	-1.3711846	0.049833886	0.19107324	PRAMOONJAGO_SOX4_TARGETS_DN	48	0.68020034	0.92146015	1	-0.69098426	-2.05138494
GO_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING	c5.BP_ GO biological process	31	-1.370967	0.07272727	0.19114217	GO_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING	31	0.6642304	0.9228944	1	-0.7067366	-2.0351974
SWEET_LUNG_CANCER_KRAS_UP	c2.CGP_ chemical and genetic perturbations	426	-1.370894	0	0.19103527	SWEET_LUNG_CANCER_KRAS_UP	437	0.8525512	0.9029029	1	-0.5183428	-2.2234452
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	c2.CGP_ chemical and genetic perturbations	119	-1.3707037	0.004854369	0.1910705	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	119	0.94372404	0.6219008	0.9886691	-0.42697966	-2.31442774
MORF_RAB5A	c4.CGN_ cancer gene neighborhoods	89	-1.3703959	0.026086956	0.19124833	MORF_RAB5A	89	-0.8817136	0.90909094	0.8421218	-2.2521095	-0.4886823
GO_OUTER_MEMBRANE	c5.CC_ GO cellular component	160	-1.3691183	0	0.19267924	GO_OUTER_MEMBRANE	163	0.76574117	0.9187817	1	-0.60337713	-2.13485947
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	c2.CGP_ chemical and genetic perturbations	19	-1.3687651	0.082051285	0.19292867	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	21	1.2308167	0.19949174	0.5388187	-0.1379484	-2.5995818
BIOCARTA_EIF_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	-1.3684845	0.107238606	0.1930648	BIOCARTA_EIF_PATHWAY	16	-1.102085	0.3102041	0.51340675	-2.4705695	-0.2663995
GO_RESPONSE_TO_MAGNESIUM_ION	c5.BP_ GO biological process	20	-1.3683425	0.079889804	0.19306234	GO_RESPONSE_TO_MAGNESIUM_ION	22	1.6318704	0.008728179	0.13167514	0.2635279	-3.0002129
GSE7852_LN_VS_THYMUS_TCONV_UP	C7_ immunologic signatures	169	-1.3674588	0	0.19396792	GSE7852_LN_VS_THYMUS_TCONV_UP	171	1.1262196	0.2305359	0.712315	-0.2412392	-2.4936784
ABRAMSON_INTERACT_WITH_AIRE	c2.CGP_ chemical and genetic perturbations	41	-1.3673623	0.05	0.19390088	ABRAMSON_INTERACT_WITH_AIRE	41	-1.9570645	0	0.01158128	-3.3244268	0.5897022
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	c2.CGP_ chemical and genetic perturbations	24	-1.3670652	0.086592175	0.19409116	CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	26	0.7972461	0.76642334	1	-0.5698191	-2.1643113
GO_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	36	-1.3668799	0.06185567	0.19412059	GO_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	42	1.0620344	0.3986095	0.81914335	-0.3048455	-2.4289143
REACTOME_UNFOLDED_PROTEIN_RESPONSE	c2.CP_REACTOME_ Reactome gene sets	70	-1.366815	0.045936394	0.1940025	REACTOME_UNFOLDED_PROTEIN_RESPONSE	70	-1.422038	0.011494253	0.19244969	-2.788853	0.055223
GSE13411_NAIVE_VS_MEMORY_BCELL_DN	C7_ immunologic signatures	170	-1.3667822	0	0.19385509	GSE13411_NAIVE_VS_MEMORY_BCELL_DN	174	0.590863	0.9969697	1	-0.7759192	-1.9576452
GNF2_HCK	c4.CGN_ cancer gene neighborhoods	72	-1.3667139	0.025089607	0.19373399	GNF2_HCK	73	0.9204927	0.6339093	1	-0.4462212	-2.2872066
MORF_UBE2A	c4.CGN_ cancer gene neighborhoods	45	-1.3665993	0.04307692	0.1936786	MORF_UBE2A	45	-1.0215068	0.34313726	0.6571457	-2.3881061	-0.3450925
GO_UNFOLDED_PROTEIN_BINDING	c5.GO molecular function	84	-1.366477	0.03508772	0.19366425	GO_UNFOLDED_PROTEIN_BINDING	84	0.67122716	0.9450317	1	-0.69524984	-2.03770416
GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP	C7_ immunologic signatures	177	-1.3660219	0.005649718	0.1940552	GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP	177	1.4100806	0.002034588	0.3256503	0.0440587	-2.7761025
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	c2.CP_REACTOME_ Reactome gene sets	23	-1.3652931	0.104395606	0.19477835	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	22	0.88930887	0.64826703	1	-0.47598423	-2.25460197
HALLMARK_CHOLESTEROL_HOMEOSTASIS	H_ hallmark gene sets	71	-1.3643665	0.048582997	0.19583964	HALLMARK_CHOLESTEROL_HOMEOSTASIS	71	0.80353904	0.8099352	1	-0.56082746	-2.16790554
DAZARD_UV_RESPONSE_CLUSTER_G1	c2.CGP_ chemical and genetic perturbations	55	-1.3639574	0.049833886	0.19614743	DAZARD_UV_RESPONSE_CLUSTER_G1	54	0.776397	0.84044945	1	-0.5875604	-2.1403544
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	181	-1.3639477	0.007407407	0.19597317	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN	184	-1.0221971	0.35714287	0.65612173	-2.3861448	-0.3417506
NGO_MALIGNANT_GLIOMA_1P_LOH	c2.CGP_ chemical and genetic perturbations	16	-1.3634732	0.10497238	0.19638267	NGO_MALIGNANT_GLIOMA_1P_LOH	16	-1.5257536	0.05078125	0.12719285	-2.8892268	0.1622804
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR	c5.GO molecular function	33	-1.3634385	0.058641974	0.19623792	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR	37	1.0925676	0.35509735	0.7684193	-0.2708709	-2.4560061
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	160	-1.3632653	0	0.19626005	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP	169	1.1650537	0.15086646	0.64605844	-0.1982116	-2.528319
GCM_SMARCC1	c4.CGN_ cancer gene neighborhoods	33	-1.3632478	0.06051873	0.19609682	GCM_SMARCC1	33	-1.6179029	0.028571429	0.08492239	-2.9811507	0.2546551
ELVIDGE_HIF1A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	61	-1.363078	0.04511278	0.19612052	ELVIDGE_HIF1A_TARGETS_UP	61	-1.0023583	0.43209878	0.6811999	-2.3654363	-0.3607197
GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP	C7_ immunologic signatures	171	-1.362828	0.007246377	0.19625425	GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP	171	-1.7311329	0	0.048026577	-3.0939609	0.3683049
GSE17721_0.5H_VS_12H_LPS_BMDC_UP	C7_ immunologic signatures	168	-1.3625475	0.005988024	0.19642846	GSE17721_0.5H_VS_12H_LPS_BMDC_UP	175	0.7359705	0.9455096	1	-0.626577	-2.098518
GO_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN	c5.BP_ GO biological process	111	-1.3616378	0.01724138	0.19745843	GO_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN	110	-1.2283341	0.12	0.34739095	-2.5899719	-0.1333037
GO_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX	c5.CC_ GO cellular component	69	-1.3614843	0.033962265	0.19746222	GO_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX	69	-1.2445018	0.10958904	0.3294544	-2.6059861	-0.1169825
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	162	-1.3603523	0.005586592	0.19873919	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP	167	-1.0275655	0.23076923	0.64398855	-2.3879178	-0.3327868
GO_RNA_METHYLTRANSFERASE_ACTIVITY	c5.GO molecular function	35	-1.3592256	0.08529412	0.20003515	GO_RNA_METHYLTRANSFERASE_ACTIVITY	36	-0.8113558	0.8072289	0.8957738	-2.1705814	-0.5478698
MODULE_299	c4.CM_ cancer modules	33	-1.359218	0.06818182	0.19984737	MODULE_299	33	0.8610004	0.6875	1	-0.4982176	-2.2202184
GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP	C7_ immunologic signatures	171	-1.3587612	0.005555556	0.20029798	GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP	173	0.8466044	0.8160569	1	-0.5121568	-2.2053656
GO_GRANULOCYTE_MIGRATION	c5.BP_ GO biological process	44	-1.3583114	0.05154639	0.20068032	GO_GRANULOCYTE_MIGRATION	50	1.3340929	0.07821229	0.3992209	-0.0242185	-2.6924043
GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP	C7_ immunologic signatures	183	-1.3580929	0.005988024	0.20078863	GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP	186	0.87299937	0.78760165	1	-0.48509353	-2.23109227
GO_TRANSITION_METAL_ION_HOMEOSTASIS	c5.BP_ GO biological process	93	-1.357232	0.009174312	0.2017175	GO_TRANSITION_METAL_ION_HOMEOSTASIS	94	1.1483934	0.23294859	0.6707925	-0.2088386	-2.5056254
ABE_VEGFA_TARGETS_30MIN	c2.CGP_ chemical and genetic perturbations	26	-1.3565313	0.07121662	0.2024535	ABE_VEGFA_TARGETS_30MIN	26	1.2141498	0.18697226	0.56966007	-0.1423815	-2.5706811
REACTOME_DEADENYLATION_OF_MRNA	c2.CP_REACTOME_ Reactome gene sets	17	-1.3562856	0.11733333	0.20259897	REACTOME_DEADENYLATION_OF_MRNA	17	-0.98095345	0.47863248	0.7124636	-2.33723905	-0.37533215
GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN	C7_ immunologic signatures	173	-1.3553402	0.006711409	0.20369568	GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN	179	1.1224878	0.21897073	0.7211291	-0.2328524	-2.477828
GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP	C7_ immunologic signatures	180	-1.3552299	0.008130081	0.20362939	GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP	184	-1.3800616	0	0.21983239	-2.7352915	0.0248317
GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP	C7_ immunologic signatures	185	-1.3546218	0.006622517	0.20425004	GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP	186	1.0693502	0.32930514	0.8066899	-0.2852716	-2.423972
DAIRKEE_TERT_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	312	-1.3540342	0	0.20482947	DAIRKEE_TERT_TARGETS_UP	313	0.7903741	0.9539078	1	-0.5636601	-2.1444083
GO_ALDITOL_METABOLIC_PROCESS	c5.BP_ GO biological process	15	-1.3530995	0.08938547	0.2058117	GO_ALDITOL_METABOLIC_PROCESS	17	0.65323776	0.9235751	1	-0.69986174	-2.00633726
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	c2.CGP_ chemical and genetic perturbations	19	-1.3530158	0.11320755	0.20572713	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	19	0.64520305	0.90166026	1	-0.70781275	-1.99821885
GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP	C7_ immunologic signatures	160	-1.352709	0.01898734	0.20597483	GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP	169	0.8212148	0.85222673	1	-0.5314942	-2.1739238
PID_S1P_S1P1_PATHWAY	c2.CP_ Canonical pathways	21	-1.3524107	0.09366391	0.2061668	PID_S1P_S1P1_PATHWAY	21	1.2146785	0.20662251	0.56789094	-0.1377322	-2.5670892
SIRNA_EIF4GI_UP	C6_ oncogenic signatures	81	-1.3524013	0.026548672	0.20598042	SIRNA_EIF4GI_UP	82	1.0470021	0.43114406	0.84486395	-0.3053992	-2.3994034
MODULE_155	c4.CM_ cancer modules	23	-1.3523434	0.09770115	0.20585874	MODULE_155	23	-0.847815	0.70046085	0.8702888	-2.2001584	-0.5045284
MODULE_307	c4.CM_ cancer modules	24	-1.3519725	0.08963586	0.20616443	MODULE_307	24	0.677544	0.90774906	1	-0.6744285	-2.0295165
KOINUMA_COLON_CANCER_MSI_UP	c2.CGP_ chemical and genetic perturbations	16	-1.351783	0.09615385	0.2062214	KOINUMA_COLON_CANCER_MSI_UP	16	1.2389848	0.17952128	0.52658546	-0.1127982	-2.5907678
GO_CELLULAR_METABOLIC_COMPOUND_SALVAGE	c5.BP_ GO biological process	34	-1.3516737	0.08116883	0.20614874	GO_CELLULAR_METABOLIC_COMPOUND_SALVAGE	34	-0.81931907	0.79285717	0.89048845	-2.17099277	-0.53235463
GO_T_CELL_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	124	-1.3515878	0	0.2060662	GO_T_CELL_RECEPTOR_SIGNALING_PATHWAY	128	1.0081705	0.4746639	0.9112641	-0.3434173	-2.3597583
GO_PHARYNGEAL_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	16	-1.3513237	0.116883114	0.20623766	GO_PHARYNGEAL_SYSTEM_DEVELOPMENT	16	-1.2208338	0.21370968	0.35451967	-2.5721575	-0.1304899
GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN	C7_ immunologic signatures	108	-1.350995	0.010050251	0.20647667	GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN	120	0.93725747	0.627572	0.99320173	-0.41373753	-2.28825247
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	23	-1.3503633	0.1	0.20705004	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	25	1.148965	0.25834364	0.67000645	-0.2013983	-2.4993283
GO_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE	c5.BP_ GO biological process	298	-1.3501601	0	0.207109	GO_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE	309	1.0234771	0.424	0.8856958	-0.326683	-2.3736372
CHRXP22	C1: positional gene sets	76	-1.3501241	0.03875969	0.20695873	CHRXP22	82	1.7502302	0	0.06455081	0.4001061	-3.1003543
VERHAAK_GLIOBLASTOMA_MESENCHYMAL	c2.CGP_ chemical and genetic perturbations	194	-1.349115	0	0.2080954	VERHAAK_GLIOBLASTOMA_MESENCHYMAL	195	1.3364031	0.015120967	0.3978816	-0.0127119	-2.6855181
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	c2.CGP_ chemical and genetic perturbations	19	-1.3489778	0.093294464	0.20809436	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	19	0.8251974	0.7197452	1	-0.5237804	-2.1741752
GO_GAP_JUNCTION	c5.CC_ GO cellular component	25	-1.3487499	0.09195402	0.20821916	GO_GAP_JUNCTION	27	-1.2850822	0.10714286	0.2974634	-2.6338321	-0.0636677
GO_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	43	-1.3486726	0.067567565	0.20814653	GO_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS	45	1.2340734	0.16704805	0.5351795	-0.1145992	-2.582746
GO_DNA_DIRECTED_RNA_POLYMERASE_II_HOLOENZYME	c5.CC_ GO cellular component	90	-1.3479574	0.033613447	0.208862	GO_DNA_DIRECTED_RNA_POLYMERASE_II_HOLOENZYME	90	0.74573606	0.90084386	1	-0.60222134	-2.09369346
GO_COFACTOR_BINDING	c5.GO molecular function	233	-1.3478519	0	0.20880723	GO_COFACTOR_BINDING	239	0.94467324	0.66498995	0.9874532	-0.40317866	-2.29252514
GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP	C7_ immunologic signatures	163	-1.3475673	0.00621118	0.20895906	GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP	168	1.0203367	0.45362905	0.89129657	-0.3272306	-2.367904
GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN	C7_ immunologic signatures	172	-1.3471593	0.012121212	0.2093511	GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN	174	-0.7411294	1	0.9406622	-2.0882887	-0.6060299
NAKAMURA_METASTASIS	c2.CGP_ chemical and genetic perturbations	38	-1.3460039	0.06188925	0.21072553	NAKAMURA_METASTASIS	41	1.0056636	0.4865497	0.9136626	-0.3403403	-2.3516675
GO_ALPHA_AMINO_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	204	-1.345711	0.007407407	0.21097077	GO_ALPHA_AMINO_ACID_METABOLIC_PROCESS	212	-1.2092086	0	0.3685144	-2.5549196	-0.1365024
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP	C7_ immunologic signatures	157	-1.3455787	0.005681818	0.21094126	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP	160	1.3104789	0.026449643	0.4253443	-0.0350998	-2.6560576
GO_MACROMOLECULAR_COMPLEX_DISASSEMBLY	c5.BP_ GO biological process	172	-1.3445299	0.0125	0.21225174	GO_MACROMOLECULAR_COMPLEX_DISASSEMBLY	176	-1.089758	0.18181819	0.53432775	-2.4342879	-0.2547719
GO_COENZYME_BINDING	c5.GO molecular function	164	-1.3440789	0	0.21269546	GO_COENZYME_BINDING	167	0.8215688	0.8470948	1	-0.5225101	-2.1656477
GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	C7_ immunologic signatures	160	-1.3439318	0.006535948	0.21270585	GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	159	0.8973105	0.7258883	1	-0.4466213	-2.2412423
PID_TCR_CALCIUM_PATHWAY	c2.CP_ Canonical pathways	24	-1.3432331	0.096692115	0.21348879	PID_TCR_CALCIUM_PATHWAY	25	1.4025397	0.06439854	0.3375439	0.0593066	-2.7457728
GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	140	-1.342837	0.010204081	0.21384226	GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	138	-1.1058831	0.09090909	0.5093937	-2.4487201	-0.2369539
GO_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS	c5.BP_ GO biological process	24	-1.3419677	0.09090909	0.21480073	GO_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS	21	-1.3855267	0.061611373	0.21550325	-2.7274944	0.043559
GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP	C7_ immunologic signatures	178	-1.3419646	0.013157895	0.21460553	GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP	182	0.66301185	0.98585856	1	-0.67895275	-2.00497645
NADLER_OBESITY_DN	c2.CGP_ chemical and genetic perturbations	43	-1.3417375	0.077181205	0.21472111	NADLER_OBESITY_DN	44	0.8598386	0.7002315	1	-0.4818989	-2.2015761
GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	C7_ immunologic signatures	178	-1.3416885	0.02	0.21459994	GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	180	0.6012575	0.9959596	1	-0.740431	-1.942946
GSE5960_TH1_VS_ANERGIC_TH1_DN	C7_ immunologic signatures	179	-1.3414749	0.006756757	0.21468985	GSE5960_TH1_VS_ANERGIC_TH1_DN	179	1.008978	0.4858586	0.91002995	-0.3324969	-2.3504529
GO_DISRUPTION_OF_CELLS_OF_OTHER_ORGANISM	c5.BP_ GO biological process	16	-1.3401841	0.114583336	0.21625042	GO_DISRUPTION_OF_CELLS_OF_OTHER_ORGANISM	17	-1.411563	0.05907173	0.1990935	-2.7517471	0.0713789
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP	c2.CGP_ chemical and genetic perturbations	23	-1.3400707	0.112021856	0.21619631	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP	23	-1.1433738	0.25773194	0.45208502	-2.4834445	-0.1966969
GO_ALDEHYDE_DEHYDROGENASE_NAD_ACTIVITY	c5.GO molecular function	18	-1.3400127	0.0875	0.21607666	GO_ALDEHYDE_DEHYDROGENASE_NAD_ACTIVITY	18	1.5018544	0.033376124	0.25100207	0.1618417	-2.8418671
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	c2.CGP_ chemical and genetic perturbations	59	-1.3396082	0.031578947	0.216467	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	62	1.0614237	0.39076576	0.8212676	-0.2781845	-2.4010319
GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	182	-1.3391991	0	0.21682583	GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP	182	0.6738604	0.9868687	1	-0.6653387	-2.0130595
GO_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS	c5.BP_ GO biological process	19	-1.3388809	0.10852713	0.21708262	GO_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS	19	1.1394923	0.29182878	0.6914775	-0.1993886	-2.4783732
MODULE_286	c4.CM_ cancer modules	34	-1.3387468	0.06626506	0.21708047	MODULE_286	33	1.3903041	0.05361305	0.34579086	0.0515573	-2.7290509
REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC	c2.CP_REACTOME_ Reactome gene sets	25	-1.3387294	0.09090909	0.21690284	REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC	26	1.206884	0.20124224	0.58092356	-0.1318454	-2.5456134
GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP	C7_ immunologic signatures	175	-1.3385231	0.006896552	0.21699695	GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP	177	-1.1893313	0	0.3950874	-2.5278544	-0.1491918
GSE17721_0.5H_VS_12H_CPG_BMDC_UP	C7_ immunologic signatures	185	-1.3383819	0.013071896	0.21700288	GSE17721_0.5H_VS_12H_CPG_BMDC_UP	185	0.9024502	0.73917425	1	-0.4359317	-2.2408321
GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP	C7_ immunologic signatures	177	-1.33807	0	0.21722548	GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP	178	0.8494792	0.8064516	1	-0.4885908	-2.1875492
KAPOSI_LIVER_CANCER_MET_UP	c2.CGP_ chemical and genetic perturbations	17	-1.337125	0.1046832	0.21832131	KAPOSI_LIVER_CANCER_MET_UP	17	-0.88562167	0.61087865	0.8378363	-2.22274667	-0.45150333
GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN	C7_ immunologic signatures	142	-1.3369898	0.01775148	0.21830878	GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN	152	0.8656885	0.80143297	1	-0.4713013	-2.2026783
GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP	C7_ immunologic signatures	137	-1.3367676	0.011111111	0.21843383	GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP	144	1.1796309	0.14256619	0.62396944	-0.1571367	-2.5163985
CHR17Q11	C1: positional gene sets	84	-1.3364962	0.03125	0.21862862	CHR17Q11	89	0.6245565	0.97545356	1	-0.7119397	-1.9610527
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	164	-1.336339	0.013071896	0.21865079	GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP	168	-0.86383474	0.9285714	0.8576332	-2.20017374	-0.47250426
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	c2.CGP_ chemical and genetic perturbations	19	-1.3362668	0.12162162	0.21855225	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	22	0.9849822	0.52163166	0.94189614	-0.3512846	-2.321249
GSE4142_NAIVE_VS_GC_BCELL_DN	C7_ immunologic signatures	164	-1.3358862	0.018518519	0.21890883	GSE4142_NAIVE_VS_GC_BCELL_DN	168	-1.3627058	0	0.23245019	-2.698592	0.0268196
LEIN_MIDBRAIN_MARKERS	c2.CGP_ chemical and genetic perturbations	73	-1.335756	0.032258064	0.21890786	LEIN_MIDBRAIN_MARKERS	78	1.1645796	0.19830328	0.6458116	-0.1711764	-2.5003356
GO_REGULATION_OF_PHAGOCYTOSIS	c5.BP_ GO biological process	55	-1.3356444	0.04659498	0.21886633	GO_REGULATION_OF_PHAGOCYTOSIS	58	1.0986996	0.32703003	0.75891936	-0.2369448	-2.434344
KIM_WT1_TARGETS_8HR_UP	c2.CGP_ chemical and genetic perturbations	156	-1.334867	0.012048192	0.21978903	KIM_WT1_TARGETS_8HR_UP	156	0.9803253	0.5443425	0.9489632	-0.3545417	-2.3151923
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP	C7_ immunologic signatures	169	-1.334644	0.005494506	0.21992293	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP	169	-1.0051048	0.42857143	0.6772834	-2.3397488	-0.3295392
GSE30083_SP1_VS_SP3_THYMOCYTE_UP	C7_ immunologic signatures	171	-1.3341186	0.012658228	0.22046179	GSE30083_SP1_VS_SP3_THYMOCYTE_UP	174	0.8380707	0.83926755	1	-0.4960479	-2.1721893
KEGG_TYPE_I_DIABETES_MELLITUS	c2.CP_BIOCARTA_ BioCarta gene sets	23	-1.3336452	0.09742121	0.22096364	KEGG_TYPE_I_DIABETES_MELLITUS	26	1.4764683	0.028325124	0.27171105	0.1428231	-2.8101135
CHR3Q28	C1: positional gene sets	16	-1.3334689	0.12637363	0.22100016	CHR3Q28	17	-1.5354178	0.041860465	0.12260584	-2.8688867	0.2019489
GO_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_TRANSCRIPTION_COACTIVATOR_ACTIVITY	c5.GO molecular function	49	-1.3325748	0.061290324	0.22209635	GO_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_TRANSCRIPTION_COACTIVATOR_ACTIVITY	49	0.75509965	0.8368954	1	-0.57747515	-2.08767445
LANDIS_ERBB2_BREAST_TUMORS_65_UP	c2.CGP_ chemical and genetic perturbations	20	-1.3321694	0.11444142	0.22245769	LANDIS_ERBB2_BREAST_TUMORS_65_UP	20	1.0688921	0.3785166	0.8073626	-0.2632773	-2.4010615
GERHOLD_ADIPOGENESIS_UP	c2.CGP_ chemical and genetic perturbations	47	-1.3320194	0.05901639	0.2224777	GERHOLD_ADIPOGENESIS_UP	48	0.6028748	0.9761092	1	-0.7291446	-1.9348942
LIN_MELANOMA_COPY_NUMBER_UP	c2.CGP_ chemical and genetic perturbations	60	-1.3312913	0.04477612	0.22338912	LIN_MELANOMA_COPY_NUMBER_UP	63	0.825363	0.7684675	1	-0.5059283	-2.1566543
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	162	-1.3309098	0.021857923	0.22367522	GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	167	-1.2253104	0	0.35037774	-2.5562202	-0.1055994
GO_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC	c5.BP_ GO biological process	58	-1.3305451	0.0609319	0.2240264	GO_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC	58	-0.7950607	0.8915663	0.90983176	-2.1256058	-0.5354844
GO_STEROL_METABOLIC_PROCESS	c5.BP_ GO biological process	105	-1.3298812	0.05022831	0.22477537	GO_STEROL_METABOLIC_PROCESS	110	1.0020341	0.50668037	0.92008656	-0.3278471	-2.3319153
LIU_IL13_MEMORY_MODEL_UP	c2.CGP_ chemical and genetic perturbations	15	-1.329515	0.12947658	0.22514522	LIU_IL13_MEMORY_MODEL_UP	15	0.60452336	0.9428192	1	-0.72499164	-1.93403836
GO_RESPONSE_TO_FOOD	c5.BP_ GO biological process	15	-1.3287727	0.124681935	0.2259143	GO_RESPONSE_TO_FOOD	17	1.0564332	0.41329858	0.8304906	-0.2723395	-2.3852059
GO_RETINOIC_ACID_BINDING	c5.GO molecular function	17	-1.3283463	0.12403101	0.22629276	GO_RETINOIC_ACID_BINDING	18	1.0593688	0.37583002	0.8256908	-0.2689775	-2.3877151
GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN	C7_ immunologic signatures	179	-1.3275096	0.020134227	0.22728734	GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN	176	1.0767077	0.3168016	0.7945457	-0.2508019	-2.4042173
GO_COPI_COATED_VESICLE	c5.CC_ GO cellular component	22	-1.3270272	0.10140845	0.22772533	GO_COPI_COATED_VESICLE	22	-1.224319	0.14761905	0.35064822	-2.5513462	-0.1027082
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN	C7_ immunologic signatures	168	-1.3269199	0	0.22766669	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN	169	-1.0352758	0.33333334	0.63014823	-2.3621957	-0.2916441
GSE17721_4H_VS_24H_POLYIC_BMDC_UP	C7_ immunologic signatures	173	-1.3264517	0.010638298	0.22811845	GSE17721_4H_VS_24H_POLYIC_BMDC_UP	174	0.6675408	0.9877426	1	-0.6589109	-1.9939925
SESTO_RESPONSE_TO_UV_C7	c2.CGP_ chemical and genetic perturbations	60	-1.3261542	0.04477612	0.22836609	SESTO_RESPONSE_TO_UV_C7	62	0.7115866	0.9025974	1	-0.6145676	-2.0377408
AKL_HTLV1_INFECTION_UP	c2.CGP_ chemical and genetic perturbations	23	-1.326054	0.124661244	0.22831501	AKL_HTLV1_INFECTION_UP	23	0.6051872	0.958231	1	-0.7208668	-1.9312412
GO_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	52	-1.3258344	0.08118081	0.22842458	GO_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS	52	-1.2361377	0.0877193	0.33951646	-2.5619721	-0.0896967
MIKKELSEN_IPS_ICP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	42	-1.325672	0.048701297	0.22844276	MIKKELSEN_IPS_ICP_WITH_H3K27ME3	50	-1.1848975	0.13592233	0.39844704	-2.5105695	-0.1407745
GO_RETINOID_X_RECEPTOR_BINDING	c5.GO molecular function	16	-1.3253863	0.13436693	0.22869396	GO_RETINOID_X_RECEPTOR_BINDING	17	0.96707004	0.5363276	0.96431285	-0.35831626	-2.29245634
DIRMEIER_LMP1_RESPONSE_EARLY	c2.CGP_ chemical and genetic perturbations	59	-1.3251513	0.04318937	0.22882515	DIRMEIER_LMP1_RESPONSE_EARLY	60	0.9507776	0.5975744	0.98135537	-0.3743737	-2.2759289
BRACHAT_RESPONSE_TO_METHOTREXATE_DN	c2.CGP_ chemical and genetic perturbations	23	-1.3250835	0.07941177	0.22873104	BRACHAT_RESPONSE_TO_METHOTREXATE_DN	24	0.7490201	0.8368098	1	-0.5760634	-2.0741036
GNF2_MMP1	c4.CGN_ cancer gene neighborhoods	26	-1.3250291	0.10385757	0.22861135	GNF2_MMP1	26	0.62380624	0.94625	1	-0.70122286	-1.94883534
GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP	C7_ immunologic signatures	150	-1.3246732	0.036809817	0.2289259	GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP	152	0.9674251	0.59589744	0.96390015	-0.3572481	-2.2920983
GO_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS	c5.BP_ GO biological process	78	-1.3244786	0.028	0.22897974	GO_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS	79	1.2543344	0.12446809	0.50294065	-0.0701442	-2.578813
CRGAARNNNNCGA_UNKNOWN	c3.TFT_ transcription factor targets	44	-1.3244692	0.094936706	0.22878963	CRGAARNNNNCGA_UNKNOWN	44	-0.7696451	0.9055118	0.92848784	-2.0941143	-0.5548241
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	c2.CGP_ chemical and genetic perturbations	118	-1.3244523	0.024390243	0.22860526	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	119	1.2322011	0.08645833	0.5370164	-0.0922512	-2.5566534
GO_T_HELPER_1_TYPE_IMMUNE_RESPONSE	c5.BP_ GO biological process	19	-1.3244084	0.11811024	0.22847968	GO_T_HELPER_1_TYPE_IMMUNE_RESPONSE	19	-0.9976442	0.43386245	0.6892224	-2.3220526	-0.3267642
GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	C7_ immunologic signatures	168	-1.3242865	0.02366864	0.2284501	GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	170	0.78577137	0.8853955	1	-0.53851513	-2.11005787
GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN	C7_ immunologic signatures	184	-1.3239706	0.005813954	0.22873287	GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN	185	0.7006845	0.9748744	1	-0.6232861	-2.0246551
GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN	C7_ immunologic signatures	168	-1.3238633	0.013333334	0.22869524	GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN	172	-0.867979	0.8888889	0.8553196	-2.1918423	-0.4558843
GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN	C7_ immunologic signatures	166	-1.3231733	0.013071896	0.22946529	GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN	166	0.5063333	1	1	-0.81684	-1.8295066
GO_RESPONSE_TO_INTERLEUKIN_4	c5.BP_ GO biological process	27	-1.3230835	0.088495575	0.22939657	GO_RESPONSE_TO_INTERLEUKIN_4	28	0.4468787	0.9963855	1	-0.8762048	-1.7699622
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG	c2.CGP_ chemical and genetic perturbations	24	-1.3230486	0.11014493	0.22925644	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG	24	-0.9803592	0.43636364	0.7135312	-2.3034078	-0.3426894
GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP	C7_ immunologic signatures	171	-1.3230226	0.006622517	0.22909723	GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP	173	-0.9893705	0.71428573	0.702946	-2.3123931	-0.3336521
CHR17Q12	C1: positional gene sets	57	-1.322408	0.038596492	0.22979839	CHR17Q12	64	-0.9113354	0.6760563	0.8062371	-2.2337434	-0.4110726
GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN	C7_ immunologic signatures	175	-1.3223329	0.013333334	0.22971103	GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN	178	0.9102316	0.69989824	1	-0.4121013	-2.2325645
GO_DENDRITIC_CELL_MIGRATION	c5.BP_ GO biological process	16	-1.3223029	0.13315217	0.22954975	GO_DENDRITIC_CELL_MIGRATION	18	-1.4888792	0.04310345	0.14979903	-2.8111821	0.1665763
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	c2.CGP_ chemical and genetic perturbations	33	-1.3219093	0.05111821	0.22998077	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	34	-0.6026362	0.9815951	0.98522955	-1.9245455	-0.7192731
VALK_AML_CLUSTER_12	c2.CGP_ chemical and genetic perturbations	27	-1.321899	0.10610932	0.22979532	VALK_AML_CLUSTER_12	27	1.114275	0.30586767	0.73142207	-0.207624	-2.436174
GO_PURINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	108	-1.3214687	0.029411765	0.23031636	GO_PURINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS	108	0.85726035	0.7747654	1	-0.46420835	-2.17872905
YAGI_AML_SURVIVAL	c2.CGP_ chemical and genetic perturbations	111	-1.3214521	0.023696683	0.23013839	YAGI_AML_SURVIVAL	113	0.6275938	0.9905561	1	-0.6938583	-1.9490459
GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP	C7_ immunologic signatures	155	-1.3212372	0	0.23024493	GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP	155	0.96474075	0.5717192	0.96535754	-0.35649645	-2.28597795
MODULE_175	c4.CM_ cancer modules	46	-1.3211855	0.09219858	0.2301124	MODULE_175	49	1.130042	0.2723164	0.7054319	-0.1911435	-2.4512275
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP	C7_ immunologic signatures	170	-1.3211108	0.03448276	0.23002733	GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP	169	1.1209726	0.2173913	0.7223411	-0.2001382	-2.4420834
CAMP_UP.V1_UP	C6_ oncogenic signatures	176	-1.321087	0	0.22986153	CAMP_UP.V1_UP	177	-0.7665119	1	0.93020695	-2.0875989	-0.5545751
GO_MLL1_2_COMPLEX	c5.CC_ GO cellular component	25	-1.3209019	0.11079545	0.22994108	GO_MLL1_2_COMPLEX	25	-0.9284048	0.5829146	0.78614634	-2.2493067	-0.3924971
WOTTON_RUNX_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	19	-1.3208572	0.12634408	0.22980832	WOTTON_RUNX_TARGETS_UP	17	1.0400031	0.4116883	0.8589375	-0.2808541	-2.3608603
CHOI_ATL_STAGE_PREDICTOR	c2.CGP_ chemical and genetic perturbations	32	-1.3207086	0.074074075	0.22983742	CHOI_ATL_STAGE_PREDICTOR	33	-0.90102834	0.6273292	0.8194309	-2.22173694	-0.41968026
REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	c2.CP_REACTOME_ Reactome gene sets	158	-1.320584	0.03076923	0.22981979	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	162	0.9832242	0.543235	0.94424087	-0.3373598	-2.3038082
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS	c5.GO molecular function	41	-1.3205321	0.061349694	0.22969975	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS	40	1.3425246	0.07482993	0.39266625	0.0219925	-2.6630567
GSE17721_12H_VS_24H_LPS_BMDC_DN	C7_ immunologic signatures	173	-1.3203318	0.022727273	0.22980826	GSE17721_12H_VS_24H_LPS_BMDC_DN	176	0.5536825	1	1	-0.7666493	-1.8740143
GO_POSTTRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION	c5.BP_ GO biological process	405	-1.320261	0	0.22971472	GO_POSTTRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION	406	-1.243417	0	0.33085558	-2.563678	-0.076844
GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	167	-1.3201628	0.006493507	0.22964476	GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP	174	0.7079819	0.9725051	1	-0.6121809	-2.0281447
GO_CHD_TYPE_COMPLEX	c5.CC_ GO cellular component	17	-1.3199046	0.13157895	0.22982742	GO_CHD_TYPE_COMPLEX	17	-1.0188714	0.4135021	0.66181296	-2.338776	-0.3010332
FINETTI_BREAST_CANCERS_KINOME_BLUE	c2.CGP_ chemical and genetic perturbations	19	-1.3194166	0.11989101	0.23037684	FINETTI_BREAST_CANCERS_KINOME_BLUE	21	0.8589299	0.6813049	1	-0.4604867	-2.1783465
REACTOME_PI_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	46	-1.3193197	0.07094595	0.23034188	REACTOME_PI_METABOLISM	47	1.1678675	0.23744293	0.64072645	-0.1514522	-2.4871872
MORF_PTPN11	c4.CGN_ cancer gene neighborhoods	100	-1.3181909	0.03508772	0.23173907	MORF_PTPN11	100	-2.0258868	0	0.00629508	-3.3440777	0.7076959
GNF2_PPP6C	c4.CGN_ cancer gene neighborhoods	33	-1.3173993	0.088737205	0.23274224	GNF2_PPP6C	33	-2.3167663	0	0.000227461	-3.6341656	0.999367
GO_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	19	-1.3171725	0.12256268	0.23289832	GO_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS	18	-0.8426883	0.7120419	0.8730105	-2.1598608	-0.4744842
GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	173	-1.316988	0.011976048	0.23295234	GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN	176	1.1360415	0.18979591	0.6960744	-0.1809465	-2.4530295
GSE3982_EOSINOPHIL_VS_DC_DN	C7_ immunologic signatures	176	-1.3168751	0.013071896	0.23290938	GSE3982_EOSINOPHIL_VS_DC_DN	175	1.0897542	0.2900302	0.77143794	-0.2271209	-2.4066293
GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP	C7_ immunologic signatures	172	-1.3163847	0.012422361	0.23344888	GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP	175	0.8125793	0.8893401	1	-0.5038054	-2.128964
GO_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE	c5.BP_ GO biological process	29	-1.3156614	0.09006211	0.23431616	GO_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE	29	0.61555386	0.954491	1	-0.70010754	-1.93121526
GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP	C7_ immunologic signatures	173	-1.3154719	0.011173184	0.23440182	GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP	177	-0.8818597	0.84615386	0.8421507	-2.1973316	-0.4336122
GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN	C7_ immunologic signatures	179	-1.3149146	0.0125	0.23499756	GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN	181	1.1360602	0.19817998	0.69632494	-0.1788544	-2.4509748
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP	C7_ immunologic signatures	177	-1.3148813	0.03311258	0.23483895	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP	181	1.0485525	0.39152372	0.8425667	-0.2663288	-2.3634338
REACTOME_SYNTHESIS_OF_PA	c2.CP_REACTOME_ Reactome gene sets	20	-1.314792	0.123943664	0.23478118	REACTOME_SYNTHESIS_OF_PA	25	1.1859996	0.25310174	0.6130522	-0.1287924	-2.5007916
GO_DENDRITE_CYTOPLASM	c5.CC_ GO cellular component	16	-1.3147291	0.13456464	0.23466277	GO_DENDRITE_CYTOPLASM	16	0.94552493	0.55396616	0.9867995	-0.36920417	-2.26025403
LEF1_Q2	c3.TFT_ transcription factor targets	184	-1.3145778	0.018404908	0.23469554	LEF1_Q2	191	0.8758702	0.7997988	1	-0.4387076	-2.190448
GO_GAP_JUNCTION_CHANNEL_ACTIVITY	c5.GO molecular function	15	-1.3142456	0.13550135	0.23498538	GO_GAP_JUNCTION_CHANNEL_ACTIVITY	16	-1.5278031	0.060869563	0.12655994	-2.8420487	0.2135575
GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN	C7_ immunologic signatures	179	-1.3136735	0.007092198	0.23567711	GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN	184	-1.0525372	0.2857143	0.60068357	-2.3662107	-0.2611363
REACTOME_APOPTOSIS	c2.CP_REACTOME_ Reactome gene sets	132	-1.3136696	0.014492754	0.2354808	REACTOME_APOPTOSIS	133	-1.3505749	0	0.24248856	-2.6642445	0.0369053
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	c2.CGP_ chemical and genetic perturbations	182	-1.3124262	0	0.23720933	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	184	0.8949795	0.7606491	1	-0.4174467	-2.2074057
HALLMARK_MTORC1_SIGNALING	H_ hallmark gene sets	189	-1.3123177	0.008064516	0.23719078	HALLMARK_MTORC1_SIGNALING	189	-2.0351102	0	0.005761911	-3.3474279	0.7227925
GO_MYELIN_SHEATH	c5.CC_ GO cellular component	154	-1.3117744	0.010810811	0.23773228	GO_MYELIN_SHEATH	153	0.62878346	0.9959184	1	-0.68299094	-1.94055786
MODULE_245	c4.CM_ cancer modules	24	-1.3115625	0.12668464	0.23781891	MODULE_245	24	-0.95203936	0.5369458	0.75365764	-2.26360186	-0.35952314
MORF_GNB1	c4.CGN_ cancer gene neighborhoods	280	-1.3114961	0.010309278	0.23771836	MORF_GNB1	281	-2.055632	0	0.004608476	-3.3671281	0.7441359
GO_RESPONSE_TO_TUMOR_NECROSIS_FACTOR	c5.BP_ GO biological process	185	-1.310457	0.006711409	0.23911446	GO_RESPONSE_TO_TUMOR_NECROSIS_FACTOR	195	1.1066948	0.25025228	0.7431586	-0.2037622	-2.4171518
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	c2.CGP_ chemical and genetic perturbations	65	-1.3099837	0.05952381	0.23964167	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	64	1.1306014	0.28335172	0.7061668	-0.1793823	-2.4405851
TEL2_Q6	c3.TFT_ transcription factor targets	209	-1.3098798	0	0.23960982	TEL2_Q6	212	0.7741659	0.94545454	1	-0.5357139	-2.0840457
GO_VITAMIN_METABOLIC_PROCESS	c5.BP_ GO biological process	104	-1.3096696	0.023364486	0.23975226	GO_VITAMIN_METABOLIC_PROCESS	108	1.3317934	0.03995794	0.40047398	0.0221238	-2.641463
MYCMAX_B	c3.TFT_ transcription factor targets	239	-1.3094074	0.008849558	0.23993117	MYCMAX_B	245	0.657855	0.9929507	1	-0.6515524	-1.9672624
GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP	C7_ immunologic signatures	174	-1.3086435	0.010869565	0.24088328	GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP	171	0.6194958	0.99693877	1	-0.6891477	-1.9281393
KLEIN_TARGETS_OF_BCR_ABL1_FUSION	c2.CGP_ chemical and genetic perturbations	41	-1.3084677	0.08231708	0.24095891	KLEIN_TARGETS_OF_BCR_ABL1_FUSION	43	0.72058547	0.87745667	1	-0.58788223	-2.02905317
GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN	C7_ immunologic signatures	156	-1.3084295	0.01754386	0.24083851	GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN	157	0.56196624	1	1	-0.74646326	-1.87039574
MODULE_522	c4.CM_ cancer modules	30	-1.3081322	0.10606061	0.24110809	MODULE_522	31	0.881474	0.6720497	1	-0.4266582	-2.1896062
GO_PRESPLICEOSOME	c5.CC_ GO cellular component	20	-1.3075922	0.12103746	0.2416932	GO_PRESPLICEOSOME	20	-1.2680185	0.14354067	0.30930188	-2.5756107	-0.0395737
GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN	C7_ immunologic signatures	171	-1.3075264	0.006134969	0.24158524	GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN	171	1.0873804	0.29310346	0.7746711	-0.220146	-2.3949068
GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_UP	C7_ immunologic signatures	172	-1.3074248	0.024096385	0.24152382	GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_UP	176	-0.9493029	0.7777778	0.7573267	-2.2567277	-0.3581219
JEPSEN_SMRT_TARGETS	c2.CGP_ chemical and genetic perturbations	33	-1.3072695	0.084848486	0.24155065	JEPSEN_SMRT_TARGETS	33	-0.8951794	0.66467065	0.82662296	-2.2024489	-0.4120901
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	170	-1.3071356	0.027210884	0.24156791	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP	173	0.9811712	0.52994925	0.9474983	-0.3259644	-2.2883068
GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN	C7_ immunologic signatures	181	-1.3066891	0.005681818	0.24210265	GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN	182	0.790722	0.90678823	1	-0.5159671	-2.0974111
GSE3982_EOSINOPHIL_VS_TH1_DN	C7_ immunologic signatures	178	-1.3056148	0	0.2435557	GSE3982_EOSINOPHIL_VS_TH1_DN	179	0.5285448	1	1	-0.77707	-1.8341596
MORF_RPA2	c4.CGN_ cancer gene neighborhoods	178	-1.3051336	0.018867925	0.24405494	MORF_RPA2	178	-1.4912688	0	0.14807743	-2.7964024	0.1861352
TGASTMAGC_NFE2_01	c3.TFT_ transcription factor targets	166	-1.3046569	0.026845638	0.24454434	TGASTMAGC_NFE2_01	172	1.1493627	0.17611337	0.6705698	-0.1552942	-2.4540196
LENAOUR_DENDRITIC_CELL_MATURATION_DN	c2.CGP_ chemical and genetic perturbations	111	-1.3045441	0.027777778	0.24451357	LENAOUR_DENDRITIC_CELL_MATURATION_DN	112	0.8775184	0.7331933	1	-0.4270257	-2.1820625
GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	165	-1.3042182	0.005813954	0.24479568	GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP	170	1.1397012	0.19187817	0.69117796	-0.164517	-2.4439194
DANG_REGULATED_BY_MYC_UP	c2.CGP_ chemical and genetic perturbations	69	-1.3040482	0.044354837	0.2448593	DANG_REGULATED_BY_MYC_UP	69	-1.4349248	0	0.18370937	-2.738973	0.1308766
GO_OVULATION	c5.BP_ GO biological process	15	-1.3037168	0.1285347	0.24520771	GO_OVULATION	17	1.6974945	0.002649007	0.081162155	0.3937777	-3.0012113
RICKMAN_HEAD_AND_NECK_CANCER_C	c2.CGP_ chemical and genetic perturbations	74	-1.3034182	0.053435113	0.2454685	RICKMAN_HEAD_AND_NECK_CANCER_C	81	1.2419484	0.12179487	0.5232302	-0.0614698	-2.5453666
GSE3982_BCELL_VS_NKCELL_UP	C7_ immunologic signatures	171	-1.3028253	0.019736841	0.24617524	GSE3982_BCELL_VS_NKCELL_UP	172	0.8802216	0.7676768	1	-0.4226037	-2.1830469
MODULE_484	c4.CM_ cancer modules	38	-1.3028172	0.0670554	0.24598204	MODULE_484	40	0.9850778	0.5039548	0.94180995	-0.3177394	-2.287895
GATGKMRGCG_UNKNOWN	c3.TFT_ transcription factor targets	60	-1.3026334	0.06177606	0.24609521	GATGKMRGCG_UNKNOWN	63	0.9818358	0.5005525	0.9464247	-0.3207976	-2.2844692
GO_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS	c5.GO molecular function	44	-1.3026316	0.08278146	0.24589649	GO_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS	44	-1.422668	0.03539823	0.19234419	-2.7252996	0.1200364
E2F1_UP.V1_DN	C6_ oncogenic signatures	171	-1.3024977	0.01724138	0.24591365	E2F1_UP.V1_DN	171	1.5924796	0	0.17171511	0.2899819	-2.8949773
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	169	-1.3021168	0.00617284	0.24630393	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP	175	1.431864	0.002028398	0.31319386	0.1297472	-2.7339808
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	c2.CGP_ chemical and genetic perturbations	24	-1.3020961	0.09803922	0.24612541	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	27	0.89744043	0.6474908	1	-0.40465567	-2.19953653
GSE339_CD8POS_VS_CD4CD8DN_DC_UP	C7_ immunologic signatures	183	-1.3019364	0.012048192	0.24616031	GSE339_CD8POS_VS_CD4CD8DN_DC_UP	186	0.7178876	0.97070706	1	-0.5840488	-2.019824
GSE17721_LPS_VS_POLYIC_24H_BMDC_UP	C7_ immunologic signatures	174	-1.3016388	0.01923077	0.24643153	GSE17721_LPS_VS_POLYIC_24H_BMDC_UP	174	-0.8440587	1	0.87259144	-2.1456975	-0.4575801
MODULE_237	c4.CM_ cancer modules	56	-1.3012722	0.05836576	0.24678981	MODULE_237	56	0.9228762	0.61195654	1	-0.378396	-2.2241484
RYTGCNNRGNAAC_MIF1_01	c3.TFT_ transcription factor targets	76	-1.3009852	0.07364341	0.24704193	RYTGCNNRGNAAC_MIF1_01	80	1.0056138	0.47463003	0.9134297	-0.2953714	-2.306599
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	c2.CGP_ chemical and genetic perturbations	105	-1.300263	0.03686636	0.24801952	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	113	-0.9445586	0.5952381	0.76330584	-2.2448216	-0.3557044
GO_COP9_SIGNALOSOME	c5.CC_ GO cellular component	29	-1.3001827	0.115384616	0.24792835	GO_COP9_SIGNALOSOME	29	-0.90659523	0.6497175	0.8135917	-2.20677793	-0.39358747
CHEN_HOXA5_TARGETS_9HR_DN	c2.CGP_ chemical and genetic perturbations	35	-1.3001506	0.10606061	0.24777296	CHEN_HOXA5_TARGETS_9HR_DN	35	-1.3194717	0.101123594	0.26730764	-2.6196223	0.0193211
HALLMARK_HEDGEHOG_SIGNALING	H_ hallmark gene sets	34	-1.3001152	0.10684931	0.24762006	HALLMARK_HEDGEHOG_SIGNALING	33	-1.181377	0.17834395	0.40311468	-2.4814922	-0.1187382
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	49	-1.3000113	0.08361204	0.24759151	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	53	1.3150035	0.09706546	0.41756994	0.0149922	-2.6150148
GO_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN	c5.BP_ GO biological process	15	-1.2998694	0.13477089	0.24759844	GO_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN	16	1.7102696	0.001321004	0.077486	0.4104002	-3.010139
GO_MICROBODY_MEMBRANE	c5.CC_ GO cellular component	55	-1.2994715	0.067669176	0.2480411	GO_MICROBODY_MEMBRANE	56	0.7132832	0.9025756	1	-0.5861883	-2.0127547
TIEN_INTESTINE_PROBIOTICS_24HR_DN	c2.CGP_ chemical and genetic perturbations	189	-1.2991161	0	0.24842367	TIEN_INTESTINE_PROBIOTICS_24HR_DN	191	-1.1058658	0	0.5090687	-2.4049819	-0.1932503
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	c2.CGP_ chemical and genetic perturbations	129	-1.2977337	0.020833334	0.250361	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	131	-0.9047521	0.7777778	0.8153659	-2.2024858	-0.3929816
GO_MONOCARBOXYLIC_ACID_BINDING	c5.GO molecular function	48	-1.2974397	0.06666667	0.25066504	GO_MONOCARBOXYLIC_ACID_BINDING	50	1.1259147	0.2919955	0.7126091	-0.171525	-2.4233544
PID_ECADHERIN_NASCENT_AJ_PATHWAY	c2.CP_ Canonical pathways	37	-1.2973435	0.08552632	0.25063697	PID_ECADHERIN_NASCENT_AJ_PATHWAY	37	0.5273345	0.99186045	1	-0.770009	-1.824678
WENG_POR_TARGETS_LIVER_UP	c2.CGP_ chemical and genetic perturbations	38	-1.2972987	0.0952381	0.25049335	WENG_POR_TARGETS_LIVER_UP	37	0.785592	0.7947846	1	-0.5117067	-2.0828907
GO_NEGATIVE_REGULATION_OF_CYTOKINE_SECRETION	c5.BP_ GO biological process	37	-1.2972177	0.10185185	0.25043344	GO_NEGATIVE_REGULATION_OF_CYTOKINE_SECRETION	36	1.5710589	0.009205984	0.18747358	0.2738412	-2.8682766
GO_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	33	-1.2971421	0.085443035	0.25036177	GO_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS	34	0.93083113	0.59224445	0.99827915	-0.36631097	-2.22797323
GO_REGULATION_OF_ACTIN_NUCLEATION	c5.BP_ GO biological process	26	-1.2970355	0.102564104	0.25032467	GO_REGULATION_OF_ACTIN_NUCLEATION	26	0.84992623	0.6849817	1	-0.44710927	-2.14696173
GSE3982_DC_VS_NEUTROPHIL_UP	C7_ immunologic signatures	184	-1.2969112	0.014184397	0.25032696	GSE3982_DC_VS_NEUTROPHIL_UP	184	0.70173377	0.9736842	1	-0.59517743	-1.99864497
GO_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY	c5.GO molecular function	44	-1.2968026	0.07717042	0.2502778	GO_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY	44	0.68870157	0.9171529	1	-0.60810103	-1.98550417
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	c2.CP_REACTOME_ Reactome gene sets	34	-1.2966439	0.114583336	0.25027156	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	37	-1.2900012	0.13125	0.29219523	-2.5866451	-0.0066427
GO_FC_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	168	-1.2964287	0.023952097	0.25042504	GO_FC_RECEPTOR_SIGNALING_PATHWAY	178	0.9252998	0.6970618	1	-0.3711289	-2.2217285
GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP	C7_ immunologic signatures	171	-1.2963084	0.017142856	0.25041562	GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP	174	0.7465911	0.9414141	1	-0.5497173	-2.0428995
GO_DETOXIFICATION	c5.BP_ GO biological process	59	-1.2958777	0.07931034	0.25091556	GO_DETOXIFICATION	64	1.273695	0.10819672	0.4816928	-0.0221827	-2.5695727
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	c2.CGP_ chemical and genetic perturbations	21	-1.2957375	0.12835822	0.2509587	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	23	-1.21149	0.18811882	0.36699277	-2.5072275	-0.0842475
GO_CELLULAR_RESPONSE_TO_INTERLEUKIN_4	c5.BP_ GO biological process	23	-1.2956723	0.12166172	0.2508746	GO_CELLULAR_RESPONSE_TO_INTERLEUKIN_4	23	0.49061838	0.9861809	1	-0.80505392	-1.78629068
GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN	C7_ immunologic signatures	174	-1.2950763	0.018181818	0.2516662	GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN	176	0.5988327	0.9979654	1	-0.6962436	-1.893909
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	60	-1.2949629	0.07462686	0.25163218	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	62	1.1471224	0.2603486	0.67365354	-0.1478405	-2.4420853
GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP	C7_ immunologic signatures	168	-1.2948297	0.012903226	0.25165632	GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP	175	1.3826154	0.009118541	0.354652	0.0877857	-2.6774451
GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN	C7_ immunologic signatures	187	-1.294703	0.01863354	0.25164816	GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN	187	-0.9913556	0.5555556	0.7004769	-2.2860586	-0.3033474
KEGG_ALZHEIMERS_DISEASE	c2.CP_BIOCARTA_ BioCarta gene sets	135	-1.294646	0.036458332	0.25155294	KEGG_ALZHEIMERS_DISEASE	137	0.84300286	0.8	1	-0.45164314	-2.13764886
GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	182	-1.2939796	0.020547945	0.25241062	GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN	182	0.9397084	0.65015167	0.9902133	-0.3542712	-2.233688
GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN	C7_ immunologic signatures	181	-1.2939327	0.012195122	0.25229007	GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN	184	-1.1911507	0	0.3927012	-2.4850834	-0.102782
GO_WATER_TRANSPORT	c5.BP_ GO biological process	16	-1.2938988	0.1425	0.25213775	GO_WATER_TRANSPORT	17	-1.4048907	0.071428575	0.20282687	-2.6987895	0.1109919
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	c2.CGP_ chemical and genetic perturbations	68	-1.2934443	0.0703125	0.2526609	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	67	-1.2714374	0.056338027	0.30870363	-2.5648817	-0.0220069
GO_PROTEIN_FOLDING	c5.BP_ GO biological process	191	-1.2933953	0.02	0.25254416	GO_PROTEIN_FOLDING	193	0.7122965	0.97365755	1	-0.5810988	-2.0056918
GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN	C7_ immunologic signatures	175	-1.2933182	0.037037037	0.25246534	GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN	176	0.78281575	0.9280648	1	-0.51050245	-2.07613395
BIOCARTA_IL12_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	18	-1.2924664	0.14948453	0.25356236	BIOCARTA_IL12_PATHWAY	18	-1.4873816	0.057268724	0.15039818	-2.779848	0.1949152
LEIN_PONS_MARKERS	c2.CGP_ chemical and genetic perturbations	83	-1.2921324	0.045454547	0.25388226	LEIN_PONS_MARKERS	86	1.1431067	0.23809524	0.6841355	-0.1490257	-2.4352391
GO_REGULATION_OF_HYDROGEN_PEROXIDE_INDUCED_CELL_DEATH	c5.BP_ GO biological process	16	-1.292066	0.15235457	0.2537926	GO_REGULATION_OF_HYDROGEN_PEROXIDE_INDUCED_CELL_DEATH	17	0.68034184	0.89290494	1	-0.61172416	-1.97240784
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	c2.CGP_ chemical and genetic perturbations	134	-1.2919921	0.032432433	0.25370997	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	138	0.7978811	0.8597561	1	-0.494111	-2.0898732
GO_SINGLE_ORGANISM_MEMBRANE_BUDDING	c5.BP_ GO biological process	67	-1.2918768	0.08029197	0.25370628	GO_SINGLE_ORGANISM_MEMBRANE_BUDDING	66	-0.6774118	1	0.96903545	-1.9692886	-0.614465
CERVERA_SDHB_TARGETS_1_DN	c2.CGP_ chemical and genetic perturbations	31	-1.2918737	0.10344828	0.2535079	CERVERA_SDHB_TARGETS_1_DN	33	1.0825689	0.35851318	0.7828059	-0.2093048	-2.3744426
GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN	C7_ immunologic signatures	180	-1.2917832	0.013245033	0.25348333	GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN	188	0.74275196	0.94254035	1	-0.54903124	-2.03453516
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	c2.CGP_ chemical and genetic perturbations	15	-1.2916589	0.15061729	0.25346053	LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	15	1.4128927	0.060102303	0.3238972	0.1212338	-2.7045516
GNF2_SPINK1	c4.CGN_ cancer gene neighborhoods	20	-1.2913555	0.13390313	0.25376838	GNF2_SPINK1	21	1.0548891	0.4136646	0.8332373	-0.2364664	-2.3462446
GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_UP	C7_ immunologic signatures	147	-1.2908385	0.011363637	0.2543549	GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_UP	157	0.86199975	0.79837066	1	-0.42883875	-2.15283825
GO_NCRNA_TRANSCRIPTION	c5.BP_ GO biological process	79	-1.2905692	0.050209206	0.254613	GO_NCRNA_TRANSCRIPTION	79	-1.4660771	0.016129032	0.16364858	-2.7566463	0.1755079
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	31	-1.2901856	0.09090909	0.2550045	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	33	-0.88875437	0.65536726	0.8366277	-2.17893997	-0.40143123
PID_PTP1B_PATHWAY	c2.CP_ Canonical pathways	47	-1.2898796	0.08846154	0.25527748	PID_PTP1B_PATHWAY	50	1.0619715	0.39154616	0.8192808	-0.2279081	-2.3518511
GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN	C7_ immunologic signatures	174	-1.2895621	0.013333334	0.25558713	GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN	170	0.88974357	0.7589013	1	-0.39981853	-2.17930567
GO_CELLULAR_AMINO_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	301	-1.289546	0	0.2554068	GO_CELLULAR_AMINO_ACID_METABOLIC_PROCESS	301	0	0	0	-1.289546	-1.289546
GO_DICARBOXYLIC_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	94	-1.2888963	0.044176705	0.2563051	GO_DICARBOXYLIC_ACID_METABOLIC_PROCESS	97	-1.3821028	0.018518519	0.21805216	-2.6709991	0.0932065
GSE14308_TH17_VS_INDUCED_TREG_DN	C7_ immunologic signatures	174	-1.2887614	0.016666668	0.2563332	GSE14308_TH17_VS_INDUCED_TREG_DN	174	1.0663615	0.33232322	0.8119816	-0.2223999	-2.3551229
GO_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	18	-1.2885114	0.13506493	0.25656852	GO_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY	19	1.5285331	0.018087855	0.22463247	0.2400217	-2.8170445
MORF_PPP6C	c4.CGN_ cancer gene neighborhoods	92	-1.2883431	0.04621849	0.25661197	MORF_PPP6C	92	-1.2029834	0.09803922	0.37822342	-2.4913265	-0.0853597
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	c2.CGP_ chemical and genetic perturbations	37	-1.2883248	0.12727273	0.2564333	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	37	0.67496103	0.93967515	1	-0.61336377	-1.96328583
GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN	C7_ immunologic signatures	165	-1.2876893	0.017045455	0.25725514	GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN	170	-0.9748406	0.54545456	0.7221506	-2.2625299	-0.3128487
GO_CARBON_CARBON_LYASE_ACTIVITY	c5.GO molecular function	46	-1.2870922	0.07931034	0.25798967	GO_CARBON_CARBON_LYASE_ACTIVITY	46	-1.0844795	0.25	0.5434647	-2.3715717	-0.2026127
GO_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY	c5.BP_ GO biological process	15	-1.28669	0.15733333	0.25842723	GO_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY	17	1.0803643	0.3815261	0.78648275	-0.2063257	-2.3670543
MORF_RAD54L	c4.CGN_ cancer gene neighborhoods	99	-1.2860476	0.067307696	0.25924343	MORF_RAD54L	100	-1.8201313	0	0.029426571	-3.1061789	0.5340837
CHRXQ24	C1: positional gene sets	24	-1.2859911	0.13084112	0.25913787	CHRXQ24	25	1.2059797	0.2093596	0.5820814	-0.0800114	-2.4919708
GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	175	-1.2858342	0.020134227	0.25922096	GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP	182	1.1654254	0.14777328	0.6460675	-0.1204088	-2.4512596
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES	c5.BP_ GO biological process	16	-1.2851759	0.1576087	0.26006776	GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES	17	0.46025372	0.99597853	1	-0.82492218	-1.74542962
GO_HYDRO_LYASE_ACTIVITY	c5.GO molecular function	40	-1.2851478	0.085443035	0.25991222	GO_HYDRO_LYASE_ACTIVITY	41	0.97499484	0.52238804	0.9557913	-0.31015296	-2.26014264
GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN	C7_ immunologic signatures	174	-1.2849367	0.03311258	0.26004267	GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN	174	1.0857648	0.30337077	0.77623814	-0.1991719	-2.3707015
GO_ACUTE_INFLAMMATORY_RESPONSE	c5.BP_ GO biological process	58	-1.2846096	0.08045977	0.26039454	GO_ACUTE_INFLAMMATORY_RESPONSE	67	1.2332411	0.14940022	0.53557307	-0.0513685	-2.5178507
GNF2_MAPT	c4.CGN_ cancer gene neighborhoods	37	-1.2843726	0.111445785	0.26056206	GNF2_MAPT	40	1.3602875	0.08246225	0.37722462	0.0759149	-2.6446601
GO_REGULATION_OF_TISSUE_REMODELING	c5.BP_ GO biological process	49	-1.2842243	0.06802721	0.2606057	GO_REGULATION_OF_TISSUE_REMODELING	57	1.3641773	0.046875	0.37310767	0.079953	-2.6484016
GO_PROTEIN_TETRAMERIZATION	c5.BP_ GO biological process	106	-1.2840456	0.05116279	0.26068425	GO_PROTEIN_TETRAMERIZATION	109	1.1007551	0.30610135	0.7562739	-0.1832905	-2.3848007
GO_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY	c5.BP_ GO biological process	33	-1.2837691	0.08945687	0.2609478	GO_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY	33	0.65305233	0.94251496	1	-0.63071677	-1.93682143
GO_METHIONINE_METABOLIC_PROCESS	c5.BP_ GO biological process	18	-1.2835991	0.14516129	0.2610564	GO_METHIONINE_METABOLIC_PROCESS	18	-1.7809007	0.004587156	0.03682765	-3.0644998	0.4973016
GO_REGULATION_OF_VIRAL_TRANSCRIPTION	c5.BP_ GO biological process	51	-1.2835644	0.08362369	0.260899	GO_REGULATION_OF_VIRAL_TRANSCRIPTION	52	-0.8389432	0.7708333	0.8772995	-2.1225076	-0.4446212
KEGG_LEISHMANIA_INFECTION	c2.CP_BIOCARTA_ BioCarta gene sets	57	-1.2834502	0.07801419	0.26089415	KEGG_LEISHMANIA_INFECTION	57	1.2127906	0.169045	0.5728359	-0.0706596	-2.4962408
CHR18Q12	C1: positional gene sets	31	-1.2833595	0.11515152	0.26082888	CHR18Q12	33	0.8793411	0.6760563	1	-0.4040184	-2.1627006
TSENG_ADIPOGENIC_POTENTIAL_DN	c2.CGP_ chemical and genetic perturbations	44	-1.2833034	0.11071429	0.26071802	TSENG_ADIPOGENIC_POTENTIAL_DN	44	1.149262	0.26914415	0.6705211	-0.1340414	-2.4325654
GO_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	37	-1.2809039	0.07973422	0.26461366	GO_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT	41	-1.492216	0.02238806	0.14774017	-2.7731199	0.2113121
GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN	C7_ immunologic signatures	160	-1.2806312	0.006134969	0.26489577	GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN	161	1.1165035	0.26060605	0.7284952	-0.1641277	-2.3971347
GO_REGULATION_OF_CELL_AGING	c5.BP_ GO biological process	30	-1.2806295	0.09011628	0.2646952	GO_REGULATION_OF_CELL_AGING	30	-0.7886622	0.88505745	0.91497636	-2.0692917	-0.4919673
GARY_CD5_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	393	-1.2804307	0	0.2648056	GARY_CD5_TARGETS_DN	392	-2.219674	0	0.000761438	-3.5001047	0.9392433
GSE3982_DC_VS_NKCELL_UP	C7_ immunologic signatures	180	-1.2801844	0.024844721	0.26499596	GSE3982_DC_VS_NKCELL_UP	181	1.4641676	0.001013171	0.2820203	0.1839832	-2.744352
GO_NUCLEOBASE_METABOLIC_PROCESS	c5.BP_ GO biological process	33	-1.2800214	0.11490683	0.26505703	GO_NUCLEOBASE_METABOLIC_PROCESS	35	1.1847618	0.22029988	0.61436325	-0.0952596	-2.4647832
GCM_TPR	c4.CGN_ cancer gene neighborhoods	30	-1.2792814	0.12753624	0.26605296	GCM_TPR	30	-1.8313941	0	0.02759446	-3.1106755	0.5521127
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	c2.CGP_ chemical and genetic perturbations	15	-1.2792708	0.16216215	0.2658616	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	15	-1.8440666	0.007692308	0.02526758	-3.1233374	0.5647958
GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP	C7_ immunologic signatures	163	-1.2789416	0.04	0.2661921	GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP	162	-1.4153552	0	0.19631429	-2.6942968	0.1364136
GSE17721_LPS_VS_CPG_1H_BMDC_UP	C7_ immunologic signatures	181	-1.2786808	0.005847953	0.26646	GSE17721_LPS_VS_CPG_1H_BMDC_UP	181	-1.1411841	0.05882353	0.45531636	-2.4198649	-0.1374967
GO_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY	c5.GO molecular function	69	-1.2786714	0.06844106	0.2662725	GO_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY	85	1.4628055	0.005347594	0.28094235	0.1841341	-2.7414769
MELLMAN_TUT1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	18	-1.278399	0.15089513	0.2665095	MELLMAN_TUT1_TARGETS_UP	18	-0.9677425	0.45412844	0.7332195	-2.2461415	-0.3106565
GO_INFLAMMATORY_RESPONSE	c5.BP_ GO biological process	349	-1.2779515	0	0.2670659	GO_INFLAMMATORY_RESPONSE	374	1.3032724	0	0.43615746	0.0253209	-2.5812239
GO_ANCHORED_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE	c5.CC_ GO cellular component	17	-1.2778741	0.13535912	0.26700467	GO_ANCHORED_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE	19	1.7749038	0	0.052922662	0.4970297	-3.0527779
GO_ESTROGEN_RECEPTOR_BINDING	c5.GO molecular function	37	-1.2773576	0.10632184	0.26768205	GO_ESTROGEN_RECEPTOR_BINDING	38	-0.9061545	0.6624204	0.81436056	-2.1835121	-0.3712031
BIOCARTA_WNT_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	25	-1.2761142	0.12044818	0.26960683	BIOCARTA_WNT_PATHWAY	25	-0.78498113	0.8367347	0.91749936	-2.06109533	-0.49113307
GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN	C7_ immunologic signatures	178	-1.2759658	0.030864198	0.26965687	GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN	180	0.89640754	0.7598784	1	-0.37955826	-2.17237334
MODULE_165	c4.CM_ cancer modules	63	-1.2757647	0.090322584	0.26980376	MODULE_165	69	1.1309663	0.25438598	0.7051272	-0.1447984	-2.406731
GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	174	-1.2755088	0.01369863	0.27002358	GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	174	0.6112759	0.99490315	1	-0.6642329	-1.8867847
GCM_MSN	c4.CGN_ cancer gene neighborhoods	26	-1.2752112	0.12429378	0.2702782	GCM_MSN	26	-1.606507	0.02247191	0.08877747	-2.8817182	0.3312958
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN	C7_ immunologic signatures	174	-1.2750484	0.013245033	0.27031946	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN	174	0.76666814	0.9284274	1	-0.50838026	-2.04171654
KRAS.600_UP.V1_UP	C6_ oncogenic signatures	217	-1.2748848	0.04109589	0.27037436	KRAS.600_UP.V1_UP	233	1.1225909	0.18484849	0.72096694	-0.1522939	-2.3974757
GO_NEUROPEPTIDE_RECEPTOR_ACTIVITY	c5.GO molecular function	27	-1.2737136	0.12034384	0.2721513	GO_NEUROPEPTIDE_RECEPTOR_ACTIVITY	32	1.0738705	0.37710842	0.7988381	-0.1998431	-2.3475841
GO_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER	c5.BP_ GO biological process	69	-1.2730788	0.071698114	0.27303812	GO_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER	69	-1.4915993	0	0.1480462	-2.7646781	0.2185205
GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	161	-1.272999	0.036363635	0.27296475	GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN	168	0.7812438	0.90253806	1	-0.4917552	-2.0542428
GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP	C7_ immunologic signatures	173	-1.2725985	0.032051284	0.2734752	GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP	180	1.4233199	0.002022245	0.3180556	0.1507214	-2.6959184
GO_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION	c5.BP_ GO biological process	26	-1.2725438	0.12162162	0.27336586	GO_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION	26	-1.4220765	0.049723756	0.19270046	-2.6946203	0.1495327
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP	C7_ immunologic signatures	134	-1.2716726	0.038251366	0.27469897	GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP	139	0.9827785	0.5308642	0.9444865	-0.2888941	-2.2544511
MORF_SMC1L1	c4.CGN_ cancer gene neighborhoods	58	-1.2707207	0.09727626	0.27610517	MORF_SMC1L1	58	-2.774286	0	0	-4.0450067	1.5035653
GO_LEUKOTRIENE_METABOLIC_PROCESS	c5.BP_ GO biological process	23	-1.2706814	0.15642458	0.27596572	GO_LEUKOTRIENE_METABOLIC_PROCESS	26	1.7237116	0.002460025	0.06780624	0.4530302	-2.994393
GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN	C7_ immunologic signatures	136	-1.2705821	0.035353534	0.27593046	GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN	140	1.1761733	0.16257669	0.62766993	-0.0944088	-2.4467554
GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP	C7_ immunologic signatures	175	-1.270236	0.058064517	0.27629593	GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP	175	0.7314035	0.9573604	1	-0.5388325	-2.0016395
GO_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	29	-1.2692934	0.12732919	0.27772102	GO_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY	28	0.6882708	0.8944785	1	-0.5810226	-1.9575642
GO_CARBOHYDRATE_CATABOLIC_PROCESS	c5.BP_ GO biological process	96	-1.2692466	0.03982301	0.2775891	GO_CARBOHYDRATE_CATABOLIC_PROCESS	100	1.3645058	0.021989528	0.3729456	0.0952592	-2.6337524
GO_POSITIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	110	-1.2692351	0.04494382	0.27739927	GO_POSITIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION	115	1.135811	0.24537988	0.6956566	-0.1334241	-2.4050461
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	c2.CGP_ chemical and genetic perturbations	19	-1.2691373	0.1627907	0.27737522	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	19	0.95613414	0.51969504	0.97559154	-0.31300316	-2.22527144
USF2_Q6	c3.TFT_ transcription factor targets	224	-1.2688892	0.007352941	0.2775813	USF2_Q6	230	0.7981646	0.92160803	1	-0.4707246	-2.0670538
BACH2_01	c3.TFT_ transcription factor targets	234	-1.2688888	0.014705882	0.27737102	BACH2_01	245	1.1381004	0.16432866	0.6939936	-0.1307884	-2.4069892
GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN	C7_ immunologic signatures	168	-1.2683537	0.029850746	0.27811757	GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN	170	0.9122834	0.7199191	1	-0.3560703	-2.1806371
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	c2.CGP_ chemical and genetic perturbations	39	-1.2678219	0.10869565	0.2788021	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	40	-0.96735436	0.515625	0.73315483	-2.23517626	-0.30046754
GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	124	-1.267661	0.042105265	0.2789131	GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	127	1.2102327	0.12783505	0.57585865	-0.0574283	-2.4778937
GSE17721_0.5H_VS_4H_CPG_BMDC_UP	C7_ immunologic signatures	182	-1.2673985	0	0.27918258	GSE17721_0.5H_VS_4H_CPG_BMDC_UP	182	0.687814	0.98084676	1	-0.5795845	-1.9552125
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP	C7_ immunologic signatures	162	-1.2672012	0.034883723	0.27931786	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP	166	1.0176917	0.4587525	0.89378226	-0.2495095	-2.2848929
GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_BINDING	c5.GO molecular function	24	-1.2663518	0.1424581	0.28060737	GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_BINDING	25	-1.6401418	0.009756098	0.07644467	-2.9064936	0.37379
GUO_TARGETS_OF_IRS1_AND_IRS2	c2.CGP_ chemical and genetic perturbations	85	-1.2659703	0.030303031	0.2810826	GUO_TARGETS_OF_IRS1_AND_IRS2	88	0.83823794	0.77942735	1	-0.42773236	-2.10420824
GO_NADP_BINDING	c5.GO molecular function	36	-1.265635	0.10130719	0.28151134	GO_NADP_BINDING	39	-0.7971044	0.8125	0.9089686	-2.0627394	-0.4685306
GO_NUCLEOID	c5.CC_ GO cellular component	36	-1.2655839	0.119873814	0.28137872	GO_NUCLEOID	37	0.8660066	0.69473684	1	-0.3995773	-2.1315905
GSE40493_BCL6_KO_VS_WT_TREG_DN	C7_ immunologic signatures	81	-1.2650603	0.09274194	0.28210068	GSE40493_BCL6_KO_VS_WT_TREG_DN	90	1.1193918	0.278481	0.7239926	-0.1456685	-2.3844521
GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_DN	C7_ immunologic signatures	137	-1.2650485	0.04597701	0.28191486	GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_DN	142	1.0704203	0.35619244	0.8043296	-0.1946282	-2.3354688
KEGG_THYROID_CANCER	c2.CP_BIOCARTA_ BioCarta gene sets	29	-1.2646447	0.13623188	0.28239608	KEGG_THYROID_CANCER	29	-1.2671312	0.11731844	0.30928615	-2.5317759	0.0024865
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	c2.CGP_ chemical and genetic perturbations	25	-1.2645794	0.1762918	0.2823046	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	27	1.027291	0.4480198	0.8804601	-0.2372884	-2.2918704
GO_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION	c5.BP_ GO biological process	15	-1.2639883	0.16497461	0.2831625	GO_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION	15	-1.1661439	0.265625	0.4224791	-2.4301322	-0.0978444
GO_IRON_ION_TRANSPORT	c5.BP_ GO biological process	49	-1.2639015	0.09122807	0.2831256	GO_IRON_ION_TRANSPORT	51	1.2339138	0.15261959	0.5352784	-0.0299877	-2.4978153
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP	C7_ immunologic signatures	159	-1.2638578	0.027624309	0.2829961	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP	162	0.88187724	0.75177306	1	-0.38198056	-2.14573504
GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP	C7_ immunologic signatures	177	-1.2635943	0.018518519	0.28322667	GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP	179	-0.78569573	1	0.9168677	-2.04929003	-0.47789857
MORF_PPP2R5E	c4.CGN_ cancer gene neighborhoods	80	-1.2630305	0.07234043	0.28398883	MORF_PPP2R5E	80	-1.4861805	0	0.15090379	-2.749211	0.22315
GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN	C7_ immunologic signatures	189	-1.2626069	0.030534351	0.28451174	GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN	189	-1.7370119	0	0.046894982	-2.9996188	0.474405
GCM_MYCL1	c4.CGN_ cancer gene neighborhoods	20	-1.2624805	0.14054054	0.28454757	GCM_MYCL1	21	0.74670726	0.81101376	1	-0.51577324	-2.00918776
REACTOME_METABOLISM_OF_NON_CODING_RNA	c2.CP_REACTOME_ Reactome gene sets	46	-1.2623037	0.12080537	0.28463525	REACTOME_METABOLISM_OF_NON_CODING_RNA	46	-2.0679238	0	0.0039812	-3.3302275	0.8056201
REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION	c2.CP_REACTOME_ Reactome gene sets	23	-1.2619127	0.16574585	0.28510308	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION	23	-0.8189761	0.7777778	0.8896441	-2.0808888	-0.4429366
GO_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS	c5.BP_ GO biological process	67	-1.2615498	0.10810811	0.28555554	GO_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS	67	0.98564684	0.5282609	0.941609	-0.27590296	-2.24719664
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	c2.CGP_ chemical and genetic perturbations	75	-1.2614431	0.1	0.2855417	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	78	0.7890268	0.8342246	1	-0.4724163	-2.0504699
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP	C7_ immunologic signatures	192	-1.2614421	0.020408163	0.28533393	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP	192	0.56962216	1	1	-0.69181994	-1.83106426
GO_POSITIVE_REGULATION_OF_INSULIN_SECRETION	c5.BP_ GO biological process	51	-1.2612804	0.06920415	0.28538507	GO_POSITIVE_REGULATION_OF_INSULIN_SECRETION	57	0.7374756	0.88189846	1	-0.5238048	-1.998756
DORN_ADENOVIRUS_INFECTION_12HR_DN	c2.CGP_ chemical and genetic perturbations	29	-1.2610874	0.1491228	0.28549278	DORN_ADENOVIRUS_INFECTION_12HR_DN	29	-0.82960504	0.78651685	0.8829542	-2.09069244	-0.43148236
GO_REGULATION_OF_INTERLEUKIN_10_PRODUCTION	c5.BP_ GO biological process	37	-1.2610601	0.13249211	0.2853246	GO_REGULATION_OF_INTERLEUKIN_10_PRODUCTION	38	1.1335726	0.27972028	0.7008581	-0.1274875	-2.3946327
GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP	C7_ immunologic signatures	159	-1.2610141	0.032432433	0.28520504	GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP	160	0.5542877	1	1	-0.7067264	-1.8153018
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR	c5.GO molecular function	31	-1.2607327	0.12232416	0.28547734	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR	32	1.2960709	0.13780919	0.44805565	0.0353382	-2.5568036
MODULE_219	c4.CM_ cancer modules	22	-1.2606876	0.1741573	0.28534842	MODULE_219	22	-1.7569977	0	0.041658398	-3.0176853	0.4963101
GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP	C7_ immunologic signatures	179	-1.2605861	0.006993007	0.28532663	GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP	179	-0.8200571	1	0.88991874	-2.0806432	-0.440529
GO_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	c5.GO molecular function	27	-1.2604924	0.16034986	0.28529277	GO_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	27	1.2668221	0.14661655	0.4888813	0.0063297	-2.5273145
GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN	C7_ immunologic signatures	161	-1.2602181	0.006289308	0.2855807	GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN	167	1.3011303	0.028282829	0.43936834	0.0409122	-2.5613484
GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN	C7_ immunologic signatures	169	-1.26001	0.013071896	0.28577083	GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN	169	0.885368	0.739615	1	-0.374642	-2.145378
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	c2.CGP_ chemical and genetic perturbations	70	-1.2600005	0.05928854	0.28558114	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	72	0.774652	0.85897434	1	-0.4853485	-2.0346525
GO_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION	c5.BP_ GO biological process	61	-1.2599934	0.0862069	0.28538114	GO_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION	65	1.034784	0.42701524	0.86826986	-0.2252094	-2.2947774
GO_FATTY_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	93	-1.2595123	0.06880734	0.2860513	GO_FATTY_ACID_BIOSYNTHETIC_PROCESS	98	1.295179	0.057142857	0.44919166	0.0356667	-2.5546913
GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP	C7_ immunologic signatures	153	-1.2594069	0.030120483	0.28604674	GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP	176	1.0967803	0.2734694	0.76132494	-0.1626266	-2.3561872
GO_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE	c5.BP_ GO biological process	180	-1.2593726	0.04511278	0.28590694	GO_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE	184	0.8494253	0.8208502	1	-0.4099473	-2.1087979
KEGG_STARCH_AND_SUCROSE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	33	-1.2590057	0.13554217	0.28632787	KEGG_STARCH_AND_SUCROSE_METABOLISM	36	0.80444175	0.77389276	1	-0.45456395	-2.06344745
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	c2.CP_REACTOME_ Reactome gene sets	29	-1.2586004	0.13249211	0.28684738	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	30	1.2789707	0.14064363	0.47239798	0.0203703	-2.5375711
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	c2.CGP_ chemical and genetic perturbations	61	-1.258369	0.08365019	0.2870412	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	62	-1.7181087	0	0.051279403	-2.9764777	0.4597397
GNF2_CARD15	c4.CGN_ cancer gene neighborhoods	51	-1.2580643	0.091836736	0.28738177	GNF2_CARD15	52	1.4178121	0.033670034	0.31986234	0.1597478	-2.6758764
GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	179	-1.2579757	0.027210884	0.28731856	GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_UP	181	0.9169689	0.7030303	1	-0.3410068	-2.1749446
MODULE_280	c4.CM_ cancer modules	36	-1.2579218	0.12751678	0.28721505	MODULE_280	40	1.0998131	0.35069445	0.75741184	-0.1581087	-2.3577349
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	c2.CGP_ chemical and genetic perturbations	326	-1.2579052	0	0.28703466	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	328	-1.3763189	0	0.22350778	-2.6342241	0.1184137
GO_REGULATION_OF_TRANSLATIONAL_ELONGATION	c5.BP_ GO biological process	21	-1.2578442	0.15406163	0.28692263	GO_REGULATION_OF_TRANSLATIONAL_ELONGATION	21	-1.4013479	0.052380953	0.20592357	-2.6591921	0.1435037
GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_UP	C7_ immunologic signatures	169	-1.257756	0.031847134	0.2868771	GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_UP	184	1.0488678	0.37638748	0.84212315	-0.2088882	-2.3066238
GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN	C7_ immunologic signatures	177	-1.2573467	0.040268455	0.28740212	GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN	179	0.7585477	0.93346775	1	-0.498799	-2.0158944
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	c2.CP_BIOCARTA_ BioCarta gene sets	50	-1.2571828	0.123188406	0.28746125	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	48	0.8340747	0.7508343	1	-0.4231081	-2.0912575
BARRIER_COLON_CANCER_RECURRENCE_UP	c2.CGP_ chemical and genetic perturbations	37	-1.256973	0.11217949	0.28764534	BARRIER_COLON_CANCER_RECURRENCE_UP	38	0.8748452	0.6863426	1	-0.3821278	-2.1318182
GSE17721_LPS_VS_POLYIC_6H_BMDC_UP	C7_ immunologic signatures	176	-1.256517	0.012738854	0.2882484	GSE17721_LPS_VS_POLYIC_6H_BMDC_UP	176	-1.1542617	0	0.43845716	-2.4107787	-0.1022553
GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP	C7_ immunologic signatures	154	-1.2565005	0.016666668	0.28807515	GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP	155	-0.9422229	0.45454547	0.7659143	-2.1987234	-0.3142776
GO_MACROLIDE_BINDING	c5.GO molecular function	18	-1.2564765	0.18767507	0.28790227	GO_MACROLIDE_BINDING	18	0.967082	0.53972256	0.9644099	-0.2893945	-2.2235585
GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN	C7_ immunologic signatures	171	-1.2564427	0.040229887	0.28775656	GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN	175	-0.82830095	1	0.88375276	-2.08474365	-0.42814175
GO_TOXIN_TRANSPORT	c5.BP_ GO biological process	34	-1.256361	0.13213213	0.28770322	GO_TOXIN_TRANSPORT	34	0.57508796	0.9787485	1	-0.68127304	-1.83144896
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	c2.CP_REACTOME_ Reactome gene sets	60	-1.2559571	0.11034483	0.2882687	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	61	-0.87304157	0.8111111	0.8519292	-2.12899867	-0.38291553
GO_PRIMARY_ALCOHOL_METABOLIC_PROCESS	c5.BP_ GO biological process	41	-1.2558924	0.12328767	0.2881724	GO_PRIMARY_ALCOHOL_METABOLIC_PROCESS	40	1.5468391	0.009111618	0.20692615	0.2909467	-2.8027315
MODULE_265	c4.CM_ cancer modules	27	-1.2558365	0.12760417	0.2880588	MODULE_265	28	0.8078894	0.75464684	1	-0.4479471	-2.0637259
GSE27434_WT_VS_DNMT1_KO_TREG_UP	C7_ immunologic signatures	168	-1.2553426	0.01183432	0.28879476	GSE27434_WT_VS_DNMT1_KO_TREG_UP	171	0.7531567	0.9313824	1	-0.5021859	-2.0084993
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP	C7_ immunologic signatures	162	-1.2552396	0.034883723	0.28875354	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP	162	1.2346598	0.07558733	0.5340476	-0.0205798	-2.4898994
KEGG_ALLOGRAFT_REJECTION	c2.CP_BIOCARTA_ BioCarta gene sets	17	-1.2547932	0.16531165	0.28936392	KEGG_ALLOGRAFT_REJECTION	18	1.3813205	0.0821382	0.35649592	0.1265273	-2.6361137
GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_DN	C7_ immunologic signatures	151	-1.2546937	0.040229887	0.2893444	GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_DN	155	0.6923494	0.97861505	1	-0.5623443	-1.9470431
GO_CYTOPLASMIC_STRESS_GRANULE	c5.CC_ GO cellular component	30	-1.2546914	0.13428572	0.2891381	GO_CYTOPLASMIC_STRESS_GRANULE	30	-1.2995752	0.09146342	0.2838299	-2.5542666	0.0448838
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	C7_ immunologic signatures	169	-1.2543024	0.039215688	0.28963766	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	172	-1.2790445	0	0.30276278	-2.5333469	0.0247421
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	c2.CGP_ chemical and genetic perturbations	24	-1.253977	0.15141957	0.28999868	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	23	-1.4031307	0.054347824	0.20394044	-2.6571077	0.1491537
GO_COPI_COATED_VESICLE_MEMBRANE	c5.CC_ GO cellular component	16	-1.2539731	0.1603261	0.2897967	GO_COPI_COATED_VESICLE_MEMBRANE	16	-1.0089407	0.44758064	0.674951	-2.2629138	-0.2450324
GSE25087_TREG_VS_TCONV_ADULT_DN	C7_ immunologic signatures	152	-1.2539655	0.012578616	0.28959745	GSE25087_TREG_VS_TCONV_ADULT_DN	150	1.0515484	0.38250256	0.8368557	-0.2024171	-2.3055139
MORF_MSH2	c4.CGN_ cancer gene neighborhoods	58	-1.2533276	0.094339624	0.2905322	MORF_MSH2	58	-2.1399276	0	0.001792544	-3.3932552	0.8866
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	176	-1.2532245	0.051948052	0.2905179	GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	180	-1.1251503	0.055555556	0.47931525	-2.3783748	-0.1280742
GSE3982_MAST_CELL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	177	-1.2528716	0.025157232	0.29101452	GSE3982_MAST_CELL_VS_NEUTROPHIL_UP	179	0.6113154	1	1	-0.6415562	-1.864187
GO_PEPTIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	20	-1.2526473	0.1707989	0.29122564	GO_PEPTIDE_CATABOLIC_PROCESS	21	1.3956165	0.064556964	0.3472569	0.1429692	-2.6482638
GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN	C7_ immunologic signatures	155	-1.2525656	0.030303031	0.29116952	GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN	156	0.9995336	0.490316	0.924392	-0.253032	-2.2520992
GO_RESPONSE_TO_ZINC_ION	c5.BP_ GO biological process	43	-1.2523586	0.11801242	0.29130468	GO_RESPONSE_TO_ZINC_ION	44	0.7136174	0.89432704	1	-0.5387412	-1.965976
GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP	C7_ immunologic signatures	152	-1.2521313	0.037037037	0.29152054	GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP	160	0.83344513	0.8343496	1	-0.41868617	-2.08557643
GSE17721_POLYIC_VS_CPG_16H_BMDC_DN	C7_ immunologic signatures	174	-1.2520461	0.014285714	0.29146668	GSE17721_POLYIC_VS_CPG_16H_BMDC_DN	181	0.5939024	0.9969574	1	-0.6581437	-1.8459485
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP	C7_ immunologic signatures	173	-1.2519941	0.052287582	0.2913327	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP	177	1.178694	0.12815338	0.62355053	-0.0733001	-2.4306881
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	c2.CGP_ chemical and genetic perturbations	112	-1.251929	0.06926407	0.2912279	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	113	0.6723526	0.975052	1	-0.5795764	-1.9242816
GSE3982_MAC_VS_BCELL_DN	C7_ immunologic signatures	164	-1.2515299	0.042682927	0.29170755	GSE3982_MAC_VS_BCELL_DN	167	1.0276892	0.439471	0.8798153	-0.2238407	-2.2792191
ZHAN_MULTIPLE_MYELOMA_CD2_DN	c2.CGP_ chemical and genetic perturbations	44	-1.2512119	0.13712375	0.29209745	ZHAN_MULTIPLE_MYELOMA_CD2_DN	44	1.0200139	0.4491917	0.8913368	-0.231198	-2.2712258
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP	C7_ immunologic signatures	185	-1.2509052	0.03164557	0.29248625	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP	185	-0.89618534	0.7692308	0.82715636	-2.14709054	-0.35471986
GO_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING	c5.BP_ GO biological process	124	-1.2507195	0.046153847	0.29262006	GO_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING	131	1.5587223	0	0.19816452	0.3080028	-2.8094418
GSE17721_12H_VS_24H_CPG_BMDC_DN	C7_ immunologic signatures	183	-1.250428	0.035714287	0.2929194	GSE17721_12H_VS_24H_CPG_BMDC_DN	184	-0.83838433	1	0.87648433	-2.08881233	-0.41204367
ENK_UV_RESPONSE_EPIDERMIS_UP	c2.CGP_ chemical and genetic perturbations	257	-1.2503139	0	0.2929188	ENK_UV_RESPONSE_EPIDERMIS_UP	261	0.78209496	0.9287149	1	-0.46821894	-2.03240886
GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP	C7_ immunologic signatures	171	-1.2502602	0.023952097	0.29280975	GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP	171	-0.7733305	1	0.9253055	-2.0235907	-0.4769297
GO_DYNEIN_BINDING	c5.GO molecular function	24	-1.2502091	0.13960114	0.2927081	GO_DYNEIN_BINDING	24	0.88138014	0.67336684	1	-0.36882896	-2.13158924
MODULE_447	c4.CM_ cancer modules	37	-1.2501549	0.13960114	0.29258946	MODULE_447	37	0.5583697	0.98124266	1	-0.6917852	-1.8085246
GO_CARBOHYDRATE_PHOSPHORYLATION	c5.BP_ GO biological process	19	-1.2495705	0.1764706	0.2934234	GO_CARBOHYDRATE_PHOSPHORYLATION	20	0.9401836	0.55754477	0.98962617	-0.3093869	-2.1897541
GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP	C7_ immunologic signatures	167	-1.2494661	0.030864198	0.29339615	GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP	170	-0.9112915	0.8181818	0.80597854	-2.1607576	-0.3381746
KEGG_HISTIDINE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	26	-1.2494044	0.13772455	0.29330963	KEGG_HISTIDINE_METABOLISM	26	1.4227221	0.044499382	0.31833163	0.1733177	-2.6721265
GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN	C7_ immunologic signatures	169	-1.2492461	0.029239766	0.29340675	GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN	174	-0.9613895	0.7777778	0.7412505	-2.2106356	-0.2878566
GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	178	-1.2490464	0.040935673	0.29357645	GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN	180	1.1560444	0.16868687	0.6603991	-0.093002	-2.4050908
GO_CARBOHYDRATE_KINASE_ACTIVITY	c5.GO molecular function	18	-1.2489039	0.16172507	0.29363465	GO_CARBOHYDRATE_KINASE_ACTIVITY	19	0.9871034	0.48701298	0.93934727	-0.2618005	-2.2360073
GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP	C7_ immunologic signatures	171	-1.2483617	0.013071896	0.29442227	GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP	176	0.6900317	0.9817998	1	-0.55833	-1.9383934
SANSOM_APC_TARGETS_REQUIRE_MYC	c2.CGP_ chemical and genetic perturbations	183	-1.2482814	0.026845638	0.29434898	SANSOM_APC_TARGETS_REQUIRE_MYC	185	0.7096328	0.97148675	1	-0.5386486	-1.9579142
ZHANG_GATA6_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	56	-1.2476648	0.10600707	0.29524663	ZHANG_GATA6_TARGETS_DN	58	0.8487052	0.73754156	1	-0.3989596	-2.09637
MODULE_355	c4.CM_ cancer modules	26	-1.2475795	0.12721893	0.29520404	MODULE_355	26	0.7074674	0.8875154	1	-0.5401121	-1.9550469
GO_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	315	-1.247259	0.04040404	0.29559112	GO_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS	315	-0.90180653	1	0.8188389	-2.14906553	-0.34545247
GSE27896_HDAC6_KO_VS_WT_TREG_DN	C7_ immunologic signatures	146	-1.2471145	0.057291668	0.295678	GSE27896_HDAC6_KO_VS_WT_TREG_DN	150	0.6591839	0.97759676	1	-0.5879306	-1.9062984
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	c2.CGP_ chemical and genetic perturbations	30	-1.2470349	0.13294798	0.29560798	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	30	0.7088301	0.8842482	1	-0.5382048	-1.955865
GNF2_RAB3A	c4.CGN_ cancer gene neighborhoods	35	-1.2466286	0.16320474	0.2961089	GNF2_RAB3A	37	1.3286322	0.08372641	0.40377718	0.0820036	-2.5752608
GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	180	-1.2464627	0.03731343	0.29618177	GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP	181	-0.9067408	0.9411765	0.81396425	-2.1532035	-0.3397219
IL15_UP.V1_UP	C6_ oncogenic signatures	152	-1.2464328	0.020547945	0.29603687	IL15_UP.V1_UP	159	1.0469635	0.3916582	0.8448893	-0.1994693	-2.2933963
REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	c2.CP_REACTOME_ Reactome gene sets	90	-1.2461907	0.06637168	0.296251	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	90	-1.8972232	0	0.017978648	-3.1434139	0.6510325
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	c2.CGP_ chemical and genetic perturbations	460	-1.2461573	0	0.29611805	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	473	0.778962	0.983	1	-0.4671953	-2.0251193
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	c2.CGP_ chemical and genetic perturbations	176	-1.2460544	0.018181818	0.2960865	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	177	-1.5273527	0	0.12652047	-2.7734071	0.2812983
PID_RAC1_PATHWAY	c2.CP_ Canonical pathways	53	-1.2459767	0.10181818	0.2960208	PID_RAC1_PATHWAY	54	-0.9621797	0.5858586	0.7395724	-2.2081564	-0.283797
GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN	C7_ immunologic signatures	171	-1.2459232	0.026143791	0.2959092	GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN	174	0.9023517	0.72717947	1	-0.3435715	-2.1482749
JIANG_HYPOXIA_VIA_VHL	c2.CGP_ chemical and genetic perturbations	32	-1.245894	0.13455658	0.29575664	JIANG_HYPOXIA_VIA_VHL	32	-1.2822441	0.10404624	0.29986408	-2.5281381	0.0363501
GO_UDP_GALACTOSYLTRANSFERASE_ACTIVITY	c5.GO molecular function	24	-1.2457747	0.16393442	0.295763	GO_UDP_GALACTOSYLTRANSFERASE_ACTIVITY	25	0.9524046	0.55694616	0.9790173	-0.2933701	-2.1981793
REACTOME_PROTEIN_FOLDING	c2.CP_REACTOME_ Reactome gene sets	49	-1.2455697	0.104166664	0.29591668	REACTOME_PROTEIN_FOLDING	50	1.0196354	0.4440678	0.89143664	-0.2259343	-2.2652051
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN	C7_ immunologic signatures	165	-1.2452848	0.044025157	0.29623687	GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN	165	1.5528337	0	0.20621827	0.3075489	-2.7981185
GO_BETA_CATENIN_TCF_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	31	-1.2452544	0.13333334	0.2960863	GO_BETA_CATENIN_TCF_COMPLEX_ASSEMBLY	31	0.7057498	0.8876812	1	-0.5395046	-1.9510042
KAAB_FAILED_HEART_VENTRICLE_DN	c2.CGP_ chemical and genetic perturbations	36	-1.2451506	0.13017751	0.2960737	KAAB_FAILED_HEART_VENTRICLE_DN	38	1.0716295	0.3593023	0.80300575	-0.1735211	-2.3167801
GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_BINDING	c5.GO molecular function	80	-1.2448026	0.09126984	0.29651502	GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_BINDING	86	-1.1596452	0.10638298	0.4309177	-2.4044478	-0.0851574
GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN	C7_ immunologic signatures	149	-1.2446764	0.07386363	0.29655886	GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN	150	1.1122977	0.24640657	0.7341565	-0.1323787	-2.3569741
GO_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA	c5.BP_ GO biological process	40	-1.244278	0.13513513	0.29711768	GO_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA	40	0.8830598	0.6565774	1	-0.3612182	-2.1273378
GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	153	-1.2442454	0.006097561	0.29697046	GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP	153	1.1964234	0.13176711	0.5962376	-0.047822	-2.4406688
GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN	C7_ immunologic signatures	91	-1.2442074	0.11158799	0.29683664	GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN	93	-1.3527658	0	0.24064729	-2.5969732	0.1085584
BOUDOUKHA_BOUND_BY_IGF2BP2	c2.CGP_ chemical and genetic perturbations	96	-1.2441818	0.075555556	0.296668	BOUDOUKHA_BOUND_BY_IGF2BP2	97	0.7926524	0.8673036	1	-0.4515294	-2.0368342
DEN_INTERACT_WITH_LCA5	c2.CGP_ chemical and genetic perturbations	23	-1.244128	0.16480447	0.29656413	DEN_INTERACT_WITH_LCA5	23	-1.6947606	0.004854369	0.057635117	-2.9388886	0.4506326
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	c2.CGP_ chemical and genetic perturbations	30	-1.2439884	0.12537314	0.29662213	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	30	1.0137924	0.46980676	0.90014774	-0.230196	-2.2577808
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	c2.CGP_ chemical and genetic perturbations	128	-1.243807	0.082125604	0.29676998	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	128	0.9160818	0.6786448	1	-0.3277252	-2.1598888
KIM_TIAL1_TARGETS	c2.CGP_ chemical and genetic perturbations	28	-1.2438015	0.13455658	0.29657617	KIM_TIAL1_TARGETS	29	0.8942639	0.62484473	1	-0.3495376	-2.1380654
GO_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN	c5.BP_ GO biological process	39	-1.2437823	0.110091746	0.2964157	GO_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN	39	-0.84456354	0.8057554	0.8723675	-2.08834584	-0.39921876
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	c2.CGP_ chemical and genetic perturbations	170	-1.2434702	0.048780486	0.2968005	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	170	0.9556578	0.5975733	0.97586495	-0.2878124	-2.199128
GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN	C7_ immunologic signatures	174	-1.2432017	0.029411765	0.2970914	GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN	181	0.9752072	0.55915064	0.95569944	-0.2679945	-2.2184089
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS	c5.GO molecular function	41	-1.243079	0.10526316	0.2971152	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS	41	0.83024216	0.7406977	1	-0.41283684	-2.07332116
GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN	C7_ immunologic signatures	173	-1.2429348	0.045454547	0.29716203	GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN	180	1.0420717	0.39979756	0.8552155	-0.2008631	-2.2850065
GO_ALPHA_AMINO_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	68	-1.2428353	0.074074075	0.29715025	GO_ALPHA_AMINO_ACID_BIOSYNTHETIC_PROCESS	72	-1.3348012	0.030303031	0.25225636	-2.5776365	0.0919659
GO_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM	c5.BP_ GO biological process	18	-1.2427784	0.17548746	0.29705346	GO_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM	18	-1.4175733	0.10280374	0.19522403	-2.6603517	0.1747949
GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_OUTER_MEMBRANE	c5.CC_ GO cellular component	20	-1.2426976	0.14488636	0.29700616	GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_OUTER_MEMBRANE	20	-0.84564054	0.65656567	0.87204975	-2.08833814	-0.39705706
GSE40273_EOS_KO_VS_WT_TREG_UP	C7_ immunologic signatures	178	-1.2426661	0.04761905	0.29685712	GSE40273_EOS_KO_VS_WT_TREG_UP	176	0.8060331	0.89344263	1	-0.436633	-2.0486992
BIOCARTA_TH1TH2_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	-1.2421454	0.18051577	0.29761344	BIOCARTA_TH1TH2_PATHWAY	15	-1.259135	0.16949153	0.31528676	-2.5012804	0.0169896
MODULE_87	c4.CM_ cancer modules	42	-1.2418733	0.14330219	0.2979115	MODULE_87	42	-1.0572674	0.37226278	0.59394	-2.2991407	-0.1846059
GO_RNA_POLYMERASE_II_TRANSCRIPTION_COFACTOR_ACTIVITY	c5.GO molecular function	84	-1.2417984	0.06719368	0.2978572	GO_RNA_POLYMERASE_II_TRANSCRIPTION_COFACTOR_ACTIVITY	84	-1.3134967	0.050847456	0.2716667	-2.5552951	0.0716983
GO_DECIDUALIZATION	c5.BP_ GO biological process	19	-1.2415706	0.16208792	0.29810604	GO_DECIDUALIZATION	20	1.2050606	0.24678664	0.5824024	-0.03651	-2.4466312
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN	C7_ immunologic signatures	176	-1.2415384	0.025316456	0.29797223	GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN	176	-1.0153856	0.55	0.665958	-2.256924	-0.2261528
BECKER_TAMOXIFEN_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	46	-1.2414905	0.10958904	0.29786557	BECKER_TAMOXIFEN_RESISTANCE_DN	45	-1.1217123	0.2601626	0.48639867	-2.3632028	-0.1197782
GCM_CDH5	c4.CGN_ cancer gene neighborhoods	26	-1.2411242	0.16223404	0.2983325	GCM_CDH5	32	0.9210522	0.61474437	1	-0.320072	-2.1621764
GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN	C7_ immunologic signatures	171	-1.2408342	0.036809817	0.29867047	GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN	176	0.7928217	0.8970737	1	-0.4480125	-2.0336559
GSE17721_LPS_VS_POLYIC_12H_BMDC_UP	C7_ immunologic signatures	182	-1.2408339	0.025806451	0.29846632	GSE17721_LPS_VS_POLYIC_12H_BMDC_UP	186	0.61648035	0.9949799	1	-0.62435355	-1.85731425
GO_MONOSACCHARIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	168	-1.2404107	0.036363635	0.29906356	GO_MONOSACCHARIDE_METABOLIC_PROCESS	178	1.0477085	0.39556003	0.8438553	-0.1927022	-2.2881192
GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	178	-1.2403083	0.040268455	0.29905573	GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP	177	0.96602374	0.577665	0.9648386	-0.27428456	-2.20633204
GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN	C7_ immunologic signatures	163	-1.240151	0.04375	0.29913247	GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN	166	1.0482445	0.4048583	0.84287214	-0.1919065	-2.2883955
GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	180	-1.2401426	0.042424243	0.2989432	GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP	186	0.8398237	0.83484393	1	-0.4003189	-2.0799663
MA_MYELOID_DIFFERENTIATION_DN	c2.CGP_ chemical and genetic perturbations	38	-1.2400919	0.13694267	0.29883954	MA_MYELOID_DIFFERENTIATION_DN	40	1.0895903	0.33904108	0.7715713	-0.1505016	-2.3296822
GO_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	58	-1.2400132	0.12142857	0.29877546	GO_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS	63	0.73928756	0.90133035	1	-0.50072564	-1.97930076
DORN_ADENOVIRUS_INFECTION_32HR_DN	c2.CGP_ chemical and genetic perturbations	35	-1.2395864	0.14739884	0.2993791	DORN_ADENOVIRUS_INFECTION_32HR_DN	36	0.8481423	0.71664697	1	-0.3914441	-2.0877287
GO_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS	c5.BP_ GO biological process	15	-1.2393569	0.19143577	0.29959404	GO_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS	15	-0.8707558	0.6331878	0.8538988	-2.1101127	-0.3686011
GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN	C7_ immunologic signatures	167	-1.2392969	0.017441861	0.29951814	GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN	172	0.771039	0.9252525	1	-0.4682579	-2.0103359
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	c2.CGP_ chemical and genetic perturbations	111	-1.2392944	0.05	0.29931885	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	125	1.4375217	0.007179487	0.30793494	0.1982273	-2.6768161
GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP	C7_ immunologic signatures	178	-1.2391617	0.0375	0.29934815	GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP	180	0.7611678	0.93434346	1	-0.4779939	-2.0003295
GO_LAMELLIPODIUM_MEMBRANE	c5.CC_ GO cellular component	19	-1.2391047	0.1521739	0.29925653	GO_LAMELLIPODIUM_MEMBRANE	19	1.1097317	0.34221038	0.7384692	-0.129373	-2.3488364
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	183	-1.2387954	0.047945205	0.29962486	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN	184	-1.813861	0	0.030837808	-3.0526564	0.5750656
GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP	C7_ immunologic signatures	177	-1.2387295	0.050632913	0.29954028	GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP	177	-1.0967448	0.2	0.5228398	-2.3354743	-0.1419847
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP	C7_ immunologic signatures	184	-1.2382975	0.046666667	0.3001411	GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP	185	0.6833864	0.975435	1	-0.5549111	-1.9216839
GO_CALCIUM_DEPENDENT_PROTEIN_BINDING	c5.GO molecular function	49	-1.2382389	0.11904762	0.30003864	GO_CALCIUM_DEPENDENT_PROTEIN_BINDING	52	1.1457127	0.28076062	0.67788875	-0.0925262	-2.3839516
GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP	C7_ immunologic signatures	91	-1.2374976	0.052863438	0.3012217	GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP	105	1.0780925	0.3533058	0.79138994	-0.1594051	-2.3155901
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_DN	C7_ immunologic signatures	173	-1.2371174	0.03311258	0.3017217	GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_DN	173	-0.70315814	1	0.9595471	-1.94027554	-0.53395926
GSE22886_NAIVE_CD8_TCELL_VS_DC_DN	C7_ immunologic signatures	177	-1.2366742	0.028368793	0.302386	GSE22886_NAIVE_CD8_TCELL_VS_DC_DN	180	0.82363284	0.86653185	1	-0.41304136	-2.06030704
ZHENG_RESPONSE_TO_ARSENITE_DN	c2.CGP_ chemical and genetic perturbations	17	-1.2365881	0.1923077	0.3023276	ZHENG_RESPONSE_TO_ARSENITE_DN	17	0.9559649	0.5429293	0.9760312	-0.2806232	-2.192553
AP1_01	c3.TFT_ transcription factor targets	227	-1.2365476	0.018867925	0.30219334	AP1_01	234	1.1651682	0.11534604	0.646046	-0.0713794	-2.4017158
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	c2.CGP_ chemical and genetic perturbations	16	-1.2362418	0.1775457	0.3025932	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	19	1.1509926	0.29820052	0.66825384	-0.0852492	-2.3872344
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	c2.CGP_ chemical and genetic perturbations	70	-1.2362114	0.10080645	0.3024387	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	74	1.5814679	0	0.17691131	0.3452565	-2.8176793
GSE27786_CD8_TCELL_VS_NKCELL_UP	C7_ immunologic signatures	176	-1.2362036	0.034722224	0.302249	GSE27786_CD8_TCELL_VS_NKCELL_UP	183	0.6619235	0.9929435	1	-0.5742801	-1.8981271
SINGH_KRAS_DEPENDENCY_SIGNATURE_	C6_ oncogenic signatures	18	-1.2361609	0.17615177	0.302136	SINGH_KRAS_DEPENDENCY_SIGNATURE_	17	1.3920816	0.06622516	0.3465483	0.1559207	-2.6282425
GO_COFACTOR_TRANSPORT	c5.BP_ GO biological process	24	-1.2360507	0.15963855	0.30213946	GO_COFACTOR_TRANSPORT	25	1.3093698	0.13167702	0.4269117	0.0733191	-2.5454205
GNF2_ICAM3	c4.CGN_ cancer gene neighborhoods	32	-1.23524	0.1491228	0.30350485	GNF2_ICAM3	31	0.97528523	0.5392039	0.9559577	-0.25995477	-2.21052523
GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP	C7_ immunologic signatures	162	-1.234983	0.044198897	0.30377275	GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP	167	1.1455417	0.19266056	0.6781677	-0.0894413	-2.3805247
REACTOME_SIGNAL_TRANSDUCTION_BY_L1	c2.CP_REACTOME_ Reactome gene sets	34	-1.2348539	0.14089347	0.30382094	REACTOME_SIGNAL_TRANSDUCTION_BY_L1	34	0.83842295	0.728655	1	-0.39643095	-2.07327685
MODULE_363	c4.CM_ cancer modules	41	-1.2347058	0.12084592	0.3038854	MODULE_363	41	0.50594556	0.99771166	1	-0.72876024	-1.74065136
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	c2.CP_BIOCARTA_ BioCarta gene sets	41	-1.2346039	0.140625	0.3038718	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	41	-1.4604306	0	0.16618975	-2.6950345	0.2258267
GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_DN	C7_ immunologic signatures	179	-1.2344567	0.038709678	0.30391282	GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_DN	184	-0.83611846	0.94736844	0.8773859	-2.07057516	-0.39833824
SIG_CHEMOTAXIS	c2.CP_ Canonical pathways	42	-1.2343252	0.14102565	0.30398056	SIG_CHEMOTAXIS	42	0.8561069	0.7098266	1	-0.3782183	-2.0904321
GO_FATTY_ACID_TRANSPORT	c5.BP_ GO biological process	44	-1.2340788	0.13268608	0.30426407	GO_FATTY_ACID_TRANSPORT	53	1.4786423	0.012222222	0.26974222	0.2445635	-2.7127211
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	c2.CGP_ chemical and genetic perturbations	159	-1.233905	0.02259887	0.30437782	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	164	1.1169533	0.23014256	0.7285035	-0.1169517	-2.3508583
GO_OLIGOSACCHARIDE_LIPID_INTERMEDIATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	19	-1.2338287	0.20304568	0.3043201	GO_OLIGOSACCHARIDE_LIPID_INTERMEDIATE_BIOSYNTHETIC_PROCESS	19	-0.9141624	0.539823	0.8019482	-2.1479911	-0.3196663
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_UP	C7_ immunologic signatures	143	-1.2336309	0.041666668	0.3044762	GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_UP	145	0.72103643	0.94165814	1	-0.51259447	-1.95466733
GO_SPINAL_CORD_PATTERNING	c5.BP_ GO biological process	21	-1.2333611	0.16804408	0.30477467	GO_SPINAL_CORD_PATTERNING	24	1.060201	0.3941606	0.82382	-0.1731601	-2.2935621
GO_RESPONSE_TO_ATP	c5.BP_ GO biological process	26	-1.2333393	0.14328358	0.304598	GO_RESPONSE_TO_ATP	26	1.4353081	0.04767726	0.31059918	0.2019688	-2.6686474
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	c2.CP_REACTOME_ Reactome gene sets	59	-1.232765	0.13043478	0.30555514	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	60	0.7098349	0.91675675	1	-0.5229301	-1.9425999
CHEN_LUNG_CANCER_SURVIVAL	c2.CGP_ chemical and genetic perturbations	22	-1.2326863	0.1757925	0.30551612	CHEN_LUNG_CANCER_SURVIVAL	24	1.0067551	0.49194548	0.91274494	-0.2259312	-2.2394414
MATTIOLI_MGUS_VS_PCL	c2.CGP_ chemical and genetic perturbations	90	-1.2320949	0.0625	0.30640095	MATTIOLI_MGUS_VS_PCL	90	-1.305572	0.08510638	0.27766955	-2.5376669	0.0734771
GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN	C7_ immunologic signatures	176	-1.2317472	0.0647482	0.30684698	GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN	182	1.2315743	0.06268959	0.53709203	-0.0001729	-2.4633215
GO_ALCOHOL_CATABOLIC_PROCESS	c5.BP_ GO biological process	52	-1.2313161	0.096345514	0.30747116	GO_ALCOHOL_CATABOLIC_PROCESS	54	1.2256815	0.16759777	0.54838836	-0.0056346	-2.4569976
GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_DN	C7_ immunologic signatures	172	-1.2307686	0.04819277	0.3083033	GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_DN	174	-1.3174111	0.071428575	0.26914495	-2.5481797	0.0866425
GSE360_DC_VS_MAC_L_DONOVANI_DN	C7_ immunologic signatures	181	-1.2307513	0.04117647	0.3081354	GSE360_DC_VS_MAC_L_DONOVANI_DN	185	0.735298	0.9625127	1	-0.4954533	-1.9660493
GO_B_CELL_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	33	-1.2306478	0.18235295	0.30812794	GO_B_CELL_RECEPTOR_SIGNALING_PATHWAY	41	1.5844258	0.004672897	0.1764395	0.353778	-2.8150736
PID_MYC_PATHWAY	c2.CP_ Canonical pathways	24	-1.2306311	0.16909622	0.30795977	PID_MYC_PATHWAY	24	-1.1751854	0.21105528	0.41069025	-2.4058165	-0.0554457
GO_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION	c5.BP_ GO biological process	35	-1.2306068	0.17117117	0.30779654	GO_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION	38	0.9502387	0.5630841	0.9816897	-0.2803681	-2.1808455
GO_SIALYLATION	c5.BP_ GO biological process	21	-1.2305331	0.17270195	0.30773234	GO_SIALYLATION	21	1.5075284	0.022164276	0.24422003	0.2769953	-2.7380615
GNF2_TAL1	c4.CGN_ cancer gene neighborhoods	61	-1.230221	0.10294118	0.30811864	GNF2_TAL1	66	-0.85881376	0.8888889	0.86177874	-2.08903476	-0.37140724
GO_MRNA_CIS_SPLICING_VIA_SPLICEOSOME	c5.BP_ GO biological process	15	-1.2301292	0.20734908	0.30811363	GO_MRNA_CIS_SPLICING_VIA_SPLICEOSOME	15	-1.1023064	0.31932774	0.513502	-2.3324356	-0.1278228
LEF1_UP.V1_UP	C6_ oncogenic signatures	165	-1.2300323	0.058139537	0.3081021	LEF1_UP.V1_UP	173	1.1394858	0.19675456	0.6911624	-0.0905465	-2.3695181
GO_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS	c5.GO molecular function	47	-1.2289373	0.11295681	0.3100324	GO_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS	50	0.98147565	0.5282392	0.9468007	-0.24746165	-2.21041295
GO_ORGANIC_ACID_BINDING	c5.GO molecular function	165	-1.2287896	0.034883723	0.31012276	GO_ORGANIC_ACID_BINDING	179	1.2572689	0.049445003	0.4995416	0.0284793	-2.4860585
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN	C7_ immunologic signatures	181	-1.2287694	0.06521739	0.30995885	GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN	182	1.1404265	0.18680203	0.6900431	-0.0883429	-2.3691959
GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN	C7_ immunologic signatures	179	-1.228633	0.029411765	0.30999133	GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN	181	0.8398423	0.85166496	1	-0.3887907	-2.0684753
GSE360_L_MAJOR_VS_T_GONDII_MAC_DN	C7_ immunologic signatures	179	-1.2283365	0.07586207	0.31036222	GSE360_L_MAJOR_VS_T_GONDII_MAC_DN	181	-1.0849539	0.2	0.542925	-2.3132904	-0.1433826
GO_FATTY_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	256	-1.228128	0.016393442	0.31056562	GO_FATTY_ACID_METABOLIC_PROCESS	263	1.3134501	0.008016032	0.419448	0.0853221	-2.5415781
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	c2.CGP_ chemical and genetic perturbations	99	-1.2280586	0.07594936	0.31048825	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	109	1.2746022	0.07403545	0.48073727	0.0465436	-2.5026608
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	c2.CGP_ chemical and genetic perturbations	69	-1.227781	0.08366534	0.3108172	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	69	-1.6628317	0	0.06718613	-2.8906127	0.4350507
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	c2.CGP_ chemical and genetic perturbations	43	-1.2273748	0.14153846	0.3113653	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	43	-0.8958532	0.7238806	0.82643324	-2.123228	-0.3315216
CHR8Q12	C1: positional gene sets	25	-1.2272673	0.1898017	0.3113678	CHR8Q12	25	-1.3601122	0.111801244	0.2346084	-2.5873795	0.1328449
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	c2.CGP_ chemical and genetic perturbations	29	-1.2272228	0.18435754	0.31125075	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	29	0.5651675	0.96817625	1	-0.6620553	-1.7923903
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN	C7_ immunologic signatures	179	-1.2270381	0.056497175	0.31140628	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN	181	1.2070463	0.09817814	0.5807742	-0.0199918	-2.4340844
GO_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY	c5.BP_ GO biological process	23	-1.2269745	0.18055555	0.3113284	GO_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY	25	1.1419935	0.28426397	0.68703765	-0.084981	-2.368968
GO_U2_TYPE_PRESPLICEOSOME	c5.CC_ GO cellular component	15	-1.2266836	0.218509	0.31168792	GO_U2_TYPE_PRESPLICEOSOME	15	-1.2028733	0.20588236	0.37814853	-2.4295569	-0.0238103
GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP	C7_ immunologic signatures	170	-1.2265244	0.054545455	0.3118162	GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP	174	1.0525428	0.37791288	0.83682966	-0.1739816	-2.2790672
GO_CELLULAR_EXTRAVASATION	c5.BP_ GO biological process	21	-1.2261562	0.20943953	0.31233123	GO_CELLULAR_EXTRAVASATION	21	-1.0411601	0.35323384	0.6206856	-2.2673163	-0.1849961
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	21	-1.2260796	0.1750663	0.31225872	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	24	-1.0723294	0.3315508	0.56574625	-2.298409	-0.1537502
GNF2_CDC27	c4.CGN_ cancer gene neighborhoods	53	-1.226004	0.1295681	0.31219867	GNF2_CDC27	57	-1.3895555	0.019417476	0.21443135	-2.6155595	0.1635515
GO_GLYOXYLATE_METABOLIC_PROCESS	c5.BP_ GO biological process	27	-1.2258071	0.17804155	0.3123751	GO_GLYOXYLATE_METABOLIC_PROCESS	26	-1.2462008	0.14857143	0.32737368	-2.4720079	0.0203937
ESC_V6.5_UP_LATE.V1_DN	C6_ oncogenic signatures	164	-1.225522	0.033898305	0.31273174	ESC_V6.5_UP_LATE.V1_DN	174	0.85785526	0.81313133	1	-0.36766674	-2.08337726
GO_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	27	-1.2253671	0.18292683	0.3128192	GO_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS	26	0.7117997	0.87189054	1	-0.5135674	-1.9371668
REACTOME_TRANSCRIPTION	c2.CP_REACTOME_ Reactome gene sets	152	-1.2253022	0.06358381	0.31273422	REACTOME_TRANSCRIPTION	153	-1.450553	0	0.17320818	-2.6758552	0.2252508
GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP	C7_ immunologic signatures	173	-1.2252924	0.04733728	0.31254965	GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP	179	0.7118428	0.95947313	1	-0.5134496	-1.9371352
GO_REGULATION_OF_CGMP_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	18	-1.2252864	0.18131869	0.31236312	GO_REGULATION_OF_CGMP_BIOSYNTHETIC_PROCESS	18	1.5668594	0.010526316	0.19253907	0.341573	-2.7921458
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	c2.CGP_ chemical and genetic perturbations	196	-1.2252783	0.058441557	0.31217667	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	196	-0.9537042	0.75	0.75168383	-2.1789825	-0.2715741
CSR_EARLY_UP.V1_UP	C6_ oncogenic signatures	145	-1.2249604	0.04232804	0.31259492	CSR_EARLY_UP.V1_UP	144	0.7415823	0.94165814	1	-0.4833781	-1.9665427
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP	C7_ immunologic signatures	157	-1.2247171	0.05625	0.31285587	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP	164	-1.0313973	0.42857143	0.6375177	-2.2561144	-0.1933198
GO_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS	c5.BP_ GO biological process	57	-1.2247136	0.09701493	0.3126594	GO_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS	63	1.4211177	0.035516094	0.31940618	0.1964041	-2.6458313
GO_GANGLIOSIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	18	-1.2246953	0.17213115	0.31248948	GO_GANGLIOSIDE_BIOSYNTHETIC_PROCESS	18	1.3188831	0.10857909	0.4127532	0.0941878	-2.5435784
GO_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	26	-1.2241596	0.16045845	0.31336647	GO_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	27	-0.93406963	0.5739645	0.7784352	-2.15822923	-0.29008997
LIU_SOX4_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	281	-1.2241454	0.009615385	0.31319556	LIU_SOX4_TARGETS_DN	282	0.5484944	1	1	-0.675651	-1.7726398
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP	C7_ immunologic signatures	161	-1.2240602	0.026490066	0.3131514	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP	165	0.97041667	0.5589431	0.96119535	-0.25364353	-2.19447687
MUELLER_METHYLATED_IN_GLIOBLASTOMA	c2.CGP_ chemical and genetic perturbations	30	-1.2239095	0.16129032	0.3132387	MUELLER_METHYLATED_IN_GLIOBLASTOMA	33	1.0663916	0.3711584	0.8119953	-0.1575179	-2.2903011
GSE39864_WT_VS_GATA3_KO_TREG_DN	C7_ immunologic signatures	175	-1.2235323	0.04605263	0.3137387	GSE39864_WT_VS_GATA3_KO_TREG_DN	176	0.5898737	0.99696356	1	-0.6336586	-1.813406
GO_REGULATION_OF_LIPID_TRANSPORT	c5.BP_ GO biological process	77	-1.2235166	0.10150376	0.3135673	GO_REGULATION_OF_LIPID_TRANSPORT	85	1.0298945	0.4378321	0.8761587	-0.1936221	-2.2534111
GSE27786_CD8_TCELL_VS_MONO_MAC_UP	C7_ immunologic signatures	180	-1.2234758	0.02189781	0.3134447	GSE27786_CD8_TCELL_VS_MONO_MAC_UP	179	0.91693866	0.69715446	1	-0.30653714	-2.14041446
CHR19Q13	C1: positional gene sets	499	-1.2233802	0	0.3134159	CHR19Q13	499	0	0	0	-1.2233802	-1.2233802
GSE3982_NEUTROPHIL_VS_TH1_DN	C7_ immunologic signatures	180	-1.2231239	0.033333335	0.31372744	GSE3982_NEUTROPHIL_VS_TH1_DN	180	-1.0534108	0.2631579	0.59888285	-2.2765347	-0.1697131
GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP	C7_ immunologic signatures	180	-1.2230943	0.033783782	0.31357646	GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP	181	-0.93441117	0.72727275	0.7785583	-2.15750547	-0.28868313
REACTOME_GLUTATHIONE_CONJUGATION	c2.CP_REACTOME_ Reactome gene sets	18	-1.2227576	0.18328841	0.31402573	REACTOME_GLUTATHIONE_CONJUGATION	18	1.3880955	0.07905138	0.34776047	0.1653379	-2.6108531
GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	153	-1.2227539	0.05027933	0.31383246	GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	157	0.7757771	0.9102956	1	-0.4469768	-1.998531
GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN	C7_ immunologic signatures	166	-1.2226928	0.02259887	0.31374213	GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN	167	0.7280588	0.9510703	1	-0.494634	-1.9507516
GO_MEDIATOR_COMPLEX	c5.CC_ GO cellular component	34	-1.2224257	0.14076246	0.31405982	GO_MEDIATOR_COMPLEX	34	-0.5773386	0.9870968	0.9877804	-1.7997643	-0.6450871
GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	146	-1.2223865	0.033333335	0.31393743	GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	151	0.6396209	0.9878049	1	-0.5827656	-1.8620074
GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN	C7_ immunologic signatures	188	-1.2223483	0.028901733	0.3138131	GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN	189	-1.4174836	0	0.19503999	-2.6398319	0.1951353
BIOCARTA_DC_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	-1.2217387	0.21186441	0.31485057	BIOCARTA_DC_PATHWAY	17	1.3214513	0.12692308	0.4113836	0.0997126	-2.54319
ETS_Q4	c3.TFT_ transcription factor targets	226	-1.2214596	0.037593983	0.3152134	ETS_Q4	228	1.0424371	0.39798996	0.85454243	-0.1790225	-2.2638967
ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN	c2.CGP_ chemical and genetic perturbations	16	-1.2213361	0.20596206	0.3152489	ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN	16	1.1638396	0.28137386	0.64751244	-0.0574965	-2.3851757
LMO2COM_01	c3.TFT_ transcription factor targets	223	-1.2212794	0.033333335	0.31515622	LMO2COM_01	232	1.2327738	0.0472837	0.5363994	0.0114944	-2.4540532
GAVIN_PDE3B_TARGETS	c2.CGP_ chemical and genetic perturbations	18	-1.2211485	0.19473684	0.3151977	GAVIN_PDE3B_TARGETS	19	-1.2895515	0.13875598	0.29222104	-2.5107	0.068403
GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN	C7_ immunologic signatures	129	-1.2210921	0.06930693	0.31511092	GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN	136	0.6804411	0.97128206	1	-0.540651	-1.9015332
GSE360_DC_VS_MAC_L_DONOVANI_UP	C7_ immunologic signatures	176	-1.2210051	0.050632913	0.31507853	GSE360_DC_VS_MAC_L_DONOVANI_UP	183	0.9043869	0.71039355	1	-0.3166182	-2.125392
REACTOME_HIV_LIFE_CYCLE	c2.CP_REACTOME_ Reactome gene sets	103	-1.2209675	0.073275864	0.3149495	REACTOME_HIV_LIFE_CYCLE	103	-2.0656102	0	0.003994034	-3.2865777	0.8446427
GO_VOLTAGE_GATED_ION_CHANNEL_ACTIVITY	c5.GO molecular function	156	-1.2207341	0.062893085	0.315233	GO_VOLTAGE_GATED_ION_CHANNEL_ACTIVITY	178	1.3618362	0.012170386	0.37616026	0.1411021	-2.5825703
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN	C7_ immunologic signatures	159	-1.2205034	0.070512824	0.3154953	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN	160	1.1607558	0.16028225	0.65139335	-0.0597476	-2.3812592
GO_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS	c5.BP_ GO biological process	16	-1.220433	0.18112245	0.3154331	GO_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS	16	0.77388245	0.78552634	1	-0.44655055	-1.99431545
PID_INTEGRIN5_PATHWAY	c2.CP_ Canonical pathways	16	-1.2203846	0.19571045	0.31532544	PID_INTEGRIN5_PATHWAY	17	-0.9016052	0.5840708	0.8190397	-2.1219898	-0.3187794
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP	C7_ immunologic signatures	186	-1.21994	0.033557046	0.31603703	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP	186	-1.2002579	0	0.3813786	-2.4201979	-0.0196821
GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP	C7_ immunologic signatures	182	-1.2199273	0.04761905	0.31585848	GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP	181	-1.020753	0.35714287	0.6572042	-2.2406803	-0.1991743
ATF6_01	c3.TFT_ transcription factor targets	110	-1.2195162	0.10628019	0.3164492	ATF6_01	114	0.64252234	0.9820486	1	-0.57699386	-1.86203854
PIONTEK_PKD1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	30	-1.2191273	0.16037735	0.31698582	PIONTEK_PKD1_TARGETS_UP	32	0.8148626	0.76309526	1	-0.4042647	-2.0339899
WALLACE_PROSTATE_CANCER_UP	c2.CGP_ chemical and genetic perturbations	18	-1.2187713	0.19186047	0.3174269	WALLACE_PROSTATE_CANCER_UP	18	0.7997158	0.75192803	1	-0.4190555	-2.0184871
KEGG_ARACHIDONIC_ACID_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	43	-1.2186488	0.13442624	0.31746665	KEGG_ARACHIDONIC_ACID_METABOLISM	49	1.7037148	0.001135074	0.08372053	0.485066	-2.9223636
KYNG_DNA_DAMAGE_UP	c2.CGP_ chemical and genetic perturbations	205	-1.2185339	0.03787879	0.31749585	KYNG_DNA_DAMAGE_UP	213	0.7802575	0.9395161	1	-0.4382764	-1.9987914
GO_VESICLE_COATING	c5.BP_ GO biological process	68	-1.2185289	0.12177122	0.31730494	GO_VESICLE_COATING	67	0.5519156	1	1	-0.6666133	-1.7704445
GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	137	-1.2181764	0.07978723	0.31777412	GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN	137	-1.2487439	0	0.32446736	-2.4669203	0.0305675
ATF1_Q6	c3.TFT_ transcription factor targets	204	-1.2179848	0.02173913	0.31796548	ATF1_Q6	213	0.89758086	0.7679112	1	-0.32040394	-2.11556566
GO_PHOTOTRANSDUCTION	c5.BP_ GO biological process	38	-1.217941	0.169279	0.3178482	GO_PHOTOTRANSDUCTION	35	-1.2769481	0.08588957	0.3050461	-2.4948891	0.0590071
GO_VITAMIN_BINDING	c5.GO molecular function	66	-1.2179177	0.12142857	0.31769532	GO_VITAMIN_BINDING	69	1.0732504	0.37012988	0.80055773	-0.1446673	-2.2911681
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN	C7_ immunologic signatures	170	-1.2178836	0.045751635	0.3175577	GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN	174	0.9283754	0.6869919	0.9993005	-0.2895082	-2.146259
GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP	C7_ immunologic signatures	164	-1.2178715	0.06593407	0.3173886	GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP	169	-0.7950878	0.9655172	0.9101498	-2.0129593	-0.4227837
GO_NEGATIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION	c5.BP_ GO biological process	33	-1.217707	0.17080745	0.31750983	GO_NEGATIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION	33	0.96784514	0.54196644	0.9635284	-0.24986186	-2.18555214
GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN	C7_ immunologic signatures	168	-1.2172266	0.03311258	0.31821594	GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN	171	0.9558445	0.6262626	0.9760327	-0.2613821	-2.1730711
GO_PRESYNAPTIC_ACTIVE_ZONE	c5.CC_ GO cellular component	27	-1.2171811	0.17906336	0.3180969	GO_PRESYNAPTIC_ACTIVE_ZONE	27	1.255652	0.15036675	0.5018593	0.0384709	-2.4728331
CHR21Q22	C1: positional gene sets	99	-1.2168571	0.08510638	0.3185374	CHR21Q22	107	0.65638167	0.9697602	1	-0.56047543	-1.87323877
GSE45365_WT_VS_IFNAR_KO_CD8A_DC_UP	C7_ immunologic signatures	172	-1.2167407	0.044303797	0.31856892	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_UP	171	0.9197983	0.66904277	1	-0.2969424	-2.136539
GO_PROTEIN_N_LINKED_GLYCOSYLATION	c5.BP_ GO biological process	72	-1.2166754	0.12267658	0.31848824	GO_PROTEIN_N_LINKED_GLYCOSYLATION	73	1.0965283	0.3222698	0.76184875	-0.1201471	-2.3132037
PID_ARF_3PATHWAY	c2.CP_ Canonical pathways	19	-1.2164841	0.19178082	0.31865236	PID_ARF_3PATHWAY	19	0.43654788	0.9962733	1	-0.77993622	-1.65303198
KEGG_AUTOIMMUNE_THYROID_DISEASE	c2.CP_BIOCARTA_ BioCarta gene sets	30	-1.2163085	0.15088758	0.3188092	KEGG_AUTOIMMUNE_THYROID_DISEASE	36	1.2166854	0.17903416	0.5631057	0.0003769	-2.4329939
GO_OLIGODENDROCYTE_DEVELOPMENT	c5.BP_ GO biological process	30	-1.2162595	0.19344263	0.31870848	GO_OLIGODENDROCYTE_DEVELOPMENT	32	-1.3358512	0.08510638	0.25224537	-2.5521107	0.1195917
GO_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH	c5.BP_ GO biological process	59	-1.2162461	0.13909775	0.31853506	GO_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH	63	0.9326902	0.61530054	0.99729645	-0.2835559	-2.1489363
GO_PEPTIDYL_ASPARAGINE_MODIFICATION	c5.BP_ GO biological process	38	-1.216094	0.14848486	0.3186344	GO_PEPTIDYL_ASPARAGINE_MODIFICATION	38	0.80510765	0.7698695	1	-0.41098635	-2.02120165
UEDA_CENTRAL_CLOCK	c2.CGP_ chemical and genetic perturbations	84	-1.2157778	0.10878661	0.3190369	UEDA_CENTRAL_CLOCK	83	0.7801987	0.86180633	1	-0.4355791	-1.9959765
MORF_TTN	c4.CGN_ cancer gene neighborhoods	35	-1.2155595	0.1461318	0.3192971	MORF_TTN	38	1.070551	0.38544154	0.8040601	-0.1450085	-2.2861105
GO_GLUTAMINE_METABOLIC_PROCESS	c5.BP_ GO biological process	20	-1.2154279	0.18235295	0.31934273	GO_GLUTAMINE_METABOLIC_PROCESS	22	-1.04016	0.38647342	0.6214669	-2.2555879	-0.1752679
GO_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION	c5.BP_ GO biological process	30	-1.215285	0.15320334	0.31942722	GO_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION	33	-1.2527273	0.15662651	0.32143596	-2.4680123	0.0374423
ABBUD_LIF_SIGNALING_1_UP	c2.CGP_ chemical and genetic perturbations	40	-1.2150433	0.13312693	0.31969395	ABBUD_LIF_SIGNALING_1_UP	43	1.530704	0.005827506	0.22067821	0.3156607	-2.7457473
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN	C7_ immunologic signatures	169	-1.2148445	0.03816794	0.31987426	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN	168	0.8948184	0.7398374	1	-0.3200261	-2.1096629
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP	C7_ immunologic signatures	172	-1.2148148	0.033557046	0.31972423	GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP	172	1.1769878	0.13171226	0.6265822	-0.037827	-2.3918026
GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	149	-1.2144814	0.06097561	0.32018366	GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	150	-0.9119434	0.8235294	0.80492216	-2.1264248	-0.302538
GO_T_CELL_RECEPTOR_COMPLEX	c5.CC_ GO cellular component	17	-1.2144134	0.20967741	0.32011402	GO_T_CELL_RECEPTOR_COMPLEX	19	1.5008163	0.026582278	0.25196114	0.2864029	-2.7152297
KEGG_DRUG_METABOLISM_CYTOCHROME_P450	c2.CP_BIOCARTA_ BioCarta gene sets	51	-1.2143916	0.1503268	0.3199625	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	54	1.515468	0.008948546	0.23547322	0.3010764	-2.7298596
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN	C7_ immunologic signatures	170	-1.2140985	0.055944055	0.32034376	GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN	176	-0.9823454	0.53333336	0.7112791	-2.1964439	-0.2317531
GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN	C7_ immunologic signatures	163	-1.2138929	0.03550296	0.32058138	GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN	166	0.8059819	0.87639314	1	-0.407911	-2.0198748
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	169	-1.2137883	0.056962024	0.32059705	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN	172	1.0375173	0.41869918	0.8631838	-0.176271	-2.2513056
GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	C7_ immunologic signatures	167	-1.2131912	0.044871796	0.3215923	GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	172	-0.92720515	0.71428573	0.78726226	-2.14039635	-0.28598605
GO_MRNA_3_END_PROCESSING	c5.BP_ GO biological process	69	-1.2131194	0.12720849	0.32152924	GO_MRNA_3_END_PROCESSING	69	-1.7462175	0	0.04445767	-2.9593369	0.5330981
GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN	C7_ immunologic signatures	171	-1.2128061	0.025806451	0.32200074	GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN	173	0.6057665	0.99898887	1	-0.6070396	-1.8185726
GO_POSITIVE_REGULATION_OF_HEMOPOIESIS	c5.BP_ GO biological process	140	-1.2127856	0.036585364	0.32184732	GO_POSITIVE_REGULATION_OF_HEMOPOIESIS	146	1.0643662	0.35913312	0.8151328	-0.1484194	-2.2771518
ELVIDGE_HYPOXIA_BY_DMOG_DN	c2.CGP_ chemical and genetic perturbations	53	-1.2121919	0.15202703	0.32283086	ELVIDGE_HYPOXIA_BY_DMOG_DN	53	0.5795515	0.9910913	1	-0.6326404	-1.7917434
GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	171	-1.2120817	0.067567565	0.32285148	GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP	180	1.2877226	0.03340081	0.4609024	0.0756409	-2.4998043
GO_LUMENAL_SIDE_OF_MEMBRANE	c5.CC_ GO cellular component	16	-1.2119646	0.19948186	0.32287794	GO_LUMENAL_SIDE_OF_MEMBRANE	17	0.8976602	0.6202861	1	-0.3143044	-2.1096248
GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN	C7_ immunologic signatures	177	-1.2119622	0.04137931	0.32268143	GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN	179	0.8166185	0.8615071	1	-0.3953437	-2.0285807
GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP	C7_ immunologic signatures	179	-1.2117655	0.05	0.3228874	GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP	180	-0.87733793	0.9166667	0.8468929	-2.08910343	-0.33442757
GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	180	-1.2117512	0.05839416	0.32272506	GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	180	-1.0254596	0.27272728	0.6491062	-2.2372108	-0.1862916
CROMER_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	74	-1.2116596	0.11811024	0.3227164	CROMER_METASTASIS_DN	75	1.3195666	0.054956898	0.41308874	0.107907	-2.5312262
GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP	C7_ immunologic signatures	178	-1.2115366	0.044871796	0.32276785	GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP	181	0.9541966	0.5991903	0.977055	-0.25734	-2.1657332
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN	C7_ immunologic signatures	181	-1.2115053	0.045161292	0.32263333	GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN	184	0.9164155	0.70193285	1	-0.2950898	-2.1279208
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	c2.CP_BIOCARTA_ BioCarta gene sets	47	-1.2108362	0.15460527	0.32380527	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	48	1.7006274	0.001144165	0.08294108	0.4897912	-2.9114636
FERRANDO_TAL1_NEIGHBORS	c2.CGP_ chemical and genetic perturbations	17	-1.2105204	0.1959799	0.32424074	FERRANDO_TAL1_NEIGHBORS	17	1.0236702	0.4622396	0.8857569	-0.1868502	-2.2341906
GO_PRIMARY_CILIUM	c5.CC_ GO cellular component	181	-1.2103473	0.09271523	0.32440037	GO_PRIMARY_CILIUM	181	1.1342782	0.19858156	0.69891524	-0.0760691	-2.3446255
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	c2.CGP_ chemical and genetic perturbations	69	-1.2103027	0.12014134	0.32429665	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	74	-1.0341954	0.36842105	0.63117504	-2.2444981	-0.1761073
GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP	C7_ immunologic signatures	185	-1.210295	0.04605263	0.32411078	GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP	188	1.2116399	0.08097166	0.5748557	0.0013449	-2.4219349
GO_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES	c5.BP_ GO biological process	32	-1.2101772	0.14971751	0.32413816	GO_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES	34	0.8790228	0.64788735	1	-0.3311544	-2.0892
GO_MRNA_BINDING	c5.GO molecular function	139	-1.2101288	0.035532996	0.32404032	GO_MRNA_BINDING	142	-1.5171783	0	0.13301136	-2.7273071	0.3070495
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	c2.CGP_ chemical and genetic perturbations	44	-1.2098999	0.14153846	0.32433438	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	48	1.1157042	0.32522124	0.7299383	-0.0941957	-2.3256041
GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	177	-1.2097781	0.061349694	0.32438788	GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN	179	-1.1932398	0.11111111	0.3906703	-2.4030179	-0.0165383
GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN	C7_ immunologic signatures	176	-1.2096806	0.07236842	0.32439804	GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN	180	1.1449488	0.17426544	0.67908347	-0.0647318	-2.3546294
GSE339_CD4POS_VS_CD8POS_DC_DN	C7_ immunologic signatures	182	-1.2096357	0.064705886	0.32428753	GSE339_CD4POS_VS_CD8POS_DC_DN	184	0.6764048	0.9817998	1	-0.5332309	-1.8860405
GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN	C7_ immunologic signatures	174	-1.2092813	0.051282052	0.3247987	GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN	182	0.7648596	0.9390863	1	-0.4444217	-1.9741409
GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN	C7_ immunologic signatures	182	-1.2091446	0.06849315	0.3248474	GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN	182	-1.9584919	0	0.011383229	-3.1676365	0.7493473
GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS	c5.GO molecular function	163	-1.2089722	0.048611112	0.3250367	GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS	171	0.8020083	0.8919192	1	-0.4069639	-2.0109805
GO_CARBOXY_LYASE_ACTIVITY	c5.GO molecular function	31	-1.2089596	0.15804598	0.32486397	GO_CARBOXY_LYASE_ACTIVITY	31	-1.2776053	0.10810811	0.30418947	-2.4865649	0.0686457
CHR2Q32	C1: positional gene sets	38	-1.2082163	0.1574074	0.32624093	CHR2Q32	36	1.0545667	0.39247945	0.83392006	-0.1536496	-2.262783
KASLER_HDAC7_TARGETS_1_DN	c2.CGP_ chemical and genetic perturbations	17	-1.2082139	0.19565217	0.32604355	KASLER_HDAC7_TARGETS_1_DN	17	1.0986571	0.35870966	0.75895655	-0.1095568	-2.306871
GSE17721_12H_VS_24H_POLYIC_BMDC_UP	C7_ immunologic signatures	176	-1.2079521	0.055555556	0.32642686	GSE17721_12H_VS_24H_POLYIC_BMDC_UP	176	0.71927196	0.96363634	1	-0.48868014	-1.92722406
GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP	C7_ immunologic signatures	165	-1.2079387	0.087248325	0.32625222	GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP	165	0.58107394	1	1	-0.62686476	-1.78901264
GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP	C7_ immunologic signatures	138	-1.2078809	0.08421053	0.3261653	GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP	146	1.1154838	0.25922132	0.72982186	-0.0923971	-2.3233647
GSE13306_TREG_VS_TCONV_DN	C7_ immunologic signatures	175	-1.2078	0.045751635	0.3261447	GSE13306_TREG_VS_TCONV_DN	174	0.72683674	0.9544995	1	-0.48096326	-1.93463674
GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN	C7_ immunologic signatures	150	-1.2075855	0.056179777	0.32639614	GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN	155	1.3976185	0.005070994	0.34439185	0.190033	-2.605204
MANALO_HYPOXIA_DN	c2.CGP_ chemical and genetic perturbations	265	-1.2074914	0.029126214	0.32637036	MANALO_HYPOXIA_DN	265	-1.8247736	0	0.028463624	-3.032265	0.6172822
GO_POSITIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION	c5.BP_ GO biological process	50	-1.207056	0.1590106	0.3270612	GO_POSITIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION	54	-1.1785748	0.16363636	0.4064349	-2.3856308	-0.0284812
MORI_IMMATURE_B_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	43	-1.2070304	0.15666667	0.32690927	MORI_IMMATURE_B_LYMPHOCYTE_UP	46	1.2398175	0.1645857	0.5260975	0.0327871	-2.4468479
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	180	-1.2069756	0.050632913	0.32683212	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN	182	-0.9649705	0.71428573	0.7354142	-2.1719461	-0.2420051
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	C7_ immunologic signatures	177	-1.2069193	0.05882353	0.32675776	GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	177	0.67619187	0.98282826	1	-0.53072743	-1.88311117
IL2_UP.V1_UP	C6_ oncogenic signatures	153	-1.2068619	0.059139784	0.32667676	IL2_UP.V1_UP	160	1.1744201	0.14343435	0.6305419	-0.0324418	-2.381282
GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN	C7_ immunologic signatures	183	-1.2063894	0.06369427	0.3274507	GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN	182	0.7049958	0.96443087	1	-0.5013936	-1.9113852
GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN	C7_ immunologic signatures	173	-1.2062697	0.042168673	0.32750508	GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN	182	1.1118945	0.24493927	0.734912	-0.0943752	-2.3181642
GCM_BECN1	c4.CGN_ cancer gene neighborhoods	59	-1.2062533	0.10687023	0.32734472	GCM_BECN1	61	-0.79080516	0.9368421	0.91386634	-1.99705846	-0.41544814
GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP	C7_ immunologic signatures	168	-1.2059581	0.062893085	0.3277456	GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP	179	1.1072356	0.24547283	0.7420997	-0.0987225	-2.3131937
BIOCARTA_MEF2D_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	-1.2056501	0.21568628	0.32818037	BIOCARTA_MEF2D_PATHWAY	17	1.6078743	0.009198424	0.14916399	0.4022242	-2.8135244
GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP	C7_ immunologic signatures	182	-1.205604	0.01898734	0.32807204	GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP	182	0.58092433	0.99797773	1	-0.62467967	-1.78652833
GO_GLYCOSPHINGOLIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	59	-1.2055739	0.14	0.32793328	GO_GLYCOSPHINGOLIPID_METABOLIC_PROCESS	60	1.5614425	0.006629834	0.19799629	0.3558686	-2.7670164
GSE3982_BASOPHIL_VS_TH1_DN	C7_ immunologic signatures	170	-1.2050462	0.056179777	0.32878992	GSE3982_BASOPHIL_VS_TH1_DN	173	-1.0166576	0.375	0.66315824	-2.2217038	-0.1883886
MODY_HIPPOCAMPUS_PRENATAL	c2.CGP_ chemical and genetic perturbations	39	-1.204745	0.17747441	0.32922974	MODY_HIPPOCAMPUS_PRENATAL	39	1.107175	0.3234245	0.7422276	-0.09757	-2.31192
GO_REGULATION_OF_GLIAL_CELL_PROLIFERATION	c5.BP_ GO biological process	20	-1.204258	0.21750663	0.3300235	GO_REGULATION_OF_GLIAL_CELL_PROLIFERATION	21	-0.9225833	0.60215056	0.7927262	-2.1268413	-0.2816747
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN	C7_ immunologic signatures	172	-1.2041937	0.048780486	0.32995296	GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN	177	0.8391101	0.831643	1	-0.3650836	-2.0433038
GSE45365_NK_CELL_VS_BCELL_UP	C7_ immunologic signatures	182	-1.2041655	0.043209877	0.3298208	GSE45365_NK_CELL_VS_BCELL_UP	183	0.63368666	0.99495965	1	-0.57047884	-1.83785216
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	c2.CGP_ chemical and genetic perturbations	72	-1.2039245	0.11111111	0.33010188	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	72	1.0627822	0.37688985	0.81809723	-0.1411423	-2.2667067
GSE27786_LIN_NEG_VS_MONO_MAC_UP	C7_ immunologic signatures	179	-1.2038654	0.04191617	0.33001283	GSE27786_LIN_NEG_VS_MONO_MAC_UP	182	0.59639394	0.99696356	1	-0.60747146	-1.80025934
CHR12Q13	C1: positional gene sets	188	-1.2037909	0.048275862	0.32996693	CHR12Q13	198	1.066461	0.3303122	0.8118326	-0.1373299	-2.2702519
PENG_GLUCOSE_DEPRIVATION_UP	c2.CGP_ chemical and genetic perturbations	43	-1.203754	0.15306123	0.32984596	PENG_GLUCOSE_DEPRIVATION_UP	43	-1.0834689	0.31623933	0.54485226	-2.2872229	-0.1202851
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR	c5.GO molecular function	19	-1.2037336	0.18156424	0.3296799	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR	20	0.66470754	0.882732	1	-0.53902606	-1.86844114
GO_LYMPHOCYTE_APOPTOTIC_PROCESS	c5.BP_ GO biological process	16	-1.203703	0.23415978	0.3295442	GO_LYMPHOCYTE_APOPTOTIC_PROCESS	17	0.82012683	0.7150466	1	-0.38357617	-2.02382983
GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	171	-1.2033793	0.046979867	0.33000705	GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	173	0.7477033	0.93434346	1	-0.455676	-1.9510826
MATTHEWS_AP1_TARGETS	c2.CGP_ chemical and genetic perturbations	16	-1.2032886	0.21932115	0.3300022	MATTHEWS_AP1_TARGETS	16	-1.1746035	0.22988506	0.4115701	-2.3778921	-0.0286851
GSE3982_NEUTROPHIL_VS_BASOPHIL_DN	C7_ immunologic signatures	172	-1.2031825	0.053475935	0.3300059	GSE3982_NEUTROPHIL_VS_BASOPHIL_DN	173	-0.80987376	1	0.8966698	-2.01305626	-0.39330874
DIRMEIER_LMP1_RESPONSE_LATE_DN	c2.CGP_ chemical and genetic perturbations	28	-1.2030157	0.20833333	0.33015174	DIRMEIER_LMP1_RESPONSE_LATE_DN	28	1.401646	0.07866508	0.3382666	0.1986303	-2.6046617
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN	C7_ immunologic signatures	179	-1.2029958	0.060402684	0.3299931	GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN	182	0.9981675	0.52116936	0.9257386	-0.2048283	-2.2011633
GENTLES_LEUKEMIC_STEM_CELL_UP	c2.CGP_ chemical and genetic perturbations	21	-1.2025834	0.18406594	0.33068678	GENTLES_LEUKEMIC_STEM_CELL_UP	22	0.55971706	0.9714994	1	-0.64286634	-1.76230046
LIU_CMYB_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	149	-1.2025456	0.05202312	0.33056435	LIU_CMYB_TARGETS_UP	151	1.2397685	0.07302231	0.5261166	0.0372229	-2.4423141
GO_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY	c5.BP_ GO biological process	18	-1.2023356	0.23383084	0.33078802	GO_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY	19	-1.6931088	0.012605042	0.05791572	-2.8954444	0.4907732
GO_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION	c5.BP_ GO biological process	41	-1.2023232	0.15358362	0.33062154	GO_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION	45	1.2290912	0.16399083	0.54277074	0.026768	-2.4314144
GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP	C7_ immunologic signatures	166	-1.2022254	0.06944445	0.33059806	GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP	170	0.7601874	0.9203269	1	-0.442038	-1.9624128
GO_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION	c5.BP_ GO biological process	23	-1.2021565	0.18956044	0.33054817	GO_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION	27	-1.0497234	0.37634408	0.60673445	-2.2518799	-0.1524331
ROSS_AML_WITH_MLL_FUSIONS	c2.CGP_ chemical and genetic perturbations	66	-1.201883	0.12267658	0.33093655	ROSS_AML_WITH_MLL_FUSIONS	68	1.1493948	0.24892704	0.6707608	-0.0524882	-2.3512778
GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN	C7_ immunologic signatures	191	-1.2018524	0.032894738	0.33080655	GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN	192	0.8441047	0.8351871	1	-0.3577477	-2.0459571
GO_NONMOTILE_PRIMARY_CILIUM	c5.CC_ GO cellular component	120	-1.2015859	0.067961164	0.33115333	GO_NONMOTILE_PRIMARY_CILIUM	119	0.99149036	0.5197095	0.9340662	-0.21009554	-2.19307626
GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	173	-1.201128	0.057142857	0.33193067	GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP	174	-1.476307	0	0.15704529	-2.677435	0.275179
LI_INDUCED_T_TO_NATURAL_KILLER_UP	c2.CGP_ chemical and genetic perturbations	258	-1.201005	0.040650405	0.33198148	LI_INDUCED_T_TO_NATURAL_KILLER_UP	261	1.0028602	0.502008	0.91850513	-0.1981448	-2.2038652
GO_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE	c5.BP_ GO biological process	43	-1.2008996	0.1574074	0.33201668	GO_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE	43	-0.7222085	0.9259259	0.95078593	-1.9231081	-0.4786911
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP	C7_ immunologic signatures	178	-1.2008938	0.0729927	0.33183202	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP	178	-0.94769025	0.6	0.7597646	-2.14858405	-0.25320355
GARY_CD5_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	417	-1.2008514	0	0.33171874	GARY_CD5_TARGETS_UP	424	0.72046757	0.997	1	-0.48038383	-1.92131897
YAMASHITA_LIVER_CANCER_STEM_CELL_DN	c2.CGP_ chemical and genetic perturbations	59	-1.2002145	0.13879004	0.33282	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	69	1.4099176	0.02753304	0.3257606	0.2097031	-2.6101321
GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN	C7_ immunologic signatures	179	-1.1999874	0.050955415	0.33307964	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN	181	0.8806	0.77530366	1	-0.3193874	-2.0805874
GO_SULFUR_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	314	-1.19998	0.011904762	0.33289704	GO_SULFUR_COMPOUND_METABOLIC_PROCESS	324	1.0426055	0.3763764	0.8542511	-0.1573745	-2.2425855
GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN	C7_ immunologic signatures	180	-1.1998999	0.033333335	0.33287886	GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN	182	0.7060076	0.9605263	1	-0.4938923	-1.9059075
GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN	C7_ immunologic signatures	117	-1.1998564	0.10344828	0.3327671	GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN	120	1.1575687	0.20186335	0.65783155	-0.0422877	-2.3574251
GSE3039_B2_VS_B1_BCELL_DN	C7_ immunologic signatures	175	-1.1997004	0.047904193	0.33288634	GSE3039_B2_VS_B1_BCELL_DN	173	0.8306729	0.8365482	1	-0.3690275	-2.0303733
ZHAN_MULTIPLE_MYELOMA_MF_UP	c2.CGP_ chemical and genetic perturbations	39	-1.1995832	0.1650165	0.3329347	ZHAN_MULTIPLE_MYELOMA_MF_UP	42	1.3388565	0.08343126	0.3970799	0.1392733	-2.5384397
GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN	C7_ immunologic signatures	141	-1.1985915	0.0625	0.3347568	GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN	150	0.68224883	0.9664634	1	-0.51634267	-1.88084033
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	C7_ immunologic signatures	149	-1.1978347	0.06451613	0.3361315	GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	153	0.5813484	0.99898064	1	-0.6164863	-1.7791831
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN	C7_ immunologic signatures	181	-1.1977594	0.055555556	0.33610833	GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN	189	1.1468488	0.18623482	0.67406344	-0.0509106	-2.3446082
MYCMAX_02	c3.TFT_ transcription factor targets	239	-1.1977513	0.04	0.33592594	MYCMAX_02	246	-0.9938188	0.4	0.6967128	-2.1915701	-0.2039325
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	178	-1.1976131	0.071428575	0.3360211	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN	179	1.1199399	0.20588236	0.72306806	-0.0776732	-2.317553
GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN	C7_ immunologic signatures	174	-1.197436	0.046979867	0.3361945	GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN	175	-1.1484562	0.11111111	0.4456577	-2.3458922	-0.0489798
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	c2.CGP_ chemical and genetic perturbations	25	-1.1968244	0.1978022	0.33729696	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	24	1.2739283	0.16125	0.48187938	0.0771039	-2.4707527
WOOD_EBV_EBNA1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	42	-1.1965718	0.13175675	0.33762652	WOOD_EBV_EBNA1_TARGETS_DN	42	1.223887	0.19221967	0.550102	0.0273152	-2.4204588
GSE27786_BCELL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	186	-1.1963229	0.08148148	0.33796114	GSE27786_BCELL_VS_NEUTROPHIL_UP	186	-1.1483378	0.0625	0.44558054	-2.3446607	-0.0479851
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	171	-1.1960882	0.05185185	0.3382623	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP	182	1.2104263	0.09447236	0.5759844	0.0143381	-2.4065145
GO_NUCLEOTIDE_EXCISION_REPAIR_PREINCISION_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	27	-1.1960874	0.20325203	0.33806762	GO_NUCLEOTIDE_EXCISION_REPAIR_PREINCISION_COMPLEX_ASSEMBLY	27	-0.9059372	0.6486486	0.81456083	-2.1020246	-0.2901502
GO_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING	c5.BP_ GO biological process	15	-1.195884	0.21573605	0.33829123	GO_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING	16	-1.7553697	0.004347826	0.04225606	-2.9512537	0.5594857
GO_LEUKOCYTE_PROLIFERATION	c5.BP_ GO biological process	75	-1.1958785	0.12301587	0.33810446	GO_LEUKOCYTE_PROLIFERATION	79	0.74279714	0.89828694	1	-0.45308136	-1.93867564
GO_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	22	-1.195519	0.21066667	0.33868864	GO_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS	21	0.92412734	0.59311223	1	-0.27139166	-2.11964634
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	c2.CP_BIOCARTA_ BioCarta gene sets	33	-1.1954883	0.1559633	0.3385445	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	37	1.1375049	0.29397875	0.69479465	-0.0579834	-2.3329932
REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS	c2.CP_REACTOME_ Reactome gene sets	24	-1.195468	0.20435968	0.33838448	REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS	25	0.63779163	0.942789	1	-0.55767637	-1.83325963
GO_RRNA_TRANSCRIPTION	c5.BP_ GO biological process	17	-1.195279	0.21428572	0.33854088	GO_RRNA_TRANSCRIPTION	17	-0.78572685	0.7357724	0.91717917	-1.98100585	-0.40955215
GO_REGULATION_OF_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLE_PROPIONATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY	c5.BP_ GO biological process	18	-1.1949159	0.22332506	0.33908004	GO_REGULATION_OF_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLE_PROPIONATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY	19	-1.4689069	0.06880734	0.16232497	-2.6638228	0.273991
GSE29618_PDC_VS_MDC_DN	C7_ immunologic signatures	166	-1.1948019	0.061643835	0.3391286	GSE29618_PDC_VS_MDC_DN	170	0.98814684	0.5030488	0.93777305	-0.20665506	-2.18294874
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN	C7_ immunologic signatures	181	-1.1944383	0.050314464	0.33965507	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN	184	0.752238	0.9300203	1	-0.4422003	-1.9466763
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN	C7_ immunologic signatures	162	-1.1944156	0.092391305	0.3395038	GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN	164	0.67371005	0.9827236	1	-0.52070555	-1.86812565
GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP	C7_ immunologic signatures	180	-1.1942142	0.04819277	0.33971822	GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP	186	1.2375938	0.052525252	0.529735	0.0433796	-2.431808
GSE17721_0.5H_VS_8H_LPS_BMDC_UP	C7_ immunologic signatures	178	-1.194183	0.059210528	0.33957702	GSE17721_0.5H_VS_8H_LPS_BMDC_UP	181	0.7230341	0.95731705	1	-0.4711489	-1.9172171
GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP	C7_ immunologic signatures	184	-1.1940769	0.05147059	0.33960146	GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP	181	0.6371384	0.993921	1	-0.5569385	-1.8312153
GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN	C7_ immunologic signatures	166	-1.1935728	0.060402684	0.3404558	GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN	173	1.1860367	0.11212121	0.6134437	-0.0075361	-2.3796095
GO_HMG_BOX_DOMAIN_BINDING	c5.GO molecular function	16	-1.1934103	0.20987654	0.34058803	GO_HMG_BOX_DOMAIN_BINDING	17	0.6486302	0.9070064	1	-0.5447801	-1.8420405
ALCALA_APOPTOSIS	c2.CGP_ chemical and genetic perturbations	72	-1.1933303	0.089965396	0.34054792	ALCALA_APOPTOSIS	73	0.87089336	0.7229946	1	-0.32243694	-2.06422366
GO_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	-1.1932074	0.22738387	0.3406195	GO_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS	17	0.6562129	0.9039191	1	-0.5369945	-1.8494203
GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN	C7_ immunologic signatures	177	-1.1929034	0.056962024	0.34107134	GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN	179	-0.9951651	0.33333334	0.6932223	-2.1880685	-0.1977383
GO_PYRIMIDINE_RIBONUCLEOSIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	26	-1.1927986	0.18322982	0.34109145	GO_PYRIMIDINE_RIBONUCLEOSIDE_METABOLIC_PROCESS	25	0.95991784	0.5601966	0.9712289	-0.23288076	-2.15271644
GSE39022_LN_VS_SPLEEN_DC_DN	C7_ immunologic signatures	174	-1.1925877	0.051612902	0.34134987	GSE39022_LN_VS_SPLEEN_DC_DN	176	0.9887291	0.5196771	0.93666595	-0.2038586	-2.1813168
MORF_PAPSS1	c4.CGN_ cancer gene neighborhoods	94	-1.1923124	0.11165048	0.34174472	MORF_PAPSS1	94	-1.8156395	0	0.030549766	-3.0079519	0.6233271
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC	c2.CP_REACTOME_ Reactome gene sets	19	-1.1922057	0.21857923	0.3417766	REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC	20	1.3383727	0.10331633	0.39711133	0.146167	-2.5305784
GO_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE	c5.BP_ GO biological process	58	-1.1912689	0.13333334	0.34356457	GO_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE	65	1.508828	0.005411256	0.24372745	0.3175591	-2.7000969
WOOD_EBV_EBNA1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	104	-1.1905402	0.06696428	0.3448945	WOOD_EBV_EBNA1_TARGETS_UP	104	0.75037616	0.903125	1	-0.44016404	-1.94091636
GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	168	-1.1902953	0.06081081	0.3452193	GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN	179	0.76239043	0.937247	1	-0.42790487	-1.95268573
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	c2.CGP_ chemical and genetic perturbations	30	-1.1900337	0.18421052	0.34555352	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	30	-2.2560525	0	0.00054339	-3.4460862	1.0660188
DARWICHE_PAPILLOMA_RISK_LOW_UP	c2.CGP_ chemical and genetic perturbations	128	-1.1898242	0.07978723	0.3458249	DARWICHE_PAPILLOMA_RISK_LOW_UP	129	1.1268166	0.22857143	0.7116488	-0.0630076	-2.3166408
GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	C7_ immunologic signatures	178	-1.1897175	0.048484847	0.34586495	GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	181	-0.7866565	1	0.9166612	-1.976374	-0.403061
GSE3982_MAST_CELL_VS_BASOPHIL_UP	C7_ immunologic signatures	164	-1.1892363	0.0875	0.3467117	GSE3982_MAST_CELL_VS_BASOPHIL_UP	164	0.92705774	0.6612411	1	-0.26217856	-2.11629404
GO_REGULATION_OF_BONE_RESORPTION	c5.BP_ GO biological process	25	-1.1891938	0.19476745	0.3466008	GO_REGULATION_OF_BONE_RESORPTION	29	1.6336517	0.007033998	0.13390772	0.4444579	-2.8228455
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	134	-1.1890109	0.065476194	0.34679428	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP	140	0.95968455	0.59939146	0.9709636	-0.22932635	-2.14869545
GO_INTRACILIARY_TRANSPORT_PARTICLE_B	c5.CC_ GO cellular component	18	-1.1890079	0.20547946	0.34660444	GO_INTRACILIARY_TRANSPORT_PARTICLE_B	18	0.48902148	0.9935065	1	-0.69998642	-1.67802938
GO_REGULATION_OF_INFLAMMATORY_RESPONSE	c5.BP_ GO biological process	233	-1.1889862	0.0625	0.34645608	GO_REGULATION_OF_INFLAMMATORY_RESPONSE	246	1.3496888	0.008048289	0.38294196	0.1607026	-2.538675
MORF_FEN1	c4.CGN_ cancer gene neighborhoods	61	-1.1889644	0.16791044	0.34629843	MORF_FEN1	61	-1.5007733	0	0.14190434	-2.6897377	0.3118089
GO_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	15	-1.1889402	0.23019803	0.34615815	GO_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT	19	1.1057194	0.34513274	0.7459305	-0.0832208	-2.2946596
MARZEC_IL2_SIGNALING_UP	c2.CGP_ chemical and genetic perturbations	100	-1.1889195	0.1005291	0.34600702	MARZEC_IL2_SIGNALING_UP	104	-1.3497227	0.018867925	0.24278896	-2.5386422	0.1608032
GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	176	-1.1887603	0.033783782	0.3461435	GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN	176	0.98280644	0.5490394	0.9445163	-0.20595386	-2.17156674
GO_NEUTROPHIL_MEDIATED_IMMUNITY	c5.BP_ GO biological process	16	-1.1886432	0.2176039	0.34620878	GO_NEUTROPHIL_MEDIATED_IMMUNITY	16	1.0153583	0.46587926	0.8962725	-0.1732849	-2.2040015
NAM_FXYD5_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	17	-1.1884885	0.20728292	0.34632787	NAM_FXYD5_TARGETS_DN	16	0.75468296	0.81404424	1	-0.43380554	-1.94317146
SHEPARD_CRUSH_AND_BURN_MUTANT_UP	c2.CGP_ chemical and genetic perturbations	177	-1.1884351	0.06535948	0.3462481	SHEPARD_CRUSH_AND_BURN_MUTANT_UP	181	0.8036037	0.89101917	1	-0.3848314	-1.9920388
GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN	C7_ immunologic signatures	177	-1.188387	0.077419356	0.34615853	GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN	182	0.87301385	0.7610887	1	-0.31537315	-2.06140085
GSE30083_SP1_VS_SP4_THYMOCYTE_UP	C7_ immunologic signatures	182	-1.1881623	0.075	0.3464189	GSE30083_SP1_VS_SP4_THYMOCYTE_UP	185	0.9334513	0.6730769	0.9965213	-0.254711	-2.1216136
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	c2.CGP_ chemical and genetic perturbations	46	-1.1879292	0.17704917	0.3467339	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	45	-1.2699116	0.11965812	0.30958337	-2.4578408	0.0819824
GO_U4_U6_X_U5_TRI_SNRNP_COMPLEX	c5.CC_ GO cellular component	21	-1.1876847	0.20435968	0.34701914	GO_U4_U6_X_U5_TRI_SNRNP_COMPLEX	21	-1.7082118	0.004608295	0.053623468	-2.8958965	0.5205271
MUELLER_PLURINET	c2.CGP_ chemical and genetic perturbations	285	-1.1875952	0.031578947	0.34701285	MUELLER_PLURINET	287	-1.8835087	0	0.019633709	-3.0711039	0.6959135
GO_NCRNA_3_END_PROCESSING	c5.BP_ GO biological process	18	-1.1875532	0.21666667	0.3469015	GO_NCRNA_3_END_PROCESSING	19	-1.6092777	0.023255814	0.08819238	-2.7968309	0.4217245
GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	173	-1.1872438	0.05479452	0.3473408	GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP	177	0.658444	0.98682874	1	-0.5287998	-1.8456878
GO_O_ACYLTRANSFERASE_ACTIVITY	c5.GO molecular function	43	-1.1872251	0.17610063	0.3471853	GO_O_ACYLTRANSFERASE_ACTIVITY	43	0.7262886	0.87096775	1	-0.4609365	-1.9135137
GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP	C7_ immunologic signatures	168	-1.1869215	0.09090909	0.34767178	GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP	175	1.066639	0.35359675	0.8116483	-0.1202825	-2.2535605
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN	C7_ immunologic signatures	181	-1.1867871	0.073619634	0.34776556	GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN	180	-1.5887166	0	0.09454637	-2.7755037	0.4019295
GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN	C7_ immunologic signatures	184	-1.1863836	0.060606062	0.34840074	GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN	185	0.81187314	0.87385553	1	-0.37451046	-1.99825674
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP	C7_ immunologic signatures	157	-1.1863011	0.09659091	0.34837767	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP	158	0.57755667	1	1	-0.60874443	-1.76385777
GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN	C7_ immunologic signatures	173	-1.1862833	0.096045196	0.3482151	GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN	173	1.009922	0.485309	0.9076818	-0.1763613	-2.1962053
GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	146	-1.1858171	0.08280255	0.34903872	GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN	149	-0.9524791	0.6666667	0.7545579	-2.1382962	-0.233338
NMYC_01	c3.TFT_ transcription factor targets	241	-1.185709	0.04109589	0.34905535	NMYC_01	244	0.7328005	0.9688129	1	-0.4529085	-1.9185095
GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS	c5.GO molecular function	53	-1.1856889	0.1521739	0.34889612	GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS	55	0.83093834	0.77986723	1	-0.35475056	-2.01662724
GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP	C7_ immunologic signatures	130	-1.1852027	0.082474224	0.34979382	GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP	135	0.8898123	0.74358976	1	-0.2953904	-2.075015
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	52	-1.1851702	0.15438597	0.3496743	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	52	-0.91304654	0.6636364	0.8034026	-2.09821674	-0.27212366
GO_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION	c5.BP_ GO biological process	69	-1.1850913	0.1468254	0.3496362	GO_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION	71	0.9897353	0.49946064	0.935398	-0.195356	-2.1748266
GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	172	-1.184814	0.06666667	0.35003304	GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP	174	-0.95680547	0.6363636	0.7466233	-2.14161947	-0.22800853
PID_IL27_PATHWAY	c2.CP_ Canonical pathways	22	-1.184685	0.20491803	0.35010293	PID_IL27_PATHWAY	22	-1.1711546	0.2311828	0.41505837	-2.3558396	-0.0135304
GO_ORGANIC_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	229	-1.1844461	0.033333335	0.3503946	GO_ORGANIC_ACID_BIOSYNTHETIC_PROCESS	241	0.97674	0.57572716	0.9534545	-0.2077061	-2.1611861
VILIMAS_NOTCH1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	45	-1.1842884	0.17869416	0.3505433	VILIMAS_NOTCH1_TARGETS_UP	49	1.2222915	0.16136363	0.5529586	0.0380031	-2.4065799
AKT_UP_MTOR_DN.V1_DN	C6_ oncogenic signatures	169	-1.183853	0.08588957	0.35126495	AKT_UP_MTOR_DN.V1_DN	172	0.9258019	0.6730575	1	-0.2580511	-2.1096549
BILANGES_SERUM_SENSITIVE_GENES	c2.CGP_ chemical and genetic perturbations	81	-1.1837353	0.13777778	0.351324	BILANGES_SERUM_SENSITIVE_GENES	81	-1.1171206	0.21052632	0.49347058	-2.3008559	-0.0666147
CHR22Q11	C1: positional gene sets	94	-1.1836485	0.12875536	0.3513124	CHR22Q11	105	1.2358412	0.10020877	0.5318135	0.0521927	-2.4194897
SESTO_RESPONSE_TO_UV_C6	c2.CGP_ chemical and genetic perturbations	35	-1.1833751	0.165625	0.3517188	SESTO_RESPONSE_TO_UV_C6	36	0.5861982	0.9764706	1	-0.5971769	-1.7695733
GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN	C7_ immunologic signatures	177	-1.1832634	0.067073174	0.35176474	GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN	180	0.69394624	0.9777553	1	-0.48931716	-1.87720964
AP1_C	c3.TFT_ transcription factor targets	236	-1.1831962	0.04347826	0.3517052	AP1_C	243	1.0808762	0.26706827	0.7859879	-0.10232	-2.2640724
GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	158	-1.1831061	0.10810811	0.3516901	GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP	172	1.1493046	0.19308943	0.67049485	-0.0338015	-2.3324107
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	c2.CGP_ chemical and genetic perturbations	216	-1.1829622	0.074074075	0.35179645	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	217	-1.3648329	0	0.23059082	-2.5477951	0.1818707
GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	C7_ immunologic signatures	88	-1.1829138	0.14285715	0.35170898	GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	92	1.4428655	0.010570824	0.2990322	0.2599517	-2.6257793
HALLMARK_IL6_JAK_STAT3_SIGNALING	H_ hallmark gene sets	77	-1.1829071	0.124	0.35152492	HALLMARK_IL6_JAK_STAT3_SIGNALING	78	1.241992	0.1172043	0.5232602	0.0590849	-2.4248991
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	c2.CGP_ chemical and genetic perturbations	34	-1.1827397	0.15820895	0.35169783	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	36	0.9971979	0.4879227	0.92652047	-0.1855418	-2.1799376
KAMIKUBO_MYELOID_CEBPA_NETWORK	c2.CGP_ chemical and genetic perturbations	25	-1.1825523	0.23780487	0.35191536	KAMIKUBO_MYELOID_CEBPA_NETWORK	25	1.3315624	0.09765142	0.4002275	0.1490101	-2.5141147
GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN	C7_ immunologic signatures	182	-1.1821856	0.05732484	0.352495	GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN	185	0.9148309	0.7106855	1	-0.2673547	-2.0970165
GO_PORE_COMPLEX	c5.CC_ GO cellular component	15	-1.1818031	0.2292683	0.35315612	GO_PORE_COMPLEX	15	1.4516147	0.057591625	0.29173484	0.2698116	-2.6334178
GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN	C7_ immunologic signatures	172	-1.1814426	0.059210528	0.3537602	GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN	176	1.0115936	0.46619576	0.9042635	-0.169849	-2.1930362
GSE14000_UNSTIM_VS_16H_LPS_DC_UP	C7_ immunologic signatures	167	-1.1813536	0.084415585	0.35376665	GSE14000_UNSTIM_VS_16H_LPS_DC_UP	168	0.7266401	0.959596	1	-0.4547135	-1.9079937
GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN	C7_ immunologic signatures	174	-1.1812785	0.06832298	0.3537287	GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN	174	0.84845394	0.82240164	1	-0.33282456	-2.02973244
HALLMARK_DNA_REPAIR	H_ hallmark gene sets	136	-1.1811795	0.09392265	0.35374436	HALLMARK_DNA_REPAIR	136	-1.250383	0.04347826	0.32292095	-2.4315625	0.0692035
GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	157	-1.1811392	0.0754717	0.35363162	GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	159	1.1296921	0.2324159	0.7060977	-0.0514471	-2.3108313
GSE17721_POLYIC_VS_CPG_12H_BMDC_DN	C7_ immunologic signatures	181	-1.181079	0.060402684	0.35356775	GSE17721_POLYIC_VS_CPG_12H_BMDC_DN	184	0.68090993	0.9777553	1	-0.50016907	-1.86198893
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN	C7_ immunologic signatures	178	-1.1806545	0.0625	0.35429484	GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN	181	-1.3477813	0	0.2436235	-2.5284358	0.1671268
GO_HEAT_SHOCK_PROTEIN_BINDING	c5.GO molecular function	82	-1.1805578	0.09398496	0.3543014	GO_HEAT_SHOCK_PROTEIN_BINDING	83	0.70091105	0.94623655	1	-0.47964675	-1.88146885
GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	C7_ immunologic signatures	177	-1.1800251	0.078431375	0.3552951	GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	180	0.93658304	0.65217394	0.99372506	-0.24344206	-2.11660814
WANG_TARGETS_OF_MLL_CBP_FUSION_DN	c2.CGP_ chemical and genetic perturbations	41	-1.1799794	0.1821192	0.3552023	WANG_TARGETS_OF_MLL_CBP_FUSION_DN	41	0.44969425	1	1	-0.73028515	-1.62967365
GO_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS	c5.BP_ GO biological process	123	-1.1798546	0.098958336	0.35528505	GO_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS	127	0.82846725	0.8216495	1	-0.35138735	-2.00832185
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	c2.CP_REACTOME_ Reactome gene sets	42	-1.1797863	0.1884058	0.35524097	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	43	0.780035	0.80836236	1	-0.3997513	-1.9598213
GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP	C7_ immunologic signatures	180	-1.1794106	0.07482993	0.3558738	GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP	180	-0.939185	0.9166667	0.77114964	-2.1185956	-0.2402256
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP	C7_ immunologic signatures	185	-1.1792265	0.075	0.35611913	GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP	184	-1.0121378	0.4	0.6699288	-2.1913643	-0.1670887
GO_NEUTRAL_LIPID_METABOLIC_PROCESS	c5.BP_ GO biological process	71	-1.1791574	0.17938931	0.35607687	GO_NEUTRAL_LIPID_METABOLIC_PROCESS	76	0.8033309	0.8196371	1	-0.3758265	-1.9824883
GO_NUCLEAR_TRANSCRIPTION_FACTOR_COMPLEX	c5.CC_ GO cellular component	121	-1.1791062	0.14213198	0.3559914	GO_NUCLEAR_TRANSCRIPTION_FACTOR_COMPLEX	123	0.83853745	0.820911	1	-0.34056875	-2.01764365
GO_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS	c5.BP_ GO biological process	34	-1.1790781	0.1764706	0.3558608	GO_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS	34	-1.6699833	0.006535948	0.06520107	-2.8490614	0.4909052
GSE25087_FETAL_VS_ADULT_TCONV_UP	C7_ immunologic signatures	169	-1.1785351	0.077922076	0.35685098	GSE25087_FETAL_VS_ADULT_TCONV_UP	171	0.62354803	0.9939148	1	-0.55498707	-1.80208313
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP	C7_ immunologic signatures	171	-1.1782036	0.06369427	0.35732412	GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP	181	1.1954067	0.1010101	0.596905	0.0172031	-2.3736103
GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP	C7_ immunologic signatures	154	-1.177948	0.088757396	0.3577325	GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP	161	1.2118092	0.094608344	0.5750669	0.0338612	-2.3897572
DAZARD_RESPONSE_TO_UV_NHEK_UP	c2.CGP_ chemical and genetic perturbations	202	-1.1779325	0.0859375	0.3575721	DAZARD_RESPONSE_TO_UV_NHEK_UP	205	0.91858447	0.7012072	1	-0.25934803	-2.09651697
LIN_NPAS4_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	57	-1.1779114	0.152	0.3574212	LIN_NPAS4_TARGETS_DN	59	-1.0049869	0.43157893	0.6772551	-2.1828983	-0.1729245
GO_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT	c5.BP_ GO biological process	15	-1.1777213	0.23160763	0.35765204	GO_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT	16	0.95794225	0.5339674	0.97364604	-0.21977905	-2.13566355
GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN	C7_ immunologic signatures	170	-1.1776968	0.082840234	0.3575156	GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN	172	1.1767223	0.14040405	0.62689984	-0.0009745	-2.3544191
GO_LACTATION	c5.BP_ GO biological process	36	-1.1774039	0.1951952	0.35793492	GO_LACTATION	37	0.5391401	0.99065423	1	-0.6382638	-1.716544
GO_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	249	-1.176688	0.042735044	0.3593027	GO_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY	266	1.1064588	0.20962888	0.74412256	-0.0702292	-2.2831468
GO_NF_KAPPAB_BINDING	c5.GO molecular function	28	-1.1764268	0.20454545	0.35969904	GO_NF_KAPPAB_BINDING	28	-0.59095466	0.97894734	0.9870191	-1.76738146	-0.58547214
WILLERT_WNT_SIGNALING	c2.CGP_ chemical and genetic perturbations	20	-1.1763797	0.21944444	0.35960227	WILLERT_WNT_SIGNALING	20	-1.2543218	0.15486726	0.31955707	-2.4307015	0.0779421
PID_FRA_PATHWAY	c2.CP_ Canonical pathways	33	-1.17629	0.18654434	0.35960135	PID_FRA_PATHWAY	33	1.5126528	0.021226415	0.2387046	0.3363628	-2.6889428
GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	C7_ immunologic signatures	169	-1.1762427	0.075	0.35951018	GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	174	0.9422753	0.63434345	0.9890999	-0.2339674	-2.118518
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP	C7_ immunologic signatures	183	-1.1762292	0.07333333	0.35934377	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP	184	-1.2395828	0	0.33520558	-2.415812	0.0633536
GO_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION	c5.BP_ GO biological process	65	-1.1760641	0.1764706	0.35949498	GO_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION	65	0.54108596	0.99674267	1	-0.63497814	-1.71715006
GO_GALACTOSYLTRANSFERASE_ACTIVITY	c5.GO molecular function	28	-1.176032	0.22629969	0.35936767	GO_GALACTOSYLTRANSFERASE_ACTIVITY	29	0.81642365	0.7609988	1	-0.35960835	-1.99245565
GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN	C7_ immunologic signatures	176	-1.1758076	0.0738255	0.3596228	GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN	178	1.1139213	0.24060914	0.73179525	-0.0618863	-2.2897289
GO_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING	c5.BP_ GO biological process	31	-1.1756632	0.18911175	0.35972267	GO_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING	34	-1.4588933	0.020689655	0.16684513	-2.6345565	0.2832301
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	c2.CP_REACTOME_ Reactome gene sets	61	-1.1748459	0.16014235	0.36129063	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	62	-1.8853862	0	0.019319132	-3.0602321	0.7105403
GSE12505_WT_VS_E2_2_HET_PDC_DN	C7_ immunologic signatures	130	-1.1747582	0.12105263	0.361283	GSE12505_WT_VS_E2_2_HET_PDC_DN	136	0.7881602	0.87001026	1	-0.386598	-1.9629184
GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	C7_ immunologic signatures	175	-1.1746781	0.105960265	0.3612599	GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	177	0.82563585	0.8721047	1	-0.34904225	-2.00031395
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	c2.CP_REACTOME_ Reactome gene sets	21	-1.1746515	0.23809524	0.36112756	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	21	-0.6179507	0.96347034	0.98189986	-1.7926022	-0.5567008
GO_MATERNAL_PLACENTA_DEVELOPMENT	c5.BP_ GO biological process	29	-1.1746082	0.19122256	0.36102536	GO_MATERNAL_PLACENTA_DEVELOPMENT	30	1.2465323	0.16262136	0.51708025	0.0719241	-2.4211405
GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP	C7_ immunologic signatures	176	-1.1745756	0.09774436	0.36090147	GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP	180	1.2323909	0.07258064	0.53702056	0.0578153	-2.4069665
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	181	-1.1745328	0.08695652	0.36079803	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP	182	0.67370915	0.9747984	1	-0.50082365	-1.84824195
REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_	c2.CP_REACTOME_ Reactome gene sets	59	-1.1742039	0.20149253	0.3613114	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_	59	-1.8700614	0	0.0213202	-3.0442653	0.6958575
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN	C7_ immunologic signatures	175	-1.1739113	0.08024691	0.36172825	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN	176	1.0761678	0.31269035	0.79452413	-0.0977435	-2.2500791
GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP	C7_ immunologic signatures	173	-1.173787	0.046666667	0.36182696	GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP	180	0.7492949	0.9378185	1	-0.4244921	-1.9230819
GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP	C7_ immunologic signatures	171	-1.1737665	0.0955414	0.36166844	GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP	177	0.6187307	0.994929	1	-0.5550358	-1.7924972
ABE_INNER_EAR	c2.CGP_ chemical and genetic perturbations	41	-1.173746	0.17482518	0.3615122	ABE_INNER_EAR	42	1.0030999	0.45598194	0.9181123	-0.1706461	-2.1768459
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN	C7_ immunologic signatures	170	-1.1736842	0.072222225	0.36146456	GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN	173	1.0680814	0.3346815	0.8088443	-0.1056028	-2.2417656
GSE3982_NEUTROPHIL_VS_TH2_DN	C7_ immunologic signatures	180	-1.173664	0.07913669	0.36132157	GSE3982_NEUTROPHIL_VS_TH2_DN	181	0.64749485	0.9888325	1	-0.52616915	-1.82115885
GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN	C7_ immunologic signatures	179	-1.173658	0.06790123	0.36114535	GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN	180	0.61546284	0.9939271	1	-0.55819516	-1.78912084
GO_RESPONSE_TO_OXYGEN_RADICAL	c5.BP_ GO biological process	16	-1.173605	0.2519685	0.36107054	GO_RESPONSE_TO_OXYGEN_RADICAL	16	0.7374666	0.8473684	1	-0.4361384	-1.9110716
GO_THIOESTER_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	46	-1.1733783	0.204947	0.3613781	GO_THIOESTER_BIOSYNTHETIC_PROCESS	48	0.7767138	0.8322222	1	-0.3966645	-1.9500921
GO_RNA_LOCALIZATION	c5.BP_ GO biological process	163	-1.1732523	0.10404624	0.3614563	GO_RNA_LOCALIZATION	165	-1.4435126	0	0.17798223	-2.6167649	0.2702603
GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	C7_ immunologic signatures	164	-1.1730993	0.044303797	0.36159977	GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	179	1.4324902	0.001013171	0.31298777	0.2593909	-2.6055895
BIOCARTA_ARAP_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	-1.1726465	0.2513369	0.36244622	BIOCARTA_ARAP_PATHWAY	17	0.8904235	0.6438172	1	-0.282223	-2.06307
GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	179	-1.172305	0.1037037	0.36301312	GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP	185	0.68959117	0.98275864	1	-0.48271383	-1.86189617
CAIRO_HEPATOBLASTOMA_UP	c2.CGP_ chemical and genetic perturbations	189	-1.1721731	0.04819277	0.36310658	CAIRO_HEPATOBLASTOMA_UP	189	0.5971215	1	1	-0.5750516	-1.7692946
GO_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	151	-1.1717782	0.07486631	0.3638474	GO_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS	161	0.871724	0.7820774	1	-0.3000542	-2.0435022
GSE27786_CD4_TCELL_VS_MONO_MAC_UP	C7_ immunologic signatures	177	-1.1717274	0.089655176	0.3637669	GSE27786_CD4_TCELL_VS_MONO_MAC_UP	179	0.78972894	0.9175992	1	-0.38199846	-1.96145634
GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN	C7_ immunologic signatures	174	-1.1710088	0.0729927	0.36517984	GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN	177	0.6907139	0.9816701	1	-0.4802949	-1.8617227
MODULE_417	c4.CM_ cancer modules	17	-1.1707857	0.23670213	0.36547542	MODULE_417	21	1.1006088	0.35227272	0.7563206	-0.0701769	-2.2713945
NAKAMURA_METASTASIS_MODEL_UP	c2.CGP_ chemical and genetic perturbations	37	-1.1705695	0.19488817	0.36577153	NAKAMURA_METASTASIS_MODEL_UP	39	1.1920907	0.22286375	0.6030336	0.0215212	-2.3626602
GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP	C7_ immunologic signatures	159	-1.1702328	0.072164945	0.3663091	GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP	172	1.2250644	0.08020305	0.54888517	0.0548316	-2.3952972
P53_DN.V2_UP	C6_ oncogenic signatures	101	-1.1697732	0.1255814	0.36707485	P53_DN.V2_UP	122	1.4377586	0.005144033	0.30758166	0.2679854	-2.6075318
GSE23695_CD57_POS_VS_NEG_NK_CELL_UP	C7_ immunologic signatures	174	-1.1697519	0.0875	0.3669177	GSE23695_CD57_POS_VS_NEG_NK_CELL_UP	175	0.76372844	0.92727274	1	-0.40602346	-1.93348034
GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN	C7_ immunologic signatures	177	-1.1696987	0.096296296	0.3668415	GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN	181	-1.0380533	0.33333334	0.6259535	-2.207752	-0.1316454
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	C7_ immunologic signatures	153	-1.1696948	0.119170986	0.3666504	GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	157	0.5432428	1	1	-0.626452	-1.7129376
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN	C7_ immunologic signatures	182	-1.1693918	0.09589041	0.36716363	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN	186	0.7638217	0.93259555	1	-0.4055701	-1.9332135
GO_SKELETAL_MUSCLE_TISSUE_REGENERATION	c5.BP_ GO biological process	21	-1.1691855	0.2	0.36747065	GO_SKELETAL_MUSCLE_TISSUE_REGENERATION	22	-1.6381496	0.009950249	0.076877326	-2.8073351	0.4689641
GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP	C7_ immunologic signatures	182	-1.1687084	0.088607594	0.36832833	GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP	182	-1.1303743	0	0.47095287	-2.2990827	-0.0383341
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	c2.CGP_ chemical and genetic perturbations	45	-1.1685784	0.207483	0.36842498	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	45	1.141505	0.26537585	0.6874175	-0.0270734	-2.3100834
BIOCARTA_SHH_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	-1.168527	0.2367688	0.36833215	BIOCARTA_SHH_PATHWAY	15	-1.3233995	0.1124031	0.26178047	-2.4919265	0.1548725
GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	179	-1.1685028	0.09677419	0.36819506	GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN	181	0.7091006	0.96884423	1	-0.4594022	-1.8776034
BORCZUK_MALIGNANT_MESOTHELIOMA_UP	c2.CGP_ chemical and genetic perturbations	278	-1.1684027	0.031578947	0.36822444	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	279	-1.6383488	0	0.07697938	-2.8067515	0.4699461
MODULE_379	c4.CM_ cancer modules	146	-1.1683912	0.08108108	0.36804572	MODULE_379	165	1.2078269	0.1136131	0.5805508	0.0394357	-2.3762181
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP	C7_ immunologic signatures	156	-1.1679913	0.09289618	0.36874044	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP	159	1.1558273	0.18034448	0.66056746	-0.012164	-2.3238186
NRF2_Q4	c3.TFT_ transcription factor targets	224	-1.1676227	0.053435113	0.36938408	NRF2_Q4	227	1.0255438	0.44723618	0.88332784	-0.1420789	-2.1931665
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	c2.CGP_ chemical and genetic perturbations	95	-1.1675186	0.1259542	0.36941928	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	98	0.8635181	0.7610526	1	-0.3040005	-2.0310367
GO_NUCLEOTIDYLTRANSFERASE_ACTIVITY	c5.GO molecular function	110	-1.1675013	0.14222223	0.36925632	GO_NUCLEOTIDYLTRANSFERASE_ACTIVITY	110	0.58043915	0.99154335	1	-0.58706215	-1.74794045
LEIN_NEURON_MARKERS	c2.CGP_ chemical and genetic perturbations	63	-1.1674633	0.16030534	0.369139	LEIN_NEURON_MARKERS	63	1.4842814	0.010881393	0.26570815	0.3168181	-2.6517447
GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN	C7_ immunologic signatures	164	-1.1674482	0.06918239	0.36896983	GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN	170	1.0340139	0.40324214	0.86979604	-0.1334343	-2.2014621
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP	C7_ immunologic signatures	173	-1.1674066	0.08053691	0.3688562	GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP	179	0.91433233	0.6970618	1	-0.25307427	-2.08173893
ZHOU_TNF_SIGNALING_30MIN	c2.CGP_ chemical and genetic perturbations	46	-1.1673799	0.20886075	0.36871994	ZHOU_TNF_SIGNALING_30MIN	46	0.90407926	0.640853	1	-0.26330064	-2.07145916
GSE3982_EOSINOPHIL_VS_NKCELL_DN	C7_ immunologic signatures	164	-1.1673092	0.07878788	0.36866793	GSE3982_EOSINOPHIL_VS_NKCELL_DN	168	0.7344672	0.94512194	1	-0.432842	-1.9017764
GO_MAST_CELL_GRANULE	c5.CC_ GO cellular component	20	-1.1673037	0.22284123	0.36848414	GO_MAST_CELL_GRANULE	21	1.3909955	0.07692308	0.34702262	0.2236918	-2.5582992
STEIN_ESRRA_TARGETS	c2.CGP_ chemical and genetic perturbations	465	-1.1668096	0	0.36938396	STEIN_ESRRA_TARGETS	468	0.9113835	0.8268268	1	-0.2554261	-2.0781931
BIOCARTA_GSK3_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	26	-1.1666894	0.2173913	0.3694661	BIOCARTA_GSK3_PATHWAY	26	-0.8763654	0.6827957	0.84696233	-2.0430548	-0.290324
SINGH_NFE2L2_TARGETS	c2.CGP_ chemical and genetic perturbations	15	-1.1666473	0.24685138	0.36936337	SINGH_NFE2L2_TARGETS	15	0.63869256	0.91458607	1	-0.52795474	-1.80533986
GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN	C7_ immunologic signatures	187	-1.1665201	0.07971015	0.36943877	GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN	188	1.026936	0.4362895	0.88118845	-0.1395841	-2.1934561
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	c2.CGP_ chemical and genetic perturbations	21	-1.1664913	0.25561798	0.36930993	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	21	0.90076166	0.62747526	1	-0.26572964	-2.06725296
GO_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	15	-1.166368	0.23237598	0.3693962	GO_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS	17	1.3350683	0.12093628	0.3977281	0.1687003	-2.5014363
MODULE_247	c4.CM_ cancer modules	24	-1.1662725	0.2122016	0.3694115	MODULE_247	27	1.7383615	0.002444988	0.06639102	0.572089	-2.904634
GNF2_MLH1	c4.CGN_ cancer gene neighborhoods	39	-1.166212	0.19117647	0.3693415	GNF2_MLH1	39	-2.4931068	0	0	-3.6593188	1.3268948
VANTVEER_BREAST_CANCER_BRCA1_UP	c2.CGP_ chemical and genetic perturbations	30	-1.1661111	0.2017291	0.36935884	VANTVEER_BREAST_CANCER_BRCA1_UP	31	-1.3166677	0.0867052	0.26980513	-2.4827788	0.1505566
GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP	C7_ immunologic signatures	173	-1.1660792	0.0882353	0.3692361	GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP	171	0.58394426	1	1	-0.58213494	-1.75002346
GO_REGULATION_OF_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	25	-1.1657789	0.2231884	0.36969832	GO_REGULATION_OF_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY	25	-1.0711733	0.3254717	0.56833357	-2.2369522	-0.0946056
GSE24726_WT_VS_E2_2_KO_PDC_DAY4_POST_DELETION_UP	C7_ immunologic signatures	186	-1.1652491	0.11888112	0.37068602	GSE24726_WT_VS_E2_2_KO_PDC_DAY4_POST_DELETION_UP	186	1.0378926	0.4249493	0.86231136	-0.1273565	-2.2031417
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP	C7_ immunologic signatures	174	-1.164475	0.09933775	0.37225163	GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP	177	1.0038778	0.49544996	0.9171613	-0.1605972	-2.1683528
BURTON_ADIPOGENESIS_PEAK_AT_16HR	c2.CGP_ chemical and genetic perturbations	39	-1.1644497	0.21782178	0.37212783	BURTON_ADIPOGENESIS_PEAK_AT_16HR	39	-2.1767764	0	0.001128457	-3.3412261	1.0123267
AP2ALPHA_01	c3.TFT_ transcription factor targets	209	-1.1640372	0.05263158	0.372902	AP2ALPHA_01	218	0.7384769	0.9567839	1	-0.4255603	-1.9025141
GSE3982_MAST_CELL_VS_NKCELL_UP	C7_ immunologic signatures	170	-1.1639638	0.1017964	0.37288252	GSE3982_MAST_CELL_VS_NKCELL_UP	169	0.8434923	0.82186234	1	-0.3204715	-2.0074561
HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY	H_ hallmark gene sets	43	-1.1639539	0.16233766	0.3727083	HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY	43	0.86645734	0.70068806	1	-0.29749656	-2.03041124
SF1_Q6	c3.TFT_ transcription factor targets	223	-1.1637225	0.060150377	0.37307653	SF1_Q6	230	0.7950756	0.9276382	1	-0.3686469	-1.9587981
GO_MODIFIED_AMINO_ACID_TRANSPORT	c5.BP_ GO biological process	22	-1.1635708	0.22972973	0.37323	GO_MODIFIED_AMINO_ACID_TRANSPORT	25	1.2324562	0.17582418	0.5371475	0.0688854	-2.396027
GO_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION	c5.BP_ GO biological process	16	-1.1633124	0.22879177	0.37360907	GO_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION	16	1.0521233	0.41688654	0.83703405	-0.1111891	-2.2154357
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	C7_ immunologic signatures	180	-1.1631943	0.051282052	0.37369296	GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	179	0.61205626	0.9959432	1	-0.55113804	-1.77525056
GO_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX	c5.CC_ GO cellular component	34	-1.1631626	0.24846625	0.3735694	GO_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX	34	0.90687406	0.6192771	1	-0.25628854	-2.07003666
GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP	C7_ immunologic signatures	158	-1.1631536	0.1097561	0.37338835	GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP	158	-0.88381535	0.9230769	0.8402762	-2.04696895	-0.27933825
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	c2.CGP_ chemical and genetic perturbations	233	-1.1630253	0.07462686	0.37349105	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	241	1.1681159	0.12437312	0.6404489	0.0050906	-2.3311412
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	c2.CP_BIOCARTA_ BioCarta gene sets	190	-1.1629165	0.07482993	0.3735594	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	212	1.1095284	0.24169184	0.7381273	-0.0533881	-2.2724449
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	37	-1.1624737	0.20353982	0.3743236	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	38	-1.0802928	0.27272728	0.5511102	-2.2427665	-0.0821809
GO_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX	c5.CC_ GO cellular component	21	-1.1624688	0.232493	0.3741356	GO_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX	21	-0.95546514	0.5	0.7483249	-2.11793394	-0.20700366
HALLMARK_GLYCOLYSIS	H_ hallmark gene sets	189	-1.1621971	0.078431375	0.37451786	HALLMARK_GLYCOLYSIS	193	1.1171857	0.23727088	0.72856486	-0.0450114	-2.2793828
GO_ZINC_ION_HOMEOSTASIS	c5.BP_ GO biological process	18	-1.1619179	0.24533333	0.3749506	GO_ZINC_ION_HOMEOSTASIS	18	0.7282401	0.8346056	1	-0.4336778	-1.890158
CHR2Q14	C1: positional gene sets	27	-1.1618267	0.23782235	0.3749629	CHR2Q14	29	-1.1334187	0.27564102	0.46768367	-2.2952454	-0.028408
GO_SINGLE_FERTILIZATION	c5.BP_ GO biological process	76	-1.1616957	0.15471698	0.37505752	GO_SINGLE_FERTILIZATION	90	1.2714235	0.08122363	0.48301232	0.1097278	-2.4331192
MYCMAX_01	c3.TFT_ transcription factor targets	227	-1.1616706	0.07633588	0.37491173	MYCMAX_01	230	0.75917673	0.943662	1	-0.40249387	-1.92084733
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	c2.CGP_ chemical and genetic perturbations	242	-1.1614553	0.050847456	0.37520614	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	270	1.3907174	0.001001001	0.34619585	0.2292621	-2.5521727
ST_FAS_SIGNALING_PATHWAY	c2.CP_ Canonical pathways	60	-1.1607515	0.14963503	0.3766257	ST_FAS_SIGNALING_PATHWAY	62	0.5689901	0.99460626	1	-0.5917614	-1.7297416
GO_LYASE_ACTIVITY	c5.GO molecular function	154	-1.1606934	0.0726257	0.37656093	GO_LYASE_ACTIVITY	156	0.93098295	0.65349543	0.9983277	-0.22971045	-2.09167635
GO_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS	c5.BP_ GO biological process	153	-1.1606616	0.088607594	0.37643805	GO_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS	163	0.87068516	0.7835366	1	-0.28997644	-2.03134676
GCGCTTT_MIR518B_MIR518C_MIR518D	c3.MIR_ microRNA targets	18	-1.1604652	0.26256984	0.37671107	GCGCTTT_MIR518B_MIR518C_MIR518D	18	-1.729227	0.004385965	0.048496492	-2.8896922	0.5687618
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN	C7_ immunologic signatures	185	-1.1604222	0.08552632	0.3766091	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN	185	-1.7816917	0	0.036822174	-2.9421139	0.6212695
GO_BASAL_PLASMA_MEMBRANE	c5.CC_ GO cellular component	28	-1.1602198	0.22857143	0.37689716	GO_BASAL_PLASMA_MEMBRANE	30	1.1550796	0.27294686	0.66159016	-0.0051402	-2.3152994
GO_EPITHELIAL_STRUCTURE_MAINTENANCE	c5.BP_ GO biological process	19	-1.1599314	0.24383561	0.3773607	GO_EPITHELIAL_STRUCTURE_MAINTENANCE	19	-0.8706294	0.6801802	0.85381633	-2.0305608	-0.289302
HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	c2.CGP_ chemical and genetic perturbations	43	-1.1598307	0.19393939	0.37741596	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	43	-1.1955786	0.16666667	0.38704583	-2.3554093	0.0357479
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	179	-1.1596607	0.08571429	0.37758777	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN	180	0.74661034	0.94259816	1	-0.41305036	-1.90627104
GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	184	-1.1595091	0.078947365	0.3777345	GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN	187	0.69985753	0.97791165	1	-0.45965157	-1.85936663
GSE20715_0H_VS_6H_OZONE_LUNG_UP	C7_ immunologic signatures	176	-1.1587043	0.08163265	0.3793471	GSE20715_0H_VS_6H_OZONE_LUNG_UP	182	0.7367367	0.9429735	1	-0.4219676	-1.895441
ENGELMANN_CANCER_PROGENITORS_UP	c2.CGP_ chemical and genetic perturbations	43	-1.158603	0.19871795	0.37938267	ENGELMANN_CANCER_PROGENITORS_UP	43	1.4990244	0.01923077	0.25491208	0.3404214	-2.6576274
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN	C7_ immunologic signatures	180	-1.1585377	0.086666666	0.37933373	GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN	183	1.0153987	0.44522613	0.8963895	-0.143139	-2.1739364
GO_GANGLIOSIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	26	-1.1585042	0.2536023	0.379202	GO_GANGLIOSIDE_METABOLIC_PROCESS	26	1.3928123	0.049566295	0.3482205	0.2343081	-2.5513165
TCF11MAFG_01	c3.TFT_ transcription factor targets	180	-1.1584196	0.09815951	0.3792167	TCF11MAFG_01	185	1.2258619	0.0715005	0.54817116	0.0674423	-2.3842815
CHESLER_BRAIN_QTL_CIS	c2.CGP_ chemical and genetic perturbations	66	-1.1580758	0.18055555	0.37979865	CHESLER_BRAIN_QTL_CIS	68	0.6823374	0.95305675	1	-0.4757384	-1.8404132
GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN	C7_ immunologic signatures	168	-1.1580231	0.12820514	0.3797247	GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN	176	1.137102	0.19071645	0.69463336	-0.0209211	-2.2951251
GO_RESPONSE_TO_NERVE_GROWTH_FACTOR	c5.BP_ GO biological process	35	-1.1578702	0.22653721	0.37986773	GO_RESPONSE_TO_NERVE_GROWTH_FACTOR	36	0.7702243	0.8173191	1	-0.3876459	-1.9280945
SEIDEN_MET_SIGNALING	c2.CGP_ chemical and genetic perturbations	19	-1.1575302	0.25885558	0.38046473	SEIDEN_MET_SIGNALING	19	-1.1663667	0.25	0.42231262	-2.3238969	0.0088365
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	c2.CGP_ chemical and genetic perturbations	102	-1.1574138	0.12565444	0.38052827	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	102	0.94239926	0.60833335	0.98909664	-0.21501454	-2.09981306
GO_REGULATION_OF_CELLULAR_SENESCENCE	c5.BP_ GO biological process	23	-1.1571984	0.22606383	0.38080642	GO_REGULATION_OF_CELLULAR_SENESCENCE	23	-0.8989078	0.6145833	0.82258683	-2.0561062	-0.2582906
GO_RETINOIC_ACID_RECEPTOR_BINDING	c5.GO molecular function	26	-1.157051	0.2521994	0.38095102	GO_RETINOIC_ACID_RECEPTOR_BINDING	27	0.94357073	0.5365854	0.98850113	-0.21348027	-2.10062173
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_DN	C7_ immunologic signatures	159	-1.1566346	0.11333334	0.38173184	GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_DN	163	1.0502762	0.39002037	0.83999646	-0.1063584	-2.2069108
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	c2.CGP_ chemical and genetic perturbations	282	-1.1561525	0.04761905	0.38264978	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	285	0.9617761	0.6326326	0.96889985	-0.1943764	-2.1179286
GO_POTASSIUM_ION_TRANSPORT	c5.BP_ GO biological process	123	-1.1559671	0.15841584	0.38289207	GO_POTASSIUM_ION_TRANSPORT	146	1.223523	0.08562691	0.5508893	0.0675559	-2.3794901
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	C7_ immunologic signatures	174	-1.1551986	0.12413793	0.38447154	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	175	-1.7044318	0	0.054606527	-2.8596304	0.5492332
GO_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN	c5.BP_ GO biological process	147	-1.1550661	0.110497236	0.38460737	GO_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN	148	-1.0111158	0.4	0.67120767	-2.1661819	-0.1439503
E2F3_UP.V1_DN	C6_ oncogenic signatures	103	-1.1550069	0.1407767	0.38454044	E2F3_UP.V1_DN	111	1.1911446	0.14315353	0.60422087	0.0361377	-2.3461515
GO_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING	c5.GO molecular function	68	-1.1550057	0.19246861	0.38434446	GO_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING	71	0.9071402	0.6511879	1	-0.2478655	-2.0621459
CHR9P24	C1: positional gene sets	30	-1.1546367	0.23659305	0.38502818	CHR9P24	32	1.5350333	0.018845702	0.21627374	0.3803966	-2.68967
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	c2.CGP_ chemical and genetic perturbations	84	-1.1546332	0.16666667	0.38483644	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	93	1.5312583	0.001039501	0.22061099	0.3766251	-2.6858915
GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN	C7_ immunologic signatures	179	-1.154539	0.090361446	0.38484216	GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN	180	0.6680757	0.9889001	1	-0.4864633	-1.8226147
CHRXQ25	C1: positional gene sets	17	-1.1544629	0.27118644	0.38482678	CHRXQ25	18	0.78823835	0.77890724	1	-0.36622455	-1.94270125
GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN	C7_ immunologic signatures	167	-1.1541494	0.10382514	0.38537288	GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN	179	0.7499173	0.93016195	1	-0.4042321	-1.9040667
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	c2.CGP_ chemical and genetic perturbations	94	-1.1540174	0.16796875	0.3854753	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	100	1.6735549	0	0.094187185	0.5195375	-2.8275723
MODULE_229	c4.CM_ cancer modules	27	-1.1539084	0.2506887	0.38553584	MODULE_229	28	0.72990006	0.84606063	1	-0.42400834	-1.88380846
GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN	C7_ immunologic signatures	173	-1.1538743	0.13496932	0.38541916	GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN	180	0.9213941	0.687247	1	-0.2324802	-2.0752684
GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	160	-1.1538426	0.10429448	0.3852964	GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	160	0.94233596	0.6401631	0.98916644	-0.21150664	-2.09617856
GO_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION	c5.BP_ GO biological process	54	-1.1536647	0.21839081	0.3855659	GO_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION	58	1.1953887	0.1773667	0.59660727	0.041724	-2.3490534
GO_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY	c5.BP_ GO biological process	52	-1.1535153	0.19736843	0.38571945	GO_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY	52	-1.3737742	0.026548672	0.22479805	-2.5272895	0.2202589
GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN	C7_ immunologic signatures	171	-1.1534944	0.11392405	0.3855697	GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN	173	1.1053675	0.25661916	0.74612075	-0.0481269	-2.2588619
USF_Q6_01	c3.TFT_ transcription factor targets	216	-1.153399	0.07801419	0.3855988	USF_Q6_01	217	0.83955175	0.8719758	1	-0.31384725	-1.99295075
GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN	C7_ immunologic signatures	180	-1.1532788	0.10666667	0.38565397	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN	184	0.75559175	0.9443883	1	-0.39768705	-1.90887055
GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN	C7_ immunologic signatures	138	-1.1528867	0.115606934	0.3864038	GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN	139	0.58997625	0.9948928	1	-0.56291045	-1.74286295
GO_TRIVALENT_INORGANIC_CATION_TRANSPORT	c5.BP_ GO biological process	37	-1.1526798	0.2379518	0.38668635	GO_TRIVALENT_INORGANIC_CATION_TRANSPORT	39	1.0574517	0.37427577	0.8285636	-0.0952281	-2.2101315
GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN	C7_ immunologic signatures	173	-1.1526778	0.125	0.38649526	GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN	177	0.86169016	0.8158698	1	-0.29098764	-2.01436796
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	c2.CGP_ chemical and genetic perturbations	37	-1.1524346	0.2035928	0.38687694	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	37	0.8065032	0.78306264	1	-0.3459314	-1.9589378
GO_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION	c5.BP_ GO biological process	15	-1.1522981	0.23846154	0.3870237	GO_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION	15	0	0	0	-1.1522981	-1.1522981
GO_ALCOHOL_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	98	-1.1520656	0.14883721	0.38735604	GO_ALCOHOL_BIOSYNTHETIC_PROCESS	103	0.7119817	0.94172734	1	-0.4400839	-1.8640473
GO_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	16	-1.1520644	0.25714287	0.38716128	GO_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS	19	-0.8702686	0.62995595	0.85351443	-2.022333	-0.2817958
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN	C7_ immunologic signatures	169	-1.1518778	0.09580839	0.38739863	GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN	167	1.1554394	0.15789473	0.6614903	0.0035616	-2.3073172
TIAN_TNF_SIGNALING_NOT_VIA_NFKB	c2.CGP_ chemical and genetic perturbations	21	-1.1516806	0.25915492	0.38765645	TIAN_TNF_SIGNALING_NOT_VIA_NFKB	21	0.80347264	0.7521793	1	-0.34820796	-1.95515324
NERF_Q2	c3.TFT_ transcription factor targets	214	-1.1515685	0.08695652	0.38772148	NERF_Q2	221	1.1252801	0.19393939	0.71457964	-0.0262884	-2.2768486
GSE17721_0.5H_VS_4H_LPS_BMDC_UP	C7_ immunologic signatures	178	-1.1515293	0.078947365	0.38760537	GSE17721_0.5H_VS_4H_LPS_BMDC_UP	180	0.7295773	0.964539	1	-0.421952	-1.8811066
GO_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	84	-1.1515102	0.17427386	0.3874556	GO_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION	87	0.99984396	0.50053364	0.9248848	-0.15166624	-2.15135416
GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP	C7_ immunologic signatures	175	-1.1514387	0.08695652	0.38743624	GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP	175	-1.0472667	0.26666668	0.61160207	-2.1987054	-0.104172
RAMALHO_STEMNESS_UP	c2.CGP_ chemical and genetic perturbations	192	-1.1512848	0.15107913	0.38760617	RAMALHO_STEMNESS_UP	192	-1.65756	0	0.069132105	-2.8088448	0.5062752
GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	142	-1.1511866	0.10614525	0.3876497	GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN	143	-1.0118368	0.41666666	0.6704692	-2.1630234	-0.1393498
GNF2_SMC1L1	c4.CGN_ cancer gene neighborhoods	26	-1.1510847	0.2265861	0.38770467	GNF2_SMC1L1	26	-2.305962	0	0.000285384	-3.4570467	1.1548773
GSE3982_EOSINOPHIL_VS_BCELL_DN	C7_ immunologic signatures	174	-1.1506796	0.103225805	0.38847107	GSE3982_EOSINOPHIL_VS_BCELL_DN	176	0.9343579	0.67070705	0.9955431	-0.2163217	-2.0850375
LANG_MYB_FAMILY_TARGETS	c2.CGP_ chemical and genetic perturbations	29	-1.1505014	0.25862068	0.38869783	LANG_MYB_FAMILY_TARGETS	29	0.7394222	0.8504222	1	-0.4110792	-1.8899236
GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN	C7_ immunologic signatures	171	-1.1504661	0.10493827	0.38857365	GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN	178	0.85556036	0.8225152	1	-0.29490574	-2.00602646
REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION	c2.CP_REACTOME_ Reactome gene sets	77	-1.1504152	0.16455697	0.3884959	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION	78	0.6317661	0.9806659	1	-0.5186491	-1.7821813
GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN	C7_ immunologic signatures	178	-1.1502855	0.10273973	0.38861057	GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN	181	0.6676872	0.9858443	1	-0.4825983	-1.8179727
CAIRO_LIVER_DEVELOPMENT_DN	c2.CGP_ chemical and genetic perturbations	187	-1.1501255	0.10526316	0.38881043	CAIRO_LIVER_DEVELOPMENT_DN	196	1.0747021	0.31041455	0.7975509	-0.0754234	-2.2248276
GO_INTESTINAL_ABSORPTION	c5.BP_ GO biological process	23	-1.1498778	0.2287234	0.38918853	GO_INTESTINAL_ABSORPTION	23	1.3718082	0.07721519	0.3655748	0.2219304	-2.521686
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	c2.CP_REACTOME_ Reactome gene sets	41	-1.1497924	0.1936508	0.38919497	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	41	-1.5099716	0.016129032	0.13677253	-2.659764	0.3601792
GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	182	-1.1497782	0.1294964	0.3890369	GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN	184	0.7072623	0.9778449	1	-0.4425159	-1.8570405
GSE20715_WT_VS_TLR4_KO_LUNG_DN	C7_ immunologic signatures	171	-1.1496282	0.13385826	0.38918692	GSE20715_WT_VS_TLR4_KO_LUNG_DN	179	0.85982966	0.8046796	1	-0.28979854	-2.00945786
GO_PIGMENT_METABOLIC_PROCESS	c5.BP_ GO biological process	56	-1.1496011	0.21498372	0.38906467	GO_PIGMENT_METABOLIC_PROCESS	58	-1.1686767	0.15789473	0.41850454	-2.3182778	0.0190756
PODAR_RESPONSE_TO_ADAPHOSTIN_DN	c2.CGP_ chemical and genetic perturbations	17	-1.1495438	0.28039703	0.3890112	PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17	-1.4541154	0.05	0.17011026	-2.6036592	0.3045716
GCM_AIP	c4.CGN_ cancer gene neighborhoods	35	-1.1495311	0.24307692	0.38884872	GCM_AIP	37	-0.9837729	0.4827586	0.70920366	-2.133304	-0.1657582
GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	186	-1.1491987	0.123188406	0.38944852	GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN	186	0.74076945	0.9443883	1	-0.40842925	-1.88996815
GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN	C7_ immunologic signatures	177	-1.1490524	0.125	0.38961047	GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN	182	0.89183277	0.74924165	1	-0.25721963	-2.04088517
REACTOME_ACYL_CHAIN_REMODELLING_OF_PE	c2.CP_REACTOME_ Reactome gene sets	17	-1.1490031	0.25459316	0.389522	REACTOME_ACYL_CHAIN_REMODELLING_OF_PE	21	1.0847517	0.3625	0.7776103	-0.0642514	-2.2337548
GO_2_IRON_2_SULFUR_CLUSTER_BINDING	c5.GO molecular function	19	-1.148943	0.25	0.38947037	GO_2_IRON_2_SULFUR_CLUSTER_BINDING	18	-0.47832778	1	0.9913925	-1.62727078	-0.67061522
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	174	-1.14857	0.10067114	0.39017087	GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP	178	0.9016975	0.74164134	1	-0.2468725	-2.0502675
GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP	C7_ immunologic signatures	160	-1.1481768	0.11931818	0.39093783	GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP	160	-2.332891	0	0.000166405	-3.4810678	1.1847142
GOLDRATH_HOMEOSTATIC_PROLIFERATION	c2.CGP_ chemical and genetic perturbations	157	-1.1481495	0.08227848	0.39079234	GOLDRATH_HOMEOSTATIC_PROLIFERATION	158	-1.1117616	0.14285715	0.50309134	-2.2599111	-0.0363879
GO_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER	c5.BP_ GO biological process	23	-1.1481057	0.23955432	0.3906859	GO_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER	23	-1.7630731	0	0.040590122	-2.9111788	0.6149674
GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	C7_ immunologic signatures	111	-1.1480426	0.11210762	0.39063412	GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	115	0.9555948	0.5985477	0.97567886	-0.1924478	-2.1036374
GSE3982_MAST_CELL_VS_BCELL_DN	C7_ immunologic signatures	154	-1.1478235	0.12820514	0.39098886	GSE3982_MAST_CELL_VS_BCELL_DN	158	1.1125447	0.2413793	0.73381025	-0.0352788	-2.2603682
GO_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	187	-1.1477362	0.08496732	0.39099327	GO_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS	196	1.0695087	0.3377282	0.80643237	-0.0782275	-2.2172449
MODULE_133	c4.CM_ cancer modules	15	-1.1476754	0.24438903	0.39094734	MODULE_133	15	-2.0045936	0.004	0.007860235	-3.152269	0.8569182
GO_POSITIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY	c5.BP_ GO biological process	52	-1.1475263	0.23411371	0.39108995	GO_POSITIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY	55	0.70163596	0.90909094	1	-0.44589034	-1.84916226
GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	C7_ immunologic signatures	120	-1.1473885	0.0964467	0.39121687	GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	130	1.1491737	0.20410256	0.67041534	0.0017852	-2.2965622
GO_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS	c5.BP_ GO biological process	70	-1.1467917	0.19921875	0.39243427	GO_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS	76	1.3520755	0.048179872	0.38279355	0.2052838	-2.4988672
GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN	C7_ immunologic signatures	174	-1.1466689	0.08176101	0.3925247	GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN	176	0.75843906	0.94129556	1	-0.38822984	-1.90510796
CHR18Q22	C1: positional gene sets	16	-1.1466138	0.2747253	0.39244792	CHR18Q22	18	0.70958483	0.86553526	1	-0.43702897	-1.85619863
GO_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	109	-1.1463932	0.12053572	0.39279145	GO_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS	117	1.0952997	0.3046632	0.76434076	-0.0510935	-2.2416929
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	c2.CGP_ chemical and genetic perturbations	197	-1.1462601	0.103896104	0.3929087	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	200	1.2124639	0.08392315	0.5735039	0.0662038	-2.358724
GSE3982_MAST_CELL_VS_MAC_UP	C7_ immunologic signatures	170	-1.1462517	0.0877193	0.39273334	GSE3982_MAST_CELL_VS_MAC_UP	173	0.9167712	0.6981707	1	-0.2294805	-2.0630229
GO_NUCLEAR_OUTER_MEMBRANE	c5.CC_ GO cellular component	19	-1.1461241	0.22284123	0.3928466	GO_NUCLEAR_OUTER_MEMBRANE	18	1.5105441	0.01986755	0.2427912	0.36442	-2.6566682
GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN	C7_ immunologic signatures	156	-1.1460321	0.14814815	0.39285776	GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN	161	1.2621399	0.050556116	0.49338067	0.1161078	-2.408172
CHRXQ13	C1: positional gene sets	48	-1.1455054	0.20679012	0.3939109	CHRXQ13	50	0.65709615	0.9469526	1	-0.48840925	-1.80260155
GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN	C7_ immunologic signatures	182	-1.145488	0.1017964	0.39375326	GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN	182	-0.95627135	0.73333335	0.7474031	-2.10175935	-0.18921665
STEIN_ESRRA_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	339	-1.1453578	0.013888889	0.39388192	STEIN_ESRRA_TARGETS_UP	340	0.9731649	0.5855856	0.95782125	-0.1721929	-2.1185227
GO_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	144	-1.1452836	0.119760476	0.39386457	GO_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS	150	1.1587228	0.18960245	0.65505123	0.0134392	-2.3040064
KIM_ALL_DISORDERS_CALB1_CORR_UP	c2.CGP_ chemical and genetic perturbations	496	-1.1449519	0.024390243	0.39443615	KIM_ALL_DISORDERS_CALB1_CORR_UP	496	0	0	0	-1.1449519	-1.1449519
NFE2_01	c3.TFT_ transcription factor targets	233	-1.144855	0.04385965	0.39448056	NFE2_01	241	1.193878	0.0831643	0.59910476	0.049023	-2.338733
GO_PRE_MRNA_BINDING	c5.GO molecular function	24	-1.1448455	0.26285714	0.39430574	GO_PRE_MRNA_BINDING	24	-1.8486102	0	0.024939422	-2.9934557	0.7037647
MODULE_139	c4.CM_ cancer modules	70	-1.1444254	0.20220588	0.39517367	MODULE_139	73	1.196999	0.1783029	0.59662783	0.0525736	-2.3414244
GSE3982_MAST_CELL_VS_TH1_UP	C7_ immunologic signatures	163	-1.14427	0.14	0.39535266	GSE3982_MAST_CELL_VS_TH1_UP	167	1.1910186	0.12778905	0.60423493	0.0467486	-2.3352886
GO_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME	c5.BP_ GO biological process	58	-1.1441705	0.19031142	0.3954283	GO_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME	60	-1.2616323	0.08888889	0.31362313	-2.4058028	0.1174618
GSE17721_CTRL_VS_CPG_8H_BMDC_UP	C7_ immunologic signatures	181	-1.1438533	0.13043478	0.39599657	GSE17721_CTRL_VS_CPG_8H_BMDC_UP	182	0.6925718	0.9777778	1	-0.4512815	-1.8364251
MODULE_300	c4.CM_ cancer modules	28	-1.1438345	0.22629969	0.39584708	MODULE_300	31	1.2707756	0.13652694	0.48361033	0.1269411	-2.4146101
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS	c5.GO molecular function	49	-1.1437154	0.24489796	0.39592442	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS	50	0.8992169	0.65642774	1	-0.2444985	-2.0429323
GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	C7_ immunologic signatures	178	-1.1435815	0.119760476	0.39605394	GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	181	1.0208327	0.443769	0.8907241	-0.1227488	-2.1644142
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN	C7_ immunologic signatures	181	-1.1434842	0.10062893	0.39608043	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN	178	0.910849	0.7171717	1	-0.2326352	-2.0543332
KAAB_FAILED_HEART_ATRIUM_DN	c2.CGP_ chemical and genetic perturbations	132	-1.1434048	0.14044943	0.39608845	KAAB_FAILED_HEART_ATRIUM_DN	132	0.6836079	0.97236437	1	-0.4597969	-1.8270127
ALONSO_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	173	-1.1433189	0.14371258	0.39608383	ALONSO_METASTASIS_UP	175	0.7251137	0.9635996	1	-0.4182052	-1.8684326
ETS1_B	c3.TFT_ transcription factor targets	226	-1.1432785	0.07936508	0.3959825	ETS1_B	232	1.0766809	0.30382293	0.79437333	-0.0665976	-2.2199594
GO_POSITIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	97	-1.1430739	0.16748768	0.39627215	GO_POSITIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS	97	-0.8635257	0.7692308	0.8579295	-2.0065996	-0.2795482
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	c2.CP_REACTOME_ Reactome gene sets	35	-1.1430705	0.22873901	0.3960881	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	35	-0.8704055	0.7096774	0.85356236	-2.013476	-0.272665
GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN	C7_ immunologic signatures	175	-1.1430621	0.121212125	0.3959107	GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN	177	-1.0569351	0.1875	0.59460247	-2.1999972	-0.086127
GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	176	-1.1430315	0.11888112	0.39579266	GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP	180	1.154381	0.18511066	0.66291	0.0113495	-2.2974125
GO_REGULATION_OF_MACROPHAGE_DIFFERENTIATION	c5.BP_ GO biological process	17	-1.1427685	0.2596685	0.39619982	GO_REGULATION_OF_MACROPHAGE_DIFFERENTIATION	18	1.0216824	0.44516972	0.8895098	-0.1210861	-2.1644509
GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	C7_ immunologic signatures	179	-1.1427633	0.12426036	0.39601904	GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	181	0.86407423	0.7993921	1	-0.27868907	-2.00683753
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	c2.CGP_ chemical and genetic perturbations	26	-1.1425338	0.24347825	0.39639688	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	26	1.2269821	0.19702603	0.5464016	0.0844483	-2.3695159
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	c2.CGP_ chemical and genetic perturbations	260	-1.1423423	0.09448819	0.3966702	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	269	0.97219473	0.57214427	0.9591089	-0.17014757	-2.11453703
KIM_LIVER_CANCER_POOR_SURVIVAL_UP	c2.CGP_ chemical and genetic perturbations	20	-1.1419668	0.2283237	0.39737785	KIM_LIVER_CANCER_POOR_SURVIVAL_UP	20	0.45805708	0.9974874	1	-0.68390972	-1.60002388
GO_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION	c5.BP_ GO biological process	30	-1.1417432	0.27272728	0.3977094	GO_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION	33	1.3199551	0.10788863	0.41208482	0.1782119	-2.4616983
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	174	-1.1416252	0.13609467	0.397789	GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN	178	0.89929235	0.7193516	1	-0.24233285	-2.04091755
GO_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION	c5.BP_ GO biological process	188	-1.1414865	0.09150327	0.397927	GO_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION	202	0.9982259	0.5035389	0.9257929	-0.1432606	-2.1397124
GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP	C7_ immunologic signatures	163	-1.1411965	0.08235294	0.39846665	GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP	170	0.7478156	0.93333334	1	-0.3933809	-1.8890121
GO_AMINOPEPTIDASE_ACTIVITY	c5.GO molecular function	37	-1.1410238	0.21974522	0.3986819	GO_AMINOPEPTIDASE_ACTIVITY	39	1.0432616	0.42281106	0.8530699	-0.0977622	-2.1842854
ST_ADRENERGIC	c2.CP_ Canonical pathways	29	-1.1408782	0.23225807	0.3988521	ST_ADRENERGIC	30	1.5449219	0.013048636	0.20895267	0.4040437	-2.6858001
GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP	C7_ immunologic signatures	156	-1.1408062	0.12230216	0.39883646	GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP	158	0.7743771	0.90909094	1	-0.3664291	-1.9151833
KEEN_RESPONSE_TO_ROSIGLITAZONE_UP	c2.CGP_ chemical and genetic perturbations	36	-1.1407565	0.21387284	0.39876586	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP	35	-0.9161725	0.5915493	0.80082285	-2.056929	-0.224584
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	152	-1.1405206	0.13259669	0.39913985	GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP	152	1.0910181	0.31160897	0.7695842	-0.0495025	-2.2315387
GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP	C7_ immunologic signatures	158	-1.140412	0.1509434	0.3992097	GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP	158	0.5519431	1	1	-0.5884689	-1.6923551
GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_UP	C7_ immunologic signatures	172	-1.1403712	0.112426035	0.3991201	GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_UP	175	0.81567407	0.8810484	1	-0.32469713	-1.95604527
GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	183	-1.1399317	0.11564626	0.40000758	GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP	185	0.8464238	0.8387424	1	-0.2935079	-1.9863555
GO_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS	c5.BP_ GO biological process	25	-1.1398705	0.24725275	0.39996538	GO_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS	30	1.1964407	0.2027027	0.596538	0.0565702	-2.3363112
GO_REGULATION_OF_DNA_BINDING	c5.BP_ GO biological process	83	-1.1397957	0.1416309	0.3999544	GO_REGULATION_OF_DNA_BINDING	86	-1.2830302	0.041666668	0.2995785	-2.4228259	0.1432345
GO_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR	c5.BP_ GO biological process	18	-1.1397609	0.27937338	0.39983982	GO_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR	17	0.47084504	0.99096775	1	-0.66891586	-1.61060594
BILANGES_RAPAMYCIN_SENSITIVE_GENES	c2.CGP_ chemical and genetic perturbations	35	-1.1395757	0.22408964	0.40008032	BILANGES_RAPAMYCIN_SENSITIVE_GENES	35	0.49226975	0.9963855	1	-0.64730595	-1.63184545
HUMMERICH_SKIN_CANCER_PROGRESSION_UP	c2.CGP_ chemical and genetic perturbations	77	-1.1395458	0.18650794	0.39995825	HUMMERICH_SKIN_CANCER_PROGRESSION_UP	80	1.019702	0.45309168	0.8914521	-0.1198438	-2.1592478
AML_Q6	c3.TFT_ transcription factor targets	228	-1.1394628	0.0625	0.39995694	AML_Q6	235	0.9019806	0.759	1	-0.2374822	-2.0414434
GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP	C7_ immunologic signatures	166	-1.1391273	0.116564415	0.40056488	GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP	167	-1.1900953	0	0.3937696	-2.3292226	0.050968
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	c2.CGP_ chemical and genetic perturbations	99	-1.139015	0.15075377	0.40063822	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	100	0.8704098	0.7313746	1	-0.2686052	-2.0094248
GSE27786_BCELL_VS_ERYTHROBLAST_UP	C7_ immunologic signatures	176	-1.1389955	0.13690476	0.4004889	GSE27786_BCELL_VS_ERYTHROBLAST_UP	178	-0.76392466	1	0.93039757	-1.90292016	-0.37507084
GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	151	-1.1389304	0.09876543	0.4004421	GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP	158	0.9699564	0.56619143	0.9613434	-0.168974	-2.1088868
GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP	C7_ immunologic signatures	183	-1.1387683	0.1119403	0.40064767	GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP	186	0.7684199	0.93434346	1	-0.3703484	-1.9071882
WANG_TNF_TARGETS	c2.CGP_ chemical and genetic perturbations	19	-1.1382968	0.25336927	0.40161106	WANG_TNF_TARGETS	20	-0.9634042	0.4473684	0.73756665	-2.101701	-0.1748926
GO_RNA_POLYADENYLATION	c5.BP_ GO biological process	28	-1.1382502	0.24645892	0.4015294	GO_RNA_POLYADENYLATION	28	-1.069608	0.3181818	0.57075924	-2.2078582	-0.0686422
GO_INTRINSIC_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE	c5.CC_ GO cellular component	22	-1.1381252	0.26567164	0.4016564	GO_INTRINSIC_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE	24	1.6770285	0.002512563	0.09409671	0.5389033	-2.8151537
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	c2.CGP_ chemical and genetic perturbations	98	-1.1376075	0.15873016	0.4027416	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	105	1.3387243	0.038065843	0.39697117	0.2011168	-2.4763318
GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP	C7_ immunologic signatures	144	-1.1375713	0.15135135	0.4026378	GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP	151	1.2756743	0.043788187	0.4798018	0.138103	-2.4132456
ZIC1_01	c3.TFT_ transcription factor targets	237	-1.1374524	0.11666667	0.40274906	ZIC1_01	239	0.9654743	0.5943775	0.9651375	-0.1719781	-2.1029267
GO_REGULATION_OF_RECEPTOR_INTERNALIZATION	c5.BP_ GO biological process	33	-1.1373192	0.23404256	0.40287495	GO_REGULATION_OF_RECEPTOR_INTERNALIZATION	37	0.9162662	0.606596	1	-0.221053	-2.0535854
GO_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH	c5.BP_ GO biological process	28	-1.1372303	0.2072072	0.40290153	GO_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH	31	-1.4448885	0.019607844	0.17713684	-2.5821188	0.3076582
GO_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY	c5.BP_ GO biological process	55	-1.1370203	0.18611987	0.40320545	GO_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY	56	1.3871603	0.04222222	0.34888247	0.25014	-2.5241806
GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP	C7_ immunologic signatures	155	-1.1366833	0.12337662	0.40381625	GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP	154	0.7404797	0.94602853	1	-0.3962036	-1.877163
GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP	C7_ immunologic signatures	178	-1.1363419	0.10326087	0.404455	GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP	182	-0.97266686	0.53333336	0.72474396	-2.10900876	-0.16367504
GO_PROSTANOID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	-1.1360359	0.2867647	0.40502256	GO_PROSTANOID_BIOSYNTHETIC_PROCESS	16	1.3566556	0.08258065	0.3799573	0.2206197	-2.4926915
GO_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE	c5.BP_ GO biological process	58	-1.1360021	0.21621622	0.40490305	GO_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE	61	0.76973176	0.8364641	1	-0.36627034	-1.90573386
GO_REGULATION_OF_BONE_REMODELING	c5.BP_ GO biological process	31	-1.1357267	0.25739646	0.4053718	GO_REGULATION_OF_BONE_REMODELING	37	1.4773364	0.01845444	0.27197632	0.3416097	-2.6130631
GNF2_MBD4	c4.CGN_ cancer gene neighborhoods	16	-1.1354405	0.2781955	0.40585133	GNF2_MBD4	16	-1.8773904	0.011952192	0.020415425	-3.0128309	0.7419499
HALLMARK_ALLOGRAFT_REJECTION	H_ hallmark gene sets	159	-1.1353254	0.11797753	0.4059295	HALLMARK_ALLOGRAFT_REJECTION	170	1.0494516	0.38453713	0.8410582	-0.0858738	-2.184777
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	c2.CGP_ chemical and genetic perturbations	16	-1.1349427	0.29007635	0.40667012	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	17	0.5832245	0.954955	1	-0.5517182	-1.7181672
GO_RIBONUCLEOPROTEIN_GRANULE	c5.CC_ GO cellular component	128	-1.1348028	0.15	0.4068141	GO_RIBONUCLEOPROTEIN_GRANULE	132	0.83712655	0.8180884	1	-0.29767625	-1.97192935
GO_POSITIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS	c5.BP_ GO biological process	31	-1.1347438	0.24528302	0.40678045	GO_POSITIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS	31	0.71153575	0.87573963	1	-0.42320805	-1.84627955
GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN	C7_ immunologic signatures	180	-1.1344357	0.09356725	0.40738168	GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN	180	1.3838761	0.001009082	0.35223132	0.2494404	-2.5183118
GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP	C7_ immunologic signatures	132	-1.1344261	0.15555556	0.40720963	GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP	136	1.0459945	0.39285713	0.84700763	-0.0884316	-2.1804206
GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN	C7_ immunologic signatures	165	-1.1343848	0.10828026	0.4070948	GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN	168	0.818773	0.8593272	1	-0.3156118	-1.9531578
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN	C7_ immunologic signatures	157	-1.1343664	0.1097561	0.40694433	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN	161	1.2105339	0.08080808	0.5761008	0.0761675	-2.3449003
GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP	C7_ immunologic signatures	167	-1.1343539	0.13043478	0.4067806	GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP	168	0.95267415	0.6185148	0.9785236	-0.18167975	-2.08702805
GNF2_BNIP3L	c4.CGN_ cancer gene neighborhoods	60	-1.1340749	0.20769231	0.40726706	GNF2_BNIP3L	64	0.80904806	0.7867403	1	-0.32502684	-1.94312296
REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	161	-1.1338686	0.16091955	0.40756127	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	163	0.91698045	0.6854508	1	-0.21688815	-2.05084905
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN	C7_ immunologic signatures	170	-1.1336771	0.10982659	0.40782243	GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN	174	0.8895257	0.74747473	1	-0.2441514	-2.0232028
PID_RET_PATHWAY	c2.CP_ Canonical pathways	39	-1.1336403	0.24252492	0.40772283	PID_RET_PATHWAY	39	0.7902094	0.811098	1	-0.3434309	-1.9238497
GO_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS	c5.CC_ GO cellular component	220	-1.1336081	0.11382114	0.4076085	GO_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS	221	0.82767224	0.889899	1	-0.30593586	-1.96128034
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	c2.CGP_ chemical and genetic perturbations	73	-1.1330574	0.16546762	0.4088319	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	74	-1.4253498	0.026666667	0.19140999	-2.5584072	0.2922924
GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	165	-1.1329523	0.1125	0.40888885	GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP	167	0.8027677	0.8695209	1	-0.3301846	-1.93572
GNATENKO_PLATELET_SIGNATURE	c2.CGP_ chemical and genetic perturbations	38	-1.1329442	0.25460124	0.40871266	GNATENKO_PLATELET_SIGNATURE	35	0.9855605	0.512426	0.9415111	-0.1473837	-2.1185047
YANG_BREAST_CANCER_ESR1_LASER_UP	c2.CGP_ chemical and genetic perturbations	29	-1.1329012	0.28695652	0.4086179	YANG_BREAST_CANCER_ESR1_LASER_UP	30	1.2159886	0.20752427	0.56451374	0.0830874	-2.3488898
GO_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION	c5.BP_ GO biological process	80	-1.1326791	0.1923077	0.40898564	GO_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION	88	1.3852825	0.020042194	0.35047424	0.2526034	-2.5179616
GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP	C7_ immunologic signatures	159	-1.132663	0.1474359	0.40882754	GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP	168	0.92081404	0.6966292	1	-0.21184896	-2.05347704
GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	C7_ immunologic signatures	155	-1.1325712	0.14124294	0.4088496	GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	160	0.49103865	1	1	-0.64153255	-1.62360985
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	c2.CGP_ chemical and genetic perturbations	33	-1.1321921	0.23028392	0.40962037	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	33	0.78565717	0.7866354	1	-0.34653493	-1.91784927
GO_NUCLEAR_ENVELOPE_REASSEMBLY	c5.BP_ GO biological process	17	-1.1320469	0.25915492	0.4097865	GO_NUCLEAR_ENVELOPE_REASSEMBLY	17	-1.2225562	0.20425531	0.35296872	-2.3546031	0.0905093
DELACROIX_RARG_BOUND_MEF	c2.CGP_ chemical and genetic perturbations	343	-1.1319883	0.04819277	0.40974972	DELACROIX_RARG_BOUND_MEF	345	1.0007436	0.5095095	0.9228945	-0.1312447	-2.1327319
GO_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS	c5.BP_ GO biological process	236	-1.1319325	0.12878788	0.4096984	GO_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS	252	1.3172146	0.016016016	0.41499075	0.1852821	-2.4491471
GO_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT	c5.BP_ GO biological process	37	-1.1318204	0.22903226	0.40977862	GO_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT	39	-1.1692584	0.18181819	0.41785744	-2.3010788	0.037438
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	c2.CGP_ chemical and genetic perturbations	92	-1.1313493	0.17012449	0.41075316	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	94	-1.5034093	0	0.14062868	-2.6347586	0.37206
VERRECCHIA_RESPONSE_TO_TGFB1_C5	c2.CGP_ chemical and genetic perturbations	20	-1.1310354	0.27322406	0.4113705	VERRECCHIA_RESPONSE_TO_TGFB1_C5	21	1.3119549	0.123904884	0.42237294	0.1809195	-2.4429903
GO_ALKALI_METAL_ION_BINDING	c5.GO molecular function	17	-1.1309681	0.2857143	0.41133866	GO_ALKALI_METAL_ION_BINDING	20	0.690678	0.8871595	1	-0.4402901	-1.8216461
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	c2.CGP_ chemical and genetic perturbations	59	-1.1305526	0.21755725	0.41218978	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	61	-1.1908361	0.15384616	0.39298823	-2.3213887	0.0602835
GO_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	151	-1.1304226	0.14383562	0.41231567	GO_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS	148	0.68580025	0.972449	1	-0.44462235	-1.81622285
GSE42724_B1_BCELL_VS_PLASMABLAST_UP	C7_ immunologic signatures	174	-1.1303701	0.12418301	0.41225576	GSE42724_B1_BCELL_VS_PLASMABLAST_UP	182	0.9179869	0.69959676	1	-0.2123832	-2.048357
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	c2.CGP_ chemical and genetic perturbations	428	-1.1303618	0.03125	0.4120852	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	430	0.6208827	1	1	-0.5094791	-1.7512445
CHRXQ22	C1: positional gene sets	61	-1.1301242	0.19465649	0.4125086	CHRXQ22	63	1.5074954	0.005428882	0.2436336	0.3773712	-2.6376196
GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	C7_ immunologic signatures	161	-1.129844	0.11931818	0.41301784	GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	161	0.50150234	1	1	-0.62834166	-1.63134634
GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP	C7_ immunologic signatures	106	-1.1293769	0.18604651	0.41394332	GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP	111	1.3208463	0.04054054	0.41155812	0.1914694	-2.4502232
GO_REGULATION_OF_STEROID_METABOLIC_PROCESS	c5.BP_ GO biological process	65	-1.1293439	0.23432343	0.41383544	GO_REGULATION_OF_STEROID_METABOLIC_PROCESS	68	1.1301732	0.26609442	0.7056583	0.0008293	-2.2595171
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	c2.CGP_ chemical and genetic perturbations	109	-1.1292307	0.1936937	0.41390485	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	109	-1.6056558	0	0.08906798	-2.7348865	0.4764251
GO_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY	c5.BP_ GO biological process	23	-1.1288117	0.260745	0.41476434	GO_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY	24	1.0326709	0.44540942	0.8723793	-0.0961408	-2.1614826
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	c2.CGP_ chemical and genetic perturbations	51	-1.1287954	0.225	0.41461968	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	52	1.2858965	0.10678532	0.4620287	0.1571011	-2.4146919
GO_LEUKOCYTE_APOPTOTIC_PROCESS	c5.BP_ GO biological process	19	-1.1286777	0.30172414	0.41472167	GO_LEUKOCYTE_APOPTOTIC_PROCESS	19	0.789645	0.74638635	1	-0.3390327	-1.9183227
AP1_Q6	c3.TFT_ transcription factor targets	226	-1.1286432	0.10576923	0.41461435	AP1_Q6	234	1.2151002	0.06030151	0.5667491	0.086457	-2.3437434
GO_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION	c5.BP_ GO biological process	70	-1.1285987	0.2145749	0.41452014	GO_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION	80	1.0183533	0.4483493	0.8923873	-0.1102454	-2.146952
GO_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE	c5.BP_ GO biological process	19	-1.1284661	0.26878613	0.41464442	GO_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE	21	0.9034912	0.6300129	1	-0.2249749	-2.0319573
GSE22886_NAIVE_CD8_TCELL_VS_DC_UP	C7_ immunologic signatures	161	-1.1284603	0.13636364	0.41446006	GSE22886_NAIVE_CD8_TCELL_VS_DC_UP	166	1.1131903	0.26192895	0.7329357	-0.01527	-2.2416506
GO_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING	c5.BP_ GO biological process	23	-1.1283683	0.27653632	0.41449037	GO_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING	23	-0.946305	0.52884614	0.7604551	-2.0746733	-0.1820633
GO_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	179	-1.1283525	0.121212125	0.41432503	GO_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS	185	0.9714662	0.58358663	0.9602062	-0.1568863	-2.0998187
MODULE_322	c4.CM_ cancer modules	52	-1.1281531	0.23793103	0.41463098	MODULE_322	57	1.1041193	0.30933633	0.74936205	-0.0240338	-2.2322724
GO_DEAMINASE_ACTIVITY	c5.GO molecular function	27	-1.1281323	0.27327326	0.4144927	GO_DEAMINASE_ACTIVITY	28	0.86234295	0.6754491	1	-0.26578935	-1.99047525
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP	C7_ immunologic signatures	158	-1.1279614	0.15116279	0.4147285	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP	158	1.1006414	0.26482618	0.75632423	-0.02732	-2.2286028
GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_UP	C7_ immunologic signatures	146	-1.1279536	0.13142857	0.41454747	GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_UP	151	0.60298353	0.9959184	1	-0.52497007	-1.73093713
MODULE_209	c4.CM_ cancer modules	75	-1.1277596	0.19157088	0.4148356	MODULE_209	78	1.1345996	0.23927039	0.6980643	0.00684	-2.2623592
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN	C7_ immunologic signatures	181	-1.1277115	0.1474359	0.414764	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN	179	-1.8701391	0	0.021397952	-2.9978506	0.7424276
BHAT_ESR1_TARGETS_VIA_AKT1_UP	c2.CGP_ chemical and genetic perturbations	258	-1.1277108	0.123893805	0.41456962	BHAT_ESR1_TARGETS_VIA_AKT1_UP	260	1.1072525	0.21242484	0.74233854	-0.0204583	-2.2349633
GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP	C7_ immunologic signatures	182	-1.1276698	0.14102565	0.41447297	GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP	183	-0.9430508	0.64705884	0.76609087	-2.0707206	-0.184619
GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	171	-1.1275396	0.125	0.41462123	GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP	178	1.1256857	0.20626895	0.7131872	-0.0018539	-2.2532253
GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN	C7_ immunologic signatures	174	-1.1275336	0.15819208	0.4144367	GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN	178	0.9442644	0.6419878	0.9881187	-0.1832692	-2.071798
GO_NUCLEOTIDE_KINASE_ACTIVITY	c5.GO molecular function	23	-1.1274046	0.26869807	0.4145416	GO_NUCLEOTIDE_KINASE_ACTIVITY	24	0.81608474	0.74358976	1	-0.31131986	-1.94348934
GSE29618_BCELL_VS_MONOCYTE_DN	C7_ immunologic signatures	168	-1.1273842	0.13333334	0.41439354	GSE29618_BCELL_VS_MONOCYTE_DN	172	1.3262644	0.023373984	0.40571177	0.1988802	-2.4536486
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	C7_ immunologic signatures	183	-1.1273777	0.08522727	0.41421688	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	182	-1.6094657	0	0.088303715	-2.7368434	0.482088
GO_FATTY_ACYL_COA_METABOLIC_PROCESS	c5.BP_ GO biological process	45	-1.1268549	0.25735295	0.41536653	GO_FATTY_ACYL_COA_METABOLIC_PROCESS	46	0.9201373	0.61538464	1	-0.2067176	-2.0469922
GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN	C7_ immunologic signatures	172	-1.1265935	0.1576087	0.415821	GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN	171	0.59220046	0.998993	1	-0.53439304	-1.71879396
GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN	C7_ immunologic signatures	178	-1.1265746	0.13142857	0.41567585	GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN	184	0.90810996	0.72469634	1	-0.21846464	-2.03468456
GO_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION	c5.BP_ GO biological process	108	-1.1261498	0.14678898	0.4165334	GO_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION	109	-1.4736347	0	0.1588948	-2.5997845	0.3474849
KEGG_SELENOAMINO_ACID_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	23	-1.1260382	0.27925533	0.41661587	KEGG_SELENOAMINO_ACID_METABOLISM	25	1.0632944	0.4051095	0.8167062	-0.0627438	-2.1893326
GO_NUCLEAR_EXPORT	c5.BP_ GO biological process	135	-1.1257657	0.14210527	0.41709685	GO_NUCLEAR_EXPORT	136	-1.2313635	0	0.34454957	-2.3571292	0.1055978
MORF_RAB11A	c4.CGN_ cancer gene neighborhoods	54	-1.1252807	0.24252492	0.41810194	MORF_RAB11A	54	-1.1729807	0.17948718	0.4140881	-2.2982614	0.0477
GSE30083_SP1_VS_SP2_THYMOCYTE_UP	C7_ immunologic signatures	171	-1.125175	0.1497006	0.4181639	GSE30083_SP1_VS_SP2_THYMOCYTE_UP	176	1.326197	0.012170386	0.40542474	0.201022	-2.451372
JAZAG_TGFB1_SIGNALING_UP	c2.CGP_ chemical and genetic perturbations	98	-1.125135	0.18721461	0.41806737	JAZAG_TGFB1_SIGNALING_UP	101	0.8482216	0.77544594	1	-0.2769134	-1.9733566
MODULE_180	c4.CM_ cancer modules	100	-1.1244837	0.1542056	0.4194609	MODULE_180	104	1.2958307	0.059134107	0.4487936	0.171347	-2.4203144
GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN	C7_ immunologic signatures	175	-1.124442	0.12195122	0.41937843	GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN	174	-0.89226377	1	0.8301903	-2.01670577	-0.23217823
GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP	C7_ immunologic signatures	152	-1.1239231	0.1827957	0.4205188	GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP	155	0.87561524	0.7494929	1	-0.24830786	-1.99953834
SP1_01	c3.TFT_ transcription factor targets	216	-1.123874	0.15079366	0.42044672	SP1_01	223	0.9377882	0.6586103	0.9932569	-0.1860858	-2.0616622
GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP	C7_ immunologic signatures	179	-1.1238738	0.15189873	0.42025033	GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP	183	1.1490349	0.18172589	0.67001635	0.0251611	-2.2729087
GSE2826_WT_VS_XID_BCELL_DN	C7_ immunologic signatures	172	-1.1238261	0.14285715	0.42018005	GSE2826_WT_VS_XID_BCELL_DN	177	1.0134202	0.4781726	0.9010704	-0.1104059	-2.1372463
QI_HYPOXIA	c2.CGP_ chemical and genetic perturbations	131	-1.123691	0.1904762	0.4202897	QI_HYPOXIA	131	1.0621946	0.35921326	0.81873006	-0.0614964	-2.1858856
AP1_Q2	c3.TFT_ transcription factor targets	229	-1.123547	0.06779661	0.42046914	AP1_Q2	238	1.3084474	0.014042126	0.4285047	0.1849004	-2.4319944
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	c2.CGP_ chemical and genetic perturbations	20	-1.1233244	0.29521278	0.4208412	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	20	0.70242864	0.8727273	1	-0.42089576	-1.82575304
MODULE_104	c4.CM_ cancer modules	258	-1.122731	0.12037037	0.42216825	MODULE_104	292	1.270661	0.016048145	0.48385105	0.14793	-2.393392
GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP	C7_ immunologic signatures	159	-1.1227114	0.17	0.42202815	GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP	162	0.73512036	0.95282054	1	-0.38759104	-1.85783176
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN	C7_ immunologic signatures	172	-1.1227111	0.12418301	0.4218317	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN	174	0.88704765	0.7525151	1	-0.23566345	-2.00975875
GO_NUCLEAR_TRANSPORT	c5.BP_ GO biological process	323	-1.1226994	0.074074075	0.42166954	GO_NUCLEAR_TRANSPORT	323	0	0	0	-1.1226994	-1.1226994
GSE18893_TCONV_VS_TREG_24H_CULTURE_UP	C7_ immunologic signatures	177	-1.1225566	0.13103448	0.42181137	GSE18893_TCONV_VS_TREG_24H_CULTURE_UP	178	1.1573148	0.15773508	0.6581427	0.0347582	-2.2798714
ANDERSEN_LIVER_CANCER_KRT19_DN	c2.CGP_ chemical and genetic perturbations	63	-1.1222739	0.23255815	0.42232952	ANDERSEN_LIVER_CANCER_KRT19_DN	66	1.3452547	0.046486486	0.38851625	0.2229808	-2.4675286
GO_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION	c5.BP_ GO biological process	22	-1.1221092	0.29032257	0.4225268	GO_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION	23	-0.8930564	0.6682243	0.8289854	-2.0151656	-0.2290528
GSE17721_POLYIC_VS_CPG_4H_BMDC_DN	C7_ immunologic signatures	174	-1.122066	0.16568047	0.42245397	GSE17721_POLYIC_VS_CPG_4H_BMDC_DN	183	-0.9786949	0.46153846	0.71573937	-2.1007609	-0.1433711
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	c2.CGP_ chemical and genetic perturbations	65	-1.1218835	0.25	0.42272857	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	68	0.9890371	0.5081433	0.9361954	-0.1328464	-2.1109206
MODULE_181	c4.CM_ cancer modules	221	-1.1217324	0.13513513	0.42290622	MODULE_181	252	1.290887	0.017017016	0.45652825	0.1691546	-2.4126194
GO_POTASSIUM_CHANNEL_COMPLEX	c5.CC_ GO cellular component	72	-1.1214678	0.20183486	0.4233668	GO_POTASSIUM_CHANNEL_COMPLEX	86	1.1686829	0.20649895	0.63903034	0.0472151	-2.2901507
GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION	c5.BP_ GO biological process	31	-1.1212887	0.25786164	0.42364332	GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION	31	-1.5029091	0.03125	0.14078139	-2.6241978	0.3816204
GO_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE	c5.CC_ GO cellular component	16	-1.1211494	0.29619566	0.42381322	GO_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE	16	0	0	0	-1.1211494	-1.1211494
GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP	C7_ immunologic signatures	182	-1.12091	0.13855422	0.4241975	GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP	188	0.89120567	0.760804	1	-0.22970433	-2.01211567
JIANG_AGING_HYPOTHALAMUS_UP	c2.CGP_ chemical and genetic perturbations	38	-1.1208414	0.2631579	0.42419612	JIANG_AGING_HYPOTHALAMUS_UP	39	-0.85564697	0.73880595	0.8626297	-1.97648837	-0.26519443
HU_ANGIOGENESIS_DN	c2.CGP_ chemical and genetic perturbations	33	-1.1208271	0.2685185	0.4240341	HU_ANGIOGENESIS_DN	35	-1.2342751	0.123595506	0.34127516	-2.3551022	0.113448
GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	156	-1.120118	0.15294118	0.42561492	GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN	163	1.2647481	0.045918368	0.49090278	0.1446301	-2.3848661
GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP	C7_ immunologic signatures	182	-1.1200916	0.1552795	0.42548078	GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP	186	0.79825133	0.8979798	1	-0.32184027	-1.91834293
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN	C7_ immunologic signatures	174	-1.119871	0.16774194	0.4258632	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN	177	-0.91815543	0.78571427	0.7979719	-2.03802643	-0.20171557
GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP	C7_ immunologic signatures	153	-1.1197937	0.12972973	0.42587152	GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP	161	0.9314794	0.6659878	0.9981149	-0.1883143	-2.0512731
HOLLERN_EMT_BREAST_TUMOR_UP	c2.CGP_ chemical and genetic perturbations	97	-1.1197543	0.16267942	0.42577615	HOLLERN_EMT_BREAST_TUMOR_UP	97	0.98115766	0.53220695	0.9474093	-0.13859664	-2.10091196
CHOW_RASSF1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	29	-1.1192117	0.28150135	0.426967	CHOW_RASSF1_TARGETS_DN	29	-1.2007744	0.17283951	0.38103873	-2.3199861	0.0815627
GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN	c5.BP_ GO biological process	145	-1.119162	0.14012739	0.42689663	GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN	149	1.1392936	0.2034588	0.69154495	0.0201316	-2.2584556
GSE4142_PLASMA_CELL_VS_GC_BCELL_DN	C7_ immunologic signatures	167	-1.11914	0.14012739	0.42674753	GSE4142_PLASMA_CELL_VS_GC_BCELL_DN	169	-0.97246575	0.6	0.72462296	-2.09160575	-0.14667425
GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP	C7_ immunologic signatures	179	-1.119078	0.13142857	0.4267162	GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP	182	1.1757361	0.14052953	0.628033	0.0566581	-2.2948141
GO_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	17	-1.1187648	0.275	0.42732337	GO_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS	17	0.81025124	0.7357513	1	-0.30851356	-1.92901604
RIZKI_TUMOR_INVASIVENESS_2D_UP	c2.CGP_ chemical and genetic perturbations	61	-1.1185935	0.24199288	0.42753196	RIZKI_TUMOR_INVASIVENESS_2D_UP	62	-0.97203505	0.57471263	0.7247819	-2.09062855	-0.14655845
GO_NUCLEOSOMAL_DNA_BINDING	c5.GO molecular function	25	-1.1185702	0.264	0.42739284	GO_NUCLEOSOMAL_DNA_BINDING	26	-1.6003307	0.025125628	0.09084547	-2.7189009	0.4817605
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN	C7_ immunologic signatures	166	-1.118416	0.14383562	0.42759335	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN	171	1.0511801	0.3753815	0.8377183	-0.0672359	-2.1695961
GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	185	-1.1180606	0.17610063	0.4283247	GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	184	1.1032239	0.259334	0.75139254	-0.0148367	-2.2212845
MORF_PPP1CC	c4.CGN_ cancer gene neighborhoods	152	-1.1178372	0.14371258	0.4287194	MORF_PPP1CC	153	-2.1427736	0	0.001741283	-3.2606108	1.0249364
GO_METHYLTRANSFERASE_COMPLEX	c5.CC_ GO cellular component	76	-1.1178113	0.19591837	0.42857093	GO_METHYLTRANSFERASE_COMPLEX	77	-1.3663342	0.01369863	0.22926772	-2.4841455	0.2485229
CHR6P21	C1: positional gene sets	243	-1.11758	0.097345136	0.4289429	CHR6P21	250	1.089673	0.25977933	0.7716561	-0.027907	-2.207253
GO_TETRAPYRROLE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	25	-1.1173456	0.2877907	0.4293309	GO_TETRAPYRROLE_BIOSYNTHETIC_PROCESS	25	0.44334924	0.9975933	1	-0.67399636	-1.56069484
WANG_RESPONSE_TO_BEXAROTENE_UP	c2.CGP_ chemical and genetic perturbations	31	-1.1172315	0.29376855	0.42942983	WANG_RESPONSE_TO_BEXAROTENE_UP	33	1.2086296	0.18955043	0.57999706	0.0913981	-2.3258611
JIANG_TIP30_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	40	-1.1172307	0.22955975	0.42923403	JIANG_TIP30_TARGETS_UP	41	-0.81881607	0.87323946	0.8895365	-1.93604677	-0.29841463
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	c2.CGP_ chemical and genetic perturbations	41	-1.1171851	0.24923077	0.42914474	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	50	1.2016331	0.18406285	0.5892204	0.084448	-2.3188182
MODULE_210	c4.CM_ cancer modules	22	-1.1170708	0.28901735	0.42928562	MODULE_210	25	1.2479929	0.16891065	0.5146187	0.1309221	-2.3650637
GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP	C7_ immunologic signatures	160	-1.117068	0.13259669	0.42909294	GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP	166	1.0285709	0.43800813	0.87818676	-0.0884971	-2.1456389
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	c2.CGP_ chemical and genetic perturbations	127	-1.1168029	0.20903955	0.42961478	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	129	0.723257	0.93977153	1	-0.3935459	-1.8400599
GO_NEURONAL_ACTION_POTENTIAL	c5.BP_ GO biological process	23	-1.1167166	0.2827381	0.42965198	GO_NEURONAL_ACTION_POTENTIAL	27	-1.1528053	0.25714287	0.44003746	-2.2695219	0.0360887
MTOR_UP.N4.V1_UP	C6_ oncogenic signatures	174	-1.116255	0.15757576	0.43063962	MTOR_UP.N4.V1_UP	182	0.74626505	0.9369278	1	-0.36998995	-1.86252005
NELSON_RESPONSE_TO_ANDROGEN_UP	c2.CGP_ chemical and genetic perturbations	77	-1.1158242	0.23505977	0.43159017	NELSON_RESPONSE_TO_ANDROGEN_UP	79	0.6496211	0.97989416	1	-0.4662031	-1.7654453
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP	C7_ immunologic signatures	151	-1.1154652	0.17964073	0.43227407	GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP	150	0.6621427	0.9777778	1	-0.4533225	-1.7776079
GO_ACETYL_COA_METABOLIC_PROCESS	c5.BP_ GO biological process	23	-1.1151444	0.27671233	0.43288973	GO_ACETYL_COA_METABOLIC_PROCESS	24	0.8041049	0.74415743	1	-0.3110395	-1.9192493
GO_HEXOSE_METABOLIC_PROCESS	c5.BP_ GO biological process	136	-1.1148034	0.14814815	0.4335706	GO_HEXOSE_METABOLIC_PROCESS	144	1.0305624	0.43295804	0.8746807	-0.084241	-2.1453658
GO_HISTONE_DEUBIQUITINATION	c5.BP_ GO biological process	20	-1.1141963	0.28225806	0.43494537	GO_HISTONE_DEUBIQUITINATION	21	-0.6637624	0.96	0.97399837	-1.7779587	-0.4504339
NGUYEN_NOTCH1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	28	-1.1141185	0.27380952	0.43496203	NGUYEN_NOTCH1_TARGETS_UP	29	-0.8767504	0.64606744	0.8471709	-1.9908689	-0.2373681
GO_ER_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	57	-1.113876	0.22413793	0.43540514	GO_ER_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS	57	-1.3126364	0.056179777	0.27212784	-2.4265124	0.1987604
CROONQUIST_NRAS_SIGNALING_UP	c2.CGP_ chemical and genetic perturbations	30	-1.1138633	0.2793296	0.4352352	CROONQUIST_NRAS_SIGNALING_UP	33	0.820053	0.7385159	1	-0.2938103	-1.9339163
LEIN_ASTROCYTE_MARKERS	c2.CGP_ chemical and genetic perturbations	35	-1.1136639	0.29927006	0.4355769	LEIN_ASTROCYTE_MARKERS	39	-1.0169528	0.40939596	0.6629853	-2.1306167	-0.0967111
GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP	C7_ immunologic signatures	178	-1.1135931	0.14666666	0.4355751	GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP	180	0.9370404	0.6517767	0.99283797	-0.1765527	-2.0506335
GO_CILIUM_MOVEMENT	c5.BP_ GO biological process	30	-1.1131313	0.27596438	0.4365666	GO_CILIUM_MOVEMENT	31	1.3504403	0.09704142	0.38381702	0.237309	-2.4635716
GO_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	38	-1.1129919	0.25519288	0.43677127	GO_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS	41	0.75781506	0.82588774	1	-0.35517684	-1.87080696
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	c2.CGP_ chemical and genetic perturbations	28	-1.112683	0.28529412	0.43738583	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	29	-1.0719715	0.3597561	0.5663785	-2.1846545	-0.0407115
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP	C7_ immunologic signatures	171	-1.112669	0.14906833	0.43722138	GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP	175	-1.3082983	0	0.27629519	-2.4209673	0.1956293
GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN	C7_ immunologic signatures	172	-1.1126572	0.17333333	0.43705013	GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN	173	0.79202634	0.91131496	1	-0.32063086	-1.90468354
GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	172	-1.1125007	0.14367816	0.437277	GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP	175	0.9575439	0.5989899	0.9747259	-0.1549568	-2.0700446
MODULE_242	c4.CM_ cancer modules	155	-1.1124082	0.19875777	0.43732896	MODULE_242	174	1.2543905	0.042510122	0.5029182	0.1419823	-2.3667987
GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP	C7_ immunologic signatures	178	-1.1123769	0.16233766	0.43722636	GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP	184	-0.7831033	1	0.918615	-1.8954802	-0.3292736
GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP	C7_ immunologic signatures	179	-1.112119	0.1764706	0.43773073	GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP	180	-1.3700669	0	0.22644153	-2.4821859	0.2579479
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP	C7_ immunologic signatures	152	-1.1119399	0.16666667	0.4380158	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP	156	1.1491548	0.17977528	0.670332	0.0372149	-2.2610947
GO_STEROID_METABOLIC_PROCESS	c5.BP_ GO biological process	180	-1.1117156	0.123595506	0.4384066	GO_STEROID_METABOLIC_PROCESS	194	0.99149245	0.53760165	0.93419707	-0.12022315	-2.10320805
GO_COFACTOR_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	145	-1.1117003	0.14973262	0.43824658	GO_COFACTOR_BIOSYNTHETIC_PROCESS	147	-0.8991578	0.8148148	0.82236236	-2.0108581	-0.2125425
GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP	C7_ immunologic signatures	169	-1.1115164	0.16778524	0.43856254	GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP	171	1.3259343	0.02535497	0.40590492	0.2144179	-2.4374507
GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	169	-1.1115074	0.13846155	0.43839082	GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	176	1.0384475	0.4124236	0.86098385	-0.0730599	-2.1499549
GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	C7_ immunologic signatures	128	-1.1114347	0.19680852	0.43837714	GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	134	0.7509949	0.9193054	1	-0.3604398	-1.8624296
GO_GOLGI_ASSOCIATED_VESICLE_MEMBRANE	c5.CC_ GO cellular component	45	-1.1108257	0.23602484	0.43981546	GO_GOLGI_ASSOCIATED_VESICLE_MEMBRANE	46	-1.1432945	0.24347825	0.4519042	-2.2541202	0.0324688
GSE28237_EARLY_VS_LATE_GC_BCELL_DN	C7_ immunologic signatures	176	-1.1106973	0.17105263	0.43996564	GSE28237_EARLY_VS_LATE_GC_BCELL_DN	178	0.9673905	0.56880736	0.9638858	-0.1433068	-2.0780878
GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN	C7_ immunologic signatures	173	-1.1105334	0.15882353	0.44020167	GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN	179	0.817341	0.86262625	1	-0.2931924	-1.9278744
GO_CARBON_OXYGEN_LYASE_ACTIVITY	c5.GO molecular function	59	-1.1102813	0.25259516	0.4406824	GO_CARBON_OXYGEN_LYASE_ACTIVITY	60	0.9326939	0.60223466	0.99741536	-0.1775874	-2.0429752
GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP	C7_ immunologic signatures	88	-1.1101981	0.22362868	0.4407212	GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP	106	1.2166744	0.12565444	0.5629644	0.1064763	-2.3268725
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	c2.CP_REACTOME_ Reactome gene sets	212	-1.1100395	0.16216215	0.44092748	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	215	-0.79041445	1	0.91366655	-1.90045395	-0.31962505
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	c2.CGP_ chemical and genetic perturbations	43	-1.1098764	0.24025974	0.44118166	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	43	1.0895025	0.34660423	0.77182615	-0.0203739	-2.1993789
MODULE_562	c4.CM_ cancer modules	18	-1.1098373	0.29708222	0.44109204	MODULE_562	18	1.0230083	0.45688546	0.88660365	-0.086829	-2.1328456
AP1_Q6_01	c3.TFT_ transcription factor targets	235	-1.1097629	0.08490566	0.44108793	AP1_Q6_01	242	1.1372867	0.15678392	0.694972	0.0275238	-2.2470496
GO_TRANSFERASE_ACTIVITY_TRANSFERRING_SULFUR_CONTAINING_GROUPS	c5.GO molecular function	52	-1.1097343	0.22483222	0.44095695	GO_TRANSFERASE_ACTIVITY_TRANSFERRING_SULFUR_CONTAINING_GROUPS	56	1.312026	0.083333336	0.42261145	0.2022917	-2.4217603
GO_MYOTUBE_DIFFERENTIATION	c5.BP_ GO biological process	43	-1.1097274	0.26751593	0.44077834	GO_MYOTUBE_DIFFERENTIATION	46	0.8039434	0.7777778	1	-0.305784	-1.9136708
GO_ADIPOSE_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	29	-1.1095757	0.2808642	0.4410155	GO_ADIPOSE_TISSUE_DEVELOPMENT	30	0.60583925	0.96043164	1	-0.50373645	-1.71541495
LEIN_MEDULLA_MARKERS	c2.CGP_ chemical and genetic perturbations	73	-1.1094261	0.23622048	0.44123113	LEIN_MEDULLA_MARKERS	77	1.0356408	0.42948717	0.8661252	-0.0737853	-2.1450669
GSE27786_LSK_VS_NKTCELL_UP	C7_ immunologic signatures	179	-1.109397	0.15068494	0.44109967	GSE27786_LSK_VS_NKTCELL_UP	184	0.78968257	0.89746195	1	-0.31971443	-1.89907957
GO_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	51	-1.1093789	0.23920266	0.44095224	GO_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	51	-0.7727712	0.9099099	0.9252841	-1.8821501	-0.3366077
GO_NEGATIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	44	-1.1093211	0.25	0.44091	GO_NEGATIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT	53	1.112367	0.29572836	0.7341566	0.0030459	-2.2216881
GO_VESICLE_TARGETING	c5.BP_ GO biological process	72	-1.1093019	0.199187	0.4407596	GO_VESICLE_TARGETING	71	0.4300852	1	1	-0.6792167	-1.5393871
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP	C7_ immunologic signatures	166	-1.1089715	0.15662651	0.44147694	GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP	168	-1.435194	0	0.1836678	-2.5441655	0.3262225
MALONEY_RESPONSE_TO_17AAG_DN	c2.CGP_ chemical and genetic perturbations	66	-1.1088132	0.23790322	0.44170532	MALONEY_RESPONSE_TO_17AAG_DN	66	-1.0048766	0.36708862	0.676809	-2.1136898	-0.1039366
REACTOME_PLATELET_SENSITIZATION_BY_LDL	c2.CP_REACTOME_ Reactome gene sets	15	-1.1086495	0.30259365	0.44193906	REACTOME_PLATELET_SENSITIZATION_BY_LDL	16	-1.2746092	0.15102041	0.3068481	-2.3832587	0.1659597
GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP	C7_ immunologic signatures	172	-1.1084872	0.1627907	0.4421699	GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP	176	0.79221	0.8857432	1	-0.3162772	-1.9006972
GO_RNA_POLYMERASE_BINDING	c5.GO molecular function	30	-1.1084771	0.28362572	0.44199875	GO_RNA_POLYMERASE_BINDING	30	-0.98804057	0.44808742	0.705579	-2.09651767	-0.12043653
HOWLIN_PUBERTAL_MAMMARY_GLAND	c2.CGP_ chemical and genetic perturbations	57	-1.1084514	0.24820144	0.441871	HOWLIN_PUBERTAL_MAMMARY_GLAND	53	1.0286381	0.4391892	0.8780612	-0.0798133	-2.1370895
GSE360_CTRL_VS_T_GONDII_MAC_UP	C7_ immunologic signatures	170	-1.1084286	0.18674698	0.44172698	GSE360_CTRL_VS_T_GONDII_MAC_UP	177	0.8439033	0.81790745	1	-0.2645253	-1.9523319
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	c2.CGP_ chemical and genetic perturbations	45	-1.1083901	0.2580645	0.44162652	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	45	0.8076485	0.768614	1	-0.3007416	-1.9160386
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN	C7_ immunologic signatures	171	-1.1083825	0.1409396	0.44144577	GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN	174	0.6087273	1	1	-0.4996552	-1.7171098
GO_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION	c5.BP_ GO biological process	75	-1.108281	0.22868218	0.44149375	GO_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION	79	0.79059595	0.81953293	1	-0.31768505	-1.89887695
GO_CEREBRAL_CORTEX_CELL_MIGRATION	c5.BP_ GO biological process	40	-1.1082621	0.25377643	0.4413507	GO_CEREBRAL_CORTEX_CELL_MIGRATION	40	1.1290017	0.29371428	0.70763904	0.0207396	-2.2372638
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	50	-1.1082087	0.26643598	0.4412852	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	48	0.8809868	0.698324	1	-0.2272219	-1.9891955
PID_ERA_GENOMIC_PATHWAY	c2.CP_ Canonical pathways	58	-1.107885	0.23684211	0.44194824	PID_ERA_GENOMIC_PATHWAY	61	-1.1066165	0.1978022	0.5077658	-2.2145015	-0.0012685
GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	C7_ immunologic signatures	158	-1.1078637	0.19883041	0.44181237	GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	166	1.1212999	0.24257933	0.7217995	0.0134362	-2.2291636
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	c2.CGP_ chemical and genetic perturbations	22	-1.1077949	0.30172414	0.44178078	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	21	0.82273555	0.74319065	1	-0.28505935	-1.93053045
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP	C7_ immunologic signatures	161	-1.1076304	0.1625	0.44200858	GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP	169	1.0251836	0.4388271	0.88353807	-0.0824468	-2.132814
GO_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION	c5.BP_ GO biological process	30	-1.1075406	0.28939828	0.44204533	GO_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION	30	0.7909165	0.8043742	1	-0.3166241	-1.8984571
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP	C7_ immunologic signatures	173	-1.1074831	0.16049382	0.4420128	GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP	179	0.6355313	0.99086297	1	-0.4719518	-1.7430144
GO_N_GLYCAN_PROCESSING	c5.BP_ GO biological process	19	-1.1073952	0.34357542	0.4420394	GO_N_GLYCAN_PROCESSING	19	1.0318745	0.46005154	0.87337565	-0.0755207	-2.1392697
GCM_BNIP1	c4.CGN_ cancer gene neighborhoods	63	-1.1073041	0.25	0.44207242	GCM_BNIP1	65	-0.87165534	0.74025977	0.85369635	-1.97895944	-0.23564876
GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP	C7_ immunologic signatures	152	-1.1071324	0.1849711	0.44235837	GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP	158	0.9310641	0.6680203	0.99858975	-0.1760683	-2.0381965
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	c2.CGP_ chemical and genetic perturbations	18	-1.107027	0.30362117	0.44242442	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	19	0.86037046	0.6770026	1	-0.24665654	-1.96739746
GSE20715_0H_VS_24H_OZONE_LUNG_DN	C7_ immunologic signatures	184	-1.1069117	0.15753424	0.44254324	GSE20715_0H_VS_24H_OZONE_LUNG_DN	186	0.9196528	0.7071935	1	-0.1872589	-2.0265645
GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP	C7_ immunologic signatures	173	-1.106619	0.19354838	0.4431649	GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP	176	0.7220964	0.96855986	1	-0.3845226	-1.8287154
GO_PIGMENT_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	42	-1.1066155	0.2857143	0.44297522	GO_PIGMENT_BIOSYNTHETIC_PROCESS	43	-1.153962	0.1509434	0.43847346	-2.2605775	0.0473465
GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN	C7_ immunologic signatures	140	-1.1065539	0.18681319	0.44293433	GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN	149	1.018502	0.46632653	0.8922066	-0.0880519	-2.1250559
GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	C7_ immunologic signatures	171	-1.1065239	0.18243243	0.4428103	GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	178	1.2742043	0.046938777	0.4816779	0.1676804	-2.3807282
GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN	C7_ immunologic signatures	168	-1.1064231	0.20134228	0.44290203	GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN	173	1.4824897	0.001014199	0.2666535	0.3760666	-2.5889128
GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN	C7_ immunologic signatures	164	-1.1061004	0.18404908	0.44355848	GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN	169	0.85657275	0.7991927	1	-0.24952765	-1.96267315
YANG_BREAST_CANCER_ESR1_DN	c2.CGP_ chemical and genetic perturbations	24	-1.1059333	0.32456142	0.4438003	YANG_BREAST_CANCER_ESR1_DN	24	0.88534856	0.6484472	1	-0.22058474	-1.99128186
GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	C7_ immunologic signatures	133	-1.1057593	0.17326732	0.444062	GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	135	1.2261996	0.11419753	0.54726166	0.1204403	-2.3319589
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP	C7_ immunologic signatures	173	-1.1056371	0.16352202	0.44419068	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP	174	0.5911637	0.9989858	1	-0.5144734	-1.6968008
GO_POSITIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE	c5.BP_ GO biological process	214	-1.1055155	0.13333334	0.44433177	GO_POSITIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE	216	0.8811346	0.7995972	1	-0.2243809	-1.9866501
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	c2.CGP_ chemical and genetic perturbations	36	-1.1053073	0.2762763	0.4446932	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	38	-1.1366298	0.24647887	0.46150413	-2.2419371	0.0313225
PID_LIS1_PATHWAY	c2.CP_ Canonical pathways	26	-1.1051995	0.30259365	0.44477034	PID_LIS1_PATHWAY	26	0.62190205	0.95625	1	-0.48329745	-1.72710155
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	c2.CGP_ chemical and genetic perturbations	497	-1.1046985	0.08888889	0.44592974	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	498	1.0797515	0.215	0.7878657	-0.024947	-2.18445
YY1_Q6	c3.TFT_ transcription factor targets	208	-1.1045209	0.1904762	0.44622272	YY1_Q6	209	-0.71488446	1	0.95231414	-1.81940536	-0.38963644
SHIN_B_CELL_LYMPHOMA_CLUSTER_2	c2.CGP_ chemical and genetic perturbations	29	-1.1045195	0.2879257	0.44603014	SHIN_B_CELL_LYMPHOMA_CLUSTER_2	30	0.77869266	0.8031026	1	-0.32582684	-1.88321216
GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN	C7_ immunologic signatures	174	-1.1045183	0.14556962	0.44583714	GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN	181	0.8039422	0.9016227	1	-0.3005761	-1.9084605
GO_CELL_CHEMOTAXIS	c5.BP_ GO biological process	117	-1.1042674	0.19617225	0.44631657	GO_CELL_CHEMOTAXIS	128	1.2891865	0.056759547	0.45903066	0.1849191	-2.3934539
GO_POSITIVE_REGULATION_OF_VIRAL_PROCESS	c5.BP_ GO biological process	80	-1.1041968	0.22088353	0.44630858	GO_POSITIVE_REGULATION_OF_VIRAL_PROCESS	79	0.47099265	1	1	-0.63320415	-1.57518945
GO_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY	c5.BP_ GO biological process	64	-1.1040332	0.27340823	0.4465703	GO_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY	69	0.8303122	0.7922078	1	-0.273721	-1.9343454
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	29	-1.1040162	0.2826087	0.44641584	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	31	1.152752	0.28485578	0.6645312	0.0487358	-2.2567682
GO_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS	c5.BP_ GO biological process	19	-1.1040078	0.30748662	0.4462422	GO_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS	19	-1.0396565	0.40930232	0.6225488	-2.1436643	-0.0643513
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP	C7_ immunologic signatures	171	-1.1038435	0.18543047	0.44648445	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP	177	1.308946	0.027190333	0.42725506	0.2051025	-2.4127895
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP	C7_ immunologic signatures	152	-1.1037567	0.1910828	0.44651812	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP	156	0.91236895	0.68629444	1	-0.19138775	-2.01612565
GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP	C7_ immunologic signatures	155	-1.1037319	0.15697674	0.44639778	GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP	158	1.3069798	0.03469388	0.4297413	0.2032479	-2.4107117
STAT1_02	c3.TFT_ transcription factor targets	223	-1.1033379	0.16535433	0.44726264	STAT1_02	225	-1.0080186	0.33333334	0.6739728	-2.1113565	-0.0953193
CHANDRAN_METASTASIS_TOP50_UP	c2.CGP_ chemical and genetic perturbations	31	-1.1032337	0.28846154	0.44733956	CHANDRAN_METASTASIS_TOP50_UP	31	-1.2504896	0.13372093	0.3230471	-2.3537233	0.1472559
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN	C7_ immunologic signatures	172	-1.103167	0.15333334	0.44733268	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN	174	-1.3075467	0	0.27654865	-2.4107137	0.2043797
GO_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	c5.BP_ GO biological process	24	-1.102978	0.31506848	0.44765854	GO_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	24	0.7535263	0.7992701	1	-0.3494517	-1.8565043
GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP	C7_ immunologic signatures	163	-1.1028578	0.1878453	0.4477753	GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP	172	0.8043593	0.88583076	1	-0.2984985	-1.9072171
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	C7_ immunologic signatures	172	-1.1022555	0.14102565	0.4491771	GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	181	1.0007792	0.5060729	0.92303705	-0.1014763	-2.1030347
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	c2.CP_BIOCARTA_ BioCarta gene sets	19	-1.102181	0.31868133	0.4491871	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	19	-1.2876289	0.125	0.2949716	-2.3898099	0.1854479
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN	c5.GO molecular function	24	-1.1021322	0.2748538	0.4491281	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN	25	1.0807432	0.37670383	0.7858174	-0.021389	-2.1828754
GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN	C7_ immunologic signatures	175	-1.1019149	0.15254237	0.44951355	GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN	178	0.51194024	1	1	-0.58997466	-1.61385514
GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP	C7_ immunologic signatures	166	-1.1017693	0.19298245	0.44969305	GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP	176	0.9899996	0.5276382	0.9350999	-0.1117697	-2.0917689
GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP	C7_ immunologic signatures	176	-1.1017143	0.19685039	0.44963986	GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP	177	-0.9402212	0.75	0.77012706	-2.0419355	-0.1614931
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	c2.CGP_ chemical and genetic perturbations	102	-1.1016847	0.2300885	0.44950902	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	104	-0.9904716	0.5	0.70179766	-2.0921563	-0.1112131
GSE3982_BASOPHIL_VS_TH2_DN	C7_ immunologic signatures	169	-1.1012646	0.17687075	0.45047042	GSE3982_BASOPHIL_VS_TH2_DN	175	0.83794767	0.82912034	1	-0.26331693	-1.93921227
MODULE_156	c4.CM_ cancer modules	18	-1.1012324	0.3263158	0.45035177	MODULE_156	18	-1.1625537	0.24637681	0.42756984	-2.2637861	0.0613213
CHR15Q25	C1: positional gene sets	33	-1.1010528	0.28440368	0.45064893	CHR15Q25	32	0.9309782	0.58441556	0.9982123	-0.1700746	-2.032031
GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN	C7_ immunologic signatures	182	-1.1007693	0.13907285	0.45121652	GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN	181	0.68425196	0.9787879	1	-0.41651734	-1.78502126
GO_ALCOHOL_METABOLIC_PROCESS	c5.BP_ GO biological process	306	-1.1007476	0.15463917	0.45107332	GO_ALCOHOL_METABOLIC_PROCESS	321	1.1613885	0.0970971	0.651242	0.0606409	-2.2621361
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	c2.CGP_ chemical and genetic perturbations	17	-1.1007075	0.29792747	0.450984	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	17	0.88069063	0.6564103	1	-0.22001687	-1.98139813
DARWICHE_PAPILLOMA_RISK_HIGH_UP	c2.CGP_ chemical and genetic perturbations	117	-1.1003851	0.20652173	0.45163816	DARWICHE_PAPILLOMA_RISK_HIGH_UP	119	1.0174239	0.44859812	0.89372385	-0.0829612	-2.117809
GO_EPITHELIAL_CILIUM_MOVEMENT	c5.BP_ GO biological process	17	-1.1001711	0.31666666	0.45201653	GO_EPITHELIAL_CILIUM_MOVEMENT	18	0.86233604	0.6666667	1	-0.23783506	-1.96250714
GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN	C7_ immunologic signatures	146	-1.1000115	0.1882353	0.45226312	GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN	147	1.1017303	0.2951992	0.75384545	0.0017188	-2.2017418
GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	171	-1.0993727	0.17777778	0.45382226	GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN	173	0.6345331	0.9908907	1	-0.4648396	-1.7339058
GO_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS	c5.BP_ GO biological process	17	-1.0991889	0.30376345	0.45415235	GO_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS	18	-1.2914292	0.15	0.29064944	-2.3906181	0.1922403
GO_POSITIVE_REGULATION_OF_RNA_SPLICING	c5.BP_ GO biological process	22	-1.0989038	0.30124223	0.4547345	GO_POSITIVE_REGULATION_OF_RNA_SPLICING	22	0.6583249	0.9156327	1	-0.4405789	-1.7572287
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	c2.CGP_ chemical and genetic perturbations	243	-1.098663	0.06451613	0.45518315	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	247	0.8803807	0.8016113	1	-0.2182823	-1.9790437
GSE40655_FOXO1_KO_VS_WT_NTREG_UP	C7_ immunologic signatures	180	-1.0986134	0.1923077	0.45512187	GSE40655_FOXO1_KO_VS_WT_NTREG_UP	182	1.0745938	0.33602422	0.79773515	-0.0240196	-2.1732072
CHRXP21	C1: positional gene sets	15	-1.0985053	0.29048842	0.45524308	CHRXP21	19	1.5644109	0.011479592	0.19467154	0.4659056	-2.6629162
GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP	C7_ immunologic signatures	171	-1.0982163	0.16107382	0.45585707	GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP	175	0.59326065	0.9959267	1	-0.50495565	-1.69147695
GSE3982_DC_VS_BASOPHIL_UP	C7_ immunologic signatures	175	-1.0981479	0.16883117	0.45582426	GSE3982_DC_VS_BASOPHIL_UP	177	1.2247373	0.0821501	0.54954636	0.1265894	-2.3228852
KEGG_BETA_ALANINE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	20	-1.0979036	0.31578946	0.45625147	KEGG_BETA_ALANINE_METABOLISM	21	1.3060602	0.14320987	0.43131244	0.2081566	-2.4039638
GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP	C7_ immunologic signatures	177	-1.0977437	0.15646258	0.45649052	GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP	178	0.82832414	0.8623482	1	-0.26941956	-1.92606784
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP	C7_ immunologic signatures	177	-1.0976632	0.17391305	0.456504	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP	178	-0.9610062	0.6	0.7415983	-2.0586694	-0.136657
UEDA_PERIFERAL_CLOCK	c2.CGP_ chemical and genetic perturbations	152	-1.0972704	0.21311475	0.45736212	UEDA_PERIFERAL_CLOCK	155	0.71676797	0.9563008	1	-0.38050243	-1.81403837
GO_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY	c5.GO molecular function	19	-1.0970414	0.35656837	0.45778978	GO_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY	22	1.5022341	0.02077922	0.25249848	0.4051927	-2.5992755
GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN	C7_ immunologic signatures	180	-1.0969571	0.1986755	0.45780745	GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN	182	-1.8042339	0	0.032275904	-2.901191	0.7072768
GERY_CEBP_TARGETS	c2.CGP_ chemical and genetic perturbations	118	-1.0969291	0.22330096	0.45768526	GERY_CEBP_TARGETS	117	0.92197573	0.6635611	1	-0.17495337	-2.01890483
AP1_Q4_01	c3.TFT_ transcription factor targets	229	-1.0967495	0.17948718	0.4579232	AP1_Q4_01	238	1.031085	0.4207871	0.8746723	-0.0656645	-2.1278345
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN	C7_ immunologic signatures	161	-1.0961945	0.17177914	0.4592411	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN	166	1.2342536	0.08097166	0.53481025	0.1380591	-2.3304481
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	168	-1.0958822	0.2032967	0.45991915	GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP	167	0.68887764	0.9765306	1	-0.40700456	-1.78475984
GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN	C7_ immunologic signatures	179	-1.0957694	0.2173913	0.4600203	GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN	179	-1.1067802	0.14285715	0.50767684	-2.2025496	0.0110108
GO_REGULATION_OF_LIPID_STORAGE	c5.BP_ GO biological process	39	-1.0956752	0.28666666	0.46008542	GO_REGULATION_OF_LIPID_STORAGE	37	0.8593616	0.68933177	1	-0.2363136	-1.9550368
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	C7_ immunologic signatures	170	-1.0954242	0.16666667	0.46056214	GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	174	0.98699397	0.5315041	0.93947476	-0.10843023	-2.08241817
GSE37301_PRO_BCELL_VS_CD4_TCELL_UP	C7_ immunologic signatures	151	-1.0953497	0.18041237	0.46057963	GSE37301_PRO_BCELL_VS_CD4_TCELL_UP	154	1.242748	0.07377049	0.5225322	0.1473983	-2.3380977
GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN	C7_ immunologic signatures	118	-1.0952674	0.20873787	0.46060088	GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN	124	1.1797161	0.16099072	0.6243119	0.0844487	-2.2749835
HNF4_DR1_Q3	c3.TFT_ transcription factor targets	227	-1.0951717	0.16393442	0.46066597	HNF4_DR1_Q3	236	0.6528836	0.9939516	1	-0.4422881	-1.7480553
GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	176	-1.0951186	0.1754386	0.4606061	GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN	181	0.81202006	0.88438135	1	-0.28309854	-1.90713866
KEGG_PEROXISOME	c2.CP_BIOCARTA_ BioCarta gene sets	73	-1.0950742	0.26618704	0.46054566	KEGG_PEROXISOME	74	0.90017277	0.6759358	1	-0.19490143	-1.99524697
GO_POSITIVE_REGULATION_OF_ENDOCYTOSIS	c5.BP_ GO biological process	100	-1.0948448	0.22705314	0.46096435	GO_POSITIVE_REGULATION_OF_ENDOCYTOSIS	108	1.261817	0.07883818	0.4936727	0.1669722	-2.3566618
GO_DRUG_TRANSPORTER_ACTIVITY	c5.GO molecular function	17	-1.0946242	0.3401015	0.4613601	GO_DRUG_TRANSPORTER_ACTIVITY	18	1.4360955	0.0503876	0.30930623	0.3414713	-2.5307197
PROVENZANI_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	167	-1.094601	0.20408164	0.46121892	PROVENZANI_METASTASIS_UP	171	0.7591836	0.9298067	1	-0.3354174	-1.8537846
EGR1_01	c3.TFT_ transcription factor targets	240	-1.0945954	0.13675214	0.4610336	EGR1_01	245	0.7006441	0.98294884	1	-0.3939513	-1.7952395
LEE_LIVER_CANCER_E2F1_DN	c2.CGP_ chemical and genetic perturbations	55	-1.0945878	0.25	0.4608569	LEE_LIVER_CANCER_E2F1_DN	54	0.73765874	0.8810872	1	-0.35692906	-1.83224654
ER_Q6_02	c3.TFT_ transcription factor targets	226	-1.0942433	0.2015504	0.46164283	ER_Q6_02	230	1.077879	0.305835	0.7917369	-0.0163643	-2.1721223
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_DN	C7_ immunologic signatures	146	-1.0939422	0.1741573	0.46223685	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_DN	148	-0.8152611	1	0.89297396	-1.9092033	-0.2786811
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	c2.CGP_ chemical and genetic perturbations	255	-1.0938847	0.14414415	0.46220157	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	256	0.6296085	0.995992	1	-0.4642762	-1.7234932
GO_PRENYLTRANSFERASE_ACTIVITY	c5.GO molecular function	15	-1.0938559	0.3134715	0.4620846	GO_PRENYLTRANSFERASE_ACTIVITY	15	-0.6340625	0.95089287	0.97885543	-1.7279184	-0.4597934
GSE27786_NKCELL_VS_ERYTHROBLAST_UP	C7_ immunologic signatures	175	-1.0932331	0.16774194	0.4636517	GSE27786_NKCELL_VS_ERYTHROBLAST_UP	175	0.8974249	0.74772036	1	-0.1958082	-1.990658
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	c2.CGP_ chemical and genetic perturbations	341	-1.0931035	0.11494253	0.46380228	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	350	1.105383	0.186	0.74620914	0.0122795	-2.1984865
GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN	C7_ immunologic signatures	180	-1.0929881	0.1754386	0.46393237	GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN	184	1.2246813	0.07106599	0.5495824	0.1316932	-2.3176694
GSE17721_LPS_VS_POLYIC_16H_BMDC_UP	C7_ immunologic signatures	182	-1.0929321	0.19727892	0.46388686	GSE17721_LPS_VS_POLYIC_16H_BMDC_UP	181	0.5992354	0.9969481	1	-0.4936967	-1.6921675
GO_CELLULAR_HORMONE_METABOLIC_PROCESS	c5.BP_ GO biological process	78	-1.0928587	0.26136363	0.46387303	GO_CELLULAR_HORMONE_METABOLIC_PROCESS	81	0.9824174	0.53168637	0.94527525	-0.1104413	-2.0752761
GO_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY	c5.GO molecular function	101	-1.0928037	0.24444444	0.46382698	GO_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY	106	0.79972285	0.85610765	1	-0.29308085	-1.89252655
MEF2_04	c3.TFT_ transcription factor targets	20	-1.092766	0.33080807	0.4637291	MEF2_04	22	1.1954025	0.23477158	0.5967335	0.1026365	-2.2881685
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	c2.CGP_ chemical and genetic perturbations	329	-1.0924901	0.1392405	0.46428278	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	349	1.4874696	0	0.26311412	0.3949795	-2.5799597
GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN	C7_ immunologic signatures	138	-1.0923495	0.20725389	0.4644584	GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN	138	0.9566909	0.5867347	0.9751954	-0.1356586	-2.0490404
GO_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	28	-1.0920768	0.31005585	0.46500605	GO_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS	27	-0.7652568	0.85465115	0.93029565	-1.8573336	-0.32682
TERAO_AOX4_TARGETS_HG_UP	c2.CGP_ chemical and genetic perturbations	26	-1.0917025	0.31666666	0.46585864	TERAO_AOX4_TARGETS_HG_UP	26	0.6083443	0.9551515	1	-0.4833582	-1.7000468
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP	C7_ immunologic signatures	167	-1.091467	0.21387284	0.46631777	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP	164	1.30091	0.02538071	0.43975	0.209443	-2.392377
GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP	C7_ immunologic signatures	151	-1.091459	0.22335026	0.46613842	GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP	153	1.1503857	0.18292683	0.6685296	0.0589267	-2.2418447
GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN	C7_ immunologic signatures	171	-1.0910457	0.19875777	0.46705672	GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN	171	0.8315649	0.83739835	1	-0.2594808	-1.9226106
GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	C7_ immunologic signatures	176	-1.0910294	0.17261904	0.46689987	GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	181	1.2579728	0.041624367	0.4989735	0.1669434	-2.3490022
ACEVEDO_LIVER_CANCER_DN	c2.CGP_ chemical and genetic perturbations	453	-1.0909402	0.0625	0.46694803	ACEVEDO_LIVER_CANCER_DN	460	1.0606378	0.278	0.82262343	-0.0303024	-2.151578
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	c2.CP_REACTOME_ Reactome gene sets	32	-1.0909101	0.3003003	0.46683338	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	32	0.75301355	0.845509	1	-0.33789655	-1.84392365
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	c2.CGP_ chemical and genetic perturbations	31	-1.0906789	0.30167598	0.4672767	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	30	0.6259686	0.94491017	1	-0.4647103	-1.7166475
GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP	C7_ immunologic signatures	163	-1.0906568	0.23648648	0.4671394	GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP	163	0.82490766	0.84994966	1	-0.26574914	-1.91556446
GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP	C7_ immunologic signatures	158	-1.0905814	0.19879518	0.46714732	GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP	161	0.87517005	0.7823887	1	-0.21541135	-1.96575145
GO_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY	c5.BP_ GO biological process	49	-1.0904187	0.28327644	0.46739888	GO_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY	53	-1.0596999	0.27	0.5887713	-2.1501186	-0.0307188
GO_EMBRYONIC_FORELIMB_MORPHOGENESIS	c5.BP_ GO biological process	30	-1.0904046	0.3008596	0.46723753	GO_EMBRYONIC_FORELIMB_MORPHOGENESIS	31	0.80817723	0.7825059	1	-0.28222737	-1.89858183
GO_VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY	c5.GO molecular function	111	-1.0904014	0.24637681	0.4670472	GO_VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY	128	1.3788828	0.00931677	0.35573092	0.2884814	-2.4692842
AP1_Q4	c3.TFT_ transcription factor targets	240	-1.089949	0.16666667	0.46810782	AP1_Q4	245	1.4122403	0	0.3232141	0.3222913	-2.5021893
HMX1_01	c3.TFT_ transcription factor targets	35	-1.0897549	0.3011696	0.46847156	HMX1_01	36	1.0189055	0.45764706	0.89185756	-0.0708494	-2.1086604
GO_HYDROGEN_PEROXIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	25	-1.0896751	0.34202898	0.4684897	GO_HYDROGEN_PEROXIDE_METABOLIC_PROCESS	27	1.2995042	0.12845138	0.4439355	0.2098291	-2.3891793
GCM_PTPRU	c4.CGN_ cancer gene neighborhoods	43	-1.0895236	0.28807947	0.46872276	GCM_PTPRU	48	1.2720215	0.12037037	0.48280257	0.1824979	-2.3615451
GNF2_SPTA1	c4.CGN_ cancer gene neighborhoods	68	-1.0893211	0.26855123	0.4690962	GNF2_SPTA1	73	0.94675833	0.58315337	0.985452	-0.14256277	-2.03607943
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN	C7_ immunologic signatures	174	-1.0892148	0.23943663	0.46919966	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN	181	0.94796646	0.62992924	0.98401946	-0.14124834	-2.03718126
AMIT_EGF_RESPONSE_120_MCF10A	c2.CGP_ chemical and genetic perturbations	37	-1.0891906	0.29139072	0.4690743	AMIT_EGF_RESPONSE_120_MCF10A	39	1.2118639	0.19369894	0.5750236	0.1226733	-2.3010545
APPIERTO_RESPONSE_TO_FENRETINIDE_DN	c2.CGP_ chemical and genetic perturbations	45	-1.0891688	0.29268292	0.46892738	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	45	-1.0208553	0.3783784	0.6576669	-2.1100241	-0.0683135
GO_REGULATION_OF_CELLULAR_RESPIRATION	c5.BP_ GO biological process	21	-1.0890483	0.3152174	0.46906546	GO_REGULATION_OF_CELLULAR_RESPIRATION	22	1.3519254	0.0966123	0.3823917	0.2628771	-2.4409737
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	172	-1.0889094	0.19871795	0.46925235	GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN	172	-1.0603806	0.26666668	0.58746326	-2.14929	-0.0285288
GSE45365_NK_CELL_VS_CD11B_DC_DN	C7_ immunologic signatures	178	-1.0888673	0.22891566	0.46918458	GSE45365_NK_CELL_VS_CD11B_DC_DN	180	0.91157454	0.7080808	1	-0.17729276	-2.00044184
GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN	C7_ immunologic signatures	152	-1.0886608	0.2375	0.46958056	GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN	151	1.1751775	0.15864892	0.62905794	0.0865167	-2.2638383
GSE27786_LSK_VS_LIN_NEG_CELL_DN	C7_ immunologic signatures	174	-1.0884097	0.1923077	0.470074	GSE27786_LSK_VS_LIN_NEG_CELL_DN	182	-1.2336959	0.05882353	0.34169972	-2.3221056	0.1452862
GSE24726_WT_VS_E2_2_KO_PDC_DN	C7_ immunologic signatures	182	-1.0883137	0.19875777	0.47014448	GSE24726_WT_VS_E2_2_KO_PDC_DN	180	0.8502693	0.81707317	1	-0.2380444	-1.938583
GO_MEMBRANE_BUDDING	c5.BP_ GO biological process	104	-1.0882571	0.21028037	0.47009158	GO_MEMBRANE_BUDDING	103	0.6816911	0.95063025	1	-0.406566	-1.7699482
GO_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	25	-1.0881039	0.32786885	0.47034308	GO_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS	26	1.2291161	0.17509247	0.54286987	0.1410122	-2.31722
MODULE_107	c4.CM_ cancer modules	66	-1.0880877	0.2625	0.47018537	MODULE_107	68	1.3908412	0.025945947	0.3464621	0.3027535	-2.4789289
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	c2.CP_REACTOME_ Reactome gene sets	48	-1.0880566	0.27244583	0.47006008	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	49	0.96787447	0.550173	0.96355337	-0.12018213	-2.05593107
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	c2.CGP_ chemical and genetic perturbations	115	-1.0880537	0.23144105	0.46986917	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	114	-1.4783262	0	0.15618053	-2.5663799	0.3902725
GO_ACETYLTRANSFERASE_COMPLEX	c5.CC_ GO cellular component	79	-1.088012	0.27436823	0.46978903	GO_ACETYLTRANSFERASE_COMPLEX	80	-1.1101557	0.26785713	0.50398046	-2.1981677	0.0221437
GROSS_ELK3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	29	-1.0877423	0.2776204	0.4703316	GROSS_ELK3_TARGETS_DN	29	1.2482455	0.18523003	0.5141571	0.1605032	-2.3359878
GO_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI	c5.BP_ GO biological process	58	-1.0875188	0.2591241	0.47075593	GO_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI	58	-0.6369333	1	0.9785248	-1.7244521	-0.4505855
BASSO_B_LYMPHOCYTE_NETWORK	c2.CGP_ chemical and genetic perturbations	126	-1.087391	0.26666668	0.47092956	BASSO_B_LYMPHOCYTE_NETWORK	126	-0.91328895	0.87096775	0.80314	-2.00067995	-0.17410205
NAKAJIMA_MAST_CELL	c2.CGP_ chemical and genetic perturbations	38	-1.0873317	0.3109756	0.47090757	NAKAJIMA_MAST_CELL	38	1.2462984	0.17162472	0.51699716	0.1589667	-2.3336301
GO_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT	c5.BP_ GO biological process	18	-1.0873175	0.3274559	0.4707531	GO_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT	21	-1.619265	0.014925373	0.0845456	-2.7065825	0.5319475
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	c2.CGP_ chemical and genetic perturbations	29	-1.0869265	0.30267063	0.47167686	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	30	0.74145144	0.84378695	1	-0.34547506	-1.82837794
GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_ARREST	c5.BP_ GO biological process	15	-1.0868648	0.33333334	0.4716683	GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_ARREST	16	1.11355	0.34214002	0.73207486	0.0266852	-2.2004148
DORN_ADENOVIRUS_INFECTION_48HR_DN	c2.CGP_ chemical and genetic perturbations	36	-1.0865455	0.3171521	0.47234347	DORN_ADENOVIRUS_INFECTION_48HR_DN	37	0.8247572	0.72	1	-0.2617883	-1.9113027
GSE360_DC_VS_MAC_DN	C7_ immunologic signatures	169	-1.0865254	0.18232045	0.4721962	GSE360_DC_VS_MAC_DN	176	0.86792225	0.7973523	1	-0.21860315	-1.95444765
GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_UP	C7_ immunologic signatures	154	-1.0862955	0.17931035	0.47262233	GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_UP	154	-0.9746526	0.625	0.72239304	-2.0609481	-0.1116429
GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	C7_ immunologic signatures	158	-1.0858953	0.24844721	0.4735364	GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	159	0.9435956	0.6340469	0.9886802	-0.1422997	-2.0294909
NFMUE1_Q6	c3.TFT_ transcription factor targets	213	-1.0857936	0.192	0.4736358	NFMUE1_Q6	216	-0.83466077	0.7777778	0.87836546	-1.92045437	-0.25113283
GO_CELLULAR_AMINO_ACID_CATABOLIC_PROCESS	c5.BP_ GO biological process	101	-1.085705	0.18644068	0.47368357	GO_CELLULAR_AMINO_ACID_CATABOLIC_PROCESS	105	0.80738235	0.8452632	1	-0.27832265	-1.89308735
GO_MONOSACCHARIDE_BINDING	c5.GO molecular function	53	-1.0855118	0.2930403	0.47403905	GO_MONOSACCHARIDE_BINDING	60	0.8724685	0.694414	1	-0.2130433	-1.9579803
GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN	C7_ immunologic signatures	179	-1.0854445	0.18965517	0.47402683	GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN	179	1.0990683	0.26565656	0.75814754	0.0136238	-2.1845128
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	c2.CGP_ chemical and genetic perturbations	194	-1.0854175	0.17857143	0.47391778	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	200	0.7245739	0.9727548	1	-0.3608436	-1.8099914
DAUER_STAT3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	43	-1.0852928	0.30476192	0.47406653	DAUER_STAT3_TARGETS_UP	44	0.93058926	0.5942529	0.9983675	-0.15470354	-2.01588206
GSE17721_LPS_VS_CPG_4H_BMDC_DN	C7_ immunologic signatures	179	-1.0849875	0.20689656	0.4747134	GSE17721_LPS_VS_CPG_4H_BMDC_DN	180	0.63573	0.9959555	1	-0.4492575	-1.7207175
GO_LIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	469	-1.0849059	0.14285715	0.47475803	GO_LIPID_BIOSYNTHETIC_PROCESS	488	1.1667798	0.044	0.6431585	0.0818739	-2.2516857
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP	C7_ immunologic signatures	163	-1.0847425	0.21693122	0.47503334	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP	167	-0.8556005	1	0.8620066	-1.940343	-0.229142
GO_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION	c5.BP_ GO biological process	24	-1.0847074	0.32934132	0.4749343	GO_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION	26	0.95622855	0.5491905	0.97566694	-0.12847885	-2.04093595
GO_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	86	-1.0842412	0.25862068	0.47604707	GO_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS	89	1.6989385	0	0.081362695	0.6146973	-2.7831797
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN	C7_ immunologic signatures	176	-1.0842206	0.16455697	0.47590184	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN	180	1.0226657	0.45259938	0.8867351	-0.0615549	-2.1068863
GO_FORELIMB_MORPHOGENESIS	c5.BP_ GO biological process	38	-1.0842023	0.29757786	0.47575045	GO_FORELIMB_MORPHOGENESIS	39	-1.1306664	0.23972602	0.47058967	-2.2148687	0.0464641
GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP	C7_ immunologic signatures	153	-1.0841612	0.20689656	0.47567046	GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP	160	0.8343553	0.82924336	1	-0.2498059	-1.9185165
GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP	C7_ immunologic signatures	174	-1.0841149	0.24475524	0.4756055	GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP	179	1.1565839	0.16480163	0.65929323	0.072469	-2.2406988
GO_GENE_SILENCING_BY_RNA	c5.BP_ GO biological process	109	-1.0835545	0.2616034	0.4770015	GO_GENE_SILENCING_BY_RNA	110	1.0382645	0.42827442	0.86146355	-0.04529	-2.121819
GO_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION	c5.BP_ GO biological process	39	-1.083486	0.3034483	0.4769833	GO_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION	39	0.7309435	0.87352246	1	-0.3525425	-1.8144295
GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN	C7_ immunologic signatures	181	-1.0834703	0.19480519	0.47682932	GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN	185	1.0868375	0.3010101	0.77544254	0.0033672	-2.1703078
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN	C7_ immunologic signatures	163	-1.0833459	0.23121387	0.4769791	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN	167	0.91215515	0.68324876	1	-0.17119075	-1.99550105
GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP	C7_ immunologic signatures	165	-1.0832947	0.2215909	0.47692594	GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP	168	0.806035	0.87614214	1	-0.2772597	-1.8893297
GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	C7_ immunologic signatures	146	-1.0829442	0.25	0.47772637	GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	149	0.9975867	0.5143737	0.9258734	-0.0853575	-2.0805309
GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN	C7_ immunologic signatures	161	-1.0827041	0.19879518	0.47820225	GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN	166	1.1538111	0.18116684	0.66334087	0.071107	-2.2365152
GO_REGULATION_OF_VACUOLE_ORGANIZATION	c5.BP_ GO biological process	39	-1.0824647	0.31410256	0.47867867	GO_REGULATION_OF_VACUOLE_ORGANIZATION	39	0.9326966	0.585168	0.9975353	-0.1497681	-2.0151613
HOSHIDA_LIVER_CANCER_SUBCLASS_S2	c2.CGP_ chemical and genetic perturbations	107	-1.08243	0.25454545	0.4785909	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	107	-1.8388021	0	0.026225343	-2.9212321	0.7563721
GO_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING	c5.BP_ GO biological process	22	-1.0821015	0.33707866	0.47932488	GO_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING	26	1.2096512	0.20522387	0.5775481	0.1275497	-2.2917527
GO_TRANSITION_METAL_ION_TRANSPORT	c5.BP_ GO biological process	96	-1.0820066	0.28444445	0.4793939	GO_TRANSITION_METAL_ION_TRANSPORT	101	1.0206378	0.45850623	0.8912047	-0.0613688	-2.1026444
GNF2_MAP2K3	c4.CGN_ cancer gene neighborhoods	65	-1.08177	0.29457363	0.4798727	GNF2_MAP2K3	69	0.6939536	0.94291985	1	-0.3878164	-1.7757236
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	c2.CGP_ chemical and genetic perturbations	61	-1.0816065	0.2519084	0.4801443	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	67	0.8528855	0.7330463	1	-0.228721	-1.934492
BRUNO_HEMATOPOIESIS	c2.CGP_ chemical and genetic perturbations	58	-1.0815705	0.2826087	0.48004812	BRUNO_HEMATOPOIESIS	62	1.182711	0.19599108	0.61886185	0.1011405	-2.2642815
CHR6Q22	C1: positional gene sets	49	-1.0812894	0.3226837	0.48062557	CHR6Q22	50	0.9100258	0.6356674	1	-0.1712636	-1.9913152
GO_RNA_POLYMERASE_CORE_ENZYME_BINDING	c5.GO molecular function	17	-1.0811708	0.3274559	0.48076886	GO_RNA_POLYMERASE_CORE_ENZYME_BINDING	17	-0.8648243	0.65677965	0.85769534	-1.9459951	-0.2163465
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP	C7_ immunologic signatures	180	-1.0811658	0.20118344	0.48058188	GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP	181	0.71378934	0.9587525	1	-0.36737646	-1.79495514
SWEET_KRAS_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	56	-1.0810364	0.3028169	0.48076096	SWEET_KRAS_TARGETS_DN	56	-0.84206045	0.78350514	0.8735248	-1.92309685	-0.23897595
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	c2.CP_REACTOME_ Reactome gene sets	109	-1.0809325	0.24285714	0.4808389	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	130	1.0933583	0.3072165	0.768243	0.0124258	-2.1742908
VILLANUEVA_LIVER_CANCER_KRT19_DN	c2.CGP_ chemical and genetic perturbations	51	-1.0807664	0.3	0.4811152	VILLANUEVA_LIVER_CANCER_KRT19_DN	56	1.1021464	0.30549452	0.7536474	0.02138	-2.1829128
GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN	C7_ immunologic signatures	142	-1.0804697	0.24719101	0.48174605	GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN	143	1.0344148	0.42594483	0.8682428	-0.0460549	-2.1148845
HAHTOLA_CTCL_CUTANEOUS	c2.CGP_ chemical and genetic perturbations	16	-1.0804185	0.34190232	0.48168936	HAHTOLA_CTCL_CUTANEOUS	17	0.9831689	0.515748	0.9440313	-0.0972496	-2.0635874
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	c2.CP_REACTOME_ Reactome gene sets	46	-1.0802174	0.3018182	0.48208123	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	46	1.0000347	0.4937286	0.92455125	-0.0801827	-2.0802521
GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN	C7_ immunologic signatures	179	-1.0802037	0.21192053	0.48191988	GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN	178	0.70702523	0.969697	1	-0.37317847	-1.78722893
UDAYAKUMAR_MED1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	125	-1.0801454	0.24545455	0.48187682	UDAYAKUMAR_MED1_TARGETS_UP	125	-1.3144231	0	0.2709092	-2.3945685	0.2342777
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	c2.CGP_ chemical and genetic perturbations	108	-1.0800692	0.27753305	0.48191628	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	110	1.2791108	0.0709072	0.47228664	0.1990416	-2.35918
GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP	C7_ immunologic signatures	178	-1.0800596	0.20689656	0.481747	GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP	181	0.7834626	0.9100101	1	-0.296597	-1.8635222
MIKKELSEN_ES_ICP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	33	-1.0800068	0.28903654	0.4816995	MIKKELSEN_ES_ICP_WITH_H3K27ME3	36	-1.4486555	0.03846154	0.17439596	-2.5286623	0.3686487
MODULE_212	c4.CM_ cancer modules	283	-1.0797518	0.1923077	0.4822246	MODULE_212	292	1.135416	0.13727455	0.696473	0.0556642	-2.2151678
GO_MAMMARY_GLAND_DUCT_MORPHOGENESIS	c5.BP_ GO biological process	27	-1.0796986	0.33529413	0.48217794	GO_MAMMARY_GLAND_DUCT_MORPHOGENESIS	27	1.0911194	0.35714287	0.76957417	0.0114208	-2.170818
GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP	C7_ immunologic signatures	157	-1.0795811	0.22023809	0.48232076	GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP	158	1.2989817	0.026422765	0.4440035	0.2194006	-2.3785628
GO_MONOVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	280	-1.0794151	0.15	0.4825759	GO_MONOVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	321	1.1986423	0.046046045	0.5953339	0.1192272	-2.2780574
MODULE_371	c4.CM_ cancer modules	21	-1.0793366	0.3172589	0.48260224	MODULE_371	22	0.8590039	0.6978233	1	-0.2203327	-1.9383405
BIOCARTA_VIP_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	23	-1.0792675	0.31578946	0.48258927	BIOCARTA_VIP_PATHWAY	23	1.1513599	0.28696743	0.6675721	0.0720924	-2.2306274
GO_ANION_HOMEOSTASIS	c5.BP_ GO biological process	34	-1.0792384	0.33333334	0.48247442	GO_ANION_HOMEOSTASIS	39	1.8205187	0	0.027408713	0.7412803	-2.8997571
GO_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	19	-1.0792284	0.32448378	0.48230156	GO_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS	19	0.72018695	0.8454546	1	-0.35904145	-1.79941535
GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP	C7_ immunologic signatures	168	-1.0790906	0.2137931	0.4825074	GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP	169	0.7911504	0.8979798	1	-0.2879402	-1.870241
GO_LYSOSOME_LOCALIZATION	c5.BP_ GO biological process	22	-1.0790417	0.32686982	0.482452	GO_LYSOSOME_LOCALIZATION	23	1.4645512	0.033128835	0.28184763	0.3855095	-2.5435929
GSE2826_WT_VS_BTK_KO_BCELL_DN	C7_ immunologic signatures	171	-1.0789585	0.24840765	0.48249328	GSE2826_WT_VS_BTK_KO_BCELL_DN	174	1.2536985	0.063894525	0.5034524	0.17474	-2.332657
GSE360_DC_VS_MAC_T_GONDII_DN	C7_ immunologic signatures	172	-1.0788347	0.19285715	0.48266035	GSE360_DC_VS_MAC_T_GONDII_DN	178	0.6971178	0.9736041	1	-0.3817169	-1.7759525
GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN	C7_ immunologic signatures	152	-1.0784804	0.21088435	0.48349658	GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN	156	-1.0432355	0.23809524	0.6177252	-2.1217159	-0.0352449
RUAN_RESPONSE_TO_TROGLITAZONE_DN	c2.CGP_ chemical and genetic perturbations	17	-1.0784649	0.34759358	0.48334324	RUAN_RESPONSE_TO_TROGLITAZONE_DN	17	-1.2899193	0.13596492	0.29199398	-2.3683842	0.2114544
GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_UP	C7_ immunologic signatures	184	-1.078203	0.2	0.48391208	GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_UP	184	0.6345691	0.9919436	1	-0.4436339	-1.7127721
GSE2585_CD80_HIGH_VS_LOW_MTEC_DN	C7_ immunologic signatures	153	-1.0781602	0.2682927	0.48382947	GSE2585_CD80_HIGH_VS_LOW_MTEC_DN	160	1.0072501	0.47648263	0.91176814	-0.0709101	-2.0854103
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP	C7_ immunologic signatures	171	-1.0778083	0.22360249	0.4846534	GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP	172	0.7432995	0.9429154	1	-0.3345088	-1.8211078
GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP	C7_ immunologic signatures	176	-1.0775832	0.22222222	0.48509443	GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP	180	-1.7037808	0	0.05455262	-2.781364	0.6261976
GTAGGCA_MIR189	c3.MIR_ microRNA targets	27	-1.0775393	0.35042736	0.48502222	GTAGGCA_MIR189	28	-0.8925476	0.6363636	0.8298576	-1.9700869	-0.1849917
GO_PLACENTA_DEVELOPMENT	c5.BP_ GO biological process	126	-1.077528	0.22222222	0.48485592	GO_PLACENTA_DEVELOPMENT	133	1.0589613	0.3782117	0.8265646	-0.0185667	-2.1364893
GO_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_VIRUS	c5.BP_ GO biological process	26	-1.0774184	0.34210527	0.48496816	GO_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_VIRUS	27	0.7020096	0.8937948	1	-0.3754088	-1.779428
CAR_MLANA	c4.CGN_ cancer gene neighborhoods	31	-1.0774101	0.3243243	0.48479176	CAR_MLANA	35	1.1123928	0.3091954	0.7341966	0.0349827	-2.1898029
AHRARNT_01	c3.TFT_ transcription factor targets	122	-1.0771173	0.24043716	0.4854442	AHRARNT_01	127	-1.1467842	0.10344828	0.4475898	-2.2239015	0.0696669
SHIN_B_CELL_LYMPHOMA_CLUSTER_3	c2.CGP_ chemical and genetic perturbations	25	-1.0771046	0.36414567	0.4852787	SHIN_B_CELL_LYMPHOMA_CLUSTER_3	27	-1.7579688	0	0.04188254	-2.8350734	0.6808642
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	c2.CGP_ chemical and genetic perturbations	16	-1.0770979	0.33333334	0.4851	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	20	1.2545923	0.19638243	0.5024811	0.1774944	-2.3316902
GO_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	37	-1.0769128	0.3260188	0.485446	GO_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS	39	0.78332686	0.80738175	1	-0.29358594	-1.86023966
PID_CMYB_PATHWAY	c2.CP_ Canonical pathways	80	-1.076875	0.25882354	0.48535183	PID_CMYB_PATHWAY	80	0.7998832	0.81289643	1	-0.2769918	-1.8767582
GO_MICROBODY	c5.CC_ GO cellular component	119	-1.0766685	0.2544643	0.4857535	GO_MICROBODY	121	0.6999724	0.95548654	1	-0.3766961	-1.7766409
GO_PROTEIN_KINASE_B_SIGNALING	c5.BP_ GO biological process	30	-1.0766437	0.3195266	0.485612	GO_PROTEIN_KINASE_B_SIGNALING	30	0.5566437	0.98273736	1	-0.52	-1.6332874
GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP	C7_ immunologic signatures	183	-1.0764976	0.20567375	0.48584878	GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP	185	-1.1191999	0	0.48989072	-2.1956975	0.0427023
GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN	C7_ immunologic signatures	164	-1.0764859	0.24479167	0.48568684	GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN	165	1.0478795	0.38508683	0.8438544	-0.0286064	-2.1243654
GO_GLUTATHIONE_METABOLIC_PROCESS	c5.BP_ GO biological process	49	-1.076398	0.28709677	0.48573774	GO_GLUTATHIONE_METABOLIC_PROCESS	51	1.3168777	0.072	0.4152614	0.2404797	-2.3932757
GSE17721_POLYIC_VS_CPG_24H_BMDC_UP	C7_ immunologic signatures	175	-1.075852	0.23780487	0.4871334	GSE17721_POLYIC_VS_CPG_24H_BMDC_UP	179	0.8283676	0.854251	1	-0.2474844	-1.9042196
GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN	C7_ immunologic signatures	175	-1.0757842	0.23602484	0.48713094	GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN	176	-1.1022341	0.1875	0.51334226	-2.1780183	0.0264499
KEGG_GALACTOSE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	22	-1.0757266	0.32891247	0.48710084	KEGG_GALACTOSE_METABOLISM	23	0.7049098	0.8815789	1	-0.3708168	-1.7806364
PTEN_DN.V1_DN	C6_ oncogenic signatures	135	-1.0753316	0.22885571	0.48802477	PTEN_DN.V1_DN	148	1.124101	0.2284836	0.7173256	0.0487694	-2.1994326
SRY_01	c3.TFT_ transcription factor targets	193	-1.0750097	0.19078948	0.48875675	SRY_01	197	1.149104	0.16197184	0.67022437	0.0740943	-2.2241137
GSE17721_CTRL_VS_CPG_12H_BMDC_UP	C7_ immunologic signatures	176	-1.0749536	0.24375	0.48871335	GSE17721_CTRL_VS_CPG_12H_BMDC_UP	176	0.72704715	0.95947313	1	-0.34790645	-1.80200075
GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP	C7_ immunologic signatures	181	-1.0745502	0.21768707	0.48969343	GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP	183	1.1902852	0.10515673	0.60615623	0.115735	-2.2648354
GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP	C7_ immunologic signatures	175	-1.0745453	0.25454545	0.48950624	GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP	185	0.99122584	0.52323234	0.9343732	-0.08331946	-2.06577114
GO_ACTIVATION_OF_IMMUNE_RESPONSE	c5.BP_ GO biological process	334	-1.0743616	0.19354838	0.48983744	GO_ACTIVATION_OF_IMMUNE_RESPONSE	356	1.1397942	0.11211211	0.69108045	0.0654326	-2.2141558
WIERENGA_PML_INTERACTOME	c2.CGP_ chemical and genetic perturbations	36	-1.0742843	0.30674848	0.48983893	WIERENGA_PML_INTERACTOME	37	0.95378023	0.5606936	0.9776539	-0.12050407	-2.02806453
ZIRN_TRETINOIN_RESPONSE_WT1_UP	c2.CGP_ chemical and genetic perturbations	21	-1.0740007	0.3454039	0.49044856	ZIRN_TRETINOIN_RESPONSE_WT1_UP	20	1.1552463	0.27820513	0.66151935	0.0812456	-2.229247
GO_CYTOKINE_ACTIVITY	c5.GO molecular function	155	-1.0738163	0.25454545	0.49077126	GO_CYTOKINE_ACTIVITY	162	1.1814933	0.121703856	0.62066066	0.107677	-2.2553096
GO_NADP_METABOLIC_PROCESS	c5.BP_ GO biological process	24	-1.0738127	0.34357542	0.49058026	GO_NADP_METABOLIC_PROCESS	24	0.7030657	0.87469286	1	-0.370747	-1.7768784
GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP	C7_ immunologic signatures	178	-1.0737942	0.2208589	0.49043873	GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP	183	0.79291236	0.89847714	1	-0.28088184	-1.86670656
GO_HYDROGEN_TRANSPORT	c5.BP_ GO biological process	102	-1.0736414	0.29032257	0.4906668	GO_HYDROGEN_TRANSPORT	111	0.800032	0.853125	1	-0.2736094	-1.8736734
GSE5960_TH1_VS_ANERGIC_TH1_UP	C7_ immunologic signatures	179	-1.0733614	0.19727892	0.49131677	GSE5960_TH1_VS_ANERGIC_TH1_UP	181	0.62066585	0.9959514	1	-0.45269555	-1.69402725
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP	C7_ immunologic signatures	176	-1.0732758	0.19333333	0.49137697	GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP	183	1.0815182	0.30152285	0.78491634	0.0082424	-2.154794
GO_POSITIVE_REGULATION_OF_DNA_BINDING	c5.BP_ GO biological process	35	-1.0731418	0.3353846	0.49155882	GO_POSITIVE_REGULATION_OF_DNA_BINDING	38	0.79906565	0.7795454	1	-0.27407615	-1.87220745
KEGG_HEMATOPOIETIC_CELL_LINEAGE	c2.CP_BIOCARTA_ BioCarta gene sets	69	-1.0730675	0.31325302	0.4915709	KEGG_HEMATOPOIETIC_CELL_LINEAGE	74	1.1745658	0.19459459	0.6306031	0.1014983	-2.2476333
GSE360_CTRL_VS_L_DONOVANI_DC_UP	C7_ immunologic signatures	179	-1.0725884	0.23448277	0.49281123	GSE360_CTRL_VS_L_DONOVANI_DC_UP	183	0.8398633	0.84428716	1	-0.2327251	-1.9124517
ER_Q6	c3.TFT_ transcription factor targets	229	-1.0725094	0.224	0.49285385	ER_Q6	245	0.75942063	0.9549098	1	-0.31308877	-1.83193003
GNF2_PRDX2	c4.CGN_ cancer gene neighborhoods	26	-1.0720631	0.338558	0.49399757	GNF2_PRDX2	28	0.9091331	0.63176894	1	-0.16293	-1.9811962
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	c2.CGP_ chemical and genetic perturbations	49	-1.0717931	0.3153153	0.4945795	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	51	0.72710127	0.87217194	1	-0.34469183	-1.79889437
GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN	C7_ immunologic signatures	158	-1.0717471	0.24223602	0.4945239	GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN	165	1.2185347	0.08897877	0.5581299	0.1467876	-2.2902818
GO_TRANSLATION_REGULATOR_ACTIVITY	c5.GO molecular function	32	-1.071335	0.3227848	0.49552372	GO_TRANSLATION_REGULATOR_ACTIVITY	32	-0.8877429	0.62777776	0.8375925	-1.9590779	-0.1835921
GO_SYMPORTER_ACTIVITY	c5.GO molecular function	124	-1.071274	0.26732674	0.49549603	GO_SYMPORTER_ACTIVITY	136	1.1576612	0.17598344	0.65793896	0.0863872	-2.2289352
CHR6P25	C1: positional gene sets	26	-1.0706705	0.33707866	0.49707523	CHR6P25	27	1.1587493	0.25748503	0.65527284	0.0880788	-2.2294198
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	c2.CGP_ chemical and genetic perturbations	64	-1.0700958	0.30923694	0.49859777	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	64	-0.7547678	0.9404762	0.93691385	-1.8248636	-0.315328
GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN	C7_ immunologic signatures	174	-1.0697216	0.21084337	0.49950403	GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN	177	0.9035183	0.7173252	1	-0.1662033	-1.9732399
GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP	C7_ immunologic signatures	179	-1.0695044	0.21893491	0.49997002	GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP	184	0.955919	0.6010152	0.9759147	-0.1135854	-2.0254234
GSE40493_BCL6_KO_VS_WT_TREG_UP	C7_ immunologic signatures	171	-1.0694337	0.2542373	0.49996188	GSE40493_BCL6_KO_VS_WT_TREG_UP	171	0.64376915	0.98678863	1	-0.42566455	-1.71320285
GO_MONOVALENT_INORGANIC_CATION_TRANSPORT	c5.BP_ GO biological process	345	-1.0690848	0.14814815	0.5007795	GO_MONOVALENT_INORGANIC_CATION_TRANSPORT	384	1.2073643	0.043043043	0.58069986	0.1382795	-2.2764491
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	178	-1.0690606	0.25308642	0.5006468	GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP	180	-1.203153	0.09090909	0.37822717	-2.2722136	0.1340924
DORN_ADENOVIRUS_INFECTION_24HR_DN	c2.CGP_ chemical and genetic perturbations	40	-1.0688796	0.328125	0.5009959	DORN_ADENOVIRUS_INFECTION_24HR_DN	40	0.98603886	0.5162413	0.9407045	-0.08284074	-2.05491846
GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	163	-1.0681231	0.24293785	0.5030737	GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN	166	0.8531534	0.7955239	1	-0.2149697	-1.9212765
MODULE_321	c4.CM_ cancer modules	105	-1.068005	0.2990196	0.5032166	MODULE_321	106	0.89628524	0.6960581	1	-0.17171976	-1.96429024
MORF_BMI1	c4.CGN_ cancer gene neighborhoods	73	-1.0678887	0.2840909	0.50333375	MORF_BMI1	73	-1.5279878	0	0.12663813	-2.5958765	0.4600991
CHR15Q14	C1: positional gene sets	31	-1.0678535	0.35913312	0.5032339	CHR15Q14	32	1.2849458	0.13549161	0.46355933	0.2170923	-2.3527993
GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP	C7_ immunologic signatures	182	-1.0674762	0.25657895	0.5041711	GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP	186	1.0203377	0.45445344	0.8914371	-0.0471385	-2.0878139
GO_LIPID_OXIDATION	c5.BP_ GO biological process	66	-1.0670182	0.2984496	0.5053026	GO_LIPID_OXIDATION	67	1.0424452	0.41353384	0.8546503	-0.024573	-2.1094634
GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_DN	C7_ immunologic signatures	170	-1.067007	0.23529412	0.50513035	GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_DN	176	0.9099292	0.693712	1	-0.1570778	-1.9769362
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	c2.CP_REACTOME_ Reactome gene sets	18	-1.0667244	0.38746437	0.5057488	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	18	0.9414313	0.5754119	0.98944503	-0.1252931	-2.0081557
GO_GLUTATHIONE_TRANSFERASE_ACTIVITY	c5.GO molecular function	26	-1.0667164	0.32344213	0.5055631	GO_GLUTATHIONE_TRANSFERASE_ACTIVITY	27	1.0868167	0.35518473	0.77537835	0.0201003	-2.1535331
YANG_BREAST_CANCER_ESR1_LASER_DN	c2.CGP_ chemical and genetic perturbations	47	-1.0665127	0.2885906	0.50597423	YANG_BREAST_CANCER_ESR1_LASER_DN	47	0.90642864	0.63381857	1	-0.16008406	-1.97294134
ST_B_CELL_ANTIGEN_RECEPTOR	c2.CP_ Canonical pathways	37	-1.0663214	0.35119048	0.50635403	ST_B_CELL_ANTIGEN_RECEPTOR	38	1.2725351	0.1261468	0.4820218	0.2062137	-2.3388565
DURCHDEWALD_SKIN_CARCINOGENESIS_DN	c2.CGP_ chemical and genetic perturbations	239	-1.0663066	0.19469027	0.50619906	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	242	0.8309277	0.88264793	1	-0.2353789	-1.8972343
JIANG_VHL_TARGETS	c2.CGP_ chemical and genetic perturbations	122	-1.0662879	0.2857143	0.5060614	JIANG_VHL_TARGETS	121	0.62445045	0.9866117	1	-0.44183745	-1.69073835
GO_NUCLEOSIDE_TRANSPORT	c5.BP_ GO biological process	15	-1.0661095	0.3802469	0.5063954	GO_NUCLEOSIDE_TRANSPORT	15	0.7553192	0.80653596	1	-0.3107903	-1.8214287
HOSHIDA_LIVER_CANCER_SUBCLASS_S3	c2.CGP_ chemical and genetic perturbations	231	-1.0655383	0.20869565	0.50791174	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	240	1.2378199	0.04527163	0.5291859	0.1722816	-2.3033582
BACH1_01	c3.TFT_ transcription factor targets	236	-1.0654579	0.25714287	0.5079443	BACH1_01	243	1.0204631	0.45381525	0.8913539	-0.0449948	-2.085921
MORF_CDK2	c4.CGN_ cancer gene neighborhoods	70	-1.0654024	0.31558937	0.5079117	MORF_CDK2	70	-2.2346056	0	0.000578277	-3.300008	1.1692032
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	168	-1.0651677	0.2625	0.5083876	GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	172	1.0569494	0.35096642	0.8291274	-0.0082183	-2.1221171
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	c2.CGP_ chemical and genetic perturbations	104	-1.0651001	0.28947368	0.50839823	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	106	-0.97857517	0.54761904	0.7153549	-2.04367527	-0.08652493
GO_NUCLEOSOME_BINDING	c5.GO molecular function	40	-1.0650297	0.33850932	0.5084068	GO_NUCLEOSOME_BINDING	41	-1.530908	0.006849315	0.12496572	-2.5959377	0.4658783
LEE_LIVER_CANCER_MYC_TGFA_UP	c2.CGP_ chemical and genetic perturbations	54	-1.0650291	0.30392158	0.50820667	LEE_LIVER_CANCER_MYC_TGFA_UP	53	0.7544325	0.87020314	1	-0.3105966	-1.8194616
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	163	-1.0649524	0.26630434	0.50823706	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	164	0.7346458	0.95131844	1	-0.3303066	-1.7995982
KRAS.DF.V1_UP	C6_ oncogenic signatures	165	-1.0649002	0.24	0.50819546	KRAS.DF.V1_UP	170	0.9750568	0.55792683	0.95584077	-0.0898434	-2.039957
GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN	C7_ immunologic signatures	181	-1.0648707	0.23717949	0.50809	GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN	185	0.96006835	0.5925177	0.97124726	-0.10480235	-2.02493905
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	c2.CGP_ chemical and genetic perturbations	28	-1.0647668	0.3371758	0.50819206	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	28	1.0871434	0.35757574	0.7752553	0.0223766	-2.1519102
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP	c2.CGP_ chemical and genetic perturbations	19	-1.0647552	0.36312848	0.5080322	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP	19	0.6900406	0.8748404	1	-0.3747146	-1.7547958
GO_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	68	-1.0643169	0.31325302	0.5091762	GO_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION	72	1.1794924	0.19238901	0.62425154	0.1151755	-2.2438093
GO_HINDLIMB_MORPHOGENESIS	c5.BP_ GO biological process	35	-1.0642748	0.3476923	0.5091048	GO_HINDLIMB_MORPHOGENESIS	36	-1.4419264	0.020833334	0.1785553	-2.5062012	0.3776516
GO_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY	c5.BP_ GO biological process	35	-1.0642506	0.3218391	0.5089724	GO_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY	37	1.3164495	0.10488677	0.41616848	0.2521989	-2.3807001
KANG_CISPLATIN_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	16	-1.0636511	0.36533332	0.5105857	KANG_CISPLATIN_RESISTANCE_UP	16	1.3180163	0.13428944	0.41356918	0.2543652	-2.3816674
GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	C7_ immunologic signatures	181	-1.0635173	0.2847222	0.5107962	GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	182	1.0635564	0.37955466	0.8166095	3.91E-05	-2.1270737
HUANG_GATA2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	132	-1.0628153	0.26804122	0.5127091	HUANG_GATA2_TARGETS_UP	136	1.0652509	0.32817337	0.8139175	0.0024356	-2.1280662
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	c2.CGP_ chemical and genetic perturbations	72	-1.0627759	0.32941177	0.5126156	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	74	-1.353678	0.043956045	0.24036111	-2.4164539	0.2909021
GAGCCAG_MIR149	c3.MIR_ microRNA targets	133	-1.0627431	0.2762431	0.51250935	GAGCCAG_MIR149	135	0.9377764	0.6277146	0.9930342	-0.1249667	-2.0005195
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	167	-1.0625648	0.25786164	0.51286894	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	172	0.86499685	0.7876643	1	-0.19756795	-1.92756165
HEIDENBLAD_AMPLICON_12P11_12_UP	c2.CGP_ chemical and genetic perturbations	29	-1.0622545	0.34705883	0.51360273	HEIDENBLAD_AMPLICON_12P11_12_UP	30	1.0330182	0.44946492	0.8720944	-0.0292363	-2.0952727
GCGNNANTTCC_UNKNOWN	c3.TFT_ transcription factor targets	111	-1.0621492	0.29864255	0.5137328	GCGNNANTTCC_UNKNOWN	111	-1.000545	0.5151515	0.6851351	-2.0626942	-0.0616042
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP	C7_ immunologic signatures	182	-1.0619316	0.25	0.5141847	GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP	184	0.70121014	0.98183656	1	-0.36072146	-1.76314174
TAKAO_RESPONSE_TO_UVB_RADIATION_DN	c2.CGP_ chemical and genetic perturbations	90	-1.0618961	0.3195021	0.51409817	TAKAO_RESPONSE_TO_UVB_RADIATION_DN	91	0.78484845	0.86778593	1	-0.27704765	-1.84674455
GSE3982_NEUTROPHIL_VS_NKCELL_UP	C7_ immunologic signatures	170	-1.0616794	0.2631579	0.51451963	GSE3982_NEUTROPHIL_VS_NKCELL_UP	171	1.2109312	0.09266803	0.57608044	0.1492518	-2.2726106
GO_MRNA_3_UTR_BINDING	c5.GO molecular function	47	-1.0615509	0.3245033	0.5146999	GO_MRNA_3_UTR_BINDING	47	-1.6263945	0.014285714	0.081895545	-2.6879454	0.5648436
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	c2.CGP_ chemical and genetic perturbations	173	-1.0614815	0.27108434	0.51470876	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	172	-1.7997283	0	0.033013176	-2.8612098	0.7382468
MODULE_444	c4.CM_ cancer modules	16	-1.0614564	0.38547486	0.5145901	MODULE_444	15	0.83210415	0.72727275	1	-0.22935225	-1.89356055
GO_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS	c5.BP_ GO biological process	32	-1.0614536	0.3617021	0.5143982	GO_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS	36	1.0387136	0.4145199	0.8607302	-0.02274	-2.1001672
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP	C7_ immunologic signatures	156	-1.0614074	0.24844721	0.51432896	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP	160	1.2513345	0.056968465	0.5092288	0.1899271	-2.3127419
GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	171	-1.0612466	0.24827586	0.51459116	GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN	177	1.1197133	0.22154471	0.7233093	0.0584667	-2.1809599
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	c2.CGP_ chemical and genetic perturbations	46	-1.0611374	0.33216783	0.51469266	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	47	-0.7138729	1	0.95276725	-1.7750103	-0.3472645
GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN	C7_ immunologic signatures	176	-1.0610778	0.21568628	0.5146751	GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN	179	0.8813057	0.78304744	1	-0.1797721	-1.9423835
GO_MONOCARBOXYLIC_ACID_TRANSPORT	c5.BP_ GO biological process	97	-1.0607724	0.2824074	0.51541626	GO_MONOCARBOXYLIC_ACID_TRANSPORT	113	1.3456913	0.03626943	0.3881149	0.2849189	-2.4064637
GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	C7_ immunologic signatures	174	-1.0607083	0.23717949	0.51539904	GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	175	1.1393017	0.18154158	0.691844	0.0785934	-2.20001
GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP	C7_ immunologic signatures	179	-1.0605481	0.25157234	0.5156817	GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP	183	-0.93043524	1	0.78280735	-1.99098334	-0.13011286
GSE6259_DEC205_POS_DC_VS_CD8_TCELL_UP	C7_ immunologic signatures	161	-1.0605382	0.26923078	0.5155144	GSE6259_DEC205_POS_DC_VS_CD8_TCELL_UP	162	0.69055074	0.97861505	1	-0.36998746	-1.75108894
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING	c2.CP_REACTOME_ Reactome gene sets	53	-1.0605178	0.32659933	0.51537573	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING	53	1.0584714	0.39527026	0.8272366	-0.0020464	-2.1189892
DARWICHE_SKIN_TUMOR_PROMOTER_UP	c2.CGP_ chemical and genetic perturbations	119	-1.0601441	0.26530612	0.5163304	DARWICHE_SKIN_TUMOR_PROMOTER_UP	119	0.94089407	0.6381443	0.9897139	-0.11925003	-2.00103817
GO_REGULATION_OF_ENDOCYTOSIS	c5.BP_ GO biological process	172	-1.0600628	0.28735632	0.5163718	GO_REGULATION_OF_ENDOCYTOSIS	186	1.0642515	0.34314722	0.81533223	0.0041887	-2.1243143
GO_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_COMPLEX	c5.CC_ GO cellular component	97	-1.0600374	0.3169643	0.5162323	GO_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_COMPLEX	97	0.777185	0.86694825	1	-0.2828524	-1.8372224
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN	C7_ immunologic signatures	172	-1.0597483	0.2635135	0.5169501	GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN	172	0.7975636	0.8844985	1	-0.2621847	-1.8573119
GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	C7_ immunologic signatures	181	-1.0596521	0.24691358	0.51703155	GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	182	0.8251428	0.85222673	1	-0.2345093	-1.8847949
REACTOME_MRNA_3_END_PROCESSING	c2.CP_REACTOME_ Reactome gene sets	32	-1.0595905	0.34662578	0.51701236	REACTOME_MRNA_3_END_PROCESSING	32	-1.867807	0	0.021672599	-2.9273975	0.8082165
GSE360_CTRL_VS_T_GONDII_MAC_DN	C7_ immunologic signatures	178	-1.0595137	0.29655173	0.5170331	GSE360_CTRL_VS_T_GONDII_MAC_DN	179	0.64048254	0.9858443	1	-0.41903116	-1.69999624
GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP	C7_ immunologic signatures	162	-1.0594636	0.25520834	0.51698214	GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP	166	0.88465405	0.7647059	1	-0.17480955	-1.94411765
GO_CRANIAL_NERVE_DEVELOPMENT	c5.BP_ GO biological process	40	-1.0594469	0.3493976	0.51684016	GO_CRANIAL_NERVE_DEVELOPMENT	42	-1.1140378	0.23846154	0.49909064	-2.1734847	0.0545909
GO_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	34	-1.0591635	0.36918604	0.5174964	GO_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION	37	0.97097516	0.5179426	0.9602958	-0.08818834	-2.03013866
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	c2.CGP_ chemical and genetic perturbations	15	-1.0588329	0.36813188	0.5182737	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	16	1.1592368	0.289987	0.65391886	0.1004039	-2.2180697
HELLER_HDAC_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	250	-1.0588287	0.2254902	0.5180811	HELLER_HDAC_TARGETS_DN	259	0.7433156	0.9649299	1	-0.3155131	-1.8021443
KEGG_VEGF_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	68	-1.0587596	0.30932203	0.518103	KEGG_VEGF_SIGNALING_PATHWAY	72	1.4087604	0.022702703	0.32681358	0.3500008	-2.46752
GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP	C7_ immunologic signatures	164	-1.0586883	0.23497267	0.5181216	GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP	178	1.3150493	0.026342452	0.41791943	0.256361	-2.3737376
GO_POSITIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS	c5.BP_ GO biological process	21	-1.0586227	0.3809524	0.5181187	GO_POSITIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS	23	1.190878	0.22195122	0.6041405	0.1322553	-2.2495007
MODULE_172	c4.CM_ cancer modules	81	-1.0583253	0.32954547	0.51886946	MODULE_172	86	1.2903047	0.05982906	0.4572027	0.2319794	-2.34863
GO_APOPTOTIC_CELL_CLEARANCE	c5.BP_ GO biological process	23	-1.0582807	0.35978836	0.5188079	GO_APOPTOTIC_CELL_CLEARANCE	23	0.5522702	0.9708738	1	-0.5060105	-1.6105509
GO_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	36	-1.0582578	0.34441087	0.5186657	GO_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS	36	0.70710444	0.8850967	1	-0.35115336	-1.76536224
GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP	C7_ immunologic signatures	170	-1.0579801	0.3144654	0.5192955	GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP	173	0.990315	0.5303644	0.93544686	-0.0676651	-2.0482951
GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP	C7_ immunologic signatures	178	-1.0579121	0.29299363	0.5192949	GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP	178	-1.2490875	0	0.32419685	-2.3069996	0.1911754
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	C7_ immunologic signatures	137	-1.0577558	0.29239765	0.51956815	GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	139	0.8396897	0.8226804	1	-0.2180661	-1.8974455
LEE_LIVER_CANCER_HEPATOBLAST	c2.CGP_ chemical and genetic perturbations	15	-1.0571121	0.35026738	0.5213284	LEE_LIVER_CANCER_HEPATOBLAST	16	1.3139805	0.12125163	0.41972584	0.2568684	-2.3710926
GO_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION	c5.BP_ GO biological process	145	-1.0570146	0.28176796	0.52141875	GO_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION	150	1.0357065	0.412666	0.8660015	-0.0213081	-2.0927211
GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN	C7_ immunologic signatures	173	-1.0568523	0.27710843	0.52174175	GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN	173	0.9455224	0.617737	0.9866757	-0.1113299	-2.0023747
GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP	C7_ immunologic signatures	173	-1.0566603	0.28671327	0.5221334	GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP	176	0.86104816	0.79878664	1	-0.19561214	-1.91770846
GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN	C7_ immunologic signatures	164	-1.0565137	0.29813665	0.52237165	GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN	169	1.2470946	0.05775076	0.51570153	0.1905809	-2.3036083
GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN	C7_ immunologic signatures	173	-1.0564977	0.2628205	0.5222194	GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN	181	0.9152358	0.7035533	1	-0.1412619	-1.9717335
GSE27786_NKTCELL_VS_ERYTHROBLAST_UP	C7_ immunologic signatures	183	-1.0564755	0.22155689	0.5220859	GSE27786_NKTCELL_VS_ERYTHROBLAST_UP	183	0.7997968	0.878942	1	-0.2566787	-1.8562723
GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP	C7_ immunologic signatures	146	-1.0564537	0.28648648	0.52195174	GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP	152	0.6461657	0.9928789	1	-0.410288	-1.7026194
GO_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE	c5.BP_ GO biological process	55	-1.0562121	0.35074627	0.5224707	GO_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE	61	0.937522	0.6064302	0.9934324	-0.1186901	-1.9937341
GSE11924_TFH_VS_TH2_CD4_TCELL_DN	C7_ immunologic signatures	165	-1.0562086	0.2658228	0.52227545	GSE11924_TFH_VS_TH2_CD4_TCELL_DN	173	-1.0048276	0.44444445	0.6765733	-2.0610362	-0.051381
TOOKER_GEMCITABINE_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	67	-1.0558313	0.31349206	0.52320474	TOOKER_GEMCITABINE_RESISTANCE_UP	69	0.8226291	0.76634514	1	-0.2332022	-1.8784604
GSE15330_HSC_VS_PRO_BCELL_DN	C7_ immunologic signatures	176	-1.0557193	0.27737227	0.5233623	GSE15330_HSC_VS_PRO_BCELL_DN	177	0.60116935	0.9969543	1	-0.45454995	-1.65688865
GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP	C7_ immunologic signatures	174	-1.055387	0.2764706	0.5241887	GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP	174	-1.5272374	0	0.12635174	-2.5826244	0.4718504
GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN	C7_ immunologic signatures	174	-1.0553786	0.2580645	0.5240133	GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN	176	0.7116459	0.9758308	1	-0.3437327	-1.7670245
GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN	C7_ immunologic signatures	183	-1.0550787	0.27564102	0.52472246	GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN	186	0.81158495	0.8857432	1	-0.24349375	-1.86666365
GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN	C7_ immunologic signatures	183	-1.0550632	0.23376623	0.52456456	GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN	185	0.8568948	0.81698686	1	-0.1981684	-1.911958
GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	C7_ immunologic signatures	177	-1.0546914	0.25903615	0.5255307	GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	176	1.1490446	0.19168358	0.67014855	0.0943532	-2.203736
GO_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	185	-1.0546794	0.2994012	0.5253636	GO_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION	198	1.121246	0.20993915	0.72173214	0.0665666	-2.1759254
GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN	C7_ immunologic signatures	171	-1.0546434	0.30821916	0.52527195	GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN	174	0.8496067	0.8206687	1	-0.2050367	-1.9042501
GO_LIPOPOLYSACCHARIDE_BINDING	c5.GO molecular function	16	-1.0543282	0.37700534	0.52601975	GO_LIPOPOLYSACCHARIDE_BINDING	19	0.922417	0.6017588	1	-0.1319112	-1.9767452
GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN	C7_ immunologic signatures	174	-1.054285	0.2872928	0.5259407	GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN	177	1.0724128	0.3275862	0.8026736	0.0181278	-2.1266978
GSE27786_NKTCELL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	173	-1.0541354	0.30864197	0.52619135	GSE27786_NKTCELL_VS_NEUTROPHIL_UP	174	0.5441853	1	1	-0.5099501	-1.5983207
GO_CELLULAR_CARBOHYDRATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	44	-1.0539806	0.33126935	0.52646255	GO_CELLULAR_CARBOHYDRATE_BIOSYNTHETIC_PROCESS	47	0.65668607	0.93792325	1	-0.39729453	-1.71066667
GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP	C7_ immunologic signatures	121	-1.0538673	0.3034826	0.5266031	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP	130	0.84129965	0.8030928	1	-0.21256765	-1.89516695
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	174	-1.053676	0.27672955	0.5269957	GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN	174	-1.1047368	0.13333334	0.5098639	-2.1584128	0.0510608
GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	171	-1.0531691	0.28645834	0.52837247	GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP	179	1.0457629	0.40546006	0.8472766	-0.0074062	-2.098932
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	c2.CP_REACTOME_ Reactome gene sets	425	-1.0530858	0.14285715	0.5284053	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	440	0.91956246	0.772	1	-0.13352334	-1.97264826
GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP	C7_ immunologic signatures	164	-1.053075	0.29268292	0.5282346	GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP	166	0.9838744	0.5547667	0.9428261	-0.0692006	-2.0369494
GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	149	-1.0526998	0.2542373	0.52919585	GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	149	1.0879734	0.30492812	0.77353024	0.0352736	-2.1406732
CHR10Q11	C1: positional gene sets	44	-1.0526373	0.3442623	0.5291913	CHR10Q11	47	1.3695338	0.064659975	0.36839768	0.3168965	-2.4221711
GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_UP	C7_ immunologic signatures	179	-1.0526052	0.25714287	0.52909243	GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_UP	182	0.803004	0.8810484	1	-0.2496012	-1.8556092
GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	176	-1.0524964	0.26	0.5292349	GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN	179	0.9211012	0.6837865	1	-0.1313952	-1.9735976
GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN	C7_ immunologic signatures	168	-1.0521673	0.26875	0.5300812	GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN	172	0.96024597	0.6107724	0.97142816	-0.09192133	-2.01241327
ROESSLER_LIVER_CANCER_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	98	-1.0521221	0.31304348	0.5300193	ROESSLER_LIVER_CANCER_METASTASIS_UP	97	1.0393512	0.41588297	0.8589043	-0.0127709	-2.0914733
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP	c2.CGP_ chemical and genetic perturbations	77	-1.0514852	0.34854773	0.53173566	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP	81	0.87647396	0.719113	1	-0.17501124	-1.92795916
GO_METHYLATION	c5.BP_ GO biological process	217	-1.0513182	0.27941176	0.53204125	GO_METHYLATION	227	0.9946339	0.52573156	0.9305041	-0.0566843	-2.0459521
GO_SPECTRIN_BINDING	c5.GO molecular function	21	-1.0512688	0.35422343	0.53198713	GO_SPECTRIN_BINDING	23	1.2025026	0.22822087	0.58800066	0.1512338	-2.2537714
GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN	C7_ immunologic signatures	182	-1.0512632	0.25531915	0.5318051	GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN	183	0.85672337	0.8006042	1	-0.19453983	-1.90798657
GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_DN	C7_ immunologic signatures	178	-1.0508673	0.2585034	0.5328406	GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_DN	179	0.78235376	0.8964467	1	-0.26851354	-1.83322106
GSE31622_WT_VS_KLF3_KO_BCELL_DN	C7_ immunologic signatures	178	-1.0506669	0.23239437	0.53327155	GSE31622_WT_VS_KLF3_KO_BCELL_DN	183	1.045335	0.38781726	0.8485167	-0.0053319	-2.0960019
GO_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING	c5.BP_ GO biological process	48	-1.0506424	0.34385964	0.53314394	GO_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING	48	0.78840524	0.79909706	1	-0.26223716	-1.83904764
SEKI_INFLAMMATORY_RESPONSE_LPS_UP	c2.CGP_ chemical and genetic perturbations	67	-1.0505602	0.31135532	0.53318393	SEKI_INFLAMMATORY_RESPONSE_LPS_UP	66	1.4015574	0.023001095	0.3377623	0.3509972	-2.4521176
GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP	C7_ immunologic signatures	151	-1.0504386	0.26900584	0.53335124	GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP	162	1.0758139	0.32786885	0.7948669	0.0253753	-2.1262525
GO_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	38	-1.050417	0.38157895	0.53321046	GO_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS	38	-1.3311309	0.05479452	0.25508657	-2.3815479	0.2807139
E47_02	c3.TFT_ transcription factor targets	207	-1.0503753	0.29078013	0.5331334	E47_02	213	1.1160688	0.2145749	0.7292187	0.0656935	-2.1664441
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	c2.CGP_ chemical and genetic perturbations	38	-1.0503743	0.31309903	0.53293216	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	37	1.3470191	0.0863061	0.38586313	0.2966448	-2.3973934
GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	134	-1.049987	0.28140703	0.5339016	GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	138	1.4942873	0.003061225	0.25722566	0.4443003	-2.5442743
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	c2.CGP_ chemical and genetic perturbations	41	-1.049767	0.36335403	0.5343884	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	45	0.8545263	0.6982857	1	-0.1952407	-1.9042933
GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	C7_ immunologic signatures	171	-1.0496988	0.3043478	0.5344065	GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	173	-1.0898266	0.09090909	0.53451496	-2.1395254	0.0401278
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	c2.CGP_ chemical and genetic perturbations	92	-1.0496516	0.32751092	0.53436655	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	93	-0.92109287	0.6551724	0.7937295	-1.97074447	-0.12855873
GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN	C7_ immunologic signatures	132	-1.0495186	0.33862433	0.53458256	GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN	137	1.1888106	0.13800205	0.60711735	0.139292	-2.2383292
GO_LEFT_RIGHT_PATTERN_FORMATION	c5.BP_ GO biological process	20	-1.049479	0.34408602	0.5345027	GO_LEFT_RIGHT_PATTERN_FORMATION	20	0.9143037	0.61398965	1	-0.1351753	-1.9637827
WNT_SIGNALING	c2.CP_ Canonical pathways	81	-1.0494094	0.3503937	0.53451544	WNT_SIGNALING	86	-1.0089349	0.41379312	0.6745796	-2.0583443	-0.0404745
GSE7509_DC_VS_MONOCYTE_UP	C7_ immunologic signatures	178	-1.0493113	0.28025478	0.5346122	GSE7509_DC_VS_MONOCYTE_UP	181	0.6875611	0.97573304	1	-0.3617502	-1.7368724
GNF2_ANK1	c4.CGN_ cancer gene neighborhoods	62	-1.0486948	0.3501805	0.5362927	GNF2_ANK1	67	0.75320375	0.87003225	1	-0.29549105	-1.80189855
GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN	C7_ immunologic signatures	168	-1.0484675	0.2875	0.5367816	GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN	169	0.8276061	0.85439837	1	-0.2208614	-1.8760736
PID_ANTHRAX_PATHWAY	c2.CP_ Canonical pathways	15	-1.0484412	0.4005168	0.53666127	PID_ANTHRAX_PATHWAY	15	-1.1125915	0.30882353	0.50209683	-2.1610327	0.0641503
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP	C7_ immunologic signatures	161	-1.0482955	0.31410256	0.5368866	GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP	159	1.2130642	0.111561865	0.5723806	0.1647687	-2.2613597
BIOCARTA_INFLAM_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	23	-1.0481753	0.37536657	0.53706646	BIOCARTA_INFLAM_PATHWAY	21	0.9950484	0.49675745	0.9301651	-0.0531269	-2.0432237
GSE27786_LSK_VS_ERYTHROBLAST_UP	C7_ immunologic signatures	181	-1.0479983	0.25862068	0.53741145	GSE27786_LSK_VS_ERYTHROBLAST_UP	181	0.8338351	0.8552632	1	-0.2141632	-1.8818334
GO_GENITALIA_DEVELOPMENT	c5.BP_ GO biological process	39	-1.0479498	0.36253777	0.537358	GO_GENITALIA_DEVELOPMENT	42	0.9556115	0.5727811	0.9758881	-0.0923383	-2.0035613
GO_PHOTORECEPTOR_OUTER_SEGMENT	c5.CC_ GO cellular component	63	-1.0476962	0.3458904	0.5379497	GO_PHOTORECEPTOR_OUTER_SEGMENT	60	0.9483484	0.5928009	0.9838287	-0.0993478	-1.9960446
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	c2.CP_BIOCARTA_ BioCarta gene sets	50	-1.0470015	0.35273972	0.5399538	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	60	0.9263313	0.62431544	1	-0.1206702	-1.9733328
BOYLAN_MULTIPLE_MYELOMA_D_DN	c2.CGP_ chemical and genetic perturbations	68	-1.0469977	0.3490909	0.5397605	BOYLAN_MULTIPLE_MYELOMA_D_DN	68	1.0866704	0.33907428	0.7754143	0.0396727	-2.1336681
GO_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT	c5.BP_ GO biological process	23	-1.046978	0.38348082	0.5396214	GO_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT	25	-1.0788531	0.3548387	0.55316067	-2.1258311	0.0318751
GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	C7_ immunologic signatures	164	-1.0467817	0.2962963	0.54005426	GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	171	0.839656	0.8504578	1	-0.2071257	-1.8864377
GO_REGULATION_OF_INTERLEUKIN_4_PRODUCTION	c5.BP_ GO biological process	22	-1.046453	0.37931034	0.54090494	GO_REGULATION_OF_INTERLEUKIN_4_PRODUCTION	25	1.404996	0.05897114	0.33299795	0.358543	-2.451449
GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP	C7_ immunologic signatures	166	-1.0464321	0.30821916	0.5407591	GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP	172	1.0920081	0.28397566	0.7692467	0.045576	-2.1384402
GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN	C7_ immunologic signatures	174	-1.0460007	0.30322582	0.54190385	GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN	177	0.57977194	0.9979592	1	-0.46622876	-1.62577264
GO_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION	c5.BP_ GO biological process	40	-1.045971	0.38062283	0.54179525	GO_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION	43	1.1021456	0.3402778	0.753494	0.0561746	-2.1481166
GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP	C7_ immunologic signatures	178	-1.045852	0.34	0.5419575	GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP	184	1.0944732	0.28254288	0.7661457	0.0486212	-2.1403252
GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP	C7_ immunologic signatures	177	-1.0454488	0.26	0.54303956	GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP	184	1.0771738	0.31813577	0.79321635	0.031725	-2.1226226
ZWANG_EGF_PERSISTENTLY_UP	c2.CGP_ chemical and genetic perturbations	29	-1.0448021	0.3700565	0.5448564	ZWANG_EGF_PERSISTENTLY_UP	30	0.8943772	0.6229117	1	-0.1504249	-1.9391793
GO_SMOOTHENED_SIGNALING_PATHWAY	c5.BP_ GO biological process	65	-1.0447011	0.33606556	0.54494804	GO_SMOOTHENED_SIGNALING_PATHWAY	68	1.0665282	0.38658148	0.8116858	0.0218271	-2.1112293
GATA2_01	c3.TFT_ transcription factor targets	95	-1.0446551	0.31779662	0.54488903	GATA2_01	97	1.0059092	0.49683544	0.91410184	-0.0387459	-2.0505643
KEGG_O_GLYCAN_BIOSYNTHESIS	c2.CP_BIOCARTA_ BioCarta gene sets	23	-1.044598	0.36797753	0.5448512	KEGG_O_GLYCAN_BIOSYNTHESIS	24	1.3539697	0.0931677	0.38267216	0.3093717	-2.3985677
GO_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY	c5.GO molecular function	17	-1.0445547	0.38659793	0.54479426	GO_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY	17	1.1097535	0.34675324	0.7385259	0.0651988	-2.1543082
LANDIS_ERBB2_BREAST_TUMORS_324_UP	c2.CGP_ chemical and genetic perturbations	135	-1.0444779	0.3137255	0.54482013	LANDIS_ERBB2_BREAST_TUMORS_324_UP	135	0.7910551	0.88362515	1	-0.2534228	-1.835533
GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN	C7_ immunologic signatures	179	-1.0441444	0.2536232	0.54564524	GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN	179	0.5347026	1	1	-0.5094418	-1.578847
GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN	C7_ immunologic signatures	172	-1.0440869	0.32098764	0.5456268	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN	172	1.3161587	0.014098691	0.4165145	0.2720718	-2.3602456
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	63	-1.0440588	0.38345864	0.5455051	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	63	1.0484675	0.41984734	0.84277993	0.0044087	-2.0925263
GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP	C7_ immunologic signatures	176	-1.0439212	0.29411766	0.5457379	GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP	176	1.0236579	0.4390244	0.88566417	-0.0202633	-2.0675791
GSE17721_CTRL_VS_POLYIC_6H_BMDC_UP	C7_ immunologic signatures	167	-1.0438536	0.33333334	0.5457399	GSE17721_CTRL_VS_POLYIC_6H_BMDC_UP	170	0.7062699	0.97357726	1	-0.3375837	-1.7501235
GO_NUCLEOBASE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	-1.0437963	0.38663486	0.545727	GO_NUCLEOBASE_BIOSYNTHETIC_PROCESS	16	-1.1612953	0.24107143	0.42826784	-2.2050916	0.117499
GO_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS	c5.BP_ GO biological process	410	-1.0434762	0.26153848	0.54652816	GO_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS	437	1.0983298	0.167	0.75873923	0.0548536	-2.141806
DASU_IL6_SIGNALING_UP	c2.CGP_ chemical and genetic perturbations	51	-1.0432982	0.3689655	0.5468606	DASU_IL6_SIGNALING_UP	51	0.84201056	0.7458194	1	-0.20128764	-1.88530876
GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP	C7_ immunologic signatures	179	-1.0431654	0.28289473	0.5470953	GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP	179	0.69749784	0.9806911	1	-0.34566756	-1.74066324
GO_BLASTOCYST_FORMATION	c5.BP_ GO biological process	26	-1.0430356	0.39660057	0.5472942	GO_BLASTOCYST_FORMATION	29	-0.71706814	0.9251337	0.95227635	-1.76010374	-0.32596746
GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP	C7_ immunologic signatures	179	-1.0428661	0.30379745	0.547642	GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP	180	0.8975658	0.74040407	1	-0.1453003	-1.9404319
GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN	C7_ immunologic signatures	183	-1.0427773	0.2820513	0.54770666	GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN	179	0.7973242	0.89564335	1	-0.2454531	-1.8401015
HNF4_01_B	c3.TFT_ transcription factor targets	214	-1.0424727	0.25384617	0.548423	HNF4_01_B	226	0.8864258	0.7794562	1	-0.1560469	-1.9288985
GNF2_SPTB	c4.CGN_ cancer gene neighborhoods	62	-1.0424522	0.3774319	0.5482834	GNF2_SPTB	67	0.7585122	0.86056644	1	-0.28394	-1.8009644
CHANG_CORE_SERUM_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	188	-1.042292	0.30201343	0.54857546	CHANG_CORE_SERUM_RESPONSE_UP	187	-1.7477574	0	0.04442731	-2.7900494	0.7054654
GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN	C7_ immunologic signatures	183	-1.0422902	0.2866242	0.54837394	GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN	184	1.1122204	0.24193548	0.7341939	0.0699302	-2.1545106
KCCGNSWTTT_UNKNOWN	c3.TFT_ transcription factor targets	90	-1.0420868	0.34686348	0.548802	KCCGNSWTTT_UNKNOWN	94	-0.8529703	0.90909094	0.86414176	-1.8950571	-0.1891165
KYNG_DNA_DAMAGE_BY_4NQO	c2.CGP_ chemical and genetic perturbations	35	-1.0419863	0.37058824	0.5489166	KYNG_DNA_DAMAGE_BY_4NQO	34	0.6055434	0.96483004	1	-0.4364429	-1.6475297
GO_VITAMIN_TRANSPORT	c5.BP_ GO biological process	24	-1.0417736	0.38873994	0.5493774	GO_VITAMIN_TRANSPORT	26	1.3403213	0.097530864	0.396288	0.2985477	-2.3820949
PPARG_01	c3.TFT_ transcription factor targets	41	-1.0414815	0.3533123	0.5500976	PPARG_01	43	-1.073258	0.33103448	0.56415117	-2.1147395	0.0317765
EPPERT_HSC_R	c2.CGP_ chemical and genetic perturbations	102	-1.0410967	0.35238096	0.5511227	EPPERT_HSC_R	103	0.99061877	0.5110643	0.9349762	-0.05047793	-2.03171547
GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	173	-1.0410632	0.26973686	0.55101997	GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP	172	0.98529065	0.54387754	0.941562	-0.05577255	-2.02635385
ZAMORA_NOS2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	65	-1.0409961	0.3292683	0.5510274	ZAMORA_NOS2_TARGETS_UP	66	-1.5627911	0	0.10826352	-2.6037872	0.521795
GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP	C7_ immunologic signatures	171	-1.0407275	0.29447854	0.55168074	GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP	177	1.0713613	0.3336714	0.8030092	0.0306338	-2.1120888
SANSOM_APC_MYC_TARGETS	c2.CGP_ chemical and genetic perturbations	191	-1.0407107	0.31578946	0.5515173	SANSOM_APC_MYC_TARGETS	194	0.73188066	0.9634518	1	-0.30883004	-1.77259136
GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	C7_ immunologic signatures	172	-1.0407001	0.33116883	0.5513414	GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	176	0.8712324	0.80040735	1	-0.1694677	-1.9119325
GO_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS	c5.BP_ GO biological process	210	-1.0406977	0.30597016	0.5511398	GO_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS	213	-1.1444553	0	0.4503184	-2.185153	0.1037576
HOELZEL_NF1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	117	-1.0406595	0.35025382	0.5510606	HOELZEL_NF1_TARGETS_UP	124	1.3209015	0.03215768	0.41160083	0.280242	-2.361561
GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN	C7_ immunologic signatures	174	-1.0405762	0.30635837	0.55113196	GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN	180	1.1445048	0.1949495	0.6808745	0.1039286	-2.185081
BILD_SRC_ONCOGENIC_SIGNATURE	c2.CGP_ chemical and genetic perturbations	55	-1.0405134	0.330855	0.5511038	BILD_SRC_ONCOGENIC_SIGNATURE	55	0.94580334	0.58434397	0.9864314	-0.09471006	-1.98631674
GSE36826_WT_VS_IL1R_KO_SKIN_DN	C7_ immunologic signatures	171	-1.0404843	0.33766234	0.5509813	GSE36826_WT_VS_IL1R_KO_SKIN_DN	170	-0.9721481	0.5714286	0.7248135	-2.0126324	-0.0683362
GSE3982_NEUTROPHIL_VS_NKCELL_DN	C7_ immunologic signatures	170	-1.0403595	0.3586207	0.55115646	GSE3982_NEUTROPHIL_VS_NKCELL_DN	171	0.93514055	0.64581233	0.99506164	-0.10521895	-1.97550005
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP	C7_ immunologic signatures	174	-1.040349	0.34591195	0.55097914	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP	176	0.9134023	0.7023209	1	-0.1269467	-1.9537513
GO_RETROMER_COMPLEX	c5.CC_ GO cellular component	19	-1.0400226	0.38157895	0.5518187	GO_RETROMER_COMPLEX	19	-1.1173636	0.28865978	0.49322367	-2.1573862	0.077341
GO_CHAPERONE_BINDING	c5.GO molecular function	75	-1.0399947	0.37916666	0.5516955	GO_CHAPERONE_BINDING	74	0.76698554	0.8609342	1	-0.27300916	-1.80698024
MODULE_399	c4.CM_ cancer modules	44	-1.039682	0.39403972	0.55250967	MODULE_399	46	1.2402967	0.14496036	0.52588445	0.2006147	-2.2799787
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	c2.CGP_ chemical and genetic perturbations	26	-1.0396153	0.3915493	0.5525069	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	26	1.1054064	0.3440594	0.74626434	0.0657911	-2.1450217
GNF2_HPN	c4.CGN_ cancer gene neighborhoods	103	-1.039566	0.33777776	0.55245924	GNF2_HPN	114	1.1261625	0.23277661	0.7122616	0.0865965	-2.1657285
TGANNYRGCA_TCF11MAFG_01	c3.TFT_ transcription factor targets	260	-1.0395103	0.24761905	0.5524366	TGANNYRGCA_TCF11MAFG_01	262	1.055577	0.34138972	0.8321455	0.0160667	-2.0950873
HALLMARK_COMPLEMENT	H_ hallmark gene sets	171	-1.0393896	0.2885906	0.5526223	HALLMARK_COMPLEMENT	169	1.2683523	0.03248731	0.48653087	0.2289627	-2.3077419
GSE11924_TH2_VS_TH17_CD4_TCELL_DN	C7_ immunologic signatures	179	-1.0392207	0.2962963	0.552948	GSE11924_TH2_VS_TH17_CD4_TCELL_DN	182	0.65407187	0.98677516	1	-0.38514883	-1.69329257
GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP	C7_ immunologic signatures	156	-1.0391911	0.32777777	0.552832	GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP	160	1.0197111	0.45296523	0.89155656	-0.01948	-2.0589022
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	C7_ immunologic signatures	170	-1.0391744	0.32885906	0.55267495	GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	174	-0.7410811	1	0.94035184	-1.7802555	-0.2980933
GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP	C7_ immunologic signatures	170	-1.039141	0.2925532	0.5525753	GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP	175	0.9422033	0.63461536	0.9889393	-0.0969377	-1.9813443
GGCNRNWCTTYS_UNKNOWN	c3.TFT_ transcription factor targets	72	-1.0391258	0.35135135	0.5524226	GGCNRNWCTTYS_UNKNOWN	73	0.56120306	0.9934924	1	-0.47792274	-1.60032886
GO_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY	c5.BP_ GO biological process	16	-1.0391151	0.38274932	0.55225337	GO_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY	16	1.008095	0.46944082	0.91112727	-0.0310201	-2.0472101
JIANG_HYPOXIA_NORMAL	c2.CGP_ chemical and genetic perturbations	282	-1.0390933	0.33035713	0.55211836	JIANG_HYPOXIA_NORMAL	286	0.6647826	0.994	1	-0.3743107	-1.7038759
SENESE_HDAC2_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	99	-1.0390652	0.38423645	0.55199605	SENESE_HDAC2_TARGETS_UP	100	-1.4338343	0	0.18395542	-2.4728995	0.3947691
KEGG_VIBRIO_CHOLERAE_INFECTION	c2.CP_BIOCARTA_ BioCarta gene sets	49	-1.0388874	0.3618421	0.5523636	KEGG_VIBRIO_CHOLERAE_INFECTION	51	0.94760823	0.5848214	0.9845397	-0.09127917	-1.98649563
REACTOME_L1CAM_INTERACTIONS	c2.CP_REACTOME_ Reactome gene sets	80	-1.0387573	0.33472803	0.55257446	REACTOME_L1CAM_INTERACTIONS	79	0.9659516	0.5567452	0.9646862	-0.0728057	-2.0047089
GO_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE	c5.BP_ GO biological process	435	-1.0387286	0.27868852	0.5524507	GO_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE	465	1.1038398	0.151	0.75015795	0.0651112	-2.1425684
GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN	C7_ immunologic signatures	167	-1.0386399	0.33766234	0.55250627	GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN	170	0.8145183	0.8819939	1	-0.2241216	-1.8531582
TAVOR_CEBPA_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	24	-1.0386233	0.37297297	0.5523524	TAVOR_CEBPA_TARGETS_DN	26	0.8769086	0.6642686	1	-0.1617147	-1.9155319
HWANG_PROSTATE_CANCER_MARKERS	c2.CGP_ chemical and genetic perturbations	23	-1.0385364	0.37931034	0.55241024	HWANG_PROSTATE_CANCER_MARKERS	26	-1.3344916	0.10404624	0.2517486	-2.373028	0.2959552
GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN	C7_ immunologic signatures	175	-1.0381408	0.3	0.5534964	GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN	177	0.8932836	0.7446808	1	-0.1448572	-1.9314244
GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_UP	C7_ immunologic signatures	164	-1.0381337	0.32142857	0.55331427	GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_UP	164	0.8177054	0.86815417	1	-0.2204283	-1.8558391
GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP	C7_ immunologic signatures	173	-1.0379581	0.3576159	0.553671	GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP	183	0.9465303	0.64004046	0.9856701	-0.0914278	-1.9844884
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	c2.CGP_ chemical and genetic perturbations	17	-1.0379561	0.40054497	0.55347383	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18	1.2425351	0.18782383	0.52175844	0.204579	-2.2804912
GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP	C7_ immunologic signatures	168	-1.037867	0.33125	0.5535449	GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP	172	0.73241156	0.9455645	1	-0.30545544	-1.77027856
GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN	C7_ immunologic signatures	174	-1.037766	0.3197279	0.55365855	GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN	171	1.14543	0.18864097	0.67801225	0.107664	-2.183196
GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN	C7_ immunologic signatures	180	-1.0375975	0.36129034	0.5539979	GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN	181	0.7386972	0.9591837	1	-0.2989003	-1.7762947
REACTOME_LYSOSOME_VESICLE_BIOGENESIS	c2.CP_REACTOME_ Reactome gene sets	21	-1.0372721	0.3640898	0.55483764	REACTOME_LYSOSOME_VESICLE_BIOGENESIS	21	1.2412215	0.18271606	0.52383816	0.2039494	-2.2784936
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	c2.CGP_ chemical and genetic perturbations	71	-1.0372624	0.36842105	0.55466115	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	73	-0.91966605	0.6666667	0.7958206	-1.95692845	-0.11759635
GO_LEUKOCYTE_DEGRANULATION	c5.BP_ GO biological process	26	-1.0372486	0.37393767	0.5545026	GO_LEUKOCYTE_DEGRANULATION	27	1.4629437	0.03101737	0.28213403	0.4256951	-2.5001923
GO_CILIARY_TRANSITION_ZONE	c5.CC_ GO cellular component	22	-1.0368353	0.3989071	0.555633	GO_CILIARY_TRANSITION_ZONE	22	0.8221472	0.7029703	1	-0.2146881	-1.8589825
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP	C7_ immunologic signatures	178	-1.036615	0.35714287	0.5561283	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP	178	0.55767494	0.99898374	1	-0.47894006	-1.59428994
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN	C7_ immunologic signatures	158	-1.0365282	0.33333334	0.556206	GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN	162	0.6153192	0.993921	1	-0.421209	-1.6518474
GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	153	-1.036334	0.33136094	0.5565984	GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN	158	0.88068527	0.7619532	1	-0.15564873	-1.91701927
GO_PROTEIN_HOMOTETRAMERIZATION	c5.BP_ GO biological process	55	-1.0363183	0.35333332	0.5564439	GO_PROTEIN_HOMOTETRAMERIZATION	57	1.129169	0.27403316	0.70754105	0.0928507	-2.1654873
GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_UP	C7_ immunologic signatures	138	-1.0362867	0.33505154	0.5563463	GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_UP	143	0.9986739	0.49176955	0.9251653	-0.0376128	-2.0349606
GO_MEMBRANE_PROTEIN_PROTEOLYSIS	c5.BP_ GO biological process	33	-1.0362189	0.39879155	0.5563677	GO_MEMBRANE_PROTEIN_PROTEOLYSIS	33	1.0512613	0.41346154	0.8375188	0.0150424	-2.0874802
GNF2_IL2RB	c4.CGN_ cancer gene neighborhoods	24	-1.0362022	0.38764045	0.55621785	GNF2_IL2RB	32	0.8477729	0.7110312	1	-0.1884293	-1.8839751
GSE29618_BCELL_VS_MONOCYTE_UP	C7_ immunologic signatures	147	-1.0360816	0.31764707	0.556395	GSE29618_BCELL_VS_MONOCYTE_UP	154	0.7144101	0.96443087	1	-0.3216715	-1.7504917
GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP	C7_ immunologic signatures	165	-1.0356091	0.30405405	0.5576701	GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP	166	1.0524422	0.37195122	0.83682746	0.0168331	-2.0880513
GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN	C7_ immunologic signatures	168	-1.0354397	0.35031846	0.5579764	GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN	180	1.2041062	0.08924949	0.584077	0.1686665	-2.2395459
GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	176	-1.0353583	0.32608697	0.55803245	GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	178	1.0508227	0.38375634	0.83836824	0.0154644	-2.086181
GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN	C7_ immunologic signatures	148	-1.034931	0.36956522	0.55918616	GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN	149	0.6504148	0.9918033	1	-0.3845162	-1.6853458
GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP	C7_ immunologic signatures	174	-1.0346609	0.31333333	0.55981976	GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP	178	0.80880016	0.88169867	1	-0.22586074	-1.84346106
GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	C7_ immunologic signatures	177	-1.0346386	0.33333334	0.55967534	GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	184	1.1250284	0.21818182	0.7150924	0.0903898	-2.159667
GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN	C7_ immunologic signatures	184	-1.0345753	0.32	0.5596792	GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN	183	-1.9283829	0	0.014721758	-2.9629582	0.8938076
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	179	-1.0345142	0.32608697	0.5596707	GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	181	1.058054	0.35015136	0.827569	0.0235398	-2.0925682
GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_DN	C7_ immunologic signatures	155	-1.0344033	0.37430167	0.55980057	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_DN	155	0.67548865	0.9716312	1	-0.35891465	-1.70989195
ETS2_B	c3.TFT_ transcription factor targets	249	-1.0341809	0.27192983	0.56032205	ETS2_B	257	1.1390606	0.1544634	0.6912864	0.1048797	-2.1732415
GSE34006_WT_VS_A2AR_KO_TREG_UP	C7_ immunologic signatures	175	-1.0340703	0.33529413	0.5604711	GSE34006_WT_VS_A2AR_KO_TREG_UP	184	1.10529	0.2616633	0.7460071	0.0712197	-2.1393603
GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	163	-1.0337609	0.32484075	0.5612606	GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP	165	0.71268785	0.95841783	1	-0.32107305	-1.74644875
GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN	C7_ immunologic signatures	171	-1.0336599	0.34146342	0.56138736	GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN	172	-0.72967416	1	0.9476879	-1.76333406	-0.30398574
GO_PHOTORECEPTOR_DISC_MEMBRANE	c5.CC_ GO cellular component	15	-1.0334997	0.42092457	0.561699	GO_PHOTORECEPTOR_DISC_MEMBRANE	15	1.0787874	0.380829	0.7896578	0.0452877	-2.1122871
GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP	C7_ immunologic signatures	173	-1.0334617	0.37012988	0.56162786	GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP	176	0.8398731	0.84879035	1	-0.1935886	-1.8733348
REACTOME_IRON_UPTAKE_AND_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	34	-1.033444	0.3580247	0.56147295	REACTOME_IRON_UPTAKE_AND_TRANSPORT	35	0.9309268	0.5891204	0.99823946	-0.1025172	-1.9643708
CHR5Q32	C1: positional gene sets	24	-1.0333971	0.38297874	0.5614288	CHR5Q32	25	0.7522702	0.80240965	1	-0.2811269	-1.7856673
PID_RHODOPSIN_PATHWAY	c2.CP_ Canonical pathways	23	-1.0333542	0.38069704	0.5613712	PID_RHODOPSIN_PATHWAY	23	0.92306584	0.5964912	1	-0.11028836	-1.95642004
GO_PROTEASOME_BINDING	c5.GO molecular function	16	-1.0333195	0.41361257	0.5612792	GO_PROTEASOME_BINDING	15	-0.64544386	0.9352227	0.9769197	-1.67876336	-0.38787564
GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	185	-1.0332918	0.33116883	0.5611608	GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	184	-0.8452555	0.8181818	0.872057	-1.8785473	-0.1880363
GO_REGULATION_OF_NECROTIC_CELL_DEATH	c5.BP_ GO biological process	21	-1.033172	0.3853211	0.5613183	GO_REGULATION_OF_NECROTIC_CELL_DEATH	23	0.8924784	0.62907267	1	-0.1406936	-1.9256504
GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN	C7_ immunologic signatures	172	-1.0330781	0.29310346	0.5614319	GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN	175	0.6476592	0.9909183	1	-0.3854189	-1.6807373
MODULE_349	c4.CM_ cancer modules	17	-1.033027	0.37467018	0.5613889	MODULE_349	17	0.9125226	0.60210806	1	-0.1205044	-1.9455496
HALLMARK_ESTROGEN_RESPONSE_LATE	H_ hallmark gene sets	181	-1.0330265	0.37762237	0.5611851	HALLMARK_ESTROGEN_RESPONSE_LATE	189	1.1499238	0.15080972	0.6701537	0.1168973	-2.1829503
GO_ZINC_II_ION_TRANSPORT	c5.BP_ GO biological process	25	-1.0329885	0.37254903	0.56110156	GO_ZINC_II_ION_TRANSPORT	26	0.5006431	0.9886364	1	-0.5323454	-1.5336316
GO_CELLULAR_AMINO_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	80	-1.032988	0.38392857	0.5608994	GO_CELLULAR_AMINO_ACID_BIOSYNTHETIC_PROCESS	86	-1.1525685	0.14754099	0.43955177	-2.1855565	0.1195805
GO_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	18	-1.0329652	0.40208876	0.5607702	GO_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORT	18	0.80026037	0.7544987	1	-0.23270483	-1.83322557
GO_HEME_METABOLIC_PROCESS	c5.BP_ GO biological process	26	-1.0327066	0.40615386	0.5614236	GO_HEME_METABOLIC_PROCESS	27	0.45543867	0.9975031	1	-0.57726793	-1.48814527
GO_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA	c5.BP_ GO biological process	26	-1.032671	0.3809524	0.5613203	GO_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA	26	0.9991549	0.5006227	0.92471707	-0.0335161	-2.0318259
GSE360_CTRL_VS_L_DONOVANI_DC_DN	C7_ immunologic signatures	173	-1.0324644	0.31012657	0.56176156	GSE360_CTRL_VS_L_DONOVANI_DC_DN	177	1.3293456	0.014098691	0.40302098	0.2968812	-2.36181
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN	C7_ immunologic signatures	150	-1.0324208	0.32608697	0.5616863	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN	164	1.3214164	0.022199798	0.410979	0.2889956	-2.3538372
GO_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION	c5.BP_ GO biological process	83	-1.032399	0.37860084	0.5615617	GO_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION	88	1.1099957	0.28783068	0.73772526	0.0775967	-2.1423947
KEGG_INOSITOL_PHOSPHATE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	51	-1.0323864	0.36397058	0.5613965	KEGG_INOSITOL_PHOSPHATE_METABOLISM	53	1.2705247	0.124860644	0.48372716	0.2381383	-2.3029111
MORF_MYL3	c4.CGN_ cancer gene neighborhoods	51	-1.032281	0.34265736	0.56153744	MORF_MYL3	57	1.3585274	0.050941307	0.37795168	0.3262464	-2.3908084
CHANGOLKAR_H2AFY_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	40	-1.0321593	0.3768546	0.5617185	CHANGOLKAR_H2AFY_TARGETS_UP	40	0.8252727	0.756213	1	-0.2068866	-1.857432
GSE17721_POLYIC_VS_CPG_1H_BMDC_UP	C7_ immunologic signatures	179	-1.0320935	0.33333334	0.56173503	GSE17721_POLYIC_VS_CPG_1H_BMDC_UP	180	-1.1518544	0.11111111	0.43997794	-2.1839479	0.1197609
GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION	c5.BP_ GO biological process	37	-1.0315912	0.38943896	0.5631259	GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION	37	-1.3163115	0.083333336	0.27003518	-2.3479027	0.2847203
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	181	-1.0313449	0.3137255	0.56373626	GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	180	1.0801296	0.3208502	0.7867611	0.0487847	-2.1114745
GO_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES	c5.GO molecular function	26	-1.0312757	0.4065282	0.563763	GO_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES	26	-0.8240957	0.8057143	0.88631785	-1.8553714	-0.20718
REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	c2.CP_REACTOME_ Reactome gene sets	18	-1.0312663	0.4250681	0.5635877	REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	18	0.96561843	0.54093957	0.96518105	-0.06564787	-1.99688473
ZHAN_V2_LATE_DIFFERENTIATION_GENES	c2.CGP_ chemical and genetic perturbations	40	-1.03105	0.36807817	0.56409883	ZHAN_V2_LATE_DIFFERENTIATION_GENES	42	1.127233	0.29646522	0.7108668	0.096183	-2.158283
REACTOME_METABOLISM_OF_CARBOHYDRATES	c2.CP_REACTOME_ Reactome gene sets	209	-1.0310011	0.30215827	0.5640359	REACTOME_METABOLISM_OF_CARBOHYDRATES	215	1.0037277	0.5015075	0.91732395	-0.0272734	-2.0347288
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN	C7_ immunologic signatures	173	-1.0309411	0.39130434	0.56402224	GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN	177	1.0298072	0.42206478	0.87579507	-0.0011339	-2.0607483
GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN	C7_ immunologic signatures	174	-1.0306131	0.32	0.56489885	GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN	180	0.9720909	0.5637105	0.95933783	-0.0585222	-2.002704
FERNANDEZ_BOUND_BY_MYC	c2.CGP_ chemical and genetic perturbations	160	-1.0305871	0.30864197	0.56476486	FERNANDEZ_BOUND_BY_MYC	164	-1.2005723	0.083333336	0.38107857	-2.2311594	0.1699852
GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP	C7_ immunologic signatures	171	-1.0305842	0.33333334	0.5645698	GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP	177	1.0118682	0.47623864	0.90415734	-0.018716	-2.0424524
GO_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	39	-1.0305728	0.4114114	0.5643973	GO_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS	40	0.906249	0.62643677	1	-0.1243238	-1.9368218
MARSON_FOXP3_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	45	-1.0304487	0.40327868	0.564612	MARSON_FOXP3_TARGETS_DN	48	0.64906394	0.9588101	1	-0.38138476	-1.67951264
GO_REGULATION_OF_KIDNEY_DEVELOPMENT	c5.BP_ GO biological process	49	-1.0302151	0.38181818	0.565188	GO_REGULATION_OF_KIDNEY_DEVELOPMENT	53	-1.4141053	0.01754386	0.19660416	-2.4443204	0.3838902
GO_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION	c5.BP_ GO biological process	58	-1.030121	0.38628158	0.5652817	GO_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION	58	-1.9815034	0	0.009688471	-3.0116244	0.9513824
TGACCTTG_SF1_Q6	c3.TFT_ transcription factor targets	217	-1.0300223	0.3432836	0.56538236	TGACCTTG_SF1_Q6	222	0.8403499	0.8535607	1	-0.1896724	-1.8703722
KEGG_TRYPTOPHAN_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	37	-1.0298061	0.38681948	0.5658994	KEGG_TRYPTOPHAN_METABOLISM	37	0.9203457	0.6	1	-0.1094604	-1.9501518
GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN	C7_ immunologic signatures	175	-1.0297599	0.3409091	0.5658492	GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN	177	1.1085396	0.2479757	0.74050856	0.0787797	-2.1382995
GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	C7_ immunologic signatures	181	-1.0297209	0.31428573	0.56577474	GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	180	-1.0221868	0.375	0.6557745	-2.0519077	-0.0075341
GO_UDP_GLYCOSYLTRANSFERASE_ACTIVITY	c5.GO molecular function	109	-1.0296531	0.3744076	0.56580156	GO_UDP_GLYCOSYLTRANSFERASE_ACTIVITY	113	1.15788	0.19711043	0.6576068	0.1282269	-2.1875331
GO_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT	c5.BP_ GO biological process	34	-1.0295991	0.4041298	0.5657786	GO_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT	34	0.65100235	0.94265234	1	-0.37859675	-1.68060145
GO_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT	c5.BP_ GO biological process	50	-1.0291953	0.39716312	0.5668904	GO_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT	52	0.7345827	0.88387823	1	-0.2946126	-1.763778
GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	140	-1.0291647	0.30331755	0.5667811	GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP	151	0.61412	0.9928789	1	-0.4150447	-1.6432847
GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN	C7_ immunologic signatures	157	-1.0288231	0.3877551	0.5676664	GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN	161	1.078412	0.31237322	0.7905643	0.0495889	-2.1072351
REACTOME_PYRUVATE_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	18	-1.0287229	0.424	0.56778055	REACTOME_PYRUVATE_METABOLISM	18	-1.0424023	0.35714287	0.6182758	-2.0711252	0.0136794
GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP	C7_ immunologic signatures	177	-1.028554	0.3561644	0.56811434	GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP	178	1.0317565	0.4185336	0.87375	0.0032025	-2.0603105
OKUMURA_INFLAMMATORY_RESPONSE_LPS	c2.CGP_ chemical and genetic perturbations	150	-1.0284404	0.35449734	0.56828827	OKUMURA_INFLAMMATORY_RESPONSE_LPS	156	0.9003621	0.72392637	1	-0.1280783	-1.9288025
REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	c2.CP_REACTOME_ Reactome gene sets	18	-1.0281681	0.398827	0.5689479	REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	18	-1.0139494	0.39647576	0.6685415	-2.0421175	-0.0142187
GO_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION	c5.BP_ GO biological process	86	-1.0278367	0.34177214	0.5697882	GO_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION	95	1.3486682	0.038014784	0.38309577	0.3208315	-2.3765049
GSE27786_CD8_TCELL_VS_NKTCELL_UP	C7_ immunologic signatures	169	-1.0274041	0.35849056	0.5709846	GSE27786_CD8_TCELL_VS_NKTCELL_UP	176	0.686371	0.9808081	1	-0.3410331	-1.7137751
GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	171	-1.0270944	0.2837838	0.5718092	GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	172	1.1382215	0.1969697	0.69391173	0.1111271	-2.1653159
GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	C7_ immunologic signatures	168	-1.0269474	0.32941177	0.57207334	GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	170	0.75262934	0.93421054	1	-0.27431806	-1.77957674
GO_SPERM_FLAGELLUM	c5.CC_ GO cellular component	48	-1.0268549	0.40894568	0.572181	GO_SPERM_FLAGELLUM	50	0.80095094	0.80246913	1	-0.22590396	-1.82780584
SHEPARD_BMYB_MORPHOLINO_UP	c2.CGP_ chemical and genetic perturbations	188	-1.0267048	0.3604651	0.5724528	SHEPARD_BMYB_MORPHOLINO_UP	193	1.0097005	0.49392712	0.9082878	-0.0170043	-2.0364053
GSE14308_TH1_VS_NATURAL_TREG_UP	C7_ immunologic signatures	176	-1.0265598	0.34177214	0.57271075	GSE14308_TH1_VS_NATURAL_TREG_UP	177	0.8032249	0.8945233	1	-0.2233349	-1.8297847
GCM_MAX	c4.CGN_ cancer gene neighborhoods	30	-1.0264946	0.40361446	0.5727164	GCM_MAX	30	-1.9440628	0	0.013003345	-2.9705574	0.9175682
GO_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	117	-1.0264175	0.37962964	0.57275826	GO_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	121	1.0744121	0.3405128	0.79808116	0.0479946	-2.1008296
GSE27786_LIN_NEG_VS_CD4_TCELL_UP	C7_ immunologic signatures	174	-1.0262643	0.369863	0.573046	GSE27786_LIN_NEG_VS_CD4_TCELL_UP	179	-1.131105	0.06666667	0.47021157	-2.1573693	0.1048407
GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_UP	C7_ immunologic signatures	174	-1.025456	0.34545454	0.5754161	GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_UP	175	0.60118425	0.9979613	1	-0.42427175	-1.62664025
KEGG_PPAR_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	58	-1.0252516	0.39051095	0.575868	KEGG_PPAR_SIGNALING_PATHWAY	64	0.74228007	0.86961323	1	-0.28297153	-1.76753167
GO_LYMPH_NODE_DEVELOPMENT	c5.BP_ GO biological process	15	-1.0252295	0.42997542	0.5757358	GO_LYMPH_NODE_DEVELOPMENT	17	1.0004643	0.51428574	0.9235655	-0.0247652	-2.0256938
MAHADEVAN_IMATINIB_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	15	-1.025135	0.40533334	0.5758186	MAHADEVAN_IMATINIB_RESISTANCE_DN	17	0.8750651	0.6779661	1	-0.1500699	-1.9002001
GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN	C7_ immunologic signatures	177	-1.0250406	0.33333334	0.57591385	GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN	176	0.9877382	0.51376146	0.9384845	-0.0373024	-2.0127788
GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN	C7_ immunologic signatures	177	-1.024964	0.374269	0.57593954	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN	180	-1.0913426	0.1	0.5317013	-2.1163066	0.0663786
GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN	C7_ immunologic signatures	178	-1.0248941	0.36094674	0.57596254	GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN	183	1.1649461	0.13965341	0.64621705	0.140052	-2.1898402
REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_	c2.CP_REACTOME_ Reactome gene sets	40	-1.0247327	0.3628049	0.57627195	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_	40	-1.9671211	0	0.010691524	-2.9918538	0.9423884
GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN	C7_ immunologic signatures	146	-1.024564	0.3726708	0.5766	GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN	149	1.2009931	0.11201629	0.5905844	0.1764291	-2.2255571
REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	20	-1.0241528	0.4051724	0.57775176	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	20	1.2924086	0.13358779	0.45400062	0.2682558	-2.3165614
GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP	C7_ immunologic signatures	162	-1.0236429	0.35632184	0.5792139	GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP	171	0.8984329	0.7520325	1	-0.12521	-1.9220758
GO_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION	c5.BP_ GO biological process	25	-1.0234843	0.41477272	0.5795272	GO_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION	26	1.0082117	0.47613218	0.91124177	-0.0152726	-2.031696
GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	151	-1.0234509	0.34463277	0.5794338	GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	153	0.70098263	0.95616716	1	-0.32246827	-1.72443353
GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP	C7_ immunologic signatures	175	-1.0234202	0.37062937	0.5793199	GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP	180	0.94920367	0.6208291	0.9830009	-0.07421653	-1.97262387
GO_RETINOL_METABOLIC_PROCESS	c5.BP_ GO biological process	23	-1.0232116	0.4262295	0.5798015	GO_RETINOL_METABOLIC_PROCESS	23	1.1948856	0.23161764	0.5973759	0.171674	-2.2180972
GO_FATTY_ACID_BETA_OXIDATION	c5.BP_ GO biological process	49	-1.0230895	0.39084506	0.5799948	GO_FATTY_ACID_BETA_OXIDATION	51	0.9501388	0.5633958	0.98176664	-0.0729507	-1.9732283
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP	C7_ immunologic signatures	171	-1.0229744	0.38513514	0.58015656	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP	171	0.6183438	0.99493414	1	-0.4046306	-1.6413182
ASTIER_INTEGRIN_SIGNALING	c2.CGP_ chemical and genetic perturbations	54	-1.0228823	0.3885135	0.5802504	ASTIER_INTEGRIN_SIGNALING	55	0.86758673	0.7162162	1	-0.15529557	-1.89046903
GSE29618_PDC_VS_MDC_UP	C7_ immunologic signatures	173	-1.0228447	0.37931034	0.58015245	GSE29618_PDC_VS_MDC_UP	177	-1.0077051	0.5625	0.6741666	-2.0305498	-0.0151396
ZHENG_IL22_SIGNALING_UP	c2.CGP_ chemical and genetic perturbations	41	-1.0227976	0.4025559	0.5801073	ZHENG_IL22_SIGNALING_UP	43	1.1847495	0.21545668	0.61423796	0.1619519	-2.2075471
GO_O_GLYCAN_PROCESSING	c5.BP_ GO biological process	42	-1.0226434	0.4117647	0.58039373	GO_O_GLYCAN_PROCESSING	47	1.2639081	0.14108352	0.49088633	0.2412647	-2.2865515
GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	C7_ immunologic signatures	175	-1.0224814	0.4	0.58072007	GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	176	0.9783201	0.56142133	0.95178306	-0.0441613	-2.0008015
GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN	C7_ immunologic signatures	182	-1.0224425	0.35403726	0.58063704	GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN	182	0.7014315	0.96960485	1	-0.321011	-1.723874
GGCKCATGS_UNKNOWN	c3.TFT_ transcription factor targets	56	-1.0224262	0.4243421	0.5804848	GGCKCATGS_UNKNOWN	61	0.58655566	0.98131865	1	-0.43587054	-1.60898186
GNF2_RAD23A	c4.CGN_ cancer gene neighborhoods	60	-1.022128	0.3881119	0.5812671	GNF2_RAD23A	64	0.82256687	0.77837837	1	-0.19956113	-1.84469487
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	c2.CGP_ chemical and genetic perturbations	150	-1.0219506	0.39181286	0.58163196	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	152	-0.8438933	0.9	0.8725426	-1.8658439	-0.1780573
GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN	C7_ immunologic signatures	152	-1.0219284	0.38011697	0.58148897	GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN	151	0.90117735	0.7249489	1	-0.12075105	-1.92310575
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_DN	C7_ immunologic signatures	143	-1.0218906	0.36969697	0.58141214	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_DN	145	1.0789013	0.3405128	0.7895856	0.0570107	-2.1007919
GO_COATED_PIT	c5.CC_ GO cellular component	63	-1.0218066	0.3774319	0.58148444	GO_COATED_PIT	63	0.81815	0.7649667	1	-0.2036566	-1.8399566
ZHAN_LATE_DIFFERENTIATION_GENES_UP	c2.CGP_ chemical and genetic perturbations	32	-1.0213186	0.4071856	0.58287466	ZHAN_LATE_DIFFERENTIATION_GENES_UP	32	-0.83624744	0.7647059	0.8775106	-1.85756604	-0.18507116
GO_POSITIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT	c5.BP_ GO biological process	20	-1.021166	0.4155496	0.5831233	GO_POSITIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT	21	0.6474443	0.9292035	1	-0.3737217	-1.6686103
GO_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION	c5.BP_ GO biological process	21	-1.021113	0.40112993	0.58310044	GO_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION	24	1.3403293	0.10635697	0.39655325	0.3192163	-2.3614423
GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP	C7_ immunologic signatures	183	-1.02087	0.4074074	0.5836653	GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP	183	0.53529817	1	1	-0.48557183	-1.55616817
GSE27786_BCELL_VS_MONO_MAC_UP	C7_ immunologic signatures	176	-1.0207515	0.38562092	0.58385897	GSE27786_BCELL_VS_MONO_MAC_UP	177	-0.8770318	1	0.8472191	-1.8977833	-0.1437197
GO_NEUROTRANSMITTER_TRANSPORTER_ACTIVITY	c5.GO molecular function	19	-1.0207137	0.42063493	0.5837806	GO_NEUROTRANSMITTER_TRANSPORTER_ACTIVITY	24	0.7147464	0.87239265	1	-0.3059673	-1.7354601
RICKMAN_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	222	-1.0206853	0.3809524	0.5836632	RICKMAN_METASTASIS_DN	226	1.3130523	0.01003009	0.4202071	0.292367	-2.3337376
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN	C7_ immunologic signatures	174	-1.020665	0.40789473	0.5835281	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN	179	0.95529443	0.6181818	0.9760178	-0.06537057	-1.97595943
GNF2_DEK	c4.CGN_ cancer gene neighborhoods	55	-1.0206057	0.40202704	0.5835208	GNF2_DEK	55	-2.7358243	0	0	-3.75643	1.7152186
GO_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS	c5.BP_ GO biological process	41	-1.0205797	0.37704918	0.58339614	GO_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS	43	1.1450145	0.26763716	0.67893887	0.1244348	-2.1655942
GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	C7_ immunologic signatures	144	-1.0204707	0.34517765	0.583549	GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	152	0.98444587	0.5319149	0.9420815	-0.03602483	-2.00491657
GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP	C7_ immunologic signatures	161	-1.0199995	0.42774567	0.5848952	GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP	172	1.1970979	0.09939148	0.59656966	0.1770984	-2.2170974
CHR12Q22	C1: positional gene sets	21	-1.0197878	0.42089552	0.5853485	CHR12Q22	23	0.89958984	0.63265306	1	-0.12019796	-1.91937764
GSE13306_TREG_RA_VS_TCONV_RA_DN	C7_ immunologic signatures	156	-1.0197831	0.37745097	0.58515346	GSE13306_TREG_RA_VS_TCONV_RA_DN	170	1.2002537	0.11032388	0.59240556	0.1804706	-2.2200368
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN	C7_ immunologic signatures	155	-1.0195477	0.38255033	0.5857518	GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN	162	1.0413307	0.4	0.85694593	0.021783	-2.0608784
MODULE_313	c4.CM_ cancer modules	15	-1.0193712	0.4314721	0.5861201	MODULE_313	15	-0.76935184	0.76623374	0.92810154	-1.78872304	-0.25001936
GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN	C7_ immunologic signatures	151	-1.0193689	0.3482587	0.58591837	GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN	149	1.3763028	0.008138352	0.35766575	0.3569339	-2.3956717
GO_DNA_TEMPLATED_TRANSCRIPTION_INITIATION	c5.BP_ GO biological process	179	-1.0191528	0.36879432	0.5863957	GO_DNA_TEMPLATED_TRANSCRIPTION_INITIATION	183	0.9000581	0.7365755	1	-0.1190947	-1.9192109
GO_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS	c5.GO molecular function	17	-1.0191202	0.42216358	0.58629876	GO_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS	18	-0.8103452	0.7681818	0.8966306	-1.8294654	-0.208775
GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	C7_ immunologic signatures	147	-1.0190433	0.33846155	0.5863249	GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	150	1.4610236	0.002047083	0.28178623	0.4419803	-2.4800669
GO_REGULATION_OF_HEMOPOIESIS	c5.BP_ GO biological process	250	-1.0189695	0.37606838	0.5863573	GO_REGULATION_OF_HEMOPOIESIS	267	1.0506177	0.34271356	0.8388059	0.0316482	-2.0695872
GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_DN	C7_ immunologic signatures	174	-1.018868	0.38418078	0.58648473	GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_DN	175	-1.1166099	0.11111111	0.49443707	-2.1354779	0.0977419
GO_MODULATION_OF_TRANSCRIPTION_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION	c5.BP_ GO biological process	18	-1.0184866	0.4227848	0.5875722	GO_MODULATION_OF_TRANSCRIPTION_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION	18	0.67551476	0.8924051	1	-0.34297184	-1.69400136
DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN	c2.CGP_ chemical and genetic perturbations	29	-1.0183921	0.41297936	0.5876605	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN	29	1.5082304	0.022619048	0.24413754	0.4898383	-2.5266225
GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN	C7_ immunologic signatures	154	-1.0183388	0.3548387	0.5876381	GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN	161	1.2310268	0.08171604	0.53809553	0.212688	-2.2493656
GO_ERAD_PATHWAY	c5.BP_ GO biological process	69	-1.0182176	0.39534885	0.5878257	GO_ERAD_PATHWAY	69	-1.2924626	0.08571429	0.28997838	-2.3106802	0.274245
NGFIC_01	c3.TFT_ transcription factor targets	224	-1.0180768	0.3809524	0.58808637	NGFIC_01	230	0.98945934	0.54116464	0.935457	-0.02861746	-2.00753614
CHR3Q27	C1: positional gene sets	45	-1.0179658	0.43377483	0.588237	CHR3Q27	46	0.855015	0.69966257	1	-0.1629508	-1.8729808
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	C7_ immunologic signatures	140	-1.017903	0.41040462	0.5882285	GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	143	0.8100151	0.8561151	1	-0.2078879	-1.8279181
BIOCARTA_MTOR_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	23	-1.017793	0.40482575	0.5883806	BIOCARTA_MTOR_PATHWAY	23	0.77375114	0.7769517	1	-0.24404186	-1.79154414
GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP	C7_ immunologic signatures	168	-1.0176586	0.3375	0.5886528	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP	169	-1.0370687	0.375	0.62732744	-2.0547273	0.0194101
GSE360_CTRL_VS_L_DONOVANI_MAC_UP	C7_ immunologic signatures	179	-1.0172296	0.41721854	0.5898883	GSE360_CTRL_VS_L_DONOVANI_MAC_UP	182	0.81528765	0.8610272	1	-0.20194195	-1.83251725
GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	C7_ immunologic signatures	178	-1.0171275	0.39751554	0.59002066	GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	178	0.79769874	0.8937247	1	-0.21942876	-1.81482624
VERRECCHIA_RESPONSE_TO_TGFB1_C1	c2.CGP_ chemical and genetic perturbations	19	-1.0171243	0.42857143	0.5898215	VERRECCHIA_RESPONSE_TO_TGFB1_C1	19	-0.7045803	0.89	0.95891327	-1.7217046	-0.312544
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP	C7_ immunologic signatures	166	-1.0170597	0.3974359	0.589836	GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP	164	0.5827938	0.9969543	1	-0.4342659	-1.5998535
GO_ALPHA_BETA_T_CELL_DIFFERENTIATION	c5.BP_ GO biological process	40	-1.0162354	0.40924093	0.59237653	GO_ALPHA_BETA_T_CELL_DIFFERENTIATION	41	0.65438074	0.94292235	1	-0.36185466	-1.67061614
GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP	C7_ immunologic signatures	174	-1.0157995	0.39490446	0.5936045	GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP	176	1.0217388	0.44949496	0.88941973	0.0059393	-2.0375383
GO_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC	c5.BP_ GO biological process	17	-1.0157489	0.43733335	0.5935511	GO_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC	18	1.4413428	0.049872123	0.3017143	0.4255939	-2.4570917
GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	167	-1.0154216	0.36723164	0.5944454	GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	170	-0.86804056	0.9230769	0.85555637	-1.88346216	-0.14738104
GO_E_BOX_BINDING	c5.GO molecular function	27	-1.0149881	0.40857142	0.59572977	GO_E_BOX_BINDING	29	1.0249699	0.45828295	0.88385123	0.0099818	-2.039958
GO_NUCLEOTIDE_EXCISION_REPAIR_PREINCISION_COMPLEX_STABILIZATION	c5.BP_ GO biological process	20	-1.014958	0.4315476	0.59561455	GO_NUCLEOTIDE_EXCISION_REPAIR_PREINCISION_COMPLEX_STABILIZATION	20	-0.67053306	0.94392526	0.9714608	-1.68549106	-0.34442494
GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP	C7_ immunologic signatures	174	-1.0149119	0.37869823	0.59556407	GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP	181	0.97856003	0.56707317	0.9511688	-0.03635187	-1.99347193
PID_CXCR4_PATHWAY	c2.CP_ Canonical pathways	94	-1.0148118	0.3983051	0.59567785	PID_CXCR4_PATHWAY	97	0.8593028	0.75630254	1	-0.155509	-1.8741146
MAX_01	c3.TFT_ transcription factor targets	234	-1.0140153	0.41964287	0.598152	MAX_01	236	0.6918332	0.98693466	1	-0.3221821	-1.7058485
GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP	C7_ immunologic signatures	156	-1.0139472	0.3815029	0.59815454	GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP	163	0.6742765	0.9806911	1	-0.3396707	-1.6882237
GO_HYDROGEN_ION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	73	-1.0136865	0.43076923	0.5988335	GO_HYDROGEN_ION_TRANSMEMBRANE_TRANSPORT	81	0.86713755	0.7302772	1	-0.14654895	-1.88082405
GO_SULFUR_AMINO_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	37	-1.0136578	0.42539683	0.5987244	GO_SULFUR_AMINO_ACID_METABOLIC_PROCESS	40	-0.8578744	0.78294575	0.8615871	-1.8715322	-0.1557834
KRAS.50_UP.V1_DN	C6_ oncogenic signatures	26	-1.0136299	0.41569766	0.5986052	KRAS.50_UP.V1_DN	29	0.9100878	0.63035494	1	-0.1035421	-1.9237177
GO_PHOTORECEPTOR_CELL_DIFFERENTIATION	c5.BP_ GO biological process	48	-1.0135092	0.39464882	0.59878105	GO_PHOTORECEPTOR_CELL_DIFFERENTIATION	48	-0.96694124	0.5229358	0.7340122	-1.98045044	-0.04656796
GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN	C7_ immunologic signatures	173	-1.0133418	0.41566265	0.5991642	GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN	173	0.7634963	0.9472617	1	-0.2498455	-1.7768381
GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP	C7_ immunologic signatures	184	-1.0132183	0.3548387	0.59934825	GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP	185	1.0082842	0.48387095	0.91180754	-0.0049341	-2.0215025
GO_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS	c5.BP_ GO biological process	71	-1.0130534	0.41869918	0.5996869	GO_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS	72	1.0173036	0.468039	0.8939231	0.0042502	-2.030357
GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN	C7_ immunologic signatures	178	-1.0130523	0.40714285	0.5994813	GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN	183	1.0238733	0.44817072	0.8855088	0.010821	-2.0369256
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	c2.CGP_ chemical and genetic perturbations	18	-1.0127211	0.41666666	0.6004075	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	18	-1.3006817	0.125	0.28308052	-2.3134028	0.2879606
QI_PLASMACYTOMA_DN	c2.CGP_ chemical and genetic perturbations	93	-1.0125536	0.3939394	0.60075986	QI_PLASMACYTOMA_DN	95	0.8681973	0.73862433	1	-0.1443563	-1.8807509
GO_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM	c5.BP_ GO biological process	18	-1.0125241	0.4519774	0.6006478	GO_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM	18	0.7918047	0.74901444	1	-0.2207194	-1.8043288
KORKOLA_EMBRYONAL_CARCINOMA_UP	c2.CGP_ chemical and genetic perturbations	34	-1.012249	0.42682928	0.60135776	KORKOLA_EMBRYONAL_CARCINOMA_UP	34	0.9991676	0.4882353	0.92480725	-0.0130814	-2.0114166
GSE10325_CD4_TCELL_VS_BCELL_DN	C7_ immunologic signatures	155	-1.0117928	0.3895349	0.6026556	GSE10325_CD4_TCELL_VS_BCELL_DN	162	0.91631883	0.7082067	1	-0.09547397	-1.92811163
GSE27786_LIN_NEG_VS_NEUTROPHIL_UP	C7_ immunologic signatures	176	-1.0117203	0.3809524	0.6026831	GSE27786_LIN_NEG_VS_NEUTROPHIL_UP	175	0.86940914	0.7800202	1	-0.14231116	-1.88112944
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	C7_ immunologic signatures	181	-1.0116694	0.4125	0.60264295	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	182	-0.81659925	1	0.8921594	-1.82826865	-0.19507015
APPIERTO_RESPONSE_TO_FENRETINIDE_UP	c2.CGP_ chemical and genetic perturbations	36	-1.0111904	0.4204204	0.60398996	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	36	1.2015212	0.18979834	0.58933824	0.1903308	-2.2127116
GO_REGULATION_OF_TELOMERE_MAINTENANCE	c5.BP_ GO biological process	63	-1.0110184	0.38867924	0.6043623	GO_REGULATION_OF_TELOMERE_MAINTENANCE	63	0.6547205	0.9557032	1	-0.3562979	-1.6657389
PID_FAK_PATHWAY	c2.CP_ Canonical pathways	58	-1.0109787	0.4125874	0.6042879	PID_FAK_PATHWAY	58	-0.798191	0.85555553	0.9080643	-1.8091697	-0.2127877
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	c2.CGP_ chemical and genetic perturbations	38	-1.010896	0.40967742	0.604345	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	38	1.1001296	0.33294117	0.75658256	0.0892336	-2.1110256
GSE13306_RA_VS_UNTREATED_TCONV_UP	C7_ immunologic signatures	169	-1.0108721	0.41975307	0.60421216	GSE13306_RA_VS_UNTREATED_TCONV_UP	179	1.263329	0.058704454	0.49194065	0.2524569	-2.2742011
CHR16P12	C1: positional gene sets	54	-1.0108477	0.4007092	0.6040806	CHR16P12	60	1.3264303	0.07	0.40587586	0.3155826	-2.337278
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	c2.CGP_ chemical and genetic perturbations	39	-1.0107708	0.43506494	0.6041266	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	39	0.71324205	0.8729977	1	-0.29752875	-1.72401285
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN	C7_ immunologic signatures	170	-1.0106242	0.4074074	0.6043962	GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN	173	0.6435228	0.99084437	1	-0.3671014	-1.654147
GO_ALPHA_AMINO_ACID_CATABOLIC_PROCESS	c5.BP_ GO biological process	85	-1.0106149	0.41152263	0.6042143	GO_ALPHA_AMINO_ACID_CATABOLIC_PROCESS	89	0.70816916	0.93040687	1	-0.30244574	-1.71878406
JAZAG_TGFB1_SIGNALING_DN	c2.CGP_ chemical and genetic perturbations	28	-1.0104879	0.44827586	0.6044363	JAZAG_TGFB1_SIGNALING_DN	29	-0.8785278	0.7225131	0.84667814	-1.8890157	-0.1319601
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	c2.CGP_ chemical and genetic perturbations	33	-1.0104835	0.414966	0.6042397	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	35	1.1717033	0.2455304	0.6348896	0.1612198	-2.1821868
GO_REGULATION_OF_MITOPHAGY	c5.BP_ GO biological process	37	-1.0103818	0.41520467	0.60435903	GO_REGULATION_OF_MITOPHAGY	37	0.94499296	0.5736342	0.9875968	-0.06538884	-1.95537476
GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	C7_ immunologic signatures	87	-1.0102451	0.38	0.6046198	GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	98	1.5045702	0	0.24741958	0.4943251	-2.5148153
GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP	C7_ immunologic signatures	178	-1.009962	0.41025642	0.6053531	GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP	182	0.8162255	0.87234044	1	-0.1937365	-1.8261875
GO_ENHANCER_BINDING	c5.GO molecular function	86	-1.0098106	0.43243244	0.6056526	GO_ENHANCER_BINDING	90	-1.2803026	0.05357143	0.30174133	-2.2901132	0.270492
GSE10325_BCELL_VS_MYELOID_UP	C7_ immunologic signatures	159	-1.0095711	0.39444444	0.60624284	GSE10325_BCELL_VS_MYELOID_UP	167	0.70099396	0.97341514	1	-0.30857714	-1.71056506
REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER	c2.CP_REACTOME_ Reactome gene sets	41	-1.0088679	0.43768996	0.60835695	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER	41	-1.1393621	0.24	0.4585817	-2.14823	0.1304942
GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN	C7_ immunologic signatures	159	-1.008865	0.43274853	0.608157	GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN	163	0.77461565	0.9132653	1	-0.23424935	-1.78348065
GO_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS	c5.BP_ GO biological process	56	-1.0087937	0.44295302	0.60818064	GO_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS	57	0.8345555	0.75137514	1	-0.1742382	-1.8433492
GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN	C7_ immunologic signatures	170	-1.0087916	0.43670887	0.6079773	GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN	172	0.7049773	0.96767676	1	-0.3038143	-1.7137689
GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN	C7_ immunologic signatures	182	-1.0087444	0.4011628	0.60791	GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN	188	1.1350762	0.1861167	0.69704723	0.1263318	-2.1438206
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	164	-1.0080165	0.42105263	0.6101476	GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP	165	0.92630017	0.69137055	1	-0.08171633	-1.93431667
GO_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	21	-1.0080055	0.43786982	0.60997623	GO_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	22	-1.0737371	0.3248731	0.56400394	-2.0817426	0.0657316
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN	C7_ immunologic signatures	183	-1.0077219	0.43283582	0.61073965	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN	185	-1.138628	0.11111111	0.45873806	-2.1463499	0.1309061
GTTGNYNNRGNAAC_UNKNOWN	c3.TFT_ transcription factor targets	95	-1.007597	0.3966942	0.61095846	GTTGNYNNRGNAAC_UNKNOWN	97	1.0014111	0.4831579	0.921534	-0.0061859	-2.0090081
GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	C7_ immunologic signatures	181	-1.0071898	0.46875	0.6121594	GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	182	0.77270055	0.9198783	1	-0.23448925	-1.77989035
GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP	C7_ immunologic signatures	180	-1.0071168	0.42142856	0.6121858	GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP	180	0.59925276	0.9979737	1	-0.40786404	-1.60636956
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	c2.CP_REACTOME_ Reactome gene sets	40	-1.0070956	0.42553192	0.6120444	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	44	1.2947638	0.1132287	0.44941345	0.2876682	-2.3018594
GSE22886_TCELL_VS_BCELL_NAIVE_UP	C7_ immunologic signatures	174	-1.006741	0.42222223	0.6130037	GSE22886_TCELL_VS_BCELL_NAIVE_UP	178	0.86110276	0.81193125	1	-0.14563824	-1.86784376
GO_RESPONSE_TO_PROTOZOAN	c5.BP_ GO biological process	17	-1.0067353	0.48767123	0.61281246	GO_RESPONSE_TO_PROTOZOAN	16	1.0774063	0.38501972	0.7926241	0.070671	-2.0841416
GO_MAST_CELL_ACTIVATION	c5.BP_ GO biological process	19	-1.006676	0.41944444	0.612806	GO_MAST_CELL_ACTIVATION	20	1.4464183	0.04822335	0.2948368	0.4397423	-2.4530943
GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP	C7_ immunologic signatures	182	-1.0066618	0.39333335	0.61264557	GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP	182	0.96253407	0.5922921	0.968577	-0.04412773	-1.96919587
MOHANKUMAR_HOXA1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	374	-1.006474	0.42028984	0.61307967	MOHANKUMAR_HOXA1_TARGETS_UP	374	0.9002145	0.799	1	-0.1062595	-1.9066885
GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP	C7_ immunologic signatures	143	-1.006454	0.424581	0.6129423	GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP	147	0.9422235	0.6347737	0.98900366	-0.0642305	-1.9486775
GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP	C7_ immunologic signatures	172	-1.0063856	0.4551282	0.6129657	GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP	175	-1.3391242	0	0.24925034	-2.3455098	0.3327386
GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_DN	C7_ immunologic signatures	176	-1.0061119	0.39751554	0.6136546	GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_DN	177	0.6809664	0.9819458	1	-0.3251455	-1.6870783
GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP	C7_ immunologic signatures	176	-1.0058208	0.4347826	0.61442405	GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP	182	1.0518302	0.37411526	0.8372731	0.0460094	-2.057651
GSE40273_GATA1_KO_VS_WT_TREG_UP	C7_ immunologic signatures	177	-1.005728	0.45394737	0.61452186	GSE40273_GATA1_KO_VS_WT_TREG_UP	178	-1.0039424	0.4375	0.6782311	-2.0096704	-0.0017856
GNF2_MSN	c4.CGN_ cancer gene neighborhoods	21	-1.0056474	0.43048128	0.61458683	GNF2_MSN	21	-0.92098343	0.59534883	0.79366946	-1.92663083	-0.08466397
MODULE_240	c4.CM_ cancer modules	16	-1.0055059	0.43915343	0.6148688	MODULE_240	16	-0.9099536	0.55776894	0.80844563	-1.9154595	-0.0955523
CHENG_RESPONSE_TO_NICKEL_ACETATE	c2.CGP_ chemical and genetic perturbations	36	-1.0054784	0.44805196	0.61474884	CHENG_RESPONSE_TO_NICKEL_ACETATE	36	-0.84118074	0.7532467	0.8744308	-1.84665914	-0.16429766
GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP	C7_ immunologic signatures	176	-1.0054439	0.45454547	0.6146539	GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP	182	1.1979413	0.10121457	0.5962676	0.1924974	-2.2033852
GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP	C7_ immunologic signatures	168	-1.0052884	0.46524063	0.6149725	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP	172	1.0977916	0.28024194	0.75949544	0.0925032	-2.10308
GSE17721_POLYIC_VS_CPG_8H_BMDC_DN	C7_ immunologic signatures	172	-1.0052834	0.43010753	0.6147789	GSE17721_POLYIC_VS_CPG_8H_BMDC_DN	173	-0.9073201	0.88235295	0.81393874	-1.9126035	-0.0979633
MORF_DNMT1	c4.CGN_ cancer gene neighborhoods	111	-1.0052613	0.4266055	0.61464983	MORF_DNMT1	112	-2.3469346	0	0.000109315	-3.3521959	1.3416733
GO_MYOTUBE_CELL_DEVELOPMENT	c5.BP_ GO biological process	20	-1.0051489	0.43965518	0.6148265	GO_MYOTUBE_CELL_DEVELOPMENT	22	1.17309	0.2640801	0.6334696	0.1679411	-2.1782389
IVANOVA_HEMATOPOIESIS_STEM_CELL	c2.CGP_ chemical and genetic perturbations	225	-1.005052	0.46031746	0.6149527	IVANOVA_HEMATOPOIESIS_STEM_CELL	231	1.2859001	0.016048145	0.4622582	0.2808481	-2.2909521
GSE360_DC_VS_MAC_UP	C7_ immunologic signatures	175	-1.0049213	0.397351	0.61517704	GSE360_DC_VS_MAC_UP	177	0.76128834	0.9313824	1	-0.24363296	-1.76620964
GO_NON_CANONICAL_WNT_SIGNALING_PATHWAY	c5.BP_ GO biological process	129	-1.0048684	0.44036698	0.6151527	GO_NON_CANONICAL_WNT_SIGNALING_PATHWAY	131	0.74132895	0.91384614	1	-0.26353945	-1.74619735
HALLMARK_PEROXISOME	H_ hallmark gene sets	93	-1.0048275	0.4331984	0.61508346	HALLMARK_PEROXISOME	96	1.0412902	0.41525424	0.8569706	0.0364627	-2.0461177
GO_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	25	-1.0047023	0.41091955	0.61527306	GO_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE	26	-1.0923316	0.30588236	0.5304216	-2.0970339	0.0876293
GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN	C7_ immunologic signatures	168	-1.0046589	0.41379312	0.6152054	GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN	175	0.8522672	0.81338745	1	-0.1523917	-1.8569261
GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	C7_ immunologic signatures	179	-1.0045276	0.410596	0.61543393	GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	179	0.86824036	0.8067141	1	-0.13628724	-1.87276796
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN	C7_ immunologic signatures	184	-1.004364	0.4370861	0.6157556	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN	182	-1.7427026	0	0.045343123	-2.7470666	0.7383386
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP	C7_ immunologic signatures	170	-1.0042199	0.45454547	0.61603194	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP	172	0.9024175	0.7457114	1	-0.1018024	-1.9066374
VALK_AML_WITH_11Q23_REARRANGED	c2.CGP_ chemical and genetic perturbations	17	-1.0041108	0.4332425	0.6161958	VALK_AML_WITH_11Q23_REARRANGED	19	1.0893126	0.35263836	0.7717569	0.0852018	-2.0934234
GO_TRANSFERASE_ACTIVITY_TRANSFERRING_HEXOSYL_GROUPS	c5.GO molecular function	161	-1.0037962	0.44198895	0.6170464	GO_TRANSFERASE_ACTIVITY_TRANSFERRING_HEXOSYL_GROUPS	166	0.9404356	0.63590264	0.98959535	-0.0633606	-1.9442318
GO_REGULATION_OF_ERAD_PATHWAY	c5.BP_ GO biological process	27	-1.0037842	0.44382024	0.61687106	GO_REGULATION_OF_ERAD_PATHWAY	27	-0.6478837	0.96842104	0.97626984	-1.6516679	-0.3559005
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP	C7_ immunologic signatures	173	-1.0037642	0.459854	0.6167305	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP	175	0.59875065	0.99593496	1	-0.40501355	-1.60251485
JIANG_AGING_CEREBRAL_CORTEX_DN	c2.CGP_ chemical and genetic perturbations	53	-1.0036451	0.4083045	0.6169421	JIANG_AGING_CEREBRAL_CORTEX_DN	54	0.73049766	0.8924612	1	-0.27314744	-1.73414276
RHODES_CANCER_META_SIGNATURE	c2.CGP_ chemical and genetic perturbations	62	-1.0035661	0.42662117	0.6170113	RHODES_CANCER_META_SIGNATURE	62	-0.9509994	0.61728394	0.75309354	-1.9545655	-0.0525667
GO_TOR_SIGNALING	c5.BP_ GO biological process	16	-1.0035287	0.43967828	0.6169289	GO_TOR_SIGNALING	16	0.96200895	0.5376623	0.9687714	-0.04151975	-1.96553765
NAKAMURA_METASTASIS_MODEL_DN	c2.CGP_ chemical and genetic perturbations	38	-1.0030426	0.4189189	0.61833847	NAKAMURA_METASTASIS_MODEL_DN	40	0.8768059	0.6786543	1	-0.1262367	-1.8798485
GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN	C7_ immunologic signatures	155	-1.0028895	0.4779874	0.61863965	GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN	154	-1.3683108	0	0.22813511	-2.3712003	0.3654213
BOYLAN_MULTIPLE_MYELOMA_C_DN	c2.CGP_ chemical and genetic perturbations	49	-1.002612	0.4276316	0.61939067	BOYLAN_MULTIPLE_MYELOMA_C_DN	51	1.4285232	0.037904125	0.31712827	0.4259112	-2.4311352
GO_CADHERIN_BINDING	c5.GO molecular function	25	-1.0025522	0.40166205	0.6193652	GO_CADHERIN_BINDING	26	0.90320677	0.61290324	1	-0.09934543	-1.90575897
MCCLUNG_DELTA_FOSB_TARGETS_2WK	c2.CGP_ chemical and genetic perturbations	42	-1.0024925	0.4364261	0.61936384	MCCLUNG_DELTA_FOSB_TARGETS_2WK	43	0.78611755	0.81609195	1	-0.21637495	-1.78861005
GO_NEGATIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME	c5.BP_ GO biological process	19	-1.0024148	0.44072166	0.6194069	GO_NEGATIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME	19	-1.6760949	0.018867925	0.06318383	-2.6785097	0.6736801
GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP	C7_ immunologic signatures	142	-1.0024136	0.4329897	0.61920273	GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP	144	-0.92896163	0.7058824	0.7857456	-1.93137523	-0.07345197
GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP	C7_ immunologic signatures	178	-1.0020918	0.44444445	0.6201167	GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP	177	-1.2769275	0	0.3047638	-2.2790193	0.2748357
CHR8Q22	C1: positional gene sets	53	-1.0019503	0.4084507	0.6204042	CHR8Q22	56	0.8077968	0.79867256	1	-0.1941535	-1.8097471
GSE14000_4H_VS_16H_LPS_DC_UP	C7_ immunologic signatures	162	-1.0015148	0.43030304	0.6217032	GSE14000_4H_VS_16H_LPS_DC_UP	164	0.8209198	0.86414707	1	-0.180595	-1.8224346
EGR3_01	c3.TFT_ transcription factor targets	76	-1.001348	0.472	0.6220624	EGR3_01	77	0.8986883	0.6605405	1	-0.1026597	-1.9000363
CHR9Q34	C1: positional gene sets	168	-1.0013186	0.43670887	0.62194544	CHR9Q34	181	1.1915082	0.11167513	0.6044239	0.1901896	-2.1928268
GO_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	20	-1.0011786	0.44602272	0.62219495	GO_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY	20	-0.68364006	0.90909094	0.967507	-1.68481866	-0.31753854
GO_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS	c5.BP_ GO biological process	103	-1.0006886	0.4678899	0.62364006	GO_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS	105	-1.152873	0.13725491	0.4402391	-2.1535616	0.1521844
GO_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY	c5.BP_ GO biological process	33	-1.0005869	0.4417178	0.6237703	GO_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY	34	1.2681808	0.13669065	0.48678836	0.2675939	-2.2687677
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	c2.CGP_ chemical and genetic perturbations	84	-1.0005491	0.4304348	0.6236851	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	83	1.085335	0.34745762	0.7769614	0.0847859	-2.0858841
GCM_SMO	c4.CGN_ cancer gene neighborhoods	56	-1.000248	0.41237113	0.62451184	GCM_SMO	56	1.0157247	0.46400887	0.8965048	0.0154767	-2.0159727
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP	C7_ immunologic signatures	182	-1.0001764	0.4047619	0.6245359	GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP	186	0.99582803	0.5335366	0.9297027	-0.00434837	-1.99600443
CHR5P13	C1: positional gene sets	42	-1.0000819	0.4357367	0.62463444	CHR5P13	43	-0.7787621	0.9029851	0.9226336	-1.778844	-0.2213198
TOOKER_GEMCITABINE_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	116	-1.0000428	0.4351852	0.6245563	TOOKER_GEMCITABINE_RESISTANCE_DN	116	-1.3825773	0	0.21811101	-2.3826201	0.3825345
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP	C7_ immunologic signatures	181	-0.99980587	0.49342105	0.62515056	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP	183	0.83553505	0.83890575	1	-0.16427082	-1.83534092
MORF_CDC10	c4.CGN_ cancer gene neighborhoods	136	-0.99927354	0.42328042	0.62679136	MORF_CDC10	136	-1.7903333	0	0.034897562	-2.78960684	0.79105976
GSE24210_TCONV_VS_TREG_UP	C7_ immunologic signatures	168	-0.9988946	0.443038	0.62786704	GSE24210_TCONV_VS_TREG_UP	171	1.2094401	0.08452138	0.5779048	0.2105455	-2.2083347
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	C7_ immunologic signatures	164	-0.99874914	0.4463277	0.62818176	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	166	1.2778388	0.04489796	0.4752576	0.27908966	-2.27658794
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN	C7_ immunologic signatures	174	-0.9982899	0.48603353	0.62955165	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN	178	0.81074095	0.8708375	1	-0.18754895	-1.80903085
MODULE_235	c4.CM_ cancer modules	71	-0.9981037	0.477551	0.62998277	MODULE_235	76	0.80371207	0.8176972	1	-0.19439163	-1.80181577
GO_MAST_CELL_MEDIATED_IMMUNITY	c5.BP_ GO biological process	17	-0.99784344	0.44619423	0.630654	GO_MAST_CELL_MEDIATED_IMMUNITY	18	1.4920639	0.033962265	0.25752294	0.49422046	-2.48990734
GSE11924_TFH_VS_TH17_CD4_TCELL_DN	C7_ immunologic signatures	176	-0.9976274	0.4691358	0.6311639	GSE11924_TFH_VS_TH17_CD4_TCELL_DN	177	0.7809641	0.9240891	1	-0.2166633	-1.7785915
GSE17721_CTRL_VS_LPS_4H_BMDC_UP	C7_ immunologic signatures	184	-0.99760807	0.48387095	0.63102275	GSE17721_CTRL_VS_LPS_4H_BMDC_UP	183	0.6258831	0.9949187	1	-0.37172497	-1.62349117
GCM_HBP1	c4.CGN_ cancer gene neighborhoods	63	-0.9973741	0.43824703	0.6316022	GCM_HBP1	63	-1.717204	0	0.05145868	-2.7145781	0.7198299
GSE6681_DELETED_FOXP3_VS_WT_TREG_UP	C7_ immunologic signatures	158	-0.9971609	0.45398772	0.6320894	GSE6681_DELETED_FOXP3_VS_WT_TREG_UP	164	1.154377	0.17904374	0.6625861	0.1572161	-2.1515379
GO_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	19	-0.99711037	0.48360655	0.63205135	GO_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS	19	-0.9835694	0.46255508	0.7094609	-1.98067977	-0.01354097
GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN	C7_ immunologic signatures	175	-0.99690986	0.3881579	0.63251275	GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN	182	0.80225617	0.8873097	1	-0.19465369	-1.79916603
GO_CELL_DIFFERENTIATION_IN_HINDBRAIN	c5.BP_ GO biological process	20	-0.99592996	0.43431637	0.63564086	GO_CELL_DIFFERENTIATION_IN_HINDBRAIN	21	0.69055384	0.8768657	1	-0.30537612	-1.6864838
GO_MRNA_SPLICE_SITE_SELECTION	c5.BP_ GO biological process	26	-0.9958636	0.4385475	0.63565737	GO_MRNA_SPLICE_SITE_SELECTION	26	-1.406817	0.08290155	0.20180632	-2.4026806	0.4109534
JAIN_NFKB_SIGNALING	c2.CGP_ chemical and genetic perturbations	65	-0.99574065	0.46530613	0.6358647	JAIN_NFKB_SIGNALING	65	-1.3092041	0.023529412	0.27535063	-2.30494475	0.31346345
GO_REGULATION_OF_STEROL_TRANSPORT	c5.BP_ GO biological process	31	-0.995723	0.4695122	0.6357107	GO_REGULATION_OF_STEROL_TRANSPORT	35	-1.132041	0.23841059	0.4689772	-2.127764	0.136318
GO_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT	c5.BP_ GO biological process	152	-0.99570006	0.47457626	0.6355654	GO_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT	152	0.80180454	0.87116563	1	-0.19389552	-1.7975046
JOHNSTONE_PARVB_TARGETS_2_UP	c2.CGP_ chemical and genetic perturbations	115	-0.9956619	0.48636365	0.63548374	JOHNSTONE_PARVB_TARGETS_2_UP	116	0.8635452	0.7431866	1	-0.1321167	-1.8592071
GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP	C7_ immunologic signatures	176	-0.9953944	0.4362416	0.63619936	GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP	176	0.99249786	0.5394737	0.93292636	-0.00289654	-1.98789226
GO_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS	c5.BP_ GO biological process	122	-0.9952093	0.46078432	0.63660276	GO_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS	131	0.88856083	0.73727936	1	-0.10664847	-1.88377013
BIOCARTA_FMLP_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	33	-0.9952003	0.41569766	0.6364176	BIOCARTA_FMLP_PATHWAY	33	1.1767979	0.24759616	0.6267206	0.1815976	-2.1719982
GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN	C7_ immunologic signatures	183	-0.99510497	0.45679012	0.6365388	GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN	185	0.98340577	0.55600405	0.9438462	-0.0116992	-1.97851074
GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	164	-0.9949704	0.44505495	0.6367878	GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN	174	0.82887506	0.84863776	1	-0.16609534	-1.82384546
HEDENFALK_BREAST_CANCER_BRACX_UP	c2.CGP_ chemical and genetic perturbations	15	-0.9948341	0.46537396	0.6370524	HEDENFALK_BREAST_CANCER_BRACX_UP	15	1.0244774	0.45694444	0.8844308	0.0296433	-2.0193115
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	c2.CGP_ chemical and genetic perturbations	71	-0.99473536	0.4431818	0.63716304	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	76	1.1722708	0.20663811	0.63402086	0.17753544	-2.16700616
GO_POSITIVE_REGULATION_OF_LIGASE_ACTIVITY	c5.BP_ GO biological process	99	-0.99461436	0.4635193	0.6373512	GO_POSITIVE_REGULATION_OF_LIGASE_ACTIVITY	100	0.8477843	0.76617956	1	-0.14683006	-1.84239866
GSE17721_LPS_VS_CPG_6H_BMDC_DN	C7_ immunologic signatures	168	-0.994612	0.425	0.6371434	GSE17721_LPS_VS_CPG_6H_BMDC_DN	166	0.7415613	0.9450661	1	-0.2530507	-1.7361733
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	c2.CGP_ chemical and genetic perturbations	201	-0.9945299	0.48251748	0.6372251	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	202	0.58974123	0.9979737	1	-0.40478867	-1.58427113
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP	C7_ immunologic signatures	174	-0.99446964	0.50666666	0.6372035	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP	173	1.1079223	0.24747474	0.7411468	0.11345266	-2.10239194
ATF_01	c3.TFT_ transcription factor targets	221	-0.9941118	0.4453125	0.63821274	ATF_01	231	0.8081052	0.9032258	1	-0.1860066	-1.802217
HOSHIDA_LIVER_CANCER_SURVIVAL_DN	c2.CGP_ chemical and genetic perturbations	102	-0.9939817	0.45726496	0.6384516	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	101	1.0879098	0.32984293	0.77366984	0.0939281	-2.0818915
GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP	C7_ immunologic signatures	171	-0.99383634	0.44848484	0.6387454	GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP	172	1.0502315	0.40304568	0.8398938	0.05639516	-2.04406784
GO_VESICLE_COAT	c5.CC_ GO cellular component	42	-0.99376136	0.44709897	0.6387746	GO_VESICLE_COAT	42	0.8898128	0.6609393	1	-0.10394856	-1.88357416
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS	c5.BP_ GO biological process	30	-0.9934989	0.4591195	0.6394504	GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS	32	0.6210599	0.9626168	1	-0.372439	-1.6145588
GO_CLATHRIN_ADAPTOR_COMPLEX	c5.CC_ GO cellular component	27	-0.9932418	0.46551725	0.6400818	GO_CLATHRIN_ADAPTOR_COMPLEX	27	1.0490432	0.42704627	0.84165853	0.0558014	-2.042285
ARNT_02	c3.TFT_ transcription factor targets	222	-0.99316496	0.46875	0.6401503	ARNT_02	226	-0.7769347	1	0.9231863	-1.77009966	-0.21623026
GSE13306_TREG_VS_TCONV_SPLEEN_DN	C7_ immunologic signatures	173	-0.9929817	0.43949044	0.64056325	GSE13306_TREG_VS_TCONV_SPLEEN_DN	175	0.98056465	0.55137336	0.9487486	-0.01241705	-1.97354635
GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	C7_ immunologic signatures	134	-0.9929605	0.45698926	0.6404224	GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	138	0.6530786	0.9815951	1	-0.3398819	-1.6460391
GO_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL	c5.BP_ GO biological process	47	-0.99279326	0.48220065	0.6407761	GO_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL	46	1.2939082	0.10795455	0.45159099	0.30111494	-2.28670146
GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP	C7_ immunologic signatures	115	-0.99274904	0.5025381	0.6407197	GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP	119	-0.9593587	0.4347826	0.7427973	-1.95210774	-0.03339034
MODULE_343	c4.CM_ cancer modules	23	-0.9926735	0.45679012	0.64076006	MODULE_343	25	1.2935654	0.125	0.45225975	0.3008919	-2.2862389
GNF2_SPI1	c4.CGN_ cancer gene neighborhoods	29	-0.9926145	0.48265895	0.6407529	GNF2_SPI1	27	0.8388078	0.7381818	1	-0.1538067	-1.8314223
GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP	C7_ immunologic signatures	148	-0.9920965	0.48108107	0.64230686	GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP	155	1.0243646	0.43654823	0.8846258	0.0322681	-2.0164611
ZHAN_MULTIPLE_MYELOMA_HP_UP	c2.CGP_ chemical and genetic perturbations	34	-0.9919593	0.45794392	0.64253813	ZHAN_MULTIPLE_MYELOMA_HP_UP	36	0.9090243	0.6399056	1	-0.082935	-1.9009836
GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN	C7_ immunologic signatures	183	-0.9919039	0.47368422	0.64250594	GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN	186	0.7770892	0.9208925	1	-0.2148147	-1.7689931
PID_INTEGRIN2_PATHWAY	c2.CP_ Canonical pathways	24	-0.99181914	0.42450142	0.6425673	PID_INTEGRIN2_PATHWAY	25	0.77473265	0.7848101	1	-0.21708649	-1.76655179
GO_TRANSCRIPTION_FACTOR_BINDING	c5.GO molecular function	468	-0.9916642	0.46666667	0.64288265	GO_TRANSCRIPTION_FACTOR_BINDING	484	0.71730894	0.996	1	-0.27435526	-1.70897314
GO_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	43	-0.9914486	0.458194	0.6434342	GO_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS	42	-0.8261863	0.76978415	0.8852856	-1.8176349	-0.1652623
GROSS_HYPOXIA_VIA_HIF1A_DN	c2.CGP_ chemical and genetic perturbations	99	-0.9912772	0.4390244	0.64382774	GROSS_HYPOXIA_VIA_HIF1A_DN	99	0.94802475	0.6191467	0.9839587	-0.04325245	-1.93930195
GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	C7_ immunologic signatures	174	-0.9912154	0.46666667	0.6438295	GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	174	1.0156565	0.46754563	0.89663416	0.0244411	-2.0068719
GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP	C7_ immunologic signatures	158	-0.9909951	0.44262296	0.6443567	GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP	159	0.8988577	0.71631205	1	-0.0921374	-1.8898528
CHR2Q35	C1: positional gene sets	42	-0.9909709	0.48231512	0.6442203	CHR2Q35	45	1.1993228	0.20250285	0.5935797	0.2083519	-2.1902937
PID_IL12_2PATHWAY	c2.CP_ Canonical pathways	53	-0.9909219	0.4778157	0.6441725	PID_IL12_2PATHWAY	57	-1.3008724	0.06315789	0.28306392	-2.2917943	0.3099505
GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP	C7_ immunologic signatures	170	-0.9906814	0.48251748	0.64479876	GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP	173	1.0933322	0.26740667	0.7681996	0.1026508	-2.0840136
GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN	C7_ immunologic signatures	160	-0.9905446	0.45454547	0.6450139	GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN	164	1.2631576	0.045824848	0.49200538	0.272613	-2.2537022
MODULE_249	c4.CM_ cancer modules	22	-0.99032015	0.4392265	0.6455677	MODULE_249	22	0.78030145	0.76492083	1	-0.2100187	-1.7706216
VALK_AML_WITH_CEBPA	c2.CGP_ chemical and genetic perturbations	32	-0.9899659	0.45619336	0.64659363	VALK_AML_WITH_CEBPA	36	0.88627994	0.6770335	1	-0.10368596	-1.87624584
GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	C7_ immunologic signatures	177	-0.989761	0.51265824	0.64709187	GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	178	1.0677842	0.33333334	0.8094104	0.0780232	-2.0575452
GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP	C7_ immunologic signatures	165	-0.9894571	0.5	0.647901	GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP	169	0.74947935	0.9427988	1	-0.23997775	-1.73893645
MODULE_160	c4.CM_ cancer modules	15	-0.9894325	0.4540943	0.6477795	MODULE_160	15	-1.6931764	0.015444015	0.058055244	-2.6826089	0.7037439
GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	C7_ immunologic signatures	150	-0.98928916	0.47474748	0.6480581	GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	152	0.89692676	0.7213779	1	-0.0923624	-1.88621592
GO_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS	c5.BP_ GO biological process	61	-0.9891915	0.4448276	0.64818144	GO_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS	65	1.0859274	0.33114034	0.7762776	0.0967359	-2.0751189
GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN	C7_ immunologic signatures	155	-0.98912394	0.50609756	0.64818907	GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN	158	-0.9278116	0.73913044	0.78706396	-1.91693554	-0.06131234
GO_AMINE_METABOLIC_PROCESS	c5.BP_ GO biological process	112	-0.9890133	0.46445498	0.6483374	GO_AMINE_METABOLIC_PROCESS	119	0.85600406	0.77582645	1	-0.13300924	-1.84501736
REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	c2.CP_REACTOME_ Reactome gene sets	72	-0.9888664	0.49103943	0.6486462	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	73	0.89931947	0.6763441	1	-0.08954693	-1.88818587
WCTCNATGGY_UNKNOWN	c3.TFT_ transcription factor targets	66	-0.9888599	0.46691176	0.6484582	WCTCNATGGY_UNKNOWN	68	0.8657113	0.7290533	1	-0.1231486	-1.8545712
GO_FERTILIZATION	c5.BP_ GO biological process	103	-0.9886739	0.4774775	0.6488971	GO_FERTILIZATION	120	1.5229828	0.001043841	0.23379365	0.5343089	-2.5116567
GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP	C7_ immunologic signatures	180	-0.98806995	0.4528302	0.6507467	GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP	181	0.8677758	0.79432625	1	-0.12029415	-1.85584575
MULLIGHAN_MLL_SIGNATURE_2_UP	c2.CGP_ chemical and genetic perturbations	368	-0.9880186	0.46052632	0.6507116	MULLIGHAN_MLL_SIGNATURE_2_UP	373	1.093628	0.222	0.7682807	0.1056094	-2.0816466
GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN	C7_ immunologic signatures	134	-0.98752564	0.4945055	0.65219545	GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN	136	-0.90156686	0.73913044	0.818777	-1.8890925	-0.08595878
GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	180	-0.98724633	0.49305555	0.6529297	GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN	183	1.0668298	0.34146342	0.811696	0.07958347	-2.05407613
PID_HIF1_TFPATHWAY	c2.CP_ Canonical pathways	57	-0.98723114	0.4773519	0.6527685	PID_HIF1_TFPATHWAY	63	0.8735742	0.70043576	1	-0.11365694	-1.86080534
MODULE_373	c4.CM_ cancer modules	20	-0.98708594	0.4542857	0.65307546	MODULE_373	21	1.5667657	0.007682459	0.19193684	0.57967976	-2.55385164
GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN	C7_ immunologic signatures	164	-0.98701876	0.50292397	0.653097	GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN	165	0.7649161	0.9231547	1	-0.22210266	-1.75193486
GO_ESTROUS_CYCLE	c5.BP_ GO biological process	17	-0.9870095	0.46335077	0.6529219	GO_ESTROUS_CYCLE	18	1.1171389	0.321519	0.7281422	0.1301294	-2.1041484
GO_ORGAN_MATURATION	c5.BP_ GO biological process	15	-0.98691785	0.48655915	0.65302277	GO_ORGAN_MATURATION	18	-1.2334542	0.19067797	0.34150833	-2.22037205	0.24653635
GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP	C7_ immunologic signatures	171	-0.9867293	0.49101797	0.65347385	GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP	173	0.6673984	0.9837728	1	-0.3193309	-1.6541277
GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN	C7_ immunologic signatures	180	-0.98662317	0.49673203	0.65362597	GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN	179	0.56969535	0.9979675	1	-0.41692782	-1.55631852
REACTOME_NUCLEOTIDE_EXCISION_REPAIR	c2.CP_REACTOME_ Reactome gene sets	46	-0.9866048	0.44771242	0.653477	REACTOME_NUCLEOTIDE_EXCISION_REPAIR	46	-1.154492	0.14782609	0.4382381	-2.1410968	0.1678872
GSE17721_POLYIC_VS_CPG_4H_BMDC_UP	C7_ immunologic signatures	173	-0.98659635	0.44375	0.6532935	GSE17721_POLYIC_VS_CPG_4H_BMDC_UP	178	0.8893289	0.76363635	1	-0.09726745	-1.87592525
GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP	C7_ immunologic signatures	166	-0.98659456	0.5277778	0.65308446	GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP	167	0.8770185	0.7744898	1	-0.10957606	-1.86361306
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	138	-0.9865747	0.48095238	0.65293026	GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN	146	1.0924184	0.2899288	0.76863265	0.1058437	-2.0789931
GNF2_S100A4	c4.CGN_ cancer gene neighborhoods	36	-0.9863566	0.4606414	0.6534645	GNF2_S100A4	38	1.0560223	0.40069285	0.83122396	0.0696657	-2.0423789
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	95	-0.98633	0.4647303	0.65333366	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	99	1.2657787	0.08350951	0.48942605	0.2794487	-2.2521087
GABP_B	c3.TFT_ transcription factor targets	239	-0.98626447	0.515625	0.6533205	GABP_B	241	-0.96088785	1	0.7415546	-1.94715232	-0.02537662
GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP	C7_ immunologic signatures	151	-0.98598975	0.47953215	0.65403235	GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP	153	0.9830717	0.53924567	0.94424474	-0.00291805	-1.96906145
KEGG_TYROSINE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	35	-0.9858746	0.4809384	0.65421486	KEGG_TYROSINE_METABOLISM	40	1.1689924	0.24142012	0.63956505	0.1831178	-2.154867
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	168	-0.98577505	0.49197862	0.65432614	GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	177	1.1800927	0.12436805	0.6232806	0.19431765	-2.16586775
BIOCARTA_NDKDYNAMIN_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	17	-0.98566765	0.4313253	0.654474	BIOCARTA_NDKDYNAMIN_PATHWAY	17	1.3065575	0.14709677	0.43089253	0.32088985	-2.29222515
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	c2.CGP_ chemical and genetic perturbations	16	-0.9856453	0.45945945	0.6543374	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	16	0.7648271	0.8056628	1	-0.2208182	-1.7504724
CHR7Q22	C1: positional gene sets	87	-0.98561186	0.5	0.6542437	CHR7Q22	89	0.71597654	0.9334741	1	-0.26963532	-1.7015884
GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP	C7_ immunologic signatures	169	-0.9853704	0.5031447	0.65486574	GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP	171	1.164587	0.15810674	0.64594865	0.1792166	-2.1499574
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN	c2.CGP_ chemical and genetic perturbations	32	-0.9852443	0.45846155	0.6551031	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN	36	1.1266329	0.31892523	0.7113669	0.1413886	-2.1118772
GO_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	26	-0.98506397	0.4355301	0.6555224	GO_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS	31	-0.81122977	0.80536914	0.8956225	-1.79629374	-0.1738342
GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP	C7_ immunologic signatures	100	-0.9849068	0.47685185	0.6558457	GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP	101	0.97539264	0.5667011	0.9559723	-0.00951416	-1.96029944
PID_INTEGRIN_CS_PATHWAY	c2.CP_ Canonical pathways	26	-0.98490596	0.47633135	0.6556322	PID_INTEGRIN_CS_PATHWAY	26	1.2729928	0.1378882	0.48221153	0.28808684	-2.25789876
GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	C7_ immunologic signatures	169	-0.98481745	0.5	0.65572447	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	174	0.8387402	0.83906883	1	-0.14607725	-1.82355765
LANDEMAINE_LUNG_METASTASIS	c2.CGP_ chemical and genetic perturbations	16	-0.9847071	0.44198895	0.65589345	LANDEMAINE_LUNG_METASTASIS	20	0.83048445	0.7078652	1	-0.15422265	-1.81519155
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	c2.CGP_ chemical and genetic perturbations	17	-0.98461396	0.4691689	0.6559946	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	19	-0.9295705	0.54146343	0.7844591	-1.91418446	-0.05504346
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	c2.CGP_ chemical and genetic perturbations	20	-0.984559	0.5026738	0.6559741	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	20	-0.8741899	0.6372093	0.85008806	-1.8587489	-0.1103691
MODULE_489	c4.CM_ cancer modules	28	-0.9845083	0.46865672	0.6559226	MODULE_489	30	-1.2215966	0.13333334	0.35413	-2.2061049	0.2370883
HALLMARK_XENOBIOTIC_METABOLISM	H_ hallmark gene sets	178	-0.9841822	0.5123457	0.65679866	HALLMARK_XENOBIOTIC_METABOLISM	183	1.2410913	0.06350806	0.52400464	0.2569091	-2.2252735
GO_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE	c5.CC_ GO cellular component	37	-0.98401916	0.45857987	0.6571195	GO_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE	37	1.1129482	0.33055887	0.73325557	0.12892904	-2.09696736
GO_GLYCOSYLATION	c5.BP_ GO biological process	224	-0.983979	0.49635038	0.65705526	GO_GLYCOSYLATION	233	1.0450737	0.3804238	0.8492102	0.0610947	-2.0290527
GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN	C7_ immunologic signatures	178	-0.98351234	0.516129	0.6584295	GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN	181	0.8253956	0.85656154	1	-0.15811674	-1.80890794
GO_ALPHA_BETA_T_CELL_ACTIVATION	c5.BP_ GO biological process	44	-0.9834002	0.4659864	0.65858424	GO_ALPHA_BETA_T_CELL_ACTIVATION	48	0.7675931	0.829483	1	-0.2158071	-1.7509933
AR_01	c3.TFT_ transcription factor targets	131	-0.98314965	0.51704544	0.6591772	AR_01	137	0.9016837	0.7226804	1	-0.08146595	-1.88483335
HUANG_GATA2_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	64	-0.9831339	0.46376812	0.65901625	HUANG_GATA2_TARGETS_DN	65	0.73478335	0.89666307	1	-0.24835055	-1.71791725
CHR4Q22	C1: positional gene sets	23	-0.98273283	0.46927375	0.6601804	CHR4Q22	26	1.4791061	0.029797377	0.26997262	0.49637327	-2.46183893
GO_PHOSPHOLIPASE_A2_ACTIVITY	c5.GO molecular function	26	-0.9825275	0.4680851	0.6606784	GO_PHOSPHOLIPASE_A2_ACTIVITY	30	1.3479162	0.095857985	0.38405195	0.3653887	-2.3304437
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	c2.CGP_ chemical and genetic perturbations	44	-0.98247653	0.4817073	0.6606234	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	44	1.3185325	0.10125142	0.41332912	0.33605597	-2.30100903
GSE17721_POLYIC_VS_CPG_24H_BMDC_DN	C7_ immunologic signatures	175	-0.9824043	0.52409637	0.660636	GSE17721_POLYIC_VS_CPG_24H_BMDC_DN	180	-0.96855974	0.6875	0.7317932	-1.95096404	-0.01384456
GO_PIGMENT_GRANULE	c5.CC_ GO cellular component	95	-0.9822833	0.5	0.66083777	GO_PIGMENT_GRANULE	97	-0.9821213	0.46666667	0.711624	-1.9644046	-0.000162
GO_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS	c5.BP_ GO biological process	22	-0.9821875	0.47246376	0.66094506	GO_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS	23	0.8097878	0.74595267	1	-0.1723997	-1.7919753
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN	C7_ immunologic signatures	175	-0.982062	0.5	0.66116625	GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN	180	1.0118966	0.49089068	0.90418875	0.0298346	-1.9939586
KAYO_CALORIE_RESTRICTION_MUSCLE_DN	c2.CGP_ chemical and genetic perturbations	75	-0.9815099	0.47583643	0.66281706	KAYO_CALORIE_RESTRICTION_MUSCLE_DN	79	1.1435143	0.24864864	0.6835972	0.1620044	-2.1250242
GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN	C7_ immunologic signatures	177	-0.9806454	0.54320985	0.66560906	GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN	182	0.86191154	0.82400817	1	-0.11873386	-1.84255694
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	c2.CGP_ chemical and genetic perturbations	73	-0.98058325	0.48062015	0.66561085	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	72	-1.3610793	0.03797468	0.2338033	-2.34166255	0.38049605
GSE20715_0H_VS_6H_OZONE_LUNG_DN	C7_ immunologic signatures	182	-0.98051953	0.5035461	0.66561574	GSE20715_0H_VS_6H_OZONE_LUNG_DN	185	1.1156439	0.2289767	0.7300512	0.13512437	-2.09616343
GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN	C7_ immunologic signatures	181	-0.9805156	0.5316456	0.6654116	GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN	182	0.71394044	0.970618	1	-0.26657516	-1.69445604
GO_INORGANIC_ANION_TRANSPORT	c5.BP_ GO biological process	107	-0.98049015	0.48387095	0.6652831	GO_INORGANIC_ANION_TRANSPORT	120	1.161619	0.18782249	0.651213	0.18112885	-2.14210915
GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP	C7_ immunologic signatures	180	-0.98040015	0.55244756	0.665376	GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP	178	0.92846704	0.6744422	0.99928725	-0.05193311	-1.90886719
GO_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	148	-0.98038524	0.49748743	0.66521347	GO_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	162	1.2639805	0.05386179	0.49123847	0.28359526	-2.24436574
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP	C7_ immunologic signatures	173	-0.9801931	0.5033557	0.665697	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP	175	0.83997923	0.8401222	1	-0.14021387	-1.82017233
CYTAGCAAY_UNKNOWN	c3.TFT_ transcription factor targets	122	-0.9800473	0.48947367	0.6659801	CYTAGCAAY_UNKNOWN	130	1.0249192	0.4499484	0.8839059	0.0448719	-2.0049665
MODULE_273	c4.CM_ cancer modules	44	-0.9795789	0.48089173	0.6672951	MODULE_273	44	0.5008019	0.99657536	1	-0.478777	-1.4803808
ARNT_01	c3.TFT_ transcription factor targets	233	-0.9790702	0.5522388	0.6688065	ARNT_01	237	0.8840925	0.7983871	1	-0.0949777	-1.8631627
GSE17721_CTRL_VS_CPG_6H_BMDC_UP	C7_ immunologic signatures	177	-0.9789407	0.52238804	0.6690289	GSE17721_CTRL_VS_CPG_6H_BMDC_UP	183	0.6645176	0.9889336	1	-0.3144231	-1.6434583
ELK1_02	c3.TFT_ transcription factor targets	222	-0.9787577	0.47107437	0.6694483	ELK1_02	226	-1.401329	0	0.20564437	-2.3800867	0.4225713
GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	C7_ immunologic signatures	168	-0.9787407	0.46666667	0.66929084	GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	164	1.17177	0.1548583	0.6347606	0.1930293	-2.1505107
GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN	C7_ immunologic signatures	176	-0.97838306	0.5096774	0.6702965	GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN	175	0.8916698	0.7502538	1	-0.08671326	-1.87005286
GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN	C7_ immunologic signatures	184	-0.97834903	0.5	0.6701883	GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN	184	0.71255887	0.97046846	1	-0.26579016	-1.6909079
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	c2.CGP_ chemical and genetic perturbations	122	-0.9782622	0.5054348	0.6702788	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	128	1.0825659	0.32615384	0.7826671	0.1043037	-2.0608281
GO_T_CELL_PROLIFERATION	c5.BP_ GO biological process	28	-0.9782433	0.456869	0.6701234	GO_T_CELL_PROLIFERATION	32	1.0582088	0.39684466	0.8274907	0.0799655	-2.0364521
MODULE_285	c4.CM_ cancer modules	45	-0.9780883	0.49825785	0.670453	MODULE_285	45	1.2280657	0.17579909	0.54375327	0.2499774	-2.206154
GO_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION	c5.BP_ GO biological process	16	-0.97801924	0.48097825	0.67048055	GO_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION	16	-0.649064	0.93457943	0.9764579	-1.62708324	-0.32895524
ROME_INSULIN_TARGETS_IN_MUSCLE_UP	c2.CGP_ chemical and genetic perturbations	386	-0.9779428	0.6231884	0.6705289	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	386	0	0	0	-0.9779428	-0.9779428
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	c2.CGP_ chemical and genetic perturbations	53	-0.97785366	0.49310344	0.67063046	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	54	-1.1641389	0.14159292	0.42510483	-2.14199256	0.18628524
LI_PROSTATE_CANCER_EPIGENETIC	c2.CGP_ chemical and genetic perturbations	26	-0.977669	0.46625766	0.67103225	LI_PROSTATE_CANCER_EPIGENETIC	27	1.5209374	0.0225	0.2360518	0.5432684	-2.4986064
GO_SAGA_TYPE_COMPLEX	c5.CC_ GO cellular component	29	-0.9776292	0.5188679	0.6709484	GO_SAGA_TYPE_COMPLEX	30	-0.75443596	0.9066667	0.9365766	-1.73206516	-0.22319324
GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN	C7_ immunologic signatures	160	-0.9775419	0.5588235	0.67103964	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN	166	1.0570964	0.35516888	0.8289377	0.0795545	-2.0346383
SU_PLACENTA	c2.CGP_ chemical and genetic perturbations	22	-0.9770786	0.48012233	0.6723898	SU_PLACENTA	24	1.5624416	0.012285012	0.19887307	0.585363	-2.5395202
GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP	C7_ immunologic signatures	137	-0.97695076	0.5224719	0.6726273	GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP	141	0.94844824	0.63357216	0.9837721	-0.02850252	-1.925399
GO_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING	c5.BP_ GO biological process	19	-0.97669065	0.50292397	0.6732823	GO_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING	23	1.1694335	0.2565104	0.6386015	0.19274285	-2.14612415
GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	184	-0.97667724	0.5405405	0.6731041	GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN	182	1.0725666	0.326284	0.8022685	0.09588936	-2.04924384
HALLMARK_PANCREAS_BETA_CELLS	H_ hallmark gene sets	30	-0.9765759	0.47239265	0.67323977	HALLMARK_PANCREAS_BETA_CELLS	37	1.0660752	0.39667457	0.8123434	0.0894993	-2.0426511
GO_PHAGOCYTIC_VESICLE	c5.CC_ GO cellular component	73	-0.9765573	0.50187266	0.67308855	GO_PHAGOCYTIC_VESICLE	74	0.9013609	0.67099565	1	-0.0751964	-1.8779182
GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP	C7_ immunologic signatures	170	-0.97654563	0.5133333	0.672909	GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP	177	1.1571581	0.173428	0.6581714	0.18061247	-2.13370373
GO_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION	c5.BP_ GO biological process	81	-0.97644174	0.48192772	0.6730419	GO_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION	83	0.6093456	0.98619956	1	-0.36709614	-1.58578734
BIOCARTA_HDAC_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	25	-0.9763042	0.4936306	0.67331314	BIOCARTA_HDAC_PATHWAY	27	1.5318319	0.016149068	0.22133084	0.5555277	-2.5081361
GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN	C7_ immunologic signatures	145	-0.97617894	0.55414015	0.67352414	GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN	152	0.7490702	0.9298067	1	-0.22710874	-1.72524914
LUCAS_HNF4A_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	51	-0.9761273	0.5	0.6734746	LUCAS_HNF4A_TARGETS_UP	54	1.1273649	0.28233972	0.7107625	0.1512376	-2.1034922
GO_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT	c5.BP_ GO biological process	28	-0.97604525	0.5029762	0.6735356	GO_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT	30	-0.9310594	0.57714283	0.78291804	-1.90710465	-0.04498585
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN	C7_ immunologic signatures	157	-0.975936	0.5595238	0.6736905	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN	164	1.019574	0.44016227	0.89153534	0.043638	-1.99551
GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP	C7_ immunologic signatures	172	-0.9757587	0.53741497	0.67407185	GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP	172	0.6470179	0.9919192	1	-0.3287408	-1.6227766
PID_S1P_S1P3_PATHWAY	c2.CP_ Canonical pathways	28	-0.97540647	0.4954955	0.67506313	PID_S1P_S1P3_PATHWAY	28	1.0908669	0.3520958	0.7696157	0.11546043	-2.06627337
COATES_MACROPHAGE_M1_VS_M2_DN	c2.CGP_ chemical and genetic perturbations	64	-0.9753777	0.50729924	0.6749457	COATES_MACROPHAGE_M1_VS_M2_DN	67	1.4628183	0.006472492	0.28143543	0.4874406	-2.438196
CYCLIN_D1_KE_.V1_UP	C6_ oncogenic signatures	171	-0.9750059	0.5179856	0.6759887	CYCLIN_D1_KE_.V1_UP	178	1.2273386	0.06795132	0.5460362	0.2523327	-2.2023445
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	c2.CGP_ chemical and genetic perturbations	137	-0.97473663	0.5165877	0.6766925	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	140	0.5642754	0.9989775	1	-0.41046123	-1.53901203
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA	c2.CP_REACTOME_ Reactome gene sets	22	-0.97448003	0.47887325	0.67734027	REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA	22	-1.825363	0.004784689	0.028469361	-2.79984303	0.85088297
GO_BASOLATERAL_PLASMA_MEMBRANE	c5.CC_ GO cellular component	185	-0.9743778	0.53896105	0.67748	GO_BASOLATERAL_PLASMA_MEMBRANE	200	1.315137	0.018181818	0.41834643	0.3407592	-2.2895148
HOLLMANN_APOPTOSIS_VIA_CD40_DN	c2.CGP_ chemical and genetic perturbations	221	-0.97421443	0.5609756	0.6778014	HOLLMANN_APOPTOSIS_VIA_CD40_DN	222	0.8713239	0.8169014	1	-0.10289053	-1.84553833
ZHANG_BREAST_CANCER_PROGENITORS_DN	c2.CGP_ chemical and genetic perturbations	130	-0.9741402	0.5255102	0.677826	ZHANG_BREAST_CANCER_PROGENITORS_DN	134	0.78298473	0.8902439	1	-0.19115547	-1.75712493
GO_TRANSFERASE_ACTIVITY_TRANSFERRING_GLYCOSYL_GROUPS	c5.GO molecular function	231	-0.97408944	0.49593496	0.677778	GO_TRANSFERASE_ACTIVITY_TRANSFERRING_GLYCOSYL_GROUPS	237	1.0394251	0.40361446	0.8591704	0.06533566	-2.01351454
GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN	C7_ immunologic signatures	100	-0.9737023	0.51184833	0.6788749	GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN	110	1.0496842	0.3904465	0.84079695	0.0759819	-2.0233865
WELCH_GATA1_TARGETS	c2.CGP_ chemical and genetic perturbations	20	-0.9733433	0.4796748	0.6798848	WELCH_GATA1_TARGETS	19	0.9089806	0.6188056	1	-0.0643627	-1.8823239
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	c2.CGP_ chemical and genetic perturbations	66	-0.9731702	0.5119048	0.6802629	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	68	-1.0603019	0.3243243	0.5873112	-2.0334721	0.0871317
GO_CILIARY_BASE	c5.CC_ GO cellular component	21	-0.9730671	0.5242424	0.68038625	GO_CILIARY_BASE	21	0.8385231	0.70737916	1	-0.134544	-1.8115902
GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP	C7_ immunologic signatures	183	-0.972757	0.5214724	0.6812369	GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP	185	0.80212957	0.88259107	1	-0.17062743	-1.77488657
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	c2.CGP_ chemical and genetic perturbations	36	-0.97259784	0.4731861	0.68153965	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	36	-1.1550872	0.1923077	0.43745425	-2.12768504	0.18248936
GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN	C7_ immunologic signatures	174	-0.9724326	0.5629139	0.6818934	GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN	177	1.0096002	0.4686235	0.90841234	0.0371676	-1.9820328
GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	175	-0.9723264	0.5329341	0.68204325	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN	177	1.1153786	0.23458038	0.7296826	0.1430522	-2.087705
GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP	C7_ immunologic signatures	86	-0.97220665	0.5065502	0.68225753	GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP	104	1.3078476	0.054393306	0.42912343	0.33564095	-2.28005425
GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	177	-0.97220606	0.6219512	0.6820405	GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN	178	-1.0169901	0.375	0.66325897	-1.98919616	0.04478404
GO_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION	c5.BP_ GO biological process	41	-0.9721645	0.5102041	0.68197846	GO_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION	40	-1.0187048	0.37956205	0.6615108	-1.9908693	0.0465403
GO_PROTEIN_HETEROTETRAMERIZATION	c5.BP_ GO biological process	18	-0.9718524	0.47354499	0.68281174	GO_PROTEIN_HETEROTETRAMERIZATION	18	1.0086514	0.48818898	0.91076094	0.036799	-1.9805038
GO_MODIFIED_AMINO_ACID_BINDING	c5.GO molecular function	55	-0.97182465	0.48880598	0.682682	GO_MODIFIED_AMINO_ACID_BINDING	58	1.3421474	0.06153846	0.39262384	0.37032275	-2.31397205
XU_GH1_AUTOCRINE_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	199	-0.9717888	0.5294118	0.68258685	XU_GH1_AUTOCRINE_TARGETS_UP	207	1.1731663	0.12286002	0.63347626	0.2013775	-2.1449551
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	70	-0.9717155	0.49382716	0.68260217	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	72	1.493421	0.005405406	0.25857642	0.5217055	-2.4651365
ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE	c2.CGP_ chemical and genetic perturbations	16	-0.9717134	0.5013928	0.68239146	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE	18	0.90425766	0.63185376	1	-0.06745574	-1.87597106
GO_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING	c5.BP_ GO biological process	16	-0.9715762	0.45544556	0.6826704	GO_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING	16	0.9840162	0.50990754	0.9425775	0.01244	-1.9555924
REACTOME_M_G1_TRANSITION	c2.CP_REACTOME_ Reactome gene sets	73	-0.97151184	0.5511811	0.68268096	REACTOME_M_G1_TRANSITION	74	-2.3788724	0	0	-3.35038424	1.40736056
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	c2.CGP_ chemical and genetic perturbations	26	-0.97149116	0.48101267	0.6825304	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	26	0.8119558	0.74875	1	-0.15953536	-1.78344696
GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	C7_ immunologic signatures	163	-0.9714797	0.5697674	0.68235195	GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	166	1.086493	0.30784914	0.77543384	0.1150133	-2.0579727
GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	176	-0.9713099	0.5064935	0.68271166	GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN	183	1.1249483	0.21068548	0.7153072	0.1536384	-2.0962582
GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN	C7_ immunologic signatures	172	-0.9711437	0.58278143	0.68304527	GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN	172	1.1961269	0.122345805	0.59645617	0.2249832	-2.1672706
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	178	-0.9707351	0.53892213	0.68419826	GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	181	0.71468157	0.9667003	1	-0.25605353	-1.68541667
MYCMAX_03	c3.TFT_ transcription factor targets	227	-0.97022647	0.5748032	0.68574965	MYCMAX_03	233	-0.9963828	0.75	0.6923525	-1.96660927	0.02615633
GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	C7_ immunologic signatures	179	-0.9701625	0.5244755	0.68575656	GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	182	0.6328115	0.99393326	1	-0.337351	-1.602974
GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP	C7_ immunologic signatures	178	-0.96964836	0.5479452	0.6873204	GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP	181	1.2929574	0.032290615	0.45247656	0.32330904	-2.26260576
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP	C7_ immunologic signatures	165	-0.96950877	0.5225806	0.6875753	GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP	171	-1.2686114	0	0.30987686	-2.23812017	0.29910263
GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	170	-0.96948445	0.54	0.6874316	GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	169	0.9878849	0.54352224	0.9380659	0.01840045	-1.95736935
GNF2_TNFSF10	c4.CGN_ cancer gene neighborhoods	25	-0.96928465	0.519337	0.68788445	GNF2_TNFSF10	24	0.682425	0.89367086	1	-0.28685965	-1.65170965
GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP	C7_ immunologic signatures	177	-0.96926934	0.55801105	0.6877182	GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP	177	0.8520381	0.8319756	1	-0.11723124	-1.82130744
GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP	C7_ immunologic signatures	161	-0.96922857	0.54605263	0.68763727	GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP	172	1.2855333	0.027439024	0.4625604	0.31630473	-2.25476187
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN	C7_ immunologic signatures	157	-0.9689267	0.5837838	0.68847984	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN	163	0.91487396	0.694332	1	-0.05405274	-1.88380066
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP	C7_ immunologic signatures	156	-0.9688384	0.5849057	0.6885754	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP	166	0.99394673	0.5276074	0.93090016	0.02510833	-1.96278513
GO_MRNA_CLEAVAGE	c5.BP_ GO biological process	17	-0.968644	0.4846154	0.6890077	GO_MRNA_CLEAVAGE	17	-1.0974145	0.34361234	0.5231963	-2.0660585	0.1287705
GSE3982_MAST_CELL_VS_BCELL_UP	C7_ immunologic signatures	167	-0.96789974	0.5508982	0.6912991	GSE3982_MAST_CELL_VS_BCELL_UP	172	1.2756184	0.03756345	0.47931063	0.30771866	-2.24351814
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN	c2.CGP_ chemical and genetic perturbations	38	-0.96789354	0.5029586	0.69109964	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN	38	1.0661212	0.38895416	0.8124373	0.09822766	-2.03401474
GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	C7_ immunologic signatures	188	-0.9677411	0.5548387	0.6914226	GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	189	0.9897735	0.52012074	0.9356712	0.0220324	-1.9575146
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	c2.CGP_ chemical and genetic perturbations	132	-0.9677319	0.575	0.6912337	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	133	-1.0332288	0.32	0.6331043	-2.0009607	0.0654969
ST_T_CELL_SIGNAL_TRANSDUCTION	c2.CP_ Canonical pathways	42	-0.96772474	0.5258064	0.6910437	ST_T_CELL_SIGNAL_TRANSDUCTION	44	0.820798	0.75688076	1	-0.14692674	-1.78852274
GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP	C7_ immunologic signatures	185	-0.9674879	0.5808383	0.69166774	GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP	186	0.6130591	0.9969574	1	-0.3544288	-1.580547
GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP	C7_ immunologic signatures	161	-0.96745145	0.5629139	0.6915787	GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP	166	1.1192106	0.22515213	0.72372264	0.15175915	-2.08666205
ODONNELL_METASTASIS_DN	c2.CGP_ chemical and genetic perturbations	19	-0.96739244	0.51069516	0.6915688	ODONNELL_METASTASIS_DN	21	-0.84212345	0.6755319	0.8737766	-1.80951589	-0.12526899
GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP	C7_ immunologic signatures	179	-0.9673529	0.58125	0.6914889	GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP	182	0.8146229	0.8652482	1	-0.15273	-1.7819758
GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	C7_ immunologic signatures	161	-0.9672802	0.5595238	0.69153374	GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	167	1.0834755	0.30306122	0.78065085	0.1161953	-2.0507557
GSE14026_TH1_VS_TH17_UP	C7_ immunologic signatures	164	-0.96709096	0.56804734	0.6919632	GSE14026_TH1_VS_TH17_UP	169	1.2756824	0.034412954	0.48000672	0.30859144	-2.24277336
GO_GLUCOSE_METABOLIC_PROCESS	c5.BP_ GO biological process	103	-0.96669763	0.53424656	0.693087	GO_GLUCOSE_METABOLIC_PROCESS	111	0.94726706	0.60414505	0.98497826	-0.01943057	-1.91396469
MODULE_8	c4.CM_ cancer modules	389	-0.96667653	0.625	0.692945	MODULE_8	389	0	0	0	-0.96667653	-0.96667653
FARMER_BREAST_CANCER_CLUSTER_6	c2.CGP_ chemical and genetic perturbations	15	-0.9666038	0.4958904	0.6929863	FARMER_BREAST_CANCER_CLUSTER_6	16	1.2311263	0.20126583	0.53805953	0.2645225	-2.1977301
GO_COENZYME_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	110	-0.96654123	0.57	0.6929741	GO_COENZYME_BIOSYNTHETIC_PROCESS	112	-0.9427483	0.6904762	0.7665745	-1.90928953	-0.02379293
GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	C7_ immunologic signatures	180	-0.9663664	0.53896105	0.69335186	GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	181	0.96849597	0.59778225	0.96273875	0.00212957	-1.93486237
GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	C7_ immunologic signatures	175	-0.96629494	0.5442177	0.6933719	GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	178	-1.1927645	0	0.3909218	-2.15905944	0.22646956
GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN	C7_ immunologic signatures	177	-0.9662849	0.5481928	0.6931871	GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN	180	0.7687842	0.9199595	1	-0.1975007	-1.7350691
GO_PLACENTA_BLOOD_VESSEL_DEVELOPMENT	c5.BP_ GO biological process	26	-0.96604335	0.50985914	0.69380194	GO_PLACENTA_BLOOD_VESSEL_DEVELOPMENT	28	0.8014112	0.76666665	1	-0.16463215	-1.76745455
MIKKELSEN_MEF_LCP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	50	-0.96579623	0.5255973	0.69443	MIKKELSEN_MEF_LCP_WITH_H3K27ME3	60	1.1861554	0.2037862	0.61326826	0.22035917	-2.15195163
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	c2.CGP_ chemical and genetic perturbations	44	-0.9653318	0.5322034	0.69577175	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	45	-2.0224776	0	0.006561159	-2.9878094	1.0571458
GO_TETRAPYRROLE_METABOLIC_PROCESS	c5.BP_ GO biological process	53	-0.9652128	0.5	0.6959574	GO_TETRAPYRROLE_METABOLIC_PROCESS	54	0.91181666	0.6305587	1	-0.05339614	-1.87702946
GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	178	-0.96493375	0.63190186	0.69670975	GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN	181	0.943162	0.639196	0.9885206	-0.02177175	-1.90809575
GO_FILOPODIUM_MEMBRANE	c5.CC_ GO cellular component	18	-0.9647716	0.51862466	0.6970477	GO_FILOPODIUM_MEMBRANE	18	0.9916693	0.4948718	0.9339624	0.0268977	-1.9564409
BOYAULT_LIVER_CANCER_SUBCLASS_G2	c2.CGP_ chemical and genetic perturbations	26	-0.9642413	0.5056818	0.69858074	BOYAULT_LIVER_CANCER_SUBCLASS_G2	26	-0.8987868	0.60732985	0.8225438	-1.8630281	-0.0654545
PID_PDGFRB_PATHWAY	c2.CP_ Canonical pathways	125	-0.96415085	0.5619048	0.6986813	PID_PDGFRB_PATHWAY	126	0.908303	0.6960082	1	-0.05584785	-1.87245385
GO_METALLO_SULFUR_CLUSTER_ASSEMBLY	c5.BP_ GO biological process	15	-0.96347964	0.48773843	0.70075387	GO_METALLO_SULFUR_CLUSTER_ASSEMBLY	15	-0.42440388	0.9957447	0.9906798	-1.38788352	-0.53907576
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	c2.CP_REACTOME_ Reactome gene sets	183	-0.96345896	0.5548387	0.70060253	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	186	-0.92122775	0.6	0.7944862	-1.88468671	-0.04223121
ZHENG_IL22_SIGNALING_DN	c2.CGP_ chemical and genetic perturbations	34	-0.9632419	0.52	0.7011692	ZHENG_IL22_SIGNALING_DN	34	1.1085602	0.3317702	0.74056876	0.1453183	-2.0718021
ELK1_01	c3.TFT_ transcription factor targets	234	-0.96321404	0.63709676	0.70103836	ELK1_01	244	1.0370132	0.40483382	0.86415064	0.07379916	-2.00022724
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP	C7_ immunologic signatures	168	-0.96321046	0.56790125	0.70082974	GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP	174	0.8768426	0.7854985	1	-0.08636786	-1.84005306
GO_CYTOSKELETAL_ADAPTOR_ACTIVITY	c5.GO molecular function	16	-0.963174	0.52272725	0.7007416	GO_CYTOSKELETAL_ADAPTOR_ACTIVITY	16	0.84152454	0.686606	1	-0.12164946	-1.80469854
GO_RNA_DEPENDENT_DNA_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	19	-0.9631472	0.5067751	0.70060974	GO_RNA_DEPENDENT_DNA_BIOSYNTHETIC_PROCESS	19	-0.5600215	0.98994976	0.9893497	-1.5231687	-0.4031257
GO_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	96	-0.96281964	0.51476794	0.7015519	GO_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS	97	0.8954222	0.7022175	1	-0.06739744	-1.85824184
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES	c2.CP_ Canonical pathways	32	-0.96257776	0.49710983	0.7021659	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES	32	-1.0699556	0.31073445	0.5704437	-2.03253336	0.10737784
GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP	C7_ immunologic signatures	170	-0.9624458	0.5534591	0.70241255	GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP	171	-0.8048801	1	0.9012983	-1.7673259	-0.1575657
GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP	C7_ immunologic signatures	171	-0.9623999	0.591716	0.7023421	GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP	171	0.92059314	0.68629444	1	-0.04180676	-1.88299304
GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	C7_ immunologic signatures	172	-0.9619799	0.58666664	0.7035193	GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	172	1.0434115	0.40384614	0.8527123	0.0814316	-2.0053914
GO_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	195	-0.96188307	0.6769231	0.70363176	GO_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	213	1.1900895	0.10240964	0.60534585	0.22820643	-2.15197257
GO_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	16	-0.96187013	0.48266667	0.7034534	GO_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY	19	1.4265672	0.050955415	0.31816012	0.46469707	-2.38843733
GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP	C7_ immunologic signatures	107	-0.9617876	0.5192308	0.7035261	GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP	119	1.333016	0.041710116	0.39955005	0.3712284	-2.2948036
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN	C7_ immunologic signatures	179	-0.96158195	0.60150373	0.7039955	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN	185	0.87237847	0.79313827	1	-0.08920348	-1.83396042
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	c2.CGP_ chemical and genetic perturbations	21	-0.96155953	0.52793294	0.7038464	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	21	-1.1585612	0.22105263	0.43233326	-2.12012073	0.19700167
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS	c5.GO molecular function	18	-0.9615349	0.5260417	0.7037145	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS	17	-1.3753171	0.08225108	0.22361432	-2.336852	0.4137822
GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP	C7_ immunologic signatures	176	-0.9615235	0.5855263	0.7035321	GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP	178	0.82297647	0.85714287	1	-0.13854703	-1.78449997
MORF_TERF2IP	c4.CGN_ cancer gene neighborhoods	111	-0.9612385	0.55714285	0.7042958	MORF_TERF2IP	111	-1.1863045	0.075	0.39797112	-2.147543	0.225066
GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN	C7_ immunologic signatures	173	-0.96113884	0.60818714	0.7044334	GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN	174	0.84660655	0.8149646	1	-0.11453229	-1.80774539
GSE27786_NKTCELL_VS_MONO_MAC_UP	C7_ immunologic signatures	179	-0.9608705	0.6092715	0.705151	GSE27786_NKTCELL_VS_MONO_MAC_UP	180	0.61572415	0.99898684	1	-0.34514635	-1.57659465
GTTNYYNNGGTNA_UNKNOWN	c3.TFT_ transcription factor targets	76	-0.96064603	0.58964145	0.7057082	GTTNYYNNGGTNA_UNKNOWN	78	1.1413293	0.22066738	0.6878991	0.18068327	-2.10197533
ACAWNRNSRCGG_UNKNOWN	c3.TFT_ transcription factor targets	55	-0.9604004	0.53818184	0.70634025	ACAWNRNSRCGG_UNKNOWN	56	-0.9473948	0.5555556	0.76019794	-1.9077952	-0.0130056
WU_HBX_TARGETS_3_UP	c2.CGP_ chemical and genetic perturbations	17	-0.96019214	0.48232323	0.70685077	WU_HBX_TARGETS_3_UP	17	-1.0411196	0.36051503	0.620435	-2.00131174	0.08092746
GSE17721_CTRL_VS_LPS_8H_BMDC_UP	C7_ immunologic signatures	171	-0.9601419	0.58598727	0.70679724	GSE17721_CTRL_VS_LPS_8H_BMDC_UP	177	0.80144364	0.87689203	1	-0.15869826	-1.76158554
GO_MICROBODY_PART	c5.CC_ GO cellular component	87	-0.96005964	0.51171875	0.70683986	GO_MICROBODY_PART	89	0.83680207	0.7783669	1	-0.12325757	-1.79686171
GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN	C7_ immunologic signatures	182	-0.96000177	0.6037736	0.70681113	GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN	182	0.6695482	0.9816887	1	-0.29045357	-1.62954997
GO_AMINO_ACID_BINDING	c5.GO molecular function	89	-0.9598234	0.5127119	0.70717627	GO_AMINO_ACID_BINDING	98	1.2869946	0.06875	0.4624012	0.3271712	-2.246818
GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN	C7_ immunologic signatures	167	-0.9594209	0.55151516	0.70831114	GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN	171	1.2214621	0.07614213	0.55345565	0.2620412	-2.180883
GO_LENS_FIBER_CELL_DIFFERENTIATION	c5.BP_ GO biological process	22	-0.9586763	0.49865952	0.7106357	GO_LENS_FIBER_CELL_DIFFERENTIATION	24	0.919853	0.6166253	1	-0.0388233	-1.8785293
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	c2.CGP_ chemical and genetic perturbations	21	-0.95846665	0.538874	0.711129	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	23	1.6748534	0.001230012	0.09437513	0.71638675	-2.63332005
GO_POSITIVE_REGULATION_OF_LIPID_TRANSPORT	c5.BP_ GO biological process	44	-0.9582802	0.51132685	0.7115661	GO_POSITIVE_REGULATION_OF_LIPID_TRANSPORT	46	1.2076954	0.19908467	0.5807362	0.2494152	-2.1659756
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	c2.CGP_ chemical and genetic perturbations	18	-0.95814663	0.5081522	0.71178603	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	18	0.81842184	0.710733	1	-0.13972479	-1.77656847
KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	175	-0.9577319	0.6257669	0.7129632	KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN	178	1.2002103	0.10050762	0.59181833	0.2424784	-2.1579422
AGGGCCA_MIR328	c3.MIR_ microRNA targets	74	-0.9573854	0.5542636	0.713906	AGGGCCA_MIR328	75	0.973209	0.5522067	0.95793337	0.0158236	-1.9305944
GO_POLYSACCHARIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	69	-0.9572436	0.5576208	0.71418905	GO_POLYSACCHARIDE_METABOLIC_PROCESS	72	1.015574	0.4681769	0.8966802	0.0583304	-1.9728176
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	179	-0.95711017	0.6486486	0.71443725	GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN	182	0.80028296	0.8885512	1	-0.15682721	-1.75739313
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN	C7_ immunologic signatures	175	-0.95707214	0.6091954	0.7143514	GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN	176	0.72725093	0.9542218	1	-0.22982121	-1.68432307
GO_PEPTIDYL_CYSTEINE_MODIFICATION	c5.BP_ GO biological process	18	-0.9567886	0.5175202	0.7150939	GO_PEPTIDYL_CYSTEINE_MODIFICATION	18	0.6667052	0.9045226	1	-0.2900834	-1.6234938
E4F1_Q6	c3.TFT_ transcription factor targets	249	-0.9566863	0.6160714	0.7152211	E4F1_Q6	261	-1.0174927	0.33333334	0.66277784	-1.974179	0.0608064
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP	C7_ immunologic signatures	175	-0.95656765	0.6304348	0.7154005	GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP	182	1.1593789	0.14141414	0.65344757	0.20281125	-2.11594655
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	C7_ immunologic signatures	159	-0.95619196	0.6013072	0.71647066	GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	160	1.1758647	0.14473684	0.6281698	0.21967274	-2.13205666
MODULE_430	c4.CM_ cancer modules	50	-0.9561849	0.51602566	0.71627283	MODULE_430	52	0.8430658	0.73063976	1	-0.1131191	-1.7992507
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP	C7_ immunologic signatures	178	-0.9561291	0.611465	0.71624374	GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP	184	0.88213927	0.76243657	1	-0.07398983	-1.83826837
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	c2.CGP_ chemical and genetic perturbations	25	-0.955953	0.5360231	0.7166403	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	25	0.6199924	0.9400245	1	-0.3359606	-1.5759454
GTGTCAA_MIR514	c3.MIR_ microRNA targets	57	-0.9559118	0.55514705	0.71655136	GTGTCAA_MIR514	58	0.8637509	0.7169811	1	-0.0921609	-1.8196627
GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	C7_ immunologic signatures	185	-0.95567214	0.58389264	0.71715736	GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	186	0.7106479	0.9656218	1	-0.24502424	-1.66632004
HINATA_NFKB_TARGETS_FIBROBLAST_UP	c2.CGP_ chemical and genetic perturbations	72	-0.9556071	0.53515625	0.71715635	HINATA_NFKB_TARGETS_FIBROBLAST_UP	75	0.7002006	0.92596567	1	-0.2554065	-1.6558077
ZHOU_TNF_SIGNALING_4HR	c2.CGP_ chemical and genetic perturbations	44	-0.9555689	0.53741497	0.7170564	ZHOU_TNF_SIGNALING_4HR	44	-0.8151119	0.8518519	0.892839	-1.7706808	-0.140457
GSE13306_RA_VS_UNTREATED_TREG_UP	C7_ immunologic signatures	168	-0.955413	0.6308725	0.71737957	GSE13306_RA_VS_UNTREATED_TREG_UP	171	0.65482485	0.97944504	1	-0.30058815	-1.61023785
GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN	C7_ immunologic signatures	113	-0.95533526	0.55803573	0.71742135	GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN	119	0.9285644	0.6601643	0.99937963	-0.02677086	-1.88389966
GO_REGULATION_OF_CELLULAR_PH	c5.BP_ GO biological process	65	-0.95508367	0.5450644	0.7180504	GO_REGULATION_OF_CELLULAR_PH	70	0.9171088	0.62704474	1	-0.03797487	-1.87219247
ESC_V6.5_UP_EARLY.V1_UP	C6_ oncogenic signatures	152	-0.95492256	0.59322035	0.718387	ESC_V6.5_UP_EARLY.V1_UP	158	0.92553693	0.6809378	1	-0.02938563	-1.88045949
GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP	C7_ immunologic signatures	174	-0.95488346	0.5822785	0.7182914	GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP	181	0.86497366	0.7951564	1	-0.0899098	-1.81985712
GO_INSULIN_SECRETION	c5.BP_ GO biological process	33	-0.95471156	0.55864197	0.718633	GO_INSULIN_SECRETION	37	0.8908525	0.6442874	1	-0.06385906	-1.84556406
GO_REGULATION_OF_INNATE_IMMUNE_RESPONSE	c5.BP_ GO biological process	306	-0.9544467	0.70886075	0.71928227	GO_REGULATION_OF_INNATE_IMMUNE_RESPONSE	314	0.89061314	0.7981928	1	-0.06383356	-1.84505984
GSE27786_LIN_NEG_VS_NKCELL_UP	C7_ immunologic signatures	176	-0.9544239	0.6686747	0.7191333	GSE27786_LIN_NEG_VS_NKCELL_UP	182	0.67819935	0.9808081	1	-0.27622455	-1.63262325
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	c2.CGP_ chemical and genetic perturbations	28	-0.95425326	0.53216374	0.71948195	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	28	-1.1411091	0.2247191	0.45513082	-2.09536236	0.18685584
GO_PROTEIN_MATURATION	c5.BP_ GO biological process	222	-0.9541731	0.5703125	0.71953744	GO_PROTEIN_MATURATION	230	0.9621445	0.5959799	0.9686998	0.0079714	-1.9163176
GO_RNA_POLYMERASE_II_TRANSCRIPTION_COREPRESSOR_ACTIVITY	c5.GO molecular function	24	-0.95413274	0.4937888	0.7194362	GO_RNA_POLYMERASE_II_TRANSCRIPTION_COREPRESSOR_ACTIVITY	24	-1.2213547	0.18229167	0.35420695	-2.17548744	0.26722196
GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	C7_ immunologic signatures	177	-0.95388067	0.60162604	0.7200599	GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	178	0.82512516	0.85147506	1	-0.12875551	-1.77900583
BOCHKIS_FOXA2_TARGETS	c2.CGP_ chemical and genetic perturbations	363	-0.953827	0.6666667	0.72000533	BOCHKIS_FOXA2_TARGETS	373	0.879562	0.857	1	-0.074265	-1.833389
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	15	-0.9538003	0.5208333	0.71987504	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	15	0	0	0	-0.9538003	-0.9538003
GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	C7_ immunologic signatures	155	-0.9531086	0.6280488	0.7219835	GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	164	1.0903494	0.30213633	0.77089506	0.1372408	-2.043458
GCM_MAPK10	c4.CGN_ cancer gene neighborhoods	78	-0.95307916	0.5720339	0.72185725	GCM_MAPK10	78	1.0483053	0.40106383	0.84318763	0.09522614	-2.00138446
GO_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL	c5.BP_ GO biological process	128	-0.9530746	0.57608694	0.7216494	GO_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL	128	0.95939165	0.58478934	0.97116065	0.00631705	-1.91246625
EPPERT_CE_HSC_LSC	c2.CGP_ chemical and genetic perturbations	34	-0.95294863	0.4937888	0.7218589	EPPERT_CE_HSC_LSC	35	1.1744984	0.24883178	0.6303763	0.22154977	-2.12744703
GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	161	-0.9528697	0.67058825	0.7218977	GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN	170	1.2158635	0.08638211	0.5648887	0.2629938	-2.1687332
GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP	C7_ immunologic signatures	180	-0.9527893	0.62666667	0.72195154	GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP	179	0.7389865	0.944668	1	-0.2138028	-1.6917758
GO_REGULATION_OF_DENDRITE_MORPHOGENESIS	c5.BP_ GO biological process	70	-0.95249224	0.5458015	0.72272605	GO_REGULATION_OF_DENDRITE_MORPHOGENESIS	71	0.99453485	0.506424	0.9304612	0.04204261	-1.94702709
REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1	c2.CP_REACTOME_ Reactome gene sets	16	-0.9518165	0.54404145	0.72481763	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1	16	-1.5649621	0.0349345	0.10713541	-2.5167786	0.6131456
GO_FOLIC_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	17	-0.9516727	0.5241935	0.72506523	GO_FOLIC_ACID_METABOLIC_PROCESS	17	-1.2779455	0.17721519	0.3043031	-2.2296182	0.3262728
GO_SARCOMERE_ORGANIZATION	c5.BP_ GO biological process	25	-0.95151407	0.5280236	0.725365	GO_SARCOMERE_ORGANIZATION	26	1.2610734	0.16565901	0.49505612	0.30955933	-2.21258747
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	c2.CGP_ chemical and genetic perturbations	108	-0.9514643	0.5859031	0.725312	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	115	1.5148398	0.001038422	0.23661558	0.5633755	-2.4663041
GO_FATTY_ACID_BINDING	c5.GO molecular function	24	-0.95105636	0.50764525	0.7264781	GO_FATTY_ACID_BINDING	23	0.8026827	0.76348037	1	-0.14837366	-1.75373906
GO_ORGANIC_ACID_TRANSPORT	c5.BP_ GO biological process	220	-0.9510374	0.68421054	0.7263131	GO_ORGANIC_ACID_TRANSPORT	243	1.3060819	0.009054326	0.43147913	0.3550445	-2.2571193
GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN	C7_ immunologic signatures	172	-0.95089686	0.6903226	0.7265779	GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN	176	0.8642508	0.8119919	1	-0.08664606	-1.81514766
RIZKI_TUMOR_INVASIVENESS_2D_DN	c2.CGP_ chemical and genetic perturbations	54	-0.95087385	0.5273312	0.7264316	RIZKI_TUMOR_INVASIVENESS_2D_DN	52	0.88538086	0.69497204	1	-0.06549299	-1.83625471
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	c2.CGP_ chemical and genetic perturbations	42	-0.9506104	0.5714286	0.72709686	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	43	0.8193914	0.74741673	1	-0.131219	-1.7700018
GO_GOLGI_ASSOCIATED_VESICLE	c5.CC_ GO cellular component	75	-0.9502911	0.57916665	0.727958	GO_GOLGI_ASSOCIATED_VESICLE	77	-1.2840359	0.06153846	0.29864436	-2.234327	0.3337448
GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN	C7_ immunologic signatures	182	-0.94978726	0.5912409	0.72940594	GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN	183	1.0631658	0.3420523	0.81683993	0.11337854	-2.01295306
MODULE_15	c4.CM_ cancer modules	318	-0.9495161	0.71428573	0.73007244	MODULE_15	326	0.727757	0.989	1	-0.2217591	-1.6772731
GSE3982_EOSINOPHIL_VS_MAC_DN	C7_ immunologic signatures	180	-0.94919586	0.6117647	0.7309204	GSE3982_EOSINOPHIL_VS_MAC_DN	183	0.9943869	0.5212551	0.93089664	0.04519104	-1.94358276
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN	C7_ immunologic signatures	160	-0.94908446	0.6506024	0.73108345	GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN	160	1.2881517	0.040609136	0.4613197	0.33906724	-2.23723616
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	c2.CGP_ chemical and genetic perturbations	480	-0.94876194	0.75438595	0.7319482	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	489	0.91954917	0.787	1	-0.02921277	-1.86831111
GCM_FANCC	c4.CGN_ cancer gene neighborhoods	107	-0.9487142	0.5973451	0.73188484	GCM_FANCC	112	0.7953569	0.859375	1	-0.1533573	-1.7440711
GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN	C7_ immunologic signatures	102	-0.9486328	0.60487807	0.7319361	GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN	108	1.1513634	0.2039749	0.66772974	0.2027306	-2.0999962
GO_GLUCAN_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	21	-0.9485863	0.525	0.7318778	GO_GLUCAN_BIOSYNTHETIC_PROCESS	23	1.0551487	0.40348694	0.8328266	0.1065624	-2.003735
PID_NECTIN_PATHWAY	c2.CP_ Canonical pathways	25	-0.94848835	0.502809	0.7319838	PID_NECTIN_PATHWAY	25	1.3020117	0.13780025	0.43833008	0.35352335	-2.25050005
GO_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_ENDONUCLEOLYTIC	c5.BP_ GO biological process	53	-0.9484789	0.5443425	0.73179185	GO_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_ENDONUCLEOLYTIC	53	0.43886614	0.99777037	1	-0.50961276	-1.38734504
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	c2.CGP_ chemical and genetic perturbations	72	-0.9483064	0.56666666	0.73214954	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	73	-1.3149914	0.027027028	0.27096513	-2.2632978	0.366685
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	c2.CGP_ chemical and genetic perturbations	62	-0.9480473	0.5714286	0.73282146	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	64	-0.91531384	0.6626506	0.8011716	-1.86336114	-0.03273346
GO_HISTONE_H4_ACETYLATION	c5.BP_ GO biological process	40	-0.9478809	0.54415953	0.7331561	GO_HISTONE_H4_ACETYLATION	41	-1.0682951	0.3006993	0.57305306	-2.016176	0.1204142
DAIRKEE_CANCER_PRONE_RESPONSE_E2	c2.CGP_ chemical and genetic perturbations	28	-0.9477335	0.51532036	0.7334228	DAIRKEE_CANCER_PRONE_RESPONSE_E2	28	0.8002802	0.7668269	1	-0.1474533	-1.7480137
KEGG_RNA_DEGRADATION	c2.CP_BIOCARTA_ BioCarta gene sets	53	-0.94758403	0.5422078	0.733708	KEGG_RNA_DEGRADATION	53	-1.3738303	0.039215688	0.22503494	-2.32141433	0.42624627
MORF_RFC4	c4.CGN_ cancer gene neighborhoods	138	-0.94740355	0.61025643	0.7341091	MORF_RFC4	139	-2.165384	0	0.00129783	-3.11278755	1.21798045
PARK_HSC_AND_MULTIPOTENT_PROGENITORS	c2.CGP_ chemical and genetic perturbations	49	-0.9473199	0.55518395	0.73415416	PARK_HSC_AND_MULTIPOTENT_PROGENITORS	49	-0.74159336	0.984252	0.9405463	-1.68891326	-0.20572654
GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	C7_ immunologic signatures	166	-0.94714415	0.6643836	0.734529	GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	167	0.873124	0.76899695	1	-0.07402015	-1.82026815
GO_GDP_BINDING	c5.GO molecular function	49	-0.9470655	0.5633803	0.7345698	GO_GDP_BINDING	49	-1.2597154	0.0859375	0.31490982	-2.2067809	0.3126499
GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP	C7_ immunologic signatures	179	-0.9469897	0.6984127	0.73457426	GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP	183	0.9680096	0.5792129	0.9638955	0.0210199	-1.9149993
GSE360_CTRL_VS_L_DONOVANI_MAC_DN	C7_ immunologic signatures	182	-0.94681054	0.6115108	0.73496574	GSE360_CTRL_VS_L_DONOVANI_MAC_DN	186	0.80623025	0.9033571	1	-0.14058029	-1.75304079
GO_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	23	-0.94650847	0.5151515	0.73574513	GO_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY	23	-1.329075	0.125	0.25751832	-2.27558347	0.38256653
GO_EXOCYTIC_VESICLE_MEMBRANE	c5.CC_ GO cellular component	51	-0.94637996	0.5780142	0.7359457	GO_EXOCYTIC_VESICLE_MEMBRANE	55	1.0187798	0.46436524	0.8922269	0.07239984	-1.96515976
GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_UP	C7_ immunologic signatures	176	-0.9462328	0.6084337	0.73618394	GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_UP	174	-0.94549406	0.5833333	0.76171803	-1.89172686	-0.00073874
GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_UP	C7_ immunologic signatures	178	-0.9462323	0.6861702	0.7359608	GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_UP	184	0.96438235	0.59434915	0.9660572	0.01815005	-1.91061465
GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	C7_ immunologic signatures	153	-0.9461578	0.6502732	0.7359675	GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	156	0.95967424	0.57942975	0.97072864	0.01351644	-1.90583204
GSE14308_TH2_VS_NATURAL_TREG_DN	C7_ immunologic signatures	181	-0.94612	0.73426574	0.7358804	GSE14308_TH2_VS_NATURAL_TREG_DN	183	1.2791384	0.03531786	0.47288233	0.3330184	-2.2252584
GO_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	393	-0.9459763	0.75	0.7361206	GO_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS	399	0.95287603	0.676	0.9783988	0.00689973	-1.89885233
GO_INTERMEDIATE_FILAMENT_ORGANIZATION	c5.BP_ GO biological process	15	-0.94593436	0.5421995	0.7360455	GO_INTERMEDIATE_FILAMENT_ORGANIZATION	19	-1.4978055	0.05116279	0.14390942	-2.44373986	0.55187114
GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	176	-0.94592625	0.68	0.73585355	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	177	0.5859188	0.9979798	1	-0.36000745	-1.53184505
GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP	C7_ immunologic signatures	179	-0.9458857	0.67333335	0.73575693	GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP	183	0.9316627	0.6771255	0.99809164	-0.014223	-1.8775484
GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP	C7_ immunologic signatures	176	-0.9455857	0.6363636	0.7365193	GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP	180	0.94266534	0.63942796	0.989046	-0.00292036	-1.88825104
GO_INORGANIC_ANION_EXCHANGER_ACTIVITY	c5.GO molecular function	15	-0.94554895	0.5101523	0.7364071	GO_INORGANIC_ANION_EXCHANGER_ACTIVITY	16	0.91707516	0.5989305	1	-0.02847379	-1.86262411
LIU_LIVER_CANCER	c2.CGP_ chemical and genetic perturbations	32	-0.94530773	0.5576324	0.73700166	LIU_LIVER_CANCER	33	1.1755557	0.24189815	0.628349	0.23024797	-2.12086343
GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	C7_ immunologic signatures	137	-0.9452568	0.63874346	0.7369533	GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	140	0.9480694	0.60958207	0.9840772	0.0028126	-1.8933262
GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN	C7_ immunologic signatures	176	-0.9452472	0.5988372	0.7367642	GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN	180	-1.0138181	0.33333334	0.6681775	-1.9590653	0.0685709
GO_INACTIVATION_OF_MAPK_ACTIVITY	c5.BP_ GO biological process	24	-0.9451334	0.545961	0.7369006	GO_INACTIVATION_OF_MAPK_ACTIVITY	24	0.7919185	0.7649939	1	-0.1532149	-1.7370519
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	c2.CGP_ chemical and genetic perturbations	96	-0.94493127	0.61885244	0.7373542	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	99	0.7739593	0.8832117	1	-0.17097197	-1.71889057
GO_ENDOCYTIC_VESICLE	c5.CC_ GO cellular component	216	-0.9445735	0.66923076	0.73830986	GO_ENDOCYTIC_VESICLE	222	1.1417605	0.16482411	0.6876002	0.197187	-2.086334
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	c2.CGP_ chemical and genetic perturbations	19	-0.94429386	0.54617417	0.73901415	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	17	-1.0873111	0.31779662	0.5396574	-2.03160496	0.14301724
EPPERT_PROGENITOR	c2.CGP_ chemical and genetic perturbations	121	-0.9440806	0.595	0.7395277	EPPERT_PROGENITOR	123	-1.1995497	0.03125	0.38215792	-2.1436303	0.2554691
GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN	C7_ immunologic signatures	111	-0.9438745	0.6412556	0.73996955	GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN	114	1.1547546	0.19314642	0.661889	0.2108801	-2.0986291
AMIT_EGF_RESPONSE_40_HELA	c2.CGP_ chemical and genetic perturbations	41	-0.9436972	0.5387324	0.7403376	AMIT_EGF_RESPONSE_40_HELA	41	0.98744816	0.48941177	0.93873763	0.04375096	-1.93114536
LEE_LIVER_CANCER_MYC_TGFA_DN	c2.CGP_ chemical and genetic perturbations	57	-0.943602	0.60915494	0.7404272	LEE_LIVER_CANCER_MYC_TGFA_DN	56	0.94635123	0.5751121	0.98585266	0.00274923	-1.88995323
GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP	C7_ immunologic signatures	173	-0.9435754	0.6766467	0.7402928	GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP	178	0.76576936	0.93292683	1	-0.17780604	-1.70934476
GO_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS	c5.BP_ GO biological process	67	-0.9432387	0.60714287	0.74119925	GO_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS	78	0.91216534	0.62726307	1	-0.03107336	-1.85540404
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN	C7_ immunologic signatures	158	-0.94316053	0.6306818	0.7412131	GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN	161	0.70459646	0.970618	1	-0.23856407	-1.64775699
GO_RESPONSE_TO_ELECTRICAL_STIMULUS	c5.BP_ GO biological process	40	-0.9430908	0.538206	0.7412407	GO_RESPONSE_TO_ELECTRICAL_STIMULUS	41	1.075115	0.36	0.7964733	0.1320242	-2.0182058
CHR12Q14	C1: positional gene sets	32	-0.9427952	0.57848835	0.74200577	CHR12Q14	33	1.2816603	0.13657407	0.4701584	0.3388651	-2.2244555
GO_NEGATIVE_REGULATION_OF_HEMOPOIESIS	c5.BP_ GO biological process	95	-0.942748	0.58436215	0.74193746	GO_NEGATIVE_REGULATION_OF_HEMOPOIESIS	103	0.77902806	0.88008344	1	-0.16371994	-1.72177606
GUTIERREZ_MULTIPLE_MYELOMA_UP	c2.CGP_ chemical and genetic perturbations	28	-0.94250584	0.5549133	0.74249524	GUTIERREZ_MULTIPLE_MYELOMA_UP	28	-1.2705803	0.0989011	0.30909613	-2.21308614	0.32807446
GSE17721_LPS_VS_CPG_8H_BMDC_DN	C7_ immunologic signatures	180	-0.9422566	0.6888889	0.7430802	GSE17721_LPS_VS_CPG_8H_BMDC_DN	179	0.6091046	0.99796957	1	-0.333152	-1.5513612
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	c2.CGP_ chemical and genetic perturbations	35	-0.9421225	0.5292308	0.74328876	MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	37	1.1711898	0.23672055	0.63657874	0.2290673	-2.1133123
YTCCCRNNAGGY_UNKNOWN	c3.TFT_ transcription factor targets	61	-0.9417774	0.5773585	0.74418867	YTCCCRNNAGGY_UNKNOWN	65	0.6436804	0.96234775	1	-0.298097	-1.5854578
GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP	C7_ immunologic signatures	181	-0.94160527	0.6938776	0.74452925	GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP	182	0.94675744	0.6315789	0.9853232	0.00515217	-1.88836271
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	c2.CP_REACTOME_ Reactome gene sets	30	-0.9414668	0.55172414	0.7447605	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	30	-1.9771888	0	0.010091218	-2.9186556	1.035722
GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN	C7_ immunologic signatures	169	-0.94098157	0.6685714	0.74609005	GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN	171	0.66141504	0.9827236	1	-0.27956653	-1.60239661
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	c2.CGP_ chemical and genetic perturbations	55	-0.94090176	0.57731956	0.74612683	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	56	0.9701191	0.53744495	0.9617145	0.02921734	-1.91102086
GO_NEGATIVE_REGULATION_OF_LIPID_STORAGE	c5.BP_ GO biological process	16	-0.94082355	0.53150684	0.74615884	GO_NEGATIVE_REGULATION_OF_LIPID_STORAGE	16	1.0247293	0.45725387	0.88439304	0.08390575	-1.96555285
GO_REGULATION_OF_T_CELL_DIFFERENTIATION	c5.BP_ GO biological process	86	-0.9406878	0.5974026	0.7463565	GO_REGULATION_OF_T_CELL_DIFFERENTIATION	94	1.1542894	0.22905621	0.6623102	0.2136016	-2.0949772
GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN	C7_ immunologic signatures	171	-0.9405723	0.65217394	0.74651283	GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN	172	0.8692831	0.7710233	1	-0.0712892	-1.8098554
GNF2_LCAT	c4.CGN_ cancer gene neighborhoods	96	-0.94055444	0.6043478	0.7463512	GNF2_LCAT	109	1.1610651	0.19395204	0.65118015	0.22051066	-2.10161954
GO_INTERMEDIATE_FILAMENT_BASED_PROCESS	c5.BP_ GO biological process	34	-0.93983203	0.52492666	0.748504	GO_INTERMEDIATE_FILAMENT_BASED_PROCESS	39	0.8967062	0.65303737	1	-0.04312583	-1.83653823
GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN	C7_ immunologic signatures	138	-0.9398156	0.6425121	0.7483305	GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN	142	1.0900366	0.299285	0.7713818	0.150221	-2.0298522
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP	C7_ immunologic signatures	159	-0.9397935	0.6666667	0.7481746	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP	160	0.5905812	0.9969481	1	-0.3492123	-1.5303747
GO_SPERM_PART	c5.CC_ GO cellular component	112	-0.9397622	0.6139535	0.7480535	GO_SPERM_PART	122	0.9359388	0.6237006	0.9941511	-0.0038234	-1.875701
GO_COATED_VESICLE_MEMBRANE	c5.CC_ GO cellular component	115	-0.9395959	0.6137566	0.7483781	GO_COATED_VESICLE_MEMBRANE	117	0.9345308	0.6476092	0.99539	-0.0050651	-1.8741267
GO_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME	c5.BP_ GO biological process	32	-0.93946457	0.5740741	0.74856406	GO_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME	34	-1.2728447	0.1097561	0.30851758	-2.21230927	0.33338013
GO_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	25	-0.9392748	0.56198347	0.748969	GO_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	25	1.1676844	0.26772615	0.6408678	0.2284096	-2.1069592
REACTOME_SULFUR_AMINO_ACID_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	22	-0.9389735	0.54366195	0.7497414	REACTOME_SULFUR_AMINO_ACID_METABOLISM	23	-0.86049765	0.6813187	0.8603715	-1.79947115	-0.07847585
GO_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY	c5.BP_ GO biological process	131	-0.9389684	0.5980392	0.7495357	GO_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY	132	0.7936163	0.8863869	1	-0.1453521	-1.7325847
GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP	C7_ immunologic signatures	172	-0.9384775	0.6730769	0.75095576	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP	177	-0.8115156	1	0.89588326	-1.7499931	-0.1269619
GO_ZYMOGEN_ACTIVATION	c5.BP_ GO biological process	94	-0.9384506	0.6296296	0.75081086	GO_ZYMOGEN_ACTIVATION	93	0.8431472	0.7669492	1	-0.0953034	-1.7815978
GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_DN	C7_ immunologic signatures	176	-0.9380565	0.6287879	0.7518096	GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_DN	174	1.0835983	0.3	0.7805446	0.1455418	-2.0216548
GO_NEUTRAL_AMINO_ACID_TRANSPORT	c5.BP_ GO biological process	30	-0.9379114	0.56182796	0.752051	GO_NEUTRAL_AMINO_ACID_TRANSPORT	34	1.0791192	0.35866985	0.78905946	0.1412078	-2.0170306
GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP	C7_ immunologic signatures	172	-0.93765396	0.6875	0.75264305	GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP	176	0.9866995	0.5310275	0.94014406	0.04904554	-1.92435346
SAGIV_CD24_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	21	-0.93763614	0.54415953	0.75248104	SAGIV_CD24_TARGETS_UP	21	1.2630298	0.1685254	0.49208617	0.32539366	-2.20066594
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	97	-0.937455	0.6031128	0.7528608	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	95	1.1372786	0.23667377	0.69484144	0.1998236	-2.0747336
GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN	C7_ immunologic signatures	170	-0.9373648	0.7302632	0.7529195	GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN	172	0.96311724	0.5884146	0.96763104	0.02575244	-1.90048204
GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN	C7_ immunologic signatures	180	-0.9373447	0.69536424	0.7527607	GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN	181	0.71089643	0.97965413	1	-0.22644827	-1.64824113
GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN	C7_ immunologic signatures	176	-0.93732333	0.6933333	0.7526033	GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN	175	0.9662993	0.59516615	0.9647038	0.02897597	-1.90362263
GO_REGULATION_OF_ICOSANOID_SECRETION	c5.BP_ GO biological process	16	-0.9373188	0.56216216	0.75239325	GO_REGULATION_OF_ICOSANOID_SECRETION	18	1.4631504	0.036942676	0.28202143	0.5258316	-2.4004692
GO_NUCLEOSIDE_SALVAGE	c5.BP_ GO biological process	15	-0.9372845	0.5336927	0.75227445	GO_NUCLEOSIDE_SALVAGE	15	-0.90156263	0.578125	0.8184131	-1.83884713	-0.03572187
GO_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	38	-0.93692714	0.58044165	0.75324553	GO_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	39	0.6355715	0.9584296	1	-0.30135564	-1.57249864
GO_CILIARY_PART	c5.CC_ GO cellular component	266	-0.93690157	0.8108108	0.75310427	GO_CILIARY_PART	270	1.2058057	0.05929648	0.5819079	0.26890413	-2.14270727
CETS1P54_01	c3.TFT_ transcription factor targets	229	-0.936752	0.69924814	0.75338024	CETS1P54_01	233	-0.9436708	0.6	0.7655285	-1.8804228	0.0069188
GO_CAJAL_BODY	c5.CC_ GO cellular component	46	-0.93647254	0.59177214	0.75408524	GO_CAJAL_BODY	47	-2.1092176	0	0.002559528	-3.04569014	1.17274506
GSE11924_TH1_VS_TH2_CD4_TCELL_DN	C7_ immunologic signatures	171	-0.9362744	0.69135803	0.75450164	GSE11924_TH1_VS_TH2_CD4_TCELL_DN	172	0.6769522	0.9777778	1	-0.2593222	-1.6132266
GO_REGULATION_OF_ANOIKIS	c5.BP_ GO biological process	23	-0.9362262	0.51554406	0.7544317	GO_REGULATION_OF_ANOIKIS	23	-0.8821488	0.66	0.8418696	-1.818375	-0.0540774
LANDIS_BREAST_CANCER_PROGRESSION_UP	c2.CGP_ chemical and genetic perturbations	40	-0.9360689	0.5744681	0.7547247	LANDIS_BREAST_CANCER_PROGRESSION_UP	40	-1.0686759	0.31111112	0.5727324	-2.0047448	0.132607
GO_HETEROTRIMERIC_G_PROTEIN_COMPLEX	c5.CC_ GO cellular component	31	-0.93604994	0.54858935	0.7545609	GO_HETEROTRIMERIC_G_PROTEIN_COMPLEX	31	0.92955565	0.5978774	0.99920386	-0.00649429	-1.86560559
NRL_DN.V1_UP	C6_ oncogenic signatures	126	-0.9359908	0.6454545	0.75453323	NRL_DN.V1_UP	127	1.2665617	0.063589744	0.48883998	0.3305709	-2.2025525
MIF1_01	c3.TFT_ transcription factor targets	159	-0.9358104	0.67058825	0.7548777	MIF1_01	164	0.89911354	0.7357724	1	-0.03669686	-1.83492394
CHR2Q31	C1: positional gene sets	61	-0.9357003	0.60942763	0.7549838	CHR2Q31	70	1.0140252	0.45883644	0.8999173	0.0783249	-1.9497255
CHR1Q41	C1: positional gene sets	27	-0.9350027	0.55587393	0.7570111	CHR1Q41	30	1.2994864	0.103942655	0.44375744	0.3644837	-2.2344891
GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP	C7_ immunologic signatures	168	-0.9350023	0.72988504	0.75678647	GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP	170	0.7241085	0.9703173	1	-0.2108938	-1.6591108
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS	c5.GO molecular function	25	-0.93496305	0.5426136	0.7566924	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS	25	-0.78771746	0.8317757	0.9159113	-1.72268051	-0.14724559
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	c2.CGP_ chemical and genetic perturbations	57	-0.9347579	0.59574467	0.75709534	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	57	1.1346805	0.27982163	0.69803387	0.1999226	-2.0694384
BIOCARTA_LAIR_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	-0.93473905	0.56164384	0.7569351	BIOCARTA_LAIR_PATHWAY	15	0.654038	0.9076087	1	-0.28070105	-1.58877705
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	C7_ immunologic signatures	176	-0.9344948	0.69078946	0.75747925	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	178	-1.4333755	0	0.18416184	-2.3678703	0.4988807
ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE	c2.CGP_ chemical and genetic perturbations	16	-0.93448555	0.54452926	0.75728583	ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE	16	1.1293731	0.3205298	0.7072455	0.19488755	-2.06385865
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	c2.CGP_ chemical and genetic perturbations	79	-0.93436986	0.6031746	0.7574243	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	80	-0.9077812	0.71428573	0.81308013	-1.84215106	-0.02658866
RASHI_NFKB1_TARGETS	c2.CGP_ chemical and genetic perturbations	16	-0.93429023	0.53524804	0.7574492	RASHI_NFKB1_TARGETS	16	1.3430916	0.10671937	0.39111358	0.40880137	-2.27738183
GO_EMBRYONIC_HEMOPOIESIS	c5.BP_ GO biological process	17	-0.93423325	0.565445	0.7573963	GO_EMBRYONIC_HEMOPOIESIS	19	0.8273835	0.72	1	-0.10684975	-1.76161675
GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN	C7_ immunologic signatures	178	-0.93402153	0.74698794	0.75784343	GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN	180	-1.8942636	0	0.018171657	-2.82828513	0.96024207
GO_PYRIDOXAL_PHOSPHATE_BINDING	c5.GO molecular function	40	-0.93396264	0.566879	0.75779516	GO_PYRIDOXAL_PHOSPHATE_BINDING	42	1.2005694	0.21107267	0.5915111	0.26660676	-2.13453204
GO_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION	c5.BP_ GO biological process	20	-0.9338349	0.54855645	0.7579698	GO_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION	22	1.4137585	0.064150944	0.32382804	0.4799236	-2.3475934
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	c2.CGP_ chemical and genetic perturbations	82	-0.9336745	0.6200873	0.75824976	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	80	0.7755364	0.84199136	1	-0.1581381	-1.7092109
GO_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY	c5.BP_ GO biological process	15	-0.933535	0.5584416	0.75847495	GO_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY	16	1.1995742	0.22948718	0.5931798	0.2660392	-2.1331092
GO_ACETYLTRANSFERASE_ACTIVITY	c5.GO molecular function	89	-0.9333788	0.6328125	0.7587455	GO_ACETYLTRANSFERASE_ACTIVITY	89	0.4647458	1	1	-0.468633	-1.3981246
CHR20P13	C1: positional gene sets	51	-0.93320274	0.58928573	0.7590851	CHR20P13	54	0.9608619	0.55333334	0.9701416	0.02765916	-1.89406464
LEE_LIVER_CANCER_ACOX1_DN	c2.CGP_ chemical and genetic perturbations	55	-0.93314594	0.5953307	0.75904566	LEE_LIVER_CANCER_ACOX1_DN	57	0.69192314	0.92914283	1	-0.2412228	-1.62506908
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN	C7_ immunologic signatures	171	-0.93295896	0.7385621	0.75941813	GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN	171	1.3357687	0.014285714	0.39908522	0.40280974	-2.26872766
RODWELL_AGING_KIDNEY_DN	c2.CGP_ chemical and genetic perturbations	114	-0.9328491	0.6407767	0.7595465	RODWELL_AGING_KIDNEY_DN	120	1.0065169	0.4953656	0.91311175	0.0736678	-1.939366
GSE17721_CTRL_VS_CPG_4H_BMDC_UP	C7_ immunologic signatures	180	-0.9328307	0.6467066	0.75937444	GSE17721_CTRL_VS_CPG_4H_BMDC_UP	181	0.76312816	0.938446	1	-0.16970254	-1.69595886
MODULE_110	c4.CM_ cancer modules	16	-0.9326403	0.5555556	0.75977266	MODULE_110	16	-1.7644813	0.008810572	0.04053383	-2.6971216	0.831841
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	c2.CGP_ chemical and genetic perturbations	44	-0.93254256	0.59574467	0.7598496	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	46	0.84954476	0.7265446	1	-0.0829978	-1.78208732
GO_EXOSOME_RNASE_COMPLEX_	c5.CC_ GO cellular component	19	-0.9321719	0.5611111	0.760824	GO_EXOSOME_RNASE_COMPLEX_	19	-1.4190116	0.06451613	0.19407544	-2.3511835	0.4868397
SIG_CD40PATHWAYMAP	c2.CP_ Canonical pathways	34	-0.9320727	0.561194	0.7609043	SIG_CD40PATHWAYMAP	34	0.73993635	0.8716137	1	-0.19213635	-1.67200905
BROWNE_HCMV_INFECTION_1HR_UP	c2.CGP_ chemical and genetic perturbations	53	-0.9317668	0.6083916	0.7616523	BROWNE_HCMV_INFECTION_1HR_UP	52	-0.9724499	0.5420561	0.7242857	-1.9042167	0.0406831
GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN	C7_ immunologic signatures	162	-0.93160725	0.67701864	0.7619156	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN	173	0.8503889	0.8307849	1	-0.08121835	-1.78199615
GO_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION	c5.BP_ GO biological process	79	-0.9312568	0.6398305	0.76280546	GO_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION	80	0.98331976	0.5316184	0.944026	0.05206296	-1.91457656
PID_ECADHERIN_KERATINOCYTE_PATHWAY	c2.CP_ Canonical pathways	19	-0.93117464	0.5229111	0.76284593	PID_ECADHERIN_KERATINOCYTE_PATHWAY	20	1.0715451	0.39746836	0.8030731	0.14037046	-2.00271974
HEIDENBLAD_AMPLICON_12P11_12_DN	c2.CGP_ chemical and genetic perturbations	21	-0.93113333	0.54901963	0.762748	HEIDENBLAD_AMPLICON_12P11_12_DN	21	0.79364944	0.7649301	1	-0.13748389	-1.72478277
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP	C7_ immunologic signatures	152	-0.9310049	0.671875	0.7629273	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP	163	0.8049983	0.89148074	1	-0.1260066	-1.7360032
GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP	C7_ immunologic signatures	165	-0.93068194	0.68944097	0.7637376	GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP	168	1.0673349	0.3529412	0.81049216	0.13665296	-1.99801684
KIM_MYCL1_AMPLIFICATION_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	18	-0.93064755	0.51829267	0.7636275	KIM_MYCL1_AMPLIFICATION_TARGETS_DN	18	0.9639329	0.5426667	0.9669614	0.03328535	-1.89458045
GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN	C7_ immunologic signatures	155	-0.9305831	0.6936416	0.7635988	GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN	157	0.70421183	0.9582485	1	-0.22637127	-1.63479493
GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP	C7_ immunologic signatures	176	-0.9303881	0.6551724	0.7639813	GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP	179	-1.2984971	0	0.284707	-2.2288852	0.368109
GO_GLYCOLIPID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	59	-0.93026173	0.63907284	0.76413876	GO_GLYCOLIPID_BIOSYNTHETIC_PROCESS	60	1.1967022	0.1874311	0.5966594	0.26644047	-2.12696393
GO_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX	c5.CC_ GO cellular component	15	-0.93010086	0.5607477	0.76444864	GO_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX	15	-0.8170528	0.73333335	0.89178264	-1.74715366	-0.11304806
PID_SYNDECAN_3_PATHWAY	c2.CP_ Canonical pathways	15	-0.92985255	0.5505319	0.7650162	PID_SYNDECAN_3_PATHWAY	16	1.2418531	0.18513514	0.52301276	0.31200055	-2.17170565
GO_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT	c5.BP_ GO biological process	175	-0.9298255	0.6797386	0.76487935	GO_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT	177	-1.1038135	0.18181819	0.5109444	-2.033639	0.173988
PID_HEDGEHOG_GLI_PATHWAY	c2.CP_ Canonical pathways	48	-0.9297156	0.59246576	0.7649836	PID_HEDGEHOG_GLI_PATHWAY	48	-1.1723999	0.19791667	0.41369236	-2.1021155	0.2426843
PID_IL8_CXCR2_PATHWAY	c2.CP_ Canonical pathways	31	-0.9296475	0.58126724	0.7649729	PID_IL8_CXCR2_PATHWAY	33	0.7758917	0.7930622	1	-0.1537558	-1.7055392
ST_GAQ_PATHWAY	c2.CP_ Canonical pathways	25	-0.92933387	0.572327	0.7657383	ST_GAQ_PATHWAY	25	1.1185042	0.33374536	0.7255004	0.18917033	-2.04783807
GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	C7_ immunologic signatures	166	-0.92932856	0.73255813	0.7655336	GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	167	-0.86884797	1	0.8545106	-1.79817653	-0.06048059
GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	177	-0.92888594	0.67785233	0.7667009	GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	181	1.2625057	0.053535353	0.49292958	0.33361976	-2.19139164
GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN	C7_ immunologic signatures	181	-0.9285964	0.7058824	0.7673787	GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN	182	-0.8023583	1	0.9036777	-1.7309547	-0.1262381
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	c2.CGP_ chemical and genetic perturbations	27	-0.92855376	0.5667656	0.76729476	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	32	1.6787513	0.001197605	0.09453018	0.75019754	-2.60730506
GO_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION	c5.BP_ GO biological process	35	-0.92828035	0.60634923	0.7679293	GO_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION	35	0.8813138	0.6439306	1	-0.04696655	-1.80959415
GO_REGULATION_OF_PEPTIDE_TRANSPORT	c5.BP_ GO biological process	203	-0.92826957	0.7631579	0.7677341	GO_REGULATION_OF_PEPTIDE_TRANSPORT	228	1.2593006	0.027135678	0.4974731	0.33103103	-2.18757017
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN	C7_ immunologic signatures	178	-0.92822456	0.6879433	0.76765865	GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN	178	0.7397415	0.9543611	1	-0.18848306	-1.66796606
PID_HIF2PATHWAY	c2.CP_ Canonical pathways	30	-0.92816377	0.5573248	0.7676306	PID_HIF2PATHWAY	31	-0.7175006	0.9548023	0.95230186	-1.64566437	-0.21066317
GNF2_HPX	c4.CGN_ cancer gene neighborhoods	101	-0.9278401	0.6146789	0.76842934	GNF2_HPX	113	1.1342274	0.23942208	0.69881874	0.2063873	-2.0620675
GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN	C7_ immunologic signatures	165	-0.927746	0.70552146	0.7685033	GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN	169	0.9106838	0.69847715	1	-0.0170622	-1.8384298
GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	C7_ immunologic signatures	184	-0.92763513	0.7553957	0.76861733	GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	182	-1.524439	0	0.12765524	-2.45207413	0.59680387
GSE22886_NAIVE_TCELL_VS_DC_DN	C7_ immunologic signatures	185	-0.9276174	0.7302632	0.7684537	GSE22886_NAIVE_TCELL_VS_DC_DN	185	0.91804564	0.6979798	1	-0.00957176	-1.84566304
GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN	C7_ immunologic signatures	182	-0.9272709	0.7718121	0.7693249	GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN	182	-1.3398533	0	0.24940798	-2.2671242	0.4125824
MEISSNER_BRAIN_ICP_WITH_H3K4ME3	c2.CGP_ chemical and genetic perturbations	26	-0.92716324	0.5531915	0.7694307	MEISSNER_BRAIN_ICP_WITH_H3K4ME3	27	0.8324855	0.7236364	1	-0.09467774	-1.75964874
CAFFAREL_RESPONSE_TO_THC_DN	c2.CGP_ chemical and genetic perturbations	28	-0.9270005	0.5609756	0.7697191	CAFFAREL_RESPONSE_TO_THC_DN	28	-1.0613003	0.36	0.58552265	-1.9883008	0.1342998
GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN	C7_ immunologic signatures	176	-0.92677075	0.75159234	0.77022064	GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN	180	0.6818017	0.98382205	1	-0.24496905	-1.60857245
GO_DISULFIDE_OXIDOREDUCTASE_ACTIVITY	c5.GO molecular function	26	-0.92645955	0.56880736	0.7709305	GO_DISULFIDE_OXIDOREDUCTASE_ACTIVITY	26	0.5884328	0.9532374	1	-0.33802675	-1.51489235
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	c2.CGP_ chemical and genetic perturbations	57	-0.9263423	0.6066176	0.77108645	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	57	-1.0149904	0.42718446	0.6668063	-1.9413327	0.0886481
GO_CILIUM_ORGANIZATION	c5.BP_ GO biological process	159	-0.92607874	0.6896552	0.77168995	GO_CILIUM_ORGANIZATION	160	1.290467	0.026289182	0.4572643	0.36438826	-2.21654574
GSE13887_RESTING_VS_ACT_CD4_TCELL_UP	C7_ immunologic signatures	74	-0.9251746	0.63786006	0.7742435	GSE13887_RESTING_VS_ACT_CD4_TCELL_UP	78	1.41191	0.022459893	0.32349914	0.4867354	-2.3370846
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	c2.CGP_ chemical and genetic perturbations	79	-0.92516774	0.6305221	0.77403754	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	79	0.7042054	0.9339827	1	-0.22096234	-1.62937314
GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN	C7_ immunologic signatures	175	-0.92482615	0.77124184	0.7748787	GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN	180	0.7386468	0.9382591	1	-0.18617935	-1.66347295
GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN	C7_ immunologic signatures	142	-0.9247711	0.70430106	0.77482116	GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN	158	1.39265	0.001020408	0.34805802	0.4678789	-2.3174211
MORF_BMPR2	c4.CGN_ cancer gene neighborhoods	43	-0.92464334	0.6026936	0.77500093	MORF_BMPR2	42	1.3343374	0.083908044	0.3988524	0.40969406	-2.25898074
MODULE_295	c4.CM_ cancer modules	20	-0.9245684	0.59365994	0.77500886	MODULE_295	21	1.245899	0.15566625	0.5176398	0.3213306	-2.1704674
GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN	C7_ immunologic signatures	166	-0.9244958	0.7277778	0.7749948	GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN	171	0.7669409	0.9047619	1	-0.1575549	-1.6914367
GO_NUCLEOTIDE_EXCISION_REPAIR	c5.BP_ GO biological process	107	-0.9244378	0.64806867	0.77495307	GO_NUCLEOTIDE_EXCISION_REPAIR	107	-1.0871438	0.20588236	0.5393287	-2.0115816	0.162706
GO_MODULATION_BY_SYMBIONT_OF_HOST_CELLULAR_PROCESS	c5.BP_ GO biological process	25	-0.924391	0.5257453	0.7748726	GO_MODULATION_BY_SYMBIONT_OF_HOST_CELLULAR_PROCESS	25	-1.3389205	0.065989845	0.24922727	-2.2633115	0.4145295
CCAGGTT_MIR490	c3.MIR_ microRNA targets	60	-0.9243618	0.63468635	0.77474207	CCAGGTT_MIR490	60	-1.1105992	0.2888889	0.50429475	-2.034961	0.1862374
LFA1_Q6	c3.TFT_ transcription factor targets	216	-0.9241819	0.7291667	0.77507365	LFA1_Q6	225	0.70208895	0.9808661	1	-0.22209295	-1.62627085
GO_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	45	-0.9241746	0.5865724	0.77487344	GO_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	44	-1.0454594	0.38392857	0.61325043	-1.969634	0.1212848
GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP	C7_ immunologic signatures	104	-0.9238494	0.68122274	0.7756575	GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP	111	1.3957108	0.019668737	0.34733132	0.4718614	-2.3195602
GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP	C7_ immunologic signatures	162	-0.9238278	0.76397514	0.77549636	GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP	165	1.0160166	0.48380566	0.8958765	0.0921888	-1.9398444
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN	C7_ immunologic signatures	151	-0.92366743	0.70414203	0.7757812	GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN	156	1.0117987	0.4720812	0.90415096	0.08813127	-1.93546613
GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP	C7_ immunologic signatures	182	-0.92361915	0.71022725	0.77570474	GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP	181	-0.9929379	0.61538464	0.6990338	-1.91655705	0.06931875
MODULE_71	c4.CM_ cancer modules	20	-0.92357004	0.5734072	0.7756415	MODULE_71	21	1.3409126	0.111817025	0.39585626	0.41734256	-2.26448264
MANTOVANI_VIRAL_GPCR_SIGNALING_DN	c2.CGP_ chemical and genetic perturbations	42	-0.9234785	0.6026059	0.7757164	MANTOVANI_VIRAL_GPCR_SIGNALING_DN	44	0.8775033	0.684633	1	-0.0459752	-1.8009818
GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	C7_ immunologic signatures	82	-0.92340356	0.6331878	0.775732	GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	87	1.0358382	0.41956523	0.8658827	0.11243464	-1.95924176
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	44	-0.9231034	0.61612904	0.7764084	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	45	-1.1074308	0.23275863	0.5070826	-2.0305342	0.1843274
GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP	C7_ immunologic signatures	179	-0.92307377	0.79569894	0.77627164	GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP	180	1.0415237	0.39311042	0.8565505	0.11844993	-1.96459747
CHR12Q24	C1: positional gene sets	180	-0.9226653	0.757764	0.7773053	CHR12Q24	184	1.3141167	0.021276595	0.4194799	0.3914514	-2.236782
GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_DN	C7_ immunologic signatures	174	-0.922597	0.73214287	0.777286	GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_DN	179	0.901599	0.7507599	1	-0.020998	-1.824196
GNF2_SERPINB5	c4.CGN_ cancer gene neighborhoods	25	-0.9225764	0.5777778	0.777123	GNF2_SERPINB5	27	1.991714	0	0.001776115	1.0691376	-2.9142904
GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP	C7_ immunologic signatures	183	-0.92232096	0.74	0.7777059	GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP	184	1.1548909	0.15175879	0.6621155	0.23256994	-2.07721186
GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP	C7_ immunologic signatures	180	-0.92216486	0.7664671	0.7779764	GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP	185	1.0025886	0.4989899	0.918596	0.08042374	-1.92475346
GO_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_CELL_CELL_SIGNALING	c5.BP_ GO biological process	61	-0.92189133	0.61278194	0.778582	GO_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_CELL_CELL_SIGNALING	70	1.1622363	0.21827957	0.6497405	0.24034497	-2.08412763
GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP	C7_ immunologic signatures	177	-0.92166084	0.7823129	0.7790687	GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP	184	0.6935229	0.9777328	1	-0.22813794	-1.61518374
GO_HEME_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	18	-0.92158544	0.54444444	0.77907515	GO_HEME_BIOSYNTHETIC_PROCESS	18	0.66840583	0.87867177	1	-0.25317961	-1.58999127
GO_DOUBLE_STRANDED_RNA_BINDING	c5.GO molecular function	57	-0.9213498	0.61904764	0.7795828	GO_DOUBLE_STRANDED_RNA_BINDING	58	-1.0172602	0.35164836	0.6631348	-1.93861	0.0959104
GO_STEROL_HOMEOSTASIS	c5.BP_ GO biological process	48	-0.92076874	0.5826772	0.7811201	GO_STEROL_HOMEOSTASIS	51	-1.083769	0.24038461	0.5443694	-2.00453774	0.16300026
GSE43955_10H_VS_30H_ACT_CD4_TCELL_DN	C7_ immunologic signatures	175	-0.920762	0.777027	0.7809176	GSE43955_10H_VS_30H_ACT_CD4_TCELL_DN	180	0.87138146	0.7747475	1	-0.04938054	-1.79214346
GO_DRUG_TRANSPORT	c5.BP_ GO biological process	21	-0.9197898	0.5860215	0.78364015	GO_DRUG_TRANSPORT	23	1.3795253	0.056603774	0.3556222	0.4597355	-2.2993151
KEGG_LYSINE_DEGRADATION	c2.CP_BIOCARTA_ BioCarta gene sets	35	-0.9197716	0.5830619	0.7834766	KEGG_LYSINE_DEGRADATION	34	0.7692055	0.81917477	1	-0.1505661	-1.6889771
KEGG_HEDGEHOG_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	46	-0.91958493	0.61904764	0.7838128	KEGG_HEDGEHOG_SIGNALING_PATHWAY	52	0.7393117	0.8851351	1	-0.18027323	-1.65889663
GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	C7_ immunologic signatures	176	-0.91903675	0.6993865	0.78525764	GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	182	0.79809433	0.8770161	1	-0.12094242	-1.71713108
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN	C7_ immunologic signatures	176	-0.91903025	0.7443609	0.78505296	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN	184	1.0332692	0.4111675	0.8716266	0.11423895	-1.95229945
GO_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY	c5.GO molecular function	18	-0.9189985	0.57881135	0.7849193	GO_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY	18	-1.0889729	0.30932203	0.5361246	-2.0079714	0.1699744
GO_DICARBOXYLIC_ACID_CATABOLIC_PROCESS	c5.BP_ GO biological process	16	-0.9188981	0.5613079	0.7849894	GO_DICARBOXYLIC_ACID_CATABOLIC_PROCESS	16	0.6486287	0.91492146	1	-0.2702694	-1.5675268
GO_CIS_GOLGI_NETWORK	c5.CC_ GO cellular component	37	-0.9188049	0.62046206	0.78504395	GO_CIS_GOLGI_NETWORK	37	0.8315392	0.74065423	1	-0.0872657	-1.7503441
TGTYNNNNNRGCARM_UNKNOWN	c3.TFT_ transcription factor targets	73	-0.9185591	0.6457565	0.785562	TGTYNNNNNRGCARM_UNKNOWN	79	1.146499	0.22679324	0.67536545	0.2279399	-2.0650581
KEGG_N_GLYCAN_BIOSYNTHESIS	c2.CP_BIOCARTA_ BioCarta gene sets	44	-0.91832435	0.5830619	0.7860523	KEGG_N_GLYCAN_BIOSYNTHESIS	44	-0.73710567	0.9440559	0.94356745	-1.65543002	-0.18121868
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	c2.CGP_ chemical and genetic perturbations	32	-0.91810966	0.5968254	0.7864833	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	34	-1.0230571	0.44720498	0.65462506	-1.94116676	0.10494744
GO_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN	c5.BP_ GO biological process	35	-0.9179924	0.62540716	0.7865959	GO_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN	37	1.4679521	0.014806378	0.2771517	0.5499597	-2.3859445
GO_POSTTRANSCRIPTIONAL_GENE_SILENCING	c5.BP_ GO biological process	36	-0.91790307	0.59876543	0.78664744	GO_POSTTRANSCRIPTIONAL_GENE_SILENCING	36	-0.75256974	0.8984375	0.93785584	-1.67047281	-0.16533333
MORF_EIF4E	c4.CGN_ cancer gene neighborhoods	80	-0.9177486	0.65917605	0.7869013	MORF_EIF4E	80	-1.5665634	0	0.10641358	-2.484312	0.6488148
GO_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR	c5.BP_ GO biological process	25	-0.91770357	0.61349696	0.78680915	GO_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR	27	0.6663847	0.9037037	1	-0.25131887	-1.58408827
GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	C7_ immunologic signatures	151	-0.9174089	0.73157895	0.787462	GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	156	0.90414304	0.70162934	1	-0.01326586	-1.82155194
GSE22886_NAIVE_CD4_TCELL_VS_DC_DN	C7_ immunologic signatures	177	-0.91732734	0.76258993	0.78747606	GSE22886_NAIVE_CD4_TCELL_VS_DC_DN	179	0.74638903	0.9402229	1	-0.17093831	-1.66371637
GO_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	243	-0.91729295	0.7983871	0.78735054	GO_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	270	1.2806706	0.02	0.47112232	0.36337765	-2.19796355
GO_NEGATIVE_REGULATION_OF_ENDOCYTOSIS	c5.BP_ GO biological process	31	-0.91704875	0.5860058	0.78787476	GO_NEGATIVE_REGULATION_OF_ENDOCYTOSIS	35	-1.4043069	0.05625	0.20314729	-2.32135565	0.48725815
GO_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE	c5.BP_ GO biological process	100	-0.91683143	0.66519827	0.7882881	GO_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE	103	0.8958497	0.71159875	1	-0.02098173	-1.81268113
GO_MATURE_B_CELL_DIFFERENTIATION	c5.BP_ GO biological process	16	-0.91679597	0.5974026	0.7881614	GO_MATURE_B_CELL_DIFFERENTIATION	17	1.0519882	0.41428572	0.83688414	0.13519223	-1.96878417
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN	c2.CGP_ chemical and genetic perturbations	41	-0.9159771	0.6242424	0.7903616	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN	42	-1.3105757	0.05839416	0.27368635	-2.2265528	0.3945986
GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS	c5.GO molecular function	216	-0.91594315	0.7950311	0.790239	GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS	221	0.5957649	0.997998	1	-0.32017825	-1.51170805
MEISSNER_BRAIN_HCP_WITH_H3K4ME2	c2.CGP_ chemical and genetic perturbations	15	-0.9155002	0.57824934	0.791353	MEISSNER_BRAIN_HCP_WITH_H3K4ME2	16	0.8654141	0.6430446	1	-0.0500861	-1.7809143
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	c2.CP_REACTOME_ Reactome gene sets	54	-0.915176	0.6201299	0.79210407	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	55	1.3675134	0.057331864	0.3703428	0.4523374	-2.2826894
GO_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX	c5.CC_ GO cellular component	29	-0.91511285	0.57239056	0.79207	GO_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX	29	-0.6663208	0.994382	0.9730455	-1.58143365	-0.24879205
MORF_TPR	c4.CGN_ cancer gene neighborhoods	136	-0.91501814	0.71794873	0.79214525	MORF_TPR	136	-0.622459	1	0.98114413	-1.53747714	-0.29255914
GNF2_RAB7L1	c4.CGN_ cancer gene neighborhoods	20	-0.9150116	0.578125	0.7919388	GNF2_RAB7L1	20	0.94186795	0.56997454	0.9888338	0.02685635	-1.85687955
GO_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	17	-0.9149961	0.59416443	0.79175127	GO_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	18	1.1155809	0.33628318	0.7298534	0.2005848	-2.030577
GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP	C7_ immunologic signatures	180	-0.91465163	0.77348065	0.7925544	GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP	180	0.9063368	0.72284263	1	-0.00831483	-1.82098843
GO_RECEPTOR_SIGNALING_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	c5.GO molecular function	85	-0.91455555	0.68085104	0.79262054	GO_RECEPTOR_SIGNALING_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY	86	1.3407136	0.04375667	0.39599395	0.42615805	-2.25526915
GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN	C7_ immunologic signatures	169	-0.9143225	0.7175141	0.79305786	GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN	173	0.75419825	0.9412361	1	-0.16012425	-1.66852075
REACTOME_PHASE_II_CONJUGATION	c2.CP_REACTOME_ Reactome gene sets	47	-0.9142908	0.64309764	0.7929277	REACTOME_PHASE_II_CONJUGATION	48	1.2333758	0.15168539	0.5358199	0.319085	-2.1476666
GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	C7_ immunologic signatures	180	-0.91395223	0.7705882	0.7937333	GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	180	-0.9738356	0.6315789	0.7234029	-1.88778783	0.05988337
GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP	C7_ immunologic signatures	160	-0.9137442	0.73214287	0.79414016	GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP	160	0.82472163	0.85136503	1	-0.08902257	-1.73846583
GO_CYTOKINE_RECEPTOR_ACTIVITY	c5.GO molecular function	73	-0.9137051	0.671875	0.79402936	GO_CYTOKINE_RECEPTOR_ACTIVITY	80	-1.2401351	0.06896552	0.33511746	-2.1538402	0.32643
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	c2.CGP_ chemical and genetic perturbations	36	-0.91359025	0.5805369	0.79413676	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	36	-0.8718062	0.6875	0.85411686	-1.78539645	-0.04178405
PID_IL8_CXCR1_PATHWAY	c2.CP_ Canonical pathways	25	-0.9132522	0.5843023	0.794947	PID_IL8_CXCR1_PATHWAY	25	1.1364172	0.30884185	0.6956904	0.223165	-2.0496694
GO_TELOMERE_MAINTENANCE_VIA_TELOMERASE	c5.BP_ GO biological process	16	-0.9129708	0.5902062	0.79555583	GO_TELOMERE_MAINTENANCE_VIA_TELOMERASE	16	-0.68334836	0.9230769	0.9673215	-1.59631916	-0.22962244
GO_COATED_MEMBRANE	c5.CC_ GO cellular component	76	-0.9128463	0.6561265	0.7957217	GO_COATED_MEMBRANE	77	1.0021844	0.47812167	0.91976076	0.0893381	-1.9150307
GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP	C7_ immunologic signatures	121	-0.9126956	0.7416268	0.79593956	GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP	128	1.2475736	0.090815276	0.5151302	0.334878	-2.1602692
GO_NEGATIVE_REGULATION_OF_DNA_BINDING	c5.BP_ GO biological process	41	-0.91242284	0.64285713	0.79650164	GO_NEGATIVE_REGULATION_OF_DNA_BINDING	42	-1.802373	0	0.03252636	-2.71479584	0.88995016
GO_ER_TO_GOLGI_TRANSPORT_VESICLE	c5.CC_ GO cellular component	51	-0.9120855	0.65555555	0.7972687	GO_ER_TO_GOLGI_TRANSPORT_VESICLE	51	0.94536203	0.59167606	0.98692983	0.03327653	-1.85744753
CGGAARNGGCNG_UNKNOWN	c3.TFT_ transcription factor targets	45	-0.91200453	0.59942365	0.79727566	CGGAARNGGCNG_UNKNOWN	47	0.5122144	0.99657536	1	-0.39979013	-1.42421893
GO_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION	c5.BP_ GO biological process	21	-0.9118493	0.5884058	0.79751664	GO_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION	24	0.9861313	0.5044136	0.940637	0.074282	-1.8979806
GO_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION	c5.BP_ GO biological process	46	-0.91171056	0.63265306	0.7977002	GO_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION	48	1.1623968	0.23041998	0.64952546	0.25068624	-2.07410736
GO_MYOSIN_V_BINDING	c5.GO molecular function	17	-0.9116493	0.56498677	0.79766583	GO_MYOSIN_V_BINDING	17	0.8753453	0.6759259	1	-0.036304	-1.7869946
GO_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE	c5.BP_ GO biological process	38	-0.9115567	0.62025315	0.79772544	GO_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE	43	1.5867394	0.00812065	0.17662568	0.6751827	-2.4982961
GO_NUCLEAR_TRANSCRIPTIONAL_REPRESSOR_COMPLEX	c5.CC_ GO cellular component	21	-0.91127485	0.5643045	0.79833	GO_NUCLEAR_TRANSCRIPTIONAL_REPRESSOR_COMPLEX	21	-0.8404151	0.7095238	0.8755376	-1.75168995	-0.07085975
GO_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	c5.BP_ GO biological process	35	-0.910912	0.62349397	0.7991831	GO_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE	37	1.5845098	0.006928407	0.1771677	0.6735978	-2.4954218
GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP	C7_ immunologic signatures	176	-0.9107275	0.7345679	0.799505	GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP	175	-1.118878	0.11111111	0.4900047	-2.0296055	0.2081505
GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_UP	C7_ immunologic signatures	182	-0.9105621	0.7763975	0.799762	GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_UP	182	0.8636971	0.80020183	1	-0.046865	-1.7742592
PETRETTO_HEART_MASS_QTL_CIS_DN	c2.CGP_ chemical and genetic perturbations	20	-0.91055846	0.58115184	0.799544	PETRETTO_HEART_MASS_QTL_CIS_DN	21	-1.2287844	0.16	0.34720314	-2.13934286	0.31822594
REACTOME_SIGNALING_BY_NOTCH	c2.CP_REACTOME_ Reactome gene sets	92	-0.91049993	0.6954315	0.79949445	REACTOME_SIGNALING_BY_NOTCH	93	0.8395498	0.7993631	1	-0.07095013	-1.75004973
GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN	C7_ immunologic signatures	170	-0.9100742	0.74657536	0.800555	GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN	171	1.0182214	0.45482233	0.8924815	0.1081472	-1.9282956
GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN	C7_ immunologic signatures	181	-0.9094135	0.76666665	0.8023172	GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN	179	-0.8579872	1	0.8617103	-1.7674007	-0.0514263
GO_LIVER_REGENERATION	c5.BP_ GO biological process	16	-0.9092572	0.5863014	0.8025409	GO_LIVER_REGENERATION	19	0.9820422	0.5127877	0.94594973	0.072785	-1.8912994
KAYO_AGING_MUSCLE_DN	c2.CGP_ chemical and genetic perturbations	101	-0.90886295	0.7113821	0.8034543	KAYO_AGING_MUSCLE_DN	104	0.79252017	0.8580376	1	-0.11634278	-1.70138312
GO_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE	c5.BP_ GO biological process	18	-0.9087933	0.58542717	0.80343366	GO_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE	18	1.1230491	0.31464967	0.7199804	0.2142558	-2.0318424
GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER	c5.BP_ GO biological process	23	-0.90849745	0.57670456	0.8040783	GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER	23	-0.93105763	0.57990867	0.7825435	-1.83955508	0.02256018
GO_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION	c5.BP_ GO biological process	16	-0.9084228	0.5696517	0.8040617	GO_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION	18	1.1646018	0.27586207	0.64623064	0.256179	-2.0730246
GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN	C7_ immunologic signatures	136	-0.9082967	0.8045977	0.80421025	GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN	138	1.2655745	0.066047475	0.48964202	0.3572778	-2.1738712
GO_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT	c5.BP_ GO biological process	20	-0.90807474	0.6342857	0.8046188	GO_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT	21	-0.93069863	0.5320197	0.78242916	-1.83877337	0.02262389
GO_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT	c5.BP_ GO biological process	37	-0.9074136	0.6515151	0.80630386	GO_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT	37	0.95274484	0.54674554	0.97856003	0.04533124	-1.86015844
GO_REGULATION_OF_PROTEIN_OLIGOMERIZATION	c5.BP_ GO biological process	26	-0.9071777	0.59117645	0.80677825	GO_REGULATION_OF_PROTEIN_OLIGOMERIZATION	28	1.1901788	0.22921616	0.60569954	0.2830011	-2.0973565
GO_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY	c5.BP_ GO biological process	39	-0.9069383	0.5974441	0.8072301	GO_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY	41	1.1538588	0.25925925	0.66363627	0.2469205	-2.0607971
WEBER_METHYLATED_HCP_IN_SPERM_UP	c2.CGP_ chemical and genetic perturbations	16	-0.90661204	0.602122	0.8079561	WEBER_METHYLATED_HCP_IN_SPERM_UP	18	1.5593555	0.015978696	0.19734985	0.65274346	-2.46596754
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP	C7_ immunologic signatures	173	-0.9062069	0.7865854	0.80887663	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP	176	1.0302782	0.43680486	0.8751354	0.1240713	-1.9364851
REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	c2.CP_REACTOME_ Reactome gene sets	65	-0.90606767	0.68217057	0.8090347	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	65	0.7536674	0.8583878	1	-0.15240027	-1.65973507
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP	C7_ immunologic signatures	174	-0.90583694	0.8366013	0.80947	GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP	173	0.5918798	0.99797773	1	-0.31395714	-1.49771674
GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP	C7_ immunologic signatures	179	-0.9055443	0.794702	0.8100837	GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP	178	0.6662742	0.9818182	1	-0.2392701	-1.5718185
KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP	C7_ immunologic signatures	172	-0.9053919	0.8011696	0.810305	KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP	177	1.213098	0.08467742	0.5724338	0.3077061	-2.1184899
GO_NEGATIVE_REGULATION_OF_CELL_AGING	c5.BP_ GO biological process	16	-0.90523636	0.59125966	0.8105292	GO_NEGATIVE_REGULATION_OF_CELL_AGING	16	0.98517007	0.50845253	0.94174993	0.07993371	-1.89040643
GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	C7_ immunologic signatures	176	-0.9048056	0.79347825	0.8115152	GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	177	-1.3776917	0	0.22230503	-2.2824973	0.4728861
GO_TRANSCRIPTION_COACTIVATOR_ACTIVITY	c5.GO molecular function	273	-0.9047736	0.8804348	0.8113704	GO_TRANSCRIPTION_COACTIVATOR_ACTIVITY	282	0.75271344	0.972973	1	-0.15206016	-1.65748704
GO_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS	c5.BP_ GO biological process	28	-0.90463996	0.60670733	0.8115262	GO_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS	32	0.53603643	0.98579884	1	-0.36860353	-1.44067639
GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	C7_ immunologic signatures	167	-0.90403885	0.7785235	0.813026	GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	174	0.8345958	0.85162604	1	-0.06944305	-1.73863465
GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN	C7_ immunologic signatures	168	-0.9040356	0.8089172	0.812805	GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN	170	0.8176305	0.86995965	1	-0.0864051	-1.7216661
GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN	C7_ immunologic signatures	160	-0.90387523	0.835443	0.8130306	GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN	164	0.748868	0.93340063	1	-0.15500723	-1.65274323
REACTOME_TOLL_RECEPTOR_CASCADES	c2.CP_REACTOME_ Reactome gene sets	104	-0.9038491	0.7014218	0.812877	REACTOME_TOLL_RECEPTOR_CASCADES	106	0.7985894	0.8580311	1	-0.1052597	-1.7024385
GCM_SMARCD1	c4.CGN_ cancer gene neighborhoods	85	-0.90300566	0.70869565	0.81508505	GCM_SMARCD1	91	0.959304	0.55520505	0.9710565	0.05629834	-1.86230966
CONRAD_STEM_CELL	c2.CGP_ chemical and genetic perturbations	37	-0.902442	0.6273292	0.8164171	CONRAD_STEM_CELL	38	0.9183782	0.6150121	1	0.0159362	-1.8208202
GO_DIOXYGENASE_ACTIVITY	c5.GO molecular function	76	-0.90222794	0.7035573	0.81678337	GO_DIOXYGENASE_ACTIVITY	76	0.8224451	0.79044515	1	-0.07978284	-1.72467304
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP	C7_ immunologic signatures	155	-0.90209347	0.8181818	0.81692773	GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP	160	1.2865288	0.03767821	0.46213603	0.38443533	-2.18862227
GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP	C7_ immunologic signatures	176	-0.9018812	0.75625	0.8173036	GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP	177	-1.0126923	0.45	0.66944414	-1.9145735	0.1108111
MODULE_411	c4.CM_ cancer modules	65	-0.9015953	0.7007299	0.8178712	MODULE_411	71	0.9492737	0.5819582	0.9830285	0.0476784	-1.850869
GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN	C7_ immunologic signatures	177	-0.90154356	0.81294966	0.8177803	GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN	178	-1.3438766	0	0.24631643	-2.24542016	0.44233304
GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_DN	C7_ immunologic signatures	171	-0.9014065	0.86904764	0.81795883	GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_DN	175	0.93904036	0.6453901	0.9914054	0.03763386	-1.84044686
GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP	C7_ immunologic signatures	134	-0.90089965	0.7724551	0.81918746	GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP	137	1.0117246	0.460041	0.9041596	0.11082495	-1.91262425
PPARA_02	c3.TFT_ transcription factor targets	114	-0.90059096	0.75	0.81981236	PPARA_02	116	0.901634	0.6884735	1	0.00104304	-1.80222496
SP1_Q6_01	c3.TFT_ transcription factor targets	223	-0.9004673	0.8981481	0.819928	SP1_Q6_01	224	-1.1053445	0.16666667	0.5089627	-2.0058118	0.2048772
RASHI_RESPONSE_TO_IONIZING_RADIATION_3	c2.CGP_ chemical and genetic perturbations	45	-0.9003745	0.64356434	0.8199423	RASHI_RESPONSE_TO_IONIZING_RADIATION_3	45	0.8481838	0.73015875	1	-0.0521907	-1.7485583
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN	c2.CGP_ chemical and genetic perturbations	15	-0.90027755	0.6025974	0.81999195	VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN	15	-1.467129	0.072649576	0.16345654	-2.36740655	0.56685145
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	C7_ immunologic signatures	135	-0.8999122	0.73239434	0.82077175	GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	145	0.92179203	0.67039675	1	0.02187983	-1.82170423
GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN	C7_ immunologic signatures	168	-0.89951915	0.8265896	0.82165855	GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN	170	-0.9598489	0.7777778	0.7420624	-1.85936805	0.06032975
GSE40666_WT_VS_STAT4_KO_CD8_TCELL_DN	C7_ immunologic signatures	168	-0.8993725	0.8251748	0.8218291	GSE40666_WT_VS_STAT4_KO_CD8_TCELL_DN	169	0.7640624	0.930824	1	-0.1353101	-1.6634349
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	74	-0.8993697	0.70342207	0.82160676	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	79	1.3413252	0.05379747	0.39457744	0.4419555	-2.2406949
GO_REGULATION_OF_MITOCHONDRION_ORGANIZATION	c5.BP_ GO biological process	185	-0.8993121	0.7972973	0.8215434	GO_REGULATION_OF_MITOCHONDRION_ORGANIZATION	187	1.0000916	0.4908722	0.92447895	0.1007795	-1.8994037
GO_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS	c5.BP_ GO biological process	16	-0.8989463	0.58476657	0.8223745	GO_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS	16	0.67697006	0.88988477	1	-0.22197624	-1.57591636
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA	c2.CP_REACTOME_ Reactome gene sets	24	-0.8986094	0.6291209	0.8230865	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA	24	0.9914521	0.4864865	0.9340738	0.0928427	-1.8900615
GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP	C7_ immunologic signatures	175	-0.89850855	0.8095238	0.8231416	GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP	181	-1.0869073	0.21052632	0.53959125	-1.98541585	0.18839875
GSE14308_TH1_VS_NATURAL_TREG_DN	C7_ immunologic signatures	176	-0.89848447	0.84210527	0.8229773	GSE14308_TH1_VS_NATURAL_TREG_DN	178	1.2399819	0.05941591	0.5260173	0.34149743	-2.13846637
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	30	-0.8984206	0.62941176	0.8229166	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	31	0.4715127	1	1	-0.4269079	-1.3699333
GSE7460_TCONV_VS_TREG_THYMUS_UP	C7_ immunologic signatures	186	-0.8981115	0.8357143	0.8235177	GSE7460_TCONV_VS_TREG_THYMUS_UP	185	1.3190688	0.009127789	0.4125548	0.4209573	-2.2171803
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	c2.CGP_ chemical and genetic perturbations	24	-0.89791125	0.61495847	0.8238146	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	25	0.83448803	0.70522386	1	-0.06342322	-1.73239928
GO_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_S_S_BONDS	c5.GO molecular function	18	-0.89754444	0.6246787	0.82458824	GO_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_S_S_BONDS	18	-0.7193534	0.9255814	0.9518074	-1.61689784	-0.17819104
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP	C7_ immunologic signatures	173	-0.89750576	0.8457143	0.8244551	GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP	178	-1.258532	0	0.3160651	-2.15603776	0.36102624
GO_ER_NUCLEUS_SIGNALING_PATHWAY	c5.BP_ GO biological process	31	-0.89724743	0.6564417	0.82493925	GO_ER_NUCLEUS_SIGNALING_PATHWAY	31	-1.293414	0.10909091	0.28908774	-2.19066143	0.39616657
CTCNANGTGNY_UNKNOWN	c3.TFT_ transcription factor targets	71	-0.89714086	0.6949807	0.82500684	CTCNANGTGNY_UNKNOWN	76	0.8416805	0.7653928	1	-0.05546036	-1.73882136
GO_PHOTORECEPTOR_INNER_SEGMENT	c5.CC_ GO cellular component	34	-0.8970333	0.6576577	0.82508284	GO_PHOTORECEPTOR_INNER_SEGMENT	35	1.0478162	0.41327125	0.84397364	0.1507829	-1.9448495
MORI_PLASMA_CELL_UP	c2.CGP_ chemical and genetic perturbations	47	-0.8968893	0.64028776	0.82524675	MORI_PLASMA_CELL_UP	47	-1.4053036	0.032258064	0.20268506	-2.3021929	0.5084143
BIOCARTA_CARM_ER_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	33	-0.8968604	0.6626506	0.8250977	BIOCARTA_CARM_ER_PATHWAY	34	0.81049675	0.7626506	1	-0.08636365	-1.70735715
PID_AVB3_OPN_PATHWAY	c2.CP_ Canonical pathways	30	-0.89683664	0.65653497	0.82493395	PID_AVB3_OPN_PATHWAY	30	1.2761123	0.14470588	0.4793625	0.37927566	-2.17294894
GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP	C7_ immunologic signatures	168	-0.89615715	0.7941176	0.826596	GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP	177	1.0884622	0.2851365	0.77331597	0.19230505	-1.98461935
SESTO_RESPONSE_TO_UV_C1	c2.CGP_ chemical and genetic perturbations	62	-0.895733	0.703125	0.82749754	SESTO_RESPONSE_TO_UV_C1	63	-1.0676191	0.32954547	0.57433194	-1.9633521	0.1718861
GO_MITOCHONDRIAL_MEMBRANE_ORGANIZATION	c5.BP_ GO biological process	84	-0.8956748	0.71428573	0.8274254	GO_MITOCHONDRIAL_MEMBRANE_ORGANIZATION	84	0.94314754	0.5946524	0.98843443	0.04747274	-1.83882234
GO_ACYL_COA_DEHYDROGENASE_ACTIVITY	c5.GO molecular function	17	-0.89495593	0.6121372	0.82916623	GO_ACYL_COA_DEHYDROGENASE_ACTIVITY	17	1.0515008	0.42302716	0.8369265	0.15654487	-1.94645673
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	c2.CGP_ chemical and genetic perturbations	57	-0.89493	0.7065637	0.82901466	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	57	0.8320038	0.756044	1	-0.0629262	-1.7269338
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP	C7_ immunologic signatures	165	-0.8948996	0.79041916	0.8288688	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP	166	-0.772872	1	0.92550594	-1.6677716	-0.1220276
GSE17721_CTRL_VS_LPS_12H_BMDC_DN	C7_ immunologic signatures	173	-0.89458656	0.82758623	0.8294784	GSE17721_CTRL_VS_LPS_12H_BMDC_DN	176	0.85319644	0.8123108	1	-0.04139012	-1.747783
REACTOME_SIGNALLING_TO_RAS	c2.CP_REACTOME_ Reactome gene sets	26	-0.8945588	0.60755813	0.82932013	REACTOME_SIGNALLING_TO_RAS	26	1.0530763	0.41728395	0.8361389	0.1585175	-1.9476351
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	C7_ immunologic signatures	179	-0.89419246	0.85542166	0.8300732	GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	181	0.8719341	0.7874494	1	-0.02225836	-1.76612656
GO_POSITIVE_REGULATION_OF_TOR_SIGNALING	c5.BP_ GO biological process	26	-0.8941035	0.60881543	0.83009017	GO_POSITIVE_REGULATION_OF_TOR_SIGNALING	27	0.59050256	0.9672727	1	-0.30360094	-1.48460606
GO_LIPID_HOMEOSTASIS	c5.BP_ GO biological process	93	-0.89408463	0.7848101	0.82990956	GO_LIPID_HOMEOSTASIS	100	0.81359136	0.8373812	1	-0.08049327	-1.70767599
GSE3982_MAC_VS_BASOPHIL_UP	C7_ immunologic signatures	173	-0.89325535	0.82285714	0.8318778	GSE3982_MAC_VS_BASOPHIL_UP	179	0.8611668	0.8172589	1	-0.03208855	-1.75442215
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN	c5.GO molecular function	23	-0.8932547	0.6094987	0.8316474	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN	26	1.2195371	0.20273632	0.5556133	0.3262824	-2.1127918
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	c2.CP_BIOCARTA_ BioCarta gene sets	24	-0.89310384	0.6286472	0.83182746	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	26	1.2514006	0.1628468	0.5093861	0.35829676	-2.14450444
GO_ATRIOVENTRICULAR_VALVE_DEVELOPMENT	c5.BP_ GO biological process	18	-0.893023	0.6111111	0.83181274	GO_ATRIOVENTRICULAR_VALVE_DEVELOPMENT	18	0.7643894	0.8041775	1	-0.1286336	-1.6574124
GNF2_MATK	c4.CGN_ cancer gene neighborhoods	20	-0.89297616	0.6336898	0.83170587	GNF2_MATK	19	1.017313	0.46233767	0.8940302	0.12433684	-1.91028916
FAELT_B_CLL_WITH_VH3_21_UP	c2.CGP_ chemical and genetic perturbations	40	-0.8929057	0.663522	0.8316726	FAELT_B_CLL_WITH_VH3_21_UP	41	0.63101554	0.9630485	1	-0.26189016	-1.52392124
GO_PURINE_NTP_DEPENDENT_HELICASE_ACTIVITY	c5.GO molecular function	90	-0.89284843	0.7419355	0.83159024	GO_PURINE_NTP_DEPENDENT_HELICASE_ACTIVITY	91	-1.0342262	0.34615386	0.6314646	-1.92707463	0.14137777
MORF_TERF1	c4.CGN_ cancer gene neighborhoods	61	-0.8926509	0.6989619	0.831884	MORF_TERF1	61	-1.8282337	0	0.027968766	-2.7208846	0.9355828
WANG_TARGETS_OF_MLL_CBP_FUSION_UP	c2.CGP_ chemical and genetic perturbations	42	-0.89254874	0.66451615	0.8319272	WANG_TARGETS_OF_MLL_CBP_FUSION_UP	41	1.2195802	0.18912797	0.5556273	0.32703146	-2.11212894
GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	C7_ immunologic signatures	168	-0.8924338	0.8197674	0.8320116	GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	171	0.85527587	0.8250758	1	-0.03715793	-1.74770967
CCCACAT_MIR2993P	c3.MIR_ microRNA targets	48	-0.8923806	0.6849315	0.83193356	CCCACAT_MIR2993P	49	0.8211119	0.78018224	1	-0.0712687	-1.7134925
GSE6259_BCELL_VS_CD4_TCELL_UP	C7_ immunologic signatures	149	-0.89218014	0.8011364	0.83225673	GSE6259_BCELL_VS_CD4_TCELL_UP	153	0.79811037	0.8778234	1	-0.09406977	-1.69029051
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G	c2.CGP_ chemical and genetic perturbations	154	-0.89217734	0.8375	0.8320324	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G	154	0.6682345	0.9756345	1	-0.22394284	-1.56041184
GO_BILE_ACID_AND_BILE_SALT_TRANSPORT	c5.BP_ GO biological process	24	-0.892061	0.61218834	0.8321192	GO_BILE_ACID_AND_BILE_SALT_TRANSPORT	26	0.9502643	0.55861247	0.9817399	0.0582033	-1.8423253
REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	c2.CP_REACTOME_ Reactome gene sets	26	-0.8915962	0.63896847	0.83311903	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	27	1.3303486	0.10121951	0.40172455	0.4387524	-2.2219448
PID_ECADHERIN_STABILIZATION_PATHWAY	c2.CP_ Canonical pathways	39	-0.8915607	0.6567164	0.8329915	PID_ECADHERIN_STABILIZATION_PATHWAY	40	1.0681175	0.39331028	0.8088318	0.1765568	-1.9596782
GO_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION	c5.BP_ GO biological process	21	-0.8913596	0.6363636	0.83330995	GO_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION	21	-0.67947567	0.92727274	0.96891946	-1.57083527	-0.21188393
GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN	C7_ immunologic signatures	174	-0.89116377	0.875969	0.83359045	GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN	174	0.6807903	0.9807692	1	-0.21037347	-1.57195407
CHR1Q22	C1: positional gene sets	56	-0.8909761	0.6586207	0.833862	CHR1Q22	57	0.6729967	0.94137543	1	-0.2179794	-1.5639728
GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	C7_ immunologic signatures	163	-0.8909429	0.8604651	0.8337303	GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	170	1.1375229	0.19168358	0.6948825	0.24658	-2.0284658
MODULE_341	c4.CM_ cancer modules	68	-0.89092994	0.7366412	0.8335361	MODULE_341	74	0.9884996	0.5172786	0.93726206	0.09756966	-1.87942954
GO_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS	c5.BP_ GO biological process	23	-0.8906239	0.610951	0.834118	GO_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS	24	-0.83581966	0.7291667	0.87687844	-1.72644356	-0.05480424
PID_AR_TF_PATHWAY	c2.CP_ Canonical pathways	48	-0.89004356	0.7022059	0.83542395	PID_AR_TF_PATHWAY	49	0.7472672	0.8582949	1	-0.14277636	-1.63731076
GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP	C7_ immunologic signatures	151	-0.89000195	0.80864197	0.8353053	GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP	150	-1.2861404	0	0.29670605	-2.17614235	0.39613845
GSE45365_CD8A_DC_VS_CD11B_DC_DN	C7_ immunologic signatures	161	-0.88983077	0.8447205	0.83555365	GSE45365_CD8A_DC_VS_CD11B_DC_DN	163	0.9611565	0.5965622	0.96980184	0.07132573	-1.85098727
GO_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING	c5.BP_ GO biological process	62	-0.8895853	0.7346154	0.8359717	GO_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING	63	0.96717495	0.5571273	0.9643591	0.07758965	-1.85676025
GO_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	126	-0.8893204	0.8341463	0.83641696	GO_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	128	0.78433925	0.88362515	1	-0.10498115	-1.67365965
GO_CELL_DEATH_IN_RESPONSE_TO_OXIDATIVE_STRESS	c5.BP_ GO biological process	18	-0.8892849	0.6495727	0.8362774	GO_CELL_DEATH_IN_RESPONSE_TO_OXIDATIVE_STRESS	18	0.6016692	0.94125324	1	-0.2876157	-1.4909541
COUP_01	c3.TFT_ transcription factor targets	222	-0.8892328	0.8534483	0.8361722	COUP_01	231	0.8271956	0.87650603	1	-0.0620372	-1.7164284
GO_MAMMARY_GLAND_LOBULE_DEVELOPMENT	c5.BP_ GO biological process	16	-0.88903946	0.6084788	0.8364435	GO_MAMMARY_GLAND_LOBULE_DEVELOPMENT	16	0.81747144	0.75	1	-0.07156802	-1.7065109
LEE_LIVER_CANCER_DENA_DN	c2.CGP_ chemical and genetic perturbations	61	-0.8890186	0.6851211	0.836266	LEE_LIVER_CANCER_DENA_DN	66	0.80618834	0.8045356	1	-0.08283026	-1.69520694
GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP	C7_ immunologic signatures	166	-0.88900197	0.84302324	0.83607835	GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP	172	0.87711877	0.7604485	1	-0.0118832	-1.76612074
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	c2.CGP_ chemical and genetic perturbations	19	-0.88867974	0.63538873	0.83668405	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	19	0.52958363	0.9848101	1	-0.35909611	-1.41826337
GO_KETONE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	19	-0.88856226	0.625323	0.83675474	GO_KETONE_BIOSYNTHETIC_PROCESS	20	0.69141203	0.88301885	1	-0.19715023	-1.57997429
PID_HNF3B_PATHWAY	c2.CP_ Canonical pathways	34	-0.8874717	0.7058824	0.83938384	PID_HNF3B_PATHWAY	42	1.0797062	0.3754386	0.78791386	0.1922345	-1.9671779
PID_EPHA2_FWD_PATHWAY	c2.CP_ Canonical pathways	18	-0.8870989	0.62334216	0.8400985	PID_EPHA2_FWD_PATHWAY	18	1.1119158	0.33838382	0.73496586	0.2248169	-1.9990147
GO_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	29	-0.8870376	0.6239554	0.8400293	GO_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	28	1.0368518	0.43764988	0.864253	0.1498142	-1.9238894
GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN	C7_ immunologic signatures	158	-0.8870276	0.8543046	0.8398219	GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN	163	1.3534225	0.017293997	0.38281915	0.4663949	-2.2404501
STOSSI_RESPONSE_TO_ESTRADIOL	c2.CGP_ chemical and genetic perturbations	40	-0.8867614	0.6390532	0.84028727	STOSSI_RESPONSE_TO_ESTRADIOL	41	1.4430336	0.030612245	0.29947862	0.5562722	-2.329795
GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN	C7_ immunologic signatures	174	-0.88619214	0.86713284	0.8415449	GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN	176	0.80352896	0.8897877	1	-0.08266318	-1.6897211
REACTOME_NOD1_2_SIGNALING_PATHWAY	c2.CP_REACTOME_ Reactome gene sets	29	-0.8859907	0.6723164	0.8418225	REACTOME_NOD1_2_SIGNALING_PATHWAY	28	0.68439066	0.8968059	1	-0.20160004	-1.57038136
ABE_VEGFA_TARGETS_2HR	c2.CGP_ chemical and genetic perturbations	27	-0.8859634	0.6515151	0.84165186	ABE_VEGFA_TARGETS_2HR	29	1.4507791	0.038323354	0.29147166	0.5648157	-2.3367425
GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	C7_ immunologic signatures	179	-0.8855059	0.8896552	0.84259784	GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	181	1.3854927	0.005065856	0.35045207	0.4999868	-2.2709986
GO_CILIUM_MORPHOGENESIS	c5.BP_ GO biological process	175	-0.8853245	0.8757764	0.84282166	GO_CILIUM_MORPHOGENESIS	177	1.3015603	0.023326572	0.4389054	0.4162358	-2.1868848
GHANDHI_DIRECT_IRRADIATION_DN	c2.CGP_ chemical and genetic perturbations	26	-0.8851032	0.64772725	0.843162	GHANDHI_DIRECT_IRRADIATION_DN	29	1.0533628	0.4159613	0.8360836	0.1682596	-1.938466
GO_INTERACTION_WITH_SYMBIONT	c5.BP_ GO biological process	41	-0.8843676	0.683871	0.8448239	GO_INTERACTION_WITH_SYMBIONT	43	0.53617465	0.991954	1	-0.34819295	-1.42054225
GO_IMMUNOLOGICAL_SYNAPSE	c5.CC_ GO cellular component	27	-0.88392806	0.6490683	0.845713	GO_IMMUNOLOGICAL_SYNAPSE	28	1.4600939	0.034606203	0.2831225	0.57616584	-2.34402196
USF_01	c3.TFT_ transcription factor targets	230	-0.88354194	0.9137931	0.8464814	USF_01	233	0.7302174	0.9688129	1	-0.15332454	-1.61375934
GO_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING	c5.GO molecular function	16	-0.88343066	0.6306818	0.8465297	GO_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING	16	0.69902694	0.8761528	1	-0.18440372	-1.5824576
GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP	C7_ immunologic signatures	172	-0.883367	0.84931505	0.84645134	GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP	176	1.0235366	0.43527013	0.88587713	0.1401696	-1.9069036
GO_PHAGOCYTOSIS	c5.BP_ GO biological process	146	-0.883067	0.8224852	0.8469886	GO_PHAGOCYTOSIS	155	1.1557271	0.1744898	0.66087186	0.2726601	-2.0387941
GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP	C7_ immunologic signatures	174	-0.88303334	0.88271606	0.8468435	GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP	177	-0.9764354	0.45454547	0.7188122	-1.85946874	0.09340206
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN	C7_ immunologic signatures	179	-0.88293093	0.8322148	0.8468735	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN	180	-0.83840793	1	0.8768083	-1.72133886	-0.044523
SESTO_RESPONSE_TO_UV_C4	c2.CGP_ chemical and genetic perturbations	17	-0.8828232	0.62032086	0.846901	SESTO_RESPONSE_TO_UV_C4	18	1.0095427	0.47355163	0.9083613	0.1267195	-1.8923659
GO_CARBOHYDRATE_DERIVATIVE_TRANSPORT	c5.BP_ GO biological process	43	-0.8827998	0.6782007	0.84672475	GO_CARBOHYDRATE_DERIVATIVE_TRANSPORT	43	1.0643731	0.38754326	0.8154019	0.1815733	-1.9471729
GSE17721_4H_VS_24H_POLYIC_BMDC_DN	C7_ immunologic signatures	179	-0.8827468	0.8834356	0.8466272	GSE17721_4H_VS_24H_POLYIC_BMDC_DN	178	0.8062004	0.88020307	1	-0.0765464	-1.6889472
GO_PROTEIN_ACETYLATION	c5.BP_ GO biological process	109	-0.8825836	0.81280786	0.84680265	GO_PROTEIN_ACETYLATION	110	-0.96759045	0.59375	0.7332627	-1.85017405	0.08500685
GO_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	23	-0.88206697	0.6279762	0.84789854	GO_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS	23	-1.0910574	0.31308413	0.5317589	-1.97312437	0.20899043
GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	C7_ immunologic signatures	165	-0.8817399	0.9030303	0.84848624	GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	168	-0.8854012	0.8	0.83798146	-1.7671411	0.0036613
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN	C7_ immunologic signatures	153	-0.88121516	0.8125	0.84957	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN	158	0.8382603	0.83502024	1	-0.04295486	-1.71947546
COLDREN_GEFITINIB_RESISTANCE_UP	c2.CGP_ chemical and genetic perturbations	71	-0.88105726	0.75095785	0.84973985	COLDREN_GEFITINIB_RESISTANCE_UP	71	-1.0747243	0.25714287	0.5622121	-1.95578156	0.19366704
GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN	C7_ immunologic signatures	176	-0.88092774	0.8888889	0.84981805	GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN	179	0.954974	0.61189514	0.9763057	0.07404626	-1.83590174
GO_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT	c5.BP_ GO biological process	17	-0.8809169	0.6106667	0.84961283	GO_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT	17	0.6331883	0.9249012	1	-0.2477286	-1.5141052
LUND_SILENCED_BY_METHYLATION	c2.CGP_ chemical and genetic perturbations	15	-0.8806033	0.60199004	0.8501495	LUND_SILENCED_BY_METHYLATION	15	0.7878969	0.75745785	1	-0.0927064	-1.6685002
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN	C7_ immunologic signatures	180	-0.88041675	0.875	0.85037243	GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN	180	-1.295152	0	0.28818765	-2.17556875	0.41473525
GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP	C7_ immunologic signatures	159	-0.8799529	0.8670886	0.8513209	GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP	164	1.015477	0.46843177	0.8966416	0.1355241	-1.8954299
GO_IMPORT_INTO_CELL	c5.BP_ GO biological process	32	-0.8799322	0.64174455	0.851139	GO_IMPORT_INTO_CELL	36	1.2705977	0.12632822	0.48367158	0.3906655	-2.1505299
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	c2.CGP_ chemical and genetic perturbations	291	-0.87967426	0.91964287	0.85155046	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	293	0.8240627	0.918429	1	-0.05561156	-1.70373696
GO_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	18	-0.87904227	0.6351351	0.85287565	GO_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS	17	-1.9604807	0	0.011303502	-2.83952297	1.08143843
GO_CYTOPLASMIC_MRNA_PROCESSING_BODY	c5.CC_ GO cellular component	58	-0.8786333	0.7191781	0.8536803	GO_CYTOPLASMIC_MRNA_PROCESSING_BODY	59	-0.93314517	0.6057692	0.77995795	-1.81177847	0.05451187
PID_CXCR3_PATHWAY	c2.CP_ Canonical pathways	40	-0.8786264	0.7047619	0.85346156	PID_CXCR3_PATHWAY	41	0.85612005	0.7027972	1	-0.02250635	-1.73474645
REACTOME_SIGNALING_BY_NOTCH1	c2.CP_REACTOME_ Reactome gene sets	65	-0.8783822	0.74206346	0.8538533	REACTOME_SIGNALING_BY_NOTCH1	66	0.7586999	0.8531318	1	-0.1196823	-1.6370821
GO_POSITIVE_REGULATION_OF_ANION_TRANSPORT	c5.BP_ GO biological process	46	-0.8781855	0.7442623	0.8540928	GO_POSITIVE_REGULATION_OF_ANION_TRANSPORT	51	1.5529103	0.005714286	0.20678562	0.6747248	-2.4310958
GO_REGULATION_OF_DENDRITE_EXTENSION	c5.BP_ GO biological process	15	-0.8780108	0.6211699	0.85428995	GO_REGULATION_OF_DENDRITE_EXTENSION	17	1.541902	0.011734028	0.2103462	0.6638912	-2.4199128
PID_HDAC_CLASSII_PATHWAY	c2.CP_ Canonical pathways	31	-0.87799525	0.7044776	0.8540973	PID_HDAC_CLASSII_PATHWAY	31	0.60531884	0.9591837	1	-0.27267641	-1.48331409
GO_ORGANIC_ACID_CATABOLIC_PROCESS	c5.BP_ GO biological process	187	-0.8779487	0.88387096	0.8539801	GO_ORGANIC_ACID_CATABOLIC_PROCESS	192	1.1426294	0.18071066	0.6852069	0.2646807	-2.0205781
GSE17721_LPS_VS_POLYIC_4H_BMDC_DN	C7_ immunologic signatures	180	-0.8777465	0.88414633	0.8542394	GSE17721_LPS_VS_POLYIC_4H_BMDC_DN	182	0.7568634	0.9359756	1	-0.1208831	-1.6346099
GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN	C7_ immunologic signatures	183	-0.877608	0.88535035	0.8543495	GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN	183	0.76691926	0.9199595	1	-0.11068874	-1.64452726
GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN	C7_ immunologic signatures	116	-0.8775075	0.8543689	0.8543694	GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN	119	0.97394514	0.5435685	0.95666	0.09643764	-1.85145264
GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_DN	C7_ immunologic signatures	180	-0.87749004	0.8766234	0.85417694	GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_DN	180	-1.5366112	0	0.1220941	-2.41410124	0.65912116
GO_TRANSPORT_VESICLE_MEMBRANE	c5.CC_ GO cellular component	118	-0.87709075	0.79385966	0.85491604	GO_TRANSPORT_VESICLE_MEMBRANE	128	1.0663292	0.34938523	0.8119736	0.18923845	-1.94341995
KEGG_ETHER_LIPID_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	26	-0.87690216	0.67551625	0.8551449	KEGG_ETHER_LIPID_METABOLISM	30	1.2254547	0.1937799	0.548386	0.34855254	-2.10235686
GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN	C7_ immunologic signatures	174	-0.87666065	0.85625	0.85549366	GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN	177	0.9858259	0.5636911	0.9412088	0.10916525	-1.86248655
GCM_PPM1D	c4.CGN_ cancer gene neighborhoods	23	-0.8766457	0.6571429	0.85529697	GCM_PPM1D	23	0.56834394	0.98288506	1	-0.30830176	-1.44498964
GO_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE	c5.BP_ GO biological process	18	-0.87590957	0.6527778	0.8568747	GO_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE	22	-0.99746424	0.45833334	0.6894022	-1.87337381	0.12155467
GO_MODIFICATION_OF_MORPHOLOGY_OR_PHYSIOLOGY_OF_OTHER_ORGANISM	c5.BP_ GO biological process	79	-0.8758352	0.8162393	0.8568221	GO_MODIFICATION_OF_MORPHOLOGY_OR_PHYSIOLOGY_OF_OTHER_ORGANISM	80	-1.0923134	0.27272728	0.5301149	-1.9681486	0.2164782
GSE17721_POLYIC_VS_CPG_6H_BMDC_DN	C7_ immunologic signatures	171	-0.8757147	0.8719512	0.85688084	GSE17721_POLYIC_VS_CPG_6H_BMDC_DN	175	-1.1727401	0.071428575	0.41364053	-2.0484548	0.2970254
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP	C7_ immunologic signatures	167	-0.875238	0.8819444	0.8577804	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP	167	-1.0213553	0.46153846	0.6572324	-1.8965933	0.1461173
GO_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING	c5.BP_ GO biological process	22	-0.87491125	0.6434783	0.8583253	GO_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING	23	-1.1913481	0.22404371	0.39260116	-2.06625935	0.31643685
BIOCARTA_BCR_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	32	-0.8748932	0.66237944	0.85813016	BIOCARTA_BCR_PATHWAY	33	1.5055157	0.013221154	0.24597901	0.6306225	-2.3804089
GSE557_CIITA_KO_VS_I_AB_KO_DC_DN	C7_ immunologic signatures	181	-0.8748738	0.91780823	0.8579449	GSE557_CIITA_KO_VS_I_AB_KO_DC_DN	184	-1.4625367	0	0.1652485	-2.3374105	0.5876629
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	c2.CGP_ chemical and genetic perturbations	21	-0.8746077	0.6314363	0.8583698	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	21	-1.2719893	0.13744076	0.30839404	-2.146597	0.3973816
GO_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	19	-0.8744184	0.6333333	0.8585984	GO_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS	20	0.6961788	0.88761175	1	-0.1782396	-1.5705972
GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	94	-0.87437445	0.78165936	0.8584708	GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP	104	0.9807215	0.54791665	0.9483227	0.10634705	-1.85509595
GO_GOLGI_STACK	c5.CC_ GO cellular component	114	-0.87435734	0.83419687	0.8582783	GO_GOLGI_STACK	115	0.87543654	0.753878	1	0.0010792	-1.74979388
GO_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING	c5.GO molecular function	19	-0.87431246	0.64325845	0.85814726	GO_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING	19	-1.080368	0.33179724	0.55165786	-1.95468046	0.20605554
GO_ASTROCYTE_DEVELOPMENT	c5.BP_ GO biological process	18	-0.8740826	0.65217394	0.85846126	GO_ASTROCYTE_DEVELOPMENT	17	-1.2312572	0.21757323	0.34442687	-2.1053398	0.3571746
GO_PROTEIN_DISULFIDE_OXIDOREDUCTASE_ACTIVITY	c5.GO molecular function	19	-0.87367433	0.65343916	0.8592155	GO_PROTEIN_DISULFIDE_OXIDOREDUCTASE_ACTIVITY	19	0.5140896	0.98221093	1	-0.35958473	-1.38776393
GO_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT	c5.BP_ GO biological process	62	-0.8733497	0.7968128	0.859769	GO_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT	62	0.8143985	0.7918015	1	-0.0589512	-1.6877482
GSE17721_CTRL_VS_CPG_1H_BMDC_UP	C7_ immunologic signatures	183	-0.8725029	0.89403975	0.8614961	GSE17721_CTRL_VS_CPG_1H_BMDC_UP	184	0.6808646	0.9807497	1	-0.1916383	-1.5533675
GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP	C7_ immunologic signatures	173	-0.8724468	0.9186047	0.8613872	GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP	175	0.77032304	0.9277721	1	-0.10212376	-1.64276984
AGGGCAG_MIR18A	c3.MIR_ microRNA targets	121	-0.87203366	0.84375	0.86217546	AGGGCAG_MIR18A	129	1.0572563	0.36102563	0.8285284	0.18522264	-1.92928996
GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN	C7_ immunologic signatures	179	-0.8714081	0.9066667	0.8634242	GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN	178	0.8101272	0.88235295	1	-0.0612809	-1.6815353
GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN	C7_ immunologic signatures	171	-0.87051713	0.8909091	0.86524314	GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN	174	0.98452383	0.55420464	0.9423385	0.1140067	-1.85504096
GO_NEGATIVE_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	16	-0.87040037	0.6518106	0.86528647	GO_NEGATIVE_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS	18	1.4558464	0.04134367	0.28728202	0.58544603	-2.32624677
TMTCGCGANR_UNKNOWN	c3.TFT_ transcription factor targets	143	-0.87021357	0.86734694	0.8654889	TMTCGCGANR_UNKNOWN	143	0.5214702	1	1	-0.34874337	-1.39168377
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN	c2.CGP_ chemical and genetic perturbations	16	-0.8702028	0.66494846	0.8652823	MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN	18	1.2071254	0.253866	0.58081204	0.3369226	-2.0773282
GO_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION	c5.BP_ GO biological process	33	-0.86942685	0.7044776	0.866863	GO_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION	37	1.174783	0.2309496	0.6301469	0.30535615	-2.04420985
GSE36009_WT_VS_NLRP10_KO_DC_DN	C7_ immunologic signatures	183	-0.8691016	0.8679245	0.8673545	GSE36009_WT_VS_NLRP10_KO_DC_DN	184	0.8676309	0.8010101	1	-0.0014707	-1.7367325
GNF2_CDH3	c4.CGN_ cancer gene neighborhoods	24	-0.8687793	0.69590646	0.867868	GNF2_CDH3	26	1.9510875	0	0.004142462	1.0823082	-2.8198668
GSE17721_POLYIC_VS_CPG_8H_BMDC_UP	C7_ immunologic signatures	172	-0.8685329	0.9017341	0.86818415	GSE17721_POLYIC_VS_CPG_8H_BMDC_UP	172	1.0995983	0.27355623	0.7577607	0.2310654	-1.9681312
GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP	C7_ immunologic signatures	145	-0.8682387	0.8786127	0.8686225	GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP	141	1.1227357	0.23258197	0.720606	0.254497	-1.9909744
GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	181	-0.86810315	0.88535035	0.8686954	GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN	183	1.3289243	0.014112903	0.40379202	0.46082115	-2.19702745
NAGY_TFTC_COMPONENTS_HUMAN	c2.CGP_ chemical and genetic perturbations	18	-0.8679899	0.6603774	0.8687233	NAGY_TFTC_COMPONENTS_HUMAN	18	-0.5799217	0.9818182	0.98836064	-1.4479116	-0.2880682
GO_PHOTORECEPTOR_CELL_MAINTENANCE	c5.BP_ GO biological process	32	-0.86780703	0.69300914	0.8689086	GO_PHOTORECEPTOR_CELL_MAINTENANCE	34	0.9851157	0.50468385	0.94180864	0.11730867	-1.85292273
GO_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION	c5.BP_ GO biological process	16	-0.8677428	0.64631045	0.8688084	GO_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION	17	1.0805626	0.35826772	0.7861938	0.2128198	-1.9483054
GSE3982_EOSINOPHIL_VS_BASOPHIL_DN	C7_ immunologic signatures	168	-0.8672054	0.8888889	0.8697832	GSE3982_EOSINOPHIL_VS_BASOPHIL_DN	169	0.7449014	0.93124366	1	-0.122304	-1.6121068
GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION	c5.BP_ GO biological process	29	-0.866851	0.6676737	0.8703602	GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION	32	1.3790814	0.072463766	0.3564594	0.5122304	-2.2459324
PARENT_MTOR_SIGNALING_DN	c2.CGP_ chemical and genetic perturbations	37	-0.86659944	0.6880734	0.87070674	PARENT_MTOR_SIGNALING_DN	38	0.9847734	0.51972157	0.94183767	0.11817396	-1.85137284
GO_HISTONE_H2A_UBIQUITINATION	c5.BP_ GO biological process	16	-0.866512	0.6481481	0.87066513	GO_HISTONE_H2A_UBIQUITINATION	16	0.49137515	0.987163	1	-0.37513685	-1.35788715
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP	C7_ immunologic signatures	177	-0.8664499	0.92948717	0.87056637	GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP	176	-1.0337253	0.36363637	0.632275	-1.9001752	0.1672754
GO_PEPTIDYL_PROLINE_MODIFICATION	c5.BP_ GO biological process	45	-0.8655675	0.739726	0.87232643	GO_PEPTIDYL_PROLINE_MODIFICATION	45	-1.0621251	0.32539684	0.5845728	-1.9276926	0.1965576
MODULE_236	c4.CM_ cancer modules	16	-0.8655097	0.645	0.8722137	MODULE_236	17	-0.5352438	0.9810427	0.9908184	-1.4007535	-0.3302659
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	c2.CGP_ chemical and genetic perturbations	32	-0.8651951	0.70317	0.8727002	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	32	-0.9739896	0.509434	0.72369623	-1.8391847	0.1087945
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP	C7_ immunologic signatures	179	-0.86496663	0.9285714	0.8729622	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP	182	0.7770042	0.9262626	1	-0.08796243	-1.64197083
CHR10Q22	C1: positional gene sets	68	-0.86474156	0.7661017	0.8732135	CHR10Q22	71	0.97163475	0.55543476	0.9601497	0.10689319	-1.83637631
HEIDENBLAD_AMPLICON_8Q24_DN	c2.CGP_ chemical and genetic perturbations	42	-0.86459464	0.7352025	0.8733167	HEIDENBLAD_AMPLICON_8Q24_DN	42	1.2974397	0.09070034	0.4464994	0.43284506	-2.16203434
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	c2.CGP_ chemical and genetic perturbations	21	-0.8642515	0.66481996	0.87382585	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	21	0.6107746	0.954488	1	-0.2534769	-1.4750261
GO_FATTY_ACID_CATABOLIC_PROCESS	c5.BP_ GO biological process	68	-0.86381537	0.816	0.87457293	GO_FATTY_ACID_CATABOLIC_PROCESS	69	1.1096967	0.30627707	0.7384706	0.24588133	-1.97351207
GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP	C7_ immunologic signatures	172	-0.86356014	0.94244605	0.8748888	GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP	179	0.98800695	0.53144014	0.9378726	0.12444681	-1.85156709
CHR10Q26	C1: positional gene sets	71	-0.86318666	0.7657993	0.87547535	CHR10Q26	74	1.2283926	0.16346154	0.5436649	0.36520594	-2.09157926
SREBP1_01	c3.TFT_ transcription factor targets	154	-0.8630908	0.89215684	0.8754483	SREBP1_01	156	0.76780415	0.91649693	1	-0.09528665	-1.63089495
GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN	C7_ immunologic signatures	179	-0.86259484	0.9121622	0.8763149	GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN	177	0.7423779	0.951417	1	-0.12021694	-1.60497274
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	c2.CGP_ chemical and genetic perturbations	96	-0.8624141	0.7905983	0.87644964	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	95	0.79193395	0.842872	1	-0.07048015	-1.65434805
GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP	C7_ immunologic signatures	187	-0.8622807	0.884058	0.8765205	GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP	189	1.0348202	0.42770475	0.86826974	0.1725395	-1.8971009
GO_RNA_DESTABILIZATION	c5.BP_ GO biological process	15	-0.86216104	0.64615387	0.8765382	GO_RNA_DESTABILIZATION	15	-0.9898378	0.45818183	0.7026404	-1.85199884	0.12767676
MODULE_410	c4.CM_ cancer modules	23	-0.86201733	0.7060519	0.8766165	MODULE_410	24	-0.7775564	0.8197674	0.92349094	-1.63957373	-0.08446093
GO_RESPONSE_TO_CADMIUM_ION	c5.BP_ GO biological process	33	-0.86200887	0.7245509	0.87639576	GO_RESPONSE_TO_CADMIUM_ION	32	1.0039752	0.4939904	0.91692376	0.14196633	-1.86598407
GO_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION	c5.BP_ GO biological process	21	-0.8618774	0.69405097	0.8764307	GO_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION	21	0.7928197	0.76696545	1	-0.0690577	-1.6546971
GCM_SUPT4H1	c4.CGN_ cancer gene neighborhoods	49	-0.8618237	0.74733096	0.87631863	GCM_SUPT4H1	55	-0.9186328	0.6972477	0.7978234	-1.7804565	0.0568091
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP	C7_ immunologic signatures	142	-0.8612284	0.87623763	0.87735534	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP	152	1.2721672	0.03248731	0.48291886	0.4109388	-2.1333956
PID_KIT_PATHWAY	c2.CP_ Canonical pathways	50	-0.86118644	0.7400722	0.87721574	PID_KIT_PATHWAY	52	1.0070211	0.48079035	0.912244	0.14583466	-1.86820754
GO_ACID_AMINO_ACID_LIGASE_ACTIVITY	c5.GO molecular function	18	-0.8607507	0.6802168	0.8779273	GO_ACID_AMINO_ACID_LIGASE_ACTIVITY	19	1.0743145	0.38113695	0.79806834	0.2135638	-1.9350652
GO_TBP_CLASS_PROTEIN_BINDING	c5.GO molecular function	19	-0.86016303	0.6573034	0.8789576	GO_TBP_CLASS_PROTEIN_BINDING	19	-1.3047603	0.18396227	0.27826813	-2.16492333	0.44459727
GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN	C7_ immunologic signatures	168	-0.85974973	0.8951049	0.8796335	GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN	170	1.0457877	0.40447155	0.84731674	0.18603797	-1.90553743
GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN	C7_ immunologic signatures	179	-0.85968643	0.9371069	0.8795374	GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN	179	-1.7067511	0	0.05413294	-2.56643753	0.84706467
GO_POSITIVE_REGULATION_OF_CELL_KILLING	c5.BP_ GO biological process	27	-0.85894734	0.68154764	0.8809024	GO_POSITIVE_REGULATION_OF_CELL_KILLING	28	-1.2722349	0.14054054	0.30888844	-2.13118224	0.41328756
MODULE_96	c4.CM_ cancer modules	23	-0.8575981	0.7	0.88354725	MODULE_96	23	0.6402767	0.9306072	1	-0.2173214	-1.4978748
GO_POSITIVE_REGULATION_OF_PROTEIN_OLIGOMERIZATION	c5.BP_ GO biological process	15	-0.85745764	0.6609337	0.88360834	GO_POSITIVE_REGULATION_OF_PROTEIN_OLIGOMERIZATION	16	1.2985225	0.126943	0.44406927	0.44106486	-2.15598014
GO_ALDO_KETO_REDUCTASE_NADP_ACTIVITY	c5.GO molecular function	19	-0.8572772	0.66307276	0.88375604	GO_ALDO_KETO_REDUCTASE_NADP_ACTIVITY	19	1.2834617	0.14158164	0.46680096	0.4261845	-2.1407389
MODULE_233	c4.CM_ cancer modules	20	-0.8570078	0.657971	0.8840936	MODULE_233	20	-1.281291	0.115384616	0.30080366	-2.1382988	0.4242832
GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP	C7_ immunologic signatures	177	-0.8568101	0.93209875	0.88425213	GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP	176	0.6509175	0.990835	1	-0.2058926	-1.5077276
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP	C7_ immunologic signatures	174	-0.85677403	0.9403973	0.88409686	GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP	178	0.64871144	0.9878665	1	-0.20806259	-1.50548547
MORF_PTEN	c4.CGN_ cancer gene neighborhoods	70	-0.85661966	0.81349206	0.8841894	MORF_PTEN	73	0.8197819	0.79044515	1	-0.03683776	-1.67640156
GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN	C7_ immunologic signatures	167	-0.8560458	0.92957747	0.8851965	GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN	169	0.66668266	0.98477155	1	-0.18936314	-1.52272846
ALONSO_METASTASIS_NEURAL_UP	c2.CGP_ chemical and genetic perturbations	16	-0.8560429	0.7010309	0.8849649	ALONSO_METASTASIS_NEURAL_UP	16	0.60422957	0.9341239	1	-0.25181333	-1.46027247
GO_PROTEIN_REFOLDING	c5.BP_ GO biological process	16	-0.85571337	0.6614173	0.88543826	GO_PROTEIN_REFOLDING	17	1.1179729	0.33976835	0.7273022	0.26225953	-1.97368627
SU_LIVER	c2.CGP_ chemical and genetic perturbations	39	-0.8556558	0.73170733	0.8853114	SU_LIVER	43	1.3220159	0.08943089	0.411049	0.4663601	-2.1776717
GO_SOLUTE_SODIUM_SYMPORTER_ACTIVITY	c5.GO molecular function	43	-0.85519505	0.7482993	0.8860596	GO_SOLUTE_SODIUM_SYMPORTER_ACTIVITY	49	1.0819179	0.3451835	0.7834509	0.22672285	-1.93711295
STONER_ESOPHAGEAL_CARCINOGENESIS_UP	c2.CGP_ chemical and genetic perturbations	35	-0.8551916	0.72727275	0.88583034	STONER_ESOPHAGEAL_CARCINOGENESIS_UP	36	-1.4618307	0.028169014	0.16545613	-2.3170223	0.6066391
GO_PRESYNAPTIC_MEMBRANE	c5.CC_ GO cellular component	47	-0.8546424	0.75974023	0.88674223	GO_PRESYNAPTIC_MEMBRANE	51	1.3698304	0.058165547	0.36830887	0.515188	-2.2244728
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN	C7_ immunologic signatures	170	-0.8546347	0.89325845	0.8865216	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN	174	1.0594567	0.3427705	0.8256094	0.204822	-1.9140914
KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	15	-0.85462993	0.6849315	0.88629293	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	19	1.1831498	0.24387097	0.6172065	0.32851987	-2.03777973
SHIN_B_CELL_LYMPHOMA_CLUSTER_5	c2.CGP_ chemical and genetic perturbations	16	-0.8543431	0.6917098	0.8866333	SHIN_B_CELL_LYMPHOMA_CLUSTER_5	17	-1.0367477	0.3877551	0.62714267	-1.8910908	0.1824046
GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN	C7_ immunologic signatures	101	-0.8543036	0.83555555	0.886473	GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN	113	0.7523382	0.9133612	1	-0.1019654	-1.6066418
GO_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS	c5.BP_ GO biological process	34	-0.85408366	0.71565497	0.88669693	GO_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS	37	0.8209206	0.7683073	1	-0.03316306	-1.67500426
GO_PRE_AUTOPHAGOSOMAL_STRUCTURE_MEMBRANE	c5.CC_ GO cellular component	15	-0.85364544	0.6839237	0.8874025	GO_PRE_AUTOPHAGOSOMAL_STRUCTURE_MEMBRANE	15	1.0586951	0.395806	0.826703	0.20504966	-1.91234054
GSE18148_CBFB_KO_VS_WT_TREG_DN	C7_ immunologic signatures	171	-0.85355586	0.8982036	0.88734853	GSE18148_CBFB_KO_VS_WT_TREG_DN	172	1.2441229	0.06307223	0.5207938	0.39056704	-2.09767876
JIANG_TIP30_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	23	-0.8534689	0.68786126	0.88727593	JIANG_TIP30_TARGETS_DN	23	-0.87750375	0.6958763	0.84685904	-1.73097265	0.02403485
MARTIN_INTERACT_WITH_HDAC	c2.CGP_ chemical and genetic perturbations	42	-0.8530682	0.75084174	0.8878432	MARTIN_INTERACT_WITH_HDAC	42	-1.1510761	0.16541353	0.44083259	-2.0041443	0.2980079
PID_RXR_VDR_PATHWAY	c2.CP_ Canonical pathways	26	-0.85298336	0.7237569	0.88778144	PID_RXR_VDR_PATHWAY	25	1.079395	0.38181818	0.78811467	0.22641164	-1.93237836
FARMER_BREAST_CANCER_CLUSTER_5	c2.CGP_ chemical and genetic perturbations	18	-0.85293925	0.66757494	0.88762397	FARMER_BREAST_CANCER_CLUSTER_5	18	-0.72529423	0.853211	0.94907653	-1.57823348	-0.12764502
VARELA_ZMPSTE24_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	28	-0.852535	0.7121212	0.8882384	VARELA_ZMPSTE24_TARGETS_DN	31	0.94881064	0.55094784	0.9833493	0.09627564	-1.80134564
REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE	c2.CP_REACTOME_ Reactome gene sets	18	-0.85235566	0.68817204	0.8883653	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE	18	0.7444475	0.8208955	1	-0.10790816	-1.59680316
PID_NFKAPPAB_ATYPICAL_PATHWAY	c2.CP_ Canonical pathways	17	-0.85213304	0.67146975	0.88859075	PID_NFKAPPAB_ATYPICAL_PATHWAY	17	1.039663	0.4260204	0.85917884	0.18752996	-1.89179604
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	c2.CGP_ chemical and genetic perturbations	33	-0.8518201	0.75766873	0.88897836	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	33	0.6451136	0.94285715	1	-0.2067065	-1.4969337
GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN	C7_ immunologic signatures	174	-0.85175043	0.93125	0.8888716	GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN	176	0.6452551	0.99188644	1	-0.20649533	-1.49700553
GCM_BCL2L1	c4.CGN_ cancer gene neighborhoods	32	-0.8503877	0.7254902	0.8914315	GCM_BCL2L1	32	0.6079066	0.96845794	1	-0.2424811	-1.4582943
GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP	C7_ immunologic signatures	173	-0.85035664	0.9375	0.8912502	GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP	175	0.9162809	0.7086294	1	0.06592426	-1.76663754
GO_CELLULAR_RESPONSE_TO_INTERLEUKIN_6	c5.BP_ GO biological process	21	-0.85001457	0.6853933	0.89169574	GO_CELLULAR_RESPONSE_TO_INTERLEUKIN_6	21	0.8370624	0.69201523	1	-0.01295217	-1.68707697
GO_WNT_SIGNALING_PATHWAY_CALCIUM_MODULATING_PATHWAY	c5.BP_ GO biological process	34	-0.8497288	0.72839504	0.89204305	GO_WNT_SIGNALING_PATHWAY_CALCIUM_MODULATING_PATHWAY	34	-0.9205925	0.5833333	0.79403085	-1.7703213	0.0708637
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN	C7_ immunologic signatures	170	-0.84954137	0.962963	0.8921647	GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN	170	-1.5572107	0	0.11131308	-2.40675207	0.70766933
GO_CIS_TRANS_ISOMERASE_ACTIVITY	c5.GO molecular function	37	-0.84938544	0.73355263	0.8922395	GO_CIS_TRANS_ISOMERASE_ACTIVITY	37	-0.943235	0.5652174	0.76634085	-1.79262044	0.09384956
GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	C7_ immunologic signatures	145	-0.8491637	0.93582886	0.89245695	GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	147	0.7251888	0.94364756	1	-0.1239749	-1.5743525
GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN	C7_ immunologic signatures	183	-0.84894115	0.91240877	0.8926539	GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN	186	0.9980062	0.5035461	0.925938	0.14906505	-1.84694735
TNCATNTCCYR_UNKNOWN	c3.TFT_ transcription factor targets	114	-0.8483981	0.9227053	0.89350235	TNCATNTCCYR_UNKNOWN	117	0.6167893	0.9897225	1	-0.2316088	-1.4651874
GO_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	21	-0.84746194	0.6970509	0.8950921	GO_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS	21	0.45131224	0.99874055	1	-0.3961497	-1.29877418
KANNAN_TP53_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	20	-0.84735805	0.6813187	0.89505273	KANNAN_TP53_TARGETS_DN	20	-1.3248147	0.07981221	0.26129907	-2.17217275	0.47745665
GO_RECEPTOR_SIGNALING_PROTEIN_ACTIVITY	c5.GO molecular function	156	-0.847358	0.9230769	0.89481527	GO_RECEPTOR_SIGNALING_PROTEIN_ACTIVITY	163	1.4817035	0.00101626	0.26723218	0.6343455	-2.3290615
GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN	C7_ immunologic signatures	176	-0.84731585	0.91719747	0.8946628	GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN	180	0.69050086	0.9818182	1	-0.15681499	-1.53781671
PID_IL4_2PATHWAY	c2.CP_ Canonical pathways	57	-0.8472725	0.81454545	0.89450896	PID_IL4_2PATHWAY	59	0.68395275	0.9402655	1	-0.16331975	-1.53122525
GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP	C7_ immunologic signatures	161	-0.84705645	0.96428573	0.8946976	GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP	160	0.94114393	0.64154786	0.98957115	0.09408748	-1.78820038
ZHAN_MULTIPLE_MYELOMA_MF_DN	c2.CGP_ chemical and genetic perturbations	33	-0.84638965	0.72839504	0.8957519	ZHAN_MULTIPLE_MYELOMA_MF_DN	34	1.1604786	0.2686916	0.6520012	0.31408895	-2.00686825
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	c2.CGP_ chemical and genetic perturbations	94	-0.846388	0.8598485	0.89551616	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	94	-1.3322802	0.041666668	0.25434113	-2.1786682	0.4858922
GSE27786_NKCELL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	180	-0.8461759	0.95804197	0.89569473	GSE27786_NKCELL_VS_NEUTROPHIL_UP	180	0.70367014	0.9675456	1	-0.14250576	-1.54984604
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_DN	C7_ immunologic signatures	143	-0.84517133	0.9558011	0.89741147	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_DN	144	1.1792746	0.14893617	0.6233838	0.33410327	-2.02444593
GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP	C7_ immunologic signatures	159	-0.8449984	0.94375	0.8975	GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP	170	1.1847262	0.11639676	0.61415493	0.3397278	-2.0297246
GO_GTP_RHO_BINDING	c5.GO molecular function	16	-0.8449428	0.67479676	0.8973732	GO_GTP_RHO_BINDING	16	0.9351687	0.58800524	0.995104	0.0902259	-1.7801115
KEGG_ACUTE_MYELOID_LEUKEMIA	c2.CP_BIOCARTA_ BioCarta gene sets	57	-0.8448714	0.7979094	0.8972713	KEGG_ACUTE_MYELOID_LEUKEMIA	57	-1.0170658	0.42857143	0.66339594	-1.8619372	0.1721944
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	71	-0.8447496	0.8228347	0.89726377	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION	71	0.6389773	0.97167754	1	-0.2057723	-1.4837269
SESTO_RESPONSE_TO_UV_C0	c2.CGP_ chemical and genetic perturbations	100	-0.8445979	0.9032258	0.8973004	SESTO_RESPONSE_TO_UV_C0	104	-0.99506134	0.44680852	0.6931574	-1.83965924	0.15046344
PID_HNF3A_PATHWAY	c2.CP_ Canonical pathways	35	-0.84448975	0.7654321	0.8972591	PID_HNF3A_PATHWAY	38	0.8299511	0.75171626	1	-0.01453865	-1.67444085
GO_NEGATIVE_REGULATION_OF_RECEPTOR_ACTIVITY	c5.BP_ GO biological process	27	-0.84415877	0.7033898	0.89764524	GO_NEGATIVE_REGULATION_OF_RECEPTOR_ACTIVITY	27	-0.9394663	0.55440414	0.7711152	-1.78362507	0.09530753
DOANE_BREAST_CANCER_CLASSES_UP	c2.CGP_ chemical and genetic perturbations	62	-0.8439605	0.8089172	0.89779794	DOANE_BREAST_CANCER_CLASSES_UP	67	1.1002468	0.31842965	0.7565321	0.2562863	-1.9442073
GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP	C7_ immunologic signatures	169	-0.8437588	0.9419355	0.8979418	GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP	170	0.7291448	0.9524773	1	-0.114614	-1.5729036
MODULE_545	c4.CM_ cancer modules	17	-0.8436912	0.6923077	0.89783174	MODULE_545	16	0.8829366	0.60589814	1	0.0392454	-1.7266278
GO_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION	c5.BP_ GO biological process	23	-0.8427869	0.70679015	0.8993324	GO_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION	25	1.2201624	0.21648216	0.5554543	0.3773755	-2.0629493
GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	C7_ immunologic signatures	149	-0.8415114	0.95628417	0.9014692	GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	149	0.8072478	0.85816324	1	-0.0342636	-1.6487592
GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP	C7_ immunologic signatures	177	-0.84138834	0.9356725	0.9014696	GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP	181	1.0775657	0.32020202	0.792073	0.23617736	-1.91895404
REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION	c2.CP_REACTOME_ Reactome gene sets	22	-0.8405596	0.72753626	0.9027998	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION	22	1.3312614	0.112801015	0.4002594	0.4907018	-2.171821
YANG_BREAST_CANCER_ESR1_BULK_UP	c2.CGP_ chemical and genetic perturbations	25	-0.84050936	0.743662	0.9026538	YANG_BREAST_CANCER_ESR1_BULK_UP	25	0.970979	0.5221675	0.9604186	0.13046964	-1.81148836
GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP	C7_ immunologic signatures	172	-0.8402487	0.9375	0.9029104	GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP	175	0.72284573	0.9543611	1	-0.11740297	-1.56309443
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B	c2.CGP_ chemical and genetic perturbations	17	-0.84005094	0.6893733	0.90304506	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B	17	-0.91791785	0.56880736	0.7978496	-1.75796879	0.07786691
GO_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION	c5.BP_ GO biological process	16	-0.8399934	0.7027027	0.90291923	GO_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION	16	1.1152692	0.33420366	0.73004174	0.2752758	-1.9552626
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	c2.CP_REACTOME_ Reactome gene sets	17	-0.83984274	0.72316384	0.9029457	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	18	1.255333	0.17357513	0.50214905	0.41549026	-2.09517574
WANG_RESPONSE_TO_FORSKOLIN_UP	c2.CGP_ chemical and genetic perturbations	19	-0.8393013	0.69187677	0.90369207	WANG_RESPONSE_TO_FORSKOLIN_UP	20	-0.8959615	0.6105769	0.8272967	-1.7352628	0.0566602
GO_CELLULAR_RESPONSE_TO_PH	c5.BP_ GO biological process	17	-0.83743936	0.7104558	0.9068233	GO_CELLULAR_RESPONSE_TO_PH	17	0.97913307	0.5136897	0.9503202	0.14169371	-1.81657243
GO_SUBSTANTIA_NIGRA_DEVELOPMENT	c5.BP_ GO biological process	36	-0.83705264	0.78488374	0.90728194	GO_SUBSTANTIA_NIGRA_DEVELOPMENT	36	-1.912612	0	0.016792301	-2.74966464	1.07555936
GO_MACROMOLECULE_DEACYLATION	c5.BP_ GO biological process	65	-0.83692724	0.81640625	0.9072523	GO_MACROMOLECULE_DEACYLATION	65	0.56131244	0.99119914	1	-0.2756148	-1.39823968
GO_CILIARY_BASAL_BODY	c5.CC_ GO cellular component	72	-0.8367833	0.8353414	0.90724933	GO_CILIARY_BASAL_BODY	73	0.98550713	0.5282609	0.9415753	0.14872383	-1.82229043
CHR13Q12	C1: positional gene sets	57	-0.83646876	0.84410644	0.90760094	CHR13Q12	63	0.5841897	0.98878926	1	-0.25227906	-1.42065846
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN	C7_ immunologic signatures	173	-0.83621347	0.9263804	0.90779483	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN	173	0.8818334	0.764467	1	0.04561993	-1.71804687
GO_REGULATION_OF_METANEPHROS_DEVELOPMENT	c5.BP_ GO biological process	20	-0.83621025	0.72432435	0.90756154	GO_REGULATION_OF_METANEPHROS_DEVELOPMENT	22	0.8425708	0.6976456	1	0.00636055	-1.67878105
GO_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	78	-0.8354523	0.8545455	0.9087086	GO_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	78	1.08021	0.3423326	0.7868768	0.2447577	-1.9156623
GO_NUCLEAR_IMPORT	c5.BP_ GO biological process	120	-0.8352586	0.9114583	0.90880495	GO_NUCLEAR_IMPORT	121	-1.2743691	0.05263158	0.30696064	-2.1096277	0.4391105
GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_DN	C7_ immunologic signatures	183	-0.83483154	0.98039216	0.9093247	GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_DN	182	-0.9807294	0.6	0.7127808	-1.81556094	0.14589786
GO_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC	c5.BP_ GO biological process	29	-0.83438563	0.74311924	0.9098809	GO_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC	29	-1.490098	0.017964073	0.14893377	-2.32448363	0.65571237
GO_CILIARY_MEMBRANE	c5.CC_ GO cellular component	67	-0.8335941	0.8373702	0.91105944	GO_CILIARY_MEMBRANE	67	1.1381468	0.2657267	0.6939401	0.3045527	-1.9717409
GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN	C7_ immunologic signatures	170	-0.83350396	0.9655172	0.9109862	GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN	170	0.65090847	0.9889113	1	-0.18259549	-1.48441243
BIOCARTA_GH_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	26	-0.8334498	0.74801064	0.91084474	BIOCARTA_GH_PATHWAY	28	-1.3259586	0.1	0.26063827	-2.1594084	0.4925088
GO_CELLULAR_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR_STIMULUS	c5.BP_ GO biological process	21	-0.8330444	0.7315068	0.91131514	GO_CELLULAR_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR_STIMULUS	22	0.7380963	0.795539	1	-0.0949481	-1.5711407
GSE42724_B1_BCELL_VS_PLASMABLAST_DN	C7_ immunologic signatures	181	-0.8325931	0.9574468	0.91184306	GSE42724_B1_BCELL_VS_PLASMABLAST_DN	184	0.72006834	0.9676441	1	-0.11252476	-1.55266144
GO_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL	c5.BP_ GO biological process	20	-0.8311242	0.7663044	0.9141482	GO_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL	21	0.94170475	0.5683814	0.9892267	0.11058055	-1.77282895
GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN	C7_ immunologic signatures	158	-0.83035904	0.9322034	0.9152124	GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN	162	0.74251044	0.9474216	1	-0.0878486	-1.57286948
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	c2.CGP_ chemical and genetic perturbations	27	-0.8301194	0.7399381	0.9153811	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	26	-2.0364957	0	0.005702721	-2.8666151	1.2063763
GSE2826_WT_VS_BTK_KO_BCELL_UP	C7_ immunologic signatures	176	-0.8300152	1	0.915319	GSE2826_WT_VS_BTK_KO_BCELL_UP	180	1.2401243	0.05	0.52581936	0.4101091	-2.0701395
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN	c2.CGP_ chemical and genetic perturbations	25	-0.82916284	0.7096774	0.9165396	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN	26	0.9104954	0.62742716	1	0.08133256	-1.73965824
GO_COATED_VESICLE	c5.CC_ GO cellular component	201	-0.828895	0.9513889	0.9167334	GO_COATED_VESICLE	205	0.87792575	0.7949495	1	0.04903075	-1.70682075
GO_EXCRETION	c5.BP_ GO biological process	38	-0.82860017	0.7795527	0.9169899	GO_EXCRETION	41	1.1217575	0.29680365	0.7222727	0.29315733	-1.95035767
DITTMER_PTHLH_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	65	-0.8285593	0.8230769	0.91681623	DITTMER_PTHLH_TARGETS_DN	65	0.82611185	0.7699019	1	-0.00244745	-1.65467115
REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS	c2.CP_REACTOME_ Reactome gene sets	24	-0.82852346	0.73214287	0.916636	REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS	24	1.0937867	0.35775337	0.7677143	0.26526324	-1.92231016
GO_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY	c5.BP_ GO biological process	31	-0.827795	0.7610063	0.91760343	GO_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY	32	-1.0178163	0.40853658	0.6625916	-1.8456113	0.1900213
GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP	C7_ immunologic signatures	170	-0.82777613	0.9402985	0.91739327	GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP	177	1.0692276	0.3472081	0.80709124	0.24145147	-1.89700373
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	c2.CGP_ chemical and genetic perturbations	42	-0.82737714	0.78333336	0.9178068	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	43	0.9257137	0.61219794	1	0.09833656	-1.75309084
DUTTA_APOPTOSIS_VIA_NFKB	c2.CGP_ chemical and genetic perturbations	29	-0.8270789	0.7329377	0.9180746	DUTTA_APOPTOSIS_VIA_NFKB	29	1.0400993	0.4377224	0.8592643	0.2130204	-1.8671782
GO_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	46	-0.82583404	0.81191224	0.91988957	GO_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS	49	1.0255378	0.4483146	0.8832084	0.19970376	-1.85137184
GO_L_ASCORBIC_ACID_BINDING	c5.GO molecular function	15	-0.82571656	0.69250643	0.919847	GO_L_ASCORBIC_ACID_BINDING	16	0.78216577	0.7798408	1	-0.04355079	-1.60788233
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP	C7_ immunologic signatures	176	-0.8251466	0.9551282	0.9205375	GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP	180	0.9102783	0.71922684	1	0.0851317	-1.7354249
GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN	C7_ immunologic signatures	159	-0.8247758	0.96732026	0.92088395	GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN	163	1.2985036	0.024291499	0.44389886	0.4737278	-2.1232794
GO_RRNA_CATABOLIC_PROCESS	c5.BP_ GO biological process	15	-0.82449466	0.7017115	0.92110234	GO_RRNA_CATABOLIC_PROCESS	16	-0.95197475	0.53070176	0.75234723	-1.77646941	0.12748009
GO_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS	c5.BP_ GO biological process	24	-0.8243674	0.7671642	0.92106324	GO_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS	24	0.7528389	0.8189763	1	-0.0715285	-1.5772063
GO_FOREBRAIN_CELL_MIGRATION	c5.BP_ GO biological process	57	-0.82365185	0.8067797	0.9220085	GO_FOREBRAIN_CELL_MIGRATION	59	1.0647624	0.37840787	0.8145734	0.24111055	-1.88841425
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP	c2.CGP_ chemical and genetic perturbations	295	-0.82347375	1	0.92205596	OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP	294	0.88703644	0.8004012	1	0.06356269	-1.71051019
GO_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS	c5.BP_ GO biological process	64	-0.8234008	0.82608694	0.9219318	GO_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS	69	1.1953567	0.16291533	0.5965602	0.3719559	-2.0187575
GO_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING	c5.GO molecular function	59	-0.82283324	0.8642857	0.92260206	GO_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING	62	-1.2173955	0.08791209	0.3592403	-2.04022874	0.39456226
REACTOME_PKB_MEDIATED_EVENTS	c2.CP_REACTOME_ Reactome gene sets	28	-0.8226687	0.7671642	0.9226303	REACTOME_PKB_MEDIATED_EVENTS	28	-0.4858177	1	0.9918375	-1.3084864	-0.336851
GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP	C7_ immunologic signatures	177	-0.8218091	0.9655172	0.92374825	GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP	179	-0.9520195	0.72727275	0.7529746	-1.7738286	0.1302104
GO_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE	c5.BP_ GO biological process	49	-0.82174563	0.7979452	0.9236086	GO_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE	56	0.9268838	0.6113586	1	0.10513817	-1.74862943
GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN	C7_ immunologic signatures	172	-0.8204444	0.9791667	0.92538536	GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN	177	0.91051525	0.716479	1	0.09007085	-1.73095965
GNF2_CASP1	c4.CGN_ cancer gene neighborhoods	89	-0.8194863	0.9295154	0.92662936	GNF2_CASP1	92	1.0444882	0.40463647	0.8501203	0.2250019	-1.8639745
GO_REGULATION_OF_MRNA_METABOLIC_PROCESS	c5.BP_ GO biological process	111	-0.8194119	0.921659	0.92650634	GO_REGULATION_OF_MRNA_METABOLIC_PROCESS	114	-1.1855428	0.078947365	0.39854172	-2.0049547	0.3661309
MATZUK_MALE_REPRODUCTION_SERTOLI	c2.CGP_ chemical and genetic perturbations	24	-0.8193281	0.734072	0.9263961	MATZUK_MALE_REPRODUCTION_SERTOLI	26	0.73898524	0.8160096	1	-0.08034286	-1.55831334
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	c2.CP_REACTOME_ Reactome gene sets	75	-0.81926286	0.89849627	0.92625016	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	76	1.1376945	0.264232	0.69473577	0.31843164	-1.95695736
GO_PROTEIN_IMPORT	c5.BP_ GO biological process	144	-0.8188264	0.97126436	0.92668414	GO_PROTEIN_IMPORT	145	-0.9327634	0.6666667	0.7806682	-1.7515898	0.113937
GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP	C7_ immunologic signatures	183	-0.8186348	0.9859155	0.9267331	GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP	187	1.0418063	0.3856999	0.85608006	0.2231715	-1.8604411
REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP	c2.CP_REACTOME_ Reactome gene sets	16	-0.818514	0.7089552	0.9266834	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP	16	-1.6248409	0.03587444	0.08259464	-2.4433549	0.8063269
VALK_AML_CLUSTER_5	c2.CGP_ chemical and genetic perturbations	23	-0.81802595	0.74242425	0.92718184	VALK_AML_CLUSTER_5	24	1.4081688	0.05562579	0.32769436	0.59014285	-2.22619475
GO_POSITIVE_REGULATION_OF_MRNA_PROCESSING	c5.BP_ GO biological process	30	-0.8178968	0.7765043	0.92713374	GO_POSITIVE_REGULATION_OF_MRNA_PROCESSING	30	0.75224626	0.8404762	1	-0.06565054	-1.57014306
KYNG_WERNER_SYNDROM_DN	c2.CGP_ chemical and genetic perturbations	23	-0.81775475	0.77322406	0.92710865	KYNG_WERNER_SYNDROM_DN	24	1.1164211	0.30922693	0.7287288	0.29866635	-1.93417585
GO_SUPEROXIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	27	-0.816963	0.7694611	0.9280689	GO_SUPEROXIDE_METABOLIC_PROCESS	28	0.9310485	0.5819071	0.9983855	0.1140855	-1.7480115
GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP	C7_ immunologic signatures	177	-0.81623244	0.9637681	0.9289509	GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP	181	0.5223429	1	1	-0.29388954	-1.33857534
GUO_HEX_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	56	-0.8157327	0.8639706	0.9294561	GUO_HEX_TARGETS_DN	59	-1.3534993	0.03125	0.23999254	-2.169232	0.5377666
GO_GLUTAMATE_METABOLIC_PROCESS	c5.BP_ GO biological process	26	-0.81566095	0.8005952	0.92933184	GO_GLUTAMATE_METABOLIC_PROCESS	28	-0.8679546	0.7277487	0.8550024	-1.68361555	0.05229365
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	c2.CGP_ chemical and genetic perturbations	15	-0.8155136	0.7120419	0.92930585	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	15	1.1833268	0.2696335	0.6174878	0.3678132	-1.9988404
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	c2.CGP_ chemical and genetic perturbations	21	-0.81536454	0.76280326	0.92928046	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	21	0.60826904	0.948503	1	-0.2070955	-1.42363358
TCTGGAC_MIR198	c3.MIR_ microRNA targets	79	-0.81514436	0.89361703	0.9293639	TCTGGAC_MIR198	78	1.0170659	0.46047008	0.8941723	0.20192154	-1.83221026
GO_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS	c5.BP_ GO biological process	16	-0.81507725	0.7246753	0.92922336	GO_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS	16	0.64856565	0.9173333	1	-0.1665116	-1.4636429
GO_COFACTOR_CATABOLIC_PROCESS	c5.BP_ GO biological process	18	-0.81409407	0.746114	0.93048143	GO_COFACTOR_CATABOLIC_PROCESS	18	1.0453922	0.42077923	0.848413	0.23129813	-1.85948627
GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN	C7_ immunologic signatures	182	-0.81406873	1	0.9302741	GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN	183	0.83475715	0.85973763	1	0.02068842	-1.64882588
MORF_SNRP70	c4.CGN_ cancer gene neighborhoods	52	-0.8136435	0.86466163	0.9306671	MORF_SNRP70	52	-1.4610631	0.01724138	0.16574778	-2.2747066	0.6474196
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_2_OXOGLUTARATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_EACH_OF_OXYGEN_INTO_BOTH_DONORS	c5.GO molecular function	37	-0.8136032	0.7871622	0.9304845	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_2_OXOGLUTARATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_EACH_OF_OXYGEN_INTO_BOTH_DONORS	36	0.57255876	0.97635937	1	-0.24104444	-1.38616196
BIOCARTA_NKT_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	21	-0.8134802	0.7668539	0.93042874	BIOCARTA_NKT_PATHWAY	22	-1.7459313	0.005780347	0.044385497	-2.5594115	0.9324511
GO_N_METHYLTRANSFERASE_ACTIVITY	c5.GO molecular function	62	-0.8130785	0.8731884	0.9307503	GO_N_METHYLTRANSFERASE_ACTIVITY	66	0.9788302	0.53812635	0.9507435	0.1657517	-1.7919087
GO_METHYL_CPG_BINDING	c5.GO molecular function	15	-0.8124998	0.722365	0.9313556	GO_METHYL_CPG_BINDING	20	-0.7966023	0.7715736	0.9089876	-1.6091021	-0.0158975
WHITEHURST_PACLITAXEL_SENSITIVITY	c2.CGP_ chemical and genetic perturbations	34	-0.81222075	0.7868339	0.93155026	WHITEHURST_PACLITAXEL_SENSITIVITY	36	1.2692778	0.14369847	0.48558968	0.45705705	-2.08149855
GO_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	20	-0.8119509	0.74931127	0.93169594	GO_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS	18	1.200234	0.23276983	0.592099	0.3882831	-2.0121849
GO_FILOPODIUM_ASSEMBLY	c5.BP_ GO biological process	16	-0.8118844	0.74462366	0.9315372	GO_FILOPODIUM_ASSEMBLY	16	1.0958111	0.36459708	0.76339597	0.2839267	-1.9076955
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE	c2.CP_REACTOME_ Reactome gene sets	16	-0.81181395	0.73246753	0.93140084	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE	17	0.8345196	0.701731	1	0.02270565	-1.64633355
PID_HDAC_CLASSI_PATHWAY	c2.CP_ Canonical pathways	65	-0.8116947	0.8677043	0.93133795	PID_HDAC_CLASSI_PATHWAY	65	0.67505527	0.95973885	1	-0.13663943	-1.48674997
GNF2_TTN	c4.CGN_ cancer gene neighborhoods	20	-0.8114636	0.7670157	0.9314464	GNF2_TTN	23	1.1929109	0.24779874	0.6003563	0.3814473	-2.0043745
GO_GENE_SILENCING	c5.BP_ GO biological process	156	-0.8113036	0.9848485	0.931417	GO_GENE_SILENCING	164	0.94960934	0.63441956	0.982719	0.13830574	-1.76091294
KEGG_ENDOMETRIAL_CANCER	c2.CP_BIOCARTA_ BioCarta gene sets	51	-0.81113476	0.8506944	0.9314158	KEGG_ENDOMETRIAL_CANCER	51	1.0473719	0.416198	0.8444459	0.23623714	-1.85850666
GO_HORMONE_RECEPTOR_BINDING	c5.GO molecular function	136	-0.8109083	0.9840425	0.9315106	GO_HORMONE_RECEPTOR_BINDING	142	0.6368075	0.98348814	1	-0.1741008	-1.4477158
GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN	C7_ immunologic signatures	140	-0.8107816	0.947644	0.9314495	GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN	141	-1.0966126	0.16666667	0.5224618	-1.9073942	0.285831
GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT	c5.BP_ GO biological process	17	-0.81033635	0.72074467	0.931851	GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT	18	1.0270054	0.4551282	0.8811944	0.21666905	-1.83734175
GO_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX	c5.CC_ GO cellular component	24	-0.81031066	0.76878613	0.93164957	GO_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX	24	-0.96421844	0.48704663	0.73620784	-1.7745291	0.15390778
GO_MOTILE_CILIUM	c5.CC_ GO cellular component	91	-0.8102024	0.9117647	0.93156767	GO_MOTILE_CILIUM	95	1.1881813	0.16578108	0.60854733	0.3779789	-1.9983837
GKCGCNNNNNNNTGAYG_UNKNOWN	c3.TFT_ transcription factor targets	52	-0.80940294	0.88129497	0.93247294	GKCGCNNNNNNNTGAYG_UNKNOWN	52	-1.2308378	0.0990991	0.34483328	-2.04024074	0.42143486
GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP	C7_ immunologic signatures	174	-0.8092652	0.98224854	0.93242174	GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP	177	0.79647684	0.8921371	1	-0.01278836	-1.60574204
MODULE_36	c4.CM_ cancer modules	143	-0.80918825	0.97159094	0.93228996	MODULE_36	144	0.66331375	0.97755104	1	-0.1458745	-1.472502
GO_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION	c5.BP_ GO biological process	109	-0.80862427	0.94871795	0.93282956	GO_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION	111	0.7514258	0.9032258	1	-0.05719847	-1.56005007
GO_REGULATION_OF_PRI_MIRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER	c5.BP_ GO biological process	17	-0.80846447	0.7583548	0.93282133	GO_REGULATION_OF_PRI_MIRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER	17	1.2614446	0.18320611	0.49411058	0.45298013	-2.06990907
GO_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS	c5.BP_ GO biological process	22	-0.80800414	0.7751479	0.93320936	GO_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS	22	-0.58310944	0.9946524	0.9884162	-1.39111358	-0.2248947
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP	C7_ immunologic signatures	169	-0.80784094	0.95977014	0.9331962	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP	169	0.8172088	0.86119556	1	0.00936786	-1.62504974
RACTNNRTTTNC_UNKNOWN	c3.TFT_ transcription factor targets	102	-0.80771434	0.92718446	0.93312436	RACTNNRTTTNC_UNKNOWN	103	-0.92411256	0.6666667	0.79023707	-1.7318269	0.11639822
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	c2.CP_BIOCARTA_ BioCarta gene sets	63	-0.80767244	0.86713284	0.9329459	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	62	1.1763359	0.22100656	0.62745446	0.36866346	-1.98400834
GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS	c5.BP_ GO biological process	24	-0.80763304	0.7651715	0.9327618	GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS	25	0.6556159	0.91504854	1	-0.15201714	-1.46324894
CHR8Q21	C1: positional gene sets	44	-0.8065922	0.84887457	0.933976	CHR8Q21	43	-1.1429143	0.2421875	0.45214635	-1.9495065	0.3363221
BOYLAN_MULTIPLE_MYELOMA_C_UP	c2.CGP_ chemical and genetic perturbations	43	-0.80612266	0.85758513	0.9343614	BOYLAN_MULTIPLE_MYELOMA_C_UP	43	0.87675864	0.66943127	1	0.07063598	-1.6828813
GO_PHOSPHATIDIC_ACID_METABOLIC_PROCESS	c5.BP_ GO biological process	26	-0.8054691	0.78208953	0.9350563	GO_PHOSPHATIDIC_ACID_METABOLIC_PROCESS	31	1.1292253	0.2994083	0.70743704	0.3237562	-1.9346944
GO_CELLULAR_CARBOHYDRATE_CATABOLIC_PROCESS	c5.BP_ GO biological process	25	-0.80503124	0.7823529	0.93540275	GO_CELLULAR_CARBOHYDRATE_CATABOLIC_PROCESS	27	1.5303876	0.018072288	0.2209393	0.72535636	-2.33541884
REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	c2.CP_REACTOME_ Reactome gene sets	68	-0.80435866	0.9123506	0.9360722	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	68	0.89097536	0.6878364	1	0.0866167	-1.69533402
KEGG_ERBB_SIGNALING_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	83	-0.8027308	0.9414226	0.938051	KEGG_ERBB_SIGNALING_PATHWAY	83	1.0402402	0.42336547	0.85910004	0.2375094	-1.842971
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	c2.CP_BIOCARTA_ BioCarta gene sets	89	-0.8025319	0.92083335	0.9380853	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	90	1.3965666	0.018848168	0.34700117	0.5940347	-2.1990985
GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	C7_ immunologic signatures	139	-0.8016866	0.97633135	0.9389648	GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	144	0.5362678	1	1	-0.2654188	-1.3379544
GO_RESPONSE_TO_INTERLEUKIN_6	c5.BP_ GO biological process	25	-0.8015543	0.7972603	0.9389073	GO_RESPONSE_TO_INTERLEUKIN_6	25	-0.7846034	0.80927837	0.91766447	-1.5861577	-0.0169509
GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN	C7_ immunologic signatures	177	-0.80059797	0.9882353	0.9399371	GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN	181	-1.3429679	0	0.24661216	-2.14356587	0.54236993
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	c2.CGP_ chemical and genetic perturbations	21	-0.80055094	0.80203044	0.9397579	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	21	-0.723461	0.86702126	0.9500336	-1.52401194	-0.07708994
GO_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY	c5.GO molecular function	42	-0.80053693	0.8327645	0.93953043	GO_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY	42	0.9629733	0.5355505	0.96773654	0.16243637	-1.76351023
GO_RECEPTOR_SIGNALING_COMPLEX_SCAFFOLD_ACTIVITY	c5.GO molecular function	21	-0.8001085	0.7709497	0.9398645	GO_RECEPTOR_SIGNALING_COMPLEX_SCAFFOLD_ACTIVITY	23	1.3651891	0.08808933	0.37212315	0.5650806	-2.1652976
GO_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS	c5.BP_ GO biological process	89	-0.7992376	0.925	0.9407329	GO_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS	90	1.2934226	0.065608464	0.45206317	0.494185	-2.0926602
GO_ATPASE_BINDING	c5.GO molecular function	68	-0.79915756	0.88235295	0.94059634	GO_ATPASE_BINDING	68	0.74250454	0.8963283	1	-0.05665302	-1.5416621
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	c2.CGP_ chemical and genetic perturbations	18	-0.7987968	0.75596815	0.9408395	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	18	0.9849181	0.53836316	0.9417144	0.1861213	-1.7837149
SCHEIDEREIT_IKK_TARGETS	c2.CGP_ chemical and genetic perturbations	18	-0.79816675	0.7372881	0.94140774	SCHEIDEREIT_IKK_TARGETS	18	0.6698457	0.9113924	1	-0.12832105	-1.46801245
GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN	C7_ immunologic signatures	173	-0.797596	0.9944751	0.94193333	GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN	181	0.84826076	0.82186234	1	0.05066476	-1.64585676
KANG_GLIS3_TARGETS	c2.CGP_ chemical and genetic perturbations	25	-0.7974203	0.7966102	0.9419018	KANG_GLIS3_TARGETS	32	1.2770449	0.13126491	0.47661424	0.4796246	-2.0744652
GNF2_MCL1	c4.CGN_ cancer gene neighborhoods	48	-0.7960029	0.8716216	0.9434484	GNF2_MCL1	48	1.0028899	0.4949608	0.9185276	0.206887	-1.7988928
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	c2.CGP_ chemical and genetic perturbations	23	-0.7957868	0.8005618	0.94348484	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	25	0.93809026	0.5710814	0.99283713	0.14230346	-1.73387706
GO_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	25	-0.795611	0.8248588	0.94346	GO_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY	25	1.0985869	0.35098523	0.75864923	0.3029759	-1.8941979
KAAB_FAILED_HEART_ATRIUM_UP	c2.CGP_ chemical and genetic perturbations	34	-0.7950561	0.8494624	0.94391483	KAAB_FAILED_HEART_ATRIUM_UP	35	-1.1106915	0.2389937	0.5047811	-1.9057476	0.3156354
GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP	C7_ immunologic signatures	178	-0.7950134	0.975	0.9437282	GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP	176	0.70091033	0.9734423	1	-0.09410307	-1.49592373
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	c2.CGP_ chemical and genetic perturbations	57	-0.7945111	0.8949416	0.94411427	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	57	-1.3377339	0.02970297	0.24993408	-2.132245	0.5432228
GO_NEGATIVE_REGULATION_OF_GENE_SILENCING	c5.BP_ GO biological process	18	-0.7943199	0.78409094	0.9441173	GO_NEGATIVE_REGULATION_OF_GENE_SILENCING	18	-0.86134857	0.7122642	0.8592762	-1.65566847	0.06702867
GO_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION	c5.BP_ GO biological process	60	-0.793565	0.89891696	0.9448203	GO_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION	72	0.99527943	0.47882736	0.93039924	0.20171443	-1.78884443
GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP	C7_ immunologic signatures	112	-0.7929445	0.9607843	0.9453579	GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP	113	0.74169385	0.9146968	1	-0.05125065	-1.53463835
MODULE_59	c4.CM_ cancer modules	23	-0.79265887	0.7875354	0.9454677	MODULE_59	25	1.4813695	0.024600247	0.26713806	0.68871063	-2.27402837
GO_MACROMOLECULE_METHYLATION	c5.BP_ GO biological process	160	-0.79089063	0.98170733	0.9473681	GO_MACROMOLECULE_METHYLATION	167	1.0751449	0.31786075	0.7964928	0.28425427	-1.86603553
BIOCARTA_CHREBP2_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	37	-0.7906075	0.8616352	0.94744515	BIOCARTA_CHREBP2_PATHWAY	38	-1.0490327	0.34507042	0.60732067	-1.8396402	0.2584252
DORN_ADENOVIRUS_INFECTION_12HR_UP	c2.CGP_ chemical and genetic perturbations	25	-0.78843594	0.8191781	0.94982386	DORN_ADENOVIRUS_INFECTION_12HR_UP	26	1.1571878	0.2864137	0.6582049	0.36875186	-1.94562374
REACTOME_METAL_ION_SLC_TRANSPORTERS	c2.CP_REACTOME_ Reactome gene sets	22	-0.7883851	0.82857144	0.9496432	REACTOME_METAL_ION_SLC_TRANSPORTERS	22	0.8764966	0.65869015	1	0.0881115	-1.6648817
GO_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	18	-0.7882883	0.77833754	0.94950914	GO_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	19	0.771576	0.7799736	1	-0.0167123	-1.5598643
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	c2.CGP_ chemical and genetic perturbations	15	-0.788212	0.77540106	0.9493507	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	15	-1.455555	0.06926407	0.16998984	-2.243767	0.667343
GO_METAL_CLUSTER_BINDING	c5.GO molecular function	57	-0.78741217	0.91821563	0.9500361	GO_METAL_CLUSTER_BINDING	57	-0.55592096	1	0.9892495	-1.34333313	-0.23149121
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN	C7_ immunologic signatures	176	-0.7872024	0.9884393	0.95002985	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN	178	1.0997779	0.2653885	0.7574146	0.3125755	-1.8869803
REACTOME_PYRIMIDINE_METABOLISM	c2.CP_REACTOME_ Reactome gene sets	21	-0.78492415	0.81179774	0.9524295	REACTOME_PYRIMIDINE_METABOLISM	22	0.8507766	0.6984536	1	0.06585245	-1.63570075
GO_REGULATION_OF_MYOBLAST_FUSION	c5.BP_ GO biological process	17	-0.7848564	0.81369865	0.9522641	GO_REGULATION_OF_MYOBLAST_FUSION	18	1.3135136	0.14570361	0.41996333	0.5286572	-2.09837
GO_REGULATION_OF_PROTEIN_ACTIVATION_CASCADE	c5.BP_ GO biological process	28	-0.7847597	0.8689459	0.95213485	GO_REGULATION_OF_PROTEIN_ACTIVATION_CASCADE	31	1.5903337	0.005980861	0.17276062	0.805574	-2.3750934
CHR11Q11	C1: positional gene sets	40	-0.7844882	0.8402556	0.9521963	CHR11Q11	41	0.93241465	0.59142214	0.997737	0.14792645	-1.71690285
GO_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS	c5.BP_ GO biological process	33	-0.78410494	0.8231707	0.95240825	GO_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS	33	0.6743659	0.94042057	1	-0.10973904	-1.45847084
GO_NUCLEAR_SPECK	c5.CC_ GO cellular component	182	-0.78377163	1	0.9525247	GO_NUCLEAR_SPECK	183	-1.1488861	0.083333336	0.4452849	-1.93265773	0.36511447
GO_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS	c5.BP_ GO biological process	20	-0.78366613	0.77608144	0.95240474	GO_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS	23	1.1333479	0.30038023	0.7002322	0.34968177	-1.91701403
RAMASWAMY_METASTASIS_UP	c2.CGP_ chemical and genetic perturbations	62	-0.78348875	0.91803277	0.9523537	RAMASWAMY_METASTASIS_UP	63	-0.8172073	0.8681319	0.89189166	-1.60069605	0.03371855
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	c2.CP_BIOCARTA_ BioCarta gene sets	15	-0.78318477	0.78918916	0.9524568	KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	15	1.2659938	0.17483443	0.48963663	0.48280903	-2.04917857
BIOCARTA_RAC1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	21	-0.78171235	0.8265583	0.9538321	BIOCARTA_RAC1_PATHWAY	23	0.9557873	0.54331684	0.9758334	0.17407495	-1.73749965
GO_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX	c5.CC_ GO cellular component	16	-0.7814664	0.79395604	0.95385057	GO_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX	16	-1.0182117	0.42105263	0.66213804	-1.7996781	0.2367453
REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	c2.CP_REACTOME_ Reactome gene sets	16	-0.7811999	0.79210526	0.9538942	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	16	-1.7122403	0.03846154	0.052284352	-2.4934402	0.9310404
GO_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS	c5.BP_ GO biological process	157	-0.781033	1	0.9538476	GO_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS	162	0.65708834	0.98472506	1	-0.12394466	-1.43812134
KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	c2.CP_BIOCARTA_ BioCarta gene sets	15	-0.780695	0.7853403	0.95398206	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	22	0.90416396	0.63247865	1	0.12346896	-1.68485896
MORF_BECN1	c4.CGN_ cancer gene neighborhoods	94	-0.7804858	0.9521739	0.95397526	MORF_BECN1	94	-0.86343074	0.8596491	0.8570097	-1.64391654	0.08294494
MODULE_226	c4.CM_ cancer modules	25	-0.78021216	0.8407311	0.95404166	MODULE_226	25	-1.9589937	0	0.011395986	-2.73920586	1.17878154
GO_NCRNA_CATABOLIC_PROCESS	c5.BP_ GO biological process	19	-0.77984643	0.7844828	0.95421195	GO_NCRNA_CATABOLIC_PROCESS	20	-1.3685279	0.07981221	0.22814529	-2.14837433	0.58868147
GO_POLYSACCHARIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	19	-0.77976364	0.79210526	0.9540565	GO_POLYSACCHARIDE_CATABOLIC_PROCESS	21	1.6201016	0.003778338	0.14037666	0.84033796	-2.39986524
GO_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY	c5.GO molecular function	57	-0.77902025	0.9020979	0.9546258	GO_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY	57	-0.85331243	0.88	0.86385274	-1.63233268	0.07429218
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	c2.CGP_ chemical and genetic perturbations	34	-0.7788877	0.825	0.9545304	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	35	0.6167257	0.9466976	1	-0.162162	-1.3956134
GO_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS	c5.BP_ GO biological process	26	-0.7782134	0.84592146	0.95501363	GO_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS	29	1.2759893	0.12623763	0.47965696	0.4977759	-2.0542027
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	c2.CP_REACTOME_ Reactome gene sets	28	-0.77814263	0.82712764	0.9548554	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	30	1.1230781	0.29206732	0.7200209	0.34493547	-1.90122073
GO_CALCIUM_ACTIVATED_CATION_CHANNEL_ACTIVITY	c5.GO molecular function	25	-0.77790374	0.84149855	0.9548585	GO_CALCIUM_ACTIVATED_CATION_CHANNEL_ACTIVITY	27	1.3599166	0.08078335	0.37764284	0.58201286	-2.13782034
GO_SPERMATID_DIFFERENTIATION	c5.BP_ GO biological process	101	-0.7777481	0.9764151	0.9547662	GO_SPERMATID_DIFFERENTIATION	110	1.0144112	0.4696017	0.8992263	0.2366631	-1.7921593
PID_NCADHERIN_PATHWAY	c2.CP_ Canonical pathways	31	-0.77683926	0.8668731	0.95548403	PID_NCADHERIN_PATHWAY	32	-1.0058243	0.45251396	0.676145	-1.78266356	0.22898504
GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN	C7_ immunologic signatures	175	-0.7764341	0.98013246	0.95567256	GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN	175	0.7306352	0.9535354	1	-0.0457989	-1.5070693
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP	C7_ immunologic signatures	180	-0.7762567	0.98101264	0.9556156	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP	181	0.9803708	0.5494949	0.94892544	0.2041141	-1.7566275
GO_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	16	-0.77622914	0.82222223	0.9553979	GO_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS	17	-0.74701315	0.78414094	0.93986803	-1.52324229	-0.02921599
MODULE_73	c4.CM_ cancer modules	21	-0.7753861	0.7837838	0.95603424	MODULE_73	22	-0.96939945	0.51941746	0.7299285	-1.74478555	0.19401335
GO_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT	c5.BP_ GO biological process	24	-0.77484906	0.84375	0.9563566	GO_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT	24	0.5083133	0.9900498	1	-0.26653576	-1.28316236
GO_TRANSCRIPTION_FACTOR_TFIID_COMPLEX	c5.CC_ GO cellular component	22	-0.7747408	0.83908045	0.95622474	GO_TRANSCRIPTION_FACTOR_TFIID_COMPLEX	22	1.328425	0.10429448	0.40345624	0.5536842	-2.1031658
GO_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	77	-0.77405894	0.9377432	0.9566884	GO_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	80	0.98248744	0.53985125	0.9452936	0.2084285	-1.75654638
REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS	c2.CP_REACTOME_ Reactome gene sets	27	-0.7735808	0.8394366	0.9569247	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS	30	0.96232635	0.5496368	0.9687555	0.18874555	-1.73590715
GO_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE	c5.CC_ GO cellular component	38	-0.77345055	0.8606811	0.9568296	GO_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE	39	1.3351771	0.083526686	0.39787987	0.56172655	-2.10862765
GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	C7_ immunologic signatures	180	-0.7720908	0.9881657	0.9579831	GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	183	0.6135403	0.99697274	1	-0.1585505	-1.3856311
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	c2.CGP_ chemical and genetic perturbations	36	-0.77131826	0.88544893	0.95852494	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	36	0.8596511	0.70857817	1	0.08833284	-1.63096936
KORKOLA_SEMINOMA_UP	c2.CGP_ chemical and genetic perturbations	35	-0.7707105	0.88622755	0.95888543	KORKOLA_SEMINOMA_UP	35	1.1109542	0.32071006	0.73611337	0.3402437	-1.8816647
GO_ODORANT_BINDING	c5.GO molecular function	59	-0.7706198	0.9460432	0.95873976	GO_ODORANT_BINDING	63	0.38353974	1	1	-0.38708006	-1.15415954
CHR16P13	C1: positional gene sets	198	-0.77044255	1	0.9586828	CHR16P13	200	0.8809959	0.78203833	1	0.11055335	-1.65143845
LUI_THYROID_CANCER_PAX8_PPARG_UP	c2.CGP_ chemical and genetic perturbations	42	-0.77002233	0.8947368	0.95886385	LUI_THYROID_CANCER_PAX8_PPARG_UP	42	-0.99223816	0.5138889	0.6992392	-1.76226049	0.22221583
STARK_HYPPOCAMPUS_22Q11_DELETION_DN	c2.CGP_ chemical and genetic perturbations	16	-0.76939905	0.795082	0.9592503	STARK_HYPPOCAMPUS_22Q11_DELETION_DN	17	-0.53620636	0.98623854	0.9910908	-1.30560541	-0.23319269
GNF2_FGR	c4.CGN_ cancer gene neighborhoods	24	-0.76924044	0.8611111	0.95916677	GNF2_FGR	25	0.71029305	0.87990195	1	-0.05894739	-1.47953349
GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN	C7_ immunologic signatures	168	-0.76919687	0.9868421	0.9589636	GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN	169	0.69908404	0.9716312	1	-0.07011283	-1.46828091
GO_CHROMATIN_SILENCING_AT_RDNA	c5.BP_ GO biological process	19	-0.7687195	0.77868855	0.95917803	GO_CHROMATIN_SILENCING_AT_RDNA	19	0.86809164	0.6827411	1	0.09937214	-1.63681114
FRASOR_TAMOXIFEN_RESPONSE_UP	c2.CGP_ chemical and genetic perturbations	46	-0.76851714	0.8877193	0.9591346	FRASOR_TAMOXIFEN_RESPONSE_UP	47	1.1006724	0.335578	0.75649816	0.33215526	-1.86918954
GO_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION	c5.BP_ GO biological process	21	-0.7684674	0.84126985	0.95894194	GO_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION	22	1.3573004	0.08165829	0.37925267	0.588833	-2.1257678
GCCATNTTG_YY1_Q6	c3.TFT_ transcription factor targets	380	-0.768442	1	0.9587248	GCCATNTTG_YY1_Q6	381	0.60814214	0.999	1	-0.16029986	-1.37658414
GO_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY	c5.BP_ GO biological process	23	-0.76838315	0.8142857	0.9585408	GO_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY	24	0.8453206	0.7055138	1	0.07693745	-1.61370375
GO_AMINO_ACID_BETAINE_METABOLIC_PROCESS	c5.BP_ GO biological process	16	-0.76789683	0.80266666	0.95876026	GO_AMINO_ACID_BETAINE_METABOLIC_PROCESS	15	0.93436736	0.55878466	0.9956421	0.16647053	-1.70226419
BIOCARTA_EIF4_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	24	-0.7665098	0.877193	0.95987195	BIOCARTA_EIF4_PATHWAY	24	1.006122	0.47225648	0.9133875	0.2396122	-1.7726318
REACTOME_SIGNALLING_TO_ERKS	c2.CP_REACTOME_ Reactome gene sets	34	-0.7662098	0.85588235	0.95991474	REACTOME_SIGNALLING_TO_ERKS	35	1.0992938	0.35119048	0.7577326	0.333084	-1.8655036
GO_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY	c5.BP_ GO biological process	16	-0.764104	0.80798006	0.9616914	GO_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY	15	1.3810232	0.08891752	0.35650486	0.6169192	-2.1451272
GNF2_JAK1	c4.CGN_ cancer gene neighborhoods	22	-0.76378036	0.87319887	0.9617383	GNF2_JAK1	23	1.1964777	0.23424494	0.59656286	0.43269734	-1.96025806
GO_INTRINSIC_COMPONENT_OF_ENDOPLASMIC_RETICULUM_MEMBRANE	c5.CC_ GO cellular component	99	-0.7627414	0.96595746	0.96246177	GO_INTRINSIC_COMPONENT_OF_ENDOPLASMIC_RETICULUM_MEMBRANE	103	0.9339482	0.631139	0.99577177	0.1712068	-1.6966896
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	c2.CGP_ chemical and genetic perturbations	17	-0.76272136	0.82288826	0.96223956	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	17	0.9631167	0.51797605	0.9674988	0.20039534	-1.72583806
GO_PH_REDUCTION	c5.BP_ GO biological process	35	-0.761929	0.8592814	0.96270424	GO_PH_REDUCTION	38	-0.7473387	0.9236641	0.94024324	-1.5092677	-0.0145903
CHOI_ATL_CHRONIC_VS_ACUTE_DN	c2.CGP_ chemical and genetic perturbations	18	-0.7613299	0.8088643	0.9629931	CHOI_ATL_CHRONIC_VS_ACUTE_DN	18	-1.477938	0.050691243	0.15596548	-2.2392679	0.7166081
GO_PROTEIN_EXPORT_FROM_NUCLEUS	c5.BP_ GO biological process	29	-0.76114434	0.8710692	0.96291584	GO_PROTEIN_EXPORT_FROM_NUCLEUS	29	-1.414619	0.04568528	0.19660106	-2.17576334	0.65347466
MODULE_4	c4.CM_ cancer modules	20	-0.7595912	0.8005115	0.96411043	MODULE_4	20	-1.3723483	0.08962264	0.224872	-2.1319395	0.6127571
GO_CELLULAR_DEFENSE_RESPONSE	c5.BP_ GO biological process	37	-0.759081	0.90342677	0.9643345	GO_CELLULAR_DEFENSE_RESPONSE	41	0.8663617	0.6976744	1	0.1072807	-1.6254427
GO_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	31	-0.75812197	0.84923077	0.96497905	GO_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS	31	0.8979772	0.62953997	1	0.13985523	-1.65609917
PID_PDGFRA_PATHWAY	c2.CP_ Canonical pathways	21	-0.7564303	0.84182304	0.966208	PID_PDGFRA_PATHWAY	21	1.1790603	0.24427481	0.6232998	0.42263	-1.9354906
PID_MTOR_4PATHWAY	c2.CP_ Canonical pathways	68	-0.75577074	0.96629214	0.9665437	PID_MTOR_4PATHWAY	68	-0.93215024	0.60465115	0.7812713	-1.68792098	0.1763795
CHR9Q21	C1: positional gene sets	36	-0.7554158	0.9163987	0.96662503	CHR9Q21	37	0.96907246	0.5382803	0.96231544	0.21365666	-1.72448826
GO_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	37	-0.7552647	0.92022794	0.9665194	GO_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS	37	0.9593662	0.57431626	0.9711143	0.2041015	-1.7146309
REACTOME_RNA_POL_I_TRANSCRIPTION	c2.CP_REACTOME_ Reactome gene sets	46	-0.7545032	0.92	0.9669514	REACTOME_RNA_POL_I_TRANSCRIPTION	47	0.89830494	0.6444695	1	0.14380174	-1.65280814
GO_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY	c5.BP_ GO biological process	15	-0.75425786	0.8431877	0.9669245	GO_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY	15	-1.0194495	0.43145162	0.66043013	-1.77370736	0.26519164
GO_PHOSPHATASE_INHIBITOR_ACTIVITY	c5.GO molecular function	33	-0.75199366	0.89973617	0.9686214	GO_PHOSPHATASE_INHIBITOR_ACTIVITY	33	0.735589	0.86281586	1	-0.01640466	-1.48758266
GO_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS	c5.BP_ GO biological process	20	-0.75140375	0.8457143	0.9688608	GO_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS	20	-1.2105502	0.22325581	0.3679046	-1.96195395	0.45914645
PID_PI3KCI_PATHWAY	c2.CP_ Canonical pathways	46	-0.75095415	0.90645164	0.96898365	PID_PI3KCI_PATHWAY	47	0.86600685	0.71590906	1	0.1150527	-1.616961
GO_ATPASE_REGULATOR_ACTIVITY	c5.GO molecular function	27	-0.7508156	0.86890244	0.96885073	GO_ATPASE_REGULATOR_ACTIVITY	27	-0.91795605	0.60714287	0.79813254	-1.66877165	0.16714045
GO_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS	c5.BP_ GO biological process	17	-0.7505054	0.8435754	0.9688637	GO_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS	20	-0.8862169	0.5920398	0.8386751	-1.6367223	0.1357115
MARKS_HDAC_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	19	-0.7502504	0.84281844	0.96883404	MARKS_HDAC_TARGETS_UP	20	-0.9144828	0.5688889	0.80222636	-1.6647332	0.1642324
GGCNKCCATNK_UNKNOWN	c3.TFT_ transcription factor targets	105	-0.750238	0.9741379	0.96860343	GGCNKCCATNK_UNKNOWN	106	-1.0780761	0.3255814	0.55493456	-1.8283141	0.3278381
GO_REGULATION_OF_MONOCYTE_CHEMOTAXIS	c5.BP_ GO biological process	17	-0.7501039	0.8346253	0.9684663	GO_REGULATION_OF_MONOCYTE_CHEMOTAXIS	16	0.8207371	0.71521455	1	0.0706332	-1.570841
GO_NEURONAL_POSTSYNAPTIC_DENSITY	c5.CC_ GO cellular component	51	-0.7483221	0.9198606	0.96966887	GO_NEURONAL_POSTSYNAPTIC_DENSITY	51	0.8568977	0.7197309	1	0.1085756	-1.6052198
BIOCARTA_KERATINOCYTE_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	45	-0.7482898	0.94666666	0.9694508	BIOCARTA_KERATINOCYTE_PATHWAY	45	1.5548189	0.008045977	0.20340094	0.8065291	-2.3031087
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	c2.CGP_ chemical and genetic perturbations	20	-0.747429	0.83458644	0.96990067	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	21	-1.2684286	0.13612565	0.30985647	-2.0158576	0.5209996
GO_SIGNAL_SEQUENCE_BINDING	c5.GO molecular function	35	-0.74733144	0.91358024	0.9697374	GO_SIGNAL_SEQUENCE_BINDING	35	-1.0087543	0.46451613	0.674383	-1.75608574	0.26142286
GO_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	-0.74673295	0.8316327	0.9699641	GO_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS	16	1.1791319	0.26436782	0.6235212	0.43239895	-1.92586485
MORF_RAB3A	c4.CGN_ cancer gene neighborhoods	71	-0.74654776	0.95555556	0.96987396	MORF_RAB3A	73	1.1150286	0.2863248	0.7308354	0.36848084	-1.86157636
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	c2.CP_BIOCARTA_ BioCarta gene sets	21	-0.7462642	0.82905984	0.9698564	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	22	1.1884483	0.23337679	0.6082347	0.4421841	-1.9347125
GO_HISTONE_MRNA_METABOLIC_PROCESS	c5.BP_ GO biological process	23	-0.74582213	0.86494255	0.96997565	GO_HISTONE_MRNA_METABOLIC_PROCESS	23	-1.8318189	0	0.027742771	-2.57764103	1.08599677
AGCGCTT_MIR518F_MIR518E_MIR518A	c3.MIR_ microRNA targets	16	-0.7455373	0.84594595	0.96996474	AGCGCTT_MIR518F_MIR518E_MIR518A	16	0.9270323	0.57457846	1	0.181495	-1.6725696
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	c2.CP_REACTOME_ Reactome gene sets	17	-0.74489135	0.86290324	0.9702475	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	17	0.56663704	0.96727747	1	-0.17825431	-1.31152839
GO_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION	c5.BP_ GO biological process	27	-0.74296635	0.877193	0.97149247	GO_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION	27	0.854612	0.6984127	1	0.11164565	-1.59757835
GNF2_BNIP2	c4.CGN_ cancer gene neighborhoods	32	-0.74288803	0.91818184	0.97131497	GNF2_BNIP2	33	-0.96668315	0.525641	0.7336723	-1.70957118	0.22379512
GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN	c5.GO molecular function	115	-0.74285924	0.99086756	0.9710915	GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN	120	1.3035539	0.037037037	0.43606135	0.56069466	-2.04641314
GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_UP	C7_ immunologic signatures	176	-0.74136114	1	0.97197074	GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_UP	176	1.055809	0.39086294	0.8317205	0.31444786	-1.79717014
GNF2_CASP4	c4.CGN_ cancer gene neighborhoods	20	-0.74043554	0.875	0.972421	GNF2_CASP4	20	1.1406034	0.2972973	0.68939906	0.40016786	-1.88103894
GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_INCISION	c5.BP_ GO biological process	36	-0.7400785	0.91588783	0.97244287	GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_INCISION	36	0.6650583	0.9369048	1	-0.0750202	-1.4051368
MODULE_278	c4.CM_ cancer modules	31	-0.7391102	0.89440995	0.9729233	MODULE_278	31	-1.2607813	0.13541667	0.31441894	-1.9998915	0.5216711
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY	c2.CP_REACTOME_ Reactome gene sets	18	-0.73852813	0.8453608	0.9731244	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY	18	-0.68368435	0.9223744	0.96784776	-1.42221248	-0.05484378
GO_PROLINE_RICH_REGION_BINDING	c5.GO molecular function	18	-0.73616374	0.87371135	0.97462374	GO_PROLINE_RICH_REGION_BINDING	18	-1.0006735	0.4032258	0.6850867	-1.73683724	0.26450976
REACTOME_SIGNALING_BY_ROBO_RECEPTOR	c2.CP_REACTOME_ Reactome gene sets	27	-0.73576885	0.90544415	0.97465146	REACTOME_SIGNALING_BY_ROBO_RECEPTOR	27	1.2592351	0.15560916	0.49751875	0.52346625	-1.99500395
GO_INTERMEDIATE_FILAMENT	c5.CC_ GO cellular component	73	-0.73558617	0.9518072	0.97453594	GO_INTERMEDIATE_FILAMENT	87	1.1559213	0.19659936	0.66080666	0.42033513	-1.89150747
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	c2.CGP_ chemical and genetic perturbations	56	-0.73550636	0.9517241	0.9743527	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	59	1.0309329	0.44918033	0.8739928	0.29542654	-1.76643926
GO_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI	c5.BP_ GO biological process	16	-0.7352958	0.84931505	0.974264	GO_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI	16	0.9422584	0.5753604	0.98902184	0.2069626	-1.6775542
GO_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT	c5.BP_ GO biological process	76	-0.733914	0.97530866	0.97501564	GO_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT	76	0.77699304	0.84973544	1	0.04307904	-1.51090704
HEDENFALK_BREAST_CANCER_BRACX_DN	c2.CGP_ chemical and genetic perturbations	18	-0.7337392	0.8563536	0.9748962	HEDENFALK_BREAST_CANCER_BRACX_DN	18	-0.95878184	0.5254237	0.74409103	-1.69252104	0.22504264
CHESLER_BRAIN_HIGHEST_EXPRESSION	c2.CGP_ chemical and genetic perturbations	36	-0.7322947	0.9074074	0.975682	CHESLER_BRAIN_HIGHEST_EXPRESSION	36	-0.82664996	0.8544304	0.8855645	-1.55894466	0.09435526
ABBUD_LIF_SIGNALING_1_DN	c2.CGP_ chemical and genetic perturbations	25	-0.7302415	0.8935574	0.9768209	ABBUD_LIF_SIGNALING_1_DN	25	-1.0001639	0.497006	0.68476325	-1.7304054	0.2699224
GO_MODIFICATION_BY_SYMBIONT_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY	c5.BP_ GO biological process	39	-0.72828126	0.9174603	0.9779279	GO_MODIFICATION_BY_SYMBIONT_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY	38	-1.1995783	0.18518518	0.38243094	-1.92785956	0.47129704
GO_EPIBOLY	c5.BP_ GO biological process	20	-0.7274748	0.8582474	0.9782236	GO_EPIBOLY	20	0.6802104	0.88917196	1	-0.0472644	-1.4076852
GO_CLATHRIN_COAT_OF_COATED_PIT	c5.CC_ GO cellular component	16	-0.72681785	0.87435895	0.9784285	GO_CLATHRIN_COAT_OF_COATED_PIT	16	1.1082594	0.36375663	0.7408494	0.38144155	-1.83507725
GO_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY	c5.BP_ GO biological process	15	-0.7268064	0.87531173	0.9781917	GO_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY	15	0.95659375	0.54433835	0.9752476	0.22978735	-1.68340015
GO_HISTONE_METHYLTRANSFERASE_ACTIVITY	c5.GO molecular function	40	-0.7267153	0.94690263	0.9780136	GO_HISTONE_METHYLTRANSFERASE_ACTIVITY	44	0.68694127	0.9214366	1	-0.03977403	-1.41365657
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	c2.CGP_ chemical and genetic perturbations	22	-0.72653186	0.8636364	0.97789526	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	22	-1.1989615	0.18421052	0.38307747	-1.92549336	0.47242964
MORF_CDC16	c4.CGN_ cancer gene neighborhoods	65	-0.72524273	0.972332	0.9784968	MORF_CDC16	66	-1.6539972	0	0.070460185	-2.37923993	0.92875447
GTGGTGA_MIR197	c3.MIR_ microRNA targets	64	-0.7250423	0.98550725	0.97837985	GTGGTGA_MIR197	65	0.8245132	0.77862597	1	0.0994709	-1.5495555
GO_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	c5.BP_ GO biological process	15	-0.72345686	0.86466163	0.9791238	GO_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY	16	1.2218566	0.22860792	0.5535126	0.49839974	-1.94531346
GO_PROTEIN_MANNOSYLATION	c5.BP_ GO biological process	15	-0.72322416	0.8582677	0.9790319	GO_PROTEIN_MANNOSYLATION	16	-1.0082362	0.4262295	0.67403215	-1.73146036	0.28501204
BIOCARTA_TFF_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	20	-0.72230506	0.908284	0.97938854	BIOCARTA_TFF_PATHWAY	21	-0.9875149	0.50731707	0.70533204	-1.70981996	0.26520984
REACTOME_BASE_EXCISION_REPAIR	c2.CP_REACTOME_ Reactome gene sets	18	-0.7217293	0.8548387	0.97951835	REACTOME_BASE_EXCISION_REPAIR	18	-1.2485096	0.1440678	0.3245259	-1.9702389	0.5267803
GO_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE	c5.CC_ GO cellular component	26	-0.7216507	0.9088319	0.97932225	GO_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE	26	-1.5689557	0.015789473	0.105434306	-2.2906064	0.847305
GO_PEROXISOME_ORGANIZATION	c5.BP_ GO biological process	33	-0.7213905	0.94011974	0.97923577	GO_PEROXISOME_ORGANIZATION	33	0.9310407	0.5860849	0.9982813	0.2096502	-1.6524312
MODULE_35	c4.CM_ cancer modules	16	-0.7210669	0.877193	0.97919655	MODULE_35	16	-1.8473113	0.008333334	0.02481101	-2.5683782	1.1262444
REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	15	-0.7210171	0.87435895	0.97898424	REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT	20	-1.5910997	0.028985508	0.094747655	-2.3121168	0.8700826
BIOCARTA_CK1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	-0.72020775	0.8559322	0.9792306	BIOCARTA_CK1_PATHWAY	16	0.55206895	0.9683377	1	-0.1681388	-1.2722767
BIOCARTA_RHO_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	30	-0.7178376	0.9177215	0.9804479	BIOCARTA_RHO_PATHWAY	31	1.0072806	0.4770318	0.9119343	0.289443	-1.7251182
GNF2_PTPN4	c4.CGN_ cancer gene neighborhoods	33	-0.71721816	0.95695364	0.9805683	GNF2_PTPN4	35	0.9138364	0.6183115	1	0.19661824	-1.63105456
MODULE_281	c4.CM_ cancer modules	25	-0.71535355	0.91764706	0.98143905	MODULE_281	25	-1.9123336	0.01010101	0.01675234	-2.62768715	1.19698005
GO_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE	c5.BP_ GO biological process	23	-0.7153094	0.8763441	0.9812223	GO_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE	23	1.1495138	0.2867738	0.6705475	0.4342044	-1.8648232
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	17	-0.71470934	0.85117495	0.9813268	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	18	0.7897264	0.765685	1	0.07501706	-1.50443574
GO_PHAGOCYTIC_CUP	c5.CC_ GO cellular component	17	-0.7145862	0.8954802	0.98115695	GO_PHAGOCYTIC_CUP	16	0.9234658	0.58507854	1	0.2088796	-1.638052
GO_MYELIN_ASSEMBLY	c5.BP_ GO biological process	15	-0.7137612	0.88082904	0.98137504	GO_MYELIN_ASSEMBLY	15	0.92957	0.5876963	0.9992907	0.2158088	-1.6433312
GO_HISTONE_UBIQUITINATION	c5.BP_ GO biological process	33	-0.7136701	0.94100296	0.9811789	GO_HISTONE_UBIQUITINATION	34	-0.9825527	0.48125	0.711021	-1.6962228	0.2688826
HALLMARK_PROTEIN_SECRETION	H_ hallmark gene sets	92	-0.71191335	0.990991	0.9819415	HALLMARK_PROTEIN_SECRETION	92	0.9119523	0.66737515	1	0.20003895	-1.62386565
GO_REGULATION_OF_PROTEIN_PHOSPHATASE_TYPE_2A_ACTIVITY	c5.BP_ GO biological process	22	-0.7118867	0.8869565	0.98171407	GO_REGULATION_OF_PROTEIN_PHOSPHATASE_TYPE_2A_ACTIVITY	22	-0.98628044	0.4471154	0.7067742	-1.69816714	0.27439374
MODULE_82	c4.CM_ cancer modules	23	-0.7116895	0.91483516	0.98158914	MODULE_82	23	-1.4003932	0.061320756	0.20611197	-2.1120827	0.6887037
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	c2.CP_REACTOME_ Reactome gene sets	16	-0.711642	0.87222224	0.98137444	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	16	-1.2743428	0.17021276	0.30668104	-1.9859848	0.5627008
GO_PROTEIN_METHYLTRANSFERASE_ACTIVITY	c5.GO molecular function	56	-0.7112997	0.9725086	0.9813193	GO_PROTEIN_METHYLTRANSFERASE_ACTIVITY	61	0.8874491	0.6949891	1	0.1761494	-1.5987488
GO_REGULATION_OF_MYELINATION	c5.BP_ GO biological process	27	-0.71097	0.9101796	0.9812848	GO_REGULATION_OF_MYELINATION	28	-0.68711567	0.96875	0.96612775	-1.39808567	-0.02385433
WANG_THOC1_TARGETS_DN	c2.CGP_ chemical and genetic perturbations	16	-0.7093307	0.87240356	0.9819615	WANG_THOC1_TARGETS_DN	16	1.3241452	0.13654618	0.4095441	0.6148145	-2.0334759
GO_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING	c5.BP_ GO biological process	17	-0.7090462	0.88950276	0.9818728	GO_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING	17	0.68284625	0.88785046	1	-0.02619995	-1.39189245
GO_PROTEIN_LOCALIZATION_TO_LYSOSOME	c5.BP_ GO biological process	16	-0.7076341	0.885	0.9824196	GO_PROTEIN_LOCALIZATION_TO_LYSOSOME	16	1.1215633	0.32105264	0.7223469	0.4139292	-1.8291974
GO_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS	c5.BP_ GO biological process	17	-0.7075249	0.86834735	0.9822312	GO_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS	19	1.1971022	0.24289405	0.5967387	0.4895773	-1.9046271
GO_REGULATION_OF_HISTONE_H3_K4_METHYLATION	c5.BP_ GO biological process	23	-0.70675826	0.91764706	0.9824103	GO_REGULATION_OF_HISTONE_H3_K4_METHYLATION	24	-0.9644671	0.507772	0.73620874	-1.67122536	0.25770884
GCM_CHUK	c4.CGN_ cancer gene neighborhoods	65	-0.7052982	0.9785408	0.9829484	GCM_CHUK	65	-1.341638	0.024390243	0.24756518	-2.0469362	0.6363398
REACTOME_PERK_REGULATED_GENE_EXPRESSION	c2.CP_REACTOME_ Reactome gene sets	24	-0.7046559	0.90886074	0.9830432	REACTOME_PERK_REGULATED_GENE_EXPRESSION	24	-1.4672052	0.036649216	0.16367322	-2.1718611	0.7625493
GO_RAN_GTPASE_BINDING	c5.GO molecular function	30	-0.7043471	0.9189189	0.9829856	GO_RAN_GTPASE_BINDING	30	-1.898266	0	0.017967317	-2.6026131	1.1939189
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	c2.CGP_ chemical and genetic perturbations	29	-0.7043188	0.9347181	0.9827604	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	29	-0.80611736	0.7745665	0.9000698	-1.51043616	0.10179856
GO_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE	c5.CC_ GO cellular component	24	-0.7039494	0.8978979	0.98270696	GO_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE	24	0.81173813	0.73006135	1	0.10778873	-1.51568753
GO_HISTONE_DEACETYLASE_COMPLEX	c5.CC_ GO cellular component	58	-0.7022171	0.9925926	0.983337	GO_HISTONE_DEACETYLASE_COMPLEX	58	0.8709938	0.6959911	1	0.1687767	-1.5732109
GNF2_PTPN6	c4.CGN_ cancer gene neighborhoods	36	-0.7008205	0.94736844	0.9838352	GNF2_PTPN6	35	1.0512905	0.38224852	0.8375341	0.35047	-1.752111
GO_PEPTIDASE_ACTIVATOR_ACTIVITY	c5.GO molecular function	34	-0.69948167	0.95757574	0.98424596	GO_PEPTIDASE_ACTIVATOR_ACTIVITY	34	0.5925201	0.96522784	1	-0.10696157	-1.29200177
GO_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY	c5.BP_ GO biological process	20	-0.69900656	0.90136987	0.98422885	GO_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY	21	1.1572782	0.26785713	0.6581299	0.45827164	-1.85628476
GO_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE	c5.BP_ GO biological process	19	-0.69844395	0.8763441	0.9842662	GO_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE	19	-0.90385294	0.5854701	0.81613564	-1.60229689	0.20540899
GO_TELENCEPHALON_GLIAL_CELL_MIGRATION	c5.BP_ GO biological process	18	-0.6974682	0.8989899	0.9845083	GO_TELENCEPHALON_GLIAL_CELL_MIGRATION	18	0.8971493	0.6264591	1	0.1996811	-1.5946175
GO_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER	c5.BP_ GO biological process	28	-0.6961732	0.937677	0.98487663	GO_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER	28	-0.7913571	0.81182796	0.91380566	-1.4875303	0.0951839
GO_GRANULOCYTE_ACTIVATION	c5.BP_ GO biological process	15	-0.6929392	0.9232804	0.9861266	GO_GRANULOCYTE_ACTIVATION	15	0	0	0	-0.6929392	-0.6929392
CHR15Q11	C1: positional gene sets	24	-0.6928774	0.9174312	0.985913	CHR15Q11	26	1.0678627	0.38519448	0.8093532	0.3749853	-1.7607401
MEISSNER_NPC_ICP_WITH_H3K4ME3	c2.CGP_ chemical and genetic perturbations	16	-0.6907088	0.8983957	0.9866524	MEISSNER_NPC_ICP_WITH_H3K4ME3	16	-0.59646267	0.94331986	0.9864308	-1.28717147	-0.09424613
GO_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION	c5.BP_ GO biological process	28	-0.68558556	0.9721362	0.98868966	GO_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION	27	0.5690244	0.9815043	1	-0.11656116	-1.25460996
ST_INTERLEUKIN_4_PATHWAY	c2.CP_ Canonical pathways	23	-0.6847664	0.918239	0.98881006	ST_INTERLEUKIN_4_PATHWAY	24	1.4927039	0.031707317	0.2574719	0.8079375	-2.1774703
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY	c2.CP_ Canonical pathways	35	-0.68395054	0.962963	0.98890084	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY	35	1.0042248	0.48402366	0.91663593	0.32027426	-1.68817534
GNF2_SELL	c4.CGN_ cancer gene neighborhoods	40	-0.6838439	0.9904762	0.9887022	GNF2_SELL	38	1.0295824	0.432243	0.8758577	0.3457385	-1.7134263
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS	c2.CP_REACTOME_ Reactome gene sets	23	-0.68326557	0.92391306	0.9887024	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS	23	-0.8761053	0.6576577	0.8471932	-1.55937087	0.19283973
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER	c2.CP_REACTOME_ Reactome gene sets	19	-0.68229103	0.90909094	0.9888487	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER	19	-0.7512539	0.8448276	0.9386013	-1.43354493	0.06896287
GO_ALDITOL_PHOSPHATE_METABOLIC_PROCESS	c5.BP_ GO biological process	29	-0.6819621	0.9522388	0.9887401	GO_ALDITOL_PHOSPHATE_METABOLIC_PROCESS	35	1.2461705	0.14868106	0.5168901	0.5642084	-1.9281326
GNF2_CD7	c4.CGN_ cancer gene neighborhoods	25	-0.680828	0.9226006	0.98895824	GNF2_CD7	27	-0.98308945	0.47027028	0.7101355	-1.66391745	0.30226145
GCM_TEC	c4.CGN_ cancer gene neighborhoods	26	-0.68041867	0.96460176	0.988882	GCM_TEC	30	0.77633244	0.80458385	1	0.09591377	-1.45675111
GO_PORE_COMPLEX_ASSEMBLY	c5.BP_ GO biological process	15	-0.6802838	0.9191375	0.9886827	GO_PORE_COMPLEX_ASSEMBLY	15	0.78140867	0.76592976	1	0.10112487	-1.46169247
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	c2.CGP_ chemical and genetic perturbations	120	-0.6773339	1	0.989606	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	121	-0.7774814	0.974359	0.9232304	-1.4548153	0.1001475
KEGG_NUCLEOTIDE_EXCISION_REPAIR	c2.CP_BIOCARTA_ BioCarta gene sets	41	-0.67711836	0.9669967	0.9894494	KEGG_NUCLEOTIDE_EXCISION_REPAIR	41	-1.1390764	0.25185186	0.45859912	-1.81619476	0.46195804
REACTOME_SYNTHESIS_OF_PC	c2.CP_REACTOME_ Reactome gene sets	18	-0.67677665	0.9281768	0.98932767	REACTOME_SYNTHESIS_OF_PC	18	0.91360146	0.61941254	1	0.23682481	-1.59037811
GO_POSITIVE_REGULATION_OF_LIPID_STORAGE	c5.BP_ GO biological process	19	-0.6756421	0.93850267	0.9895348	GO_POSITIVE_REGULATION_OF_LIPID_STORAGE	17	0.9404664	0.5644737	0.9897613	0.2648243	-1.6161085
GO_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR	c5.BP_ GO biological process	18	-0.67552346	0.9230769	0.98934126	GO_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR	18	-0.86736524	0.6445498	0.8547966	-1.5428887	0.19184178
GNF2_RPA1	c4.CGN_ cancer gene neighborhoods	27	-0.67463505	0.9470588	0.9894402	GNF2_RPA1	27	-2.1869903	0	0.000875949	-2.86162535	1.51235525
GO_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING	c5.GO molecular function	27	-0.6729122	0.9459459	0.9898291	GO_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING	29	1.1108389	0.32853717	0.736006	0.4379267	-1.7837511
BIOCARTA_IGF1MTOR_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	20	-0.67290807	0.9327731	0.98959035	BIOCARTA_IGF1MTOR_PATHWAY	20	0.692062	0.88688946	1	0.01915393	-1.36497007
MORF_SS18	c4.CGN_ cancer gene neighborhoods	58	-0.67289275	0.9815498	0.9893538	MORF_SS18	58	0.7915462	0.81718063	1	0.11865345	-1.46443895
GO_REGULATION_OF_PROTEIN_HOMODIMERIZATION_ACTIVITY	c5.BP_ GO biological process	20	-0.6726471	0.91780823	0.98919755	GO_REGULATION_OF_PROTEIN_HOMODIMERIZATION_ACTIVITY	20	0.6871857	0.87435234	1	0.0145386	-1.3598328
GO_ERBB_SIGNALING_PATHWAY	c5.BP_ GO biological process	73	-0.6671486	0.99593496	0.99091715	GO_ERBB_SIGNALING_PATHWAY	74	1.0808707	0.3390558	0.78570837	0.4137221	-1.7480193
CTCTAGA_MIR526C_MIR518F_MIR526A	c3.MIR_ microRNA targets	51	-0.666483	0.98402554	0.99091923	CTCTAGA_MIR526C_MIR518F_MIR526A	52	1.0303016	0.4147157	0.875189	0.3638186	-1.6967846
REACTOME_ACTIVATION_OF_GENES_BY_ATF4	c2.CP_REACTOME_ Reactome gene sets	21	-0.6609172	0.94101125	0.99254286	REACTOME_ACTIVATION_OF_GENES_BY_ATF4	21	-1.3754402	0.07526882	0.22376323	-2.0363574	0.714523
WANG_RESPONSE_TO_ANDROGEN_UP	c2.CGP_ chemical and genetic perturbations	24	-0.6606926	0.9682081	0.99236405	WANG_RESPONSE_TO_ANDROGEN_UP	25	-0.9668259	0.535	0.7339955	-1.6275185	0.3061333
KEGG_PRION_DISEASES	c2.CP_BIOCARTA_ BioCarta gene sets	29	-0.66056305	0.975	0.99216175	KEGG_PRION_DISEASES	30	1.3227551	0.10221675	0.41166198	0.66219205	-1.98331815
DORSAM_HOXA9_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	33	-0.66017246	0.97947216	0.9920502	DORSAM_HOXA9_TARGETS_UP	33	-1.0099581	0.4251497	0.6729177	-1.67013056	0.34978564
CHR4Q24	C1: positional gene sets	17	-0.6590125	0.92411923	0.9921641	CHR4Q24	17	-1.2723393	0.1585903	0.30903554	-1.9313518	0.6133268
GO_REGULATION_OF_ISOTYPE_SWITCHING	c5.BP_ GO biological process	19	-0.6585677	0.934555	0.99207294	GO_REGULATION_OF_ISOTYPE_SWITCHING	21	-1.2749342	0.14285715	0.30660936	-1.9335019	0.6163665
GCM_NUMA1	c4.CGN_ cancer gene neighborhoods	51	-0.6565158	0.99646646	0.99247825	GCM_NUMA1	51	0.5612175	0.9874715	1	-0.0952983	-1.2177333
GCM_DENR	c4.CGN_ cancer gene neighborhoods	43	-0.6546399	0.9935484	0.9928329	GCM_DENR	43	-1.0960741	0.25179857	0.52361846	-1.750714	0.4414342
GO_EXCITATORY_POSTSYNAPTIC_POTENTIAL	c5.BP_ GO biological process	26	-0.65232044	0.96657383	0.9932825	GO_EXCITATORY_POSTSYNAPTIC_POTENTIAL	27	1.296971	0.13725491	0.44715327	0.64465056	-1.94929144
GCM_CSNK1D	c4.CGN_ cancer gene neighborhoods	28	-0.6521453	0.97183096	0.99309456	GCM_CSNK1D	28	-0.987067	0.48241207	0.7059004	-1.6392123	0.3349217
FINETTI_BREAST_CANCERS_KINOME_GRAY	c2.CGP_ chemical and genetic perturbations	15	-0.6519759	0.9369863	0.9929013	FINETTI_BREAST_CANCERS_KINOME_GRAY	15	-0.5940492	0.9640288	0.9866373	-1.2460251	-0.0579267
PID_LKB1_PATHWAY	c2.CP_ Canonical pathways	44	-0.6511664	0.99335545	0.99290085	PID_LKB1_PATHWAY	44	-0.91005	0.6439394	0.8085542	-1.5612164	0.2588836
REACTOME_EGFR_DOWNREGULATION	c2.CP_REACTOME_ Reactome gene sets	22	-0.64838153	0.93732196	0.9934395	REACTOME_EGFR_DOWNREGULATION	22	1.331085	0.11435832	0.40036693	0.68270347	-1.97946653
GO_BETA_TUBULIN_BINDING	c5.GO molecular function	33	-0.64784855	0.9631728	0.99334043	GO_BETA_TUBULIN_BINDING	34	1.0404136	0.41306883	0.85864854	0.39256505	-1.68826215
CHR7Q35	C1: positional gene sets	24	-0.64575434	0.96703297	0.99367094	CHR7Q35	25	-0.9157752	0.54395604	0.8014923	-1.56152954	0.27002086
GTCTACC_MIR379	c3.MIR_ microRNA targets	19	-0.6455611	0.94647884	0.9934812	GTCTACC_MIR379	19	-0.82251865	0.7355769	0.8879346	-1.46807975	0.17695755
BIOCARTA_ACTINY_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	19	-0.6451495	0.96629214	0.9933535	BIOCARTA_ACTINY_PATHWAY	19	-0.8215967	0.7641509	0.88879716	-1.4667462	0.1764472
PID_ARF6_DOWNSTREAM_PATHWAY	c2.CP_ Canonical pathways	15	-0.6425737	0.9248705	0.9937875	PID_ARF6_DOWNSTREAM_PATHWAY	15	1.076282	0.38722295	0.7944759	0.4337083	-1.7188557
GO_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT	c5.BP_ GO biological process	68	-0.6421535	1	0.9936534	GO_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT	68	-0.98497885	0.4477612	0.70657456	-1.62713235	0.34282535
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	c2.CP_REACTOME_ Reactome gene sets	50	-0.63849854	0.99044585	0.9943402	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	50	-2.096442	0	0.002962608	-2.73494054	1.45794346
GO_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX	c5.CC_ GO cellular component	18	-0.63788444	0.96100277	0.99426115	GO_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX	19	1.2716372	0.16153847	0.48373207	0.63375276	-1.90952164
GO_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE	c5.BP_ GO biological process	15	-0.6375021	0.91939545	0.9941097	GO_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE	16	0.64569974	0.90208876	1	0.00819764	-1.28320184
GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE	c5.BP_ GO biological process	29	-0.6363641	0.98083067	0.994152	GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE	29	1.052893	0.41240877	0.83619654	0.4165289	-1.6892571
GO_SYNTAXIN_1_BINDING	c5.GO molecular function	18	-0.63417697	0.95555556	0.9944315	GO_SYNTAXIN_1_BINDING	18	0.8189087	0.7431421	1	0.18473173	-1.45308567
GO_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT	c5.BP_ GO biological process	23	-0.6337482	0.9820896	0.99428344	GO_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT	25	1.1416011	0.28325123	0.6874797	0.5078529	-1.7753493
NICK_RESPONSE_TO_PROC_TREATMENT_DN	c2.CGP_ chemical and genetic perturbations	22	-0.6330527	0.9747191	0.99421215	NICK_RESPONSE_TO_PROC_TREATMENT_DN	22	-0.49579114	1	0.99172467	-1.12884384	-0.13726156
PID_CD40_PATHWAY	c2.CP_ Canonical pathways	29	-0.6325161	0.973913	0.99409676	PID_CD40_PATHWAY	30	0.7390981	0.85406697	1	0.106582	-1.3716142
GO_STEROID_CATABOLIC_PROCESS	c5.BP_ GO biological process	20	-0.6316023	0.968	0.99406266	GO_STEROID_CATABOLIC_PROCESS	21	1.140808	0.3117207	0.6889526	0.5092057	-1.7724103
GO_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS	c5.BP_ GO biological process	20	-0.62812436	0.95095366	0.9946009	GO_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS	20	1.1391461	0.2825521	0.6912186	0.51102174	-1.76727046
GO_NUCLEAR_PORE	c5.CC_ GO cellular component	68	-0.625859	0.996124	0.99484545	GO_NUCLEAR_PORE	69	-1.5478721	0.013157895	0.116491966	-2.1737311	0.9220131
GO_MONOVALENT_INORGANIC_ANION_HOMEOSTASIS	c5.BP_ GO biological process	16	-0.62538916	0.9467787	0.9947043	GO_MONOVALENT_INORGANIC_ANION_HOMEOSTASIS	18	1.741492	0	0.06575021	1.11610284	-2.36688116
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	c2.CGP_ chemical and genetic perturbations	21	-0.6252612	0.9677419	0.9944909	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	22	1.0371345	0.42409638	0.8639208	0.4118733	-1.6623957
GO_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR	c5.BP_ GO biological process	16	-0.6239456	0.9463277	0.9945165	GO_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR	16	0.9152673	0.58670145	1	0.2913217	-1.5392129
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	c2.CGP_ chemical and genetic perturbations	30	-0.61736643	0.9703264	0.995613	CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	32	-0.863495	0.70469797	0.8572414	-1.48086143	0.24612857
KEGG_BASAL_TRANSCRIPTION_FACTORS	c2.CP_BIOCARTA_ BioCarta gene sets	33	-0.61542064	0.9909366	0.995722	KEGG_BASAL_TRANSCRIPTION_FACTORS	33	0.99340284	0.4806565	0.9308832	0.3779822	-1.60882348
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	c2.CGP_ chemical and genetic perturbations	17	-0.61341393	0.952	0.9958325	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	18	0.8680473	0.6597938	1	0.25463337	-1.48146123
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	c2.CP_REACTOME_ Reactome gene sets	24	-0.60949504	0.97626114	0.9963089	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	25	0.61486036	0.9500609	1	0.00536532	-1.2243554
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	15	-0.60787714	0.96568626	0.9963472	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	16	0.7507776	0.7950392	1	0.14290046	-1.35865474
GO_AXONEME_PART	c5.CC_ GO cellular component	20	-0.60753447	0.99206346	0.996172	GO_AXONEME_PART	20	1.1543089	0.2690815	0.6623893	0.54677443	-1.76184337
BIOCARTA_STRESS_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	25	-0.60573304	0.98044693	0.9962185	BIOCARTA_STRESS_PATHWAY	24	0.97859025	0.5226438	0.9511921	0.37285721	-1.58432329
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	c2.CP_REACTOME_ Reactome gene sets	20	-0.60214275	0.9708223	0.9965455	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	21	0.955658	0.54770756	0.97599643	0.35351525	-1.55780075
GNF2_RAP1B	c4.CGN_ cancer gene neighborhoods	28	-0.5997991	0.98165137	0.9966585	GNF2_RAP1B	28	0.91762954	0.6022032	1	0.31783044	-1.51742864
GO_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	28	-0.5924466	0.9883721	0.9974735	GO_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	29	0.9034698	0.6259169	1	0.3110232	-1.4959164
GO_REGULATION_OF_PROTEIN_SUMOYLATION	c5.BP_ GO biological process	18	-0.5830635	0.9722222	0.9984427	GO_REGULATION_OF_PROTEIN_SUMOYLATION	18	1.1504822	0.301423	0.6684214	0.5674187	-1.7335457
CHR2Q12	C1: positional gene sets	33	-0.5828459	0.99376947	0.9982305	CHR2Q12	34	0.9547248	0.55726093	0.9764605	0.3718789	-1.5375707
GO_MRNA_TRANSCRIPTION	c5.BP_ GO biological process	20	-0.5818572	0.9790026	0.99810416	GO_MRNA_TRANSCRIPTION	21	-0.94493306	0.5322581	0.76262164	-1.52679026	0.36307586
IKEDA_MIR133_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	41	-0.5735214	1	0.99878573	IKEDA_MIR133_TARGETS_UP	41	0.7145866	0.894186	1	0.1410652	-1.288108
CHR2P14	C1: positional gene sets	21	-0.57049024	0.99210525	0.9988591	CHR2P14	23	-0.9907598	0.47058824	0.701649	-1.56125004	0.42026956
REACTOME_DEFENSINS	c2.CP_REACTOME_ Reactome gene sets	17	-0.5684884	0.98356164	0.9988072	REACTOME_DEFENSINS	22	-1.1452588	0.25438598	0.44982114	-1.7137472	0.5767704
GO_HISTONE_H3_DEACETYLATION	c5.BP_ GO biological process	22	-0.562482	0.9971831	0.99913806	GO_HISTONE_H3_DEACETYLATION	22	-0.68860316	0.9103139	0.9659451	-1.25108516	0.12612116
MODULE_86	c4.CM_ cancer modules	39	-0.5623655	0.9967742	0.9989078	MODULE_86	39	-1.1738025	0.19285715	0.41292313	-1.736168	0.611437
GOLUB_ALL_VS_AML_DN	c2.CGP_ chemical and genetic perturbations	21	-0.55974114	0.9886364	0.9988841	GOLUB_ALL_VS_AML_DN	22	1.3696777	0.08554217	0.36852854	0.80993656	-1.92941884
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS	c5.BP_ GO biological process	33	-0.5548225	0.9944904	0.9990241	GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS	34	0.7446893	0.85189575	1	0.1898668	-1.2995118
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	c2.CP_REACTOME_ Reactome gene sets	31	-0.54448915	0.997006	0.99955136	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	31	-1.8283195	0	0.028047863	-2.37280865	1.28383035
GO_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING	c5.BP_ GO biological process	20	-0.54157585	0.98245615	0.99950814	GO_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING	20	-0.989476	0.44927537	0.70300126	-1.53105185	0.44790015
GO_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR	c5.BP_ GO biological process	20	-0.5384658	0.9893617	0.9994691	GO_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR	20	0.8872295	0.6462141	1	0.3487637	-1.4256953
GO_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEIN_CATABOLIC_PROCESS	c5.BP_ GO biological process	15	-0.52862275	0.99208444	0.99978405	GO_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEIN_CATABOLIC_PROCESS	15	0.5019266	0.98558325	1	-0.02669615	-1.03054935
GO_BILE_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	18	-0.5187307	0.9918478	1	GO_BILE_ACID_BIOSYNTHETIC_PROCESS	19	1.2550231	0.16305733	0.50240064	0.7362924	-1.7737538
GO_PHAGOSOME_ACIDIFICATION	c5.BP_ GO biological process	24	-0.50714564	0.99701494	1	GO_PHAGOSOME_ACIDIFICATION	26	0.5870141	0.9687109	1	0.07986846	-1.09415974
GO_PROTEIN_ADP_RIBOSYLATION	c5.BP_ GO biological process	20	-0.50580966	0.99723756	1	GO_PROTEIN_ADP_RIBOSYLATION	20	0.777225	0.7942708	1	0.27141534	-1.28303466
CHR13Q32	C1: positional gene sets	26	-0.50222325	1	0.9999382	CHR13Q32	25	1.2529666	0.16985646	0.5050587	0.75074335	-1.75518985
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	c2.CGP_ chemical and genetic perturbations	15	-0.49743924	0.9887324	0.99985605	HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	16	-0.8328723	0.7113821	0.8803286	-1.33031154	0.33543306
GO_TRNA_TRANSPORT	c5.BP_ GO biological process	32	-0.48861298	1	0.9998602	GO_TRNA_TRANSPORT	32	-1.9690249	0	0.010599745	-2.45763788	1.48041192
GCM_BAG5	c4.CGN_ cancer gene neighborhoods	33	-0.48516262	1	0.9997111	GCM_BAG5	33	-1.2681865	0.11643836	0.30959696	-1.75334912	0.78302388
REACTOME_ZINC_TRANSPORTERS	c2.CP_REACTOME_ Reactome gene sets	15	-0.48405337	0.99759036	0.99949825	REACTOME_ZINC_TRANSPORTERS	15	-0.77447456	0.7896679	0.92497194	-1.25852793	0.29042119
GO_EXON_EXON_JUNCTION_COMPLEX	c5.CC_ GO cellular component	19	-0.48080844	1	0.99933743	GO_EXON_EXON_JUNCTION_COMPLEX	19	-0.8978787	0.60833335	0.82406765	-1.37868714	0.41707026
GO_FLAVONOID_METABOLIC_PROCESS	c5.BP_ GO biological process	15	-0.46554175	0.99749374	0.99940723	GO_FLAVONOID_METABOLIC_PROCESS	16	1.3939694	0.080474935	0.34647644	0.92842765	-1.85951115
GO_PIRNA_METABOLIC_PROCESS	c5.BP_ GO biological process	15	0	0	0	GO_PIRNA_METABOLIC_PROCESS	15	1.7814696	0	0.050349746	1.7814696	-1.7814696
GO_FATTY_ACID_DERIVATIVE_TRANSPORT	c5.BP_ GO biological process	20	0	0	0	GO_FATTY_ACID_DERIVATIVE_TRANSPORT	20	1.7662207	0.002567394	0.05362299	1.7662207	-1.7662207
WEBER_METHYLATED_ICP_IN_FIBROBLAST	c2.CGP_ chemical and genetic perturbations	15	0	0	0	WEBER_METHYLATED_ICP_IN_FIBROBLAST	15	1.6684014	0.001331558	0.09681541	1.6684014	-1.6684014
GO_DETECTION_OF_TEMPERATURE_STIMULUS	c5.BP_ GO biological process	15	0	0	0	GO_DETECTION_OF_TEMPERATURE_STIMULUS	15	1.6266676	0.003963012	0.13440807	1.6266676	-1.6266676
PHESSE_TARGETS_OF_APC_AND_MBD2_UP	c2.CGP_ chemical and genetic perturbations	17	0	0	0	PHESSE_TARGETS_OF_APC_AND_MBD2_UP	17	1.584151	0.007926024	0.17531799	1.584151	-1.584151
GO_XY_BODY	c5.CC_ GO cellular component	15	0	0	0	GO_XY_BODY	15	1.5692636	0.016107382	0.18957959	1.5692636	-1.5692636
GO_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION	c5.BP_ GO biological process	15	0	0	0	GO_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION	15	1.5357407	0.01997337	0.21659493	1.5357407	-1.5357407
MODULE_368	c4.CM_ cancer modules	15	0	0	0	MODULE_368	15	1.518898	0.02110818	0.23674542	1.518898	-1.518898
GO_INOSITOL_PHOSPHATE_MEDIATED_SIGNALING	c5.BP_ GO biological process	17	0	0	0	GO_INOSITOL_PHOSPHATE_MEDIATED_SIGNALING	17	1.5160283	0.022368422	0.23526677	1.5160283	-1.5160283
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	c2.CP_REACTOME_ Reactome gene sets	16	0	0	0	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	16	1.4852339	0.038512617	0.26515815	1.4852339	-1.4852339
GO_MEMBRANE_RAFT_ORGANIZATION	c5.BP_ GO biological process	16	0	0	0	GO_MEMBRANE_RAFT_ORGANIZATION	16	1.4766406	0.030503979	0.27175096	1.4766406	-1.4766406
GO_SODIUM_CHANNEL_COMPLEX	c5.CC_ GO cellular component	17	0	0	0	GO_SODIUM_CHANNEL_COMPLEX	17	1.4677789	0.028277636	0.2766289	1.4677789	-1.4677789
KEGG_GRAFT_VERSUS_HOST_DISEASE	c2.CP_BIOCARTA_ BioCarta gene sets	21	0	0	0	KEGG_GRAFT_VERSUS_HOST_DISEASE	21	1.4500012	0.036432162	0.291097	1.4500012	-1.4500012
GO_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION	c5.BP_ GO biological process	15	0	0	0	GO_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION	15	1.4468446	0.037433155	0.29496938	1.4468446	-1.4468446
GO_NARROW_PORE_CHANNEL_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_NARROW_PORE_CHANNEL_ACTIVITY	15	1.4442341	0.0501355	0.2990569	1.4442341	-1.4442341
REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	c2.CP_REACTOME_ Reactome gene sets	15	0	0	0	REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	15	1.4262103	0.060288336	0.31804842	1.4262103	-1.4262103
GO_REGULATION_OF_INTERLEUKIN_8_SECRETION	c5.BP_ GO biological process	16	0	0	0	GO_REGULATION_OF_INTERLEUKIN_8_SECRETION	16	1.4253496	0.07608695	0.3191228	1.4253496	-1.4253496
GO_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION	c5.BP_ GO biological process	15	0	0	0	GO_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION	15	1.4174021	0.058900524	0.32040244	1.4174021	-1.4174021
GO_MALE_MEIOSIS_I	c5.BP_ GO biological process	16	0	0	0	GO_MALE_MEIOSIS_I	16	1.4090627	0.083333336	0.32775885	1.4090627	-1.4090627
GO_ESTABLISHMENT_OF_TISSUE_POLARITY	c5.BP_ GO biological process	16	0	0	0	GO_ESTABLISHMENT_OF_TISSUE_POLARITY	16	1.3937638	0.08256881	0.3460491	1.3937638	-1.3937638
CHR7P12	C1: positional gene sets	15	0	0	0	CHR7P12	15	1.3857224	0.07908847	0.35071734	1.3857224	-1.3857224
GO_RETINOL_DEHYDROGENASE_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_RETINOL_DEHYDROGENASE_ACTIVITY	15	1.3788314	0.06997456	0.3552269	1.3788314	-1.3788314
GO_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	0	0	0	GO_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS	15	1.3773164	0.071614586	0.35751802	1.3773164	-1.3773164
NIELSEN_LIPOSARCOMA_UP	c2.CGP_ chemical and genetic perturbations	16	0	0	0	NIELSEN_LIPOSARCOMA_UP	16	1.3711386	0.09986505	0.36764452	1.3711386	-1.3711386
BIOCARTA_COMP_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	0	0	0	BIOCARTA_COMP_PATHWAY	16	1.360563	0.08778626	0.377183	1.360563	-1.360563
GO_INORGANIC_ION_IMPORT_INTO_CELL	c5.BP_ GO biological process	15	0	0	0	GO_INORGANIC_ION_IMPORT_INTO_CELL	15	1.356126	0.0978836	0.38099822	1.356126	-1.356126
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	c2.CGP_ chemical and genetic perturbations	16	0	0	0	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	16	1.3540995	0.09833972	0.38350376	1.3540995	-1.3540995
GO_REGULATION_OF_INTERLEUKIN_13_PRODUCTION	c5.BP_ GO biological process	15	0	0	0	GO_REGULATION_OF_INTERLEUKIN_13_PRODUCTION	15	1.3446882	0.105614975	0.38966742	1.3446882	-1.3446882
MODULE_431	c4.CM_ cancer modules	15	0	0	0	MODULE_431	15	1.3384392	0.104	0.39714223	1.3384392	-1.3384392
GO_NITRIC_OXIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	15	0	0	0	GO_NITRIC_OXIDE_METABOLIC_PROCESS	15	1.3313997	0.13060686	0.40028873	1.3313997	-1.3313997
MODULE_267	c4.CM_ cancer modules	15	0	0	0	MODULE_267	15	1.3283094	0.11914324	0.40308005	1.3283094	-1.3283094
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	c2.CGP_ chemical and genetic perturbations	15	0	0	0	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15	1.3218894	0.1185372	0.41099703	1.3218894	-1.3218894
GENTLES_LEUKEMIC_STEM_CELL_DN	c2.CGP_ chemical and genetic perturbations	15	0	0	0	GENTLES_LEUKEMIC_STEM_CELL_DN	15	1.3193777	0.1305483	0.41327426	1.3193777	-1.3193777
KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION	c2.CGP_ chemical and genetic perturbations	15	0	0	0	KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION	15	1.3172653	0.13350785	0.41533318	1.3172653	-1.3172653
GO_NEGATIVE_REGULATION_OF_TISSUE_REMODELING	c5.BP_ GO biological process	15	0	0	0	GO_NEGATIVE_REGULATION_OF_TISSUE_REMODELING	15	1.3012594	0.14304636	0.4393806	1.3012594	-1.3012594
GO_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT	c5.BP_ GO biological process	16	0	0	0	GO_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT	16	1.2970544	0.14795244	0.44706818	1.2970544	-1.2970544
GO_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING	c5.BP_ GO biological process	16	0	0	0	GO_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING	16	1.288553	0.15575916	0.46039304	1.288553	-1.288553
REACTOME_INTRINSIC_PATHWAY	c2.CP_REACTOME_ Reactome gene sets	16	0	0	0	REACTOME_INTRINSIC_PATHWAY	16	1.2812424	0.15727392	0.47096294	1.2812424	-1.2812424
GO_CATION_AMINO_ACID_SYMPORTER_ACTIVITY	c5.GO molecular function	16	0	0	0	GO_CATION_AMINO_ACID_SYMPORTER_ACTIVITY	16	1.2811593	0.16162944	0.4710582	1.2811593	-1.2811593
GO_ARGININE_METABOLIC_PROCESS	c5.BP_ GO biological process	17	0	0	0	GO_ARGININE_METABOLIC_PROCESS	17	1.2758476	0.16710526	0.47953352	1.2758476	-1.2758476
GO_MUSCLE_MYOSIN_COMPLEX	c5.CC_ GO cellular component	16	0	0	0	GO_MUSCLE_MYOSIN_COMPLEX	16	1.2749258	0.14414415	0.4810229	1.2749258	-1.2749258
REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	c2.CP_REACTOME_ Reactome gene sets	16	0	0	0	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	16	1.2678838	0.1684492	0.48667467	1.2678838	-1.2678838
KEGG_ASTHMA	c2.CP_BIOCARTA_ BioCarta gene sets	17	0	0	0	KEGG_ASTHMA	17	1.2642342	0.17716536	0.49103954	1.2642342	-1.2642342
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	c2.CP_BIOCARTA_ BioCarta gene sets	15	0	0	0	KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	15	1.2593796	0.17693315	0.49759278	1.2593796	-1.2593796
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	c2.CGP_ chemical and genetic perturbations	15	0	0	0	NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	15	1.2572943	0.20236531	0.49965686	1.2572943	-1.2572943
GO_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION	c5.BP_ GO biological process	17	0	0	0	GO_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION	17	1.2504793	0.20284238	0.50938445	1.2504793	-1.2504793
GO_REGULATION_OF_EXIT_FROM_MITOSIS	c5.BP_ GO biological process	15	0	0	0	GO_REGULATION_OF_EXIT_FROM_MITOSIS	15	1.2416171	0.19261214	0.5229826	1.2416171	-1.2416171
GO_RESPONSE_TO_FOLIC_ACID	c5.BP_ GO biological process	15	0	0	0	GO_RESPONSE_TO_FOLIC_ACID	15	1.2213216	0.2293578	0.5534803	1.2213216	-1.2213216
GO_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	16	0	0	0	GO_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	16	1.2209204	0.19918145	0.55427635	1.2209204	-1.2209204
GO_DENTATE_GYRUS_DEVELOPMENT	c5.BP_ GO biological process	15	0	0	0	GO_DENTATE_GYRUS_DEVELOPMENT	15	1.2206659	0.22062664	0.5543842	1.2206659	-1.2206659
REACTOME_ACYL_CHAIN_REMODELLING_OF_PI	c2.CP_REACTOME_ Reactome gene sets	15	0	0	0	REACTOME_ACYL_CHAIN_REMODELLING_OF_PI	15	1.2161767	0.2148541	0.5640771	1.2161767	-1.2161767
GO_LIPASE_INHIBITOR_ACTIVITY	c5.GO molecular function	16	0	0	0	GO_LIPASE_INHIBITOR_ACTIVITY	16	1.2094014	0.2141901	0.57788295	1.2094014	-1.2094014
GO_PHOSPHATIDYLCHOLINE_BINDING	c5.GO molecular function	16	0	0	0	GO_PHOSPHATIDYLCHOLINE_BINDING	16	1.2030298	0.22921914	0.5867251	1.2030298	-1.2030298
GO_FATTY_ACID_LIGASE_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_FATTY_ACID_LIGASE_ACTIVITY	15	1.1998717	0.2516469	0.5923929	1.1998717	-1.1998717
GO_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL	c5.BP_ GO biological process	16	0	0	0	GO_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL	16	1.1884991	0.26675603	0.6081896	1.1884991	-1.1884991
GO_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	16	0	0	0	GO_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS	16	1.1826727	0.2527027	0.61885726	1.1826727	-1.1826727
GO_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSPORT	c5.BP_ GO biological process	15	0	0	0	GO_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSPORT	15	1.1792411	0.2348285	0.62335604	1.1792411	-1.1792411
ABE_VEGFA_TARGETS	c2.CGP_ chemical and genetic perturbations	16	0	0	0	ABE_VEGFA_TARGETS	16	1.1746162	0.2757256	0.63056314	1.1746162	-1.1746162
GO_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.BP_ GO biological process	15	0	0	0	GO_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	15	1.1707721	0.27069646	0.63706684	1.1707721	-1.1707721
GO_POSITIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS	c5.BP_ GO biological process	15	0	0	0	GO_POSITIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS	15	1.1643138	0.29366106	0.6465414	1.1643138	-1.1643138
GO_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING	c5.BP_ GO biological process	17	0	0	0	GO_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING	17	1.1631804	0.28112966	0.64778566	1.1631804	-1.1631804
GO_PEPTIDE_ANTIGEN_BINDING	c5.GO molecular function	15	0	0	0	GO_PEPTIDE_ANTIGEN_BINDING	15	1.1430948	0.30779392	0.6840205	1.1430948	-1.1430948
KANG_FLUOROURACIL_RESISTANCE_DN	c2.CGP_ chemical and genetic perturbations	15	0	0	0	KANG_FLUOROURACIL_RESISTANCE_DN	15	1.1212757	0.31007752	0.72175765	1.1212757	-1.1212757
GO_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	17	0	0	0	GO_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY	17	1.1155785	0.34078947	0.7297003	1.1155785	-1.1155785
GO_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	c5.BP_ GO biological process	16	0	0	0	GO_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	16	1.1118286	0.3359894	0.7349075	1.1118286	-1.1118286
BIOCARTA_GATA3_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	0	0	0	BIOCARTA_GATA3_PATHWAY	15	1.0855746	0.37384412	0.77680016	1.0855746	-1.0855746
MURAKAMI_UV_RESPONSE_6HR_DN	c2.CGP_ chemical and genetic perturbations	18	0	0	0	MURAKAMI_UV_RESPONSE_6HR_DN	18	1.082377	0.39655173	0.7832207	1.082377	-1.082377
OZANNE_AP1_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	15	0	0	0	OZANNE_AP1_TARGETS_UP	15	1.0803385	0.3841146	0.7864502	1.0803385	-1.0803385
GO_ACETYLCHOLINE_BINDING	c5.GO molecular function	20	0	0	0	GO_ACETYLCHOLINE_BINDING	20	1.078678	0.38541666	0.78969884	1.078678	-1.078678
LE_SKI_TARGETS_UP	c2.CGP_ chemical and genetic perturbations	15	0	0	0	LE_SKI_TARGETS_UP	15	1.0740874	0.38624337	0.7983261	1.0740874	-1.0740874
MURAKAMI_UV_RESPONSE_1HR_UP	c2.CGP_ chemical and genetic perturbations	15	0	0	0	MURAKAMI_UV_RESPONSE_1HR_UP	15	1.0662955	0.3857729	0.81197315	1.0662955	-1.0662955
GO_MORPHOGENESIS_OF_AN_ENDOTHELIUM	c5.BP_ GO biological process	16	0	0	0	GO_MORPHOGENESIS_OF_AN_ENDOTHELIUM	16	1.0596888	0.43064728	0.82519233	1.0596888	-1.0596888
GO_NOSE_DEVELOPMENT	c5.BP_ GO biological process	15	0	0	0	GO_NOSE_DEVELOPMENT	15	1.0487039	0.43243244	0.84252745	1.0487039	-1.0487039
GO_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION	c5.BP_ GO biological process	16	0	0	0	GO_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION	16	1.0441085	0.4168831	0.8504404	1.0441085	-1.0441085
GO_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS	c5.BP_ GO biological process	17	0	0	0	GO_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS	17	1.0324396	0.4440104	0.8727619	1.0324396	-1.0324396
GO_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY	c5.BP_ GO biological process	15	0	0	0	GO_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY	15	1.0319436	0.42837837	0.87322205	1.0319436	-1.0319436
GO_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING	c5.GO molecular function	15	0	0	0	GO_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING	15	1.0273923	0.42627347	0.88048345	1.0273923	-1.0273923
GO_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY	c5.BP_ GO biological process	16	0	0	0	GO_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY	16	1.026626	0.44750655	0.8818696	1.026626	-1.026626
GO_REGULATION_OF_FATTY_ACID_BETA_OXIDATION	c5.BP_ GO biological process	15	0	0	0	GO_REGULATION_OF_FATTY_ACID_BETA_OXIDATION	15	1.0258031	0.4415243	0.88326347	1.0258031	-1.0258031
GO_NEUROTRANSMITTER_SODIUM_SYMPORTER_ACTIVITY	c5.GO molecular function	18	0	0	0	GO_NEUROTRANSMITTER_SODIUM_SYMPORTER_ACTIVITY	18	1.0226552	0.44545454	0.8866369	1.0226552	-1.0226552
REACTOME_ACYL_CHAIN_REMODELLING_OF_PS	c2.CP_REACTOME_ Reactome gene sets	15	0	0	0	REACTOME_ACYL_CHAIN_REMODELLING_OF_PS	15	1.0202677	0.45927903	0.8912949	1.0202677	-1.0202677
ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE	c2.CGP_ chemical and genetic perturbations	16	0	0	0	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE	16	1.0124794	0.4828496	0.90326273	1.0124794	-1.0124794
GO_VOLTAGE_GATED_ANION_CHANNEL_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_VOLTAGE_GATED_ANION_CHANNEL_ACTIVITY	15	1.0116422	0.4857143	0.9042075	1.0116422	-1.0116422
GO_GABAERGIC_NEURON_DIFFERENTIATION	c5.BP_ GO biological process	15	0	0	0	GO_GABAERGIC_NEURON_DIFFERENTIATION	15	1.0083445	0.47651008	0.911712	1.0083445	-1.0083445
GO_EPITHELIAL_CELL_FATE_COMMITMENT	c5.BP_ GO biological process	15	0	0	0	GO_EPITHELIAL_CELL_FATE_COMMITMENT	15	1.0079287	0.48158255	0.91064763	1.0079287	-1.0079287
REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	c2.CP_REACTOME_ Reactome gene sets	15	0	0	0	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	15	1.0035555	0.48335552	0.9175846	1.0035555	-1.0035555
GO_REGULATION_OF_COLLATERAL_SPROUTING	c5.BP_ GO biological process	16	0	0	0	GO_REGULATION_OF_COLLATERAL_SPROUTING	16	1.0007677	0.5013624	0.9229433	1.0007677	-1.0007677
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	c2.CGP_ chemical and genetic perturbations	15	0	0	0	NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	15	0.9951952	0.5064767	0.9303055	0.9951952	-0.9951952
MODULE_215	c4.CM_ cancer modules	15	0	0	0	MODULE_215	15	0.9889202	0.5115962	0.93650997	0.9889202	-0.9889202
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	c2.CP_REACTOME_ Reactome gene sets	18	0	0	0	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	18	0.9776624	0.49222797	0.95201075	0.9776624	-0.9776624
GO_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS	c5.BP_ GO biological process	16	0	0	0	GO_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS	16	0.97093856	0.52956635	0.96015376	0.97093856	-0.97093856
GO_GLUTATHIONE_PEROXIDASE_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_GLUTATHIONE_PEROXIDASE_ACTIVITY	15	0.9677628	0.5304233	0.9636768	0.9677628	-0.9677628
GO_PHAGOCYTOSIS_RECOGNITION	c5.BP_ GO biological process	19	0	0	0	GO_PHAGOCYTOSIS_RECOGNITION	19	0.957656	0.55739796	0.9744768	0.957656	-0.957656
GO_POST_ANAL_TAIL_MORPHOGENESIS	c5.BP_ GO biological process	17	0	0	0	GO_POST_ANAL_TAIL_MORPHOGENESIS	17	0.95414186	0.54768044	0.97697693	0.95414186	-0.95414186
GO_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING	c5.BP_ GO biological process	17	0	0	0	GO_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING	17	0.9481823	0.5723514	0.98409826	0.9481823	-0.9481823
GO_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY	c5.GO molecular function	17	0	0	0	GO_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY	17	0.94808125	0.5714286	0.9843023	0.94808125	-0.94808125
GO_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION	c5.BP_ GO biological process	17	0	0	0	GO_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION	17	0.94803554	0.54993516	0.98405766	0.94803554	-0.94803554
GO_SERTOLI_CELL_DEVELOPMENT	c5.BP_ GO biological process	15	0	0	0	GO_SERTOLI_CELL_DEVELOPMENT	15	0.9387807	0.5561497	0.9914367	0.9387807	-0.9387807
CHR5Q15	C1: positional gene sets	15	0	0	0	CHR5Q15	15	0.9279102	0.5897772	0.9996786	0.9279102	-0.9279102
GO_ACTIVATION_OF_PROTEIN_KINASE_A_ACTIVITY	c5.BP_ GO biological process	16	0	0	0	GO_ACTIVATION_OF_PROTEIN_KINASE_A_ACTIVITY	16	0.92729205	0.5845347	1	0.92729205	-0.92729205
GO_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION	c5.BP_ GO biological process	15	0	0	0	GO_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION	15	0.9262754	0.586755	1	0.9262754	-0.9262754
PID_LPA4_PATHWAY	c2.CP_ Canonical pathways	15	0	0	0	PID_LPA4_PATHWAY	15	0.9198997	0.60288334	1	0.9198997	-0.9198997
GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL	c5.BP_ GO biological process	17	0	0	0	GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL	17	0.9153067	0.6119593	1	0.9153067	-0.9153067
GO_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY	15	0.9143931	0.59681696	1	0.9143931	-0.9143931
GO_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT	c5.BP_ GO biological process	16	0	0	0	GO_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT	16	0.90650445	0.61182517	1	0.90650445	-0.90650445
MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	c2.CGP_ chemical and genetic perturbations	15	0	0	0	MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	15	0.89926547	0.620506	1	0.89926547	-0.89926547
MODULE_116	c4.CM_ cancer modules	15	0	0	0	MODULE_116	15	0.8957037	0.6230159	1	0.8957037	-0.8957037
REACTOME_ACYL_CHAIN_REMODELLING_OF_PG	c2.CP_REACTOME_ Reactome gene sets	16	0	0	0	REACTOME_ACYL_CHAIN_REMODELLING_OF_PG	16	0.8918568	0.62435895	1	0.8918568	-0.8918568
BIOCARTA_TALL1_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	0	0	0	BIOCARTA_TALL1_PATHWAY	15	0.88913196	0.6289474	1	0.88913196	-0.88913196
BIOCARTA_IL22BP_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	16	0	0	0	BIOCARTA_IL22BP_PATHWAY	16	0.8887503	0.6380208	1	0.8887503	-0.8887503
KEGG_RENIN_ANGIOTENSIN_SYSTEM	c2.CP_BIOCARTA_ BioCarta gene sets	15	0	0	0	KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	0.88585585	0.6151798	1	0.88585585	-0.88585585
GO_CATECHOLAMINE_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	17	0	0	0	GO_CATECHOLAMINE_BIOSYNTHETIC_PROCESS	17	0.88463175	0.6466069	1	0.88463175	-0.88463175
GO_RECEPTOR_AGONIST_ACTIVITY	c5.GO molecular function	16	0	0	0	GO_RECEPTOR_AGONIST_ACTIVITY	16	0.8787658	0.6569149	1	0.8787658	-0.8787658
GO_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	c5.GO molecular function	16	0	0	0	GO_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	16	0.86826056	0.640625	1	0.86826056	-0.86826056
GO_ACID_THIOL_LIGASE_ACTIVITY	c5.GO molecular function	16	0	0	0	GO_ACID_THIOL_LIGASE_ACTIVITY	16	0.86794555	0.66151863	1	0.86794555	-0.86794555
TGCACGA_MIR517A_MIR517C	c3.MIR_ microRNA targets	16	0	0	0	TGCACGA_MIR517A_MIR517C	16	0.86563116	0.6732283	1	0.86563116	-0.86563116
GO_INTRINSIC_COMPONENT_OF_THE_CYTOPLASMIC_SIDE_OF_THE_PLASMA_MEMBRANE	c5.CC_ GO cellular component	15	0	0	0	GO_INTRINSIC_COMPONENT_OF_THE_CYTOPLASMIC_SIDE_OF_THE_PLASMA_MEMBRANE	15	0.84997267	0.69536424	1	0.84997267	-0.84997267
GO_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS	c5.BP_ GO biological process	15	0	0	0	GO_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS	15	0.8492204	0.6921087	1	0.8492204	-0.8492204
GO_PHOSPHATIDYLINOSITOL_PHOSPHATE_KINASE_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_PHOSPHATIDYLINOSITOL_PHOSPHATE_KINASE_ACTIVITY	15	0.8439028	0.68598384	1	0.8439028	-0.8439028
GO_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY	15	0.84361875	0.69559413	1	0.84361875	-0.84361875
BIOCARTA_LONGEVITY_PATHWAY	c2.CP_BIOCARTA_ BioCarta gene sets	15	0	0	0	BIOCARTA_LONGEVITY_PATHWAY	15	0.83713734	0.68839633	1	0.83713734	-0.83713734
CHR18Q23	C1: positional gene sets	15	0	0	0	CHR18Q23	15	0.8336955	0.70068026	1	0.8336955	-0.8336955
MURAKAMI_UV_RESPONSE_24HR	c2.CGP_ chemical and genetic perturbations	18	0	0	0	MURAKAMI_UV_RESPONSE_24HR	18	0.8316662	0.70610684	1	0.8316662	-0.8316662
LOPEZ_EPITHELIOID_MESOTHELIOMA	c2.CGP_ chemical and genetic perturbations	16	0	0	0	LOPEZ_EPITHELIOID_MESOTHELIOMA	16	0.826608	0.7098446	1	0.826608	-0.826608
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	c2.CGP_ chemical and genetic perturbations	15	0	0	0	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	15	0.81738293	0.7415882	1	0.81738293	-0.81738293
GO_SPERM_CAPACITATION	c5.BP_ GO biological process	16	0	0	0	GO_SPERM_CAPACITATION	16	0.80530953	0.7360406	1	0.80530953	-0.80530953
GO_PROTEIN_LOCALIZATION_TO_SYNAPSE	c5.BP_ GO biological process	15	0	0	0	GO_PROTEIN_LOCALIZATION_TO_SYNAPSE	15	0.80097526	0.7342747	1	0.80097526	-0.80097526
GO_GABA_RECEPTOR_COMPLEX	c5.CC_ GO cellular component	18	0	0	0	GO_GABA_RECEPTOR_COMPLEX	18	0.7907578	0.76159793	1	0.7907578	-0.7907578
GO_AMINO_ACID_IMPORT	c5.BP_ GO biological process	15	0	0	0	GO_AMINO_ACID_IMPORT	15	0.7807267	0.7822686	1	0.7807267	-0.7807267
GO_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION	c5.BP_ GO biological process	16	0	0	0	GO_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION	16	0.7768771	0.7727891	1	0.7768771	-0.7768771
ST_G_ALPHA_S_PATHWAY	c2.CP_ Canonical pathways	15	0	0	0	ST_G_ALPHA_S_PATHWAY	15	0.76286227	0.8118421	1	0.76286227	-0.76286227
GO_OTIC_VESICLE_DEVELOPMENT	c5.BP_ GO biological process	15	0	0	0	GO_OTIC_VESICLE_DEVELOPMENT	15	0.73372144	0.8165997	1	0.73372144	-0.73372144
GO_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE	c5.BP_ GO biological process	16	0	0	0	GO_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE	16	0.71760136	0.8403694	1	0.71760136	-0.71760136
GO_RESPONSE_TO_SALT	c5.BP_ GO biological process	15	0	0	0	GO_RESPONSE_TO_SALT	15	0.71354383	0.84575164	1	0.71354383	-0.71354383
GO_SPERMATID_NUCLEUS_DIFFERENTIATION	c5.BP_ GO biological process	17	0	0	0	GO_SPERMATID_NUCLEUS_DIFFERENTIATION	17	0.69587004	0.86760926	1	0.69587004	-0.69587004
GO_CARDIAC_MYOFIBRIL_ASSEMBLY	c5.BP_ GO biological process	15	0	0	0	GO_CARDIAC_MYOFIBRIL_ASSEMBLY	15	0.68641025	0.8777174	1	0.68641025	-0.68641025
WANG_RECURRENT_LIVER_CANCER_DN	c2.CGP_ chemical and genetic perturbations	15	0	0	0	WANG_RECURRENT_LIVER_CANCER_DN	15	0.6797375	0.88282293	1	0.6797375	-0.6797375
GO_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS	c5.BP_ GO biological process	15	0	0	0	GO_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS	15	0.65974575	0.8979866	1	0.65974575	-0.65974575
GO_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN	c5.BP_ GO biological process	15	0	0	0	GO_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN	15	0.6548517	0.9077734	1	0.6548517	-0.6548517
GO_GTP_DEPENDENT_PROTEIN_BINDING	c5.GO molecular function	15	0	0	0	GO_GTP_DEPENDENT_PROTEIN_BINDING	15	0.6521569	0.91298527	1	0.6521569	-0.6521569
GO_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE	c5.BP_ GO biological process	15	0	0	0	GO_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE	15	0.64363784	0.9131016	1	0.64363784	-0.64363784
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	c2.CGP_ chemical and genetic perturbations	16	0	0	0	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	16	0.6434019	0.9146982	1	0.6434019	-0.6434019
GO_NEUROPEPTIDE_BINDING	c5.GO molecular function	19	0	0	0	GO_NEUROPEPTIDE_BINDING	19	0.64062405	0.91320753	1	0.64062405	-0.64062405
GO_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS	c5.BP_ GO biological process	15	0	0	0	GO_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS	15	0.62743026	0.92572945	1	0.62743026	-0.62743026
GO_SOLUTE_PROTON_ANTIPORTER_ACTIVITY	c5.GO molecular function	16	0	0	0	GO_SOLUTE_PROTON_ANTIPORTER_ACTIVITY	16	0.625018	0.9166667	1	0.625018	-0.625018
GO_PARAXIAL_MESODERM_DEVELOPMENT	c5.BP_ GO biological process	16	0	0	0	GO_PARAXIAL_MESODERM_DEVELOPMENT	16	0.6203466	0.9213333	1	0.6203466	-0.6203466
KEGG_PHENYLALANINE_METABOLISM	c2.CP_BIOCARTA_ BioCarta gene sets	17	0	0	0	KEGG_PHENYLALANINE_METABOLISM	17	0.6147196	0.92268044	1	0.6147196	-0.6147196
GO_GRANULOCYTE_DIFFERENTIATION	c5.BP_ GO biological process	15	0	0	0	GO_GRANULOCYTE_DIFFERENTIATION	15	0.55643874	0.969697	1	0.55643874	-0.55643874
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	c2.CGP_ chemical and genetic perturbations	17	0	0	0	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	17	0.55095	0.97269183	1	0.55095	-0.55095
CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	c2.CGP_ chemical and genetic perturbations	15	0	0	0	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	15	0.54171675	0.9790026	1	0.54171675	-0.54171675
HUMMERICH_BENIGN_SKIN_TUMOR_DN	c2.CGP_ chemical and genetic perturbations	15	0	0	0	HUMMERICH_BENIGN_SKIN_TUMOR_DN	15	0.4675676	0.9932705	1	0.4675676	-0.4675676
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	c2.CGP_ chemical and genetic perturbations	16	0	0	0	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	16	-2.2625117	0	0.000409212	-2.2625117	2.2625117
REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT	c2.CP_REACTOME_ Reactome gene sets	16	0	0	0	REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT	16	-1.7469226	0.015810277	0.044529315	-1.7469226	1.7469226
GO_CHEMOKINE_BINDING	c5.GO molecular function	15	0	0	0	GO_CHEMOKINE_BINDING	15	-1.664697	0.024193548	0.06662802	-1.664697	1.664697
GO_T_CELL_LINEAGE_COMMITMENT	c5.BP_ GO biological process	15	0	0	0	GO_T_CELL_LINEAGE_COMMITMENT	15	-1.6031913	0.024193548	0.089711145	-1.6031913	1.6031913
GO_APOPTOTIC_DNA_FRAGMENTATION	c5.BP_ GO biological process	15	0	0	0	GO_APOPTOTIC_DNA_FRAGMENTATION	15	-1.5760915	0.030042918	0.101807244	-1.5760915	1.5760915
GO_REGULATION_OF_MESODERM_DEVELOPMENT	c5.BP_ GO biological process	15	0	0	0	GO_REGULATION_OF_MESODERM_DEVELOPMENT	15	-1.559918	0.066079296	0.109707005	-1.559918	1.559918
GO_MESENCHYMAL_TO_EPITHELIAL_TRANSITION	c5.BP_ GO biological process	15	0	0	0	GO_MESENCHYMAL_TO_EPITHELIAL_TRANSITION	15	-1.4988005	0.0647482	0.14349341	-1.4988005	1.4988005
GO_POSITIVE_REGULATION_OF_DNA_RECOMBINATION	c5.BP_ GO biological process	15	0	0	0	GO_POSITIVE_REGULATION_OF_DNA_RECOMBINATION	15	-1.4548048	0.044247787	0.17022969	-1.4548048	1.4548048
GO_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING	c5.GO molecular function	16	0	0	0	GO_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING	16	-1.3963814	0.08627451	0.20986345	-1.3963814	1.3963814
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	c2.CGP_ chemical and genetic perturbations	17	0	0	0	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	17	-1.3535227	0.09663866	0.24026568	-1.3535227	1.3535227
GO_MRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER	c5.BP_ GO biological process	15	0	0	0	GO_MRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER	15	-1.3265848	0.14693877	0.26033422	-1.3265848	1.3265848
GO_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	0	0	0	GO_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS	15	-1.3184881	0.12601626	0.26851407	-1.3184881	1.3184881
GO_RESPONSE_TO_VITAMIN_E	c5.BP_ GO biological process	15	0	0	0	GO_RESPONSE_TO_VITAMIN_E	15	-1.2856394	0.16226415	0.29724488	-1.2856394	1.2856394
GO_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS	c5.BP_ GO biological process	16	0	0	0	GO_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS	16	-1.2797369	0.15720524	0.30197632	-1.2797369	1.2797369
GO_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING	c5.BP_ GO biological process	16	0	0	0	GO_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING	16	-1.2449406	0.171875	0.32898927	-1.2449406	1.2449406
MODULE_68	c4.CM_ cancer modules	18	0	0	0	MODULE_68	18	-1.172693	0.2603306	0.41342273	-1.172693	1.172693
GO_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS	c5.BP_ GO biological process	18	0	0	0	GO_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS	18	-1.1092064	0.28761062	0.50536186	-1.1092064	1.1092064
GO_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING	c5.BP_ GO biological process	15	0	0	0	GO_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING	15	-1.1071454	0.31601733	0.50707954	-1.1071454	1.1071454
REACTOME_GAP_JUNCTION_ASSEMBLY	c2.CP_REACTOME_ Reactome gene sets	16	0	0	0	REACTOME_GAP_JUNCTION_ASSEMBLY	16	-1.0998192	0.30522087	0.5188846	-1.0998192	1.0998192
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	c2.CGP_ chemical and genetic perturbations	20	0	0	0	MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	20	-1.0788999	0.30660376	0.5534144	-1.0788999	1.0788999
GO_STRUCTURAL_CONSTITUENT_OF_EYE_LENS	c5.GO molecular function	18	0	0	0	GO_STRUCTURAL_CONSTITUENT_OF_EYE_LENS	18	-1.068567	0.2991453	0.5726635	-1.068567	1.068567
GO_JAK_STAT_CASCADE_INVOLVED_IN_GROWTH_HORMONE_SIGNALING_PATHWAY	c5.BP_ GO biological process	15	0	0	0	GO_JAK_STAT_CASCADE_INVOLVED_IN_GROWTH_HORMONE_SIGNALING_PATHWAY	15	-1.0567803	0.34251967	0.5939218	-1.0567803	1.0567803
GO_PROTEIN_HYDROXYLATION	c5.BP_ GO biological process	15	0	0	0	GO_PROTEIN_HYDROXYLATION	15	-1.0352347	0.41255605	0.6298825	-1.0352347	1.0352347
GO_REGULATION_OF_RESPONSE_TO_FOOD	c5.BP_ GO biological process	17	0	0	0	GO_REGULATION_OF_RESPONSE_TO_FOOD	17	-1.0248729	0.40329218	0.6504885	-1.0248729	1.0248729
REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN	c2.CP_REACTOME_ Reactome gene sets	15	0	0	0	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN	15	-1.0245484	0.40711462	0.6507298	-1.0245484	1.0245484
GO_CELLULAR_SODIUM_ION_HOMEOSTASIS	c5.BP_ GO biological process	17	0	0	0	GO_CELLULAR_SODIUM_ION_HOMEOSTASIS	17	-1.0207773	0.3898305	0.6575301	-1.0207773	1.0207773
GO_REGULATION_OF_ACROSOME_REACTION	c5.BP_ GO biological process	15	0	0	0	GO_REGULATION_OF_ACROSOME_REACTION	15	-1.00669	0.41960785	0.67536575	-1.00669	1.00669
GO_RESPONSE_TO_ACIDIC_PH	c5.BP_ GO biological process	16	0	0	0	GO_RESPONSE_TO_ACIDIC_PH	16	-0.9981657	0.45525292	0.6879159	-0.9981657	0.9981657
GO_DNA_BINDING_BENDING	c5.GO molecular function	16	0	0	0	GO_DNA_BINDING_BENDING	16	-0.9856648	0.48636365	0.706674	-0.9856648	0.9856648
GO_REVERSE_CHOLESTEROL_TRANSPORT	c5.BP_ GO biological process	15	0	0	0	GO_REVERSE_CHOLESTEROL_TRANSPORT	15	-0.9803109	0.48497853	0.7133115	-0.9803109	0.9803109
GO_EXODEOXYRIBONUCLEASE_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_EXODEOXYRIBONUCLEASE_ACTIVITY	15	-0.96311444	0.5247934	0.7381536	-0.96311444	0.96311444
GO_STEROL_TRANSPORTER_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_STEROL_TRANSPORTER_ACTIVITY	15	-0.96083885	0.4635193	0.7413291	-0.96083885	0.96083885
GO_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES	c5.BP_ GO biological process	17	0	0	0	GO_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES	17	-0.93635166	0.5217391	0.7763489	-0.93635166	0.93635166
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP	c2.CGP_ chemical and genetic perturbations	15	0	0	0	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP	15	-0.92848504	0.55465585	0.7863115	-0.92848504	0.92848504
GO_NEGATIVE_REGULATION_OF_BEHAVIOR	c5.BP_ GO biological process	16	0	0	0	GO_NEGATIVE_REGULATION_OF_BEHAVIOR	16	-0.925015	0.5365854	0.7888429	-0.925015	0.925015
MODULE_298	c4.CM_ cancer modules	18	0	0	0	MODULE_298	18	-0.90945303	0.5964912	0.8092972	-0.90945303	0.90945303
GO_REGULATION_OF_APPETITE	c5.BP_ GO biological process	20	0	0	0	GO_REGULATION_OF_APPETITE	20	-0.8857664	0.6696833	0.83825153	-0.8857664	0.8857664
GO_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS	c5.BP_ GO biological process	15	0	0	0	GO_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS	15	-0.8810702	0.6229508	0.8432152	-0.8810702	0.8810702
GO_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS	c5.BP_ GO biological process	17	0	0	0	GO_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS	17	-0.8665327	0.64529914	0.85586995	-0.8665327	0.8665327
GO_PHASIC_SMOOTH_MUSCLE_CONTRACTION	c5.BP_ GO biological process	15	0	0	0	GO_PHASIC_SMOOTH_MUSCLE_CONTRACTION	15	-0.85455424	0.6698113	0.8619454	-0.85455424	0.85455424
GO_CYTOPLASMIC_DYNEIN_COMPLEX	c5.CC_ GO cellular component	15	0	0	0	GO_CYTOPLASMIC_DYNEIN_COMPLEX	15	-0.8315095	0.704918	0.8809741	-0.8315095	0.8315095
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	c2.CGP_ chemical and genetic perturbations	17	0	0	0	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	17	-0.7955492	0.7824268	0.9098456	-0.7955492	0.7955492
GO_POTASSIUM_ION_HOMEOSTASIS	c5.BP_ GO biological process	16	0	0	0	GO_POTASSIUM_ION_HOMEOSTASIS	16	-0.7920716	0.77729255	0.91347027	-0.7920716	0.7920716
GO_MANNOSE_BINDING	c5.GO molecular function	16	0	0	0	GO_MANNOSE_BINDING	16	-0.7638171	0.79646015	0.9301573	-0.7638171	0.7638171
GO_GLUCOSYLTRANSFERASE_ACTIVITY	c5.GO molecular function	15	0	0	0	GO_GLUCOSYLTRANSFERASE_ACTIVITY	15	-0.75667334	0.852	0.9354854	-0.75667334	0.75667334
MODULE_539	c4.CM_ cancer modules	16	0	0	0	MODULE_539	16	-0.73442274	0.8647541	0.9446488	-0.73442274	0.73442274
NIELSEN_LEIOMYOSARCOMA_UP	c2.CGP_ chemical and genetic perturbations	15	0	0	0	NIELSEN_LEIOMYOSARCOMA_UP	15	-0.731546	0.85223365	0.946263	-0.731546	0.731546
GO_NEPHRIC_DUCT_DEVELOPMENT	c5.BP_ GO biological process	15	0	0	0	GO_NEPHRIC_DUCT_DEVELOPMENT	15	-0.62695843	0.9117647	0.980705	-0.62695843	0.62695843
GO_RRNA_METHYLATION	c5.BP_ GO biological process	15	0	0	0	GO_RRNA_METHYLATION	15	-0.61711943	0.9162996	0.98182344	-0.61711943	0.61711943
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1	c2.CP_REACTOME_ Reactome gene sets	17	0	0	0	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1	17	-0.5820243	0.9831933	0.98829776	-0.5820243	0.5820243
GO_ENDOLYSOSOME	c5.CC_ GO cellular component	15	0	0	0	GO_ENDOLYSOSOME	15	-0.533482	0.9917355	0.99064493	-0.533482	0.533482
